PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Balakuntla, J; Prabhakara, S; Arakere, G				Balakuntla, Jayanth; Prabhakara, Sushma; Arakere, Gayathri			Novel Rearrangements in the Staphylococcal Cassette Chromosome Mec Type V Elements of Indian ST772 and ST672 Methicillin Resistant Staphylococcus aureus Strains	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; DISEASE CLONE; EMERGENCE; INFECTIONS; GUIDELINES; GENES	Staphylococcus aureus is a commensal gram positive bacteria which causes severe and non severe infections in humans and livestock. In India, ST772 is a dominant and ST672 is an emerging clone of Staphylococcus aureus. Both cause serious human diseases, and carry type V SCCmec elements. The objective of this study was to characterize SCCmec type V elements of ST772 and ST672 because the usual PCR methods did not amplify all primers specific to the type. Whole genome sequencing analysis of seven ST772 and one ST672 S. aureus isolates revealed that the SCCmec elements of six of the ST772 isolates were the smallest of the extant type V elements and in addition have several other novel features. Only one ST772 isolate and the ST672 isolate carried bigger SCCmec cassettes which were composites carrying multiple ccrC genes. These cassettes had some similarities to type V SCCmec element from M013 isolate (ST59) from Taiwan in certain aspects. SCCmec elements of all Indian isolates had an inversion of the mec complex, similar to the bovine SCCmec type X. This study reveals that six out of seven ST772 S. aureus isolates have a novel type V (5C2) SCCmec element while one each of ST772 and ST672 isolates have a composite SCCmec type V element (5C2&5) formed by the integration of type V SCCmec into a MSSA carrying a SCC element, in addition to the mec gene complex inversions and extensive recombinations.	[Balakuntla, Jayanth; Prabhakara, Sushma; Arakere, Gayathri] Indian Inst Sci, Soc Innovat & Dev, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Arakere, G (corresponding author), Indian Inst Sci, Soc Innovat & Dev, Bangalore 560012, Karnataka, India.	gayathri.arakere@gmail.com			Department of Biotechnology [BT/IN/New Indigo/16/GA/2010]; Swedish International Development Agency grant	Department of Biotechnology; Swedish International Development Agency grant	This work has been made possible through a Department of Biotechnology grant (BT/IN/New Indigo/16/GA/2010) and Swedish International Development Agency grant to GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2008, JPN J INFECT DIS, V61, P393; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Brennan GI, 2012, J CLIN MICROBIOL, V50, P841, DOI 10.1128/JCM.06354-11; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chlebowicz MA, 2013, INT J MED MICROBIOL, V303, P422, DOI 10.1016/j.ijmm.2013.05.005; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Golding GR, 2012, J BACTERIOL, V194, P6627, DOI 10.1128/JB.01680-12; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Huang TW, 2012, J BACTERIOL, V194, P1256, DOI 10.1128/JB.06666-11; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Khedkar S, 2012, J BACTERIOL, V194, P6946, DOI 10.1128/JB.01868-12; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Nadig S, 2012, CLIN OPHTHALMOL, V6, P165, DOI 10.2147/OPTH.S23878; Neela Vasanthakumari, 2009, Int J Infect Dis, V13, pe131, DOI 10.1016/j.ijid.2008.07.009; O'Brien FG, 2005, ANTIMICROB AGENTS CH, V49, P5129, DOI 10.1128/AAC.49.12.5129-5132.2005; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Prabhakara S, 2012, J BACTERIOL, V194, P3727, DOI 10.1128/JB.00480-12; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Shambat S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-64; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Yamaguchi T, 2012, JPN J INFECT DIS, V65, P175; Zanger P, 2012, CLIN INFECT DIS, V54, P483, DOI 10.1093/cid/cir822; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2	33	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94293	10.1371/journal.pone.0094293	http://dx.doi.org/10.1371/journal.pone.0094293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722327	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000336909100050
J	Camberg, JL; Viola, MG; Rea, L; Hoskins, JR; Wickner, S				Camberg, Jodi L.; Viola, Marissa G.; Rea, Leslie; Hoskins, Joel R.; Wickner, Sue			Location of Dual Sites in E. coli FtsZ Important for Degradation by ClpXP; One at the C-Terminus and One in the Disordered Linker	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASES; DIVISION PROTEIN FTSZ; ESCHERICHIA-COLI; CYTOSKELETAL PROTEIN; BACTERIAL CYTOKINESIS; BINDING DOMAIN; CHAPERONE CLPX; RECOGNITION; SUBSTRATE; EXPRESSION	ClpXP is a two-component ATP-dependent protease that unfolds and degrades proteins bearing specific recognition signals. One substrate degraded by Escherichia coli ClpXP is FtsZ, an essential cell division protein. FtsZ forms polymers that assemble into a large ring-like structure, termed the Z-ring, during cell division at the site of constriction. The FtsZ monomer is composed of an N-terminal polymerization domain, an unstructured linker region and a C-terminal conserved region. To better understand substrate selection by ClpXP, we engineered FtsZ mutant proteins containing amino acid substitutions or deletions near the FtsZ C-terminus. We identified two discrete regions of FtsZ important for degradation of both FtsZ monomers and polymers by ClpXP in vitro. One region is located 30 residues away from the C-terminus in the unstructured linker region that connects the polymerization domain to the C-terminal region. The other region is near the FtsZ C-terminus and partially overlaps the recognition sites for several other FtsZ-interacting proteins, including MinC, ZipA and FtsA. Mutation of either region caused the protein to be more stable and mutation of both caused an additive effect, suggesting that both regions are important. We also observed that in vitro MinC inhibits degradation of FtsZ by ClpXP, suggesting that some of the same residues in the C-terminal site that are important for degradation by ClpXP are important for binding MinC.	[Camberg, Jodi L.; Rea, Leslie; Hoskins, Joel R.; Wickner, Sue] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Camberg, Jodi L.; Viola, Marissa G.] Univ Rhode Isl, Dept Cell & Mol Biol, Coll Environm & Life Sci, Kingston, RI 02881 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Rhode Island	Camberg, JL (corresponding author), NCI, Mol Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	cambergj@mail.uri.edu; wickners@mail.nih.gov	Camberg, Jodi/AAX-3737-2020		NIH National Cancer Institute, Center for Cancer Research [1ZIABC008710-35]; Rhode Island Foundation Medical Research Fund [20123829]; NATIONAL CANCER INSTITUTE [ZIABC008710] Funding Source: NIH RePORTER	NIH National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rhode Island Foundation Medical Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH National Cancer Institute, Center for Cancer Research (Award #1ZIABC008710-35) and the Rhode Island Foundation Medical Research Fund (Award # #20123829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhakim AH, 2008, MOL CELL, V30, P39, DOI 10.1016/j.molcel.2008.02.013; Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Dougan DA, 2003, MOL CELL; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Feng JY, 2013, J PROTEOME RES, V12, P547, DOI 10.1021/pr300394r; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gardner KAJA, 2013, MOL MICROBIOL, V89, P264, DOI 10.1111/mmi.12279; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100; Park EY, 2007, J MOL BIOL, V367, P514, DOI 10.1016/j.jmb.2007.01.003; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Szeto TH, 2001, J BACTERIOL, V183, P6684, DOI 10.1128/JB.183.22.6684-6687.2001; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Thibault G, 2012, J PHYS CHEM B, V116, P6717, DOI 10.1021/jp212024b; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	48	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94964	10.1371/journal.pone.0094964	http://dx.doi.org/10.1371/journal.pone.0094964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722340	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100147
J	Liu, J; Zhang, GL; Huang, GQ; Li, L; Li, CP; Wang, M; Liang, XY; Xie, D; Yang, CM; Li, Y; Sun, XR; Zhang, HS; Wan, BS; Zhang, WH; Yu, H; Zhang, RY; Yu, YN; Wang, Z; Wang, YY				Liu, Jun; Zhang, Guo-Liang; Huang, Gui-Qin; Li, Li; Li, Chun-Ping; Wang, Mei; Liang, Xiao-Yan; Xie, Di; Yang, Chang-Ming; Li, Yan; Sun, Xiu-Rong; Zhang, Hong-Sen; Wan, Bai-Song; Zhang, Wei-Hua; Yu, Hao; Zhang, Ru-Yang; Yu, Ya-Nan; Wang, Zhong; Wang, Yong-Yan			Therapeutic Effect of Jinzhen Oral Liquid for Hand Foot and Mouth Disease: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							ENTEROVIRUS 71; CLINICAL-FEATURES; PULMONARY-EDEMA; BAICALIN; EPIDEMIC; MANAGEMENT	Background: No specific antiviral agent against hand foot and mouth disease (HFMD) is available for clinical practice today. Objective: To evaluate the efficacy and safety of Jinzhen oral solution in treating uncomplicated HFMD. Methods: In this randomized, double-blind, placebo-controlled trial, 399 children aged 1 to 7 years with laboratory confirmed HFMD were randomized to receive Jinzhen oral liquid or placebo 3 times daily for 7 days with a 3-day follow-up. The primary outcomes were time to the first disappearance of oral ulcers and vesicles on hand or foot and time to the first normalization of temperature (fever clearance). Results: There were 199 children enrolling into the Jinzhen group including 79 with fever and 200 into the placebo group including 93 with fever. Jinzhen reduced the time to the first disappearance of oral ulcers and vesicles on hand or foot to 4.9 days (95% CI, 4.6 to 5.2 days), compared with 5.7 days (95% CI, 5.4 to 6.0 days) in the placebo group (P = 0.0036). The median time of fever clearance was shorter in the 79 children who received Jinzhen (43.41 hrs, 95% CI, 37.05 to 49.76) than that in the 93 children who received placebo (54.92 hrs, 95% CI, 48.16 to 61.68) (P = 0.0161). Moreover, Jinzhen reduced the risk of symptoms by 28.5% compared with placebo (HR, 0.7150, 95% CI, 0.5719 to 0.8940, P = 0.0032). More importantly, treatment failure rate was significantly lower in the Jinzhen group (8.04%) compared with that in the placebo group (15.00%) (P = 0.0434). The incidence of serious adverse events did not differ significantly between the two groups (9 in Jinzhen group vs. 18 in placebo, P = 0.075). Conclusions: Children with HFMD may benefit from Jinzhen oral liquid treatment as compared with placebo.	[Liu, Jun; Yu, Ya-Nan; Wang, Zhong; Wang, Yong-Yan] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Zhang, Guo-Liang] Anhui Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Infect Dis, Hefei, Anhui, Peoples R China; [Huang, Gui-Qin; Sun, Xiu-Rong; Zhang, Hong-Sen] Infect Dis Hosp Cangzhou City, Dept Infect Dis, Cangzhou, Hebei, Peoples R China; [Li, Li; Wang, Mei; Liang, Xiao-Yan; Xie, Di; Yang, Chang-Ming; Li, Yan] Fifth Peoples Hosp Guiyang City, Dept Infect Dis, Guiyang, Guizhou, Peoples R China; [Wan, Bai-Song; Zhang, Wei-Hua] Infect Dis Hosp Tangshan City, Dept Infect Dis, Tangshan, Hebei, Peoples R China; [Yu, Hao; Zhang, Ru-Yang] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; Anhui University of Chinese Medicine; Nanjing Medical University	Wang, Z (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.	zhonw@vip.sina.com; wangyongyan2010@sina.cn	Yu, Yan/GYV-4514-2022; Wang, Zhong/AAY-7574-2020; liang, xiaoyan/GYJ-5006-2022; zhang, weihua/GXV-1334-2022		Traditional Chinese Medicine (TCM) Research Project of TCM Preventing and Curing Infectious Diseases of State Administration of TCM of People's Republic of China [200907001-5]	Traditional Chinese Medicine (TCM) Research Project of TCM Preventing and Curing Infectious Diseases of State Administration of TCM of People's Republic of China	This work was supported by the Traditional Chinese Medicine (TCM) Research Project of TCM Preventing and Curing Infectious Diseases of State Administration of TCM of People's Republic of China [200907001-5](http://www.satcm.gov.cn/). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; China's National Health and Family Planning Commission Office for Disease Control and Prevention National Patriotic Public Health Campaign Office), 2011, OV NAT EP NOT DIS JA; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gao SY, 2009, CHINA MED HERALD, V6, P244; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsieh Chia-Jung, 2007, Clin Mol Allergy, V5, P5, DOI 10.1186/1476-7961-5-5; Kim DS, 2010, PLANTA MED, V76, P678, DOI 10.1055/s-0029-1240649; Li MH, 2009, BRIT J PHARMACOL, V157, P244, DOI 10.1111/j.1476-5381.2009.00139.x; Liu L, 2009, INT IMMUNOPHARMACOL, V9, P1568, DOI 10.1016/j.intimp.2009.09.013; Lu J, 2011, J ETHNOPHARMACOL, V134, P911, DOI 10.1016/j.jep.2011.01.049; [陆权 LU Quan], 2010, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V25, P383; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ministry of Health of P.R.C, DIAGN TREATM GUID HF; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pharmacopoeia Commission of the People's Republic of China, 2010, PHARMACOPOEIA PEOPLE, VI, P829; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Tan LQ, 2011, CHINESE FOREIGN WOME, V19, P300; THOMAS I, 1993, CUTIS, V52, P265; Toida M, 2003, J CLIN LASER MED SUR, V21, P363, DOI 10.1089/104454703322650176; Tsai CC, 2006, NEUROPHARMACOLOGY, V51, P709, DOI 10.1016/j.neuropharm.2006.05.010; Tu XK, 2009, NEUROCHEM RES, V34, P1626, DOI 10.1007/s11064-009-9953-4; Wang SM, 2005, PEDIATR PULM, V39, P219, DOI 10.1002/ppul.20157; Wang Z, 2011, J CLIN PHARMACOL, V51, P1132, DOI 10.1177/0091270010382913; Woo KJ, 2006, IMMUNOBIOLOGY, V211, P359, DOI 10.1016/j.imbio.2006.02.002; Xu G, 2010, BIOL PHARM BULL, V33, P238, DOI 10.1248/bpb.33.238; Yoon SB, 2009, J ETHNOPHARMACOL, V125, P286, DOI 10.1016/j.jep.2009.06.027; Zhang G. L., 2010, CLIN J TRADITIONAL C, V22, P574	30	5	8	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94466	10.1371/journal.pone.0094466	http://dx.doi.org/10.1371/journal.pone.0094466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722423	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100074
J	Kozor, R; Grieve, SM; Buchholz, S; Kaye, S; Darke, S; Bhindi, R; Figtree, GA				Kozor, Rebecca; Grieve, Stuart M.; Buchholz, Stefan; Kaye, Sharlene; Darke, Shane; Bhindi, Ravinay; Figtree, Gemma A.			Regular Cocaine Use Is Associated with Increased Systolic Blood Pressure, Aortic Stiffness and Left Ventricular Mass in Young Otherwise Healthy Individuals	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; MYOCARDIAL INJURY; SELF-REPORT; ABUSE; DYSFUNCTION; AUSTRALIA; SYDNEY; OBESE; MEN	Background: The cardiovascular impact of cocaine use in otherwise healthy individuals who consider themselves `social' users is not well established. Methods/Results: Twenty regular cocaine users and 20 control subjects were recruited by word-of-mouth. Cardiovascular magnetic resonance was performed to assess cardiac and vascular structure and function. Cocaine users had higher systolic blood pressure compared to non-users (134 +/- 11 vs 126 +/- 11 mmHg, p = 0.036), a finding independent of age, body surface area, smoking and alcohol consumption. Cocaine use was associated with increased arterial stiffness - reflected by reduced aortic compliance (1.3 +/- 0.2 vs 1.7 +/- 0.5 cm(2) x 10(2).mmHg(-1), p = 0.004), decreased distensibility (3.8 +/- 0.9 vs 5.1 +/- 1.4 mmHg(-1).10(-3), p = 0.001), increased stiffness index (2.6 +/- 0.6 vs 2.1 +/- 0.6, p = 0.005), and higher pulse wave velocity (5.1 +/- 0.6 vs 4.4 +/- 0.6 m.s(-1), p = 0.001). This change in aortic stiffness was independent of vessel wall thickness. Left ventricular mass was 18% higher in cocaine users (124 +/- 25 vs 105 +/- 16 g, p = 0.01), a finding that was independent of body surface area, and left atrial diameter was larger in the user group than controls (3.8 +/- 0.6 vs 3.5 +/- 0.3 cm, p = 0.04). The increased left ventricular mass, systolic blood pressure and vascular stiffness measures were all associated with duration and/or frequency of cocaine use. No late gadolinium enhancement or segmental wall motion abnormalities were seen in any of the subjects. Conclusions: Compared with the non-user control cohort, cocaine users had increased aortic stiffness and systolic blood pressure, associated with greater left ventricular mass. These measures are all well known risk factors for premature cardiovascular events, highlighting the dangers of cocaine use, even in a `social' setting, and have important public health implications.	[Kozor, Rebecca; Grieve, Stuart M.; Bhindi, Ravinay; Figtree, Gemma A.] Univ Sydney, Kolling Inst Med Res, North Shore Heart Res Grp, Sydney, NSW 2006, Australia; [Kozor, Rebecca; Buchholz, Stefan; Bhindi, Ravinay; Figtree, Gemma A.] Royal N Shore Hosp, Dept Cardiol, Sydney, NSW, Australia; [Grieve, Stuart M.] Univ Sydney, Sydney Med Sch, Sydney Translat Imaging Lab, Sydney, NSW 2006, Australia; [Kaye, Sharlene; Darke, Shane] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; University of Sydney; University of New South Wales Sydney	Figtree, GA (corresponding author), Univ Sydney, Kolling Inst Med Res, North Shore Heart Res Grp, Sydney, NSW 2006, Australia.	gemma.figtree@sydney.edu.au	Kozor, Rebecca/AAG-6610-2021; Grieve, Stuart/A-5093-2012	Kaye, Sharlene/0000-0002-7657-5105; Grieve, Stuart/0000-0002-2712-157X; Kozor, Rebecca/0000-0002-6437-5018	Heart Research Australia	Heart Research Australia	Kozor received a grant from Heart Research Australia (http://www.heartresearch.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquaro GD, 2011, HEART, V97, P2056, DOI 10.1136/hrt.2011.226977; Australian Institute of Health and Welfare, 2010, DRUG STAT SER, V25; BERTOLET BD, 1990, CLIN CARDIOL, V13, P323, DOI 10.1002/clc.4960130505; Bigi MAB, 2008, ECHOCARDIOGR-J CARD, V25, P308, DOI 10.1111/j.1540-8175.2007.00593.x; BOEHRER JD, 1992, J AM COLL CARDIOL, V20, P90, DOI 10.1016/0735-1097(92)90142-A; BRICKNER ME, 1991, CIRCULATION, V84, P1130, DOI 10.1161/01.CIR.84.3.1130; Buchholz S, 2010, EUR HEART J, V31, P1422, DOI 10.1093/eurheartj/ehq036; CHAKKO S, 1992, J AM COLL CARDIOL, V20, P1168, DOI 10.1016/0735-1097(92)90374-V; Chan W, 2012, INTERN MED J, V42, P7, DOI 10.1111/j.1445-5994.2011.02606.x; Cuspidi C, 2009, J HUM HYPERTENS, V23, P728, DOI 10.1038/jhh.2009.16; Daniel JC, 2007, J VASC SURG, V46, P427, DOI 10.1016/j.jvs.2007.05.040; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; Figtree GA, 2011, JACC-CARDIOVASC INTE, V4, P137, DOI 10.1016/j.jcin.2010.09.026; Hando J, 1997, ADDICTION, V92, P173, DOI 10.1111/j.1360-0443.1997.tb03650.x; Hollander JE, 2008, ANN EMERG MED, V51, pS18, DOI 10.1016/j.annemergmed.2007.11.008; Ibrahim ESH, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-26; Joly L, 2009, HYPERTENSION, V54, P421, DOI 10.1161/HYPERTENSIONAHA.109.133645; Kaye S, 2004, DRUG ALCOHOL REV, V23, P391, DOI 10.1080/09595230412331324518; Kaye S, 2004, ADDICTION, V99, P1315, DOI 10.1111/j.1360-0443.2004.00875.x; Kerns William Ii, 1997, Journal of Emergency Medicine, V15, P321, DOI 10.1016/S0736-4679(97)00003-6; Kozel NJ, 1985, NATL I DRUG ABUSE NI, V61, P136; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Ledgerwood DM, 2008, ADDICT BEHAV, V33, P1131, DOI 10.1016/j.addbeh.2008.04.009; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; Mani V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-10; McCance-Katz EF, 1998, BIOL PSYCHIAT, V44, P250, DOI 10.1016/S0006-3223(97)00426-5; MOLITERNO DJ, 1994, NEW ENGL J MED, V330, P454, DOI 10.1056/NEJM199402173300702; PENG SK, 1989, ARCH PATHOL LAB MED, V113, P842; PEREZREYES M, 1992, LIFE SCI, V51, P553, DOI 10.1016/0024-3205(92)90224-D; Pradhan L, 2008, CARDIOVASC TOXICOL, V8, P161, DOI 10.1007/s12012-008-9025-z; Ren SQ, 2006, AM J CARDIOL, V97, P1085, DOI 10.1016/j.amjcard.2005.10.056; Robaei D, 2010, EUR HEART J, V31, P2446, DOI 10.1093/eurheartj/ehq229; Westenberg JJM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-2	35	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e89710	10.1371/journal.pone.0089710	http://dx.doi.org/10.1371/journal.pone.0089710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717541	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000007
J	Pearce, W; Holmberg, K; Hellsten, I; Nerlich, B				Pearce, Warren; Holmberg, Kim; Hellsten, Iina; Nerlich, Brigitte			Climate Change on Twitter: Topics, Communities and Conversations about the 2013 IPCC Working Group 1 Report	PLOS ONE			English	Article							POLITICS; CARBON	In September 2013 the Intergovernmental Panel on Climate Change published its Working Group 1 report, the first comprehensive assessment of physical climate science in six years, constituting a critical event in the societal debate about climate change. This paper analyses the nature of this debate in one public forum: Twitter. Using statistical methods, tweets were analyzed to discover the hashtags used when people tweeted about the IPCC report, and how Twitter users formed communities around their conversational connections. In short, the paper presents the topics and tweeters at this particular moment in the climate debate. The most used hashtags related to themes of science, geographical location and social issues connected to climate change. Particularly noteworthy were tweets connected to Australian politics, US politics, geoengineering and fracking. Three communities of Twitter users were identified. Researcher coding of Twitter users showed how these varied according to geographical location and whether users were supportive, unsupportive or neutral in their tweets about the IPCC. Overall, users were most likely to converse with users holding similar views. However, qualitative analysis suggested the emergence of a community of Twitter users, predominantly based in the UK, where greater interaction between contrasting views took place. This analysis also illustrated the presence of a campaign by the non-governmental organization Avaaz, aimed at increasing media coverage of the IPCC report.	[Pearce, Warren; Nerlich, Brigitte] Univ Nottingham, Sch Sociol & Social Policy, Inst Sci & Soc, Nottingham NG7 2RD, England; [Holmberg, Kim; Hellsten, Iina] Vrije Univ Amsterdam, Dept Org Sci, Amsterdam, Netherlands	University of Nottingham; Vrije Universiteit Amsterdam	Pearce, W (corresponding author), Univ Nottingham, Sch Sociol & Social Policy, Inst Sci & Soc, Nottingham NG7 2RD, England.	warren.pearce@nottingham.ac.uk	Holmberg, Kim/A-6840-2010; Pearce, Warren/V-3279-2019	Holmberg, Kim/0000-0002-4185-9298; Pearce, Warren/0000-0001-6884-3854; Nerlich, Brigitte/0000-0001-6617-7827	Economic and Social Research Council [RES-360-25-0068]; Leverhulme Trust in the UK [RP2011-SP-013]; Dutch Scientific Organization in the Netherlands (NWO-ORA) [464-10-077]; ESRC [ES/I014926/1] Funding Source: UKRI; Economic and Social Research Council [ES/I014926/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust in the UK(Leverhulme Trust); Dutch Scientific Organization in the Netherlands (NWO-ORA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors acknowledge the support of the Economic and Social Research Council (RES-360-25-0068) and the Leverhulme Trust (RP2011-SP-013) in the UK, and the Dutch Scientific Organization in the Netherlands (NWO-ORA grant 464-10-077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott T, 2012, OUR PLAN ABOLISH CAR; Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], 2013, WHOS MOST POW CLIM S; [Anonymous], 2013, NOW SEND MESS UK MED; [Anonymous], 2013, LEADERS DEBATE CLIMA; [Anonymous], 2013, NOW SEND MESS TOP UK; Australian Government Department of the Environment, 2011, LAUNCH CLIM COMM; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Baxter L. A., 2010, VOICING RELATIONSHIP, DOI [10.4135/9781452230344, DOI 10.4135/9781452230344]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyd D, 2010, P ANN HICSS, P1657; Bruns A., 2008, INFORM POLITY, V13, P71, DOI [DOI 10.3233/IP-2008-0141, 10.3233/IP-2008-0141]; Bruns A., 2011, P 6 EUR CONS POL RES, P1; Bruns A, 2012, J TECHNOL HUMAN SERV, V30, P160, DOI 10.1080/15228835.2012.744249; Cha M, 2012, IEEE T SYST MAN CY A, V42, P991, DOI 10.1109/TSMCA.2012.2183359; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207; Collins L, 2013, MAK SCI PUBLIC; Connor S., 2013, INDEPENDENT; Corner A, 2012, CLIMATIC CHANGE, V114, P463, DOI 10.1007/s10584-012-0424-6; Crowley K, 2013, WIRES CLIM CHANGE, V4, P603, DOI 10.1002/wcc.239; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Edenhofer O., 2014, CONTRIBUTION WORKING; Elsasser SW, 2013, AM BEHAV SCI, V57, P754, DOI 10.1177/0002764212469800; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Greenberg S, 2013, INSIDE GOP REPORT FO; Hoffman AJ, 2011, ORGAN ENVIRON, V24, P3, DOI 10.1177/1086026611404336; Honeycutt C., 2009, P 2009 42 HAW INT C, P1, DOI [10.1109/HICSS.2009.89, DOI 10.1109/HICSS.2009.89]; Huang J., 2010, P 21 ACM C HYP HYP, P173, DOI [10.1145/1810617.1810647, DOI 10.1145/1810617.1810647]; Hulme M, 2012, NAT CLIM CHANGE, V2, P223, DOI 10.1038/nclimate1459; Intergovernmental Panel on Climate Change, 2012, PRINC GOV IPCC WORK; Intergovernmental Panel on Climate Change, 2013, KEY DAT AR5 SCHED; Jaspal R, 2012, PUBLIC UNDERST SCI; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Koteyko N, 2013, GEOGR J, V179, P74, DOI 10.1111/j.1475-4959.2012.00479.x; Koteyko N, 2010, SCI COMMUN, V32, P25, DOI 10.1177/1075547009340421; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin Y-R, 2013, RISING TIDES RISING; Aiello LM, 2013, IEEE T MULTIMEDIA, V15, P1268, DOI 10.1109/TMM.2013.2265080; Marres Noortje, 2005, MAKING THINGS PUBLIC, P922; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Morton O, 2013, HELIOPHAGE; Moser SC, 2014, ADAPTIVE CHALLENGE C; Nerlich B, 2009, GLOBAL ENVIRON CHANG, V19, P345, DOI 10.1016/j.gloenvcha.2009.03.001; Painter J, 2011, POLES APART INT REPO; Revkin A, 2012, DOT EARTH BLOG; Royal Society, 2013, NEXT STEPS CLIM SCI; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Small TA, 2011, INFORM COMMUN SOC, V14, P872, DOI 10.1080/1369118X.2011.554572; Stilgoe J, 2013, GUARD POLIT SCI; Swart NC, 2012, NAT CLIM CHANGE, V2, P134, DOI 10.1038/nclimate1421; The Royal Society, 2009, GEOENG CLIM SCI GOV; Thelwall M, 2009, SYNTHESIS LECT INFOR, DOI [10.2200/S00176ED1V01Y200903ICR004, DOI 10.2200/S00176ED1V01Y200903ICR004]; Wilkinson D, 2011, SOC SCI COMPUT REV, V29, P387, DOI 10.1177/0894439310378979; Yardi S., 2010, B SCI TECHNOL SOC, V30, P316, DOI 10.1177/0270467610380011	55	117	118	4	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94785	10.1371/journal.pone.0094785	http://dx.doi.org/10.1371/journal.pone.0094785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718388	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000334339000145
J	Saslow, LR; Kim, S; Daubenmier, JJ; Moskowitz, JT; Phinney, SD; Goldman, V; Murphy, EJ; Cox, RM; Moran, P; Hecht, FM				Saslow, Laura R.; Kim, Sarah; Daubenmier, Jennifer J.; Moskowitz, Judith T.; Phinney, Stephen D.; Goldman, Veronica; Murphy, Elizabeth J.; Cox, Rachel M.; Moran, Patricia; Hecht, Fredrick M.			A Randomized Pilot Trial of a Moderate Carbohydrate Diet Compared to a Very Low Carbohydrate Diet in Overweight or Obese Individuals with Type 2 Diabetes Mellitus or Prediabetes	PLOS ONE			English	Article							BLOOD-GLUCOSE; FATTY-ACIDS; WEIGHT-LOSS; QUESTIONNAIRE; INSULIN; ENERGY	We compared the effects of two diets on glycated hemoglobin (HbA1c) and other health-related outcomes in overweight or obese adults with type 2 diabetes or prediabetes (HbA1c>6%). We randomized participants to either a medium carbohydrate, low fat, calorie-restricted, carbohydrate counting diet (MCCR) consistent with guidelines from the American Diabetes Association (n = 18) or a very low carbohydrate, high fat, non calorie-restricted diet whose goal was to induce nutritional ketosis (LCK, n = 16). We excluded participants receiving insulin; 74% were taking oral diabetes medications. Groups met for 13 sessions over 3 months and were taught diet information and psychological skills to promote behavior change and maintenance. At 3 months, mean HbA1c level was unchanged from baseline in the MCCR diet group, while it decreased 0.6% in the LCK group; there was a significant between group difference in HbA1c change favoring the LCK group (-0.6%, 95% CI, -1.1% to -0.03%, p = 0.04). Forty-four percent of the LCK group discontinued one or more diabetes medications, compared to 11% of the MCCR group (p = 0.03); 31% discontinued sulfonylureas in the LCK group, compared to 5% in the MCCR group (p = 0.05). The LCK group lost 5.5 kg vs. 2.6 kg lost in MCCR group (p = 0.09). Our results suggest that a very low carbohydrate diet coupled with skills to promote behavior change may improve glycemic control in type 2 diabetes while allowing decreases in diabetes medications.	[Saslow, Laura R.; Kim, Sarah; Daubenmier, Jennifer J.; Moskowitz, Judith T.; Goldman, Veronica; Murphy, Elizabeth J.; Moran, Patricia; Hecht, Fredrick M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Phinney, Stephen D.] UC Davis Sch Med Emeritus, Davis, CA USA; [Cox, Rachel M.] Childrens Hosp & Res Ctr, Oakland, CA USA	University of California System; University of California San Francisco	Saslow, LR (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	SaslowL@ocim.ucsf.edu		Saslow, Laura/0000-0003-3991-3205; phinney, stephen/0000-0002-3322-3978	William K. Bowes, Jr. Foundation; NIH from the National Center for Complementary and Alternative Medicine (NCCAM) [T32AT003997]; NIH from the National Institute of Mental Health [K24 MH093225]; NIH from NCCAM [K24 AT007827]; National Center for Complementary & Integrative Health [T32AT003997, K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH093225] Funding Source: NIH RePORTER	William K. Bowes, Jr. Foundation; NIH from the National Center for Complementary and Alternative Medicine (NCCAM); NIH from the National Institute of Mental Health; NIH from NCCAM; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was supported by a grant from the William K. Bowes, Jr. Foundation. Laura Saslow was supported by NIH grant T32AT003997 from the National Center for Complementary and Alternative Medicine (NCCAM). Judith Moskowitz was supported by NIH grant K24 MH093225 from the National Institute of Mental Health. Frederick Hecht was supported by NIH grant K24 AT007827 from NCCAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso A, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-9; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Association AD, 2011, AM DIAB ASS COMPL GU; Association AD, 2009, ALL CARB COUNT; BARTONE PT, 1989, J NERV MENT DIS, V177, P317, DOI 10.1097/00005053-198906000-00001; Boden G, 2005, ANN INTERN MED, V142, P403, DOI 10.7326/0003-4819-142-6-200503150-00006; BURNS TW, 1963, J LAB CLIN MED, V62, P646; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daubenmier J, 2011, J OBES, V2011, DOI 10.1155/2011/651936; Daubenmier JJ, 2005, PSYCHOL WOMEN QUART, V29, P207, DOI 10.1111/j.1471-6402.2005.00183.x; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; Gannon MC, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-16; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; McClain AD, 2013, DIABETES OBESITY; MERTZ W, 1991, AM J CLIN NUTR, V54, P291, DOI 10.1093/ajcn/54.2.291; Moskowitz JT, 2003, PSYCHOSOM MED, V65, P620, DOI 10.1097/01.PSY.0000073873.74829.23; Moskowitz JT, 2011, J HLTH PSYCHOL; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Santos F, 2012, OBESITY REV; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Subar AF, 2012, J ACAD NUTR DIET, V112, P1134, DOI 10.1016/j.jand.2012.04.016; Sumithran P, 2008, OBES RES CLIN PRACT, V2, P1, DOI 10.1016/j.orcp.2007.11.003; TAYLOR LA, 1988, J BEHAV MED, V11, P279, DOI 10.1007/BF00844433; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Westman EC, 2008, NUTR METAB, V5, DOI [10.1186/1743-7075-5-10, 10.1186/1743-7075-5-36]; White MA, 2002, OBES RES, V10, P107, DOI 10.1038/oby.2002.17	33	104	106	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e91027	10.1371/journal.pone.0091027	http://dx.doi.org/10.1371/journal.pone.0091027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24717684	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000009
J	Svendsen, JC; Genz, J; Anderson, WG; Stol, JA; Watkinson, DA; Enders, EC				Svendsen, Jon C.; Genz, Janet; Anderson, W. Gary; Stol, Jennifer A.; Watkinson, Douglas A.; Enders, Eva C.			Evidence of Circadian Rhythm, Oxygen Regulation Capacity, Metabolic Repeatability and Positive Correlations between Forced and Spontaneous Maximal Metabolic Rates in Lake Sturgeon Acipenser fulvescens	PLOS ONE			English	Article							NONMIGRATORY THREESPINE STICKLEBACK; GUPPIES POECILIA-RETICULATA; SWIMMING PERFORMANCE; JUVENILE ATLANTIC; WHITE STURGEON; GREEN STURGEON; INTRASPECIFIC VARIATION; ENVIRONMENTAL HYPOXIA; AEROBIC CAPACITY; CONSUMPTION RATE	Animal metabolic rate is variable and may be affected by endogenous and exogenous factors, but such relationships remain poorly understood in many primitive fishes, including members of the family Acipenseridae (sturgeons). Using juvenile lake sturgeon (Acipenser fulvescens), the objective of this study was to test four hypotheses: 1) A. fulvescens exhibits a circadian rhythm influencing metabolic rate and behaviour; 2) A. fulvescens has the capacity to regulate metabolic rate when exposed to environmental hypoxia; 3) measurements of forced maximum metabolic rate (MMRF) are repeatable in individual fish; and 4) MMRF correlates positively with spontaneous maximum metabolic rate (MMRS). Metabolic rates were measured using intermittent flow respirometry, and a standard chase protocol was employed to elicit MMRF. Trials lasting 24 h were used to measure standard metabolic rate (SMR) and MMRS. Repeatability and correlations between MMRF and MMRS were analyzed using residual body mass corrected values. Results revealed that A. fulvescens exhibit a circadian rhythm in metabolic rate, with metabolism peaking at dawn. SMR was unaffected by hypoxia (30% air saturation (O-2sat)), demonstrating oxygen regulation. In contrast, MMRF was affected by hypoxia and decreased across the range from 100% O-2sat to 70% O-2sat. MMRF was repeatable in individual fish, and MMRF correlated positively with MMRS, but the relationships between MMRF and MMRS were only revealed in fish exposed to hypoxia or 24 h constant light (i.e. environmental stressor). Our study provides evidence that the physiology of A. fulvescens is influenced by a circadian rhythm and suggests that A. fulvescens is an oxygen regulator, like most teleost fish. Finally, metabolic repeatability and positive correlations between MMRF and MMRS support the conjecture that MMRF represents a measure of organism performance that could be a target of natural selection.	[Svendsen, Jon C.; Stol, Jennifer A.; Watkinson, Douglas A.; Enders, Eva C.] Fisheries & Oceans Canada, Winnipeg, MB, Canada; [Svendsen, Jon C.] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, P-4100 Oporto, Portugal; [Genz, Janet] Univ West Georgia, Dept Biol, Carrollton, GA USA; [Anderson, W. Gary] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	Fisheries & Oceans Canada; Universidade do Porto; University System of Georgia; University of West Georgia; University of Manitoba	Svendsen, JC (corresponding author), Fisheries & Oceans Canada, Winnipeg, MB, Canada.	jos@aqua.dtu.dk	Enders, Eva/G-9804-2019; Quality, Aquaculture Seafood/AAD-7718-2019; Svendsen, Jon Christian/J-2716-2013	Enders, Eva/0000-0003-2103-0359; Svendsen, Jon Christian/0000-0002-0273-0985	Manitoba Hydro; Natural Sciences and Engineering Research Council of Canada in Canada [311909]; Foundation for Science and Technology (FCT) [SFRH/BPD/89473/2012]	Manitoba Hydro; Natural Sciences and Engineering Research Council of Canada in Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding in support of this research was provided to WGA by Manitoba Hydro (http://www.hydro.mb.ca/) and Natural Sciences and Engineering Research Council of Canada Discovery Grant (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp) (Number 311909) in Canada. This research was partially supported by a grant (SFRH/BPD/89473/2012) from the Foundation for Science and Technology (FCT; http://www.fct.pt/index.phtml.pt) in Portugal to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2007, ENVIRON BIOL FISH, V79, P211, DOI 10.1007/s10641-006-9049-9; Baker DW, 2005, PHYSIOL BIOCHEM ZOOL, V78, P916, DOI 10.1086/432860; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Beale A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3769; Behrens JW, 2007, MAR BIOL, V150, P1365, DOI 10.1007/s00227-006-0456-4; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Boldsen MM, 2013, COMP BIOCHEM PHYS A, V165, P22, DOI 10.1016/j.cbpa.2013.01.027; BOUJARD T, 1992, ENVIRON BIOL FISH, V35, P109, DOI 10.1007/BF00002186; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; BURGGREN WW, 1978, RESP PHYSIOL, V34, P171, DOI 10.1016/0034-5687(78)90026-9; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Cech JJ, 2002, J APPL ICHTHYOL, V18, P320, DOI 10.1046/j.1439-0426.2002.00362.x; Chappell M, 2004, PHYSIOL BIOCHEM ZOOL, V77, P27, DOI 10.1086/378920; Coppack T, 2011, J ORNITHOL, V152, P67, DOI 10.1007/s10336-011-0708-z; Crocker CE, 2002, J APPL ICHTHYOL, V18, P338, DOI 10.1046/j.1439-0426.2002.00411.x; Crocker CE, 1997, ENVIRON BIOL FISH, V50, P383, DOI 10.1023/A:1007362018352; Cutts CJ, 2002, FUNCT ECOL, V16, P73, DOI 10.1046/j.0269-8463.2001.00603.x; Dalziel AC, 2012, J EXP BIOL, V215, P3587, DOI 10.1242/jeb.071951; Dalziel AC, 2012, EVOLUTION, V66, P1226, DOI 10.1111/j.1558-5646.2011.01498.x; Dalziel AC, 2012, J EXP BIOL, V215, P746, DOI 10.1242/jeb.065425; Farrell AP, 2009, FISH PHYSIOL, V27, P487, DOI 10.1016/S1546-5098(08)00011-3; Forsythe PS, 2012, J FISH BIOL, V81, P35, DOI 10.1111/j.1095-8649.2012.03308.x; Forsythe PS, 2012, CAN J FISH AQUAT SCI, V69, P60, DOI 10.1139/F2011-132; Franklin PA, 2013, NZ J MAR FR IN PRESS, DOI [10.1080/00288330.2013.827123, DOI 10.1080/00288330.2013.827123]; Hughes G.M., 1981, P121; Husak JF, 2006, FUNCT ECOL, V20, P1080, DOI 10.1111/j.1365-2435.2006.01195.x; Irschick DJ, 2005, EVOLUTION, V59, P1579; Irschick D, 2007, PHYSIOL BIOCHEM ZOOL, V80, P557, DOI 10.1086/521203; Irschick DJ, 2008, EVOL ECOL RES, V10, P177; Jones EA, 2007, J EXP BIOL, V210, P3422, DOI 10.1242/jeb.005744; Jordan AD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P178, DOI 10.1086/510565; Kearney MR, 2012, AM NAT, V180, P546, DOI 10.1086/667860; Kieffer JD, 2001, J EXP BIOL, V204, P4281; Killen SS, 2013, TRENDS ECOL EVOL, V28, P651, DOI 10.1016/j.tree.2013.05.005; Kim WS, 1997, MAR ECOL PROG SER, V153, P293, DOI 10.3354/meps153293; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Lankford SE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P599, DOI 10.1086/430687; Lankford SE, 2003, COMP BIOCHEM PHYS A, V135, P291, DOI 10.1016/S1095-6433(03)00075-8; Losos JB, 2002, J ZOOL, V258, P57, DOI 10.1017/S0952836902001206; Mayfield RB, 2004, T AM FISH SOC, V133, P961, DOI 10.1577/T02-144.1; McBryan TL, 2013, INTEGR COMP BIOL, V53, P648, DOI 10.1093/icb/ict066; McKenzie DJ, 2007, J FISH BIOL, V70, P651, DOI 10.1111/j.1095-8649.2007.01337.x; MCKENZIE DJ, 1995, FISH PHYSIOL BIOCHEM, V14, P341, DOI 10.1007/BF00003373; Niitepold K, 2013, J EXP BIOL, V216, P1388, DOI 10.1242/jeb.080739; NONNOTTE G, 1993, RESP PHYSIOL, V91, P71, DOI 10.1016/0034-5687(93)90090-W; Norin T, 2011, J EXP BIOL, V214, P1668, DOI 10.1242/jeb.054205; Odell JP, 2003, J EXP BIOL, V206, P3707, DOI 10.1242/jeb.00613; Oufiero CE, 2011, ECOLOGY, V92, P170, DOI 10.1890/09-1912.1; Oufiero CE, 2009, FUNCT ECOL, V23, P969, DOI 10.1111/j.1365-2435.2009.01571.x; Pagan DNM, 2012, J HERPETOL, V46, P253, DOI 10.1670/11-105; Perry SF, 2009, FISH PHYSIOL, V27, P193, DOI 10.1016/S1546-5098(08)00005-8; Peyric E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073209; Pollock MS, 2007, ENVIRON REV, V15, P1, DOI 10.1139/a06-006; Priede I.G., 1985, P33; RANDALL DJ, 1992, J EXP BIOL, V170, P113; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; ROSS LG, 1988, COMP BIOCHEM PHYS A, V89, P637, DOI 10.1016/0300-9629(88)90846-8; RUER PM, 1987, AQUACULTURE, V62, P45, DOI 10.1016/0044-8486(87)90183-9; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Svendsen JC, 2013, J EXP BIOL, V216, P3564, DOI 10.1242/jeb.083089; Svendsen JC, 2010, J EXP BIOL, V213, P2177, DOI 10.1242/jeb.041368; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; ULTSCH GR, 1981, J COMP PHYSIOL, V142, P439, DOI 10.1007/BF00688973; Urbina MA, 2012, COMP BIOCHEM PHYS A, V161, P301, DOI 10.1016/j.cbpa.2011.11.011; Virani NA, 2000, COMP BIOCHEM PHYS A, V126, P397, DOI 10.1016/S1095-6433(00)00219-1; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; White CR, 2013, J EXP BIOL, V216, P1763, DOI 10.1242/jeb.076562; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9	70	43	43	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94693	10.1371/journal.pone.0094693	http://dx.doi.org/10.1371/journal.pone.0094693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718688	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000137
J	Yu, XH; Ge, NJ; Guo, X; Shen, SQ; Liang, J; Huang, XJ; Wan, SG; Xing, JL; Huang, QC; Yang, YF				Yu, Xiaohe; Ge, Naijian; Guo, Xu; Shen, Shuqun; Liang, Jun; Huang, Xiaojun; Wan, Shaogui; Xing, Jingliang; Huang, Qichao; Yang, Yefa			Genetic Variants in the EPCAM Gene Is Associated with the Prognosis of Transarterial Chemoembolization Treated Hepatocellular Carcinoma with Portal Vein Tumor Thrombus	PLOS ONE			English	Article							CELL ADHESION MOLECULE; CANCER; EXPRESSION; CD326	The epithelial cell adhesion molecule (EPCAM) is involved in the tumorigenesis and progression of many malignancies, including hepatocellular carcinoma (HCC). Single nucleotide polymorphisms (SNPs) of EPCAM have been reported to be with the risk and prognosis of several malignancies. However, the association of SNPs in EPCAM gene with the prognosis of HCC patients has never been investigated. In this study, two functional SNPs (rs1126497 and rs1421) in the EPCAM gene were selected and genotyped in a cohort of 448 unresectable Chinese HCC patients treated by TACE. The association of the two SNPs with the overall survival (OS) of patients was assessed by univariate and multivariate Cox proportional hazards model and Kaplan-Meier curve. Our data showed that there was no significant association between either SNP and OS of patients. However, in the stratified analysis, the variant-containing genotypes (WV+VV) of SNP rs1126497 exhibited a significant association with poorer OS in HCC patients who had portal vein tumor thrombus (PVTT) in multivariate analysis of Cox proportional hazard model (hazard ratio, 1.71; 95% confidence interval, 1.16-2.53, P = 0.007), and in Kaplan-Meier curve analysis (P = 0.023), comparing to those carrying wild-type genotype. Our results suggest that SNP rs1126497 in the EPCAM gene may serve as an independent prognosis biomarker for unresectable HCC patient with PVTT, which warranted further validating investigation.	[Yu, Xiaohe; Ge, Naijian; Shen, Shuqun; Liang, Jun; Yang, Yefa] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Radioact Intervent, Shanghai, Peoples R China; [Guo, Xu] Cell Engn Res Ctr, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Guo, Xu] Dept Cell Biol, Xian, Shaanxi, Peoples R China; [Huang, Xiaojun; Xing, Jingliang; Huang, Qichao] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shaanxi, Peoples R China; [Wan, Shaogui] Henan Univ, Pharmaceut Coll, Kaifeng, Henan, Peoples R China	Naval Medical University; Henan University	Huang, QC (corresponding author), Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shaanxi, Peoples R China.	huangqichao1@163.com; yangyefa66@163.com	Huang, Qichao/K-5706-2018		National Natural Science Foundation of China [81272522]; New Century Excellent Talents in University [81171966]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants 81272522 from the National Natural Science Foundation of China and grants 81171966 from New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2012, INT J ONCOL, V41, P2150, DOI 10.3892/ijo.2012.1631; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fouse SD, 2013, CANCER CELL, V23, P711, DOI 10.1016/j.ccr.2013.05.016; Gutzmer R, 2004, J IMMUNOL, V173, P1023, DOI 10.4049/jimmunol.173.2.1023; Hu M, 2012, MOL BIOL REP, V39, P7303, DOI 10.1007/s11033-012-1560-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jia LZ, 2012, ACTA MED OKAYAMA, V66, P131; Jiang L, 2011, BREAST CANCER RES TR, V126, P487, DOI 10.1007/s10549-010-1094-6; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pak MG, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-53; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Shi G, 2013, METHODS; Song DS, 2013, WORLD J GASTROENTERO, V19, P4679, DOI 10.3748/wjg.v19.i29.4679; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Wu L, 2010, CANCER BIOTHER RADIO, V25, P657, DOI 10.1089/cbr.2010.0801; Xue TC, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-60; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang Y, 2014, CANCER SCI, V105, P89, DOI 10.1111/cas.12318	29	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93416	10.1371/journal.pone.0093416	http://dx.doi.org/10.1371/journal.pone.0093416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718422	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000031
J	Zhang, H; Su, YJ; Zhou, WW; Wang, SW; Xu, PX; Yu, XL; Liu, RT				Zhang, He; Su, Ya-jing; Zhou, Wei-wei; Wang, Shao-wei; Xu, Peng-xin; Yu, Xiao-lin; Liu, Rui-tian			Activated Scavenger Receptor A Promotes Glial Internalization of A beta	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; MICROGLIAL ACTIVATION; NEURONAL VIABILITY; SIGNALING PATHWAYS; TRANSGENIC MICE; PEPTIDE; PHAGOCYTOSIS; CLEARANCE; CELLS	Beta-amyloid (Ab) aggregates have a pivotal role in pathological processing of Alzheimer's disease (AD). The clearance of Ab monomer or aggregates is a causal strategy for AD treatment. Microglia and astrocytes are the main macrophages that exert critical neuroprotective roles in the brain. They may effectively clear the toxic accumulation of Ab at the initial stage of AD, however, their functions are attenuated because of glial overactivation. In this study, we first showed that heptapeptide XD4 activates the class A scavenger receptor (SR-A) on the glia by increasing the binding of Ab to SR-A, thereby promoting glial phagocytosis of Ab oligomer in microglia and astrocytes and triggering intracellular mitogen-activated protein kinase (MAPK) signaling cascades. Moreover, XD4 enhances the internalization of A beta monomers to microglia and astrocytes through macropinocytosis or SR-A-mediated phagocytosis. Furthermore, XD4 significantly inhibits A beta oligomer-induced cytotoxicity to glial cells and decreases the production of proinflammatory cytokines, such as TNF-alpha and IL-1 beta, in vitro and in vivo. Our findings may provide a novel strategy for AD treatment by activating SR-A.	[Zhang, He; Zhou, Wei-wei; Wang, Shao-wei; Xu, Peng-xin; Yu, Xiao-lin; Liu, Rui-tian] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Zhang, He] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Su, Ya-jing] Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tsinghua University; Ningxia University	Yu, XL (corresponding author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China.	rtliu@home.ipe.ac.cn; yuxiaolin@home.ipe.ac.cn			National Natural Science Foundation of China [30971012, 81171014]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs	This work was supported by grants from the National Natural Science Foundation of China (30971012 and 81171014) and the National Science and Technology Major Projects of New Drugs (2012ZX09103301-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; Cornejo F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/895651; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; ElKhoury J, 1996, NATURE, V382, P716; Frautschy SA, 1998, AM J PATHOL, V152, P307; Frenkel D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3030; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lue LF, 2001, NEUROBIOL AGING, V22, P945, DOI 10.1016/S0197-4580(01)00311-6; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mohamed A, 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/127984; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Prokop Stefan, 2013, Acta Neuropathol, V126, P461; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Wilkinson K, 2012, INT J ALZHEIMERS DIS, V2012, DOI [DOI 10.1155/2012/489456, 10.1155/2012/489456]; Xue D, 2012, NEUROBIOL DIS, V46, P701, DOI 10.1016/j.nbd.2012.03.013; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345	33	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94197	10.1371/journal.pone.0094197	http://dx.doi.org/10.1371/journal.pone.0094197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718459	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000087
J	Cai, L; Chen, L; Johnson, D; Gao, Y; Mandal, P; Fang, M; Tu, ZY; Huang, YP				Cai, Lu; Chen, Lei; Johnson, David; Gao, Yong; Mandal, Prashant; Fang, Min; Tu, Zhiying; Huang, Yingping			Integrating Water Flow, Locomotor Performance and Respiration of Chinese Sturgeon during Multiple Fatigue-Recovery Cycles	PLOS ONE			English	Article							REPEAT SWIMMING PERFORMANCE; SALMON ONCORHYNCHUS-NERKA; ACIPENSER-SINENSIS; MODEL SELECTION; BEHAVIOR; SPEED; RIVER; TEMPERATURE; METABOLISM; VELOCITY	The objective of this study is to provide information on metabolic changes occurring in Chinese sturgeon (an ecologically important endangered fish) subjected to repeated cycles of fatigue and recovery and the effect on swimming capability. Fatigue-recovery cycles likely occur when fish are moving through the fishways of large dams and the results of this investigation are important for fishway design and conservation of wild Chinese sturgeon populations. A series of four stepped velocity tests were carried out successively in a Steffensen-type swimming respirometer and the effects of repeated fatigue-recovery on swimming capability and metabolism were measured. Significant results include: (1) critical swimming speed decreased from 4.34 bl/s to 2.98 bl/s; (2) active oxygen consumption (i.e. the difference between total oxygen consumption and routine oxygen consumption) decreased from 1175 mgO(2)/kg to 341 mgO(2)/kg and was the primary reason for the decrease in U-crit; (3) excess post-exercise oxygen consumption decreased from 36 mgO(2)/kg to 22 mgO(2)/kg; (4) with repeated step tests, white muscle (anaerobic metabolism) began contributing to propulsion at lower swimming speeds. Therefore, Chinese sturgeon conserve energy by swimming efficiently and have high fatigue recovery capability. These results contribute to our understanding of the physiology of the Chinese sturgeon and support the conservation efforts of wild populations of this important species.	[Cai, Lu; Fang, Min; Tu, Zhiying; Huang, Yingping] Collaborat Innovat Ctr Geo Hazards & Ecoenvironm, Yichang, Hubei Province, Peoples R China; [Chen, Lei; Gao, Yong] China Three Gorges Project Corp, Inst Chinese Sturgeon Res, Yichang, Peoples R China; [Johnson, David; Mandal, Prashant; Fang, Min; Tu, Zhiying; Huang, Yingping] China Three Gorges Univ, Minist Educ, Engn Res Ctr Ecoenvironm Gorges Reservoir Reg 3, Yichang, Peoples R China; [Johnson, David] Ferrum Coll, Sch Nat Sci & Math, Ferrum, VA USA	China Three Gorges Corporation; China Three Gorges University	Huang, YP (corresponding author), Collaborat Innovat Ctr Geo Hazards & Ecoenvironm, Yichang, Hubei Province, Peoples R China.	yingpinghuang@126.com			Major Science and Technology Program for Water Pollution Control and Treatment in the National Twelfth Five-Year Plan of China [2012ZX07104-002-04]; National Nature Science Foundation of China [50979049, 51309140]	Major Science and Technology Program for Water Pollution Control and Treatment in the National Twelfth Five-Year Plan of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science and Technology Program for Water Pollution Control and Treatment in the National Twelfth Five-Year Plan of China (Grant number: 2012ZX07104-002-04) and the National Nature Science Foundation of China (Grant number: 50979049, 51309140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; BARTHEM RB, 1991, BIOL CONSERV, V55, P339, DOI 10.1016/0006-3207(91)90037-A; Behrens JW, 2006, J EXP MAR BIOL ECOL, V331, P208, DOI 10.1016/j.jembe.2005.10.012; Billard R, 2001, REV FISH BIOL FISHER, V10, P355; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cai L, 2014, FISH PHYSIOL BIOCHEM, V40, P491, DOI 10.1007/s10695-013-9860-0; Cai L, 2013, J EXP ZOOL PART A, V319A, P149, DOI 10.1002/jez.1780; Castro-Santos T, 2005, J EXP BIOL, V208, P421, DOI 10.1242/jeb.01380; Castro-Santos T, 2013, CAN J FISH AQUAT SCI, V70, P280, DOI 10.1139/cjfas-2012-0186; Cheong TS, 2006, ENVIRON BIOL FISH, V77, P197, DOI 10.1007/s10641-006-9071-y; Cooke SJ, 2008, FISHERIES, V33, P321, DOI 10.1577/1548-8446-33.7.321; Deslauriers D, 2012, CAN J ZOOL, V90, P345, DOI 10.1139/Z2012-004; Farrell AP, 1998, J EXP BIOL, V201, P2183; Fu SJ, 2013, OECOLOGIA, V173, P343, DOI 10.1007/s00442-013-2626-7; Guo Bai-Fu, 2011, Acta Hydrobiologica Sinica, V35, P940; He X, 2013, J FISH BIOL, V82, P1047, DOI 10.1111/j.1095-8649.2012.12015.x; Herrmann JP, 2000, J FISH BIOL, V57, P746, DOI [10.1006/jfbi.2000.1348, 10.1111/j.1095-8649.2000.tb00272.x]; Hu JY, 2009, P NATL ACAD SCI USA, V106, P9339, DOI 10.1073/pnas.0809434106; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jain KE, 2003, J EXP BIOL, V206, P3569, DOI 10.1242/jeb.00588; Jain KE, 1998, CAN J ZOOL, V76, P1488, DOI 10.1139/cjz-76-8-1488; Jaric I, 2012, SCIENTOMETRICS, V90, P715, DOI 10.1007/s11192-011-0583-7; JONES DR, 1982, CAN J ZOOL, V60, P1131, DOI 10.1139/z82-157; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Lee CG, 2003, J EXP BIOL, V206, P3253, DOI 10.1242/jeb.00548; MacNutt MJ, 2004, J FISH BIOL, V65, P342, DOI 10.1111/j.0022-1112.2004.00453.x; Marras S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072815; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Pang X, 2013, J COMP PHYSIOL B, V183, P99, DOI 10.1007/s00360-012-0690-7; Peake SJ, 2004, FISH FISHERIES SERIE, V27, P147; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Pon LB, 2009, J FISH BIOL, V74, P1323, DOI 10.1111/j.1095-8649.2009.02213.x; ROME LC, 1990, J EXP BIOL, V154, P163; Svendsen JC, 2010, J EXP BIOL, V213, P2177, DOI 10.1242/jeb.041368; Rodriguez TT, 2006, ECOL ENG, V27, P37, DOI 10.1016/j.ecoleng.2005.09.015; Tierney KB, 2004, J FISH DIS, V27, P663, DOI 10.1111/j.1365-2761.2004.00590.x; Tu ZY, 2012, J EXP ZOOL PART A, V317A, P294, DOI 10.1002/jez.1723; Tu ZY, 2011, HYDROBIOLOGIA, V675, P119, DOI 10.1007/s10750-011-0809-y; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Van Leeuwen TE, 2011, J ANIM ECOL, V80, P1012, DOI 10.1111/j.1365-2656.2011.01841.x; Wang C, 2013, J APPL ICHTHYOL, V29, P31, DOI 10.1111/jai.12094; Webber JD, 2007, T AM FISH SOC, V136, P402, DOI 10.1577/T06-064.1; Wei Q, 2004, J APPL ICHTHYOL, V20, P321, DOI 10.1111/j.1439-0426.2004.00593.x; [危起伟 Wei Qiwei], 2013, [中国水产科学, Journal of Fishery Sciences of China], V20, P1; Wei QW, 1997, ENVIRON BIOL FISH, V48, P241, DOI 10.1023/A:1007395612241; Xie P, 2003, SCIENCE, V302, P1149; Xie SG, 2007, FISHERIES, V32, P343; Yagci O, 2010, ECOL ENG, V36, P36, DOI 10.1016/j.ecoleng.2009.09.007	51	14	18	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94345	10.1371/journal.pone.0094345	http://dx.doi.org/10.1371/journal.pone.0094345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714585	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900121
J	Das, B; Satapathy, T; Kar, SK; Hazra, RK				Das, Biswadeep; Satapathy, Truptimayee; Kar, Santanu K.; Hazra, Rupenangshu K.			Genetic Structure and Wolbachia Genotyping in Naturally Occurring Populations of Aedes albopictus across Contiguous Landscapes of Orissa, India	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; CHIKUNGUNYA VIRUS; MOLECULAR INVESTIGATIONS; ALLELE FREQUENCY; TIGER MOSQUITO; EASTERN INDIA; DENGUE VIRUS; OUTBREAKS; PHYLOGENY; EVOLUTION	Background: Aedes albopictus has recently been implicated as a major vector in the emergence of dengue and chikungunya in several parts of India, like Orissa, which is gradually gaining endemicity for arboviral diseases. Ae. albopictus is further known to be naturally infected with Wolbachia (maternally inherited bacterium), which causes cytoplasmic incompatibility (CI) in mosquitoes leading to sperm-egg incompatibility inducing the death of embryo. Knowledge of genetic diversity of Ae. albopictus, along with revealing the type of Wolbachia infection in Ae. albopictus is important to explore the genetic and biological characteristics of Ae. albopictus, prior to exploring the uses of CI-based vector control strategies. In this study, we assessed the population genetic structure and the pattern of Wolbachia infection in Ae. albopictus mosquitoes of Orissa. Methods and Results: Ae. albopictus mosquitoes were collected from 15 districts representing the four physiographical regions of Orissa from 2010-2012, analyzed for genetic variability at seven microsatellite loci and genotyped for Wolbachia strain detection using wsp gene primers. Most microsatellite markers were successfully amplified and were polymorphic, showing moderate genetic structure among all geographic populations (F-ST = 0.088). Genetic diversity was high (F-ST = 0.168) in Coastal Plains populations when compared with other populations, which was also evident from cluster analyses that showed most Coastal Plains populations consisted of a separate genetic cluster. Genotyping analyses revealed that Wolbachia-infected Ae. albopictus field populations of Orissa were mostly superinfected with wAlbA and wAlbB strains. Wolbachia superinfection was more pronounced in the Coastal Plain populations. Conclusion: High genetic structure and Wolbachia superinfection, observed in the Coastal Plain populations of Orissa suggested it to be genetically and biologically more unique than other populations, and hence could influence their vectorial attributes. Such high genetic diversity observed among Coastal Plains populations could be attributed to multiple introductions of Ae. albopictus in this region.	[Das, Biswadeep; Satapathy, Truptimayee; Kar, Santanu K.; Hazra, Rupenangshu K.] Reg Med Res Ctr, Dept Med Entomol, Bhubaneswar, Orissa, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar	Hazra, RK (corresponding author), Reg Med Res Ctr, Dept Med Entomol, Bhubaneswar, Orissa, India.	rupenkh@yahoo.co.in	Das, Biswadeep/AAX-5120-2020	Das, Biswadeep/0000-0001-8214-3600				Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Barraud PJ, 1934, FAMILY CULICIDAE TRI, P217; Belkhir K., 2001, GENETIX 4 02 LOGICIE; Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; Cornuet JM, 1996, GENETICS, V144, P2001; Das B, 2013, J VECTOR DIS, V50, P147; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Das B, 2012, INFECT GENET EVOL, V12, P1094, DOI 10.1016/j.meegid.2012.03.012; Das B, 2012, TROP MED INT HEALTH, V17, P235, DOI 10.1111/j.1365-3156.2011.02899.x; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Dwibedi B, 2011, INDIAN J MED RES, V133, P316; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 2005, NATURE, V436, P189, DOI 10.1038/436189a; HOLM S, 1979, SCAND J STAT, V6, P65; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1423, DOI 10.1098/rspb.2001.1656; Kalra N. L., 1997, Dengue Bulletin, V21, P84; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; MANTEL N, 1967, CANCER RES, V27, P209; Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nei M., 1987, MOL EVOLUTIONARY GEN; Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189; Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Schneider S., 2000, ARLEQUIN VERSION 20; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Smith CEG, 1956, J TROP MED HYG, V59, P3; TABACHNICK WJ, 1995, PARASITOL TODAY, V11, P27, DOI 10.1016/0169-4758(95)80105-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	50	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94094	10.1371/journal.pone.0094094	http://dx.doi.org/10.1371/journal.pone.0094094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714653	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900081
J	de Wijk, RA; He, W; Mensink, MGJ; Verhoeven, RHG; de Graaf, C				de Wijk, Rene A.; He, Wei; Mensink, Manon G. J.; Verhoeven, Rob H. G.; de Graaf, Cees			ANS Responses and Facial Expressions Differentiate between the Taste of Commercial Breakfast Drinks	PLOS ONE			English	Article							EMOTIONS	The high failure rate of new market introductions, despite initial successful testing with traditional sensory and consumer tests, necessitates the development of other tests. This study explored the ability of selected physiological and behavioral measures of the autonomic nervous system (ANS) to distinguish between repeated exposures to foods from a single category (breakfast drinks) and with similar liking ratings. In this within-subject study 19 healthy young adults sipped from five breakfast drinks, each presented five times, while ANS responses (heart rate, skin conductance response and skin temperature), facial expressions, liking, and intensities were recorded. The results showed that liking was associated with increased heart rate and skin temperature, and more neutral facial expressions. Intensity was associated with reduced heart rate and skin temperature, more neutral expressions and more negative expressions of sadness, anger and surprise. Strongest associations with liking were found after 1 second of tasting, whereas strongest associations with intensity were found after 2 seconds of tasting. Future studies should verify the contribution of the additional information to the prediction of market success.	[de Wijk, Rene A.; He, Wei; Mensink, Manon G. J.; Verhoeven, Rob H. G.] Wageningen Univ & Res Ctr, Wageningen, Netherlands; [de Wijk, Rene A.; de Graaf, Cees] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	de Wijk, RA (corresponding author), Wageningen Univ & Res Ctr, Wageningen, Netherlands.	rene.dewijk@wur.nl						Aue T, 2007, BIOL PSYCHOL, V74, P347, DOI 10.1016/j.biopsycho.2006.09.001; Danner L, 2013, FOOD QUAL P IN PRESS, DOI [10.1016/j.foodq-ual.2013.01.004, DOI 10.1016/J.FOODQ-UAL.2013.01.004]; de Wijk RA, 2012, FOOD QUAL PREFER, V26, P196, DOI 10.1016/j.foodqual.2012.04.015; Delplanque S, 2009, EMOTION, V9, P316, DOI 10.1037/a0015369; Desmet PMA, 2008, APPETITE, V50, P290, DOI 10.1016/j.appet.2007.08.003; Ekman P, 1992, PHILOS T ROYAL SOC B; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Frijda N, 1999, WELL BEING FDN HEDON, P190; GILBERT AN, 1987, CHEM SENSES, V12, P355, DOI 10.1093/chemse/12.2.355; He W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00110; King SC, 2010, FOOD QUAL PREFER, V21, P168, DOI 10.1016/j.foodqual.2009.02.005; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Maier A, 2007, INFLUENCE PRATIQUES; Park B, 2005, PERS SOC PSYCHOL REV, V9, P108, DOI 10.1207/s15327957pspr0902_2; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rozin P., 1999, WELL BEING FDN HEDON, P109; Steiner J E, 1973, Symp Oral Sens Percept, P254; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; van Kuilenburg H, 2005, LECT NOTES ARTIF INT, V3720, P194, DOI 10.1007/11564096_22; Zeinstra GG, 2009, FOOD QUAL PREFER, V20, P620, DOI 10.1016/j.foodqual.2009.07.002	20	64	65	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93823	10.1371/journal.pone.0093823	http://dx.doi.org/10.1371/journal.pone.0093823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714107	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900052
J	Gnoli, A; Puglisi, A; Sarracino, A; Vulpiani, A				Gnoli, Andrea; Puglisi, Andrea; Sarracino, Alessandro; Vulpiani, Angelo			Nonequilibrium Brownian Motion beyond the Effective Temperature	PLOS ONE			English	Article							FLUCTUATION-DISSIPATION; TRANSITION; LIQUIDS	The condition of thermal equilibrium simplifies the theoretical treatment of fluctuations as found in the celebrated Einstein's relation between mobility and diffusivity for Brownian motion. Several recent theories relax the hypothesis of thermal equilibrium resulting in at least two main scenarios. With well separated timescales, as in aging glassy systems, equilibrium Fluctuation-Dissipation Theorem applies at each scale with its own "effective'' temperature. With mixed timescales, as for example in active or granular fluids or in turbulence, temperature is no more well-defined, the dynamical nature of fluctuations fully emerges and a Generalized Fluctuation-Dissipation Theorem (GFDT) applies. Here, we study experimentally the mixed timescale regime by studying fluctuations and linear response in the Brownian motion of a rotating intruder immersed in a vibro-fluidized granular medium. Increasing the packing fraction, the system is moved from a dilute single-timescale regime toward a denser multiple-timescale stage. Einstein's relation holds in the former and is violated in the latter. The violation cannot be explained in terms of effective temperatures, while the GFDT is able to impute it to the emergence of a strong coupling between the intruder and the surrounding fluid. Direct experimental measurements confirm the development of spatial correlations in the system when the density is increased.	[Gnoli, Andrea; Puglisi, Andrea; Sarracino, Alessandro; Vulpiani, Angelo] CNR, Ist Sistemi Complessi, Rome, Italy; [Gnoli, Andrea; Puglisi, Andrea; Sarracino, Alessandro; Vulpiani, Angelo] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Sarracino, Alessandro] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, Unite Mixte Rech 7600, Paris, France	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Puglisi, A (corresponding author), CNR, Ist Sistemi Complessi, Rome, Italy.	andrea.puglisi@roma1.infn.it	Gnoli, Andrea/AAY-2499-2020; Puglisi, Andrea/C-5566-2008	Gnoli, Andrea/0000-0003-2981-7199; Puglisi, Andrea/0000-0002-7229-9457; Sarracino, Alessandro/0000-0003-3686-0822	Italian MIUR [RBID08Z9JE, 2009PYYZM5]	Italian MIUR(Ministry of Education, Universities and Research (MIUR))	The authors acknowledge the support of the Italian MIUR under the grants: FIRB-IDEAS n. RBID08Z9JE. AP and AV acknowledge the support of the Italian MIUR under the grant PRIN n. 2009PYYZM5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiesi M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.010602; Berthier L, 2013, NAT PHYS, V9, P310, DOI [10.1038/NPHYS2592, 10.1038/nphys2592]; Berthier L, 2011, REV MOD PHYS, V83, P587, DOI 10.1103/RevModPhys.83.587; Bialke J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168301; Crisanti A, 2003, J PHYS A-MATH GEN, V36, pR181, DOI 10.1088/0305-4470/36/21/201; Cugliandolo LF, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/48/483001; D'Anna G, 2003, NATURE, V424, P909, DOI 10.1038/nature01867; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Fiege A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.098001; Fily Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235702; Gnoli A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.120601; Hayakawa H, 2005, PHYSICA D, V205, P48, DOI 10.1016/j.physd.2004.12.011; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Joubaud S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.130601; Keys AS, 2007, NAT PHYS, V3, P260, DOI 10.1038/nphys572; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Lippiello E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036104; Loi D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051111; Makse HA, 2002, NATURE, V415, P614, DOI 10.1038/415614a; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Marconi UMB, 2008, PHYS REP, V461, P111, DOI 10.1016/j.physrep.2008.02.002; Ono IK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.095703; Orpe AV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238001; Puglisi A, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08016; Sarracino A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/34001; Sarracino A, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04013; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Villamaina D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07024; Wang P, 2006, NAT PHYS, V2, P526, DOI 10.1038/nphys366	30	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93720	10.1371/journal.pone.0093720	http://dx.doi.org/10.1371/journal.pone.0093720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714671	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900044
J	Kondo, S; Bottos, A; Allegood, JC; Masson, R; Maurer, FG; Genoud, C; Kaeser, P; Huwiler, A; Murakami, M; Spiegel, S; Hynes, NE				Kondo, Shunya; Bottos, Alessia; Allegood, Jeremy C.; Masson, Regis; Maurer, Francisca G.; Genoud, Christel; Kaeser, Patrick; Huwiler, Andrea; Murakami, Masato; Spiegel, Sarah; Hynes, Nancy E.			Memo Has a Novel Role in S1P Signaling and Crucial for Vascular Development	PLOS ONE			English	Article							SPHINGOSINE KINASE-1 EXPRESSION; PROTEIN-COUPLED RECEPTOR; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; SPHINGOSINE-1-PHOSPHATE; EDG-1; LAMELLIPODIA; 1-PHOSPHATE; INHIBITION; LINKS	Memo is a conserved protein that was identified as an essential mediator of tumor cell motility induced by receptor tyrosine kinase activation. Here we show that Memo null mouse embryonic fibroblasts (MEFs) are impaired in PDGF-induced migration and this is due to a defect in sphingosine-1-phosphate (S1P) signaling. S1P is a bioactive phospholipid produced in response to multiple stimuli, which regulates many cellular processes. S1P is secreted to the extracellular milieu where it exerts its function by binding a family of G-protein coupled receptors (S1PRs), causing their activation in an autocrine or paracrine manner. The process, termed cell-autonomous S1PR signaling, plays a role in survival and migration. Indeed, PDGF uses cell-autonomous S1PR signaling to promote cell migration; we show here that this S1P pathway requires Memo. Using vascular endothelial cells (HUVECs) with Memo knock-down we show that their survival in conditions of serum-starvation is impaired. Furthermore, Memo loss in HUVECs causes a reduction of junctional VE-cadherin and an increase in sprout formation. Each of these phenotypes is rescued by S1P or S1P agonist addition, showing that Memo also plays an important role in cell-autonomous S1PR signaling in endothelial cells. We also produced conventional and endothelial cell-specific conditional Memo knock-out mouse strains and show that Memo is essential for embryonic development. Starting at E13.5 embryos of both strains display bleeding and other vascular problems, some of the phenotypes that have been described in mouse strains lacking S1PRs. The essential role of Memo in embryonic vascular development may be due in part to alterations in S1P signaling. Taken together our results show that Memo has a novel role in the S1P pathway and that Memo is needed to promote cell-autonomous S1PR activation.	[Kondo, Shunya; Bottos, Alessia; Masson, Regis; Maurer, Francisca G.; Genoud, Christel; Kaeser, Patrick; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Allegood, Jeremy C.; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA USA; [Kaeser, Patrick; Hynes, Nancy E.] Univ Basel, Basel, Switzerland; [Huwiler, Andrea] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Murakami, Masato] Novartis Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Virginia Commonwealth University; University of Basel; University of Bern; Novartis	Hynes, NE (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	nancy.hynes@fmi.ch		genoud, christel/0000-0002-0933-9911	Novartis Research Foundation; Swiss National Science Foundation [SNF 310030A-121574, 310030B-138674]; EU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Novartis Research Foundation (http://www.fmi.ch/), the Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx): SNF 310030A-121574 and 310030B-138674, and the EU FP6 Integrated Project-TRANSFOG (http://www.healthcompetence.eu/converis/publicweb/project/3397; jsessionid = 6e322a0cc3a9c0b0b0016ec382f9? show = Person). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Benseddik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055211; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Haenzi B, 2013, FASEB J; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qiu C, 2008, J BIOL CHEM, V283, P2734, DOI 10.1074/jbc.M703523200; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schlatter ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032501; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Sorokin AV, 2013, ONCOGENE, V32, P3130, DOI 10.1038/onc.2012.327; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Waters D, 2006, FASEB J, V20, pA1058; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	46	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94114	10.1371/journal.pone.0094114	http://dx.doi.org/10.1371/journal.pone.0094114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714781	Green Published, gold			2022-12-27	WOS:000334160900085
J	Segolodi, TM; Henderson, FL; Rose, CE; Turner, KT; Zeh, C; Fonjungo, PN; Niska, R; Hart, C; Paxton, LA				Segolodi, Tebogo M.; Henderson, Faith L.; Rose, Charles E.; Turner, Kyle T.; Zeh, Clement; Fonjungo, Peter N.; Niska, Richard; Hart, Clyde; Paxton, Lynn A.			Normal Laboratory Reference Intervals among Healthy Adults Screened for a HIV Pre-Exposure Prophylaxis Clinical Trial in Botswana	PLOS ONE			English	Article							REFERENCE RANGES; POPULATION; HEMATOLOGY; AFRICAN; VALUES	Introduction: Accurate clinical laboratory reference values derived from a local or regional population base are required to correctly interpret laboratory results. In Botswana, most reference intervals used to date are not standardized across clinical laboratories and are based on values derived from populations in the United States or Western Europe. Methods: We measured 14 hematologic and biochemical parameters of healthy young adults screened for participation in the Botswana HIV Pre-exposure Prophylaxis Study using tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) (TDF2 Study). Reference intervals were calculated using standard methods, stratified by gender, and compared with the sitederived reference values used for the TDF2 study (BOTUSA ranges), the Division of AIDS (DAIDS) Grading Table for Adverse Events, the Botswana public health laboratories, and other regional references. Results: Out of 2533 screened participants, 1786 met eligibility criteria for participation in study and were included in the analysis. Our reference values were comparable to those of the Botswana public health system except for amylase, blood urea nitrogen (BUN), phosphate, total and direct bilirubin. Compared to our reference values, BOTUSA reference ranges would have classified participants as out of range for some analytes, with amylase (50.8%) and creatinine (32.0%) producing the highest out of range values. Applying the DAIDS toxicity grading system to the values would have resulted in 45 and 18 participants as having severe or life threatening values for amylase and hemoglobin, respectively. Conclusion: Our reference values illustrate the differences in hematological and biochemical analyte ranges between African and Western populations. Thus, the use of western-derived reference laboratory values to screen a group of Batswana adults resulted in many healthy people being classified as having out-of-range blood analytes. The need to establish accurate local or regional reference values is apparent and we hope our results can be used to that end in Botswana.	[Segolodi, Tebogo M.; Henderson, Faith L.; Fonjungo, Peter N.] United States Centers Dis Control & Prevent Botsw, Gaborone, Botswana; [Rose, Charles E.; Fonjungo, Peter N.; Niska, Richard; Hart, Clyde; Paxton, Lynn A.] United States Centers Dis Control & Prevent, Atlanta, GA USA; [Zeh, Clement] United States Centers Dis Control & Prevent Kenya, 4ICF Int, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Segolodi, TM (corresponding author), United States Centers Dis Control & Prevent Botsw, Gaborone, Botswana.	hor9@cdc.gov			Botswana Ministry of Health; US Centers for Disease Control and Prevention	Botswana Ministry of Health; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Botswana Ministry of Health and the US Centers for Disease Control and Prevention funded this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussmann H, 2004, CLIN DIAGN LAB IMMUN, V11, P930, DOI 10.1128/CDLI.11.5.930-935.2004; DAIDS, 2004, DIV AIDS TABL GRAD S; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kratz A, 1998, NEW ENGL J MED, V339, P1063, DOI 10.1056/NEJM199810083391508; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maphephu SM, 2011, S AFRI MED J, V101; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Mine M, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.5; Mold JW, 1998, J FAM PRACTICE, V46, P233; National Committee for Clinical Laboratory Standards (NCCLS), 2000, C28A2 NCCLS CLIN LAB, V20; Roman VRG, 2012, CLIN VACCINE IMMUNOL, V19, P1322, DOI 10.1128/CVI.00170-12; Rustad P, 2003, REFERENCE INTERVALS; Solberg HE, 2001, TIETZ FUNDAMENTALS C; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	19	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93034	10.1371/journal.pone.0093034	http://dx.doi.org/10.1371/journal.pone.0093034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714095	gold, Green Published			2022-12-27	WOS:000334160900012
J	Spiotto, MT; Weichselbaum, RR				Spiotto, Michael T.; Weichselbaum, Ralph R.			Comparison of 3D Confromal Radiotherapy and Intensity Modulated Radiotherapy with or without Simultaneous Integrated Boost during Concurrent Chemoradiation for Locally Advanced Head and Neck Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; RADIATION-THERAPY; ACCELERATED RADIOTHERAPY; STANDARD FRACTIONATION; IMRT; CHEMOTHERAPY; SIB	Objective: Radiotherapy techniques have evolved from 3D conformal radiotherapy (3D-CRT) to intensity modulated radiotherapy (IMRT) where boost fields are delivered either sequentially (IMRTseq) or with a simultaneous integrated boost (IMRT+ SIB). Our goal was to compare the outcomes of patients treated with IMRT+ SIB to traditional standards. Methods: We analyzed the efficacy and toxicity of patients treated with concurrent chemoradiation using 3D-CRT, IMRTseq or IMRT+ SIB. Between 1993 and 2012, 379 patients with non-metastatic Stage III-IV head and neck squamous cell cancer were treated with concurrent chemoradiation using 3D-CRT (n = 125), IMRTseq (n = 120) and IMRT+ SIB (n = 134). Results: Patients treated with any technique had similar rates of 2y local control, 2y regional control, 2y progression free survival and 2y overall survival. Patients treated with IMRT+ SIB had lower rates acute toxicity according to Grade 3 or greater mucositis (3D-CRT: 44.0% vs. IMRTseq: 36.7% vs. IMRT+ SIB: 22.4%; P<.0001), dermatitis (3D-CRT: 44.0% vs. IMRTseq: 20.0% vs. IMRT+ SIB: 7.5%; P<.0001) and feeding tube placement during radiotherapy (3D-CRT: 80.0% vs. IMRTseq: 50.8% vs. IMRT+ SIB: 44.0%; P<.0001) as well as late toxicity as measured by feeding tube use (P<.0001) and tracheostomy use (P<.0001). On multivariate analysis, IMRT+ SIB predicted for less mucositis, dermatitis and feeding tube use compared to 3D-CRT and for less dermatitis compared to IMRTseq. Conclusions: Compared to 3D-CRT and IMRTseq, IMRT+ SIB provided similar outcomes and potentially less toxicity indicating it is a feasible technique for chemoradiation in locally advanced head and neck cancer.	[Spiotto, Michael T.; Weichselbaum, Ralph R.] Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Spiotto, Michael T.; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat Oncol, Hosp & Hlth Sci Syst, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center; University of Chicago	Spiotto, MT (corresponding author), Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	mspiotto@radonc.uchicago.edu	Spiotto, Michael/AAC-8331-2021		Burroughs Wellcome Career Award for Medical Scientists; Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE [R25CA132822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	M.T.S. was supported by a grant from the Burroughs Wellcome Career Award for Medical Scientists and the Fanconi Anemia Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang K, 2010, INT J RADIAT ONCOL, V77, P1, DOI 10.1016/j.ijrobp.2010.01.019; Brizel DM, 1998, NEW ENGL J MED, V338, P1798, DOI 10.1056/NEJM199806183382503; Chao KSC, 2003, INT J RADIAT ONCOL, V55, P312, DOI 10.1016/S0360-3016(02)03940-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cozzi L, 2004, INT J RADIAT ONCOL, V58, P617, DOI 10.1016/j.ijrobp.2003.09.059; Eisbruch A, 2010, INT J RADIAT ONCOL, V76, P1333, DOI 10.1016/j.ijrobp.2009.04.011; Franceschini D, 2013, LARYNGOSCOPE, V123, pE97, DOI 10.1002/lary.24257; Fu KK, 2000, INT J RADIAT ONCOL, V48, P7, DOI 10.1016/S0360-3016(00)00663-5; Karnofsky DA, 1949, CLIN EVALUATION CHEM; Lauve A, 2004, INT J RADIAT ONCOL, V60, P374, DOI 10.1016/j.ijrobp.2004.03.010; Leclerc M, 2013, RADIOTHER ONCOL, V106, P333, DOI 10.1016/j.radonc.2013.03.002; Lee NY, 2007, INT J RADIAT ONCOL, V69, P459, DOI 10.1016/j.ijrobp.2007.03.013; Lee SW, 2006, INT J RADIAT ONCOL, V65, P152, DOI 10.1016/j.ijrobp.2005.10.040; Mohan R, 2000, INT J RADIAT ONCOL, V46, P619, DOI 10.1016/S0360-3016(99)00438-1; Montejo ME, 2011, INT J RADIAT ONCOL, V81, pE845, DOI 10.1016/j.ijrobp.2010.10.021; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Orlandi E, 2010, CRIT REV ONCOL HEMAT, V73, P111, DOI 10.1016/j.critrevonc.2009.03.003; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Palazzi M, 2006, TUMORI J, V92, P503, DOI 10.1177/030089160609200607; Schwartz M, 2007, OTOLARYNG HEAD NECK, V136, P549, DOI 10.1016/j.otohns.2006.10.044; Studer G, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-7; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X	22	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94456	10.1371/journal.pone.0094456	http://dx.doi.org/10.1371/journal.pone.0094456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714187	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900134
J	He, LY; Han, XT; Yu, ZM				He, Liyan; Han, Xiaotian; Yu, Zhiming			A Rare Phaeodactylum tricornutum Cruciform Morphotype: Culture Conditions, Transformation and Unique Fatty Acid Characteristics	PLOS ONE			English	Article							FLUORESCENCE METHOD; CARBON FIXATION; DIATOM; BIODIESEL; REVEALS	A rare Phaeodactylum tricornutum cruciform morphotype was obtained and stabilized with a proportion of more than 31.3% in L1 medium and is reported for the first time. Long-term culture and observation showed that the cruciform morphotype was capable of transforming to the oval form following the degeneration of arms by two processes. After three months of culture, four morphotypes existed in a relatively stable proportion in culture for six months (10.5% for oval, 11.3% for fusiform, 37.2% for triradiate and 41.0% for cruciform). Low temperature was particularly beneficial for cruciform cell formation. As the culture temperature decreased from 25 degrees C to 10 degrees C, the percentage of the cruciform morphotype increased from 39.1% to 55.3% approximately. The abundant cruciform cells endowed this strain with unique fatty acid characteristics. The strain cultured at 15 degrees C showed both maximum content of neutral lipid in a single cell and total yield. The maximum content of fatty acid methyl esters was C16: 1 for Phaeodactylum tricornutum cultured at four temperatures (43.82% to 50.82%), followed by C16: 0 (20.47% to 22.65%). Unique fatty acid composition endowed this strain with excellent quality for biodiesel production.	[He, Liyan; Han, Xiaotian; Yu, Zhiming] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [He, Liyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, ZM (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	zyu@qdio.ac.cn		Yu, Zhiming/0000-0003-0377-1129	National Natural Science Foundation of China [2011CB2009001]; State Oceanic Administration Project [GHME2001SW02]; Funds for Creative Research Groups of China [41121064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Oceanic Administration Project; Funds for Creative Research Groups of China(Science Fund for Creative Research Groups)	This work was financially supported by the National Natural Science Foundation of China (2011CB2009001), the State Oceanic Administration Project (GHME2001SW02) and the Funds for Creative Research Groups of China (41121064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartual A, 2008, BOT MAR, V51, P350, DOI 10.1515/BOT.2008.047; Bartual A, 2011, DIATOM RES, V26, P243, DOI 10.1080/0269249X.2011.619365; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brennan L, 2012, J MICROBIOL METH, V90, P137, DOI 10.1016/j.mimet.2012.03.020; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; Chen W, 2011, BIORESOURCE TECHNOL, V102, P135, DOI 10.1016/j.biortech.2010.06.076; Cooper MS, 2010, J BIOSCI BIOENG, V109, P198, DOI 10.1016/j.jbiosc.2009.08.004; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; De Martino A, 2011, PROTIST, V162, P462, DOI 10.1016/j.protis.2011.02.002; Desbois AP, 2010, J MAR BIOL ASSOC UK, V90, P769, DOI 10.1017/S0025315409991366; Fabris M, 2012, PLANT J, V70, P1004, DOI 10.1111/j.1365-313X.2012.04941.x; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Garcia MCC, 2005, PROCESS BIOCHEM, V40, P297, DOI 10.1016/j.procbio.2004.01.016; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hyka P, 2013, BIOTECHNOL ADV, V31, P2, DOI 10.1016/j.biotechadv.2012.04.007; Jiang HM, 2004, J PHYCOL, V40, P651, DOI 10.1111/j.1529-8817.2004.03112.x; Knothe G, 2006, J AM OIL CHEM SOC, V83, P823, DOI 10.1007/s11746-006-5033-y; Lapuerta M, 2009, ENERG POLICY, V37, P4337, DOI 10.1016/j.enpol.2009.05.049; LEWIN JC, 1958, J GEN MICROBIOL, V18, P418, DOI 10.1099/00221287-18-2-418; Liu CP, 2005, MICRON, V36, P545, DOI 10.1016/j.micron.2005.05.001; Montsant A, 2005, PLANT PHYSIOL, V137, P500, DOI 10.1104/pp.104.052829; Phukan MM, 2011, APPL ENERG, V88, P3307, DOI 10.1016/j.apenergy.2010.11.026; Radakovits R, 2011, METAB ENG, V13, P89, DOI 10.1016/j.ymben.2010.10.003; Scala S, 2002, PLANT PHYSIOL, V129, P993, DOI 10.1104/pp.010713; Stanley MS, 2007, EUR J PHYCOL, V42, P191, DOI 10.1080/09670260701240863; Tesson B, 2009, BOT MAR, V52, P104, DOI 10.1515/BOT.2009.012; Valenzuela J, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-40; VELTKAMP CJ, 1994, HYDROBIOLOGIA, V288, P33, DOI 10.1007/BF00006803; WILSON DP, 1946, J MAR BIOL ASSOC UK, V26, P235, DOI 10.1017/S002531540001211X; Zendejas FJ, 2012, BIOTECHNOL BIOENG, V109, P1146, DOI 10.1002/bit.24395	32	11	12	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93922	10.1371/journal.pone.0093922	http://dx.doi.org/10.1371/journal.pone.0093922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710200	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800071
J	Kuijpers, MAR; Chiu, YT; Nada, RM; Carels, CEL; Fudalej, PS				Kuijpers, Mette A. R.; Chiu, Yu-Ting; Nada, Rania M.; Carels, Carine E. L.; Fudalej, Piotr S.			Three-dimensional Imaging Methods for Quantitative Analysis of Facial Soft Tissues and Skeletal Morphology in Patients with Orofacial Clefts: A Systematic Review	PLOS ONE			English	Review							BEAM COMPUTED-TOMOGRAPHY; SECONDARY ALVEOLAR BONE; DENTAL ARCH RELATIONSHIPS; LIP-NOSE DEFORMITY; RAPID MAXILLARY EXPANSION; PRIMARY PALATAL REPAIR; CLASS-III MALOCCLUSION; QUALITY-OF-LIFE; UNILATERAL CLEFT; ADULT PATIENTS	Background: Current guidelines for evaluating cleft palate treatments are mostly based on two-dimensional (2D) evaluation, but three-dimensional (3D) imaging methods to assess treatment outcome are steadily rising. Objective: To identify 3D imaging methods for quantitative assessment of soft tissue and skeletal morphology in patients with cleft lip and palate. Data sources: Literature was searched using PubMed (1948-2012), EMBASE (1980-2012), Scopus (2004-2012), Web of Science (1945-2012), and the Cochrane Library. The last search was performed September 30, 2012. Reference lists were hand searched for potentially eligible studies. There was no language restriction. Study selection: We included publications using 3D imaging techniques to assess facial soft tissue or skeletal morphology in patients older than 5 years with a cleft lip with/or without cleft palate. We reviewed studies involving the facial region when at least 10 subjects in the sample size had at least one cleft type. Only primary publications were included. Data extraction: Independent extraction of data and quality assessments were performed by two observers. Results: Five hundred full text publications were retrieved, 144 met the inclusion criteria, with 63 high quality studies. There were differences in study designs, topics studied, patient characteristics, and success measurements; therefore, only a systematic review could be conducted. Main 3D-techniques that are used in cleft lip and palate patients are CT, CBCT, MRI, stereophotogrammetry, and laser surface scanning. These techniques are mainly used for soft tissue analysis, evaluation of bone grafting, and changes in the craniofacial skeleton. Digital dental casts are used to evaluate treatment and changes over time. Conclusion: Available evidence implies that 3D imaging methods can be used for documentation of CLP patients. No data are available yet showing that 3D methods are more informative than conventional 2D methods. Further research is warranted to elucidate it.	[Kuijpers, Mette A. R.; Nada, Rania M.; Carels, Carine E. L.; Fudalej, Piotr S.] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands; [Kuijpers, Mette A. R.; Carels, Carine E. L.] Radboud Univ Nijmegen, Med Ctr, Cleft Palate Craniofacial Unit, NL-6525 ED Nijmegen, Netherlands; [Chiu, Yu-Ting] Chang Gung Mem Hosp, Dept Dent & Craniofacial Ctr, Taipei 10591, Taiwan; [Fudalej, Piotr S.] Univ Bern, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Fudalej, Piotr S.] Palacky Univ, Dept Orthodont, CR-77147 Olomouc, Czech Republic	Radboud University Nijmegen; Radboud University Nijmegen; Chang Gung Memorial Hospital; University of Bern; Palacky University Olomouc	Kuijpers, MAR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Craniofacial Biol, NL-6525 ED Nijmegen, Netherlands.	orthodontics@dent.umcn.nl	Fudalej, Piotr/AAT-6154-2021; Carels, C.E.L./H-8020-2014; Carels, Carine E.L./E-6676-2016; Fudalej, Piotr/AAD-6871-2019; Kuijpers, Mette/H-3308-2015	Fudalej, Piotr/0000-0001-8777-7434; Carels, Carine E.L./0000-0002-8974-9223; Kuijpers, Mette/0000-0001-6462-9789				Agarwal R, 2012, J CRANIOFAC SURG, V23, P1338, DOI 10.1097/SCS.0b013e31826466d8; Al-Omari I, 2003, CLEFT PALATE-CRAN J, V40, P530, DOI 10.1597/1545-1569(2003)040<0530:AAOTMO>2.0.CO;2; Alonso N, 2010, TISSUE ENG PART C-ME, V16, P1183, DOI [10.1089/ten.tec.2009.0824, 10.1089/ten.TEC.2009.0824]; American Cleft Palate Association, 2009, GUID TEAM EV AM CLEF; Aras I, 2012, CLEFT PALATE-CRAN J, V49, pE75, DOI 10.1597/12-004; Arctander K, 2005, SCAND J PLAST RECONS, V39, P11, DOI 10.1080/02844310410021749; Asquith JA, 2012, CLEFT PALATE-CRAN J, V49, P530, DOI 10.1597/10-099; Atik B, 2008, J CRANIOFAC SURG, V19, P566, DOI 10.1097/SCS.0b013e31816ae746; Ayoub A, 2011, CLEFT PALATE-CRAN J, V48, P379, DOI 10.1597/10-057; Ayoub A, 2011, CLEFT PALATE-CRAN J, V48, P578, DOI 10.1597/09-148; Ayoub A, 2011, CLEFT PALATE-CRAN J, V48, P571, DOI 10.1597/09-147; Bejdova S, 2012, J CRANIO MAXILL SURG, V40, P201, DOI 10.1016/j.jcms.2011.04.013; Bennun RD, 1999, PLAST RECONSTR SURG, V104, P616, DOI 10.1097/00006534-199909030-00002; Bilwatsch S, 2006, J CRANIO MAXILL SURG, V34, P253, DOI 10.1016/j.jcms.2006.03.001; Bos A, 2011, ANGLE ORTHOD, V81, P865, DOI 10.2319/070110-365.1; Brons S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041898; Bugaighis I, 2010, EUR J ORTHODONT, V32, P514, DOI 10.1093/ejo/cjp140; Chawla O, 2013, CLEFT PALATE-CRAN J, V50, P182, DOI 10.1597/11-283; Chawla O, 2012, EUR J ORTHODONT, V34, P768, DOI 10.1093/ejo/cjr096; Chen PKT, 2011, CLEFT PALATE-CRAN J, V48, P445, DOI 10.1597/09-087; Cheung T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043405; Choi J, 2012, J PLAST RECONSTR AES, V65, P1461, DOI 10.1016/j.bjps.2012.05.025; Chowdhury SKR, 2006, MED J ARMED FORCES I, V62, P231; Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4; Clark SL, 2011, J CRANIOFAC SURG, V22, P333, DOI 10.1097/SCS.0b013e318200d874; Contreras V, 2011, J MAXILO, V33, P105; Dado DV, 1997, PLAST RECONSTR SURG, V99, P1840, DOI 10.1097/00006534-199706000-00006; Denny AD, 1999, CLEFT PALATE-CRAN J, V36, P144, DOI 10.1597/1545-1569(1999)036<0144:SABGUM>2.3.CO;2; Devlin MF, 2007, CLEFT PALATE-CRAN J, V44, P391, DOI 10.1597/06-179.1; Dickinson BP, 2008, PLAST RECONSTR SURG, V121, P209, DOI 10.1097/01.prs.0000293870.64781.12; Dogan S, 2012, CLEFT PALATE-CRAN J, V49, P347, DOI 10.1597/10-269; Duffy S, 2000, CLEFT PALATE-CRAN J, V37, P137, DOI 10.1597/1545-1569(2000)037<0137:TDAOTC>2.3.CO;2; European Commission, 2012, RAD PROT 172 CON BEA; Feichtinger M, 2006, J CRANIO MAXILL SURG, V34, P144, DOI 10.1016/j.jcms.2005.11.005; Feichtinger M, 2008, BRIT J ORAL MAX SURG, V46, P278, DOI 10.1016/j.bjoms.2007.12.010; Feichtinger M, 2007, CLEFT PALATE-CRAN J, V44, P142, DOI 10.1597/06-047.1; Ferrario VF, 2003, ANN PLAS SURG, V51, P390, DOI 10.1097/01.SAP.0000067966.98832.96; Ferrario VF, 2003, CLEFT PALATE-CRAN J, V40, P544, DOI 10.1597/1545-1569(2003)040<0544:AQTAOA>2.0.CO;2; Ferrario VF, 2003, J CRANIOFAC SURG, V14, P739, DOI 10.1097/00001665-200309000-00026; Ferrario VF, 2003, PLAST RECONSTR SURG, V111, P2149, DOI 10.1097/01.PRS.0000060107.43208.21; Garib DG, 2012, CLEFT PALATE-CRAN J, V49, P208, DOI 10.1597/10-198; Gordon JM, 2009, ANGLE ORTHOD, V79, P1000, DOI 10.2319/082108-441.1; Grewal NS, 2009, PLAST RECONSTR SURG, V124, P1590, DOI 10.1097/PRS.0b013e3181b99e2e; Hamada Y, 2005, CLEFT PALATE-CRAN J, V42, P128, DOI 10.1597/03-035.1; Hathaway R, 2011, CLEFT PALATE-CRAN J, V48, P244, DOI 10.1597/09-181.1; Hegab AF, 2012, J ORAL MAXIL SURG, V70, pE337, DOI 10.1016/j.joms.2012.01.013; Herford AS, 2007, J ORAL MAXIL SURG, V65, P2136, DOI 10.1016/j.joms.2007.06.670; Hoefert CS, 2010, J OROFAC ORTHOP, V71, P221, DOI 10.1007/s00056-010-9932-z; Hoefert CS, 2010, J OROFAC ORTHOP, V71, P136, DOI 10.1007/s00056-010-9931-0; Honda Y, 2002, CLEFT PALATE-CRAN J, V39, P527, DOI 10.1597/1545-1569(2002)039<0527:RBPPFA>2.0.CO;2; Honma K, 1999, J ORAL MAXIL SURG, V57, P1209, DOI 10.1016/S0278-2391(99)90488-3; Iino M, 2005, SCAND J PLAST RECONS, V39, P15, DOI 10.1080/02844310410035410; Kau Chung H, 2011, Orthodontics (Chic.), V12, P188; Kawakami S, 2003, CLEFT PALATE-CRAN J, V40, P569, DOI 10.1597/02-052; Kilpelainen PVJ, 1996, CLEFT PALATE-CRAN J, V33, P483, DOI 10.1597/1545-1569(1996)033<0483:PAICPS>2.3.CO;2; Kilpelainen PVJ, 1996, CLEFT PALATE-CRAN J, V33, P477, DOI 10.1597/1545-1569(1996)033<0477:PMATOC>2.3.CO;2; Kim KR, 2008, ANGLE ORTHOD, V78, P631, DOI 10.2319/0003-3219(2008)078[0631:CIGSAB]2.0.CO;2; Kita H, 2004, CLEFT PALATE-CRAN J, V41, P36, DOI 10.1597/02-071; Kolbenstvedt A, 2002, ACTA RADIOL, V43, P567, DOI 10.1034/j.1600-0455.2002.430605.x; Korbmacher H, 2007, J OROFAC ORTHOP, V68, P278, DOI 10.1007/s00056-007-0653-x; Kratzsch H, 2000, J Orofac Orthop, V61, P305, DOI 10.1007/PL00001901; Kratzsch H, 2000, J Orofac Orthop, V61, P421, DOI 10.1007/PL00001910; Krey KF, 2009, J OROFAC ORTHOP, V70, P237, DOI 10.1007/s00056-009-8814-8; Krimmel M, 2011, J ORAL MAXIL SURG, V69, P80, DOI 10.1016/j.joms.2010.03.009; Kuijpers-Jagtman AM, 2000, CLEFT PALATE-CRAN J, V37, P527, DOI 10.1597/1545-1569(2000)037<0527:TIOSAO>2.0.CO;2; Lagravere MO, 2005, ANGLE ORTHOD, V75, P1046; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee SH, 2011, J ORAL MAXIL SURG, V69, P2644, DOI 10.1016/j.joms.2011.01.004; Leenarts CMR, 2012, INT J ORAL MAX SURG, V41, P180, DOI 10.1016/j.ijom.2011.11.004; Li F, 2011, HUA XI KOU QIANG YI, V29, P167; Li Fang, 2011, Hua Xi Kou Qiang Yi Xue Za Zhi, V29, P161; Li HQ, 2011, J ORAL MAXIL SURG, V69, pE549, DOI 10.1016/j.joms.2011.07.024; Li JT, 2012, OR SURG OR MED OR PA, V113, P300, DOI 10.1016/j.tripleo.2011.03.007; Long RE, 2011, CLEFT PALATE-CRAN J, V48, P239, DOI 10.1597/09-180.1; Maull DJ, 1999, CLEFT PALATE-CRAN J, V36, P391, DOI 10.1597/1545-1569(1999)036<0391:LTEONM>2.3.CO;2; McCance AM, 1997, CLEFT PALATE-CRAN J, V34, P58, DOI 10.1597/1545-1569(1997)034<0058:TDATPT>2.3.CO;2; McCance AM, 1997, CLEFT PALATE-CRAN J, V34, P36, DOI 10.1597/1545-1569(1997)034<0036:TDATPT>2.3.CO;2; Mercado A, 2011, CLEFT PALATE-CRAN J, V48, P259, DOI 10.1597/09-186.1; Meyer-Marcotty P, 2011, J CRANIO MAXILL SURG, V39, P158, DOI 10.1016/j.jcms.2010.05.001; Meyer-Marcotty P, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2008.11.023; Meyer-Marcotty P, 2009, J OROFAC ORTHOP, V70, P224, DOI 10.1007/s00056-009-8813-9; Mikoya T, 2010, CLEFT PALATE-CRAN J, V47, P454, DOI 10.1597/09-172; Millar K, 2013, CLEFT PALATE-CRAN J, V50, P150, DOI 10.1597/10-222; Miyamoto J, 2007, PLAST RECONSTR SURG, V120, P1612, DOI 10.1097/01.prs.0000267421.69284.c7; Miyamoto J, 2012, J PLAST RECONSTR AES, V65, P169, DOI 10.1016/j.bjps.2011.08.036; Miyamoto J, 2010, J PLAST RECONSTR AES, V63, P9, DOI 10.1016/j.bjps.2008.08.071; Mori A, 2005, BRIT J PLAST SURG, V58, P318, DOI 10.1016/j.bjps.2004.11.019; Nagasao T, 2008, J CRANIO MAXILL SURG, V36, P321, DOI 10.1016/j.jcms.2008.02.003; Nagasao T, 2008, PLAST RECONSTR SURG, V121, P2074, DOI 10.1097/PRS.0b013e3181706f87; Nagasao T, 2009, CLEFT PALATE-CRAN J, V46, P154, DOI 10.1597/07-177.1; Nagasao T, 2009, CLEFT PALATE-CRAN J, V46, P9, DOI 10.1597/07-169.1; Nakamura N, 2005, CLEFT PALATE-CRAN J, V42, P633, DOI 10.1597/03-151.1; Nakamura N, 2011, J ORAL MAXIL SURG, V69, pE469, DOI 10.1016/j.joms.2011.03.041; Nakamura N, 2011, J CRANIO MAXILL SURG, V39, P305, DOI 10.1016/j.jcms.2010.05.008; Nakamura N, 2010, J ORAL MAXIL SURG, V68, P2248, DOI 10.1016/j.joms.2009.06.012; Oberoi S, 2010, CLEFT PALATE-CRAN J, V47, P507, DOI 10.1597/08-171; Oberoi S, 2009, CLEFT PALATE-CRAN J, V46, P503, DOI 10.1597/08-153.1; Oh TS, 2011, J CRANIOFAC SURG, V22, P2080, DOI 10.1097/SCS.0b013e3182319971; Okawachi T, 2011, J ORAL MAXIL SURG, V69, P322, DOI 10.1016/j.joms.2010.05.057; Ozawa T, 2007, CLEFT PALATE-CRAN J, V44, P286, DOI 10.1597/06-054; Ozgur F, 2000, ANN PLAS SURG, V44, P8, DOI 10.1097/00000637-200044010-00002; Padricelli G., 2012, MONDO ORTOD, V37, P46, DOI [10.1016/j.mor.2011.11.001, DOI 10.1016/J.MOR.2011.11.001]; Proff P, 2006, J CRANIO MAXILL SURG, V34, P26, DOI 10.1016/S1010-5182(06)60007-3; Quereshy FA, 2012, J ORAL MAXIL SURG, V70, P188, DOI 10.1016/j.joms.2011.01.027; Raphael B, 2002, Ann Chir Plast Esthet, V47, P196, DOI 10.1016/S0294-1260(02)00105-X; Ras F, 1997, CLEFT PALATE-CRAN J, V34, P438, DOI 10.1597/1545-1569(1997)034<0438:SPOTLA>2.3.CO;2; RAS F, 1994, CLEFT PALATE-CRAN J, V31, P116, DOI 10.1597/1545-1569(1994)031<0116:TDEOFA>2.3.CO;2; RAS F, 1995, CLEFT PALATE-CRAN J, V32, P463, DOI 10.1597/1545-1569(1995)032<0463:LSOTDC>2.3.CO;2; RAS F, 1994, CLEFT PALATE-CRAN J, V31, P461, DOI 10.1597/1545-1569(1994)031<0461:FLRDIC>2.3.CO;2; RAS F, 1995, ANGLE ORTHOD, V65, P233; Rosenstein SW, 1997, CLEFT PALATE-CRAN J, V34, P199, DOI 10.1597/1545-1569(1997)034<0199:CODCFP>2.3.CO;2; Russell KA, 2001, CLEFT PALATE-CRAN J, V38, P476, DOI 10.1597/1545-1569(2001)038<0476:NMASPA>2.0.CO;2; Russell K, 2011, CLEFT PALATE-CRAN J, V48, P265, DOI 10.1597/09-187.1; Russell KA, 2011, CLEFT PALATE-CRAN J, V48, P28, DOI 10.1597/09-040; Rychlik D, 2012, J CRANIOFAC SURG, V23, P118, DOI 10.1097/SCS.0b013e318240faa0; Saijo H, 2010, J PLAST SURG HAND SU, V44, P21, DOI 10.3109/02844310903350857; Sander M, 2011, CLEFT PALATE-CRAN J, V48, P20, DOI 10.1597/09-007; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Santiago PE, 1998, CLEFT PALATE-CRAN J, V35, P77, DOI 10.1597/1545-1569(1998)035<0077:RNFABG>2.3.CO;2; Schliephake H, 2006, INT J ORAL MAX SURG, V35, P25, DOI 10.1016/j.ijom.2005.06.007; Schwenzer-Zimmerer K, 2008, CLEFT PALATE-CRAN J, V45, P607, DOI 10.1597/07-116.1; Schwenzer-Zimmerer K, 2008, J CRANIO MAXILL SURG, V36, P431, DOI 10.1016/j.jcms.2008.05.003; Sehhati-Chafai-Leuwer S, 2006, J CRANIO MAXILL SURG, V34, P351, DOI 10.1016/j.jcms.2006.03.006; Seike T, 2012, J MED INVESTIG, V59, P152, DOI 10.2152/jmi.59.152; Shaw WC, 2000, EUROCLEFT PROJECT 19; Shirota T, 2010, INT J ORAL MAX SURG, V39, P904, DOI 10.1016/j.ijom.2010.04.050; Simanca E, 2011, J CRANIOFAC SURG, V22, P1622, DOI 10.1097/SCS.0b013e31822e8ca0; Smahel Z, 2004, CLEFT PALATE-CRAN J, V41, P416, DOI 10.1597/03-053.1; Smahel Z, 2003, CLEFT PALATE-CRAN J, V40, P577, DOI 10.1597/1545-1569(2003)040<0577:TMOTPI>2.0.CO;2; Smahel Z, 2009, CLEFT PALATE-CRAN J, V46, P399, DOI 10.1597/07-199.1; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stauber I, 2008, J OROFAC ORTHOP, V69, P268, DOI 10.1007/s00056-008-0746-1; Stewart A, 1996, INT J ORAL MAX SURG, V25, P171, DOI 10.1016/S0901-5027(96)80023-3; Suri S, 2008, AM J ORTHOD DENTOFAC, V134, P418, DOI 10.1016/j.ajodo.2006.09.065; Suzuki H, 1999, ARCH OTOLARYNGOL, V125, P1000, DOI 10.1001/archotol.125.9.1000; Suzuki H, 2001, AURIS NASUS LARYNX, V28, P257, DOI 10.1016/S0385-8146(00)00122-X; Tai CCE, 2000, J ORAL MAXIL SURG, V58, P1241, DOI 10.1053/joms.2000.16623; Tanikawa C, 2010, CLEFT PALATE-CRAN J, V47, P611, DOI 10.1597/09-099; Tian W, 2010, J CRANIOFAC SURG, V21, P578, DOI 10.1097/SCS.0b013e3181d08bee; Tian W, 2010, J CRANIOFAC SURG, V21, P568, DOI 10.1097/SCS.0b013e3181d08bd1; Trindade-Suedam IK, 2012, J CRANIOFAC SURG, V23, P1283, DOI 10.1097/SCS.0b013e3182519ab5; Trotman CA, 2010, J DENT RES, V89, P728, DOI 10.1177/0022034510365485; Trotman CA, 2000, PLAST RECONSTR SURG, V105, P1273, DOI 10.1097/00006534-200004040-00003; Tulunoglu O, 2011, EUR J DENT, V5, P451; Vadodaria S, 2000, BRIT J PLAST SURG, V53, P191, DOI 10.1054/bjps.1999.3308; van der Meij AJW, 2003, ORAL SURG ORAL MED O, V96, P19, DOI 10.1016/S1079-2104(03)00266-X; Van der Meij AJW, 2001, ORAL SURG ORAL MED O, V92, P136, DOI 10.1067/moe.2001.115274; van Loon B, 2010, INT J ORAL MAX SURG, V39, P534, DOI 10.1016/j.ijom.2010.03.022; van Loon B, 2011, RHINOLOGY, V49, P546, DOI 10.4193/Rhino.11.092; van Vlijmen OJC, 2012, J AM DENT ASSOC, V143, P241, DOI 10.14219/jada.archive.2012.0148; Vasiliauskas A, 2010, ELEKTRON ELEKTROTECH, P107; Veli I, 2011, KOREAN J ORTHOD, V41, P431, DOI 10.4041/kjod.2011.41.6.431; Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x; Wojtaszek-Slominska A, 2010, J CRANIO MAXILL SURG, V38, P155, DOI 10.1016/j.jcms.2009.04.005; Wu YL, 2013, CLEFT PALATE-CRAN J, V50, P696, DOI 10.1597/11-144.1; Yamawaki Y, 1999, PLAST RECONSTR SURG, V104, P350, DOI 10.1097/00006534-199908000-00004; Ye B, 2012, CLEFT PALATE-CRAN J, V49, P561, DOI 10.1597/09-236; Ye B, 2010, J CRANIOFAC SURG, V21, P811, DOI 10.1097/SCS.0b013e3181d879fa; Yin N, 2001, CHIN J STOMATOL, V36, P133; Yin NB, 2005, PLAST RECONSTR SURG, V115, P1239, DOI 10.1097/01.PRS.0000156777.99552.1D; Yoshida S, 2013, CLEFT PALATE-CRAN J, V50, P671, DOI 10.1597/11-062; Yoshihara M, 2012, AM J ORTHOD DENTOFAC, V141, pS92, DOI 10.1016/j.ajodo.2011.09.011; Zhang Yong, 2012, Shanghai Kou Qiang Yi Xue, V21, P308; Zhou WH, 2013, CLEFT PALATE-CRAN J, V50, P88, DOI 10.1597/11-182; Zreaqat M, 2012, INT J ORAL MAX SURG, V41, P783, DOI 10.1016/j.ijom.2012.02.003	165	61	63	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93442	10.1371/journal.pone.0093442	http://dx.doi.org/10.1371/journal.pone.0093442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710215	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800033
J	Nelson, MC; Morrison, HG; Benjamino, J; Grim, SL; Graf, J				Nelson, Michael C.; Morrison, Hilary G.; Benjamino, Jacquelynn; Grim, Sharon L.; Graf, Joerg			Analysis, Optimization and Verification of Illumina-Generated 16S rRNA Gene Amplicon Surveys	PLOS ONE			English	Article							DIGESTIVE-TRACT MICROBIOTA; SEQUENCE DATA; COMMUNITY; DIVERSITY; QUALITY; CORE; DNA	The exploration of microbial communities by sequencing 16S rRNA genes has expanded with low-cost, high-throughput sequencing instruments. Illumina-based 16S rRNA gene sequencing has recently gained popularity over 454 pyrosequencing due to its lower costs, higher accuracy and greater throughput. Although recent reports suggest that Illumina and 454 pyrosequencing provide similar beta diversity measures, it remains to be demonstrated that pre-existing 454 pyrosequencing workflows can transfer directly from 454 to Illumina MiSeq sequencing by simply changing the sequencing adapters of the primers. In this study, we modified 454 pyrosequencing primers targeting the V4-V5 hypervariable regions of the 16S rRNA gene to be compatible with Illumina sequencers. Microbial communities from cows, humans, leeches, mice, sewage, and termites and a mock community were analyzed by 454 and MiSeq sequencing of the V4-V5 region and MiSeq sequencing of the V4 region. Our analysis revealed that reference-based OTU clustering alone introduced biases compared to de novo clustering, preventing certain taxa from being observed in some samples. Based on this we devised and recommend an analysis pipeline that includes read merging, contaminant filtering, and reference-based clustering followed by de novo OTU clustering, which produces diversity measures consistent with de novo OTU clustering analysis. Low levels of dataset contamination with Illumina sequencing were discovered that could affect analyses that require highly sensitive approaches. While moving to Illumina-based sequencing platforms promises to provide deeper insights into the breadth and function of microbial diversity, our results show that care must be taken to ensure that sequencing and processing artifacts do not obscure true microbial diversity.	[Nelson, Michael C.; Benjamino, Jacquelynn; Graf, Joerg] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Morrison, Hilary G.; Grim, Sharon L.] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA	University of Connecticut; Marine Biological Laboratory - Woods Hole	Graf, J (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	joerg.graf@uconn.edu	Graf, Joerg/ABI-2447-2020	Graf, Joerg/0000-0001-5320-2712; Benjamino, Jacquelynn/0000-0001-8746-9124; Nelson, Michael/0000-0002-9042-5904; Morrison, Hilary/0000-0003-0281-326X	Emerging Frontiers in Research and Innovation - Multicellular and Inter-kingdom Signaling (EFRI-MIKS) grant; US National Science Foundation; NIH [RO1 GM095390]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095390] Funding Source: NIH RePORTER	Emerging Frontiers in Research and Innovation - Multicellular and Inter-kingdom Signaling (EFRI-MIKS) grant; US National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially funded by an Emerging Frontiers in Research and Innovation - Multicellular and Inter-kingdom Signaling (EFRI-MIKS) grant awarded by the US National Science Foundation to Joerg Graf and NIH RO1 GM095390 to JG and HGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Illumina, 2013, BEST PRACT HIGH SENS; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Marteinsson VT, 2013, ISME J, V7, P427, DOI 10.1038/ismej.2012.97; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ram JL, 2011, SYST BIOL REPROD MED, V57, P162, DOI 10.3109/19396368.2011.555598; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; REYSENBACH AL, 1992, APPL ENVIRON MICROB, V58, P3417, DOI 10.1128/AEM.58.10.3417-3418.1992; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STAHL DA, 1985, APPL ENVIRON MICROB, V49, P1379, DOI 10.1128/AEM.49.6.1379-1384.1985; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Worthen PL, 2006, APPL ENVIRON MICROB, V72, P4775, DOI 10.1128/AEM.00356-06; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	42	220	229	3	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94249	10.1371/journal.pone.0094249	http://dx.doi.org/10.1371/journal.pone.0094249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722003	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100044
J	Holm, SR; Svenning, JC				Holm, Sandra Ravnsbk; Svenning, Jens-Christian			180,000 Years of Climate Change in Europe: Avifaunal Responses and Vegetation Implications	PLOS ONE			English	Article							LATE PLEISTOCENE; QUATERNARY REFUGIA; GLACIAL REFUGIA; POLLEN RECORDS; RANGE SHIFTS; TREES; CONSEQUENCES; PALEOECOLOGY; ENVIRONMENTS; ASSEMBLAGES	Providing an underutilized source of information for paleoenvironmental reconstructions, birds are rarely used to infer paleoenvironments despite their well-known ecology and extensive Quaternary fossil record. Here, we use the avian fossil record to investigate how Western Palearctic bird assemblages and species ranges have changed across the latter part of the Pleistocene, with focus on the links to climate and the implications for vegetation structure. As a key issue we address the full-glacial presence of trees in Europe north of the Mediterranean region, a widely debated issue with evidence for and against emerging from several research fields and data sources. We compiled and analyzed a database of bird fossil occurrences from archaeological sites throughout the Western Palearctic and spanning the Saalian-Eemian-Weichselian stages, i.e. 190,000-10,000 years BP. In general, cold and dry-adapted species dominated these late Middle Pleistocene and Late Pleistocene fossil assemblages, with clear shifts of northern species southwards during glacials, as well as northwards and westwards shifts of open-vegetation species from the south and east, respectively and downwards shifts of alpine species. A direct link to climate was clear in Northwestern Europe. However, in general, bird assemblages more strongly reflected vegetation changes, underscoring their usefulness for inferring the vegetation structure of past landscapes. Forest-adapted birds were found in continuous high proportions throughout the study period, providing support for the presence of trees north of the Alps, even during full-glacial stages. Furthermore, the results suggest forest-dominated but partially open Eemian landscapes in the Western Palearctic, including the Northwestern European subregion.	[Holm, Sandra Ravnsbk; Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark	Aarhus University	Holm, SR (corresponding author), Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark.	s.ravnsbaekholm@gmail.com	Svenning, Jens-Christian/C-8977-2012	Svenning, Jens-Christian/0000-0002-3415-0862	European Research Council [ERC-2012-StG-310886-HISTFUNC]; Aarhus University; Aarhus University Research Foundation under the AU IDEAS program	European Research Council(European Research Council (ERC)European Commission); Aarhus University; Aarhus University Research Foundation under the AU IDEAS program	JCS was supported by the European Research Council (ERC-2012-StG-310886-HISTFUNC). The authors additionally consider this article a contribution by Centre for Biocultural History, funded by Aarhus University and Aarhus University Research Foundation under the AU IDEAS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2011, GLOBAL ECOL BIOGEOGR, V20, P87, DOI 10.1111/j.1466-8238.2010.00572.x; Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; [Anonymous], CALPAL COLOGNE RADIO; BAIRD RF, 1989, PALAEOGEOGR PALAEOCL, V69, P241, DOI 10.1016/0031-0182(89)90167-3; Bassinot FC, 2007, ENCY QUATERNARY SCI, V18, P1740; Bedetti C, 2007, RIV ITAL PALEONTOL S, V113, P487, DOI 10.13130/2039-4942/5888; BEHRE KE, 1989, QUATERNARY SCI REV, V8, P25, DOI 10.1016/0277-3791(89)90019-X; BELL FG, 1969, NEW PHYTOL, V68, P913, DOI 10.1111/j.1469-8137.1969.tb06490.x; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Binney HA, 2009, QUATERNARY SCI REV, V28, P2445, DOI 10.1016/j.quascirev.2009.04.016; BirdLife International, IUCN RED LIST BIRDS; BirdLife International Nature Serve, 2012, BIRD SPEC DISTR MAPS; Birks HJB, 2008, PLANT ECOL DIVERS, V1, P147, DOI 10.1080/17550870802349146; Bittmann F, 2007, VEG HIST ARCHAEOBOT, V16, P139, DOI 10.1007/s00334-006-0082-6; Bochenski Zygmunt, 2002, Acta Zoologica Cracoviensia, V45, P239; Bochenski Zygmunt, 2004, Acta Zoologica Cracoviensia, V47, P27; Bowen D.Q., 1978, QUATERNARY GEOLOGY S; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; Chase PG, 2007, J HUM EVOL, V52, P217, DOI 10.1016/j.jhevol.2006.09.003; COOPE GR, 1973, NATURE, V245, P335, DOI 10.1038/245335a0; Coope GR, 2002, QUATERNARY RES, V57, P401, DOI 10.1006/qres.2002.2332; Coope GR, 1995, J QUATERNARY SCI, V10, P391, DOI 10.1002/jqs.3390100409; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Dalen L, 2005, BIOL J LINN SOC, V84, P79, DOI 10.1111/j.1095-8312.2005.00415.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Ehlers J, 2007, ENCY QUATERNARY SCI, P1085; Finlayson C., 2011, AVIAN SURVIVORS HIST; Finlayson C, 2011, QUATERNARY SCI REV, V30, P1525, DOI 10.1016/j.quascirev.2011.01.010; Finlayson G, 2008, QUATERN INT, V181, P55, DOI 10.1016/j.quaint.2007.01.009; Flagstad O, 2003, EVOLUTION, V57, P658; Fox-Dobbs K, 2006, GEOLOGY, V34, P685, DOI 10.1130/G22571.1; GRAHAM RW, 1990, TRENDS ECOL EVOL, V5, P289, DOI 10.1016/0169-5347(90)90083-P; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hoek WZ, 1997, VEG HIST ARCHAEOBOT, V6, P197, DOI 10.1007/BF01370442; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B, 2003, QUATERNARY RES, V59, P195, DOI 10.1016/S0033-5894(02)00016-9; HUNTLEY B, 1989, J BIOGEOGR, V16, P5, DOI 10.2307/2845307; Huntley B, 1988, GLACIAL HOLOCENE VEG; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Jackson ST, 1997, QUATERNARY SCI REV, V16, P1, DOI 10.1016/S0277-3791(96)00047-9; Johnsen S. J., 2007, ENCY QUATERNARY SCI, P1250, DOI [10.1016/B0-444-52747-8/00345-8, DOI 10.1016/B0-44-452747-8/00345-8]; KOLSTRUP E, 1992, J QUATERNARY SCI, V7, P163, DOI 10.1002/jqs.3390070207; Lyons SK, 2003, J MAMMAL, V84, P385, DOI 10.1644/1545-1542(2003)084<0385:AQAOTR>2.0.CO;2; Marco AS, 2004, ARDEOLA, V51, P91; Markova AK, 2010, QUATERN INT, V212, P149, DOI 10.1016/j.quaint.2009.02.010; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Natural Earth, FREE VECT RAST MAP D; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2001, FINGERPRINTS OF CLIMATE CHANGE, P57; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Rodriguez J, 2006, PALAEOGEOGR PALAEOCL, V239, P355, DOI 10.1016/j.palaeo.2006.02.001; Roucoux K, 2010, GEOPH RES ABSTR, V12, P15216; Sanchez-Marco A, 1999, J HUM EVOL, V37, P375, DOI 10.1006/jhev.1999.0345; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Shackleton NJ, 2003, GLOBAL PLANET CHANGE, V36, P151, DOI 10.1016/S0921-8181(02)00181-9; STEADMAN DW, 1987, QUATERNARY RES, V28, P415, DOI 10.1016/0033-5894(87)90008-1; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stewart JR, 2003, NEANDERTHALS MODERN, P103; Svenning JC, 2002, BIOL CONSERV, V104, P133, DOI 10.1016/S0006-3207(01)00162-8; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Svenning JC, 2013, AM J BOT, V100, P1266, DOI 10.3732/ajb.1200469; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Taylor RE, 1997, CHRONOMETRIC DATING; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tomek Teresa, 2005, Acta Zoologica Cracoviensia, V48A, P43, DOI 10.3409/173491505783995743; Tomek T, 2012, PALAEONTOL ELECTRON, V15; Tyrberg T, 1999, SM C PALEOB, P139; Tyrberg T., 1998, PLEISTOCENE BIRDS PA; Tyrberg T, 2008, ONLINE SUPPLEMENT PL; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5; Varela S, 2011, PALAEOGEOGR PALAEOCL, V310, P451, DOI 10.1016/j.palaeo.2011.07.021; WALKER MJC, 1994, J QUATERNARY SCI, V9, P109, DOI 10.1002/jqs.3390090204; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Walther GR., 2001, FINGERPRINTS CLIMATE; Watts WA, 1988, LATE TERTIARY PLEIST; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Yalden DW, 2009, HISTORY OF BRITISH BIRDS, P1; ZAGWIJN W.H., 1989, Q INT, V3, P57, DOI DOI 10.1016/1040-6182(89)90074-8; Zagwijn WH, 1996, QUATERNARY SCI REV, V15, P451, DOI 10.1016/0277-3791(96)00011-X; ZIMINA RP, 1973, J MAMMAL, V54, P327, DOI 10.2307/1379120	89	30	31	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94021	10.1371/journal.pone.0094021	http://dx.doi.org/10.1371/journal.pone.0094021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718387	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000067
J	Lage, MD; Pittman, AMC; Roncador, A; Cellini, B; Tucker, CL				Lage, Melissa D.; Pittman, Adrianne M. C.; Roncador, Alessandro; Cellini, Barbara; Tucker, Chandra L.			Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria	PLOS ONE			English	Article							ALANINEGLYOXYLATE AMINOTRANSFERASE; CRYSTAL-STRUCTURE; MAJOR ALLELE; AGXT GENE; IN-VITRO; TYPE-1; MUTATIONS; DIMERIZATION; STABILITY; PHENOTYPE	Primary Hyperoxaluria Type 1 (PH1) is a rare autosomal recessive kidney stone disease caused by deficiency of the peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT), which is involved in glyoxylate detoxification. Over 75 different missense mutations in AGT have been found associated with PH1. While some of the mutations have been found to affect enzyme activity, stability, and/or localization, approximately half of these mutations are completely uncharacterized. In this study, we sought to systematically characterize AGT missense mutations associated with PH1. To facilitate analysis, we used two high-throughput yeast-based assays: one that assesses AGT specific activity, and one that assesses protein stability. Approximately 30% of PH1-associated missense mutations are found in conjunction with a minor allele polymorphic variant, which can interact to elicit complex effects on protein stability and trafficking. To better understand this allele interaction, we functionally characterized each of 34 mutants on both the major (wild-type) and minor allele backgrounds, identifying mutations that synergize with the minor allele. We classify these mutants into four distinct categories depending on activity/stability results in the different alleles. Twelve mutants were found to display reduced activity in combination with the minor allele, compared with the major allele background. When mapped on the AGT dimer structure, these mutants reveal localized regions of the protein that appear particularly sensitive to interactions with the minor allele variant. While the majority of the deleterious effects on activity in the minor allele can be attributed to synergistic interaction affecting protein stability, we identify one mutation, E274D, that appears to specifically affect activity when in combination with the minor allele.	[Lage, Melissa D.; Pittman, Adrianne M. C.; Tucker, Chandra L.] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Roncador, Alessandro; Cellini, Barbara] Univ Verona, Sect Biol Chem, Dept Life Sci & Reprod, I-37100 Verona, Italy; [Tucker, Chandra L.] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO USA	Duke University; University of Verona; University of Colorado System; University of Colorado Anschutz Medical Campus	Tucker, CL (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	chandra.tucker@ucdenver.edu	Cellini, Barbara/AAC-6401-2019; Tucker, Chandra/F-6842-2011	Cellini, Barbara/0000-0002-5221-9288; Tucker, Chandra/0000-0003-3033-1786	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK81584]; Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081584] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (grant number R01DK81584) and the Oxalosis and Hyperoxaluria Foundation to C. L. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; Cellini B, 2010, BIOCHIMIE, V92, P1801, DOI 10.1016/j.biochi.2010.08.005; Cellini B, 2010, P NATL ACAD SCI USA, V107, P2896, DOI 10.1073/pnas.0908565107; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Coulter-Mackie MB, 2005, MOL GENET METAB, V86, P172, DOI 10.1016/j.ymgme.2005.05.005; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DANPURE CJ, 1993, AM J HUM GENET, V53, P417; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Frishberg Y, 2005, AM J NEPHROL, V25, P269, DOI 10.1159/000086357; Hopper ED, 2008, J BIOL CHEM, V283, P30493, DOI 10.1074/jbc.M803525200; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Lumb MJ, 1999, J BIOL CHEM, V274, P20587, DOI 10.1074/jbc.274.29.20587; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Mesa-Torres N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071963; Monico CG, 2007, J AM SOC NEPHROL, V18, P1905, DOI 10.1681/ASN.2006111230; Oppici E, 2013, BBA-MOL BASIS DIS, V1832, P2277, DOI 10.1016/j.bbadis.2013.09.002; Oppici E, 2013, PROTEINS, V81, P1457, DOI 10.1002/prot.24300; Oppici E, 2012, MOL GENET METAB, V105, P132, DOI 10.1016/j.ymgme.2011.09.033; Pey AL, 2011, AMINO ACIDS, V41, P1233, DOI 10.1007/s00726-010-0801-2; Pittman AMC, 2012, GENETICS, V192, P831, DOI 10.1534/genetics.112.143750; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Robbiano A, 2010, J NEPHROL, V23, P667; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; Williams E, 2007, CLIN CHEM, V53, P1216, DOI 10.1373/clinchem.2006.084434; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	28	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94338	10.1371/journal.pone.0094338	http://dx.doi.org/10.1371/journal.pone.0094338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718375	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000105
J	Li, SJ; Jiang, L; Fu, X; Huang, S; Huang, YN; Li, XR; Chen, JW; Li, Y; Luo, HL; Wang, F; Ou, SY; Jiang, YM				Li, Shao-Jun; Jiang, Li; Fu, Xue; Huang, Shuang; Huang, Yan-Ni; Li, Xiang-Rong; Chen, Jing-Wen; Li, Yong; Luo, Hai-Lan; Wang, Fang; Ou, Shi-Yan; Jiang, Yue-Ming			Pallidal Index as Biomarker of Manganese Brain Accumulation and Associated with Manganese Levels in Blood: A Meta-Analysis	PLOS ONE			English	Article							HIGH SIGNAL INTENSITY; MAGNETIC-RESONANCE-SPECTROSCOPY; BASAL GANGLIA; T1-WEIGHTED MRI; IMAGING CHANGES; EXPOSURE; T1; ENCEPHALOPATHY; DEPOSITION; PREDICTOR	Objective: The current study was designed to evaluate the sensitivity, feasibility, and effectiveness of the pallidal index (PI) serving as a biomarker of brain manganese (Mn) accumulation, which would be used as an early diagnosis criteria for Mn neurotoxicity. Methods: The weighted mean difference (WMD) of the PI between control and Mn-exposed groups was estimated by using a random-effects or fixed-effects meta-analysis with 95% confidence interval (CI) performed by STATA software version 12.1. Moreover, the R package "metacor'' was used to estimate correlation coefficients between PI and blood Mn (MnB). Results: A total of eight studies with 281 occupationally Mn-exposed workers met the inclusion criteria. Results were pooled and performed with the Meta-analysis. Our data indicated that the PI of the exposed group was significantly higher than that of the control (WMD: 7.76; 95% CI: 4.86, 10.65; I-2 =85.7%, p<0.0001). A random effects model was used to perform meta-analysis. These findings were remarkably robust in the sensitivity analysis, and publication bias was shown in the included studies. Seven out of the eight studies reported the Pearson correlation (r) values. Significantly positive correlation between PI and MnB was observed (r = 0.42; 95% CI, 0.31, 0.52). Conclusions: PI can be considered as a sensitive, feasible, effective and semi-quantitative index in evaluating brain Mn accumulation. MnB can also augment the evaluation of brain Mn accumulation levels in the near future. However, the results should be interpreted with caution.	[Li, Shao-Jun; Huang, Shuang; Huang, Yan-Ni; Chen, Jing-Wen; Li, Yong; Luo, Hai-Lan; Wang, Fang; Ou, Shi-Yan; Jiang, Yue-Ming] Guangxi Med Univ, Sch Publ Hlth, Dept Toxicol, Nanning, Guangxi, Peoples R China; [Jiang, Li] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Nanning, Guangxi, Peoples R China; [Fu, Xue] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Li, Xiang-Rong] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiol, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Guangxi Medical University	Jiang, YM (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Dept Toxicol, Nanning, Guangxi, Peoples R China.	ymjianggxmu@163.com	Jiang, Yueming/AAJ-5538-2020	Jiang, Yueming/0000-0002-4648-9572	National Natural Science Foundation of China [81072320, 30760210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China Grant #81072320 and #30760210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 1997, JPEN-PARENTER ENTER, V21, P41, DOI 10.1177/014860719702100141; Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; Arora M, 2012, ENVIRON SCI TECHNOL, V46, P5118, DOI 10.1021/es203569f; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Benz MR, 2011, EUR J PEDIATR, V170, P747, DOI 10.1007/s00431-010-1333-1; Boojar MMA, 2002, ARCH ENVIRON HEALTH, V57, P519, DOI 10.1080/00039890209602083; Chang Y, 2010, OCCUP ENVIRON MED, V67, P809, DOI 10.1136/oem.2009.052761; Chang Y, 2010, J MAGN RESON IMAGING, V31, P1020, DOI 10.1002/jmri.22104; Chang Y, 2009, NEUROTOXICOLOGY, V30, P950, DOI 10.1016/j.neuro.2009.07.008; Chang Y, 2009, NEUROTOXICOLOGY, V30, P555, DOI 10.1016/j.neuro.2009.04.002; Choi DS, 2007, NEUROTOXICOLOGY, V28, P284, DOI 10.1016/j.neuro.2006.05.020; Coory MD, 2010, INT J EPIDEMIOL, V39, P932, DOI 10.1093/ije/dyp157; Criswell SR, 2012, OCCUP ENVIRON MED, V69, P437, DOI 10.1136/oemed-2011-100119; da Silva CJ, 2008, ARCH NEUROL-CHICAGO, V65, P983, DOI 10.1001/archneur.65.7.983; Dietz MC, 2001, ENVIRON RES, V85, P37, DOI 10.1006/enrs.2000.4068; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Dorman DC, 2006, TOXICOL SCI, V92, P219, DOI 10.1093/toxsci/kfj209; Du F-q, 2009, CHIN OCCUP MED, P181; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; ERIKSSON H, 1992, ARCH TOXICOL, V66, P403, DOI 10.1007/BF02035130; Fernandez-Rodriguez R, 2010, EUR J NEUROL, V17, P1463, DOI 10.1111/j.1468-1331.2010.03076.x; Golub MS, 2005, NEUROTOXICOL TERATOL, V27, P615, DOI 10.1016/j.ntt.2005.04.003; Grunecker B, 2012, NMR BIOMED; Han JH, 2008, INHAL TOXICOL, V20, P1075, DOI [10.1080/08958370802116634, 10.1080/08958370802116634 ]; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Ihara Hiroko, 1998, Nippon Acta Radiologica, V58, P479; Iinuma Y, 2003, PEDIATR SURG INT, V19, P268, DOI 10.1007/s00383-002-0929-6; INOUE E, 1991, RADIOLOGY, V179, P551, DOI 10.1148/radiology.179.2.2014310; Iregren A, 1999, NEUROTOXICOLOGY, V20, P315; Jiang YM, 2007, NEUROTOXICOLOGY, V28, P126, DOI 10.1016/j.neuro.2006.08.005; Kim E, 2005, NEUROTOXICOLOGY, V26, P351, DOI 10.1016/j.neuro.2005.01.007; Kim EA, 2007, NEUROTOXICOLOGY, V28, P276, DOI 10.1016/j.neuro.2006.05.013; Kim Y, 1999, NEUROTOXICOLOGY, V20, P901; Kim Y, 2011, NEUROTOXICOLOGY, V32, P100, DOI 10.1016/j.neuro.2010.11.004; Kozic D, 2003, EUR J NEUROL, V10, P587, DOI 10.1046/j.1468-1331.2003.00661.x; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; Kuo YT, 2005, J MAGN RESON IMAGING, V21, P334, DOI 10.1002/jmri.20285; [李向荣 Li Xiangrong], 2010, [中华放射学杂志, Chinese Journal of Radiology], V44, P605; Li Y, 2013, NEUROTOXICOLOGY, V35, P101, DOI 10.1016/j.neuro.2012.12.008; Maeda H, 1997, NEURORADIOLOGY, V39, P546, DOI 10.1007/s002340050464; Menezes JA, 2011, ENVIRON RES, V111, P156, DOI 10.1016/j.envres.2010.09.006; Nelson G, 2012, NEUROTOXICOLOGY, V33, P683, DOI 10.1016/j.neuro.2012.01.003; NELSON K, 1993, BRIT J IND MED, V50, P510; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; Oikonomou A, 2012, J MAGN RESON IMAGING, V35, P426, DOI 10.1002/jmri.22892; Pal PK, 1999, NEUROTOXICOLOGY, V20, P227; Park JD, 2007, INHAL TOXICOL, V19, P965, DOI 10.1080/08958370701516108; Park NH, 2003, NEUROTOXICOLOGY, V24, P909, DOI 10.1016/S0161-813X(03)00111-6; Pautler RG, 2004, PHYSIOLOGY, V19, P168, DOI 10.1152/physiol.00016.2004; POMIERLAYRARGUES G, 1995, LANCET, V345, P735, DOI 10.1016/S0140-6736(95)90909-5; Qin Wei-ping, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P793; Rose C, 1999, GASTROENTEROLOGY, V117, P640, DOI 10.1016/S0016-5085(99)70457-9; Sen S, 2011, TOXICOL SCI, V121, P160, DOI 10.1093/toxsci/kfr033; Shin YC, 2007, NEUROTOXICOLOGY, V28, P257, DOI 10.1016/j.neuro.2006.03.014; Silva AC, 2008, J NEUROSCI METH, V167, P246, DOI 10.1016/j.jneumeth.2007.08.020; Spahr L, 1996, HEPATOLOGY, V24, P1116; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Takeda A, 2003, BRAIN RES, V965, P279, DOI 10.1016/S0006-8993(02)04157-4; Vymazal J, 1996, AM J NEURORADIOL, V17, P333; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185	62	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93900	10.1371/journal.pone.0093900	http://dx.doi.org/10.1371/journal.pone.0093900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718592	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000055
J	Mao, YY; Reiprich, S; Wegner, M; Fritzsch, B				Mao, YanYan; Reiprich, Simone; Wegner, Michael; Fritzsch, Bernd			Targeted Deletion of Sox10 by Wnt1-cre Defects Neuronal Migration and Projection in the Mouse Inner Ear	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; NERVOUS-SYSTEM DEVELOPMENT; CRANIAL NEURAL CREST; HAIR-CELLS; COCHLEOVESTIBULAR GANGLION; COCHLEAR INNERVATION; WAARDENBURG-SYNDROME; SENSORY EPITHELIA; AUDITORY-SYSTEM; EXPRESSION	Sensory nerves of the brainstem are mostly composed of placode-derived neurons, neural crest-derived neurons and neural crest-derived Schwann cells. This mixed origin of cells has made it difficult to dissect interdependence for fiber guidance. Inner ear-derived neurons are known to connect to the brain after delayed loss of Schwann cells in ErbB2 mutants. However, the ErbB2 mutant related alterations in the ear and the brain compound interpretation of the data. We present here a new model to evaluate exclusively the effect of Schwann cell loss on inner ear innervation. Conditional deletion of the neural crest specific transcription factor, Sox10, using the rhombic lip/neural crest specific Wnt1-cre driver spares Sox10 expression in the ear. We confirm that neural crest-derived cells provide a stop signal for migrating spiral ganglion neurons. In the absence of Schwann cells, spiral ganglion neurons migrate into the center of the cochlea and even out of the ear toward the brain. Spiral ganglion neuron afferent processes reach the organ of Corti, but many afferent fibers bypass the organ of Corti to enter the lateral wall of the cochlea. In contrast to this peripheral disorganization, the central projection to cochlear nuclei is normal. Compared to ErbB2 mutants, conditional Sox10 mutants have limited cell death in spiral ganglion neurons, indicating that the absence of Schwann cells alone contributes little to the embryonic survival of neurons. These data suggest that neural crest-derived cells are dispensable for all central and some peripheral targeting of inner ear neurons. However, Schwann cells provide a stop signal for migratory spiral ganglion neurons and facilitate proper targeting of the organ of Corti by spiral ganglion afferents.	[Mao, YanYan; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Mao, YanYan] Shandong Univ, Prov Hosp, Jinan 250100, Peoples R China; [Reiprich, Simone; Wegner, Michael] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Iowa; Shandong University; University of Erlangen Nuremberg	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Fritzsch, Bernd/0000-0002-4882-8398; Wegner, Michael/0000-0002-4586-3294	NIH [R01 DC 005590];  [P30 DC010362]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010362, R01DC005590] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a NIH grant (R01 DC 005590) to B. F. and in part by P30 DC010362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Begbie J, 2001, SCIENCE, V294, P595, DOI 10.1126/science.1062028; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Bondurand N, 2013, DEV BIOL, V382, P330, DOI 10.1016/j.ydbio.2013.04.024; Breuskin I, 2010, J NEUROCHEM, V114, P1827, DOI 10.1111/j.1471-4159.2010.06897.x; Breuskin I, 2009, DEV BIOL, V335, P327, DOI 10.1016/j.ydbio.2009.09.007; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Chaoui A, 2011, HUM MUTAT, V32, P1436, DOI 10.1002/humu.21583; Coate TM, 2013, SEMIN CELL DEV BIOL, V24, P460, DOI 10.1016/j.semcdb.2013.04.003; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Duncan J, 2011, JOVE-J VIS EXP, DOI 10.3791/2451; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Folgueras AR, 2009, P NATL ACAD SCI USA, V106, P16451, DOI 10.1073/pnas.0908507106; Freter S, 2013, DEVELOPMENT, V140, P3595, DOI 10.1242/dev.091033; Freyer L, 2011, DEVELOPMENT, V138, P5403, DOI 10.1242/dev.069849; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; FRITZSCH B, 1993, DEV BRAIN RES, V74, P122, DOI 10.1016/0165-3806(93)90091-N; Fritzsch B, 1997, J NEUROSCI, V17, P6213; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; Fritzsch B, 2013, EVOL DEV, V15, P63, DOI 10.1111/ede.12015; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Frob F, 2012, GLIA, V60, P806, DOI 10.1002/glia.22310; Graham A, 2004, DEV DYNAM, V229, P5, DOI 10.1002/dvdy.10442; Green SH, 2012, ANAT REC, V295, P1877, DOI 10.1002/ar.22587; Jahan I, 2010, CELL TISSUE RES, V341, P95, DOI 10.1007/s00441-010-0984-6; Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714; Lopez DE, 1999, J COMP NEUROL, V415, P160; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Maklad A, 1999, J VESTIBUL RES-EQUIL, V9, P387; Maklad A, 2010, CELL TISSUE RES, V340, P303, DOI 10.1007/s00441-010-0944-1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Monsonego-Ornan E, 2012, DEV BIOL, V364, P162, DOI 10.1016/j.ydbio.2012.01.028; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; Nishizaki K, 1998, ORL-J OTO-RHIN-LARYN, V60, P267, DOI 10.1159/000027608; O'Neill P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2036; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Orita Y, 1999, ACTA OTO-LARYNGOL, P22; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Reiprich S, 2008, MOL BIOL CELL, V19, P1575, DOI 10.1091/mbc.E07-08-0782; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Sandell LL, 2014, DEV BIOL, V385, P200, DOI 10.1016/j.ydbio.2013.11.009; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; Simmons D, 2011, SPRINGER HANDB AUDIT, V38, P187, DOI 10.1007/978-1-4419-7070-1_7; Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512; Steventon B, 2014, DEV BIOL, DOI [10.1016/j.ydbio.2014.1001.1021, DOI 10.1016/J.YDBIO.2014.1001.1021]; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Tessarollo L, 2004, J NEUROSCI, V24, P2575, DOI 10.1523/JNEUROSCI.5514-03.2004; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; Wakaoka T, 2013, HEARING RES, V302, P17, DOI 10.1016/j.heares.2013.05.003; Wang SZ, 2013, J NEUROSCI, V33, P12242, DOI 10.1523/JNEUROSCI.5736-12.2013; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002	68	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94580	10.1371/journal.pone.0094580	http://dx.doi.org/10.1371/journal.pone.0094580			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718611	Green Published, gold			2022-12-27	WOS:000334339000133
J	Ozdogan, M				Ozdogan, Mutlu			A Practical and Automated Approach to Large Area Forest Disturbance Mapping with Remote Sensing	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LANDSAT RECORD; CLASSIFICATION; CARBON; ALGORITHMS; ACCURACY; DYNAMICS; PATTERNS; CLIMATE; IMAGES	In this paper, I describe a set of procedures that automate forest disturbance mapping using a pair of Landsat images. The approach is built on the traditional pair-wise change detection method, but is designed to extract training data without user interaction and uses a robust classification algorithm capable of handling incorrectly labeled training data. The steps in this procedure include: i) creating masks for water, non-forested areas, clouds, and cloud shadows; ii) identifying training pixels whose value is above or below a threshold defined by the number of standard deviations from the mean value of the histograms generated from local windows in the short-wave infrared (SWIR) difference image; iii) filtering the original training data through a number of classification algorithms using an n-fold cross validation to eliminate mislabeled training samples; and finally, iv) mapping forest disturbance using a supervised classification algorithm. When applied to 17 Landsat footprints across the U. S. at five-year intervals between 1985 and 2010, the proposed approach produced forest disturbance maps with 80 to 95% overall accuracy, comparable to those obtained from traditional approaches to forest change detection. The primary sources of mis-classification errors included inaccurate identification of forests (errors of commission), issues related to the land/water mask, and clouds and cloud shadows missed during image screening. The approach requires images from the peak growing season, at least for the deciduous forest sites, and cannot readily distinguish forest harvest from natural disturbances or other types of land cover change. The accuracy of detecting forest disturbance diminishes with the number of years between the images that make up the image pair. Nevertheless, the relatively high accuracies, little or no user input needed for processing, speed of map production, and simplicity of the approach make the new method especially practical for forest cover change analysis over very large regions.	[Ozdogan, Mutlu] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Ozdogan, Mutlu] Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ozdogan, M (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	ozdogan@wisc.edu		Ozdogan, Mutlu/0000-0002-1707-3375	NASA Land Cover Land Use Change (LCLUC) program [NNX08AK77G]; USDA Hatch Act Formula Funds	NASA Land Cover Land Use Change (LCLUC) program(National Aeronautics & Space Administration (NASA)); USDA Hatch Act Formula Funds	This work was partially funded by NASA Land Cover Land Use Change (LCLUC) program (NNX08AK77G) and USDA Hatch Act Formula Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697217224; Baumann M, 2012, REMOTE SENS ENVIRON, V124, P174, DOI 10.1016/j.rse.2012.05.001; Birdsey RA, 2003, POTENTIAL OF U.S. FOREST SOILS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P15; Breiman L., 2017, CLASSIFICATION REGRE; Brodley CE, 1999, J ARTIF INTELL RES, V11, P131, DOI 10.1613/jair.606; Brodley CE, 1996, INT GEOSCI REMOTE SE, P1379, DOI 10.1109/IGARSS.1996.516669; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Cohen WB, 2002, ECOSYSTEMS, V5, P122, DOI 10.1007/s10021-001-0060-X; Cohen WB, 2001, INT J REMOTE SENS, V22, P2279, DOI 10.1080/014311601300229827; Cohen WB, 1998, PHOTOGRAMM ENG REM S, V64, P293; Collins JB, 1996, REMOTE SENS ENVIRON, V56, P66, DOI 10.1016/0034-4257(95)00233-2; Congalton R.G., 2019, ASSESSING ACCURACY R, VThird, DOI 10.1201/9780429052729; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Coops NC, 2010, FOREST ECOL MANAG, V259, P2355, DOI 10.1016/j.foreco.2010.03.008; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Goward S, 2006, PHOTOGRAMM ENG REM S, V72, P1155, DOI 10.14358/PERS.72.10.1155; Goward SN, 1997, PHOTOGRAMM ENG REM S, V63, P887; Healey SP, 2006, REMOTE SENS ENVIRON, V101, P115, DOI 10.1016/j.rse.2005.12.006; Healey SP, 2005, REMOTE SENS ENVIRON, V97, P301, DOI 10.1016/j.rse.2005.05.009; Houghton RA, 2003, GLOBAL CHANGE BIOL, V9, P500, DOI 10.1046/j.1365-2486.2003.00620.x; Hsu C-W, 2001, PRACTICAL GUIDE SUPP; Huang C, 2002, INT J REMOTE SENS, V23, P725, DOI 10.1080/01431160110040323; Huang CQ, 2008, REMOTE SENS ENVIRON, V112, P970, DOI 10.1016/j.rse.2007.07.023; Huang CQ, 2010, REMOTE SENS ENVIRON, V114, P183, DOI 10.1016/j.rse.2009.08.017; Huang CQ, 2009, INT J DIGIT EARTH, V2, P195, DOI 10.1080/17538940902801614; Huang CQ, 2009, REMOTE SENS ENVIRON, V113, P1430, DOI 10.1016/j.rse.2008.06.016; Irons JR, 2006, PHOTOGRAMM ENG REM S, V72, P1102; Kauth RJ, 1976, P REM SENS DAT W LAF, P367; Kavzoglu T, 2009, INT J APPL EARTH OBS, V11, P352, DOI 10.1016/j.jag.2009.06.002; Kennedy RE, 2012, REMOTE SENS ENVIRON, V122, P117, DOI 10.1016/j.rse.2011.09.024; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Knights D, 2011, ISME J, V5, P570, DOI 10.1038/ismej.2010.148; Lallich S, 2002, LECT NOTES ARTIF INT, V2366, P5; Lefsky MA, 2003, REMOTE SENSING OF FOREST ENVIRONMENTS: CONCEPTS AND CASE STUDIES, P13; Lin CF, 2004, PATTERN RECOGN LETT, V25, P1647, DOI 10.1016/j.patrec.2004.06.009; Lin CJ, 2002, IEEE T NEURAL NETWOR, V13, P1045, DOI 10.1109/TNN.2002.1031937; Liu SG, 2004, ENVIRON MANAGE, V33, pS442, DOI 10.1007/s00267-003-9152-z; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Lunetta RS, 2004, REMOTE SENS ENVIRON, V89, P444, DOI 10.1016/j.rse.2003.10.022; Mantero P, 2005, IEEE T GEOSCI REMOTE, V43, P559, DOI 10.1109/TGRS.2004.842022; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Potere D, 2007, PHOTOGRAMM ENG REM S, V73, P783, DOI 10.14358/PERS.73.7.783; Sanchez JS, 2003, PATTERN RECOGN LETT, V24, P1015, DOI 10.1016/S0167-8655(02)00225-8; Scholkopf B., 2001, LEARNING KERNELS; SINGH A, 1989, INT J REMOTE SENS, V10, P989, DOI 10.1080/01431168908903939; Song C, 2001, REMOTE SENS ENVIRON, V75, P230, DOI 10.1016/S0034-4257(00)00169-3; Suykens JAK, 2002, NEUROCOMPUTING, V48, P85, DOI 10.1016/S0925-2312(01)00644-0; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Tsujinishi D, 2003, NEURAL NETWORKS, V16, P785, DOI 10.1016/S0893-6080(03)00110-2; Vapnik V., 1979, ESTIMATION DEPENDENC, V27, P5165; WOODCOCK C, 1992, INT J REMOTE SENS, V13, P3167, DOI 10.1080/01431169208904109; Wulder MA, 2005, CAN J REMOTE SENS, V31, P421, DOI 10.5589/m05-026; Zhu GB, 2002, REMOTE SENS ENVIRON, V80, P233, DOI 10.1016/S0034-4257(01)00305-4; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028; Zollner PA, 2008, FOR EC MANAGE, V254, P524	63	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e78438	10.1371/journal.pone.0078438	http://dx.doi.org/10.1371/journal.pone.0078438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717283	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000001
J	Saragusty, J; Shavit-Meyrav, A; Yamaguchi, N; Nadler, R; Bdolah-Abram, T; Gibeon, L; Hildebrandt, TB; Shamir, MH				Saragusty, Joseph; Shavit-Meyrav, Anat; Yamaguchi, Nobuyuki; Nadler, Rona; Bdolah-Abram, Tali; Gibeon, Laura; Hildebrandt, Thomas B.; Shamir, Merav H.			Comparative Skull Analysis Suggests Species-Specific Captivity-Related Malformation in Lions (Panthera leo)	PLOS ONE			English	Article							CHEETAHS ACINONYX-JUBATUS; VITAMIN-A; CEREBELLAR HERNIATION; HYPOVITAMINOSIS; AFRICA; TIGRIS; SIZE	Lion (Panthera leo) populations have dramatically decreased worldwide with a surviving population estimated at 32,000 across the African savannah. Lions have been kept in captivity for centuries and, although they reproduce well, high rates of stillbirths as well as morbidity and mortality of neonate and young lions are reported. Many of these cases are associated with bone malformations, including foramen magnum (FM) stenosis and thickened tentorium cerebelli. The precise causes of these malformations and whether they are unique to captive lions remain unclear. To test whether captivity is associated with FM stenosis, we evaluated 575 lion skulls of wild (N = 512) and captive (N = 63) origin. Tiger skulls (N = 276; 56 captive, 220 wild) were measured for comparison. While no differences were found between males and females or between subadults and adults in FM height (FMH), FMH of captive lions (17.36 +/- 3.20 mm) was significantly smaller and with greater variability when compared to that in wild lions (19.77 +/- 2.11 mm). There was no difference between wild (18.47 +/- 1.26 mm) and captive (18.56 +/- 1.64 mm) tigers in FMH. Birth origin (wild vs. captive) as a factor for FMH remained significant in lions even after controlling for age and sex. Whereas only 20/473 wild lions (4.2%) had FMH equal to or smaller than the 5(th) percentile of the wild population (16.60 mm), this was evident in 40.4% (23/57) of captive lion skulls. Similar comparison for tigers found no differences between the captive and wild populations. Lions with FMH equal to or smaller than the 5(th) percentile had wider skulls with smaller cranial volume. Cranial volume remained smaller in both male and female captive lions when controlled for skull size. These findings suggest species-and captivity-related predisposition for the pathology in lions.	[Saragusty, Joseph; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Shavit-Meyrav, Anat; Bdolah-Abram, Tali; Shamir, Merav H.] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Yamaguchi, Nobuyuki] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Nadler, Rona] Zool Ctr Tel Aviv Ramat Gan, Ramat Gan, Israel; [Gibeon, Laura] NYC Vet Specialists, New York, NY USA	Leibniz Institut fur Zoo und Wildtierforschung; Hebrew University of Jerusalem; University of Oxford	Saragusty, J (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	saragusty@izw-berlin.de	Yamaguchi, Nobuyuki/AAN-4884-2020; Saragusty, Joseph/M-5030-2016	Yamaguchi, Nobuyuki/0000-0002-6492-6588; Saragusty, Joseph/0000-0002-9274-7800				BAKER JR, 1977, VET REC, V100, P154, DOI 10.1136/vr.100.8.154; Barnett R, 2006, CONSERV GENET, V7, P507, DOI 10.1007/s10592-005-9062-0; BARTSCH R C, 1975, Onderstepoort Journal of Veterinary Research, V42, P43; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Breitenmoser U, 2008, IUCN 2012 IUCN RED L; BURROUGHS REJ, 1988, J S AFR VET ASSOC, V59, P81; Chandra AMS, 1999, J VET DIAGN INVEST, V11, P465, DOI 10.1177/104063879901100514; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Darwin C, 1859, ORIGIN SPECIES MEANS; De Risio L, 2010, VET REC, V167, P534, DOI 10.1136/vr.c4802; Demmel U., 1965, Zoologische Garten Leipzig, V31, P327; Depauw S, 2012, ZOO BIOL, V31, P629, DOI 10.1002/zoo.20427; Duckler GL, 1998, ZOO BIOL, V17, P135, DOI 10.1002/(SICI)1098-2361(1998)17:2<135::AID-ZOO8>3.0.CO;2-A; GHEBREMESKEL K, 1988, COMP BIOCHEM PHYS B, V89, P279, DOI 10.1016/0305-0491(88)90224-6; Gross-Tsubery R, 2010, VET RADIOL ULTRASOUN, V51, P34, DOI 10.1111/j.1740-8261.2009.01617.x; Haas Sarah K., 2005, Mammalian Species, P1; Hollister N., 1917, P US NATL MUS, V53, P177, DOI DOI 10.5479/SI.00963801.53-2196.177; Howell A. B., 1925, Journal of Mammalogy, V6, P163, DOI 10.2307/1373626; Ibrahim C, 2014, J PEDIATR GASTR NUTR, V58, P368, DOI 10.1097/MPG.0000000000000231; McCain S, 2008, J ZOO WILDLIFE MED, V39, P421, DOI 10.1638/2007-0157.1; Mellanby E, 1941, J PHYSIOL-LONDON, V99, P467, DOI 10.1113/jphysiol.1941.sp003916; O'Regan H, 2006, INT J OSTEOARCHAEOL, V16, P385, DOI 10.1002/oa.835; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; OSULLIVAN BM, 1977, AUST VET J, V53, P187, DOI 10.1111/j.1751-0813.1977.tb00168.x; Pfaff SE, 2002, AFRICAN LION PANTHER; Qorbani M, 2013, OBESITY FACTS, V6, P483, DOI 10.1159/000356011; Rabner M, 2014, J PERINATOL, V34, P49, DOI 10.1038/jp.2013.114; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Shamir MH, 2008, J ZOO WILDLIFE MED, V39, P455, DOI 10.1638/2006-0064.1; Shamir MH, 2012, J ZOO WILDLIFE MED, V43, P207, DOI 10.1638/2010-0038.1; Shamir MH, 1998, J WILDLIFE DIS, V34, P661, DOI 10.7589/0090-3558-34.3.661; van Velzen SKT, 1967, DUTCH J DENT, V74, P17; Williams BG, 1996, ANIM WELFARE, V5, P271; Winges KM, 2013, J NEUROPHTH IN PRESS, DOI [10.1097/WNO.0b013e31829c51f7, DOI 10.1097/WNO.OB013E31829C51F7]; Yamaguchi N, 2009, BIOL J LINN SOC, V98, P85, DOI 10.1111/j.1095-8312.2009.01249.x; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705; Zuccarelli Micah D., 2004, BIOS (Ocean Grove), V75, P131, DOI 10.1893/0005-3155(2004)075<0131:CMAOCV>2.0.CO;2	38	6	6	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94527	10.1371/journal.pone.0094527	http://dx.doi.org/10.1371/journal.pone.0094527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718586	Green Published, gold			2022-12-27	WOS:000334339000130
J	Zhou, ZH; Karnaukhova, E; Rajabi, M; Reeder, K; Chen, TN; Dhawan, S; Kozlowski, S				Zhou, Zhao-Hua; Karnaukhova, Elena; Rajabi, Mohsen; Reeder, Kelly; Chen, Trina; Dhawan, Subhash; Kozlowski, Steven			Oversulfated Chondroitin Sulfate Binds to Chemokines and Inhibits Stromal Cell- Derived Factor-1 Mediated Signaling in Activated T Cells	PLOS ONE			English	Article							HEPARIN; RECEPTOR; SDF-1; CXCR4; GLYCOSAMINOGLYCANS; FACTOR-1-ALPHA; TRAFFICKING; RECRUITMENT; EXPRESSION; SELECTIN	Oversulfated chondroitin sulfate (OSCS), a member of the glycosaminoglycan (GAG) family, was a contaminant in heparin that was linked to the 2008 heparin adverse events in the US. Because of its highly negative charge, OSCS can interact with many components of the contact and immune systems. We have previously demonstrated that OSCS inhibited the complement classical pathway by binding C1 inhibitor and potentiating its interaction with C1s. In the present study, by using surface plasmon resonance, we found OSCS interacts with T cell chemokines that can impact adaptive immunity. The binding of OSCS to stromal cell-derived factor-1 (SDF-1) chemokines, SDF-1 alpha and SDF-1 beta, caused a significant change in the secondary structures of these chemokines as detected by far- ultraviolet circular dichroism spectra analysis. Functionally, OSCS binding profoundly inhibited SDF-1-induced calcium mobilization and T cell chemotaxis. Imaging flow cytometry revealed T cell morphological changes mediated by SDF-1 alpha were completely blocked by OSCS. We conclude that the OSCS, a past contaminant in heparin, has broad interactions with the components of the human immune system beyond the contact and complement systems, and that may explain, in part, prior OSCS-related adverse events, while suggesting potentially useful therapeutic applications for related GAGs in the control of inflammation.	[Zhou, Zhao-Hua; Reeder, Kelly; Chen, Trina; Kozlowski, Steven] US FDA, Ctr Drug Evaluat & Res, Div Monoclonal Antibodies, Bethesda, MD 20014 USA; [Karnaukhova, Elena] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Bethesda, MD 20014 USA; [Rajabi, Mohsen] US FDA, Ctr Drug Evaluat & Res, Off Pharmaceut Sci, Div Therapeut Proteins,Off Biotechnol, Bethesda, MD 20014 USA; [Dhawan, Subhash] US FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kozlowski, S (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Monoclonal Antibodies, Bethesda, MD 20014 USA.	Steven.Kozlowski@fda.hhs.gov	Zhou, Zhaohua/AGR-4892-2022		Intramural Research Program of the US Food and Drug Administration	Intramural Research Program of the US Food and Drug Administration	This research was supported by the Intramural Research Program of the US Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Dettin M, 2004, J MED CHEM, V47, P3058, DOI 10.1021/jm031067a; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gubina E, 2002, BLOOD, V99, P2518, DOI 10.1182/blood.V99.7.2518; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hattori K, 2003, LEUKEMIA LYMPHOMA, V44, P575, DOI 10.1080/1042819021000037985; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; KALTER ES, 1985, J INFECT DIS, V151, P1019, DOI 10.1093/infdis/151.6.1019; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; King CS, 2007, CHEST, V131, P507, DOI 10.1378/chest.06-1861; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; LUKACS NW, 1995, BLOOD, V86, P2767; Mikhailov D, 1999, J BIOL CHEM, V274, P25317, DOI 10.1074/jbc.274.36.25317; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Murdoch C, 2000, BLOOD, V95, P3032; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Qian Y, 2010, PROG MOL BIOL TRANSL, V93, P395, DOI [10.1016/s1877-1173(10)93017-2, 10.1016/S1877-1173(10)93017-2]; Rabin RL, 1999, J IMMUNOL, V162, P3840; Rek A, 2009, BBA-PROTEINS PROTEOM, V1794, P577, DOI 10.1016/j.bbapap.2009.01.001; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Sierra MD, 2004, BLOOD, V103, P2452; Sweeney EA, 2001, ANN NY ACAD SCI, V938, P48; Tami C, 2008, BIOMATERIALS, V29, P4808, DOI 10.1016/j.biomaterials.2008.08.024; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tomczak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036151; Volpi N, 2012, ELECTROPHORESIS, V33, P1531, DOI 10.1002/elps.201100479; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zhang SY, 2012, J BIOL CHEM, V287, P5542, DOI 10.1074/jbc.M111.314716; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047296; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034978; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	49	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94402	10.1371/journal.pone.0094402	http://dx.doi.org/10.1371/journal.pone.0094402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718687	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000118
J	Anand, P; Grigoryan, A; Bhuiyan, MH; Ueberheide, B; Russell, V; Quinonez, J; Moy, P; Chait, BT; Poget, SF; Holford, M				Anand, Prachi; Grigoryan, Alexandre; Bhuiyan, Mohammed H.; Ueberheide, Beatrix; Russell, Victoria; Quinonez, Jose; Moy, Patrick; Chait, Brian T.; Poget, Sebastien F.; Holford, Mande			Sample Limited Characterization of a Novel Disulfide-Rich Venom Peptide Toxin from Terebrid Marine Snail Terebra variegata	PLOS ONE			English	Article							MU-CONOTOXIN PIIIA; 3-DIMENSIONAL STRUCTURE; CHANNEL BLOCKER; CONUS PEPTIDES; SUPERFAMILY; DISCOVERY; ISOMERS; SYSTEM; KIIIA; MODEL	Disulfide-rich peptide toxins found in the secretions of venomous organisms such as snakes, spiders, scorpions, leeches, and marine snails are highly efficient and effective tools for novel therapeutic drug development. Venom peptide toxins have been used extensively to characterize ion channels in the nervous system and platelet aggregation in haemostatic systems. A significant hurdle in characterizing disulfide-rich peptide toxins from venomous animals is obtaining significant quantities needed for sequence and structural analyses. Presented here is a strategy for the structural characterization of venom peptide toxins from sample limited (4 ng) specimens via direct mass spectrometry sequencing, chemical synthesis and NMR structure elucidation. Using this integrated approach, venom peptide Tv1 from Terebra variegata was discovered. Tv1 displays a unique fold not witnessed in prior snail neuropeptides. The novel structural features found for Tv1 suggest that the terebrid pool of peptide toxins may target different neuronal agents with varying specificities compared to previously characterized snail neuropeptides.	[Anand, Prachi; Grigoryan, Alexandre; Russell, Victoria; Quinonez, Jose; Moy, Patrick; Holford, Mande] City Univ New York Hunter Coll & Grad Ctr, Dept Chem & Biochem, New York, NY 10021 USA; [Holford, Mande] Amer Museum Nat Hist, New York, NY 10024 USA; [Bhuiyan, Mohammed H.; Poget, Sebastien F.] CUNY, Coll Staten Isl & Grad Ctr, Dept Chem, New York, NY USA; [Ueberheide, Beatrix] NYU, NYU Langone Med Ctr, New York, NY USA; [Chait, Brian T.] Rockefeller Univ, New York, NY 10021 USA	American Museum of Natural History (AMNH); City University of New York (CUNY) System; New York University; NYU Langone Medical Center; Rockefeller University	Anand, P (corresponding author), City Univ New York Hunter Coll & Grad Ctr, Dept Chem & Biochem, New York, NY 10021 USA.	mholford@hunter.cuny.edu	Anand, Prachi/H-6134-2019	Anand, Prachi/0000-0002-9176-5791; Ueberheide, Beatrix/0000-0003-2512-0204; Holford, Mande/0000-0001-9476-2687	NSF-CHE [1247550]; Camille Dreyfus Teacher Scholar Award from the Camille and Henry Dreyfus Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314] Funding Source: NIH RePORTER	NSF-CHE(National Science Foundation (NSF)); Camille Dreyfus Teacher Scholar Award from the Camille and Henry Dreyfus Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mande Holford acknowledges funding from NSF-CHE 1247550 (www.nsf.gov) and The Camille Dreyfus Teacher Scholar Award from the Camille and Henry Dreyfus Foundation (http://www.dreyfus.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 1999, DRUG DEVELOP RES, V46, P219; Bhatia S, 2012, J PROTEOME RES, V11, P4191, DOI 10.1021/pr300312h; Bhattacharyya M, 2013, MOL BIOSYST, V9, P1340, DOI 10.1039/c3mb25534d; Bouchet P, 2009, DEEP-SEA RES PT II, V56, P1724, DOI 10.1016/j.dsr2.2009.05.033; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulaj G, 2008, CURR OPIN CHEM BIOL, V12, P441, DOI 10.1016/j.cbpa.2008.07.012; Castelin M, 2012, MOL PHYLOGENET EVOL, V64, P21, DOI 10.1016/j.ympev.2012.03.001; Chalkley RJ, 2006, J AM SOC MASS SPECTR, V17, P1271, DOI 10.1016/j.jasms.2006.05.017; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; CUSHMAN DW, 1991, HYPERTENSION, V17, P589, DOI 10.1161/01.HYP.17.4.589; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du WH, 2007, FEBS J, V274, P2596, DOI 10.1111/j.1742-4658.2007.05795.x; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Escoubas P, 2008, J MASS SPECTROM, V43, P279, DOI 10.1002/jms.1389; Favreau P, 2006, TOXICON, V47, P676, DOI 10.1016/j.toxicon.2006.01.020; Favreau P, 2009, CURR OPIN PHARMACOL, V9, P594, DOI 10.1016/j.coph.2009.05.006; Foley SF, 2008, ANAL BIOCHEM, V377, P95, DOI 10.1016/j.ab.2008.02.025; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Han YH, 2006, FEBS J, V273, P4972, DOI 10.1111/j.1742-4658.2006.05493.x; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; Holford M, 2009, MOL BIOL EVOL, V26, P15, DOI 10.1093/molbev/msn211; Imperial JS, 2003, TOXICON, V42, P391, DOI 10.1016/S0041-0101(03)00169-7; Imperial JS, 2008, J BIOL CHEM, V283, P23026, DOI 10.1074/jbc.M800084200; Imperial JS, 2007, J EXP ZOOL PART B, V308B, P744, DOI 10.1002/jez.b.21195; Jacob RB, 2010, CELL MOL LIFE SCI, V67, P17, DOI 10.1007/s00018-009-0125-0; Jakubowski JA, 2004, ANAL CHEM, V76, P6541, DOI 10.1021/ac0494376; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; Kendel Y, 2013, TOXINS, V5, P1043, DOI 10.3390/toxins5051043; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Koh CY, 2012, TOXICON, V59, P497, DOI 10.1016/j.toxicon.2011.03.017; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McDougal OM, 2004, BIOCHEMISTRY-US, V43, P425, DOI 10.1021/bi0353732; McDougal OM, 2008, BIOCHEMISTRY-US, V47, P2826, DOI 10.1021/bi702388b; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Nair SS, 2006, ANAL CHEM, V78, P8082, DOI 10.1021/ac0607764; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Prashanth JR, 2012, TOXICON, V60, P470, DOI 10.1016/j.toxicon.2012.04.340; Quinton L, 2007, J PROTEOME RES, V6, P3216, DOI 10.1021/pr070142t; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shon KJ, 1998, J NEUROSCI, V18, P4473; Tayo LL, 2010, J PROTEOME RES, V9, P2292, DOI 10.1021/pr901032r; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Vetter I, 2012, CURR TOP MED CHEM, V12, P1546, DOI 10.2174/156802612802652457; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Q, 2008, TOXICON, V51, P813, DOI 10.1016/j.toxicon.2007.12.007; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Yao SG, 2008, BIOCHEMISTRY-US, V47, P10940, DOI 10.1021/bi801010u; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	62	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94122	10.1371/journal.pone.0094122	http://dx.doi.org/10.1371/journal.pone.0094122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713808	gold, Green Published			2022-12-27	WOS:000334160900088
J	Bowler, M; Anderson, M; Montes, D; Perez, P; Mayor, P				Bowler, Mark; Anderson, Matt; Montes, Daniel; Perez, Pedro; Mayor, Pedro			Refining Reproductive Parameters for Modelling Sustainability and Extinction in Hunted Primate Populations in the Amazon	PLOS ONE			English	Article							FEMALE; IMPACT; FOREST; MANAGEMENT; PATTERNS; MAMMALS; AREA	Primates are frequently hunted in Amazonia. Assessing the sustainability of hunting is essential to conservation planning. The most-used sustainability model, the 'Production Model', and more recent spatial models, rely on basic reproductive parameters for accuracy. These parameters are often crudely estimated. To date, parameters used for the Amazon's most-hunted primate, the woolly monkey (Lagothrix spp.), come from captive populations in the 1960s, when captive births were rare. Furthermore, woolly monkeys have since been split into five species. We provide reproductive parameters calculated by examining the reproductive organs of female Poeppig's woolly monkeys (Lagothrix poeppigii), collected by hunters as part of their normal subsistence activity. Production was 0.48-0.54 young per female per year, and an interbirth interval of 22.3 to 25.2 months, similar to parameters from captive populations. However, breeding was seasonal, which imposes limits on the maximum reproductive rate attainable. We recommend the use of spatial models over the Production Model, since they are less sensitive to error in estimated reproductive rates. Further refinements to reproductive parameters are needed for most primate taxa. Methods like ours verify the suitability of captive reproductive rates for sustainability analysis and population modelling for populations under differing conditions of hunting pressure and seasonality. Without such research, population modelling is based largely on guesswork.	[Bowler, Mark; Anderson, Matt] San Diego Zoo Global Inst Conservat Res, Escondido, CA 92027 USA; [Bowler, Mark] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Montes, Daniel; Perez, Pedro; Mayor, Pedro] Yavari Conservac & Uso Sostenible YAVACUS, Iquitos, Loreto, Peru; [Mayor, Pedro] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain	University of St Andrews; Autonomous University of Barcelona	Bowler, M (corresponding author), San Diego Zoo Global Inst Conservat Res, Escondido, CA 92027 USA.	mark@markbowler.com	Bowler, Mark/I-1967-2019; Mayor, Pedro/D-6359-2015; Mayor, Pedro/AAC-2871-2021	Bowler, Mark/0000-0001-5236-3477; Mayor, Pedro/0000-0001-5297-792X; 				Agostinelli C., 2011, R PACKAGE CIRCULAR C; Alvard MS, 1997, CONSERV BIOL, V11, P977, DOI 10.1046/j.1523-1739.1997.96047.x; Ange-van Heugten K, 2008, INT J PRIMATOL, V29, P183, DOI 10.1007/s10764-008-9233-1; Aquino Rolando, 2007, Rev. peru biol., V14, P181; Begon M., 2009, ECOLOGY INDIVIDUALS; Bodmer R., 2004, PEOPLE NATURE WILDLI, P199; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Bodmer RE, 2004, HUNTING NEOTROPICAL, P201; Bodmer Richard E., 2004, P299; Bodmer Richard E., 2000, Conservation Biology Series (Cambridge), V3, P277; Carnegie SD, 2011, INT J PRIMATOL, V32, P1076, DOI 10.1007/s10764-011-9523-x; Chacon RJ, 2012, ETHICS OF ANTHROPOLOGY AND AMERINDIAN RESEARCH: REPORTING ON ENVIRONMENTAL DEGRADATION AND WARFARE, P1, DOI 10.1007/978-1-4614-1065-2; Cheney DL, 1998, REPROD SUCCESS, P384; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; da Silva Maria N.F., 2005, Neotropical Primates, V13, P31, DOI 10.1896/1413-4705.13.2.31; DELANY MJ, 1982, MAMMAL ECOLOGY; Di Fiore A, 2014, 83 ANN M AM ASS PHYS; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; DiFiore A, 1997, THESIS U CALIFORNIA; DUNBAR RIM, 1995, ANIM BEHAV, V50, P1071, DOI 10.1016/0003-3472(95)80107-3; Eisenberg JF., 1999, MAMMALS NEOTROPICS C; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fang T., 2008, CERTIFICACION PIELES, P210; Fiore A Di, MOL PHYLOGE IN PRESS; FitzGibbon C, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P449; FITZGIBBON CD, 1995, CONSERV BIOL, V9, P1116, DOI [10.1046/j.1523-1739.1995.9051116.x, 10.1046/j.1523-1739.1995.9051085.x-i1]; Flowerdew J.R., 1987, MAMMALS THEIR REPROD; Fooden J., 1963, Journal of Mammalogy, V44, P213, DOI 10.2307/1377454; FRANZEN M, 2005, THESIS U CALIFORNIA; Franzen M., 2006, ENVIRON CONSERV, V33, P1; Gavin MC, 2007, BIOL CONSERV, V134, P64, DOI 10.1016/j.biocon.2006.07.011; Mayor PG, 2010, EUR J WILDLIFE RES, V56, P681, DOI 10.1007/s10344-010-0379-8; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Groves C.P., 2001, PRIMATE TAXONOMY; *INT COMM VET EMBR, 1994, NOM EMBR VET; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2012, IUCN RED LIST THREAT; JOSHI NV, 1991, THEOR POPUL BIOL, V40, P211, DOI 10.1016/0040-5809(91)90053-I; Levi T, 2009, J APPL ECOL, P46804; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; Mack D., 1978, International Zoo Yearbook, V18, P117, DOI 10.1111/j.1748-1090.1978.tb00239.x; Matthews LJ, 2008, AM J PHYS ANTHROPOL, V137, P245, DOI 10.1002/ajpa.20859; Mayor P, 2011, ANIM REPROD SCI, V128, P123, DOI 10.1016/j.anireprosci.2011.09.009; Mayor P, 2012, ANIMAL REPROD SCI; Mayor P, 2012, AM J PRIMATOL, V74, P1006, DOI 10.1002/ajp.22051; Mayor P, 2009, EUR J WILDLIFE RES, V55, P631, DOI 10.1007/s10344-009-0312-1; McCullough D.R., 1987, P535; Mena P, 2000, BIOL RESOURCE MANAGE, P57; Milner-Gulland, 2007, CONSERVATION SUSTAIN; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Mooney JC, 1999, ZOO BIOL, V18, P421, DOI 10.1002/(SICI)1098-2361(1999)18:5&lt;421::AID-ZOO7&gt;3.0.CO;2-6; Muchaal PK, 1999, CONSERV BIOL, V13, P385, DOI 10.1046/j.1523-1739.1999.013002385.x; Nishimura A., 1990, Science and Engineering Review of Doshisha University, V31, P87; Nishimura A, 2003, INT J PRIMATOL, V24, P707, DOI 10.1023/A:1024681703616; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Nowak R, 1999, WALKERS MAMMALS WORL, P538; Ohl-Schacherer J, 2007, CONSERV BIOL, V21, P1174, DOI 10.1111/j.1523-1739.2007.00759.x; Parathian HE, 2010, AM J PRIMATOL, V72, P855, DOI 10.1002/ajp.20816; PERES C A, 1991, Oryx, V25, P89; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; PUERTAS P, 1993, BIODIVERS CONSERV, V2, P586, DOI 10.1007/BF00051959; Puertas P, 1999, THESIS U FLORIDA; Puertas Pablo E., 2004, P123; R Core Team, 2012, R LANG ENV STAT COMP; Robinson J.G., 1991, P415; Robinson J.G., 1987, P69; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; ROBINSON JG, 1986, OECOLOGIA, V68, P516, DOI 10.1007/BF00378765; Robinson JG, 1999, J WILDLIFE MANAGE, V63, P1, DOI 10.2307/3802482; Robinson John G., 1994, Oryx, V28, P249, DOI 10.1017/S0030605300028647; Rylands Anthony B., 2000, Neotropical Primates, V8, P61; Sadler TW, 1985, LANGMANS MED EMBRIOL, P424; Schmitt CA, WOOLLY MONKEY BEHAV; Shanee S, 2011, INT J PRIMATOL, V32, P691, DOI 10.1007/s10764-011-9495-x; Shepard Glenn H., 2002, Cambridge Studies in Biological and Evolutionary Anthropology, V29, P101; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Slade NA, 1998, CONSERV BIOL, V12, P148, DOI 10.1046/j.1523-1739.1998.96273.x; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Urbani B., 2005, J ANTHROPOL SCI, V83, P89; Vickers W.T., 1991, P53; Williams L., 1967, International Zoo Yearbook, V7, P86, DOI 10.1111/j.1748-1090.1967.tb00329.x; WOLF RH, 1975, LAB ANIM SCI, V25, P814	84	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93625	10.1371/journal.pone.0093625	http://dx.doi.org/10.1371/journal.pone.0093625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714614	Green Published, gold			2022-12-27	WOS:000334160900041
J	Cai, J; Feng, J; Xie, SL; Wang, FP; Xu, QF				Cai, Jin; Feng, Jia; Xie, Shulian; Wang, Feipeng; Xu, Qiufeng			Laminaria japonica Extract, an Inhibitor of Clavibater michiganense Subsp Sepedonicum	PLOS ONE			English	Article							BACTERIAL RING ROT; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; VOLATILE COMPONENTS; ESSENTIAL OIL; ANTIFUNGAL ACTIVITY; PYRUVATE-KINASE; CELL-MEMBRANE; CAUSAL AGENT; IN-VITRO	Bacterial ring rot of potato is one of the most serious potato plant and tuber diseases. Laminaria japonica extract was investigated for its antimicrobial activity against Clavibater michiganense subsp. sepedonicum (Spieckermann & Kotthoff) Davis et al., the causative agent of bacterial ring rot of potato. The results showed that the optimum extraction conditions of antimicrobial substances from L. japonica were an extraction temperature of 80 degrees C, an extraction time of 12 h, and a solid to liquid ratio of 1: 25. Active compounds of L. japonica were isolated by solvent partition, thin layer chromatography (TLC) and column chromatography. All nineteen fractionations had antimicrobial activities against C. michiganense subsp. sepedonicum, while Fractionation three (Fr. 3) had the highest (P<0.05) antimicrobial activity. Chemical composition analysis identified a total of 26 components in Fr. 3. The main constituents of Fr. 3 were alkanes (80.97%), esters (5.24%), acids (4.87%) and alcohols (2.21%). Antimicrobial activity of Fr. 3 against C. michiganense subsp. sepedonicum could be attributed to its ability to damage the cell wall and cell membrane, induce the production of reactive oxygen species (ROS), increase cytosolic Ca2+ concentration, inhibit the glycolytic pathway (EMP) and tricarboxylic acid (TCA) cycle, inhibit protein and nucleic acid synthesis, and disrupt the normal cycle of DNA replication. These findings indicate that L. japonica extracts have potential for inhibiting C. michiganense subsp. sepedonicum.	[Cai, Jin; Feng, Jia; Xie, Shulian; Wang, Feipeng; Xu, Qiufeng] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China	Shanxi University	Xie, SL (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	xiesl@sxu.edu.cn						Abdel-Monaim MF, 2011, CROP PROT, V30, P185, DOI 10.1016/j.cropro.2010.09.016; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Antony J., 2006, Sensor Review, V26, P227, DOI 10.1108/02602280610675519; Asano T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003581; Avila JG, 1999, J ETHNOPHARMACOL, V66, P75, DOI 10.1016/S0378-8741(98)00203-7; Bagheri-Gavkosh S, 2009, MYCOPATHOLOGIA, V168, P249, DOI 10.1007/s11046-009-9220-x; BAKKEN LR, 1987, MICROBIAL ECOL, V13, P103, DOI 10.1007/BF02011247; Barros L, 2007, EUR FOOD RES TECHNOL, V225, P151, DOI 10.1007/s00217-006-0394-x; Bernardo-Gil MG, 2009, J SUPERCRIT FLUID, V49, P32, DOI 10.1016/j.supflu.2008.12.004; Boussaada O, 2009, J ESSENT OIL RES, V21, P179, DOI 10.1080/10412905.2009.9700142; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady N. C., 1984, NATURE PROPERTIES SO, P528; Cardoso RA, 2010, GENET MOL RES, V9, P231, DOI 10.4238/vol9-1gmr688; Castro MS, 2005, PROTEIN PEPTIDE LETT, V12, P13; Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4; Chen JC, 2007, CURR BIOL, V17, pR203, DOI 10.1016/j.cub.2007.01.031; Chen Y, 1994, FOOD FERMENT IND, V3, P26; Chen YJ, 2012, J SCI FOOD AGR, V92, P1937, DOI 10.1002/jsfa.5565; CHENG KJ, 1970, J BACTERIOL, V104, P748, DOI 10.1128/JB.104.2.748-753.1970; Cheng XL, 2013, RSC ADV, V3, P2296, DOI 10.1039/c2ra23131j; Choi YS, 2012, MEAT SCI, V91, P1, DOI 10.1016/j.meatsci.2011.11.011; Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025; Dhankhar Sandeep, 2012, Recent Pat Antiinfect Drug Discov, V7, P242; Diez C, 2008, J CHROMATOGR A, V1180, P10, DOI 10.1016/j.chroma.2007.12.036; Efthimiadou EK, 2008, BIOORG MED CHEM LETT, V18, P4033, DOI 10.1016/j.bmcl.2008.05.115; Efthimiadou EK, 2010, J INORG BIOCHEM, V104, P455, DOI 10.1016/j.jinorgbio.2009.12.019; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; FRIEDLANDER ML, 1984, J CLIN PATHOL, V37, P961, DOI 10.1136/jcp.37.9.961; [耿飞 GENG Fei], 2011, [食品科学, Food Science], V32, P88; Go H, 2010, TOXICOL IN VITRO, V24, P1546, DOI 10.1016/j.tiv.2010.06.018; Gulec C, 2007, ASIAN J CHEM, V19, P4069; Haines LR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000373; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1994, NUTR REV, V52, P253; Han GY, 2002, J INORG BIOCHEM, V91, P230, DOI 10.1016/S0162-0134(02)00369-0; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006; Huang CB, 2010, ARCH ORAL BIOL, V55, P555, DOI 10.1016/j.archoralbio.2010.05.009; Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P3799, DOI 10.1021/jf960133x; Imura Y, 2007, BBA-BIOMEMBRANES, V1768, P2578, DOI 10.1016/j.bbamem.2007.06.013; Ippolito A, 2000, CROP PROT, V19, P715, DOI 10.1016/S0261-2194(00)00095-8; Jia XY, 2010, CHROMATOGRAPHIA, V71, P839, DOI 10.1365/s10337-010-1547-4; Karabay-Yavasoglu NU, 2007, PHYTOTHER RES, V21, P153, DOI 10.1002/ptr.2045; Khan MSA, 2011, PHYTOMEDICINE, V19, P48, DOI 10.1016/j.phymed.2011.07.005; Kilickap E, 2010, INT J ADV MANUF TECH, V49, P911, DOI 10.1007/s00170-009-2469-x; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kumar A, 2009, AFR J PHARM PHARMACO, V3, P560; Kumar RS, 2008, J INORG BIOCHEM, V102, P234, DOI 10.1016/j.jinorgbio.2007.08.005; LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1; Li LR, 2013, APPL MICROBIOL BIOT, V97, P1711, DOI 10.1007/s00253-012-4352-1; Li N, 2005, FOOD CHEM TOXICOL, V43, P421, DOI 10.1016/j.fct.2004.12.001; Li QQ, 2010, EUR J PHARMACOL, V626, P146, DOI 10.1016/j.ejphar.2009.09.044; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Liu RM, 2002, FOOD FERM IND, V29, P61; Liu X, 2009, EUR FOOD RES TECHNOL, V229, P247, DOI 10.1007/s00217-009-1057-5; Lu X, 2012, APPL MICROBIOL BIOT, V95, P939, DOI 10.1007/s00253-011-3793-2; Lupea AX, 2003, REV CHIM-BUCHAREST, V54, P923; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Michielin EMZ, 2009, BIORESOURCE TECHNOL, V100, P6615, DOI 10.1016/j.biortech.2009.07.061; Mori IC, 2004, PLANT PHYSIOL, V135, P702, DOI 10.1104/pp.104.042069; MUIRHEAD KA, 1985, BIO-TECHNOL, V3, P337, DOI 10.1038/nbt0485-337; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Muthukumar A, 2010, CROP PROT, V29, P1483, DOI 10.1016/j.cropro.2010.08.009; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Nishida M, 2006, J CHROMATOGR B, V842, P106, DOI 10.1016/j.jchromb.2006.07.039; Ozdemir G, 2006, PHARM BIOL, V44, P183, DOI 10.1080/13880200600685949; Palic R, 2002, FLAVOUR FRAG J, V17, P323, DOI 10.1002/ffj.1084; Passos XS, 2003, PHARM BIOL, V41, P319, DOI 10.1076/phbi.41.5.319.15936; Peng ZF, 2012, CARBOHYD POLYM, V89, P1022, DOI 10.1016/j.carbpol.2012.03.043; POLITOFF AL, 1969, J GEN PHYSIOL, V53, P498, DOI 10.1085/jgp.53.4.498; Qiu YE, 2004, XINJIANG AGR SCI, P88; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Rizwan K, 2012, INT J MOL SCI, V13, P6440, DOI 10.3390/ijms13056440; Schepers E, 2009, J IMMUNOL METHODS, V348, P74, DOI 10.1016/j.jim.2009.07.002; SECOR GA, 1987, AM POTATO J, V64, P699; Shen HM, 1996, FREE RADICAL BIO MED, V21, P139, DOI 10.1016/0891-5849(96)00019-6; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Sinek K, 2012, ASIAN J CHEM, V24, P1931; Smania A. Jr., 1999, International Journal of Medicinal Mushrooms, V1, P325; Song Feng-ping, 2009, Chinese Journal of Pesticide Science, V11, P213; Sukatar A, 2006, ANN MICROBIOL, V56, P275, DOI 10.1007/BF03175018; Sun L, 2003, J CHROMATOGR A, V1014, P165, DOI 10.1016/S0021-9673(03)00574-0; Talibi I, 2012, CROP PROT, V35, P41, DOI 10.1016/j.cropro.2011.12.016; Tarushi A, 2009, J INORG BIOCHEM, V103, P898, DOI 10.1016/j.jinorgbio.2009.03.007; Tseng CK, 2001, J APPL PHYCOL, V13, P375, DOI 10.1023/A:1017972812576; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; Valiei M, 2011, J MED PLANTS RES, V5, P6972, DOI 10.5897/JMPR11.963; van Beckhoven JRCM, 2002, J APPL MICROBIOL, V93, P840, DOI 10.1046/j.1365-2672.2002.01765.x; van der Wolf JM, 2005, J PHYTOPATHOL, V153, P358, DOI 10.1111/j.1439-0434.2005.00985.x; Wang C, 2013, LIFE SCI, V92, P1004, DOI 10.1016/j.lfs.2013.03.016; Wang GuanLin, 2005, Scientia Agricultura Sinica, V38, P2321; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang J, 2013, INT J FOOD MICROBIOL, V161, P151, DOI 10.1016/j.ijfoodmicro.2012.11.025; Wang QA, 2010, ARCH MICROBIOL, V192, P893, DOI 10.1007/s00203-010-0617-1; Wu PG, 2010, BIOMATERIALS, V31, P7526, DOI 10.1016/j.biomaterials.2010.06.032; Xiong JH, 2007, FOOD MACH, V23, P78; Yang DM, 2010, J CHIN I FOOD SCI TE, V10, P47; Yang WW, 2013, ENVIRON TOXICOL PHAR, V35, P320, DOI 10.1016/j.etap.2013.01.006; Yao XL, 2012, FOOD CHEM, V132, P1883, DOI 10.1016/j.foodchem.2011.12.021; Yayli N, 2006, TURK J CHEM, V30, P71; Yun Bao-Yi, 2012, Yao Xue Xue Bao, V47, P1587; ZENG CK, 1984, HYDROBIOLOGIA, V116, P152; [郑怡 Zheng Yi], 2004, [海洋科学, Marine Sciences], V28, P42; Zhou W, 2010, CHROMATOGRAPHIA, V72, P719, DOI 10.1365/s10337-010-1747-y; Zito P, 2011, NAT PROD RES, V25, P1339, DOI 10.1080/14786419.2010.535157; 陈云, 2010, [山西农业科学, Journal of Shanxi Agricultural Sciences], V38, P140	111	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94329	10.1371/journal.pone.0094329	http://dx.doi.org/10.1371/journal.pone.0094329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714388	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900117
J	Hyland, PL; Hu, N; Rotunno, M; Su, H; Wang, CY; Wang, LM; Pfeiffer, RM; Gherman, B; Giffen, C; Dykes, C; Dawsey, SM; Abnet, CC; Johnson, KM; Acosta, RD; Young, PE; Cash, BD; Taylor, PR				Hyland, Paula L.; Hu, Nan; Rotunno, Melissa; Su, Hua; Wang, Chaoyu; Wang, Lemin; Pfeiffer, Ruth M.; Gherman, Barbara; Giffen, Carol; Dykes, Cathy; Dawsey, Sanford M.; Abnet, Christian C.; Johnson, Kathryn M.; Acosta, Ruben D.; Young, Patrick E.; Cash, Brooks D.; Taylor, Philip R.			Global Changes in Gene Expression of Barrett's Esophagus Compared to Normal Squamous Esophagus and Gastric Cardia Tissues	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; INCREASING INCIDENCE; CDX-2 EXPRESSION; CANCER INCIDENCE; RISK; DIFFERENTIATION; PREVALENCE; METAPLASIA; EPITHELIUM; CELLS	Background: Barrett's esophagus (BE) is a metaplastic precursor lesion of esophageal adenocarcinoma (EA), the most rapidly increasing cancer in western societies. While the prevalence of BE is increasing, the vast majority of EA occurs in patients with undiagnosed BE. Thus, we sought to identify genes that are altered in BE compared to the normal mucosa of the esophagus, and which may be potential biomarkers for the development or diagnosis of BE. Design: We performed gene expression analysis using HG-U133A Affymetrix chips on fresh frozen tissue samples of Barrett's metaplasia and matched normal mucosa from squamous esophagus (NE) and gastric cardia (NC) in 40 BE patients. Results: Using a cut off of 2-fold and P, 1.12E-06 (0.05 with Bonferroni correction), we identified 1324 differentially expressed genes comparing BE vs NE and 649 differentially-expressed genes comparing BE vs NC. Except for individual genes such as the SOXs and PROM1 that were dysregulated only in BE vs NE, we found a subset of genes (n = 205) whose expression was significantly altered in both BE vs NE and BE vs NC. These genes were overrepresented in different pathways, including TGF-beta and Notch. Conclusion: Our findings provide additional data on the global transcriptome in BE tissues compared to matched NE and NC tissues which should promote further understanding of the functions and regulatory mechanisms of genes involved in BE development, as well as insight into novel genes that may be useful as potential biomarkers for the diagnosis of BE in the future.	[Hyland, Paula L.; Hu, Nan; Rotunno, Melissa; Su, Hua; Wang, Chaoyu; Wang, Lemin; Pfeiffer, Ruth M.; Dawsey, Sanford M.; Abnet, Christian C.; Taylor, Philip R.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Hyland, Paula L.] NCI, Canc Prevent Fellowship Program, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Gherman, Barbara] Westat Corp, Rockville, MD USA; [Giffen, Carol] Informat Management Serv Inc, Silver Spring, MD USA; [Dykes, Cathy; Johnson, Kathryn M.; Acosta, Ruben D.; Young, Patrick E.; Cash, Brooks D.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat; Information Management Services, Inc.; Walter Reed National Military Medical Center	Hyland, PL (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	hylandpl@mail.nih.gov	Young, Patrick/HHS-0244-2022; Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843	National Institutes of Health, National Cancer Institute; Division of Cancer Epidemiology and Genetics; Cancer Prevention Fellowship Program, Division of Cancer Prevention, NCI; Health and Social Care (HSC), Northern Ireland, UK; Public Health Agency [CDV/3756/07] Funding Source: researchfish	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Cancer Prevention Fellowship Program, Division of Cancer Prevention, NCI; Health and Social Care (HSC), Northern Ireland, UK; Public Health Agency	This research was supported by Intramural Research Program of the National Institutes of Health, National Cancer Institute, the Division of Cancer Epidemiology and Genetics, the Cancer Prevention Fellowship Program, Division of Cancer Prevention, NCI (to P. L. H); and Health and Social Care (HSC), Northern Ireland, UK (to P. L. H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2012, ENDOCR-RELAT CANCER, V19, pL5, DOI 10.1530/ERC-11-0364; [Anonymous], 2010, SEER STAT DAT INC SE; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asonuma S, 2008, GASTROENTEROLOGY, V134, pA437; Barrett MT, 2002, NEOPLASIA, V4, P121, DOI 10.1038/sj.neo.7900221; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Clemons NJ, 2012, AM J PHYSIOL-GASTR L, V303, pG1335, DOI 10.1152/ajpgi.00291.2012; Coleman HG, 2011, EUR J EPIDEMIOL, V26, P739, DOI 10.1007/s10654-011-9596-z; Conio M, 2001, GUT, V48, P304, DOI 10.1136/gut.48.3.304; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Cook MB, 2007, CANCER EPIDEM BIOMAR, V16, P2090, DOI 10.1158/1055-9965.EPI-07-0432; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; di Pietro M, 2012, GASTROENTEROLOGY, V142, pS127, DOI 10.1053/j.gastro.2012.03.017; Eda A, 2003, J GASTROENTEROL, V38, P14, DOI 10.1007/s005350300001; Edelstein ZR, 2007, GASTROENTEROLOGY, V133, P403, DOI 10.1053/j.gastro.2007.05.026; Edelstein ZR, 2009, AM J GASTROENTEROL, V104, P834, DOI 10.1038/ajg.2009.137; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fitzgerald RC, 2006, GUT, V55, P1810, DOI 10.1136/gut.2005.089144; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; Greenawalt DM, 2007, INT J CANCER, V120, P1914, DOI 10.1002/ijc.22501; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Hayeck TJ, 2010, DIS ESOPHAGUS, V23, P451, DOI 10.1111/j.1442-2050.2010.01054.x; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lefort K, 2011, CELL, V145, P1003, DOI 10.1016/j.cell.2011.06.008; LEVINE DS, 1989, LAB INVEST, V60, P418; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Manterola C, 2002, J CLIN EPIDEMIOL, V55, P1041, DOI 10.1016/S0895-4356(02)00454-7; Mendelson J, 2011, CANCER-AM CANCER SOC, V117, P3691, DOI 10.1002/cncr.25861; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Onwuegbusi BA, 2006, GUT, V55, P764, DOI 10.1136/gut.2005.076430; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Reid BJ, 2011, CLIN CANCER RES, V17, P3512, DOI 10.1158/1078-0432.CCR-09-2358; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rubio CA, 2011, HISTOPATHOLOGY, V58, P796, DOI 10.1111/j.1365-2559.2011.03830.x; Salo JA, 1996, ANN MED, V28, P305, DOI 10.3109/07853899608999085; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schier S, 2005, ONCOLOGY-BASEL, V69, P9, DOI 10.1159/000086625; Solaymani-Dodaran M, 2004, GUT, V53, P1070, DOI 10.1136/gut.2003.028076; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Vallbohmer D, 2006, DIS ESOPHAGUS, V19, P260, DOI 10.1111/j.1442-2050.2006.00586.x; van Baal JWPM, 2008, SCAND J GASTROENTERO, V43, P132, DOI 10.1080/00365520701676575; Van Baal JWPM, 2005, GASTROENTEROLOGY, V129, P1274, DOI 10.1053/j.gastro.2005.07.026; van Soest EM, 2005, GUT, V54, P1062, DOI 10.1136/gut.2004.063685; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Wang S, 2006, ONCOGENE, V25, P3346, DOI 10.1038/sj.onc.1209357; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; WESTERVELD BD, 1987, GASTROENTEROLOGY, V93, P774, DOI 10.1016/0016-5085(87)90439-2; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	52	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93219	10.1371/journal.pone.0093219	http://dx.doi.org/10.1371/journal.pone.0093219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714516	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900018
J	Tan, L; Wang, Y; Zhou, LL; Shi, Y; Zhang, F; Liu, L; Nie, SF				Tan, Li; Wang, Ying; Zhou, Lingling; Shi, Yun; Zhang, Fan; Liu, Li; Nie, Shaofa			Parkinson's Disease and Risk of Fracture: A Meta-Analysis of Prospective Cohort Studies	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HIP FRACTURE; OLDER MEN; OSTEOPOROTIC FRACTURES; WOMEN; FALLS; ASSOCIATION; PREDICTION; VALIDITY; PEOPLE	Backgrounds/Objective: Parkinson's disease (PD) is the second most common neurodegenerative disease among the elderly population. However, epidemiological evidence on the relationship of PD with risk of fracture has not been systematically assessed. Therefore, we performed this meta-analysis of prospective studies to explore the association between PD and risk of fracture. Methods: PubMed, Embase, Web of Science and Cochrane Library up to February 26, 2014 were searched to identify eligible studies. Random-effects model was used to pool the results. Results: Six studies that totally involved 69,387 participants were included for analysis. Overall, PD patients had an increased risk of fracture compared with control subjects (pooled hazard ratio = 2.66, 95% confidence interval: 2.10-3.36). No publication bias was observed across studies and the subgroup as well as sensitivity analysis suggested that the general results were robust. Conclusion: The present study suggested that PD is associated with an increased risk of fracture. However, given the limited number and moderate quality of included studies, well-designed prospective cohort studies are required to confirm the findings from this meta-analysis.	[Tan, Li; Wang, Ying; Zhou, Lingling; Shi, Yun; Zhang, Fan; Liu, Li; Nie, Shaofa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	sf_nie@mails.tjmu.edu.cn	Wang, Ying/AAP-8234-2021	Wang, Ying/0000-0002-6058-9131				*AG WHO, 2008, WHO GLOB REP FALLS P; Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhattacharya RK, 2012, MOVEMENT DISORD, V27, P1440, DOI 10.1002/mds.25073; Boonen S, 2008, CURR MED RES OPIN, V24, P1781, DOI 10.1185/03007990802115796; Chen SD, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-1; Chen YY, 2012, PARKINSONISM RELAT D, V18, P506, DOI 10.1016/j.parkreldis.2012.01.014; Chen Z, 2004, MENOPAUSE, V11, P264, DOI 10.1097/01.GME.0000094210.15096.FD; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dennison EM, 2012, BONE, V50, P1288, DOI 10.1016/j.bone.2012.02.639; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Edwards MH, 2013, BONE, V52, P541, DOI 10.1016/j.bone.2012.11.006; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fink HA, 2008, OSTEOPOROSIS INT, V19, P1277, DOI 10.1007/s00198-008-0584-4; Fink HA, 2005, J AM GERIATR SOC, V53, P1559, DOI 10.1111/j.1532-5415.2005.53464.x; Genever RW, 2005, AGE AGEING, V34, P21, DOI 10.1093/ageing/afh203; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Gregson CL, 2013, OSTEOPOROS INT; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Hartholt KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022227; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hiorth YH, 2013, EUR J NEUROL, V20, P160, DOI 10.1111/j.1468-1331.2012.03821.x; Hundrup YA, 2004, SCAND J PUBLIC HEALT, V32, P136, DOI 10.1080/14034940310017490; JOHNELL O, 1992, AGE AGEING, V21, P32, DOI 10.1093/ageing/21.1.32; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Melton LJ, 2006, MOVEMENT DISORD, V21, P1361, DOI 10.1002/mds.20946; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Pouwels S, 2013, OSTEOPOROSIS INT, V24, P2283, DOI 10.1007/s00198-013-2300-2; Rosenthal L, 2010, METHODS MOL BIOL, V594, P427, DOI 10.1007/978-1-60761-411-1_30; Schneider JL, 2008, OSTEOPOROSIS INT, V19, P1093, DOI 10.1007/s00198-008-0583-5; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taylor BC, 2004, J AM GERIATR SOC, V52, P1479, DOI 10.1111/j.1532-5415.2004.52410.x; van den Bos F, 2013, AGE AGEING, V42, P156, DOI 10.1093/ageing/afs161; Walker RW, 2013, MOVEMENT DISORD, V28, P334, DOI 10.1002/mds.25297; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721; Yang J, 2012, BONE, V51, P376, DOI 10.1016/j.bone.2012.05.024; Zhao Y, 2013, BONE, V52, P498, DOI 10.1016/j.bone.2012.09.013	42	23	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94379	10.1371/journal.pone.0094379	http://dx.doi.org/10.1371/journal.pone.0094379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714656	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900124
J	Tseng, LC; Zhang, CJ; Cheng, CM; Xu, HY; Hsu, CH; Jiang, YJ				Tseng, Li-Chuan; Zhang, Chengjin; Cheng, Chun-Mei; Xu, Haoying; Hsu, Chia-Hao; Jiang, Yun-Jin			New Classes of Mind Bomb-Interacting Proteins Identified from Yeast Two-Hybrid Screens	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; ANKYRIN REPEAT DOMAIN; ASPARAGINYL HYDROXYLATION; LIQUID FACETS; IN-VIVO; NOTCH; HYPOXIA; DEGRADATION; HIF-1-ALPHA; MIB2	Notch signaling pathway defines an evolutionarily conserved mechanism in cell-fate determination in a broad spectrum of developmental processes through local cell interactions. mind bomb (mib) encodes an E3 ubiquitin ligase that is involved in Notch activation through Delta ubiquitylation and internalization. To further dissect the function of Mib, two yeast two-hybrid screens for zebrafish Mib/Mib2-binding proteins with different strategies have been performed. 81 putative interesting proteins were discovered and classified into six groups: ubiquitin proteasome pathway, cytoskeleton, trafficking, replication/transcription/translation factors, cell signaling and others. Confirmed by coimmunoprecipitation (Co-IP), Mib interacted with four tested proteins: ubiquitin specific protease 1 (Usp1), ubiquitin specific protease 9 (Usp9), tumornecrosis-factor-receptor-associated factor (TRAF)-binding domain (Trabid)/zinc finger, RAN-binding domain containing 1 (Zranb1) and hypoxia-inducible factor 1, alpha subunit inhibitor (Hif1an)/factor inhibiting HIF 1 (Fih-1). Usp1, Usp9, Trabid and Fih-1 also bound to zebrafish Mib2, a Mib homolog with similar structural domains and functions. Both Mib and Mib2 can ubiquitylate Trabid and Fih-1, indicating a potential regulating role of Mib and Mib2 on Trabid and Fih-1 and, furthermore, the possible involvement of Notch signaling in hypoxia-regulated differentiation, tumorigenesis and NF-kappa B pathway. Finally, functions of confirmed Mib/Mib2-interacting proteins are collated, summarized and hypothesized, which depicts a regulating network beyond Notch signaling.	[Tseng, Li-Chuan; Cheng, Chun-Mei; Hsu, Chia-Hao; Jiang, Yun-Jin] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan Town, Miaoli County, Taiwan; [Zhang, Chengjin; Xu, Haoying; Jiang, Yun-Jin] Natl Univ Singapore, Inst Mol & Cell Biol, Lab Dev Signalling & Patterning, Singapore 117548, Singapore; [Hsu, Chia-Hao] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Jiang, Yun-Jin] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Jiang, Yun-Jin] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan	National Health Research Institutes - Taiwan; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National Tsing Hua University; National Chung Hsing University; National Taiwan University	Jiang, YJ (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan Town, Miaoli County, Taiwan.	yjjiang@nhri.org.tw	Jiang, Yun-Jin/E-3995-2010	Jiang, Yun-Jin/0000-0003-0499-7306; HSU, CHIA-HAO/0000-0001-6920-0316	Agency of Science, Technology and Research (A*STAR), Singapore; National Health Research Institutes, Taiwan [MG-102-PP-13, MG-102-PP-14]; National Science Council, Taiwan [NSC 102-2321-B-400-018, 100-2911-I-400-002, 100-2311-B-400-001-MY3]	Agency of Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Agency of Science, Technology and Research (A*STAR, http://www.a-star.edu.sg), Singapore, the National Health Research Institutes (http://www.nhri.org.tw), Taiwan (MG-102-PP-13 and MG-102-PP-14) and grants from the National Science Council (http://web1.nsc.gov.tw), Taiwan (NSC 102-2321-B-400-018, 100-2911-I-400-002 and 100-2311-B-400-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Carrasco-Rando M, 2008, DEVELOPMENT, V135, P849, DOI 10.1242/dev.015529; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Cunningham LA, 2012, BEHAV BRAIN RES, V227, P410, DOI 10.1016/j.bbr.2011.08.002; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fukuba H, 2008, NEUROSCI LETT, V433, P209, DOI 10.1016/j.neulet.2007.12.069; Fukuba H, 2007, BIOCHEM BIOPH RES CO, V353, P324, DOI 10.1016/j.bbrc.2006.12.051; Gao W, 2012, ARTHRITIS RHEUM-US, V64, P2104, DOI 10.1002/art.34397; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hing HK, 1999, EUR J CELL BIOL, V78, P690, DOI 10.1016/S0171-9335(99)80037-5; Horn S, 2012, P NATL ACAD SCI USA, V109, P7356, DOI 10.1073/pnas.1203605109; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jeong HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036359; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kang K, 2013, J BIOL CHEM, V288, P2580, DOI 10.1074/jbc.M112.398263; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Kopan R, 2002, J CELL SCI, V115, P1095; Kwon DY, 2013, MOL BIOL CELL, V24, P1863, DOI 10.1091/mbc.E13-01-0042; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nguyen HT, 2007, J CELL BIOL, V179, P219, DOI 10.1083/jcb.200708135; O'Neill L.A., 2000, SCI STKE, V2000, pRE1, DOI DOI 10.1126/STKE.2000.44.RE1; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Porazzi P, 2012, ENDOCRINOLOGY, V153, P5645, DOI 10.1210/en.2011-1888; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sainson RCA, 2006, TRENDS MOL MED, V12, P141, DOI 10.1016/j.molmed.2006.02.001; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stempin CC, 2011, J BIOL CHEM, V286, P37147, DOI 10.1074/jbc.M111.263384; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Takeuchi T, 2005, AM J PATHOL, V166, P1817, DOI 10.1016/S0002-9440(10)62491-1; Tse WKF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-637; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Yamamoto M, 2010, DEVELOPMENT, V137, P2527, DOI 10.1242/dev.051011; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034; Zhang JZ, 2012, G3-GENES GENOM GENET, V2, P1563, DOI 10.1534/g3.112.003780; Zhang LG, 2009, AM J PHYSIOL-CELL PH, V297, pC1275, DOI 10.1152/ajpcell.00214.2009; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	75	25	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93394	10.1371/journal.pone.0093394	http://dx.doi.org/10.1371/journal.pone.0093394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714733	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900026
J	Wang, JY; Wang, CY; Huang, YS; Chen, PF; Huang, KY; Chou, P; Lian, WC; Lee, CC				Wang, Jen-Yu; Wang, Cheng-Yi; Huang, Yung-Sung; Chen, Pin-Fan; Huang, Kuang-Yung; Chou, Pesus; Lian, Wei-Cheng; Lee, Ching-Chih			Increased Risk of Ischemic Stroke after Hyperosmolar Hyperglycemic State: A Population-Based Follow-Up Study	PLOS ONE			English	Article							DIABETIC-PATIENTS; OXIDATIVE STRESS; GLUCOSE; PREVALENCE; KETOACIDOSIS; MORTALITY; DIAGNOSIS; HEALTH; MEN	Background: Although much attention has been focused on the association between chronic hyperglycemia and cerebrovascular diseases in type 2 diabetes mellitus (DM) patients, there is no data regarding the risk of ischemic stroke after a hyperosmolar hyperglycemic state (HHS) attack. The objective of this study was to investigate the risk of ischemic stroke in type 2 DM patients after an HHS attack. Methods: From 2004 to 2008, this retrospective observational study was conducted on a large cohort of Taiwanese using Taiwan's National Health Insurance Research Database (NHIRD). We identified 19,031 type 2 DM patients who were discharged with a diagnosis of HHS and 521,229 type 2 DM patients without an HHS diagnosis. Using the propensity score generated from logistic regression models, conditional on baseline covariates, we matched 19,031 type 2 DM patients with an HHS diagnosis with the same number from the comparison cohort. The one-year cumulative rate for ischemic stroke was estimated using the Kaplan-Meier method. After adjusting covariates, Cox proportional hazard regression was used to compute the adjusted one-year rate of ischemic stroke. Results: Of the patients sampled, 1,810 (9.5%) of the type 2 DM patients with HHS and 996 (5.2%) of the comparison cohort developed ischemic stroke during the one-year follow-up period. After adjusting for covariates, the adjusted HR for developing ischemic stroke during the one-year follow-up period was 1.8 (95% C. I., 1.67 to 1.95, P<0.001) for type 2 DM patients with HHS compared with those without HHS. Conclusion: Although DM is a well-recognized risk factor for atherosclerosis, type 2 DM patients that have suffered a HHS attacks are at an increased risk of developing ischemic stroke compared with those without HHS.	[Wang, Jen-Yu; Wang, Cheng-Yi] Fu Jen Cathol Univ, Cardinal Tien Hosp, Sch Med, Dept Internal Med, New Taipei City, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Chen, Pin-Fan; Lian, Wei-Cheng] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan; [Huang, Kuang-Yung; Lian, Wei-Cheng; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Educ, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lian, WC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan.	hematcd2@hotmail.com; hematcd@hotmail.com						Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiasson JL, 2003, CAN MED ASSOC J, V168, P859; Chu C H, 2001, Chang Gung Med J, V24, P345; DECOURTENMYERS G, 1988, STROKE, V19, P623, DOI 10.1161/01.STR.19.5.623; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Fadini GP, 2011, DIABETES RES CLIN PR, V94, P172, DOI 10.1016/j.diabres.2011.06.018; FOSTER DW, 1983, NEW ENGL J MED, V309, P159; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Kitabchi AE, 2006, ENDOCRIN METAB CLIN, V35, P725, DOI 10.1016/j.ecl.2006.09.006; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; LORBER D, 1995, MED CLIN N AM, V79, P39, DOI 10.1016/S0025-7125(16)30083-9; McFadden E, 2009, STROKE, V40, P1070, DOI 10.1161/STROKEAHA.108.533414; Moulin T, 1997, EUR NEUROL, V38, P10, DOI 10.1159/000112896; NEDERGAARD M, 1987, BRAIN RES, V408, P79, DOI 10.1016/0006-8993(87)90360-X; Pasticci MB, 2013, NEW MICROBIOL, V36, P193; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Resnick HE, 2001, J CLIN EPIDEMIOL, V54, P869, DOI 10.1016/S0895-4356(01)00359-6; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94155	10.1371/journal.pone.0094155	http://dx.doi.org/10.1371/journal.pone.0094155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714221	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900095
J	Wolter, T; Steinbrecher, T; Trauner, D; Elstner, M				Wolter, Tino; Steinbrecher, Thomas; Trauner, Dirk; Elstner, Marcus			Ligand Photo-Isomerization Triggers Conformational Changes in iGluR2 Ligand Binding Domain	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; DYNAMICS; ACTIVATION; SIMULATION; AGONIST	Neurological glutamate receptors bind a variety of artificial ligands, both agonistic and antagonistic, in addition to glutamate. Studying their small molecule binding properties increases our understanding of the central nervous system and a variety of associated pathologies. The large, oligomeric multidomain membrane protein contains a large and flexible ligand binding domains which undergoes large conformational changes upon binding different ligands. A recent application of glutamate receptors is their activation or inhibition via photo-switchable ligands, making them key systems in the emerging field of optochemical genetics. In this work, we present a theoretical study on the binding mode and complex stability of a novel photo-switchable ligand, ATA-3, which reversibly binds to glutamate receptors ligand binding domains (LBDs). We propose two possible binding modes for this ligand based on flexible ligand docking calculations and show one of them to be analogues to the binding mode of a similar ligand, 2-BnTetAMPA. In long MD simulations, it was observed that transitions between both binding poses involve breaking and reforming the T686-E402 protein hydrogen bond. Simulating the ligand photo-isomerization process shows that the two possible configurations of the ligand azo-group have markedly different complex stabilities and equilibrium binding modes. A strong but slow protein response is observed after ligand configuration changes. This provides a microscopic foundation for the observed difference in ligand activity upon light-switching.	[Wolter, Tino; Steinbrecher, Thomas; Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, D-76021 Karlsruhe, Germany; [Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Trauner, Dirk] Ctr Integrated Prot Sci, Munich, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Munich; University of Munich	Elstner, M (corresponding author), Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, D-76021 Karlsruhe, Germany.	marcus.elstner@kit.edu	Elstner, Marcus/H-3463-2013		Deutsche Forschungsgemeinschaft [FOR 1279]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FOR 1279, "Protein-based Photo293 switches") (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinaminpathy Y, 2006, MOL PHARMACOL, V69, P5, DOI 10.1124/mol.105.016691; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; Asztely F, 1996, MOL NEUROBIOL, V12, P1, DOI 10.1007/BF02740744; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Dingledine R, 1999, PHARMACOL REV, V51, P7; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Lau A, 2007, STRUCTURE; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Lodge D, 2009, NEUROPHARMACOLOGY, V56, P6, DOI 10.1016/j.neuropharm.2008.08.006; Nguyen PH, 2006, CHEM PHYS, V323, P36, DOI 10.1016/j.chemphys.2005.08.047; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stawski P, 2012, ANGEW CHEM INT EDIT, V51, P5748, DOI 10.1002/anie.201109265; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vogensen SB, 2007, J MED CHEM, V50, P2408, DOI 10.1021/jm061439q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wolter T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058774	24	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92716	10.1371/journal.pone.0092716	http://dx.doi.org/10.1371/journal.pone.0092716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713651	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900008
J	Fezeu, LK; Laporte, F; Kesse-Guyot, E; Andreeva, VA; Blacher, J; Hercberg, S; Galan, P				Fezeu, Leopold K.; Laporte, Francois; Kesse-Guyot, Emmanuelle; Andreeva, Valentina A.; Blacher, Jacques; Hercberg, Serge; Galan, Pilar			Baseline Plasma Fatty Acids Profile and Incident Cardiovascular Events in the SU.FOL.OM3 Trial: The Evidence Revisited	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALPHA-LINOLENIC ACID; MIDDLE-AGED ADULTS; FISH-OIL; MYOCARDIAL-INFARCTION; DIETARY-INTAKE; DOCOSAHEXAENOIC ACID; ATHEROSCLEROSIS RISK; INSULIN SENSITIVITY; SERUM-LIPIDS	Objective: We aimed to investigate the association between baseline plasma fatty acids profile and the risk of future major cardiovascular events in patients with a history of ischaemic heart disease or ischemic stroke. Methods: Baseline plasma fatty acids as well as established cardiovascular risk factors were measured in 2,263 patients enrolled in the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids randomized controlled trial. Incident major cardiovascular, cardiac and cerebrovascular events were ascertained during the 4.7 years of follow up. Hazard ratios were obtained from Cox proportional hazards models after adjustment for cardiovascular risk factors. Results: During the follow-up, 154, 379 and 84 patients had major cardiovascular, cardiac and cerebrovascular events respectively. Upon adjustment for gender, initial event, baseline age and BMI, the risk of developing a major cardiovascular event decreased significantly in successive quartiles of arachidonic acid (P-trend<0.002), total omega 3 polyunsaturated fatty acids (P-trend<0.03), docosapentaenoic acid (P-trend< 0.019), docosahexaenoic acid (P-trend<0.004), eicosapentaenoic acid + docosahexaenoic acid (P-trend<0.03) and eicosapentaenoic acid + docosapentaenoic acid + docosahexaenoic acid (P-trend<0.02). This inverse association was borderline significant with increased quartiles of stearidonic acid (P-trend<0.06). In the full model, only stearidonic acid remained inversely associated with the risk of developing a major cardiovascular event (P-trend<0.035), a cardiac event (P-trend<0.016) or a cerebrovascular event (P-trend<0.014), while arachidonic acid was inversely associated with the risk a cerebrovascular event (P-trend<0.033). Conclusion: The inverse association of long chain omega 3 polyunsaturated fatty acids with recurrence of Cardiovascular diseases was mainly driven by well-known cardiovascular risk factors.	[Fezeu, Leopold K.; Kesse-Guyot, Emmanuelle; Andreeva, Valentina A.; Blacher, Jacques; Hercberg, Serge; Galan, Pilar] Univ Paris 07, Univ Paris 05,Univ Paris 13, Cnam,Sorbonne Paris Cite, Inserm,Inra,Ctr Epidemiol & Biostat EPIBIOS,EREN, Bobigny, France; [Laporte, Francois] CHU Grenoble, Dept Biochim Pharmacol Toxicol, F-38043 Grenoble, France; [Blacher, Jacques] Univ Paris 05, AP HP, Fac Med, Paris, France; [Blacher, Jacques] Ctr Diagnost & Therapeut, Hotel Dieu, Paris, France; [Hercberg, Serge] Hop Avicenne, Dept Sante Publ, F-93009 Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Fezeu, LK (corresponding author), Univ Paris 07, Univ Paris 05,Univ Paris 13, Cnam,Sorbonne Paris Cite, Inserm,Inra,Ctr Epidemiol & Biostat EPIBIOS,EREN, Bobigny, France.	l.fezeu@uren.smbh.univ-paris13.fr	Kesse-Guyot, Emmanuelle/K-4689-2012; Serge, Hercberg/F-3038-2017; Fezeu, Leopold/F-2804-2017; Andreeva, Valentina/F-2680-2017; Blacher, Jacques/F-2685-2017; Pilar, Galan/F-2908-2017; Kesse-Guyot, Emmanuelle/ABH-7347-2020; Kesse-Guyot, Emmanuelle/F-2692-2017; HERCBERG, Serge/B-4429-2008	Serge, Hercberg/0000-0002-3168-1350; Fezeu, Leopold/0000-0002-7589-3179; Andreeva, Valentina/0000-0001-9480-5210; Blacher, Jacques/0000-0003-4860-4279; Pilar, Galan/0000-0003-1706-3107; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; HERCBERG, Serge/0000-0002-3168-1350	French National Research Agency [R02010JJ]; Ministry of Health; Sodexo; Candia; Unilever; Danone; Roche Laboratories; Merck Eprova AG; Pierre Fabre Laboratories; Catalent Pharma Solutions	French National Research Agency(French National Research Agency (ANR)); Ministry of Health; Sodexo; Candia; Unilever(Unilever); Danone(Danone Nutricia); Roche Laboratories; Merck Eprova AG; Pierre Fabre Laboratories; Catalent Pharma Solutions	The SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids trial was funded by the French National Research Agency (grant R02010JJ), the Ministry of Health, Sodexo, Candia, Unilever, Danone, Roche Laboratories, Merck Eprova AG, Pierre Fabre Laboratories, and Catalent Pharma Solutions. Treatment capsules (active and placebo) were provided free of charge by Roche Laboratories, Merck Eprova AG, Pierre Fabre Laboratories, and Catalent Pharma Solutions. The sponsors provided funding for operational aspects of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsetoey H, 2009, J NUTR, V139, P507, DOI 10.3945/jn.108.096446; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P391, DOI 10.1586/14779072.6.3.391; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Czernichow S, 2010, BRIT J NUTR, V104, P788, DOI 10.1017/S0007114510002096; Egeland G M, 2001, Int J Circumpolar Health, V60, P143; Eussen SR, 2012, EUR HEART J; Filion KB, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-24; Galan P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6273; Harris W, 2010, CURR OPIN CLIN NUTR, V13, P125, DOI 10.1097/MCO.0b013e3283357242; Harris WS, 2007, ATHEROSCLEROSIS, V193, P1, DOI 10.1016/j.atherosclerosis.2007.03.018; He K, 2009, PROG CARDIOVASC DIS, V52, P95, DOI 10.1016/j.pcad.2009.06.003; Hooper L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003177.PUB2; Hu FB, 2003, CIRCULATION, V107, P1852, DOI 10.1161/01.CIR.0000062644.42133.5F; Itakura H, 2011, J ATHEROSCLER THROMB, V18, P99, DOI 10.5551/jat.5876; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kromhout D, 2012, EUR HEART J, V33, P436, DOI 10.1093/eurheartj/ehr362; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Lee SH, 2009, CIRC J, V73, P2250, DOI 10.1253/circj.CJ-09-0327; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Leon H., 2008, BMJ-BRIT MED J, V337, P2931; Manger MS, 2010, AM J CLIN NUTR, V92, P244, DOI 10.3945/ajcn.2010.29175; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Ohrvall M, 1996, ATHEROSCLEROSIS, V127, P65, DOI 10.1016/S0021-9150(96)05936-9; Oomen CM, 2001, AM J CLIN NUTR, V74, P457; Overby NC, 2009, BRIT J NUTR, V102, pS56, DOI 10.1017/S000711450999314X; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Rissanen T, 2000, CIRCULATION, V102, P2677, DOI 10.1161/01.CIR.102.22.2677; Roger VL, 2010, CIRCULATION, V121, P863, DOI 10.1161/CIRCULATIONAHA.109.897249; SALONEN JT, 1985, AM J CARDIOL, V56, P226, DOI 10.1016/0002-9149(85)90839-2; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; Wang CC, 2006, AM J CLIN NUTR, V84, P5, DOI 10.1093/ajcn/84.1.5; Wang L, 2003, NUTR METAB CARDIOVAS, V13, P256, DOI 10.1016/S0939-4753(03)80029-7; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017	44	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92548	10.1371/journal.pone.0092548	http://dx.doi.org/10.1371/journal.pone.0092548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710321	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800014
J	Chiu, HY; Hsu, HY; Kuo, LC; Su, FC; Yu, HI; Hua, SC; Lu, CH				Chiu, Haw-Yen; Hsu, Hsiu-Yun; Kuo, Li-Chieh; Su, Fong-Chin; Yu, Hui-I; Hua, Shih-Che; Lu, Chieh-Hsiang			How the Impact of Median Neuropathy on Sensorimotor Control Capability of Hands for Diabetes: An Achievable Assessment from Functional Perspectives	PLOS ONE			English	Article							CARPAL-TUNNEL-SYNDROME; PERIPHERAL NEUROPATHY; PRECISION GRIP; SUBCLINICAL NEUROPATHY; MELLITUS; FORCE; COORDINATION; DIAGNOSIS; COMPLICATIONS; MANIPULATION	To comprehend the sensorimotor control ability in diabetic hands, this study investigated the sensation, motor function and precision pinch performances derived from a pinch-holding-up activity (PHUA) test of the hands of diabetic patients and healthy subjects. The precision, sensitivity and specificity of the PHUA test in the measurements of diabetic patients were also analyzed. We hypothesized that the diabetic hands would have impacts on the sensorimotor functions of the hand performances under functionally quantitative measurements. One hundred and fifty-nine patients with clinically defined diabetes mellitus (DM) and 95 age-and gender-matched healthy controls were included. Semmes-Weinstein monofilament (SWM), static and moving two-point discrimination (S2PD and M2PD), maximal pinch strength and precision pinch performance tests were conducted to evaluate the sensation, motor and sensorimotor status of the recruited hands. The results showed that there were significant differences (all p<0.05) in SWM, S2PD, M2PD and maximum pinch strength between the DM and control groups. A higher force ratio in the DM patients than in the controls (p<0.001) revealed a poor ability of pinch force adjustment in the DM patients. The percentage of maximal pinch strength was also significantly different (p<0.001) between the DM and control groups. The sensitivity, specificity and area under the receiver operating characteristic curve were 0.85, 0.51, and 0.724, respectively, for the PHUA test. Statistically significant degradations in sensory and motor functions and sensorimotor control ability were observed in the hands of the diabetic patients. The PHUA test could be feasibly used as a clinical tool to determine the sensorimotor function of the hands of diabetic patients from a functional perspective.	[Chiu, Haw-Yen] Chi Mei Med Ctr, Dept Surg, Sect Plast Surg, Tainan, Taiwan; [Hsu, Hsiu-Yun] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Tainan 70101, Taiwan; [Hsu, Hsiu-Yun; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 70101, Taiwan; [Kuo, Li-Chieh; Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Yu, Hui-I; Hua, Shih-Che; Lu, Chieh-Hsiang] Chiayi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Chiayi, Taiwan; [Lu, Chieh-Hsiang] Natl Chung Cheng Univ, Coll Management, Dept Business Adm, Chiayi, Chiayi County, Taiwan; [Lu, Chieh-Hsiang] Ta Tung Inst Commerce & Technol, Chiayi, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chia-Yi Christian Hospital; National Chung Cheng University	Lu, CH (corresponding author), Chiayi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Chiayi, Taiwan.	chhslu@gmail.com	SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021; Hsu, Hsiu-Yun/AGZ-2698-2022	SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096; Kuo, Li-Chieh/0000-0002-5644-655X	Ditmanson Medical Foundation, Chiayi Christian Hospital, Taiwan	Ditmanson Medical Foundation, Chiayi Christian Hospital, Taiwan	This work was supported by a research grant from the Ditmanson Medical Foundation, Chiayi Christian Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augurelle AS, 2003, J NEUROPHYSIOL, V89, P665, DOI 10.1152/jn.00249.2002; Bertora P, 1998, J NEUROL, V245, P81, DOI 10.1007/s004150050182; BORSEY DQ, 1983, DIABETES CARE, V6, P10, DOI 10.2337/diacare.6.1.10; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Cederlund RI, 2009, J DIABETES COMPLICAT, V23, P32, DOI 10.1016/j.jdiacomp.2007.09.002; Cetinus E, 2005, DIABETES RES CLIN PR, V70, P278, DOI 10.1016/j.diabres.2005.03.028; Cheliout-Heraut F, 2005, JOINT BONE SPINE, V72, P412, DOI 10.1016/j.jbspin.2004.10.003; Chiu HY, 2009, J ORTHOP RES, V27, P1116, DOI 10.1002/jor.20859; De Vegt F, 1998, DIABETES CARE, V21, P1686, DOI 10.2337/diacare.21.10.1686; El-Salem K, 2009, J CLIN NEUROPHYSIOL, V26, P50, DOI 10.1097/WNP.0b013e31819862ee; Fitzgibbons PG, 2008, J HAND SURG-AM, V33A, P771, DOI 10.1016/j.jhsa.2008.01.038; FLANAGAN JR, 1995, EXP BRAIN RES, V105, P455; FORSSBERG H, 1991, EXP BRAIN RES, V85, P451; GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P632, DOI 10.2106/00004623-198365050-00008; Gibbons CH, 2010, DIABETES CARE, V33, P2629, DOI 10.2337/dc10-0763; Hsu HY, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-26; JABLECKI CK, 1993, MUSCLE NERVE, V16, P1392; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Jurado J, 2009, EUR J CLIN INVEST, V39, P183, DOI 10.1111/j.1365-2362.2008.02074.x; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Lee SY, 2003, J KOREAN MED SCI, V18, P103; Lowe BD, 1999, ERGONOMICS, V42, P550, DOI 10.1080/001401399185469; MCPHEE SD, 1987, AM J OCCUP THER, V41, P158, DOI 10.5014/ajot.41.3.158; Moharic M, 2012, J DIABETES COMPLICAT, V26, P319, DOI 10.1016/j.jdiacomp.2012.04.008; Nowak DA, 2005, MOVEMENT DISORD, V20, P11, DOI 10.1002/mds.20299; Nowak DA, 2001, EUR J NEUROSCI, V14, P756, DOI 10.1046/j.0953-816x.2001.01697.x; Perkins BA, 2001, DIABETES CARE, V24, P250, DOI 10.2337/diacare.24.2.250; PIRART J, 1977, DIABETES METAB, V3, P245; Redmond CL, 2012, J DIABETES COMPLICAT, V26, P313, DOI 10.1016/j.jdiacomp.2012.04.009; Redmond CL, 2009, J RHEUMATOL, V36, P2766, DOI 10.3899/jrheum.090239; Sahin S, 2009, NEUROL SCI, V30, P281, DOI 10.1007/s10072-009-0089-8; Solli O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-18; Soreide K, 2011, ANN SURG, V253, P27, DOI 10.1097/SLA.0b013e318204a892; Su PH, 2013, ULTRASOUND IN PRESS; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; VINIK AI, 1999, AM J MED, V107, P17, DOI DOI 10.1016/S0002-9343(99)00009-1; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	39	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94452	10.1371/journal.pone.0094452	http://dx.doi.org/10.1371/journal.pone.0094452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722361	gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100072
J	Monajemi, M; Woodworth, CF; Zipperlen, K; Gallant, M; Grant, MD; Larijani, M				Monajemi, Mahdis; Woodworth, Claire F.; Zipperlen, Katrin; Gallant, Maureen; Grant, Michael D.; Larijani, Mani			Positioning of APOBEC3G/F Mutational Hotspots in the Human Immunodeficiency Virus Genome Favors Reduced Recognition by CD8(+) T Cells	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; CELLULAR IMMUNE-RESPONSES; DENDRITIC CELLS; VIF PROTEIN; CYTIDINE DEAMINATION; LYMPHOCYTE ACTIVITY; TYPE-1 INFECTION; CTL RECOGNITION; VIRAL ESCAPE; IN-VIVO	Due to constitutive expression in cells targeted by human immunodeficiency virus (HIV), and immediate mode of viral restriction upon HIV entry into the host cell, APOBEC3G (A3G) and APOBEC3F (A3F) have been considered primarily as agents of innate immunity. Recent bioinformatic and mouse model studies hint at the possibility that mutation of the HIV genome by these enzymes may also affect adaptive immunity but whether this occurs in HIV-infected individuals has not been examined. We evaluated whether APOBEC-mediated mutations within common HIV CD8(+) T cell epitopes can potentially enhance or diminish activation of HIV-specific CD8(+) T cells from infected individuals. We compared ex vivo activation of CD8(+) T lymphocytes from HIV-infected individuals by wild type HIV peptide epitopes and synthetic variants bearing simulated A3G/F-induced mutations by measuring interferon-gamma (IFN-gamma) production. We found that A3G/F-induced mutations consistently diminished HIV-specific CD8(+) T cell responses against the common epitopes we tested. If this reflects a significant trend in vivo, then adaptation by HIV to enrich sequences that are favored for mutation by A3G/F (A3G/F hotspots) in portions of its genome that encode immunogenic CD8(+) T cell epitopes would favor CTL escape. Indeed, we found the most frequently mutated A3G motif (CCC) is enriched up to 6-fold within viral genomic sequences encoding immunodominant CD8(+) T cell epitopes in Gag, Pol and Nef. Within each gene, A3G/F hotspots are more abundant in sequences encoding epitopes that are commonly recognized due to their HLA restriction. Thus, in our system, mutations of the HIV genome, mimicking A3G/F activity, appeared to abrogate or severely reduce CTL recognition. We suggest that the physiological significance of this potential effect in facilitating CTL escape is echoed in the adaptation of the HIV genome to enrich A3G/F hotspots in sequences encoding CTL epitopes that are more immunogenic at the population level.	[Monajemi, Mahdis; Woodworth, Claire F.; Zipperlen, Katrin; Gallant, Maureen; Grant, Michael D.; Larijani, Mani] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada	Memorial University Newfoundland	Grant, MD (corresponding author), Mem Univ Newfoundland, Fac Med, Div Biomed Sci, Immunol & Infect Dis Program, St John, NF, Canada.	mgrant@mun.ca; mlarijani@mun.ca			CIHR [MOP111132, OCH131580, HOP-111725, HOP-93428, HC1-112568]; Canadian Foundation for AIDS Research (CANFAR); Wallace Ingram Award; Research and Development Corporation (Newfoundland)	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for AIDS Research (CANFAR); Wallace Ingram Award; Research and Development Corporation (Newfoundland)	This work was supported by CIHR (MOP111132 and OCH131580) and Canadian Foundation for AIDS Research (CANFAR) operating grants, the Wallace Ingram Award, the Research and Development Corporation (Newfoundland) funding to ML, and by CIHR operating grants (HOP-111725, HOP-93428) and CIHR catalyst grant (HC1-112568) to MG. ML holds a CIHR New Investigator award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; Almeida CAM, 2011, J IMMUNOL, V187, P2502, DOI 10.4049/jimmunol.1100691; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Barouch DH, 2002, VACCINE, V20, pA66, DOI 10.1016/S0264-410X(02)00390-0; Belanger K, 2013, NUCLEIC ACIDS RES, V41, P7438, DOI 10.1093/nar/gkt527; Betts MR, 1999, AIDS RES HUM RETROV, V15, P1219, DOI 10.1089/088922299310313; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brennan CA, 2012, J VIROL; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Casartelli N, 2010, J EXP MED, V207, P39, DOI 10.1084/jem.20091933; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chiu YL, 2011, METHODS MOL BIOL, V718, P185, DOI 10.1007/978-1-61779-018-8_12; Chiu YL, 2009, PHILOS T R SOC B, V364, P689, DOI 10.1098/rstb.2008.0193; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Fourati S, 2010, AIDS, V24, P2313, DOI 10.1097/QAD.0b013e32833e515a; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Geels MJ, 2003, J VIROL, V77, P12430, DOI 10.1128/JVI.77.23.12430-12440.2003; Gladney KH, 2012, VACCINE, V30, P6997, DOI 10.1016/j.vaccine.2012.09.067; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huang XL, 2000, CLIN DIAGN LAB IMMUN, V7, P279, DOI 10.1128/CDLI.7.2.279-287.2000; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Klarmann GJ, 2003, J BIOL CHEM, V278, P7902, DOI 10.1074/jbc.M207223200; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Letvin NL, 2001, J CLIN INVEST, V107, P273, DOI 10.1172/JCI12174; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Mason RA, 2004, J IMMUNOL, V172, P7212, DOI 10.4049/jimmunol.172.11.7212; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Monajemi M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-35; Novitsky V, 2002, J VIROL, V76, P10155, DOI 10.1128/JVI.76.20.10155-10168.2002; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Pohling J, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-129; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Rohowsky-Kochan C, 1998, HUM IMMUNOL, V59, P802, DOI 10.1016/S0198-8859(98)00086-X; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Wang XJ, 2007, J BIOL CHEM, V282, P1585, DOI 10.1074/jbc.M610150200; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yamanaka R, 2007, BIOSCI TRENDS, V1, P52; Yebra G, 2011, J ANTIMICROB CHEMOTH, V66, P941, DOI 10.1093/jac/dkr012; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XF, 2006, CURR OPIN HIV AIDS, V1, P187, DOI 10.1097/01.COH.0000221590.03670.32; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	78	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93428	10.1371/journal.pone.0093428	http://dx.doi.org/10.1371/journal.pone.0093428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722422	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000336909100016
J	Morgan, KL; Rahman, MA; Hill, RA; Zhou, SM; Bijlsma, G; Khanom, A; Lyons, RA; Brophy, ST				Morgan, Kelly L.; Rahman, Muhammad A.; Hill, Rebecca A.; Zhou, Shang-Ming; Bijlsma, Gunnar; Khanom, Ashrafunnesa; Lyons, Ronan A.; Brophy, Sinead T.			Physical Activity and Excess Weight in Pregnancy Have Independent and Unique Effects on Delivery and Perinatal Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; CESAREAN DELIVERY; RISK-FACTOR; NULLIPAROUS WOMEN; EXERCISE; LABOR; COMPLICATIONS; HEALTH; FETAL	Background: This study examines the effect of low daily physical activity levels and overweight/obesity in pregnancy on delivery and perinatal outcomes. Methods: A prospective cohort study combining manually collected postnatal notes with anonymised data linkage. A total of 466 women sampled from the Growing Up in Wales: Environments for Healthy Living study. Women completed a questionnaire and were included in the study if they had an available Body mass index (BMI) (collected at 12 weeks gestation from antenatal records) and/or a physical activity score during pregnancy (7-day Actigraph reading). The full statistical model included the following potential confounding factors: maternal age, parity and smoking status. Main outcome measures included induction rates, duration of labour, mode of delivery, infant health and duration of hospital stay. Findings: Mothers with lower physical activity levels were more likely to have an instrumental delivery (including forceps, ventouse and elective and emergency caesarean) in comparison to mothers with higher activity levels (adjusted OR: 1.72(95% CI: 1.05 to 2.9)). Overweight/obese mothers were more likely to require an induction (adjusted OR: 1.93 (95% CI 1.14 to 3.26), have a macrosomic baby (adjusted OR: 1.96 (95% CI 1.08 to 3.56) and a longer hospital stay after delivery (adjusted OR: 2.69 (95% CI 1.11 to 6.47). Conclusions: The type of delivery was associated with maternal physical activity level and not BMI. Perinatal outcomes (large for gestational age only) were determined by maternal BMI.	[Morgan, Kelly L.; Rahman, Muhammad A.; Hill, Rebecca A.; Zhou, Shang-Ming; Khanom, Ashrafunnesa; Brophy, Sinead T.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Bijlsma, Gunnar] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6525 ED Nijmegen, Netherlands; [Lyons, Ronan A.] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales	Swansea University; Radboud University Nijmegen; Swansea University	Morgan, KL (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	kelly.morgan@swansea.ac.uk	Rahman, Muhammad Azizur/GLR-8606-2022; Zhou, Shang-Ming/A-8443-2008	Rahman, Muhammad Azizur/0000-0002-0805-7461; Khanom, Ashrafunnesa/0000-0002-5735-6601; Brophy, Sinead/0000-0001-7417-2858; Morgan, Kelly/0000-0002-8685-1177; Lyons, Ronan/0000-0001-5225-000X; Zhou, Shang-Ming/0000-0002-0719-9353	Swansea University; National Institute for Social Care and Health Research; MRC [MR/K023233/1, MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K023233/1, MR/K006525/1] Funding Source: researchfish	Swansea University; National Institute for Social Care and Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for the study was provided by Swansea University and National Institute for Social Care and Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Arrowsmith S, 2011, BJOG-INT J OBSTET GY, V118, P578, DOI 10.1111/j.1471-0528.2010.02889.x; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Barakat R, 2008, BRIT J SPORT MED, V42, P674, DOI 10.1136/bjsm.2008.047837; Barakat R, 2012, J MATERN-FETAL NEO M, V25, P2372, DOI 10.3109/14767058.2012.696165; BECKMANN CRB, 1990, J REPROD MED, V35, P704; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Botkin C, 1991, Fam Pract Res J, V11, P387; Brophy S ZS-M, 2013, 3 INT C AMB MON PHYS; Bungum T J, 2000, J Obstet Gynecol Neonatal Nurs, V29, P258, DOI 10.1111/j.1552-6909.2000.tb02047.x; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Cheng YW, 2010, OBSTET GYNECOL, V116, P1127, DOI 10.1097/AOG.0b013e3181f5eaf0; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; CLAPP JF, 1984, MED SCI SPORT EXER, V16, P556; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Department of Health, 2006, NHS MAT STAT E 2004; Downs DS, 2004, J MIDWIFERY WOM HEAL, V49, P138, DOI 10.1016/j.jmwh.2003.11.009; Duncombe D, 2006, AUST NZ J OBSTET GYN, V46, P288, DOI 10.1111/j.1479-828X.2006.00594.x; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Mesas AE, 2012, J NUTR, V142, P1321, DOI 10.3945/jn.112.158154; Evans GW, 2012, PEDIATRICS, V129, pE68, DOI 10.1542/peds.2010-3647; Evenson KR, 2002, EPIDEMIOLOGY, V13, P653, DOI 10.1097/00001648-200211000-00009; Fleten C, 2010, OBSTET GYNECOL, V115, P331, DOI 10.1097/AOG.0b013e3181ca4414; Forouhari S, 2009, IRANIAN CRESCENT MED, V11; Frederick IO, 2008, MATERN CHILD HLTH J, V12, P557, DOI 10.1007/s10995-007-0276-2; Freinkel N, 2008, CIBA FDN S 63 PREGN, P3; Haakstad LAH, 2007, ACTA OBSTET GYN SCAN, V86, P559, DOI 10.1080/00016340601185301; Hill R, 2010, PROTOCOL BASELINE AS, P1; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P239, DOI 10.1067/mob.2003.441; Kapellou O, 2011, ACTA PAEDIATR, V100, P1416, DOI 10.1111/j.1651-2227.2011.02427.x; Kardel KR, 1998, AM J OBSTET GYNECOL, V178, P280, DOI 10.1016/S0002-9378(98)80013-6; Koepp UMS, 2012, ACTA OBSTET GYN SCAN, V91, P243, DOI 10.1111/j.1600-0412.2011.01321.x; Kramer MS MS, 2006, COCHRANE DATABASE SY, V19; Lof M, 2008, ACTA OBSTET GYN SCAN, V87, P524, DOI 10.1080/00016340802012288; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Maternity Care Working Party, 2007, MAK NORM BIRTH REAL; MCWP MCWP, 2007, MAK NORM BIRTH REAL, P1; Melzer K, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.876; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Myles TD, 2002, OBSTET GYNECOL, V100, P959, DOI 10.1016/S0029-7844(02)02323-2; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; PARILLA BV, 1993, OBSTET GYNECOL, V81, P392; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Raebel MA, 2004, ARCH INTERN MED, V164, P2135, DOI 10.1001/archinte.164.19.2135; RICE PL, 1991, J SPORT MED PHYS FIT, V31, P95; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sheiner E, 2004, PAEDIATR PERINAT EP, V18, P196, DOI 10.1111/j.1365-3016.2004.00557.x; Smith JF, 1997, OBSTET GYNECOL, V90, P344, DOI 10.1016/S0029-7844(97)00284-6; STERNFELD B, 1995, MED SCI SPORT EXER, V27, P634; Sui ZX, 2013, INT J WOMENS HEALTH, V5, P389, DOI 10.2147/IJWH.S34042; Syngelaki A, 2011, FETAL DIAGN THER, V30, P250, DOI 10.1159/000328083; TREFFERS PE, 1993, BMJ-BRIT MED J, V307, P1017, DOI 10.1136/bmj.307.6911.1017; van Hees VT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022922; Vasudevan C, 2011, ARCH DIS CHILD-FETAL, V96, pF378, DOI 10.1136/adc.2009.170928; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2010, GLOB STAT REP NONC D; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; WOLFE LA, 1989, SPORTS MED, V8, P273, DOI 10.2165/00007256-198908050-00003	61	24	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94532	10.1371/journal.pone.0094532	http://dx.doi.org/10.1371/journal.pone.0094532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722411	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100092
J	Nakatsu, Y; Matsuoka, M; Chang, TH; Otsuki, N; Noda, M; Kimura, H; Sakai, K; Kato, H; Takeda, M; Kubota, T				Nakatsu, Yuichiro; Matsuoka, Mayumi; Chang, Tsung-Hsien; Otsuki, Noriyuki; Noda, Masahiro; Kimura, Hirokazu; Sakai, Kouji; Kato, Hiroshi; Takeda, Makoto; Kubota, Toru			Functionally Distinct Effects of the C-Terminal Regions of IKK epsilon and TBK1 on Type I IFN Production	PLOS ONE			English	Article							BINDING KINASE 1; CRYSTAL-STRUCTURE; BETA; ACTIVATION; TANK; INFLAMMATION; ENHANCEOSOME; INFECTION; INHIBITOR; MECHANISM	Inhibitor of kappa B kinase epsilon (IKK epsilon) and TANK binding kinase 1 (TBK1), so-called non-canonical IKKs or IKK-related kinases, are involved in the cellular innate immunity by inducing type I IFNs. Two kinases commonly phosphorylate transcription factors IRF3 and IRF7 in type I IFN production pathway. In contrast to TBK1, underlying mechanisms of IKK epsilon activation and regions required for activation of downstream molecules are poorly understood. In this study, we investigated regions of IKK epsilon required for the activation of type I IFN promoter specially, by focusing on the C-terminal region. To show the functional significance of the IKK epsilon C-terminal region on type I IFN production, we employed various mutant forms of IKK epsilon and compared to corresponding region of TBK1. We identified the specific regions and residues of IKK epsilon involved in the activation of downstream signaling. Interestingly, corresponding region and residues are not required for activation of downstream signaling by TBK1. The results highlight the importance of the C-terminal region in the functional activity of IKK epsilon in innate immune response and also the difference in activation mechanisms between IKK epsilon and the closely related TBK1.	[Nakatsu, Yuichiro; Otsuki, Noriyuki; Sakai, Kouji; Kato, Hiroshi; Takeda, Makoto; Kubota, Toru] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan; [Matsuoka, Mayumi] Natl Inst Infect Dis, Dept Bacteriol 3, Tokyo, Japan; [Chang, Tsung-Hsien] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Noda, Masahiro; Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kaohsiung Veterans General Hospital; National Institute of Infectious Diseases (NIID)	Kubota, T (corresponding author), Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan.	kubota@nih.go.jp	SAKAI, KOUJI/J-4436-2018; Takeda, Makoto/J-2550-2018; Chang, Tsung-Hsien/AAG-9384-2019	Takeda, Makoto/0000-0002-8194-7727; Chang, Tsung-Hsien/0000-0003-4806-7864	Ministry of Education, Culture, Sports, Science and Technology of Japan [25460582]; Grants-in-Aid for Scientific Research [25460582] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grant-in-Aid 25460582 for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Pham AM, 2010, VIRUSES-BASEL, V2, P55, DOI 10.3390/v2010055; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Verhelst K, 2013, BIOCHEM PHARMACOL, V85, P873, DOI 10.1016/j.bcp.2013.01.007; Wang LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043756; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052	24	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94999	10.1371/journal.pone.0094999	http://dx.doi.org/10.1371/journal.pone.0094999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722368	gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100149
J	Park, S; Kim, Y; Shin, HR; Lee, B; Shin, A; Jung, KW; Jee, SH; Kim, DH; Yun, YH; Park, SK; Boniol, M; Boffetta, P				Park, Sohee; Kim, Yeonju; Shin, Hai-Rim; Lee, Boram; Shin, Aesun; Jung, Kyu-Won; Jee, Sun Ha; Kim, Dong Hyun; Yun, Young Ho; Park, Sue Kyung; Boniol, Mathieu; Boffetta, Paolo			Population-Attributable Causes of Cancer in Korea: Obesity and Physical Inactivity	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; PREVALENCE; POLYMORPHISMS; OVERWEIGHT; BURDEN; TRENDS; MEN	Background: Changes in lifestyle including obesity epidemic and reduced physical activity influenced greatly to increase the cancer burden in Korea. The purpose of the current study was to perform a systematic assessment of cancers attributable to obesity and physical inactivity in Korea. Methodology/Principal Findings: Gender-and cancer site-specific population-attributable fractions (PAF) were estimated using the prevalence of overweight and obesity in 1992-1995 from a large-scale prospective cohort study, the prevalence of low physical activity in 1989 from a Korean National Health Examination Survey, and pooled relative risk estimates from Korean epidemiological studies. The overall PAF was then estimated using 2009 national cancer incidence data from the Korea Central Cancer Registry. Excess body weight was responsible for 1,444 (1.5%) and 2,004 (2.2%) cancer cases among men and women, respectively, in 2009 in Korea. Among men, 6.8% of colorectal, 2.9% of pancreatic, and 16.0% of kidney cancer was attributable to excess body weight. In women, 6.6% of colorectal, 3.9% of pancreatic, 18.7% of kidney, 8.2% of postmenopausal breast, and 32.7% of endometrial cancer was attributable to excess body weight. Low leisure-time physical activity accounted for 8.8% of breast cancer, whereas the PAF for overall cancer was low (0.1% in men, 1.4% in women). Projections suggest that cancers attributable to obesity will increase by 40% in men and 16% in women by 2020. Conclusions/Significance: With a significantly increasing overweight and physically inactive population, and increasing incidence of breast and colorectal cancers, Korea faces a large cancer burden attributable to these risk factors. Had the obese population of Korea remained stable, a large portion of obesity-related cancers could have been avoided. Efficient cancer prevention programs that aim to reduce obesity-and physical inactivity-related health problems are essential in Korea.	[Park, Sohee; Shin, Hai-Rim; Lee, Boram; Shin, Aesun; Jung, Kyu-Won] Natl Canc Ctr, Div Canc Registrat & Surveillance, Goyang, South Korea; [Kim, Yeonju] Natl Canc Ctr, Div Canc Early Detect, Goyang, South Korea; [Shin, Hai-Rim] World Hlth Org, Western Pacific Reg Off, Manila, Philippines; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Kim, Dong Hyun] Hallym Univ, Dept Social & Prevent Med, Chunchon, South Korea; [Yun, Young Ho] Korea Univ, Coll Med, Seoul 136705, South Korea; [Park, Sue Kyung] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Boniol, Mathieu; Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); World Health Organization; Yonsei University; Yonsei University Health System; Hallym University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Icahn School of Medicine at Mount Sinai	Shin, HR (corresponding author), Natl Canc Ctr, Div Canc Registrat & Surveillance, Goyang, South Korea.	Shinh@wpro.who.int	Shin, Aesun/E-9145-2014; Boffetta, Paolo/AAI-7767-2021; Kim, Yeonju/D-8948-2013; Boniol, Mathieu/F-9623-2011	Shin, Aesun/0000-0002-6426-1969; Boffetta, Paolo/0000-0002-3811-2791; Kim, Yeonju/0000-0002-2570-750X; Boniol, Mathieu/0000-0003-1052-5604; Jee, Sun Ha/0000-0001-9519-3068; Park, Sohee/0000-0001-8513-5163	National Cancer Center [NCC-0710160, NCC-1010210]	National Cancer Center	This work was supported by a research grant from the National Cancer Center (No. NCC-0710160, NCC-1010210, www.ncc.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Byers T, 2002, CA-CANCER J CLIN, V52, P92, DOI 10.3322/canjclin.52.2.92; Chung YW, 2006, DIGEST LIVER DIS, V38, P668, DOI 10.1016/j.dld.2006.05.014; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Do MinHee, 2003, Korean Journal of Nutrition, V36, P40; Ferlay J, 2010, INT J CANC; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Han SH, 2008, BREAST CANCER RES TR, V110, P387, DOI 10.1007/s10549-007-9730-5; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; *IARC, 2002, IARC HDB CANC PREV; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Inoue S, 2000, ASIA PACIFIC PERSPEC; Jee SH, 2008, INT J CANCER, V123, P1892, DOI 10.1002/ijc.23719; Jung KW, 2012, CANCER RES TREAT, V44, P11, DOI 10.4143/crt.2012.44.1.11; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim DH, 2002, J KOREAN ASS CANC PR, V7, P116; Kim DM, 2005, OBES REV, V6, P117, DOI 10.1111/j.1467-789X.2005.00173.x; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Parkin DM, 2011, BRIT J CANCER, V105, pS34, DOI 10.1038/bjc.2011.481; Polednak AP, 2008, CANCER DETECT PREV, V32, P190, DOI 10.1016/j.cdp.2008.08.004; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Renehan AG, 2010, INT J CANCER, V126, P692, DOI 10.1002/ijc.24803; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Tong SY, 2009, BJOG-INT J OBSTET GY, V116, P1046, DOI 10.1111/j.1471-0528.2009.02186.x; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; World Cancer Research Fund American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P210; Yoo KY, 1998, J KOREAN CANC ASS, V17, P435; Yun YH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-366	30	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e90871	10.1371/journal.pone.0090871	http://dx.doi.org/10.1371/journal.pone.0090871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722008	Green Accepted, Green Published, gold			2022-12-27	WOS:000336909100005
J	Black, BJ; Gu, L; Mohanty, SK				Black, Bryan J.; Gu, Ling; Mohanty, Samarendra K.			Highly Effective Photonic Cue for Repulsive Axonal Guidance	PLOS ONE			English	Article							NEURONAL GROWTH CONES; RETINAL GANGLION-CELLS; ADULT GOLDFISH RETINA; MOLECULAR-MECHANISMS; ION CHANNELS; EXPLANT CULTURE; ACTIN; TEMPERATURE; CA2+	In vivo nerve repair requires not only the ability to regenerate damaged axons, but most importantly, the ability to guide developing or regenerating axons along paths that will result in functional connections. Furthermore, basic studies in neuroscience and neuro-electronic interface design require the ability to construct in vitro neural circuitry. Both these applications require the development of a noninvasive, highly effective tool for axonal growth-cone guidance. To date, a myriad of technologies have been introduced based on chemical, electrical, mechanical, and hybrid approaches (such as electro-chemical, optofluidic flow and photo-chemical methods). These methods are either lacking in desired spatial and temporal selectivity or require the introduction of invasive external factors. Within the last fifteen years however, several attractive guidance cues have been developed using purely light based cues to achieve axonal guidance. Here, we report a novel, purely optical repulsive guidance technique that uses low power, near infrared light, and demonstrates the guidance of primary goldfish retinal ganglion cell axons through turns of up to 120 degrees and over distances of similar to 90 mu m.	[Black, Bryan J.; Gu, Ling; Mohanty, Samarendra K.] Univ Texas Arlington, Dept Phys, Biophys & Physiol Grp, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Mohanty, SK (corresponding author), Univ Texas Arlington, Dept Phys, Biophys & Physiol Grp, POB 19059, Arlington, TX 76019 USA.	smohanty@uta.edu						ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; BERNHARDT R, 1989, J COMP NEUROL, V284, P119, DOI 10.1002/cne.902840109; Blau A, 2001, J NEUROSCI METH, V112, P65, DOI 10.1016/S0165-0270(01)00458-7; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Chedotal A., 2010, COLD SPRING HARBOR P, V2; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899; Ehrlicher A, 2007, METHOD CELL BIOL, V83, P495, DOI 10.1016/S0091-679X(07)83021-4; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Fawcett J, 2002, SPINAL CORD, V40, P615, DOI 10.1038/sj.sc.3101328; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fohlmeister JF, 2010, J NEUROPHYSIOL, V103, P1357, DOI 10.1152/jn.00123.2009; Fromherz P, 2006, ANN NY ACAD SCI, V1093, P143, DOI 10.1196/annals.1382.011; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Harada Y, 1996, OPT COMMUN, V124, P529, DOI 10.1016/0030-4018(95)00753-9; HARRELSON AL, 1992, J EXP ZOOL, V261, P310, DOI 10.1002/jez.1402610310; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Huang XH, 2006, PHOTOCHEM PHOTOBIOL, V82, P412, DOI 10.1562/2005-12-14-RA-754; Inatani M, 2005, NATURWISSENSCHAFTEN, V92, P549, DOI 10.1007/s00114-005-0042-5; Jesse F, 2013, BIOMED OPT EXPRESS, V4, P614, DOI 10.1364/BOE.4.000614; LANDRETH GE, 1979, BRAIN RES, V161, P39, DOI 10.1016/0006-8993(79)90194-X; LANDRETH GE, 1976, BRAIN RES, V118, P299, DOI 10.1016/0006-8993(76)90714-9; LIU Y, 1995, BIOPHYS J, V68, P2137, DOI 10.1016/S0006-3495(95)80396-6; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Mathew M, 2010, J NEUROSCI METH, V186, P196, DOI 10.1016/j.jneumeth.2009.11.018; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Mohanty SK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2983663; Mohanty SK, 2005, OPT LETT, V30, P2596, DOI 10.1364/OL.30.002596; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Niranjan PS, 2003, J CHEM PHYS, V119, P4070, DOI 10.1063/1.1592499; PATEL N, 1982, J NEUROSCI, V2, P483; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; SACHS F, 1991, MOL CELL BIOCHEM, V104, P57; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Stuhrmann B, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1863812; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wu T, 2012, J R SOC INTERFACE, V9, P535, DOI 10.1098/rsif.2011.0351; Wu T, 2012, NAT PHOTONICS, V6, P62, DOI [10.1038/nphoton.2011.287, 10.1038/NPHOTON.2011.287]; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698	47	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e86292	10.1371/journal.pone.0086292	http://dx.doi.org/10.1371/journal.pone.0086292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717339	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000002
J	Douard, V; Patel, C; Lee, J; Tharabenjasin, P; Williams, E; Fritton, JC; Sabbagh, Y; Ferraris, RP				Douard, Veronique; Patel, Chirag; Lee, Jacklyn; Tharabenjasin, Phuntila; Williams, Edek; Fritton, J. Christopher; Sabbagh, Yves; Ferraris, Ronaldo P.			Chronic High Fructose Intake Reduces Serum 1,25 (OH)(2)D-3 Levels in Calcium-Sufficient Rodents	PLOS ONE			English	Article							VITAMIN-D; RAT; TRANSPORTERS; RECEPTOR; DEFICIENCY; METABOLISM; ABSORPTION; EXPRESSION; RESISTANCE; FGF-23	Excessive fructose consumption inhibits adaptive increases in intestinal Ca2+ transport in lactating and weanling rats with increased Ca2+ requirements by preventing the increase in serum levels of 1,25(OH)(2)D-3. Here we tested the hypothesis that chronic fructose intake decreases 1,25(OH)(2)D-3 levels independent of increases in Ca2+ requirements. Adult mice fed for five wk a high glucose-low Ca2+ diet displayed expected compensatory increases in intestinal and renal Ca2+ transporter expression and activity, in renal CYP27B1 (coding for 1 alpha-hydroxylase) expression as well as in serum 1,25(OH)(2)D-3 levels, compared with mice fed isocaloric glucose- or fructose-normal Ca2+ diets. Replacing glucose with fructose prevented these increases in Ca2+ transporter, CYP27B1, and 1,25(OH)(2)D-3 levels induced by a low Ca2+ diet. In adult mice fed for three mo a normal Ca2+ diet, renal expression of CYP27B1 and of CYP24A1 (24-hydroxylase) decreased and increased, respectively, when the carbohydrate source was fructose instead of glucose or starch. Intestinal and renal Ca2+ transporter activity and expression did not vary with dietary carbohydrate. To determine the time course of fructose effects, a high fructose or glucose diet with normal Ca2+ levels was fed to adult rats for three mo. Serum levels of 1,25(OH)(2)D-3 decreased and of FGF23 increased significantly over time. Renal expression of CYP27B1 and serum levels of 1,25(OH)(2)D-3 still decreased in fructose-compared to those in glucose-fed rats after three mo. Serum parathyroid hormone, Ca2+ and phosphate levels were normal and independent of dietary sugar as well as time of feeding. Thus, chronically high fructose intakes can decrease serum levels of 1,25(OH)(2)D-3 in adult rodents experiencing no Ca2+ stress and fed sufficient levels of dietary Ca2+. This finding is highly significant because fructose constitutes a substantial portion of the average diet of Americans already deficient in vitamin D.	[Douard, Veronique; Patel, Chirag; Lee, Jacklyn; Tharabenjasin, Phuntila; Ferraris, Ronaldo P.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ USA; [Williams, Edek; Fritton, J. Christopher] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Fritton, J. Christopher] RBHS, New Jersey Med Sch, Dept Orthopaed, Newark, NJ USA; [Sabbagh, Yves] Sanofi Co, Sanofi Genzyme R&D Ctr, Tissue Protect & Repair, Genzyme, Framingham, MA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Sanofi-Aventis; Genzyme Corporation	Douard, V (corresponding author), INRA, UMR1913, MICALIS, Jouy En Josas, France.	veronique.douard@jouy.inra.fr	Sabbagh, Yves/I-9792-2019; Douard, veronique/AAU-6271-2020	Sabbagh, Yves/0000-0001-5339-6705; Fritton, James/0000-0002-6475-7622	National Science Foundation [IOS-1121049]; Foundation of UMDNJ; Benjamin Delessert Foundation	National Science Foundation(National Science Foundation (NSF)); Foundation of UMDNJ; Benjamin Delessert Foundation	This work was supported by the National Science Foundation (IOS-1121049 to RPF). The work also received support from the Foundation of UMDNJ (RPF), and the Benjamin Delessert Foundation (to V. Douard). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn BS, 2008, ENDOCRINOLOGY, V149, P3196, DOI 10.1210/en.2007-1655; Bischoff-Ferrari HA, 2011, ANN NUTR METAB, V59, P17, DOI 10.1159/000332069; Bogden JD, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-34; Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816; Brini M, 2009, PFLUG ARCH EUR J PHY, V457, P657, DOI 10.1007/s00424-008-0505-6; Brown AJ, 2005, ARCH BIOCHEM BIOPHYS, V437, P51, DOI 10.1016/j.abb.2005.02.007; Christakos S, 2012, RHEUM DIS CLIN N AM, V38, P1, DOI 10.1016/j.rdc.2012.03.003; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Douard V, 2008, J PHYSIOL-LONDON, V586, P3657, DOI 10.1113/jphysiol.2008.155226; Douard V, 2008, ENDOCRINOLOGY, V149, P409, DOI 10.1210/en.2007-0906; Douard V, 2013, AM J PHYSIOL-ENDOC M, V304, pE1303, DOI 10.1152/ajpendo.00582.2012; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Douard V, 2012, GASTROENTEROLOGY, V142, pS557; Douard V, 2012, FASEB J, V26, P707, DOI 10.1096/fj.11-190264; Douard V, 2010, J AM SOC NEPHROL, V21, P261, DOI 10.1681/ASN.2009080795; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Luong KVQ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-89; Kirchner S, 2008, AM J CLIN NUTR, V87, P1028, DOI 10.1093/ajcn/87.4.1028; Krauss RM, 2006, AM J CLIN NUTR, V83, P1025, DOI 10.1093/ajcn/83.5.1025; Lieben L, 2010, BONE, V47, P301, DOI 10.1016/j.bone.2010.04.595; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Nakayama T, 2010, AM J PHYSIOL-RENAL, V298, pF712, DOI 10.1152/ajprenal.00433.2009; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Sakaki T, 2005, FRONT BIOSCI, V10, P119; SCHEDL HP, 1985, J CLIN INVEST, V76, P1871, DOI 10.1172/JCI112181; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Wood RJ, 1998, ENDOCRINOLOGY, V139, P3843, DOI 10.1210/en.139.9.3843; Yu XJ, 2005, BONE, V36, P971, DOI 10.1016/j.bone.2005.03.002	35	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93611	10.1371/journal.pone.0093611	http://dx.doi.org/10.1371/journal.pone.0093611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718641	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000039
J	Durruthy-Durruthy, J; Briggs, SF; Awe, J; Ramathal, CY; Karumbayaram, S; Lee, PC; Heidmann, JD; Clark, A; Karakikes, I; Loh, KM; Wu, JC; Hoffman, AR; Byrne, J; Pera, RAR; Sebastiano, V				Durruthy-Durruthy, Jens; Briggs, Sharon F.; Awe, Jason; Ramathal, Cyril Y.; Karumbayaram, Saravanan; Lee, Patrick C.; Heidmann, Julia D.; Clark, Amander; Karakikes, Ioannis; Loh, Kyle M.; Wu, Joseph C.; Hoffman, Andrew R.; Byrne, James; Pera, Renee A. Reijo; Sebastiano, Vittorio			Rapid and Efficient Conversion of Integration-Free Human Induced Pluripotent Stem Cells to GMP-Grade Culture Conditions	PLOS ONE			English	Article							SOMATIC-CELLS; GENERATION; VECTOR	Data suggest that clinical applications of human induced pluripotent stem cells (hiPSCs) will be realized. Nonetheless, clinical applications will require hiPSCs that are free of exogenous DNA and that can be manufactured through Good Manufacturing Practice (GMP). Optimally, derivation of hiPSCs should be rapid and efficient in order to minimize manipulations, reduce potential for accumulation of mutations and minimize financial costs. Previous studies reported the use of modified synthetic mRNAs to reprogram fibroblasts to a pluripotent state. Here, we provide an optimized, fully chemically defined and feeder-free protocol for the derivation of hiPSCs using synthetic mRNAs. The protocol results in derivation of fully reprogrammed hiPSC lines from adult dermal fibroblasts in less than two weeks. The hiPSC lines were successfully tested for their identity, purity, stability and safety at a GMP facility and cryopreserved. To our knowledge, as a proof of principle, these are the first integration-free iPSCs lines that were reproducibly generated through synthetic mRNA reprogramming that could be putatively used for clinical purposes.	[Durruthy-Durruthy, Jens; Briggs, Sharon F.; Ramathal, Cyril Y.; Pera, Renee A. Reijo; Sebastiano, Vittorio] Stanford Univ, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Durruthy-Durruthy, Jens; Briggs, Sharon F.; Ramathal, Cyril Y.; Pera, Renee A. Reijo; Sebastiano, Vittorio] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Awe, Jason; Karumbayaram, Saravanan; Lee, Patrick C.; Clark, Amander; Byrne, James] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Awe, Jason; Lee, Patrick C.; Byrne, James] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Karumbayaram, Saravanan] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA USA; [Heidmann, Julia D.; Hoffman, Andrew R.] Stanford Univ, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Clark, Amander] Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90024 USA; [Karakikes, Ioannis; Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Karakikes, Ioannis; Wu, Joseph C.] Stanford Univ, Dept Med, Dept Cardiol, Stanford, CA 94305 USA; [Loh, Kyle M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California Los Angeles; Stanford University; Stanford University; Stanford University	Sebastiano, V (corresponding author), Stanford Univ, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	vsebast@stanford.edu	; Wu, Joseph/H-1067-2013	Loh, Kyle/0000-0002-8042-0149; Wu, Joseph/0000-0002-6068-8041; Karakikes, Ioannis/0000-0002-4348-600X; Byrne, James/0000-0002-2232-292X; Hoffman, Andrew/0000-0002-0145-1917; Reijo Pera, Renee/0000-0002-6487-1329	National Institutes of Health grant through the National Heart Lung and Blood Institute [U01 HL100397, U01 HL099776, R01 HL113006]; National Institute of Child Health and Human Development (NICHD) [U54 HD068158]; California Institute for Regenerative Medicine [TR3-05569]; NIH Research Project Grant [R01-GM09031]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD068158, U54HD068158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113006, U01HL099776, U01HL100397] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	National Institutes of Health grant through the National Heart Lung and Blood Institute; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH Research Project Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by a National Institutes of Health grant through the National Heart Lung and Blood Institute (U01 HL100397, U01 HL099776, and R01 HL113006), the National Institute of Child Health and Human Development (NICHD U54 HD068158 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research), the California Institute for Regenerative Medicine (TR3-05569), and the NIH Research Project Grant (R01-GM09031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awe JP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt246; Byrne JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007118; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Goh PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081622; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Karakikes I., 2013, STEM CELLS TRANSL ME, DOI 10.5966/sctm.2013-0110; Karumbayaram S, 2012, STEM CELL TRANSL MED, V1, P36, DOI 10.5966/sctm.2011-0001; Loh KM, 2014, CELL STEM C IN PRESS, V14; Merling RK, 2013, BLOOD, V121, pE98, DOI 10.1182/blood-2012-03-420273; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	20	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94231	10.1371/journal.pone.0094231	http://dx.doi.org/10.1371/journal.pone.0094231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718618	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000093
J	Elfwing, S; Doya, K				Elfwing, Stefan; Doya, Kenji			Emergence of Polymorphic Mating Strategies in Robot Colonies	PLOS ONE			English	Article							REPRODUCTIVE STRATEGIES; GENETIC-POLYMORPHISM; TACTICS; EVOLUTION; INSTABILITY; DIMORPHISM; SWORDTAIL; SELECTION; SUCCESS	Polymorphism has fascinated evolutionary biologists since the time of Darwin. Biologists have observed discrete alternative mating strategies in many different species. In this study, we demonstrate that polymorphic mating strategies can emerge in a colony of hermaphrodite robots. We used a survival and reproduction task where the robots maintained their energy levels by capturing energy sources and physically exchanged genotypes for the reproduction of offspring. The reproductive success was dependent on the individuals' energy levels, which created a natural trade-off between the time invested in maintaining a high energy level and the time invested in attracting mating partners. We performed experiments in environments with different density of energy sources and observed a variety in the mating behavior when a robot could see both an energy source and a potential mating partner. The individuals could be classified into two phenotypes: 1) forager, who always chooses to capture energy sources, and 2) tracker, who keeps track of potential mating partners if its energy level is above a threshold. In four out of the seven highest fitness populations in different environments, we found subpopulations with distinct differences in genotype and in behavioral phenotype. We analyzed the fitnesses of the foragers and the trackers by sampling them from each subpopulation and mixing with different ratios in a population. The fitness curves for the two subpopulations crossed at about 25% of foragers in the population, showing the evolutionary stability of the polymorphism. In one of those polymorphic populations, the trackers were further split into two subpopulations: (strong trackers) and (weak trackers). Our analyses show that the population consisting of three phenotypes also constituted several stable polymorphic evolutionarily stable states. To our knowledge, our study is the first to demonstrate the emergence of polymorphic evolutionarily stable strategies within a robot evolution framework.	[Elfwing, Stefan; Doya, Kenji] Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Elfwing, S (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan.	elfwing@oist.jp; doya@oist.jp	Elfwing, Stefan/G-2940-2015; Doya, Kenji/B-5841-2015	Elfwing, Stefan/0000-0001-6689-1000; Doya, Kenji/0000-0002-2446-6820				ANDERSON WW, 1969, P NATL ACAD SCI USA, V64, P190, DOI 10.1073/pnas.64.1.190; BISAZZA A, 1993, MAR BEHAV PHYSIOL, V23, P257, DOI 10.1080/10236249309378869; Brockmann HJ, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P25, DOI 10.1017/CBO9780511542602.003; Brockmann HJ, 2001, ADV STUD BEHAV, V30, P1, DOI 10.1016/S0065-3454(01)80004-8; BROCKMANN HJ, 1992, ANIM BEHAV, V44, P653, DOI 10.1016/S0003-3472(05)80293-3; Da Rold F, 2011, ADAPT BEHAV, V19, P317, DOI 10.1177/1059712311417737; Darwin C., 1874, DESCENT MAN SELECTIO; Darwin C, 1859, ORIGIN SPECIES MEANS; Darwin C, 1987, CORRESPONDENCE C DAR; Doya K, 2005, ADAPT BEHAV, V13, P149, DOI 10.1177/105971230501300206; Elfwing S, 2011, ADAPT BEHAV, V19, P101, DOI 10.1177/1059712310397633; Elfwing S, 2009, LECT NOTES COMPUT SC, V5864, P638, DOI 10.1007/978-3-642-10684-2_71; Ficici S. G., 2000, P 2000 GEN EV COMP C, P927; Floreano D, 2007, CURR BIOL, V17, P514, DOI 10.1016/j.cub.2007.01.058; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; Fogel DB, 1997, BIOSYSTEMS, V44, P135, DOI 10.1016/S0303-2647(97)00050-6; FOGEL DB, 1995, COM ADAP SY, P565; Fogel GB, 1998, ECOL MODEL, V109, P283, DOI 10.1016/S0304-3800(98)00068-4; Ford EB, 1975, ECOLOGICAL GENETICS; GADGIL M, 1972, AM NAT, V106, P574, DOI 10.1086/282797; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Leonard JL, 2006, INTEGR COMP BIOL, V46, P349, DOI 10.1093/icb/icj041; Mappes T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001687; Maynard Smith, 1998, EVOL GENET; Maynard Smith J., 1982, pi; Mitri S, 2009, PNAS, V106; Mitri S, 2011, P ROY SOC B-BIOL SCI, V278, P378, DOI 10.1098/rspb.2010.1407; Ng AY, 1999, MACHINE LEARNING, PROCEEDINGS, P278; RADWAN J, 1995, HEREDITY, V74, P669, DOI 10.1038/hdy.1995.91; Roulin A, 2003, J AVIAN BIOL, V34, P393, DOI 10.1111/j.0908-8857.2003.03139.x; RUBENSTEIN DI, 1980, LIMITS ACTION ALLOCA, P65; Rummery G. A, 1994, SARSA MODIFIED CONNE; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; SANDELL M, 1992, AM NAT, V139, P177, DOI 10.1086/285319; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Svensson EI, 2009, EVOL ECOL, V23, P93, DOI 10.1007/s10682-007-9208-2; Tarapore D, 2010, BEHAV ECOL SOCIOBIOL, V64, P675, DOI 10.1007/s00265-009-0885-4; THOMPSON CW, 1993, BEHAV ECOL SOCIOBIOL, V33, P137, DOI 10.1007/BF00216593; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; Waibel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000615; Wischmann S, 2012, PNAS; ZIMMERER EJ, 1989, EVOLUTION, V43, P1298, DOI 10.1111/j.1558-5646.1989.tb02576.x	48	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93622	10.1371/journal.pone.0093622	http://dx.doi.org/10.1371/journal.pone.0093622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717898	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000040
J	Loitfelder, M; Fazekas, F; Koschutnig, K; Fuchs, S; Petrovic, K; Ropele, S; Pichler, A; Jehna, M; Langkammer, C; Schmidt, R; Neuper, C; Enzinger, C				Loitfelder, Marisa; Fazekas, Franz; Koschutnig, Karl; Fuchs, Siegrid; Petrovic, Katja; Ropele, Stefan; Pichler, Alexander; Jehna, Margit; Langkammer, Christian; Schmidt, Reinhold; Neuper, Christa; Enzinger, Christian		Bio TechMed Initiative	Brain Activity Changes in Cognitive Networks in Relapsing-Remitting Multiple Sclerosis - Insights from a Longitudinal fMRI Study	PLOS ONE			English	Article							EARLY-STAGE; IMPAIRMENT; MS; REORGANIZATION; DYSFUNCTION; BATTERY; TESTS; MRI	Background: Extrapolations from previous cross-sectional fMRI studies suggest cerebral functional changes with progression of Multiple Sclerosis (MS), but longitudinal studies are scarce. We assessed brain activation changes over time in MS patients using a cognitive fMRI paradigm and examined correlations with clinical and cognitive status and brain morphology. Methods: 13 MS patients and 15 healthy controls (HC) underwent MRI including fMRI (go/no-go task), neurological and neuropsychological exams at baseline (BL) and follow-up (FU; minimum 12, median 20 months). We assessed estimates of and changes in fMRI activation, total brain and subcortical grey matter volumes, cortical thickness, and T2-lesion load. Bland-Altman (BA) plots served to assess fMRI signal variability. Results: Cognitive and disability levels remained largely stable in the patients. With the fMRI task, both at BL and FU, patients compared to HC showed increased activation in the insular cortex, precuneus, cerebellum, posterior cingulate cortex, and occipital cortex. At BL, patients vs. HC also had lower caudate nucleus, thalamus and putamen volumes. Over time, patients (but not HC) demonstrated fMRI activity increments in the left inferior parietal lobule. These correlated with worse single-digit-modality test (SDMT) performance. BA-plots attested to reproducibility of the fMRI task. In the patients, the right caudate nucleus decreased in volume which again correlated with worsening SDMT performance. Conclusions: Given preserved cognitive performance, the increased activation at BL in the patients may be viewed as largely adaptive. In contrast, the negative correlation with SDMT performance suggests increasing parietal activation over time to be maladaptive. Several areas with purported relevance for cognition showed decreased volumes at BL and right caudate nucleus volume decline correlated with decreasing SDMT performance. This highlights the dynamics of functional changes and the strategic importance of specific brain areas for cognitive processes in MS.	[Loitfelder, Marisa; Fazekas, Franz; Fuchs, Siegrid; Petrovic, Katja; Ropele, Stefan; Pichler, Alexander; Langkammer, Christian; Schmidt, Reinhold; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Jehna, Margit; Enzinger, Christian] Med Univ Graz, Dept Radiol, Div Neuroradiol, Graz, Austria; [Koschutnig, Karl; Neuper, Christa] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Graz	Enzinger, C (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	chris.enzinger@medunigraz.at	Jehna, Margit/M-9873-2017; Koschutnig, Karl/W-3106-2019; Schmidt, Reinhold/E-1137-2014; Langkammer, Christian/AAC-9044-2020	Koschutnig, Karl/0000-0001-6234-0498; Langkammer, Christian/0000-0002-7097-9707; Jehna, Margit/0000-0003-3376-7753				Amann M, 2011, HUM BRAIN MAPP, V32, P1704, DOI 10.1002/hbm.21142; Amato MP, 2010, MULT SCLER, V16, P1474, DOI 10.1177/1352458510380089; [Anonymous], 1981, MANUAL WISCONSIN CAR; Audoin B, 2008, MULT SCLER J, V14, P786, DOI 10.1177/1352458508089360; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Cardinal KS, 2008, MULT SCLER, V14, P465, DOI 10.1177/1352458507084263; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Huijbregts SCJ, 2004, NEUROLOGY, V63, P335, DOI 10.1212/01.WNL.0000129828.03714.90; Huijbregts SCJ, 2006, J NEUROL SCI, V245, P187, DOI 10.1016/j.jns.2005.07.018; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lansley J, 2013, NEUROSCI BIOBEHAV R, V37, P819, DOI 10.1016/j.neubiorev.2013.03.006; Loitfelder M, 2011, NEUROLOGY, V76, P526, DOI 10.1212/WNL.0b013e31820b75cf; Mainero C, 2006, J NEUROL SCI, V245, P93, DOI 10.1016/j.jns.2005.08.024; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Piras MR, 2003, J NEUROL NEUROSUR PS, V74, P878, DOI 10.1136/jnnp.74.7.878; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Rocca MA, 2012, NEUROLOGY, V79, P1449, DOI 10.1212/WNL.0b013e31826d5f10; Smith AM, 2009, J NEUROL SCI, V281, P58, DOI 10.1016/j.jns.2009.02.366; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Sonder JM, 2013, MULT SCLER; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strober L, 2009, MULT SCLER J, V15, P1077, DOI 10.1177/1352458509106615	30	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93715	10.1371/journal.pone.0093715	http://dx.doi.org/10.1371/journal.pone.0093715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718105	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000044
J	Luthi, F; Deriaz, O; Vuistiner, P; Burrus, C; Hilfiker, R				Luthi, Francois; Deriaz, Olivier; Vuistiner, Philippe; Burrus, Cyrille; Hilfiker, Roger			Predicting Non Return to Work after Orthopaedic Trauma: The Wallis Occupational Rehabilitation RisK (WORRK) Model	PLOS ONE			English	Article							LOW-BACK-PAIN; QUALITY-OF-LIFE; HEALTH-SERVICE NEEDS; VOCATIONAL-REHABILITATION; SELF-REPORT; EXTERNAL VALIDATION; FUNCTIONAL RECOVERY; CASE COMPLEXITY; GENE SELECTION; RANDOM FOREST	Background: Workers with persistent disabilities after orthopaedic trauma may need occupational rehabilitation. Despite various risk profiles for non-return-to-work (non-RTW), there is no available predictive model. Moreover, injured workers may have various origins (immigrant workers), which may either affect their return to work or their eligibility for research purposes. The aim of this study was to develop and validate a predictive model that estimates the likelihood of non-RTW after occupational rehabilitation using predictors which do not rely on the worker's background. Methods: Prospective cohort study (3177 participants, native (51%) and immigrant workers (49%)) with two samples: a) Development sample with patients from 2004 to 2007 with Full and Reduced Models, b) External validation of the Reduced Model with patients from 2008 to March 2010. We collected patients' data and biopsychosocial complexity with an observer rated interview (INTERMED). Non-RTW was assessed two years after discharge from the rehabilitation. Discrimination was assessed by the area under the receiver operating curve (AUC) and calibration was evaluated with a calibration plot. The model was reduced with random forests. Results: At 2 years, the non-RTW status was known for 2462 patients (77.5% of the total sample). The prevalence of nonRTW was 50%. The full model (36 items) and the reduced model (19 items) had acceptable discrimination performance (AUC 0.75, 95% CI 0.72 to 0.78 and 0.74, 95% CI 0.71 to 0.76, respectively) and good calibration. For the validation model, the discrimination performance was acceptable (AUC 0.73; 95% CI 0.70 to 0.77) and calibration was also adequate. Conclusions: Non-RTW may be predicted with a simple model constructed with variables independent of the patient's education and language fluency. This model is useful for all kinds of trauma in order to adjust for case mix and it is applicable to vulnerable populations like immigrant workers.	[Luthi, Francois; Burrus, Cyrille] Clin Romande Readaptat Suvacare, Dept Musculoskeletal Rehabil, Sion, Switzerland; [Luthi, Francois; Deriaz, Olivier; Vuistiner, Philippe; Burrus, Cyrille; Hilfiker, Roger] Clin Romande Readaptat Suvacare, Inst Rech Readaptat, Sion, Switzerland; [Luthi, Francois] Univ Lausanne Hosp, Dept Appareil Locomoteur, Hop Orthoped, Lausanne, Switzerland; [Vuistiner, Philippe] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Hilfiker, Roger] Univ Appl Sci & Arts Western Switzerland Valais, Sch Hlth Sci, Sion, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Luthi, F (corresponding author), Clin Romande Readaptat Suvacare, Dept Musculoskeletal Rehabil, Sion, Switzerland.	francois.luthi@crr-suva.ch	Vuistiner, Philippe/AAD-5010-2020; Hilfiker, Roger/E-2846-2010	Hilfiker, Roger/0000-0001-8662-6116; Vuistiner, Philippe/0000-0002-2661-4970				Ballabeni P, 2011, J OCCUP REHABIL, V21, P43, DOI 10.1007/s10926-010-9255-3; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burrus C, 2009, ARCH PHYS MED REHAB, V90, P1499, DOI 10.1016/j.apmr.2009.03.014; Chamberlain MA, 2009, J REHABIL MED, V41, P856, DOI 10.2340/16501977-0457; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Clay FJ, 2012, J OCCUP REHABIL, V22, P363, DOI 10.1007/s10926-012-9354-4; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Clay FJ, 2010, J REHABIL MED, V42, P162, DOI 10.2340/16501977-0495; Clay FJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-6; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Committee on Injury Scaling, 1998, ABBR INJ SCAL AIS 98; Coutu MF, 2007, J OCCUP REHABIL, V17, P522, DOI 10.1007/s10926-007-9089-9; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; de Jonge P, 2004, GEN HOSP PSYCHIAT, V26, P147, DOI 10.1016/j.genhosppsych.2003.09.001; De Jonge P, 2003, PSYCHOSOM MED, V65, P997, DOI 10.1097/01.PSY.0000097332.77685.C8; de Jonge P, 2002, J PSYCHOSOM RES, V52, P25, DOI 10.1016/S0022-3999(01)00309-9; de Jonge P, 2003, PSYCHOSOM MED, V65, P534, DOI 10.1097/01.PSY.0000077504.01963.1B; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Diaz-Uriarte R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-328; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Fadyl JK, 2010, DISABIL REHABIL, V32, P1173, DOI 10.3109/09638281003653302; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025862; Gobelet C, 2007, DISABIL REHABIL, V29, P1405, DOI 10.1080/09638280701315060; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hazard RG, 1996, SPINE, V21, P945, DOI 10.1097/00007632-199604150-00008; Hepp U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003635; Hilfiker R, 2007, EUR SPINE J, V16, P1755, DOI 10.1007/s00586-007-0433-8; Hoefsmit N, 2012, J OCCUP REHABIL, V22, P462, DOI 10.1007/s10926-012-9359-z; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Huyse FJ, 1999, GEN HOSP PSYCHIAT, V21, P39, DOI 10.1016/S0163-8343(98)00057-7; Iakova M, 2012, J OCCUP REHABIL, V22, P532, DOI 10.1007/s10926-012-9369-x; Jensen OK, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-140; Kadakia RJ, 2012, J ORTHOP TRAUMA; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; King J, 2012, J AM GERIATR SOC, V60, P569, DOI 10.1111/j.1532-5415.2011.03844.x; Laisne F, 2012, DISABIL REHABIL, V34, P1912, DOI 10.3109/09638288.2012.729362; Luthi F, 2011, DISABIL REHABIL, V33, P2544, DOI 10.3109/09638288.2011.579223; Lydell M, 2005, J REHABIL MED, V37, P281, DOI 10.1080/16501970510030255; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MACKENZIE EJ, 1988, JAMA-J AM MED ASSOC, V260, P3290, DOI 10.1001/jama.260.22.3290; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; Mannion AF, 2007, NAT CLIN PRACT RHEUM, V3, P610, DOI 10.1038/ncprheum0646; Matsuzaki H, 2009, J HAND SURG-AM, V34A, P880, DOI 10.1016/j.jhsa.2009.02.009; Matzer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041775; McCauley Linda A, 2005, AAOHN J, V53, P313; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Ottosson C, 2005, J TRAUMA, V58, P553, DOI 10.1097/01.TA.0000152634.66513.AF; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Pransky GS, 2006, SPINE, V31, P690, DOI 10.1097/01.brs.0000202761.20896.02; R Core Team, 2021, R LANGUAGE ENV STAT; Perez ER, 2012, ETHNIC HEALTH, V17, P563, DOI 10.1080/13557858.2012.730606; Scerri M, 2006, JOINT BONE SPINE, V73, P736, DOI 10.1016/j.jbspin.2005.12.012; Schellingerhout JM, 2010, SPINE, V35, pE827, DOI 10.1097/BRS.0b013e3181d85ad5; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Siroky DS, 2009, STAT SURV, V3, P147, DOI 10.1214/07-SS033; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sloots M, 2010, EUR J PHYS REHAB MED, V46, P505; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stiefel FC, 1999, GEN HOSP PSYCHIAT, V21, P49, DOI 10.1016/S0163-8343(98)00061-9; Stiefel FC, 1999, SPINE, V24, P378, DOI 10.1097/00007632-199902150-00017; Stiefel FC, 2006, MED CLIN N AM, V90, P713, DOI 10.1016/j.mcna.2006.05.006; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Toien K, 2012, INJURY, V43, P1606, DOI 10.1016/j.injury.2011.03.038; Urso-Baiarda F, 2008, Int J Surg, V6, P45, DOI 10.1016/j.ijsu.2007.09.001; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vlasveld MC, 2012, J OCCUP REHABIL, V22, P118, DOI 10.1007/s10926-011-9326-0; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Wasiak R, 2007, J OCCUP REHABIL, V17, P766, DOI 10.1007/s10926-007-9101-4; Wolfe F, 2009, ARTHRIT RHEUM-ARTHR, V61, P667, DOI 10.1002/art.24428; Yohannes AM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-105; Young AE, 2013, SPINE, V38, P2279, DOI 10.1097/BRS.0000000000000016	81	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94268	10.1371/journal.pone.0094268	http://dx.doi.org/10.1371/journal.pone.0094268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718689	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000099
J	Tognon, E; Wollscheid, N; Cortese, K; Tacchetti, C; Vaccari, T				Tognon, Emiliana; Wollscheid, Nadine; Cortese, Katia; Tacchetti, Carlo; Vaccari, Thomas			ESCRT-0 Is Not Required for Ectopic Notch Activation and Tumor Suppression in Drosophila	PLOS ONE			English	Article							MOSAIC ANALYSIS; COMPLEX; ENDOSOMES; MACHINERY; VPS25; PROTEINS; VACUOLAR; SCREEN; SYSTEM; CELLS	Multivesicular endosome (MVE) sorting depends on proteins of the Endosomal Sorting Complex Required for Transport (ESCRT) family. These are organized in four complexes (ESCRT-0, -I, -II, -III) that act in a sequential fashion to deliver ubiquitylated cargoes into the internal luminal vesicles (ILVs) of the MVE. Drosophila genes encoding ESCRT-I, -II, -III components function in sorting signaling receptors, including Notch and the JAK/STAT signaling receptor Domeless. Loss of ESCRT-I, -II, -III in Drosophila epithelia causes altered signaling and cell polarity, suggesting that ESCRTs genes are tumor suppressors. However, the nature of the tumor suppressive function of ESCRTs, and whether tumor suppression is linked to receptor sorting is unclear. Unexpectedly, a null mutant in Hrs, encoding one of the components of the ESCRT-0 complex, which acts upstream of ESCRT-I, -II, -III in MVE sorting is dispensable for tumor suppression. Here, we report that two Drosophila epithelia lacking activity of Stam, the other known components of the ESCRT-0 complex, or of both Hrs and Stam, accumulate the signaling receptors Notch and Dome in endosomes. However, mutant tissue surprisingly maintains normal apico-basal polarity and proliferation control and does not display ectopic Notch signaling activation, unlike cells that lack ESCRT-I, -II, -III activity. Overall, our in vivo data confirm previous evidence indicating that the ESCRT-0 complex plays no crucial role in regulation of tumor suppression, and suggest re-evaluation of the relationship of signaling modulation in endosomes and tumorigenesis.	[Tognon, Emiliana; Wollscheid, Nadine; Vaccari, Thomas] Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Cortese, Katia; Tacchetti, Carlo] Univ Genoa, Dipartimento Med Sperimentale, DIMES, Genoa, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Genoa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Vaccari, T (corresponding author), Ist FIRC Oncol Mol, IFOM, IFOM IEO Campus, Milan, Italy.	thomas.vaccari@ifom.eu	Vaccari, Thomas/B-1945-2015; Cortese, Katia/AAC-2990-2021	Vaccari, Thomas/0000-0002-6231-7105; TACCHETTI, CARLO/0000-0003-4602-000X; Cortese, Katia/0000-0001-9218-8933	AIRC (Associazione Italiana Ricerca sul Cancro) [6118]; Telethon Italia [GGP13225]; Compagnia San Paolo (Torino) [2011.1172]; AIRC IG [12035]	AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Telethon Italia(Fondazione Telethon); Compagnia San Paolo (Torino)(Compagnia di San Paolo); AIRC IG(Fondazione AIRC per la ricerca sul cancro)	This work was supported by AIRC (Associazione Italiana Ricerca sul Cancro- http://www.airc.it) startup grant# 6118 (TV), by Telethon Italia (http://www.telethon.it) grant# GGP13225 (TV), by Compagnia San Paolo (Torino- http://www.compagnia.torino.it) grant# 2011.1172 (CT), and by AIRC IG grant# 12035 (CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bilodeau PS, 2002, NATURE CELL BIOL, V8; Blanc C, 2009, TRAFFIC, V10, P161, DOI 10.1111/j.1600-0854.2008.00855.x; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chanut-Delalande H, 2007, GENETICS, V176, P2177, DOI 10.1534/genetics.107.073890; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Deng WM, 2001, DEVELOPMENT, V128, P4737; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Goentoro LA, 2006, GENESIS, V44, P66, DOI 10.1002/gene.20184; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kobia F, 2014, MOL ONCOL, V8, P207, DOI 10.1016/j.molonc.2013.11.002; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leung K, 2008, TRAFFIC COPENHAGEN D; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Newsome TP, 2000, DEVELOPMENT, V127, P851; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Robinson BS, 2011, CELL CYCLE, V10, P4110, DOI 10.4161/cc.10.23.18243; Roegiers F, 2009, GENETICS, V182, P407, DOI 10.1534/genetics.109.101808; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schneider M, 2013, J CELL SCI, V126, P645, DOI 10.1242/jcs.116590; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Stuffers S, 2008, EXPT CELL RES; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Woodfield SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056021; Yousefian J, 2013, J CELL SCI, V126, P1583, DOI 10.1242/jcs.114934	46	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93987	10.1371/journal.pone.0093987	http://dx.doi.org/10.1371/journal.pone.0093987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718108	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000062
J	Liao, JC; Ho, CH; Liang, FW; Wang, JJ; Lin, KC; Chio, CC; Kuo, JR				Liao, Jen-Chieh; Ho, Chung-Han; Liang, Fu-Wen; Wang, Jhi-Joung; Lin, Kao-Chang; Chio, Chung-Ching; Kuo, Jinn-Rung			One-Year Mortality Associations in Hemodialysis Patients after Traumatic Brain Injury-An Eight-Year Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; STAGE RENAL-DISEASE; LONG-TERM SURVIVAL; REPLACEMENT THERAPY; PROLONGED STAY; RESOURCE USE; IMPACT; DIALYSIS; OUTCOMES; RISK	Purpose: This study aimed to investigate the one-year mortality associations in hemodialysis patients who underwent neurosurgical intervention after traumatic brain injury (TBI) using a nationwide database in Taiwan. Materials and Methods: An age-and gender-matched longitudinal cohort study of 4416 subjects, 1104 TBI patients with end-stage renal disease (ESRD) and 3312 TBI patients without ESRD, was conducted using the National Health Insurance Research Database in Taiwan between January 2000 and December 2007. The demographic characteristics, length of stay (LOS), length of ICU stay, length of ventilation (LOV), and tracheostomy were collected and analyzed. The co-morbidities of hypertension (HTN), diabetes mellitus (DM), myocardial infarction (MI), stroke, and heart failure (HF) were also evaluated. Results: TBI patients with ESRD presented a shorter LOS, a longer length of ICU stay and LOV, and a higher percentage of comorbidities compared with those without ESRD. TBI patients with ESRD displayed a stable trend of one-year mortality rate, 75.82% to 76.79%, from 2000-2007. For TBI patients with ESRD, the median survival time was 0.86 months, and preexisting stroke was a significant risk factor of mortality (HR: 1.29, 95% C.I.: 1.08-1.55). Pre-existing DM (HR: 1.35, 95% C.I.: 1.12-1.63) and MI (HR: 1.61, 95% C.I.: 1.07-2.42) effect on the mortality in ESRD patients who underwent TBI surgical intervention in the younger (age < 65) and older (age >= 65) population, respectively. In addition, the length of ICU stay and tracheostomy may provide important information to predict the mortality risk. Conclusions: This is the first report indicating an increased risk of one-year mortality among TBI patients with a pre-existing ERSD insult. Comorbidities were more common in TBI patients with ESRD. Physicians should pay more attention to TBI patients with ESRD based on the status of age, comorbidities, length of ICU stay, and tracheostomy to improve their survival.	[Liao, Jen-Chieh; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Lin, Kao-Chang; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Inst Publ Hlth, Tainan 70101, Taiwan; [Lin, Kao-Chang; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; National Cheng Kung University; Southern Taiwan University of Science & Technology; Chia Nan University of Pharmacy & Science	Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477; Liang, Fu-Wen/0000-0002-3396-037X				Arabi Y, 2002, INT J QUAL HEALTH C, V14, P403, DOI 10.1093/intqhc/14.5.403; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002; Bell M, 2008, CRIT CARE MED, V36, P2773, DOI 10.1097/CCM.0b013e318187815a; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chan M, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/715807; Chapman RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7867; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chien CC, 2012, AM J HYPERTENS, V25, P900, DOI 10.1038/ajh.2012.60; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; Dhanani J, 2013, J THORAC CARDIOV SUR, V146, P90, DOI 10.1016/j.jtcvs.2012.06.037; Freeman BD, 2005, CRIT CARE MED, V33, P2513, DOI 10.1097/01.CCM.0000186369.91799.44; Gale SC, 2007, AM SURGEON, V73, P454; Gogbashian A, 2004, EUR J CARDIO-THORAC, V25, P695, DOI 10.1016/j.ejcts.2004.02.022; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Heyland DK, 1998, CHEST, V114, P192, DOI 10.1378/chest.114.1.192; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; HWANG SJ, 2000, ACTA NEPHROL, V14, P139; Insurance BoNH, 2002, NAT HLTH INS ANN STA; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; Iseki K, 1996, KIDNEY INT, V50, P1672, DOI 10.1038/ki.1996.484; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Laupland KB, 2006, CHEST, V129, P954, DOI 10.1378/chest.129.4.954; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lok CE, 2004, NEPHROL DIAL TRANSPL, V19, P3098, DOI 10.1093/ndt/gfh540; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Murakami M, 2004, NEUROL MED-CHIR, V44, P225, DOI 10.2176/nmc.44.225; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Prevention CfDCa, 2010, GET STATS TRAUM BRAI; Rhodes A, 2011, INTENS CARE MED, V37, P1466, DOI 10.1007/s00134-011-2299-9; Rothen HU, 2007, INTENS CARE MED, V33, P1329, DOI 10.1007/s00134-007-0690-3; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Sood MM, 2011, NEPHROL DIAL TRANSPL, V26, P2965, DOI 10.1093/ndt/gfq835; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; *SYST USRD, 2005, USRDS 2005 ANN DAT R; System URD, 1998, USRDS 1998 ANN DAT R; System USRD, 2019, ANN DAT REP; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; TOMITA J, 1995, AM J KIDNEY DIS, V25, P405, DOI 10.1016/0272-6386(95)90101-9; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Weissman C, 2000, INTENS CARE MED, V26, P1319, DOI 10.1007/s001340000612; Weissman C, 1997, CRIT CARE MED, V25, P1594, DOI 10.1097/00003246-199709000-00031; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	52	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93956	10.1371/journal.pone.0093956	http://dx.doi.org/10.1371/journal.pone.0093956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714730	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900066
J	Sharma, S; Ghosh, S; Singh, LK; Sarkar, A; Malhotra, R; Garg, OP; Singh, Y; Sharma, RS; Bhakuni, DS; Das, TK; Biswas, S				Sharma, Saurabh; Ghosh, Sreejoyee; Singh, Lalit Kumar; Sarkar, Ashish; Malhotra, Rajesh; Garg, Onkar Prasad; Singh, Yogendra; Sharma, Radhey Shyam; Bhakuni, Darshan Singh; Das, Taposh Kumar; Biswas, Sagarika			Identification of Autoantibodies against Transthyretin for the Screening and Diagnosis of Rheumatoid Arthritis	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; DISEASE SEVERITY; VITAMIN-A; SERUM; BIOMARKERS; DESTRUCTION; PREALBUMIN; MEMBRANE; ANTIGEN; MARKER	Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic and inflammatory rheumatic disease that leads to inflammation of the joints and surrounding tissues. Identification of novel protein(s) associated with severity of RA is a prerequisite for better understanding of pathogenesis of this disease that may also have potential to serve as novel biomarkers in the diagnosis of RA. Present study was undertaken to compare the amount of autoantigens and autoantibodies in the plasma of RA patients in comparison to healthy controls. Plasma samples were collected from the patients suffering from RA, Osteoarthritis (OA), Systemic lupus erythematosus (SLE) and healthy volunteers. The screening of plasma proteins were carried out using 2-dimensional gel electrophoresis followed by identification of differentially expressed protein by MALDI-TOF MS/MS. Among several differentially expressed proteins, transthyretin (TTR) has been identified as one of the protein that showed significantly up regulated expression in the plasma of RA patients. The results were further validated by Western blot analysis and ELISA. In comparison to OA synovium, an exclusive significantly high expression of TTR in RA has been validated through IHC, Western blotting and IEM studies. Most importantly, the increase in expression of TTR with the progression of severity of RA condition has been observed. The autoantibodies against TTR present in the RA plasma were identified using immunoprecipitation-Western methods. The significant production of autoantibodies was validated by ELISA and Western blot analysis using recombinant pure protein of TTR. Hence, these novel observations on increase in TTR expression with the increase in severity of RA conditions and significant production of autoantibodies against TTR clearly suggest that a systematic studies on the role TTR in the pathogenesis of RA is immediately required and TTR may be used as a serum diagnostic marker together with other biochemical parameters and clinical symptoms for RA screening and diagnosis.	[Sharma, Saurabh; Ghosh, Sreejoyee; Singh, Lalit Kumar; Sarkar, Ashish; Singh, Yogendra; Biswas, Sagarika] CSIR, Inst Genom & Integrat Biol, Dept Genom & Mol Med, Delhi, India; [Sharma, Saurabh; Sharma, Radhey Shyam] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Garg, Onkar Prasad; Bhakuni, Darshan Singh] Army Hosp Res & Referral, Dept Clin Immunol & Rheumatol, New Delhi, India; [Malhotra, Rajesh] All India Inst Med Sci, Dept Orthopaed, New Delhi, India; [Das, Taposh Kumar] All India Inst Med Sci, Dept Anat, New Delhi 110029, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Biswas, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Dept Genom & Mol Med, Delhi, India.	sagarika.biswas@igib.res.in			Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR), New Delhi, India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Financial assistance was partly provided by Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2014, EMBO J IN PRESS; Berry DC, 2012, MOL CELL BIOL, V32, P3851, DOI 10.1128/MCB.00775-12; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Bo GP, 2009, CLIN RHEUMATOL, V28, P191, DOI 10.1007/s10067-008-1013-y; Bromberg J, 2013, NAT MED, V19, P269, DOI 10.1038/nm.3124; Chang XT, 2013, J RHEUMATOL, V40, P219, DOI 10.3899/jrheum.120751; DAVIS PJ, 1972, J CLIN INVEST, V51, P515, DOI 10.1172/JCI106839; Deng YX, 2003, CANCER-AM CANCER SOC, V98, P2576, DOI 10.1002/cncr.11849; Drake RR, 2005, EXPERT REV MOL DIAGN, V5, P93, DOI 10.1586/14737159.5.1.93; Escher N, 2007, NEOPLASIA, V9, P254, DOI 10.1593/neo.06805; Feng JT, 2005, PROTEOMICS, V5, P4581, DOI 10.1002/pmic.200401309; GAY S, 1993, ANN RHEUM DIS, V52, pS39, DOI 10.1136/ard.52.Suppl_1.S39; GITLIN D, 1970, NATURE, V228, P995, DOI 10.1038/228995a0; Howard BA, 2003, PROTEOMICS, V3, P1720, DOI 10.1002/pmic.200300514; Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706; Iwaki-Egawa S, 2004, J RHEUMATOL, V31, P17; Johnson AM, 2007, CLIN CHEM LAB MED, V47, P419; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Karpova MA, 2010, J PROTEOMICS, V73, P537, DOI 10.1016/j.jprot.2009.09.011; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Liao H, 2004, ARTHRITIS RHEUM-US, V50, P3792, DOI 10.1002/art.20720; Marchi N, 2003, J NEUROSCI, V23, P1949; Marten NW, 1996, BIOCHEM J, V317, P361, DOI 10.1042/bj3170361; Mittler RS, 2004, NAT MED, V10, P1047, DOI 10.1038/nm1004-1047; Ni M, 2013, CLIN EXP RHEUMATOL, V31, P394; Niu QA, 2010, INT IMMUNOL, V22, P611, DOI 10.1093/intimm/dxq043; PETERSON PA, 1971, J BIOL CHEM, V246, P34; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Saroha A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046374; Sekine T, 2001, ANN RHEUM DIS, V60, P49, DOI 10.1136/ard.60.1.49; SMITH RM, 1991, P NATL ACAD SCI USA, V88, P6893, DOI 10.1073/pnas.88.15.6893; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Trocme C, 2009, ANN RHEUM DIS, V68, P1328, DOI 10.1136/ard.2008.093153; Tsuruha J, 2001, ARTHRITIS RHEUM, V44, P838, DOI 10.1002/1529-0131(200104)44:4<838::AID-ANR140>3.3.CO;2-3; Wang J, 2012, PLOS ONE, V7; Westhoff CM, 2007, SEMIN HEMATOL, V44, P42, DOI 10.1053/j.seminhematol.2006.09.010; Wolfe F, 1997, AM J MED, V103, P12; ZIFF M, 1990, J RHEUMATOL, V17, P127	39	18	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93905	10.1371/journal.pone.0093905	http://dx.doi.org/10.1371/journal.pone.0093905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714506	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900058
J	Henning, CHCA; Zarnekow, N; Hedtrich, J; Stark, S; Turk, K; Laudes, M				Henning, Christian H. C. A.; Zarnekow, Nana; Hedtrich, Johannes; Stark, Sascha; Tuerk, Kathrin; Laudes, Matthias			Identification of Direct and Indirect Social Network Effects in the Pathophysiology of Insulin Resistance in Obese Human Subjects	PLOS ONE			English	Article							EARLY-ONSET OBESITY; PROPENSITY SCORE; OVERWEIGHT; ASSOCIATION; CHILDREN; MUTATION; BMI	Objective: The aim of the present study was to examine to what extent different social network mechanisms are involved in the pathogenesis of obesity and insulin-resistance. Design: We used nonparametric and parametric regression models to analyse whether individual BMI and HOMA-IR are determined by social network characteristics. Subjects and Methods: A total of 677 probands (EGO) and 3033 social network partners (ALTER) were included in the study. Data gathered from the probands include anthropometric measures, HOMA-IR index, health attitudes, behavioural and socio- economic variables and social network data. Results: We found significant treatment effects for ALTERs frequent dieting (p < 0.001) and ALTERs health oriented nutritional attitudes (p, 0.001) on EGO's BMI, establishing a significant indirect network effect also on EGO's insulin resistance. Most importantly, we also found significant direct social network effects on EGO's insulin resistance, evidenced by an effect of ALTERs frequent dieting (p = 0.033) and ALTERs sport activities (p = 0.041) to decrease EGO's HOMA-IR index independently of EGO's BMI. Conclusions: Social network phenomena appear not only to be relevant for the spread of obesity, but also for the spread of insulin resistance as the basis for type 2 diabetes. Attitudes and behaviour of peer groups influence EGO's health status not only via social mechanisms, but also via socio- biological mechanisms, i.e. higher brain areas might be influenced not only by biological signals from the own organism, but also by behaviour and knowledge from different human individuals. Our approach allows the identification of peer group influence controlling for potential homophily even when using cross-sectional observational data.	[Henning, Christian H. C. A.; Zarnekow, Nana; Hedtrich, Johannes; Stark, Sascha] Univ Kiel, Inst Agr Econ, Kiel, Germany; [Tuerk, Kathrin; Laudes, Matthias] Univ Kiel, Dept Internal Med 1, Kiel, Germany	University of Kiel; University of Kiel	Henning, CHCA (corresponding author), Univ Kiel, Inst Agr Econ, Kiel, Germany.	chenning@ae.uni-kiel.de	Laudes, Matthias/C-8885-2011	Ziesmer, Johannes/0000-0001-5950-4199	federal ministry of education and research (BMBF) [0315540A, DRKS00005285]	federal ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study is funded by the federal ministry of education and research (BMBF), Number: 0315540A, DRKS00005285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Bandura A., 1986, SOCIAL FDN THOUGHT A; Battiston S, 2004, COMPLEX DYNAMICS EC, P355; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557; Fletcher A, 2011, J EPIDEMIOL COMMUN H, V65, P548, DOI 10.1136/jech.2010.113936; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frankort A, 2012, INT J OBESITY, V36, P627, DOI 10.1038/ijo.2011.213; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hung CCC, 2004, DIABETES, V53, P2461, DOI 10.2337/diabetes.53.9.2461; Johns D, 2010, EVERYTHING IS CONTAG; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Marks DL, 2004, AM J MED GENET A, V126A, P267, DOI 10.1002/ajmg.a.20600; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moore S, 2009, J PUBLIC HEALTH-UK, V31, P175, DOI 10.1093/pubmed/fdn104; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Turconi G, 2006, EUR J NUTR, V45, P136, DOI 10.1007/s00394-005-0571-x; Valente TW, 2008, SOCIAL NETWORKS HLTH; Van der Gaag M, 2005, SOC NETWORKS, V27, P21; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	41	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93860	10.1371/journal.pone.0093860	http://dx.doi.org/10.1371/journal.pone.0093860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710599	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800058
J	Schwarz, ST; Afzal, M; Morgan, PS; Bajaj, N; Gowland, PA; Auer, DP				Schwarz, Stefan T.; Afzal, Mohammed; Morgan, Paul S.; Bajaj, Nin; Gowland, Penny A.; Auer, Dorothee P.			The 'Swallow Tail' Appearance of the Healthy Nigrosome - A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; DIFFERENTIAL-DIAGNOSIS; CLINICAL-DIAGNOSIS; HUMAN BRAIN	There is no well-established in vivo marker of nigral degeneration in Parkinson's disease (PD). An ideal imaging marker would directly mirror the loss of substantia nigra dopaminergic neurones, which is most prominent in sub-regions called nigrosomes. High-resolution, iron-sensitive, magnetic resonance imaging (MRI) at 7T allows direct nigrosome-1 visualisation in healthy people but not in PD. Here, we investigated the feasibility of nigrosome-1 detection using 3T - susceptibility weighted (SWI) MRI and the diagnostic accuracy that can be achieved for diagnosing PD in a clinical population. 114 high-resolution 3T - SWI-scans were reviewed consisting of a prospective case-control study in 19 subjects ( 10 PD, 9 controls) and a retrospective cross-sectional study in 95 consecutive patients undergoing routine clinical SWI-scans (. 50 years, 9 PD, 81 non-PD, 5 non-diagnostic studies excluded). Two raters independently classified subjects into PD and non-PD according to absence or presence of nigrosome-1, followed by consensus reading. Diagnostic accuracy was assessed against clinical diagnosis as gold standard. Absolute inter-and intra-rater agreement was >= 94%(kappa >= 0.82,p < 0.001). In the prospective study 8/9 control and 8/10 PD; and in the retrospective study 77/81 non-PD and all 9 PD subjects were correctly classified. Diagnostic accuracy of the retrospective cohort was: sensitivity 100%, specificity 95%, NPV 1, PPV 0.69 and accuracy 96% which dropped to 91% when including non-diagnostic scans (`intent to diagnose'). The healthy nigrosome-1 can be readily depicted on high-resolution 3T - SWI giving rise to a `swallow tail' appearance of the dorsolateral substantia nigra, and this feature is lost in PD. Visual radiological assessment yielded a high diagnostic accuracy for PD vs. an unselected clinical control population. Assessing the substantia nigra on SWI for the typical `swallow tail' appearance has potential to become a new and easy applicable 3T MRI diagnostic tool for nigral degeneration in PD.	[Schwarz, Stefan T.; Auer, Dorothee P.] Univ Nottingham, Sch Med, Div Clin Neurosci, Nottingham, England; [Afzal, Mohammed] Nottingham Univ Hosp NHS Trust, Dept Med, Nottingham, England; [Morgan, Paul S.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Bajaj, Nin] Nottingham Univ Hosp NHS Trust, Dept Neurol, Nottingham, England; [Gowland, Penny A.] Sir Peter Mansfield Magnet Resonance Ctr, Sch Phys & Astron, Nottingham, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham University Hospital NHS Trust; Nottingham University Hospital NHS Trust; University of Nottingham	Schwarz, ST (corresponding author), Univ Nottingham, Sch Med, Div Clin Neurosci, Nottingham, England.	stefan.schwarz@nottingham.ac.uk	Gowland, Penny A./I-9016-2012	Gowland, Penny A./0000-0002-4900-4817; Auer, Dorothee P./0000-0002-4745-3635; Morgan, Paul/0000-0002-5870-1446	Special Trustees for Nottingham University Hospital [STR 82/04/N]; Multiple System Atrophy Trust; Medical Research Council [G0901321]; National Institute for Health Research UK (Academic Clinical Lectureship); Medical Research Council [MC_PC_12019] Funding Source: researchfish; National Institute for Health Research [CL-2010-12-004] Funding Source: researchfish; MRC [G0901321, MC_PC_12019] Funding Source: UKRI	Special Trustees for Nottingham University Hospital; Multiple System Atrophy Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research UK (Academic Clinical Lectureship); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The prospective substudy was co-funded by Special Trustees for Nottingham University Hospital (Grant Ref: STR 82/04/N), the Sarah Matheson Trust (now Multiple System Atrophy Trust founded by Sarah Matheson, No reference number given (http://www.msatrust.org.uk), and the Medical Research Council (Grant Ref: G0901321). The author S.T. Schwarz is funded by the National Institute for Health Research UK (Academic Clinical Lectureship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj N, 2013, J NEUROL NEUROSUR PS, V84, P1288, DOI 10.1136/jnnp-2012-304436; Bak Thomas H, 2007, Pract Neurol, V7, P245; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Berg D, 2008, LANCET NEUROL, V7, P1044, DOI 10.1016/S1474-4422(08)70239-4; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Fahn S, 1987, RECENT DEV PARKINSON; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hauser RA, 2012, J NEUROIMAGING, V22, P225, DOI 10.1111/j.1552-6569.2011.00583.x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hotter A, 2009, MOVEMENT DISORD, V24, pS711, DOI 10.1002/mds.22648; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kohn MA, 2013, ACAD EMERG MED, V20, P1194, DOI 10.1111/acem.12255; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Lehericy S, 2012, MOVEMENT DISORD, V27, P822, DOI 10.1002/mds.25015; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Mahlknecht P, 2010, NEURODEGENER DIS, V7, P300, DOI 10.1159/000314495; Massey LA, 2012, MOVEMENT DISORD, V27, P1755, DOI 10.1002/mds.24968; Meara J, 1999, AGE AGEING, V28, P99, DOI 10.1093/ageing/28.2.99; Meijer FJA, 2013, J NEUROL SCI, V332, P21, DOI 10.1016/j.jns.2013.06.032; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Schwarz ST, 2011, MOVEMENT DISORD, V26, P1633, DOI 10.1002/mds.23722; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang J, 2013, DRUG DISCOV TODAY, V18, P155, DOI 10.1016/j.drudis.2012.09.001; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x; Zhang W, 2009, NEUROSCI BULL, V25, P353, DOI 10.1007/s12264-009-0225-8	35	188	206	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93814	10.1371/journal.pone.0093814	http://dx.doi.org/10.1371/journal.pone.0093814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710392	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800054
J	Stadelmann, K; Latshang, TD; Nussbaumer-Ochsner, Y; Tarokh, L; Ulrich, S; Kohler, M; Bloch, KE; Achermann, P				Stadelmann, Katrin; Latshang, Tsogyal D.; Nussbaumer-Ochsner, Yvonne; Tarokh, Leila; Ulrich, Silvia; Kohler, Malcolm; Bloch, Konrad E.; Achermann, Peter			Impact of Acetazolamide and CPAP on Cortical Activity in Obstructive Sleep Apnea Patients	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; SLOW-WAVE ACTIVITY; DAYTIME SLEEPINESS; SPECTRAL-ANALYSIS; BENZODIAZEPINE HYPNOTICS; DOUBLE-BLIND; EEG; ALTITUDE; ARCHITECTURE; MECHANISMS	Study Objectives: 1) To investigate the impact of acetazolamide, a drug commonly prescribed for altitude sickness, on cortical oscillations in patients with obstructive sleep apnea syndrome (OSAS). 2) To examine alterations in the sleep EEG after short- term discontinuation of continuous positive airway pressure (CPAP) therapy. Design: Data from two double- blind, placebo- controlled randomized cross- over design studies were analyzed. Setting: Polysomnographic recordings in sleep laboratory at 490 m and at moderate altitudes in the Swiss Alps: 1630 or 1860 m and 2590 m. Patients: Study 1: 39 OSAS patients. Study 2: 41 OSAS patients. Interventions: Study 1: OSAS patients withdrawn from treatment with CPAP. Study 2: OSAS patients treated with autoCPAP. Treatment with acetazolamide (500-750 mg) or placebo at moderate altitudes. Measurements and Results: An evening dose of 500 mg acetazolamide reduced slow-wave activity (SWA; approximately 10%) and increased spindle activity (approximately 10%) during non-REM sleep. In addition, alpha activity during wake after lights out was increased. An evening dose of 250 mg did not affect these cortical oscillations. Discontinuation of CPAP therapy revealed a reduction in SWA (5-10%) and increase in beta activity (approximately 25%). \Conclusions: The higher evening dose of 500 mg acetazolamide showed the `` spectral fingerprint'' of Benzodiazepines, while 250 mg acetazolamide had no impact on cortical oscillations. However, both doses had beneficial effects on oxygen saturation and sleep quality.	[Stadelmann, Katrin; Tarokh, Leila; Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Stadelmann, Katrin; Kohler, Malcolm; Bloch, Konrad E.; Achermann, Peter] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Latshang, Tsogyal D.; Nussbaumer-Ochsner, Yvonne; Ulrich, Silvia; Kohler, Malcolm; Bloch, Konrad E.] Univ Bern, Univ Hosp Child & Adolescent Psychiat & Psychothe, Bern, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Bern; University Hospital of Bern	Achermann, P (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	acherman@pharma.uzh.ch	Achermann, Peter/N-1215-2014	Achermann, Peter/0000-0002-0208-3511; Tarokh, Leila/0000-0003-4014-428X; Ulrich, Silvia/0000-0002-5250-5022	University of Zurich Research Priority Program (URPP Integrative Human Physiology); Swiss National Science Foundation; Lung League Zurich; Center for Clinical Research, University of Zurich; Center for Clinical Research, University Hospital	University of Zurich Research Priority Program (URPP Integrative Human Physiology); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lung League Zurich; Center for Clinical Research, University of Zurich; Center for Clinical Research, University Hospital	This study was supported by a research grant from the University of Zurich Research Priority Program (URPP Integrative Human Physiology), the Swiss National Science Foundation, the Lung League Zurich and the Center for Clinical Research, University of Zurich and University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH D, 1994, PSYCHOPHARMACOLOGY, V114, P209, DOI 10.1007/BF02244838; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Borbely A A, 1982, Hum Neurobiol, V1, P195; BORBELY AA, 1983, EUR J PHARMACOL, V89, P157, DOI 10.1016/0014-2999(83)90622-2; BORBELY AA, 1985, HUM NEUROBIOL, V4, P189; BRUNNER DP, 1991, PSYCHOPHARMACOLOGY, V104, P1, DOI 10.1007/BF02244546; Caruana-Montaldo B, 2000, CHEST, V117, P205, DOI 10.1378/chest.117.1.205; Dijk DJ, 2010, SLEEP, V33, P211, DOI 10.1093/sleep/33.2.211; Dingli K, 2002, EUR RESPIR J, V20, P1246, DOI 10.1183/09031936.02.00288202; Engleman HM, 1997, THORAX, V52, P114, DOI 10.1136/thx.52.2.114; ENGLEMAN HM, 1993, THORAX, V48, P911, DOI 10.1136/thx.48.9.911; Fietze I, 1997, J SLEEP RES, V6, P128, DOI 10.1046/j.1365-2869.1997.00029.x; Fischer R, 2004, EUR RESPIR J, V23, P47, DOI 10.1183/09031936.03.00113102; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gottselig JM, 2002, BRAIN, V125, P373, DOI 10.1093/brain/awf021; Guilleminault C, 2001, EUR RESPIR J, V17, P838, DOI 10.1183/09031936.01.17508380; Heinzer R, 2001, CHEST, V119, P1807, DOI 10.1378/chest.119.6.1807; Himanen SL, 2003, SLEEP MED, V4, P229, DOI 10.1016/S1389-9457(02)00239-3; Ho ML, 2011, NEUROL INT, V3, P60, DOI 10.4081/ni.2011.e15; Hoshikawa M, 2007, J APPL PHYSIOL, V103, P2005, DOI 10.1152/japplphysiol.00315.2007; Jackson E. K., 2006, GOODMAN GILMANS PHAR, P297; Javaheri S, 2006, AM J RESP CRIT CARE, V173, P234, DOI 10.1164/rccm.200507-1035OC; Johnson PL, 2010, J SLEEP RES, V19, P148, DOI 10.1111/j.1365-2869.2009.00745.x; Latshang TD, 2013, SLEEP IN PRESS; Latshang TD, 2012, JAMA-J AM MED ASSOC, V308, P2390, DOI 10.1001/jama.2012.94847; Leaf DE, 2007, J APPL PHYSIOL, V102, P1313, DOI 10.1152/japplphysiol.01572.2005; McArdle N, 2001, AM J RESP CRIT CARE, V164, P1459, DOI 10.1164/ajrccm.164.8.2008146; Morisson F, 2001, CHEST, V119, P45, DOI 10.1378/chest.119.1.45; Morisson F, 1998, EUR RESPIR J, V11, P1135, DOI 10.1183/09031936.98.11051135; Nussbaumer-Ochsner Y, 2012, SLEEP, V35, P419, DOI 10.5665/sleep.1708; Nussbaumer-Ochsner Y, 2012, CHEST, V141, P131, DOI 10.1378/chest.11-0375; Nussbaumer-Ochsner Y, 2010, THORAX, V65, P429, DOI 10.1136/thx.2009.125849; Ondze B, 2003, CLIN NEUROPHYSIOL, V114, P867, DOI 10.1016/S1388-2457(02)00389-9; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Ritchie ND, 2012, J TRAVEL MED, V19, P298, DOI 10.1111/j.1708-8305.2012.00629.x; Stadelmann K, 2014, J SLEEP RES IN PRESS; Stadelmann K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076945; Staley Kevin J., 2002, Epilepsy Curr, V2, P35, DOI 10.1046/j.1535-7597.2002.00018.x; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; West JB, 2007, HIGH ALTITUDE MED PH, P251	42	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93931	10.1371/journal.pone.0093931	http://dx.doi.org/10.1371/journal.pone.0093931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710341	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000334159800074
J	Linsler, S; Kraemer, D; Driess, C; Oertel, J; Kammers, K; Rahnenfuhrer, J; Ketter, R; Urbschat, S				Linsler, Stefan; Kraemer, Dennis; Driess, Christina; Oertel, Joachim; Kammers, Kai; Rahnenfuehrer, Joerg; Ketter, Ralf; Urbschat, Steffi			Molecular Biological Determinations of Meningioma Progression and Recurrence	PLOS ONE			English	Article							NUMERICAL CHROMOSOME-ABERRATIONS; SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENES; IN-SITU HYBRIDIZATION; HUMAN CANCERS; PROMOTER HYPERMETHYLATION; CYTOGENETIC PROGRESSION; PROGNOSTIC-SIGNIFICANCE; ANAPLASTIC MENINGIOMAS; MALIGNANT PROGRESSION	Meningiomas are tumors that arise from the coverings of the brain or spinal cord. 5% of the cases turn into malignant forms with aggressive clinical behavior and increased risk of tumor recurrence. One hundred and five patients with meningiomas were operated by open surgery. To investigate predictors of meningioma recurrence in total 124 samples of 105 patients were investigated by iFISH. Dual-probe hybridization was performed to access chromosomal alterations of chromosomes 1p-, 9p- and 22q. Additionally, methylation of TIMP3 and p16 was analyzed with MS-PCR. Of the 105 investigated tumors 59.1% (62/105) were WHO grade I, 33.3% (35/105) were WHO grade II and 7.7% (8/105) were anaplastic meningiomas (grade III), respectively. The histopathological data correlates with the recurrence rate of the investigated meningiomas. Hypermethylation of TIMP3 was detected in 13.3% of all meningiomas: 10.9% in WHO grade I meningiomas, 25.0% in grade II and 14.3% in grade III meningiomas, respectively. No correlation of TIMP3 hypermethylation with tumor recurrence or WHO grade (p = 0.2) was observed. Interestingly, deletion of 1p36 emerged as a significant predictor of shorter overall survival (log rank test, p<0.001), whereas TIMP3 promoter methylation had no significant effect on overall survival (log rank test, p = 0.799). The results of the current study support the finding that the deletion of chromosome 1p is an independent marker of meningioma recurrence and progression (p = 0.0097). Therefore the measurement of genetic aberrations in meningiomas allows in a combined histological approach a more precise assessment of the prognosis of meningiomas than histopathology alone.	[Linsler, Stefan; Kraemer, Dennis; Driess, Christina; Oertel, Joachim; Ketter, Ralf; Urbschat, Steffi] Univ Saarland, Dept Neurosurg, Homburg, Germany; [Kammers, Kai; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Kammers, Kai] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Saarland University; Dortmund University of Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ketter, R (corresponding author), Univ Saarland, Dept Neurosurg, Homburg, Germany.	ralf.ketter@uks.eu	Linsler, Stefan N./ADW-5829-2022; Oertel, Joachim/AAO-5012-2021	Linsler, Stefan N./0000-0001-9829-5879; Rahnenfuhrer, Jorg/0000-0002-8947-440X				Al-Mefty O, 2004, J NEUROSURG, V101, P210, DOI 10.3171/jns.2004.101.2.0210; Bachman KE, 1999, CANCER RES, V59, P798; Bai YX, 2007, WORLD J GASTROENTERO, V13, P3883; Barski D, 2010, BRAIN PATHOL, V20, P623, DOI 10.1111/j.1750-3639.2009.00340.x; BEKS JWF, 1988, ACTA NEUROCHIR, V95, P3, DOI 10.1007/BF01793074; BELLO MJ, 1994, GENE CHROMOSOME CANC, V9, P296, DOI 10.1002/gcc.2870090411; Bello MJ, 2004, ACTA NEUROPATHOL, V108, P413, DOI 10.1007/s00401-004-0911-6; Bostrom J, 2001, AM J PATHOL, V159, P661, DOI 10.1016/S0002-9440(10)61737-3; Deodhar K, 2012, J MED VIROL, V84, P1054, DOI 10.1002/jmv.23310; Esteller M, 2000, CANCER RES, V60, P129; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HENN W, 1995, CANCER GENET CYTOGEN, V79, P144, DOI 10.1016/0165-4608(94)00135-X; Herman JG, 1997, CANCER RES, V57, P837; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hilska M, 2007, INT J CANCER, V121, P714, DOI 10.1002/ijc.22747; HOPMAN AHN, 1988, HISTOCHEMISTRY, V89, P307, DOI 10.1007/BF00500631; Ishino S, 1998, CANCER, V83, P360, DOI 10.1002/(SICI)1097-0142(19980715)83:2<360::AID-CNCR21>3.0.CO;2-Q; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Ketter R, 2001, J NEUROSURG, V95, P601, DOI 10.3171/jns.2001.95.4.0601; Ketter R, 2008, NEUROSURGERY, V62, P61, DOI 10.1227/01.NEU.0000311062.72626.D6; Ketter R, 2007, INT J CANCER, V121, P1473, DOI 10.1002/ijc.22855; Ketter R, 2007, J NEURO-ONCOL, V83, P213, DOI 10.1007/s11060-006-9318-7; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Liu YH, 2005, HUM PATHOL, V36, P416, DOI 10.1016/j.humpath.2005.02.006; Lomas J, 2005, GENE CHROMOSOME CANC, V42, P314, DOI 10.1002/gcc.20141; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; Mellai M, 2012, J NEURO-ONCOL, V107, P617, DOI 10.1007/s11060-011-0787-y; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Muhlisch J, 2007, J NEURO-ONCOL, V83, P17, DOI 10.1007/s11060-006-9309-8; Muellenbach R, 1989, TRENDS GENET, V5, P391; Muller P, 1999, CLIN CANCER RES, V5, P3569; Nakamura M, 2005, LAB INVEST, V85, P165, DOI 10.1038/labinvest.3700223; Niedermayer I, 1997, J NEUROPATH EXP NEUR, V56, P879, DOI 10.1097/00005072-199708000-00006; Niedermayer I, 1996, CLIN NEUROPATHOL, V15, P330; Ninomiya I, 2008, ONCOL REP, V20, P1489, DOI 10.3892/or_00000170; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Perry A, 1996, CANCER, V77, P2567, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2567::AID-CNCR21>3.0.CO;2-P; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A., 2007, WHO CLASSIFICATION T; PULST SM, 1993, NEUROLOGY, V43, P2096, DOI 10.1212/WNL.43.10.2096; Righini CA, 2007, B CANCER, V94, P191; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sayagues JM, 2002, CYTOMETRY, V50, P153, DOI 10.1002/cyto.10075; Simon M, 2001, J NEURO-ONCOL, V55, P149, DOI 10.1023/A:1013863630293; SIMPSON D, 1957, J NEUROL NEUROSUR PS, V20, P22, DOI 10.1136/jnnp.20.1.22; Stuart MA, 2013, J NEUROPATHOL EXP NE; Ueki T, 2000, CANCER RES, V60, P1835; Urbschat S, 2011, INT J ONCOL, V39, P1601, DOI 10.3892/ijo.2011.1199; van Tilborg AAG, 2006, J PATHOL, V208, P564, DOI 10.1002/path.1909; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WELLENREUTHER R, 1995, AM J PATHOL, V146, P827; ZANG KD, 1967, NATURE, V216, P84, DOI 10.1038/216084a0; ZANG KD, 1982, CANCER GENET CYTOGEN, V6, P249, DOI 10.1016/0165-4608(82)90063-2; Zang KD, 2001, CYTOGENET CELL GENET, V93, P207, DOI 10.1159/000056986; ZANG KD, 1968, ANGEW CHEM INT EDIT, V7, P709, DOI 10.1002/anie.196807091	58	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94987	10.1371/journal.pone.0094987	http://dx.doi.org/10.1371/journal.pone.0094987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722350	gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100148
J	Nguyen, NP; Dinh, TN; Shen, Y; Thai, MT				Nguyen, Nam P.; Dinh, Thang N.; Shen, Yilin; Thai, My T.			Dynamic Social Community Detection and Its Applications	PLOS ONE			English	Article								Community structure is one of the most commonly observed features of Online Social Networks (OSNs) in reality. The knowledge of this feature is of great advantage: it not only provides helpful insights into developing more efficient social-aware solutions but also promises a wide range of applications enabled by social and mobile networking, such as routing strategies in Mobile Ad Hoc Networks (MANETs) and worm containment in OSNs. Unfortunately, understanding this structure is very challenging, especially in dynamic social networks where social interactions are evolving rapidly. Our work focuses on the following questions: How can we efficiently identify communities in dynamic social networks? How can we adaptively update the network community structure based on its history instead of recomputing from scratch? To this end, we present Quick Community Adaptation (QCA), an adaptive modularity-based framework for not only discovering but also tracing the evolution of network communities in dynamic OSNs. QCA is very fast and efficient in the sense that it adaptively updates and discovers the new community structure based on its history together with the network changes only. This flexible approach makes QCA an ideal framework applicable for analyzing large-scale dynamic social networks due to its lightweight computing-resource requirement. To illustrate the effectiveness of our framework, we extensively test QCA on both synthesized and real-world social networks including Enron, arXiv e-print citation, and Facebook networks. Finally, we demonstrate the applicability of QCA in real applications: (1) A social-aware message forwarding strategy in MANETs, and (2) worm propagation containment in OSNs. Competitive results in comparison with other methods reveal that social-based techniques employing QCA as a community detection core outperform current available methods.	[Nguyen, Nam P.; Dinh, Thang N.; Shen, Yilin; Thai, My T.] Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL USA	State University System of Florida; University of Florida	Nguyen, NP (corresponding author), Towson Univ, Dept Comp & Informat Sci, Towson, MD 21252 USA.	npnguyen@towson.edu	Dinh, Thang N/C-3390-2009; Nguyen, Nguyen/GVT-4511-2022; Nguyen, Ngoc/HHZ-0886-2022	Dinh, Thang N/0000-0003-4847-8356; 	NSF [0953284]; DTRA YIP [HDTRA1-09-1-0061]; Division Of Computer and Network Systems [0953284] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DTRA YIP; Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work is partially supported by NSF CAREER Award #0953284 and DTRA YIP HDTRA1-09-1-0061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArXivData, 2003, KDD CUP 2003; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bose A, 2006, P 5 ACM WORKSH WIR S, P95, DOI [10.1145/1161289.1161307, DOI 10.1145/1161289.1161307]; Chaintreau A, 2007, IEEE T MOBILE COMPUT, V6, P606, DOI 10.1109/TMC.2007.1060; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Daly E, 2007, MOBIHOC'07: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P32; Dinh TN, 2009, IEEE IPCCC, P161, DOI 10.1109/PCCC.2009.5403845; Dourisboure Y., 2007, P 16 INT C WORLD WID, P461, DOI [10.1145/1242572.1242635, DOI 10.1145/1242572.1242635]; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Hui P, 2007, FIFTH ANNUAL IEEE INTERNATIONAL CONFERENCE ON PERVASIVE COMPUTING AND COMMUNICATIONS WORKSHOPS, PROCEEDINGS, P65, DOI 10.1109/PERCOMW.2007.55; Hui P, 2008, MOBIHOC'08: PROCEEDINGS OF THE NINTH ACM INTERNATIONAL SYMPOSIUM ON MOBILE AD HOC NETWORKING AND COMPUTING, P241, DOI 10.1145/1374618.1374652; Kim HA, 2004, USENIX ASSOCIATION PROCEEDINGS OF THE 13TH USENIX SECURITY SYMPOSIUM, P271; Kumar R, 2005, WORLD WIDE WEB, V8, P159, DOI 10.1007/s11280-004-4872-4; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Leskovec J., 2010, P 19 INT C WORLD WID; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Lin Y.R., 2008, P 17 INT C WORLD WID, P685, DOI [10.1145/1367497.1367590, DOI 10.1145/1367497.1367590]; Lin YR, 2009, ACM T KNOWL DISCOV D, V3, DOI 10.1145/1514888.1514891; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2009, UNDERST COMPLEX SYST, P11, DOI 10.1007/978-3-642-01284-6_2; Sekar V, 2006, I C DEPEND SYS NETWO, P189, DOI 10.1109/DSN.2006.6; Sun JM, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P687; Tantipathananandh C, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P827; Toyoda M., 2003, P 14 ACM C HYP HYP, P28, DOI [DOI 10.1145/900051.900059, 10.1145/900051.900059]; Viswanath B, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P37; Wakita K, 2007, 16 INT WORLD WIDE WE, P1275, DOI [10.1145/1242572.1242805, DOI 10.1145/1242572.1242805]; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Weaver N, 2004, P 13 C USENIX SEC S, V13, P3; Ye ZQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046115; Zhang YZ, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P997; Zhu ZC, 2009, IEEE INFOCOM SER, P1476, DOI 10.1109/INFCOM.2009.5062064	36	71	74	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91431	10.1371/journal.pone.0091431	http://dx.doi.org/10.1371/journal.pone.0091431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722164	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100007
J	Zhong, L; Zhang, JM; Zhao, XD; Tan, RS; Wan, M				Zhong, Liang; Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Wan, Min			Automatic Localization of the Left Ventricle from Cardiac Cine Magnetic Resonance Imaging: A New Spectrum-Based Computer-Aided Tool	PLOS ONE			English	Article							REGIONAL WALL CURVEDNESS; HEART-FAILURE; MR-IMAGES; EJECTION FRACTION; SEGMENTATION; STRESS; TRACKING; SHAPES; MODELS; SNAKES	Traditionally, cardiac image analysis is done manually. Automatic image processing can help with the repetitive tasks, and also deal with huge amounts of data, a task which would be humanly tedious. This study aims to develop a spectrum-based computer-aided tool to locate the left ventricle using images obtained via cardiac magnetic resonance imaging. Discrete Fourier Transform was conducted pixelwise on the image sequence. Harmonic images of all frequencies were analyzed visually and quantitatively to determine different patterns of the left and right ventricles on spectrum. The first and fifth harmonic images were selected to perform an anisotropic weighted circle Hough detection. This tool was then tested in ten volunteers. Our tool was able to locate the left ventricle in all cases and had a significantly higher cropping ratio of 0.165 than did earlier studies. In conclusion, a new spectrum-based computer aided tool has been proposed and developed for automatic left ventricle localization. The development of this technique, which will enable the automatic location and further segmentation of the left ventricle, will have a significant impact in research and in diagnostic settings. We envisage that this automated method could be used by radiographers and cardiologists to diagnose and assess ventricular function in patients with diverse heart diseases.	[Zhong, Liang; Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Wan, Min] Natl Heart Ctr Singapore, Bioengn Dept, Singapore, Singapore; [Zhong, Liang; Tan, Ru San] Duke NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Wan, Min] ASTAR, Inst High Performance Comp, Singapore, Singapore	National Heart Centre Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC)	Wan, M (corresponding author), Natl Heart Ctr Singapore, Bioengn Dept, Singapore, Singapore.	wanmin1983@gmail.com		zhao, xiaodan/0000-0003-1469-8027; Tan, Ru San/0000-0003-2086-6517; ZHONG, LIANG/0000-0003-3608-4173; Zhang, Jun-Mei/0000-0002-2257-1803	National Research Foundation [NRF2011NRF-POC001-068]; National Medical Research Council [NMRC/EDG/1037/2011]; SERC Biomedical Engineering Programme Grants [1211480003, 1321480012]	National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SERC Biomedical Engineering Programme Grants	This work was supported by the National Research Foundation (NRF2011NRF-POC001-068), the National Medical Research Council (NMRC/EDG/1037/2011), and SERC Biomedical Engineering Programme Grants 1211480003 and 1321480012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Cocosco CA, 2004, INT CONGR SER, V1268, P1126, DOI 10.1016/j.ics.2004.03.179; Gering DT, 2003, LECT NOTES COMPUT SC, V2878, P524; GUPTA A, 1993, COMPUT CARDIOL, P747; Huang JZ, 2007, I S BIOMED IMAGING, P852, DOI 10.1109/ISBI.2007.356986; Huang W, 2010, J SIGNAL PROCESS SYS, V59, P143, DOI 10.1007/s11265-008-0294-3; Jolly MP, 2008, LECT NOTES COMPUT SC, V5241, P110, DOI 10.1007/978-3-540-85988-8_14; Jolly MP, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P501, DOI 10.1109/ICCV.2001.937558; Jones M., 2001, PROC CVPR IEEE, P1; Kaus MR, 2004, MED IMAGE ANAL, V8, P245, DOI 10.1016/j.media.2004.06.015; Lin X, 2006, LECT NOTES COMPUT SC, V4190, P728; Muller A, 2005, COMPUT CARDIOL, V32, P21; Nascimento J, 2008, IEEE IMAGE PROC, P553, DOI 10.1109/ICIP.2008.4711814; Nascimento JC, 2008, IEEE T IMAGE PROCESS, V17, P392, DOI 10.1109/TIP.2007.915552; Paragios N, 2002, INT J COMPUT VISION, V50, P345, DOI 10.1023/A:1020882509893; Pavani SK, 2010, PATTERN RECOGN, V43, P160, DOI 10.1016/j.patcog.2009.05.011; Pednekar A, 2006, IEEE T BIO-MED ENG, V53, P1425, DOI 10.1109/TBME.2006.873684; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; RANGANATH S, 1995, IEEE T MED IMAGING, V14, P328, DOI 10.1109/42.387714; Santarelli MF, 2003, MED ENG PHYS, V25, P149, DOI 10.1016/S1350-4533(02)00144-3; Silva I, 2010, INT J TOMOGRAPHY SIM, V13, P60; Sorgel W, 1997, PROC SPIE, V3034, P333, DOI 10.1117/12.274120; Wu KC, 2003, CIRC RES, V93, P1146, DOI 10.1161/01.RES.0000103863.40055.E8; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Xu Pham C., 2000, HDB MED IMAGING, P129, DOI 10.1117/3.831079.ch3; Zhong L, 2011, AM J PHYSIOL-HEART C, V300, pH1653, DOI 10.1152/ajpheart.00021.2011; Zhong L, 2013, INT J CARDIOL, V168, P1975, DOI 10.1016/j.ijcard.2012.12.084; Zhong L, 2012, AM J PHYSIOL-HEART C, V302, pH1306, DOI 10.1152/ajpheart.00679.2011; Zhong L, 2011, ANN ACAD MED SINGAP, V40, P179; Zhong L, 2009, AM J PHYSIOL-HEART C, V296, pH573, DOI 10.1152/ajpheart.00525.2008	30	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e92382	10.1371/journal.pone.0092382	http://dx.doi.org/10.1371/journal.pone.0092382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722328	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100011
J	Henriksen, DP; Brabrand, M; Lassen, AT				Henriksen, Daniel Pilsgaard; Brabrand, Mikkel; Lassen, Annmarie Touborg			Prognosis and Risk Factors for Deterioration in Patients Admitted to a Medical Emergency Department	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; VITAL SIGNS; ADMISSION; CARE; ASSOCIATION; COHORT; SCORE; WARD	Objective: Patients that initially appear stable on arrival to the hospital often have less intensive monitoring of their vital signs, possibly leading to excess mortality. The aim was to describe risk factors for deterioration in vital signs and the related prognosis among patients with normal vital signs at arrival to a medical emergency department (MED). Design and setting: Single-centre, retrospective cohort study of all patients admitted to the MED from September 2010-August 2011. Subjects: Patients were included when their vital signs (systolic blood pressure, pulse rate, respiratory rate, Glasgow Coma Scale, oxygen saturation and temperature) were within the normal range at arrival. Deterioration was defined as a deviation from the defined normal range 2-24 hours after arrival. Results: 4292 of the 6257 (68.6%) admitted to the MED had a full set of vital signs at first presentation, 1440/4292 (33.6%) had all normal vital signs and were included in study, 44.0% were male, median age 64 years (5th/95th percentile: 21-90 years) and 446/1440 (31.0%) deteriorated within 24 hours. Independent risk factors for deterioration included age 65-84 years odds ratio (OR): 1.79 (95% confidence interval [CI]: 1.27-2.52), 85+ years OR 1.67 (95% CI: 1.10-2.55), Do-not-attempt-to-resuscitate order OR 3.76 (95% CI: 1.37-10.31) and admission from the open general ED OR 1.35 (95% CI: 1.07-1.71). Thirty-day mortality was 7.9% (95% CI: 5.5-10.7%) among deteriorating patients and 1.9% (95% CI: 1.2-3.0%) among the non-deteriorating, hazard ratio 4.11 (95% CI: 2.38-7.10). Conclusions: Among acutely admitted medical patients who arrive with normal vital signs, 31.0% showed signs of deterioration within 24 hours. Risk factors included old age, Do-not-attempt-to-resuscitate order, admission from the open general ED. Thirty-day mortality among patients with deterioration was four times higher than among non-deteriorating patients. Further research is needed to determine whether intensified monitoring of vital signs can help to prevent deterioration or mortality among medical emergency patients.	[Henriksen, Daniel Pilsgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark; [Brabrand, Mikkel] Sydvestjysk Sygehus, Dept Med, Esbjerg, Denmark	University of Southern Denmark; Odense University Hospital	Henriksen, DP (corresponding author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark.	dphenriksen@health.sdu.dk	Lassen, Annmarie/AAA-5816-2019; Brabrand, Mikkel/F-7276-2011	Brabrand, Mikkel/0000-0002-3340-8251; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195; Lassen, Annmarie/0000-0003-4942-6152	University of Southern Denmark; Research Foundation of Odense University Hospital; philanthropically private fund TrygFonden given; philanthropically private fund	University of Southern Denmark; Research Foundation of Odense University Hospital; philanthropically private fund TrygFonden given; philanthropically private fund	DPH was supported by: University of Southern Denmark, The Research Foundation of Odense University Hospital, as well as an unrestricted grant from the philanthropically private fund TrygFonden given to the University of Southern Denmark. ATL was supported by an unrestricted grant from the philanthropically private fund TrygFonden given to University of Southern Denmark, and is employed as a consultant at the Department of Emergency Medicine, Odense University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong B, 2008, EMERG MED J, V25, P799, DOI 10.1136/emj.2007.052951; Barfod C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-29; Barfod C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-28; Bleyer AJ, 2011, RESUSCITATION, V82, P1387, DOI 10.1016/j.resuscitation.2011.06.033; Buist M, 2004, RESUSCITATION, V62, P137, DOI 10.1016/j.resuscitation.2004.03.005; Centre for Clinical Practice at NICE (UK), 2007, NICE CLIN GUIDEL, V50, P1; Farley H, 2010, ACAD EMERG MED, V17, P718, DOI 10.1111/j.1553-2712.2010.00796.x; Fuhrmann L, 2008, RESUSCITATION, V77, P325, DOI 10.1016/j.resuscitation.2008.01.009; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goldhill DR, 1999, ANAESTHESIA, V54, P853; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; Hands C, 2013, BMJ QUAL SAF, V22, P719, DOI 10.1136/bmjqs-2013-001954; Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159; Jones D, 2013, RESUSCITATION, V84, P1029, DOI 10.1016/j.resuscitation.2013.01.013; Kellett J, 2011, EUR J INTERN MED, V22, P375, DOI 10.1016/j.ejim.2011.03.005; Kennedy M, 2010, ACAD EMERG MED, V17, P1080, DOI 10.1111/j.1553-2712.2010.00872.x; Lighthall GK, 2009, RESUSCITATION, V80, P1264, DOI 10.1016/j.resuscitation.2009.08.012; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schmidt Morten, 2010, Clin Epidemiol, V2, P195, DOI 10.2147/CLEP.S12171; Scott I, 2009, INT J QUAL HEALTH C, V21, P397, DOI 10.1093/intqhc/mzp045; Simchen E, 2007, CRIT CARE MED, V35, P449, DOI 10.1097/01.CCM.0000253407.89594.15; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wuerz R, 2001, ACAD EMERG MED, V8, P61	27	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94649	10.1371/journal.pone.0094649	http://dx.doi.org/10.1371/journal.pone.0094649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718637	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000136
J	Leiguez, E; Giannotti, KC; Moreira, V; Matsubara, MH; Gutierrez, JM; Lomonte, B; Rodriguez, JP; Balsinde, J; Teixeira, C				Leiguez, Elbio; Giannotti, Karina Cristina; Moreira, Vanessa; Matsubara, Marcio Hideki; Maria Gutierrez, Jose; Lomonte, Bruno; Pablo Rodriguez, Juan; Balsinde, Jesus; Teixeira, Catarina			Critical Role of TLR2 and MyD88 for Functional Response of Macrophages to a Group IIA-Secreted Phospholipase A(2) from Snake Venom	PLOS ONE			English	Article							LIPID BODY FORMATION; SATURATED FATTY-ACIDS; TOLL-LIKE RECEPTOR-4; BOTHROPS-ASPER; HUMAN MONOCYTES; MYOTOXIC PHOSPHOLIPASES; SIGNALING PATHWAYS; INSULIN-RESISTANCE; INNATE IMMUNITY; IN-VIVO	The snake venom MT-III is a group IIA secreted phospholipase A(2) (sPLA(2)) enzyme with functional and structural similarities with mammalian pro-inflammatory sPLA(2)s of the same group. Previously, we demonstrated that MT-III directly activates the innate inflammatory response of macrophages, including release of inflammatory mediators and formation of lipid droplets (LDs). However, the mechanisms coordinating these processes remain unclear. In the present study, by using TLR2(-/-) or MyD88(-/-) or C57BL/6 (WT) male mice, we report that TLR2 and MyD88 signaling have a critical role in MT-III-induced inflammatory response in macrophages. MT-III caused a marked release of PGE(2), PGD(2), PGJ(2), IL-1 beta and IL-10 and increased the number of LDs in WT macrophages. In MT-III-stimulated TLR2(-/-) macrophages, formation of LDs and release of eicosanoids and cytokines were abrogated. In MyD88(-/-) macrophages, MT-III-induced release of PGE(2), IL-1 beta and IL-10 was abrogated, but release of PGD(2) and PGJ(2) was maintained. In addition, COX-2 protein expression seen in MT-III-stimulated WT macrophages was abolished in both TLR2(-/-) and MyD88(-/-) cells, while perilipin 2 expression was abolished only in MyD88 2/2 cells. We further demonstrated a reduction of saturated, monounsaturated and polyunsaturated fatty acids and a release of the TLR2 agonists palmitic and oleic acid from MT-III-stimulated WT macrophages compared with WT control cells, thus suggesting these fatty acids as major messengers for MT-III-induced engagement of TLR2/MyD88 signaling. Collectively, our findings identify for the first time a TLR2 and MyD88-dependent mechanism that underlies group IIA sPLA(2)-induced inflammatory response in macrophages.	[Leiguez, Elbio; Giannotti, Karina Cristina; Moreira, Vanessa; Matsubara, Marcio Hideki; Teixeira, Catarina] Inst Butantan, Farmacol Lab, Sao Paulo, Brazil; [Maria Gutierrez, Jose; Lomonte, Bruno] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Pablo Rodriguez, Juan] Univ Nacl Nordeste, FACENA, Lab Invest Prot, Corrientes, Argentina; [Pablo Rodriguez, Juan; Balsinde, Jesus] Inst Biol & Genet Mol, Eicosanoid Res Div, Valladolid, Spain	Instituto Butantan; Universidad Costa Rica; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Teixeira, C (corresponding author), Inst Butantan, Farmacol Lab, Sao Paulo, Brazil.	cteixeir@usp.br	moreira, vanessa/GQO-7744-2022; Balsinde, Jesús/C-7833-2018; Lomonte, Bruno/B-8862-2019; Teixeira, Catarina/AAT-6243-2020; Gutiérrez, José/GSJ-1846-2022; Leiguez, Elbio/B-3899-2018; Leiguez, Elbio/P-7248-2014; Giannotti, Karina Cristina/L-5215-2013; Giannotti, Karina Cristina/B-3878-2018; Teixeira, Catarina/C-6124-2013; Moreira, Vanessa/D-6190-2012	Balsinde, Jesús/0000-0002-4157-6714; Lomonte, Bruno/0000-0003-2419-6469; Teixeira, Catarina/0000-0001-5887-7663; Leiguez, Elbio/0000-0001-6677-2060; Giannotti, Karina Cristina/0000-0001-5165-8716; Moreira, Vanessa/0000-0001-5579-3069; Rodriguez, Juan Pablo/0000-0002-8713-7178; Gutierrez, Jose Maria/0000-0001-8385-3081	FAPESP, Sao Paulo, Brazil [11/21341-5, 10/06345-1]; INCTTOX, Sao Paulo, Brazil [573790/2008-6]; CNPq PQ, Brazil [306920/2011-5]; Spanish Ministery of Science and Innovation, Spain [BFU2010-18826]	FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCTTOX, Sao Paulo, Brazil; CNPq PQ, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Spanish Ministery of Science and Innovation, Spain	This investigation was supported by research grants from FAPESP, Sao Paulo, Brazil (www.fapesp.br), grants 11/21341-5 and 10/06345-1, INCTTOX, Sao Paulo, Brazil (www.incttox.com.br), grant 573790/2008-6, CNPq PQ, Brazil (www.cnpq.br), grant 306920/2011-5, Brazil, Spanish Ministery of Science and Innovation, Spain (http://web.micinn.es/), grant BFU2010-18826. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Bryant KJ, 2011, J BIOL CHEM, V286, P2492, DOI 10.1074/jbc.M110.123927; Calvete JJ, 2011, ACTA CHIM SLOV, V58, P629; Carneiro AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076233; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chaves F, 1998, TOXICON, V36, P1861, DOI 10.1016/S0041-0101(98)00107-X; Chavez-Sanchez L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-117; Choudhury RP, 2005, NAT CLIN PRACT CARD, V2, P309, DOI 10.1038/ncpcardio0195; Cole JE, 2010, EXPERT REV CARDIOVAS, V8, P1619, DOI 10.1586/ERC.10.149; Corsini E, 2002, TOXICOL IN VITRO, V16, P427, DOI 10.1016/S0887-2333(02)00023-1; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feingold KR, 2010, ATHEROSCLEROSIS, V209, P81, DOI 10.1016/j.atherosclerosis.2009.08.042; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Han Xinbing, 2012, ROLE IL 10 ATHEROSCL; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Iwata H, 2012, CURR ATHEROSCLER REP, V14, P484, DOI 10.1007/s11883-012-0267-7; KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2; Karabina SA, 2010, BIOCHIMIE, V92, P594, DOI 10.1016/j.biochi.2010.02.002; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kini R. M., 1997, VENOM PHOSPHOLIPASE, P1; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Leiguez E, 2011, J LEUKOCYTE BIOL, V90, P155, DOI 10.1189/jlb.0510263; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu YF, 2008, MED HYPOTHESES, V70, P314, DOI 10.1016/j.mehy.2007.05.030; Loures FV, 2011, INFECT IMMUN, V79, P2470, DOI 10.1128/IAI.00375-10; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Magalhaes KG, 2010, J INFECT DIS, V202, P1369, DOI 10.1086/656477; McGettrick AF, 2007, BRIT J HAEMATOL, V139, P185, DOI 10.1111/j.1365-2141.2007.06802.x; Moreira V, 2008, TOXICON, V52, P428, DOI 10.1016/j.toxicon.2008.06.012; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nicolaou G, 2010, CURR OPIN LIPIDOL, V21, P427, DOI 10.1097/MOL.0b013e32833cacd5; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Persson J, 2007, BIOCHEM BIOPH RES CO, V363, P1020, DOI 10.1016/j.bbrc.2007.09.074; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Sarov-Blat L, 2007, ARTERIOSCL THROM VAS, V27, P1115, DOI 10.1161/ATVBAHA.106.138990; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shridas P, 2011, J IMMUNOL, V187, P482, DOI 10.4049/jimmunol.1003552; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Surh YJ, 2011, BIOCHEM PHARMACOL, V82, P1335, DOI 10.1016/j.bcp.2011.07.100; TAKAYAMA K, 1994, J BIOL CHEM, V269, P2241; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teixeira C, 2009, TOXICON, V54, P988, DOI 10.1016/j.toxicon.2009.05.026; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang J, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-139; Yedgar S, 2006, BBA-MOL CELL BIOL L, V1761, P1373, DOI 10.1016/j.bbalip.2006.08.003; Yu L, 2012, CELL MOL LIFE SCI, V69, P935, DOI 10.1007/s00018-011-0864-6; Zuliani JP, 2005, TOXICON, V46, P523, DOI 10.1016/j.toxicon.2005.06.017; Zuliani JP, 2005, TOXICON, V45, P335, DOI 10.1016/j.toxicon.2004.11.004	74	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93741	10.1371/journal.pone.0093741	http://dx.doi.org/10.1371/journal.pone.0093741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718259	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000045
J	Lv, B; Nitcher, R; Han, XL; Wang, SY; Ni, F; Li, K; Pearce, S; Wu, JJ; Dubcovsky, J; Fu, DL				Lv, Bo; Nitcher, Rebecca; Han, Xiuli; Wang, Shuyun; Ni, Fei; Li, Kun; Pearce, Stephen; Wu, Jiajie; Dubcovsky, Jorge; Fu, Daolin			Characterization of FLOWERING LOCUS T1 (FT1) Gene in Brachypodium and Wheat	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; LOCUS-T; VERNALIZATION GENES; PROTEIN; BARLEY; HD3A; PHOTOPERIOD; DISTANCE; SIGNAL; TIME	The phase transition from vegetative to reproductive growth is a critical event in the life cycle of flowering plants. FLOWERING LOCUS T (FT) plays a central role in the regulation of this transition by integrating signals from multiple flowering pathways in the leaves and transmitting them to the shoot apical meristem. In this study, we characterized FT homologs in the temperate grasses Brachypodium distachyon and polyploid wheat using transgenic and mutant approaches. Downregulation of FT1 by RNAi was associated with a significant downregulation of the FT-like genes FT2 and FT4 in Brachypodium and FT2 and FT5 in wheat. In a transgenic wheat line carrying a highly-expressed FT1 allele, FT2 and FT3 were upregulated under both long and short days. Overexpression of FT1 caused extremely early flowering during shoot regeneration in both Brachypodium and hexaploid wheat, and resulted in insufficient vegetative tissue to support the production of viable seeds. Downregulation of FT1 transcripts by RNA interference (RNAi) resulted in non-flowering Brachypodium plants and late flowering plants (2-4 weeks delay) in wheat. A similar delay in heading time was observed in tetraploid wheat plants carrying mutations for both FT-A1 and FT-B1. Plants homozygous only for mutations in FT-B1 flowered later than plants homozygous only for mutations in FT-A1, which corresponded with higher transcript levels of FTB1 relative to FT-A1 in the early stages of development. Taken together, our data indicate that FT1 plays a critical role in the regulation of flowering in Brachypodium and wheat, and that this role is associated with the simultaneous regulation of other FT-like genes. The differential effects of mutations in FT-A1 and FT-B1 on wheat heading time suggest that different allelic combinations of FT1 homoeologs could be used to adjust wheat heading time to improve adaptation to changing environments.	[Lv, Bo; Han, Xiuli; Wang, Shuyun; Ni, Fei; Li, Kun; Wu, Jiajie; Fu, Daolin] Shandong Agr Univ, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Nitcher, Rebecca; Pearce, Stephen; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Dubcovsky, Jorge] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California Davis; Howard Hughes Medical Institute	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu; dlfu@sdau.edu.cn	Pearce, Stephen/HHS-1613-2022; Dubcovsky, Jorge/T-5214-2019; Dubcovsky, Jorge/A-4969-2008	Dubcovsky, Jorge/0000-0002-7571-4345	National Natural Science Foundation of China [31110103917, 30871323]; Natural Science Foundation of Shandong Province [JQ201107]; National Research Initiative [2011-67013-30077, 2011-68002-30029]; USDA National Institute of Food and Agriculture; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Research Initiative(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was supported by the National Natural Science Foundation of China (31110103917, 30871323) and the Natural Science Foundation of Shandong Province (JQ201107). Dr. Dubcovsky and Rebecca Nitcher acknowledge support from the National Research Initiative (grants 2011-67013-30077 and 2011-68002-30029) from the USDA National Institute of Food and Agriculture, and by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation grant GBMF3031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bragg JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041916; Brambilla V, 2013, J INTEGR PLANT BIOL, V55, P410, DOI 10.1111/jipb.12033; Chen A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003134; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Falconer D.S., 1964, INTRO QUANTITATIVE G; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Fu DL, 2007, MOL GENET GENOMICS, V277, P301, DOI 10.1007/s00438-006-0189-6; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kikuchi R, 2009, PLANT PHYSIOL, V149, P1341, DOI 10.1104/pp.108.132134; Kim W, 2013, J EXP BOT, V64, P1715, DOI 10.1093/jxb/ert036; Kippes N, 2014, MOL GENET GENOMICS, V289, P47, DOI 10.1007/s00438-013-0788-y; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li W, 2011, CLONING FUNCTIONAL A; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Loukoianov A, 2005, PLANT PHYSIOL, V138, P2364, DOI 10.1104/pp.105.064287; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nitcher R, 2013, MOL GENET GENOMICS, V288, P261, DOI 10.1007/s00438-013-0746-8; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Pearce S, 2013, PLANT PHYSIOL, V163, P1433, DOI 10.1104/pp.113.225854; Peterson R., 2010, International Journal of Plant Biology, V1, P66; Ream T S, 2012, Cold Spring Harb Symp Quant Biol, V77, P105, DOI 10.1101/sqb.2013.77.014449; Ream TS, 2014, PLANT PHYSIOL, V164, P694, DOI 10.1104/pp.113.232678; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schwartz CJ, 2010, BIOENERG RES, V3, P38, DOI 10.1007/s12155-009-9069-3; Shaw LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079459; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Shimada S, 2009, PLANT J, V58, P668, DOI 10.1111/j.1365-313X.2009.03806.x; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taoka K, 2013, TRENDS PLANT SCI, V18, P287, DOI 10.1016/j.tplants.2013.02.002; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; WEEKS JT, 1993, PLANT PHYSIOL, V102, P1077, DOI 10.1104/pp.102.4.1077; Wu L, 2013, PLANT CELL, V25, P4363, DOI 10.1105/tpc.113.118620; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yoshida T, 2010, THEOR APPL GENET, V120, P543, DOI 10.1007/s00122-009-1174-3	54	71	74	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94171	10.1371/journal.pone.0094171	http://dx.doi.org/10.1371/journal.pone.0094171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718312	Green Published, gold			2022-12-27	WOS:000334339000084
J	Schreier, VN; Petho, L; Orban, E; Marquardt, A; Petre, BA; Mezo, G; Manea, M				Schreier, Verena Natalie; Petho, Lilla; Orban, Erika; Marquardt, Andreas; Petre, Brindusa Alina; Mezo, Gabor; Manea, Marilena			Protein Expression Profile of HT-29 Human Colon Cancer Cells after Treatment with a Cytotoxic Daunorubicin-GnRH-III Derivative Bioconjugate	PLOS ONE			English	Article							DISULFIDE-ISOMERASE EXPRESSION; HORMONE-RELEASING HORMONE; ACID-BINDING PROTEIN; HEAT-SHOCK PROTEINS; DOWN-REGULATION; DRUG; RECEPTORS; HSP70; ADENOCARCINOMA; CHEMOTHERAPY	Targeted delivery of chemotherapeutic agents is a new approach for the treatment of cancer, which provides increased selectivity and decreased systemic toxicity. We have recently developed a promising drug delivery system, in which the anticancer drug daunorubicin (Dau) was attached via oxime bond to a gonadotropin-releasing hormone-III (GnRH-III) derivative used as a targeting moiety (Glp-His-Trp-Lys(Ac)-His-Asp-Trp-Lys(Dau = Aoa)-Pro-Gly-NH2; Glp = pyroglutamic acid, Ac = acetyl; Aoa = aminooxyacetyl). This bioconjugate exerted in vitro cytostatic/cytotoxic effect on human breast, prostate and colon cancer cells, as well as significant in vivo tumor growth inhibitory effect on colon carcinoma bearing mice. In our previous studies, H-Lys(Dau = Aoa)-OH was identified as the smallest metabolite produced in the presence of rat liver lysosomal homogenate, which was able to bind to DNA in vitro. To get a deeper insight into the mechanism of action of the bioconjugate, changes in the protein expression profile of HT-29 human colon cancer cells after treatment with the bioconjugate or free daunorubicin were investigated by mass spectrometry-based proteomics. Our results indicate that several metabolism-related proteins, molecular chaperons and proteins involved in signaling are differently expressed after targeted chemotherapeutic treatment, leading to the conclusion that the bioconjugate exerts its cytotoxic action by interfering with multiple intracellular processes.	[Schreier, Verena Natalie; Petho, Lilla; Manea, Marilena] Univ Konstanz, Dept Chem, Constance, Germany; [Petho, Lilla; Orban, Erika; Mezo, Gabor] MTA ELTE Res Grp Peptide Chem, Budapest, Hungary; [Marquardt, Andreas] Univ Konstanz, Prote Facil, Constance, Germany; [Petre, Brindusa Alina] Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania; [Manea, Marilena] Univ Konstanz, Zukunftskolleg, Constance, Germany	University of Konstanz; University of Konstanz; Alexandru Ioan Cuza University; University of Konstanz	Manea, M (corresponding author), Univ Konstanz, Dept Chem, Constance, Germany.	marilena.manea@uni-konstanz.de	Petho, Lilla/I-7502-2018; Petre, Brindusa/S-8307-2016	Petho, Lilla/0000-0002-0298-3341; 	University of Konstanz (Zukunftskolleg) [879/08]; University of Konstanz (Young Scholar Fund) [462/12]; Hungarian National Science Fund [OTKA NK 77485, K 104045]; Romanian National Authority for Scientific Research, CNCS-UEFISCDI [PN-II-RU-TE-2011-3-0038]	University of Konstanz (Zukunftskolleg); University of Konstanz (Young Scholar Fund); Hungarian National Science Fund; Romanian National Authority for Scientific Research, CNCS-UEFISCDI	This work was supported by grants from the University of Konstanz (Zukunftskolleg, Project 879/08 and Young Scholar Fund, Project 462/12), the Hungarian National Science Fund (OTKA NK 77485 and K 104045) and by Romanian National Authority for Scientific Research, CNCS-UEFISCDI (PN-II-RU-TE-2011-3-0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman-Onal Y, 2011, Patent No. [US20110104701 A1, 20110104701A1]; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; Cao XR, 2010, DISCRETE EVENT DYN S, V20, P1, DOI 10.1007/s10626-010-0088-1; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Engel J, 2012, EXPERT OPIN INV DRUG, V21, P891, DOI 10.1517/13543784.2012.685128; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Grivicich I, 2007, INT J COLORECTAL DIS, V22, P1201, DOI 10.1007/s00384-007-0307-x; Junqin L, 2012, J BIOSCI MED, V2, P1; Kovacs M, 2002, J NEUROENDOCRINOL, V14, P647, DOI 10.1046/j.1365-2826.2002.00828.x; Li ZY, 2008, INT J CANCER, V123, P2377, DOI 10.1002/ijc.23808; Limonta P, 2012, ENDOCR REV, V33, P784, DOI 10.1210/er.2012-1014; Lovas S, 1998, J PEPT RES, V52, P384; Majumdar S, 2012, MED RES REV, V32, P637, DOI 10.1002/med.20225; Manea M, 2013, PROTEIN PEPTIDE LETT, V20, P439, DOI 10.2174/092986613805290381; Manea M, 2012, ANTI-CANCER DRUG, V23, P90, DOI 10.1097/CAD.0b013e32834bb6b4; Manea M, 2011, BIOCONJUGATE CHEM, V22, P1320, DOI 10.1021/bc100547p; Mezo G, 2010, EXPERT OPIN DRUG DEL, V7, P79, DOI 10.1517/17425240903418410; Musch MW, 2001, CELL GROWTH DIFFER, V12, P419; Nagai Masahiro, 2012, Biomol Concepts, V3, P307, DOI 10.1515/bmc-2011-0068; Nagy A, 2005, CURR PHARM DESIGN, V11, P1167, DOI 10.2174/1381612053507594; Orban E, 2011, BIOCONJUGATE CHEM, V22, P2154, DOI 10.1021/bc2004236; Orban E, 2011, AMINO ACIDS, V41, P469, DOI 10.1007/s00726-010-0766-1; Rensen WM, 2009, ONCOGENE, V28, P1748, DOI 10.1038/onc.2009.24; Riddick DS, 2005, DRUG METAB DISPOS, V33, P1083, DOI 10.1124/dmd.105.004374; Ropponen K, 1998, CANCER RES, V58, P342; Sarto C, 2000, ELECTROPHORESIS, V21, P1218, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1218::AID-ELPS1218>3.3.CO;2-8; Schlage P, 2011, J CONTROL RELEASE, V156, P170, DOI 10.1016/j.jconrel.2011.08.005; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017; Westphalen S, 2000, INT J ONCOL, V17, P1063; Zamanian M, 2013, PATHOL ONCOL RES, V19, P149, DOI 10.1007/s12253-012-9600-2; Zhong SY, 2011, ANTICANCER RES, V31, P1659	37	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94041	10.1371/journal.pone.0094041	http://dx.doi.org/10.1371/journal.pone.0094041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718594	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000072
J	Ezeh, PC; Lauer, FT; MacKenzie, D; McClain, S; Liu, KJ; Hudson, LG; Gandolfi, AJ; Burchiel, SW				Ezeh, Peace C.; Lauer, Fredine T.; MacKenzie, Debra; McClain, Shea; Liu, Ke Jian; Hudson, Laurie G.; Gandolfi, A. Jay; Burchiel, Scott W.			Arsenite Selectively Inhibits Mouse Bone Marrow Lymphoid Progenitor Cell Development In Vivo and In Vitro and Suppresses Humoral Immunity In Vivo	PLOS ONE			English	Article							GENE-EXPRESSION; POLY(ADP-RIBOSE) POLYMERASE-1; CYTOKINE SECRETION; OXIDATIVE STRESS; EXPOSURE; ACID; PROLIFERATION; TOXICITY	It is known that exposure to As+3 via drinking water causes a disruption of the immune system and significantly compromises the immune response to infection. The purpose of these studies was to assess the effects of As+3 on bone marrow progenitor cell colony formation and the humoral immune response to a T-dependent antigen response (TDAR) in vivo. In a 30 day drinking water study, mice were exposed to 19, 75, or 300 ppb As+3. There was a decrease in bone marrow cell recovery, but not spleen cell recovery at 300 ppb As+3. In the bone marrow, As+3 altered neither the expression of CD34+ and CD38+ cells, markers of early hematopoietic stem cells, nor CD452-/CD105+, markers of mesenchymal stem cells. Spleen cell surface marker CD45 expression on B cells (CD19+), T cells (CD3+), T helper cells (CD4+) and cytotoxic T cells (CD8+), natural killer (NK+), and macrophages (Mac 1+) were not altered by the 30 day in vivo As+3 exposure. Functional assays of CFU-B colony formation showed significant selective suppression (p < 0.05) by 300 ppb As+3 exposure, whereas CFU-GM formation was not altered. The TDAR of the spleen cells was significantly suppressed at 75 and 300 ppb As+3. In vitro studies of the bone marrow revealed a selective suppression of CFU-B by 50 nM As+3 in the absence of apparent cytotoxicity. Monomethylarsonous acid (MMA(+3)) demonstrated a dose-dependent and selective suppression of CFU-B beginning at 5 nM (p < 0.05). MMA(+3) suppressed CFU-GM formation at 500 nM, a concentration that proved to be nonspecifically cytotoxic. As+5 did not suppress CFU-B and/or CFU-GM in vitro at concentrations up to 500 nM. Collectively, these results demonstrate that As+3 and likely its metabolite (MMA(+3)) target lymphoid progenitor cells in mouse bone marrow and mature B and T cell activity in the spleen.	[Ezeh, Peace C.; Lauer, Fredine T.; MacKenzie, Debra; McClain, Shea; Liu, Ke Jian; Hudson, Laurie G.; Burchiel, Scott W.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Gandolfi, A. Jay] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of New Mexico; University of Arizona	Burchiel, SW (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	sburchiel@salud.unm.edu			NIH [1R01ES019968-01A1]; University of Arizona Superfund Program [ES 04940]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019968, P42ES004940, P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103400] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona Superfund Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH grant 1R01ES019968-01A1. The MMA+3 was prepared in the Synthetic Core of the Southwest Environmental Health Sciences Center (ES 06694) and supplied by the University of Arizona Superfund Program (ES 04940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, TOXICOL SCI, V129, P305, DOI 10.1093/toxsci/kfs202; Andrew AS, 2006, ENVIRON HEALTH PERSP, V114, P1193, DOI 10.1289/ehp.9008; Aposhian HV, 2000, CHEM RES TOXICOL, V13, P693, DOI 10.1021/tx000114o; Argos M, 2006, CANCER EPIDEM BIOMAR, V15, P1367, DOI 10.1158/1055-9965.EPI-06-0106; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Biswas R, 2008, HUM EXP TOXICOL, V27, P381, DOI 10.1177/0960327108094607; Burchiel SW, 2009, TOXICOL APPL PHARM, V241, P253, DOI 10.1016/j.taap.2009.09.019; Carsetti R, 2000, J EXP MED, V191, P5, DOI 10.1084/jem.191.1.5; Cheng HYY, 2004, ONCOGENE, V23, P3603, DOI 10.1038/sj.onc.1207466; Cooper KL, 2013, TOXICOL APPL PHARM, V269, P81, DOI 10.1016/j.taap.2013.03.008; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Drobna Z, 2009, CHEM RES TOXICOL, V22, P1713, DOI 10.1021/tx900179r; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; Engstrom KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053732; Flora SJS, 2011, FREE RADICAL BIO MED, V51, P257, DOI 10.1016/j.freeradbiomed.2011.04.008; Fujihara J, 2010, TOXICOL APPL PHARM, V243, P292, DOI 10.1016/j.taap.2009.11.020; Gamble MV, 2007, AM J CLIN NUTR, V86, P1202, DOI 10.1093/ajcn/86.4.1202; Healy SM, 1998, TOXICOL APPL PHARM, V148, P65, DOI 10.1006/taap.1997.8306; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Irons RD, 1985, TOXICOLOGY BLOOD BON; King BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393504; Kozul CD, 2008, CHEM-BIOL INTERACT, V173, P129, DOI 10.1016/j.cbi.2008.02.008; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Lauer FT, 2013, J TOXICOL ENV HEAL A, V76, P16, DOI 10.1080/15287394.2012.722521; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Li Q, 2010, TOXICOL APPL PHARM, V245, P344, DOI 10.1016/j.taap.2010.03.020; Liu ZJ, 2006, ENVIRON HEALTH PERSP, V114, P527, DOI 10.1289/ehp.8600; Macoch M, 2013, TOXICOL APPL PHARM, V266, P204, DOI 10.1016/j.taap.2012.11.008; Mercedes M, 2007, TOXICOL APPL PHARM, V222, P381, DOI 10.1016/j.taap.2006.12.018; Morzadec C, 2012, TOXICOLOGY, V300, P46, DOI 10.1016/j.tox.2012.05.025; Morzadec C, 2012, TOXICOL APPL PHARM, V262, P217, DOI 10.1016/j.taap.2012.05.004; Nielson MG, 2010, 20105199 US GEOL SUR, P69; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Rocha-Amador DO, 2011, ENVIRON TOXICOL PHAR, V32, P399, DOI 10.1016/j.etap.2011.08.004; Soto-Pena GA, 2006, FASEB J, V20, P779, DOI 10.1096/fj.05-4860fje; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Sun XG, 2013, ELECTRON J QUAL THEO, P1; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Vernhet L, 2008, ENVIRON TOXICOL, V23, P263, DOI 10.1002/tox.20334	41	25	28	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93920	10.1371/journal.pone.0093920	http://dx.doi.org/10.1371/journal.pone.0093920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714590	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900060
J	Giovati, L; Gallo, A; Masoero, F; Cerioli, C; Ciociola, T; Conti, S; Magliani, W; Polonelli, L				Giovati, Laura; Gallo, Antonio; Masoero, Francesco; Cerioli, Carla; Ciociola, Tecla; Conti, Stefania; Magliani, Walter; Polonelli, Luciano			Vaccination of Heifers with Anaflatoxin Improves the Reduction of Aflatoxin B-1 Carry Over in Milk of Lactating Dairy Cows	PLOS ONE			English	Article							INCLUSION; ADJUVANTS; WATER; M1	It was previously reported that injection of anaflatoxin B-1 (AnAFB(1)) conjugated to keyhole limpet hemocyanin (KLH), together with Freund's adjuvant, was effective in inducing in cows a long lasting titer of anti-aflatoxin B1 (AFB(1)) antibodies (Abs), cross-reacting with other aflatoxins, which were able to hinder, proportionally to their titer, the secretion of aflatoxin M-1 (AFM(1)) into the milk of cows continuously fed with AFB(1). According to anti-AFB(1) Ab titer, 50% of the vaccinated cows were recognized as high responder animals. In an attempt to prepare a more effective formulation for vaccination of cows, it was compared the immunogenicity, in Holstein Friesian heifers, of AnAFB(1) covalently conjugated to KLH or to recombinant diphtheria toxin (CRM197) molecules, and injected together with various adjuvants. This study demonstrated that injection of AnAFB(1) conjugated to KLH and mixed with complete (priming) and incomplete Freund's adjuvant (boosters), as in the previous schedule of immunization, was the most effective regimen for inducing Ab responses against AFB(1), although pre-calving administration could increase the effectiveness of vaccination, resulting in 100% high responder animals. After one booster dose at the beginning of the milk production cycle, anti-AFB(1) Ab titers were comparable to those recorded at the end of the immunization schedule, and proved to be effective in reducing significantly AFB(1) carry over, as AFM(1), from feed to milk. Pre-calving vaccination of dairy heifers with conjugated AnAFB(1), adjuvated with complete and incomplete Freund's adjuvant, may represent the most effective tool for preventing the public health hazard constituted by milk and cheese contaminated with aflatoxins.	[Giovati, Laura; Ciociola, Tecla; Conti, Stefania; Magliani, Walter; Polonelli, Luciano] Univ Parma, Dipartimento Sci Biomed Biotecnol & Traslaz, Unita Microbiol & Virol, I-43100 Parma, Italy; [Gallo, Antonio; Masoero, Francesco; Cerioli, Carla] Univ Cattolica Sacro Cuore, Fac Agr, Ist Sci Alimenti Nutr, Piacenza, Italy	University of Parma; Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Magliani, W (corresponding author), Univ Parma, Dipartimento Sci Biomed Biotecnol & Traslaz, Unita Microbiol & Virol, I-43100 Parma, Italy.	walter.magliani@unipr.it	Gallo, Antonio/B-1382-2010; Ciociola, Tecla/AFN-5212-2022; Conti, Stefania/N-3558-2015; Giovati, Laura/ABH-7376-2020; Ciociola, Tecla/HCH-2453-2022	Gallo, Antonio/0000-0002-4700-4450; Ciociola, Tecla/0000-0001-6499-2545; Conti, Stefania/0000-0001-9973-8352; GIOVATI, LAURA/0000-0001-7514-1789; MASOERO, Francesco/0000-0002-0373-6051; CERIOLI, Carla/0000-0001-5598-9782	Fondazione Cassa di Risparmio di Parma e Piacenza	Fondazione Cassa di Risparmio di Parma e Piacenza	This work was supported by funds from "Fondazione Cassa di Risparmio di Parma e Piacenza'' http://www.fondazionecrp.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, OFFICIAL J EUROPEAN, VL358, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHU FS, 1977, APPL ENVIRON MICROB, V33, P1125, DOI 10.1128/AEM.33.5.1125-1128.1977; CHU FS, 1977, J ASSOC OFF ANA CHEM, V60, P791; Eaton D. L, 1994, TOXICOLOGY AFLATOXIN; El Khoury A, 2011, FOOD CONTROL, V22, P1695, DOI 10.1016/j.foodcont.2011.04.001; Food and Agriculture Organization, 2004, FAO Food and Nutrition Paper, P1; Gallo A, 2010, FOOD ADDIT CONTAM A, V27, P54, DOI 10.1080/02652030903207219; Galvano F, 1996, J FOOD PROTECT, V59, P1079, DOI 10.4315/0362-028X-59.10.1079; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100F, P225; Jouany JP, 2007, ANIM FEED SCI TECH, V137, P342, DOI 10.1016/j.anifeedsci.2007.06.009; Kanra G, 2003, PEDIATR INT, V45, P314, DOI 10.1046/j.1442-200X.2003.01706.x; Kanungo L, 2014, FOOD AGR IMMUNOL, V25, P467, DOI 10.1080/09540105.2013.837031; Kolossova A, 2009, 23997 EUR EN; Kutz RE, 2009, J DAIRY SCI, V92, P3959, DOI 10.3168/jds.2009-2031; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LANGONE JJ, 1975, RES COMMUN CHEM PATH, V10, P163; LEE NJ, 1995, J AGR FOOD CHEM, V43, P1730, DOI 10.1021/jf00054a060; Littell RC, 1998, J ANIM SCI, V76, P1216; Masoero F, 2009, ANIM FEED SCI TECH, V150, P34, DOI 10.1016/j.anifeedsci.2008.07.009; MCLEAN M, 1995, PHARMACOL THERAPEUT, V65, P163, DOI 10.1016/0163-7258(94)00054-7; Moschini M, 2008, ANIM FEED SCI TECH, V147, P292, DOI 10.1016/j.anifeedsci.2008.01.010; NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015; PHILLIPS TD, 1988, POULTRY SCI, V67, P243, DOI 10.3382/ps.0670243; Phillips TD, 2002, ADV EXP MED BIOL, V504, P157; Pietri A., 2009, International Journal of Dairy Science, V4, P34, DOI 10.3923/ijds.2009.34.42; Piva G, 1995, NUTR RES, V5, P689; Polonelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026777; Rahimi E, 2012, B ENVIRON CONTAM TOX, V89, P158, DOI 10.1007/s00128-012-0616-9; Riahi-Zanjani B, 2013, MYCOTOXIN RES, V29, P271, DOI 10.1007/s12550-013-0179-6; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; VELDMAN A, 1992, ANIM PROD, V55, P163, DOI 10.1017/S0003356100037417; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Xu QH, 2006, BIOCONJUGATE CHEM, V17, P1508, DOI 10.1021/bc060083u	38	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94440	10.1371/journal.pone.0094440	http://dx.doi.org/10.1371/journal.pone.0094440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714096	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900132
J	Ho, TH; Caughey, GE; Shakib, S				Ho, Tam H.; Caughey, Gillian E.; Shakib, Sepehr			Guideline Compliance in Chronic Heart Failure Patients with Multiple Comorbid Diseases: Evaluation of an Individualised Multidisciplinary Model of Care	PLOS ONE			English	Article							OUTCOMES; ADHERENCE; QUALITY	Objective: To assess the impact of individualised, reconciled evidence-based recommendations (IRERs) and multidisciplinary care in patients with chronic heart failure (CHF) on clinical guideline compliance for CHF and common comorbid conditions. Design and setting: A retrospective hospital clinical audit conducted between 1(st) July 2006 and February 2011. Participants: A total of 255 patients with a diagnosis of CHF who attended the Multidisciplinary Ambulatory Consulting Services (MACS) clinics, at the Royal Adelaide Hospital, were included. Main outcome measures: Compliance with Australian clinical guideline recommendations for CHF, atrial fibrillation, diabetes mellitus and ischaemic heart disease. Results: Study participants had a median of eight medical conditions (IQR 6-10) and were on an average of 10 (64) unique medications. Compliance with clinical guideline recommendations for pharmacological therapy for CHF, comorbid atrial fibrillation, diabetes or ischaemic heart disease was high, ranging from 86% for lipid lowering therapy to 98% anti-platelet agents. For all conditions, compliance with lifestyle recommendations was lower than pharmacological therapy, ranging from no podiatry reviews for CHF patients with comorbid diabetes to 75% for heart failure education. Concordance with many guideline recommendations was significantly associated if the patient had IRERs determined, a greater number of recommendations, more clinic visits or if patients participated in a heart failure program. Conclusions: Despite the high number of comorbid conditions and resulting complexity of the management, high compliance to clinical guideline recommendations was associated with IRER determination in older patients with CHF. Importantly these recommendations need to be communicated to the patient's general practitioner, regularly monitored and adjusted at clinic visits.	[Ho, Tam H.; Shakib, Sepehr] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia; [Caughey, Gillian E.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia	Royal Adelaide Hospital; University of South Australia	Shakib, S (corresponding author), Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia.	ssshakib@gmail.com		Caughey, Gillian/0000-0003-1192-4121				[Anonymous], 2008, THER GUID CARD VERS; [Anonymous], 2009, THER GUID END VERS 4; [Anonymous], 2011, GUID PREV DET MAN CH; Australian Institute of Health and Welfare (AIHW) and the National Heart Foundation of Australia (NHFA), 2004, HEART STROK VASC DIS, P140; Borgstedt Johanna, 2009, Journal of Pharmacy Practice and Research, V39, P186; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; Caughey GE, 2011, DRUGS AGING, V28, P1; Fonarow GC, 2008, CIRC-HEART FAIL, V1, P98, DOI 10.1161/CIRCHEARTFAILURE.108.772228; Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4; Hauptman PJ, 2008, J CARD FAIL, V14, P801, DOI 10.1016/j.cardfail.2008.10.005; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Krum H, 2001, MED J AUSTRALIA, V174, P439, DOI 10.5694/j.1326-5377.2001.tb143369.x; Lainscak M, 2007, EUR J HEART FAIL, V9, P292, DOI 10.1016/j.ejheart.2006.07.007; McMurray JJV, 2003, EUR HEART J SUPPL, V5, P3, DOI 10.1016/S1520-765X(03)80002-0; National Heart Foundation of Australia, 2010, MULT CAR PEOPL CHRON; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Sheikh JI, 1986, CLIN GERONTOLOGY GUI, P6165; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; White HD, 2005, LANCET, V366, P1989, DOI 10.1016/S0140-6736(05)67761-6; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074	21	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93129	10.1371/journal.pone.0093129	http://dx.doi.org/10.1371/journal.pone.0093129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714369	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000334160900015
J	Shao, J; Choe, V; Cheng, HL; Tsai, YC; Weissman, AM; Luo, SW; Rao, H				Shao, Jia; Choe, Vitnary; Cheng, Haili; Tsai, Yien Che; Weissman, Allan M.; Luo, Shiwen; Rao, Hai			Ubiquitin Ligase gp78 Targets Unglycosylated Prion Protein PrP for Ubiquitylation and Degradation	PLOS ONE			English	Article							PROTEASOME SYSTEM; ENDOPLASMIC-RETICULUM; MISFOLDED PRP; DISEASES; DYSFUNCTION; PATHWAY	Prion protein PrP is a central player in several devastating neurodegenerative disorders, including mad cow disease and Creutzfeltd-Jacob disease. Conformational alteration of PrP into an aggregation-prone infectious form PrPSc can trigger pathogenic events. How levels of PrP are regulated is poorly understood. Human PrP is known to be degraded by the proteasome, but the specific proteolytic pathway responsible for PrP destruction remains elusive. Here, we demonstrate that the ubiquitin ligase gp78, known for its role in protein quality control, is critical for unglycosylated PrP ubiquitylation and degradation. Furthermore, C-terminal sequences of PrP protein are crucial for its ubiquitylation and degradation. Our study reveals the first ubiquitin ligase specifically involved in prion protein PrP degradation and PrP sequences crucial for its turnover. Our data may lead to a new avenue to control PrP level and pathogenesis.	[Shao, Jia; Luo, Shiwen] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Choe, Vitnary; Cheng, Haili; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Frederick, MD 21701 USA	Nanchang University; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Luo, SW (corresponding author), Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	shiwenluo@ncu.edu.cn; raoh@uthscsa.edu	Cheng, Haili/AGG-8193-2022	Cheng, Haili/0000-0002-1860-3585; Tsai, Yien Che/0000-0001-9624-1092; RAO, HAI/0000-0002-4235-2210	NIH [GM 078085]; Welch Foundation [AQ-1747]; Department of Defense [W911NF-11-10466]; NSFC [81060095]; 973 Program of China [2010CB535001]; 555 Program of Jiangxi; Center for Cancer Research, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC009392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Department of Defense(United States Department of Defense); NSFC(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); 555 Program of Jiangxi; Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HR and SL are supported by the NIH (GM 078085), the Welch Foundation (AQ-1747), and the Department of Defense (W911NF-11-10466), NSFC (81060095), 973 Program of China (2010CB535001) and 555 Program of Jiangxi. AMW is supported by the Center for Cancer Research, National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aguzzi A, 2012, NAT NEUROSCI, V15, P936, DOI 10.1038/nn.3120; Andre R, 2012, PRION, V6, P32, DOI 10.4161/pri.6.1.18272; Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Ciechanover A, 2013, BIOORGAN MED CHEM, V21, P3400, DOI 10.1016/j.bmc.2013.01.056; Dantuma NP, 2010, CARDIOVASC RES, V85, P263, DOI 10.1093/cvr/cvp255; Dennissen FJA, 2012, PROG NEUROBIOL, V96, P190, DOI 10.1016/j.pneurobio.2012.01.003; Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224; Dron M, 2009, J GEN VIROL, V90, P2050, DOI 10.1099/vir.0.010082-0; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Nunziante M, 2011, J BIOL CHEM, V286, P33942, DOI 10.1074/jbc.M111.272617; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383	26	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92290	10.1371/journal.pone.0092290	http://dx.doi.org/10.1371/journal.pone.0092290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714645	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900004
J	Zingg, W; Cartier, V; Inan, C; Touveneau, S; Theriault, M; Gayet-Ageron, A; Clergue, F; Pittet, D; Walder, B				Zingg, Walter; Cartier, Vanessa; Inan, Cigdem; Touveneau, Sylvie; Theriault, Michel; Gayet-Ageron, Angele; Clergue, Francois; Pittet, Didier; Walder, Bernhard			Hospital-Wide Multidisciplinary, Multimodal Intervention Programme to Reduce Central Venous Catheter-Associated Bloodstream Infection	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; CARE-ASSOCIATED INFECTION; HEALTH-CARE; ATTRIBUTABLE COST; HAND HYGIENE; PREVENTION; SIMULATION; IMPACT; COMPLICATIONS; INSERTION	Central line-associated bloodstream infection (CLABSI) is the major complication of central venous catheters (CVC). The aim of the study was to test the effectiveness of a hospital-wide strategy on CLABSI reduction. Between 2008 and 2011, all CVCs were observed individually and hospital-wide at a large university-affiliated, tertiary care hospital. CVC insertion training started from the 3rd quarter and a total of 146 physicians employed or newly entering the hospital were trained in simulator workshops. CVC care started from quarter 7 and a total of 1274 nurses were trained by their supervisors using a web-based, modular, e-learning programme. The study included 3952 patients with 6353 CVCs accumulating 61,366 catheter-days. Hospital-wide, 106 patients had 114 CLABSIs with a cumulative incidence of 1.79 infections per 100 catheters. We observed a significant quarterly reduction of the incidence density (incidence rate ratios [95% confidence interval]: 0.92 [0.88-0.96]; P < 0.001) after adjusting for multiple confounders. The incidence densities (n/1000 catheter-days) in the first and last study year were 2.3/1000 and 0.7/1000 hospital-wide, 1.7/1000 and 0.4/1000 in the intensive care units, and 2.7/1000 and 0.9/1000 in non-intensive care settings, respectively. Median time-to-infection was 15 days (Interquartile range, 8-22). Our findings suggest that clinically relevant reduction of hospital-wide CLABSI was reached with a comprehensive, multidisciplinary and multimodal quality improvement programme including aspects of behavioural change and key principles of good implementation practice. This is one of the first multimodal, multidisciplinary, hospital-wide training strategies successfully reducing CLABSI.	[Zingg, Walter; Touveneau, Sylvie; Gayet-Ageron, Angele; Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; [Cartier, Vanessa; Inan, Cigdem; Clergue, Francois; Walder, Bernhard] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Touveneau, Sylvie; Theriault, Michel] Univ Hosp Geneva, Dept Nursing, Geneva, Switzerland; [Touveneau, Sylvie; Theriault, Michel] Univ Hosp Geneva, WHO, Collaborating Ctr Patient Safety, Geneva, Switzerland; [Pittet, Didier] Fac Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; World Health Organization; University of Geneva	Zingg, W (corresponding author), Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland.	walter.zingg@hcuge.ch		Gayet-Ageron, Angele/0000-0002-6164-9693	University of Geneva Hospitals	University of Geneva Hospitals	The project was a quality improvement program financed by the University of Geneva Hospitals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2010, AM J INFECT CONTROL, V38, P449, DOI 10.1016/j.ajic.2009.08.017; Barsuk JH, 2010, ACAD MED, V85, pS9, DOI 10.1097/ACM.0b013e3181ed436c; Barsuk JH, 2009, CRIT CARE MED, V37, P2697, DOI 10.1097/CCM.0b013e3181a57bc1; Barsuk JH, 2009, ARCH INTERN MED, V169, P1420, DOI 10.1001/archinternmed.2009.215; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Damschroder LJ, 2009, QUAL SAF HEALTH CARE, V18, P434, DOI 10.1136/qshc.2009.034199; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; DePalo VA, 2010, QUAL SAF HEALTH CARE, V19, P555, DOI 10.1136/qshc.2009.038265; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Edwards R, 2012, LANCET INFECT DIS, V12, P318, DOI 10.1016/S1473-3099(11)70283-3; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; Evans LV, 2010, QUAL SAF HEALTH CARE, V19, pI42, DOI 10.1136/qshc.2010.042168; Evans LV, 2010, ACAD MED, V85, P1462, DOI 10.1097/ACM.0b013e3181eac9a3; Freixas N, 2013, CLIN MICROBIOL INFEC, V19, P838, DOI 10.1111/1469-0691.12049; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842; Guerin K, 2010, AM J INFECT CONTROL, V38, P430, DOI 10.1016/j.ajic.2010.03.007; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kaye J, 2000, AM J INFECT CONTROL, V28, P197, DOI 10.1016/S0196-6553(00)90028-2; Khouli H, 2011, CHEST, V139, P80, DOI 10.1378/chest.10-0979; Koll BS, 2008, JT COMM J QUAL PATIE, V34, P713, DOI 10.1016/S1553-7250(08)34094-X; Lankford MG, 2003, EMERG INFECT DIS, V9, P217; Levine SA, 2007, J AM GERIATR SOC, V55, P1281, DOI 10.1111/j.1532-5415.2007.01205.x; Lin DM, 2013, JT COMM J QUAL PATIE, V39, P51, DOI 10.1016/S1553-7250(13)39008-4; Lloyd B, 2009, HEALTH PROMOT J AUST, V20, P151, DOI 10.1071/HE09151; Marra AR, 2010, AM J INFECT CONTROL, V38, P434, DOI 10.1016/j.ajic.2009.11.012; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Miller RS, 2010, J TRAUMA, V68, P23, DOI 10.1097/TA.0b013e3181c82678; Miyachi H, 2007, AM J INFECT CONTROL, V35, P115, DOI 10.1016/j.ajic.2006.09.003; Parienti JJ, 2008, JAMA-J AM MED ASSOC, V299, P2413, DOI 10.1001/jama.299.20.2413; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost Peter J, 2004, Jt Comm J Qual Saf, V30, P59; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; RICHET H, 1990, J CLIN MICROBIOL, V28, P2520, DOI 10.1128/JCM.28.11.2520-2525.1990; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rubinson L, 2005, INFECT CONT HOSP EP, V26, P525, DOI 10.1086/502579; Saint S, 2010, INFECT CONT HOSP EP, V31, P901, DOI 10.1086/655459; Tedja R, 2014, INFECT CONT HOSP EP, V35, P164, DOI 10.1086/674856; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D; Zingg W, 2009, J HOSP INFECT, V73, P41, DOI 10.1016/j.jhin.2009.05.015; Zingg W, 2011, CURR OPIN INFECT DIS, V24, P377, DOI 10.1097/QCO.0b013e32834811ed; Zingg W, 2008, BEST PRACT RES-CLIN, V22, P407, DOI 10.1016/j.bpa.2008.05.007; Zingg W, 2009, CRIT CARE MED, V37, P2167, DOI 10.1097/CCM.0b013e3181a02d8f	49	43	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93898	10.1371/journal.pone.0093898	http://dx.doi.org/10.1371/journal.pone.0093898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714418	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900057
J	Choi, YS; Yoon, S; Kim, KL; Yoo, J; Song, P; Kim, M; Shin, YE; Yang, WJ; Noh, JE; Cho, HS; Kim, S; Chung, J; Ryu, SH				Choi, Yoon Sup; Yoon, Soomin; Kim, Kyung-Lock; Yoo, Jiho; Song, Parkyong; Kim, Minsoo; Shin, Young-Eun; Yang, Won Jun; Noh, Jung-eun; Cho, Hyun-soo; Kim, Sanguk; Chung, Junho; Ryu, Sung Ho			Computational Design of Binding Proteins to EGFR Domain II	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DATA-BANK; EVOLUTIONARY CONSERVATION; TRANSMEMBRANE PROTEINS; INTERACTION NETWORKS; FACTOR RECEPTOR; CANCER-THERAPY; PHASE-I; COMPLEX; ANTICALINS	We developed a process to produce novel interactions between two previously unrelated proteins. This process selects protein scaffolds and designs protein interfaces that bind to a surface patch of interest on a target protein. Scaffolds with shapes complementary to the target surface patch were screened using an exhaustive computational search of the human proteome and optimized by directed evolution using phage display. This method was applied to successfully design scaffolds that bind to epidermal growth factor receptor (EGFR) domain II, the interface of EGFR dimerization, with high reactivity toward the target surface patch of EGFR domain II. One potential application of these tailor-made protein interactions is the development of therapeutic agents against specific protein targets.	[Choi, Yoon Sup; Yoon, Soomin; Kim, Minsoo; Yang, Won Jun; Chung, Junho] Seoul Natl Univ, Sch Med, Canc Res Inst, Seoul, South Korea; [Choi, Yoon Sup; Kim, Sanguk; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea; [Yoon, Soomin; Yang, Won Jun; Chung, Junho] Seoul Natl Univ, Sch Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Choi, Yoon Sup; Kim, Kyung-Lock; Song, Parkyong; Shin, Young-Eun; Noh, Jung-eun; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Yoo, Jiho; Cho, Hyun-soo] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea; [Kim, Minsoo] Scripps Korea Antibody Inst, Chunchon, South Korea; [Kim, Sanguk] Pohang Univ Sci & Technol POSTECH, Div IT Convergence Engn, Pohang, South Korea; [Choi, Yoon Sup] KT Inst Convergence Technol, Seoul, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Yonsei University; Pohang University of Science & Technology (POSTECH)	Kim, S (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea.	sukim@postech.ac.kr; junhochung@me.com; sungho@postech.ac.kr		Kim, Kyung Lock/0000-0001-6514-4935; Kim, Sanguk/0000-0002-3449-3814; Yoo, Jiho/0000-0002-0864-2142; Ryu, Sung Ho/0000-0003-0913-3048	Cancer Research Institute; Seoul National University [cri-12-1]; National Research Foundation of Korea (NRF); Korean government (MEST) [2013R1A2A1A03010110]; Korean government [2010-0028684]	Cancer Research Institute; Seoul National University; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean government(Korean Government)	This study was supported by a research grant from the Cancer Research Institute, Seoul National University (cri-12-1), a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2013R1A2A1A03010110). This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (No. 2010-0028684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig I, 2004, BIOCHEMISTRY-US, V43, P5562, DOI 10.1021/bi035879k; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Bianco R, 2007, INT J BIOCHEM CELL B, V39, P1416, DOI 10.1016/j.biocel.2007.05.008; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Choi YS, 2010, NUCLEIC ACIDS RES, V38, pW450, DOI 10.1093/nar/gkq328; Choi YS, 2009, PROTEINS, V77, P14, DOI 10.1002/prot.22410; Cohen GH, 2005, ACTA CRYSTALLOGR D, V61, P628, DOI 10.1107/S0907444905007870; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Getmanova EV, 2006, CHEM BIOL, V13, P549, DOI 10.1016/j.chembiol.2005.12.009; Goel R, 2011, MOL BIOTECHNOL, V48, P87, DOI 10.1007/s12033-010-9336-8; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Ladner Robert C, 2007, Biotechnol Genet Eng Rev, V24, P1; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Lockhart AC, 2005, SEMIN ONCOL, V32, P432, DOI 10.1053/j.seminoncol.2005.06.015; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Schlehuber S, 2005, DRUG DISCOV TODAY, V10, P23, DOI 10.1016/S1359-6446(04)03294-5; Schlehuber S, 2005, EXPERT OPIN BIOL TH, V5, P1453, DOI 10.1517/14712598.5.11.1453; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Skerra A, 2007, CURR OPIN MOL THER, V9, P336; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Stumpp MT, 2007, CURR OPIN DRUG DISC, V10, P153; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tolcher AW, 2011, CLIN CANCER RES, V17, P363, DOI 10.1158/1078-0432.CCR-10-1411; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	47	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92513	10.1371/journal.pone.0092513	http://dx.doi.org/10.1371/journal.pone.0092513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710267	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800013
J	Kim, YS; Park, JH; Choi, SJ; Bae, JY; Ahn, DK; McKemy, DD; Bae, YC				Kim, Yun Sook; Park, Jun Hong; Choi, Su Jung; Bae, Jin Young; Ahn, Dong Kuk; McKemy, David D.; Bae, Yong Chul			Central Connectivity of Transient Receptor Potential Melastatin 8-Expressing Axons in the Brain Stem and Spinal Dorsal Horn	PLOS ONE			English	Article							TRIGEMINAL SUBNUCLEUS CAUDALIS; PRIMARY AFFERENT TERMINALS; SUBSTANCE-P; SENSORY NEURONS; PRESYNAPTIC INHIBITION; COLD SENSITIVITY; NUCLEAR-COMPLEX; LOW-TEMPERATURE; ORALIS NEURONS; HUMAN SKIN	Transient receptor potential melastatin 8 (TRPM8) ion channels mediate the detection of noxious and innocuous cold and are expressed by primary sensory neurons, but little is known about the processing of the TRPM8-mediated cold information within the trigeminal sensory nuclei (TSN) and the spinal dorsal horn (DH). To address this issue, we characterized TRPM8-positive (+) neurons in the trigeminal ganglion and investigated the distribution of TRPM8+ axons and terminals, and their synaptic organization in the TSN and in the DH using light and electron microscopic immunohistochemistry in transgenic mice expressing a genetically encoded axonal tracer in TRPM8+ neurons. TRPM8 was expressed in a fraction of small myelinated primary afferent fibers (23.7%) and unmyelinated fibers (76.3%), suggesting that TRPM8-mediated cold is conveyed via C and A delta afferents. TRPM8+ axons were observed in all TSN, but at different densities in the dorsal and ventral areas of the rostral TSN, which dominantly receive sensory afferents from intra- and perioral structures and from the face, respectively. While synaptic boutons arising from A delta and non-peptidergic C afferents usually receive many axoaxonic contacts and form complex synaptic arrangements, TRPM8+ boutons arising from afferents of the same classes of fibers showed a unique synaptic connectivity; simple synapses with one or two dendrites and sparse axoaxonic contacts. These findings suggest that TRPM8-mediated cold is conveyed via a specific subset of C and A delta afferent neurons and is processed in a unique manner and differently in the TSN and DH.	[Kim, Yun Sook; Park, Jun Hong; Choi, Su Jung; Bae, Jin Young; Ahn, Dong Kuk; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea; [McKemy, David D.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	Kyungpook National University; University of Southern California	Bae, YC (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea.	ycbae@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) [2012-0009328]; Ministry of Education, Science and Technology	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF, 2012-0009328) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GV, 1996, BRAIN RES, V715, P125, DOI 10.1016/0006-8993(95)01580-9; ALVAREZ FJ, 1993, J COMP NEUROL, V329, P472, DOI 10.1002/cne.903290405; ALVAREZ FJ, 1992, J NEUROSCI, V12, P2901, DOI 10.1523/JNEUROSCI.12-08-02901.1992; Bae YC, 2005, BRAIN RES, V1060, P118, DOI 10.1016/j.brainres.2005.08.042; Bae YC, 2004, J COMP NEUROL, V478, P62, DOI 10.1002/cne.20272; Bae YC, 2000, J COMP NEUROL, V418, P299; BAE YC, 1994, J COMP NEUROL, V348, P121, DOI 10.1002/cne.903480107; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Campero M, 1996, J PHYSIOL-LONDON, V497, P565, DOI 10.1113/jphysiol.1996.sp021789; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Craig AD, 2001, J NEUROPHYSIOL, V86, P856, DOI 10.1152/jn.2001.86.2.856; DALLEL R, 1990, BRAIN RES, V521, P95, DOI 10.1016/0006-8993(90)91529-P; DALLEL R, 1988, BRAIN RES, V448, P7, DOI 10.1016/0006-8993(88)91096-7; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; Dellarole A, 2008, J COMP NEUROL, V511, P318, DOI 10.1002/cne.21845; Dessem D, 2007, J NEUROPHYSIOL, V98, P214, DOI 10.1152/jn.00990.2006; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; DUBNER R, 1975, J NEUROPHYSIOL, V38, P1373, DOI 10.1152/jn.1975.38.6.1373; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; He YF, 2000, BRAIN RES, V860, P203, DOI 10.1016/S0006-8993(00)02042-4; Ishida Y, 2009, J COMP NEUROL, V514, P131, DOI 10.1002/cne.22000; Kim YS, 2008, J COMP NEUROL, V506, P627, DOI 10.1002/cne.21544; Kim YS, 2010, J COMP NEUROL, V518, P687, DOI 10.1002/cne.22238; Knowlton WM, 2011, CURR PHARM BIOTECHNO, V12, P68; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; KNYIHARCSILLIK E, 1982, J COMP NEUROL, V210, P376, DOI 10.1002/cne.902100405; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Li JL, 1997, J COMP NEUROL, V378, P508, DOI 10.1002/(SICI)1096-9861(19970224)378:4<508::AID-CNE6>3.0.CO;2-6; Ma QP, 2001, EUR J NEUROSCI, V13, P2099, DOI 10.1046/j.0953-816x.2001.01586.x; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moldrich RX, 2010, J COMP NEUROL, V518, P3645, DOI 10.1002/cne.22445; Oakden EL, 1998, NEUROSCIENCE, V84, P1197, DOI 10.1016/S0306-4522(97)00550-2; OLSSON KA, 1991, EXP BRAIN RES, V84, P115; OLSZEWSKI J, 1950, J COMP NEUROL, V92, P401, DOI 10.1002/cne.900920305; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; RIBEIRODASILVA A, 1989, J COMP NEUROL, V281, P497, DOI 10.1002/cne.902810402; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57, DOI 10.1177/10454411000110010401; SHIGENAGA Y, 1983, BRAIN RES, V277, P201, DOI 10.1016/0006-8993(83)90928-9; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Sugimoto T, 1998, BRAIN RES, V783, P158, DOI 10.1016/S0006-8993(97)01176-1; Sugimoto T, 1997, J COMP NEUROL, V378, P425, DOI 10.1002/(SICI)1096-9861(19970217)378:3<425::AID-CNE9>3.0.CO;2-5; Sutherland FI, 2002, J COMP NEUROL, V452, P154, DOI 10.1002/cne.10374; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Xing H, 2006, J NEUROPHYSIOL, V95, P1221, DOI 10.1152/jn.01035.2005; Yabuta NH, 1996, J COMP NEUROL, V374, P436, DOI 10.1002/(SICI)1096-9861(19961021)374:3<436::AID-CNE8>3.0.CO;2-2; Yeo EJ, 2010, J COMP NEUROL, V518, P4134, DOI 10.1002/cne.22369; Yoshida A, 2001, J NEUROSCI, V21, P6298, DOI 10.1523/JNEUROSCI.21-16-06298.2001; Yoshida A, 1998, J COMP NEUROL, V401, P308; Zanotto KL, 2007, J NEUROPHYSIOL, V97, P966, DOI 10.1152/jn.00996.2006	53	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94080	10.1371/journal.pone.0094080	http://dx.doi.org/10.1371/journal.pone.0094080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710558	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800097
J	Makki, K; Taront, S; Molendi-Coste, O; Bouchaert, E; Neve, B; Eury, E; Lobbens, S; Labalette, M; Duez, H; Staels, B; Dombrowicz, D; Froguel, P; Wolowczuk, I				Makki, Kassem; Taront, Solenne; Molendi-Coste, Olivier; Bouchaert, Emmanuel; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Labalette, Myriam; Duez, Helene; Staels, Bart; Dombrowicz, David; Froguel, Philippe; Wolowczuk, Isabelle			Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice	PLOS ONE			English	Article							LINKED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; MATURE-ONSET OBESITY; NF-KAPPA-B; ADIPOSE-TISSUE; GLUCOSE-INTOLERANCE; SUPPRESSOR-CELLS; MAMMALIAN TARGET; MTOR INHIBITION; SKELETAL-MUSCLE	The "mechanistic target of rapamycin'' (mTOR) is a central controller of growth, proliferation and/or motility of various cell-types ranging from adipocytes to immune cells, thereby linking metabolism and immunity. mTOR signaling is overactivated in obesity, promoting inflammation and insulin resistance. Therefore, great interest exists in the development of mTOR inhibitors as therapeutic drugs for obesity or diabetes. However, despite a plethora of studies characterizing the metabolic consequences of mTOR inhibition in rodent models, its impact on immune changes associated with the obese condition has never been questioned so far. To address this, we used a mouse model of high-fat diet (HFD)-fed mice with and without pharmacologic mTOR inhibition by rapamycin. Rapamycin was weekly administrated to HFD-fed C57BL/6 mice for 22 weeks. Metabolic effects were determined by glucose and insulin tolerance tests and by indirect calorimetry measures of energy expenditure. Inflammatory response and immune cell populations were characterized in blood, adipose tissue and liver. In parallel, the activities of both mTOR complexes (e. g. mTORC1 and mTORC2) were determined in adipose tissue, muscle and liver. We show that rapamycin-treated mice are leaner, have enhanced energy expenditure and are protected against insulin resistance. These beneficial metabolic effects of rapamycin were associated to significant changes of the inflammatory profiles of both adipose tissue and liver. Importantly, immune cells with regulatory functions such as regulatory T-cells (Tregs) and myeloid-derived suppressor cells (MDSCs) were increased in adipose tissue. These rapamycin-triggered metabolic and immune effects resulted from mTORC1 inhibition whilst mTORC2 activity was intact. Taken together, our results reinforce the notion that controlling immune regulatory cells in metabolic tissues is crucial to maintain a proper metabolic status and, more generally, comfort the need to search for novel pharmacological inhibitors of the mTOR signaling pathway to prevent and/or treat metabolic diseases.	[Makki, Kassem; Taront, Solenne; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Froguel, Philippe; Wolowczuk, Isabelle] Lille Pasteur Inst, CNRS, UMR 8199, Lille, France; [Makki, Kassem; Taront, Solenne; Molendi-Coste, Olivier; Bouchaert, Emmanuel; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Labalette, Myriam; Duez, Helene; Staels, Bart; Dombrowicz, David; Froguel, Philippe; Wolowczuk, Isabelle] Univ Lille 2, Lille, France; [Makki, Kassem; Taront, Solenne; Molendi-Coste, Olivier; Bouchaert, Emmanuel; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Duez, Helene; Staels, Bart; Dombrowicz, David; Froguel, Philippe; Wolowczuk, Isabelle] EGID, Lille, France; [Molendi-Coste, Olivier; Bouchaert, Emmanuel; Duez, Helene; Staels, Bart; Dombrowicz, David] Lille Pasteur Inst, INSERM, UMR1011, Lille, France; [Labalette, Myriam] Univ Lille 2, CHRU Lille, Inst Immunol, Lille, France; [Labalette, Myriam] Univ Lille 2, EA 2686, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, UMR 8199, Lille, France.	P.froguel@imperial.ac.uk; isabelle.wolowczuk@good.ibl.fr	Staels, Bart/N-9497-2016; Neve, Bernadette/J-6008-2014; FROGUEL, Philippe/O-6799-2017; LABALETTE, Myriam/M-4203-2018; Duez, Helene/M-7609-2017; BOUCHAERT, Emmanuel/AFU-7112-2022; Duez, Helene/AAC-3217-2019; Dombrowicz, David/F-7044-2013; DEZITTER, Solenne/N-5219-2018	Staels, Bart/0000-0002-3784-1503; Neve, Bernadette/0000-0003-1516-1379; FROGUEL, Philippe/0000-0003-2972-0784; LABALETTE, Myriam/0000-0002-1524-9891; BOUCHAERT, Emmanuel/0000-0003-2558-9862; Duez, Helene/0000-0002-4130-7987; Dombrowicz, David/0000-0002-0485-8923; Molendi-Coste, Olivier/0000-0002-0498-9456; wolowczuk, isabelle/0000-0001-6692-6904; DEZITTER, Solenne/0000-0001-5850-7291	Centre National de la Recherche Scientifique (CNRS); Ministere de l'Enseignement Superieur et de la Recherche	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche	The work was supported by the Centre National de la Recherche Scientifique (CNRS). K. M. was supported by a doctoral grant from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, AM J HEALTH-SYST PH, V56, P2177; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Blagosklonny MV, 2011, CELL CYCLE, V10, P4217, DOI 10.4161/cc.10.24.18595; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Chen X, 2013, OBES REV, V14, P568, DOI 10.1111/obr.12033; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Elia M, 1992, World Rev Nutr Diet, V70, P68; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Gabrysova L, 2011, EUR J IMMUNOL, V41, P1242, DOI 10.1002/eji.201041073; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lees JR, 2011, CURR OPIN IMMUNOL, V23, P692, DOI 10.1016/j.coi.2011.07.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Macia L, 2006, J IMMUNOL, V177, P5997, DOI 10.4049/jimmunol.177.9.5997; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Sun S, 2012, ANN REV NUTR; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Verwaerde C, 2006, SCAND J IMMUNOL, V64, P457, DOI 10.1111/j.1365-3083.2006.01791.x; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3; Ye Lan, 2012, Frontiers in Genetics, V3, P177, DOI 10.3389/fgene.2012.00177; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	60	48	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92684	10.1371/journal.pone.0092684	http://dx.doi.org/10.1371/journal.pone.0092684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710396	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800016
J	Park, SJ; Umemoto, T; Saito-Adachi, M; Shiratsuchi, Y; Yamato, M; Nakai, K				Park, Sung-Joon; Umemoto, Terumasa; Saito-Adachi, Mihoko; Shiratsuchi, Yoshiko; Yamato, Masayuki; Nakai, Kenta			Computational Promoter Modeling Identifies the Modes of Transcriptional Regulation in Hematopoietic Stem Cells	PLOS ONE			English	Article							FACTOR-BINDING SITES; GENE-EXPRESSION; SELF-RENEWAL; DNA-SEQUENCES; PROGENITOR CELLS; HUMAN GENOME; BLOOD STEM; QUIESCENCE; DIFFERENTIATION; LANDSCAPE	Extrinsic and intrinsic regulators are responsible for the tight control of hematopoietic stem cells (HSCs), which differentiate into all blood cell lineages. To understand the fundamental basis of HSC biology, we focused on differentially expressed genes (DEGs) in long-term and short-term HSCs, which are closely related in terms of cell development but substantially differ in their stem cell capacity. To analyze the transcriptional regulation of the DEGs identified in the novel transcriptome profiles obtained by our RNA-seq analysis, we developed a computational method to model the linear relationship between gene expression and the features of putative regulatory elements. The transcriptional regulation modes characterized here suggest the importance of transcription factors (TFs) that are expressed at steady state or at low levels. Remarkably, we found that 24 differentially expressed TFs targeting 21 putative TF-binding sites contributed significantly to transcriptional regulation. These TFs tended to be modulated by other nondifferentially expressed TFs, suggesting that HSCs can achieve flexible and rapid responses via the control of nondifferentially expressed TFs through a highly complex regulatory network. Our novel transcriptome profiles and new method are powerful tools for studying the mechanistic basis of cell fate decisions.	[Park, Sung-Joon; Saito-Adachi, Mihoko; Nakai, Kenta] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Umemoto, Terumasa; Shiratsuchi, Yoshiko; Yamato, Masayuki] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	University of Tokyo; Tokyo Women's Medical University	Nakai, K (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan.	knakai@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009	Nakai, Kenta/0000-0002-8721-8883; Park, Sung-Joon/0000-0002-1774-9590; Saito-Adachi, Mihoko/0000-0001-9213-0184	Research on Applying Health Technology, Health and Labour Sciences by the Ministry of Health, Labour and Welfare, Japan	Research on Applying Health Technology, Health and Labour Sciences by the Ministry of Health, Labour and Welfare, Japan	This work was supported by Research on Applying Health Technology, Health and Labour Sciences by the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bonzanni N, 2013, BIOINFORMATICS, V29, P80, DOI 10.1093/bioinformatics/btt243; Boyle P, 2010, PLANT SIGNAL BEHAV, V5, P629, DOI 10.4161/psb.5.6.11570; Brown KK, 1999, DIABETES, V48, P1415, DOI 10.2337/diabetes.48.7.1415; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chotinantakul K, 2012, BONE MARROW RES, DOI 10.1155/2012/270425; Chute JP, 2010, MOL ENDOCRINOL, V24, P1, DOI 10.1210/me.2009-0332; Diffner E, 2013, BLOOD, V121, P2289, DOI 10.1182/blood-2012-07-446120; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Ghiaur G, 2013, P NATL ACAD SCI US; Hannah R, 2011, EXP HEMATOL, V39, P531, DOI 10.1016/j.exphem.2011.02.009; Henke BR, 1998, J MED CHEM, V41, P5020, DOI 10.1021/jm9804127; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irie T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr173; Karlsson G, 2013, CELL REP, V4, P642, DOI 10.1016/j.celrep.2013.07.020; KAWANA M, 1995, MOL CELL BIOL, V15, P4225; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Liebermann DA, 1998, INT J ONCOL, V12, P685; Liu PC, 2011, PHYSIOL GENOMICS, V43, P1117, DOI 10.1152/physiolgenomics.00099.2011; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miranda-Saavedra D, 2009, NUCLEIC ACIDS RES, V37, pD873, DOI 10.1093/nar/gkn854; Mirshekar-Syahkal B, 2013, HAEMATOLOGICA, V98, P163, DOI 10.3324/haematol.2012.070789; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okada S, 1999, BLOOD, V93, P816, DOI 10.1182/blood.V93.3.816.403k21_816_825; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park SJ, 2013, GENE DEV, V27, P2736, DOI 10.1101/gad.227926.113; Park SJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S50; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shen LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059070, 10.1371/journal.pone.0077077, 10.1371/journal.pone.0077515]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Umemoto T, 2012, BLOOD, V119, P83, DOI 10.1182/blood-2011-02-335430; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176; Whichard ZL, 2010, BLOOD, V115, P2339, DOI 10.1182/blood-2009-08-215798; Whitfield TW, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r50; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wozniak RJ, 2008, MOL CELL BIOL, V28, P6681, DOI 10.1128/MCB.01061-08; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yu SY, 2012, CELL STEM CELL, V11, P207, DOI 10.1016/j.stem.2012.05.021; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	64	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93853	10.1371/journal.pone.0093853	http://dx.doi.org/10.1371/journal.pone.0093853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710559	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800057
J	Bini, EI; Espinosa, DM; Castillo, BM; Payan, JB; Colucci, D; Cruz, AF; Zatarain, ZL; Alfonseca, E; Pardo, MR; Bottasso, O; Pando, RH				Isabel Bini, Estela; Mata Espinosa, Dulce; Marquina Castillo, Brenda; Barrios Payan, Jorge; Colucci, Dario; Francisco Cruz, Alejandro; Lucia Zatarain, Zyanya; Alfonseca, Edgar; Romano Pardo, Marta; Bottasso, Oscar; Hernandez Pando, Rogelio			The Influence of Sex Steroid Hormones in the Immunopathology of Experimental Pulmonary Tuberculosis	PLOS ONE			English	Article							GENDER-DIFFERENCES; RISK-FACTORS; INFECTION; ESTROGEN; RESPONSES; IMMUNE; CELLS; RESISTANCE; MODULATE; GROWTH	The relation between men and women suffering pulmonary tuberculosis is 7/3 in favor to males. Sex hormones could be a significant factor for this difference, considering that testosterone impairs macrophage activation and pro-inflammatory cytokines production, while estrogens are proinflammatory mediator's inducer. The aim of this work was to compare the evolution of tuberculosis in male and female mice using a model of progressive disease. BALB/c mice, male and female were randomized into two groups: castrated or sham-operated, and infected by the intratracheal route with a high dose of Mycobacterium tuberculosis strain H37Rv. Mice were euthanized at different time points and in their lungs were determined bacilli loads, inflammation, cytokines expression, survival and testosterone levels in serum. Non-castrated male mice showed significant higher mortality and bacilli burdens during late disease than female and castrated male animals. Compared to males, females and castrated males exhibited significant higher inflammation in all lung compartments, earlier formation of granulomas and pneumonia, while between castrated and non-castrated females there were not significant differences. Females and castrated males expressed significant higher TNF-alpha, IFN gamma, IL12, iNOS and IL17 than non-castrated males during the first month of infection. Serum Testosterone of males showed higher concentration during late infection. Orchidectomy at day 60 post-infection produced a significant decrease of bacilli burdens in coexistence with higher expression of TNF alpha, IL12 and IFN gamma. Thus, male mice are more susceptible to tuberculosis than females and this was prevented by castration suggesting that testosterone could be a tuberculosis susceptibility factor.	[Isabel Bini, Estela; Mata Espinosa, Dulce; Marquina Castillo, Brenda; Barrios Payan, Jorge; Francisco Cruz, Alejandro; Lucia Zatarain, Zyanya; Alfonseca, Edgar; Hernandez Pando, Rogelio] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City, DF, Mexico; [Isabel Bini, Estela; Colucci, Dario; Bottasso, Oscar] Fac Med Sci, Inst Immunol, Rosario, Santa Fe, Argentina; [Romano Pardo, Marta] CINVESTAV, Dept Physiol & Biophys, Mexico City 14000, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Pando, RH (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Pathol, Expt Pathol Sect, Mexico City, DF, Mexico.	rhdezpando@hotmail.com	Francisco-Cruz, Alejandro/AIC-9273-2022; Bini, Estela/F-8924-2018	Bini, Estela/0000-0001-9256-429X; Hernandez-Pando, Rogelio/0000-0003-1292-3833	University of United Nations (UNU_BIOLAC program); Argentinian-Mexican agreement of bilateral scientific collaboration CONICET/CONACyT [J000.345]; UNU-BIOLAC	University of United Nations (UNU_BIOLAC program); Argentinian-Mexican agreement of bilateral scientific collaboration CONICET/CONACyT; UNU-BIOLAC	This work was supported by grants from the University of United Nations (UNU_BIOLAC program), and Argentinian-Mexican agreement of bilateral scientific collaboration CONICET/CONACyT (contract: J000.345). E Bini was awarded with a Ph.D. scholarship from UNU-BIOLAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1985, AM J PATHOL, V121, P531; Ahmed SA, 1999, ENVIRON HEALTH PERSP, V107, P681, DOI 10.2307/3434327; Asai K, 2001, SHOCK, V16, P340, DOI 10.1097/00024382-200116050-00003; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; BROWN IN, 1987, IMMUNOLOGY, V62, P587; Buckley AR, 2001, LUPUS, V10, P684, DOI 10.1191/096120301717164912; Bustamante J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.043406; BUTTERWO.M, 1967, NATURE, V214, P1224, DOI 10.1038/2141224a0; Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308; Cutolo M, 2002, ANN NY ACAD SCI, V966, P131, DOI 10.1111/j.1749-6632.2002.tb04210.x; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; del Rey A, 2007, BRAIN BEHAV IMMUN, V21, P171, DOI 10.1016/j.bbi.2006.06.005; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; EIDINGER D, 1972, J EXP MED, V136, P1098, DOI 10.1084/jem.136.5.1098; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; FOX HS, 1991, J IMMUNOL, V146, P4362; Hernandez Pando R, 1998, IMMUNOLOGY, V5, P234; HernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lin CM, 2008, SLEEP MED REV, V12, P481, DOI 10.1016/j.smrv.2007.11.003; Martinez AN, 2000, INT J TUBERC LUNG D, V4, P26; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Okada M, 1997, CARDIOVASC RES, V34, P529, DOI 10.1016/S0008-6363(97)00060-6; Pando RH, 2010, INFECT IMMUN, V78, P3168, DOI 10.1128/IAI.00023-10; RHODES K, 1969, ANN RHEUM DIS, V28, P104, DOI 10.1136/ard.28.2.104; Roberts ML, 2009, J EXP BIOL, V212, P3125, DOI 10.1242/jeb.030726; Roden AC, 2004, J IMMUNOL, V173, P6098, DOI 10.4049/jimmunol.173.10.6098; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Silver RF, 1998, J IMMUNOL, V160, P2408; Tekkel M, 2002, INT J TUBERC LUNG D, V6, P887; Tsuyuguchi K, 2001, CLIN EXP IMMUNOL, V123, P428, DOI 10.1046/j.1365-2249.2001.01474.x; Uplekar M, 1999, WHOTB2000280; Weiss MG, 2008, INT J TUBERC LUNG D, V12, P829; WHO, 2009, GLOB TUB CONTR 2009; YAMAMOTO Y, 1990, AM REV RESPIR DIS, V142, P430, DOI 10.1164/ajrccm/142.2.430; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; ZUCKERMAN SH, 1995, IMMUNOLOGY, V86, P18	45	47	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93831	10.1371/journal.pone.0093831	http://dx.doi.org/10.1371/journal.pone.0093831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722144	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100026
J	Jank, JM; Maier, EM; Reiss, DD; Haslbeck, M; Kemter, KF; Truger, MS; Sommerhoff, CP; Ferdinandusse, S; Wanders, RJ; Gersting, SW; Muntau, AC				Jank, Johanna M.; Maier, Esther M.; Reiss, Dunja D.; Haslbeck, Martin; Kemter, Kristina F.; Truger, Marietta S.; Sommerhoff, Christian P.; Ferdinandusse, Sacha; Wanders, Ronald J.; Gersting, Soren W.; Muntau, Ania C.			The Domain-Specific and Temperature-Dependent Protein Misfolding Phenotype of Variant Medium-Chain acyl-CoA Dehydrogenase	PLOS ONE			English	Article							MILD MCAD DEFICIENCY; ACID BETA-OXIDATION; NEW-YORK-STATE; COENZYME-A; PREVALENT MUTATION; GENETIC-DEFECTS; PHENYLKETONURIA; IDENTIFICATION; STABILITY; ORGANIZATION	The implementation of expanded newborn screening programs reduced mortality and morbidity in medium-chain acyl-CoA dehydrogenase deficiency (MCADD) caused by mutations in the ACADM gene. However, the disease is still potentially fatal. Missense induced MCADD is a protein misfolding disease with a molecular loss-of-function phenotype. Here we established a comprehensive experimental setup to analyze the structural consequences of eight ACADM missense mutations (p. Ala52Val, p. Tyr67His, p. Tyr158His, p. Arg206Cys, p. Asp266Gly, p. Lys329Glu, p. Arg334Lys, p. Arg413Ser) identified after newborn screening and linked the corresponding protein misfolding phenotype to the site of side-chain replacement with respect to the domain. With fever being the crucial risk factor for metabolic decompensation of patients with MCADD, special emphasis was put on the analysis of structural and functional derangements related to thermal stress. Based on protein conformation, thermal stability and kinetic stability, the molecular phenotype in MCADD depends on the structural region that is affected by missense-induced conformational changes with the central beta-domain being particularly prone to structural derangement and destabilization. Since systematic classification of conformational derangements induced by ACADM mutations may be a helpful tool in assessing the clinical risk of patients, we scored the misfolding phenotype of the variants in comparison to p. Lys329Glu (K304E), the classical severe mutation, and p. Tyr67His (Y42H), discussed to be mild. Experiments assessing the impact of thermal stress revealed that mutations in the ACADM gene lower the temperature threshold at which MCAD loss-of-function occurs. Consequently, increased temperature as it occurs during intercurrent infections, significantly increases the risk of further conformational derangement and loss of function of the MCAD enzyme explaining the life-threatening clinical courses observed during fever episodes. Early and aggressive antipyretic treatment thus may be life-saving in patients suffering from MCADD.	[Jank, Johanna M.; Maier, Esther M.; Reiss, Dunja D.; Kemter, Kristina F.; Truger, Marietta S.; Gersting, Soren W.; Muntau, Ania C.] Univ Munich, Dr von Hauner Childrens Hosp, Dept Mol Pediat, Munich, Germany; [Haslbeck, Martin] Tech Univ Munich, Dept Chem, Garching, Germany; [Sommerhoff, Christian P.] Univ Munich, Inst Lab Med, Munich, Germany; [Ferdinandusse, Sacha; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Lab Med,Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Ferdinandusse, Sacha; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat,Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Munich; Technical University of Munich; University of Munich; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Muntau, AC (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Dept Mol Pediat, Munich, Germany.	Ania.Muntau@med.lmu.de	Haslbeck, Martin/A-4413-2013; Gersting, Soeren/D-4612-2011	Ferdinandusse, Sacha/0000-0002-7738-5709; Gersting, Soeren/0000-0001-7482-4748	Deutsche Forschungsgemeinschaft [MA 2227/3-1]; Bavarian Genome Research Network; SHS International Gesellschaft fur klinische Ernahrung GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bavarian Genome Research Network; SHS International Gesellschaft fur klinische Ernahrung GmbH	This work was supported by the Deutsche Forschungsgemeinschaft, grant MA 2227/3-1, the Bavarian Genome Research Network, and the SHS International Gesellschaft fur klinische Ernahrung GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Arnold GL, 2010, MOL GENET METAB, V99, P263, DOI 10.1016/j.ymgme.2009.10.188; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BROSS P, 1993, BIOCHIM BIOPHYS ACTA, V1182, P264, DOI 10.1016/0925-4439(93)90068-C; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; CARTIER N, 1994, ARCH PEDIATRIE, V1, P243; Chou YW, 2012, ARCH BIOCHEM BIOPHYS, V520, P74, DOI 10.1016/j.abb.2012.02.015; Dessein AF, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-26; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x; Gregersen N, 2000, EUR J PEDIATR, V159, pS213, DOI 10.1007/PL00014406; GREGERSEN N, 1991, CLIN CHIM ACTA, V203, P23, DOI 10.1016/0009-8981(91)90153-4; Gregersen N, 2008, J INHERIT METAB DIS, V31, P643, DOI 10.1007/s10545-008-0990-y; Grosse SD, 2006, GENET MED, V8, P205, DOI 10.1097/01.gim.0000204472.25153.8d; IAFOLLA AK, 1994, J PEDIATR-US, V124, P409, DOI 10.1016/S0022-3476(94)70363-9; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Levy HL, 2010, GENET MED, V12, pS213, DOI 10.1097/GIM.0b013e3181fe5d77; Li H, 2010, BRAIN DEV-JPN, V32, P362, DOI 10.1016/j.braindev.2009.06.001; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; Maier EM, 2009, HUM MOL GENET, V18, P1612, DOI 10.1093/hmg/ddp079; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; Nasser I, 2004, BBA-MOL BASIS DIS, V1690, P22, DOI 10.1016/j.bbadis.2004.04.008; Nichols MJ, 2008, AM J MED GENET A, V146A, P610, DOI 10.1002/ajmg.a.32192; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Reilly L, 2004, EUR J BIOCHEM, V271, P4053, DOI 10.1111/j.1432-1033.2004.04343.x; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; Smith EH, 2010, MOL GENET METAB, V100, P241, DOI 10.1016/j.ymgme.2010.04.001; Sturm M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045110; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Touw CML, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-43; Touw CML, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-30; Trefz FK, 2009, J PEDIATR-US, V154, P700, DOI 10.1016/j.jpeds.2008.11.040; Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; WILCKEN B, 1994, ARCH DIS CHILD, V70, P410, DOI 10.1136/adc.70.5.410; Wilcken B, 2013, SCIENCE, V342, P197, DOI 10.1126/science.1243944; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; YOKOTA I, 1990, J CLIN INVEST, V86, P1000, DOI 10.1172/JCI114761; Yusupov R, 2010, MOL GENET METAB, P1; Zolkipli Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017534; Zschocke J, 2001, HUM GENET, V108, P404, DOI 10.1007/s004390100501	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93852	10.1371/journal.pone.0093852	http://dx.doi.org/10.1371/journal.pone.0093852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718418	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000049
J	Shimamoto, R; Amano, N; Ichisaka, T; Watanabe, A; Yamanaka, S; Okita, K				Shimamoto, Ren; Amano, Naoki; Ichisaka, Tomoko; Watanabe, Akira; Yamanaka, Shinya; Okita, Keisuke			Generation and Characterization of Induced Pluripotent Stem Cells from Aid-Deficient Mice	PLOS ONE			English	Article						`	CYTIDINE DEAMINASE AID; MOUSE SOMATIC-CELLS; DNA METHYLATION; ANTIBODY DIVERSIFICATION; HUMAN FIBROBLASTS; B-CELLS; GENOME; DEMETHYLATION; HYPERMUTATION; EXPRESSION	It has been shown that DNA demethylation plays a pivotal role in the generation of induced pluripotent stem (iPS) cells. However, the underlying mechanism of this action is still unclear. Previous reports indicated that activation-induced cytidine deaminase (Aid, also known as Aicda) is involved in DNA demethylation in several developmental processes, as well as cell fusion-mediated reprogramming. Based on these reports, we hypothesized that Aid may be involved in the DNA demethylation that occurs during the generation of iPS cells. In this study, we examined the function of Aid in iPS cell generation using Aid knockout (Aid(-/-)) mice expressing a GFP reporter under the control of a pluripotent stem cell marker, Nanog. By introducing Oct3/4, Sox2, Klf4 and c-Myc, Nanog-GFP-positive iPS cells could be generated from the fibroblasts and primary B cells of Aid(-/-) mice. Their induction efficiency was similar to that of wild-type (Aid(+/+)) iPS cells. The Aid(-/-) iPS cells showed normal proliferation and gave rise to chimeras, indicating their capacity for self-renewal and pluripotency. A comprehensive DNA methylation analysis showed only a few differences between Aid(+/+) and Aid(-/-) iPS cells. These data suggest that Aid does not have crucial functions in DNA demethylation during iPS cell generation.	[Shimamoto, Ren; Amano, Naoki; Ichisaka, Tomoko; Watanabe, Akira; Yamanaka, Shinya; Okita, Keisuke] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Okita, K (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	okita@cira.kyoto-u.ac.jp		Okita, Keisuke/0000-0001-5806-1090	Leading Project of Ministry of Education, Culture, Sports, Science (MEXT); Japan Society for the Promotion of Science (JSPS)	Leading Project of Ministry of Education, Culture, Sports, Science (MEXT); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from the Leading Project of Ministry of Education, Culture, Sports, Science (MEXT), a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of Japan Society for the Promotion of Science (JSPS) (to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bhutani N, 2013, FASEB J, V27, P1107, DOI 10.1096/fj.12-222125; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Eminli S, DIFFERENTIATION STAG, DOI [10.1038/ng.428, DOI 10.1038/NG.428]; Fritz EL, 2013, NAT IMMUNOL, V14, P749, DOI 10.1038/ni.2616; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Habib O, 2014, STEM CELLS DEV, V23, P209, DOI 10.1089/scd.2013.0337; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Hogenbirk MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069815; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jeong KS, 2005, BIOCHEM BIOPH RES CO, V335, P1211, DOI 10.1016/j.bbrc.2005.08.015; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Oka K, 1997, J BIOL CHEM, V272, P1456, DOI 10.1074/jbc.272.39.24387; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	59	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94735	10.1371/journal.pone.0094735	http://dx.doi.org/10.1371/journal.pone.0094735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718089	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000140
J	Theys, C; Wouters, J; Ghesquiere, P				Theys, Catherine; Wouters, Jan; Ghesquiere, Pol			Diffusion Tensor Imaging and Resting-State Functional MRI-Scanning in 5-and 6-Year-Old Children: Training Protocol and Motion Assessment	PLOS ONE			English	Article							ATTENTION DEFICIT/HYPERACTIVITY DISORDER; HEAD MOTION; PREPARING CHILDREN; CONNECTIVITY; FMRI; SEDATION; IMPACT	Advanced Magnetic Resonance Imaging (MRI) techniques such as Diffusion Tensor Imaging (DTI) and resting-state functional MRI (rfMRI) are widely used to study structural and functional neural connectivity. However, as these techniques are highly sensitive to motion artifacts and require a considerable amount of time for image acquisition, successful acquisition of these images can be challenging to complete with certain populations. This is especially true for young children. This paper describes a new approach termed the 'submarine protocol', designed to prepare 5- and 6-year-old children for advanced MRI scanning. The submarine protocol aims to ensure that successful scans can be acquired in a time-and resource-efficient manner, without the need for sedation. This manuscript outlines the protocol and details its outcomes, as measured through the number of children who completed the scanning procedure and analysis of the degree of motion present in the acquired images. Seventy-six children aged between 5.8 and 6.9 years were trained using the submarine protocol and subsequently underwent DTI and rfMRI scanning. After completing the submarine protocol, 75 of the 76 children (99%) completed their DTI-scan and 72 children (95%) completed the full 35-minute scan session. Results of diffusion data, acquired in 75 children, showed that the motion in 60 of the scans (80%) did not exceed the threshold for excessive motion. In the rfMRI scans, this was the case for 62 of the 71 scans (87%). When placed in the context of previous studies, the motion data of the 5- and 6-year-old children reported here were as good as, or better than those previously reported for groups of older children (i.e., 8-year-olds). Overall, this study shows that the submarine protocol can be used successfully to acquire DTI and rfMRI scans in 5 and 6-year-old children, without the need for sedation or lengthy training procedures.	[Theys, Catherine; Wouters, Jan] Katholieke Univ Leuven, ExpORL, Louvain, Belgium; [Theys, Catherine] Univ Canterbury, New Zealand Inst Language Brain & Behav, Christchurch 1, New Zealand; [Ghesquiere, Pol] Katholieke Univ Leuven, Parenting & Special Educ Res Unit, Leuven, Belgium	KU Leuven; KU Leuven	Theys, C (corresponding author), Katholieke Univ Leuven, ExpORL, Louvain, Belgium.	Catherine.Theys@canterbury.ac.nz	Ghesquière, Pol/B-9226-2009; Wouters, Jan/D-1800-2015	Ghesquière, Pol/0000-0001-9056-7550; Wouters, Jan/0000-0002-0093-698X	Research Fund KU Leuven [OT/12/044, PDMK/12/140]; Research Foundation - Flanders (FWO Vlaanderen) [G.0920.12, V456712N]	Research Fund KU Leuven(KU Leuven); Research Foundation - Flanders (FWO Vlaanderen)(FWO)	This study has been funded by grants OT/12/044 and PDMK/12/140 of the Research Fund KU Leuven (http://www.kuleuven.be/research/funding/) and grants G.0920.12 and V456712N of the Research Foundation - Flanders (FWO Vlaanderen - http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; de Bie HMA, 2010, EUR J PEDIATR, V169, P1079, DOI 10.1007/s00431-010-1181-z; DiFrancesco MW, 2013, J MAGN RESON IMAGING, V38, P1184, DOI 10.1002/jmri.24082; Hallowell LM, 2008, PEDIATR RADIOL, V38, P271, DOI 10.1007/s00247-007-0704-x; Hopkins KL, 1999, NEUROIMAG CLIN N AM, V9, P1; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Klaver P, 2008, NEUROIMAGE, V39, P1815, DOI 10.1016/j.neuroimage.2007.11.009; Lawson GR, 2000, ARCH DIS CHILD, V82, P150, DOI 10.1136/adc.82.2.150; Leemans A, 2009, INT SOC MAGN RES MED, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Mills Kathryn L, 2012, Front Psychiatry, V3, P2, DOI 10.3389/fpsyt.2012.00002; Peeva MG, 2013, NEUROIMAGE-CLIN, V3, P234, DOI 10.1016/j.nicl.2013.08.011; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raschle N, 2012, ANN NY ACAD SCI, V1252, P43, DOI 10.1111/j.1749-6632.2012.06457.x; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Satterthwaite TD, 2013, NEUROIMAGE, V83, P45, DOI 10.1016/j.neuroimage.2013.06.045; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Uddin LQ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00458; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Wilke M, 2012, NEUROIMAGE, V59, P2062, DOI 10.1016/j.neuroimage.2011.10.043; Yerys BE, 2009, HUM BRAIN MAPP, V30, P3426, DOI 10.1002/hbm.20767; Yuan WH, 2009, HUM BRAIN MAPP, V30, P1481, DOI 10.1002/hbm.20616; Zhou ZY, 2011, MAGN RESON IMAGING, V29, P230, DOI 10.1016/j.mri.2010.06.022	28	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94019	10.1371/journal.pone.0094019	http://dx.doi.org/10.1371/journal.pone.0094019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718364	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000066
J	Chowdhury, MYE; Li, R; Kim, JH; Park, ME; Kim, TH; Pathinayake, P; Weeratunga, P; Song, MK; Son, HY; Hong, SP; Sung, MH; Lee, JS; Kim, CJ				Chowdhury, Mohammed Y. E.; Li, Rui; Kim, Jae-Hoon; Park, Min-Eun; Kim, Tae-Hwan; Pathinayake, Prabuddha; Weeratunga, Prasanna; Song, Man Ki; Son, Hwa-Young; Hong, Seung-Pyo; Sung, Moon-Hee; Lee, Jong-Soo; Kim, Chul-Joong			Mucosal Vaccination with Recombinant Lactobacillus casei-Displayed CTA1-Conjugated Consensus Matrix Protein-2 (sM2) Induces Broad Protection against Divergent Influenza Subtypes in BALB/c Mice	PLOS ONE			English	Article							VIRUS-LIKE PARTICLE; MONOCLONAL-ANTIBODY; FUSION PROTEIN; DNA VACCINES; LACTIC-ACID; M2 PROTEIN; T-CELLS; ADJUVANT; IMMUNITY; SURFACE	To develop a safe and effective mucosal vaccine against pathogenic influenza viruses, we constructed recombinant Lactobacillus casei strains that express conserved matrix protein 2 with (pgsA-CTA1-sM2/L. casei) or without (pgsA-sM2/L. casei) cholera toxin subunit A1 (CTA1) on the surface. The surface localization of the fusion protein was verified by cellular fractionation analyses, flow cytometry and immunofluorescence microscopy. Oral and nasal inoculations of recombinant L. casei into mice resulted in high levels of serum immunoglobulin G (IgG) and mucosal IgA. However, the conjugation of cholera toxin subunit A1 induced more potent mucosal, humoral and cell-mediated immune responses. In a challenge test with 10 MLD50 of A/EM/Korea/W149/06(H5N1), A/Puerto Rico/8/34(H1N1), A/Aquatic bird /Korea/W81/2005(H5N2), A/ Aquatic bird/Korea/W44/2005(H7N3), and A/Chicken/Korea/116/2004(H9N2) viruses, the recombinant pgsA-CTA1-sM2/L. casei provided better protection against lethal challenges than pgsA-sM2/L. casei, pgsA/L. casei and PBS in mice. These results indicate that mucosal immunization with recombinant L. casei expressing CTA1-conjugated sM2 protein on its surface is an effective means of eliciting protective immune responses against diverse influenza subtypes.	[Chowdhury, Mohammed Y. E.; Li, Rui; Kim, Jae-Hoon; Park, Min-Eun; Kim, Tae-Hwan; Pathinayake, Prabuddha; Weeratunga, Prasanna; Son, Hwa-Young; Lee, Jong-Soo; Kim, Chul-Joong] Chungnam Natl Univ, Coll Vet Med, Plus Program BK21, Taejon, South Korea; [Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Hong, Seung-Pyo; Sung, Moon-Hee] BioLeaders Corp, Taejon, South Korea; [Chowdhury, Mohammed Y. E.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Chittagong, Bangladesh	Chungnam National University; International Vaccine Institute	Lee, JS (corresponding author), Chungnam Natl Univ, Coll Vet Med, Plus Program BK21, Taejon, South Korea.	jongsool@cnu.ac.kr; cjkim@cnu.ac.kr	Weeratunga, Prasanna/GWZ-5169-2022	Weeratunga, Prasanna/0000-0001-6366-7628; Lee, Jong-Soo/0000-0001-5119-0711; Weeratunga, Prasanna/0000-0002-4258-6025; Pathinayake, Prabuddha/0000-0002-4947-5918; Son, Hwa-Young/0000-0003-4388-0952; Kim, Chul-Joong/0000-0001-8827-6332; Chowdhury, Mohammed/0000-0003-0935-705X	Korea Research Council of Fundamental Science and Technology; KRIBB Initiative program [KGM0821113]; Animal, Plant and Fisheries Quarantine and Inspection Agency (QIA) [Z-1541779, 2013-1181]	Korea Research Council of Fundamental Science and Technology; KRIBB Initiative program; Animal, Plant and Fisheries Quarantine and Inspection Agency (QIA)	This study was supported by the National Agenda Project grant from the Korea Research Council of Fundamental Science and Technology and the KRIBB Initiative program (Grant no. KGM0821113) and the Internal Research Fund of Animal, Plant and Fisheries Quarantine and Inspection Agency (QIA)(Grant no. Z-1541779, 2013-1181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren L, 1998, IMMUNOL CELL BIOL, V76, P280, DOI 10.1046/j.1440-1711.1998.00750.x; [Anonymous], FIELDS VIROLOGY; Bermudez-Humaran LG, 2013, CURR OPIN MICROBIOL, V16, P278, DOI 10.1016/j.mib.2013.06.002; Bermudez-Humaran LG, 2009, HUM VACCINES, V5, P264, DOI 10.4161/hv.5.4.7553; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Eriksson AM, 2004, J IMMUNOL, V173, P3310, DOI 10.4049/jimmunol.173.5.3310; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ionescu RM, 2006, J PHARM SCI-US, V95, P70, DOI 10.1002/jps.20493; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Kang SM, 2011, VIRUS RES, V162, P31, DOI 10.1016/j.virusres.2011.09.037; Kim MC, 2013, ANTIVIR RES, V99, P328, DOI 10.1016/j.antiviral.2013.06.010; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lee JS, 2006, J VIROL, V80, P4079, DOI 10.1128/JVI.80.8.4079-4087.2006; Lee JS, 2000, NAT BIOTECHNOL, V18, P645, DOI 10.1038/76494; Lei H, 2010, VIROLOGY, V407, P319, DOI 10.1016/j.virol.2010.08.007; Liu DQ, 2012, APPL MICROBIOL BIOT, V93, P2437, DOI 10.1007/s00253-011-3734-0; Mannam P, 2004, INFECT IMMUN, V72, P3444, DOI 10.1128/IAI.72.6.3444-3450.2004; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Moon HJ, 2012, VET MICROBIOL, V160, P277, DOI 10.1016/j.vetmic.2012.05.035; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Narita J, 2006, APPL ENVIRON MICROB, V72, P269, DOI 10.1128/AEM.72.1.269-275.2006; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; Poo H, 2006, INT J CANCER, V119, P1702, DOI 10.1002/ijc.22035; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2013, VIRAL IMMUNOL, V26, P385, DOI 10.1089/vim.2013.0013; Shata MT, 2001, J VIROL, V75, P9665, DOI 10.1128/JVI.75.20.9665-9670.2001; Shaw DM, 2000, IMMUNOLOGY, V100, P510, DOI 10.1046/j.1365-2567.2000.00069.x; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song MK, 2010, World Intellectual Property Organization patent, Patent No. [WO2010046783, 2010046783]; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sui ZW, 2010, ARCH VIROL, V155, P535, DOI 10.1007/s00705-010-0621-4; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Wang Z, 2011, CLIN VACCINE IMMUNOL, V19, P174; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; Wu F, 2009, VACCINE, V27, P4320, DOI 10.1016/j.vaccine.2009.04.075; Xin KQ, 2003, BLOOD, V102, P223, DOI 10.1182/blood-2003-01-0110; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zou P, 2005, INT IMMUNOPHARMACOL, V5, P631, DOI 10.1016/j.intimp.2004.12.005	56	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94051	10.1371/journal.pone.0094051	http://dx.doi.org/10.1371/journal.pone.0094051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714362	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900075
J	Dziasko, MA; Armer, HE; Levis, HJ; Shortt, AJ; Tuft, S; Daniels, JT				Dziasko, Marc A.; Armer, Hannah E.; Levis, Hannah J.; Shortt, Alex J.; Tuft, Stephen; Daniels, Julie T.			Localisation of Epithelial Cells Capable of Holoclone Formation In Vitro and Direct Interaction with Stromal Cells in the Native Human Limbal Crypt	PLOS ONE			English	Article							STEM-CELLS; STEM/PROGENITOR CELLS; CORNEAL EPITHELIUM; PROGENITOR CELLS; N-CADHERIN; NICHE; TRANSDIFFERENTIATION; IDENTIFICATION; KERATINOCYTE; MELANOCYTES	Limbal epithelial stem cells (LESCs) are essential to maintain the transparent ocular surface required for vision. Despite great advances in our understanding of ocular stem cell biology over the last decade, the exact location of the LESC niche remains unclear. In the present study we have used in vitro clonal analysis to confirm that limbal crypts provide a niche for the resident LESCs. We have used high-resolution imaging of the basal epithelial layer at the limbus to identify cells with a morphology consistent with stem cells that were only present within the basal layer of the limbal crypts. These cells are proximal to limbal stromal cells suggesting direct cell-to-cell interaction. Serial block-face scanning electron microscopy (SBFSEM) confirmed that the putative LESCs are indeed in direct contact with cells in the underlying stroma, a contact that is facilitated by focal basement membrane interruptions. Limbal mesenchymal cells previously identified in the human limbus collocate in the crypt-rich limbal stromal area in the vicinity of LESCs and may be involved in the cell-to-cell contact revealed by SBFSEM. We also observed a high population of melanocytes within the basal layer of the limbal crypts. From these observations we present a three dimensional reconstruction of the LESC niche in which the stem cell is closely associated and maintained by both dendritic pigmented limbal melanocytes and elongated limbal stromal cells.	[Dziasko, Marc A.; Levis, Hannah J.; Shortt, Alex J.; Daniels, Julie T.] UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England; [Armer, Hannah E.] UCL, Inst Ophthalmol, Imaging unit, London, England; [Shortt, Alex J.; Tuft, Stephen] Moorfields Eye Hosp NHS Fdn Trust, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Dziasko, MA (corresponding author), UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.	marc.dziasko.11@ucl.ac.uk	Levis, Hannah/AAH-6556-2019; Shortt, Alex/C-7782-2014	Levis, Hannah/0000-0002-3923-1178; Daniels, Julie/0000-0003-2099-9360; Shortt, Alex/0000-0001-6576-3875	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; National Institute for Health Research [CL-2009-18-007] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology and a Stem Cell Initiative Award from the Special Trustees of Moorfields Eye Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Branch MJ, 2012, INVEST OPHTH VIS SCI, V53, P5109, DOI 10.1167/iovs.11-8673; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Dravida S, 2005, DEV BRAIN RES, V160, P239, DOI 10.1016/j.devbrainres.2005.09.008; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5130, DOI 10.1167/iovs.03-0584; GIPSON IK, 1989, EYE, V3, P132, DOI 10.1038/eye.1989.21; Goldberg M F, 1982, Trans Am Ophthalmol Soc, V80, P155; GRAVES BASIL, 1934, BRIT JOUR OPHTHALMOL, V18, P305, DOI 10.1136/bjo.18.6.305; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; Higa K, 2013, STEM CELL RES, V10, P147, DOI 10.1016/j.scr.2012.11.001; Higa K, 2009, INVEST OPHTH VIS SCI, V50, P4640, DOI 10.1167/iovs.09-3503; Kawasaki S, 2006, EXP EYE RES, V82, P293, DOI 10.1016/j.exer.2005.07.001; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Notara M, 2010, STEM CELL RES, V5, P188, DOI 10.1016/j.scr.2010.07.002; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pinnamaneni N, 2012, STEM CELLS, V30, P1059, DOI 10.1002/stem.1100; Polisetty N, 2008, MOL VIS, V14, P431; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Xie HT, 2011, STEM CELLS, V29, P1874, DOI 10.1002/stem.743; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	35	68	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94283	10.1371/journal.pone.0094283	http://dx.doi.org/10.1371/journal.pone.0094283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714106	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900112
J	Li, Y; Wu, QH; Liu, CJ; Kang, Z; Xie, X; Yin, H; Jiao, ML; Liu, GX; Hao, YH; Ning, N				Li, Ye; Wu, Qunhong; Liu, Chaojie; Kang, Zheng; Xie, Xin; Yin, Hui; Jiao, Mingli; Liu, Guoxiang; Hao, Yanhua; Ning, Ning			Catastrophic Health Expenditure and Rural Household Impoverishment in China: What Role Does the New Cooperative Health Insurance Scheme Play?	PLOS ONE			English	Article							MEDICAL SCHEME; CARE; SYSTEM; PAYMENTS; POOR	Objective: To determine whether the New Cooperative Medical Insurance Scheme (NCMS) is associated with decreased levels of catastrophic health expenditure and reduced impoverishment due to medical expenses in rural households of China. Methods: An analysis of a national representative sample of 38,945 rural households (129,635 people) from the 2008 National Health Service Survey was performed. Logistic regression models used binary indicator of catastrophic health expenditure as dependent variable, with household consumption, demographic characteristics, health insurance schemes, and chronic illness as independent variables. Results: Higher percentage of households experiencing catastrophic health expenditure and medical impoverishment correlates to increased health care need. While the higher socio-economic status households had similar levels of catastrophic health expenditure as compared with the lowest. Households covered by the NCMS had similar levels of catastrophic health expenditure and medical impoverishment as those without health insurance. Conclusion: Despite over 95% of coverage, the NCMS has failed to prevent catastrophic health expenditure and medical impoverishment. An upgrade of benefit packages is needed, and effective cost control mechanisms on the provider side needs to be considered.	[Li, Ye; Wu, Qunhong; Kang, Zheng; Xie, Xin; Yin, Hui; Jiao, Mingli; Liu, Guoxiang; Hao, Yanhua; Ning, Ning] Harbin Med Univ, Sch Hlth Management, Dept Social Med, Harbin, Heilongjiang, Peoples R China; [Liu, Chaojie] La Trobe Univ, Sch Publ Hlth, Bundoora, Vic, Australia	Harbin Medical University; La Trobe University	Wu, QH (corresponding author), Harbin Med Univ, Sch Hlth Management, Dept Social Med, Harbin, Heilongjiang, Peoples R China.	wuqunhong@163.com; lgx6301@163.com	hao, yan/HGB-0465-2022; Liu, Chaojie/Q-6915-2018	Liu, Chaojie/0000-0003-0877-0424	National Natural Science Fund [71333003, 71073044, 71203049]	National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Fund (key grant : 71333003, and general grant 71073044, 71203049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari SR, 2009, HEALTH POLICY PLANN, V24, P129, DOI 10.1093/heapol/czn052; [Anonymous], 2005, CHINA HLTH STAT YB 2; [Anonymous], 2012, SYNOPSIS CHINA STAT; [Anonymous], 2012, CHINA HLTH STAT YB 2; [Anonymous], 2009, CHIN STAT YB; [Anonymous], 2009, HLTH FIN STRAT AS PA; Babiarz KS, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5617; Bethany AB, 2007, SAS GLOBAL FORUM; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Cavagnero E., 2006, HLTH FINANCING ARGEN; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Chinese State Council, 2002, DECISION CPC CENTR; Ekman B, 2007, HEALTH POLICY, V83, P304, DOI 10.1016/j.healthpol.2007.02.004; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Liu YL, 2004, B WORLD HEALTH ORGAN, V82, P532; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Ministry of Health of China, 2011, CHIN HLTH STAT YB 20; National Bureau of Statistics of China, 2012, CHINA STAT, V2012, P4; Rao K, 2010, CHANGES HLTH SERVICE; SHI LY, 1993, B WORLD HEALTH ORGAN, V71, P723; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Sun XY, 2009, HEALTH ECON, V18, P103, DOI 10.1002/hec.1346; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; The Ministry of Health Department, 2011, MAJ REP WORKS NCMS 2; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7982-0; Wang H, 2005, HEALTH POLICY PLANN, V20, P366, DOI 10.1093/heapol/czi045; Wang H, 2006, SOC SCI MED, V63, P1236, DOI 10.1016/j.socscimed.2006.03.008; WHO (World Health Organization), 2004, IMPL NEW COOP MED SC; Wong CK, 2012, SOC WORK PUBLIC HLTH, V27, P521, DOI 10.1080/19371910903183219; World Health Organization, 2009, TECHN BRIEFS POL MAR; World Health Organization, 2010, 37 WHO; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K., 2005, DISTRIBUTION HLTH PA; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; You XD, 2009, HEALTH POLICY, V91, P1, DOI 10.1016/j.healthpol.2008.11.012; Zhang LY, 2010, TROP MED INT HEALTH, V15, P468, DOI 10.1111/j.1365-3156.2010.02469.x; ZHU NS, 1989, B WORLD HEALTH ORGAN, V67, P431	41	54	57	9	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93253	10.1371/journal.pone.0093253	http://dx.doi.org/10.1371/journal.pone.0093253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714605	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900020
J	Sandes, JM; Fontes, A; Regis-Da-Silva, CG; De Castro, MCAB; Lima-Junior, CG; Silva, FPL; Vasconcellos, MLAA; Figueiredo, RCBQ				Sandes, Jana M.; Fontes, Adriana; Regis-Da-Silva, Carlos G.; De Castro, Maria C. A. Brelaz; Lima-Junior, Claudio G.; Silva, Fabio P. L.; Vasconcellos, Mario L. A. A.; Figueiredo, Regina C. B. Q.			Trypanosoma cruzi Cell Death Induced by the Morita-Baylis-Hillman Adduct 3-Hydroxy-2-Methylene-3-(4-Nitrophenylpropanenitrile)	PLOS ONE			English	Article							APOPTOSIS; AUTOPHAGY; MITOCHONDRIAL; INHIBITORS; PATHWAYS; MARKERS; DRUGS	Chagas disease, caused by the protozoan Trypanosoma cruzi, remains a serious health concern due to the lack of effective vaccines or satisfactory treatment. In the search for new compounds against this neglected disease, we have previously demonstrated that the compound 3-Hydroxy-2-methylene-3-(4-nitrophenylpropanenitrile) (MBHA3), derived from the Morita-Baylis-Hillman reaction, effectively caused a loss of viability in both the epimastigote and trypomastigote forms. However, the mechanisms of parasite death elicited by MBHA3 remain unknown. The aim of this study was to better understand the morphophysiological changes and the mechanism of cell death induced by MBHA3 treatment on T. cruzi. To perform this analysis, we used confocal microscopy and flow cytometry to monitor the fluorescent probes such as annexin-V/ propidium iodide (AV/PI), calcein-AM/ethidium homodimer (CA/EH), acridine orange (AO) and rhodamine 123 (Rho 123). Lower concentrations of MBHA3 led to alterations in the mitochondrial membrane potential and AO labeling, but did not decrease the viability of the epimastiogote forms, as determined by the CA/EH and AV/PI assays. Conversely, treatment with higher concentrations of MBHA3 led to extensive plasma membrane damage, loss of mitochondrion membrane potential, DNA fragmentation and acidification of the cytoplasm. Our findings suggest that at higher concentrations, MBHA3 induces T. cruzi epimastigote death by necrosis in a mitochondrion-dependent manner.	[Sandes, Jana M.; Figueiredo, Regina C. B. Q.] Centro Pesquisas Aggeu Magalhaes, Dept Microbiol, Recife, PE, Brazil; [Fontes, Adriana] Univ Fed Pernambuco, Dept Biofis & Radiobiol, Recife, PE, Brazil; [Regis-Da-Silva, Carlos G.] Ctr Pesquisas Goncalo Moniz, Lab Biol Parasitaria, Salvador, BA, Brazil; [De Castro, Maria C. A. Brelaz] Ctr Pesquisas Aggeu Magalhaes, Dept Immunol, Recife, PE, Brazil; [Lima-Junior, Claudio G.; Silva, Fabio P. L.; Vasconcellos, Mario L. A. A.] Univ Fed Paraiba, Dept Quim, LASOM PB, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal da Paraiba	Figueiredo, RCBQ (corresponding author), Centro Pesquisas Aggeu Magalhaes, Dept Microbiol, Recife, PE, Brazil.	bressan@cpqam.fiocruz.br	Lima, Claudio Gabriel/AAC-7580-2019; Vasconcellos, Mario/AAI-2777-2021; FIGUEIREDO, REGINA/T-7230-2019; FIGUEIREDO, REGINA CBQ/N-2800-2013; de Castro, Maria Carolina Accioly Brelaz/AAV-5606-2020; Fontes, Adriana/T-5789-2019; FIGUEIREDO, REGINA CELIA BRESSAN QUEIROZ/GWU-9395-2022	de Castro, Maria Carolina Accioly Brelaz/0000-0003-2205-0618; Fontes, Adriana/0000-0003-4675-2163; FIGUEIREDO, REGINA/0000-0001-5806-0944; Lima-Junior, Claudio/0000-0001-6570-8999	CNPq; FIOCRUZ/CPQAM; PDTIS/FIOCRUZ; FACEPE	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ/CPQAM; PDTIS/FIOCRUZ; FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was supported by CNPq, FIOCRUZ/CPQAM, PDTIS/FIOCRUZ and FACEPE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Basavaiah D, 2012, CHEM SOC REV, V41, P68, DOI 10.1039/c1cs15174f; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Cormier O, 2012, AUTOPHAGY, V8, P252, DOI 10.4161/auto.8.2.18618; Das M, 2001, J CELL SCI, V114, P2461; de Souza ROMA, 2007, EUR J MED CHEM, V42, P99, DOI 10.1016/j.ejmech.2006.07.013; Demoro B, 2012, DALTON T, V41, P6468, DOI 10.1039/c2dt12179d; Tonin LTD, 2009, EUR J MED CHEM, V44, P1745, DOI 10.1016/j.ejmech.2008.03.044; Erdelyi P, 2011, J CELL SCI, V124, P1510, DOI 10.1242/jcs.080192; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gatti R, 1998, J HISTOCHEM CYTOCHEM, V46, P895, DOI 10.1177/002215549804600804; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055497; Khademvatan S, 2011, BRAZ J INFECT DIS, V15, P442, DOI [10.1590/S1413-86702011000500005, 10.1016/S1413-8670(11)70225-2]; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lee WK, 2006, AM J PHYSIOL-CELL PH, V291, pC195, DOI 10.1152/ajpcell.00641.2005; Lima CG, 2012, BIOORGAN MED CHEM, V20, P3954, DOI 10.1016/j.bmc.2012.04.061; Luder CGK, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-116; Marinho FD, 2011, MEM I OSWALDO CRUZ, V106, P507, DOI 10.1590/S0074-02762011000400021; Menna-Barreto RFS, 2009, MICRON, V40, P157, DOI 10.1016/j.micron.2008.08.003; Montalvetti A, 2003, J BIOL CHEM, V278, P17075, DOI 10.1074/jbc.M210467200; Neto RLM, 2011, EXP PARASITOL, V127, P215, DOI 10.1016/j.exppara.2010.07.020; Nishikawa T, 2010, ANN SURG ONCOL, V17, P592, DOI 10.1245/s10434-009-0696-x; Pritchett TL, 2012, CELL DEATH DIFFER, V19, P1069, DOI 10.1038/cdd.2011.200; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Salomon CJ, 2012, J PHARM SCI-US, V101, P888, DOI 10.1002/jps.23010; Sandes JM, 2010, BIOORG CHEM, V38, P190, DOI 10.1016/j.bioorg.2010.06.003; Shang XJ, 2009, J ANDROL, V30, P122, DOI 10.2164/jandrol.108.005629; Smirlis D, 2011, VIRULENCE, V2, P253, DOI 10.4161/viru.2.3.16278; Soeiro Maria de Nazare C, 2011, Open Med Chem J, V5, P21, DOI 10.2174/1874104501105010021; Szajnman SH, 2003, BIOORG MED CHEM LETT, V13, P3231, DOI 10.1016/S0960-894X(03)00663-2; Tait JF, 2008, J NUCL MED, V49, P1573, DOI 10.2967/jnumed.108.052803; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Worthen C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000678; Wu YC, 2012, METHOD CELL BIOL, V107, P297, DOI 10.1016/B978-0-12-394620-1.00010-2	40	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93936	10.1371/journal.pone.0093936	http://dx.doi.org/10.1371/journal.pone.0093936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714638	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900062
J	Jacquot, M; Gonnet, M; Ferquel, E; Abrial, D; Claude, A; Gasqui, P; Choumet, V; Charras-Garrido, M; Garnier, M; Faure, B; Sertour, N; Dorr, N; De Goer, J; Vourc'h, G; Bailly, X				Jacquot, Maude; Gonnet, Mathieu; Ferquel, Elisabeth; Abrial, David; Claude, Alexandre; Gasqui, Patrick; Choumet, Valerie; Charras-Garrido, Myriam; Garnier, Martine; Faure, Benjamin; Sertour, Natacha; Dorr, Nelly; De Goer, Jocelyn; Vourc'h, Gwenael; Bailly, Xavier			Comparative Population Genomics of the Borrelia burgdorferi Species Complex Reveals High Degree of Genetic Isolation among Species and Underscores Benefits and Constraints to Studying Intra-Specific Epidemiological Processes	PLOS ONE			English	Article							FREQUENCY-DEPENDENT SELECTION; LYME BORRELIOSIS; SENSU-LATO; DIFFERENTIAL TRANSMISSION; SEQUENCE-ANALYSIS; RESERVOIR HOSTS; DIVERSITY; EVOLUTION; AFZELII; RODENTS	Lyme borreliosis, one of the most frequently contracted zoonotic diseases in the Northern Hemisphere, is caused by bacteria belonging to different genetic groups within the Borrelia burgdorferi species complex, which are transmitted by ticks among various wildlife reservoirs, such as small mammals and birds. These features make the Borrelia burgdorferi species complex an attractive biological model that can be used to study the diversification and the epidemiology of endemic bacterial pathogens. We investigated the potential of population genomic approaches to study these processes. Sixty-three strains belonging to three species within the Borrelia burgdorferi complex were isolated from questing ticks in Alsace (France), a region where Lyme disease is highly endemic. We first aimed to characterize the degree of genetic isolation among the species sampled. Phylogenetic and coalescent-based analyses revealed clear delineations: there was a similar to 50 fold difference between intra-specific and inter-specific recombination rates. We then investigated whether the population genomic data contained information of epidemiological relevance. In phylogenies inferred using most of the genome, conspecific strains did not cluster in clades. These results raise questions about the relevance of different strategies when investigating pathogen epidemiology. For instance, here, both classical analytic approaches and phylodynamic simulations suggested that population sizes and migration rates were higher in B. garinii populations, which are normally associated with birds, than in B. burgdorferi s.s. populations. The phylogenetic analyses of the infection-related ospC gene and its flanking region provided additional support for this finding. Traces of recombination among the B. burgdorferi s. s. lineages and lineages associated with small mammals were found, suggesting that they shared the same hosts. Altogether, these results provide baseline evidence that can be used to formulate hypotheses regarding the host range of B. burgdorferi lineages based on population genomic data.	[Jacquot, Maude; Gonnet, Mathieu; Abrial, David; Claude, Alexandre; Gasqui, Patrick; Charras-Garrido, Myriam; Faure, Benjamin; Dorr, Nelly; De Goer, Jocelyn; Vourc'h, Gwenael; Bailly, Xavier] INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France; [Ferquel, Elisabeth; Choumet, Valerie; Garnier, Martine; Sertour, Natacha] Inst Pasteur, CNR Borrelia, Paris, France	INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Jacquot, M (corresponding author), INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France.	maude.jacquot@gmail.com	Jacquot, Maude/T-7584-2019; Bailly, Xavier/C-6254-2011	Jacquot, Maude/0000-0001-5945-4689; Bailly, Xavier/0000-0001-6959-7974; FAURE, Benjamin/0000-0003-4521-9252	French National Institute for Agricultural Research (INRA) through the 'AIP Bioressources' initiative; Auvergne region through the 'Lifegrid' program; European Union through the European Regional Development Fund (ERDF); French Ministry of Higher Education and Research (MESR); ERDF; OSCAR project of the French National Research Agency; 'Lifegrid' program	French National Institute for Agricultural Research (INRA) through the 'AIP Bioressources' initiative; Auvergne region through the 'Lifegrid' program(Region Auvergne-Rhone-Alpes); European Union through the European Regional Development Fund (ERDF); French Ministry of Higher Education and Research (MESR)(Ministry of Research, France); ERDF(European Commission); OSCAR project of the French National Research Agency(French National Research Agency (ANR)); 'Lifegrid' program	This work was supported by funding from the French National Institute for Agricultural Research (INRA) through the 'AIP Bioressources 2009' initiative, the Auvergne region through the 'Lifegrid' program, and the European Union through the European Regional Development Fund (ERDF). Maude Jacquot received PhD funding from the French Ministry of Higher Education and Research (MESR), Mathieu Gonnet was supported by the ERDF and by the OSCAR project of the French National Research Agency. Alexandre Claude was supported by the 'Lifegrid' program. Interactions between members of the INRA and the Pasteur Institute are promoted by the 'Tick and Tick-Borne Diseases' (TMT) group, which is part of the Research Consortium on Biological Interactions (GdR REID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1974, AUTOM CONTROL IEEE T, V19, P1974; Balloux F., 2010, BACTERIAL POPULATION, P103; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Brisson D, 2006, AM J TROP MED HYG, V74, P615, DOI 10.4269/ajtmh.2006.74.615; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2008, P ROY SOC B-BIOL SCI, V275, P227, DOI 10.1098/rspb.2007.1208; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Castillo-Ramirez S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-300; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dubska L, 2009, APPL ENVIRON MICROB, V75, P596, DOI 10.1128/AEM.01674-08; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2003, GENETICS, V164, P1567; Ferquel E, 2006, APPL ENV MICROBIOL; Giombini E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-39; Gu X, 1995, MOL BIOL EVOL; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hanincova K, 2003, PARASITOLOGY, V126, P11, DOI 10.1017/S0031182002002548; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Haven J, 2011, GENETICS, V189, P951, DOI 10.1534/genetics.111.130773; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; HEDRICK PW, 1987, GENETICS, V117, P331; Hellgren O, 2011, J EVOLUTION BIOL, V24, P159, DOI 10.1111/j.1420-9101.2010.02148.x; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hu CM, 1997, ZBL BAKT-INT J MED M, V285, P558; Hudson R.R., 1990, OXF SURV EVOL BIOL, V7, P44; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1986, GENETICS, V113, P1057; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; Humair PF, 1998, ZBL BAKT-INT J MED M, V287, P521, DOI 10.1016/S0934-8840(98)80194-1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacquot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088581; JUKES T H, 1969, P21; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Koelle K, 2012, J R SOC INTERFACE, V9, P997, DOI 10.1098/rsif.2011.0495; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; LEWONTIN RC, 1964, GENETICS, V50, P757; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Mongodin EF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-693; Moran P., 1958, MATH P CAMBRIDGE PHI, V54, P60, DOI DOI 10.1017/S0305004100033193; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Qiu WG, 1997, HEREDITAS, V127, P203, DOI 10.1111/j.1601-5223.1997.00203.x; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Richter D, 2000, EMERG INFECT DIS, V6, P133, DOI 10.3201/eid0602.000205; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAIBLE UE, 1989, J EXP MED, V170, P1427, DOI 10.1084/jem.170.4.1427; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Taragel'ova V, 2008, APPL ENVIRON MICROB, V74, P1289, DOI 10.1128/AEM.01060-07; Tavare S, 1986, LECT MATH LIFE SCI, V17; Team R, 2011, R LANG ENV STAT COMP; Vollmer SA, 2011, ENVIRON MICROBIOL, V13, P184, DOI 10.1111/j.1462-2920.2010.02319.x; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wiuf C, 2000, GENETICS, V155, P451; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1931, GENETICS, V16, P0097	78	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94384	10.1371/journal.pone.0094384	http://dx.doi.org/10.1371/journal.pone.0094384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721934	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000336909100062
J	Li, XH; Yang, H; Huang, SM; Qiu, Y				Li, Xuehui; Yang, Hui; Huang, Suming; Qiu, Yi			Histone Deacetylase 1 and p300 Can Directly Associate with Chromatin and Compete for Binding in a Mutually Exclusive Manner	PLOS ONE			English	Article							GENE-TRANSCRIPTION; IN-VIVO; ACETYLATION; COMPLEX; RECRUITMENT; YEAST; METHYLATION; HDACS; DNA; PROMOTER	Lysine acetyltransferases (KATs) and histone deacetylases (HDACs) are important epigenetic modifiers and dynamically cycled on active gene promoters to regulate transcription. Although HDACs are recruited to gene promoters and DNA hypersensitive sites through interactions with DNA binding factors, HDAC activities are also found globally in intergenic regions where DNA binding factors are not present. It is suggested that HDACs are recruited to those regions through other distinct, yet undefined mechanisms. Here we show that HDACs can be directly recruited to chromatin in the absence of other factors through direct interactions with both DNA and core histone subunits. HDACs interact with DNA in a non-sequence specific manner. HDAC1 and p300 directly bind to the overlapping regions of the histone H3 tail and compete for histone binding. Previously we show that p300 can acetylate HDAC1 to attenuate deacetylase activity. Here we have further mapped two distinct regions of HDAC1 that interact with p300. Interestingly, these regions of HDAC1 also associate with histone H3. More importantly, p300 and HDAC1 compete for chromatin binding both in vitro and in vivo. Therefore, the mutually exclusive associations of HDAC1/p300, p300/histone, and HDAC1/histone on chromatin contribute to the dynamic regulation of histone acetylation by balancing HDAC or KAT activity present at histones to reorganize chromatin structure and regulate transcription.	[Li, Xuehui; Yang, Hui; Qiu, Yi] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Qiu, Y (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	qiuy@ufl.edu		, Yi/0000-0002-3282-6072	National Institutes of Health [R01 HL095674, R01 HL091929, R01 HL 090589]; Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091929, R01HL090589, R01HL095674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [R01 HL095674 to YQ, R01 HL091929 to SH, and R01 HL 090589 to SH]; and the Florida Bankhead Coley Research Foundation to YQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WJ, 2003, J BIOL CHEM, V278, P1504, DOI 10.1074/jbc.M209355200; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Degenhardt T, 2009, J MOL BIOL, V388, P225, DOI 10.1016/j.jmb.2009.03.024; Drouin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001173; Eckner R, 1996, BIOL CHEM, V377, P685; Foglietti C, 2006, J BIOL CHEM, V281, P17968, DOI 10.1074/jbc.M511945200; Geisberg J. V., 2005, CURR PROTOC MOL BIOL, P8; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goodman RH, 2000, GENE DEV, V14, P1553; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; He SH, 2013, J CELL PHYSIOL, V228, P1525, DOI 10.1002/jcp.24311; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Liu Y, 2012, J BIOL CHEM; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; RIKITAKE Y, 1992, MOL CELL BIOL, V12, P2826, DOI 10.1128/MCB.12.6.2826; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Simone C, 2004, ONCOGENE, V23, P2177, DOI 10.1038/sj.onc.1207327; Stavreva DA, 2012, BBA-GENE REGUL MECH, V1819, P657, DOI 10.1016/j.bbagrm.2012.03.004; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tang ZY, 2013, CELL, V154, P297, DOI 10.1016/j.cell.2013.06.027; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	54	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94523	10.1371/journal.pone.0094523	http://dx.doi.org/10.1371/journal.pone.0094523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722339	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100089
J	Oladimeji, O; Isaakidis, P; Obasanya, OJ; Eltayeb, O; Khogali, M; Van den Bergh, R; Kumar, AMV; Hinderaker, SG; Abdurrahman, ST; Lawson, L; Cuevas, LE				Oladimeji, Olanrewaju; Isaakidis, Petros; Obasanya, Olusegun J.; Eltayeb, Osman; Khogali, Mohammed; Van den Bergh, Rafael; Kumar, Ajay M. V.; Hinderaker, Sven Gudmund; Abdurrahman, Saddiq T.; Lawson, Lovett; Cuevas, Luis E.			Intensive-Phase Treatment Outcomes among Hospitalized Multidrug-Resistant Tuberculosis Patients: Results from a Nationwide Cohort in Nigeria	PLOS ONE			English	Article							COMMUNITY-BASED TREATMENT; SOUTH-AFRICA; METAANALYSIS; CULTURE; THERAPY; LIMA; PERU	Background: Nigeria is faced with a high burden of Human Immunodeficiency Virus (HIV) infection and multidrug-resistant tuberculosis (MDR-TB). Treatment outcomes among MDR-TB patients registered across the globe have been poor, partly due to high loss-to-follow-up. To address this challenge, MDR-TB patients in Nigeria are hospitalized during the intensive-phase(IP) of treatment (first 6-8 months) and are provided with a package of care including standardized MDR-TB treatment regimen, antiretroviral therapy (ART) and cotrimoxazole prophylaxis (CPT) for HIV-infected patients, nutritional and psychosocial support. In this study, we report the end-IP treatment outcomes among them. Methods: In this retrospective cohort study, we reviewed the patient records of all bacteriologically-confirmed MDR-TB patients admitted for treatment between July 2010 and October 2012. Results: Of 162 patients, 105(65%) were male, median age was 34 years and 28(17%) were HIV-infected; all 28 received ART and CPT. Overall, 138(85%) were alive and culture negative at the end of IP, 24(15%) died and there was no loss-to-follow-up. Mortality was related to low CD4-counts at baseline among HIV-positive patients. The median increase in body mass index among those documented to be underweight was 2.6 kg/m(2) (p<0.01) and CD4-counts improved by a median of 52 cells/microL among the HIV-infected patients (p<0.01). Conclusions: End-IP treatment outcomes were exceptional compared to previously published data from international cohorts, thus confirming the usefulness of a hospitalized model of care. However, less than five percent of all estimated 3600 MDR-TB patients in Nigeria were initiated on treatment during the study period. Given the expected scale-up of MDR-TB care, the hospitalized model is challenging to sustain and the national TB programme is contemplating to move to ambulatory care. Hence, we recommend using both ambulatory and hospitalized approaches, with the latter being reserved for selected high-risk groups.	[Oladimeji, Olanrewaju; Lawson, Lovett] Zankli Med Ctr, Abuja, Nigeria; [Oladimeji, Olanrewaju; Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Isaakidis, Petros; Khogali, Mohammed; Van den Bergh, Rafael] MSF, Operat Res Unit, Luxembourg, Luxembourg; [Obasanya, Olusegun J.] Fed Minist Hlth, Natl TB & Leprosy Control Unit, Abuja, Nigeria; [Eltayeb, Osman] Damien Fdn Belgium, Nigeria Project, Ibadan, Nigeria; [Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Hinderaker, Sven Gudmund] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Abdurrahman, Saddiq T.] Fed Capital Terr, TB & Leprosy Control Program, Abuja, Nigeria	Liverpool School of Tropical Medicine; University of Liverpool; Doctors Without Borders; University of Bergen	Oladimeji, O (corresponding author), Zankli Med Ctr, Abuja, Nigeria.	droladfb@gmail.com	Oladimeji, Olanrewaju/AAE-9633-2019; Cuevas, Luis E/I-3697-2015	Oladimeji, Olanrewaju/0000-0002-5356-901X; Cuevas, Luis E/0000-0002-6581-0587; Lawson, Lovett/0000-0001-9019-7537; Isaakidis, Petros/0000-0002-7881-1554; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Van den Bergh, Rafael/0000-0001-6277-8713	Medecins Sans Frontieres Luxembourg, Brussels Operational Centre, Luxembourg; Bloomberg Philanthropies; Department for International Development (DFID), UK; European and Developing Countries Clinical Trial Partnership (EDCTP)	Medecins Sans Frontieres Luxembourg, Brussels Operational Centre, Luxembourg; Bloomberg Philanthropies; Department for International Development (DFID), UK; European and Developing Countries Clinical Trial Partnership (EDCTP)	Funding for the course was provided by Medecins Sans Frontieres Luxembourg, Brussels Operational Centre, Luxembourg, the Bloomberg Philanthropies, and the Department for International Development (DFID), UK. Dr Olanrewaju Oladimeji is a research fellow based in Abuja Nigeria, jointly appointed by Zankli Medical Services, Nigeria and the Liverpool School of Tropical Medicine, United Kingdom and funded by a Strategic Award grant from the European and Developing Countries Clinical Trial Partnership (EDCTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Andrews JR, 2007, J INFECT DIS, V196, pS482, DOI 10.1086/521121; [Anonymous], 2009, MAN MDR TB FIELD GUI; Brust J, 2010, PLOS ONE, V6; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Federal Ministry of Health Nigeria Department of Public Health, 2010, NAT TUB LEPR CONTR P, V5th; Federal Ministry of Health Nigeria (FMOH), 2012, NATL DRUG RES TB PRE; Hafkin J, 2013, INT J TUBERC LUNG D, V17, P348, DOI 10.5588/ijtld.12.0100; Harries AD, 2004, INT J TUBERC LUNG D, V8, P204; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; James C, 2011, CULTURE CONVERSION H; Jenkins HE, 2013, INT J TUBERC LUNG D, V17, P373, DOI 10.5588/ijtld.12.0464; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Khann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059903; Kilale AM, 2013, PUBLIC HEALTH ACTION, V3, P156, DOI 10.5588/pha.12.0103; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Qi W, 2011, INT J TUBERC LUNG D, V15, P137; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2012, MULT EXT DRUG RES TB; World Health Organization (WHO), 2013, MULT EXT DRUG RES	26	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94393	10.1371/journal.pone.0094393	http://dx.doi.org/10.1371/journal.pone.0094393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722139	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000336909100065
J	Pectasides, E; Rampias, T; Sasaki, C; Perisanidis, C; Kouloulias, V; Burtness, B; Zaramboukas, T; Rimm, D; Fountzilas, G; Psyrri, A				Pectasides, Eirini; Rampias, Theodoros; Sasaki, Clarence; Perisanidis, Christos; Kouloulias, Vassilis; Burtness, Barbara; Zaramboukas, Thomas; Rimm, David; Fountzilas, George; Psyrri, Amanda			Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; AUTOMATED QUANTITATIVE-ANALYSIS; E-CADHERIN EXPRESSION; BETA-CATENIN; NUCLEAR-LOCALIZATION; TISSUE MICROARRAYS; CANCER; ACTIVATION; BINDING; IDENTIFICATION	Background: Elucidating the molecular phenotype of cancers with high metastatic potential will facilitate the development of novel therapeutic approaches to the disease. Gene expression profiles link epithelial to mesenchymal transition (EMT) phenotype with high-risk HNSCC. We sought to determine the role of protein biomarkers of EMT in head and neck squamous carcinoma (HNSC) prognosis. Methods: Protein expression analysis of EGFR, beta-catenin and E-cadherin was performed on a cohort of 102 patients with HNSCC recruited between 1992 and 2005 using automated quantitative protein analysis (AQUA). We evaluated associations with clinicopathological parameters and prognosis. Results: There were 67 patients with primary squamous cell carcinoma of the head and neck in this cohort who met inclusion criteria and for whom we had complete E-cadherin, beta-catenin and EGFR expression data. High E-cadherin expressers had longer 5-year progression-free survival (PFS) compared to those with low E-cadherin (59.7% versus 40.6%, p = 0.04) and overall survival (OS) (69.6% versus 44.3%, p = 0.05). Kaplan-Meier analysis showed that patients with low beta-catenin-expressing tumors trended toward worse 5-year PFS (p = 0.057). High EGFR expressers had inferior OS compared to low EGFR expressers (27.7% vs. 54%, p = 0.029). In the multivariable analysis context, E-cadherin remained an independent predictor of improved OS (HR = 0.204, 95% CI 0.043 to 0.972, p = 0.046) while EGFR trended towards significance for OS. Conclusions: The putative markers of EMT defined within a panel of HNSCC using AQUA are associated with tumors of poor prognosis.	[Pectasides, Eirini; Psyrri, Amanda] Yale Univ, Sch Med, Dept Internal Med Med Oncol, New Haven, CT 06520 USA; [Rampias, Theodoros; Sasaki, Clarence; Psyrri, Amanda] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT USA; [Perisanidis, Christos] Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, Vienna, Austria; [Kouloulias, Vassilis] Univ Athens, Attikon Univ Hosp, Dept Radiotherapy, Athens, Greece; [Kouloulias, Vassilis] Univ Athens, Attikon Univ Hosp, Dept Internal Med Med Oncol, Athens, Greece; [Burtness, Barbara] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Zaramboukas, Thomas] Aristotle Univ Thessaloniki, Sch Med, Dept Pathol, GR-54006 Thessaloniki, Greece; [Rimm, David] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Fountzilas, George] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, GR-54006 Thessaloniki, Greece	Yale University; Yale University; Medical University of Vienna; National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; Fox Chase Cancer Center; Aristotle University of Thessaloniki; Yale University; Aristotle University of Thessaloniki	Psyrri, A (corresponding author), Yale Univ, Sch Med, Dept Internal Med Med Oncol, New Haven, CT 06520 USA.	dp237@email.med.yale.edu	Rampias, Theodoros/AAX-7941-2020; Fountzilas, George/ABF-2139-2020; Kouloulias, Vassilis/AAD-7348-2019	Rampias, Theodoros/0000-0002-5460-5334; Fountzilas, George/0000-0001-8045-2186; Rimm, David/0000-0001-5820-4397	Yale School of Medicine Institutional startup funds; Virginia Alden Wright Fund	Yale School of Medicine Institutional startup funds; Virginia Alden Wright Fund	This study was funded by Yale School of Medicine Institutional startup funds (AP) and the Virginia Alden Wright Fund (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Camp RL, 2000, LAB INVEST, V80, P1943, DOI 10.1038/labinvest.3780204; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Francavilla C, 2007, J CELL SCI, V120, P4388, DOI 10.1242/jcs.010744; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Harigopal M, 2005, CLIN CANCER RES, V11, P4083, DOI 10.1158/1078-0432.CCR-04-2191; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Orsulic S, 1999, J CELL SCI, V112, P1237; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pectasides E, 2010, CLIN CANCER RES, V16, P2427, DOI 10.1158/1078-0432.CCR-09-2658; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reshetnikova G, 2007, CELL BIOL INT, V31, P366, DOI 10.1016/j.cellbi.2007.01.022; Rimm DL, 2001, EXP MOL PATHOL, V70, P255, DOI 10.1006/exmp.2001.2363; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200; Wong AST, 2003, J CELL BIOL, V161, P1191, DOI 10.1083/jcb.200212033	30	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94273	10.1371/journal.pone.0094273	http://dx.doi.org/10.1371/journal.pone.0094273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722213	Green Submitted, gold, Green Published			2022-12-27	WOS:000336909100048
J	Choi, MY; Kohler, R; Meer, RKV; Neupert, S; Predel, R				Choi, Man-Yeon; Koehler, Rene; Meer, Robert K. Vander; Neupert, Susanne; Predel, Reinhard			Identification and Expression of Capa Gene in the Fire Ant, Solenopsis invicta	PLOS ONE			English	Article							MANDUCA-SEXTA ALLATOTROPIN; AMERICAN COCKROACH; DROSOPHILA-MELANOGASTER; PERISYMPATHETIC ORGANS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; PROTEIN HORMONES; TOBACCO HAWKMOTH; NERVOUS-SYSTEM; CLEAVAGE SITES	Recent genome analyses suggested the absence of a number of neuropeptide genes in ants. One of the apparently missing genes was the capa gene. Capa gene expression in insects is typically associated with the neuroendocrine system of abdominal ganglia; mature CAPA peptides are known to regulate diuresis and visceral muscle contraction. The apparent absence of the capa gene raised questions about possible compensation of these functions. In this study, we re-examined this controversial issue and searched for a potentially unrecognized capa gene in the fire ant, Solenopsis invicta. We employed a combination of data mining and a traditional PCR-based strategy using degenerate primers designed from conserved amino acid sequences of insect capa genes. Our findings demonstrate that ants possess and express a capa gene. As shown by MALDI-TOF mass spectrometry, processed products of the S. invicta capa gene include three CAPA periviscerokinins and low amounts of a pyrokinin which does not have the C-terminal WFGPRLa motif typical of CAPA pyrokinins in other insects. The capa gene was found with two alternative transcripts in the CNS. Within the ventral nerve cord, two capa neurons were immunostained in abdominal neuromeres 2-5, respectively, and projected into ventrally located abdominal perisympathetic organs (PSOs), which are the major hormone release sites of abdominal ganglia. The ventral location of these PSOs is a characteristic feature and was also found in another ant, Atta sexdens.	[Choi, Man-Yeon; Meer, Robert K. Vander] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Koehler, Rene; Neupert, Susanne; Predel, Reinhard] Univ Cologne, Bioctr, Inst Zool, D-50931 Cologne, Germany	United States Department of Agriculture (USDA); University of Cologne	Choi, MY (corresponding author), USDA ARS, Hort Crops Res Unit, Corvallis, OR USA.	mychoi@ars.usda.gov; rpredel@uni-koeln.de	Predel, Reinhard/O-5243-2015	Choi, Man-yeon/0000-0003-0769-380X	Deutsche Forschungsgemeinschaft [Predel 595/6-1, Predel 595/6-2, 766/9-1]; Luxemburg Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Luxemburg Foundation	The authors acknowledge the financial assistance of the Deutsche Forschungsgemeinschaft (Predel 595/6-1, 2; 766/9-1) and Luxemburg Foundation ( to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks W.A., 1981, AATSS21 USDA SEA; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V335, P14, DOI 10.1016/j.bbrc.2005.07.038; Choi MY, 2011, J INSECT PHYSIOL, V57, P161, DOI 10.1016/j.jinsphys.2010.10.008; Choi MY, 2009, CELL TISSUE RES, V335, P431, DOI 10.1007/s00441-008-0721-6; Davies SA, 2013, GEN COMP ENDOCR, V188, P60, DOI 10.1016/j.ygcen.2013.03.012; Davis NT, 1996, MICROSC RES TECHNIQ, V35, P201, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;201::AID-JEMT3&gt;3.0.CO;2-Q; East P, 1996, REGUL PEPTIDES, V67, P1, DOI 10.1016/S0167-0115(96)00109-7; Eckert M, 1999, CELL TISSUE RES, V295, P159, DOI 10.1007/s004410051222; Gabilondo H, 2011, MECH DEVELOP, V128, P208, DOI 10.1016/j.mod.2011.01.002; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Horodyski FM, 2001, PEPTIDES, V22, P263, DOI 10.1016/S0196-9781(00)00378-8; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P924, DOI 10.1016/S0006-291X(02)02798-5; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P628, DOI 10.1016/S0006-291X(02)02709-2; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Lee KY, 2002, PEPTIDES, V23, P1933, DOI 10.1016/S0196-9781(02)00181-X; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Loi PK, 2004, J EXP BIOL, V207, P3681, DOI 10.1242/jeb.01186; Ma PWK, 2000, J INSECT PHYSIOL, V46, P221, DOI 10.1016/S0022-1910(99)00174-2; Melcher C, 2006, PLOS BIOL, V4, P316, DOI 10.1371/journal.pbio.0040068; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Neupert S, 2014, EUPA OPEN PROTEOMICS; Neupert S, 2010, PEPTIDES, V31, P408, DOI 10.1016/j.peptides.2009.09.021; Neupert S, 2009, J NEUROCHEM, V111, P757, DOI 10.1111/j.1471-4159.2009.06361.x; Niven JE, 2008, ANNU REV ENTOMOL, V53, P253, DOI 10.1146/annurev.ento.52.110405.091322; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Predel R, 2003, PEPTIDES, V24, P1457, DOI 10.1016/j.peptides.2003.07.020; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Predel R, 1999, INSECT BIOCHEM MOLEC, V29, P139, DOI 10.1016/S0965-1748(98)00117-9; PREDEL R, 1995, PEPTIDES, V16, P61, DOI 10.1016/0196-9781(94)00144-U; Predel R, 1998, PEPTIDES, V19, P801, DOI 10.1016/S0196-9781(98)00019-9; Predel R, 2013, PEPTIDES, V41, P2, DOI 10.1016/j.peptides.2012.12.009; Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p; Predel R, 2007, J COMP NEUROL, V500, P498, DOI 10.1002/cne.21183; Raabe M., 1983, Advances in Insect Physiology, V17, P205, DOI 10.1016/S0065-2806(08)60219-2; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Santos JG, 2006, CELL TISSUE RES, V326, P187, DOI 10.1007/s00441-006-0211-7; Southey BR, 2008, BIOINFORMATICS, V24, P815, DOI 10.1093/bioinformatics/btn044; Suska A, 2011, DEV BIOL, V353, P72, DOI 10.1016/j.ydbio.2011.02.015; Taylor PA, 1996, EUR J BIOCHEM, V239, P588, DOI 10.1111/j.1432-1033.1996.0588u.x; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Wegener C, 2010, METHODS MOL BIOL, V615, P117, DOI 10.1007/978-1-60761-535-4_9; WILLE ALVARO, 1961, REV BIOL TROP, V9, P117; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	49	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94274	10.1371/journal.pone.0094274	http://dx.doi.org/10.1371/journal.pone.0094274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718032	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000100
J	Jay, CV; Grebmeier, JM; Fischbach, AS; McDonald, TL; Cooper, LW; Hornsby, F				Jay, Chadwick V.; Grebmeier, Jacqueline M.; Fischbach, Anthony S.; McDonald, Trent L.; Cooper, Lee W.; Hornsby, Fawn			Pacific Walrus (Odobenus rosmarus divergens) Resource Selection in the Northern Bering Sea	PLOS ONE			English	Article							HIERARCHICAL PATCH DYNAMICS; LAWRENCE-ISLAND POLYNYA; CHUKCHI SEAS; PROTECTED AREAS; CALORIC CONTENT; ICE; SEDIMENTATION; AVAILABILITY; CLIMATE; SCALES	The Pacific walrus is a large benthivore with an annual range extending across the continental shelves of the Bering and Chukchi Seas. We used a discrete choice model to estimate site selection by adult radio-tagged walruses relative to the availability of the caloric biomass of benthic infauna and sea ice concentration in a prominent walrus wintering area in the northern Bering Sea (St. Lawrence Island polynya) in 2006, 2008, and 2009. At least 60% of the total caloric biomass of dominant macroinfauna in the study area was composed of members of the bivalve families Nuculidae, Tellinidae, and Nuculanidae. Model estimates indicated walrus site selection was related most strongly to tellinid bivalve caloric biomass distribution and that walruses selected lower ice concentrations from the mostly high ice concentrations that were available to them (quartiles: 76%, 93%, and 99%). Areas with high average predicted walrus site selection generally coincided with areas of high organic carbon input identified in other studies. Projected decreases in sea ice in the St. Lawrence Island polynya and the potential for a concomitant decline of bivalves in the region could result in a northward shift in the wintering grounds of walruses in the northern Bering Sea.	[Jay, Chadwick V.; Fischbach, Anthony S.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99504 USA; [Grebmeier, Jacqueline M.; Cooper, Lee W.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [McDonald, Trent L.; Hornsby, Fawn] Western EcoSyst Technol Inc, Laramie, WY USA	United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland Center for Environmental Science	Jay, CV (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99504 USA.	cjay@usgs.gov	Cooper, Lee W./E-5251-2012; Grebmeier, Jacqueline/L-9805-2013	Cooper, Lee W./0000-0001-7734-8388; Grebmeier, Jacqueline/0000-0001-7624-3568	U.S. National Science Foundation [ARC-082290]; North Pacific Research Board (BSIERP) [B67]; U.S. Fish & Wildlife Service; U.S. Geological Survey; North Pacific Research Board (NPRB) [632]; U.S. National Science Foundation; U.S. Geological Survey, Ecosystems Mission Area, Wildlife Program, and North Pacific Research Board (NPRB) [B67]; BEST-BSIERP Bering Sea Project [136]	U.S. National Science Foundation(National Science Foundation (NSF)); North Pacific Research Board (BSIERP); U.S. Fish & Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey); North Pacific Research Board (NPRB); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Geological Survey, Ecosystems Mission Area, Wildlife Program, and North Pacific Research Board (NPRB); BEST-BSIERP Bering Sea Project	Financial support was provided to PIs Grebmeier and Cooper through the U.S. National Science Foundation (ARC-082290) and the North Pacific Research Board (BSIERP Project B67). Walrus tagging data in 2006 was obtained from a separate project with financial support from U.S. Fish & Wildlife Service, U.S. Geological Survey, and North Pacific Research Board (NPRB # 632). Tagging data in 2008 and 2009 was obtained specifically for this project with ship and aerial support from the U.S. National Science Foundation and financial support from the U.S. Geological Survey, Ecosystems Mission Area, Wildlife Program, and North Pacific Research Board (NPRB # B67). This work was assigned the following project numbers: BEST-BSIERP Bering Sea Project publication number 136 and NPRB publication number 480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; BRAWN VM, 1968, J FISH RES BOARD CAN, V25, P1803, DOI 10.1139/f68-166; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burns J.J., 1981, E BERING SEA SHELF O, V2, P781; Carriere MA, 2010, CAN J ZOOL, V88, P846, DOI 10.1139/Z10-048; CAVALIERI DJ, 1991, J GEOPHYS RES-OCEANS, V96, P21989, DOI 10.1029/91JC02335; Collecte Localisation Satellites, 2011, ARG US MAN; Cooper LW, 2013, DEEP-SEA RES PT II, V94, P31, DOI 10.1016/j.dsr2.2013.03.009; Cooper LW, 2012, DEEP-SEA RES PT II, V65-70, P141, DOI 10.1016/j.dsr2.2012.02.002; Cooper LW, 2002, MAR ECOL PROG SER, V226, P13, DOI 10.3354/meps226013; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Danielson S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003268; Dedrick KR, 2001, CAN J REMOTE SENS, V27, P457, DOI 10.1080/07038992.2001.10854887; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Douglas DC, 2010, 20101176 US GEOL SUR, P1; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; FAY F H, 1985, Mammalian Species, P1, DOI 10.2307/3503810; Fay F.H., 1982, 74 US FISH WILDF SER; Fay FH, 1977, PB273505 UD DEP COMM; FEDER HM, 1994, MAR ECOL PROG SER, V111, P171, DOI 10.3354/meps111171; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; GREBMEIER JM, 1995, J GEOPHYS RES-OCEANS, V100, P4439, DOI 10.1029/94JC02198; Hondolero D, 2012, POLAR BIOL, V35, P637, DOI 10.1007/s00300-011-1107-x; Jay CV, 2012, MAR ECOL PROG SER, V468, P1, DOI 10.3354/meps10057; Jay CV, 2011, POLAR BIOL, V34, P1065, DOI 10.1007/s00300-011-0967-4; Jay CV, 2010, MAR ECOL PROG SER, V407, P293, DOI 10.3354/meps08575; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Lindqvist C, 2009, ZOOL SCR, V38, P113, DOI 10.1111/j.1463-6409.2008.00364.x; Lovvorn JR, 2014, ECOL APPL, V24, P396, DOI 10.1890/13-0411.1; Lovvorn JR, 2013, MAR ECOL PROG SER, V489, P245, DOI 10.3354/meps10439; Lovvorn JR, 2009, ECOL APPL, V19, P1596, DOI 10.1890/08-1193.1; Manly B.F.J., 2002, RESOURCE SELECTION A; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; OLIVER JS, 1983, FISH B-NOAA, V81, P501; Partington K, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001623; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Sheffield G, 2009, MAR MAMMAL SCI, V25, P761, DOI 10.1111/j.1748-7692.2009.00316.x; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; STIRLING I, 1980, ARCTIC, V33, P303; STOKER S., 1978, THESIS U ALASKA FAIR; Stoker S, 1981, E BERING SEA SHELF O, P1069; STRINGER WJ, 1991, ARCTIC, V44, P164; Tynan CT, 1997, ARCTIC, V50, P308, DOI 10.14430/arctic1113; Wang MY, 2012, DEEP-SEA RES PT II, V65-70, P46, DOI 10.1016/j.dsr2.2012.02.022; Wilt LM, 2012, THESIS U MARYLAND CO; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172	54	29	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93035	10.1371/journal.pone.0093035	http://dx.doi.org/10.1371/journal.pone.0093035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717979	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000024
J	Lu, S; Wang, RX; Cai, CL; Liang, JB; Xu, LC; Miao, SY; Wang, LF; Song, W				Lu, Shan; Wang, Renxian; Cai, Congli; Liang, Junbo; Xu, Longchang; Miao, Shiying; Wang, Linfang; Song, Wei			Small Kinetochore Associated Protein (SKAP) Promotes UV-Induced Cell Apoptosis through Negatively Regulating Pre-mRNA Processing Factor 19 (Prp19)	PLOS ONE			English	Article							COMPLEX; DEATH; INTERACTS; U5	Apoptosis is a regulated cellular suicide program that is critical for the development and maintenance of healthy tissues. Previous studies have shown that small kinetochore associated protein (SKAP) cooperates with kinetochore and mitotic spindle proteins to regulate mitosis. However, the role of SKAP in apoptosis has not been investigated. We have identified a new interaction involving SKAP, and we propose a mechanism through which SKAP regulates cell apoptosis. Our experiments demonstrate that both overexpression and knockdown of SKAP sensitize cells to UV-induced apoptosis. Further study has revealed that SKAP interacts with Pre-mRNA processing Factor 19 (Prp19). We find that UV-induced apoptosis can be inhibited by ectopic expression of Prp19, whereas silencing Prp19 has the opposite effect. Additionally, SKAP negatively regulates the protein levels of Prp19, whereas Prp19 does not alter SKAP expression. Finally, rescue experiments demonstrate that the pro-apoptotic role of SKAP is executed through Prp19. Taken together, these findings suggest that SKAP promotes UV-induced cell apoptosis by negatively regulating the anti-apoptotic protein Prp19.	[Lu, Shan; Wang, Renxian; Cai, Congli; Liang, Junbo; Xu, Longchang; Miao, Shiying; Wang, Linfang; Song, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Biochem & Mol Biol,State Key Lab Med Mol Bio, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Song, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Biochem & Mol Biol,State Key Lab Med Mol Bio, Beijing 100730, Peoples R China.	songwei@ibms.pumc.edu.cn	王, 任先/HHS-8169-2022; Xu, Lon Chang/HGU-1004-2022; Liang, Junbo/AFN-3446-2022		State Key Laboratory Special fund from the Ministry of Science [2060204]; National Important Research Plan of China [2012BAI31B08, 2012CB944902, 2011CB944302]; National Natural Sciences Foundation of China [81101855]; Specialized Research Fund for the Doctoral Program of Higher Education [20111106120018]	State Key Laboratory Special fund from the Ministry of Science; National Important Research Plan of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the State Key Laboratory Special fund from the Ministry of Science (2060204), grants from the National Important Research Plan of China (2012BAI31B08, 2012CB944902, and 2011CB944302), a grant from the National Natural Sciences Foundation of China (81101855), and grants from the Specialized Research Fund for the Doctoral Program of Higher Education (20111106120018, 20111106120018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bachelor MA, 2004, J BIOL CHEM, V279, P42658, DOI 10.1074/jbc.M406626200; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chanarat S, 2011, GENE DEV, V25, P1147, DOI 10.1101/gad.623411; Cheng XW, 2012, FEBS LETT, V586, P1497, DOI 10.1016/j.febslet.2012.04.005; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; HENRIQUES JAP, 1980, GENETICS, V95, P273; Hofmann JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074851; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Qiao Y, 2004, CELL RES, V14, P197, DOI 10.1038/sj.cr.7290220; Rai Nirendra K, 2005, Int J Low Extrem Wounds, V4, P138, DOI 10.1177/1534734605280018; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wang XD, 2001, GENE DEV, V15, P2922; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030	30	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92712	10.1371/journal.pone.0092712	http://dx.doi.org/10.1371/journal.pone.0092712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718257	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000017
J	Moore, KA; Stanton, ML				Moore, Kara A.; Stanton, Maureen L.			Propagule Limitation, Disparate Habitat Quality, and Variation in Phenotypic Selection at a Local Species Range Boundary	PLOS ONE			English	Article							INTERSPECIFIC COMPETITION; FITNESS VARIATION; ANNUAL PLANTS; EVOLUTION; LIMITS; ADAPTATION; POPULATIONS; DISPERSAL; CLIMATE; NICHE	Adaptation to novel conditions beyond current range boundaries requires the presence of suitable sites within dispersal range, but may be impeded when emigrants encounter poor habitat and sharply different selection pressures. We investigated fine-scale spatial heterogeneity in ecological dynamics and selection at a local population boundary of the annual plant Gilia tricolor. In two years, we planted G. tricolor seeds in core habitat, margin habitat at the edge of the local range, and exterior habitat in order to measure spatial and temporal variation in habitat quality, opportunity for selection, and selection on phenotypic traits. We found a striking decline in average habitat quality with distance from the population core, yet some migrant seeds were successful in suitable, unoccupied microsites at and beyond the range boundary. Total and direct selection on four out of five measured phenotypic traits varied across habitat zones, as well as between years. Moreover, the margin habitat often exerted unique selection pressures that were not intermediate between core and exterior habitats. This study reveals that a combination of ecological and evolutionary forces, including propagule limitation, variation in habitat quality and spatial heterogeneity in phenotypic selection may reduce opportunities for adaptive range expansion, even across a very local population boundary.	[Moore, Kara A.; Stanton, Maureen L.] Univ Calif Davis, Ctr Populat Biol, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Moore, KA (corresponding author), Univ Calif Davis, Ctr Populat Biol, Dept Ecol & Evolut, Davis, CA 95616 USA.	kmoore@ucdavis.edu			NSF [DEB-0919230]	NSF(National Science Foundation (NSF))	This project was funded by NSF grant DEB-0919230, http://www.nsf.gov/div/index.jsp?div=DEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHIYALY SAK, 1993, HEREDITY, V70, P22, DOI 10.1038/hdy.1993.4; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Angert AL, 2008, EVOLUTION, V62, P2660, DOI 10.1111/j.1558-5646.2008.00471.x; [Anonymous], 1991, EVOLUTIONARY GENETIC; ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; Baack EJ, 2006, ECOLOGY, V87, P2736, DOI 10.1890/0012-9658(2006)87[2736:EFLTDO]2.0.CO;2; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; BRADSHAW AD, 1991, ANN BOT-LONDON, V67, P5, DOI 10.1093/oxfordjournals.aob.a088209; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Broitman BR, 2008, ECOLOGY, V89, pS81, DOI 10.1890/08-0635.1; Case TJ, 2005, OIKOS, V108, P28, DOI 10.1111/j.0030-1299.2005.13148.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Castilla JC, 2004, P NATL ACAD SCI USA, V101, P8517, DOI 10.1073/pnas.0401921101; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CROW JF, 1958, AM ANTHROPOL, V60, P1; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Eckhart VM, 2011, AM NAT, V178, pS26, DOI 10.1086/661782; Emery NC, 2011, EVOLUTION, V65, P1011, DOI 10.1111/j.1558-5646.2010.01183.x; Filin I, 2008, AM NAT, V172, P233, DOI 10.1086/589459; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Geber MA, 2005, EVOLUTION, V59, P521; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; KAWECKI TJ, 1995, EVOL ECOL, V9, P38, DOI 10.1007/BF01237695; Kingsolver JG, 2012, EVOL ECOL, V26, P1101, DOI 10.1007/s10682-012-9563-5; Kramer HAC, 2011, PLANT ECOL, V212, P1887, DOI 10.1007/s11258-011-9961-8; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Leger EA, 2007, J EVOLUTION BIOL, V20, P1090, DOI 10.1111/j.1420-9101.2006.01292.x; LINHART YB, 1988, EVOLUTION, V42, P1047, DOI 10.1111/j.1558-5646.1988.tb02523.x; MACNAIR MR, 1993, NEW PHYTOL, V124, P541, DOI 10.1111/j.1469-8137.1993.tb03846.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Moeller DA, 2012, ECOLOGY, V93, P1036, DOI 10.1890/11-1462.1; Moore KA, 2011, SERPENTINE MODEL EVO; Moore KA, 2009, ECOLOGY, V90, P378, DOI 10.1890/07-1753.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PRIMACK RB, 1992, CONSERV BIOL, V6, P513, DOI 10.1046/j.1523-1739.1992.06040513.x; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Scheiner SM, 2002, EVOLUTION, V56, P2156, DOI 10.1111/j.0014-3820.2002.tb00140.x; SCHERFF EJ, 1994, OIKOS, V69, P405, DOI 10.2307/3545853; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Stratton DA, 1998, EVOLUTION, V52, P678, DOI 10.2307/2411263; TERBORGH J, 1971, Ecology (Washington D C), V52, P23, DOI 10.2307/1934735; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; Wright JW, 2006, EVOL ECOL RES, V8, P1; Zuur Alain F., 2009, P1	51	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e89404	10.1371/journal.pone.0089404	http://dx.doi.org/10.1371/journal.pone.0089404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717472	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000005
J	Smith, HK; Matthews, KG; Oldham, JM; Jeanplong, F; Falconer, SJ; Bass, JJ; Senna-Salerno, M; Bracegirdle, JW; McMahon, CD				Smith, Heather K.; Matthews, Kenneth G.; Oldham, Jenny M.; Jeanplong, Ferenc; Falconer, Shelley J.; Bass, James J.; Senna-Salerno, Monica; Bracegirdle, Jeremy W.; McMahon, Christopher D.			Translational Signalling, Atrogenic and Myogenic Gene Expression during Unloading and Reloading of Skeletal Muscle in Myostatin-Deficient Mice	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; MYOFIBRILLAR PROTEIN-SYNTHESIS; HYDROXY-BETA-METHYLBUTYRATE; GROWTH-FACTOR-I; SATELLITE CELLS; ELECTROPHORETIC SEPARATION; GEL ELECTROPHORESIS; MESSENGER-RNAS; SOLEUS MUSCLE; MYOD	Skeletal muscles of myostatin null (Mstn(2/2)) mice are more susceptible to atrophy during hind limb suspension (HS) than are muscles of wild-type mice. Here we sought to elucidate the mechanism for this susceptibility and to determine if Mstn(2/2) mice can regain muscle mass after HS. Male Mstn(2/2) and wild-type mice were subjected to 0, 2 or 7 days of HS or 7 days of HS followed by 1, 3 or 7 days of reloading (n = 6 per group). Mstn(2/2) mice lost more mass from muscles expressing the fast type IIb myofibres during HS and muscle mass was recovered in both genotypes after reloading for 7 days. Concentrations of MAFbx and MuRF1 mRNA, crucial ligases regulating the ubiquitin-proteasome system, but not MUSA1, a BMP-regulated ubiquitin ligase, were increased more in muscles of Mstn(2/2) mice, compared with wild-type mice, during HS and concentrations decreased in both genotypes during reloading. Similarly, concentrations of LC3b, Gabarapl1 and Atg4b, key effectors of the autophagy-lysosomal system, were increased further in muscles of Mstn(2/2) mice, compared with wild-type mice, during HS and decreased in both genotypes during reloading. There was a greater abundance of 4E-BP1 and more bound to eIF4E in muscles of Mstn(2/2) compared with wild-type mice (P, 0.001). The ratio of phosphorylated to total eIF2a increased during HS and decreased during reloading, while the opposite pattern was observed for rpS6. Concentrations of myogenic regulatory factors (MyoD, Myf5 and myogenin) mRNA were increased during HS in muscles of Mstn(2/2) mice compared with controls (P, 0.001). We attribute the susceptibility of skeletal muscles of Mstn(2/2) mice to atrophy during HS to an up-and downregulation, respectively, of the mechanisms regulating atrophy of myofibres and translation of mRNA. These processes are reversed during reloading to aid a faster rate of recovery of muscle mass in Mstn(2/2) mice.	[Smith, Heather K.] Univ Auckland, Dept Sport & Exercise Sci, Auckland 1, New Zealand; [Matthews, Kenneth G.; Oldham, Jenny M.; Jeanplong, Ferenc; Falconer, Shelley J.; Senna-Salerno, Monica; Bracegirdle, Jeremy W.; McMahon, Christopher D.] AgResearch, Ruakura Agr Ctr, Hamilton, New Zealand; [Bass, James J.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Auckland; AgResearch - New Zealand; University of Auckland	McMahon, CD (corresponding author), AgResearch, Ruakura Agr Ctr, Hamilton, New Zealand.	chris.mcmahon@agresearch.co.nz	Jeanplong, Ferenc/M-4920-2013	Falconer, Shelley/0000-0003-2860-3842; Bracegirdle, Jeremy/0000-0002-9471-4527	Marsden Fund, a division of the Royal Society of New Zealand	Marsden Fund, a division of the Royal Society of New Zealand	This research was supported by a grant from the Marsden Fund, a division of the Royal Society of New Zealand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alway SE, 2001, EXP PHYSIOL, V86, P509, DOI 10.1113/eph8602235; Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Amthor H, 2009, P NATL ACAD SCI USA, V106, P7479, DOI 10.1073/pnas.0811129106; Attaix D, 2010, CURR OPIN CLIN NUTR, V13, P223, DOI 10.1097/MCO.0b013e328338b9a6; Baldwin Kenneth M, 2013, Front Physiol, V4, P284, DOI 10.3389/fphys.2013.00284; Bamman MM, 1999, ELECTROPHORESIS, V20, P466, DOI 10.1002/(SICI)1522-2683(19990301)20:3<466::AID-ELPS466>3.0.CO;2-7; BAR A, 1988, FEBS LETT, V235, P153, DOI 10.1016/0014-5793(88)81253-5; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Blough ER, 1996, ANAL BIOCHEM, V233, P31, DOI 10.1006/abio.1996.0003; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bruusgaard JC, 1985, J APPL PHYSIOL, V113, P290, DOI [10.1152/japplphysiol.00436, DOI 10.1152/JAPPLPHYSIOL.00436]; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dumont N, 2008, AM J PHYSIOL-REG I, V295, pR1831, DOI 10.1152/ajpregu.90318.2008; Ekmark M, 2007, J PHYSIOL-LONDON, V584, P637, DOI 10.1113/jphysiol.2007.141457; Eley HL, 2007, BIOCHEM J, V407, P113, DOI 10.1042/BJ20070651; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Frenette J, 2002, AM J PHYSIOL-REG I, V282, pR351, DOI 10.1152/ajpregu.00189.2001; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; GenStat, 2003, GENSTAT; Giger JM, 2000, AM J PHYSIOL-CELL PH, V278, pC1153, DOI 10.1152/ajpcell.2000.278.6.C1153; Giger JM, 2009, J APPL PHYSIOL, V107, P1204, DOI 10.1152/japplphysiol.00344.2009; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Girgenrath S, 2004, MUSCLE NERVE; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haddad F, 2006, J APPL PHYSIOL, V100, P433, DOI 10.1152/japplphysiol.01203.2005; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hornberger TA, 2001, AM J PHYSIOL-CELL PH, V281, pC179, DOI 10.1152/ajpcell.2001.281.1.C179; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; Lee JY, 2011, BIOCHEM BIOPH RES CO, V415, P632, DOI 10.1016/j.bbrc.2011.10.124; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Machida S, 2004, MED SCI SPORT EXER, V36, P52, DOI 10.1249/01.MSS.0000106175.24978.84; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V285, pE82, DOI 10.1152/ajpendo.00275.2002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Mozdziak PE, 1999, AVIAT SPACE ENVIR MD, V70, P511; Murakami T, 2008, ANAT SCI INT, V83, P68, DOI 10.1111/j.1447-073x.2007.00205.x; Okamoto T, 2011, J PHYSIOL SCI, V61, P537, DOI 10.1007/s12576-011-0175-6; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Reardon KA, 2001, MUSCLE NERVE, V24, P893, DOI 10.1002/mus.1086.abs; Reiser PJ, 1998, AM J PHYSIOL-HEART C, V274, pH1048, DOI 10.1152/ajpheart.1998.274.3.H1048; RILEY DA, 1992, J APPL PHYSIOL, V73, pS33, DOI 10.1152/jappl.1992.73.2.S33; Rodino-Klapac LR, 2009, MUSCLE NERVE, V39, P283, DOI 10.1002/mus.21244; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schmalbruch H, 2000, MUSCLE NERVE, V23, P617, DOI 10.1002/(SICI)1097-4598(200004)23:4<617::AID-MUS22>3.0.CO;2-Y; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seiliez I, 2013, GEN COMP ENDOCR, V186, P9, DOI 10.1016/j.ygcen.2013.02.008; Shavlakadze T, 2009, BIOGERONTOLOGY; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130, DOI 10.1152/jappl.1987.63.1.130; THOMASON DB, 1989, AM J PHYSIOL, V257, pR300, DOI 10.1152/ajpregu.1989.257.2.R300; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Wheeler MT, 1999, AM J PHYSIOL-CELL PH, V276, pC1069, DOI 10.1152/ajpcell.1999.276.5.C1069; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	91	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94356	10.1371/journal.pone.0094356	http://dx.doi.org/10.1371/journal.pone.0094356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718581	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000109
J	Lima, AJS; Hoogeveen-Westerveld, M; Nakashima, A; Maat-Kievit, A; van den Ouweland, A; Halley, D; Kikkawa, U; Nellist, M				Lima, Arthur Jorge Santiago; Hoogeveen-Westerveld, Marianne; Nakashima, Akio; Maat-Kievit, Anneke; van den Ouweland, Ans; Halley, Dicky; Kikkawa, Ushio; Nellist, Mark			Identification of Regions Critical for the Integrity of the TSC1-TSC2-TBC1D7 Complex	PLOS ONE			English	Article							TSC1; HAMARTIN; TUBERIN; PROTEIN; TBC1D7; DOMAIN; INDIVIDUALS; SUBUNIT; GROWTH	The TSC1-TSC2-TBC1D7 complex is an important negative regulator of the mechanistic target of rapamycin complex 1 that controls cell growth in response to environmental cues. Inactivating TSC1 and TSC2 mutations cause tuberous sclerosis complex (TSC), an autosomal dominant disorder characterised by the occurrence of benign tumours in various organs and tissues, notably the brain, skin and kidneys. TBC1D7 mutations have not been reported in TSC patients but homozygous inactivation of TBC1D7 causes megaencephaly and intellectual disability. Here, using an exon-specific deletion strategy, we demonstrate that some regions of TSC1 are not necessary for the core function of the TSC1-TSC2 complex. Furthermore, we show that the TBC1D7 binding site is encoded by TSC1 exon 22 and identify amino acid residues involved in the TSC1-TBC1D7 interaction.	[Lima, Arthur Jorge Santiago; Hoogeveen-Westerveld, Marianne; Maat-Kievit, Anneke; van den Ouweland, Ans; Halley, Dicky; Nellist, Mark] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Nakashima, Akio; Kikkawa, Ushio] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan	Erasmus University Rotterdam; Erasmus MC; Kobe University	Nellist, M (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	m.nellist@erasmusmc.nl	Kievit, Anneke/O-8830-2014		Department of Clinical Genetics, Erasmus MC	Department of Clinical Genetics, Erasmus MC	The study was supported by the Department of Clinical Genetics, Erasmus MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Capo-Chichi JM, 2013, J MED GENET, V50, P740, DOI 10.1136/jmedgenet-2013-101680; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Hoogeveen-Westerveld M, 2012, HUM MUTAT, V33, P476, DOI 10.1002/humu.22007; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Hoogeveen-Westerveld M, 2010, BBA-MOL BASIS DIS, V1802, P774, DOI 10.1016/j.bbadis.2010.06.004; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martinez T, 2013, HUM GENET, V132, P481, DOI 10.1007/s00439-013-1288-1; Mozaffari M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-88; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; NELLIST M, 1993, CELL, V75, P1305; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; Rosner M, 2008, MUTAT RES-REV MUTAT, V658, P234, DOI 10.1016/j.mrrev.2008.01.001; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Structural genetics consortium, 2011, CRYST STRUCT HUM TBC; Sun W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3135; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822	28	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93940	10.1371/journal.pone.0093940	http://dx.doi.org/10.1371/journal.pone.0093940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714658	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900063
J	Parmar, HB; Barry, C; Duncan, R				Parmar, Hirendrasinh B.; Barry, Chris; Duncan, Roy			Polybasic Trafficking Signal Mediates Golgi Export, ER Retention or ER Export and Retrieval Based on Membrane-Proximity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; BABOON REOVIRUS; FUSION; MOTIFS; TRANSPORT; RECOGNITION; REQUIRES	Trafficking of integral membrane proteins between the ER and Golgi complex, and protein sorting and trafficking between the TGN and endosomal/lysosomal compartments or plasma membranes, are dependent on cis-acting, linear amino acid sorting signals. Numerous sorting signals of this type have been identified in the cytoplasmic domains of membrane proteins, several of which rely on basic residues. A novel Golgi export signal that relies on a membrane-proximal polybasic motif (PBM) was recently identified in the reptilian reovirus p14 protein, a representative of an unusual group of bitopic fusion-associated small transmembrane (FAST) proteins encoded by fusogenic orthoreoviruses and responsible for cell-cell fusion and syncytium formation. Using immunofluorescence microscopy, cell surface immunofluorescence, and endoglycosidase H assays, we now show the p14 PBM can mediate several distinct trafficking functions depending on its proximity to the transmembrane domain (TMD). When present within 4-residues of the TMD it serves as a Golgi export signal, but when located at the C-terminus of the 68-residue p14 cytoplasmic endodomain it functions as an ER retention signal. The PBM has no effect on protein trafficking when located at an internal position in the cytoplasmic domain. When present in both membrane-proximal and -distal locations, the PBMs promote export to, and efficient retrieval from, the Golgi complex. Interestingly, the conflicting trafficking signals provided by two PBMs induces extensive ER tubulation and segregation of ER components. These studies highlight how a single trafficking signal in a simple transmembrane protein can have remarkably diverse, position-dependent effects on protein trafficking and ER morphogenesis.	[Parmar, Hirendrasinh B.; Barry, Chris; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Duncan, Roy] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	roy.duncan@dal.ca	Barry, Christopher/G-5843-2015	Barry, Christopher/0000-0002-5413-5918; Duncan, Roy/0000-0002-5162-5081	Natural Sciences and Engineering Research Council of Canada (NSERC); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program (CRTP) with funding from the Dalhousie Cancer Research Program (DCRP)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program (CRTP) with funding from the Dalhousie Cancer Research Program (DCRP)	This work was funded by a grant to R.D. from the Natural Sciences and Engineering Research Council of Canada (NSERC). C.B. was supported by scholarships from the Nova Scotia Health Research Foundation (NSHRF) and the Cancer Research Training Program (CRTP) with funding from the Dalhousie Cancer Research Program (DCRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boutilier J, 2011, CURR TOP MEMBR, V68, P107, DOI 10.1016/B978-0-12-385891-7.00005-2; Brown CW, 2009, J VIROL, V83, P552, DOI 10.1128/JVI.01921-08; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Cobbold C, 2003, TRENDS CELL BIOL, V13, P639, DOI 10.1016/j.tcb.2003.10.008; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2005, J VIROL, V79, P6216, DOI 10.1128/JVI.79.10.6216-6226.2005; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Guo H, 2013, VIRUS RES, V171, P129, DOI 10.1016/j.virusres.2012.11.011; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Hardt B, 2003, GLYCOBIOLOGY, V13, P159, DOI 10.1093/glycob/cwg013; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Lu L, 2013, MOL BIOL CELL, V24, P1020, DOI 10.1091/mbc.E12-08-0575; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Parmar HB, 2014, MOL BIOL CE IN PRESS; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Top D, 2005, EMBO J, V24, P2980, DOI 10.1038/sj.emboj.7600767; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	44	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94194	10.1371/journal.pone.0094194	http://dx.doi.org/10.1371/journal.pone.0094194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714640	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900103
J	Wen, S; Zhang, HM; Li, YS; Wang, N; Zhang, WW; Yang, K; Wu, NN; Chen, X; Deng, F; Liao, Z; Zhang, JH; Zhang, Q; Yan, ZJ; Liu, W; Zhang, ZL; Ye, JX; Deng, YL; Zhou, GL; Luu, HH; Haydon, RC; Shi, LL; He, TC; Wei, GH				Wen, Sheng; Zhang, Hongmei; Li, Yasha; Wang, Ning; Zhang, Wenwen; Yang, Ke; Wu, Ningning; Chen, Xian; Deng, Fang; Liao, Zhan; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Zhang, Zhonglin; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.; He, Tong-Chuan; Wei, Guanghui			Characterization of Constitutive Promoters for piggyBac Transposon-Mediated Stable Transgene Expression in Mesenchymal Stem Cells (MSCs)	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOGENIC DIFFERENTIATION; SELECTION	Multipotent mesenchymal stem cells (MSCs) can undergo self-renewal and give rise to multi-lineages under given differentiation cues. It is frequently desirable to achieve a stable and high level of transgene expression in MSCs in order to elucidate possible molecular mechanisms through which MSC self-renewal and lineage commitment are regulated. Retroviral or lentiviral vector-mediated gene expression in MSCs usually decreases over time. Here, we choose to use the piggyBac transposon system and conduct a systematic comparison of six commonly-used constitutive promoters for their abilities to drive RFP or firefly luciferase expression in somatic HEK-293 cells and MSC iMEF cells. The analyzed promoters include three viral promoters (CMV, CMV-IVS, and SV40), one housekeeping gene promoter (UbC), and two composite promoters of viral and housekeeping gene promoters (hEFH and CAG-hEFH). CMV-derived promoters are shown to drive the highest transgene expression in HEK-293 cells, which is however significantly reduced in MSCs. Conversely, the composite promoter hEFH exhibits the highest transgene expression in MSCs whereas its promoter activity is modest in HEK-293 cells. The reduced transgene expression driven by CMV promoters in MSCs may be at least in part caused by DNA methylation, or to a lesser extent histone deacetlyation. However, the hEFH promoter is not significantly affected by these epigenetic modifications. Taken together, our results demonstrate that the hEFH composite promoter may be an ideal promoter to drive long-term and high level transgene expression using the piggyBac transposon vector in progenitor cells such as MSCs.	[Wen, Sheng; Li, Yasha; Yang, Ke; Wu, Ningning; Zhang, Qian; Liu, Wei; He, Tong-Chuan; Wei, Guanghui] Chongqing Med Univ, Chongqing Stem Cell Therapy & Engn Ctr, Key Lab Pediat, Minist Educ,Stem Cell Biol & Therapy Lab,Children, Chongqing, Peoples R China; [Wen, Sheng; Li, Yasha; Yang, Ke; Wu, Ningning; Zhang, Qian; Liu, Wei; He, Tong-Chuan; Wei, Guanghui] Chongqing Med Univ, Childrens Hosp, Dept Urol, Chongqing, Peoples R China; [Zhang, Hongmei] Chongqing Med Univ, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Zhang, Hongmei] Chongqing Med Univ, Affiliated Hosp Stomatol, Chongqing, Peoples R China; [Zhang, Hongmei; Wang, Ning; Zhang, Wenwen; Yang, Ke; Wu, Ningning; Chen, Xian; Deng, Fang; Liao, Zhan; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Zhang, Zhonglin; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.] Univ Chicago, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA; [Zhang, Wenwen; Wu, Ningning; Chen, Xian; Zhang, Junhui; Yan, Zhengjian; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China; [Zhang, Wenwen; Wu, Ningning; Chen, Xian; Zhang, Junhui; Yan, Zhengjian; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Sch Clin Diagnost Med, Chongqing, Peoples R China; [Wang, Ning; Wu, Ningning; Chen, Xian; Zhang, Junhui; Yan, Zhengjian; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Wang, Ning; Deng, Fang] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Cell Biol, Chongqing, Peoples R China; [Wang, Ning; Deng, Fang] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Liao, Zhan] Cent S Univ, Affiliated Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Hunan, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Army Medical University; Central South University; Wuhan University; Chongqing University	He, TC (corresponding author), Chongqing Med Univ, Chongqing Stem Cell Therapy & Engn Ctr, Key Lab Pediat, Minist Educ,Stem Cell Biol & Therapy Lab,Children, Chongqing, Peoples R China.	tche@uchicago.edu; guanghuiwei2012@gmail.com		Deng, Fang/0000-0002-7927-5394	National Institutes of Health; 973 Program of the Ministry of Science and Technology (MOST) of China [2011CB707906]; National Natural Science Foundation of China [81370701]; Program for Innovation Team Building at Higher Education Institutions in Chongqing, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of the Ministry of Science and Technology (MOST) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovation Team Building at Higher Education Institutions in Chongqing, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The reported work was supported in part by research grants from the National Institutes of Health (RCH, TCH and HHL), the 973 Program of the Ministry of Science and Technology (MOST) of China (#2011CB707906 to TCH), National Natural Science Foundation of China (# 81370701 to GW), and the 2013 Program for Innovation Team Building at Higher Education Institutions in Chongqing, China (to GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Choi KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072184; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Ellis J, 2005, CURR GENE THER, V5, P367, DOI 10.2174/1566523054546233; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kong YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1187, DOI 10.1159/000354518; Krishnan M, 2005, FASEB J, V19, P106, DOI 10.1096/fj.05-4551fje; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Liu X, 2013, J CELL MOL MED; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; MIYAZAKI J, 1989, GENE, V79, P269; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rival-Gervier S, 2013, MOL THER, V21, P1536, DOI 10.1038/mt.2013.131; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shui W, 2013, J BIOMED MAT RES A; Stewart R, 2008, REGEN MED, V3, P505, DOI 10.2217/17460751.3.4.505; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Wang X, 2013, J BIOMED MAT RES A; Wang Y, 2013, J ORTHOP RES; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073086; Zhang WW, 2013, INT J MED SCI, V10, P1888, DOI 10.7150/ijms.6019; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	48	41	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94397	10.1371/journal.pone.0094397	http://dx.doi.org/10.1371/journal.pone.0094397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714676	gold, Green Submitted, Green Published			2022-12-27	WOS:000334160900125
J	Widderich, N; Hoppner, A; Pittelkow, M; Heider, J; Smits, SHJ; Bremer, E				Widderich, Nils; Hoeppner, Astrid; Pittelkow, Marco; Heider, Johann; Smits, Sander H. J.; Bremer, Erhard			Biochemical Properties of Ectoine Hydroxylases from Extremophiles and Their Wider Taxonomic Distribution among Microorganisms	PLOS ONE			English	Article							COMPATIBLE SOLUTE ECTOINE; TETRAHYDROPYRIMIDINE DERIVATIVES; TRANSCRIPTIONAL REGULATOR; ACIDIPHILIUM-CRYPTUM; BIOSYNTHESIS GENES; ESCHERICHIA-COLI; GLYCINE BETAINE; SP NOV.; HYDROXYECTOINE; BACTERIUM	Ectoine and hydroxyectoine are well-recognized members of the compatible solutes and are widely employed by microorganisms as osmostress protectants. The EctABC enzymes catalyze the synthesis of ectoine from the precursor L-aspartate-beta-semialdehyde. A subgroup of the ectoine producers can convert ectoine into 5-hydroxyectoine through a region-selective and stereospecific hydroxylation reaction. This compatible solute possesses stress-protective and function-preserving properties different from those of ectoine. Hydroxylation of ectoine is carried out by the EctD protein, a member of the non-heme-containing iron (II) and 2-oxoglutarate-dependent dioxygenase superfamily. We used the signature enzymes for ectoine (EctC) and hydroxyectoine (EctD) synthesis in database searches to assess the taxonomic distribution of potential ectoine and hydroxyectoine producers. Among 6428 microbial genomes inspected, 440 species are predicted to produce ectoine and of these, 272 are predicted to synthesize hydroxyectoine as well. Ectoine and hydroxyectoine genes are found almost exclusively in Bacteria. The genome context of the ect genes was explored to identify proteins that are functionally associated with the synthesis of ectoines; the specialized aspartokinase Ask_Ect and the regulatory protein EctR. This comprehensive in silico analysis was coupled with the biochemical characterization of ectoine hydroxylases from microorganisms that can colonize habitats with extremes in salinity (Halomonas elongata), pH (Alkalilimnicola ehrlichii, Acidiphilium cryptum), or temperature (Sphingopyxis alaskensis, Paenibacillus lautus) or that produce hydroxyectoine very efficiently over ectoine (Pseudomonas stutzeri). These six ectoine hydroxylases all possess similar kinetic parameters for their substrates but exhibit different temperature stabilities and differ in their tolerance to salts. We also report the crystal structure of the Virgibacillus salexigens EctD protein in its apo-form, thereby revealing that the iron-free structure exists already in a pre-set configuration to incorporate the iron catalyst. Collectively, our work defines the taxonomic distribution and salient biochemical properties of the ectoine hydroxylase protein family and contributes to the understanding of its structure.	[Widderich, Nils; Pittelkow, Marco; Heider, Johann; Bremer, Erhard] Univ Marburg, Dept Biol, Microbiol Lab, Marburg, Germany; [Widderich, Nils] Max Planck Inst Terr Microbiol, Emeritus Grp RK Thauer, D-35043 Marburg, Germany; [Hoeppner, Astrid] Univ Dusseldorf, XRay Facil & Crystal Farm, Dusseldorf, Germany; [Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany; [Heider, Johann; Bremer, Erhard] Univ Marburg, Ctr Synthet Microbiol, LOEWE, Marburg, Germany	Philipps University Marburg; Max Planck Society; Heinrich Heine University Dusseldorf	Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	sander.smits@hhu.de; bremer@biologie.uni-marburg.de	Heider, Johann/Y-2291-2018; Heider, Johann/ABA-7877-2021; Heider, Johann/A-1833-2012	Heider, Johann/0000-0001-8328-9716; Heider, Johann/0000-0001-8328-9716; Hoeppner, Astrid/0000-0002-7076-5936	Deutsche Forschungsgemeinschaft [SFB 987]; LOEWE program of the state of Hessen (via the Centre for Synthetic Microbiology, SYNMIKRO; Marburg); Max-Planck Institute for terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie; initiative "Fit for Excellence" of the Heinrich-Heine University of Dusseldorf; International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE program of the state of Hessen (via the Centre for Synthetic Microbiology, SYNMIKRO; Marburg); Max-Planck Institute for terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); initiative "Fit for Excellence" of the Heinrich-Heine University of Dusseldorf; International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	Funding for this study was generously provided by grants from the Deutsche Forschungsgemeinschaft through the SFB 987 and the LOEWE program of the state of Hessen (via the Centre for Synthetic Microbiology, SYNMIKRO; Marburg) (both to J.H. and E. B.), a contribution from the Max-Planck Institute for terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer (to N.W.), by the Fonds der Chemischen Industrie (to E. B.) and by the initiative "Fit for Excellence" of the Heinrich-Heine University of Dusseldorf (to A. H. and S.H.J.S.). N.W. war partly funded by the International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Becker J, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-110; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bestvater Thorsten, 2008, Saline Syst, V4, P12, DOI 10.1186/1746-1448-4-12; Bilgin AA, 2004, FEMS MICROBIOL ECOL, V49, P137, DOI 10.1016/j.femsec.2003.08.018; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; BROWN AD, 1976, BACTERIOL REV, V40, P803, DOI 10.1128/MMBR.40.4.803-846.1976; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; da Costa M. S., 1998, V61, P117; Doan VT, 2013, APPL MICROBIOL BIOT, V97, P6271, DOI 10.1007/s00253-012-4528-8; Eilert E, 2013, J BIOTECHNOL, V167, P85, DOI 10.1016/j.jbiotec.2013.02.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALINSKI EA, 1994, FEMS MICROBIOL REV, V15, P95, DOI 10.1111/j.1574-6976.1994.tb00128.x; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Hangasky JA, 2013, METALLOMICS, V5, P287, DOI 10.1039/c3mt20153h; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hoeft SE, 2007, INT J SYST EVOL MICR, V57, P504, DOI 10.1099/ijs.0.64576-0; Hoffmann T, 2013, J BACTERIOL, V195, P510, DOI 10.1128/JB.01505-12; INBAR L, 1988, J BIOL CHEM, V263, P16014; INBAR L, 1993, EUR J BIOCHEM, V214, P897, DOI 10.1111/j.1432-1033.1993.tb17993.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2011, J BACTERIOL, V193, P4699, DOI 10.1128/JB.05270-11; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; Kurz M, 2010, APPL ENVIRON MICROB, V76, P5452, DOI 10.1128/AEM.00686-10; Kusel K, 1999, APPL ENVIRON MICROB, V65, P3633; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mead DA, 2012, STAND GENOMIC SCI, V6, P366, DOI 10.4056/sigs.2605792; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustakhimov II, 2012, BIOCHEMISTRY-MOSCOW+, V77, P857, DOI 10.1134/S0006297912080068; Mustakhimov II, 2010, J BACTERIOL, V192, P410, DOI 10.1128/JB.00553-09; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; Ongagna-Yhombi SY, 2013, APPL ENVIRON MICROB, V79, P5038, DOI 10.1128/AEM.01008-13; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Pflughoeft KJ, 2003, APPL ENVIRON MICROB, V69, P5919, DOI 10.1128/AEM.69.10.5919-5927.2003; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Reshetnikov AS, 2011, EXTREMOPHILES, V15, P653, DOI 10.1007/s00792-011-0396-x; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; Reuter K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010647; Rodriguez-Moya J, 2013, APPL ENVIRON MICROB, V79, P1018, DOI 10.1128/AEM.02774-12; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Saum Stephan H, 2008, Saline Syst, V4, P4, DOI 10.1186/1746-1448-4-4; Schubert T, 2007, APPL ENVIRON MICROB, V73, P3343, DOI 10.1128/AEM.02482-06; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Seip B, 2011, APPL ENVIRON MICROB, V77, P1368, DOI 10.1128/AEM.02124-10; Shikuma NJ, 2013, ENVIRON MICROBIOL, V15, P1387, DOI 10.1111/j.1462-2920.2012.02805.x; Sims D, 2009, STAND GENOMIC SCI, V1, P12, DOI 10.4056/sigs.761; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Thompson JD, 2000, NUCLEIC ACIDS RES, V28, P2919, DOI 10.1093/nar/28.15.2919; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Vancanneyt M, 2001, INT J SYST EVOL MICR, V51, P73, DOI 10.1099/00207713-51-1-73; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; VREELAND RH, 1980, INT J SYST BACTERIOL, V30, P485, DOI 10.1099/00207713-30-2-485; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Witt EMHJ, 2011, APPL MICROBIOL BIOT, V91, P113, DOI 10.1007/s00253-011-3211-9; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yan DL, 2011, APPL ENVIRON MICROB, V77, P6763, DOI 10.1128/AEM.05257-11; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105	84	53	62	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93809	10.1371/journal.pone.0093809	http://dx.doi.org/10.1371/journal.pone.0093809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714029	Green Published, gold			2022-12-27	WOS:000334160900050
J	Wilson, AM; Chiodo, VA; Boye, SL; Brecha, NC; Hauswirth, WW; Di Polo, A				Wilson, Ariel M.; Chiodo, Vince A.; Boye, Sanford L.; Brecha, Nicholas C.; Hauswirth, William W.; Di Polo, Adriana			Inhibitor of Apoptosis-Stimulating Protein of p53 (iASPP) Is Required for Neuronal Survival after Axonal Injury	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPTIC-NERVE; NEUROTROPHIC FACTOR; ASPP FAMILY; DEATH; ACTIVATION; EXPRESSION; PUMA; AXOTOMY; CANCER	The transcription factor p53 mediates the apoptosis of post-mitotic neurons exposed to a wide range of stress stimuli. The apoptotic activity of p53 is tightly regulated by the apoptosis-stimulating proteins of p53 (ASPP) family members: ASPP1, ASPP2 and iASPP. We previously showed that the pro-apoptotic members ASPP1 and ASPP2 contribute to p53-dependent death of retinal ganglion cells (RGCs). However, the role of the p53 inhibitor iASPP in the central nervous system (CNS) remains to be elucidated. To address this, we asked whether iASPP contributes to the survival of RGCs in an in vivo model of acute optic nerve damage. We demonstrate that iASPP is expressed by injured RGCs and that iASPP phosphorylation at serine residues, which increase iASPP affinity towards p53, is significantly reduced following axotomy. We show that short interference RNA (siRNA)-induced iASPP knockdown exacerbates RGC death, whereas adeno-associated virus (AAV)-mediated iASPP expression promotes RGC survival. Importantly, our data also demonstrate that increasing iASPP expression in RGCs downregulates p53 activity and blocks the expression of pro-apoptotic targets PUMA and Fas/CD95. This study demonstrates a novel role for iASPP in the survival of RGCs, and provides further evidence of the importance of the ASPP family in the regulation of neuronal loss after axonal injury.	[Wilson, Ariel M.; Di Polo, Adriana] Univ Montreal, Univ Montreal Hosp Res Ctr CR CHUM, Dept Neurosci, Montreal, PQ, Canada; [Wilson, Ariel M.; Di Polo, Adriana] Univ Montreal, Univ Montreal Hosp Res Ctr CR CHUM, Grpe Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Chiodo, Vince A.; Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA	Universite de Montreal; Universite de Montreal; State University System of Florida; University of Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Di Polo, A (corresponding author), Univ Montreal, Univ Montreal Hosp Res Ctr CR CHUM, Dept Neurosci, Montreal, PQ, Canada.	adriana.di.polo@umontreal.ca		hauswirth, william/0000-0002-3244-4947	Canadian Institutes of Health Research [CIHR-VIH-105439]; National Institutes of Health [NIH EY021721]; Macula Vision Research Foundation; Research to Prevent Blindness Inc.; NATIONAL EYE INSTITUTE [R01EY004067, P30EY021721] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000764] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by a grant from the Canadian Institutes of Health Research to ADP (CIHR-VIH-105439), and in part by the National Institutes of Health (NIH EY021721), the Macula Vision Research Foundation and Research to Prevent Blindness Inc. (WWH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo-Barriuso M, 2013, INVEST OPHTH VIS SCI, V54, P4249, DOI 10.1167/iovs.12-11451; Ahn J, 2009, J BIOL CHEM, V284, P13812, DOI 10.1074/jbc.M808821200; Ao Y, 2001, ONCOGENE, V20, P2720, DOI 10.1038/sj.onc.1204352; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Gabriel R, 1998, NEUROSCI LETT, V247, P179, DOI 10.1016/S0304-3940(98)00323-1; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Gregory M, 2011, PLOS ONE, V6; Guo Y, 2008, BIOCHEM BIOPH RES CO, V375, P1, DOI 10.1016/j.bbrc.2008.07.055; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Jin SQ, 2003, ONCOGENE, V22, P8536, DOI 10.1038/sj.onc.1206907; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; Kim HS, 2005, BRAIN RES, V1057, P17, DOI 10.1016/j.brainres.2005.07.005; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Li GL, 2011, MOL CELL BIOCHEM, V350, P193, DOI 10.1007/s11010-010-0698-9; Li SJ, 2012, ONCOL REP, V28, P133, DOI 10.3892/or.2012.1778; Liu H, 2009, LEUKEMIA RES, V33, P1243, DOI 10.1016/j.leukres.2009.02.016; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu ZJ, 2008, CANCER INVEST, V26, P878, DOI 10.1080/07357900801965042; Liu ZZ, 2012, MED ONCOL, V29, P3381, DOI 10.1007/s12032-012-0306-9; Lopez CD, 2000, MOL CELL BIOL, V20, P8018, DOI 10.1128/MCB.20.21.8018-8025.2000; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Pernet V, 2006, BRAIN, V129, P1014, DOI 10.1093/brain/awl015; Pernet V, 2005, J NEUROCHEM, V93, P72, DOI 10.1111/j.1471-4159.2005.03002.x; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rodriguez A, 2013, J COMP NEUR IN PRESS; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schlamp CL, 2013, MOL VIS, V19, P1387; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wilson AM, 2012, GENE THER, V19, P127, DOI 10.1038/gt.2011.142; Wilson AM, 2013, J NEUROSCI, V33, P2205, DOI 10.1523/JNEUROSCI.2635-12.2013; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang B, 2011, PROSTATE CANCER P D, V14, P219, DOI 10.1038/pcan.2011.25; Zhang XW, 2005, LEUKEMIA RES, V29, P179, DOI 10.1016/j.leukres.2004.07.001; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	61	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94175	10.1371/journal.pone.0094175	http://dx.doi.org/10.1371/journal.pone.0094175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714389	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900097
J	Chojnacki, RM; Vas, J; Andersen, IL				Chojnacki, Rachel M.; Vas, Judit; Andersen, Inger Lise			The Effects of Prenatal Stocking Densities on the Fear Responses and Sociality of Goat ( Capra hircus) Kids	PLOS ONE			English	Article							DOMESTIC GOAT; INDIVIDUAL RECOGNITION; EMOTIONAL REACTIVITY; BIRTH-WEIGHT; GROUP-SIZE; STRESS; BEHAVIOR; DISCRIMINATION; ORGANIZATION; GROWTH	relatively little research has been done on how prenatal social stress affects farm animals such as goats. Here, we use the operational description of `stress' as "physical or perceived threats to homeostasis.'' The aim of this study was to investigate the prenatal effects of different herd densities on the fear responses and sociality of goat kids. Pregnant Norwegian dairy goats were exposed to high, medium or low prenatal animal density treatments throughout gestation ( 1.0, 2.0 or 3.0 m 2 per animal, respectively). One kid per litter was subjected to two behavioral tests at 5 weeks of age. The `social test' was applied to assess the fear responses, sociality and social recognition skills when presented with a familiar and unfamiliar kid and the `separation test' assessed the behavioral coping skills when isolated. The results indicate goat kids from the highest prenatal density of 1.0 m 2 were more fearful than the kids from the lower prenatal densities ( i.e. made more escape attempts ( separation test: P < 0.001) and vocalizations ( social test: P, 0.001; separation test: P, 0.001). This effect was more pronounced in females than males in the high density ( vocalizations; social test: P, 0.001; separation test: P < 0.001) and females were generally more social than males. However, goat kids did not differentiate between a familiar and an unfamiliar kid at 5 weeks of age and sociality was not affected by the prenatal density treatment. We conclude that high animal densities during pregnancy in goats produce offspring that have a higher level of fear, particularly in females. Behavioral changes in offspring that occur as an effect of prenatal stress are of high importance as many of the females are recruited to the breeding stock of dairy goats.	[Chojnacki, Rachel M.; Vas, Judit; Andersen, Inger Lise] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Norwegian University of Life Sciences	Chojnacki, RM (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	Rachel.Chojnacki@nmbu.no	Vas, Judit/GRJ-7640-2022		EU [FP7-KBBE-2010-4]	EU(European Commission)	This study was conducted in frame of the Animal Welfare Indicators project (AWIN), which was financed by the EU VII Framework programme (FP7-KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY JC, 1994, SMALL RUMINANT RES, V13, P103, DOI 10.1016/0921-4488(94)90038-8; Andersen IL, 2008, APPL ANIM BEHAV SCI, V114, P132, DOI 10.1016/j.applanim.2008.01.007; Andersen IL, 2007, APPL ANIM BEHAV SCI, V108, P89, DOI 10.1016/j.applanim.2006.10.015; Andersen IL, 2011, APPL ANIM BEHAV SCI, V134, P136, DOI 10.1016/j.applanim.2011.08.003; ANDERSON DK, 1985, BRAIN RES, V332, P113, DOI 10.1016/0006-8993(85)90394-4; [Anonymous], 1988, P AUST SOC ANIM PROD; Asher MR, 2004, J MAMMAL, V85, P788, DOI 10.1644/BNS-012; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Barroso FG, 2000, APPL ANIM BEHAV SCI, V69, P35, DOI 10.1016/S0168-1591(00)00113-1; Beaulieu AD, 2010, J ANIM SCI, V88, P2767, DOI 10.2527/jas.2009-2222; Boivin X, 1996, APPL ANIM BEHAV SCI, V48, P61, DOI 10.1016/0168-1591(95)01019-X; Braastad BO, 1998, APPL ANIM BEHAV SCI, V57, P157, DOI 10.1016/S0168-1591(97)00114-7; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; Briefer E, 2011, ANIM COGN, V14, P585, DOI 10.1007/s10071-011-0396-3; Briefer EF, 2013, APPL ANIM BEHAV SCI, V146, P45, DOI 10.1016/j.applanim.2013.03.007; Briefer EF, 2012, P ROY SOC B-BIOL SCI, V279, P3749, DOI 10.1098/rspb.2012.0986; Briefer EF, 2012, ANIM BEHAV, V83, P991, DOI 10.1016/j.anbehav.2012.01.020; BROOM DM, 1988, APPL ANIM BEHAV SCI, V20, P5, DOI 10.1016/0168-1591(88)90122-0; Burton C, 2006, BEHAV NEUROSCI, V120, P665, DOI 10.1037/0735-7044.120.3.665; Cabrera RA, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-42; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; CHRISTIAN JJ, 1958, ENDOCRINOLOGY, V63, P517, DOI 10.1210/endo-63-5-517; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clarke AS, 1997, ANN NY ACAD SCI, V807, P490, DOI 10.1111/j.1749-6632.1997.tb51947.x; CLARKE AS, 1993, DEV PSYCHOBIOL, V26, P293, DOI 10.1002/dev.420260506; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; DEPASSILLE AM, 1995, APPL ANIM BEHAV SCI, V45, P201, DOI 10.1016/0168-1591(95)00622-Y; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Estanislau C, 2005, BEHAV BRAIN RES, V163, P70, DOI 10.1016/j.bbr.2005.04.003; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; Faerevik G, 2006, APPL ANIM BEHAV SCI, V99, P205, DOI 10.1016/j.applanim.2005.10.012; FOURNIER F, 1995, ANIM BEHAV, V49, P1449, DOI 10.1016/0003-3472(95)90066-7; FRIDE E, 1984, DEV PSYCHOBIOL, V17, P651; Fujioka A, 2006, NEUROSCIENCE, V141, P907, DOI 10.1016/j.neuroscience.2006.04.046; GHEUSI G, 1994, BEHAV PROCESS, V33, P59, DOI 10.1016/0376-6357(94)90060-4; Hayashi A, 1998, INT J DEV NEUROSCI, V16, P209, DOI 10.1016/S0736-5748(98)00028-8; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kapoor A, 2009, BEHAV BRAIN RES, V197, P144, DOI 10.1016/j.bbr.2008.08.018; Kay G, 1998, PHYSIOL BEHAV, V63, P397, DOI 10.1016/S0031-9384(97)00456-3; Keil NM, 2012, ANIM COGN, V15, P913, DOI 10.1007/s10071-012-0518-6; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; Koba Y, 2009, ANIM SCI J, V80, P98, DOI 10.1111/j.1740-0929.2008.00597.x; Krueger K, 2011, ANIM COGN, V14, P245, DOI 10.1007/s10071-010-0358-1; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lemasson A, 2009, ANIM COGN, V12, P693, DOI 10.1007/s10071-009-0229-9; LICKLITER RE, 1984, APPL ANIM BEHAV SCI, V12, P245, DOI 10.1016/0168-1591(84)90117-5; LICKLITER RE, 1987, APPL ANIM BEHAV SCI, V19, P137, DOI 10.1016/0168-1591(87)90210-3; Ligout S, 2004, ANIM BEHAV, V68, P785, DOI 10.1016/j.anbehav.2004.01.008; Ligout S, 2004, BEHAVIOUR, V141, P617, DOI 10.1163/1568539041166744; Ligout S, 2003, ANIM BEHAV, V65, P1109, DOI 10.1006/anbe.2003.2139; Ligout S, 2002, APPL ANIM BEHAV SCI, V76, P239, DOI 10.1016/S0168-1591(02)00015-1; Lui CC, 2011, NEUROCHEM INT, V58, P434, DOI 10.1016/j.neuint.2011.01.002; Maletinska J, 2002, BEHAVIOUR, V139, P975, DOI 10.1163/156853902320387927; Marchlewska-Koj A, 2003, PHYSIOL BEHAV, V79, P671, DOI 10.1016/S0031-9384(03)00168-9; Millman ST, 2001, SOCIAL COGNITION FAR; Miranda-de la Lama GC, 2010, SMALL RUMINANT RES, V90, P1, DOI 10.1016/j.smallrumres.2010.01.006; Murmu MS, 2006, EUR J NEUROSCI, V24, P1477, DOI 10.1111/j.1460-9568.2006.05024.x; Nishio H, 2001, INT J DEV NEUROSCI, V19, P37, DOI 10.1016/S0736-5748(00)00070-8; NOWAK R, 1990, DEV PSYCHOBIOL, V23, P285, DOI 10.1002/dev.420230307; OBRIEN PH, 1988, APPL ANIM BEHAV SCI, V21, P209, DOI 10.1016/0168-1591(88)90110-4; Ohkawa T, 1987, Nihon Naibunpi Gakkai Zasshi, V63, P823; Patin V, 2005, DEV BRAIN RES, V160, P265, DOI 10.1016/j.devbrainres.2005.09.010; Patt A, 2012, APPL ANIM BEHAV SCI, V138, P47, DOI 10.1016/j.applanim.2012.02.012; Poindron P, 2007, HORM BEHAV, V52, P99, DOI 10.1016/j.yhbeh.2007.03.023; Porter RH, 2001, BEHAVIOUR, V138, P207, DOI 10.1163/15685390151074384; PORTER RH, 1995, APPL ANIM BEHAV SCI, V45, P239, DOI 10.1016/0168-1591(95)00630-B; R Core Team, 2018, R LANG ENV STAT COMP; RICHARDSON C, 1978, BRIT VET J, V134, P181, DOI 10.1016/S0007-1935(17)33543-1; Roussel S, 2005, HORM BEHAV, V47, P256, DOI 10.1016/j.yhbeh.2004.09.010; Roussel S, 2004, APPL ANIM BEHAV SCI, V85, P259, DOI 10.1016/j.applanim.2003.11.006; Roussel-Huchette S, 2008, APPL ANIM BEHAV SCI, V109, P275, DOI 10.1016/j.applanim.2007.02.005; SACHS BD, 1978, ANIM BEHAV, V26, P678, DOI 10.1016/0003-3472(78)90134-3; Sachser N, 1996, PHYSIOL BEHAV, V60, P589, DOI 10.1016/S0031-9384(96)80036-9; Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6; SCHNEIDER ML, 1992, DEV PSYCHOBIOL, V25, P427, DOI 10.1002/dev.420250604; SHACKLETON DM, 1984, J ANIM SCI, V58, P500, DOI 10.2527/jas1984.582500x; Shi J, 2007, MAMMALIA MAMM, V69, P185; Siebert K, 2011, APPL ANIM BEHAV SCI, V131, P53, DOI 10.1016/j.applanim.2011.01.003; Silanikove N, 2000, SMALL RUMINANT RES, V35, P181, DOI 10.1016/S0921-4488(99)00096-6; SZURAN T, 1994, BEHAV BRAIN RES, V65, P153, DOI 10.1016/0166-4328(94)90100-7; TAKAHASHI LK, 1992, PHYSIOL BEHAV, V51, P319, DOI 10.1016/0031-9384(92)90147-T; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Vas J, 2013, APPL ANIM BEHAV SCI, V147, P117, DOI 10.1016/j.applanim.2013.04.009; VELAZQUEZMOCTEZUMA J, 1993, PHYSIOL BEHAV, V53, P443, DOI 10.1016/0031-9384(93)90137-5; WARD IL, 1972, SCIENCE, V175, P82, DOI 10.1126/science.175.4017.82; Weinstock M, 1997, NEUROSCI BIOBEHAV R, V21, P1, DOI 10.1016/S0149-7634(96)00014-0; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Wu J, 2007, BRAIN RES, V1141, P205, DOI 10.1016/j.brainres.2007.01.024; Zhu ZL, 2004, J NEUROSCI RES, V78, P837, DOI 10.1002/jnr.20338	91	7	7	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94253	10.1371/journal.pone.0094253	http://dx.doi.org/10.1371/journal.pone.0094253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710177	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800129
J	Gebreegziabiher, D; Desta, K; Desalegn, G; Howe, R; Abebe, M				Gebreegziabiher, Dawit; Desta, Kassu; Desalegn, Girmay; Howe, Rawleigh; Abebe, Markos			The Effect of Maternal Helminth Infection on Maternal and Neonatal Immune Function and Immunity to Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; IN-UTERO; CONGENITAL TUBERCULOSIS; WUCHERERIA-BANCROFTI; CYTOKINE RESPONSES; BCG VACCINATION; TGF-BETA; CHILDHOOD; PREGNANCY	Background: M. tuberculosis and helminth infection each affects one third of the world population. Helminth infections down regulate cell mediated immune responses and this may contribute to lower efficacy of BCG vaccination and higher prevalence of tuberculosis. Objective: To determine the effect of maternal helminth infection on maternal and neonatal immune function and immunity to TB. Methods: In this cross sectional study, eighty five pregnant women were screened for parasitic and latent TB infections using Kato-Katz and QFT-GIT tests, respectively. IFN-gamma and IL-4 ELISpot on Cord blood Mononuclear Cells, and total IgE and TB specific IgG ELISA on cord blood plasma was performed to investigate the possible effect of maternal helminth and/or latent TB co-infection on maternal and neonatal immune function and immunity to TB. Result: The prevalence of helminth infections in pregnant women was 27% (n=23), with Schistosoma mansoni the most common helminth species observed (20% of women were infected). Among the total of 85 study participants 25.8% were QFT-GIT positive and 17% had an indeterminate result. The mean total IgE value of cord blood was significantly higher in helminth positive than negative women (0.76 vs 0.47, p=0.042). Cross placental transfer of TB specific IgG was significantly higher in helminth positive (21.9 +/- 7.9) than negative (12.3 +/- 5.1), p=0.002) Latent TB Infection positive participants. The IFN-gamma response of CBMCs to ESAT-6/CFP-10 cocktail (50 vs 116, p=0.018) and PPD (58 vs 123, p=0.02) was significantly lower in helminth positive than negative participants. There was no significant difference in IL-4 response of CBMCs between helminth negative and positive participants. Conclusions: Maternal helminth infection had a significant association with the IFN-gamma response of CBMCs, total IgE and cross placental transfer of TB specific IgG. Therefore, further studies should be conducted to determine the effect of these factors on neonatal immune response to BCG vaccination.	[Gebreegziabiher, Dawit; Desalegn, Girmay; Howe, Rawleigh; Abebe, Markos] AHRI, Addis Ababa, Ethiopia; [Gebreegziabiher, Dawit; Desta, Kassu; Desalegn, Girmay] Univ Addis Ababa, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Gebreegziabiher, Dawit] Mekelle Univ, Mekele, Ethiopia	Addis Ababa University; Mekelle University	Abebe, M (corresponding author), AHRI, Addis Ababa, Ethiopia.	markosabebe@yahoo.com		Desalegn, Girmay/0000-0001-8150-1277	NORAD; Sida through AHRI core budget; Addis Ababa University; Mekelle University	NORAD(CGIAR); Sida through AHRI core budget; Addis Ababa University; Mekelle University	This study was financially supported by NORAD and Sida through AHRI core budget and Addis Ababa University and Mekelle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NALA FDN REP DEW PRO; BAIDOO SE, 2010, J BACTERIOL RES, V2, P9; Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Bentwich Z., 2010, Open Biology Journal, V3, P97, DOI 10.2174/1874196701003030097; Bourke CD, 2011, PARASITOLOGY, V138, P139, DOI 10.1017/S0031182010001216; Chen A, 2004, AM J ROENTGENOL, V182, P253, DOI 10.2214/ajr.182.1.1820253; Christian P, 2004, LANCET, V364, P981, DOI 10.1016/S0140-6736(04)17023-2; Cooper PJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-184; Dagnew Alemnew F, 2012, BMC Res Notes, V5, P415, DOI 10.1186/1756-0500-5-415; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Elias D, 2005, CLIN EXP IMMUNOL, V139, P398, DOI 10.1111/j.1365-2249.2004.02719.x; Elias D, 2005, VACCINE, V23, P1326, DOI 10.1016/j.vaccine.2004.09.038; Elias D, 2001, CLIN EXP IMMUNOL, V123, P219, DOI 10.1046/j.1365-2249.2001.01446.x; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Elliott AM, 2007, CLIN TRIALS, V4, P42, DOI 10.1177/1740774506075248; Elliott AM, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-115; Elston DM, 2006, J AM ACAD DERMATOL, V54, P172, DOI 10.1016/j.jaad.2005.09.020; Faheem S, BMC INFECT DIS, V10; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Hassan G, 1994, TUBERCULOSIS, V13, P73; Hassan G, 2006, JK SCI, V8; Kariminia A, 2009, J EVAL CLIN PRACT, V15, P148, DOI 10.1111/j.1365-2753.2008.00970.x; King CL, 1998, J IMMUNOL, V160, P3578; Kozakiewicz L, 2013, ADV EXP MED BIOL, V783, P225, DOI 10.1007/978-1-4614-6111-1_12; Laartz BW, 2002, INFECT CONT HOSP EP, V23, P573, DOI 10.1086/501973; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Latorre I, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-348; Legesse M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-89; Legesse M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-354; Leng QB, 2006, INT IMMUNOL, V18, P637, DOI 10.1093/intimm/dxh375; Liu ZG, 2002, J IMMUNOL, V169, P6959, DOI 10.4049/jimmunol.169.12.6959; Loto OM, 2012, REV J PREGNANCY; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; Mahanty S, 1996, J INFECT DIS, V173, P769, DOI 10.1093/infdis/173.3.769; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Malhotra I, 2006, J INFECT DIS, V193, P1005, DOI 10.1086/500472; Malhotra I, 2003, INFECT IMMUN, V71, P5231, DOI 10.1128/IAI.71.9.5231-5237.2003; Manivannan S, 2012, INDIAN J EXP BIOL, V50, P542; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; Pearce EJ, 2005, PARASITE IMMUNOL, V27, P265, DOI 10.1111/j.1365-3024.2005.00765.x; Pit DSS, 2000, ALLERGY, V55, P732, DOI 10.1034/j.1398-9995.2000.00477.x; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Raja A, 2004, INDIAN J MED RES, V120, P213; Reinharda G, 2002, BIOMEDICAL BIOPHYSIC, V245, P933; Seydel LS, 2012, AM J TROP MED HYG, V86, P613, DOI 10.4269/ajtmh.2012.11-0463; Sheriff FG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-52; Soboslay PT, 1999, CLIN EXP IMMUNOL, V117, P130; Stewart GR, 1999, CLIN EXP IMMUNOL, V117, P517; Woodburn PW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000473	52	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93429	10.1371/journal.pone.0093429	http://dx.doi.org/10.1371/journal.pone.0093429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710174	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800032
J	Kumichel, A; Knust, E				Kumichel, Alexandra; Knust, Elisabeth			Apical Localisation of Crumbs in the Boundary Cells of the Drosophila Hindgut Is Independent of Its Canonical Interaction Partner Stardust	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ZONULA ADHERENS FORMATION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; PHOTORECEPTOR MORPHOGENESIS; CYTOPLASMIC DOMAIN; POLARITY PROTEINS; COMPLEX; JUNCTIONS; NEUROBLASTS	The transmembrane protein Crumbs/Crb is a key regulator of apico-basal epithelial cell polarity, both in Drosophila and in vertebrates. In most cases studied so far, the apical localisation of Drosophila Crumbs depends on the interaction of its C-terminal amino acids with the scaffolding protein Stardust. Consequently, embryos lacking either Crumbs or Stardust develop a very similar phenotype, characterised by the loss of epithelial tissue integrity and cell polarity in many epithelia. An exception is the hindgut, which is not affected by the loss of either gene. The hindgut is a single layered epithelial tube composed of two cell populations, the boundary cells and the principal cells. Here we show that Crumbs localisation in the principal cells depends on Stardust, similarly to other embryonic epithelia. In contrast, localisation of Crumbs in the boundary cells does not require Stardust and is independent of its PDZ domain- and FERM-domain binding motifs. In line with this, the considerable upregulation of Crumbs in boundary cells is not followed by a corresponding upregulation of its canonical binding partners. Our data are the first to suggest a mechanism controlling apical Crumbs localisation, which is independent of its conserved FERM- and PDZ-domain binding motifs.	[Kumichel, Alexandra; Knust, Elisabeth] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Knust, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	knust@mpi-cbg.de			Max-Planck Society (MPG)	Max-Planck Society (MPG)(Max Planck Society)	This work was supported by the Max-Planck Society (MPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2012, NAT CELL BIOL, V14, P1235, DOI 10.1038/ncb2635; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bulgakova NA, 2008, J CELL SCI, V121, P2018, DOI 10.1242/jcs.031088; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Ellenbroek SIJ, 2012, SEMIN CANCER BIOL, V22, P208, DOI 10.1016/j.semcancer.2012.02.012; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Fan SL, 2007, J CELL BIOL, V178, P387, DOI 10.1083/jcb.200609096; Fletcher GC, 2012, CURR BIOL, V22, P1116, DOI 10.1016/j.cub.2012.04.020; Fuss B, 2002, CURR BIOL, V12, P171; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Grawe F, 1996, DEVELOPMENT, V122, P951; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Iwaki DD, 2002, MECH DEVELOP, V114, P71, DOI 10.1016/S0925-4773(02)00061-8; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klose S, 2013, G3-GENES GENOM GENET, V3, P153, DOI 10.1534/g3.112.005074; Krahn MP, 2010, J CELL BIOL, V190, P751, DOI 10.1083/jcb.201006029; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Letizia A, 2013, J CELL SCI, V126, P2157, DOI 10.1242/jcs.122382; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Murakami R, 2001, J MORPHOL, V248, P144, DOI 10.1002/jmor.1025; Muschalik N, 2011, J CELL SCI, V124, P3715, DOI 10.1242/jcs.091223; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pocha SM, 2011, CURR BIOL, V21, P1111, DOI 10.1016/j.cub.2011.05.007; Revenu C, 2012, MOL BIOL CELL, V23, P324, DOI 10.1091/mbc.E11-09-0765; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Richard M, 2009, EUR J CELL BIOL, V88, P765, DOI 10.1016/j.ejcb.2009.07.006; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Soplop NH, 2012, DEV DYNAM, V241, P759, DOI 10.1002/dvdy.23749; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Walmsley SJ, 2012, AM J PHYSIOL-RENAL, V302, pF1465, DOI 10.1152/ajprenal.00390.2011; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Whiteman EL, 2014, MOL CELL BIOL, V34, P43, DOI 10.1128/MCB.00999-13; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Zhou B, 2011, DEV BIOL, V360, P87, DOI 10.1016/j.ydbio.2011.09.009; Zou J, 2012, DEV CELL, V22, P1261, DOI 10.1016/j.devcel.2012.03.007	77	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94038	10.1371/journal.pone.0094038	http://dx.doi.org/10.1371/journal.pone.0094038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710316	Green Published, gold			2022-12-27	WOS:000334159800092
J	Husseiny, MI; Kaye, A; Zebadua, E; Kandeel, F; Ferreri, K				Husseiny, Mohamed I.; Kaye, Alexander; Zebadua, Emily; Kandeel, Fouad; Ferreri, Kevin			Tissue-Specific Methylation of Human Insulin Gene and PCR Assay for Monitoring Beta Cell Death	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; CD8 T-CELLS; TYPE-1; RISK; MOUSE; PATHOGENESIS; PREDICTION; RELATIVES; THERAPY; DISEASE	The onset of metabolic dysregulation in type 1 diabetes (T1D) occurs after autoimmune destruction of the majority of pancreatic insulin-producing beta cells. We previously demonstrated that the DNA encoding the insulin gene is uniquely unmethylated in these cells and then developed a methylation-specific PCR (MSP) assay to identify circulating beta cell DNA in streptozotocin-treated mice prior to the rise in blood glucose. The current study extends to autoimmune non-obese diabetic (NOD) mice and humans, showing in NOD mice that beta cell death occurs six weeks before the rise in blood sugar and coincides with the onset of islet infiltration by immune cells, demonstrating the utility of MSP for monitoring T1D. We previously reported unique patterns of methylation of the human insulin gene, and now extend this to other human tissues. The methylation patterns of the human insulin promoter, intron 1, exon 2, and intron 2 were determined in several normal human tissues. Similar to our previous report, the human insulin promoter was unmethylated in beta cells, but methylated in all other tissues tested. In contrast, intron 1, exon 2 and intron 2 did not exhibit any tissue-specific DNA methylation pattern. Subsequently, a human MSP assay was developed based on the methylation pattern of the insulin promoter and human islet DNA was successfully detected in circulation of T1D patients after islet transplantation therapy. Signal levels of normal controls and pre-transplant samples were shown to be similar, but increased dramatically after islet transplantation. In plasma the signal declines with time but in whole blood remains elevated for at least two weeks, indicating that association of beta cell DNA with blood cells prolongs the signal. This assay provides an effective method to monitor beta cell destruction in early T1D and in islet transplantation therapy.	[Husseiny, Mohamed I.; Kaye, Alexander; Zebadua, Emily; Kandeel, Fouad; Ferreri, Kevin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA USA; [Husseiny, Mohamed I.] Zagazig Univ, Fac Pharm, Zagazig, Egypt	City of Hope; Beckman Research Institute of City of Hope; Egyptian Knowledge Bank (EKB); Zagazig University	Ferreri, K (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA USA.	kferreri@coh.org		Elsayed, Mohamed Ibrahim Husseiny/0000-0002-3470-2858; Ferreri, Kevin/0000-0003-0379-0389	Juvenile Diabetes Research Foundation [JDRF 1-2008-1009]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was kindly supported by the Juvenile Diabetes Research Foundation (JDRF 1-2008-1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Burke ZD, 2012, STEM CELL REV REP, V8, P586, DOI 10.1007/s12015-012-9350-2; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Chen Hsin-Wei, 2007, Rev Diabet Stud, V4, P56, DOI 10.1900/RDS.2007.4.56; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Dabelea D, 2012, DIABETOLOGIA, V55, P3359, DOI 10.1007/s00125-012-2719-6; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Eisenbarth GS, 2004, ADV EXP MED BIOL, V552, P268; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fisher MM, 2013, ENDOCRINOLOGY; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Husseiny MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047942; Korpos E, 2013, DIABETES, V62, P531, DOI 10.2337/db12-0432; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; Lebastchi J, 2013, DIABETES, V62, P1676, DOI 10.2337/db12-1207; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Meier JJ, 2012, DIABETOLOGIA; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Rossini AA, 2004, DIABETES, V53, P267, DOI 10.2337/diabetes.53.2.267; Sosenko JM, 2013, DIABETES CARE, V36, P2615, DOI 10.2337/dc13-0425; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; VARDI P, 1991, DIABETOLOGIA, V34, P93, DOI 10.1007/BF00500379	31	52	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94591	10.1371/journal.pone.0094591	http://dx.doi.org/10.1371/journal.pone.0094591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722187	gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100104
J	Grigorova, M; Punab, M; Punab, AM; Poolamets, O; Vihljajev, V; Zilaitiene, B; Erenpreiss, J; Matulevicius, V; Laan, M				Grigorova, Marina; Punab, Margus; Punab, Anna Maria; Poolamets, Olev; Vihljajev, Vladimir; Zilaitiene, Birute; Erenpreiss, Juris; Matulevicius, Valentinas; Laan, Maris			Reproductive Physiology in Young Men Is Cumulatively Affected by FSH-Action Modulating Genetic Variants: FSHR-29G/A and c. 2039 A/G, FSHB-211G/T	PLOS ONE			English	Article							MALE-INFERTILITY; PROMOTER POLYMORPHISM; SERUM FSH; RECEPTOR; 2039A-GREATER-THAN-G; ASSOCIATION; POPULATION; EXPRESSION; LEVEL	Follicle-Stimulating Hormone Receptor (FSHR) -29G/ A polymorphism (rs1394205) was reported to modulate gene expression and reproductive parameters in women, but data in men is limited. We aimed to bring evidence to the effect of FSHR -29G/ A variants in men. In Baltic young male cohort (n = 982; Estonians, Latvians, Lithuanians; aged 20.262.0 years), the FSHR -29 A-allele was significantly associated with higher serum FSH (linear regression: effect 0.27 IU/ L; P = 0.0019, resistant to Bonferroni correction for multiple testing) and showed a non-significant trend for association with higher LH (0.19 IU/ L) and total testosterone (0.93 nmol/ L), but reduced Inhibin B (-7.84 pg/ mL) and total testes volume (effect -1.00 mL). Next, we extended the study and tested the effect of FSHR gene haplotypes determined by the allelic combination of FSHR -29G/ A and a well-studied variant c. 2039 A/G (Asn680Ser, exon 10). Among the FSHR -29A/2039G haplotype carriers (A-Ser; haplotype-based linear regression), this genetic effect was enhanced for FSH (effect 0.40 IU/ L), Inhibin B (216.57 pg/ mL) and total testes volume (2.34 mL). Finally, we estimated the total contribution of three known FSH-action modulating SNPs (FSHB -211G/ T; FSHR -29G/ A, c. 2039 A/G) to phenotypic variance in reproductive parameters among young men. The major FSH-action modulating SNPs explained together 2.3%, 1.4%, 1.0 and 1.1% of the measured variance in serum FSH, Inhibin B, testosterone and total testes volume, respectively. In contrast to the young male cohort, neither FSHR -29G/ A nor FSHR haplotypes appeared to systematically modulate the reproductive physiology of oligozoospermic idiopathic infertile patients (n = 641, Estonians; aged 31.5 +/- 6.0 years). In summary, this is the first study showing the significant effect of FSHR 29G/A on male serum FSH level. To account for the genetic effect of known common polymorphisms modulating FSHaction, we suggest haplotype-based analysis of FSHR SNPs (FSHR -29G/A, c. 2039 A/G) in combination with FSHB -211G/ T testing.	[Grigorova, Marina; Punab, Anna Maria; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, EE-50090 Tartu, Estonia; [Punab, Margus; Poolamets, Olev; Vihljajev, Vladimir] Tartu Univ Hosp, Androl Unit, Tartu, Estonia; [Zilaitiene, Birute; Matulevicius, Valentinas] Lithuanian Univ Hlth Sci, Med Acad, Inst Endocrinol, Kaunas, Lithuania; [Erenpreiss, Juris] Riga Stradins Univ, Androl Lab, Riga, Latvia	University of Tartu; Lithuanian University of Health Sciences; Riga Stradins University	Laan, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, Ulikooli 18, EE-50090 Tartu, Estonia.	maris.laan@ut.ee	Laan, Maris/A-4100-2011; Grigorova, Marina/B-1257-2014	Laan, Maris/0000-0002-8519-243X; Grigorova, Marina/0000-0002-8947-5816; Punab, Margus/0000-0001-9601-6311	European Union [QLRT-2001-02911]; Estonian Science Foundation [ETF9030]; Wellcome Trust [070191/Z/03/A]; Estonian Ministry of Education and Science [SF0180022s12]; Estonian Research Council [PUT181]; European Union; project HAPPY PREGNANCY [3.2.0701.12-0047]	European Union(European Commission); Estonian Science Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Ministry of Education and Science(Ministry of Education and Research, Estonia); Estonian Research Council(Estonian Research Council); European Union(European Commission); project HAPPY PREGNANCY	The recruitment of the Baltic male cohort was financed by European Union 5th Framework project QLRT-2001-02911 (MP, BZ., JE). The genetic research has been financed by Estonian Science Foundation Grant ETF9030 (ML); Wellcome Trust International Senior Research Fellowship (070191/Z/03/A) in Biomedical Science in Central Europe (ML); Estonian Ministry of Education and Science Core Grant SF0180022s12 (ML); by Estonian Research Council project PUT181 (MP) and by the European Union through the European Regional Development Fund, project HAPPY PREGNANCY, no. 3.2.0701.12-0047 (ML, MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrekar SK, 2009, REPROD BIOMED ONLINE, V18, P509, DOI 10.1016/S1472-6483(10)60127-7; Ahda Y, 2005, J ANDROL, V26, P494, DOI 10.2164/jandrol.04186; Balkan M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/640318; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Desai SS, 2011, J CLIN ENDOCR METAB, V96, P2805, DOI 10.1210/jc.2011-1064; Ferlin A, 2011, FERTIL STERIL, V96, P1344, DOI 10.1016/j.fertnstert.2011.09.034; Grigorova M, 2013, ANDROLOGY-US, V1, P293, DOI 10.1111/j.2047-2927.2012.00028.x; Grigorova M, 2008, HUM REPROD, V23, P2160, DOI 10.1093/humrep/den216; Grigorova M, 2011, J CLIN ENDOCR METAB, V96, pE1534, DOI 10.1210/jc.2011-0632; Grigorova M, 2010, J CLIN ENDOCR METAB, V95, P100, DOI 10.1210/jc.2009-1010; Laan M, 2012, CURR OPIN ENDOCRINOL, V19, P220, DOI 10.1097/MED.0b013e3283534b11; Lend AK, 2010, SYST BIOL REPROD MED, V56, P84, DOI 10.3109/19396360903456676; Li YC, 2011, CLIN CHIM ACTA, V412, P1048, DOI 10.1016/j.cca.2011.02.016; Lindgren I, 2012, PHARMACOGENET GENOM, V22, P667, DOI 10.1097/FPC.0b013e3283566c42; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nagirnaja L, 2010, MOL CELL ENDOCRINOL, V329, P4, DOI 10.1016/j.mce.2010.04.024; Nakayama T, 2006, HYPERTENSION, V48, P512, DOI 10.1161/01.HYP.0000233877.84343.d7; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Pengo M, 2006, REPROD BIOMED ONLINE, V13, P795, DOI 10.1016/S1472-6483(10)61026-7; Prescott J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037815; Punab M, 2002, INT J ANDROL, V25, P243, DOI 10.1046/j.1365-2605.2002.00359.x; PUNAB M, 2007, THESIS, P25; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Siegel ET, 2013, REPROD SCI, V20, P211, DOI 10.1177/1933719112461184; Simoni M, 1999, J CLIN ENDOCR METAB, V84, P751, DOI 10.1210/jc.84.2.751; Tuttelmann F, 2012, J CLIN ENDOCR METAB, V97, P3639, DOI 10.1210/jc.2012-1761; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Wu W, 2012, GENE, V505, P388, DOI 10.1016/j.gene.2012.02.023; Wunsch A, 2005, FERTIL STERIL, V84, P446, DOI 10.1016/j.fertnstert.2005.02.031; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	35	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94244	10.1371/journal.pone.0094244	http://dx.doi.org/10.1371/journal.pone.0094244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718625	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000094
J	Neumann, C; Garreis, F; Paulsen, F; Hammer, CM; Birke, MT; Scholz, M				Neumann, Carolin; Garreis, Fabian; Paulsen, Friedrich; Hammer, Christian M.; Birke, Marco T.; Scholz, Michael			Osteopontin Is Induced by TGF-beta 2 and Regulates Metabolic Cell Activity in Cultured Human Optic Nerve Head Astrocytes	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; PRIMARY OPEN-ANGLE; TRABECULAR MESHWORK; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; AQUEOUS-HUMOR; UP-REGULATION; MURINE MODEL; EXPRESSION; GLAUCOMA	The aqueous humor (AH) component transforming growth factor (TGF)-beta 2 is strongly correlated to primary open-angle glaucoma (POAG), and was shown to up-regulate glaucoma-associated extracellular matrix (ECM) components, members of the ECM degradation system and heat shock proteins (HSP) in primary ocular cells. Here we present osteopontin (OPN) as a new TGF-beta 2 responsive factor in cultured human optic nerve head (ONH) astrocytes. Activation was initially demonstrated by Oligo GEArray microarray and confirmed by semiquantitative (sq) RT-PCR, realtime RT-PCR and western blot. Expressions of most prevalent OPN receptors CD44 and integrin receptor subunits alpha V, alpha 4, alpha 5, alpha 6, alpha 9, beta 1, beta 3 and beta 5 by ONH astrocytes were shown by sqRT-PCR and immunofluorescence labeling. TGF-beta 2 treatment did not affect their expression levels. OPN did not regulate gene expression of described TGF-beta 2 targets shown by sqRT-PCR. In MTS-assays, OPN had a time- and dose-dependent stimulating effect on the metabolic activity of ONH astrocytes, whereas TGF-beta 2 significantly reduced metabolism. OPN signaling via CD44 mediated a repressive outcome on metabolic activity, whereas signaling via integrin receptors resulted in a pro-metabolic effect. In summary, our findings characterize OPN as a TGF-beta 2 responsive factor that is not involved in TGF-beta 2 mediated ECM and HSP modulation, but affects the metabolic activity of astrocytes. A potential involvement in a protective response to TGF-beta 2 triggered damage is indicated, but requires further investigation.	[Neumann, Carolin; Garreis, Fabian; Paulsen, Friedrich; Hammer, Christian M.; Scholz, Michael] Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany; [Birke, Marco T.] Tufts Univ, Dept Ophthalmol, Boston, MA 02111 USA	University of Erlangen Nuremberg; Tufts University	Garreis, F (corresponding author), Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany.	Fabian.garreis@anatomie2.med.uni-erlangen.de		Paulsen, Friedrich/0000-0002-0527-0953; Scholz, Michael/0000-0001-8440-6785	Muck Foundation, University Erlangen Nuremberg; Johannes and Frieda Marohn Foundation, University Erlangen Nuremberg; Deutsche Forschungsgemeinschaft (DFG); Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	Muck Foundation, University Erlangen Nuremberg; Johannes and Frieda Marohn Foundation, University Erlangen Nuremberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	FG was supported in part by the Muck Foundation, University Erlangen Nuremberg. MS was supported by the Johannes and Frieda Marohn Foundation, University Erlangen Nuremberg. The authors acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Friedrich-Alexander-University Erlangen-Nurnberg (FAU) within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/493043; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Birke MT, 2010, INVEST OPHTH VIS SCI, V51, P5759, DOI 10.1167/iovs.10-5558; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; Comi C, 2009, J ALZHEIMERS DIS; Del Rio P, 2011, GLIA, V59, P821, DOI 10.1002/glia.21155; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Diekmann H, 2013, CELL TISSUE RES, V353, P327, DOI 10.1007/s00441-013-1596-8; Eitzman DT, 1997, ADV EXP MED BIOL, V425, P131; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Fuchshofer R, 2003, EXP EYE RES, V77, P757, DOI 10.1016/S0014-4835(03)00220-3; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Gottanka J, 2005, INVEST OPHTH VIS SCI, V46, P4170, DOI 10.1167/iovs.05-0289; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Gross TS, 2005, J BONE MINER RES, V20, P250, DOI 10.1359/JBMR.041004; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Heiduschka P, 2010, EXP EYE RES, V91, P779, DOI 10.1016/j.exer.2010.09.001; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; HERNANDEZ MR, 1990, AM J OPHTHALMOL, V109, P180, DOI 10.1016/S0002-9394(14)75984-7; Howell GR, 2008, PROG BRAIN RES, V173, P303, DOI 10.1016/S0079-6123(08)01122-9; Iczkiewicz J, 2006, BRAIN RES, V1118, P239, DOI 10.1016/j.brainres.2006.08.036; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; Iyer P, 2012, INVEST OPHTH VIS SCI, V53, P4952, DOI 10.1167/iovs.12-9681; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jin JK, 2006, BRAIN RES, V1072, P227, DOI 10.1016/j.brainres.2005.12.013; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Lee MY, 1999, NEUROSCI LETT, V271, P81, DOI 10.1016/S0304-3940(99)00526-1; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Neumann C, 2008, INVEST OPHTH VIS SCI, V49, P1464, DOI 10.1167/iovs.07-1053; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; NODA M, 1988, J BIOL CHEM, V263, P13916; Okamoto H, 2007, MOL CELL BIOCHEM, V300, P1, DOI 10.1007/s11010-006-9368-3; Padanilam BJ, 1996, ENDOCRINOLOGY, V137, P2133, DOI 10.1210/en.137.5.2133; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sabo-Attwood T, 2011, AM J PATHOL, V178, P1975, DOI 10.1016/j.ajpath.2011.01.048; Saika S, 2003, INVEST OPHTH VIS SCI, V44, P1622, DOI 10.1167/iovs.02-0873; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Scholz M, 2008, INVEST OPHTH VIS SCI, V49, P613, DOI 10.1167/iovs.07-0745; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; Tambuyzer BR, 2012, CELL BIOL INT, V36, P1233, DOI 10.1042/CBI20120172; Tektas OY, 2010, INVEST OPHTH VIS SCI, V51, P5083, DOI 10.1167/iovs.09-5101; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wahl V, 2013, NEUROSCIENCE; Wang KX, 2008, CYTOKINE GROWTH FACT; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Yu AL, 2007, EXP EYE RES, V84, P694, DOI 10.1016/j.exer.2006.12.008; Yu AL, 2010, INVEST OPHTH VIS SCI, V51, P5718, DOI 10.1167/iovs.10-5679; Yu AL, 2009, INVEST OPHTH VIS SCI, V50, P1707, DOI 10.1167/iovs.08-1961; Zhang GX, 2004, WORLD J GASTROENTERO, V10, P205	63	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92762	10.1371/journal.pone.0092762	http://dx.doi.org/10.1371/journal.pone.0092762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718314	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000019
J	Shi, XD; DiRenzo, D; Guo, LW; Franco, SR; Wang, BW; Seedial, S; Kent, KC				Shi, Xudong; DiRenzo, Daniel; Guo, Lian-Wang; Franco, Sarah R.; Wang, Bowen; Seedial, Stephen; Kent, K. Craig			TGF-beta/Smad3 Stimulates Stem Cell/Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PHENOTYPIC MODULATION; PROGENITOR CELLS; DIFFERENTIATION; PROLIFERATION; SMAD3; PDGF; TRANSCRIPTION; RECRUITMENT	Atherosclerotic-associated diseases are the leading cause of death in the United States. Despite recent progress, interventional treatments for atherosclerosis can be complicated by restenosis resulting from neo-intimal hyperplasia. We have previously demonstrated that TGF-beta and its downstream signaling protein Smad3:1) are up-regulated following vascular injury, 2) together drive smooth muscle cell (SMC) proliferation and migration and 3) enhance the development of intimal hyperplasia. In order to determine a mechanism through which TGF-beta/Smad3 promote these effects, Affymetrix gene expression arrays were performed on primary rat SMCs infected with Smad3 and stimulated with TGF-beta or infected with GFP alone. More than 200 genes were differentially expressed (>2.0 fold change, p<0.05) in TGF-beta/Smad3 stimulated SMCs. We then performed GO term enrichment analysis using the DAVID bioinformatics database and found that TGF-beta/ Smad3 activated the expression of multiple genes related to either development or cell differentiation, several of which have been shown to be associated with multipotent stem or progenitor cells. Quantitative real-time PCR confirmed up-regulation of several developmental genes including FGF1, NGF, and Wnt11 (by 2.5, 6 and 7 fold, respectively) as well as stem/progenitor cell associated genes CD34 and CXCR4 (by 10 and 45 fold, respectively). In addition, up-regulation of these factors at protein levels were also confirmed by Western blotting, or by immunocytochemistry (performed for CXCR4 and NGF). Finally, TGF-beta/Smad3 down regulated transcription of SMC contractile genes as well as protein production of smooth muscle alpha actin, calponin, and smooth muscle myosin heavy chain. These combined results suggest that TGF-beta/Smad3 stimulation drives SMCs to a phenotypically altered state of de-differentiation through the up-regulation of developmental related genes.	[Shi, Xudong; DiRenzo, Daniel; Guo, Lian-Wang; Franco, Sarah R.; Wang, Bowen; Seedial, Stephen; Kent, K. Craig] Univ Wisconsin Hosp & Clin, Dept Surg, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Guo, LW (corresponding author), Univ Wisconsin Hosp & Clin, Dept Surg, Madison, WI 53792 USA.	guo@surgery.wisc.edu; kent@surgery.wisc.edu			National Heart, Lung, Blood Institute [HL-068673, HL-110853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110853, R01HL068673] Funding Source: NIH RePORTER	National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Heart, Lung, Blood Institute R01 Grant (HL-068673, to K.C.K.) and a T32 training Grant (HL-110853, to K.C.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Crcareva A, 2005, EXP HEMATOL, V33, P1459, DOI 10.1016/j.exphem.2005.09.001; de Haan G, 2003, DEV CELL, V4, P241, DOI 10.1016/S1534-5807(03)00018-2; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Ferlosio A, 2012, ATHEROSCLEROSIS, V224, P51, DOI 10.1016/j.atherosclerosis.2012.07.016; FINA L, 1990, BLOOD, V75, P2417; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.005; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Imamura H, 2010, ATHEROSCLEROSIS, V211, P114, DOI 10.1016/j.atherosclerosis.2010.02.040; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kundi R, 2009, CARDIOVASC RES, V84, P326, DOI 10.1093/cvr/cvp220; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Ma XL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001894; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nakayama N, 2004, DEVELOPMENT, V131, P229, DOI 10.1242/dev.00901; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Rodriguez-Menocal L, 2009, CARDIOVASC RES, V81, P46, DOI 10.1093/cvr/cvn265; Salmon M, 2012, CIRC RES, V111, P685, DOI 10.1161/CIRCRESAHA.112.269811; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Serrano AG, 2010, BLOOD, V115, P3895, DOI 10.1182/blood-2009-10-247395; Si Y, 2012, ARTERIOSCL THROM VAS, V32, P943, DOI 10.1161/ATVBAHA.111.244921; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Suwanabol PA, 2012, J VASC SURG, V56, P446, DOI 10.1016/j.jvs.2011.12.038; Suwanabol PA, 2012, AM J PHYSIOL-HEART C, V302, pH2211, DOI 10.1152/ajpheart.00966.2011; Suwanabol PA, 2011, J SURG RES, V167, P287, DOI 10.1016/j.jss.2010.12.020; Takahashi M, 2012, INT J MOL MED, V29, P357, DOI 10.3892/ijmm.2011.847; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Thomas JA, 2009, AM J PHYSIOL-HEART C, V296, pH442, DOI 10.1152/ajpheart.00165.2008; Tiano HF, 2002, CANCER RES, V62, P3395; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	63	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93995	10.1371/journal.pone.0093995	http://dx.doi.org/10.1371/journal.pone.0093995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718260	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000063
J	Du, QS; Wang, SQ; Chen, D; Meng, JZ; Huang, RB				Du, Qi-Shi; Wang, Shu-Qing; Chen, Dong; Meng, Jian-Zong; Huang, Ri-Bo			In Depth Analysis on the Binding Sites of Adamantane Derivatives in HCV ( Hepatitis C Virus) p7 Channel Based on the NMR Structure	PLOS ONE			English	Article							LAMARCKIAN GENETIC ALGORITHM; COUPLED-CLUSTER SINGLES; CATION-PI INTERACTIONS; ION-CHANNEL; PROTEIN; DRUG; RATIONALIZATION; SENSITIVITY; AMANTADINE; PREDICTION	Background: The recently solved solution structure of HCV (hepatitis C virus) p7 ion channel provides a solid structure basis for drug design against HCV infection. In the p7 channel the ligand amantadine (or rimantadine) was determined in a hydrophobic pocket. However the pharmocophore (-NH2) of the ligand was not assigned a specific binding site. Results: The possible binding sites for amino group of adamantane derivatives is studied based on the NMR structure of p7 channel using QM calculation and molecular modeling. In the hydrophobic cavity and nearby three possible binding sites are proposed: His17, Phe20, and Trp21. The ligand binding energies at the three binding sites are studied using high level QM method CCSD(T)/6-311+G(d,p) and AutoDock calculations, and the interaction details are analyzed. The potential application of the binding sites for rational inhibitor design are discussed. Conclusions: Some useful viewpoints are concluded as follows. (1) The amino group (-NH2) of adamantane derivatives is protonated (-NH3+), and the positively charged cation may form cation-pi interactions with aromatic amino acids. (2) The aromatic amino acids (His17, Phe20, and Trp21) are the possible binding sites for the protonated amino group (-NH3+) of adamantane derivatives, and the cation-pi bond energies are 3 to 5 times stronger than the energies of common hydrogen bonds. (3) The higher inhibition potent of rimantadine than amantadine probably because of its higher pK(a) value (pK(a) = 10.40) and the higher positive charge in the amino group. The potential application of p7 channel structure for inhibitor design is discussed.	[Du, Qi-Shi; Chen, Dong; Huang, Ri-Bo] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Nanning, Guangxi, Peoples R China; [Wang, Shu-Qing] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China; [Chen, Dong; Meng, Jian-Zong; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, San Diego, CA USA	Tianjin Medical University; Guangxi University	Du, QS (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Nanning, Guangxi, Peoples R China.	du.qishi@aliyun.com			National Science Foundation of China (NSFC) [31370716, 31360207]; BaGui Scholar's Program Foundation	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); BaGui Scholar's Program Foundation	This work was supported by grants from the National Science Foundation of China (NSFC) under the contract numbers 31370716 and 31360207, and by the BaGui Scholar's Program Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Du QS, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-92; Du QS, 2012, J MOL GRAPH MODEL, V34, P38, DOI 10.1016/j.jmgm.2011.12.002; Du QS, 2012, J COMPUT CHEM, V33, P153, DOI 10.1002/jcc.21951; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Fuhrmann J, 2010, J COMPUT CHEM, V31, P1911, DOI 10.1002/jcc.21478; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; Gu RX, 2011, J AM CHEM SOC, V133, P10817, DOI 10.1021/ja1114198; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; LEE TJ, 1988, CHEM PHYS LETT, V150, P406, DOI 10.1016/0009-2614(88)80427-5; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Mihm U, 2006, ANTIVIR THER, V11, P507; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Pielak RM, 2010, PROTEIN CELL, V1, P246, DOI 10.1007/s13238-010-0025-y; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; PURVIS GD, 1982, J CHEM PHYS, V76, P1910, DOI 10.1063/1.443164; Rosenberg MR, 2010, P NATL ACAD SCI USA, V107, P13866, DOI 10.1073/pnas.1002051107; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SCUSERIA GE, 1989, J CHEM PHYS, V90, P3700, DOI 10.1063/1.455827; SCUSERIA GE, 1988, J CHEM PHYS, V89, P7382, DOI 10.1063/1.455269; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; SPECTOR R, 1988, J PHARMACOL EXP THER, V244, P516; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Wang QY, 2013, CURR TOP MED CHEM, V13, P1141, DOI 10.2174/15680266113139990002; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wermuth G, 1998, PURE APPL CHEM, V70, P1129, DOI 10.1351/pac199870051129; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	46	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93613	10.1371/journal.pone.0093613	http://dx.doi.org/10.1371/journal.pone.0093613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714586	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900040
J	Cohen, DD; Gomez-Arbelaez, D; Camacho, PA; Pinzon, S; Hormiga, C; Trejos-Suarez, J; Duperly, J; Lopez-Jaramillo, P				Dylan Cohen, Daniel; Gomez-Arbelaez, Diego; Anthony Camacho, Paul; Pinzon, Sandra; Hormiga, Claudia; Trejos-Suarez, Juanita; Duperly, John; Lopez-Jaramillo, Patricio			Low Muscle Strength Is Associated with Metabolic Risk Factors in Colombian Children: The ACFIES Study	PLOS ONE			English	Article							SHUTTLE-RUN TEST; INSULIN SENSITIVITY; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; MUSCULAR STRENGTH; BIRTH-WEIGHT; YOUNG MEN; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; HANDGRIP STRENGTH	Purpose: In youth, poor cardiorespiratory and muscular strength are associated with elevated metabolic risk factors. However, studies examining associations between strength and risk factors have been done exclusively in high income countries, and largely in Caucasian cohorts. The aim of this study was to assess these interactions in schoolchildren in Colombia, a middle income Latin American country. Methods: We measured body mass index, body composition, handgrip strength (HG), cardiorespiratory fitness (CRF) and metabolic risk factors in 669 low-middle socioeconomic status Colombian schoolchildren (mean age 11.52 +/- 1.13, 47% female). Associations between HG, CRF and metabolic risk factors were evaluated. Results: HG and CRF were inversely associated with blood pressure, HOMA index and a composite metabolic risk score (p < 0.001 for all) and HG was also inversely associated with triglycerides and C-reactive protein (CRP) (both p < 0.05). Associations between HG and risk factors were marginally weakened after adjusting for CRF, while associations between CRF and these factors were substantially weakened after adjusting for HG. Linear regression analyses showed inverse associations between HG and systolic BP (beta = 0.101; p = 0.047), diastolic BP (beta = 0.241; p >= 0.001), HOMA (beta = 0.164; p = 0.005), triglycerides (beta = 0.583; p = 0.026) and CRP (beta = 20.183; p = 0.037) but not glucose (p = 0.698) or HDL cholesterol (p = 0.132). The odds ratios for having clustered risk in the weakest quartile compared with the strongest quartile were 3.0 (95% confidence interval: 1.81-4.95). Conclusions: In Colombian schoolchildren both poorer handgrip strength/kg body mass and cardiorespiratory fitness were associated with a worse metabolic risk profile. Associations were stronger and more consistent between handgrip and risk factors than between cardiorespiratory fitness and these risk factors. Our findings indicate the addition of handgrip dynamometry to non-invasive youth health surveillance programs would improve the accuracy of the assessment of cardiometabolic health.	[Dylan Cohen, Daniel; Gomez-Arbelaez, Diego; Anthony Camacho, Paul; Hormiga, Claudia; Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander FOSCAL, Direcc Invest, Santander, Colombia; [Dylan Cohen, Daniel; Gomez-Arbelaez, Diego; Pinzon, Sandra; Lopez-Jaramillo, Patricio] Univ Santander UDES, Fac Ciencias Salud, Santander, Colombia; [Duperly, John] Univ Los Andes, Fac Med, Bogota, Colombia	Universidad Industrial de Santander; Universidad de los Andes (Colombia)	Lopez-Jaramillo, P (corresponding author), Fdn Oftalmol Santander FOSCAL, Direcc Invest, Santander, Colombia.	jplopezj@gmail.com	Gómez-Arbeláez, Diego/K-1883-2013	Gómez-Arbeláez, Diego/0000-0001-6150-0066; Camacho, Paul Anthony/0000-0002-6233-9582; Duperly Sanchez, John/0000-0002-6401-8395; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Trejos-Suarez, Juanita/0000-0002-0697-3386	mayor's office of the city of Bucaramanga (Colombia); Fundacion MAPFRE (Spain)	mayor's office of the city of Bucaramanga (Colombia); Fundacion MAPFRE (Spain)	The study was funded primarily by the mayor's office of the city of Bucaramanga (Colombia) and secondarily by a grant from the Fundacion MAPFRE (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000192; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arsenault JE, 2011, BRIT J NUTR, V1, P1; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Artero EG, 2011, PEDIATR DIABETES, V12, P704, DOI 10.1111/j.1399-5448.2011.00769.x; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Benefice E, 1999, ANN HUM BIOL, V26, P443, DOI 10.1080/030144699282561; Benson AC, 2006, INT J PEDIATR OBES, V1, P222, DOI 10.1080/17477160600962864; Bergmann GG, 2013, J PHYS ACTIVITY HLTH; Brons C, 2008, J CLIN ENDOCR METAB, V93, P3885, DOI 10.1210/jc.2008-0630; Cohen DD, 2010, ACTA PAEDIATR, V99, P1065, DOI 10.1111/j.1651-2227.2010.01723.x; CONPES (Consejo Nacional de Politica Economica y Social Republica de Colombia Departamento Nacional de Planeacion), 2005, 3386 CONPES; Davis JN, 2011, MED SCI SPORT EXER, V43, P2195, DOI 10.1249/MSS.0b013e31821f5d4e; Dodds R, 2012, J NUTR HEALTH AGING, V16, P609, DOI 10.1007/s12603-012-0053-9; dos Santos FK, 2013, ANN HUM BIOL, V40, P15, DOI 10.3109/03014460.2012.720708; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Grontved A, 2013, BRIT J SPORTS MED; Janz KF, 2008, MED SCI SPORT EXER, V40, P767, DOI 10.1249/MSS.0b013e3181620ed1; Jensen CB, 2007, J CLIN ENDOCR METAB, V92, P1530, DOI 10.1210/jc.2006-2360; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Lee S, 2012, EUR J CLIN NUTR, V66, P1366, DOI 10.1038/ejcn.2012.142; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Martinez-Gomez D, 2011, SCAND J MED SCI SPOR, V21, P310, DOI 10.1111/j.1600-0838.2009.01036.x; Martinez-Gomez D, 2012, ATHEROSCLEROSIS, V221, P260, DOI 10.1016/j.atherosclerosis.2011.12.032; Moura-Dos-Santos M, 2013, AM J HUM BIOL, V25, P58, DOI 10.1002/ajhb.22341; Ng N, 2009, GLOBAL HLTH ACTION, Vs1, P17; Nightingale CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036236; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Petroski Edio Luiz, 2011, Rev. salud pública, V13, P219, DOI 10.1590/S0124-00642011000200004; Ridgway CL, 2011, INT J PEDIATR OBES, V6, pE590, DOI 10.3109/17477166.2010.526225; Ruiz JR, 2008, ARCH PEDIAT ADOL MED, V162, P462, DOI 10.1001/archpedi.162.5.462; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Sandercock G, 2012, J SPORT SCI, V30, P679, DOI 10.1080/02640414.2012.660185; Shaibi GQ, 2006, MED SCI SPORT EXER, V38, P1208, DOI 10.1249/01.mss.0000227304.88406.0f; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Tremblay Mark S, 2010, Health Rep, V21, P7; Trudeau F, 2003, CAN J APPL PHYSIOL, V28, P257, DOI 10.1139/h03-020; Unni US, 2009, EUR J CLIN NUTR, V63, P1206, DOI 10.1038/ejcn.2009.32; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	44	94	100	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93150	10.1371/journal.pone.0093150	http://dx.doi.org/10.1371/journal.pone.0093150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714401	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900016
J	Lasecka, L; Baron, MD				Lasecka, Lidia; Baron, Michael D.			The Nairovirus Nairobi Sheep Disease Virus/Ganjam Virus Induces the Translocation of Protein Disulphide Isomerase-Like Oxidoreductases from the Endoplasmic Reticulum to the Cell Surface and the Extracellular Space	PLOS ONE			English	Article							CONGO-HEMORRHAGIC-FEVER; UUKUNIEMI VIRUS; DUGBE VIRUS; THIOL/DISULFIDE EXCHANGE; MEMBRANE-FUSION; GANJAM VIRUS; RNA SEGMENT; INTERMEDIATE COMPARTMENT; NUCLEOCAPSID PROTEIN; NOSOCOMIAL OUTBREAK	Nairobi sheep disease virus (NSDV) of the genus Nairovirus causes a haemorrhagic gastroenteritis in sheep and goats with mortality up to 90%; the virus is found in East and Central Africa, and in India, where the virus is called Ganjam virus. NSDV is closely related to the human pathogen Crimean-Congo haemorrhagic fever virus, which also causes a haemorrhagic disease. As with other nairoviruses, replication of NSDV takes place in the cytoplasm and the new virus particles bud into the Golgi apparatus; however, the effect of viral replication on cellular compartments has not been studied extensively. We have found that the overall structure of the endoplasmic reticulum (ER), the ER-Golgi intermediate compartment and the Golgi were unaffected by infection with NSDV. However, we observed that NSDV infection led to the loss of protein disulphide isomerase (PDI), an oxidoreductase present in the lumen of the endoplasmic reticulum (ER) and which assists during protein folding, from the ER. Further investigation showed that NSDV-infected cells have high levels of PDI at their surface, and PDI is also secreted into the culture medium of infected cells. Another chaperone from the PDI family, ERp57, was found to be similarly affected. Analysis of infected cells and expression of individual viral glycoproteins indicated that the NSDV PreGn glycoprotein is involved in redistribution of these soluble ER oxidoreductases. It has been suggested that extracellular PDI can activate integrins and tissue factor, which are involved respectively in pro-inflammatory responses and disseminated intravascular coagulation, both of which manifest in many viral haemorrhagic fevers. The discovery of enhanced PDI secretion from NSDV-infected cells may be an important finding for understanding the mechanisms underlying the pathogenicity of haemorrhagic nairoviruses.	[Lasecka, Lidia; Baron, Michael D.] Pirbright Inst, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Baron, MD (corresponding author), Pirbright Inst, Woking, Surrey, England.	michael.baron@pirbright.ac.uk	Dykes, Lidia/HHM-9104-2022	Lasecka-Dykes, Lidia/0000-0003-3188-4198	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00740X/1, BB/F006764/1]; BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute; BBSRC PhD studentship; BBSRC [BBS/E/I/00001718, BB/F00740X/1, BB/F006764/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001718, BB/F00740X/1, BB/F006764/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants BB/F00740X/1 and BB/F006764/1 from the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) and the BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute. LL was the recipient of a BBSRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrowicz P, 2008, HAMOSTASEOLOGIE, V28, P77; Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Andres G, 1998, J VIROL, V72, P8988; Bergeron E, 2007, J VIROL, V81, P13271, DOI 10.1128/JVI.01647-07; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; bin Tarif A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-71; Bodur H, 2010, INT J INFECT DIS, V14, pE704, DOI 10.1016/j.ijid.2010.02.2240; BOOTH TF, 1991, VIRUS RES, V21, P199, DOI 10.1016/0168-1702(91)90033-R; BOSHELL J, 1970, INDIAN J MED RES, V58, P561; Bridgen A, 2002, VIROLOGY, V294, P364, DOI 10.1006/viro.2001.1324; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; Burt FJ, 1997, ARCH PATHOL LAB MED, V121, P839; Burt FJ, 1996, EPIDEMIOL INFECT, V116, P353, DOI 10.1017/S0950268800052687; Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CASH P, 1985, J GEN VIROL, V66, P141, DOI 10.1099/0022-1317-66-1-141; Cho K, 2011, ANTIOXID REDOX SIGN, V15, P621, DOI 10.1089/ars.2010.3756; CLERX JPM, 1981, VIROLOGY, V108, P361, DOI 10.1016/0042-6822(81)90444-X; CLERX JPM, 1981, J GEN VIROL, V55, P165, DOI 10.1099/0022-1317-55-1-165; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P799; DAUBNEY R., 1931, PARASITOLOGY, V23, P507, DOI 10.1017/S0031182000013895; DAVIDWES.TS, 1974, J GEN VIROL, V23, P297, DOI 10.1099/0022-1317-23-3-297; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P259, DOI 10.1017/S0022172400025092; DAVIES FG, 1978, J COMP PATHOL, V88, P519, DOI 10.1016/0021-9975(78)90005-1; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P251, DOI 10.1017/S0022172400025080; DAVIES FG, 1982, J COMP PATHOL, V92, P15, DOI 10.1016/0021-9975(82)90039-1; DAVIES FG, 1976, J COMP PATHOL, V86, P497, DOI 10.1016/0021-9975(76)90058-X; Drosten C, 2002, J CLIN MICROBIOL, V40, P1122, DOI 10.1128/JCM.40.3.1122-1123.2002; Dunster L, 2002, EMERG INFECT DIS, V8, P1005, DOI 10.3201/eid0809.010510; ElAzazy OME, 1997, T ROY SOC TROP MED H, V91, P275, DOI 10.1016/S0035-9203(97)90072-9; ELLIS DS, 1981, ARCH VIROL, V70, P189, DOI 10.1007/BF01315125; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; GENTSCH J, 1977, J GEN VIROL, V34, P257, DOI 10.1099/0022-1317-34-2-257; Groocock CM, 1998, FOREIGN ANIMAL DIS; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HARRISONLAVOIE KJ, 1993, EMBO J, V12, P2847, DOI 10.1002/j.1460-2075.1993.tb05946.x; HEWLETT MJ, 1977, J VIROL, V21, P1085, DOI 10.1128/JVI.21.3.1085-1093.1977; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Honig JE, 2004, VIROLOGY, V321, P29, DOI 10.1016/j.virol.2003.09.042; HOWARTH JA, 1965, J COMP PATHOL THERAP, V75, P437, DOI 10.1016/0021-9975(65)90024-1; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jain S, 2009, J VIROL, V83, P241, DOI 10.1128/JVI.01407-08; Jain S, 2008, J VIROL, V82, P12039, DOI 10.1128/JVI.01406-08; Jantti J, 1997, J VIROL, V71, P1162; Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Joshi MV, 2005, J MED ENTOMOL, V42, P204, DOI 10.1603/0022-2585(2005)042[0204:IOGVFT]2.0.CO;2; JOUBERT JR, 1985, S AFR MED J, V68, P722; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Levi M, 2013, INTERN EMERG MED, V8, P23, DOI 10.1007/s11739-012-0859-9; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Marriott A. C., 1996, The Bunyaviridae., P91; MARRIOTT AC, 1992, VIROLOGY, V190, P606, DOI 10.1016/0042-6822(92)90898-Y; Marriott AC, 1996, J GEN VIROL, V77, P1775, DOI 10.1099/0022-1317-77-8-1775; MATSUOKA Y, 1991, CURR TOP MICROBIOL, V169, P161; Montgomery RE, 1917, J COMP PATHOL, V30; Nabeth P, 2004, EMERG INFECT DIS, V10, P1881, DOI 10.3201/eid1010.040586; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Netherton C, 2004, J VIROL, V78, P3710, DOI 10.1128/JVI.78.7.3710-3721.2004; Novoa RR, 2005, J VIROL, V79, P10852, DOI 10.1128/JVI.79.17.10852-10863.2005; Osterud B, 2001, SEMIN THROMB HEMOST, V27, P605, DOI 10.1055/s-2001-18866; Papa A, 2004, EMERG INFECT DIS, V10, P1465, DOI 10.3201/eid1008.040162; Papa A, 2010, CLIN MICROBIOL INFEC, V16, P843, DOI 10.1111/j.1469-0691.2009.02996.x; Papa A, 2002, EMERG INFECT DIS, V8, P50, DOI 10.3201/eid0801.010087; Papa A, 2006, J CLIN VIROL, V36, P272, DOI 10.1016/j.jcv.2006.04.007; PERSSON R, 1991, J CELL BIOL, V112, P257, DOI 10.1083/jcb.112.2.257; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; PETTERSSON RF, 1973, VIROLOGY, V56, P608, DOI 10.1016/0042-6822(73)90062-7; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Popescu NI, 2010, THROMB RES, V125, pS38, DOI 10.1016/j.thromres.2010.01.034; Ramanathan HN, 2008, VIROLOGY, V374, P138, DOI 10.1016/j.virol.2007.12.030; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Rodriguez F, 1996, VET REC, V139, P249, DOI 10.1136/vr.139.11.249; Rouiller I, 1998, J VIROL, V72, P2373, DOI 10.1128/JVI.72.3.2373-2387.1998; Rwambo PM, 1996, ARCH VIROL, V141, P1479, DOI 10.1007/BF01718249; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; Saunders PM, 2011, TISSUE ANTIGENS, V78, P161, DOI 10.1111/j.1399-0039.2011.01735.x; Schmidt S, 2013, MOL IMMUNOL, V55, P49, DOI 10.1016/j.molimm.2012.11.006; Shi XH, 2004, J VIROL, V78, P5414, DOI 10.1128/JVI.78.10.5414-5422.2004; Simon M, 2009, VIROLOGY, V385, P313, DOI 10.1016/j.virol.2008.11.020; Strandin T, 2011, J GEN VIROL, V92, P1189, DOI 10.1099/vir.0.027896-0; Sudeep AB, 2009, INDIAN J MED RES, V130, P514; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Terasaki K, 2011, P NATL ACAD SCI USA, V108, P804, DOI 10.1073/pnas.1013155108; UEDA K, 1992, JPN J VET RES, V40, P133; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; Veijola J, 1999, J VIROL, V73, P6123, DOI 10.1128/JVI.73.7.6123-6127.1999; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; Wan SW, 2012, J CELL BIOCHEM, V113, P1681, DOI 10.1002/jcb.24037; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; WATRET GE, 1985, J GEN VIROL, V66, P2513, DOI 10.1099/0022-1317-66-11-2513; WEINBREN M. P., 1958, JOUR COMP PATHOL AND THERAP, V68, P174, DOI 10.1016/S0368-1742(58)80018-1; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; White WR, 2008, FOREIGN ANIMAL DIS, P335; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Williams RJ, 2000, TROP MED INT HEALTH, V5, P99, DOI 10.1046/j.1365-3156.2000.00524.x; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	121	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94656	10.1371/journal.pone.0094656	http://dx.doi.org/10.1371/journal.pone.0094656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714576	gold, Green Submitted, Green Published			2022-12-27	WOS:000334160900140
J	Morris, S; Karlsen, S; Chung, N; Hill, M; Chitty, LS				Morris, Stephen; Karlsen, Saffron; Chung, Nancy; Hill, Melissa; Chitty, Lyn S.			Model-Based Analysis of Costs and Outcomes of Non-Invasive Prenatal Testing for Down's Syndrome Using Cell Free Fetal DNA in the UK National Health Service	PLOS ONE			English	Article							MATERNAL PLASMA; ANEUPLOIDY; DIAGNOSIS; WOMEN; AMNIOCENTESIS; GENOME	Background: Non-invasive prenatal testing (NIPT) for Down's syndrome (DS) using cell free fetal DNA in maternal blood has the potential to dramatically alter the way prenatal screening and diagnosis is delivered. Before NIPT can be implemented into routine practice, information is required on its costs and benefits. We investigated the costs and outcomes of NIPT for DS as contingent testing and as first-line testing compared with the current DS screening programme in the UK National Health Service. Methods: We used a pre-existing model to evaluate the costs and outcomes associated with NIPT compared with the current DS screening programme. The analysis was based on a hypothetical screening population of 10,000 pregnant women. Model inputs were taken from published sources. The main outcome measures were number of DS cases detected, number of procedure-related miscarriages and total cost. Results: At a screening risk cut-off of 1:150 NIPT as contingent testing detects slightly fewer DS cases, has fewer procedure-related miscarriages, and costs the same as current DS screening (around UK 280,000) pound at a cost of 500 pound per NIPT. As first-line testing NIPT detects more DS cases, has fewer procedure-related miscarriages, and is more expensive than current screening at a cost of 50 pound per NIPT. When NIPT uptake increases, NIPT detects more DS cases with a small increase in procedure-related miscarriages and costs. Conclusions: NIPT is currently available in the private sector in the UK at a price of 400- pound 900 pound. If the NHS cost was at the lower end of this range then at a screening risk cut-off of 1:150 NIPT as contingent testing would be cost neutral or cost saving compared with current DS screening. As first-line testing NIPT is likely to produce more favourable outcomes but at greater cost. Further research is needed to evaluate NIPT under real world conditions.	[Morris, Stephen; Karlsen, Saffron] UCL, Dept Appl Hlth Res, London, England; [Chung, Nancy] Univ Exeter, NHS Fetal Anomaly Screening Programme, Exeter, Devon, England; [Hill, Melissa; Chitty, Lyn S.] UCL Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Hill, Melissa; Chitty, Lyn S.] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Hill, Melissa; Chitty, Lyn S.] Univ Coll London Hosp NHS Fdn Trust, Fetal Med Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Morris, S (corresponding author), UCL, Dept Appl Hlth Res, London, England.	steve.morris@ucl.ac.uk	Hill, Melissa/AIC-6192-2022	Morris, Stephen/0000-0002-5828-3563; chitty, lyn/0000-0002-4857-7138	National Institute for Health Research (NIHR) [RP-PG-0707-10107]; Central and East London NIHR Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research [NF-SI-0513-10141, RP-PG-0707-10107] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1253] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Central and East London NIHR Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	This study was funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (the "RAPID'' project; RP-PG-0707-10107), the Central and East London NIHR Comprehensive Local Research Network, the Great Ormond Street Hospital Children's Charity and the NIHR Biomedical Research Centre at Great Ormond Street Hospital. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OBSTET GYNECOL, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Antenatal Results and Choices, 2013, NON PREN TEST SYNDR; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Boon EMJ, 2013, PRENATAL DIAG, V33, P563, DOI 10.1002/pd.4111; Bray IC, 1998, PRENATAL DIAG, V18, P1045, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1045::AID-PD403>3.3.CO;2-I; Chetty S, 2013, PRENATAL DIAG, V33, P542, DOI 10.1002/pd.4125; Chitty LS, 2006, BMJ-BRIT MED J, V332, P452, DOI 10.1136/bmj.38730.655197.AE; Chitty LS, 2012, AM J OBSTET GYNECOL, V206, P269, DOI 10.1016/j.ajog.2012.02.021; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; Department of Health, 2011, 15423 DEP HLTH, P16211; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Futch T, 2013, PRENATAL DIAG, V33, P569, DOI 10.1002/pd.4123; Garfield SS, 2012, J MANAGED CARE MED, V15, P34; Gilbert RE, 2000, COST EFFECTIVENES SA; Gray JAM, 2004, NATL SYNDROME SCREEN; HESonline, MAT DAT 2010 11; Kagan KO, 2007, PRENATAL DIAG, V27, P34, DOI 10.1002/pd.1615; Langlois S, 2013, J OBSTET GYNAECOL CA, V35, P177, DOI 10.1016/S1701-2163(15)31025-2; Lewis C, 2013, PUBLIC HEALTH GENOM, V16, P223, DOI 10.1159/000353523; Liang DS, 2013, PRENATAL DIAG, V33, P409, DOI 10.1002/pd.4033; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Morris JK, 2011, NATL SYNDROME CYTOGE; NHS Choices, 2013, TESTS SYNDR; NHS FASP. Screening for Down's syndrome: UK NSC policy recommenda-ations, 2011, 2011 2014 MOD BEST P; NHS Fetal Anomaly Screening Programme, 2012, DEC PLANN TOOL; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Ohno M, 2013, PRENATAL DIAG, V33, P630, DOI 10.1002/pd.4156; ONS, 2010, LIV BIRT ENGL WAL CH; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Rowe R, 2008, PRENATAL DIAG, V28, P1245, DOI 10.1002/pd.2125; Song K, 2013, J MATERN-FETAL NEO M, V26, P1180, DOI 10.3109/14767058.2013.770464; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Wald NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058732; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Wald NJ, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/HTA2010; Wright D, 2009, DQASS DETECTION RATE	40	82	84	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93559	10.1371/journal.pone.0093559	http://dx.doi.org/10.1371/journal.pone.0093559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714162	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900033
J	Li, W; Claypool, MD; Friera, AM; McLaughlin, J; Baltgalvis, KA; Smith, IJ; Kinoshita, T; White, K; Lang, W; Godinez, G; Payan, DG; Kinsella, TM				Li, Wei; Claypool, Mark D.; Friera, Annabelle M.; McLaughlin, John; Baltgalvis, Kristen A.; Smith, Ira J.; Kinoshita, Taisei; White, Kathy; Lang, Wayne; Godinez, Guillermo; Payan, Donald G.; Kinsella, Todd M.			Noninvasive Imaging of In Vivo MuRF1 Expression during Muscle Atrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; GLUCOCORTICOID-RECEPTOR; DISUSE; INVOLVE; DISEASE; MASS	Numerous human diseases can lead to atrophy of skeletal muscle, and loss of this tissue has been correlated with increased mortality and morbidity rates. Clinically addressing muscle atrophy remains an unmet medical need, and the development of preclinical tools to assist drug discovery and basic research in this effort is important for advancing this goal. In this report, we describe the development of a bioluminescent gene reporter rat, based on the zinc finger nuclease-targeted insertion of a bicistronic luciferase reporter into the 39 untranslated region of a muscle specific E3 ubiquitin ligase gene, MuRF1 (Trim63). In longitudinal studies, we noninvasively assess atrophy-related expression of this reporter in three distinct models of muscle loss (sciatic denervation, hindlimb unloading and dexamethasone-treatment) and show that these animals are capable of generating refined detail on in vivo MuRF1 expression with high temporal and anatomical resolution.	[Li, Wei; Claypool, Mark D.; Friera, Annabelle M.; McLaughlin, John; Baltgalvis, Kristen A.; Smith, Ira J.; Kinoshita, Taisei; White, Kathy; Lang, Wayne; Godinez, Guillermo; Payan, Donald G.; Kinsella, Todd M.] Rigel Pharmaceut Inc, Discovery Res, San Francisco, CA 94080 USA		Kinsella, TM (corresponding author), Rigel Pharmaceut Inc, Discovery Res, San Francisco, CA 94080 USA.	tkinsella@rigel.com			Rigel Pharmaceuticals Inc.	Rigel Pharmaceuticals Inc.	Financial support for this work was provided by Rigel Pharmaceuticals Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Arbogast S, 2007, J APPL PHYSIOL, V102, P956, DOI 10.1152/japplphysiol.00538.2006; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Bodine S., 2013, INT J BIOCH CELL BIO; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571; DESPLANCHES D, 1987, J APPL PHYSIOL, V63, P558, DOI 10.1152/jappl.1987.63.2.558; Files DC, 2012, AM J RESP CRIT CARE, V185, P825, DOI 10.1164/rccm.201106-1150OC; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; GRINDELAND RE, 1994, AM J PHYSIOL, V267, pR316, DOI 10.1152/ajpregu.1994.267.1.R316; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Kelkar M, 2012, CURR OPIN PHARMACOL, V12, P592, DOI 10.1016/j.coph.2012.07.014; Labeit S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/693741; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Macpherson PCD, 2011, J CELL BIOCHEM, V112, P2149, DOI 10.1002/jcb.23136; Maguire KK, 2013, J CLIN INVEST, V123, P2298, DOI 10.1172/JCI68458; Marimuthu K, 2011, J APPL PHYSIOL, V110, P555, DOI 10.1152/japplphysiol.00962.2010; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Radek KA, 2008, J APPL PHYSIOL, V104, P1295, DOI 10.1152/japplphysiol.00977.2007; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Watson ML, 2012, AM J PHYSIOL-ENDOC M, V302, pE1210, DOI 10.1152/ajpendo.00512.2011; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94032	10.1371/journal.pone.0094032	http://dx.doi.org/10.1371/journal.pone.0094032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710205	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800091
J	Liu, XD; Gao, LH; Zhao, A; Zhang, R; Ji, BH; Wang, L; Zheng, YL; Zeng, BF; Valenzuela, RK; He, L; Ma, J				Liu, Xudong; Gao, Linghan; Zhao, Aman; Zhang, Rui; Ji, Baohu; Wang, Lei; Zheng, Yonglan; Zeng, Bingfang; Valenzuela, Robert K.; He, Lin; Ma, Jie			Identification of Duplication Downstream of BMP2 in a Chinese Family with Brachydactyly Type A2 (BDA2)	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; INDIAN HEDGEHOG; MISSENSE MUTATIONS; GENE-EXPRESSION; GROWTH-PLATE; BONE; ROR2; GDF5; TRANSCRIPTION; MECHANISMS	Brachydactyly type A2 (BDA2, MIM 112600) is characterized by the deviation and shortening of the middle phalange of the index finger and the second toe. Using genome-wide linkage analysis in a Chinese BDA2 family, we mapped the maximum candidate interval of BDA2 to a similar to 1.5 Mb region between D20S194 and D20S115 within chromosome 20p12.3 and found that the pairwise logarithm of the odds score was highest for marker D20S156 (Zmax = 6.09 at theta = 0). Based on functional and positional perspectives, the bone morphogenetic protein 2 (BMP2) gene was identified as the causal gene for BDA2 in this region, even though no point mutation was detected in BMP2. Through further investigation, we identified a 4,671 bp (Chr20: 6,809,218-6,813,888) genomic duplication downstream of BMP2. This duplication was located within the linked region, co-segregated with the BDA2 phenotype in this family, and was not found in the unaffected family members and the unrelated control individuals. Compared with the previously reported duplications, the duplication in this family has a different breakpoint flanked by the microhomologous sequence GATCA and a slightly different length. Some other microhomologous nucleotides were also found in the duplicated region. In summary, our findings support the conclusions that BMP2 is the causing gene for BDA2, that the genomic location corresponding to the duplication region is prone to structural changes associated with malformation of the digits, and that this tendency is probably caused by the abundance of microhomologous sequences in the region.	[Liu, Xudong; Zeng, Bingfang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Gao, Linghan; Zhao, Aman; Wang, Lei; He, Lin] Shanghai Jiao Tong Univ, Biox Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Zhang, Rui; Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Ji, Baohu; Ma, Jie] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Zheng, Yonglan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Valenzuela, Robert K.] ASTAR, Human Genet Genome Inst Singapore, Singapore, Singapore; [Zhang, Rui] Xi An Jiao Tong Univ, Affiliated Hosp, Xian Hong Hui Hosp, Sch Med, Xian 710049, Shaanxi, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Xi'an Jiaotong University; University of California System; University of California San Diego; University of Chicago; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Xi'an Jiaotong University	He, L (corresponding author), Shanghai Jiao Tong Univ, Biox Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	helinhelin@gmail.com; majie.paper@gmail.com	Zheng, Yonglan/O-4112-2019; Zheng, Yonglan/C-4236-2011	Zheng, Yonglan/0000-0001-6597-7072; Zhang, Rui/0000-0002-8664-6915	National Natural Science Foundation of China [30700453, 81121001, 31371298, 81301151]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Leading Academic Discipline Project [B205]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); Shanghai Municipal Commission of Science and Technology Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Natural Science Foundation of China (No. 30700453; No. 81121001; No. 31371298; No. 81301151), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the Shanghai Municipal Commission of Science and Technology Program 09DJ1400601, the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams KL, 2004, J BIOL CHEM, V279, P15916, DOI 10.1074/jbc.M313531200; Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Armour CM, 2002, J MED GENET, V39, P186, DOI 10.1136/jmg.39.3.186; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Baur ST, 2000, DEVELOPMENT, V127, P605; Bell J., 1951, TREASURY HUMAN INHER, P1; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; FITCH N, 1979, J MED GENET, V16, P36, DOI 10.1136/jmg.16.1.36; Fritz DT, 2004, J BIOL CHEM, V279, P48950, DOI 10.1074/jbc.M409620200; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gao B, 2009, NATURE, V458, P1196, DOI 10.1038/nature07862; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Johnson D, 2003, AM J HUM GENET, V72, P984, DOI 10.1086/374721; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; Kjaer KW, 2006, J MED GENET, V43, P225, DOI 10.1136/jmg.2005.034058; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kornak U, 2003, AM J HUM GENET, V73, P447, DOI 10.1086/377110; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lehmann K, 2006, EUR J HUM GENET, V14, P1248, DOI 10.1038/sj.ejhg.5201708; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Ma G, 2011, CELL RES, V21, P1343, DOI 10.1038/cr.2011.76; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Mohr O.L., 1919, NEW TYPE HEREDITARY, P5; Mundlos S, 2009, CLIN GENET, V76, P123, DOI 10.1111/j.1399-0004.2009.01238.x; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Ploger F, 2008, HUM MOL GENET, V17, P1222, DOI 10.1093/hmg/ddn012; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Su PQ, 2011, J MED GENET, V48, P312, DOI 10.1136/jmg.2010.084814; Sugiura T, 1999, BIOCHEM J, V338, P433, DOI 10.1042/0264-6021:3380433; Temtamy SA, 1978, GENETICS HAND MALFOR; Temtamy SA, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-15; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Uchikawa M, 2004, MECH DEVELOP, V121, P1145, DOI 10.1016/j.mod.2004.05.009; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xing QH, 2003, AM J HUM GENET, V73, P377, DOI 10.1086/377007; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	57	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94201	10.1371/journal.pone.0094201	http://dx.doi.org/10.1371/journal.pone.0094201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710560	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800116
J	Villani, G; Shevelev, I; Orlando, E; Pospiech, H; Syvaoja, JE; Markkanen, E; Hubscher, U; Le Gac, NT				Villani, Giuseppe; Shevelev, Igor; Orlando, Eleonora; Pospiech, Helmut; Syvaoja, Juhani E.; Markkanen, Enni; Hubscher, Ulrich; Le Gac, Nicolas Tanguy			Gap-Directed Translesion DNA Synthesis of an Abasic Site on Circular DNA Templates by a Human Replication Complex	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; POLYMERASE-DELTA; PROTEIN-A; EPSILON; LAMBDA; BETA; ELONGATION; GENERATION; PRIMPOL; LESIONS	DNA polymerase epsilon(pol epsilon) is believed to be the leading strand replicase in eukaryotes whereas pols lambda and beta are thought to be mainly involved in re-synthesis steps of DNA repair. DNA elongation by the human pol e is halted by an abasic site (apurinic/apyrimidinic (AP) site). We have previously reported that human pols lambda,beta and eta can perform translesion synthesis (TLS) of an AP site in the presence of pol epsilon. In the case of pol lambda and beta, this TLS requires the presence of a gap downstream from the product synthetized by the epsilon replicase. However, since these studies were conducted exclusively with a linear DNA template, we decided to test whether the structure of the template could influence the capacity of the pols epsilon,lambda, beta and eta to perform TLS of an AP site. Therefore, we have investigated the replication of damaged ``minicircle'' DNA templates. In addition, replication of circular DNA requires, beyond DNA pols, the processivity clamp PCNA, the clamp loader replication factor C (RFC), and the accessory proteins replication protein A (RPA). Finally we have compared the capacity of unmodified versus monoubiquitinated PCNA in sustaining TLS by pols lambda and eta on a circular template. Our results indicate that in vitro gap-directed TLS synthesis by pols lambda and beta in the presence of pol epsilon, RPA and PCNA is unaffected by the structure of the DNA template. Moreover, monoubiquitination of PCNA does not affect TLS by pol lambda while it appears to slightly stimulate TLS by pol eta.	[Villani, Giuseppe; Orlando, Eleonora; Le Gac, Nicolas Tanguy] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Villani, Giuseppe; Orlando, Eleonora; Le Gac, Nicolas Tanguy] Univ Toulouse 3, Inst Pharmacol & Biol Struct, Toulouse, France; [Shevelev, Igor; Pospiech, Helmut] Leibniz Inst Age Res, Fritz Lipman Inst, Jena, Germany; [Shevelev, Igor; Pospiech, Helmut] Univ Oulu, Dept Biochem, Oulu, Finland; [Syvaoja, Juhani E.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Markkanen, Enni] Gray Inst Radiat Oncol & Biol, Dept Oncol, Dept Grp, Biochem Grp, Oxford, England; [Hubscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Finland National Institute for Health & Welfare; University of Oulu; University of Eastern Finland; University of Oxford; University of Zurich	Le Gac, NT (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	ntlg@ipbs.fr	Markkanen, Enni/V-9784-2017; Pospiech, Helmut/J-8598-2015	Markkanen, Enni/0000-0001-7780-8233; 	Swiss National Science Foundation; Grant Electricite de France [NRB62013-07]; Academy of Finland [251576]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grant Electricite de France; Academy of Finland(Academy of Finland)	EM and UH are supported by the Swiss National Science Foundation (http://www.snf.ch). GV was supported by the Grant Electricite de France NRB62013-07 (http://france.edf.com). JES was supported by grant 251576 from the Academy of Finland (http://www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker T. A., 2005, DNA REPLICATION; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Chary P, 2012, CHEM RES TOXICOL, V25, P2744, DOI 10.1021/tx300368f; Eger S, 2011, CHEMBIOCHEM, V12, P2807, DOI 10.1002/cbic.201100444; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hubscher U., 2010, DNA POLYM DISCOVERY; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Le Gac NT, 2004, J MOL BIOL, V336, P1023, DOI 10.1016/j.jmb.2004.01.005; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Locatelli GA, 2010, BIOCHEM J, V429, P573, DOI 10.1042/BJ20100405; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Shevelev I, 2003, NUCLEIC ACIDS RES, V31, P6916, DOI 10.1093/nar/gkg896; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Tomer G, 1999, BIOCHEMISTRY-US, V38, P5948, DOI 10.1021/bi982599+; van Loon Barbara, 2009, V521, P345, DOI [10.1007/978-1-60327-817-5_19, 10.1007/978-1-60327-815-7_19]; Villani G, 2011, J BIOL CHEM, V286, P32094, DOI 10.1074/jbc.M111.246611; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93908	10.1371/journal.pone.0093908	http://dx.doi.org/10.1371/journal.pone.0093908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710081	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800068
J	Jiang, ZY; Yin, J; Fu, WF; Mo, YJ; Pan, YG; Dai, L; Huang, HD; Li, SW; Zhao, J				Jiang, Zeyong; Yin, Jun; Fu, Wenfan; Mo, Yijun; Pan, Youguang; Dai, Lu; Huang, Haoda; Li, Siwen; Zhao, Jian			miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MICRORNA CLUSTER; STEM-CELLS; CANCER; EXPRESSION; MIR-17-92; AXIS; EMT	MicroRNAs (miRNAs) have been proven to play crucial roles in cancer, including tumor chemotherapy resistance and metastasis of non-small-cell lung cancer (NSCLC). TGF beta signal pathway abnormality is widely found in cancer and correlates with tumor proliferation, apoptosis and metastasis. Here, miR-17, 20a, 20b were detected down-regulated in A549/DDP cells (cisplatin resistance) compared with A549 cells (cisplatin sensitive). Over-expression of miR-17, 20a, 20b can not only decrease cisplatin-resistant but also reduce migration by inhibiting epithelial-to-mesenchymal transition (EMT) in A549/DDP cells. These functions of miR-17, 20a, 20b may be caused at least in part via inhibition of TGF beta signal pathway, as miR-17, 20a, 20b are shown to directly target and repress TGF-beta receptor 2 (TGF beta R2) which is an important component of TGF beta signal pathway. Consequently, our study suggests that miRNA 17 family (including miR-17, 20a, 20b) can act as TGF beta R2 suppressor for reversing cisplatin-resistant and suppressing metastasis in NSCLC.	[Jiang, Zeyong; Yin, Jun; Fu, Wenfan; Mo, Yijun; Pan, Youguang; Dai, Lu; Huang, Haoda; Li, Siwen; Zhao, Jian] Guangzhou Med Univ, Ctr Canc, Dept Chest Surg, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zhao, J (corresponding author), Guangzhou Med Univ, Ctr Canc, Dept Chest Surg, Guangzhou, Guangdong, Peoples R China.	tottijun@163.com			Science and Technology Plan Project of Guangdong Province in China [2011B061300040, 2012B061700048]; Medical Science and Technology Project of Guangzhou City in China [20131A011163]	Science and Technology Plan Project of Guangdong Province in China; Medical Science and Technology Project of Guangzhou City in China	This research was supported by grants from the Science and Technology Plan Project of Guangdong Province in China (2011B061300040, 2012B061700048), Medical Science and Technology Project of Guangzhou City in China (20131A011163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi WR, 2012, HEPATO-GASTROENTEROL, V59, P1960, DOI 10.5754/hge11750; Chang CC, 2013, ORAL ONCOL, V49, P923, DOI 10.1016/j.oraloncology.2013.03.430; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Edme N, 2002, J CELL SCI, V115, P2591; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Iwano Masayuki, 2010, Front Biosci (Schol Ed), V2, P229; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jevnaker AM, 2011, J CELL PHYSIOL, V226, P2257, DOI 10.1002/jcp.22562; Jin HY, 2013, EMBO J, V32, P2377, DOI 10.1038/emboj.2013.178; Judson I, 2000, DRUGS, V59, P29, DOI 10.2165/00003495-200059004-00004; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Mallini P, 2014, CANCER TREAT REV, V40, P341, DOI 10.1016/j.ctrv.2013.09.008; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Murphy BL, 2013, CANCER RES, V73, P7068, DOI 10.1158/0008-5472.CAN-13-0927; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Reed John C., 1999, Current Opinion in Oncology, V11, P68, DOI 10.1097/00001622-199901000-00014; Rudd R, 1991, RESP DIS PRACTICE, V7, P12; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Subramaniam Sangeetha, 2013, J Carcinog, V12, P3, DOI 10.4103/1477-3163.107958; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Tan M, 2013, TOXICOL LETT, V223, P1, DOI 10.1016/j.toxlet.2013.08.011; Visbal AL, 2005, CHEST, V128, P2933, DOI 10.1378/chest.128.4.2933	31	73	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94639	10.1371/journal.pone.0094639	http://dx.doi.org/10.1371/journal.pone.0094639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722426	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100112
J	Nilsson, C; Waldo, ML; Nilsson, K; Santillo, A; Vestberg, S				Nilsson, Christer; Waldo, Maria Landqvist; Nilsson, Karin; Santillo, Alexander; Vestberg, Susanna			Age-Related Incidence and Family History in Frontotemporal Dementia: Data from the Swedish Dementia Registry	PLOS ONE			English	Article							EARLY-ONSET DEMENTIAS; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; PREVALENCE; DIAGNOSIS; EPIDEMIOLOGY; RELATIVES; ACCURACY; GENETICS	Objectives: Frontotemporal dementia (FTD) is considered to be a mainly early-onset neurodegenerative disorder with a strong hereditary component. The aim of the study was to investigate age-related incidence and family history in FTD compared to other dementia disorders, especially Alzheimer's disease (AD). Methods: The Swedish Dementia Registry (SveDem) registers all new cases of dementia diagnosed by the participating centres, including data on demographics, diagnosis, and investigations used. Data for the period 2008-2011 were extracted and compared with age-related population data on a regional and national level. Results: There were 20 305 patients registered in SveDem during 2008-2011, whereof 352 received a diagnosis of FTD. Mean age at diagnosis for FTD was 69.6 years and almost 70% of FTD cases were 65 years or older at the time of diagnosis. Both FTD and AD showed an increased incidence with age, which reached a maximum in the age group 80-84 years at 6.04 and 202 cases per 100 000 person-years, respectively. The proportion of cases with a positive family history was significantly lower in FTD than in AD. Conclusions: Contrary to general opinion within the field, data from SveDem show that the incidence of FTD increases with age, and that the majority of cases are diagnosed after the age of 65 years. In addition, data from SveDem might suggest that the importance of hereditary factors in general is similar in FTD and AD. The recognition of these findings has important consequences for the diagnosis, treatment and care of patients with FTD.	[Nilsson, Christer; Waldo, Maria Landqvist; Nilsson, Karin; Santillo, Alexander] Skane Univ Hosp, Dept Memory Disorders, Lund, Sweden; [Nilsson, Christer; Santillo, Alexander] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [Waldo, Maria Landqvist; Nilsson, Karin; Vestberg, Susanna] Lund Univ, Dept Clin Sci, Geriatr Psychiat Unit, Lund, Sweden; [Vestberg, Susanna] Lund Univ, Dept Psychol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Lund University	Nilsson, C (corresponding author), Skane Univ Hosp, Dept Memory Disorders, Lund, Sweden.	christer.nilsson@med.lu.se	Landqvist, Maria/B-6270-2019	Landqvist, Maria/0000-0003-3262-8938; Santillo, Alexander/0000-0001-9717-0820	Skane Regional Council; Lund University	Skane Regional Council; Lund University	The study was funded by grants from the regional agreement on medical training and clinical research (ALF) between the Skane Regional Council and Lund University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baborie A, 2012, ARCH NEUROL-CHICAGO, V69, P1052, DOI 10.1001/archneurol.2011.3323; Baborie A, 2011, ACTA NEUROPATHOL, V121, P365, DOI 10.1007/s00401-010-0765-z; Berg L, 2001, Lakartidningen, V98, P3531; Borroni B, 2010, J ALZHEIMERS DIS, V19, P111, DOI 10.3233/JAD-2010-1208; Boxer AL, 2013, LANCET NEUROL, V12, P149, DOI 10.1016/S1474-4422(12)70320-4; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; de Simone V, 2007, DEMENT GERIATR COGN, V23, P1, DOI 10.1159/000096317; Garre-Olmo J, 2010, NEUROLOGY, V75, P1249, DOI 10.1212/WNL.0b013e3181f5d4c4; Grasbeck A, 2005, DEMENT GERIATR COGN, V19, P145, DOI 10.1159/000082886; Halliday G, 2012, ACTA NEUROPATHOL, V124, P373, DOI 10.1007/s00401-012-1030-4; Hodges JR, 2010, BRAIN, V133, P300, DOI 10.1093/brain/awp248; Ikejima C, 2009, STROKE, V40, P2709, DOI 10.1161/STROKEAHA.108.542308; Johnson JK, 2005, ARCH NEUROL-CHICAGO, V62, P925, DOI 10.1001/archneur.62.6.925; Knopman DS, 2011, J MOL NEUROSCI, V45, P330, DOI 10.1007/s12031-011-9538-y; Knopman DS, 2004, NEUROLOGY, V62, P506, DOI 10.1212/01.WNL.0000106827.39764.7E; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lobo A, 2000, NEUROLOGY S5, P54; Lovestone S, 2009, LISHMANS ORGANIC PSY, P543; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mendez MF, 2007, ARCH NEUROL-CHICAGO, V64, P830, DOI 10.1001/archneur.64.6.830; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Muangpaisan W, 2009, J EPIDEMIOL, V19, P281, DOI 10.2188/jea.JE20081034; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Paulson HL, 2011, SEMIN NEUROL, V31, P449, DOI 10.1055/s-0031-1299784; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Religa D, 2012, DEMENT GERIATR COGN, V33, P90, DOI 10.1159/000337038; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rosso SM, 2003, BRAIN, V126, P2016, DOI 10.1093/brain/awg204; Seelaar H, 2008, NEUROLOGY, V71, P1220, DOI 10.1212/01.wnl.0000319702.37497.72; Snowden JS, 2011, BRAIN, V134, P2478, DOI 10.1093/brain/awr189; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541	37	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94901	10.1371/journal.pone.0094901	http://dx.doi.org/10.1371/journal.pone.0094901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722237	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100144
J	Rossi, G; Pengo, G; Caldin, M; Piccionello, AP; Steiner, JM; Cohen, ND; Jergens, AE; Suchodolski, JS				Rossi, Giacomo; Pengo, Graziano; Caldin, Marco; Piccionello, Angela Palumbo; Steiner, Joerg M.; Cohen, Noah D.; Jergens, Albert E.; Suchodolski, Jan S.			Comparison of Microbiological, Histological, and Immunomodulatory Parameters in Response to Treatment with Either Combination Therapy with Prednisone and Metronidazole or Probiotic VSL#3 Strains in Dogs with Idiopathic Inflammatory Bowel Disease	PLOS ONE			English	Article							REAL-TIME PCR; GRADIENT GEL-ELECTROPHORESIS; COLONIC EPITHELIAL-CELLS; GERMAN-SHEPHERD DOGS; LACTIC-ACID BACTERIA; ULCERATIVE-COLITIS; CROHNS-DISEASE; GASTROINTESTINAL-TRACT; MICROBIAL COMMUNITIES; MINIATURE DACHSHUNDS	Background: Idiopathic inflammatory bowel disease (IBD) is a common chronic enteropathy in dogs. There are no published studies regarding the use of probiotics in the treatment of canine IBD. The objectives were to compare responses to treatment with either combination therapy (prednisone and metronidazole) or probiotic strains (VSL#3) in dogs with IBD. Methodology and Principal Findings: Twenty pet dogs with a diagnosis of IBD, ten healthy pet dogs, and archived control intestinal tissues from three euthanized dogs were used in this open label study. Dogs with IBD were randomized to receive either probiotic (D-VSL#3, n = 10) or combination drug therapy (D-CT, n = 10). Dogs were monitored for 60 days (during treatment) and re-evaluated 30 days after completing treatment. The CIBDAI (P < 0.001), duodenal histology scores (P < 0.001), and CD3+ cells decreased post-treatment in both treatment groups. FoxP3+ cells (p < 0.002) increased in the D-VSL#3 group after treatment but not in the D-CT group. TGF-beta+ cells increased in both groups after treatment (P = 0.0043) with the magnitude of this increase being significantly greater for dogs in the D-VSL#3 group compared to the D-CT group. Changes in apical junction complex molecules occludin and claudin-2 differed depending on treatment. Faecalibacterium and Turicibacter were significantly decreased in dogs with IBD at T0, with a significant increase in Faecalibacterium abundance observed in the animals treated with VSL#3 strains. Conclusions: A protective effect of VSL#3 strains was observed in dogs with IBD, with a significant decrease in clinical and histological scores and a decrease in CD3+ T-cell infiltration. Protection was associated with an enhancement of regulatory T-cell markers (FoxP3+ and TGF-beta+), specifically observed in the probiotic-treated group and not in animals receiving combination therapy. A normalization of dysbiosis after long-term therapy was observed in the probiotic group. Larger scale studies are warranted to evaluate the clinical efficacy of VSL#3 in canine IBD.	[Rossi, Giacomo; Piccionello, Angela Palumbo] Univ Camerino, Sch Vet Med Sci, I-62032 Camerino, Italy; [Pengo, Graziano] Clin St Antonio, Cremona, Italy; [Caldin, Marco] San Marco Labs, Padua, Italy; [Steiner, Joerg M.; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA; [Cohen, Noah D.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX USA; [Jergens, Albert E.] Iowa State Univ, Coll Vet Med, Dept Vet Clin Sci, Ames, IA USA	University of Camerino; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Iowa State University	Suchodolski, JS (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.	jsuchodolski@cvm.tamu.edu	PICCIONELLO, ANGELA PALUMBO/AAO-9434-2020; Fiumefreddo, Andrea/T-2977-2019; piccionello, angela palumbo/K-6749-2013; Rossi, Giacomo/HCI-9726-2022	PICCIONELLO, ANGELA PALUMBO/0000-0003-4076-4729; piccionello, angela palumbo/0000-0003-4076-4729; rossi, giacomo/0000-0001-8617-5984; Suchodolski, Jan/0000-0002-2176-6932				Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031238; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Colitz CMH, 2000, AM J VET RES, V61, P139, DOI 10.2460/ajvr.2000.61.139; Contractor NV, 1998, J IMMUNOL, V160, P385; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Day MJ, 2008, J COMP PATHOL, V138, pS1, DOI 10.1016/j.jcpa.2008.01.001; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dossin O, 2011, J VET INTERN MED, V25, P215, DOI 10.1111/j.1939-1676.2010.0671.x; ENGEL AG, 1986, HUM PATHOL, V17, P704, DOI 10.1016/S0046-8177(86)80180-0; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Furet JP, 2004, INT J FOOD MICROBIOL, V97, P197, DOI 10.1016/j.ijfoodmicro.2004.04.020; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Garcia-Mazcorro JF, 2012, MICROBIOLOGYOPEN, V1, P340, DOI 10.1002/mbo3.36; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Garcia-Mazcorro JF, 2011, FEMS MICROBIOL ECOL, V78, P542, DOI 10.1111/j.1574-6941.2011.01185.x; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; German AJ, 2000, DIGEST DIS SCI, V45, P7, DOI 10.1023/A:1005436721798; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Jergens AE, 2010, J VET INTERN MED, V24, P269, DOI 10.1111/j.1939-1676.2009.0447.x; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; Larsen N, 2011, FEMS MICROBIOL ECOL, V75, P482, DOI 10.1111/j.1574-6941.2010.01024.x; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Ohta H, 2013, VET IMMUNOL IMMUNOP, V155, P259, DOI 10.1016/j.vetimm.2013.07.006; Ohta H, 2011, AM J VET RES, V72, P1046, DOI 10.2460/ajvr.72.8.1046; Petrof EO, 2004, GASTROENTEROLOGY, V127, P1474, DOI 10.1053/j.gastro.2004.09.001; Pinheiro D, 2011, IMMUNOLOGY, V132, P111, DOI 10.1111/j.1365-2567.2010.03346.x; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Ridyard AE, 2007, J HISTOCHEM CYTOCHEM, V55, P1049, DOI 10.1369/jhc.7A7211.2007; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rioux KP, 2005, GASTROENTEROL CLIN N, V34, P465, DOI 10.1016/j.gtc.2005.05.005; Rossi G, 2000, INFECT IMMUN, V68, P4769, DOI 10.1128/IAI.68.8.4769-4772.2000; Sauter SN, 2006, J ANIM PHYSIOL AN N, V90, P269, DOI 10.1111/j.1439-0396.2005.00595.x; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Simpson KW, 2011, VET CLIN N AM-SMALL, V41, P381, DOI 10.1016/j.cvsm.2011.02.003; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2011, J ANIM SCI, V89, P1520, DOI 10.2527/jas.2010-3377; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; SUTHERLAND L, 1991, GUT, V32, P1071, DOI 10.1136/gut.32.9.1071; Tamura Y, 2013, VET IMMUNOL IMMUNOP, V156, P32, DOI 10.1016/j.vetimm.2013.09.017; Turner D, 2012, J PEDIATR GASTR NUTR, V55, P340, DOI 10.1097/MPG.0b013e3182662233; Tursi A, 2010, AM J GASTROENTEROL, V105, P2218, DOI 10.1038/ajg.2010.218; Vitali B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-4; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Wilke VL, 2012, AM J VET RES, V73, P1219, DOI 10.2460/ajvr.73.8.1219; Wise MG, 2005, APPL ENVIRON MICROB, V71, P3911, DOI 10.1128/AEM.71.7.3911-3916.2005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x	53	156	160	6	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94699	10.1371/journal.pone.0094699	http://dx.doi.org/10.1371/journal.pone.0094699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722235	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100124
J	Shabani, F; Kumar, L				Shabani, Farzin; Kumar, Lalit			Sensitivity Analysis of CLIMEX Parameters in Modeling Potential Distribution of Phoenix dactylifera L.	PLOS ONE			English	Article							SPECIES-DISTRIBUTION MODELS; DATE-PALM; CLIMATE-CHANGE; CUTTING PARAMETERS; TAGUCHI METHOD; ALIEN PLANT; OPTIMIZATION; DESIGN; UNCERTAINTY; INVASIONS	Using CLIMEX and the Taguchi Method, a process-based niche model was developed to estimate potential distributions of Phoenix dactylifera L. (date palm), an economically important crop in many counties. Development of the model was based on both its native and invasive distribution and validation was carried out in terms of its extensive distribution in Iran. To identify model parameters having greatest influence on distribution of date palm, a sensitivity analysis was carried out. Changes in suitability were established by mapping of regions where the estimated distribution changed with parameter alterations. This facilitated the assessment of certain areas in Iran where parameter modifications impacted the most, particularly in relation to suitable and highly suitable locations. Parameter sensitivities were also evaluated by the calculation of area changes within the suitable and highly suitable categories. The low temperature limit (DV2), high temperature limit (DV3), upper optimal temperature (SM2) and high soil moisture limit (SM3) had the greatest impact on sensitivity, while other parameters showed relatively less sensitivity or were insensitive to change. For an accurate fit in species distribution models, highly sensitive parameters require more extensive research and data collection methods. Results of this study demonstrate a more cost effective method for developing date palm distribution models, an integral element in species management, and may prove useful for streamlining requirements for data collection in potential distribution modeling for other species as well.	[Shabani, Farzin; Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New England	Shabani, F (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	fshabani@myune.edu.au	shabani, Farzin/P-1033-2019; Kumar, Lalit/A-6397-2011	shabani, Farzin/0000-0002-5100-8921; Kumar, Lalit/0000-0002-9205-756X				ABBAS IH, 1991, MYCOL RES, V95, P509, DOI 10.1016/S0953-7562(09)80857-5; Ahmed MVOM, 2011, SCI HORTIC-AMSTERDAM, V127, P367, DOI 10.1016/j.scienta.2010.11.011; Al-Senaidy AM, 2011, SAUDI J BIOL SCI, V18, P293, DOI 10.1016/j.sjbs.2011.04.005; Al-Shahib W, 2003, INT J FOOD SCI NUTR, V54, P247, DOI [10.1080/09637480120091982, 10.1080/096374803766666120]; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; AUDA H, 1979, RADIAT PHYS CHEM, V14, P775, DOI 10.1016/0146-5724(79)90113-4; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bokhary H A, 2010, Saudi J Biol Sci, V17, P327, DOI 10.1016/j.sjbs.2010.06.005; Botes A., 2002, DATE PALM CULTIVATIO, P292; Burgman MA, 2005, ECOLOGY, V86, P2007, DOI 10.1890/04-0906; Chao CT, 2007, HORTSCIENCE, V42, P1077, DOI 10.21273/HORTSCI.42.5.1077; Day M.D., 2003, Biocontrol News and Information, V24, p63N; Elhoumaizi M., 2001, GENETIC RESOURCES CR, V49, P483; Eshraghi P, 2005, AFR J BIOTECHNOL, V4, P1309; Ferry M, 2002, J INT PALM SOC, V46; Ghani JA, 2004, J MATER PROCESS TECH, V145, P84, DOI 10.1016/S0924-0136(03)00865-3; Gomez-Vidal S, 2006, MICRON, V37, P624, DOI 10.1016/j.micron.2006.02.003; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hallgren WS, 2000, GLOBAL CHANGE BIOL, V6, P483, DOI 10.1046/j.1365-2486.2000.00325.x; HAMBY DM, 1994, ENVIRON MONIT ASSESS, V32, P135, DOI 10.1007/BF00547132; Hanspach J, 2011, GLOBAL ECOL BIOGEOGR, V20, P779, DOI 10.1111/j.1466-8238.2011.00649.x; Hasan S., 2006, INT J AGRIC BIOL, V8, P1; HEAKAL MS, 1989, GEODERMA, V44, P261, DOI 10.1016/0016-7061(89)90035-9; Intergovernmental Panel on Climate Change { IPCC, 2007, GENEBRA SUICA; Jain SM, 2011, DATE PALM BIOTECHNOLOGY, P271, DOI 10.1007/978-94-007-1318-5_14; Johnson CJ, 2008, ECOL MODEL, V213, P143, DOI 10.1016/j.ecolmodel.2007.11.013; Kassem HA, 2012, J SOIL SCI PLANT NUT, V12, P45, DOI 10.4067/S0718-95162012000100005; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Khavyat M., 2007, American-Eurasian Journal of Agricultural and Environmental Science, V2, P289; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Lee KH, 1996, AIAA J, V34, P1059, DOI 10.2514/3.13187; Mahmoudi H., 2008, J ORGANIC SYSTEMS, V3, P30; Markhand GS, 2010, PAK J BOT, V42, P3715; Marques J, 2011, PLANT PHYSIOL BIOCH, V49, P388, DOI 10.1016/j.plaphy.2011.02.008; Merow C, 2011, AM NAT, V178, P30, DOI 10.1086/660295; Nalbant M, 2007, MATER DESIGN, V28, P1379, DOI 10.1016/j.matdes.2006.01.008; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Olfert O, 2006, ENTOMOL EXP APPL, V120, P221, DOI 10.1111/j.1570-7458.2006.00445.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Phadke M.S., 1995, QUALITY ENG USING RO; Reilly D, 2012, GURRA DOWNS DATA PAL; Robertson MP, 2004, DIVERS DISTRIB, V10, P461, DOI 10.1111/j.1366-9516.2004.00108.x; Shabani F, 2014, J AGR SCI-CAMBRIDGE, V152, P543, DOI 10.1017/S0021859613000816; Shabani F, 2014, THEORETICAL APPL CLI, V115; Shabani F., 2013, J FOOD AGR ENV, V11; Shabani F, 2013, J EARTH SCI CLIMATE, V4; Shabani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083404; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Sharma GR, 2005, WEED BIOL MANAG, V5, P157, DOI 10.1111/j.1445-6664.2005.00178.x; Shayesteh N., 2010, Julius-Kuhn-Archiv, P151; Shayesteh N., 2010, 10 INT WORK C STOR P; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R. W., 2007, CLIMEX VERSION 3 USE, P10; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040969; Tengberg M., 2011, J ARID ENVIRON, V5, P1; THAMAN R R, 1974, Micronesica, V10, P17; Unal R, 1991, ANN C INT SOC PAR AN, P13; van Klinken RD, 2009, GLOBAL ECOL BIOGEOGR, V18, P688, DOI 10.1111/j.1466-8238.2009.00483.x; Waldner F, 2013, IMPLEMENTATION TAGUC; Weng WC, 2007, IEEE T ANTENN PROPAG, V55, P723, DOI 10.1109/TAP.2007.891548; Wharton TN, 2004, DIVERS DISTRIB, V10, P253, DOI 10.1111/j.1366-9516.2004.00090.x; Yang WH, 1998, J MATER PROCESS TECH, V84, P122, DOI 10.1016/S0924-0136(98)00079-X	68	24	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94867	10.1371/journal.pone.0094867	http://dx.doi.org/10.1371/journal.pone.0094867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722140	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100142
J	Eyun, SI; Wang, HC; Pauchet, Y; Ffrench-Constant, RH; Benson, AK; Valencia-Jimenez, A; Moriyama, EN; Siegfried, BD				Eyun, Seong-il; Wang, Haichuan; Pauchet, Yannick; Ffrench-Constant, Richard H.; Benson, Andrew K.; Valencia-Jimenez, Arnubio; Moriyama, Etsuko N.; Siegfried, Blair D.			Molecular Evolution of Glycoside Hydrolase Genes in the Western Corn Rootworm (Diabrotica virgifera virgifera)	PLOS ONE			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; DENDROCTONUS-PONDEROSAE HOPKINS; HYPOTHENEMUS-HAMPEI COLEOPTERA; MALARIA VECTOR MOSQUITO; MOUNTAIN PINE-BEETLE; COFFEE BERRY BORER; RNA-SEQ DATA; CDNA CLONING; CELLULASE GENE; CLOSTRIDIUM-THERMOCELLUM	Cellulose is an important nutritional resource for a number of insect herbivores. Digestion of cellulose and other polysaccharides in plant-based diets requires several types of enzymes including a number of glycoside hydrolase (GH) families. In a previous study, we showed that a single GH45 gene is present in the midgut tissue of the western corn rootworm, Diabrotica virgifera virgifera (Coleoptera: Chrysomelidae). However, the presence of multiple enzymes was also suggested by the lack of a significant biological response when the expression of the gene was silenced by RNA interference. In order to clarify the repertoire of cellulose-degrading enzymes and related GH family proteins in D. v. virgifera, we performed next-generation sequencing and assembled transcriptomes from the tissue of three different developmental stages (eggs, neonates, and third instar larvae). Results of this study revealed the presence of seventy-eight genes that potentially encode GH enzymes belonging to eight families (GH45, GH48, GH28, GH16, GH31, GH27, GH5, and GH1). The numbers of GH45 and GH28 genes identified in D. v. virgifera are among the largest in insects where these genes have been identified. Three GH family genes (GH45, GH48, and GH28) are found almost exclusively in two coleopteran superfamilies (Chrysomeloidea and Curculionoidea) among insects, indicating the possibility of their acquisitions by horizontal gene transfer rather than simple vertical transmission from ancestral lineages of insects. Acquisition of GH genes by horizontal gene transfers and subsequent lineage-specific GH gene expansion appear to have played important roles for phytophagous beetles in specializing on particular groups of host plants and in the case of D. v. virgifera, its close association with maize.	[Eyun, Seong-il; Moriyama, Etsuko N.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Wang, Haichuan; Valencia-Jimenez, Arnubio; Siegfried, Blair D.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Moriyama, Etsuko N.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Benson, Andrew K.] Univ Nebraska, Lincoln, NE USA; [Pauchet, Yannick; Ffrench-Constant, Richard H.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Valencia-Jimenez, Arnubio] Univ Exeter, Penryn, England; [Valencia-Jimenez, Arnubio] Univ Caldas, Fac Ciencias Agr, Manizales, Colombia	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Max Planck Society; University of Exeter; Universidad de Caldas	Siegfried, BD (corresponding author), Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA.	bsiegfried1@unl.edu	Eyun, Seong-il/Q-8872-2019; Pauchet, Yannick/AAU-9751-2021	Eyun, Seong-il/0000-0003-4687-1066; Pauchet, Yannick/0000-0002-2918-8946; Benson, Andrew/0000-0001-6330-0252; Valencia-Jimenez, Arnubio/0000-0003-3328-2932; ffrench-Constant, Richard/0000-0001-5385-9888	Consortium for Plant Biotechnology Research (CPBR) [GO12026-333]; Pioneer Hi-Bred International	Consortium for Plant Biotechnology Research (CPBR); Pioneer Hi-Bred International	This work was supported by the Consortium for Plant Biotechnology Research (CPBR Agreement GO12026-333) and Pioneer Hi-Bred International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna R, 2012, P NATL ACAD SCI USA, V109, P4197, DOI 10.1073/pnas.1121190109; Allen ML, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2701; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Berger E, 2007, FEMS MICROBIOL LETT, V268, P194, DOI 10.1111/j.1574-6968.2006.00583.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Bragatto I, 2010, INSECT BIOCHEM MOLEC, V40, P861, DOI 10.1016/j.ibmb.2010.08.006; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Calderon-Cortes N, 2010, INSECT MOL BIOL, V19, P323, DOI 10.1111/j.1365-2583.2010.00991.x; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Celorio-Mancera MD, 2008, ARTHROPOD-PLANT INTE, V2, P215, DOI 10.1007/s11829-008-9050-7; Chang CJ, 2012, INSECT BIOCHEM MOLEC, V42, P629, DOI 10.1016/j.ibmb.2012.05.002; Chen XY, 2009, PLANT SIGNAL BEHAV, V4, P489, DOI 10.4161/psb.4.6.8359; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cleveland LR, 1924, BIOL BULL-US, V46, P178, DOI 10.2307/1536507; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; Eigenheer AL, 2003, GENE, V316, P127, DOI 10.1016/S0378-1119(03)00749-2; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2013, PHYLIP PHYLOGENY INF; Ferreira AHP, 2003, INSECT BIOCHEM MOLEC, V33, P253, DOI 10.1016/S0965-1748(02)00239-4; Ferreira AHP, 2001, INSECT BIOCHEM MOLEC, V31, P1065, DOI 10.1016/S0965-1748(01)00054-6; Fischer R, 2013, ADV BIOCHEM ENG BIOT, V136, P51, DOI 10.1007/10_2013_206; Fujita K, 2006, BIOCHEM BIOPH RES CO, V345, P502, DOI 10.1016/j.bbrc.2006.04.126; Gao Y, 2008, ZOOL SCI, V25, P1139, DOI 10.2108/zsj.25.1139; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Genta FA, 2003, INSECT BIOCHEM MOLEC, V33, P1085, DOI 10.1016/S0965-1748(03)00121-8; Genta FA, 2007, BBA-PROTEINS PROTEOM, V1774, P1079, DOI 10.1016/j.bbapap.2007.07.006; Genta FA, 2009, INSECT BIOCHEM MOLEC, V39, P861, DOI 10.1016/j.ibmb.2009.10.003; Girard C, 1999, INSECT BIOCHEM MOLEC, V29, P549, DOI 10.1016/S0965-1748(99)00029-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harada Y, 2004, DEV GENES EVOL, V214, P159, DOI 10.1007/s00427-004-0392-6; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Hughes AL, 2012, IMMUNOGENETICS, V64, P549, DOI 10.1007/s00251-012-0610-8; Hung YL, 2012, APPL ENVIRON MICROB, V78, P4294, DOI 10.1128/AEM.07473-11; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Joshi N., SICKLE WINDOWED ADAP; Juge N, 2006, TRENDS PLANT SCI, V11, P359, DOI 10.1016/j.tplants.2006.05.006; Kamm B, 2004, APPL MICROBIOL BIOT, V64, P137, DOI 10.1007/s00253-003-1537-7; Kanagawa M, 2011, J BIOL CHEM, V286, P29158, DOI 10.1074/jbc.M111.256701; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Kovalchuk SN, 2009, CARBOHYD RES, V344, P191, DOI 10.1016/j.carres.2008.10.028; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SJ, 2004, COMP BIOCHEM PHYS B, V139, P107, DOI 10.1016/j.cbpc.2004.06.015; Li L, 2003, EUKARYOT CELL, V2, P1091, DOI 10.1128/EC.2.5.1091-1098.2003; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ljungdahl LG, 2008, ANN NY ACAD SCI, V1125, P308, DOI 10.1196/annals.1419.030; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; Marques AR, 2003, BIOCHEM J, V370, P793, DOI 10.1042/BJ20021249; MARTIN MM, 1991, PHILOS T R SOC B, V333, P281, DOI 10.1098/rstb.1991.0078; Mian IS, 1998, BLOOD CELL MOL DIS, V24, P83, DOI 10.1006/bcmd.1998.9998; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakashima K, 2002, INSECT BIOCHEM MOLEC, V32, P777, DOI 10.1016/S0965-1748(01)00160-6; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Opota O, 2008, COMP BIOCHEM PHYS B, V149, P419, DOI 10.1016/j.cbpb.2007.11.002; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1021; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scharf ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021709; Scharf ME, 2010, INSECT BIOCHEM MOLEC, V40, P611, DOI 10.1016/j.ibmb.2010.06.002; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shen ZC, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.24; Siegfried BD, 2005, INSECT MOL BIOL, V14, P137, DOI 10.1111/j.1365-2583.2005.00538.x; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Song JM, 2010, COMP BIOCHEM PHYS B, V155, P403, DOI 10.1016/j.cbpb.2010.01.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636; Tokuda G, 2007, GENE, V401, P131, DOI 10.1016/j.gene.2007.06.028; Tokuda G, 2007, BIOL LETTERS, V3, P336, DOI 10.1098/rsbl.2007.0073; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Valencia A, 2013, GENE, V513, P260, DOI 10.1016/j.gene.2012.10.046; Valentine Barry D., 2006, Insecta Mundi, V19, P247; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Vega FE, 2012, BIOL J LINN SOC, V107, P86, DOI 10.1111/j.1095-8312.2012.01912.x; Waller J. M., 2007, Coffee pests, diseases and their management, P325, DOI 10.1079/9781845931292.0325; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; Wheeler D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059262; Willis JD, 2011, J INSECT PHYSIOL, V57, P300, DOI 10.1016/j.jinsphys.2010.11.019; Wyman CE, 2003, BIOTECHNOL PROGR, V19, P254, DOI 10.1021/bp025654l; Xu BZ, 2001, EUR J BIOCHEM, V268, P3718, DOI 10.1046/j.1432-1327.2001.02280.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Q, 2013, INSECT BIOCHEM MOLEC, V43, P907, DOI 10.1016/j.ibmb.2013.07.003; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zhang YHP, 2005, P NATL ACAD SCI USA, V102, P7321, DOI 10.1073/pnas.0408734102; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhou XG, 2007, GENE, V395, P29, DOI 10.1016/j.gene.2007.01.004	107	51	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94052	10.1371/journal.pone.0094052	http://dx.doi.org/10.1371/journal.pone.0094052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718603	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000073
J	Nielsen, NH; Backes, G; Stougaard, J; Andersen, SU; Jahoor, A				Nielsen, Nanna Hellum; Backes, Gunter; Stougaard, Jens; Andersen, Stig Uggerhoj; Jahoor, Ahmed			Genetic Diversity and Population Structure Analysis of European Hexaploid Bread Wheat (Triticum aestivum L.) Varieties	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; WINTER-WHEAT; RHT8 LOCUS; SHORT ARM; RESISTANCE; MARKERS; CULTIVARS; RUST; DART; SSR	Progress in plant breeding is facilitated by accurate information about genetic structure and diversity. Here, Diversity Array Technology (DArT) was used to characterize a population of 94 bread wheat (Triticum aestivum L.) varieties of mainly European origin. In total, 1,849 of 7,000 tested markers were polymorphic and could be used for population structure analysis. Two major subgroups of wheat varieties, GrI and GrII, were identified using the program STRUCTURE, and confirmed by principal component analysis (PCA). These subgroups were largely separated according to origin; GrI comprised varieties from Southern and Eastern Europe, whereas GrII contained mostly modern varieties from Western and Northern Europe. A large proportion of the markers contributing most to the genetic separation of the subgroups were located on chromosome 2D near the Reduced height 8 (Rht8) locus, and PCR-based genotyping suggested that breeding for the Rht8 allele had a major impact on subgroup separation. Consistently, analysis of linkage disequilibrium (LD) suggested that different selective pressures had acted on chromosome 2D in the two subgroups. Our data provides an overview of the allele composition of bread wheat varieties anchored to DArT markers, which will facilitate targeted combination of alleles following DArT-based QTL studies. In addition, the genetic diversity and distance data combined with specific Rht8 genotypes can now be used by breeders to guide selection of crossing parents.	[Nielsen, Nanna Hellum; Jahoor, Ahmed] Nord Seed AS, Odder, Denmark; [Nielsen, Nanna Hellum; Stougaard, Jens; Andersen, Stig Uggerhoj] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Backes, Gunter] Univ Copenhagen, Fac Life Sci, Dept Agr Sci, Copenhagen, Denmark; [Backes, Gunter] Fac Agr, Dept Organ Breeding & Agrobiodivers, Dept Mol Biol & Genet, Kassel, Witzenhausen, Germany; [Jahoor, Ahmed] Swedish Univ Agr Sci, Dept Plant Breeding, Alnarp, Sweden	Aarhus University; University of Copenhagen; Swedish University of Agricultural Sciences	Nielsen, NH (corresponding author), Nord Seed AS, Odder, Denmark.	nhni@nordicseed.com		Stougaard, Jens/0000-0002-9312-2685; Andersen, Stig U./0000-0002-1096-1468; Backes, Gunter/0000-0002-9902-0428	Danish Ministry of Science Innovation and Higher Education; Nordic Seed A/S; Erstatningsfonden for Markfro	Danish Ministry of Science Innovation and Higher Education; Nordic Seed A/S; Erstatningsfonden for Markfro	This project was funded by The Danish Ministry of Science Innovation and Higher Education, Erstatningsfonden for Markfro and Nordic Seed A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe TD, 2013, GENET RESOUR CROP EV, V60, P1547, DOI 10.1007/s10722-012-9941-4; Benson J, 2012, PLANT GENOME-US, V5, P71, DOI 10.3835/plantgenome2011.11.0027; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Buckler ES, 2002, CURR OPIN PLANT BIOL, V5, P107, DOI 10.1016/S1369-5266(02)00238-8; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2009, MOL BREEDING, V23, P23, DOI 10.1007/s11032-008-9210-6; Charmet G, 2011, CR BIOL, V334, P212, DOI 10.1016/j.crvi.2010.12.013; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Christiansen MJ, 2006, THEOR APPL GENET, V112, P581, DOI 10.1007/s00122-005-0128-7; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAOSTAT, 2022, TURKEYS HAZELNUT PRO; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Francki MG, 2009, MOL GENET GENOMICS, V281, P181, DOI 10.1007/s00438-008-0403-9; Graybosch RA, 2001, UNEASY UNIONS QUALIT; Gupta P K, 2008, Int J Plant Genomics, V2008, P896451, DOI 10.1155/2008/896451; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; KOEBNER RMD, 1995, THEOR APPL GENET, V90, P740, DOI 10.1007/BF00222142; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; Landjeva S, 2007, EUPHYTICA, V156, P271, DOI 10.1007/s10681-007-9371-0; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; Marone D, 2012, MOL GENET GENOMICS, V287, P741, DOI 10.1007/s00438-012-0714-8; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Purnhauser L, 2011, EUPHYTICA, V179, P287, DOI 10.1007/s10681-010-0312-y; Rabinovich SV, 1998, EUPHYTICA, V100, P323, DOI 10.1023/A:1018361819215; Risser P, 2011, PHYTOPATHOLOGY, V101, P1209, DOI 10.1094/PHYTO-08-10-0203; Roder MS, 2002, THEOR APPL GENET, V106, P67, DOI 10.1007/s00122-002-1061-7; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Roussel V, 2005, THEOR APPL GENET, V111, P162, DOI 10.1007/s00122-005-2014-8; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; Schmidt AL, 2004, EUPHYTICA, V135, P239, DOI 10.1023/B:EUPH.0000014874.85495.59; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Spielmeyer W, 2005, THEOR APPL GENET, V111, P731, DOI 10.1007/s00122-005-2058-9; Spiertz JHJ, 2009, NJAS-WAGEN J LIFE SC, V56, P281, DOI 10.1016/S1573-5214(09)80001-8; van Ginkel M, 2007, FIELD CROP RES, V104, P86, DOI 10.1016/j.fcr.2007.02.005; Weng Y, 2002, THEOR APPL GENET, V104, P1078, DOI 10.1007/s00122-001-0804-1; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Worland AJ, 2001, EUPHYTICA, V119, P155, DOI 10.1023/A:1017582122775; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004; Zhang LY, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-42; Zheleva D, 2006, BIOTECHNOL EQ; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003	53	82	83	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94000	10.1371/journal.pone.0094000	http://dx.doi.org/10.1371/journal.pone.0094000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718292	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000064
J	Conway, DP; Holt, M; McNulty, A; Couldwell, DL; Smith, DE; Davies, SC; Cunningham, P; Keen, P; Guy, R				Conway, Damian P.; Holt, Martin; McNulty, Anna; Couldwell, Deborah L.; Smith, Don E.; Davies, Stephen C.; Cunningham, Philip; Keen, Phillip; Guy, Rebecca		Sydney Rapid HIV Test Study	Multi-Centre Evaluation of the Determine HIV Combo Assay when Used for Point of Care Testing in a High Risk Clinic-Based Population	PLOS ONE			English	Article							P24 ANTIGEN; RAPID TESTS; TRANSMISSION; INFECTION; MEN; PREVENTION; ANTIBODY; SEX; DIAGNOSIS; SETTINGS	Background: Determine HIV Combo (DHC) is the first point of care assay designed to increase sensitivity in early infection by detecting both HIV antibody and antigen. We conducted a large multi-centre evaluation of DHC performance in Sydney sexual health clinics. Methods: We compared DHC performance (overall, by test component and in early infection) with conventional laboratory HIV serology (fourth generation screening immunoassay, supplementary HIV antibody, p24 antigen and Western blot tests) when testing gay and bisexual men attending four clinic sites. Early infection was defined as either acute or recent HIV infection acquired within the last six months. Results: Of 3,190 evaluation specimens, 39 were confirmed as HIV-positive (12 with early infection) and 3,133 were HIV-negative by reference testing. DHC sensitivity was 87.2% overall and 94.4% and 0% for the antibody and antigen components, respectively. Sensitivity in early infection was 66.7% (all DHC antibody reactive) and the DHC antigen component detected none of nine HIV p24 antigen positive specimens. Median HIV RNA was higher in false negative than true positive cases (238,025 vs. 37,591 copies/ml; p = 0.022). Specificity overall was 99.4% with the antigen component contributing to 33% of false positives. Conclusions: The DHC antibody component detected two thirds of those with early infection, while the DHC antigen component did not enhance performance during point of care HIV testing in a high risk clinic-based population.	[Conway, Damian P.; Keen, Phillip; Guy, Rebecca] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Holt, Martin] Univ New S Wales, Ctr Social Res Hlth, Sydney, NSW, Australia; [McNulty, Anna] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNulty, Anna; Smith, Don E.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Couldwell, Deborah L.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Couldwell, Deborah L.] Univ Sydney, Sydney Emerging Infect & Biosecur Inst, Sydney, NSW 2006, Australia; [Smith, Don E.] Albion Ctr, Sydney, NSW, Australia; [Davies, Stephen C.] Royal N Shore Hosp, North Shore Sexual Hlth Serv, Sydney, NSW, Australia; [Cunningham, Philip] Univ New S Wales, St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Cunningham, Philip] St Vincents Hosp, NSW State Reference Lab HIV, Sydney, NSW 2010, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; University of New South Wales Sydney	Conway, DP (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	dconway@kirby.unsw.edu.au	Conway, Damian Patrick/F-2789-2012; Cunningham, Philip/GZH-1820-2022; Holt, Martin/X-6482-2019	Conway, Damian Patrick/0000-0003-3316-2199; Holt, Martin/0000-0002-2586-8274; Guy, Rebecca/0000-0002-2929-4634; Keen, Phillip/0000-0002-2678-0645; Cunningham, Philip/0000-0003-2613-6910	National Health & Medical Research Council STI Program Grant; NSW Ministry of Health; Australian Rotary Health/Sydney CBD Rotary Club	National Health & Medical Research Council STI Program Grant; NSW Ministry of Health; Australian Rotary Health/Sydney CBD Rotary Club	The Sydney Rapid HIV Test Study was supported by funding from the National Health & Medical Research Council STI Program Grant (http://www.nhmrc.gov.au/) and NSW Ministry of Health (http://www.health.nsw.gov.au). DPC was supported by a scholarship from Australian Rotary Health/Sydney CBD Rotary Club (http://www.australianrotaryhealth.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Bhowan K, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.4; Brauer M, 2013, J VIROL METHODS, V189, P180, DOI 10.1016/j.jviromet.2013.01.017; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Chetty V, 2012, J CLIN VIROL, V54, P180, DOI 10.1016/j.jcv.2012.02.021; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Communicable Diseases Network Australia, 2013, AUSTR NAT NOT DIS CA; Faraoni S, 2013, J CLIN VIROL, V57, P84, DOI 10.1016/j.jcv.2013.01.007; Feigin A, 2013, SEX HEALTH, V10, P166, DOI 10.1071/SH12064; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hull P, 2013, SYDNEY GAY COMMUNITY; Inverness Medical, 2009, DET HIV 1 2 AG AB CO; Jones CB, 2012, J INFECT DIS, V206, P1947, DOI 10.1093/infdis/jis617; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Laperche S, 2012, J INFECT DIS, V206, P1946, DOI 10.1093/infdis/jis616; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Learmonth KM, 2008, J CLIN MICROBIOL, V46, P1692, DOI 10.1128/JCM.01761-07; Louie B, 2008, J CLIN MICROBIOL, V46, P1494, DOI 10.1128/JCM.01945-07; Masciotra S, 2013, J CLIN VIROL, V58, pE54, DOI 10.1016/j.jcv.2013.07.002; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; Naylor E, 2011, SEX TRANSM INFECT, V87, P311, DOI 10.1136/sextrans-2011-050056; New South Wales Centre for Population Health, 2013, HIV NSW DAT PERF MON, P12; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, DEF AC REC EARL HIV, pI; Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Peeling RW, 2006, NAT REV MICROBIOL, pS2, DOI [10.1038/nrmicro1522, 10.1038/nrmicro1568, 10.1038/nrmico1522]; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Pilcher CD, 2010, J INFECT DIS, V201, pS7, DOI 10.1086/650393; Plate DK, 2007, AIDS RES HUM RETROV, V23, P1491, DOI 10.1089/aid.2007.0020; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Poynten IM, 2010, HIV MED, V11, P635, DOI 10.1111/j.1468-1293.2010.00833.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Stekler J, 2005, AIDS, V19, P1323, DOI 10.1097/01.aids.0000180105.73264.81; Stekler JD, 2013, J CLIN VIROL, V58, pE119, DOI 10.1016/j.jcv.2013.09.018; Taegtmeyer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028019; The Kirby Institute, 2013, HIV AIDS VIR HEP SEX; Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081	47	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94062	10.1371/journal.pone.0094062	http://dx.doi.org/10.1371/journal.pone.0094062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714441	gold, Green Published			2022-12-27	WOS:000334160900077
J	Crompton, MJ; Dunstan, RH; Macdonald, MM; Gottfries, J; von Eiff, C; Roberts, TK				Crompton, Marcus J.; Dunstan, R. Hugh; Macdonald, Margaret M.; Gottfries, Johan; von Eiff, Christof; Roberts, Timothy K.			Small Changes in Environmental Parameters Lead to Alterations in Antibiotic Resistance, Cell Morphology and Membrane Fatty Acid Composition in Staphyloccus lugdunensis	PLOS ONE			English	Article							SMALL COLONY VARIANTS; LIPID-COMPOSITION; SUSCEPTIBILITY; BIOSYNTHESIS; TEMPERATURE; BACTERIA; SKIN	Staphylococcus lugdunensis has emerged as a major cause of community-acquired and nosocomial infections. This bacterium can rapidly adapt to changing environmental conditions to survive and capitalize on opportunities to colonize and infect through wound surfaces. It was proposed that S. lugdunensis would have underlying alterations in metabolic homeostasis to provide the necessary levels of adaptive protection. The aims of this project were to examine the impacts of subtle variations in environmental conditions on growth characteristics, cell size and membrane fatty acid composition in S. lugdunensis. Liquid broth cultures of S. lugdunensis were grown under varying combinations of pH (6-8), temperature (35-39(circle)C) and osmotic pressure (0-5% sodium chloride w/w) to reflect potential ranges of conditions encountered during transition from skin surfaces to invasion of wound sites. The cells were harvested at the mid-exponential phase of growth and assessed for antibiotic minimal inhibitory concentration (MIC), generation time, formation of small colony variants, cell size (by scanning electron microscopy) and membrane fatty acid composition. Stress regimes with elevated NaCl concentrations resulted in significantly higher antibiotic resistance (MIC) and three of the combinations with 5% NaCl had increased generation times (P < 0.05). It was found that all ten experimental growth regimes, including the control and centroid cultures, yielded significantly different profiles of plasma membrane fatty acid composition (P < 0.0001). Alterations in cell size (P < 0.01) were also observed under the range of conditions with the most substantial reduction occurring when cells were grown at 39(circle)C, pH 8 (514652 nm, mean 6 Standard Deviation) compared with cells grown under control conditions at 37(circle)C with pH 7 (702676 nm, P < 0.01). It was concluded that S. lugdunensis responded to slight changes in environmental conditions by altering plasma membrane fatty acid composition, growth rates and morphology to achieve optimal adaptations for survival in changing environments.	[Gottfries, Johan] Gothenburg Univ, Dept Chem, Gothenburg, Sweden; [von Eiff, Christof] Univ Munster, Inst Med Microbiol, D-48149 Munster, Germany; [Crompton, Marcus J.; Dunstan, R. Hugh; Macdonald, Margaret M.; Roberts, Timothy K.] Univ Newcastle, Sch Environm & Life Sci, Metab Res Grp, Callaghan, NSW 2308, Australia	University of Gothenburg; University of Munster; University of Newcastle	Dunstan, RH (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Metab Res Grp, Callaghan, NSW 2308, Australia.	hugh.dunstan@newcastle.edu.au	Roberts, Tim K/A-4286-2009; Gottfries, Johan/M-3445-2016	Gottfries, Johan/0000-0001-7135-4664	University of Newcastle; Harold Stannet Williams and Judith Mason research grant	University of Newcastle; Harold Stannet Williams and Judith Mason research grant	This work was supported by University of Newcastle funds for post-graduate research as well as the Harold Stannet Williams and Judith Mason research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.anz.com.au/resources/2/f/2fce2b804a47773887c8cfac93b0266b/MasonNatMedGuidelines.pdf?CACHEID = 2fce2b804a47773887c8cfac93b0266b The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, COMPR REV FOOD SCI F, V5, P71; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baumert N, 2002, MICROB DRUG RESIST, V8, P253, DOI 10.1089/10766290260469507; Behme RJ, 1996, J CLIN MICROBIOL, V34, P3075, DOI 10.1128/JCM.34.12.3075-3084.1996; Bellamy R, 2002, CLIN INFECT DIS, V35, pE32, DOI 10.1086/341304; Bower CK, 1999, INT J FOOD MICROBIOL, V50, P33, DOI 10.1016/S0168-1605(99)00075-6; Brown GK, 2001, AUST VET J, V79, P554, DOI 10.1111/j.1751-0813.2001.tb10747.x; Butt HL, 1998, J MED MICROBIOL, V47, P577, DOI 10.1099/00222615-47-7-577; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; Celeste CJ, 2013, VET SURG, V42, P147, DOI 10.1111/j.1532-950X.2012.00966.x; Dowhan W, 2004, BBA-BIOMEMBRANES, V1666, P19, DOI 10.1016/j.bbamem.2004.04.010; Frank K. L., 2008, Clinical Microbiology Newsletter, V30, P55, DOI 10.1016/j.clinmicnews.2008.03.004; Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07; FRENEY J, 1988, INT J SYST BACTERIOL, V38, P168, DOI 10.1099/00207713-38-2-168; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KOMARATAT P, 1975, BIOCHIM BIOPHYS ACTA, V398, P464, DOI 10.1016/0005-2760(75)90197-6; Kriegeskorte A, 2011, PROTEOMICS, V11, P2476, DOI 10.1002/pmic.201000796; Laan EVDD, 2003, J BACTERIOL, V185, P3773, DOI 10.1128/JB.185.3773.3779.2003; Lenhardt R, 2006, ANESTHESIOLOGY, V105, P1117, DOI 10.1097/00000542-200612000-00011; LEPAGE G, 1986, J LIPID RES, V27, P114; McMahon MAS, 2007, APPL ENVIRON MICROB, V73, P211, DOI 10.1128/AEM.00578-06; Norris V, 2004, FEBS LETT, V561, P3, DOI 10.1016/S0014-5793(04)00135-8; Onyango LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029031; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Sado-Kamdem SL, 2009, INT J FOOD MICROBIOL, V129, P288, DOI 10.1016/j.ijfoodmicro.2008.12.010; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Seifert H, 2005, EMERG INFECT DIS, V11, P1283, DOI 10.3201/eid1108.041177; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; van Voorst F, 2000, BIOCHEM J, V347, P601, DOI 10.1042/bj3470601; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wehrli PM, 2014, J CHEMOMETRICS	36	24	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92296	10.1371/journal.pone.0092296	http://dx.doi.org/10.1371/journal.pone.0092296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714666	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900005
J	Wang, YS; Cheng, SL; Fang, HJ; Yu, GR; Xu, MJ; Dang, XS; Li, LS; Wang, L				Wang, Yongsheng; Cheng, Shulan; Fang, Huajun; Yu, Guirui; Xu, Minjie; Dang, Xusheng; Li, Linsen; Wang, Lei			Simulated Nitrogen Deposition Reduces CH4 Uptake and Increases N2O Emission from a Subtropical Plantation Forest Soil in Southern China	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; GREENHOUSE-GAS FLUXES; ALPINE MEADOW SOIL; METHANE OXIDATION; SPRUCE FOREST; OXIDE FLUXES; ENVIRONMENTAL-FACTORS; CO2; RESPONSES; DENITRIFICATION	To date, few studies are conducted to quantify the effects of reduced ammonium (NH4+) and oxidized nitrate (NO3-) on soil CH4 uptake and N2O emission in the subtropical forests. In this study, NH4Cl and NaNO3 fertilizers were applied at three rates: 0, 40 and 120 kg N ha(-1) yr(-1). Soil CH4 and N2O fluxes were determined twice a week using the static chamber technique and gas chromatography. Soil temperature and moisture were simultaneously measured. Soil dissolved N concentration in 0-20 cm depth was measured weekly to examine the regulation to soil CH4 and N2O fluxes. Our results showed that one year of N addition did not affect soil temperature, soil moisture, soil total dissolved N (TDN) and NH4+-N concentrations, but high levels of applied NH4Cl and NaNO3 fertilizers significantly increased soil NO3 (-)-N concentration by 124% and 157%, respectively. Nitrogen addition tended to inhibit soil CH4 uptake, but significantly promoted soil N2O emission by 403% to 762%. Furthermore, NH4+-N fertilizer application had a stronger inhibition to soil CH4 uptake and a stronger promotion to soil N2O emission than NO3--N application. Also, both soil CH4 and N2O fluxes were driven by soil temperature and moisture, but soil inorganic N availability was a key integrator of soil CH4 uptake and N2O emission. These results suggest that the subtropical plantation soil sensitively responses to atmospheric N deposition, and inorganic N rather than organic N is the regulator to soil CH4 uptake and N2O emission.	[Wang, Yongsheng; Fang, Huajun; Yu, Guirui; Dang, Xusheng; Li, Linsen; Wang, Lei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Wang, Yongsheng; Cheng, Shulan; Xu, Minjie; Dang, Xusheng; Wang, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, HJ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	fanghj@igsnrr.ac.cn	于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966	National Natural Science Foundation of China [31290222, 31130009, 31290221, 31070435, 41071166]; Development Plan Program of State Key Basic Research [2012CB41710, 32010CB833502, 2010CB833501]; Bingwei's Funds for Young Talents from Institute of Geographical Sciences and Natural Resources Research, CAS [2011RC202]; CAS Strategic Priority Program [XDA 05050600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Plan Program of State Key Basic Research; Bingwei's Funds for Young Talents from Institute of Geographical Sciences and Natural Resources Research, CAS; CAS Strategic Priority Program	This project was supported by National Natural Science Foundation of China (No. 31290222, 31130009, 31290221, 31070435, and 41071166), Development Plan Program of State Key Basic Research (No. 2012CB41710, 32010CB833502, and 2010CB833501), Bingwei's Funds for Young Talents from Institute of Geographical Sciences and Natural Resources Research, CAS, (No. 2011RC202) and CAS Strategic Priority Program (No. XDA 05050600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson EL, 2010, ECOLOGY, V91, P3242, DOI 10.1890/09-2185.1; Basiliko N, 2009, CAN J FOREST RES, V39, P1220, DOI 10.1139/X09-043; Bijoor NS, 2008, GLOBAL CHANGE BIOL, V14, P2119, DOI 10.1111/j.1365-2486.2008.01617.x; Bodelier PLE, 2011, CURR OPIN ENV SUST, V3, P379, DOI 10.1016/j.cosust.2011.06.002; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Borken W, 2002, SOIL BIOL BIOCHEM, V34, P1815, DOI 10.1016/S0038-0717(02)00171-2; Butterbach-Bahl K, 1998, ATMOS ENVIRON, V32, P559, DOI 10.1016/S1352-2310(97)00234-3; CASTRO MS, 1994, CAN J FOREST RES, V24, P9, DOI 10.1139/x94-002; Chan ASK, 2006, FEMS MICROBIOL ECOL, V57, P343, DOI 10.1111/j.1574-6941.2006.00127.x; Chen GC, 2012, SOIL BIOL BIOCHEM, V48, P175, DOI 10.1016/j.soilbio.2012.01.029; Department of Forest Resources Management S, 2010, FOR RESOUR MANAG, V1, P3; Dutaur L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002734; Fang HJ, 2010, BIOGEOSCIENCES, V7, P395, DOI 10.5194/bg-7-395-2010; Fang HJ, 2014, GEODERMA, V213, P444, DOI 10.1016/j.geoderma.2013.08.006; Fang HJ, 2012, PLANT SOIL, V351, P177, DOI 10.1007/s11104-011-0942-4; Hu Zheng-hua, 2011, China Environmental Science, V31, P892; IPCC, 2001, ADV CLIM CHANG RES; Jang I, 2011, SOIL BIOL BIOCHEM, V43, P620, DOI 10.1016/j.soilbio.2010.11.032; Jassal RS, 2011, GEODERMA, V162, P182, DOI 10.1016/j.geoderma.2011.02.002; Kim YS, 2012, ATMOS ENVIRON, V46, P36, DOI 10.1016/j.atmosenv.2011.10.034; KING GM, 1994, NATURE, V370, P282, DOI 10.1038/370282a0; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lin S, 2012, AGR ECOSYST ENVIRON, V146, P168, DOI 10.1016/j.agee.2011.10.024; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Luo GJ, 2013, BIOGEOSCIENCES, V10, P3205, DOI 10.5194/bg-10-3205-2013; Martinson GO, 2013, BIOGEOCHEMISTRY, V112, P625, DOI 10.1007/s10533-012-9753-9; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Merino A, 2004, SOIL BIOL BIOCHEM, V36, P917, DOI 10.1016/j.soilbio.2004.02.006; Mohanty SR, 2006, APPL ENVIRON MICROB, V72, P1346, DOI 10.1128/AEM.72.2.1346-1354.2006; Nyerges G, 2009, FEMS MICROBIOL LETT, V297, P131, DOI 10.1111/j.1574-6968.2009.01674.x; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Reay DS, 2004, SOIL BIOL BIOCHEM, V36, P2059, DOI 10.1016/j.soilbio.2004.06.002; Rowlings DW, 2012, GLOBAL CHANGE BIOL, V18, P726, DOI 10.1111/j.1365-2486.2011.02563.x; SFA (State Forestry Administration), 2007, CHIN FOR 1999 2005; Steinkamp R, 2001, SOIL BIOL BIOCHEM, V33, P145, DOI 10.1016/S0038-0717(00)00124-3; Steudler PA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001394; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Topp E, 1997, CAN J SOIL SCI, V77, P167, DOI 10.4141/S96-107; Venterea RT, 2003, GLOBAL CHANGE BIOL, V9, P346, DOI 10.1046/j.1365-2486.2003.00591.x; Wang H, 2013, FOREST ECOL MANAG, V300, P4, DOI 10.1016/j.foreco.2012.04.005; Wang LF, 2008, SOIL SCI PLANT NUTR, V54, P786, DOI 10.1111/j.1747-0765.2008.00297.x; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Wen XF, 2010, BIOGEOSCIENCES, V7, P357, DOI 10.5194/bg-7-357-2010; Werner C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007388; Whalen SC, 2000, GEOMICROBIOL J, V17, P237; Xu XK, 2004, BIOL FERT SOILS, V40, P215, DOI 10.1007/s00374-004-0768-9; Xu YB, 2007, EUR J SOIL SCI, V58, P1293, DOI 10.1111/j.1365-2389.2007.00923.x; Xu YB, 2013, J SOIL SEDIMENT, V13, P699, DOI 10.1007/s11368-013-0650-1; Zhang JB, 2013, NATURE, V3, P1; Zhang JB, 2011, ENVIRON RES, V111, P643, DOI 10.1016/j.envres.2011.04.005; Zhang JB, 2009, SOIL BIOL BIOCHEM, V41, P2551, DOI 10.1016/j.soilbio.2009.09.016; Zhang W, 2008, PLANT SOIL, V306, P221, DOI 10.1007/s11104-008-9575-7; Zhang W, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002094; Zhang W, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009195; Zhu J, 2013, SOIL BIOL BIOCHEM, V57, P577, DOI 10.1016/j.soilbio.2012.09.017	58	34	44	11	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93571	10.1371/journal.pone.0093571	http://dx.doi.org/10.1371/journal.pone.0093571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714387	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900036
J	Gu, CJ; Zheng, F; Long, LK; Wang, J; Ding, SJ				Gu, Chunjuan; Zheng, Fei; Long, Liangkun; Wang, Jing; Ding, Shaojun			Engineering the Expression and Characterization of Two Novel Laccase Isoenzymes from Coprinus comatus in Pichia pastoris by Fusing an Additional Ten Amino Acids Tag at N-Terminus	PLOS ONE			English	Article							MELANOCARPUS-ALBOMYCES LACCASE; TRAMETES-VERSICOLOR LACCASE; REDOX POTENTIAL LACCASE; MULTI-COPPER OXIDASE; HETEROLOGOUS EXPRESSION; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; PLEUROTUS-ERYNGII; FUNGAL LACCASES; GENE	The detail understanding of physiological/biochemical characteristics of individual laccase isoenzymes in fungi is necessary for fundamental and application purposes, but our knowledge is still limited for most of fungi due to difficult to express laccases heterologously. In this study, two novel laccase genes, named lac3 and lac4, encoding proteins of 547 and 532-amino acids preceded by 28 and 16-residue signal peptides, respectively, were cloned from the edible basidiomycete Coprinus comatus. They showed 70% identity but much lower homology with other fungal laccases at protein level (less than 58%). Two novel laccase isoenzymes were successfully expressed in Pichia pastoris by fusing an additional 10 amino acids (Thr-Pro-Phe-Pro-Pro-Phe-Asn-Thr-Asn-Ser) tag at N-terminus, and the volumetric activities could be dramatically enhanced from undetectable level to 689 and 1465 IU/l for Lac3 and Lac4, respectively. Both laccases possessed the lowest Km and highest k(cat)/K-m value towards syringaldazine, followed by ABTS, guaiacol and 2,6-dimethylphenol similar as the low redox potential laccases from other microorganisms. Lac3 and Lac4 showed resistant to SDS, and retained 31.86% and 43.08% activity in the presence of 100 mM SDS, respectively. Lac3 exhibited higher decolorization efficiency than Lac4 for eleven out of thirteen different dyes, which may attribute to the relatively higher catalytic efficiency of Lac3 than Lac4 (in terms of k(cat/)K(m)) towards syringaldazine and ABTS. The mild synergistic decolorization by two laccases was observed for triphenylmethane dyes but not for anthraquinone and azo dyes.	[Gu, Chunjuan; Zheng, Fei; Long, Liangkun; Wang, Jing; Ding, Shaojun] Nanjing Forestry Univ, Coll Chem Engn, Dept Biol Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Ding, SJ (corresponding author), Nanjing Forestry Univ, Coll Chem Engn, Dept Biol Engn, Nanjing, Jiangsu, Peoples R China.	dshaojun@hotmail.com			National Natural Science Foundation of China (NSFC) [30871987]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (NSFC) (Grant No. 30871987) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andberg M, 2009, FEBS J, V276, P6285, DOI 10.1111/j.1742-4658.2009.07336.x; Bai YG, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-33; Baker CJO, 2000, ABSTR PAP AM CHEM S, V219, pU281; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bao SY, 2013, MOL BIOL REP, V40, P1927, DOI 10.1007/s11033-012-2249-9; Bleve G, 2008, APPL MICROBIOL BIOT, V79, P731, DOI 10.1007/s00253-008-1479-1; Bohlin C, 2006, APPL BIOCHEM BIOTECH, V129, P195, DOI 10.1385/ABAB:129:1:195; Brown MA, 2002, INORG CHIM ACTA, V331, P232, DOI 10.1016/S0020-1693(01)00814-3; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; CANTERS GW, 1993, FEBS LETT, V325, P39, DOI 10.1016/0014-5793(93)81410-2; Cassland P, 1999, APPL MICROBIOL BIOT, V52, P393, DOI 10.1007/s002530051537; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Christenson A, 2006, BBA-BIOENERGETICS, V1757, P1634, DOI 10.1016/j.bbabio.2006.08.008; Ciullini I, 2008, BIORESOURCE TECHNOL, V99, P7003, DOI 10.1016/j.biortech.2008.01.019; Guo M, 2006, APPL MICROBIOL BIOT, V71, P848, DOI 10.1007/s00253-005-0210-8; Herter S, 2013, J MOL CATAL B-ENZYM, V90, P91, DOI 10.1016/j.molcatb.2013.01.020; Hilden K, 2013, APPL MICROBIOL BIOT, V97, P1589, DOI 10.1007/s00253-012-4011-6; Hoshida H, 2001, J BIOSCI BIOENG, V92, P372, DOI 10.1263/jbb.92.372; Jolivalt C, 2005, APPL MICROBIOL BIOT, V66, P450, DOI 10.1007/s00253-004-1717-0; Kiiskinen LL, 2004, MICROBIOL-SGM, V150, P3065, DOI 10.1099/mic.0.27147-0; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Klonowska A, 2005, ENZYME MICROB TECH, V36, P34, DOI 10.1016/j.enzmictec.2004.03.022; Klonowska A, 2002, EUR J BIOCHEM, V269, P6119, DOI 10.1046/j.1432-1033.2002.03324.x; KOIKEDA S, 1993, J BIOL CHEM, V268, P18801; Kokol V, 2007, ENZYME MICROB TECH, V40, P1673, DOI 10.1016/j.enzmictec.2006.08.015; Koschorreck K, 2008, ARCH BIOCHEM BIOPHYS, V474, P213, DOI 10.1016/j.abb.2008.03.009; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; Lin YQ, 2013, MOL BIOL REP, V40, P1487, DOI 10.1007/s11033-012-2191-x; Lu X, 2010, MYCOSCIENCE, V51, P68, DOI 10.1007/s10267-009-0002-6; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Polak J, 2012, BIOTECHNOL PROGR, V28, P93, DOI 10.1002/btpr.713; Rodriguez E, 2008, J BIOTECHNOL, V134, P9, DOI 10.1016/j.jbiotec.2007.12.008; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uthandi S, 2010, APPL ENVIRON MICROB, V76, P733, DOI 10.1128/AEM.01757-09; Wong KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066426; Yan KL, 2009, J MICROBIOL BIOTECHN, V19, P1421, DOI 10.4014/jmb.0901.0033; Yano A, 2009, MICROBIOL RES, V164, P642, DOI 10.1016/j.micres.2008.12.001; Zhao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038817; Zheng F, 2013, J IND MICROBIOL BIOT, V40, P1083, DOI 10.1007/s10295-013-1312-4	44	37	40	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93912	10.1371/journal.pone.0093912	http://dx.doi.org/10.1371/journal.pone.0093912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710109	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800069
J	Hejblum, G; Lambotte, O; Galicier, L; Coppo, P; Marzac, C; Aumont, C; Fardet, L				Hejblum, Gilles; Lambotte, Olivier; Galicier, Lionel; Coppo, Paul; Marzac, Christophe; Aumont, Cedric; Fardet, Laurence			A Web-Based Delphi Study for Eliciting Helpful Criteria in the Positive Diagnosis of Hemophagocytic Syndrome in Adult Patients	PLOS ONE			English	Article							CLINICAL-FEATURES; LYMPHOHISTIOCYTOSIS; PATHOGENESIS; DISORDERS	The diagnosis of the reactive form of hemophagocytic syndrome in adults remains particularly difficult since none of the clinical or laboratory manifestations are specific. We undertook a study in order to elicit which features constitute helpful criteria for a positive diagnosis. In this Delphi study, the features investigated in the questionnaire and the experts invited to participate in the survey were issued from a bibliographic search. The questionnaire was iteratively proposed to experts via a web-based application with a feedback of the results observed at the preceding Delphi round. Experts were asked to label each investigated criterion in one of the following categories: absolutely required, important, of minor interest, or not assessable in the routine practice environment. A positive consensus was a priori defined as at least 75% answers observed in the categories absolutely required and important. The questionnaire investigated 26 criteria and 24 experts originating from 13 countries participated in the second and final Delphi round. A positive consensus was reached for the nine following criteria: unilineage cytopenia, bicytopenia, pancytopenia, presence of hemophagocytosis pictures on a bone marrow aspirate or on a tissue biopsy, high ferritin level, fever, organomegaly, presence of a predisposing underlying disease, and high level of lactate dehydrogenase. A negative consensus was reached for 13 criteria, and an absence of consensus was observed for 4 criteria. The study constitutes the first initiative to date for defining international guidelines devoted to the positive diagnosis of the reactive form of hemophagocytic syndrome.	[Hejblum, Gilles] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Hejblum, Gilles] Univ Paris 06, Univ Sorbonne, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Hejblum, Gilles] Hop St Antoine, AP HP, F-75571 Paris, France; [Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France; [Lambotte, Olivier] Univ Paris Sud, Fac Med Paris Sud 11, F-94275 Le Kremlin Bicetre, France; [Galicier, Lionel] Hop St Louis, AP HP, Paris, France; [Coppo, Paul] Hop St Antoine, AP HP, Serv Hematol, F-75571 Paris, France; [Coppo, Paul] Univ Paris 06, Univ Sorbonne, Fac Med Pierre & Marie Curie, Paris, France; [Marzac, Christophe] Hop St Antoine, AP HP, Serv Hematol Biol, F-75571 Paris, France; [Aumont, Cedric] Univ Paris 06, Univ Sorbonne, Grp Rech Clin 7, MyPAC, Paris, France; [Aumont, Cedric] Hop Bicetre, AP HP, Serv Hematol Biol, Le Kremlin Bicetre, France; [Fardet, Laurence] Hop St Antoine, AP HP, Serv Med Interne, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Hejblum, G (corresponding author), INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France.	gilles.hejblum@inserm.fr	Hejblum, Gilles/N-6337-2017; Lambotte, Olivier/GRT-0160-2022	Hejblum, Gilles/0000-0003-0127-1964; Aumont, Cedric/0000-0002-7118-4295				Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Dakley NC, 1969, DELPHI METHOD EXPT S; Davi S, 2011, J RHEUMATOL, V38, P764, DOI 10.3899/jrheum.100996; Debin M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-138; Fardet L, 2008, ARTHRITIS RHEUM, V58, P1521, DOI 10.1002/art.23415; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Fukaya S, 2008, RHEUMATOLOGY, V47, P1686, DOI 10.1093/rheumatology/ken342; Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P428, DOI 10.1111/j.1651-2227.1991.tb11878.x; Henter JI, 2004, CRIT REV ONCOL HEMAT, V50, P157, DOI 10.1016/j.critrevonc.2004.01.002; Imashuku S, 1997, INT J HEMATOL, V66, P135; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kleynberg Roman Leonid, 2012, Clin Adv Hematol Oncol, V10, P726; Larroche C, 2012, JOINT BONE SPINE, V79, P356, DOI 10.1016/j.jbspin.2011.10.015; Linstone H. A., 1975, DELPHI METHOD TECHNI; Rosado FGN, 2013, AM J CLIN PATHOL, V139, P713, DOI 10.1309/AJCP4ZDKJ4ICOUAT; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Usmani GN, 2013, BRIT J HAEMATOL, V161, P609, DOI 10.1111/bjh.12293; Verbsky JW, 2006, ANN MED, V38, P20, DOI 10.1080/07853890500465189; WONG KF, 1992, AM J MED, V93, P177, DOI 10.1016/0002-9343(92)90048-G	22	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94024	10.1371/journal.pone.0094024	http://dx.doi.org/10.1371/journal.pone.0094024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710079	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800088
J	Li, P; Liu, TT; Liu, JJ; Zhang, Q; Lou, FL; Kong, F; Cheng, GH; Bjorkholm, M; Zheng, CY; Xu, DW				Li, Ping; Liu, Tiantian; Liu, Jiajia; Zhang, Qing; Lou, Fenglan; Kong, Feng; Cheng, Guanghui; Bjorkholm, Magnus; Zheng, Chengyun; Xu, Dawei			Promoter Polymorphism in the Serotonin Transporter ( 5-HTT) Gene Is Significantly Associated with Leukocyte Telomere Length in Han Chinese	PLOS ONE			English	Article							BIASED ATTENTION; LIFE STRESS; DEPRESSION; POPULATION; MORTALITY; HALLMARKS; DEMENTIA	The serotonin transporter gene (5-HTT)-linked polymorphic region (5-HTTLPR) plays an important role in modulating mood and behavior by regulating 5-HTT expression and thereby controlling the concentration of serotonin (5-HT) in brain synapses: The homozygous shorter allele (S/S) in 5-HTTLPR results in lower 5-HTT expression coupled with stronger psychopathological reactions to stressful experiences compared to the homozygous long (L/L) and heterozygous (S/L) alleles. Psychological insults and mood disorders have been shown to cause accelerated telomere shortening, a marker of biological aging, however, it is currently unclear whether the allelic variants of 5-HTTLPR affect telomere length (TL) in the healthy population without mood disorders. In the present study, we determined the relationship between TL and the 5HTTLPR variants in healthy Han Chinese. The 5-HTTLPR genotyping and leukocyte TL analysis of 280 young female Han Chinese freshmen showed a significantly shorter TL in 149 of them carrying the 5-HTTLPR S/S version compared to those ( 131) with the L/S or L/ S plus L/L genotypes (mean = SD, 0.533 +/- 0.241 for S/ S vs 0.607 +/- 0.312 for L/ S, P = 0.034; or vs 0.604 +/- 0.313 for L/ S plus L/ L, P = 0.038). Similar results were achieved in the other cohort including 220 adult healthy individuals of different age, gender and profession (0.691=0.168 for S/ S vs 0.729 +/- 0.211 for L/ S, P = 0.046, or vs 0.725 +/- 0.213 for L/ S plus L/ L, P = 0.039). Taken together, shorter leukocyte TL is significantly associated with the 5-HTTLPR S/S allelic variant, which may be implicated in psychological stress-related health problems.	[Li, Ping; Liu, Jiajia; Zhang, Qing; Lou, Fenglan] Shandong Univ, Sch Nursing, Jinan 250100, Peoples R China; [Liu, Tiantian] Shandong Univ, Sch Med, Dept Microbiol, Jinan 250100, Peoples R China; [Kong, Feng; Cheng, Guanghui; Xu, Dawei] Shandong Univ, Hosp 2, Cent Res Lab, Jinan 250100, Peoples R China; [Zheng, Chengyun] Shandong Univ, Hosp 2, Dept Hematol, Jinan 250100, Peoples R China; [Liu, Jiajia; Bjorkholm, Magnus; Xu, Dawei] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden; [Liu, Tiantian; Bjorkholm, Magnus; Xu, Dawei] Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Liu, Tiantian; Bjorkholm, Magnus; Xu, Dawei] Karolinska Inst, Stockholm, Sweden	Shandong University; Shandong University; Shandong University; Shandong University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Li, P (corresponding author), Shandong Univ, Sch Nursing, Jinan 250100, Peoples R China.	pingli12@sdu.edu.cn; Dawei.Xu@ki.se		Xu, Dawei/0000-0003-3141-4524	National Basic Research Program of China (973 Program) [2012CB911202]; Shandong Province Natural Science Foundation [Y2003C08, ZR2009DM022]; Independent Innovation Foundation of Shandong University [2012TS093]; National Natural Science Foundation of China [81071721]; Swedish Research Council; Karolinska Institutet Foundations	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Foundations(Karolinska Institutet)	The study was supported by grants from The National Basic Research Program of China (Grant No. 973 Program 2012CB911202), the Shandong Province Natural Science Foundation (Nos Y2003C08 and ZR2009DM022) and Independent Innovation Foundation of Shandong University (No 2012TS093), National Natural Science Foundation of China (No 81071721), Swedish Research Council, Karolinska Institutet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NP, 2010, GERONTOLOGY, V56, P390, DOI 10.1159/000268620; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Aviv A, 2009, HYPERTENSION, V53, P590, DOI 10.1161/HYPERTENSIONAHA.109.128926; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Beevers CG, 2007, J ABNORM PSYCHOL, V116, P208, DOI 10.1037/0021-843X.116.1.208; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Brocke B, 2006, MOL PSYCHIATR, V11, P1106, DOI 10.1038/sj.mp.4001908; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; De Meyer T, 2011, PSYCHOSOM MED, V73, P524, DOI 10.1097/PSY.0b013e31822ed876; Deelen J, 2014, INT J EPIDEMIOL, V43, P878, DOI 10.1093/ije/dyt267; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Geronimus AT, HUM NAT, V21, P19; Gibb BE, 2009, J CLIN CHILD ADOLESC, V38, P415, DOI 10.1080/15374410902851705; Halvorsen TL, 2000, J ENDOCRINOL, V166, P103, DOI 10.1677/joe.0.1660103; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P1332, DOI 10.1001/archneurol.2012.1541; Kiecolt-Glaser JK, 2010, BRAIN BEHAV IMMUN, V24, P529, DOI 10.1016/j.bbi.2010.02.002; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li P, 2012, INT J BIOCHEM CELL B, V44, P1531, DOI 10.1016/j.biocel.2012.06.020; Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51; Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Osinsky R, 2008, EMOTION, V8, P584, DOI 10.1037/a0012826; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Thomason ME, 2010, BIOL PSYCHOL, V85, P38, DOI 10.1016/j.biopsycho.2010.04.009; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686	42	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94442	10.1371/journal.pone.0094442	http://dx.doi.org/10.1371/journal.pone.0094442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710073	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800147
J	Pahlavian, SH; Yiallourou, T; Tubbs, RS; Bunck, AC; Loth, F; Goodin, M; Raisee, M; Martin, BA				Pahlavian, Soroush Heidari; Yiallourou, Theresia; Tubbs, R. Shane; Bunck, Alexander C.; Loth, Francis; Goodin, Mark; Raisee, Mehrdad; Martin, Bryn A.			The Impact of Spinal Cord Nerve Roots and Denticulate Ligaments on Cerebrospinal Fluid Dynamics in the Cervical Spine	PLOS ONE			English	Article							COMPUTATIONAL FLOW-ANALYSIS; CHIARI-I MALFORMATION; SUBARACHNOID SPACE; FORAMEN MAGNUM; CSF FLOW; PRESSURE RECORDINGS; VEIN GRAFTS; SYRINGOMYELIA; HYDRODYNAMICS; ANATOMY	Cerebrospinal fluid (CSF) dynamics in the spinal subarachnoid space (SSS) have been thought to play an important pathophysiological role in syringomyelia, Chiari I malformation (CM), and a role in intrathecal drug delivery. Yet, the impact that fine anatomical structures, including nerve roots and denticulate ligaments (NRDL), have on SSS CSF dynamics is not clear. In the present study we assessed the impact of NRDL on CSF dynamics in the cervical SSS. The 3D geometry of the cervical SSS was reconstructed based on manual segmentation of MRI images of a healthy volunteer and a patient with CM. Idealized NRDL were designed and added to each of the geometries based on in vivo measurments in the literature and confirmation by a neuroanatomist. CFD simulations were performed for the healthy and patient case with and without NRDL included. Our results showed that the NRDL had an important impact on CSF dynamics in terms of velocity field and flow patterns. However, pressure distribution was not altered greatly although the NRDL cases required a larger pressure gradient to maintain the same flow. Also, the NRDL did not alter CSF dynamics to a great degree in the SSS from the foramen magnum to the C1 level for the healthy subject and CM patient with mild tonsillar herniation (similar to 6 mm). Overall, the NRDL increased fluid mixing phenomena and resulted in a more complex flow field. Comparison of the streamlines of CSF flow revealed that the presence of NRDL lead to the formation of vortical structures and remarkably increased the local mixing of the CSF throughout the SSS.	[Pahlavian, Soroush Heidari; Raisee, Mehrdad] Univ Tehran, Coll Engn, Sch Mech Engn, Ctr Excellence Design & Optimizat Energy Syst CED, Tehran, Iran; [Yiallourou, Theresia] Ecole Polytech Fed Lausanne, Lab Hemodynam & Cardiovasc Technol, CH-1015 Lausanne, Switzerland; [Tubbs, R. Shane] Childrens Alabama, Birmingham, AL USA; [Bunck, Alexander C.] Univ Hosp Cologne, Dept Radiol, Cologne, Germany; [Loth, Francis; Martin, Bryn A.] Univ Akron, Conquer Chiari Res Ctr, Dept Mech Engn, Akron, OH 44325 USA; [Goodin, Mark] SimuTech Grp, Hudson, OH USA; [Raisee, Mehrdad] Univ Tehran, Coll Engn, Sch Mech Engn, Hydraul Machinery Res Inst, Tehran, Iran	University of Tehran; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Cologne; University System of Ohio; University of Akron; University of Tehran	Martin, BA (corresponding author), Univ Akron, Conquer Chiari Res Ctr, Dept Mech Engn, Akron, OH 44325 USA.	director@chiari-research.org	Bunck, Alexander C/M-6389-2014; Martin, Bryn A./N-6640-2016	Bunck, Alexander C/0000-0003-0986-0042; Martin, Bryn A./0000-0003-1234-7880	Conquer Chiari Research Foundation; National Institute of Health [1R15NS071455-01]; Swiss National Science Foundation [205321_132695/1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS071455] Funding Source: NIH RePORTER	Conquer Chiari Research Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Conquer Chiari Research Foundation, National Institute of Health (Grant No. 1R15NS071455-01), and the Swiss National Science Foundation (Grant No. 205321_132695/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algin O, 2010, ACAD RADIOL, V17, P181, DOI 10.1016/j.acra.2009.08.011; Alleyne CH, 1998, SURG NEUROL, V50, P213, DOI 10.1016/S0090-3019(97)00315-7; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Bertram CD, 2005, J BIOMECH ENG-T ASME, V127, P1099, DOI 10.1115/1.2073607; Bilston LE, 2006, CLIN BIOMECH, V21, P579, DOI 10.1016/j.clinbiomech.2006.01.009; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; BRADLEY WG, 1986, RADIOLOGY, V159, P611, DOI 10.1148/radiology.159.3.3704142; Bradley WG, 1996, RADIOLOGY, V198, P523, DOI 10.1148/radiology.198.2.8596861; Bunck AC, 2012, EUR RADIOL, V22, P1860, DOI 10.1007/s00330-012-2457-7; Bunck AC, 2011, EUR RADIOL, V21, P1788, DOI 10.1007/s00330-011-2105-7; Cheng S, 2012, J BIOMECH, V45, P1186, DOI 10.1016/j.jbiomech.2012.01.050; Cirovic S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005159; Clarke EC, 2013, J NEUROSURG, V118, P1135, DOI 10.3171/2013.2.JNS12759; Cousins J, 2009, AM J NEURORADIOL, V30, P1587, DOI 10.3174/ajnr.A1507; Elliott NSJ, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005849; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Haines D.E., 2008, NEUROANATOMY ATLAS S; Haughton VM, 2003, AM J NEURORADIOL, V24, P169; Heiss JD, 1999, J NEUROSURG, V91, P553, DOI 10.3171/jns.1999.91.4.0553; Hendelman MDW, 2005, ATLAS FUNCTIONAL NEU, V2nd; Hsu Y, 2012, ANESTH ANALG, V115, P386, DOI 10.1213/ANE.0b013e3182536211; Kalata W., 2002, NUMERICAL SIMULATION; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kurtcuoglu V, 2005, J BIOMECH ENG-T ASME, V127, P264, DOI 10.1115/1.1865191; Kurtcuoglu V, 2007, J BIOMECH, V40, P1235, DOI 10.1016/j.jbiomech.2006.05.031; Lang J., 1993, CLIN ANATOMY CERVICA; Lee L, 2013, J NEUROSCI RES; Levy L M, 1999, Magn Reson Imaging Clin N Am, V7, P573; Linge SO, 2011, AM J NEURORADIOL, V32, P1474, DOI 10.3174/ajnr.A2496; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Mancall EL, 2011, GRAYS CLIN NEUROANAT; Martin BA, 2005, J BIOMECH ENG-T ASME, V127, P1110, DOI 10.1115/1.2073687; Martin BA, 2012, AM J PHYSIOL-HEART C, V302, pH1492, DOI 10.1152/ajpheart.00658.2011; Martin BA, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000089; Martin BA, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-17; Meyerson SL, 2000, J VASC SURG, V31, P910, DOI 10.1067/mva.2000.105957; Miyan JA, 2003, CAN J PHYSIOL PHARM, V81, P317, DOI 10.1139/Y03-027; Oi S, 2006, CHILD NERV SYST, V22, P662, DOI 10.1007/s00381-005-0020-4; Papisov MI, 2013, MOL PHARM; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Roldan A, 2009, AM J NEURORADIOL, V30, P941, DOI 10.3174/ajnr.A1489; Sahtout Wassila, 2012, Nonlinear Biomed Phys, V6, P2, DOI 10.1186/1753-4631-6-2; Sansur CA, 2003, J NEUROSURG, V98, P453, DOI 10.3171/jns.2003.98.3.0453; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Sharma A, 2012, NEURORADIOLOGY, V54, P133, DOI 10.1007/s00234-011-0861-3; Sigmund EE, 2012, NMR BIOMED, V25, P891, DOI 10.1002/nbm.1809; Skelly CL, 2001, ANN VASC SURG, V15, P110, DOI 10.1007/BF02693810; Stockman HW, 2006, J BIOMECH ENG-T ASME, V128, P106, DOI 10.1115/1.2132372; Stoodley MA, 1999, NEUROSURGERY, V44, P1065, DOI 10.1097/00006123-199905000-00068; Sweetman B, 2011, ANN BIOMED ENG, V39, P484, DOI 10.1007/s10439-010-0141-0; Tubbs RS, 2001, J NEUROSURG, V94, P271, DOI 10.3171/spi.2001.94.2.0271; Weller RO, 1998, J NEUROPATH EXP NEUR, V57, P885, DOI 10.1097/00005072-199810000-00001; WILLIAMS B, 1981, ACTA NEUROCHIR, V58, P167, DOI 10.1007/BF01407124; WILLIAMS B, 1981, ACTA NEUROCHIR, V59, P123, DOI 10.1007/BF01411198; WILLIAMS B, 1980, J ROY SOC MED, V73, P798, DOI 10.1177/014107688007301109; Williams H, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-7; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284; Zamir M., 2010, PHYS CORONARY BLOOD	60	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e91888	10.1371/journal.pone.0091888	http://dx.doi.org/10.1371/journal.pone.0091888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710111	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800011
J	Travers-Trolet, M; Shin, YJ; Shannon, LJ; Moloney, CL; Field, JG				Travers-Trolet, Morgane; Shin, Yunne-Jai; Shannon, Lynne J.; Moloney, Coleen L.; Field, John G.			Combined Fishing and Climate Forcing in the Southern Benguela Upwelling Ecosystem: An End-to-End Modelling Approach Reveals Dampened Effects	PLOS ONE			English	Article							INDIVIDUAL-BASED MODEL; MARINE ECOSYSTEMS; TROPHIC INTERACTIONS; MULTIPLE STRESSORS; BOTTOM-UP; FISHERIES; RESPONSES; IMPACTS; SYSTEMS; BIODIVERSITY	The effects of climate and fishing on marine ecosystems have usually been studied separately, but their interactions make ecosystem dynamics difficult to understand and predict. Of particular interest to management, the potential synergism or antagonism between fishing pressure and climate forcing is analysed in this paper, using an end-to-end ecosystem model of the southern Benguela ecosystem, built from coupling hydrodynamic, biogeochemical and multispecies fish models (ROMS-N(2)P(2)Z(2)D(2)-OSMOSE). Scenarios of different intensities of upwelling-favourable wind stress combined with scenarios of fishing top-predator fish were tested. Analyses of isolated drivers show that the bottom-up effect of the climate forcing propagates up the food chain whereas the top-down effect of fishing cascades down to zooplankton in unfavourable environmental conditions but dampens before it reaches phytoplankton. When considering both climate and fishing drivers together, it appears that top-down control dominates the link between top-predator fish and forage fish, whereas interactions between the lower trophic levels are dominated by bottom-up control. The forage fish functional group appears to be a central component of this ecosystem, being the meeting point of two opposite trophic controls. The set of combined scenarios shows that fishing pressure and upwelling-favourable wind stress have mostly dampened effects on fish populations, compared to predictions from the separate effects of the stressors. Dampened effects result in biomass accumulation at the top predator fish level but a depletion of biomass at the forage fish level. This should draw our attention to the evolution of this functional group, which appears as both structurally important in the trophic functioning of the ecosystem, and very sensitive to climate and fishing pressures. In particular, diagnoses considering fishing pressure only might be more optimistic than those that consider combined effects of fishing and environmental variability.	[Travers-Trolet, Morgane] IFREMER, Fisheries Lab, Sete, France; [Shin, Yunne-Jai] IRD, CRH UMR EME 212, Sete, France; [Shin, Yunne-Jai; Shannon, Lynne J.; Moloney, Coleen L.; Field, John G.] Univ Cape Town, Marine Res Inst, ZA-7700 Rondebosch, South Africa	Ifremer; Institut de Recherche pour le Developpement (IRD); University of Cape Town	Travers-Trolet, M (corresponding author), IFREMER, Fisheries Lab, Sete, France.	morgane.travers@ifremer.fr	Shannon, Lynne J/A-1612-2015; Shin, Yunne-Jai/A-7575-2012; Moloney, Coleen/B-4363-2009	Shannon, Lynne J/0000-0001-7842-0636; Shin, Yunne-Jai/0000-0002-7259-9265; Moloney, Coleen/0000-0001-6663-8814; Travers-Trolet, Morgane/0000-0003-1493-662X	EUR-OCEANS Network of Excellence (European Commission) [FP6-511106]; European Collaborative Project MEECE (European Commission) [FP7-212085]; EMIBIOS project through French Foundation for Research on Biodiversity (FRB) [APP-SCEN-2010-II]	EUR-OCEANS Network of Excellence (European Commission)(European CommissionEuropean Commission Joint Research Centre); European Collaborative Project MEECE (European Commission); EMIBIOS project through French Foundation for Research on Biodiversity (FRB)	This work was partially funded by the EUR-OCEANS Network of Excellence (contract of the European Commission No FP6-511106), by the European Collaborative Project MEECE (contract of the European Commission No FP7-212085) and by the EMIBIOS project through a grant from the French Foundation for Research on Biodiversity (FRB), "Modeling and Scenarios of Biodiversity" call for proposals, grant number APP-SCEN-2010-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Breitburg DL, 2005, MARINE CONSERVATION; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; da Silva A.M., 1994, ATLAS SURFACE MARINE, V6; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Duboz R, 2010, ECOL MODEL, V221, P840, DOI 10.1016/j.ecolmodel.2009.11.023; Dunlop ES, 2009, EVOL APPL, V2, P246, DOI 10.1111/j.1752-4571.2009.00087.x; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Freon P, 2009, PROG OCEANOGR, V83, P97, DOI 10.1016/j.pocean.2009.07.034; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Goni R, 1998, OCEAN COAST MANAGE, V40, P37, DOI 10.1016/S0964-5691(98)00037-4; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Griffiths MH, 2000, S AFR J MARINE SCI, V22, P81, DOI 10.2989/025776100784125663; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Henderson PA, 2011, J EXP MAR BIOL ECOL, V400, P78, DOI 10.1016/j.jembe.2011.02.028; Hunt GL, 2006, PROG OCEANOGR, V68, P115, DOI 10.1016/j.pocean.2006.02.008; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kone V, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002427; Laugen AT, 2014, FISH FISH, V15, P65, DOI 10.1111/faf.12007; Link JS, 2010, ICES J MAR SCI, V67, P787, DOI 10.1093/icesjms/fsp258; Miller EF, 2011, ICES J MAR SCI, V68, P2123, DOI 10.1093/icesjms/fsr167; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Palkovacs EP, 2011, TRENDS ECOL EVOL, V26, P616, DOI 10.1016/j.tree.2011.08.004; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Payne AL, 1995, BIOL FISHERIES S AFR, P15; Penven P, 2001, S AFR J SCI, V97, P472; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Rademeyer RA, 2008, AFR J MAR SCI, V30, P263, DOI 10.2989/AJMS.2008.30.2.7.557; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Roy C, 2007, AFR J MAR SCI, V29, P309, DOI 10.2989/AJMS.2007.29.3.1.331; Sala E, 2006, TRENDS ECOL EVOL, V21, P479, DOI 10.1016/j.tree.2006.07.006; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Shannon LJ, 2000, ICES J MAR SCI, V57, P720, DOI 10.1006/jmsc.2000.0716; Shannon L, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P158; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Shin YJ, 2004, CAN J FISH AQUAT SCI, V61, P414, DOI 10.1139/F03-154; Shin YJ, 2001, AQUAT LIVING RESOUR, V14, P65, DOI 10.1016/S0990-7440(01)01106-8; Townsend CR, 2008, J APPL ECOL, V45, P1810, DOI 10.1111/j.1365-2664.2008.01548.x; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; Travers M, 2010, PROG OCEANOGR, V84, P118, DOI 10.1016/j.pocean.2009.09.014; Travers M, 2009, ECOL MODEL, V220, P3089, DOI 10.1016/j.ecolmodel.2009.08.016; Travers M, 2009, COUPLAGE MODELES TRO; Travers-Trolet M, 2014, AFR J MAR SCI, V36, P11, DOI 10.2989/1814232X.2014.883326; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Watermeyer KE, 2008, AFR J MAR SCI, V30, P351, DOI 10.2989/AJMS.2008.30.2.11.561; Watermeyer KE, 2008, AFR J MAR SCI, V30, P383, DOI 10.2989/AJMS.2008.30.2.12.562; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	63	53	54	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94286	10.1371/journal.pone.0094286	http://dx.doi.org/10.1371/journal.pone.0094286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710351	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800132
J	Wang, JZ; Cai, CP; Wang, SL				Wang, Jianzhang; Cai, Changping; Wang, Shili			Merocel versus Nasopore for Nasal Packing: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							SYNTHETIC POLYURETHANE FOAM; ENDOSCOPIC SINUS SURGERY; POSTOPERATIVE PACKING; DOUBLE-BLIND; FIBRIN GLUE; GEL	Objective: To compare the clinical outcomes, including efficacy and complications, of Merocel versus Nasopore as a nasal packing material after nasal surgery. Methods: Relevant randomized controlled trials were identified from electronic databases (The Cochrane Library, PubMed, EMBASE, China National Knowledge Infrastructure and Chinese Biomedical Database). Conference proceedings and references from identified trials and review articles were also searched. Outcome measures were pain during nasal packing, pain and bleeding upon packing removal, pressure sensation, nasal blockage, formation of synechiae, mucosal healing, and patients' general satisfaction. Results: Seven randomized controlled trials met criteria for analysis. Compared with Merocel, Nasopore significantly reduced patients' subjective symptoms including in situ pain (pain experienced while packing is in place), nasal pressure, pain and bleeding during packing removal, and increased patients' general satisfaction with nasal packing. There were no significant differences in nasal obstruction, adhesion and mucosal healing between the Merocel and Nasopore groups. Conclusions: Preliminary evidence suggests that Nasopore may be superior to Merocel as a nasal packing material with regard to in situ pain, pain and bleeding upon removal, pressure, and general satisfaction and does not differ from Merocel in terms of nasal obstruction, tissue adhesion, and long-term mucosal healing.	[Wang, Jianzhang; Cai, Changping; Wang, Shili] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Otolaryngol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, SL (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Dept Otolaryngol, Shanghai 200030, Peoples R China.	shiliwangruijin@hotmail.com			Science and Technology Commission of Shanghai Municipality, China [114119a6400]	Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was funded by the Science and Technology Commission of Shanghai Municipality, China (114119a6400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antisdel JL, 2009, OTOLARYNG HEAD NECK, V141, P353, DOI 10.1016/j.otohns.2009.06.078; Ardehali MM, 2009, INT J ORAL MAX SURG, V38, P1022, DOI 10.1016/j.ijom.2009.05.012; Arya AK, 2003, RHINOLOGY, V41, P241; Athanasiadis T, 2008, LARYNGOSCOPE, V118, P1088, DOI 10.1097/MLG.0b013e31816ba576; Bajaj Y, 2009, INT J CLIN PRACT, V63, P757, DOI 10.1111/j.1742-1241.2008.01799.x; Dubin MR, 2009, OTOLARYNG CLIN N AM, V42, P279, DOI 10.1016/j.otc.2009.01.015; Hu J, 2012, CUEH, V8, P38; Kastl KG, 2009, AMJ RHINOL ALLERGY, V23, P80, DOI 10.2500/ajra.2009.23.3267; Kennedy DW, 1998, ARCH OTOLARYNGOL, V124, P107, DOI 10.1001/archotol.124.1.107; Kim ST, 2013, INT J PEDIATR OTORHI, V77, P113, DOI 10.1016/j.ijporl.2012.10.007; Kim YS, 2011, AM J RHINOL ALLERGY, V25, pE77, DOI 10.2500/ajra.2011.25.3600; LU C., 2013, CHIN J OTORHINOLARYN, V21, P184; Moher David, 2009, Open Med, V3, pe123; NUNEZ DA, 1991, CLIN OTOLARYNGOL, V16, P549, DOI 10.1111/j.1365-2273.1991.tb00971.x; Pomerantz J, 2005, ANN OTO RHINOL LARYN, V114, P699, DOI 10.1177/000348940511400908; Qian D, 2013, GHIN MED GUIDE, V11, P272; SAMAD I, 1992, J OTOLARYNGOL, V21, P88; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shoman N, 2009, J OTOLARYNGOL-HEAD N, V38, P112, DOI 10.2310/7070.2008.OA0217; STEVENS RW, 1951, AMA ARCH OTOLARYNGOL, V54, P191; TAASAN V, 1981, LARYNGOSCOPE, V91, P1163; TOBACK J, 1983, ARCH OTOLARYNGOL, V109, P627; Vaiman M, 2002, OTOLARYNG HEAD NECK, V126, P388, DOI 10.1067/mhn.2002.123345; Vaiman M, 2002, RHINOLOGY, V40, P185; VONSCHOENBERG M, 1993, J LARYNGOL OTOL, V107, P902; Wang YP, 2011, J CHIN MED ASSOC, V74, P16, DOI 10.1016/j.jcma.2010.09.001; Weber R, 2000, RHINOLOGY, V38, P49; Weber R, 2001, AM J OTOLARYNG, V22, P306, DOI 10.1053/ajot.2001.26499; Wormald PJ, 2006, AM J RHINOL, V20, P7, DOI 10.1177/194589240602000102; Yilmaz MS, 2013, OTOLARYNG HEAD NECK, V148, P140, DOI 10.1177/0194599812465587	30	32	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93959	10.1371/journal.pone.0093959	http://dx.doi.org/10.1371/journal.pone.0093959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710428	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800076
J	Alves, ER; Gomes, LT; Ribatski-Silva, D; Mendes, CRJ; Leal-Santos, FA; Simoes, LR; Mello, MBC; Fontes, CJF				Alves-Junior, Eduardo R.; Gomes, Luciano T.; Ribatski-Silva, Daniele; Mendes, Clebson Rodrigues J.; Leal-Santos, Fabio A.; Simoes, Luciano R.; Mello, Marcia Beatriz C.; Fontes, Cor Jesus F.			Assumed White Blood Cell Count of 8,000 Cells/mu L Overestimates Malaria Parasite Density in the Brazilian Amazon	PLOS ONE			English	Article							THICK	Quantification of parasite density is an important component in the diagnosis of malaria infection. The accuracy of this estimation varies according to the method used. The aim of this study was to assess the agreement between the parasite density values obtained with the assumed value of 8,000 cells/mu L and the automated WBC count. Moreover, the same comparative analysis was carried out for other assumed values of WBCs. The study was carried out in Brazil with 403 malaria patients who were infected in different endemic areas of the Brazilian Amazon. The use of a fixed WBC count of 8,000 cells/mu L to quantify parasite density in malaria patients led to overestimated parasitemia and resulted in low reliability when compared to the automated WBC count. Assumed values ranging between 5,000 and 6,000 cells/mu L, and 5,500 cells/mu L in particular, showed higher reliability and more similar values of parasite density when compared between the 2 methods. The findings show that assumed WBC count of 5,500 cells/mu L could lead to a more accurate estimation of parasite density for malaria patients in this endemic region.	[Alves-Junior, Eduardo R.; Gomes, Luciano T.; Ribatski-Silva, Daniele; Mendes, Clebson Rodrigues J.; Leal-Santos, Fabio A.; Simoes, Luciano R.; Mello, Marcia Beatriz C.; Fontes, Cor Jesus F.] Fed Univ Mato Grosso Cuiaba, Julio Muller Hosp, Cuiaba, Mato Grosso, Brazil; [Alves-Junior, Eduardo R.; Gomes, Luciano T.] Univ Univ Ctr, Biomed Dept, Varzea Grande, Mato Grosso, Brazil; [Gomes, Luciano T.; Fontes, Cor Jesus F.] Facimed Course Med, Dept Med, Cacoal, Rondonia, Brazil	Universidade Federal de Mato Grosso do Sul	Fontes, CJF (corresponding author), Fed Univ Mato Grosso Cuiaba, Julio Muller Hosp, Cuiaba, Mato Grosso, Brazil.	corfontes@gmail.com	Alves, Eduardo Rodrigues/B-8148-2016; Santos, Fabio/C-2708-2012; Fontes, Cor JF/G-7331-2018; Gomes, Luciano/E-9090-2018	Alves, Eduardo Rodrigues/0000-0002-4785-0008; Fontes, Cor JF/0000-0003-2756-0588; Gomes, Luciano/0000-0002-4036-3688; Santos, Fabio/0000-0002-3261-4379	Brazilian National Council for Scientific and Technological Development; State of Mato Grosso Research Foundation PRONEX/CNPq/FAPEMAT (Malaria Network)	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Mato Grosso Research Foundation PRONEX/CNPq/FAPEMAT (Malaria Network)	Financial support was provided by the Brazilian National Council for Scientific and Technological Development and State of Mato Grosso Research Foundation PRONEX/CNPq/FAPEMAT (Malaria Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Gyasi D, 2012, MALARIA J, V11, P1; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DOWLING MAC, 1966, B WORLD HEALTH ORGAN, V34, P249; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gonzalez B, 2009, INVEST CLIN, V50, P187; Haggaz AD, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-6; HIDEMI E, 1989, REV SAUDE PUBL, V23, P58; Jeremiah ZA, 2007, ANN TROP PAEDIATR, V27, P75, DOI 10.1179/146532807X170547; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Limaye Charulata S, 2012, J Assoc Physicians India, V60, P15; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; Olliaro P, 2011, TROP MED INT HEALTH, V16, P551, DOI 10.1111/j.1365-3156.2011.02738.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; World Health Organisation, 2010, BAS MAL MICR LEARN G, P69	16	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94193	10.1371/journal.pone.0094193	http://dx.doi.org/10.1371/journal.pone.0094193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721983	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100043
J	Blagodatskaya, E; Blagodatsky, S; Anderson, TH; Kuzyakov, Y				Blagodatskaya, Evgenia; Blagodatsky, Sergey; Anderson, Traute-Heidi; Kuzyakov, Yakov			Microbial Growth and Carbon Use Efficiency in the Rhizosphere and Root-Free Soil	PLOS ONE			English	Article							BACTERIAL-GROWTH; DNA CONTENTS; BIOMASS; RESPIRATION; COMMUNITIES; NITROGEN; DIVERSITY; TURNOVER; FUNGAL; MINERALIZATION	Plant-microbial interactions alter C and N balance in the rhizosphere and affect the microbial carbon use efficiency (CUE)the fundamental characteristic of microbial metabolism. Estimation of CUE in microbial hotspots with high dynamics of activity and changes of microbial physiological state from dormancy to activity is a challenge in soil microbiology. We analyzed respiratory activity, microbial DNA content and CUE by manipulation the C and nutrients availability in the soil under Beta vulgaris. All measurements were done in root-free and rhizosphere soil under steady-state conditions and during microbial growth induced by addition of glucose. Microorganisms in the rhizosphere and root-free soil differed in their CUE dynamics due to varying time delays between respiration burst and DNA increase. Constant CUE in an exponentially-growing microbial community in rhizosphere demonstrated the balanced growth. In contrast, the CUE in the root-free soil increased more than three times at the end of exponential growth and was 1.5 times higher than in the rhizosphere. Plants alter the dynamics of microbial CUE by balancing the catabolic and anabolic processes, which were decoupled in the root-free soil. The effects of N and C availability on CUE in rhizosphere and root-free soil are discussed.	[Blagodatskaya, Evgenia; Kuzyakov, Yakov] Univ Gottingen, Busgen Inst, D-37073 Gottingen, Germany; [Blagodatskaya, Evgenia; Blagodatsky, Sergey] Russian Acad Sci, Inst Physicochem & Biol Problems Soil Sci, Pushchino 142292, Russia; [Blagodatsky, Sergey] Univ Hohenheim, Inst Plant Prod & Agroecol Trop & Subtrop, Stuttgart, Germany; [Anderson, Traute-Heidi] Thunen Inst Climate Smart Agr vTI, Braunschweig, Germany	University of Gottingen; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Physicohemical & Biological Problems of Soil Science; University Hohenheim; Johann Heinrich von Thunen Institute	Blagodatskaya, E (corresponding author), Univ Gottingen, Busgen Inst, D-37073 Gottingen, Germany.	janeblag@mail.ru	Kuzyakov, Yakov/D-1605-2010; Blagodatsky, Sergey/F-2734-2010; Blagodatskaya, Evgenia/L-7177-2017	Kuzyakov, Yakov/0000-0002-9863-8461; Blagodatsky, Sergey/0000-0003-1428-6014; Blagodatskaya, Evgenia/0000-0002-8284-4017	European Commission [IIF 039907-MICROSOM]; Alexander von Humboldt Foundation; Russian Academy of Sciences [6123.2014.4]; Russian Foundation for Basic Research [12-04-01170]; German Research Foundation (DFG) [KU 1184/13-1/2]	European Commission(European CommissionEuropean Commission Joint Research Centre); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); German Research Foundation (DFG)(German Research Foundation (DFG))	This authors acknowledge the following: the European Commission (Marie Curie IIF program, project IIF 039907-MICROSOM) for supporting EB (http://ec.europa.eu/research/mariecurieactions/); the Alexander von Humboldt Foundation for supporting SB (http://www.humboldt-foundation.de/web/start.html); Russian Academy of Sciences (Scientific School Program 6123.2014.4, https://grants.extech.ru/grants/res/winners.php?OZ = 4&TZ = S&year = 2014); Russian Foundation for Basic Research (grant No 12-04-01170, http://www.rfbr.ru/rffi/ru/); and German Research Foundation (DFG) within project KU 1184/13-1/2 (http://www.dfg.de/en/). The funders had no role in study, design, data collection and analysis, decision to manuscript, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; ANDERSON TH, 1985, SOIL BIOL BIOCHEM, V17, P197, DOI 10.1016/0038-0717(85)90115-4; ANDERSON TH, 1986, Z PFLANZ BODENKUNDE, V149, P457, DOI 10.1002/jpln.19861490409; Anderson TH, 2008, LANDBAUFORSCH VOLK, V58, P19; Anderson TH, 2013, SOIL BIOL BIOCHEM, V57, P487, DOI 10.1016/j.soilbio.2012.09.031; ANDREWS JH, 1986, ADV MICROB ECOL, V9, P99; [Anonymous], 1975, PRINCIPLES MICROBIAL; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blagodatskaya EV, 2007, APPL SOIL ECOL, V37, P95, DOI 10.1016/j.apsoil.2007.05.002; Blagodatskaya E. V., 2003, Mikrobiologiya, V72, P840; Blagodatskaya EV, 2009, EUROP J SOIL SCI, V60; BLAGODATSKIY SA, 1993, EURASIAN SOIL SCI+, V25, P85; Blagodatsky SA, 2006, EURASIAN SOIL SCI+, V39, P290, DOI 10.1134/S1064229306030082; Blagodatsky SA, 2000, BIOL FERT SOILS, V32, P73, DOI 10.1007/s003740000219; Blagodatsky SA, 1998, SOIL BIOL BIOCHEM, V30, P1757, DOI 10.1016/S0038-0717(98)00029-7; Blagodatsky SA, 2002, EURASIAN SOIL SCI+, V35, P874; Bradford MA, 2013, BIOGEOCHEMISTRY, V113, P271, DOI 10.1007/s10533-012-9822-0; Cheng WX, 2009, SOIL BIOL BIOCHEM, V41, P1795, DOI 10.1016/j.soilbio.2008.04.018; CHRISTENSEN H, 1993, FEMS MICROBIOL ECOL, V102, P129, DOI 10.1111/j.1574-6968.1993.tb05804.x; CHRISTENSEN H, 1995, MICROBIAL ECOL, V29, P49, DOI 10.1007/BF00217422; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dorodnikov M, 2009, FEMS MICROBIOL ECOL, V69, P43, DOI 10.1111/j.1574-6941.2009.00697.x; Gardenas AI, 2011, SOIL BIOL BIOCHEM, V43, P702, DOI 10.1016/j.soilbio.2010.04.006; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Goddard VJ, 2001, PLANT SOIL, V232, P181, DOI 10.1023/A:1010302607616; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; HEINEMEYER O, 1989, PLANT SOIL, V116, P191, DOI 10.1007/BF02214547; Herron PM, 2009, SOIL BIOL BIOCHEM, V41, P1262, DOI 10.1016/j.soilbio.2009.03.010; Hill PW, 2008, SOIL BIOL BIOCHEM, V40, P616, DOI 10.1016/j.soilbio.2007.09.008; Joergensen RG, 2006, J PLANT NUTR SOIL SC, V169, P295, DOI 10.1002/jpln.200521941; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; Kuzyakov Y, 2013, NEW PHYTOL, V198, P656, DOI 10.1111/nph.12235; Leckie SE, 2004, SOIL BIOL BIOCHEM, V36, P529, DOI 10.1016/j.soilbio.2003.10.014; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Marstorp H, 1999, SOIL BIOL BIOCHEM, V31, P1443, DOI 10.1016/S0038-0717(99)00065-6; Marstorp H, 2000, SOIL BIOL BIOCHEM, V32, P879, DOI 10.1016/S0038-0717(99)00210-2; ModelMaker, 1997, MODELMAKER VERS 3 0; Panikov NS, 2010, HANDB ENVIRON ENG, V10, P121, DOI 10.1007/978-1-60327-140-0_4; Panikov NS, 1996, J MICROBIOL METH, V24, P219, DOI 10.1016/0167-7012(95)00074-7; Panikov NS, 1995, MICROBIAL GROWTH KIN; Paterson E, 2009, NEW PHYTOL, V184, P19, DOI 10.1111/j.1469-8137.2009.03001.x; Paterson E, 2009, SOIL BIOL BIOCHEM, V41, P1352, DOI 10.1016/j.soilbio.2009.02.012; PAYNE WJ, 1970, ANNU REV MICROBIOL, V24, P17, DOI 10.1146/annurev.mi.24.100170.000313; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rousk J, 2007, FEMS MICROBIOL ECOL, V62, P258, DOI 10.1111/j.1574-6941.2007.00398.x; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schneckenberger K, 2008, SOIL BIOL BIOCHEM, V40, P1981, DOI 10.1016/j.soilbio.2008.02.020; Thiet RK, 2006, SOIL BIOL BIOCHEM, V38, P837, DOI 10.1016/j.soilbio.2005.07.010; van Bodegom P, 2007, MICROB ECOL, V53, P513, DOI 10.1007/s00248-006-9049-5; Weigel HJ, 2005, PEDOSPHERE, V15, P728; Wutzler T, 2012, SOIL BIOL BIOCHEM, V45, P102, DOI 10.1016/j.soilbio.2011.10.004; Zachow C, 2008, MICROB ECOL, V55, P119, DOI 10.1007/s00248-007-9257-7	54	138	147	9	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93282	10.1371/journal.pone.0093282	http://dx.doi.org/10.1371/journal.pone.0093282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722409	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100015
J	Dobele, S; Gardner, M; Schroter, S; Hontzsch, D; Stockle, U; Freude, T				Doebele, Stefan; Gardner, Michael; Schroeter, Steffen; Hoentzsch, Dankward; Stoeckle, Ulrich; Freude, Thomas			DLS 5.0-The Biomechanical Effects of Dynamic Locking Screws	PLOS ONE			English	Article							INTERNAL FIXATORS; LOCKED PLATES; FIXATION; FRACTURES; EVOLUTION; STABILITY; BIOLOGY	Introduction: Indirect reduction of dia-/metaphyseal fractures with minimally invasive implant application bridges the fracture zone in order to protect the soft-tissue and blood supply. The goal of this fixation strategy is to allow stable motion at the fracture site to achieve indirect bone healing with callus formation. However, concerns have arisen that the high axial stiffness and eccentric position of locked plating constructs may suppress interfragmentary motion and callus formation, particularly under the plate. The reason for this is an asymmetric fracture movement. The biological need for sufficient callus formation and secondary bone healing is three-dimensional micro movement in the fracture zone. The DLS was designed to allow for increased fracture site motion. The purpose of the current study was to determine the biomechanical effect of the DLS_5.0. Methods: Twelve surrogate bone models were used for analyzing the characteristics of the DLS_5.0. The axial stiffness and the interfragmentary motion of locked plating constructs with DLS were compared to conventional constructs with Locking Head Screws (LS_5.0). A quasi-static axial load of 0 to 2.5 kN was applied. Relative motion was measured. Results: The dynamic system showed a biphasic axial stiffness distribution and provided a significant reduction of the initial axial stiffness of 74.4%. Additionally, the interfragmentary motion at the near cortex increased significantly from 0.033 mm to 0.210 mm (at 200N). Conclusions: The DLS may ultimately be an improvement over the angular stable plate osteosynthesis. The advantages of the angular stability are not only preserved but even supplemented by a dynamic element which leads to homogenous fracture movement and to a potentially uniform callus distribution.	[Doebele, Stefan; Schroeter, Steffen; Hoentzsch, Dankward; Stoeckle, Ulrich; Freude, Thomas] Univ Tubingen, BG Trauma Ctr, Tubingen, Germany; [Gardner, Michael] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO USA	Eberhard Karls University of Tubingen; Washington University (WUSTL)	Dobele, S (corresponding author), Univ Tubingen, BG Trauma Ctr, Tubingen, Germany.	sdoebele@bgu-tuebingen.de		Dobele, Stefan/0000-0002-8827-043X				Bottlang M, 2009, J BONE JOINT SURG AM, V91A, P1985, DOI 10.2106/JBJS.H.01038; Claes L, 2011, J ORTHOP TRAUMA, V25, pS4, DOI 10.1097/BOT.0b013e318207093e; Egol KA, 2004, J ORTHOP TRAUMA, V18, P488, DOI 10.1097/00005131-200409000-00003; Foux A, 1997, CLIN ORTHOP RELAT R, P232; Gardner MJ, 2010, INJURY, V41, P652, DOI 10.1016/j.injury.2010.02.022; Henderson Christopher E, 2008, Iowa Orthop J, V28, P73; Kubiak EN, 2006, J BONE JOINT SURG AM, V88A, P189, DOI 10.2106/JBJS.F.00703; Perren S M, 2003, Ther Umsch, V60, P713, DOI 10.1024/0040-5930.60.12.713; Perren SM, 2002, J BONE JOINT SURG BR, V84B, P1093, DOI 10.1302/0301-620X.84B8.13752; Schmal H, 2011, J ORTHOP TRAUMA, V25, pS15, DOI 10.1097/BOT.0b013e31820711d3; Smith Wade R, 2008, Instr Course Lect, V57, P25; Stoffel K, 2003, INJURY, V34, P11, DOI 10.1016/j.injury.2003.09.021; Uhthoff HK, 2006, J ORTHOP SCI, V11, P118, DOI 10.1007/s00776-005-0984-7	13	20	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91933	10.1371/journal.pone.0091933	http://dx.doi.org/10.1371/journal.pone.0091933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722267	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100010
J	Byers, JE; Smith, RS; Weiskel, HW; Robertson, CY				Byers, James E.; Smith, Rachel S.; Weiskel, Heidi W.; Robertson, Charles Y.			A Non-Native Prey Mediates the Effects of a Shared Predator on an Ecosystem Service	PLOS ONE			English	Article							TOP-DOWN CONTROL; CRASSOSTREA-VIRGINICA; MERCENARIA-MERCENARIA; CHESAPEAKE BAY; LONG-TERM; CALLINECTES-SAPIDUS; HARD CLAMS; BLUE-CRAB; OYSTERS; MARINE	Non-native species can alter ecosystem functions performed by native species often by displacing influential native species. However, little is known about how ecosystem functions may be modified by trait-mediated indirect effects of non-native species. Oysters and other reef-associated filter feeders enhance water quality by controlling nutrients and contaminants in many estuarine environments. However, this ecosystem service may be mitigated by predation, competition, or other species interactions, especially when such interactions involve non-native species that share little evolutionary history. We assessed trophic and other interference effects on the critical ecosystem service of water filtration in mesocosm experiments. In single-species trials, typical field densities of oysters (Crassostrea virginica) reduced water-column chlorophyll a more strongly than clams (Mercenaria mercenaria). The non-native filter-feeding reef crab Petrolisthes armatus did not draw down chlorophyll a. In multi-species treatments, oysters and clams combined additively to influence chlorophyll a drawdown. Petrolisthes did not affect net filtration when added to the bivalve-only treatments. Addition of the predatory mud crab Panopeus herbstii did not influence oyster feeding rates, but it did stop chlorophyll a drawdown by clams. However, when Petrolisthes was also added in with the clams, the clams filtered at their previously unadulterated rates, possibly because Petrolisthes drew the focus of predators or habituated the clams to crab stimuli. In sum, oysters were the most influential filter feeder, and neither predators nor competitors interfered with their net effect on water-column chlorophyll. In contrast, clams filtered less, but were more sensitive to predators as well as a facilitative buffering effect of Petrolisthes, illustrating that non-native species can indirectly affect an ecosystem service by aiding the performance of a native species.	[Byers, James E.; Smith, Rachel S.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Weiskel, Heidi W.; Robertson, Charles Y.] Skidaway Inst Oceanog, Savannah, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Byers, JE (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jebyers@uga.edu	Byers, James/AFJ-8413-2022	Byers, James/0000-0001-9240-0287	Georgia Sea Grant; NSF (OCE) [0961853]; Directorate For Geosciences [0961853] Funding Source: National Science Foundation	Georgia Sea Grant; NSF (OCE)(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Georgia Sea Grant and NSF (OCE-#0961853) are acknowledged for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman I, 2011, FRONT ECOL ENVIRON, V9, P183, DOI 10.1890/080186; ARNOLD WS, 1984, J EXP MAR BIOL ECOL, V80, P207, DOI 10.1016/0022-0981(84)90150-3; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Breitburg DL, 2000, J SHELLFISH RES, V19, P371; Byers JE, 2005, ECOLOGY, V86, P487, DOI 10.1890/03-0580; Byrnes J, 2009, ECOL LETT, V12, P830, DOI 10.1111/j.1461-0248.2009.01339.x; CAINE EA, 1975, J EXP MAR BIOL ECOL, V18, P277, DOI 10.1016/0022-0981(75)90112-4; Canning-Clode J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029657; Carlton JT, 1999, MALACOLOGIA, V41, P439; Christian JM, 1999, ECOLOGY, V80, P2397, DOI 10.1890/0012-9658(1999)080[2397:LTEIOA]2.0.CO;2; Cox GW, 2004, ALIEN SPECIES EVOLUT; DAME RF, 1992, J EXP MAR BIOL ECOL, V164, P147, DOI 10.1016/0022-0981(92)90171-6; EGGLESTON DB, 1990, B MAR SCI, V46, P62; Ermgassen PSEZ, 2013, ESTUAR COAST, V36, P36, DOI 10.1007/s12237-012-9559-y; Freeman AS, 2006, SCIENCE, V313, P831, DOI 10.1126/science.1125485; Fulford RS, 2007, MAR ECOL PROG SER, V336, P43, DOI 10.3354/meps336043; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Grizzle RE, 2008, ESTUAR COAST, V31, P1208, DOI 10.1007/s12237-008-9098-8; Grizzle RE, 2006, J SHELLFISH RES, V25, P643, DOI 10.2983/0730-8000(2006)25[643:ANISMF]2.0.CO;2; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Hershner C, 2008, CONSERV BIOL, V22, P544, DOI 10.1111/j.1523-1739.2008.00957.x; Hill JM, 2013, OECOLOGIA, V172, P79, DOI 10.1007/s00442-012-2488-4; Hollebone AL, 2007, MAR ECOL PROG SER, V336, P211, DOI 10.3354/meps336211; Hollebone AL, 2008, BIOL INVASIONS, V10, P347, DOI 10.1007/s10530-007-9134-9; Johnston BR, 2012, CAN J ZOOL, V90, P128, DOI 10.1139/Z11-113; Kimbro DL, 2012, ECOLOGY, V93, P334, DOI 10.1890/11-0596.1; Koteen LE, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044001; Levinton JS, 2011, J SHELLFISH RES, V30, P526; Lodge DM, 2012, ANNU REV ECOL EVOL S, V43, P449, DOI 10.1146/annurev-ecolsys-111511-103919; Matsuzaki SS, 2013, GLOBAL ECOL BIOGEOGR, V22, P1071, DOI 10.1111/geb.12067; Mattingly WB, 2012, BIOL INVASIONS, V14, P2639, DOI 10.1007/s10530-012-0259-0; MC DERMOTT JOHN J., 1960, PROC PENNSYLVANIA ACAD SCI, V34, P199; Newell RIE, 2005, NATO SCI S SS IV EAR, V47, P93; Newell RIE, 2004, ESTUARIES, V27, P793, DOI 10.1007/BF02912041; Newell RIE, 2007, MAR ECOL PROG SER, V341, P293, DOI 10.3354/meps341293; Noonburg EG, 2005, ECOLOGY, V86, P2555, DOI 10.1890/05-0143; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pattemore DE, 2012, P ROY SOC B-BIOL SCI, V279, P1597, DOI 10.1098/rspb.2011.2036; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Piehler MF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00082.1; Pomeroy LR, 2006, MAR ECOL PROG SER, V325, P301, DOI 10.3354/meps325301; Porter ET, 2004, MAR ECOL PROG SER, V271, P61, DOI 10.3354/meps271061; RIISGARD HU, 1988, MAR ECOL PROG SER, V45, P217, DOI 10.3354/meps045217; ROSS PG, 2006, 9 INT C SHELLF REST; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Smaal AC, 1997, AQUAT LIVING RESOUR, V10, P23, DOI 10.1051/alr:1997003; Smee DL, 2006, J CHEM ECOL, V32, P605, DOI 10.1007/s10886-005-9021-8; TENORE KR, 1973, MAR BIOL, V21, P190, DOI 10.1007/BF00355249; Verity PG, 2002, ESTUARIES, V25, P961, DOI 10.1007/BF02691344; WALKER RL, 1984, ESTUARIES, V7, P19, DOI 10.2307/1351953; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WHETSTONE JM, 1981, ESTUARIES, V4, P153, DOI 10.2307/1351680	54	8	8	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93969	10.1371/journal.pone.0093969	http://dx.doi.org/10.1371/journal.pone.0093969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718023	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000061
J	Churkin, A; Avihoo, A; Shapira, M; Barash, D				Churkin, Alexander; Avihoo, Assaf; Shapira, Michal; Barash, Danny			RNAthermsw: Direct Temperature Simulations for Predicting the Location of RNA Thermometers	PLOS ONE			English	Article							SECONDARY STRUCTURE; MESSENGER-RNA; THERMOSENSOR; TRANSLATION; ELEMENTS; SERVER	The mechanism of RNA thermometers is a subject of growing interest. Also known as RNA thermosensors, these temperature-sensitive segments of the mRNA regulate gene expression by changing their secondary structure in response to temperature fluctuations. The detection of RNA thermometers in various genes of interest is valuable as it could lead to the discovery of new thermometers participating in fundamental processes such as preferential translation during heatshock. RNAthermsw is a user-friendly webserver for predicting the location of RNA thermometers using direct temperature simulations. It operates by analyzing dotted figures generated as a result of a moving window that performs successive energy minimization folding predictions. Inputs include the RNA sequence, window size, and desired temperature change. RNAthermsw can be freely accessed at http://www.cs.bgu.ac.il/similar to rnathemsw/RNAthemsw/ (with the slash sign at the end). The website contains a help page with explanations regarding the exact usage.	[Churkin, Alexander; Barash, Danny] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Avihoo, Assaf] Microsoft Res Israel, Herzliyya, Israel; [Shapira, Michal] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Barash, D (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel.	dbarash@cs.bgu.ac.il		Shapira, Michal/0000-0002-6164-7874	Kreitman Foundation at Ben-Gurion University	Kreitman Foundation at Ben-Gurion University	This work was supported by the Kreitman Foundation at Ben-Gurion University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Avihoo A, 2005, IEEE COMP SYST BIOIN, P235; Avihoo A, 2011, THESIS B GURION U BE; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Chursov A, 2013, NUCLEIC ACIDS RES, V41, pW486, DOI 10.1093/nar/gkt486; DING Y, 2013, NATURE, DOI DOI 10.1038/NATURE12756; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kortmann J, 2011, NUCLEIC ACIDS RES, V39, P2855, DOI 10.1093/nar/gkq1252; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mortimer Stefanie A, 2012, Curr Protoc Chem Biol, V4, P275, DOI 10.1002/9780470559277.ch120019; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nocker A, 2001, NUCLEIC ACIDS RES, V29, P4800, DOI 10.1093/nar/29.23.4800; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Shah P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011308; Waldminghaus T, 2007, MOL GENET GENOMICS, V278, P555, DOI 10.1007/s00438-007-0272-7; Waldminghaus T, 2007, MOL MICROBIOL, V65, P413, DOI 10.1111/j.1365-2958.2007.05794.x; Waldminghaus T, 2009, RNA BIOL, V6, P455, DOI 10.4161/rna.6.4.9014; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94340	10.1371/journal.pone.0094340	http://dx.doi.org/10.1371/journal.pone.0094340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718440	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000106
J	Cusick, MF; Libbey, JE; Trede, NS; Fujinami, RS				Cusick, Matthew F.; Libbey, Jane E.; Trede, Nikolaus S.; Fujinami, Robert S.			Targeting Insulin-Like Growth Factor 1 Leads to Amelioration of Inflammatory Demyelinating Disease	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN PROTEOLIPID PROTEIN; MULTIPLE-SCLEROSIS; FACTOR-I; GLATIRAMER ACETATE; ZEBRAFISH SCREEN; IMMUNE-RESPONSES; SYSTEM; VIRUS	In patients with multiple sclerosis ( MS) and in mice with experimental autoimmune encephalomyelitis (EAE), proliferating autoreactive T cells play an important role in the pathogenesis of the disease. Due to the importance of these myelin-specific T cells, these cells have been therapeutic targets in a variety of treatments. Previously we found that Lenaldekar (LDK), a novel small molecule, could inhibit exacerbations in a preclinical model of MS when given at the start of an EAE exacerbation. In those studies, we found that LDK could inhibit human T cell recall responses and murine myelin responses in vitro. In these new studies, we found that LDK could inhibit myelin specific T cell responses through the insulin-like growth factor-1 receptor (IGF-1R) pathway. Alteration of this pathway led to marked reduction in T cell proliferation and expansion. Blocking this pathway could account for the observed decreases in clinical signs and inflammatory demyelinating disease, which was accompanied by axonal preservation. Our data indicate that IGF-1R could be a potential target for new therapies for the treatment of autoimmune diseases where autoreactive T cell expansion is a requisite for disease.	[Cusick, Matthew F.; Libbey, Jane E.; Fujinami, Robert S.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Trede, Nikolaus S.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Trede, Nikolaus S.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Trede, Nikolaus S.] Univ Utah, Dept Pediat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Fujinami, RS (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	Robert.Fujinami@hsc.utah.edu		Cusick, Matthew/0000-0002-0383-9747	Emma Mary Deland Foundation; NIH [T32AI055434]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055434] Funding Source: NIH RePORTER	Emma Mary Deland Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was from the Emma Mary Deland Foundation (RSF) and NIH T32AI055434 (MFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1992, Semin Immunol, V4, P105; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Blanchette F, 2008, J NEUROL, V255, P26, DOI 10.1007/s00415-008-1005-5; Brennan DC, 2013, REV MED VIROL, V23, P97, DOI 10.1002/rmv.1733; BROWN A, 1982, LAB INVEST, V46, P171; Cannella B, 2000, AM J PATHOL, V157, P933, DOI 10.1016/S0002-9440(10)64606-8; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cusick MF, 2012, J NEUROIMMUNOL, V244, P35, DOI 10.1016/j.jneuroim.2011.12.024; Donia M, 2009, J AUTOIMMUN, V33, P135, DOI 10.1016/j.jaut.2009.06.003; Frank JA, 2002, MULT SCLER, V8, P24, DOI 10.1191/1352458502ms768oa; Genoud S, 2005, J NEUROIMMUNOL, V168, P40, DOI 10.1016/j.jneuroim.2005.06.033; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380; Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Li W, 1998, J NEUROPATH EXP NEUR, V57, P426; Libbey JE, 2011, VACCINE, V29, P3356, DOI 10.1016/j.vaccine.2010.08.103; Libbey JE, 2010, J NEUROIMMUNE PHARM, V5, P168, DOI 10.1007/s11481-010-9215-x; Lovett-Racke AE, 1998, J CLIN INVEST, V101, P1797, DOI 10.1172/JCI1486; McMorris FA, 1996, BRAIN PATHOL, V6, P313, DOI 10.1111/j.1750-3639.1996.tb00858.x; Paintlia AS, 2010, GLIA, V58, P1669, DOI 10.1002/glia.21039; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; Sagnelli E, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/945950; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SOBEL RA, 1990, J NEUROPATH EXP NEUR, V49, P468, DOI 10.1097/00005072-199009000-00002; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Theil DJ, 2001, J NEUROVIROL, V7, P220; Tsunoda I, 1998, J NEUROPATH EXP NEUR, V57, P758, DOI 10.1097/00005072-199808000-00005; Tsunoda I, 1997, VIROLOGY, V228, P388, DOI 10.1006/viro.1996.8382; Tsunoda I, 2003, AM J PATHOL, V162, P1259, DOI 10.1016/S0002-9440(10)63922-3; Tsunoda I, 2001, J VIROL, V75, P7494, DOI 10.1128/JVI.75.16.7494-7505.2001; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Ulfig N, 1998, CELL TISSUE RES, V291, P433, DOI 10.1007/s004410051013; Webster HD, 1997, MULT SCLER J, V3, P113, DOI 10.1177/135245859700300210; Wu Tianfu, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P145	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94486	10.1371/journal.pone.0094486	http://dx.doi.org/10.1371/journal.pone.0094486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718491	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000127
J	Kaplan, I; McArt, SH; Thaler, JS				Kaplan, Ian; McArt, Scott H.; Thaler, Jennifer S.			Plant Defenses and Predation Risk Differentially Shape Patterns of Consumption, Growth, and Digestive Efficiency in a Guild of Leaf- Chewing Insects	PLOS ONE			English	Article							STRESS; TOMATO; HERBIVORES; RESISTANCE; JASMONATE; PREY; RESPONSES; TADPOLES; BEHAVIOR; LARVAE	Herbivores are squeezed between the two omnipresent threats of variable food quality and natural enemy attack, but these two factors are not independent of one another. The mechanisms by which organisms navigate the dual challenges of foraging while avoiding predation are poorly understood. We tested the effects of plant defense and predation risk on herbivory in an assemblage of leaf-chewing insects on Solanum lycopersicum (tomato) that included two Solanaceae specialists (Manduca sexta and Leptinotarsa decemlineata) and one generalist (Trichoplusia ni). Defenses were altered using genetic manipulations of the jasmonate phytohormonal cascade, whereas predation risk was assessed by exposing herbivores to cues from the predaceous stink bug, Podisus maculiventris. Predation risk reduced herbivore food intake by an average of 29% relative to predator-free controls. Interestingly, this predator-mediated impact on foraging behavior largely attenuated when quantified in terms of individual growth rate. Only one of the three species experienced lower body weight under predation risk and the magnitude of this effect was small (17% reduction) compared with effects on foraging behavior. Manduca sexta larvae, compensated for their predator-induced reduction in food intake by more effectively converting leaf tissue to body mass. They also had higher whole-body lipid content when exposed to predators, suggesting that individuals convert energy to storage forms to draw upon when risk subsides. In accordance with expectations based on insect diet breadth, plant defenses tended to have a stronger impact on consumption and growth in the generalist than the two specialists. These data both confirm the ecological significance of predators in the foraging behavior of herbivorous prey and demonstrate how sophisticated compensatory mechanisms allow foragers to partially offset the detrimental effects of reduced food intake. The fact that these mechanisms operated across a wide range of plant resistance phenotypes suggests that compensation is not always constrained by reduced food quality.	[Kaplan, Ian] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [McArt, Scott H.; Thaler, Jennifer S.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [McArt, Scott H.; Thaler, Jennifer S.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University; Cornell University	Kaplan, I (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	ikaplan@purdue.edu			National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2006-35302-17431]	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This project was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, Grant no. 2006-35302-17431 to JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Anholt BR, 1998, EVOL ECOL, V12, P729, DOI 10.1023/A:1006589616931; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Bernays EA, 1997, ECOL ENTOMOL, V22, P121, DOI 10.1046/j.1365-2311.1997.00042.x; Bronmark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030467; Castellanos I, 2006, ANIM BEHAV, V72, P461, DOI 10.1016/j.anbehav.2006.02.005; Chapman RF., 2012, INSECTS STRUCTURE FU; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Danner BJ, 2003, OECOLOGIA, V137, P352, DOI 10.1007/s00442-003-1362-9; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Denno R.F., 1983, VARIABLE PLANTS HERB; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; FRITZ RS, 1992, PLANT RESISTANCE HER; Gotthard K, 2000, J ANIM ECOL, V69, P896, DOI 10.1046/j.1365-2656.2000.00432.x; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; HOO CRS, 1984, ENVIRON ENTOMOL, V13, P843, DOI 10.1093/ee/13.3.843; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; HSIAO TH, 1968, ANN ENTOMOL SOC AM, V61, P485, DOI 10.1093/aesa/61.2.485; Janssens L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0350; Johansson F, 2009, J ANIM ECOL, V78, P772, DOI 10.1111/j.1365-2656.2009.01530.x; Kaplan I, 2010, OIKOS, V119, P1105, DOI 10.1111/j.1600-0706.2009.18311.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Lavoie B, 2004, ENVIRON ENTOMOL, V33, P1062, DOI 10.1603/0046-225X-33.4.1062; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; MORAN N, 1980, J THEOR BIOL, V86, P247, DOI 10.1016/0022-5193(80)90004-1; OROZCOCARDENAS M, 1993, P NATL ACAD SCI USA, V90, P8273, DOI 10.1073/pnas.90.17.8273; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2009, J ANIM ECOL, V78, P1103, DOI 10.1111/j.1365-2656.2009.01602.x; Rayapuram C, 2006, PLANT CELL ENVIRON, V29, P1585, DOI 10.1111/j.1365-3040.2006.01534.x; Relyea RA, 2004, ENVIRON TOXICOL CHEM, V23, P1080, DOI 10.1897/03-259; Relyea RA, 2001, P NATL ACAD SCI USA, V98, P2491, DOI 10.1073/pnas.031076198; Relyea RA, 2003, ECOL APPL, V13, P1515, DOI 10.1890/02-5298; Relyea RA, 1999, ECOLOGY, V80, P2117, DOI 10.1890/0012-9658(1999)080[2117:QTRBPI]2.0.CO;2; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Scott IM, 2010, J CHEM ECOL, V36, P490, DOI 10.1007/s10886-010-9780-8; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Slansky F. J. R., 1985, COMPREHENSIVE INSECT, V8, P88; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Stamp NE, 1993, CATERPILLARS ECOLOGI; Steiner UK, 2007, ANIM BEHAV, V74, P1473, DOI 10.1016/j.anbehav.2007.02.016; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Thaler JS, 2008, ENTOMOL EXP APPL, V128, P34, DOI 10.1111/j.1570-7458.2008.00737.x; Thaler JS, 2012, P NATL ACAD SCI USA, V109, P12075, DOI 10.1073/pnas.1208070109; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; Thaler JS, ECOLOGICAL IN PRESS; Tilmon KJ, 2008, EVOLUTIONARY BIOL HE; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Warburg MS, 1997, OECOLOGIA, V112, P314, DOI 10.1007/s004420050314; White T. C. R., 1993, INADEQUATE ENV NITRO; YAMAMOTO ROBERT T., 1960, ANN ENT SOC AMER, V53, P503, DOI 10.1093/aesa/53.4.503; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	65	35	35	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93714	10.1371/journal.pone.0093714	http://dx.doi.org/10.1371/journal.pone.0093714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718036	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000043
J	Reichmann, TL; Effenberger, HS; Ipser, H				Reichmann, Thomas L.; Effenberger, Herta S.; Ipser, Herbert			Experimental Investigation of the Cd-Pr Phase Diagram	PLOS ONE			English	Article							RARE-EARTH; LIQUID-METAL; INTERMETALLIC COMPOUNDS; REDUCTIVE EXTRACTION; CRYSTAL-STRUCTURE; CADMIUM SYSTEM; ELEMENTS; SALT; THERMODYNAMICS; ALUMINUM	The complete Cd-Pr equilibrium phase diagram was investigated with a combination of powder-XRD, SEM and DTA. All intermetallic compounds within this system, already reported in literature, could be confirmed: CdPr, Cd2Pr, Cd3Pr, Cd45Pr11, Cd58Pr13, Cd6Pr and Cd11Pr. The corresponding phase boundaries were determined at distinct temperatures. The homogeneity range of the high-temperature allotropic modification of Pr could be determined precisely and a limited solubility of 22.1 at.% Cd was derived. Additionally, single-crystal X-ray diffraction was employed to investigate structural details of Cd2Pr; it is isotypic to the AlB2-type structure with a z value of the Cd site of 0.5. DTA results of alloys located in the adjacent two-phase fields of Cd2Pr suggested a phase transformation between 893 and 930 degrees C. For the phase Cd3Pr it was found that the lattice parameter a changes linearly with increasing Cd content, following Vegard's rule. The corresponding defect mechanism could be evaluated from structural data collected with single-crystal XRD. Introduction of a significant amount of vacancies on the Pr site and the reduction in symmetry of one Cd position (8c to 32f) resulted in a noticeable decrease of all R-values.	[Reichmann, Thomas L.; Ipser, Herbert] Univ Vienna, Dept Inorgan Chem Mat Chem, Vienna, Austria; [Effenberger, Herta S.] Univ Vienna, Dept Mineral & Crystallog, Vienna, Austria	University of Vienna; University of Vienna	Reichmann, TL (corresponding author), Univ Vienna, Dept Inorgan Chem Mat Chem, Vienna, Austria.	Thomas.Reichmann@univie.ac.at			Austrian Science Fund (FWF) [P 23270-N19]; Austrian Science Fund (FWF) [P 23270] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) under Project No. P 23270-N19 (www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JP, 1991, IND ENG CHEM RES, V30, P141, DOI 10.1021/ie00049a022; Binnewies M., 1999, THERMODYNAMIC DATA E; Bradley AJ, 1933, J I MET, V51, P131; BRUZZONE G, 1974, J LESS-COMMON MET, V37, P289, DOI 10.1016/0022-5088(74)90045-9; BRUZZONE G, 1973, J LESS-COMMON MET, V30, P361, DOI 10.1016/0022-5088(73)90147-1; BRUZZONE G, 1971, J LESS-COMMON MET, V25, P295, DOI 10.1016/0022-5088(71)90153-6; BRUZZONE G, 1973, J LESS-COMMON MET, V30, P303, DOI 10.1016/0022-5088(73)90115-X; Conocar O, 2006, NUCL SCI ENG, V153, P253, DOI 10.13182/NSE06-A2611; FORNASINI ML, 1978, ACTA CRYSTALLOGR B, V34, P2093, DOI 10.1107/S0567740878007505; Gschneidner Jr K.A., 1988, B ALLOY PHASE DIAGRA, V9, P130; Hoffmann RD, 2001, Z KRISTALLOGR, V216, P127, DOI 10.1524/zkri.216.3.127.20327; IANDELLI A, 1968, J LESS-COMMON MET, V15, P273, DOI 10.1016/0022-5088(68)90186-0; Iandelli A, 1954, GAZZ CHIM ITAL, V84, P463; JOHNSON I, 1988, J NUCL MATER, V154, P169, DOI 10.1016/0022-3115(88)90131-6; JOHNSON I, 1964, T METALL SOC AIME, V230, P1485; JOHNSON I, 1966, ASM TRANS Q, V59, P352; Koester W., 1965, Z METALLKD, V56, P695; Kurata M, 1995, J NUCL MATER, V227, P110, DOI 10.1016/0022-3115(95)00146-8; Kurata M, 2001, J PHASE EQUILIB, V22, P232, DOI 10.1361/105497101770338707; Kusma JB, 1966, CRYSTAL STRUCTURES S, P1025; Laidler J. J., 1997, Progress in Nuclear Energy, V31, P131, DOI 10.1016/0149-1970(96)00007-8; LARSON AC, 1971, ACTA CRYSTALL B-STRU, VB 27, P1875, DOI 10.1107/S0567740871005028; LAUBE E, 1964, MONATSH CHEM VERW TL, V95, P1504, DOI 10.1007/BF00901705; MORIYAMA H, 1994, J ALLOY COMPD, V213, P354, DOI 10.1016/0925-8388(94)90930-X; Moriyama H, 1998, J ALLOY COMPD, V271, P587, DOI 10.1016/S0925-8388(98)00165-0; MULOKOZI AM, 1977, J LESS-COMMON MET, V53, P205, DOI 10.1016/0022-5088(77)90105-9; Olander D, 2009, J NUCL MATER, V389, P1, DOI 10.1016/j.jnucmat.2009.01.297; Piao SY, 2008, INORG CHEM, V47, P1079, DOI 10.1021/ic701962b; Piao S, 2006, Z KRISTALLOGR, V221, P391, DOI 10.1524/zkri.2006.221.5-7.391; Reichmann TL, 2014, METALL MATER TRANS A, V45A, P1171, DOI 10.1007/s11661-013-2065-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skolyszewska-Kuhberger B, 2014, CALPHAD, V44, P14, DOI 10.1016/j.calphad.2013.07.005; SPEDDING FH, 1961, J LESS-COMMON MET, V3, P110, DOI 10.1016/0022-5088(61)90003-0; TANG J, 1989, J LESS-COMMON MET, V149, P341, DOI 10.1016/0022-5088(89)90509-2; Veleckis E, 1964, ANL6925; Yamana H, 2000, J NUCL MATER, V278, P37, DOI 10.1016/S0022-3115(99)00228-7	36	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94025	10.1371/journal.pone.0094025	http://dx.doi.org/10.1371/journal.pone.0094025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718502	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000069
J	Zhao, YX; Cai, MJ; Zhang, XB; Li, YR; Zhang, JH; Zhao, HL; Kong, F; Zheng, YL; Qiu, FZ				Zhao, Yanxin; Cai, Manjun; Zhang, Xiaobo; Li, Yurong; Zhang, Jianhua; Zhao, Hailiang; Kong, Fei; Zheng, Yonglian; Qiu, Fazhan			Genome-Wide Identification, Evolution and Expression Analysis of mTERF Gene Family in Maize	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PLANT-MITOCHONDRIA; PROTEIN COMPLEX; TRANSCRIPTION; TERMINATION; DNA; REVEALS; RNA; ALIGNMENT; ELEMENTS	Plant mitochondrial transcription termination factor (mTERF) genes comprise a large family with important roles in regulating organelle gene expression. In this study, a comprehensive database search yielded 31 potential mTERF genes in maize (Zea mays L.) and most of them were targeted to mitochondria or chloroplasts. Maize mTERF were divided into nine main groups based on phylogenetic analysis, and group IX represented the mitochondria and species-specific clade that diverged from other groups. Tandem and segmental duplication both contributed to the expansion of the mTERF gene family in the maize genome. Comprehensive expression analysis of these genes, using microarray data and RNA-seq data, revealed that these genes exhibit a variety of expression patterns. Environmental stimulus experiments revealed differential up or down-regulation expression of maize mTERF genes in seedlings exposed to light/dark, salts and plant hormones, respectively, suggesting various important roles of maize mTERF genes in light acclimation and stress-related responses. These results will be useful for elucidating the roles of mTERF genes in the growth, development and stress response of maize.	[Zhao, Yanxin; Cai, Manjun; Zhang, Xiaobo; Li, Yurong; Zhang, Jianhua; Zhao, Hailiang; Kong, Fei; Zheng, Yonglian; Qiu, Fazhan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University	Qiu, FZ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	qiufazhan@gmail.com	Zhao, Yanxin/GMW-8700-2022	Cai, Manjun/0000-0001-7134-3463	National Natural Science Foundation of China [91335205]; National High Technology Research and Development Program of China (863 Program) [2012AA101104]; National Basic Research Program of China (973 Program) [2014CB138203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by Project No. 91335205 supported by National Natural Science Foundation of China, the National High Technology Research and Development Program of China (863 Program) (2012AA101104) and the National Basic Research Program of China (973 Program) (2014CB138203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Binder S, 2003, PHILOS T R SOC B, V358, P181, DOI 10.1098/rstb.2002.1179; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cao BQ, 2006, BIOINFORMATICS, V22, P303, DOI 10.1093/bioinformatics/bti784; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dash S, 2012, NUCLEIC ACIDS RES, V40, pD1194, DOI 10.1093/nar/gkr938; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Friso G, 2010, PLANT PHYSIOL, V152, P1219, DOI 10.1104/pp.109.152694; Gagliardi D., 2007, PLANT MITOCHONDRIA, V31, P50, DOI DOI 10.1002/9780470986592.CH3; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hammani K, 2014, NUCL ACIDS IN PRESS; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Jimenez-Menendez N, 2010, NAT STRUCT MOL BIOL, V17, P891, DOI 10.1038/nsmb.1859; Khong GN, 2008, BIOTECHNOL GENET ENG, V25, P381, DOI 10.5661/bger-25-381; Kim M, 2012, PLANT CELL, V24, P3349, DOI 10.1105/tpc.112.101006; Kleine T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00233; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Kuhn K, 2007, PLANT CELL, V19, P959, DOI 10.1105/tpc.106.046839; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Majeran W, 2012, PLANT PHYSIOL, V158, P156, DOI 10.1104/pp.111.188474; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Meskauskiene R, 2009, PLANT J, V60, P399, DOI 10.1111/j.1365-313X.2009.03965.x; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Quesada V, 2011, PLANT J, V68, P738, DOI 10.1111/j.1365-313X.2011.04726.x; Roberti M, 2006, NUCLEIC ACIDS RES, V34, P2109, DOI 10.1093/nar/gkl181; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Robles P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042924; Robles P, 2012, MOL PLANT, V5, P294, DOI 10.1093/mp/sss016; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schnable JC, 2011, MAYDICA, V56, P183; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schonfeld C, 2004, J BIOL CHEM, V279, P50366, DOI 10.1074/jbc.M408477200; Schrodinger L., 2013, PYMOL MOL GRAPHICS S; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Soderlund C, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr123; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Spahr H, 2010, BIOCHEM BIOPH RES CO, V397, P386, DOI 10.1016/j.bbrc.2010.04.130; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wobbe L, 2013, NUCLEIC ACIDS RES, V41, P6553, DOI 10.1093/nar/gkt313; Yakubovskaya E, 2012, STRUCTURE, V20, P1940, DOI 10.1016/j.str.2012.08.027; Yakubovskaya E, 2010, CELL, V141, P982, DOI 10.1016/j.cell.2010.05.018; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	75	39	42	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94126	10.1371/journal.pone.0094126	http://dx.doi.org/10.1371/journal.pone.0094126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718683	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000079
J	Fan, Z; Sehm, T; Rauh, M; Buchfelder, M; Eyupoglu, IY; Savaskan, NE				Fan, Zheng; Sehm, Tina; Rauh, Manfred; Buchfelder, Michael; Eyupoglu, Ilker Y.; Savaskan, Nicolai E.			Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis	PLOS ONE			English	Article							TEMOZOLOMIDE-INDUCED APOPTOSIS; NEURONAL CELL-DEATH; VASCULAR-PERMEABILITY; MALIGNANT GLIOMAS; ENERGY-METABOLISM; KINASE INHIBITOR; GLIOBLASTOMA; RECEPTOR; CANCER; BEVACIZUMAB	Children and adults with the most aggressive form of brain cancer, malignant gliomas or glioblastoma, often develop cerebral edema as a life-threatening complication. This complication is routinely treated with dexamethasone (DEXA), a steroidal anti-inflammatory drug with pleiotropic action profile. Here we show that dexamethasone reduces murine and rodent glioma tumor growth in a concentration-dependent manner. Low concentrations of DEXA are already capable of inhibiting glioma cell proliferation and at higher levels induce cell death. Further, the expression of the glutamate antiporter xCT (system Xc(-); SLC7a11) and VEGFA is up-regulated after DEXA treatment indicating early cellular stress responses. However, in human gliomas DEXA exerts differential cytotoxic effects, with some human glioma cells (U251, T98G) resistant to DEXA, a finding corroborated by clinical data of dexamethasone non-responders. Moreover, DEXA-resistant gliomas did not show any xCT alterations, indicating that these gene expressions are associated with DEXA-induced cellular stress. Hence, siRNA-mediated xCT knockdown in glioma cells increased the susceptibility to DEXA. Interestingly, cell viability of primary human astrocytes and primary rodent neurons is not affected by DEXA. We further tested the pharmacological effects of DEXA on brain tissue and showed that DEXA reduces tumor-induced disturbances of the microenvironment such as neuronal cell death and tumor-induced angiogenesis. In conclusion, we demonstrate that DEXA inhibits glioma cell growth in a concentration and species-dependent manner. Further, DEXA executes neuroprotective effects in brains and reduces tumor-induced angiogenesis. Thus, our investigations reveal that DEXA acts pleiotropically and impacts tumor growth, tumor vasculature and tumor-associated brain damage.	[Fan, Zheng; Sehm, Tina; Buchfelder, Michael; Eyupoglu, Ilker Y.; Savaskan, Nicolai E.] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neurosurg, D-91054 Erlangen, Bavaria, Germany; [Rauh, Manfred] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, D-91054 Erlangen, Bavaria, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Savaskan, NE (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neurosurg, D-91054 Erlangen, Bavaria, Germany.	savaskan@gmx.net	Savaskan, Nicolai/D-2923-2018	Savaskan, Nicolai/0000-0003-1348-094X	Deutsche Forschungsgemeinschaft (DFG); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); China Scholarship Council [CSC: 2011627126]; Deutsche Forschungsgemeinschaft [DFG Ey 94-2/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); China Scholarship Council(China Scholarship Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge support by the Deutsche Forschungsgemeinschaft (DFG) and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme 'Open Access Publishing'. This study was in part supported by the China Scholarship Council (CSC: 2011627126) and the Deutsche Forschungsgemeinschaft (DFG Ey 94-2/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannai M, 2001, EUR J IMMUNOL, V31, P3361, DOI 10.1002/1521-4141(200111)31:11<3361::AID-IMMU3361>3.0.CO;2-Z; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Benedetti S, 2003, GENE THER, V10, P188, DOI 10.1038/sj.gt.3301863; Bertorelli R, 1998, NEUROSCI LETT, V246, P41, DOI 10.1016/S0304-3940(98)00221-3; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cuneo KC, 2012, INT J RADIAT ONCOL, V82, P2018, DOI 10.1016/j.ijrobp.2010.12.074; Dardzinski BJ, 2000, PEDIATR RES, V48, P248, DOI 10.1203/00006450-200008000-00021; Darpolor MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016621; Das A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-36; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Eyupoglu IY, 2013, NAT REV NEUROL, V9, P141, DOI 10.1038/nrneurol.2012.279; Eyupoglu IY, 2005, J NEUROSURG, V102, P738, DOI 10.3171/jns.2005.102.4.0738; Eyupoglu IY, 2003, BRAIN RES PROTOC, V11, P1, DOI 10.1016/S1385-299X(02)00186-1; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Feng Y, 2011, NEUROSCIENCE, V179, P223, DOI 10.1016/j.neuroscience.2011.01.050; Harada M, 2012, LEUKEMIA LYMPHOMA, V53, P2041, DOI 10.3109/10428194.2012.678004; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Hempen C, 2002, SUPPORT CARE CANCER, V10, P322, DOI 10.1007/s00520-001-0333-0; Hock SW, 2013, EVOLUTION MOL BIOL B, V638, P125; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; JELSMAN R, 1967, J NEUROSURG, V27, P388, DOI 10.3171/jns.1967.27.5.0388; Kaal ECA, 2004, CURR OPIN ONCOL, V16, P593, DOI 10.1097/01.cco.0000142076.52721.b3; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kloosterhof NK, 2013, GENE CHROMOSOME CANC, V52, P665, DOI 10.1002/gcc.22062; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; KROH H, 1988, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V134, P523; Lambert W, 2001, INVEST OPHTH VIS SCI, V42, P2315; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Marantidou A, 2010, J NEURO-ONCOL, V100, P89, DOI 10.1007/s11060-010-0142-8; Miller J D, 1977, Neurosurgery, V1, P114; Narita Y, 2013, JPN J CLIN ONCOL, V43, P587, DOI 10.1093/jjco/hyt051; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Pace A, 2013, J NEURO-ONCOL, V111, P83, DOI 10.1007/s11060-012-0993-2; Rinne ML, 2013, EXPERT OPIN EMERG DR, V18, P137, DOI 10.1517/14728214.2013.794784; Robe PA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-32; Savaskan NE, 2011, ONCOGENE, V30, P43, DOI 10.1038/onc.2010.391; Savaskan NE, 2010, ANN ANAT, V192, P309, DOI 10.1016/j.aanat.2010.07.003; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SILBERGELD DL, 1991, J NEURO-ONCOL, V10, P179, DOI 10.1007/BF00146880; Spaner DE, 2012, LEUKEMIA, V26, P1144, DOI 10.1038/leu.2011.329; STORRING FK, 1954, J PATHOL BACTERIOL, V68, P231, DOI 10.1002/path.1700680128; Sur P, 2005, GLIA, V50, P160, DOI 10.1002/glia.20168; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tung S, 2013, BLOOD, V122, P969, DOI 10.1182/blood-2013-03-489468; TUOR UI, 1993, BRAIN RES, V604, P165, DOI 10.1016/0006-8993(93)90364-S; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; VECHT CJ, 1994, NEUROLOGY, V44, P675, DOI 10.1212/WNL.44.4.675; Villeneuve J, 2008, BRAIN PATHOL, V18, P401, DOI 10.1111/j.1750-3639.2008.00139.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wen PY, 2005, CANC NERVOUS SYSTEM, P243; Wenzel EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038188; YUAN F, 1994, CANCER RES, V54, P4564; Zuniga RM, 2010, J NEURO-ONCOL, V99, P237, DOI 10.1007/s11060-010-0121-0	62	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93264	10.1371/journal.pone.0093264	http://dx.doi.org/10.1371/journal.pone.0093264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714627	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900021
J	Kent, BP; Rinaldo, A; Yeh, FC; Verstynen, T				Kent, Brian P.; Rinaldo, Alessandro; Yeh, Fang-Cheng; Verstynen, Timothy			Mapping Topographic Structure in White Matter Pathways with Level Set Trees	PLOS ONE			English	Article							IN-VIVO; TRACTOGRAPHY; CONNECTIVITY; QUANTIFICATION; CLASSIFICATION; CONSISTENCY; STABILITY	Fiber tractography on diffusion imaging data offers rich potential for describing white matter pathways in the human brain, but characterizing the spatial organization in these large and complex data sets remains a challenge. We show that level set trees-which provide a concise representation of the hierarchical mode structure of probability density functions-offer a statistically-principled framework for visualizing and analyzing topography in fiber streamlines. Using diffusion spectrum imaging data collected on neurologically healthy controls (N = 30), we mapped white matter pathways from the cortex into the striatum using a deterministic tractography algorithm that estimates fiber bundles as dimensionless streamlines. Level set trees were used for interactive exploration of patterns in the endpoint distributions of the mapped fiber pathways and an efficient segmentation of the pathways that had empirical accuracy comparable to standard nonparametric clustering techniques. We show that level set trees can also be generalized to model pseudo-density functions in order to analyze a broader array of data types, including entire fiber streamlines. Finally, resampling methods show the reliability of the level set tree as a descriptive measure of topographic structure, illustrating its potential as a statistical descriptor in brain imaging analysis. These results highlight the broad applicability of level set trees for visualizing and analyzing high-dimensional data like fiber tractography output.	[Kent, Brian P.; Rinaldo, Alessandro] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Yeh, Fang-Cheng] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Verstynen, Timothy] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Verstynen, Timothy] Carnegie Mellon Univ, Ctr Neural Basis Computat, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Verstynen, T (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	timothyv@andrew.cmu.edu	Yeh, Fang-Cheng/E-9698-2012	Yeh, Fang-Cheng/0000-0002-7946-2173; Verstynen, Timothy/0000-0003-4720-0336	Army Research Laboratory [W911NF-10-2-0022]; NSF CAREER [DMS 114967]; Division Of Mathematical Sciences [1149677] Funding Source: National Science Foundation	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was sponsored by the Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-10-2-0022. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U. S. Government. The U. S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein. This research was also supported by NSF CAREER grant DMS 114967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ADV NEURAL INFORM PR; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Azzalini A, 2007, STAT COMPUT, V17, P71, DOI 10.1007/s11222-006-9010-y; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Ben-Hur Asa, 2002, Pac Symp Biocomput, P6; Billingsley P., 2012, WILEY SERIES PROBABI; Brun A, 2004, LECT NOTES COMPUT SC, V3216, P368; Catani M, 2013, BRAIN; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Corouge I, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P344; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; DEVROYE LP, 1977, ANN STAT, V5, P536, DOI 10.1214/aos/1176343851; Ding ZH, 2003, MAGNET RESON MED, V49, P716, DOI 10.1002/mrm.10415; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Ferraty F., 2006, SPR S STAT; Garyfallidis E, 2011, 17 ANN M ORG HUM BRA, P1; Gerig G, 2004, P ANN INT IEEE EMBS, V26, P4421; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Greenberg AS, 2012, J NEUROSCI, V32, P2773, DOI 10.1523/JNEUROSCI.5419-11.2012; Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hartigan J., 1975, CLUSTERING ALGORITHM; HARTIGAN JA, 1981, J AM STAT ASSOC, V76, P388, DOI 10.2307/2287840; Hastie T, 2009, ELEMENTS STAT LEARNI, P510, DOI [978-0387848570, DOI 10.1007/978-0-387-84858-7]; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Jbabdi S, 2013, CURRENT OPINION NEUR, P1; Jonasson L, 2005, P INT SOC MAGN RES I; KPOTUFE S., 2011, P 28 INT C MACH LEAR, P225; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017; Maier M, 2009, THEOR COMPUT SCI, V410, P1749, DOI 10.1016/j.tcs.2009.01.009; Makris N, 2009, CEREB CORTEX, V19, P777, DOI 10.1093/cercor/bhn124; Moberts B, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P65; O'Donnell L, 2005, LECT NOTES COMPUT SC, V3749, P140; O'Donnell LJ, 2013, NEUROIMAGE; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prasad G, 2011, MICCAI 2011 WORKSH C; Pyles JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061611; R Core Team, 2012, R LANG ENV STAT COMP, DOI 3-900051-07-0; RAGSDALE CW, 1990, P NATL ACAD SCI USA, V87, P6196, DOI 10.1073/pnas.87.16.6196; Rao P, 1983, NONPARAMETRIC FUNCTI; Richards JW, 2009, MON NOT R ASTRON SOC, V399, P1044, DOI 10.1111/j.1365-2966.2009.15349.x; Richards JW, 2009, ASTROPHYS J, V691, P32, DOI 10.1088/0004-637X/691/1/32; Rinaldo A, 2012, J MACH LEARN RES, V13, P905; Rinaldo A, 2010, ANN STAT, V38, P2678, DOI 10.1214/10-AOS797; Shimony JS, 2002, P INT SOC MAGN RES I; SMITH SP, 1980, PATTERN RECOGN, V12, P177, DOI 10.1016/0031-3203(80)90042-4; Tsai A, 2007, IEEE C COMP VIS PATT, P1, DOI [10.1109/CVPR.2007.383096., DOI 10.1109/CVPR.2007.383096]; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Verstynen TD, 2012, J NEUROPHYSIOLOGY; Verstynen T, 2011, J NEUROPHYSIOL, V105, P336, DOI 10.1152/jn.00698.2010; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang XG, 2011, NEUROIMAGE, V54, P290, DOI 10.1016/j.neuroimage.2010.07.050; Wang Y., 2012, J NANOMATER, V2012, P1, DOI DOI 10.1186/1687-6180-2012-40; Wassermann D, 2010, NEUROIMAGE, V51, P228, DOI 10.1016/j.neuroimage.2010.01.004; Wassermann D, 2008, MICCAI 2008 WORKSH M, V2, P1; Wassermann D, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/526906; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wishart D., 1969, NUMERICAL TAXONOMY, P282; Xia Y, 2005, LECT NOTES COMPUT SC, V3749, P205; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yeh FC, 2010, 2INT SOC MAGNET RES; Zhang S, 2005, P INT SOC MAGN RES I, P2727; Zhang S, 2008, IEEE T VIS COMPUT GR, V14, P1044, DOI 10.1109/TVCG.2008.52; Zvitia O, 2008, I S BIOMED IMAGING, P692, DOI 10.1109/ISBI.2008.4541090	73	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93344	10.1371/journal.pone.0093344	http://dx.doi.org/10.1371/journal.pone.0093344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714673	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900024
J	Liu, Y; Rao, U; McClure, J; Konopa, P; Manocheewa, S; Kim, M; Chen, L; Troyer, RM; Tebit, DM; Holte, S; Arts, EJ; Mullins, JI				Liu, Yi; Rao, Ushnal; McClure, Jan; Konopa, Philip; Manocheewa, Siriphan; Kim, Moon; Chen, Lennie; Troyer, Ryan M.; Tebit, Denis M.; Holte, Sarah; Arts, Eric J.; Mullins, James I.			Impact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds	PLOS ONE			English	Article							T-LYMPHOCYTE EPITOPES; DOUBLE-BLIND; VIRUS; FITNESS; VACCINE; ESCAPE; GAG; INFECTION; COMPENSATION; EVOLUTION	It has been hypothesized that a single mutation at a highly conserved amino acid site (HCS) can be severely deleterious to HIV in most if not all isolate-specific genetic backgrounds. Consequently, potentially universal HIV-1 vaccines exclusively targeting highly conserved regions of the viral proteome have been proposed. To test this hypothesis, we examined the impact of 10 Gag-p24 and 9 Env-gp120 HCS single mutations on viral fitness. In the original founder sequence of the subject in whom these mutations were identified, all Gag-p24 HCS mutations significantly reduced viral replication fitness, including 7 that were lethal. Similar results were obtained at 9/10 sites when the same mutations were introduced into the founder sequences of two epidemiologically unlinked subjects. In contrast, none of the 9 Env-gp120 HCS mutations were lethal in the original founder sequence, and four had no fitness cost. Hence, HCS mutations in Gag-p24 are likely to be severely deleterious in different HIV-1 subtype B backgrounds; however, some HCS mutations in both Gag-p24 and Env-gp120 fragments can be well tolerated. Therefore, when designing HIV-1 immunogens that are intended to force the virus to nonviable escape pathways, the fitness constraints on the HIV segments included should be considered beyond their conservation level.	[Liu, Yi; Rao, Ushnal; McClure, Jan; Konopa, Philip; Manocheewa, Siriphan; Kim, Moon; Chen, Lennie; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Troyer, Ryan M.; Tebit, Denis M.; Arts, Eric J.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Liu, Y (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	yiliu197@uw.edu	Troyer, Ryan/ABE-2221-2021; Tebit, Denis/ABE-1824-2020	Troyer, Ryan/0000-0001-8908-5853; Tebit, Denis/0000-0002-4540-6245; Arts, Eric/0000-0002-4880-7968	National Institutes of Health [AI081569, AI47734, AI57005, AI27757]; Bill and Melinda Gates Foundation [43437]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049170, R37AI047734, P01AI057005, R21AI081569, R01AI047734, P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [AI081569 to Y.L., AI47734 and AI57005 to J.I.M., AI27757 to the University of Washington Center for AIDS Research Computational Biology Core led by J.I.M.], and the Bill and Melinda Gates Foundation [43437 to J.I.M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; CAHALL DL, 1975, INFECT IMMUN, V12, P833, DOI 10.1128/IAI.12.4.833-840.1975; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Janes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043396; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Koval CE, 2006, VIROLOGY, V353, P184, DOI 10.1016/j.virol.2006.05.021; Lanxon-Cookson EC, 2013, J VIROL METHODS, V194, P7, DOI 10.1016/j.jviromet.2013.07.062; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; LIU Y, 2012, J VIROL MET IN PRESS; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Liu Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015639, 10.1371/journal.pone.0022241]; Llano A, 2009, HIV MOL IMMUNOL, V2009, P3, DOI DOI 10.1016/J.M0LIMM.2008.12.019; Ma JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-261; McClure J, 2007, JAIDS-J ACQ IMM DEF, V44, P254, DOI 10.1097/QAI.0b013e318030f5c5; PATARCA R, 1985, NATURE, V318, P390, DOI 10.1038/318390a0; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; Stekler Joanne, 2004, Curr HIV/AIDS Rep, V1, P68, DOI 10.1007/s11904-004-0010-2; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	42	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94240	10.1371/journal.pone.0094240	http://dx.doi.org/10.1371/journal.pone.0094240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713822	gold, Green Submitted, Green Published			2022-12-27	WOS:000334160900108
J	Oshio, T; Kawashima, R; Kawamura, YI; Hagiwara, T; Mizutani, N; Okada, T; Otsubo, T; Inagaki-Ohara, K; Matsukawa, A; Haga, T; Kakuta, S; Iwakura, Y; Hosokawa, S; Dohi, T				Oshio, Tomoyuki; Kawashima, Rei; Kawamura, Yuki I.; Hagiwara, Teruki; Mizutani, Noriko; Okada, Toshihiko; Otsubo, Takeshi; Inagaki-Ohara, Kyoko; Matsukawa, Akihiro; Haga, Tatsuya; Kakuta, Shigeru; Iwakura, Yoichiro; Hosokawa, Seijiro; Dohi, Taeko			Chemokine Receptor CCR8 Is Required for Lipopolysaccharide-Triggered Cytokine Production in Mouse Peritoneal Macrophages	PLOS ONE			English	Article							T-CELLS; CUTTING EDGE; RECRUITMENT; ACTIVATION; EXPRESSION; ROLES; IDENTIFICATION; ANTAGONISTS; INHIBITION; EOSINOPHIL	Chemokine (C-C motif) receptor 8 (CCR8), the chemokine receptor for chemokine (C-C motif) ligand 1 (CCL1), is expressed in T-helper type-2 lymphocytes and peritoneal macrophages (PM phi) and is involved in various pathological conditions, including peritoneal adhesions. However, the role of CCR8 in inflammatory responses is not fully elucidated. To investigate the function of CCR8 in macrophages, we compared cytokine secretion from mouse PM phi or bone marrow-derived macrophages (BMM phi) stimulated with various Toll-like receptor (TLR) ligands in CCR8 deficient (CCR8(-/-)) and wild-type (WT) mice. We found that CCR8(-/-) PM phi demonstrated attenuated secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-10 when stimulated with lipopolysaccharide (LPS). In particular, LPS-induced IL-10 production absolutely required CCR8. CCR8-dependent cytokine secretion was characteristic of PM phi but not BMM phi. To further investigate this result, we selected the small molecule compound R243 from a library of compounds with CCR8-antagonistic effects on CCL1-induced Ca2+ flux and CCL1-driven PM phi aggregation. Similar to CCR8(-/-) PM phi, R243 attenuated secretion of TNF-alpha, IL-6, and most strikingly IL-10 from WT PM phi, but not BMM phi. CCR8(-/-)PM phi and R243-treated WT PM phi both showed suppressed c-jun N-terminal kinase activity and nuclear factor-kappa B signaling after LPS treatment when compared with WT PM phi. A c-Jun signaling pathway inhibitor also produced an inhibitory effect on LPS-induced cytokine secretion that was similar to that of CCR8 deficiency or R243 treatment. As seen in CCR8(-/-) mice, administration of R243 attenuated peritoneal adhesions in vivo. R243 also prevented hapten-induced colitis. These results are indicative of cross talk between signaling pathways downstream of CCR8 and TLR-4 that induces cytokine production by PMQ. Through use of CCR8(-/-) mice and the new CCR8 inhibitor, R243, we identified a novel macrophage innate immune response pathway that involves a chemokine receptor.	[Oshio, Tomoyuki; Kawashima, Rei; Kawamura, Yuki I.; Hagiwara, Teruki; Mizutani, Noriko; Okada, Toshihiko; Otsubo, Takeshi; Inagaki-Ohara, Kyoko; Dohi, Taeko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Res Inst, Dept Gastroenterol, Ichikawa, Chiba, Japan; [Oshio, Tomoyuki] Jichi Med Univ, Dept Dermatol, Shimotsuke, Tochigi, Japan; [Kawashima, Rei] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Matsukawa, Akihiro] Okayama Univ, Dept Pathol & Expt Med, Okayama, Okayama, Japan; [Haga, Tatsuya] Gakushuin Univ, Dept Life Sci, Mejiro Ku, Tokyo 171, Japan; [Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Div Expt Anim Immunol, Noda, Chiba 278, Japan; [Hosokawa, Seijiro] Waseda Univ, Fac Adv Sci & Engn, Dept Appl Chem, Shinjuku Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Jichi Medical University; Kitasato University; Okayama University; Gakushuin University; University of Tokyo; Waseda University	Dohi, T (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Res Inst, Dept Gastroenterol, Ichikawa, Chiba, Japan.	dohi@ri.ncgm.go.jp	Iwakura, Yoichiro/E-5457-2011; Kakuta, Shigeru/L-2241-2018; Otsubo, Takeshi/G-6123-2014	Iwakura, Yoichiro/0000-0002-9934-5775; Kakuta, Shigeru/0000-0002-5900-1425; Matsukawa, Akihiro/0000-0002-5081-6089; Hosokawa, Seijiro/0000-0002-8036-532X	Research on Health Sciences focusing on Drug Innovation [KHC2206]; grants for Research on New Drug Development [H21-007]; Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology; National Center for Global Health and Medicine [21-110, 22-205, 25-104]; Ministry of Health, Labor and Welfare	Research on Health Sciences focusing on Drug Innovation; grants for Research on New Drug Development; Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Research on Health Sciences focusing on Drug Innovation (KHC2206) grants and contracts, grants for Research on New Drug Development (H21-007) and Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan, Grants-in-Aid for Scientific Research (B and C) and for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, and by a grant from the National Center for Global Health and Medicine (21-110, 22-205, 25-104), Ministry of Health, Labor and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Cantor J, 2007, J IMMUNOL, V179, P5760, DOI 10.4049/jimmunol.179.9.5760; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240; Debes GF, 2011, NAT IMMUNOL, V12, P111, DOI 10.1038/ni0211-111; DEVI S, 1995, J IMMUNOL, V154, P5376; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Goya I, 1998, J IMMUNOL, V160, P1975; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; JAKWAY JP, 1986, SCIENCE, V234, P743, DOI 10.1126/science.3095921; Jenkins TJ, 2007, J MED CHEM, V50, P566, DOI 10.1021/jm061118e; Karlsson AKC, 2011, BIOCHEM BIOPH RES CO, V407, P764, DOI 10.1016/j.bbrc.2011.03.097; KATAKAMI Y, 1988, IMMUNOLOGY, V64, P719; Kawashima R, 2012, J IMMUNOASS IMMUNOCH, V33, P291, DOI 10.1080/15321819.2011.638409; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Lira SA, 2012, IMMUNOL RES, V54, P111, DOI 10.1007/s12026-012-8313-7; Matsukawa A, 2006, FASEB J, V20, P302, DOI 10.1096/fj.04-1728fje; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Reimer MK, 2011, CLIN VACCINE IMMUNOL, V18, P2050, DOI 10.1128/CVI.05275-11; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Wang L, 2013, THORAX, V68, P506, DOI 10.1136/thoraxjnl-2012-203012; ZHANG XK, 1993, J IMMUNOL, V150, P1011; Zingoni A, 1998, J IMMUNOL, V161, P547	33	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94445	10.1371/journal.pone.0094445	http://dx.doi.org/10.1371/journal.pone.0094445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714157	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900133
J	Pilot, M; Dabrowski, MJ; Hayrapetyan, V; Yavruyan, EG; Kopaliani, N; Tsingarska, E; Bujalska, B; Kaminski, S; Bogdanowicz, W				Pilot, Malgorzata; Dabrowski, Michal J.; Hayrapetyan, Vahram; Yavruyan, Eduard G.; Kopaliani, Natia; Tsingarska, Elena; Bujalska, Barbara; Kaminski, Stanislaw; Bogdanowicz, Wieslaw			Genetic Variability of the Grey Wolf Canis lupus in the Caucasus in Comparison with Europe and the Middle East: Distinct or Intermediary Population?	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOMES; LINKAGE DISEQUILIBRIUM; DOMESTIC DOGS; WOLVES; DNA; HYBRIDIZATION; SIZE; PROGRAM; HISTORY; ORIGIN	Despite continuous historical distribution of the grey wolf (Canis lupus) throughout Eurasia, the species displays considerable morphological differentiation that resulted in delimitation of a number of subspecies. However, these morphological discontinuities are not always consistent with patterns of genetic differentiation. Here we assess genetic distinctiveness of grey wolves from the Caucasus (a region at the border between Europe and West Asia) that have been classified as a distinct subspecies C. l. cubanensis. We analysed their genetic variability based on mtDNA control region, microsatellite loci and genome-wide SNP genotypes (obtained for a subset of the samples), and found similar or higher levels of genetic diversity at all these types of loci as compared with other Eurasian populations. Although we found no evidence for a recent genetic bottleneck, genome-wide linkage disequilibrium patterns suggest a long-term demographic decline in the Caucasian population - a trend consistent with other Eurasian populations. Caucasian wolves share mtDNA haplotypes with both Eastern European and West Asian wolves, suggesting past or ongoing gene flow. Microsatellite data also suggest gene flow between the Caucasus and Eastern Europe. We found evidence for moderate admixture between the Caucasian wolves and domestic dogs, at a level comparable with other Eurasian populations. Taken together, our results show that Caucasian wolves are not genetically isolated from other Eurasian populations, share with them the same demographic trends, and are affected by similar conservation problems.	[Pilot, Malgorzata] Lincoln Univ, Sch Life Sci, Lincoln, England; [Dabrowski, Michal J.; Bujalska, Barbara; Bogdanowicz, Wieslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Hayrapetyan, Vahram] Armenian Natl Agrarian Univ, Stepanakert Branch, Stepanakert, Armenia; [Yavruyan, Eduard G.] Natl Acad Sci Armenia, Sci Ctr Zool & Hydroecol, Yerevan, Armenia; [Kopaliani, Natia] Ilia State Univ, Inst Ecol, Tbilisi, Georgia; [Tsingarska, Elena] BALKANI Wildlife Soc, Sofia, Bulgaria; [Kaminski, Stanislaw] Univ Warmia & Mazury, Dept Anim Genet, Olsztyn, Poland; [Dabrowski, Michal J.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	University of Lincoln; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Academy of Sciences of Armenia; Ilia State University; University of Warmia & Mazury; Uppsala University	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland.	wieslawb@miiz.waw.pl	Dabrowski, Michal J./AAV-1219-2020; Kaminski, Stanislaw/AAB-5726-2022; Dabrowski, Michal/D-4369-2014	Dabrowski, Michal J./0000-0003-1269-6722; Pilot, Malgorzata/0000-0002-6057-5768; KAMINSKI, STANISLAW/0000-0003-3909-4959; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Science and Higher Education [N N303 566339]; National Science Centre (Poland) [2011/01/B/NZ8/02978]; Foundation for Polish Science	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre (Poland)(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This study was funded by the grant no. N N303 566339 from the Ministry of Science and Higher Education and the grant no. 2011/01/B/NZ8/02978 from the National Science Centre (Poland) to W. Bogdanowicz. M. Pilot was supported by the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Aggarwal RK, 2003, GENOME BIOL, V4, pP6; Altobello G, 1921, FAUNA ABRUZZO MOLISE, P38; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; Bakeev Yu.N., 1978, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V83, P45; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Cabrera A, 1907, B REAL SOC ESPANOLA, V7; Cornuet JM, 1996, GENETICS, V144, P2001; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; Dabrowski MJ, 2014, MOL ECOL RESOUR, V14, P361, DOI 10.1111/1755-0998.12177; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Fabbri E, 2014, CONSERV GENET, V15, P187, DOI 10.1007/s10592-013-0530-7; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Gurielidze Z, 2004, P I ZOOLOGY GEORGIAN, V22, P100; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; HOLMES NG, 1995, ANIM GENET, V26, P132, DOI 10.1111/j.1365-2052.1995.tb02659.x; Iacolina L, 2010, MAMM BIOL, V75, P341, DOI 10.1016/j.mambio.2010.02.004; Ishiguro N, 2009, ZOOL SCI, V26, P765, DOI 10.2108/zsj.26.765; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Khosravi R, 2013, ZOOL SCI, V30, P27, DOI 10.2108/zsj.30.27; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kopaliani N, 2014, J HEREDITY IN PRESS; KurtUn B., 1968, PLEISTOCENE MAMMALS; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; Mech L. David, 2003, P1; MECH LD, 1987, J MAMMAL, V68, P871, DOI 10.2307/1381570; Mech LD, 2010, IUCN 2012 IUCN RED L; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Moura AE, 2014, CONSERV GENET, V15, P405, DOI 10.1007/s10592-013-0547-y; Musiani M., 2010, WORLD WOLVES NEW PER; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nowak Ronald M., 2003, P239; Ognev S. I., 1923, Biol Mitteil Timiriazeff Inst Moscow Zool Lief, V1, P102; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pilot M, 2014, HEREDITY, V112, P428, DOI 10.1038/hdy.2013.122; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039341; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086409; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Sastre N, 2011, CONSERV GENET, V12, P701, DOI 10.1007/s10592-010-0177-6; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; SHIBUYA H, 1994, ANIM GENET, V25, P122, DOI 10.1111/j.1365-2052.1994.tb00094.x; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Sommer R, 2005, MAMM BIOL, V70, P227, DOI 10.1016/j.mambio.2004.12.001; Stronen AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076454; Sykes W.H., 1831, P ZOOL SOC LOND, V1830-1831, P99; Tarkhnishvili D, 2012, BIOL J LINN SOC, V105, P231, DOI 10.1111/j.1095-8312.2011.01788.x; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Verardi A, 2006, MOL ECOL, V15, P2845, DOI 10.1111/j.1365-294X.2006.02995.x; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 2003, HEREDITY, V90, P17, DOI 10.1038/sj.hdy.6800175; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Weiss S, 2007, PHYLOGEOGRAPHY SO EU	77	25	25	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93828	10.1371/journal.pone.0093828	http://dx.doi.org/10.1371/journal.pone.0093828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714198	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000334160900054
J	Sandroff, BM; Motl, RW; Pilutti, LA; Learmonth, YC; Ensari, I; Dlugonski, D; Klaren, RE; Balantrapu, S; Riskin, BJ				Sandroff, Brian M.; Motl, Robert W.; Pilutti, Lara A.; Learmonth, Yvonne C.; Ensari, Ipek; Dlugonski, Deirdre; Klaren, Rachel E.; Balantrapu, Swathi; Riskin, Barry J.			Accuracy of StepWatch (TM) and ActiGraph Accelerometers for Measuring Steps Taken among Persons with Multiple Sclerosis	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; NEUROLOGIC IMPAIRMENT; WALKING; AMBULATION; ADULTS; MS	Introduction: There has been increased interest in the objective monitoring of free-living walking behavior using accelerometers in clinical research involving persons with multiple sclerosis (MS). The current investigation examined and compared the accuracy of the StepWatch activity monitor and ActiGraph model GT3X+ accelerometer for capturing steps taken during various speeds of prolonged, over-ground ambulation in persons with MS who had mild, moderate, and severe disability. Methods: Sixty-three persons with MS underwent a neurological examination for generation of an EDSS score and undertook two trials of walking on the GAITRite electronic walkway. Participants were fitted with accelerometers, and undertook three modified six-minute walk (6MW) tests that were interspersed with 10-15 minutes of rest. The first 6MW was undertaken at a comfortable walking speed (CWS), and the two remaining 6MW tests were undertaken above (faster walking speed; FWS) or below (slower walking speed; SWS) the participant's CWS. The actual number of steps taken was counted through direct observation using hand-tally counters. Results: The StepWatch activity monitor (99.8%-99.9%) and ActiGraph model GT3X+ accelerometer (95.6%-97.4%) both demonstrated highly accurate measurement of steps taken under CWS and FWS conditions. The StepWatch had better accuracy (99.0%) than the ActiGraph (95.5%) in the overall sample under the SWS condition, and this was particularly apparent in those with severe disability (StepWatch: 95.7%; ActiGraph: 87.3%). The inaccuracy in measurement for the ActiGraph was associated with alterations of gait (e.g., slower gait velocity, shorter step length, wider base of support). Conclusions: This research will help inform the choice of accelerometer to be adopted in clinical trials of MS wherein the monitoring of free-living walking behavior is of particular value.	[Sandroff, Brian M.; Motl, Robert W.; Pilutti, Lara A.; Learmonth, Yvonne C.; Ensari, Ipek; Dlugonski, Deirdre; Klaren, Rachel E.; Balantrapu, Swathi; Riskin, Barry J.] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Motl, RW (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL 61820 USA.	robmotl@illinois.edu	Ensari, Ipek/I-8930-2019	Ensari, Ipek/0000-0001-7745-8501; Sandroff, Brian/0000-0002-2013-7632; Learmonth, Yvonne/0000-0002-4857-8480	Acorda Therapeutics	Acorda Therapeutics	This research was supported by an investigator initiated grant from Acorda Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daumer M, 2007, BIOMED TECH, V52, P149, DOI 10.1515/BMT.2007.028; Dlugonski D, 2013, ARCH PHYS M IN PRESS; Feys P, 2013, MULT SCLER RELAT DIS, V2, P238, DOI 10.1016/j.msard.2013.01.004; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Learmonth YC, 2013, MULT SCLER IN PRESS; Lord SE, 2004, ARCH PHYS MED REHAB, V85, P234, DOI 10.1016/j.apmr.2003.05.002; Motl R W, 2008, Minerva Med, V99, P157; Motl RW, 2010, PHYS THER REV, V15, P204, DOI 10.1179/174328810X12814016178953; Motl RW, 2012, EXPERT REV NEUROTHER, V12, P1079, DOI [10.1586/ern.12.74, 10.1586/ERN.12.74]; Motl RW, 2011, J SPORT EXERCISE PSY, V33, P734, DOI 10.1123/jsep.33.5.734; Motl RW, 2011, NEUROL SCI, V32, P255, DOI 10.1007/s10072-010-0396-0; Motl RW, 2011, DISABIL HEALTH J, V4, P52, DOI 10.1016/j.dhjo.2010.02.003; Motl RW, 2010, ARCH PHYS MED REHAB, V91, P1942, DOI 10.1016/j.apmr.2010.08.011; Motl RW, 2010, GAIT POSTURE, V31, P506, DOI 10.1016/j.gaitpost.2010.02.011; Pearson OR, 2004, QJM-INT J MED, V97, P463, DOI 10.1093/qjmed/hch084; Pilutti LA, 2013, ARCH PHYS MED REHAB, V94, P575, DOI 10.1016/j.apmr.2012.08.214; Ratzker PK, 1997, J NEUROL REHABIL, V11, P207; Schmidt AL, 2011, J GERIATR PHYS THER, V34, P41, DOI 10.1519/JPT.0b013e31820aa921; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001	23	71	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93511	10.1371/journal.pone.0093511	http://dx.doi.org/10.1371/journal.pone.0093511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714028	gold, Green Published			2022-12-27	WOS:000334160900030
J	You, XD; Huang, PT; Zhang, C; Wang, MH; Zhang, Y; Hong, YR; Wei, SM; Liu, CM; Pu, ZX; Zhang, JM; Chen, SY				You, Xiangdong; Huang, Pintong; Zhang, Chao; Wang, Minghui; Zhang, Ying; Hong, Yurong; Wei, Shumei; Liu, Chunmei; Pu, Zhaoxia; Zhang, Jianmin; Chen, Shuyuan			Relationship between Enhanced Intensity of Contrast Enhanced Ultrasound and Microvessel Density of Aortic Atherosclerostic Plaque in Rabbit Model	PLOS ONE			English	Article							CAROTID PLAQUE; VASA VASORUM; INTRAPLAQUE NEOVASCULARIZATION; ANGIOGENESIS; SYMPTOMATOLOGY; QUANTIFICATION; ASSOCIATION	The aim of this study was to evaluate the relationship between enhanced intensity of contrast enhanced ultrasound and microvessel density of aortic atherosclerotic plaque in rabbit model. The abdominal aortas of thirty-six male New Zealand rabbits were damaged by balloon expansion and the animals were then fed a high fat diet for 12 weeks. Twenty-seven plaques on the near aortic wall were detected using conventional ultrasound examination. The maximum thickness of each plaque was recorded. CEUS was performed on these 27 plaques and the time-intensity curves (TICs) were analyzed offline. Using the quantitative ACQ software, features such as the arrival time (AT), time to peak (TTP), baseline intensity (BI), peak intensity (PI) and enhanced intensity (EI) (EI = PI-BI) were assessed. Inter-and intra-observer agreement of EI were assessed using the Bland-Altman test. After CEUS examination, the rabbits were sacrificed for pathological examination and CD34 monoclonal antibody immunohistochemical detection. Microvessel density (MVD) was counted under the microscope. The relationship between indexes of CEUS and the level of MVD was analyzed. There was a good positive linear correlation between EI and MVD (gamma = 0. 854, P < 0. 001), the intraclass correlations for inter-and intra-observer agreement for EI were 0.73 and 0.82 respectively, suggesting that EI may be act as a useful index for plaque risk stratification in animal models.	[You, Xiangdong; Huang, Pintong; Zhang, Chao; Wang, Minghui; Zhang, Ying; Hong, Yurong; Liu, Chunmei; Pu, Zhaoxia] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Ultrasonog, Hangzhou, Zhejiang, Peoples R China; [Wei, Shumei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol Surg, Hangzhou, Zhejiang, Peoples R China; [Chen, Shuyuan] Baylor Univ, Med Ctr Dallas, Baylor Res Inst, Dallas, TX USA	Zhejiang University; Zhejiang University; Zhejiang University; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Huang, PT (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Ultrasonog, Hangzhou, Zhejiang, Peoples R China.	huangpintong@126.com			National Natural Science Funds of China [81071164, 81271584]; Science and Technology Department of Zhejiang Province [2008C33012]; Zhejiang Nature Science Foundation [Y2080718]; Main International Project of Zhejiang Province of China [2009C14017]; Major Science and Technology Project in Medical and Health of Zhejiang Province [wkj2011-2-007]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province; Zhejiang Nature Science Foundation; Main International Project of Zhejiang Province of China; Major Science and Technology Project in Medical and Health of Zhejiang Province	This study was supported by grants from the National Natural Science Funds (Grant No. 81071164, 81271584) of China, Science and Technology Department of Zhejiang Province (2008C33012), Zhejiang Nature Science Foundation (Y2080718), the Main International Project of Zhejiang Province of China (No. 2009C14017), and Major Science and Technology Project in Medical and Health of Zhejiang Province (co-constructed Project by the Province and the Ministry) (wkj2011-2-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus Z, 2014, ULTRASOUND MED BIOL, V40, P25, DOI 10.1016/j.ultrasmedbio.2013.09.010; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Coli S, 2008, J AM COLL CARDIOL, V52, P223, DOI 10.1016/j.jacc.2008.02.082; Dunmore BJ, 2007, J VASC SURG, V45, P155, DOI 10.1016/j.jvs.2006.08.072; Giannarelli C, 2010, JACC-CARDIOVASC IMAG, V3, P1256, DOI 10.1016/j.jcmg.2010.09.017; Giannoni MF, 2009, EUR J VASC ENDOVASC, V37, P722, DOI 10.1016/j.ejvs.2008.12.028; Hiyama T, 2010, NEUROL MED-CHIR, V50, P1056, DOI 10.2176/nmc.50.1056; Ho-Tin-Noe B, 2011, TRENDS CARDIOVAS MED, V21, P183, DOI 10.1016/j.tcm.2012.05.007; Huang PT, 2008, J CLIN ULTRASOUND, V36, P346, DOI 10.1002/jcu.20448; Huang PT, 2010, WORLD J CARDIOL, V2, P89, DOI 10.4330/wjc.v2.i4.89; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Lee SC, 2010, JACC-CARDIOVASC IMAG, V3, P1265, DOI 10.1016/j.jcmg.2010.08.017; McCarthy MJ, 1999, J VASC SURG, V30, P261, DOI 10.1016/S0741-5214(99)70136-9; Moguillansky D, 2011, EUR HEART J, V32, P646, DOI 10.1093/eurheartj/ehq197; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Pelisek J, 2012, CIRC J, V76, P1274, DOI 10.1253/circj.CJ-11-0768; Phillips P, 2004, EUR RADIOL, V14, pP4, DOI 10.1007/s10406-004-0075-4; Shah F, 2007, VASC MED, V12, P291, DOI 10.1177/1358863X07083363; Staub D, 2010, STROKE, V41, P41, DOI 10.1161/STROKEAHA.109.560342; Vavuranakis M, 2013, VASA, V42, P184, DOI 10.1024/0301-1526/a000267; Vicenzini E, 2007, STROKE, V38, P2841, DOI 10.1161/STROKEAHA.107.487918; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xiong L, 2009, RADIOLOGY, V251, P583, DOI 10.1148/radiol.2512081829	24	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92445	10.1371/journal.pone.0092445	http://dx.doi.org/10.1371/journal.pone.0092445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713618	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900007
J	Zhu, F; Wang, WG; Hou, YY; Shi, JD; Liu, ZL; He, DM; Bai, CX; Li, SQ; Jiang, LY				Zhu, Fen; Wang, Weige; Hou, Yingyong; Shi, Jindong; Liu, Zilong; He, Deming; Bai, Chunxue; Li, Shanqun; Jiang, Liyan			MAML2 Rearrangement in Primary Pulmonary Mucoepidermoid Carcinoma and the Correlation with FLT1 Expression	PLOS ONE			English	Article							FUSION ONCOGENE; MECT1-MAML2; TRANSLOCATION; LUNG	Introduction: Primary pulmonary mucoepidermoid carcinoma (PMEC) is an uncommon neoplasm with remarkable resemblance to mucoepidermoid carcinoma of the salivary glands. The latter has been shown to harbor t(11,19) resulting in MECT1-MAML2 fusion, which may be of diagnostic and prognostic values. However, the importance of such feature in PMEC has not been well studied. Methods: We detected MAML2 rearrangement using fluorescence in situ hybridization (FISH) in tissue samples from 42 cases of PMEC and 40 of adenosquamous carcinoma (ASC), and the expression of potential downstream targets of MECT1-MAML2, including HES1, FLT1 and NR4A2 with immunohistochemistry (IHC). The findings were then examined regarding the clinicopathological parameters and patient outcomes. Results: FISH analysis revealed MAML2 rearrangement in 50% of the PMEC cases, and such property was prominent in considerable younger patients (33 versus 60 years; p = 0.001) and restricted to cases of low and intermediate grades. IHC analysis showed that FLT1 and HES1 were expressed at lower level in MAML2 rearranged group than MAML2 non-rearranged group (p, 0.001 and p = 0.023, respectively). Survival analysis showed significant correlation between MAML2 rearrangement and overall survival (p = 0.023) or disease-free survival (p = 0.027) as well as correlation between FLT1 and overall survival (p = 0.009). Conclusions: MAML2 rearrangement appears frequent in PMEC and specific with this tumor. Both the presence of MAML2 rearrangement and absence of FLT1 tend to confer a favorable clinical outcome. These findings suggest that molecular detection of MAML2 rearrangement combined with FLT1 may be of important clinical value for PMEC.	[Zhu, Fen; Liu, Zilong; Bai, Chunxue; Li, Shanqun] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Wang, Weige] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Hou, Yingyong; He, Deming] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Jiang, Liyan] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China; [Wang, Weige] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shi, Jindong] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Li, SQ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China.	li.shanqun@zs-hospital.sh.cn; jiang_liyan2000@126.com.cn	Li, Shanqun/AAI-7205-2020	shanqun, li/0000-0002-8096-9780; Bai, Chunxue/0000-0001-5798-3130	Shanghai Committee of Science and Technology [13430720500]; Shanghai Leading Academic Discipline Project [B115]; National Natural Science Foundation of China [81372524]; Shanghai Committee of Health and Family Planning [20134007]	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Health and Family Planning	Support was provided by Shanghai Committee of Science and Technology (NO. 13430720500) and Shanghai Leading Academic Discipline Project (NO. B115). National Natural Science Foundation of China (No. 81372524), Shanghai Committee of Health and Family Planning (No. 20134007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; AUCLAIR PL, 1992, CANCER, V69, P2021, DOI 10.1002/1097-0142(19920415)69:8<2021::AID-CNCR2820690803>3.0.CO;2-7; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Chin CH, 2008, RESPIROLOGY, V13, P275, DOI 10.1111/j.1440-1843.2007.01207.x; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Enlund F, 2004, EXP CELL RES, V292, P21, DOI 10.1016/j.yexcr.2003.09.007; Garcia JJ, 2011, HUM PATHOL, V42, P2001, DOI 10.1016/j.humpath.2011.02.028; Han SW, 2008, LUNG CANCER, V61, P30, DOI 10.1016/j.lungcan.2007.11.014; Martins C, 2004, J MOL DIAGN, V6, P205, DOI 10.1016/S1525-1578(10)60511-9; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; O'Neill ID, 2009, ORAL ONCOL, V45, P2, DOI 10.1016/j.oraloncology.2008.03.012; Okabe M, 2006, CLIN CANCER RES, V12, P3902, DOI 10.1158/1078-0432.CCR-05-2376; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Rossi G, 2009, LUNG CANCER, V63, P159, DOI 10.1016/j.lungcan.2008.09.007; Seethala RR, 2009, HEAD NECK PATHOL, V3, P69, DOI 10.1007/s12105-009-0102-9; Seethala RR, 2010, AM J SURG PATHOL, V34, P1106, DOI 10.1097/PAS.0b013e3181de3021; Seethala RR., 2008, MODERN PATHOL, V21, p241A; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Travis WD., 2004, TRAVIS WB WHO CLASSI; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Xi JJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-232; Zhu F, 2013, J THORAC ONCOL, V8, P1578, DOI 10.1097/JTO.0b013e3182a7d272	22	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94399	10.1371/journal.pone.0094399	http://dx.doi.org/10.1371/journal.pone.0094399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714697	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900126
J	Li, WJ; Liu, J; Jackson, K; Shi, RH; Zhao, YF				Li, Wenjuan; Liu, Joan; Jackson, Kasey; Shi, Runhua; Zhao, Yunfeng			Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PYRUVATE-KINASE; IN-VITRO; INHIBITION; PHOSPHORYLATION; AP-1; TRANSFORMATION; TRANSCRIPTION; PACLITAXEL; INDUCTION	Shikonin, a small-molecule natural product which inhibits the activity of pyruvate kinase M2 (PKM2), has been studied as an anti-cancer drug candidate in human cancer models. Here, our results demonstrate that shikonin is able to sensitize human breast cancer cells to chemotherapy by paclitaxel (taxol). Human breast adenocarcinoma MBA-MD-231 cells, which have higher levels of PKM2 expression and activity compared with MCF-7 cells, were selected to study further. The concentrations of shikonin and taxol were first selected at which they did not significantly induce cytotoxicity when treated alone, whereas the combination induced apoptosis. Surprisingly, PKM2 activity was decreased by shikonin, but not by the combination treatment. To identify the potential targets of this combination, human phospho-kinase antibody array analysis was performed and results indicated that the combination treatment inhibited the activation of ERK, Akt, and p70S6 kinases, which are known to contribute to breast cancer progression. Finally, how the combination affects breast cancer cell growth in vivo was tested using a xenograft tumor model. The results indicated that shikonin plus taxol prolonged animal survival and reduced tumor size than the vehicle treatment group. In summary, our results suggest that shikonin has a potential as an adjuvant for breast cancer therapy.	[Li, Wenjuan; Liu, Joan; Jackson, Kasey; Zhao, Yunfeng] LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71103 USA; [Shi, Runhua] LSU Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA USA; [Li, Wenjuan] Hebei Univ, Sch Basic Med, Baoding, Hebei, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Hebei University	Zhao, YF (corresponding author), LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71103 USA.	yzhao1@lsuhsc.edu			NIH [1R03CA167689]; NATIONAL CANCER INSTITUTE [R03CA167689] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NIH Grant Number 1R03CA167689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fahy BN, 2004, J AM COLL SURGEONS, V198, P591, DOI 10.1016/j.jamcollsurg.2003.12.005; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hou Y, 2006, YAKUGAKU ZASSHI, V126, P1383, DOI 10.1248/yakushi.126.1383; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Liu GM, 2001, CANCER RES, V61, P5749; Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200; Moody TW, 2001, BREAST CANCER RES TR, V68, P55, DOI 10.1023/A:1017994722130; Nguyen DM, 2004, J THORAC CARDIOV SUR, V127, P365, DOI 10.1016/j.jtcvs.2003.09.033; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu Z, 2004, J PHARMACOL SCI, V94, P166, DOI 10.1254/jphs.94.166; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195	22	52	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94079	10.1371/journal.pone.0094079	http://dx.doi.org/10.1371/journal.pone.0094079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710512	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800096
J	Brazaitis, M; Eimantas, N; Daniuseviciute, L; Baranauskiene, N; Skrodeniene, E; Skurvydas, A				Brazaitis, Marius; Eimantas, Nerijus; Daniuseviciute, Laura; Baranauskiene, Neringa; Skrodeniene, Erika; Skurvydas, Albertas			Time Course of Physiological and Psychological Responses in Humans during a 20-Day Severe-Cold-Acclimation Programme	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; THERMOREGULATORY RESPONSES; SKELETAL-MUSCLE; TEMPERATURE; ADAPTATION; STRESS; IMMERSION; THERMOGENESIS; PREDICTION; EPHEDRINE	The time course of physiological and psychological markers during cold acclimation (CA) was explored. The experiment included 17 controlled (i.e., until the rectal temperature reached 35.5 degrees C or 170 min had elapsed; for the CA-17 session, the subjects (n = 14) were immersed in water for the same amount of time as that used in the CA-1 session) head-out water immersions at a temperature of 14 degrees C over 20 days. The data obtained in this study suggest that the subjects exhibited a thermoregulatory shift from peripheral-to-central to solely central input thermoregulation, as well as from shivering to non-shivering thermogenesis throughout the CA. In the first six CA sessions, a hypothermic type of acclimation was found; further CA (CA-7 to CA-16) led to a transitional shift to a hypothermic-insulative type of acclimation. Interestingly, when the subjects were immersed in water for the same time as that used in the CA-1 session (CA-17), the CA led to a hypothermic type of acclimation. The presence of a metabolic type of thermogenesis was evident only under thermoneutral conditions. Cold-water immersion decreased the concentration of cold-stress markers, reduced the activity of the innate immune system, suppressed specific immunity to a lesser degree and yielded less discomfort and cold sensation. We found a negative correlation between body mass index and D metabolic heat production before and after CA.	[Brazaitis, Marius; Eimantas, Nerijus; Baranauskiene, Neringa; Skurvydas, Albertas] Lithuanian Sports Univ, Sports Sci & Innovat Inst, Kaunas, Lithuania; [Daniuseviciute, Laura] Kaunas Univ Technol, Dept Educ Studies, Kaunas, Lithuania; [Skrodeniene, Erika] Lithuanian Univ Hlth Sci, Med Acad, Dept Lab Med, Kaunas, Lithuania	Lithuanian Sports University; Kaunas University of Technology; Lithuanian University of Health Sciences	Brazaitis, M (corresponding author), Lithuanian Sports Univ, Sports Sci & Innovat Inst, Kaunas, Lithuania.	marius_brazaitis@yahoo.com						ALLEN TH, 1956, METABOLISM, V5, P346; ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; ASTRUP A, 1985, AM J CLIN NUTR, V42, P83, DOI 10.1093/ajcn/42.1.83; BITTEL J, 1992, INT J SPORTS MED, V13, pS172, DOI 10.1055/s-2007-1024630; BITTEL JHM, 1987, J APPL PHYSIOL, V62, P1627, DOI 10.1152/jappl.1987.62.4.1627; Brazaitis M, 2012, MUSCLE NERVE, V46, P799, DOI 10.1002/mus.23397; Brazaitis M, 2010, J THERM BIOL, V35, P386, DOI 10.1016/j.jtherbio.2010.08.002; Brazaitis M, 2010, APPL ERGON, V42, P46, DOI 10.1016/j.apergo.2010.04.001; Burton AC, 1935, J NUTR, V9, P261, DOI 10.1093/jn/9.3.261; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Castellani JW, 1998, J APPL PHYSIOL, V85, P204, DOI 10.1152/jappl.1998.85.1.204; Drinkwater Eric, 2008, V53, P74, DOI 10.1159/000151551; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; GALBO H, 1979, ACTA PHYSIOL SCAND, V105, P326, DOI 10.1111/j.1748-1716.1979.tb06348.x; Golden FS, 1997, BRIT J ANAESTH, V79, P214, DOI 10.1093/bja/79.2.214; GOLDEN FSC, 1988, J PHYSIOL-LONDON, V396, P349, DOI 10.1113/jphysiol.1988.sp016965; Ha Minja, 1996, Applied Human Science, V15, P33, DOI 10.2114/jpa.15.33; HAMMEL H. T., 1963, FED PROC, V22, P846; Hoehn K., 2010, HUMAN ANATOMY PHYSL; HONG SK, 1973, FED PROC, V32, P1614; Jansky L, 1996, PFLUG ARCH EUR J PHY, V432, P368, DOI 10.1007/s004240050146; Lagerspetz KYH, 2006, J THERM BIOL, V31, P332, DOI 10.1016/j.jtherbio.2006.01.003; Launay JC, 2009, IND HEALTH, V47, P221, DOI 10.2486/indhealth.47.221; LEBLANC J, 1979, J APPL PHYSIOL, V47, P1207, DOI 10.1152/jappl.1979.47.6.1207; Leon Lisa R, 2010, Front Biosci (Schol Ed), V2, P916; Lesna I, 1999, J THERM BIOL, V24, P63, DOI 10.1016/S0306-4565(98)00041-2; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lieberman HR, 2009, AVIAT SPACE ENVIR MD, V80, P629, DOI 10.3357/ASEM.2431.2009; Makinen Tiina Maria, 2010, Front Biosci (Schol Ed), V2, P1047; Mantoni T, 2008, AVIAT SPACE ENVIR MD, V79, P765, DOI 10.3357/ASEM.2216.2008; MCARDLE WD, 1984, J APPL PHYSIOL, V56, P1572, DOI 10.1152/jappl.1984.56.6.1572; Moran DS, 1999, J APPL PHYSIOL, V86, P895, DOI 10.1152/jappl.1999.86.3.895; Nater UM, 2013, CURR OPIN PSYCHIATR, V26, P440, DOI 10.1097/YCO.0b013e328363b4ed; O'Brien C, 2000, J APPL PHYSIOL, V89, P242, DOI 10.1152/jappl.2000.89.1.242; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; PALACIOS R, 1982, SCAND J IMMUNOL, V15, P25, DOI 10.1111/j.1365-3083.1982.tb00618.x; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; RADOMSKI MW, 1982, J APPL PHYSIOL, V53, P610, DOI 10.1152/jappl.1982.53.3.610; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; SCHOLANDER PF, 1958, J APPL PHYSIOL, V12, P1; SIMONSEN L, 1993, INT J OBESITY, V17, pS47; SIMONSEN L, 1992, AM J PHYSIOL, V263, pE850, DOI 10.1152/ajpendo.1992.263.5.E850; SKRESLET S, 1968, J APPL PHYSIOL, V24, P177, DOI 10.1152/jappl.1968.24.2.177; Stephens M, 2011, CLIN ENDOCRINOL, V74, P661, DOI 10.1111/j.1365-2265.2011.04018.x; Stocks Jodie M., 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P263, DOI 10.2114/jpa.20.263; Taylor NAS, 2006, J THERM BIOL, V31, P90, DOI 10.1016/j.jtherbio.2005.11.007; Tikuisis P, 2000, J APPL PHYSIOL, V89, P1403, DOI 10.1152/jappl.2000.89.4.1403; Tikuisis P, 2001, EUR J APPL PHYSIOL, V85, P264, DOI 10.1007/s004210100484; TIPTON MJ, 1989, CLIN SCI, V77, P581, DOI 10.1042/cs0770581; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vybiral S, 2000, EXP PHYSIOL, V85, P321, DOI 10.1111/j.1469-445X.2000.01909.x; Wang QD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021006, 10.1371/journal.pone.0028114]; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; YOUNG AJ, 1986, J APPL PHYSIOL, V60, P1542, DOI 10.1152/jappl.1986.60.5.1542	56	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94698	10.1371/journal.pone.0094698	http://dx.doi.org/10.1371/journal.pone.0094698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722189	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100123
J	Huet, T; Miannay, FA; Patton, JR; Thore, S				Huet, Tiphaine; Miannay, Francois-Alexandre; Patton, Jeffrey R.; Thore, Stephane			Steroid Receptor RNA Activator (SRA) Modification by the Human Pseudouridine Synthase 1 (hPus1p): RNA Binding, Activity, and Atomic Model	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; TRUD REVEALS; RECOGNITION; COMPLEX; DOMAIN; PUS1P; YEAST; SITE; PROTEINS	The most abundant of the modified nucleosides, and once considered as the "fifth'' nucleotide in RNA, is pseudouridine, which results from the action of pseudouridine synthases. Recently, the mammalian pseudouridine synthase 1 (hPus1p) has been reported to modulate class I and class II nuclear receptor responses through its ability to modify the Steroid receptor RNA Activator (SRA). These findings highlight a new level of regulation in nuclear receptor (NR)-mediated transcriptional responses. We have characterised the RNA association and activity of the human Pus1p enzyme with its unusual SRA substrate. We validate that the minimal RNA fragment within SRA, named H7, is necessary for both the association and modification by hPus1p. Furthermore, we have determined the crystal structure of the catalytic domain of hPus1p at 2.0 angstrom resolution, alone and in a complex with several molecules present during crystallisation. This model shows an extended C-terminal helix specifically found in the eukaryotic protein, which may prevent the enzyme from forming a homodimer, both in the crystal lattice and in solution. Our biochemical and structural data help to understand the hPus1p active site architecture, and detail its particular requirements with regard to one of its nuclear substrates, the non-coding RNA SRA.	[Huet, Tiphaine; Thore, Stephane] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Miannay, Francois-Alexandre] Univ Geneva, Dept Phys Chem, Geneva, Switzerland; [Patton, Jeffrey R.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA	University of Geneva; University of Geneva; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Thore, S (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.	stephane.thore@unige.ch	Thore, stéphane/M-7759-2014; Thore, Stephane/AAW-6482-2020	Thore, stéphane/0000-0001-7058-3887; Thore, Stephane/0000-0001-7058-3887	Swiss National Science Foundation [31003A_140924, 31003A_124909]; Ligue Genevoise contre le Cancer [1011]; foundation E. Boninchi; foundation E L. Schmidheiny; Swiss National Science Foundation R'equip grant [316030-128787]; University of Geneva; University of South Carolina, School of Medicine; South Carolina INBRE; Worldwide Cancer Research [14-0346] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ligue Genevoise contre le Cancer; foundation E. Boninchi; foundation E L. Schmidheiny; Swiss National Science Foundation R'equip grant(Swiss National Science Foundation (SNSF)); University of Geneva; University of South Carolina, School of Medicine; South Carolina INBRE; Worldwide Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the Swiss National Science Foundation (No31003A_140924 and 31003A_124909 to S. T.), and the Ligue Genevoise contre le Cancer (No1011 to S. T.). This study would not have been possible without the establishment of the Biostructural platform that was possible due to the generous support of the foundation E. Boninchi, the foundation E & L. Schmidheiny, the Swiss National Science Foundation R'equip grant (No316030-128787) and the University of Geneva. The work was possible thanks to a Research Development Fund grant from the University of South Carolina, School of Medicine (to J.R.P.) and a grant from South Carolina INBRE (to J.R.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alian A, 2009, J MOL BIOL, V388, P785, DOI 10.1016/j.jmb.2009.03.029; Arluison V, 1999, BIOCHIMIE, V81, P751, DOI 10.1016/S0300-9084(99)80133-3; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Behm-Ansmant I, 2006, RNA, V12, P1583, DOI 10.1261/rna.100806; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Chen JG, 1999, RNA, V5, P409, DOI 10.1017/S1355838299981591; CORTESE R, 1974, J BIOL CHEM, V249, P1103; Czudnochowski N, 2013, J MOL BIOL, V425, P3875, DOI 10.1016/j.jmb.2013.05.014; Dong Xuesong, 2006, RNA Biol, V3, P115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2004, FEBS LETT, V565, P59, DOI 10.1016/j.febslet.2004.03.085; Foster PG, 2000, NAT STRUCT BIOL, V7, P23; Ghosh SK, 2012, BIOCHEMISTRY-US, V51, P8163, DOI 10.1021/bi300602r; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Hoang C, 2004, RNA, V10, P1026, DOI 10.1261/rna.7240504; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Massenet S, 1999, MOL CELL BIOL, V19, P2142; McCleverty CJ, 2007, J MOL BIOL, V373, P1243, DOI 10.1016/j.jmb.2007.08.053; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizutani K, 2004, BIOCHEMISTRY-US, V43, P4454, DOI 10.1021/bi036079c; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Pan H, 2007, J MOL BIOL, V367, P1459, DOI 10.1016/j.jmb.2007.01.084; PATTON JR, 1991, MOL CELL BIOL, V11, P5998, DOI 10.1128/MCB.11.12.5998; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Ramamurthy V, 1999, J BIOL CHEM, V274, P22225, DOI 10.1074/jbc.274.32.22225; SAMUELSSON T, 1990, J BIOL CHEM, V265, P8782; Sibert BS, 2008, RNA, V14, P1895, DOI 10.1261/rna.984508; Sibert BS, 2012, NUCLEIC ACIDS RES, V40, P2107, DOI 10.1093/nar/gkr1017; Simos G, 1996, EMBO J, V15, P2270, DOI 10.1002/j.1460-2075.1996.tb00580.x; Sivaraman J, 2002, NAT STRUCT BIOL, V9, P353, DOI 10.1038/nsb788; Sunita S, 2006, J MOL BIOL, V359, P998, DOI 10.1016/j.jmb.2006.04.019; Zhao XS, 2007, MOL ENDOCRINOL, V21, P686, DOI 10.1210/me.2006-0414; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	43	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94610	10.1371/journal.pone.0094610	http://dx.doi.org/10.1371/journal.pone.0094610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722331	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100107
J	Amberbir, A; Medhin, G; Hanlon, C; Britton, J; Davey, G; Venn, A				Amberbir, Alemayehu; Medhin, Girmay; Hanlon, Charlotte; Britton, John; Davey, Gail; Venn, Andrea			Effects of Early Life Paracetamol Use on the Incidence of Allergic Disease and Sensitization: 5 Year Follow-Up of an Ethiopian Birth Cohort	PLOS ONE			English	Article							ACETAMINOPHEN USE; GLUTATHIONE LEVELS; ASTHMA; RISK; CHILDHOOD; CHILDREN; WHEEZE; ECZEMA; RHINOCONJUNCTIVITIS; ASSOCIATION	Introduction: The hypothesis that paracetamol, one of the most widely used medicines, may increase the risk of asthma and allergic disease is of obvious importance but prospective cohort data looking at dose and timing of exposure are lacking. Objective: The aim of the study is to investigate the role of paracetamol use in early life on the prevalence and incidence of wheeze, eczema, rhinitis and allergic sensitization, prospectively over 5 years in an Ethiopian birth cohort. Methods: In 2005/6 a birth cohort of 1006 newborns was established in Butajira, Ethiopia. Questionnaire data on allergic disease symptoms, paracetamol use and numerous potential confounders were collected at ages 1, 3 and 5, and allergen skin sensitivity measured at ages 3 and 5. Multivariate logistic regression was used to determine independent effects of paracetamol exposure on the incidence of each outcome between ages 3 and 5, and prevalence at age 5. Findings: Paracetamol use in the first 3 years of life was reported in 60% of children and was associated with increased incidence of wheeze, eczema, rhinitis and allergic sensitisation between ages 3 and 5 which was statistically significant for wheeze and eczema. High exposure (reported use in the past month at age 1 and 3) was associated with a more than 3-fold increased risk of new onset wheeze (adjusted odds ratio (OR) 3.64; 95% confidence interval, 1.34 to 9.90) compared to never users. Use in the past year at age 3 but not age 1 was associated with ORs at least as large as those for use in first year of life only. Significant positive dose-response effects of early life use were seen in relation to the prevalence of all outcomes at age 5. Conclusions: Use of paracetamol in early life is a strong risk factor for incident allergic disease in childhood.	[Amberbir, Alemayehu] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Amberbir, Alemayehu; Britton, John; Venn, Andrea] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Hanlon, Charlotte] Univ Addis Ababa, Dept Psychiat, Addis Ababa, Ethiopia; [Davey, Gail] Univ Brighton, Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; Addis Ababa University; Addis Ababa University; University of Brighton; University of Sussex	Amberbir, A (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	alemayehu.amberbir@lshtm.ac.uk	Amberbir, Alemayehu/HGC-2647-2022; Hanlon, Charlotte/AAH-7769-2020	Hanlon, Charlotte/0000-0002-7937-3226; Medhin, Girmay/0000-0003-2146-4261	Asthma United Kingdom [07/036]; Medical Research Council [MR/K023195/1B] Funding Source: researchfish; Asthma UK [07/036] Funding Source: researchfish	Asthma United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The study was funded by Asthma United Kingdom project grant (07/036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberbir A, 2011, CLIN EXP ALLERGY, V41, P1422, DOI 10.1111/j.1365-2222.2011.03831.x; Amberbir A, 2011, AM J RESP CRIT CARE, V183, P165, DOI 10.1164/rccm.201006-0989OC; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Beasley RW, 2011, AM J RESP CRIT CARE, V183, P171, DOI 10.1164/rccm.201005-0757OC; Belyhun Y, 2010, CLIN EXP ALLERGY, V40, P619, DOI 10.1111/j.1365-2222.2010.03479.x; Berhane Y., 1999, ETHIOP J HEALTH DEV, V13, P1; Davey G, 2005, J ALLERGY CLIN IMMUN, V116, P863, DOI 10.1016/j.jaci.2005.05.045; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Etminan M, 2009, CHEST, V136, P1316, DOI 10.1378/chest.09-0865; Eyers S, 2011, CLIN EXP ALLERGY, V41, P482, DOI 10.1111/j.1365-2222.2010.03691.x; Farquhar H, 2010, CLIN EXP ALLERGY, V40, P32, DOI 10.1111/j.1365-2222.2009.03378.x; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Lowe AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4616; MICHELI L, 1994, ENVIRON HEALTH PERSP, V102, P63, DOI 10.1289/ehp.94102s963; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nassini R, 2010, FASEB J, V24, P4904, DOI 10.1096/fj.10-162438; Nuttall SL, 2003, J CLIN PHARM THER, V28, P289, DOI 10.1046/j.1365-2710.2003.00493.x; Nuttall SL, 2003, J CLIN PHARM THER, V28, P251, DOI 10.1046/j.1365-2710.2003.00492.x; Perzanowski MS, 2008, J ALLERGY CLIN IMMUN, V121, pS231, DOI 10.1016/j.jaci.2007.12.914; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rebordosa C, 2008, INT J EPIDEMIOL, V37, P583, DOI 10.1093/ije/dyn070; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Yemaneberhan H, 1997, LANCET, V350, P85, DOI 10.1016/S0140-6736(97)01151-3	30	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93869	10.1371/journal.pone.0093869	http://dx.doi.org/10.1371/journal.pone.0093869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718577	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000053
J	Shine, R; Spencer, CL; Keogh, JS				Shine, Richard; Spencer, Carol L.; Keogh, J. Scott			Morphology, Reproduction and Diet in Australian and Papuan Death Adders (Acanthophis, Elapidae)	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; SEASONAL-VARIATION; FORAGING BEHAVIOR; NATURAL-SELECTION; CANE TOADS; SNAKES; ECOLOGY; PREY; ANTARCTICUS; PREDATOR	Death adders (genus Acanthophis) differ from most other elapid snakes, and resemble many viperid snakes, in their thickset morphology and ambush foraging mode. Although these snakes are widely distributed through Australia and Papua New Guinea, their basic biology remains poorly known. We report morphological and ecological data based upon dissection of > 750 museum specimens drawn from most of the range of the genus. Female death adders grow larger than conspecific males, to about the same extent in all taxa (20% in mean adult snout-vent length, = SVL). Most museum specimens were adult rather than juvenile animals, and adult males outnumbered females in all taxa except A. pyrrhus. Females have shorter tails (relative to SVL) than males, and longer narrower heads (relative to head length) in some but not all species. The southern A. antarcticus is wider-bodied (relative to SVL) than the other Australian species. Fecundity of these viviparous snakes was similar among taxa (mean litter sizes 8 to 14). Death adders encompass a broad range of ecological attributes, taking a wide variety of vertebrate prey, mostly lizards (55%), frogs and mammals (each 21%; based on 217 records). Dietary composition differed among species (e. g. frogs were more common in tropical than temperate-zone species), and shifted with snake body size (endotherms were taken by larger snakes) and sex (male death adders took more lizards than did females). Overall, death adders take a broader array of prey types, including active fast-moving taxa such as endotherms and large diurnal skinks, than do most other Australian elapids of similar body sizes. Ambush foraging is the key to capturing such elusive prey.	[Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia; [Spencer, Carol L.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Keogh, J. Scott] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of Sydney; University of California System; University of California Berkeley; Australian National University	Shine, R (corresponding author), Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au	Keogh, Scott/C-8441-2009	Keogh, Scott/0000-0002-1373-6186	Australian Research Council (Shine); Carnegie Museum Collection Study Grant in Herpetology (Spencer); Society for Study of Amphibians and Reptiles Student Travel Award (Spencer)	Australian Research Council (Shine)(Australian Research Council); Carnegie Museum Collection Study Grant in Herpetology (Spencer); Society for Study of Amphibians and Reptiles Student Travel Award (Spencer)	The work was supported financially by the Australian Research Council (Shine), Carnegie Museum Collection Study Grant in Herpetology (Spencer), and the Society for Study of Amphibians and Reptiles Student Travel Award (Spencer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin K. P., 1999, Records of the Western Australian Museum, V19, P277; Arnold Stevan J., 1993, P87; Brown GP, 2004, BEHAV ECOL SOCIOBIOL, V56, P257, DOI 10.1007/s00265-004-0778-5; Brown GP, 2013, BIOL INVASIONS, V15, P1005, DOI 10.1007/s10530-012-0346-2; Brown GP, 2011, ECOLOGY, V92, P422, DOI 10.1890/10-0536.1; BURGER WL, 1950, SCIENCE, V112, P431, DOI 10.1126/science.112.2911.431; CAMILLERI C, 1990, COPEIA, P649, DOI 10.2307/1446430; CHISZAR D, 1990, J HERPETOL, V24, P253, DOI 10.2307/1564391; Christian K, 2007, PHYSIOL BIOCHEM ZOOL, V80, P522, DOI 10.1086/519959; Clark RW, 2012, BIOL LETTERS, V8, P523, DOI 10.1098/rsbl.2011.1217; COOPER SD, 1985, CAN J FISH AQUAT SCI, V42, P1720, DOI 10.1139/f85-216; Downes S, 2001, ECOLOGY, V82, P1293, DOI 10.1890/0012-9658(2001)082[1293:WDTLIA]2.0.CO;2; Downes SJ, 2002, BEHAV ECOL, V13, P551, DOI 10.1093/beheco/13.4.551; DUVALL D, 1985, NATL GEOGR RES, V1, P80; Eskew EA, 2009, J ZOOL, V277, P179, DOI 10.1111/j.1469-7998.2008.00527.x; Farallo VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030316; Fearn Simon, 2001, Herpetofauna (Sydney), V31, P19; Fearn Simon, 1994, Herpetofauna (Sydney), V24, P1; Goiran C, 2013, CORAL REEFS, V32, P527, DOI 10.1007/s00338-012-1008-7; Greene H. W., 1997, SNAKES EVOLUTION MYS; Hagman M, 2008, FUNCT ECOL, V22, P1134, DOI 10.1111/j.1365-2435.2008.01466.x; Hagman M, 2009, P ROY SOC B-BIOL SCI, V276, P2813, DOI 10.1098/rspb.2009.0192; HENDERSON RW, 1987, HERPETOLOGICA, V43, P241; Johnston G, 1996, J ZOOL, V239, P187, DOI 10.1111/j.1469-7998.1996.tb05446.x; Kaiser Hinrich, 2013, Herpetological Review, V44, P8; KING RB, 1989, BIOL J LINN SOC, V38, P133, DOI 10.1111/j.1095-8312.1989.tb01570.x; Natusch DJD, 2014, J HERPETOL, V48, P317, DOI 10.1670/12-207; Nelson XJ, 2010, ANIM BEHAV, V79, P555, DOI 10.1016/j.anbehav.2009.12.011; Phillips BL, 2010, ANIM CONSERV, V13, P53, DOI 10.1111/j.1469-1795.2009.00295.x; Phillips B, 2007, AM NAT, V170, P936, DOI 10.1086/522845; Pianka ER, 2006, LIZARDS; Pintor AFV, 2011, TOXICON, V57, P68, DOI 10.1016/j.toxicon.2010.10.001; Pintor AFV, 2010, TOXICON, V56, P1035, DOI 10.1016/j.toxicon.2010.07.008; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Reinert Howard K., 1993, P201; Reiserer Randall S., 2002, P361; RODDA GH, 1992, HERPETOL J, V2, P110; Sazima J, 1992, BIOL PITVIPERS, P199; Scott ML, 2013, ANIM BEHAV, V85, P1493, DOI 10.1016/j.anbehav.2013.04.003; SHINE R, 1992, EVOLUTION, V46, P828, DOI 10.1111/j.1558-5646.1992.tb02088.x; SHINE R, 1991, FUNCT ECOL, V5, P493, DOI 10.2307/2389631; Shine R, 2000, TRENDS ECOL EVOL, V15, P221, DOI 10.1016/S0169-5347(00)01853-X; Shine R, 1999, P ROY SOC B-BIOL SCI, V266, P2147, DOI 10.1098/rspb.1999.0901; SHINE R, 1982, J HERPETOL, V16, P383, DOI 10.2307/1563568; SHINE R, 1983, COPEIA, P198, DOI 10.2307/1444714; SHINE R, 1982, J HERPETOL, V16, P388, DOI 10.2307/1563569; Shine R, 2001, BIOL J LINN SOC, V74, P121, DOI 10.1006/bijl.2001.0560; Shine R, 1998, OECOLOGIA, V116, P113, DOI 10.1007/s004420050569; SHINE R, 1994, COPEIA, P851; Shine R, 1996, COPEIA, P290; SHINE R, 1980, HERPETOLOGICA, V36, P281; SHINE R, 1994, COPEIA, P326; Shine R., 1991, AUSTR SNAKES NATURAL; Shine Richard, 2007, P173, DOI 10.1017/CBO9780511752438.008; Shine Richard, 2005, P221; Shine R, 2012, ADV STUD BEHAV, V44, P1, DOI 10.1016/B978-0-12-394288-3.00001-0; Shine Richard, 1993, P49; TINKLE DW, 1970, EVOLUTION, V24, P55, DOI 10.1111/j.1558-5646.1970.tb01740.x; Vincent SE, 2005, ANIM BEHAV, V70, P715, DOI 10.1016/j.anbehav.2005.01.002; Vincent SE, 2004, J ZOOL, V264, P53, DOI 10.1017/S0952836904005503; Wall M, 2013, ASIAN HERPETOL RES, V4, P9, DOI 10.3724/SP.J.1245.2013.00009; Wasko DK, 2012, ZOOLOGY, V115, P179, DOI 10.1016/j.zool.2011.10.001; Webb JK, 2004, COPEIA, P357, DOI 10.1643/CH-03-171R1; Webb JK, 2006, EVOLUTION, V60, P115, DOI 10.1554/05-460.1; Webb JK, 2005, AUSTRAL ECOL, V30, P201, DOI 10.1111/j.1442-9993.2005.01437.x; Webb JK, 2002, J HERPETOL, V36, P505; Webb JK, 2002, ECOL RES, V17, P59, DOI 10.1046/j.1440-1703.2002.00463.x; Wilson D, 2007, BIOL BOAS PYTHONS, P141; Wuster W, 2005, MOL PHYLOGENET EVOL, V34, P1, DOI 10.1016/j.ympev.2004.08.018	69	13	14	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94216	10.1371/journal.pone.0094216	http://dx.doi.org/10.1371/journal.pone.0094216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718608	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000092
J	Sieradzka, D; Power, RA; Freeman, D; Cardno, AG; McGuire, P; Plomin, R; Meaburn, EL; Dudbridge, F; Ronald, A				Sieradzka, Dominika; Power, Robert A.; Freeman, Daniel; Cardno, Alastair G.; McGuire, Philip; Plomin, Robert; Meaburn, Emma L.; Dudbridge, Frank; Ronald, Angelica			Are Genetic Risk Factors for Psychosis Also Associated with Dimension-Specific Psychotic Experiences in Adolescence?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR AFFECTIVE-DISORDER; SCHIZOPHRENIA; POPULATION; SCHIZOTYPY; SYMPTOMS; HERITABILITY; METAANALYSIS; GENOTYPE; TRAITS	Psychosis has been hypothesised to be a continuously distributed quantitative phenotype and disorders such as schizophrenia and bipolar disorder represent its extreme manifestations. Evidence suggests that common genetic variants play an important role in liability to both schizophrenia and bipolar disorder. Here we tested the hypothesis that these common variants would also influence psychotic experiences measured dimensionally in adolescents in the general population. Our aim was to test whether schizophrenia and bipolar disorder polygenic risk scores (PRS), as well as specific single nucleotide polymorphisms (SNPs) previously identified as risk variants for schizophrenia, were associated with adolescent dimension-specific psychotic experiences. Self-reported Paranoia, Hallucinations, Cognitive Disorganisation, Grandiosity, Anhedonia, and Parent-rated Negative Symptoms, as measured by the Specific Psychotic Experiences Questionnaire (SPEQ), were assessed in a community sample of 2, 152 16-year-olds. Polygenic risk scores were calculated using estimates of the log of odds ratios from the Psychiatric Genomics Consortium GWAS stage-1 mega-analysis of schizophrenia and bipolar disorder. The polygenic risk analyses yielded no significant associations between schizophrenia and bipolar disorder PRS and the SPEQ measures. The analyses on the 28 individual SNPs previously associated with schizophrenia found that two SNPs in TCF4 returned a significant association with the SPEQ Paranoia dimension, rs17512836 (p-value = 2.57x10(-4)) and rs9960767 (p-value = 6.23x10(-4)). Replication in an independent sample of 16-year-olds (N = 3,427) assessed using the Psychotic-Like Symptoms Questionnaire (PLIKS-Q), a composite measure of multiple positive psychotic experiences, failed to yield significant results. Future research with PRS derived from larger samples, as well as larger adolescent validation samples, would improve the predictive power to test these hypotheses further. The challenges of relating adult clinical diagnostic constructs such as schizophrenia to adolescent psychotic experiences at a genetic level are discussed.	[Sieradzka, Dominika; Meaburn, Emma L.; Ronald, Angelica] Univ London, Ctr Brain & Cognit Dev, London, England; [Power, Robert A.; Plomin, Robert] Kings Coll London, MRC, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London, England; [Freeman, Daniel] Univ Oxford, Dept Psychiat, Oxford, England; [Cardno, Alastair G.] Univ Leeds, Acad Unit Psychiat & Behav Sci, Leeds, W Yorkshire, England; [McGuire, Philip] Kings Coll London, Inst Psychiat, London, England; [Dudbridge, Frank] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	University of London; Birkbeck University London; University of London; King's College London; University of Oxford; University of Leeds; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Sieradzka, D (corresponding author), Univ London, Ctr Brain & Cognit Dev, London, England.	dsiera01@mail.bbk.ac.uk	Freeman, Daniel/C-6851-2009; Ronald, Angelica/C-7812-2009	Freeman, Daniel/0000-0002-2541-2197; Ronald, Angelica/0000-0002-9576-2176; McGuire, Philip/0000-0003-4381-0532; Plomin, Robert/0000-0002-0756-3629; Meaburn, Emma/0000-0001-8096-9089; Power, Robert/0000-0003-0276-0399	Medical Research Council [G1100559, G0901245, G0500079, G19/2]; UK Medical Research Council; Wellcome Trust [092731]; Wellcome Trust Case Control Consortium 2 project [085475/B/08/Z, 085475/Z/08/Z]; Economic and Social Research Council; Economic and Social Research Council [1099627] Funding Source: researchfish; Medical Research Council [MC_PC_15018, G0902308, G9817803B, MR/K006215/1] Funding Source: researchfish; MRC [G0500079, G1100559, G19/2, G0901245, G0902308, MR/K006215/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust Case Control Consortium 2 project; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council [G1100559 to A. R., G0901245, G0500079, G19/2 to R. P.] and the UK Medical Research Council and the Wellcome Trust [092731] to ALSPAC. Genome-wide genotyping was made possible by grants from the Wellcome Trust Case Control Consortium 2 project (085475/B/08/Z; 085475/Z/08/Z). D. S. was supported by the Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bergen SE, 2012, CURR OPIN PSYCHIATR, V25, P76, DOI 10.1097/YCO.0b013e32835035dd; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Cummings E, 2010, SCHIZOPHR RES, V122, P273, DOI 10.1016/j.schres.2010.05.022; Cyhlarova E, 2005, SCHIZOPHR RES, V80, P253, DOI 10.1016/j.schres.2005.07.037; Derks EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037852; DeRosse P, 2006, AM J PSYCHIAT, V163, P532, DOI 10.1176/appi.ajp.163.3.532; DeRosse P, 2006, SCHIZOPHR RES, V87, P28, DOI 10.1016/j.schres.2006.06.008; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ericson M, 2011, BEHAV GENET, V41, P499, DOI 10.1007/s10519-010-9401-x; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Fanous AH, 2005, MOL PSYCHIATR, V10, P6, DOI 10.1038/sj.mp.4001571; Fanous AH, 2012, AM J PSYCHIAT, V169, P1309, DOI 10.1176/appi.ajp.2012.12020218; Fonseca-Pedrero E, 2009, SCHIZOPHR RES, V111, P53, DOI 10.1016/j.schres.2009.03.006; Fossati A, 2003, PERS INDIV DIFFER, V35, P1007, DOI 10.1016/S0191-8869(02)00314-8; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Hur YM, 2012, PSYCHIAT RES, V199, P98, DOI 10.1016/j.psychres.2012.04.024; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P1673, DOI 10.4088/JCP.v68n1106; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lehman EL, 1975, NONPARAMETRICS STAT; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lin CCH, 2007, BEHAV GENET, V37, P334, DOI 10.1007/s10519-006-9104-5; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011, Nat Genet, V43, P977, DOI 10.1038/ng.943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rijsdijk FV, 2011, AM J MED GENET B, V156B, P89, DOI 10.1002/ajmg.b.31145; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ronald A, 2014, SCHIZOPHR B IN PRESS; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Trzaskowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058676; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P565, DOI 10.1093/oxfordjournals.schbul.a033478; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Wigman JTW, 2011, SCHIZOPHRENIA BULL, V37, P850, DOI 10.1093/schbul/sbp154; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zammit S, 2014, SCHIZOPHR B IN PRESS; Zammit S, 2011, BRIT J PSYCHIAT, V199, P380, DOI 10.1192/bjp.bp.111.091421	47	45	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94398	10.1371/journal.pone.0094398	http://dx.doi.org/10.1371/journal.pone.0094398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718684	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000117
J	Sugiyama, K; Ebinuma, H; Nakamoto, N; Sakasegawa, N; Murakami, Y; Chu, P; Usui, S; Ishibashi, Y; Wakayama, Y; Taniki, N; Murata, H; Saito, Y; Fukasawa, M; Saito, K; Yamagishi, Y; Wakita, T; Takaku, H; Hibi, T; Saito, H; Kanai, T				Sugiyama, Kazuo; Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Sakasegawa, Noriko; Murakami, Yuko; Chu, Po-sung; Usui, Shingo; Ishibashi, Yuka; Wakayama, Yuko; Taniki, Nobuhito; Murata, Hiroko; Saito, Yoshimasa; Fukasawa, Masayoshi; Saito, Kyoko; Yamagishi, Yoshiyuki; Wakita, Takaji; Takaku, Hiroshi; Hibi, Toshifumi; Saito, Hidetsugu; Kanai, Takanori			Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RNA REPLICATION; LIPID DROPLET; CORE PROTEIN; CANCER; TRANSPORTERS; HEPATOCYTES; SECRETION; MEMBRANE; NRF2	Most of experiments for HCV infection have been done using lytic infection systems, in which HCV-infected cells inevitably die. Here, to elucidate metabolic alteration in HCV-infected cells in a more stable condition, we established an HCVpersistently- infected cell line, designated as HPI cells. This cell line has displayed prominent steatosis and supported HCV infection for more than 2 years, which is the longest ever reported. It enabled us to analyze metabolism in the HCV-infected cells integrally combining metabolomics and expression arrays. It revealed that rate- limiting enzymes for biosynthesis of cholesterol and fatty acids were up-regulated with actual increase in cholesterol, desmosterol (cholesterol precursor) and pool of fatty acids. Notably, the pentose phosphate pathway was facilitated with marked up-regulation of glucose-6-phosphate dehydrogenase, a rete-limiting enzyme, with actual increase in NADPH. In its downstream, enzymes for purine synthesis were also up-regulated resulting in increase of purine. Contrary to common cancers, the TCA cycle was preferentially facilitated comparing to glycolysis pathway with a marked increase of most of amino acids. Interestingly, some genes controlled by nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a master regulator of antioxidation and metabolism, were constitutively up- regulated in HPI cells. Knockdown of Nrf2 markedly reduced steatosis and HCV infection, indicating that Nrf2 and its target genes play important roles in metabolic alteration and HCV infection. In conclusion, HPI cell is a bona fide HCV-persistently-infected cell line supporting HCV infection for years. This cell line sustained prominent steatosis in a hypermetabolic status producing various metabolites. Therefore, HPI cell is a potent research tool not only for persistent HCV infection but also for liver metabolism, overcoming drawbacks of the lytic infection systems.	[Sugiyama, Kazuo] Keio Univ, Sch Med, Ctr Study Chron Liver Dis, Tokyo, Japan; [Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Chu, Po-sung; Usui, Shingo; Ishibashi, Yuka; Wakayama, Yuko; Taniki, Nobuhito; Murata, Hiroko; Yamagishi, Yoshiyuki; Saito, Hidetsugu; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Sakasegawa, Noriko] Keio Univ, Sch Med, Grad Sch, Tokyo, Japan; [Murakami, Yuko; Saito, Yoshimasa; Saito, Hidetsugu] Keio Univ, Fac Pharm, Div Pharmacotherapeut, Tokyo, Japan; [Fukasawa, Masayoshi; Saito, Kyoko] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Tokyo, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Chiba, Japan; [Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Chiba Institute of Technology; Kitasato University	Sugiyama, K (corresponding author), Keio Univ, Sch Med, Ctr Study Chron Liver Dis, Tokyo, Japan.	sygiyamkz@a8.keio.jp	Fukasawa, Masayoshi/ABD-7655-2020; Taniki, Nobuhito/ABT-6589-2022	Fukasawa, Masayoshi/0000-0002-0702-0691; Taniki, Nobuhito/0000-0003-3627-5412; Kanai, Takanori/0000-0002-1466-4532; Chu, Po-sung/0000-0002-8687-2760	Japan Society for the Promotion of Science (JSPS) KAKENHI [23590551]; Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was funded by the Japan Society for the Promotion of Science (JSPS) KAKENHI (23590551), a grant-in-aid for research on hepatitis from the Ministry of Health, Labor and Welfare of Japan, and the National Cancer Center Research and Development Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Carvajal-Yepes M, 2011, J BIOL CHEM, V286, P8941, DOI 10.1074/jbc.M110.186684; Date T, 2012, MICROBIOL IMMUNOL, V56, P308, DOI 10.1111/j.1348-0421.2012.00437.x; DEFvd Putte, 2013, J HEPATOLOGY; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ganan-Gomez I, 2013, FREE RADICAL BIOL ME; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; GOODMAN ZD, 1995, SEMIN LIVER DIS, V15, P70, DOI 10.1055/s-2007-1007264; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kato N, 2003, BIOCHEM BIOPH RES CO, V306, P756, DOI 10.1016/S0006-291X(03)01047-7; Lee JL, 2003, TOXICOL APPL PHARM, V192, P294, DOI 10.1016/S0041-008X(03)00301-6; LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Masson J, 1999, PHARMACOL REV, V51, P439; Mitsuishi Y, 2012, KEAP1 NRF2 SYSTEM CA; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nishitsuji H, 2013, J VIROL, V87, P8169, DOI 10.1128/JVI.00974-13; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; PARTIN JS, 1974, GASTROENTEROLOGY, V67, P107; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q; Seronello S, 2010, J BIOL CHEM; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Silberstein E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000910; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; Zerenturk EJ, 2013, PROG LIPID RES, V52, P666, DOI 10.1016/j.plipres.2013.09.002; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	56	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94460	10.1371/journal.pone.0094460	http://dx.doi.org/10.1371/journal.pone.0094460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718268	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000123
J	Wei, CH; Lu, J; Xu, LY; Liu, G; Wang, ZG; Zhao, FP; Zhang, L; Han, X; Du, LX; Liu, CS				Wei, Caihong; Lu, Jian; Xu, Lingyang; Liu, Gang; Wang, Zhigang; Zhao, Fuping; Zhang, Li; Han, Xu; Du, Lixin; Liu, Chousheng			Genetic Structure of Chinese Indigenous Goats and the Special Geographical Structure in the Southwest China as a Geographic Barrier Driving the Fragmentation of a Large Population	PLOS ONE			English	Article							MULTIPLE MATERNAL ORIGINS; MITOCHONDRIAL-DNA; PHYLOGEOGRAPHIC STRUCTURE; DIVERSITY; LINEAGES; BREEDS; SHEEP	Background: China has numerous native domestic goat breeds, however, extensive studies are focused on the genetic within the fewer breeds and limited regions, the population demograogic history and origin of Chinese goats are still unclear. The roles of geographical structure have not been analyzed in Chinese goat domestic process. In this study, the genetic relationships of Chinese indigenous goat populations were evaluated using 30 microsatellite markers. Methodology/Principal Findings: Forty Chinese indigenous populations containing 2078 goats were sampled from different geographic regions of China. Moderate genetic diversity at the population level (H-S of 0.644) and high population diversity at the species level (H-T value of 0.737) were estimated. Significant moderate population differentiation was detected (F-ST value of 0.129). Significant excess homozygosity (F-IS of 0.105) and recent population bottlenecks were detected in thirty-six populations. Neighbour-joining tree, principal components analysis and Bayesian clusters all revealed that Chinese goat populations could be subdivided into at least four genetic clusters: Southwest China, South China, Northwest China and East China. It was observed that the genetic diversity of Northern China goats was highest among these clusters. The results here suggested that the goat populations in Southwest China might be the earliest domestic goats in China. Conclusions/Significance: Our results suggested that the current genetic structure of Chinese goats were resulted from the special geographical structure, especially in the Western China, and the Western goat populations had been separated by the geographic structure (Hengduan Mountains and Qinling Mountains-Huaihe River Line) into two clusters: the Southwest and Northwest. It also indicated that the current genetic structure was caused by the geographical origin mainly, in close accordance with the human's migration history throughout China. This study provides a fundamental genetic profile for the conservation of these populations and better to understand the domestication process and origin of Chinese goats.	[Wei, Caihong; Xu, Lingyang; Zhao, Fuping; Zhang, Li; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China; [Lu, Jian; Liu, Gang; Wang, Zhigang; Han, Xu; Liu, Chousheng] Natl Anim Husb Serv, Natl Ctr Preservat & Utilizat Genet Resources Ani, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Du, LX (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China.	lxdu@263.net; liuchousheng@sina.com	Xu, Lingyang/W-8664-2019		National Key Technology R&D Program of China [2011BAD28B05-2]; Ministry of Agriculture [[2013] 36]	National Key Technology R&D Program of China(National Key Technology R&D Program); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by grant 2011BAD28B05-2 from the National Key Technology R&D Program of China and Ministry of Agriculture 2013 Protection Project of Animal Germplasm Resources (No. [2013] 36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Cornuet JM, 1999, GENETICS, V153, P1989; Dalvit C, 2009, J ANIM SCI, V87, P3837, DOI 10.2527/jas.2008-1682; Di R, 2011, ANIM GENET, V42, P428, DOI 10.1111/j.1365-2052.2010.02072.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J, 2008, PHYLOGENY INFERENCE; Glowatzki-Mullis ML, 2009, J ANIM BREED GENET, V126, P164, DOI 10.1111/j.1439-0388.2008.00768.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051649; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kijas JW, 2013, ANIM GENET, V44, P325, DOI 10.1111/age.12011; Kim KS, 2002, ASIAN AUSTRAL J ANIM, V15, P461, DOI 10.5713/ajas.2002.461; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Lai SJ, 2007, ANIM GENET, V38, P77, DOI 10.1111/j.1365-2052.2007.01555.x; Li JY, 2008, CZECH J ANIM SCI, V53, P315, DOI 10.17221/347-CJAS; Li MH, 2002, GENET SEL EVOL, V34, P729, DOI [10.1186/1297-9686-34-6-729, 10.1051/gse:2002032]; Li Xianglong, 1999, Acta Veterinaria et Zootechnica Sinica, V30, P313; Lin BZ, 2013, ANIM GENET, V44, P79, DOI 10.1111/j.1365-2052.2012.02358.x; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; Meadow R.H., 1993, HARAPPAN CIVILIZATIO, V2nd, P295; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nomura K, 2012, ANIM GENET, V43, P760, DOI 10.1111/j.1365-2052.2012.02334.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Poissant J, 2009, MOL ECOL RESOUR, V9, P1121, DOI 10.1111/j.1755-0998.2009.02575.x; PORTER V, 1996, GOATS WORLD; Pringle H, 1998, SCIENCE, V282, P1448, DOI 10.1126/science.282.5393.1448; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; Wu YP, 2009, ANIM SCI J, V80, P372, DOI 10.1111/j.1740-0929.2009.00659.x; Xiang-Long L, 2004, J ANIM BREED GENET, V121, P350, DOI 10.1111/j.1439-0388.2004.00465.x; Yuan JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034955; Zhang LiYing, 2012, African Journal of Biotechnology, V11, P11671; Zhong T, 2013, TROP ANIM HEALTH PRO, V45, P1833, DOI 10.1007/s11250-013-0432-1	45	26	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94435	10.1371/journal.pone.0094435	http://dx.doi.org/10.1371/journal.pone.0094435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718092	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000121
J	Zhao, L; Gao, QY; Ye, Y; Zhou, JF; Shui, RD; Shen, MW				Zhao, Lei; Gao, Qiyang; Ye, Yan; Zhou, Jifan; Shui, Rende; Shen, Mowei			The Role of Spatial Configuration in Multiple Identity Tracking	PLOS ONE			English	Article							MULTIELEMENT VISUAL TRACKING; OBJECT TRACKING; PUZZLING FINDINGS; MEMORY; INHIBITION; ATTENTION; ORGANIZATION; REGULARITIES; INFORMATION; RESOURCES	Background: The simultaneous tracking and identification of multiple moving objects encountered in everyday life requires one to correctly bind identities to objects. In the present study, we investigated the role of spatial configuration made by multiple targets when observers are asked to track multiple moving objects with distinct identities. Methodology/Principal Findings: The overall spatial configuration made by the targets was manipulated: In the constant condition, the configuration remained as a virtual convex polygon throughout the tracking, and in the collapsed condition, one of the moving targets (critical target) crossed over an edge of the virtual polygon during tracking, destroying it. Identification performance was higher when the configuration remained intact than when it collapsed (Experiments 1a, 1b, and 2). Moreover, destroying the configuration affected the allocation of dynamic attention: the critical target captured more attention than did the other targets. However, observers were worse at identifying the critical target and were more likely to confuse it with the targets that formed the virtual crossed edge (Experiments 3-5). Experiment 6 further showed that the visual system constructs an overall configuration only by using the targets (and not the distractors); identification performance was not affected by whether the distractor violated the spatial configuration. Conclusions/Significance: In sum, these results suggest that the visual system may integrate targets (but not distractors) into a spatial configuration during multiple identity tracking, which affects the distribution of dynamic attention and the updating of identity-location binding.	[Zhao, Lei; Gao, Qiyang; Ye, Yan; Zhou, Jifan; Shui, Rende; Shen, Mowei] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Shen, MW (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mwshen@zju.edu.cn			National Natural Science Foundation of China [31170975, 31170974, 31271089]; Key Project of Humanities and Social Sciences, Ministry of Education [07JZD0029]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Humanities and Social Sciences, Ministry of Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (31170975, 31170974, and 31271089), Key Project of Humanities and Social Sciences, Ministry of Education (07JZD0029), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R, 2006, Q J EXP PSYCHOL, V59, P1101, DOI 10.1080/02724980543000097; Alvarez GA, 2005, J EXP PSYCHOL GEN, V134, P461, DOI 10.1037/0096-3445.134.4.461; Alvarez GA, 2005, J EXP PSYCHOL HUMAN, V31, P643, DOI 10.1037/0096-1523.31.4.643; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; ALVAREZ GA, 2007, J VISION, V7; Blaxton C. L., 2011, J VISION, V11, P279, DOI [http://dx.doi.org/10.1167/11.11.279, DOI 10.1167/11.11.279]; Botterill K, 2011, EXP PSYCHOL, V58, P196, DOI 10.1027/1618-3169/a000085; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brady TF, 2009, J EXP PSYCHOL GEN, V138, P487, DOI 10.1037/a0016797; Clair RS, 2010, J VISION, P10; Fehd H, 2008, J VISION, V8, P504; Fehd HM, 2008, COGNITION, V108, P201, DOI 10.1016/j.cognition.2007.11.008; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; Fehd HM, 2007, J VISION, V7, P999; Fencsik DE, 2007, PERCEPT PSYCHOPHYS, V69, P567, DOI 10.3758/BF03193914; Feria CS, 2012, PERCEPTION, V41, P287, DOI 10.1068/p7053; Flombaum JI, 2008, COGNITION, V107, P904, DOI 10.1016/j.cognition.2007.12.015; Franconeri SL, 2008, PSYCHON B REV, V15, P802, DOI 10.3758/PBR.15.4.802; Gmeindl L, 2011, ATTEN PERCEPT PSYCHO, V73, P2130, DOI 10.3758/s13414-011-0180-0; Hollingworth A, 2000, VIS COGN, V7, P213, DOI 10.1080/135062800394775; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Howard CJ, 2008, VISION RES, V48, P1164, DOI 10.1016/j.visres.2008.01.023; HOWE PDL, 2010, J VISION, V10; Howe PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041491; Hudson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043796; Iordanescu L, 2009, J VISION, V9, DOI 10.1167/9.4.1; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Oliva A, 2005, NEUROBIOLOGY ATTENTI, P696; Olson IR, 2005, PERCEPT PSYCHOPHYS, V67, P185, DOI 10.3758/BF03206483; Olson IR, 2004, PSYCHOL AGING, V19, P310, DOI 10.1037/0882-7974.19.2.310; Papenmeier F, 2013, TRACKING LOCATION FE; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2006, SPATIAL VISION, V19, P485, DOI 10.1163/156856806779194017; Pylyshyn ZW, 2006, VIS COGN, V14, P175, DOI 10.1080/13506280544000200; Pylyshyn ZW, 2008, VIS COGN, V16, P1011, DOI 10.1080/13506280802247486; Pylyshyn ZW, 2001, COGNITION, V80, P127, DOI 10.1016/S0010-0277(00)00156-6; Pylyshyn ZW, 2004, VIS COGN, V11, P801, DOI 10.1080/13506280344000518; Saiki J, 2003, J VISION, V3, P6, DOI 10.1167/3.1.2; Scholl BJ, 1999, COGNITIVE PSYCHOL, V38, P259, DOI 10.1006/cogp.1998.0698; Scholl BJ, 2001, COGNITION, V80, P159, DOI 10.1016/S0010-0277(00)00157-8; Scholl BJ, 2001, RELATIONSHIP P UNPUB; Shen MW, 2013, J COGNITIVE NEUROSCI, V25, P743, DOI 10.1162/jocn_a_00348; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Watson DG, 2000, PERCEPT PSYCHOPHYS, V62, P471, DOI 10.3758/BF03212099; Woodman GF, 2003, PSYCHON B REV, V10, P80, DOI 10.3758/BF03196470; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; Zelinsky GJ, 2008, VIS COGN, V16, P553, DOI 10.1080/13506280802000752; Zimmer HD, 2006, PSYCHOL RES-PSYCH FO, V70, P1, DOI 10.1007/s00426-004-0186-5	52	8	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93835	10.1371/journal.pone.0093835	http://dx.doi.org/10.1371/journal.pone.0093835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718370	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000048
J	Botta, C; Langerholc, T; Cencic, A; Cocolin, L				Botta, Cristian; Langerholc, Tomaz; Cencic, Avrelija; Cocolin, Luca			In Vitro Selection and Characterization of New Probiotic Candidates from Table Olive Microbiota	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LISTERIA-MONOCYTOGENES INFECTION; LACTOBACILLUS-PLANTARUM; CACO-2 CELLS; ADHESION; ASSAY; AGGREGATION; SURVIVAL; STRAINS; IMPACT	To date, only a few studies have investigated the complex microbiota of table olives in order to identify new probiotic microorganisms, even though this food matrix has been shown to be a suitable source of beneficial lactic acid bacteria (LAB). Two hundred and thirty eight LAB, belonging to Lactobacillus plantarum, Lactobacillus pentosus and Leuconostoc mesenteroides species, and isolated from Nocellara Etnea table olives, have been screened in this survey through an in vitro approach. A simulation of transit tolerance in the upper human gastrointestinal tract, together with autoaggregation and hydrophobicity, have been decisive in reducing the number of LAB to 17 promising probiotics. None of the selected strains showed intrinsic resistances towards a broad spectrum of antibiotics and were therefore accurately characterized on an undifferentiated and 3D functional model of the human intestinal tract made up of H4-1 epithelial cells. As far as the potential colonization of the intestinal tract is concerned, a high adhesion ratio was observed for Lb. plantarum O2T60C (over 9%) when tested in the 3D functional model, which closely mimics real intestinal conditions. The stimulation properties towards the epithelial barrier integrity and the in vitro inhibition of L. monocytogenes adhesion and invasion have also been assessed. Lb. plantarum S1T10A and S11T3E enhanced trans-epithelial electrical resistance (TEER) and therefore the integrity of the polarized epithelium in the 3D model. Moreover, S11T3E showed the ability to inhibit L. monocytogenes invasion in the undifferentiated epithelial model. The reduction in L. monocytogenes infection, together with the potential enhancement of barrier integrity and an adhesion ratio that was above the average in the 3D functional model (6.9%) would seem to suggest the Lb. plantarum S11T3E strain as the most interesting candidate for possible in vivo animal and human trials.	[Botta, Cristian; Cocolin, Luca] Univ Turin, Dept Forestry Agr & Food Sci, Turin, Italy; [Langerholc, Tomaz; Cencic, Avrelija] Univ Maribor, Fac Agr & Life Sci, Dept Microbiol Biochem Mol Biol & Biotechnol, SLO-2000 Maribor, Slovenia	University of Turin; University of Maribor	Cocolin, L (corresponding author), Univ Turin, Dept Forestry Agr & Food Sci, Turin, Italy.	lucasimone.cocolin@unito.it	Cocolin, Luca/H-5091-2012; Botta, Cristian/F-5885-2013	Cocolin, Luca/0000-0003-4799-7074; Botta, Cristian/0000-0003-1102-3294	EU [243471-PROBIOLIVES]	EU(European Commission)	The conducted research received funding from the EU (FP7/2007-2013), under grant agreement no. 243471-PROBIOLIVES (www.probiolives.eu). The information in this document only reflects the authors' views and the Community is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Archambaud C, 2012, P NATL ACAD SCI USA, V109, P16684, DOI 10.1073/pnas.1212809109; Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005; Arroyo-Lopez FN, 2008, INT J FOOD MICROBIOL, V128, P189, DOI 10.1016/j.ijfoodmicro.2008.08.018; Bautista-Gallego J, 2013, FOOD RES INT, V50, P135, DOI 10.1016/j.foodres.2012.10.004; BERGAMINI A, 1992, J VIROL METHODS, V40, P275, DOI 10.1016/0166-0934(92)90086-S; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bevilacqua A, 2010, J FOOD SCI, V75, pM536, DOI 10.1111/j.1750-3841.2010.01793.x; Bories G, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.732; Botes M, 2008, ARCH MICROBIOL, V190, P573, DOI 10.1007/s00203-008-0408-0; Botta C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00245; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Cocolin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069074; Collado MC, 2008, EUR FOOD RES TECHNOL, V226, P1065, DOI 10.1007/s00217-007-0632-x; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; Corcoran BM, 2007, MICROBIOL-SGM, V153, P291, DOI 10.1099/mic.0.28966-0; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; CROW VL, 1995, INT DAIRY J, V5, P45, DOI 10.1016/0958-6946(94)P1598-8; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Dias FS, 2013, BIOSCI J, V29, P1678; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Dobson A, 2011, FEMS MICROBIOL ECOL, V76, P602, DOI 10.1111/j.1574-6941.2011.01069.x; Elkins CA, 2004, APPL ENVIRON MICROB, V70, P7200, DOI 10.1128/AEM.70.12.7200-7209.2004; Food and Agriculture Organization of the United Nations World Health Organization, 2002, GUIDELINES EVALUATIO; Hummel AS, 2007, APPL ENVIRON MICROB, V73, P730, DOI 10.1128/AEM.02105-06; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; Jensen H, 2012, INT J FOOD MICROBIOL, V153, P216, DOI 10.1016/j.ijfoodmicro.2011.11.020; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Klingberg TD, 2005, APPL ENVIRON MICROB, V71, P7528, DOI 10.1128/AEM.71.11.7528-7530.2005; Koo OK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029277; Kos B, 2003, J APPL MICROBIOL, V94, P981, DOI 10.1046/j.1365-2672.2003.01915.x; Langerholc T, 2011, TRENDS FOOD SCI TECH, V22, pS11, DOI 10.1016/j.tifs.2011.03.010; Lavermicocca P, 2006, DIGESTIVE LIVER D S2, V38; Lin WH, 2006, FOOD MICROBIOL, V23, P74, DOI 10.1016/j.fm.2005.01.013; Maragkoudakis PA, 2010, INT J FOOD MICROBIOL, V141, pS91, DOI 10.1016/j.ijfoodmicro.2009.12.024; Marteau P, 2003, BEST PRACT RES CL GA, V17, P725, DOI 10.1016/S1521-6918(03)00055-6; Moal VLL, 2013, MICROBIOL MOL BIOL R, V77, P380, DOI 10.1128/MMBR.00064-12; Nakamura S, 2012, ANAEROBE, V18, P19, DOI 10.1016/j.anaerobe.2011.11.006; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Ogawa M, 2001, INFECT IMMUN, V69, P1101, DOI 10.1128/IAI.69.2.1101-1108.2001; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P281, DOI 10.1007/s00244-002-1278-0; Ortakci F, 2012, J DAIRY SCI, V95, P6274, DOI 10.3168/jds.2012-5476; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Paolillo R, 2009, INT IMMUNOPHARMACOL, V9, P1265, DOI 10.1016/j.intimp.2009.07.008; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Petrovic T, 2012, ARCH BIOL SCI, V64, P1473, DOI 10.2298/ABS1204473P; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Possemiers S, 2013, J AGR FOOD CHEM, V61, P9380, DOI 10.1021/jf402137r; Puertollano MA, 2002, CLIN DIAGN LAB IMMUN, V9; Rivera-Espinoza Y, 2010, FOOD MICROBIOL, V27, P1, DOI 10.1016/j.fm.2008.06.008; Rowan NJ, 2000, J CLIN MICROBIOL, V38, P2643, DOI 10.1128/JCM.38.7.2643-2648.2000; Saad N, 2013, LWT-FOOD SCI TECHNOL, V50, P1, DOI 10.1016/j.lwt.2012.05.014; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Teuber M, 1999, ANTON LEEUW INT J G, V76, P115, DOI 10.1023/A:1002035622988; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; TOBA T, 1991, LETT APPL MICROBIOL, V13, P102, DOI 10.1111/j.1472-765X.1991.tb00581.x; Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; Tuo YF, 2013, J DAIRY SCI, V96, P4252, DOI 10.3168/jds.2013-6547; Williams NT, 2010, AM J HEALTH-SYST PH, V67, P449, DOI 10.2146/ajhp090168; Yamada F, 2006, J MICROBIOL METH, P66; Zhou JS, 2005, INT J FOOD MICROBIOL, V98, P211, DOI 10.1016/j.ijfoodmicro.2004.05.011	68	80	81	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94457	10.1371/journal.pone.0094457	http://dx.doi.org/10.1371/journal.pone.0094457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714329	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900135
J	Chan, CS; Rhodes, JE				Chan, Christian S.; Rhodes, Jean E.			Measuring Exposure in Hurricane Katrina: A Meta-Analysis and an Integrative Data Analysis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SOCIAL SUPPORT; MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; PSYCHOSOCIAL IMPACT; SCREENING SCALES; UNITED-STATES; PET LOSS; DISASTER; PTSD	To date there is no consensus on the operationalization of exposure severity in the study of the impact of natural disasters. This is problematic because incomplete and inconsistent measurement of exposure limits the internal and external validity of disaster studies. The current paper examined the predictive validity of severity measures in two interrelated studies of Hurricane Katrina survivors. First, in a meta-analysis of eight studies that measured both exposure severity and posttraumatic stress, the effect size was estimated to be r = .266. The moderating effects of sample and study characteristics were examined and we found that minority status and number of stressors assessed were significant moderators. Second, in an integrative data analysis of five independent samples of Hurricane Katrina survivors, the impact of specific wdisaster-related stressors on mental health was compared. Threat to physical integrity of self and others were found to have the strongest association with posttraumatic stress (PTS) and general psychological distress (GPD). The lack of basic necessities, such as food, water, and medical care, and loss of pet were also found to be strongly associated with both PTS and GPD. The results from the two studies are integrated and their implication for disaster research and relief are discussed.	[Chan, Christian S.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Rhodes, Jean E.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA	University of Hong Kong; University of Massachusetts System; University of Massachusetts Boston	Chan, CS (corresponding author), Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China.	shaunlyn@hku.hk	Chan, Christian/D-9637-2011; Chan, Christian S./AAB-2686-2021; Chan, Christian S/AAD-2761-2021	Chan, Christian/0000-0003-2616-5199; Chan, Christian S./0000-0003-2616-5199; 	National PERISHIP award by the Natural Hazards Center; Bollinger Memorial Research Grant; Graduate Student Assembly at the University of Massachusetts Boston	National PERISHIP award by the Natural Hazards Center; Bollinger Memorial Research Grant; Graduate Student Assembly at the University of Massachusetts Boston	This work was funded by a National PERISHIP award provided by the Natural Hazards Center and a Bollinger Memorial Research Grant awarded to Christian Chan by the Graduate Student Assembly at the University of Massachusetts Boston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya-Jackson L, 1995, CHILD PTSD CHECKLIST; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Beaudoin CE, 2009, HEALTH COMMUN, V24, P515, DOI 10.1080/10410230903104905; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Borenstein M., 2005, COMPREHENSIVE META A; Breslau N, 1999, AM J PSYCHIAT, V156, P908, DOI 10.1176/ajp.156.6.908; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Briere J, 2000, J TRAUMA STRESS, V13, P661, DOI 10.1023/A:1007814301369; Cepeda A, 2010, COMMUNITY MENT HLT J, V46, P612, DOI 10.1007/s10597-009-9286-4; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cieslak R, 2009, ANXIETY STRESS COPIN, V22, P449, DOI 10.1080/10615800802403815; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Cooper H, 2008, AM PSYCHOL, V63, P839, DOI 10.1037/0003-066X.63.9.839; Curran PJ, 2009, PSYCHOL METHODS, V14, P81, DOI 10.1037/a0015914; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elal G, 2005, J TRAUMA STRESS, V18, P213, DOI 10.1002/jts.20030; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Elliott JR, 2006, SOC SCI RES, V35, P295, DOI 10.1016/j.ssresearch.2006.02.003; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Fothergill A, 1999, DISASTERS, V23, P156, DOI 10.1111/1467-7717.00111; Friedman MJ, 2006, METHODS DISASTER MEN, P289; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.1111/j.1467-8624.1984.tb00276.x; GOENJIAN AK, 1994, AM J PSYCHIAT, V151, P895; Green B. L., 1991, J CONSULT CLIN PSYCH, V3, P538, DOI DOI 10.1037/1040-3590.3.4.538; GREEN BL, 1990, J APPL SOC PSYCHOL, V20, P1632, DOI 10.1111/j.1559-1816.1990.tb01498.x; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Heir T, 2008, PSYCHIATRY, V71, P266, DOI 10.1521/psyc.2008.71.3.266; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirschel MJ, 2009, PSYCHOL SERV, V6, P293, DOI 10.1037/a0017467; Hunt M, 2008, ANTHROZOOS, V21, P109, DOI 10.2752/175303708X305765; Kaplan RM, 2005, MED CARE, V43, P79; Keane T. M., 2008, GUIDE ASSESSMENTS WO, P293; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kilpatrick D., 1989, NATL WOMENS STUDY PT; LaJoie AS, 2010, DISASTERS, V34, P1031, DOI 10.1111/j.1467-7717.2010.01181.x; Lawson EJ, 2007, J HEALTH CARE POOR U, V18, P341, DOI 10.1353/hpu.2007.0039; LeClere FB, 1997, SOC FORCES, V76, P169, DOI 10.2307/2580322; Leong, 2007, J AM PSYCHIAT NURSES, V13, P257, DOI DOI 10.1177/1078390307307260; Little TD, 1997, MULTIVAR BEHAV RES, V32, P53, DOI 10.1207/s15327906mbr3201_3; Litz B.T, 1993, PTSD CHECKL PCL REL; Logan JR, 2006, WORKING PAPER; Lowe SR, 2009, J TRAUMA STRESS, V22, P244, DOI 10.1002/jts.20403; McFarlane AC, 2006, METHODS DISASTER MEN; McLeish AC, 2008, DEPRESS ANXIETY, V25, P416, DOI 10.1002/da.20426; Neria Y., 2009, MENTAL HLTH DISASTER, DOI 10.1017/CBO9780511730030; Netland M, 2005, J TRAUMA STRESS, V18, P507, DOI 10.1002/jts.20059; Netland M, 2001, J TRAUMA STRESS, V14, P311, DOI 10.1023/A:1011164901867; Norris F., 2009, MENTAL HLTH DISASTER, P29, DOI [10.1017/CBO9780511730030.003, DOI 10.1017/CBO9780511730030.003]; NORRIS FH, 1993, J APPL SOC PSYCHOL, V23, P1263, DOI 10.1111/j.1559-1816.1993.tb01032.x; Norris FH, 2005, CNS SPECTRUMS, V10, P132, DOI 10.1017/S1092852900019477; Norris FH, 2005, AM J COMMUN PSYCHOL, V36, P15, DOI 10.1007/s10464-005-6230-9; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2009, J TRAUMA STRESS, V22, P91, DOI 10.1002/jts.20389; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pynoos R., 1998, UCLA PTSD INDEX DSM; Reuther ET, 2010, J TRAUMA STRESS, V23, P519, DOI 10.1002/jts.20549; Rhodes J, 2010, AM J ORTHOPSYCHIAT, V80, P237, DOI 10.1111/j.1939-0025.2010.01027.x; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; Shelby RA, 2005, J TRAUMA STRESS, V18, P347, DOI 10.1002/jts.20033; Solomon S.D., 1992, PTSD RES Q, V3, P1; SOLOMON SD, 1987, J APPL SOC PSYCHOL, V17, P1092, DOI 10.1111/j.1559-1816.1987.tb02349.x; Spence PR, 2007, SOCIOL SPECTRUM, V27, P653, DOI 10.1080/02732170701533939; Sprang G., 2009, TRAUMATOLOGY, V15, P10, DOI [10.1177/1534765609331607, DOI 10.1177/1534765609331607]; STEINGLASS P, 1990, J APPL SOC PSYCHOL, V20, P1746, DOI 10.1111/j.1559-1816.1990.tb01509.x; Sterne JAC, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P75, DOI 10.1002/0470870168.ch5; Ticehurst S, 1996, INT J GERIATR PSYCH, V11, P943, DOI 10.1002/(SICI)1099-1166(199611)11:11<943::AID-GPS412>3.3.CO;2-2; United States Census Bureau, 2007, STAT COUNT QUICK FAC; United States Census Bureau, 2011, STAT COUNT QUICK FAC; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Wadsworth ME, 2009, ANXIETY STRESS COPIN, V22, P413, DOI 10.1080/10615800902855781; Wang PS, 2008, AM J PSYCHIAT, V165, P34, DOI 10.1176/appi.ajp.2007.07030502; Weathers FW, 1991, PTSD CHECKLIST CIVIL; Weems CF, 2007, BEHAV RES THER, V45, P2295, DOI 10.1016/j.brat.2007.04.013; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; White IK, 2007, J BLACK STUD, V37, P523, DOI 10.1177/0021934706296191; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Williams DR, 1997, RACIAL DIFFERENCES P	84	43	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92899	10.1371/journal.pone.0092899	http://dx.doi.org/10.1371/journal.pone.0092899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24713851	Green Published, gold			2022-12-27	WOS:000334160900009
J	Liu, XF; Zhou, J; Abid, MDN; Yan, HH; Huang, H; Wan, LM; Feng, ZH; Chen, J				Liu, Xiaofeng; Zhou, Jie; Abid, Morad Dirhem Naji; Yan, Huanhuan; Huang, Hao; Wan, Limin; Feng, Zuohua; Chen, Juan			Berberine Attenuates Axonal Transport Impairment and Axonopathy Induced by Calyculin A in N2a Cells	PLOS ONE			English	Article							SPATIAL MEMORY RETENTION; PROTEIN PHOSPHATASE 2A; TAU-HYPERPHOSPHORYLATION; NEUROFILAMENT PROTEINS; NEUROBLASTOMA-CELLS; ALZHEIMERS-DISEASE; OKADAIC ACID; IN-VIVO; PHOSPHORYLATION; INHIBITION	Berberine is a primary component of the most functional extracts of Coptidis rhizome used in traditional Chinese medicine for centuries. Recent reports indicate that Berberine has the potential to prevent and treat Alzheimer's disease (AD). The previous studies reported that Calyculin A (CA) impaired the axonal transport in neuroblastoma-2a (N2a) cells. Berberine attenuated tau hyperphosphorylation and cytotoxicity induced by CA. Our study aimed at investigating the effects of Berberine on the axonal transport impairment induced by CA in N2a cells. The results showed that Berberine could protect the cell from CA -induced toxicity in metabolism and viability, as well as hyperphosphorylation of tau and neurofilaments (NFs). Furthermore, Berberine could reverse CA-induced axonal transport impairment significantly. Berberine also partially reversed the phosphorylation of the catalytic subunit of PP-2A at Tyrosine 307, a crucial site negatively regulating the activity of PP-2A, and reduced the levels of malondialdehyde and the activity of superoxide dismutase, markers of oxidative stress, induced by CA. The present work for the first time demonstrates that Berberine may play a role in protecting against CA-induced axonal transport impairment by modulating the activity of PP-2A and oxidative stress. Our findings also suggest that Berberine may be a potential therapeutic drug for AD.	[Liu, Xiaofeng; Zhou, Jie; Yan, Huanhuan; Huang, Hao; Wan, Limin; Feng, Zuohua; Chen, Juan] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China; [Abid, Morad Dirhem Naji] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China.	chenjuanlinda@gmail.com			National Natural Science Foundation of China [81371416, 81371508, 31171027, 31000471]; Important National Science & Technology Specific Projects [2009ZX09301-014]; Hubei Province Natural Science Foundation [2011CDB365]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science & Technology Specific Projects; Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province)	This work was supported in part by grants from the National Natural Science Foundation of China (Grant No. 81371416, 81371508, 31171027 and 31000471), the Important National Science & Technology Specific Projects (Grant No. 2009ZX09301-014) and the Hubei Province Natural Science Foundation (Grant No. 2011CDB365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2000, J CELL BIOL, V150, P165, DOI 10.1083/jcb.150.1.165; Arendt T, 1998, NEUROBIOL AGING, V19, P3, DOI 10.1016/S0197-4580(98)00003-7; Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Bajaj NPS, 2000, AMYOTROPH LATERAL SC, V1, P319, DOI 10.1080/146608200300079563; Benitez-King G, 2003, EXP NEUROL, V182, P151, DOI 10.1016/S0014-4886(03)00085-2; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hung TM, 2008, J ETHNOPHARMACOL, V119, P74, DOI 10.1016/j.jep.2008.05.041; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jung C, 2000, CELL MOTIL CYTOSKEL, V47, P120, DOI 10.1002/1097-0169(200010)47:2<120::AID-CM3>3.0.CO;2-6; Jung C, 2000, BRAIN RES, V856, P12, DOI 10.1016/S0006-8993(99)02314-8; KATO Y, 1988, DRUG EXP CLIN RES, V14, P723; Kins S, 2001, J BIOL CHEM, V276, P38193; Kobe Hitoshi, 2002, Journal of Nippon Medical School, V69, P542, DOI 10.1272/jnms.69.542; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Li SP, 2004, J PINEAL RES, V36, P186, DOI 10.1111/j.1600-079X.2004.00116.x; Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8; Liu SJ, 2002, ACTA PHARMACOL SIN, V23, P183; MalchiodiAlbedi F, 1997, J NEUROSCI RES, V48, P425, DOI 10.1002/(SICI)1097-4547(19970601)48:5<425::AID-JNR4>3.0.CO;2-G; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Miller CCJ, 2002, CELL MOL LIFE SCI, V59, P323, DOI 10.1007/s00018-002-8425-7; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pappolla MA, 1997, J NEUROSCI, V17, P1683; RICHARD S, 1989, J SUBMICR CYTOL PATH, V21, P461; Sang HC, 2001, NEUROSCI LETT, V312, P141, DOI 10.1016/S0304-3940(01)02206-6; Singh J, 2009, J ETHNOPHARMACOL, V123, P22, DOI 10.1016/j.jep.2009.02.038; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Strack S, 1997, MOL BRAIN RES, V49, P15, DOI 10.1016/S0169-328X(97)00117-4; Sun L, 2003, NEUROSCIENCE, V118, P1175, DOI 10.1016/S0306-4522(02)00697-8; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Wang DL, 2004, J PINEAL RES, V37, P11, DOI 10.1111/j.1600-079X.2004.00130.x; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Wataya T, 2002, J BIOL CHEM, V277, P4644, DOI 10.1074/jbc.M110913200; Xiong YF, 2011, J PINEAL RES, V50, P319, DOI 10.1111/j.1600-079X.2010.00846.x; Yabe JT, 2000, CELL MOTIL CYTOSKEL, V45, P249, DOI 10.1002/(SICI)1097-0169(200004)45:4<249::AID-CM1>3.0.CO;2-M; Yang XF, 2011, J PSYCHOPHARMACOL, V25, P1118, DOI 10.1177/0269881110367723; Yang Y, 2007, J NEUROCHEM, V102, P878, DOI 10.1111/j.1471-4159.2007.04603.x; Yu G, 2011, J ALZHEIMERS DIS, V24, P525, DOI 10.3233/JAD-2011-101779; Zhou J, 2010, LIFE SCI, V86, P532, DOI 10.1016/j.lfs.2010.02.009; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	47	18	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93974	10.1371/journal.pone.0093974	http://dx.doi.org/10.1371/journal.pone.0093974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713870	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900069
J	Matsudaira, K; Konishi, H; Miyoshi, K; Isomura, T; Inuzuka, K				Matsudaira, Ko; Konishi, Hiroaki; Miyoshi, Kota; Isomura, Tatsuya; Inuzuka, Kyoko			Potential Risk Factors of Persistent Low Back Pain Developing from Mild Low Back Pain in Urban Japanese Workers	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; DISABILITY; PREVALENCE; OCCUPATION; EXPERIENCE; MANAGEMENT; SEVERITY; DISTRESS; BURDEN; CARE	Study Design: Two-year, prospective cohort data from the Japan epidemiological research of occupation-related back pain study in urban settings were used for this analysis. Objective: To examine the association between aggravated low back pain and psychosocial factors among Japanese workers with mild low back pain. Summary of Background Data: Although psychosocial factors are strongly indicated as yellow flags of low back pain (LBP) leading to disability, the association between aggravated LBP and psychosocial factors has not been well assessed in Japanese workers. Methods: At baseline, 5,310 participants responded to a self-administered questionnaire including questions about individual characteristics, ergonomic work demands, and work-related psychosocial factors (response rate: 86.5%), with 3,811 respondents completing the 1-year follow-up questionnaire. The target outcome was aggravation of mild LBP into persistent LBP during the follow-up period. Incidence was calculated for the participants with mild LBP during the past year at baseline. Logistic regression was used to explore risk factors associated with persistent LBP. Results: Of 1,675 participants who had mild LBP during the preceding year, 43 (2.6%) developed persistent LBP during the follow-up year. Multivariate analyses adjusted for individual factors and an ergonomic factor found statistically significant or almost significant associations of the following psychosocial factors with persistent LBP: interpersonal stress at work [adjusted odds ratio (OR): 1.96 and 95% confidence interval (95%CI): 1.00-3.82], job satisfaction (OR: 2.34, 95%CI: 1.21-4.54), depression (OR: 1.92, 95%CI: 1.00-3.69), somatic symptoms (OR: 2.78, 95%CI: 1.44-5.40), support from supervisors (OR: 2.01, 95%CI: 1.05-3.85), previous sick-leave due to LBP (OR: 1.94, 95%CI: 0.98-3.86) and family history of LBP with disability (OR: 1.98, 95%CI: 1.04-3.78). Conclusions: Psychosocial factors are important risk factors for persistent LBP in urban Japanese workers. It may be necessary to take psychosocial factors into account, along with physical work demands, to reduce LBP related disability.	[Matsudaira, Ko] Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kawasaki, Kanagawa, Japan; [Konishi, Hiroaki] Nagasaki Rosai Hosp, Dept Orthopaed Surg, Nagasaki, Japan; [Miyoshi, Kota] Yokohama Rosai Hosp, Spine Ctr, Yokohama, Kanagawa, Japan; [Isomura, Tatsuya; Inuzuka, Kyoko] CLINICAL STUDY SUPPORT Inc, Dept Clin Res, Nagoya, Aichi, Japan	Yokohama Rosai Hospital	Matsudaira, K (corresponding author), Univ Tokyo, Fac Med, Century Med & Res Ctr 22, Dept Med Res & Management Musculoskeletal Pain,Bu, Tokyo 113, Japan.	kohart801@gmail.com						Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Bernard B., 1997, MUSCULOSKELETAL DISO; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Coggon D, 2013, PAIN, V154, P856, DOI 10.1016/j.pain.2013.02.008; Crook J, 2002, J OCCUP REHABIL, V12, P277, DOI 10.1023/A:1020278708861; Currie SR, 2004, PAIN, V107, P54, DOI 10.1016/j.pain.2003.09.015; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Evans Subhadra, 2008, J Pain Manag, V1, P237; HARATANI T, 1993, JPN J IND HLTH S, V35, pS214; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Isaac M, 1994, SCREENER SOMATOFORM; KAPLAN C, 1988, J GEN INTERN MED, V3, P177, DOI 10.1007/BF02596128; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Kawakami N, 2005, PREV MED, V41, P471, DOI 10.1016/j.ypmed.2005.01.001; Kori SH, 1990, PAIN MANAG, V3, P35; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; Linton SJ, 2000, NECK BACK PAIN SCI E, P57; Lynch AM, 2006, J PAIN, V7, P244, DOI 10.1016/j.jpain.2005.11.001; Maetzel A, 2002, BEST PRACT RES CL RH, V16, P23, DOI 10.1053/berh.2001.0204; Matsudaira K, 2012, SPINE, V37, P1324, DOI 10.1097/BRS.0b013e3182498382; Matsudaira K, 2011, OCCUP ENVIRON MED, V68, P191, DOI 10.1136/oem.2009.053645; Miller RP, 1991, CLIN J PAIN, V7, DOI DOI 10.1097/00002508-199103000-00053; Ministry of Health Labour and Welfare, 2010, SURV LIV COND; Muto S, 2006, IND HEALTH, V44, P123, DOI 10.2486/indhealth.44.123; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Ono Y., 1996, JAPANESE J STRESS SC, V10, P273; Osborn Jody, 2010, Pain, V148, P268, DOI 10.1016/j.pain.2009.11.007; Papageorgiou AC, 1996, PAIN, V66, P181, DOI 10.1016/0304-3959(96)03022-9; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; Shaw WS, 2001, DISABIL REHABIL, V23, P815; Shima S, 1985, SEISHIN IGAKU, V27, P717; Shimomitsu T, 2004, OCCUP MENTAL HLTH, V12, P25; Snook SH, 2004, J ELECTROMYOGR KINES, V14, P153, DOI 10.1016/j.jelekin.2003.09.006; Spielberger C.D., 1970, STAI MANUAL; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Waddell G, 2004, THE BACK PAIN REVOLU, P241; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Westman AE, 2011, CLIN J PAIN, V27, P567, DOI 10.1097/AJP.0b013e318219ab6c; Williams RM, 2007, DISABIL REHABIL, V29, P607, DOI 10.1080/09638280600841513; Yokoyama K, 1990, Nihon Koshu Eisei Zasshi, V37, P913	45	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93924	10.1371/journal.pone.0093924	http://dx.doi.org/10.1371/journal.pone.0093924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714616	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900061
J	Reynolds, SJ; Martin, GR; Dawson, A; Wearn, CP; Hughes, BJ				Reynolds, S. James; Martin, Graham R.; Dawson, Alistair; Wearn, Colin P.; Hughes, B. John			The Sub-Annual Breeding Cycle of a Tropical Seabird	PLOS ONE			English	Article							CIRCANNUAL RHYTHMS; SOOTY TERN; SUCCESS; POPULATION; ISLAND; MOLT; FUSCATA; REGIME; COLONY; OCEAN	Breeding periodicity allows organisms to synchronise breeding attempts with the most favourable ecological conditions under which to raise offspring. For most animal species, ecological conditions vary seasonally and usually impose an annual breeding schedule on their populations; sub-annual breeding schedules will be rare. We use a 16-year dataset of breeding attempts by a tropical seabird, the sooty tern (Onychoprion fuscatus), on Ascension Island to provide new insights about this classical example of a population of sub-annually breeding birds that was first documented in studies 60 years previously on the same island. We confirm that the breeding interval of this population has remained consistently sub-annual. By ringing>17000 birds and re-capturing a large sample of them at equivalent breeding stages in subsequent seasons, we reveal for the first time that many individual birds also consistently breed sub-annually (i.e. that sub-annual breeding is an individual as well as a population breeding strategy). Ascension Island sooty terns appear to reduce their courtship phase markedly compared with conspecifics breeding elsewhere. Our results provide rare insights into the ecological and physiological drivers of breeding periodicity, indicating that reduction of the annual cycle to just two life-history stages, breeding and moult, is a viable life-history strategy and that moult may determine the minimum time between breeding attempts.	[Reynolds, S. James; Martin, Graham R.; Hughes, B. John] Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Ctr Ornithol, Birmingham, W Midlands, England; [Reynolds, S. James] Land Forces Directorate, Army Ornithol Soc, Andover, Hants, England; [Dawson, Alistair] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Wearn, Colin P.] Royal Air Force, Headquarters Air Command, Royal Air Force Ornithol Soc, High Wycombe, Bucks, England	University of Birmingham; UK Centre for Ecology & Hydrology (UKCEH)	Reynolds, SJ (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Ctr Ornithol, Birmingham, W Midlands, England.	J.Reynolds.2@bham.ac.uk; rasuk@btconnect.com	Reynolds, Silas James/AAM-1372-2020; Dawson, Alistair/B-4221-2012	Dawson, Alistair/0000-0001-6492-872X; Hughes, B. John/0000-0002-4537-065X	Army Ornithological Society (AOS); Royal Air Force Ornithological Society (RAFOS); Royal Naval Birdwatching Society (RNBWS); Royal Society for the Protection of Birds (RSPB); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Army Ornithological Society (AOS); Royal Air Force Ornithological Society (RAFOS); Royal Naval Birdwatching Society (RNBWS); Royal Society for the Protection of Birds (RSPB); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The logistics for fieldwork including the ringing activities reported in this study were supported financially by the Army Ornithological Society (AOS), the Royal Air Force Ornithological Society (RAFOS), the Royal Naval Birdwatching Society (RNBWS) and the Royal Society for the Protection of Birds (RSPB). The funders had no role in the preparation of the manuscript for publication.	ASHMOLE N. P., 1963, IBIS, V103b, P297, DOI 10.1111/j.1474-919X.1963.tb06757.x; ASHMOLE N. PHILIP, 1963, POSTILLA [YALE PEABODY MUS], V76, P1; ASHMOLE NP, 1968, CONDOR, V70, P35, DOI 10.2307/1366507; ASHMOLE NP, 1965, P NATL ACAD SCI USA, V53, P311, DOI 10.1073/pnas.53.2.311; Baker J. R., 1938, P161; BROOKE MD, 1995, BIOL J LINN SOC, V56, P199, DOI 10.1006/bijl.1995.0061; CHAPIN JAMES P., 1959, AUK, V76, P153; CHAPIN JAMES P., 1954, AUK, V71, P1; CHASTEL O, 1995, IBIS, V137, P360, DOI 10.1111/j.1474-919X.1995.tb08033.x; Coulson John C., 2002, P87; Darwin Charles, 1844, GEOLOGICAL OBSERVATI; Dawson A, 1997, J BIOL RHYTHM, V12, P371, DOI 10.1177/074873049701200409; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dawson A, 2007, P ROY SOC B-BIOL SCI, V274, P721, DOI 10.1098/rspb.2006.0067; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; DIAMOND AW, 1976, IBIS, V118, P414, DOI 10.1111/j.1474-919X.1976.tb02029.x; DIAMOND AW, 1986, J ZOOL, V210, P527; DINSMORE J J, 1972, Bulletin of the Florida State Museum Biological Sciences, V16, P129; FEARE CJ, 1976, J ZOOL, V179, P317; GWINNER E, 1977, ANNU REV ECOL SYST, V8, P381, DOI 10.1146/annurev.es.08.110177.002121; Hamer Keith C., 2002, P217; HARRINGTON BA, 1974, BIRD BANDING, V45, P115, DOI 10.2307/4512021; Hart-Davis D, 1972, ASCENSION STORY S AT; Hughes BJ, 2008, IBIS, V150, P122, DOI 10.1111/j.1474-919X.2008.00838.x; Hughes B. John, 2012, Bulletin of the African Bird Club, V19, P166; Immelmann K., 1971, P341; Jaquemet S, 2007, DEEP-SEA RES PT I, V54, P130, DOI 10.1016/j.dsr.2006.10.003; Jouventin P, 2002, P ROY SOC B-BIOL SCI, V269, P1955, DOI 10.1098/rspb.2002.2080; KING BR, 1992, EMU, V92, P1, DOI 10.1071/MU9920001; Lack D., 1954, P343; Le Corre M, 2001, J ZOOL, V254, P239, DOI 10.1017/S0952836901000759; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I, 2011, J ORNITHOL, V152, P169, DOI 10.1007/s10336-011-0689-y; PARSONS J, 1976, IBIS, V118, P537; PRYSJONES RP, 1980, IBIS, V122, P76, DOI 10.1111/j.1474-919X.1980.tb00873.x; Ratcliffe N, 2008, IBIS, V150, P300, DOI 10.1111/j.1474-919X.2007.00778.x; RICKLEFS RE, 1966, EVOLUTION, V20, P235, DOI 10.1111/j.1558-5646.1966.tb03358.x; Schreiber E.A., 2002, P179; Schreiber EA, 2002, BIRDS N AM; SNOW DW, 1967, IBIS, V109, P14, DOI 10.1111/j.1474-919X.1967.tb00003.x; SNOW DW, 1965, AUK, V82, P591, DOI 10.2307/4083221; Stonehouse B., 1962, Ibis, V103b, P124, DOI 10.1111/j.1474-919X.1962.tb07242.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Williams T., 2012, PHYSL ADAPTATIONS BR; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149	45	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93582	10.1371/journal.pone.0093582	http://dx.doi.org/10.1371/journal.pone.0093582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714514	Green Published, Green Accepted, gold			2022-12-27	WOS:000334160900038
J	Taube, M; Pienkowska, JR; Jarmolowski, A; Kozak, M				Taube, Michal; Pienkowska, Joanna R.; Jarmolowski, Artur; Kozak, Maciej			Low-Resolution Structure of the Full-Length Barley (Hordeum vulgare) SGT1 Protein in Solution, Obtained Using Small-Angle X-Ray Scattering	PLOS ONE			English	Article							BIOLOGICAL MACROMOLECULES; ESSENTIAL COMPONENT; SECONDARY STRUCTURE; FUNCTIONAL-ANALYSIS; SELF-ASSOCIATION; DOMAIN; HSP90; ACCUMULATION; RESISTANCE; COMPLEXES	SGT1 is an evolutionarily conserved eukaryotic protein involved in many important cellular processes. In plants, SGT1 is involved in resistance to disease. In a low ionic strength environment, the SGT1 protein tends to form dimers. The protein consists of three structurally independent domains (the tetratricopeptide repeats domain (TPR), the CHORD-and SGT1-containing domain (CS), and the SGT1-specific domain (SGS)), and two less conserved variable regions (VR1 and VR2). In the present study, we provide the low-resolution structure of the barley (Hordeum vulgare) SGT1 protein in solution and its dimer/monomer equilibrium using small-angle scattering of synchrotron radiation, ab-initio modeling and circular dichroism spectroscopy. The multivariate curve resolution least-square method (MCR-ALS) was applied to separate the scattering data of the monomeric and dimeric species from a complex mixture. The models of the barley SGT1 dimer and monomer were formulated using rigid body modeling with ab-initio structure prediction. Both oligomeric forms of barley SGT1 have elongated shapes with unfolded inter-domain regions. Circular dichroism spectroscopy confirmed that the barley SGT1 protein had a modular architecture, with an alpha-helical TPR domain, a beta-sheet sandwich CS domain, and a disordered SGS domain separated by VR1 and VR2 regions. Using molecular docking and ab-initio protein structure prediction, a model of dimerization of the TPR domains was proposed.	[Taube, Michal; Kozak, Maciej] Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, Poznan, Poland; [Pienkowska, Joanna R.] Adam Mickiewicz Univ, Fac Biol, Inst Expt BiFol, Dept Cell Biol, Poznan, Poland; [Jarmolowski, Artur] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Dept Gene Express, Poznan, Poland	Adam Mickiewicz University	Kozak, M (corresponding author), Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, Poznan, Poland.	mkozak@amu.edu.pl		Pienkowska, Joanna/0000-0003-0372-121X; Taube, Michal/0000-0002-8876-929X; Kozak, Maciej/0000-0003-3312-6518	Polish Ministry of Science and Higher Education [N N202 127237]; National Science Centre [2012/05/N/ST3/03087]; POLAPGEN-BD [UDA POIG.01.03.01-00-101/08]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland); POLAPGEN-BD	This work was supported in part by grant N N202 127237 (MK) from the Polish Ministry of Science and Higher Education. The work was also supported by the grant (2012/05/N/ST3/03087) from National Science Centre (MT) and by POLAPGEN-BD (UDA POIG.01.03.01-00-101/08) grant (AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bansal PK, 2009, J BIOL CHEM, V284, P18692, DOI 10.1074/jbc.M109.012732; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Blobel J, 2009, J AM CHEM SOC, V131, P4378, DOI 10.1021/ja808490b; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Jaumot J, 2005, CHEMOMETR INTELL LAB, V76, P101, DOI 10.1016/j.chemolab.2004.12.007; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozak M, 2005, J APPL CRYSTALLOGR, V38, P555, DOI 10.1107/S0021889805010472; Kozak M, 2002, ACTA BIOCHIM POL, V49, P509; Krachler AM, 2010, PROTEINS, V78, P2131, DOI 10.1002/prot.22726; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Meldau S, 2011, PLANT SIGNAL BEHAV, V6, P1479, DOI 10.4161/psb.6.10.17708; Muroga Y, 2000, BIOPHYS CHEM, V83, P197, DOI 10.1016/S0301-4622(99)00141-6; Nowotny M, 2000, J BIOL CHEM, V275, P31178, DOI 10.1074/jbc.M001622200; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Pernot P, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012009; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 1997, PROTEINS, V27, P110; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Williamson TE, 2008, BIOPHYS J, V94, P4906, DOI 10.1529/biophysj.107.113167; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	62	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93313	10.1371/journal.pone.0093313	http://dx.doi.org/10.1371/journal.pone.0093313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714665	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900023
J	Wessels, JM; Wu, L; Leyland, NA; Wang, HM; Foster, WG				Wessels, Jocelyn M.; Wu, Liang; Leyland, Nicholas A.; Wang, Hongmei; Foster, Warren G.			The Brain-Uterus Connection: Brain Derived Neurotrophic Factor (BDNF) and Its Receptor (Ntrk2) Are Conserved in the Mammalian Uterus	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; EUTOPIC ENDOMETRIUM; ENDOTHELIAL-CELLS; FACTOR EXPRESSION; TRKB; ACTIVATION; INNERVATION; RELEASE; COMPLEX	The neurotrophins are neuropeptides that are potent regulators of neurite growth and survival. Although mainly studied in the brain and nervous system, recent reports have shown that neurotrophins are expressed in multiple target tissues and cell types throughout the body. Additionally, dysregulation of neurotrophins has been linked to several disease conditions including Alzheimer's, Parkinson's, Huntington's, psychiatric disorders, and cancer. Brain derived neurotrophic factor (BDNF) is a member of the neurotrophin family that elicits its actions through the neurotrophic tyrosine receptor kinase type 2 (Ntrk2). Together BDNF and Ntrk2 are capable of activating the adhesion, angiogenesis, apoptosis, and proliferation pathways. These pathways are prominently involved in reproductive physiology, yet a cross-species examination of BDNF and Ntrk2 expression in the mammalian uterus is lacking. Herein we demonstrated the conserved nature of BDNF and Ntrk2 across several mammalian species by mRNA and protein sequence alignment, isolated BDNF and Ntrk2 transcripts in the uterus by Real-Time PCR, localized both proteins to the glandular and luminal epithelium, vascular smooth muscle, and myometrium of the uterus, determined that the major isoforms expressed in the human endometrium were pro-BDNF, and truncated Ntrk2, and finally demonstrated antibody specificity. Our findings suggest that BDNF and Ntrk2 are transcribed, translated, and conserved across mammalian species including human, mouse, rat, pig, horse, and the bat.	[Wessels, Jocelyn M.; Leyland, Nicholas A.; Foster, Warren G.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Wu, Liang; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	McMaster University; Chinese Academy of Sciences; Institute of Zoology, CAS	Foster, WG (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada.	fosterw@mcmaster.ca			Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided by an operating grant from the Natural Sciences and Engineering Research Council. Ms. Jocelyn Wessels received a Vanier scholarship from the Canadian Institutes of Health Research (CIHR) and is a student member of the CIHR Training Program in Reproduction, Early Development, and the Impact on Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2002, J CLIN ENDOCR METAB, V87, P890, DOI 10.1210/jc.87.2.890; Anger DL, 2007, ENDOCRINE, V31, P167, DOI 10.1007/s12020-007-0025-8; Bao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070616; Baxter GT, 1997, J NEUROSCI, V17, P2683; Browne AS, 2012, FERTIL STERIL, V98, P713, DOI 10.1016/j.fertnstert.2012.05.027; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Donnez O, 2013, J ENDOMETR PELVIC PA, V5, P68, DOI 10.5301/je.5000155; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garces MF, 2013, CLIN ENDOCRINOL OXF; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Gilmore JH, 2003, J NEUROIMMUNOL, V138, P49, DOI 10.1016/S0165-5728(03)00095-X; GOTZ R, 1992, J NEUROCHEM, V59, P432, DOI 10.1111/j.1471-4159.1992.tb09389.x; Gray K, 2008, FEBS LETT, V582, P907, DOI 10.1016/j.febslet.2008.02.026; Hahn C, 2006, J ALLERGY CLIN IMMUN, V117, P787, DOI 10.1016/j.jaci.2005.12.1339; Harel S, 2006, MOL HUM REPROD, V12, P357, DOI 10.1093/molehr/gal033; Huang YQ, 2011, ARCH GYNECOL OBSTET, V283, P775, DOI 10.1007/s00404-010-1718-4; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Kawamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049328; Kawamura K, 2011, ENDOCRINOLOGY, V152, P1090, DOI 10.1210/en.2010-1124; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kawamura N, 2010, ENDOCRINOLOGY, V151, P3006, DOI 10.1210/en.2009-1378; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Krizsan-Agbas D, 2003, EUR J NEUROSCI, V18, P2760, DOI 10.1111/j.1460-9568.2003.03029.x; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030246; Liu Y, 2012, SCIENCE, V338, P1357, DOI 10.1126/science.1228258; Lommatzsch M, 2006, PSYCHONEUROENDOCRINO, V31, P388, DOI 10.1016/j.psyneuen.2005.09.003; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Maruyama E, 2007, INT J BIOCHEM CELL B, V39, P1930, DOI 10.1016/j.biocel.2007.05.012; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Metsis M, 2001, CELL MOL LIFE SCI, V58, P1014, DOI 10.1007/PL00000916; Meyer M, 2012, NEUROSCIENCE, V201, P267, DOI 10.1016/j.neuroscience.2011.11.034; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Newman TA, 2013, HUM REPROD, V28, P2502, DOI 10.1093/humrep/det274; Noga O, 2008, CLIN EXP ALLERGY, V38, P473, DOI 10.1111/j.1365-2222.2007.02907.x; Noga O, 2003, CLIN EXP ALLERGY, V33, P649, DOI 10.1046/j.1365-2222.2003.01586.x; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Quinn MJ, 2002, AM J OBSTET GYNECOL, V187, P1515, DOI 10.1067/mob.2002.130007; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rost B, 2005, REGUL PEPTIDES, V124, P19, DOI 10.1016/j.regpep.2004.06.024; Russo N, 2012, GYNECOL ENDOCRINOL, V28, P492, DOI 10.3109/09513590.2011.633667; Schulte-Herbruggen O, 2007, J REPROD IMMUNOL, V74, P170, DOI 10.1016/j.jri.2006.10.003; Shibayama E, 1996, AM J PATHOL, V148, P1807; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tervonen TA, 2006, EUR J NEUROSCI, V24, P1277, DOI 10.1111/j.1460-9568.2006.05010.x; Wang LH, 2005, J PHARMACOL EXP THER, V312, P1007, DOI 10.1124/jpet.104.077800; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Zhang XP, 2007, BIOL REPROD, V77, P358, DOI 10.1095/biolreprod.106.058958; Zhang XM, 2010, FERTIL STERIL, V94, P730, DOI 10.1016/j.fertnstert.2009.03.026; Zhou H, 1997, J NEUROSCI RES, V49, P281, DOI 10.1002/(SICI)1097-4547(19970801)49:3<281::AID-JNR3>3.0.CO;2-8	65	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94036	10.1371/journal.pone.0094036	http://dx.doi.org/10.1371/journal.pone.0094036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714156	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900072
J	Boender, AJ; Koning, NA; van den Heuvel, JK; Luijendijk, MCM; van Rozen, AJ; la Fleur, SE; Adan, RAH				Boender, Arjen J.; Koning, Nivard A.; van den Heuvel, Jose K.; Luijendijk, Mieneke C. M.; van Rozen, Andrea J.; la Fleur, Susanne E.; Adan, Roger A. H.			AAV-Mediated Gene Transfer of the Obesity-Associated Gene Etv5 in Rat Midbrain Does Not Affect Energy Balance or Motivated Behavior	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; HYPOTHALAMUS; EXPRESSION; NEURONS; LOCI	Several genome-wide association studies have implicated the transcription factor E-twenty-six version 5 (Etv5) in the regulation of body mass index. Further substantiating the role of Etv5 in feeding behavior are the findings that targeted disruption of Etv5 in mice leads to decreased body weight gain and that expression of Etv5 is decreased in the ventral tegmental area and substantia nigra pars compacta (VTA/SNpc) after food restriction. As Etv5 has been suggested to influence dopaminergic neurotransmission by driving the expression of genes that are responsible for the synthesis and release of dopamine, we investigated if expression levels of Etv5 are dependent on nutritional state and subsequently influence the expression levels of tyrosine hydroxylase. While it was shown that Etv5 expression in the VTA/SNpc increases after central administration of leptin and that Etv5 was able to drive expression of tyrosine hydroxylase in vitro, AAVmediated gene transfer of Etv5 into the VTA/SNpc of rats did not alter expression of tyrosine hydroxylase in vivo. Moreover, AAV-mediated gene transfer of Etv5 in the VTA/SNpc did not affect measures of energy balance or performances in a progressive ratio schedule. Thus, these data do not support a role for increased expression of Etv5 in the VTA/SNpc in the regulation of feeding behavior.	[Boender, Arjen J.; Koning, Nivard A.; Luijendijk, Mieneke C. M.; van Rozen, Andrea J.; Adan, Roger A. H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [van den Heuvel, Jose K.; la Fleur, Susanne E.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Adan, RAH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	r.a.h.adan@umcutrecht.nl		Boender, Arjen/0000-0002-6018-3588	European Community [245009, 266408]	European Community(European Commission)	This work was funded by the European Community's Seventh Framework Programme (FP7/2007-2013 under grant agreement no 245009 and 266408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boender AJ, 2012, OBESITY, V20, P2420, DOI 10.1038/oby.2012.128; de Backer MWA, 2011, INT J OBESITY, V35, P629, DOI 10.1038/ijo.2010.169; de Backer MWA, 2010, J MOL ENDOCRINOL, V45, P341, DOI 10.1677/JME-10-0057; de Backer MWA, 2010, HUM GENE THER, V21, P673, DOI 10.1089/hum.2009.169; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Schlesser HN, 2008, BIOL REPROD, V78, P483, DOI 10.1095/biolreprod.107.062935; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007; Wang SR, 2010, J NEUROSCI, V30, P9224, DOI 10.1523/JNEUROSCI.1977-10.2010; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	14	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94159	10.1371/journal.pone.0094159	http://dx.doi.org/10.1371/journal.pone.0094159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710089	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800108
J	Hu, ZX; Duan, SS; Xu, N; Mulholland, MR				Hu, Zhangxi; Duan, Shunshan; Xu, Ning; Mulholland, Margaret R.			Growth and Nitrogen Uptake Kinetics in Cultured Prorocentrum donghaiense	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; ALEXANDRIUM-CATENELLA DINOPHYCEAE; EAST CHINA; ORGANIC NITROGEN; AUREOCOCCUS-ANOPHAGEFFERENS; DINOFLAGELLATE BLOOMS; PEPTIDE HYDROLYSIS; LIMITED GROWTH; RED TIDE; EUTROPHICATION	We compared growth kinetics of Prorocentrum donghaiense cultures on different nitrogen (N) compounds including nitrate (NO3-), ammonium (NH4+), urea, glutamic acid (glu), dialanine (diala) and cyanate. P. donghaiense exhibited standard Monod-type growth kinetics over a range of N concentraions (0.5-500 mu mol NL-1 for NO3- and NH4+ , 0.5- 50 mu mol N L-1 for urea, 0.5-100 mu mol N L-1 for glu and cyanate, and 0.5-200 mu mol N L-1 for diala) for all of the N compounds tested. Cultures grown on glu and urea had the highest maximum growth rates (mu(m), 1.51=0.06 d(-1) and 1.50=0.05 d(-1), respectively). However, cultures grown on cyanate, NO3- , and NH4+ had lower half saturation constants (K-mu, 0.28-0.51 mu mol N L-1). N uptake kinetics were measured in NO3--deplete and -replete batch cultures of P. donghaiense. In NO3--deplete batch cultures, P. donghaiense exhibited Michaelis-Menten type uptake kinetics for NO3(-), NH4+, urea and algal amino acids; uptake was saturated at or below 50 mu mol N L-1. In NO3--replete batch cultures, NH4+, urea, and algal amino acid uptake kinetics were similar to those measured in NO3--deplete batch cultures. Together, our results demonstrate that P. donghaiense can grow well on a variety of N sources, and exhibits similar uptake kinetics under both nutrient replete and deplete conditions. This may be an important factor facilitating their growth during bloom initiation and development in N-enriched estuaries where many algae compete for bioavailable N and the nutrient environment changes as a result of algal growth.	[Hu, Zhangxi] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Hu, Zhangxi; Duan, Shunshan; Xu, Ning] Jinan Univ, Res Ctr Hydrobiol, Guangzhou, Guangdong, Peoples R China; [Mulholland, Margaret R.] Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA USA	Chinese Academy of Sciences; Institute of Oceanology, CAS; Jinan University; Old Dominion University	Xu, N (corresponding author), Jinan Univ, Res Ctr Hydrobiol, Guangzhou, Guangdong, Peoples R China.	txuning@163.com; mmulholl@odu.edu	Mulholland, Margaret R/E-8480-2011	Mulholland, Margaret R/0000-0001-8819-189X	China Scholarship Council; NOAA; NSF; Natural Science Foundation of China (NSFC) [40776078, 40876074, 41176104]; Directorate For Geosciences [1155666] Funding Source: National Science Foundation	China Scholarship Council(China Scholarship Council); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors acknowledge the financial support from the China Scholarship Council to Zhangxi Hu. In addition, this work was supported by NOAA and NSF grants to MRM, and Natural Science Foundation of China (NSFC) (Grant Numbers 40776078, 40876074, 41176104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN CM, 1964, BIOCHEMISTRY-US, V3, P1238, DOI 10.1021/bi00897a010; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Bronk DA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P385, DOI 10.1016/B978-0-12-372522-6.00008-6; Chai C, 2006, HYDROBIOLOGIA, V563, P313, DOI 10.1007/s10750-006-0021-7; Cochlan WP, 2008, HARMFUL ALGAE, V8, P111, DOI 10.1016/j.hal.2008.08.008; COCHLAN WP, 1991, J PHYCOL, V27, P673; COCHLAN WP, 1991, MAR ECOL PROG SER, V69, P103, DOI 10.3354/meps069103; Cochlan WP, 2003, AGU ANTARCTIC RES SE, V78, P159; Collos Y, 2004, J PHYCOL, V40, P96, DOI 10.1046/j.1529-8817.2004.03034.x; COWIE GL, 1992, MAR CHEM, V37, P223, DOI 10.1016/0304-4203(92)90079-P; Dugdale RC, 2007, ESTUAR COAST SHELF S, V73, P17, DOI 10.1016/j.ecss.2006.12.008; EPPLEY RW, 1969, J PHYCOL, V5, P375, DOI 10.1111/j.1529-8817.1969.tb02628.x; Fan CL, 2003, HARMFUL ALGAE, V2, P283, DOI 10.1016/S1568-9883(03)00047-7; Fu MZ, 2009, CONT SHELF RES, V29, P2178, DOI 10.1016/j.csr.2009.08.010; Glibert PM, 2006, ECOL STU AN, V189, P341, DOI 10.1007/978-3-540-32210-8_26; Glibert PM, 2012, HARMFUL ALGAE, V14, P231, DOI 10.1016/j.hal.2011.10.023; Gobler CJ, 2012, HARMFUL ALGAE, V17, P64, DOI 10.1016/j.hal.2012.03.001; Goldman J. C., 1983, NITROGEN MAR ENV, P233, DOI DOI 10.1016/B978-0-12-160280-2.50015-8; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; GUILLARD RR, 1973, J PHYCOL, V9, P233; HARRISON PJ, 1989, MAR ECOL PROG SER, V52, P301, DOI 10.3354/meps052301; HEALEY FP, 1980, MICROBIAL ECOL, V5, P281, DOI 10.1007/BF02020335; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Herndon J, 2007, HARMFUL ALGAE, V6, P260, DOI 10.1016/j.hal.2006.08.006; Hu ZX, 2012, HARMFUL ALGAE, V13, P72, DOI 10.1016/j.hal.2011.10.004; [胡章喜 Hu Zhangxi], 2010, [环境科学学报, Acta Scientiae Circumstantiae], V30, P1265; Jauzein C, 2008, AQUAT MICROB ECOL, V53, P271, DOI 10.3354/ame01249; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Kana TM, 2004, HARMFUL ALGAE, V3, P377, DOI 10.1016/j.hal.2004.06.008; Kudela RM, 2008, HARMFUL ALGAE, V7, P278, DOI 10.1016/j.hal.2007.12.016; Kudela RM, 2000, AQUAT MICROB ECOL, V21, P31, DOI 10.3354/ame021031; Li J, 2011, CHIN J OCEANOL LIMN, V29, P746, DOI 10.1007/s00343-011-0504-x; Li J, 2010, HARMFUL ALGAE, V9, P531, DOI 10.1016/j.hal.2010.03.007; Li J, 2009, MAR ECOL PROG SER, V383, P11, DOI 10.3354/meps07975; Lindehoff E, 2011, HARMFUL ALGAE, V12, P70, DOI 10.1016/j.hal.2011.09.001; Lomas MW, 1999, MAR BIOL, V133, P541, DOI 10.1007/s002270050494; Lu DD, 2005, HARMFUL ALGAE, V4, P493, DOI 10.1016/j.hal.2004.08.015; Lu Dou-ding, 2001, Chinese Journal of Oceanology and Limnology, V19, P337; Lu SH, 2004, HYDROBIOLOGIA, V512, P231, DOI 10.1023/B:HYDR.0000020331.75003.18; Maguer JF, 2007, J PHYCOL, V43, P295, DOI 10.1111/j.1529-8817.2007.00334.x; MONOD J., 1942, Research on the Glowth of Bacterial Cultures.; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Mulholland MR, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P303, DOI 10.1016/B978-0-12-372522-6.00007-4; Mulholland MR, 2009, LIMNOL OCEANOGR, V54, P856, DOI 10.4319/lo.2009.54.3.0856; Mulholland MR, 2002, LIMNOL OCEANOGR, V47, P1094, DOI 10.4319/lo.2002.47.4.1094; Paerl HW, 1997, LIMNOL OCEANOGR, V42, P1154, DOI 10.4319/lo.1997.42.5_part_2.1154; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Seeyave S, 2009, MAR ECOL PROG SER, V379, P91, DOI 10.3354/meps07898; Shen ZL, 2003, AMBIO, V32, P65; SMITH REH, 1982, J PHYCOL, V18, P275; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Taylor GT, 2006, MAR ECOL PROG SER, V312, P67, DOI 10.3354/meps312067; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Wang JH, 2009, SCI TOTAL ENVIRON, V407, P4012, DOI 10.1016/j.scitotenv.2009.02.040; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Yan T., 2002, 23 PICES, P21; Yu J, 2007, TERR ATMOS OCEAN SCI, V18, P1011, DOI 10.3319/TAO.2007.18.5.1011(Oc); Yuan XC, 2012, ESTUAR COAST, V35, P325, DOI 10.1007/s12237-011-9433-3; Zhou M, 2010, ENV SETTINGS HARMFUL, P133; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009	67	14	17	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94030	10.1371/journal.pone.0094030	http://dx.doi.org/10.1371/journal.pone.0094030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710151	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800090
J	Koval, OA; Tkachenko, AV; Fomin, AS; Semenov, DV; Nushtaeva, AA; Kuligina, EV; Zavjalov, EL; Richter, VA				Koval, Olga A.; Tkachenko, Anastasiya V.; Fomin, Alexandr S.; Semenov, Dmitry V.; Nushtaeva, Anna A.; Kuligina, Elena V.; Zavjalov, Eugeny L.; Richter, Vladimir A.			Lactaptin Induces p53-Independent Cell Death Associated with Features of Apoptosis and Autophagy and Delays Growth of Breast Cancer Cells in Mouse Xenografts	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; HUMAN-MILK; MOLECULAR-MECHANISMS; SELF-DIGESTION; TUMOR-CELLS; PROTEIN; DRUG; CHLOROQUINE; INHIBITION; COMBINATION	Lactaptin, the proteolytic fragment of human milk kappa-casein, induces the death of various cultured cancer cells. The mechanisms leading to cell death after lactaptin treatment have not been well characterized. In this study the in vivo and in vitro effects of a recombinant analogue of lactaptin (RL2) were examined. Following treatment with the recombinant analogue of lactaptin strong caspase -3, -7 activation was detected. As a consequence of caspase activation we observed the appearance of a sub-G1 population of cells with subdiploid DNA content. Dynamic changes in the mRNA and protein levels of apoptosis-related genes were estimated. No statistically reliable differences in p53 mRNA level or protein level were found between control and RL2-treated cells. We observed that RL2 constitutively suppressed bcl-2 mRNA expression and down regulated Bcl-2 protein expression in MDA-MB-231 cells. We demonstrated that RL2 penetrates cancer and non-transformed cells. Identification of the cellular targets of the lactaptin analogue revealed that alpha/beta-tubulin and alpha-actinin-1 were RL2-bound proteins. As the alteration in cellular viability in response to protein stimulus can be realized not only by way of apoptosis but also by autophagy, we examined the implications of autophagy in RL2-dependent cell death. We also found that RL2 treatment induces LC3-processing, which is a hallmark of autophagy. The autophagy inhibitor chloroquine enhanced RL2 cytotoxicity to MDA-MB-231 cells, indicating the pro- survival effect of RL2-dependent autophagy. The antitumour potential of RL2 was investigated in vivo in mouse xenografts bearing MDA-MB-231 cells. We demonstrated that the recombinant analogue of lactaptin significantly suppressed the growth of solid tumours. Our results indicate that lactaptin could be a new molecule for the development of anticancer drugs.	[Koval, Olga A.; Tkachenko, Anastasiya V.; Fomin, Alexandr S.; Semenov, Dmitry V.; Nushtaeva, Anna A.; Kuligina, Elena V.; Richter, Vladimir A.] RUS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia; [Koval, Olga A.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Zavjalov, Eugeny L.] RUS, Inst Cytol & Genet, SB, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Koval, OA (corresponding author), RUS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia.	o.koval@niboch.nsc.ru	Tkachenko, Anastasiya/H-9649-2016; Fomin, Alexandr/AAP-6413-2020; Koval, Olga/G-8836-2013; Richter, Vladimir/G-9750-2013; Semenov, Dmitry V/Q-9153-2017; Nushtaeva, Anna/I-1547-2016; Fomin, Alexander/U-5928-2019	Nushtaeva, Anna/0000-0001-9367-807X; Koval, Olga/0000-0001-7788-2249; Kuligina, Elena/0000-0003-3145-1878	Siberian Branch of the Russian Academy of Sciences under the Program "Science to Medicine'' [13]; Siberian Branch of the Russian Academy of Sciences under the Integration Project [94]; Russian Foundation for Basic Research [13-04-01313a, 13-04-011457a]; Russian Federal Target Programs [16.N08.12.1009]	Siberian Branch of the Russian Academy of Sciences under the Program "Science to Medicine''; Siberian Branch of the Russian Academy of Sciences under the Integration Project; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Target Programs	The study was supported by the Siberian Branch of the Russian Academy of Sciences under the Program "Science to Medicine'' (Project no. 13) and Integration Project (no. 94), by grants from the Russian Foundation for Basic Research (Grant nos. 13-04-01313a and 13-04-011457a) and by a grant from Russian Federal Target Programs (Grant no. 16.N08.12.1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bedner E, 2000, EXP CELL RES, V259, P308, DOI 10.1006/excr.2000.4955; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkley M., 1992, BIOCONJUGATE CHEM, V1, P2; Bruck WM, 2014, BIOCHIMIE, V97, P138, DOI 10.1016/j.biochi.2013.10.007; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Edlund A, 1996, GENE, V174, P65, DOI 10.1016/0378-1119(96)00351-4; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Floris R, 2003, CURR PHARM DESIGN, V9, P1257, DOI 10.2174/1381612033454810; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Han J, 2013, J BIOL CHEM, V288, P20315, DOI 10.1074/jbc.M113.461350; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JS, 2009, BIOL PHARM BULL, V32, P150, DOI 10.1248/bpb.32.150; Kanyshkova TG, 2003, EUR J BIOCHEM, V270, P3353, DOI 10.1046/j.1432-1033.2003.03715.x; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Klionsky DJ, 2010, AUTOPHAGY, V6, P438, DOI 10.4161/auto.6.4.12244; Koval OA, 2012, BIOCHIMIE, V94, P2467, DOI 10.1016/j.biochi.2012.08.017; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liepke C, 2001, J CHROMATOGR B, V752, P369, DOI 10.1016/S0378-4347(00)00516-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Meng XW, 2006, CURR OPIN CELL BIOL, V18, P668, DOI 10.1016/j.ceb.2006.10.008; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morgner J, 2013, CELL CYCLE, V12, P2929, DOI 10.4161/cc.26213; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Nakamura T, 2013, J BIOL CHEM, V288, P14408, DOI 10.1074/jbc.M112.437889; Nekipelaya VV, 2008, DOKL BIOCHEM BIOPHYS, V419, P58, DOI 10.1134/S1607672908020038; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Semenov DV, 2010, PROTEIN J, V29, P174, DOI 10.1007/s10930-010-9237-5; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; STROMQVIST M, 1995, J PEDIATR GASTR NUTR, V21, P288, DOI 10.1097/00005176-199510000-00006; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Upreti M, 2008, MOL CANCER THER, V7, P2224, DOI 10.1158/1535-7163.MCT-07-2299; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Zinn RL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-16	48	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93921	10.1371/journal.pone.0093921	http://dx.doi.org/10.1371/journal.pone.0093921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710119	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800070
J	Poot, AJ; den Elzen, WPJ; Blom, JW; Gussekloo, J				Poot, Antonius J.; den Elzen, Wendy P. J.; Blom, Jeanet W.; Gussekloo, Jacobijn			Level of Satisfaction of Older Persons with Their General Practitioner and Practice: Role of Complexity of Health Problems	PLOS ONE			English	Article							GERIATRIC DEPRESSION SCALE; PATIENT-SATISFACTION; CARE; PERFORMANCE; EXPERIENCE; QUALITY	Background: Satisfaction is widely used to evaluate and direct delivery of medical care; a complicated relationship exists between patient satisfaction, morbidity and age. This study investigates the relationships between complexity of health problems and level of patient satisfaction of older persons with their general practitioner (GP) and practice. Methods and Findings: This study is embedded in the ISCOPE (Integrated Systematic Care for Older Persons) study. Enlisted patients aged >= 75 years from 59 practices received a written questionnaire to screen for complex health problems (somatic, functional, psychological and social). For 2664 randomly chosen respondents (median age 82 years; 68% female) information was collected on level of satisfaction (satisfied, neutral, dissatisfied) with their GP and general practice, and demographic and clinical characteristics including complexity of health problems. Of all participants, 4% was dissatisfied with their GP care, 59% neutral and 37% satisfied. Between these three categories no differences were observed in age, gender, country of birth or education level. The percentage of participants dissatisfied with their GP care increased from 0.4% in those with 0 problem domains to 8% in those with 4 domains, i.e. having complex health problems (p < 0.001). Per additional health domain with problems, the risk of being dissatisfied increased 1.7 times (95% CI 1.4-2.14; p < 0.001). This was independent of age, gender, and demographic and clinical parameters (adjusted OR 1.4, 95% CI 1.1-1.8; p = 0.021). Conclusion: In older persons, dissatisfaction with general practice is strongly correlated with rising complexity of health problems, independent of age, demographic and clinical parameters. It remains unclear whether complexity of health problems is a patient characteristic influencing the perception of care, or whether the care is unable to handle the demands of these patients. Prospective studies are needed to investigate the causal associations between care organization, patient characteristics, indicators of quality, and patient perceptions.	[Poot, Antonius J.; den Elzen, Wendy P. J.; Blom, Jeanet W.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Poot, AJ (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	a.j.poot@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021	Gussekloo, Jacobijn/0000-0001-7186-8278; den Elzen, Wendy/0000-0002-6774-4077	ZonMw, the Netherlands, Organization for Health Research and Development, ZonMw [311060201]	ZonMw, the Netherlands, Organization for Health Research and Development, ZonMw	This study was funded by ZonMw, the Netherlands, Organization for Health Research and Development, ZonMw number 311060201. Role of the sponsor: The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. http://www.zonmw.nl.	Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90; Chang JT, 2006, ANN INTERN MED, V144, P665, DOI 10.7326/0003-4819-144-9-200605020-00010; Collins K, 2003, SOC SCI MED, V57, P2465, DOI 10.1016/S0277-9536(03)00098-4; Crow R, 2002, Health Technol Assess, V6, P1; DATH P, 1994, FAM PRACT, V11, P260, DOI 10.1093/fampra/11.3.260; de Waal MWM, 2012, PSYCHIAT RES, V197, P280, DOI 10.1016/j.psychres.2011.08.019; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griffiths F, 2007, ANN FAM MED, V5, P377, DOI 10.1370/afm.727; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; Iezzoni LI, 2003, ARCH INTERN MED, V163, P2085, DOI 10.1001/archinte.163.17.2085; Jaques H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3164; Johnston CB, 2013, JAMA INTERN MED, V173, P2025, DOI 10.1001/jamainternmed.2013.11356; Kempen GIJM, 1996, SOC SCI MED, V43, P1601, DOI 10.1016/S0277-9536(96)00057-3; Kupfer JM, 2012, JAMA-J AM MED ASSOC, V308, P139, DOI 10.1001/jama.2012.7381; Salisbury C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5004; Salisbury C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4224; Steverink N, 2001, J GERONTOL B-PSYCHOL, V56, pP364, DOI 10.1093/geronb/56.6.P364	19	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94326	10.1371/journal.pone.0094326	http://dx.doi.org/10.1371/journal.pone.0094326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710557	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800136
J	Meng, XY; Yu, HL; Zhang, WC; Wang, TH; Mai, X; Liu, HT; Xu, RC				Meng, Xiang-yan; Yu, Hai-long; Zhang, Wen-cheng; Wang, Tian-hui; Mai, Xia; Liu, Hong-tao; Xu, Rui-cheng			ZFP580, a Novel Zinc-Finger Transcription Factor, Is Involved in Cardioprotection of Intermittent High-Altitude Hypoxia against Myocardial Ischemia-Reperfusion Injury	PLOS ONE			English	Article							PROTEIN-KINASES; INFARCT SIZE; HEART; APOPTOSIS; INHIBITION; ADAPTATION; ACTIVATION; EXPRESSION; PROTECTION; GENES	Background: ZFP580 is a novel C2H2 type zinc-finger transcription factor recently identified by our laboratory. We previously showed that ZFP580 may be involved in cell survival and growth. The aim of this study was to elucidate whether ZFP580 is involved in the cardioprotective effects of intermittent high-altitude (IHA) hypoxia against myocardial ischemia-reperfusion (I/R) injury. Methods and Results: After rats were subjected to myocardial ischemia for 30 min followed by reperfusion, ZFP580 expression in the left ventricle was measured. ZFP580 protein expression was found to be up-regulated within 1 h and decreased at 2 h after reperfusion. Comparing normoxic and IHA hypoxia-adapted rats (5000 m, 6 h day(-1), 6 weeks) following I/R injury (30 min ischemia and 2 h reperfusion), we found that adaptation to IHA hypoxia attenuated infarct size and plasma leakage of lactate dehydrogenase and creatine kinase-MB. In addition, ZFP580 expression in the myocardium was up-regulated by IHA hypoxia. Consistent with this result, ZFP580 expression was found to be significantly increased in cultured H9c2 myocardial cells in the hypoxic preconditioning group compared with those in the control group following simulated I/R injury (3 h simulated ischemic hypoxia and 2 h reoxygenation). To determine the role of ZFP580 in apoptosis, lentivirus-mediated gene transfection was performed in H9c2 cells 72 h prior to simulated I/R exposure. The results showed that ZFP580 overexpression significantly inhibited I/R-induced apoptosis and caspase-3 activation. H9c2 cells were pretreated with or without PD98059, an inhibitor of ERK1/2 phosphorylation, and Western blot results showed that PD98059 (10 mu M) markedly suppressed I/R-induced up-regulation of ZFP580 expression. Conclusions: Our findings demonstrate that the cardioprotective effect of IHA hypoxia against I/R injury is mediated via ZFP580, a downstream target of ERK1/2 signaling with anti-apoptotic roles in myocardial cells.	[Meng, Xiang-yan; Wang, Tian-hui; Liu, Hong-tao] Acad Mil Med Sci, Inst Hlth & Environm Med, Tianjin, Peoples R China; [Meng, Xiang-yan; Yu, Hai-long; Zhang, Wen-cheng; Mai, Xia] Logist Univ Chinese Peoples Armed Police Force, Dept Physiol & Pathophysiol, Tianjin, Peoples R China; [Xu, Rui-cheng] Logist Univ Chinese Peoples Armed Police Force, Tianjin Key Lab Biomarkers Occupat & Environm Haz, Tianjin, Peoples R China	Academy of Military Medical Sciences - China	Liu, HT (corresponding author), Acad Mil Med Sci, Inst Hlth & Environm Med, Tianjin, Peoples R China.	liuhongt@sina.com; xu_rc@sohu.com			Tianjin Natural Science Foundation [12JCYBJC15900]; Science Foundation of CAPF logistics university [WYM201108]; National Natural Science Foundation of China [81170106, 81370439, 81373108]	Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); Science Foundation of CAPF logistics university; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Tianjin Natural Science Foundation 12JCYBJC15900 (http://www.tstc.gov.cn) and the Science Foundation of CAPF logistics university WYM201108 (http://www.wjyxy.com). This work was also supported in part by National Natural Science Foundation of China (No. 81170106; No. 81370439; No. 81373108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asemu G, 1999, J MOL CELL CARDIOL, V31, P1821, DOI 10.1006/jmcc.1999.1013; Baxter GF, 1997, ANN MED, V29, P345, DOI 10.3109/07853899708999359; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Chen L, 2006, AM J PHYSIOL-CELL PH, V290, pC1221, DOI 10.1152/ajpcell.00526.2005; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Kolar F, 2004, PHYSIOL RES, V53, pS3; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; [孟祥艳 MENG Xiangyan], 2011, [中国病理生理杂志, Chinese Journal of Pathophysiology], V27, P1127; Neckar J, 2004, PHYSIOL RES, V53, P621; Nelson DP, 2002, ANN THORAC SURG, V73, P156, DOI 10.1016/S0003-4975(01)03303-3; Plumier JCL, 1996, J MOL CELL CARDIOL, V28, P1251, DOI 10.1006/jmcc.1996.0115; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Strniskova M, 2006, GEN PHYSIOL BIOPHYS, V25, P25; Sun HY, 2010, BIOCHEM BIOPH RES CO, V395, P361, DOI 10.1016/j.bbrc.2010.04.019; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; Vassalli G, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/928954; Wang ZH, 2012, EXP PHYSIOL, V97, P1105, DOI 10.1113/expphysiol.2012.065102; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhang WC, 2008, ACTA ACAD MED CPAF, V17, P161; [张文成 Zhang Wencheng], 2003, [基础医学与临床, Basic Medical Sciences and Clinics], V23, P279; Zhao ZQ, 2003, CARDIOVASC RES, V59, P132, DOI 10.1016/S0008-6363(03)00344-4; Zhu YB, 2008, LIFE SCI J, V5, P11	28	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94635	10.1371/journal.pone.0094635	http://dx.doi.org/10.1371/journal.pone.0094635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722354	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100109
J	Zhang, H; Li, JC; Sun, WJ; Hu, Y; Zhang, GF; Shen, MW; Shi, XY				Zhang, He; Li, Jingchao; Sun, Wenjie; Hu, Yong; Zhang, Guofu; Shen, Mingwu; Shi, Xiangyang			Hyaluronic Acid-Modified Magnetic Iron Oxide Nanoparticles for MR Imaging of Surgically Induced Endometriosis Model in Rats	PLOS ONE			English	Article							DEEP PELVIC ENDOMETRIOSIS; BIOMEDICAL APPLICATIONS; CONTRAST AGENTS; ADNEXAL MASSES; TUMORS; DIAGNOSIS; DELIVERY; FABRICATION; STRATEGIES	Endometriosis is defined as the presence of endometrial tissue outside the uterine, which may affect nearly 60% of women in reproductive age. Deep infiltrating endometriosis (DIE) defined as an endometriotic lesion penetrating into the retroperitoneal space or the wall of the pelvic organs to a depth of at least 5 mm represents the most diagnostic challenge. Herein, we reported the use of hyaluronic acid (HA)-modified magnetic iron oxide nanoparticles (HA-Fe3O4 NPs) for magnetic resonance (MR) imaging of endometriotic lesions in the rodent model. Sixteen endometriotic lesions were surgically induced in eight rats by autologous transplantation. Four weeks after lesion induction, three rats were scanned via MR imaging after tail vein injection of the HA-Fe3O4 NPs. Accordingly, the remaining five mice were sacrificed in the corresponding time points. The ectopic uterine tissues (EUTs) were confirmed by histological analysis. Quantification of Fe in the EUT was also performed by inductively coupled plasma-optical emission spectroscopy. Our results showed that by using the HA-Fe3O4 NPs, the EUTs were able to be visualized via T-2-weighted MR imaging at 2 hours post injection, corroborating the Prussian blue staining results. The developed HA-Fe3O4 NPs could be used as negative contrast agents for sensitively detecting endometriosis in a mouse model and may be applied for future hyperthermia treatment of endometriosis.	[Zhang, He; Zhang, Guofu] Fudan Univ, Obstet & Gynecol Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Li, Jingchao; Sun, Wenjie; Hu, Yong; Shen, Mingwu; Shi, Xiangyang] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China	Fudan University; Donghua University	Zhang, GF (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Radiol, Shanghai 200433, Peoples R China.	guofuzh@msn.com; mwshen@dhu.edu.cn; xshi@dhu.edu.cn	Hu, Yong/A-9308-2018; Shi, Xiangyang/A-1289-2007; shen, mingwu/B-2534-2012; Li, Jingchao/AAK-6909-2021	Hu, Yong/0000-0003-1425-6093; Shi, Xiangyang/0000-0001-6785-6645; 				Bae KH, 2006, BIOTECHNOL PROGR, V22, P297, DOI 10.1021/bp050312b; Bazot M, 2004, RADIOLOGY, V232, P379, DOI 10.1148/radiol.2322030762; Bazot M, 2011, EUR J RADIOL, V80, pE331, DOI 10.1016/j.ejrad.2010.12.006; Benagiano G, 2014, HUM REPROD UPDATE, V20, P386, DOI 10.1093/humupd/dmt052; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Busard MPH, 2010, J MAGN RESON IMAGING, V31, P1117, DOI 10.1002/jmri.22139; Cai HD, 2013, ACS APPL MATER INTER, V5, P1722, DOI 10.1021/am302883m; Chen Y, 2010, ACS NANO, V4, P6001, DOI 10.1021/nn1015117; Chertok B, 2010, BIOMATERIALS, V31, P6317, DOI 10.1016/j.biomaterials.2010.04.043; CORNILLIE FJ, 1990, FERTIL STERIL, V53, P978; Cramer DW, 2002, ANN NY ACAD SCI, V955, P11, DOI 10.1111/j.1749-6632.2002.tb02761.x; Dilks P, 2010, EUR RADIOL, V20, P2176, DOI 10.1007/s00330-010-1795-6; Griffin N, 2010, SEMIN ULTRASOUND CT, V31, P330, DOI 10.1053/j.sult.2010.07.002; Grummer R, 2006, HUM REPROD UPDATE, V12, P641, DOI 10.1093/humupd/dml026; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Jiang G, 2008, BIOPOLYMERS, V89, P635, DOI 10.1002/bip.20978; Kamat M, 2010, BIOCONJUGATE CHEM, V21, P2128, DOI 10.1021/bc100354m; Kinkel K, 2006, EUR RADIOL, V16, P285, DOI 10.1007/s00330-005-2882-y; Kumar R, 2010, ACS NANO, V4, P699, DOI 10.1021/nn901146y; Kyriazi S, 2011, RADIOLOGY, V261, P182, DOI 10.1148/radiol.11110577; Larsen EKU, 2009, ACS NANO, V3, P1947, DOI 10.1021/nn900330m; Lebovic DI, 2004, FERTIL STERIL, V82, P1008, DOI 10.1016/j.fertnstert.2004.02.148; Lee HJ, 2012, MAGN RESON IMAGING, V30, P860, DOI 10.1016/j.mri.2012.02.020; Lee N, 2012, NANO LETT, V12, P3127, DOI 10.1021/nl3010308; Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c; Li JC, 2014, BIOMATERIALS, V35, P3666, DOI 10.1016/j.biomaterials.2014.01.011; Li JC, 2013, ACS APPL MATER INTER, V5, P10357, DOI 10.1021/am4034526; Li JC, 2013, BIOMATERIALS, V34, P8382, DOI 10.1016/j.biomaterials.2013.07.070; Liu HL, 2008, BIOMATERIALS, V29, P4003, DOI 10.1016/j.biomaterials.2008.06.031; McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014; Pan BF, 2007, CANCER RES, V67, P8156, DOI 10.1158/0008-5472.CAN-06-4762; Salaa E, 2010, EUR J RADIOL, V76, P367, DOI 10.1016/j.ejrad.2010.01.026; Schreinemacher MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033241; Shi XY, 2008, ADV MATER, V20, P1671, DOI 10.1002/adma.200702770; Thomassin-Naggara I, 2009, EUR RADIOL, V19, P1544, DOI 10.1007/s00330-009-1299-4; TOGASHI K, 1991, RADIOLOGY, V180, P73, DOI 10.1148/radiology.180.1.2052726; Turcheniuk K, 2013, NANOSCALE, V5, P10729, DOI 10.1039/c3nr04131j; Wang ZJ, 2008, PEDIATR RADIOL, V38, P529, DOI 10.1007/s00247-008-0764-6; Xie J, 2007, ADV MATER, V19, P3163, DOI 10.1002/adma.200701975; Xu CJ, 2013, ADV DRUG DELIVER REV, V65, P732, DOI 10.1016/j.addr.2012.10.008; Xu CJ, 2009, DALTON T, P5583, DOI 10.1039/b900272n	41	34	35	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94718	10.1371/journal.pone.0094718	http://dx.doi.org/10.1371/journal.pone.0094718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722347	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100127
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-Hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			A Carapace-Like Bony 'Body Tube' in an Early Triassic Marine Reptile and the Onset of Marine Tetrapod Predation	PLOS ONE			English	Article							TURTLE; SAUROPTERYGIA; EVOLUTION; ORIGIN; CHINA; ICHTHYOSAUR; VENTILATION; SKELETON; MUSCLE	Parahupehsuchus longus is a new species of marine reptile from the Lower Triassic of Yuan'an County, Hubei Province, China. It is unique among vertebrates for having a body wall that is completely surrounded by a bony tube, about 50 cm long and 6.5 cm deep, comprising overlapping ribs and gastralia. This tube and bony ossicles on the back are best interpreted as anti-predatory features, suggesting that there was predation pressure upon marine tetrapods in the Early Triassic. There is at least one sauropterygian that is sufficiently large to feed on Parahupehsuchus in the Nanzhang-Yuan'an fauna, together with six more species of potential prey marine reptiles with various degrees of body protection. Modern predators of marine tetrapods belong to the highest trophic levels in the marine ecosystem but such predators did not always exist through geologic time. The indication of marine-tetrapod feeding in the Nanzhang-Yuan'an fauna suggests that such a trophic level emerged for the first time in the Early Triassic. The recovery from the end-Permian extinction probably proceeded faster than traditionally thought for marine predators. Parahupehsuchus has superficially turtle-like features, namely expanded ribs without intercostal space, very short transverse processes, and a dorsal outgrowth from the neural spine. However, these features are structurally different from their turtle counterparts. Phylogeny suggests that they are convergent with the condition in turtles, which has a fundamentally different body plan that involves the folding of the body wall. Expanded ribs without intercostal space evolved at least twice and probably even more among reptiles.	[Chen, Xiao-Hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Dept Geol, Minist Educ, Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	China Geological Survey Project [1212010611603, 1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]	China Geological Survey Project(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Geological Survey Project 1212010611603 to Xiao-hong Chen, the China Geological Survey Projects 1212011120148 to Long Cheng, and the National Natural Science Foundation of China Projects 40920124002 and 41372016 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll RL, 1991, PHILOS T R SOC B, V28, P131; Chen XH, 2013, ACTA GEOL SIN-ENGL, V87, P672, DOI 10.1111/1755-6724.12078; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Cheng L, 2012, J EARTH SCI-CHINA, V23, P33, DOI 10.1007/s12583-012-0231-z; Collin Rachel, 1997, P451, DOI 10.1016/B978-012155210-7/50024-7; DEBUFFRENIL V, 1985, ZOOMORPHOLOGY, V105, P336, DOI 10.1007/BF00312066; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hirasawa T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3107; Hoffstetter R., 1969, P201; Holz M, 1999, J AFR EARTH SCI, V29, P51, DOI 10.1016/S0899-5362(99)00079-2; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; LAURENTI JN, SPECIMEN MEDICUM EXH; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Li C, 2014, GEOL MAG, V151, P100, DOI 10.1017/S001675681300023X; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Lyson TR, 2013, CURR BIOL, V23, P1113, DOI 10.1016/j.cub.2013.05.003; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Munns SL, 2012, J EXP BIOL, V215, P845, DOI 10.1242/jeb.061952; Nagashima H, 2009, SCIENCE, V325, P193, DOI 10.1126/science.1173826; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Osborn HF, 1903, REPTILIAN SUBCLASSES, P449; Piscitelli MA, 2013, J MORPHOL, V274, P1425, DOI 10.1002/jmor.20192; Rieppel O, 1998, J VERTEBR PALEONTOL, V18, P545, DOI 10.1080/02724634.1998.10011082; Romer AS, 1956, OSTEOLOGY REPTILES, Vxxi; Rossmann T, 2002, NEUES JAHRB GEOL P-A, V224, P197; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; Schachner ER, 2011, ANAT REC, V294, P1532, DOI 10.1002/ar.21439; Scheyer TM, 2010, PALAEONTOL ELECTRON, V13; WALL WP, 1983, J PALEONTOL, V57, P197; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Weishampel D.B., 2004, DINOSAURIA, Vxviii; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Young C. c., 1965, Vertebrata Palasiatica, V9, P315; Young CC, 1972, AQUATIC REPTILES TRI, P17; Young CC, 1972, AQUATIC REPTILES TRI, P28	39	19	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94396	10.1371/journal.pone.0094396	http://dx.doi.org/10.1371/journal.pone.0094396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718682	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000116
J	Kummer, S; Flottmann, M; Schwanhausser, B; Sieben, C; Veit, M; Selbach, M; Klipp, E; Herrmann, A				Kummer, Susann; Floettmann, Max; Schwanhaeusser, Bjorn; Sieben, Christian; Veit, Michael; Selbach, Matthias; Klipp, Edda; Herrmann, Andreas			Alteration of Protein Levels during Influenza Virus H1N1 Infection in Host Cells: A Proteomic Survey of Host and Virus Reveals Differential Dynamics	PLOS ONE			English	Article							WEST-NILE-VIRUS; A VIRUS; NS1 PROTEIN; NUCLEAR EXPORT; MESSENGER-RNA; AMINO-ACIDS; POLY(A)-BINDING PROTEIN; TRANSLATION INITIATION; GENE-EXPRESSION; MATRIX PROTEIN	We studied the dynamics of the proteome of influenza virus A/PR/8/34 (H1N1) infected Madin-Darby canine kidney cells up to 12 hours post infection by mass spectrometry based quantitative proteomics using the approach of stable isotope labeling by amino acids in cell culture (SILAC). We identified 1311 cell proteins and, apart from the proton channel M2, all major virus proteins. Based on their abundance two groups of virus proteins could be distinguished being in line with the function of the proteins in genesis and formation of new virions. Further, the data indicate a correlation between the amount of proteins synthesized and their previously determined copy number inside the viral particle. We employed bioinformatic approaches such as functional clustering, gene ontology, and pathway (KEGG) enrichment tests to uncover co-regulated cellular protein sets, assigned the individual subsets to their biological function, and determined their interrelation within the progression of viral infection. For the first time we are able to describe dynamic changes of the cellular and, of note, the viral proteome in a time dependent manner simultaneously. Through cluster analysis, time dependent patterns of protein abundances revealed highly dynamic up-and/or down-regulation processes. Taken together our study provides strong evidence that virus infection has a major impact on the cell status at the protein level.	[Kummer, Susann; Floettmann, Max; Sieben, Christian; Klipp, Edda; Herrmann, Andreas] Humboldt Univ, Dept Biol, Fac Math & Nat Sci 1, Berlin, Germany; [Schwanhaeusser, Bjorn; Selbach, Matthias] Max Delbruck Ctr Mol Med, Berlin, Germany; [Veit, Michael] Inst Virol, Dept Vet Med, Berlin, Germany	Humboldt University of Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Klipp, E (corresponding author), Humboldt Univ, Dept Biol, Fac Math & Nat Sci 1, Berlin, Germany.	edda.klipp@rz.hu-berlin.de; andreas.herrmann@rz.hu-berlin.de	Sieben, Christian/Z-6050-2019	Sieben, Christian/0000-0002-2836-2623; Kummer, Susann/0000-0003-1010-9889; Veit, Michael/0000-0002-7638-1829	Federal Ministry of Education and Research; ViroSign; Deutsche Forschungsgemeinschaft [SFB 740]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); ViroSign; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was supported by the Federal Ministry of Education and Research (to M. S., E. K., A. H.; ViroSign; http://www.bmbf.de/en/index.php) and the Deutsche Forschungsgemeinschaft (to M. V. and A. H., SFB 740; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBO C, 1995, J VIROL, V69, P3799, DOI 10.1128/JVI.69.6.3799-3806.1995; ALONSOCAPLEN FV, 1991, MOL CELL BIOL, V11, P1092, DOI 10.1128/MCB.11.2.1092; Amanchy R., 2005, SCI STKE, V2005, P12; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barman S, 2003, VIROLOGY, V305, P138, DOI 10.1006/viro.2002.1731; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Bortz E, 2011, GENOME MED, V3, DOI 10.1186/gm283; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cheung TKW, 2007, ANN NY ACAD SCI, V1102, P1, DOI 10.1196/annals.1408.001; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; DELALUNA S, 1995, J VIROL, V69, P2427, DOI 10.1128/JVI.69.4.2427-2433.1995; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; Dent JE, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-27; Dove BK, 2012, PROTEOMICS, V12, P1431, DOI 10.1002/pmic.201100470; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Emmott E, 2010, J PROTEOME RES, V9, P5335, DOI 10.1021/pr100593g; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fiume L, 2011, EUR J PHARMACOL, V670, P39, DOI 10.1016/j.ejphar.2011.08.038; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Huang XY, 2001, VIROLOGY, V287, P405, DOI 10.1006/viro.2001.1067; Hui EKW, 2006, J VIROL, V80, P5697, DOI 10.1128/JVI.02729-05; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Jivotovskaya AV, 2006, MOL CELL BIOL, V26, P1355, DOI 10.1128/MCB.26.4.1355-1372.2006; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Korte T, 1997, J BIOL CHEM, V272, P9764; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kroeker AL, 2013, J PROTEOME RES, V12, P3139, DOI 10.1021/pr400464p; Lamb R. A., 1996, FIELDS VIROLOGY, P1353; Law GL, 2013, NAT REV MICROBIOL, V11, P455, DOI 10.1038/nrmicro3036; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; Merle E, 1999, J CELL BIOCHEM, V74, P628, DOI 10.1002/(SICI)1097-4644(19990915)74:4<628::AID-JCB12>3.0.CO;2-I; Meyniel-Schicklin L, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014738; Momose F, 1996, BIOCHIMIE, V78, P1103, DOI 10.1016/S0300-9084(97)86736-3; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nass N, 2009, BIOL CHEM, V390, P915, DOI 10.1515/BC.2009.083; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; PRIVALSKY ML, 1978, P NATL ACAD SCI USA, V75, P3625, DOI 10.1073/pnas.75.8.3625; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; ROTT R, 1984, EMBO J, V3, P3329, DOI 10.1002/j.1460-2075.1984.tb02299.x; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Salminen A, 2010, J CELL PHYSIOL, V224, P1, DOI 10.1002/jcp.22119; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SHAPIRO GI, 1987, J VIROL, V61, P764, DOI 10.1128/JVI.61.3.764-773.1987; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Sharma K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020215; Shih SR, 1996, VIROLOGY, V226, P430, DOI 10.1006/viro.1996.0673; Simpson-Holley M, 2002, VIROLOGY, V301, P212, DOI 10.1006/viro.2002.1595; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; UENO M, 1989, AM J PHYSIOL, V257, pC743, DOI 10.1152/ajpcell.1989.257.4.C743; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008	82	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94257	10.1371/journal.pone.0094257	http://dx.doi.org/10.1371/journal.pone.0094257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718678	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000334339000097
J	Wang, AY; Nie, WY; Li, HX; Hou, YH; Yu, Z; Fan, Q; Sun, RP				Wang, Aiyun; Nie, Wenying; Li, Haixia; Hou, Yuhua; Yu, Zhen; Fan, Qing; Sun, Ruopeng			Epigenetic Upregulation of Corticotrophin-Releasing Hormone Mediates Postnatal Maternal SeparationInduced Memory Deficiency	PLOS ONE			English	Article							EARLY-LIFE STRESS; LONG-TERM POTENTIATION; CPG-BINDING-PROTEIN; ENVIRONMENTAL ENRICHMENT; MOUSE HIPPOCAMPUS; DNA METHYLATION; SYNAPTIC PLASTICITY; HISTONE DEACETYLASE; FACTOR RECEPTORS; BDNF EXPRESSION	Accumulating evidences demonstrated that early postnatal maternal separation induced remarkable social and memory defects in the adult rodents. Early-life stress induced long-lasting functional adaptation of neuroendocrine hypothalamic-pituitary- adrenal axis, including neuropeptide corticotrophin- releasing hormone (CRH) in the brain. In the present study, a significantly increased hippocampal CRH was observed in the adult rats with postnatal maternal separation, and blockade of CRHR1 signaling significantly attenuated the hippocampal synaptic dysfunction and memory defects in the modeled rats. Postnatal maternal separation enduringly increased histone H3 acetylation and decreased cytosine methylation in Crh promoter region, resulting from the functional adaptation of several transcriptional factors, in the hippocampal CA1 of the modeled rats. Enriched environment reversed the epigenetic upregulation of CRH, and ameliorated the hippocampal synaptic dysfunction and memory defects in the adult rats with postnatal maternal separation. This study provided novel insights into the epigenetic mechanism underlying postnatal maternal separation- induced memory deficiency, and suggested environment enrichment as a potential approach for the treatment of this disorder.	[Wang, Aiyun; Nie, Wenying; Li, Haixia; Hou, Yuhua; Yu, Zhen; Fan, Qing; Sun, Ruopeng] Shandong Univ, Qilu Hosp, Dept Pediat, Jinan, Shandong, Peoples R China	Shandong University	Sun, RP (corresponding author), Shandong Univ, Qilu Hosp, Dept Pediat, Jinan, Shandong, Peoples R China.	rpsun01@163.com						Arai JA, 2011, BRAIN RES BULL, V85, P30, DOI 10.1016/j.brainresbull.2010.11.003; Blank T, 2003, J NEUROSCI, V23, P700, DOI 10.1523/JNEUROSCI.23-02-00700.2003; Blank T, 2002, J NEUROSCI, V22, P3788; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Branchi I, 2011, NEUROSCI LETT, V495, P168, DOI 10.1016/j.neulet.2011.03.038; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Chen J, 2012, J NEUROENDOCRINOL, V24, P1055, DOI 10.1111/j.1365-2826.2012.02306.x; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Diehl LA, 2014, NEUROCHEM RES, V39, P384, DOI 10.1007/s11064-013-1230-x; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Feng JA, 2010, NAT NEUROSCI, V13, P1039, DOI 10.1038/nn0910-1039; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hollrigel GS, 1998, NEUROSCIENCE, V84, P71, DOI 10.1016/S0306-4522(97)00499-5; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kuzumaki N, 2011, HIPPOCAMPUS, V21, P127, DOI 10.1002/hipo.20775; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levine A, 2012, NEUROBIOL DIS, V45, P488, DOI 10.1016/j.nbd.2011.09.005; Lian SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080638; Liu L, 2013, J BIOL CHEM, V288, P34719, DOI 10.1074/jbc.M113.506568; Lowery EG, 2010, NEUROPSYCHOPHARMACOL, V35, P1241, DOI 10.1038/npp.2009.209; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Mychasiuk R, 2012, BEHAV BRAIN RES, V228, P294, DOI 10.1016/j.bbr.2011.11.036; Na ES, 2013, NEUROPSYCHOPHARMACOL, V38, P212, DOI 10.1038/npp.2012.116; Neigh GN, 2013, NEUROSCIENCE, V249, P139, DOI 10.1016/j.neuroscience.2012.09.075; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Ouyang HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062192; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pita-Almenar JD, 2012, LEARN MEMORY, V19, P615, DOI 10.1101/lm.023259.111; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071691; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Row BW, 2008, NEUROBIOL LEARN MEM, V89, P370, DOI 10.1016/j.nlm.2007.10.008; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Shum FWF, 2007, LEARN MEMORY, V14, P304, DOI 10.1101/lm.530607; Skwara AJ, 2012, BEHAV BRAIN RES, V234, P1, DOI 10.1016/j.bbr.2012.06.003; Smith GK, 2014, HIPPOCAMPUS, V24, P354, DOI 10.1002/hipo.22229; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Thompson WR, 1954, CAN J PSYCHOLOGY, V8, P17, DOI 10.1037/h0083595; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; Typlt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081270; Valentino RJ, 2013, MOL PHARMACOL, V83, P737, DOI 10.1124/mol.112.083550; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang HL, 1998, EUR J NEUROSCI, V10, P3428, DOI 10.1046/j.1460-9568.1998.00352.x; Wang XD, 2013, NAT NEUROSCI, V16, P706, DOI 10.1038/nn.3395; Xie L, 2013, J NEUROCHEM, V125, P457, DOI 10.1111/jnc.12210; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	64	41	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94394	10.1371/journal.pone.0094394	http://dx.doi.org/10.1371/journal.pone.0094394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718660	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000115
J	Zhang, Z; Zhang, Y; Mou, Z; Chu, SF; Chen, XY; He, WB; Guo, XF; Yuan, YH; Takahashi, M; Chen, NH				Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Guo, Xiaofeng; Yuan, Yuhe; Takahashi, Masami; Chen, Naihong			Tyrosine 402 Phosphorylation of Pyk2 Is Involved in Ionomycin-Induced Neurotransmitter Release	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASE; TRANSMITTER RELEASE; SYNAPTIC VESICLES; CEREBRAL-ISCHEMIA; SIGNALING EVENTS; NERVOUS-SYSTEM; SRC; PYK2/CAK-BETA; FAK	Protein tyrosine kinases, which are highly expressed in the central nervous system, are implicated in many neural processes. However, the relationship between protein tyrosine kinases and neurotransmitter release remains unknown. In this study, we found that ionomycin, a Ca2+ ionophore, concurrently induced asynchronous neurotransmitter release and phosphorylation of a non-receptor protein tyrosine kinase, proline-rich tyrosine kinase 2 (Pyk2), in clonal rat pheochromocytoma PC12 cells and cerebellar granule cells, whereas introduction of Pyk2 siRNA dramatically suppressed ionomycin-induced neurotransmitter release. Further study indicated that Tyr-402 (Y402) in Pyk2, instead of other tyrosine sites, underwent rapid phosphorylation after ionomycin induction in 1 min to 2 min. We demonstrated that the mutant of Pyk2 Y402 could abolish ionomycin-induced dopamine (DA) release by transfecting cells with recombinant Pyk2 and its mutants (Y402F, Y579F, Y580F, and Y881F). In addition, Src inhibition could prolong phosphorylation of Pyk2 Y402 and increase DA release. These findings suggested that Pyk2 was involved in ionomycin-induced neurotransmitter release through phosphorylation of Y402.	[Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Yuan, Yuhe; Chen, Naihong] Chinese Acad Sci, Inst Mat Med, Dept Pharmacol,State Key Lab Bioact Subst & Funct, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, Beijing, Peoples R China; [Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Yuan, Yuhe; Chen, Naihong] Chinese Acad Sci, Ctr Neurosci, Beijing, Peoples R China; [Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Yuan, Yuhe; Chen, Naihong] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Wenbin; Guo, Xiaofeng] Shanxi Univ Tradit Chinese Med, Basic Med Coll, Taiyuan, Peoples R China; [Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 228, Japan	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kitasato University	Takahashi, M (corresponding author), Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 228, Japan.	masami@med.kitasato-u.ac.jp; chennh@imm.ac.cn			National Natural Science Foundation of China [81274122, 81073078, 81001487, 81373510, 81373998, 90713045]; National Key Sci-Tech Major Special Item [2012ZX09301002-004, 2012ZX09103101-006]; National 863 Program of China [2012AA020303]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1007]; Beijing Natural Science Foundation [7131013]; Research Fund for the Doctoral Program of Higher Education of China [20121106130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Major Special Item; National 863 Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by grants from the National Natural Science Foundation of China Grants (No. 81274122, No. 81073078, No. 81001487, No. 81373510, No. 81373998, Key Program No. 90713045), National Key Sci-Tech Major Special Item (No. 2012ZX09301002-004, No. 2012ZX09103101-006), National 863 Program of China (No. 2012AA020303), Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1007), the Beijing Natural Science Foundation (7131013), and the Research Fund for the Doctoral Program of Higher Education of China (20121106130001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atluri PP, 1998, J NEUROSCI, V18, P8214; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; BURGAYA F, 1995, EUR J NEUROSCI, V7, P1810, DOI 10.1111/j.1460-9568.1995.tb00700.x; Cheung HH, 2000, J CEREBR BLOOD F MET, V20, P505, DOI 10.1097/00004647-200003000-00009; Cummings DD, 1996, J NEUROSCI, V16, P5312; Derkinderen P, 1998, EUR J NEUROSCI, V10, P1667, DOI 10.1046/j.1460-9568.1998.00174.x; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gurd JW, 1997, NEUROCHEM INT, V31, P635, DOI 10.1016/S0197-0186(97)00022-3; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Jensen K, 2000, BRAIN RES, V880, P198, DOI 10.1016/S0006-8993(00)02746-3; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Katagiri T, 2000, J BIOL CHEM, V275, P19645, DOI 10.1074/jbc.M909828199; Kirischuk S, 2003, J PHYSIOL-LONDON, V548, P753, DOI 10.1113/jphysiol.2002.037036; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lim ST, 2009, J BIOL CHEM; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Tian DH, 2000, J NEUROSCI, V20, P6478, DOI 10.1523/JNEUROSCI.20-17-06478.2000; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94574	10.1371/journal.pone.0094574	http://dx.doi.org/10.1371/journal.pone.0094574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718602	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000132
J	Bhattacharjee, K; Joshi, SR				Bhattacharjee, Kaushik; Joshi, Santa Ram			NEMiD: A Web-Based Curated Microbial Diversity Database with Geo-Based Plotting	PLOS ONE			English	Article							GRADIENTS; RESOURCE	The majority of the Earth's microbes remain unknown, and that their potential utility cannot be exploited until they are discovered and characterized. They provide wide scope for the development of new strains as well as biotechnological uses. The documentation and bioprospection of microorganisms carry enormous significance considering their relevance to human welfare. This calls for an urgent need to develop a database with emphasis on the microbial diversity of the largest untapped reservoirs in the biosphere. The data annotated in the North-East India Microbial database (NEMiD) were obtained by the isolation and characterization of microbes from different parts of the Eastern Himalayan region. The database was constructed as a relational database management system (RDBMS) for data storage in MySQL in the back-end on a Linux server and implemented in an Apache/PHP environment. This database provides a base for understanding the soil microbial diversity pattern in this megabiodiversity hotspot and indicates the distribution patterns of various organisms along with identification. The NEMiD database is freely available at www.mblabnehu.info/nemid/.	[Bhattacharjee, Kaushik; Joshi, Santa Ram] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India	North Eastern Hill University	Joshi, SR (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India.	srjoshi2006@yahoo.co.in	Joshi/F-2097-2015; Bhattacharjee, Dr. Kaushik/C-7676-2013	Bhattacharjee, Dr. Kaushik/0000-0002-2866-2239; Joshi, Santa Ram/0000-0001-8080-484X	Department of Electronics & Information Technology, Ministry of Communications & Information Technology, Government of India, New Delhi [DIT/R&D/BIO/15(14)/2008]	Department of Electronics & Information Technology, Ministry of Communications & Information Technology, Government of India, New Delhi	This work was funded by the Department of Electronics & Information Technology, Ministry of Communications & Information Technology, Government of India, New Delhi [Grant number No. DIT/R&D/BIO/15(14)/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034613; Bedathur SJ, 2003, INFORM SYST, V28, P347, DOI 10.1016/S0306-4379(02)00073-X; Bhattacharjee K, 2012, BIOINFORMATION, V8, P548, DOI 10.6026/97320630008548; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Demain AL, 2000, BIOTECHNOL ADV, V18, P499, DOI 10.1016/S0734-9750(00)00049-5; Devi Lamabam Sophiya, 2012, Mycobiology, V40, P151, DOI 10.5941/MYCO.2012.40.3.151; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Holdener III A. T., 2008, AJAX DEFINITIVE GUID; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kumar A, 2010, CURR SCI INDIA, V99, P98; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lyngwi NA, 2013, REV BIOL TROP, V61, P467; Mahe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043117; Majhi MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063083; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Triplet T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq011; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Xu QF, 2006, BIOINFORMATICS, V22, P2876, DOI 10.1093/bioinformatics/btl490; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	24	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94088	10.1371/journal.pone.0094088	http://dx.doi.org/10.1371/journal.pone.0094088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714636	Green Published, gold			2022-12-27	WOS:000334160900080
J	Merckel, LG; Verkooijen, HM; Peters, NHGM; Mann, RM; Veldhuis, WB; Storm, RK; Weits, T; Duvivier, KM; van Dalen, T; Mali, WPTM; Peeters, PHM; van den Bosch, MAAJ				Merckel, Laura G.; Verkooijen, Helena M.; Peters, Nicky H. G. M.; Mann, Ritse M.; Veldhuis, Wouter B.; Storm, Remmert K.; Weits, Teun; Duvivier, Katya M.; van Dalen, Thijs; Mali, Willem P. Th M.; Peeters, Petra H. M.; van den Bosch, Maurice A. A. J.			The Added Diagnostic Value of Dynamic Contrast-Enhanced MRI at 3.0 T in Nonpalpable Breast Lesions	PLOS ONE			English	Article							MAMMOGRAPHY; GUIDELINES; ACCURACY; CANCER	Objective: To investigate the added diagnostic value of 3.0 Tesla breast MRI over conventional breast imaging in the diagnosis of in situ and invasive breast cancer and to explore the role of routine versus expert reading. Materials and Methods: We evaluated MRI scans of patients with nonpalpable BI-RADS 3-5 lesions who underwent dynamic contrast-enhanced 3.0 Tesla breast MRI. Initially, MRI scans were read by radiologists in a routine clinical setting. All histologically confirmed index lesions were re-evaluated by two dedicated breast radiologists. Sensitivity and specificity for the three MRI readings were determined, and the diagnostic value of breast MRI in addition to conventional imaging was assessed. Interobserver reliability between the three readings was evaluated. Results: MRI examinations of 207 patients were analyzed. Seventy-eight of 207 (37.7%) patients had a malignant lesion, of which 33 (42.3%) patients had pure DCIS and 45 (57.7%) invasive breast cancer. Sensitivity of breast MRI was 66.7% during routine, and 89.3% and 94.7% during expert reading. Specificity was 77.5% in the routine setting, and 61.0% and 33.3% during expert reading. In the routine setting, MRI provided additional diagnostic information over clinical information and conventional imaging, as the Area Under the ROC Curve increased from 0.76 to 0.81. Expert MRI reading was associated with a stronger improvement of the AUC to 0.87. Interobserver reliability between the three MRI readings was fair and moderate. Conclusions: 3.0 T breast MRI of nonpalpable breast lesions is of added diagnostic value for the diagnosis of in situ and invasive breast cancer.	[Merckel, Laura G.; Peters, Nicky H. G. M.; Veldhuis, Wouter B.; Duvivier, Katya M.; Mali, Willem P. Th M.; van den Bosch, Maurice A. A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands; [Mann, Ritse M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Storm, Remmert K.] Albert Schweitzer Hosp, Dept Radiol, Dordrecht, Netherlands; [Weits, Teun] Diakonessen Hosp, Dept Radiol, Utrecht, Netherlands; [van Dalen, Thijs] Diakonessen Hosp, Dept Surg, Utrecht, Netherlands; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Duvivier, Katya M.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Albert Schweitzer Ziekenhuis; Diakonessenhuis; Diakonessenhuis; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	Merckel, LG (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	L.G.Merckel-2@umcutrecht.nl	Mann, R.M./L-4502-2015; Mali, Willem PThM/I-1123-2014; Merckel, Laura/ABE-2750-2020	Mann, R.M./0000-0001-8111-1930; Mali, Willem PThM/0000-0003-4391-0904; Veldhuis, Wouter/0000-0002-9798-6843				Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; BASSETT LW, 1992, RADIOL CLIN N AM, V30, P93; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; DeMartini Wendy, 2008, Top Magn Reson Imaging, V19, P143, DOI 10.1097/RMR.0b013e31818a40a5; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Grobbee DE, 2008, CLIN EPIDEMIOLOGY; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hrung JM, 1999, ACAD RADIOL, V6, P387, DOI 10.1016/S1076-6332(99)80189-5; Ikeda DM, 2001, J MAGN RESON IMAGING, V13, P889, DOI 10.1002/jmri.1127; Ikeda O, 1999, ACTA RADIOL, V40, P585, DOI 10.3109/02841859909175592; Jansen SA, 2008, MED PHYS, V35, P3102, DOI 10.1118/1.2936220; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Kuhl CK, 2006, RADIOLOGY, V239, P666, DOI 10.1148/radiol.2392050509; Malur S, 2001, BREAST CANCER RES, V3, P55, DOI 10.1186/bcr271; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Medeiros LR, 2011, BREAST CANCER RES TR, V126, P273, DOI 10.1007/s10549-010-1326-9; Mussurakis S, 1996, BRIT J RADIOL, V69, P1009, DOI 10.1259/0007-1285-69-827-1009; Newell D, 2010, EUR RADIOL, V20, P771, DOI 10.1007/s00330-009-1616-y; Peters NHGM, 2011, EUR J CANCER, V47, P879, DOI 10.1016/j.ejca.2010.11.035; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; Pinker K, 2014, INVEST RADIOL; Rosen EL, 2007, BREAST J, V13, P545, DOI 10.1111/j.1524-4741.2007.00513.x; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Shimauchi A, 2011, RADIOLOGY, V258, P696, DOI 10.1148/radiol.10100409; Turnbull LW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14010; Veltman J, 2010, EUR J RADIOL, V74, P514, DOI 10.1016/j.ejrad.2009.03.053; Veronesi U, 2010, ONCOLOGIST, V15, P1248, DOI 10.1634/theoncologist.2010-0123; Wedegartner U, 2001, EUR RADIOL, V11, P1645, DOI 10.1007/s003300100885	29	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94233	10.1371/journal.pone.0094233	http://dx.doi.org/10.1371/journal.pone.0094233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713637	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900107
J	Poretsky, R; Rodriguez-R, LM; Luo, CW; Tsementzi, D; Konstantinidis, KT				Poretsky, Rachel; Rodriguez-R, Luis M.; Luo, Chengwei; Tsementzi, Despina; Konstantinidis, Konstantinos T.			Strengths and Limitations of 16S rRNA Gene Amplicon Sequencing in Revealing Temporal Microbial Community Dynamics	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; DIVERSITY; PATTERNS; PROCHLOROCOCCUS; CLASSIFICATION; VARIABILITY; RESILIENCE; REDUNDANCY; RESISTANCE; HABITATS	This study explored the short-term planktonic microbial community structure and resilience in Lake Lanier (GA, USA) while simultaneously evaluating the technical aspects of identifying taxa via 16S rRNA gene amplicon and metagenomic sequence data. 16S rRNA gene amplicons generated from four temporally discrete samples were sequenced with 454 GS-FLX-Ti yielding similar to 40,000 rRNA gene sequences from each sample and representing similar to 300 observed OTUs. Replicates obtained from the same biological sample clustered together but several biases were observed, linked to either the PCR or sequencing-preparation steps. In comparisons with companion whole-community shotgun metagenome datasets, the estimated number of OTUs at each timepoint was concordant, but 1.5 times and similar to 10 times as many phyla and genera, respectively, were identified in the metagenomes. Our analyses showed that the 16S rRNA gene captures broad shifts in community diversity over time, but with limited resolution and lower sensitivity compared to metagenomic data. We also identified OTUs that showed marked shifts in abundance over four close timepoints separated by perturbations and tracked these taxa in the metagenome vs. 16S rRNA amplicon data. A strong summer storm had less of an effect on community composition than did seasonal mixing, which revealed a distinct succession of organisms. This study provides insights into freshwater microbial communities and advances the approaches for assessing community diversity and dynamics in situ.	[Poretsky, Rachel; Tsementzi, Despina; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Rodriguez-R, Luis M.; Luo, Chengwei; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Rodriguez-R, Luis M.; Luo, Chengwei; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Ctr Bioinformat Computat Genom, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Poretsky, R (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	microbe@uic.edu	Rodriguez-R, Luis M./S-6996-2018; Konstantinidis, Kostas/ABE-7113-2020	Rodriguez-R, Luis M./0000-0001-7603-3093; Konstantinidis, Kostas/0000-0002-0954-4755; Tsementzi, Despina/0000-0002-4578-1918	U.S. Department of Energy [DE-SC0006662]; U.S. National Science Foundation [1241046]; Direct For Biological Sciences [1241046] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by the U.S. Department of Energy (Award DE-SC0006662) and by U.S. National Science Foundation (Award 1241046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Corzo A, 1999, J PLANKTON RES, V21, P1575, DOI 10.1093/plankt/21.8.1575; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kent AD, 2004, MICROB ECOL, V48, P550, DOI 10.1007/s00248-004-0244-y; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Luo C, NUC ACIDS RES; Luo CW, 2012, ISME J, V6, P898, DOI 10.1038/ismej.2011.147; McDonald IR, 2005, INT J SYST EVOL MICR, V55, P1827, DOI 10.1099/ijs.0.63716-0; Methe BA, 1999, HYDROBIOLOGIA, V401, P77, DOI 10.1023/A:1003782209607; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Newton RJ, 2011, ENVIRON MICROBIOL, V13, P887, DOI 10.1111/j.1462-2920.2010.02387.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Portillo MC, 2012, ENVIRON MICROBIOL, V14, P2417, DOI 10.1111/j.1462-2920.2012.02785.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-R LM, 2014, BIOINFORMATICS, V30, P629, DOI 10.1093/bioinformatics/btt584; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; Shade A, 2012, ISME J, V6, P2153, DOI 10.1038/ismej.2012.56; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stenuite S, 2009, J PLANKTON RES, V31, P1531, DOI 10.1093/plankt/fbp090; Steven B, 2012, ENV MICROBIOL REP, V4, P248, DOI 10.1111/j.1758-2229.2012.00328.x; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275; Zwisler W, 2003, AQUAT MICROB ECOL, V31, P211, DOI 10.3354/ame031211	62	316	324	3	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93827	10.1371/journal.pone.0093827	http://dx.doi.org/10.1371/journal.pone.0093827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714158	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900053
J	Beigel, F; Friedrich, M; Probst, C; Sotlar, K; Goke, B; Diegelmann, J; Brand, S				Beigel, Florian; Friedrich, Matthias; Probst, Corina; Sotlar, Karl; Goeke, Burkhard; Diegelmann, Julia; Brand, Stephan			Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial Restitution via Increased Cell Proliferation, Decreased Apoptosis and Upregulation of SERPIN Family Members	PLOS ONE			English	Article							CROHNS-DISEASE; PROTEIN-KINASE; GROWTH-FACTOR; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; INTERLEUKIN-6; LYMPHOCYTES; FRACTALKINE; MIGRATION	Objective: Oncostatin M (OSM) is produced by activated T cells, monocytes, and dendritic cells and signals through two distinct receptor complexes consisting of gp130 and LIFR (I) or OSMR-beta and gp130 (II), respectively. Aim of this study was to analyze the role of OSM in intestinal epithelial cells (IEC) and intestinal inflammation. Methods: OSM expression and OSM receptor distribution was analyzed by PCR and immunohistochemistry experiments, signal transduction by immunoblotting. Gene expression studies were performed by microarray analysis and RT-PCR. Apoptosis was measured by caspases-3/7 activity. IEC migration and proliferation was studied in wounding and water soluble tetrazolium assays. Results: The IEC lines Caco-2, DLD-1, SW480, HCT116 and HT-29 express mRNA for the OSM receptor subunits gp130 and OSMR-b, while only HCT116, HT-29 and DLD-1 cells express LIFR mRNA. OSM binding to its receptor complex activates STAT1, STAT3, ERK-1/2, SAPK/JNK-1/2, and Akt. Microarray analysis revealed 79 genes that were significantly up-regulated (adj.-p <= 0.05) by OSM in IEC. Most up-regulated genes belong to the functional categories "immunity and defense'' (p=2.1x10(-7)), "apoptosis'' (p=3.7x10(-4)) and "JAK/STAT cascade'' (p=3.4x10(-6)). Members of the SERPIN gene family were among the most strongly up-regulated genes. OSM significantly increased STAT3- and MEK1-dependent IEC cell proliferation (p < 0.05) and wound healing (p=3.9x10(-5)). OSM protein expression was increased in colonic biopsies of patients with active inflammatory bowel disease (IBD). Conclusions: OSM promotes STAT3-dependent intestinal epithelial cell proliferation and wound healing in vitro. Considering the increased OSM expression in colonic biopsy specimens of patients with active IBD, OSM upregulation may modulate a barrier-protective host response in intestinal inflammation. Further in vivo studies are warranted to elucidate the exact role of OSM in intestinal inflammation and the potential of OSM as a drug target in IBD.	[Beigel, Florian; Friedrich, Matthias; Probst, Corina; Goeke, Burkhard; Diegelmann, Julia; Brand, Stephan] Univ Munich, Univ Hosp Munich Grosshadern, Dept Med 2, Munich, Germany; [Sotlar, Karl] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Clin Prevent Dent & Parodontol, Munich, Germany	University of Munich; University of Munich; University of Munich	Brand, S (corresponding author), Univ Munich, Univ Hosp Munich Grosshadern, Dept Med 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [BE 4490/2-1, BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium)	This work is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BE 4490/2-1) to F. Beigel. S. Brand is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BR 1912/6-1) and the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Boutten A, 1998, AM J RESP CELL MOL, V18, P511, DOI 10.1165/ajrcmb.18.4.2772; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brand S, 2005, EXP CELL RES, V310, P117, DOI 10.1016/j.yexcr.2005.07.006; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brand S, 2005, EXP CELL RE IN PRESS; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Calabrese F, 2008, THORAX, V63, P795, DOI 10.1136/thx.2007.088583; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; de Koning PJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022645; Diegelmann J, 2012, J BIOL CHEM; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dumas A, 2012, J CELL MOL MED, V16, P1274, DOI 10.1111/j.1582-4934.2011.01412.x; Fearon U, 2006, ARTHRITIS RHEUM-US, V54, P3152, DOI 10.1002/art.22161; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Hoffmann DC, 2011, J BIOL CHEM, V286, P28889, DOI 10.1074/jbc.M111.249979; Hohensinner PJ, 2009, FASEB J, V23, P774, DOI 10.1096/fj.08-108035; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanda J, 2009, INT J HEMATOL, V90, P545, DOI 10.1007/s12185-009-0443-x; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Matthews VB, 2005, EXP CELL RES, V306, P252, DOI 10.1016/j.yexcr.2005.02.010; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Migita K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3333; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nagaishi T, 2008, MUCOSAL IMMUNOL, V1, pS39, DOI 10.1038/mi.2008.50; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Paul-Pletzer K, 2006, DRUG TODAY, V42, P559, DOI 10.1358/dot.2006.42.9.1025692; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Quarta S, 2010, J PATHOL, V221, P343, DOI 10.1002/path.2708; Rega G, 2005, CIRCULATION, V111, P1938, DOI 10.1161/01.CIR.0000161823.55935.BE; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; Roda G, 2009, INFLAMM BOWEL DIS, V15, P1775, DOI 10.1002/ibd.21023; Sanchez AL, 2003, J INTERF CYTOK RES, V23, P193, DOI 10.1089/107999003765027393; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Shin SH, 2012, INT WOUND J; Taga T, 1997, ANN MED, V29, P63, DOI 10.3109/07853899708998744; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; THOMA B, 1994, J BIOL CHEM, V269, P6215; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uchiyama K, 2012, AM J PHYSIOL-GASTR L, V302, pG1163, DOI 10.1152/ajpgi.00292.2011; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Wahl AF, 2001, ANN RHEUM DIS, V60, pIII75; Weiss TW, 2003, CARDIOVASC RES, V59, P628, DOI 10.1016/S0008-6363(03)00463-2; Woo JK, 2012, ONCOGENE, V31, P2187, DOI 10.1038/onc.2011.410	64	39	40	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93498	10.1371/journal.pone.0093498	http://dx.doi.org/10.1371/journal.pone.0093498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710357	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800036
J	Chekabab, SM; Jubelin, G; Dozois, CM; Harel, J				Chekabab, Samuel Mohammed; Jubelin, Gregory; Dozois, Charles M.; Harel, Josee			PhoB Activates Escherichia coli O157: H7 Virulence Factors in Response to Inorganic Phosphate Limitation	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; ACANTHAMOEBA-CASTELLANII; REGULON; GENE; PST; EXPRESSION; REGULATOR; SYSTEM; OPERON; PROTEIN	Enterohemorrhagic Escherichia coli (EHEC), an emerging food-and water-borne hazard, is highly pathogenic to humans. In the environment, EHEC must survive phosphate (Pi) limitation. The response to such Pi starvation is an induction of the Pho regulon including the Pst system that senses Pi variation. The interplay between the virulence of EHEC, Pho-Pst system and environmental Pi remains unknown. To understand the effects of Pi deprivation on the molecular mechanisms involved in EHEC survival and virulence under Pho regulon control, we undertook transcriptome profiling of the EDL933 wild-type strain grown under high Pi and low Pi conditions and its isogenic triangle phoB mutant grown in low Pi conditions. The differentially expressed genes included 1067 Pi-dependent genes and 603 PhoB-dependent genes. Of these 131 genes were both Pi and PhoB-dependent. Differentially expressed genes that were selected included those involved in Pi homeostasis, cellular metabolism, acid stress, oxidative stress and RpoS-dependent stress responses. Differentially expressed virulence systems included the locus of enterocyte effacement (LEE) encoding the type-3 secretion system (T3SS) and its effectors, as well as BP-933W prophage encoded Shiga toxin 2 genes. Moreover, PhoB directly regulated LEE and stx2 gene expression through binding to specific Pho boxes. However, in Pi-rich medium, constitutive activation of the Pho regulon decreased LEE gene expression and reduced adherence to HeLa cells. Together, these findings reveal that EHEC has evolved a sophisticated response to Pi limitation involving multiple biochemical strategies that contribute to its ability to respond to variations in environmental Pi and to coordinating the virulence response.	[Chekabab, Samuel Mohammed; Harel, Josee] Univ Montreal, Fac Med Vet, Res Grp Infect Dis Swine, St Hyacinthe, PQ J2S 7C6, Canada; [Jubelin, Gregory] INRA Clermont Ferrand Theix, Unite Microbiol UR454, St Genes Champanelle, France; [Dozois, Charles M.] Inst Armand Frappier, INRS, Laval, PQ, Canada	Universite de Montreal; INRAE; University of Quebec; Institut national de la recherche scientifique (INRS)	Harel, J (corresponding author), Univ Montreal, Fac Med Vet, Res Grp Infect Dis Swine, St Hyacinthe, PQ J2S 7C6, Canada.	josee.harel@umontreal.ca	Harel, Josée/H-1933-2011	Harel, Josée/0000-0002-7822-3795; JUBELIN, Gregory/0000-0002-9902-0663; Chekabab, Samuel M/0000-0002-5636-4095	Natural Sciences and Engineering Research [250129-07, 25120-13]; Centre de Recherche en Infectiologie Porcine et Aviaire from Fonds de Recherche du Quebec Nature et technologies [RS-170946]	Natural Sciences and Engineering Research(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre de Recherche en Infectiologie Porcine et Aviaire from Fonds de Recherche du Quebec Nature et technologies	This work was supported by Discovery grants (250129-07) to C. M. D. and (25120-13) to J.H. from the Natural Sciences and Engineering Research and the strategic grant (RS-170946) Centre de Recherche en Infectiologie Porcine et Aviaire from Fonds de Recherche du Quebec Nature et technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arribas-Bosacoma R, 2007, J MOL BIOL, V366, P626, DOI 10.1016/j.jmb.2006.11.038; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; Bertrand N, 2010, INFECT IMMUN, V78, P5324, DOI 10.1128/IAI.00452-10; Bhatt S, 2011, TRENDS MICROBIOL, V19, P217, DOI 10.1016/j.tim.2011.01.004; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Carruthers MD, 2010, FEMS MICROBIOL LETT, V312, P15, DOI 10.1111/j.1574-6968.2010.02098.x; Chan FY, 1996, J BACTERIOL, V178, P3974, DOI 10.1128/jb.178.13.3974-3977.1996; Chekabab SM, 2013, FEMS MICROBIOL LETT, V341, P1, DOI 10.1111/1574-6968.12078; Chekabab SM, 2012, MICROBIOLOGYOPEN, V1, P427, DOI 10.1002/mbo3.40; Cheng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050682; Cheng C, 2009, INFECT IMMUN, V77, P1936, DOI 10.1128/IAI.01246-08; Crepin S, 2012, INFECT IMMUN, V80, P2802, DOI 10.1128/IAI.00162-12; Crepin S, 2011, VET MICROBIOL, V153, P82, DOI 10.1016/j.vetmic.2011.05.043; Crepin S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-568; DAIGLE F, 1995, INFECT IMMUN, V63, P4924, DOI 10.1128/IAI.63.12.4924-4927.1995; Danhorn T, 2004, J BACTERIOL, V186, P4492, DOI 10.1128/JB.186.14.4492-4501.2004; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; FISHER SL, 1995, J BIOL CHEM, V270, P23143, DOI 10.1074/jbc.270.39.23143; Gao R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003927; Gao R, 2013, P NATL ACAD SCI USA, V110, P672, DOI 10.1073/pnas.1214587110; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; Gobert AP, 2007, J IMMUNOL, V178, P8168, DOI 10.4049/jimmunol.178.12.8168; Graveline R, 2011, ETUDE MECANISMES MOL; Graveline R, 2011, MOL MICROBIOL, V81, P1286, DOI 10.1111/j.1365-2958.2011.07761.x; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Haack KR, 2003, INFECT IMMUN, V71, P384, DOI 10.1128/IAI.71.1.384-392.2003; Hancock D, 2001, INT J FOOD MICROBIOL, V66, P71, DOI 10.1016/S0168-1605(00)00487-6; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Imamovic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032393; JANS DA, 1983, BIOCHEM J, V211, P717, DOI 10.1042/bj2110717; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; KAYNE LH, 1993, J CLIN INVEST, V91, P915, DOI 10.1172/JCI116313; Kendall MM, 2010, MOL MICROBIOL, V76, P1306, DOI 10.1111/j.1365-2958.2010.07174.x; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamarche MG, 2010, CURR MICROBIOL, V60, P356, DOI 10.1007/s00284-009-9549-x; Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005; Lemann Jacob Jr., 1993, P46; LITTLE JW, 1995, REGULATION GENE EXPR, P453; Loewen PC, 1998, CAN J MICROBIOL, V44, P707, DOI 10.1139/cjm-44-8-707; Magid J., 1996, HUMIC SUBSTANCES TER, P429; Mandel MJ, 2005, J BACTERIOL, V187, P434, DOI 10.1128/JB.187.2.434-442.2005; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Muhldorfer I, 1996, INFECT IMMUN, V64, P495; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Pieper R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066462; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Ptashne M, 1992, GENETIC SWITCH PHAGE; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; STROCKBINE NA, 1986, INFECT IMMUN, V53, P135, DOI 10.1128/IAI.53.1.135-140.1986; Suziedeliene E, 1999, J BACTERIOL, V181, P2084; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Tyler JS, 2004, J BACTERIOL, V186, P7670, DOI 10.1128/JB.186.22.7670-7679.2004; Unkmeir A, 2000, INFECT IMMUN, V68, P4856, DOI 10.1128/IAI.68.9.4856-4864.2000; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; WALTON J, 1979, CLIN SCI, V56, P407, DOI 10.1042/cs0560407; Wanner Barry L., 1994, Biodegradation, V5, P175, DOI 10.1007/BF00696458; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047314; Yoshida Y, 2012, GENE, V502, P27, DOI 10.1016/j.gene.2012.03.064; Yoshida Y, 2010, MOL GENET GENOMICS, V284, P197, DOI 10.1007/s00438-010-0559-y; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043; Zubkov MV, 2007, ENVIRON MICROBIOL, V9, P2079, DOI 10.1111/j.1462-2920.2007.01324.x	82	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94285	10.1371/journal.pone.0094285	http://dx.doi.org/10.1371/journal.pone.0094285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710330	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000334159800131
J	Li, LH; Wang, ZC; Yu, J; Zhang, YQ				Li, Li-Hong; Wang, Zhe-Chen; Yu, Jin; Zhang, Yu-Qiu			Ovariectomy Results in Variable Changes in Nociception, Mood and Depression in Adult Female Rats	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; CINGULATE CORTEX CONTRIBUTES; ESTRADIOL REPLACEMENT; ESTROGEN REPLACEMENT; AFFECTIVE COMPONENT; WATER-MAZE; PAIN; HYPERALGESIA; PROGESTERONE; MODULATION	Decline in the ovarian hormones with menopause may influence somatosensory, cognitive, and affective processing. The present study investigated whether hormonal depletion alters the nociceptive, depressive-like and learning behaviors in experimental rats after ovariectomy (OVX), a common method to deplete animals of their gonadal hormones. OVX rats developed thermal hyperalgesia in proximal and distal tail that was established 2 weeks after OVX and lasted the 7 weeks of the experiment. A robust mechanical allodynia was also occurred at 5 weeks after OVX. In the 5(th) week after OVX, dilute formalin (5%)-induced nociceptive responses (such as elevating and licking or biting) during the second phase were significantly increased as compared to intact and sham-OVX females. However, chronic constriction injury (CCI) of the sciatic nerve-induced mechanical allodynia did not differ as hormonal status (e. g. OVX and ovarian intact). Using formalin-induced conditioned place avoidance (F-CPA), which is believed to reflect the pain-related negative emotion, we further found that OVX significantly attenuated F-CPA scores but did not alter electric foot-shock-induced CPA (S-CPA). In the open field and forced swimming test, there was an increase in depressive-like behaviors in OVX rats. There was no detectable impairment of spatial performance by Morris water maze task in OVX rats up to 5 weeks after surgery. Estrogen replacement retrieved OVX-induced nociceptive hypersensitivity and depressive-like behaviors. This is the first study to investigate the impacts of ovarian removal on nociceptive perception, negative emotion, depressive-like behaviors and spatial learning in adult female rats in a uniform and standard way.	[Li, Li-Hong; Wang, Zhe-Chen; Zhang, Yu-Qiu] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China; [Li, Li-Hong; Wang, Zhe-Chen; Zhang, Yu-Qiu] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Yu, Jin] Fudan Univ, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, YQ (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China.	yuqiuzhang@fudan.edu.cn	Zhang, Yu-Qiu/AAS-2516-2020; Wang, Zhechen/AEU-1735-2022; Zhang, Yu-Qiu/CAF-6295-2022	Wang, Zhechen/0000-0002-9071-2348; 	National Basic Research Program of China [2013CB531905]; National Natural Science Foundation of China [31121061, 31070973, 31271183]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB531905) and the National Natural Science Foundation of China (31121061, 31070973, and 31271183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amandusson A, 2013, FRONT NEUROENDOCRIN, V34, P329, DOI 10.1016/j.yfrne.2013.06.001; BEATTY WW, 1977, PHYSIOL BEHAV, V19, P1, DOI 10.1016/0031-9384(77)90149-4; Bekku N, 2006, PSYCHOPHARMACOLOGY, V187, P170, DOI 10.1007/s00213-006-0395-2; BERNARDI M, 1989, PHYSIOL BEHAV, V45, P1067, DOI 10.1016/0031-9384(89)90238-2; Bradshaw HB, 2002, MATURITAS, V41, P157, DOI 10.1016/S0378-5122(01)00261-4; Cao H, 2009, J NEUROSCI, V29, P3307, DOI 10.1523/JNEUROSCI.4300-08.2009; Ceccarelli Ilaria, 2003, Reprod Biol Endocrinol, V1, P24, DOI 10.1186/1477-7827-1-24; Chen BL, 2012, NEUROL SCI, V33, P527, DOI 10.1007/s10072-011-0743-9; Craft RM, 2007, PAIN, V132, pS3, DOI 10.1016/j.pain.2007.09.028; Daniel JM, 2006, ENDOCRINOLOGY, V147, P607, DOI 10.1210/en.2005-0998; de Chaves G, 2009, PHYSIOL BEHAV, V97, P420, DOI 10.1016/j.physbeh.2009.03.016; DEBEUN R, 1991, PHYSIOL BEHAV, V50, P995, DOI 10.1016/0031-9384(91)90427-P; Devall AJ, 2011, BEHAV BRAIN RES, V225, P334, DOI 10.1016/j.bbr.2011.07.038; Estrada-Camarena E, 2011, J PSYCHOPHARMACOL, V25, P1365, DOI 10.1177/0269881111408456; Fedotova J., 2012, ISRN PHARM, V2012, DOI 10.5402/2012/305645; Galea LAM, 2002, PHYSIOL BEHAV, V77, P217, DOI 10.1016/S0031-9384(02)00849-1; Gasbarri A, 2012, REV NEUROSCIENCE, V23, P587, DOI 10.1515/revneuro-2012-0051; Halbreich U, 2001, CNS DRUGS, V15, P797, DOI 10.2165/00023210-200115100-00005; Han M, 2013, J NEUROSCI; Herlitz A, 2007, MENOPAUSE, V14, P425, DOI 10.1097/01.gme.0000247019.86748.e3; Hosseini M, 2010, CLINICS, V65, P803, DOI [10.1590/S1807-59322010000800011, 10.1590/S1807-59322020000800012]; Hunter DA, 2011, SYNAPSE, V65, P643, DOI 10.1002/syn.20890; Jelks KB, 2007, J NEUROSCI, V27, P6903, DOI 10.1523/JNEUROSCI.0909-07.2007; Ji YP, 2003, J NEUROSCI, V23, P3908; Ji YP, 2005, PAIN, V117, P433, DOI 10.1016/j.pain.2005.07.011; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Kobayashi T, 2000, AM J PHYSIOL-REG I, V278, pR863, DOI 10.1152/ajpregu.2000.278.4.R863; Krzanowska EK, 1999, BRAIN RES, V821, P224, DOI 10.1016/S0006-8993(98)01364-X; Kuba T, 2006, HORM BEHAV, V49, P441, DOI 10.1016/j.yhbeh.2005.09.007; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Liu Q, 2008, PHARMACOGENOMICS J, V8, P375, DOI 10.1038/sj.tpj.6500485; Liu Q, 2012, J AFFECT DISORDERS, V141, P367, DOI 10.1016/j.jad.2012.03.018; Ma B, 2011, PURINERG SIGNAL, V7, P73, DOI 10.1007/s11302-010-9212-9; Mannino CA, 2007, J PAIN, V8, P334, DOI 10.1016/j.jpain.2006.10.002; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Markowska AL, 2002, J NEUROSCI, V22, P10985; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nappi RE, 1999, GYNECOL OBSTET INVES, V47, P29, DOI 10.1159/000010058; Okuda K, 2011, J ANESTH, V25, P392, DOI 10.1007/s00540-011-1142-3; Patki G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074522; Ping SE, 2008, J NEUROSCI RES, V86, P1588, DOI 10.1002/jnr.21609; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Rachman IM, 1998, P NATL ACAD SCI USA, V95, P13941, DOI 10.1073/pnas.95.23.13941; Rieche-Rossler A, 2007, SWISS MED WKLY, V137, P565; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Sanoja R, 2005, PAIN, V118, P243, DOI 10.1016/j.pain.2005.08.021; Sanoja R, 2008, EUR J PAIN, V12, P573, DOI 10.1016/j.ejpain.2007.09.003; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Smith CC, 2005, J NEUROSCI, V25, P7780, DOI 10.1523/JNEUROSCI.0762-05.2005; Tall JM, 2001, PHARMACOL BIOCHEM BE, V68, P99, DOI 10.1016/S0091-3057(00)00461-5; Tanimoto S, 2003, EUR J NEUROSCI, V18, P2343, DOI 10.1046/j.1460-9568.2003.02952.x; Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; Walf AA, 2009, PSYCHONEUROENDOCRINO, V34, P909, DOI [10.1016/j.psyneuen.2009.01.004, 10.1016/j.psyneuen.2009.07.005]; Wu WW, 2013, J NEUROSCI, V33, P16158, DOI 10.1523/JNEUROSCI.2001-13.2013; Xiao X, 2013, CEREB CORTEX, V23, P2190, DOI 10.1093/cercor/bhs201; Yan XJ, 2014, J PAIN, V15, P204, DOI 10.1016/j.jpain.2013.10.012; Zhang Y, 2012, NEUROCHEM RES, V37, P2697, DOI 10.1007/s11064-012-0859-1; Zhao H, 2005, NEUROPEPTIDES, V39, P433, DOI 10.1016/j.npep.2005.03.001; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	60	67	69	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94312	10.1371/journal.pone.0094312	http://dx.doi.org/10.1371/journal.pone.0094312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710472	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800134
J	Liu, L; Jiao, JH; Wang, Y; Wu, JY; Huang, DS; Teng, WP; Chen, L				Liu, Lei; Jiao, Jinghua; Wang, Yu; Wu, Jingyang; Huang, Desheng; Teng, Weiping; Chen, Lei			TGF-beta1 Gene Polymorphism in Association with Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; EXPRESSION	Background: Transforming growth factor-beta (TGF-beta 1) gene has been regarded as an important mechanism in angiogenesis, endothelial cell proliferation, adhesion, and the deposition of extracellular matrix. The TGF-beta 1 gene may be involved in the development of diabetic retinopathy (DR) through disrupting angiogenesis. However, studies investigating the relationship between 2509C/T and +869T/C(L10P) polymorphisms and DR yielded contradictory and inconclusive outcomes. In order to realize these ambiguous findings, a meta-analysis was performed to assess the association between the TGF-beta 1 gene polymorphisms and susceptibility to DR. Methodology/Principal Findings: We conducted a search of all English reports on studies for the association between the TGF-beta 1 gene polymorphisms and susceptibility to DR using Medline, the Cochrane Library, EMbase, Web of Science, Google (scholar), and all Chinese reports were identified manually and on-line using CBMDisc, Chongqing VIP database, and CNKI database. The strict selection criteria and exclusion criteria were determined, and odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations. The fixed or random effect model was selected based on the heterogeneity test among studies. Publication bias was estimated using Begg's funnel plots and Egger's regression test. Results: A total of three studies were included in the meta-analysis and all included studies analyzed patients with type 2 diabetes. For +869T/C(L10P) polymorphism, significant association was observed in an allele model (L versus P: OR = 1.34, 95%CI = 1.03-1.73) and the recessive model (LL versus LP+ PP: OR = 1.70, 95%CI = 1.13-2.56). As regards -509C/T polymorphism, no obvious associations were found for all genetic models. Conclusions: This meta-analysis suggested that the +869T/C(L10P) polymorphism in TGF beta 1 gene would be a potential protect factor for DR. However, the -509C/T polymorphism is not associated with DR.	[Liu, Lei; Wu, Jingyang; Chen, Lei] China Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Shenyang, Liaoning Provin, Peoples R China; [Jiao, Jinghua] Fengtian Hosp, Shenyang Med Coll, Dept Anesthesiol, Shenyang, Liaoning Provin, Peoples R China; [Wang, Yu] China Med Univ, Dept Dev, Shenyang, Liaoning Provin, Peoples R China; [Wang, Yu] China Med Univ, Planning Off, Shenyang, Liaoning Provin, Peoples R China; [Liu, Lei; Huang, Desheng] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Teng, Weiping; Chen, Lei] China Med Univ, Affiliated Hosp 1, Inst Endocrinol, Dept Endocrinol & Metab,Liaoning Prov Key Lab End, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Shenyang Medical College; China Medical University; China Medical University; China Medical University; China Medical University	Chen, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Shenyang, Liaoning Provin, Peoples R China.	carol1422@163.com			National Natural Science Funds [81300783]	National Natural Science Funds(National Natural Science Foundation of China (NSFC))	This work has been supported by the grant The National Natural Science Funds, (Project Number: 81300783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhary S, 2009, DIABETES, V58, P2137, DOI 10.2337/db09-0059; BATTEGAY EJ, 1995, J MOL MED, V73, P333; Beranek M, 2002, AM J MED GENET, V109, P278, DOI 10.1002/ajmg.10372; Bran GM, 2010, INT J MOL MED, V25, P915, DOI 10.3892/ijmm_00000422; Buraczynska M, 2007, NEPHRON PHYSIOL, V106, P69, DOI 10.1159/000104874; Chung EJ, 2011, BIOCHEM BIOPH RES CO, V415, P367, DOI 10.1016/j.bbrc.2011.10.074; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Howell JE, 2006, CURR DRUG TARGETS, V7, P547, DOI 10.2174/138945006776818692; KIM SJ, 1989, J BIOL CHEM, V264, P402; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nunes I, 1998, J Am Optom Assoc, V69, P643; Paine SK, 2012, MOL VIS, V18, P2749; Pfeiffer A, 1997, DIABETES, V46, pS26, DOI 10.2337/diab.46.2.S26; Saika Shizuya, 2009, Front Biosci (Schol Ed), V1, P376, DOI 10.2741/s32; Wong TYH, 2003, KIDNEY INT, V63, P1831, DOI 10.1046/j.1523-1755.2003.00919.x; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346; Yamashita Hidetoshi, 1997, Nippon Ganka Gakkai Zasshi, V101, P927; Zorena K, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/614908	21	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94160	10.1371/journal.pone.0094160	http://dx.doi.org/10.1371/journal.pone.0094160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710116	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800109
J	Zhao, LN; Li, JY; Yu, T; Chen, GC; Yuan, YH; Chen, QK				Zhao, Li-Na; Li, Jie-Yao; Yu, Tao; Chen, Guang-Cheng; Yuan, Yu-Hong; Chen, Qi-Kui			5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PRIMARY SCLEROSING CHOLANGITIS; OLMSTED COUNTY; CANCER RISK; DYSPLASIA; THERAPY; ACID; CHEMOPREVENTION; SULFASALAZINE; PROGRESSION	Background: Although the chemopreventive effect of 5-aminosalicylates on patients with ulcerative colitis has been extensively studied, the results remain controversial. This updated review included more recent studies and evaluated the effectiveness of 5-aminosalicylates use on colorectal neoplasia prevention in patients with ulcerative colitis. Methods: Up to July 2013, we searched Medline, Embase, Web of Science, Cochrane CENTRAL, and SinoMed of China for all relevant observational studies (case-control and cohort) about the effect of 5-aminosalicylates on the risk of colorectal neoplasia among patients with ulcerative colitis. The Newcastle-Ottawa Scale was used to assess the quality of studies. Adjusted odds ratios (ORs) were extracted from each study. A random-effects model was used to generate pooled ORs and 95% confidence intervals (95% CI). Publication bias and heterogeneity were assessed. Results: Seventeen studies containing 1,508 cases of colorectal neoplasia and a total of 20,193 subjects published from 1994 to 2012 were analyzed. 5-aminosalicylates use was associated with a reduced risk of colorectal neoplasia in patients with ulcerative colitis (OR 0.63; 95% CI 0.48-0.84). Pooled OR of a higher average daily dose of 5-aminosalicylates (sulfasalazine >= 2.0 g/ d, mesalamine >= 1.2 g/ d) was 0.51 [0.35-0.75]. Pooled OR of 5-aminosalicylates use in patients with extensive ulcerative colitis was 1.00 [0.53-1.89]. Conclusion: Our pooled results indicated that 5-aminosalicylates use was associated with a reduced risk of colorectal neoplasia in patients with ulcerative colitis, especially in the cases with a higher average daily dose of 5-aminosalicylates use. However, the chemopreventive benefit of 5-aminosalicylates use in patients with extensive ulcerative colitis was limited.	[Zhao, Li-Na; Li, Jie-Yao; Yu, Tao; Chen, Guang-Cheng; Yuan, Yu-Hong; Chen, Qi-Kui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yu, T (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	yutao2014@126.com	Zhao, Lina/GVR-7716-2022; YUAN, YUHONG/ABC-5917-2020		National Natural Science Foundation of China [81270442, 81000152]; Youthful Teacher Foster Plan of Sun Yat-Sen University [09ykpy10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youthful Teacher Foster Plan of Sun Yat-Sen University	This study was supported by the National Natural Science Foundation of China (No. 81270442 and No. 81000152) and the Youthful Teacher Foster Plan of Sun Yat-Sen University (No. 09ykpy10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JM, 2008, ALIMENT PHARM THER, V29, P459; Baars JE, 2011, AM J GASTROENTEROL, V106, P319, DOI 10.1038/ajg.2010.428; Bernstein CN, 2011, AM J GASTROENTEROL, V106, P731, DOI 10.1038/ajg.2011.50; Bernstein CN, 2003, AM J GASTROENTEROL, V98, P2784, DOI 10.1016/j.amjgastroenterol.2003.08.022; Carrat F, 2010, GASTROENTEROLOGY, V138, pS47; Collins PD, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000279.pub3; Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub3; Georgescu EF, 2009, GASTROENTEROLOGY, V136, pA764; Gong W, 2012, DIGEST DIS SCI, V57, P503, DOI 10.1007/s10620-011-1890-9; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Jess T, 2006, GASTROENTEROLOGY, V130, P1039, DOI 10.1053/j.gastro.2005.12.037; Jess T, 2007, AM J GASTROENTEROL, V102, P829, DOI 10.1111/j.1572-0241.2007.01070.x; Jess T, 2012, GASTROENTEROLOGY, V143, P375, DOI 10.1053/j.gastro.2012.04.016; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Kornbluth A, 2010, AM J GASTROENTEROL, V105, P501, DOI 10.1038/ajg.2009.727; Lashner BA, 1997, GASTROENTEROLOGY, V112, P29, DOI 10.1016/S0016-5085(97)70215-4; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lim W, 2010, COCHRANE DB SYST REV, V12; Lindberg BU, 2001, DIS COLON RECTUM, V44, P77, DOI 10.1007/BF02234825; Lyakhovich A, 2010, ALIMENT PHARM THER, V31, P202, DOI 10.1111/j.1365-2036.2009.04195.x; Moody GA, 1996, EUR J GASTROEN HEPAT, V8, P1179, DOI 10.1097/00042737-199612000-00009; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Nguyen GC, 2012, AM J GASTROENTEROL, V107, P1298, DOI 10.1038/ajg.2012.198; Nourani S, 2008, GASTROENTEROLOGY, V134, pA660; PINCZOWSKI D, 1994, GASTROENTEROLOGY, V107, P117, DOI 10.1016/0016-5085(94)90068-X; Rubin DT, 2006, CLIN GASTROENTEROL H, V4, P1346, DOI 10.1016/j.cgh.2006.08.014; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Smith T, 2006, GASTROENTEROLOGY, V130, pA653; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Subramanian V, 2011, BEST PRACT RES CL GA, V25, P593, DOI 10.1016/j.bpg.2011.09.003; Tang J, 2010, DIGEST DIS SCI, V55, P1696, DOI 10.1007/s10620-009-0942-x; Terdiman JP, 2007, INFLAMM BOWEL DIS, V13, P367, DOI 10.1002/ibd.20074; Ullman T, 2008, CLIN GASTROENTEROL H, V6, P1225, DOI 10.1016/j.cgh.2008.05.020; van Schaik FDM, 2012, GUT, V61, P235, DOI 10.1136/gut.2011.237412; van Staa TP, 2005, GUT, V54, P1573, DOI 10.1136/gut.2005.070896; Velayos FS, 2006, GASTROENTEROLOGY, V130, P1941, DOI 10.1053/j.gastro.2006.03.028; Velayos FS, 2005, AM J GASTROENTEROL, V100, P1345, DOI 10.1111/j.1572-0241.2005.41442.x; Wells G.A., NEWCASTLE OTTAWA SCA; Winther KV, 2004, CLIN GASTROENTEROL H, V2, P1088, DOI 10.1016/S1542-3565(04)00543-9	40	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94208	10.1371/journal.pone.0094208	http://dx.doi.org/10.1371/journal.pone.0094208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710620	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800118
J	Andre, ED; Grinberg, F; Farrher, E; Maximov, II; Shah, NJ; Meyer, C; Jaspar, M; Muto, V; Phillips, C; Balteau, E				Andre, Elodie D.; Grinberg, Farida; Farrher, Ezequiel; Maximov, Ivan I.; Shah, N. Jon; Meyer, Christelle; Jaspar, Mathieu; Muto, Vincenzo; Phillips, Christophe; Balteau, Evelyne			Influence of Noise Correction on Intra- and Inter-Subject Variability of Quantitative Metrics in Diffusion Kurtosis Imaging	PLOS ONE			English	Article							NON-GAUSSIAN DIFFUSION; RICIAN NOISE; BRAIN-TISSUE; WATER DIFFUSION; MR-IMAGES; SPIN-ECHO; TENSOR; MODEL; RECONSTRUCTION; PARAMETERS	Diffusion kurtosis imaging (DKI) is a promising extension of diffusion tensor imaging, giving new insights into the white matter microstructure and providing new biomarkers. Given the rapidly increasing number of studies, DKI has a potential to establish itself as a valuable tool in brain diagnostics. However, to become a routine procedure, DKI still needs to be improved in terms of robustness, reliability, and reproducibility. As it requires acquisitions at higher diffusion weightings, results are more affected by noise than in diffusion tensor imaging. The lack of standard procedures for post-processing, especially for noise correction, might become a significant obstacle for the use of DKI in clinical routine limiting its application. We considered two noise correction schemes accounting for the noise properties of multichannel phased-array coils, in order to improve the data quality at signal-to-noise ratio (SNR) typical for DKI. The SNR dependence of estimated DKI metrics such as mean kurtosis (MK), mean diffusivity (MD) and fractional anisotropy (FA) is investigated for these noise correction approaches in Monte Carlo simulations and in in vivo human studies. The intra-subject reproducibility is investigated in a single subject study by varying the SNR level and SNR spatial distribution. Then the impact of the noise correction on inter-subject variability is evaluated in a homogeneous sample of 25 healthy volunteers. Results show a strong impact of noise correction on the MK estimate, while the estimation of FA and MD was affected to a lesser extent. Both intra-and inter-subject SNR-related variability of the MK estimate is considerably reduced after correction for the noise bias, providing more accurate and reproducible measures. In this work, we have proposed a straightforward method that improves accuracy of DKI metrics. This should contribute to standardization of DKI applications in clinical studies making valuable inferences in group analysis and longitudinal studies.	[Andre, Elodie D.; Meyer, Christelle; Jaspar, Mathieu; Muto, Vincenzo; Phillips, Christophe; Balteau, Evelyne] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Grinberg, Farida; Farrher, Ezequiel; Maximov, Ivan I.; Shah, N. Jon] Inst Neurosci & Med 4, Julich, Germany; [Grinberg, Farida; Shah, N. Jon] Rhein Westfal TH Aachen, Julich Aachen Res Alliance, Dept Neurol, Fac Med, Aachen, Germany; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium	University of Liege; RWTH Aachen University; University of Liege	Grinberg, F (corresponding author), Inst Neurosci & Med 4, Julich, Germany.	f.grinberg@fz-juelich.de	Maximov, Ivan I./A-8242-2012; Muto, Vincenzo/AAS-5220-2020; Shah, N. Jon/H-5849-2013; Phillips, Christophe/M-3025-2017	Muto, Vincenzo/0000-0001-5100-9927; Shah, N. Jon/0000-0002-8151-6169; Maximov, Ivan I./0000-0001-6319-6774; Farrher, Ezequiel/0000-0003-2902-8667; Phillips, Christophe/0000-0002-4990-425X	EU; Belgian National Funds of Scientific Research (FNRS); les Actions de Recherche Concertees (ARC, ULg); la Fondation Medicale Reine Elisabeth (FMRE); Walloon Excellence in Lifesciences and Biotechnology (WELBIO); Wellcome Trust Biotechnology and Biological Sciences Research Council (BBSRC); FEDER - RW; European Regional Development Fund; Belgian Walloon Government	EU(European Commission); Belgian National Funds of Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); les Actions de Recherche Concertees (ARC, ULg); la Fondation Medicale Reine Elisabeth (FMRE); Walloon Excellence in Lifesciences and Biotechnology (WELBIO)(WELBIO); Wellcome Trust Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FEDER - RW; European Regional Development Fund(European Commission); Belgian Walloon Government	This work was funded by the EU within the PEOPLE Programme (FP7): Initial Training Networks (FP7-PEOPLE-ITN-2008), the Belgian National Funds of Scientific Research (FNRS), les Actions de Recherche Concertees (ARC, ULg), la Fondation Medicale Reine Elisabeth (FMRE), the Walloon Excellence in Lifesciences and Biotechnology (WELBIO), the Wellcome Trust Biotechnology and Biological Sciences Research Council (BBSRC), FEDER - RW, the European Regional Development Fund and the Belgian Walloon Government (Project FEDER/RADIOMED 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aja-Fernandez S, 2012, MAGN RESON MED, V67, P580, DOI 10.1002/mrm.23020; Aja-Fernandez S, 2009, MAGN RESON IMAGING, V27, P1397, DOI 10.1016/j.mri.2009.05.025; Andersson JLR, 2008, NEUROIMAGE, V42, P1340, DOI 10.1016/j.neuroimage.2008.05.053; Assaf Y, 1998, J MAGN RESON, V131, P69, DOI 10.1006/jmre.1997.1313; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Blockx I, 2012, NEUROIMAGE, V63, P653, DOI 10.1016/j.neuroimage.2012.06.032; Chung S, 2010, NEUROIMAGE, V49, P631, DOI 10.1016/j.neuroimage.2009.06.067; Constantinides CD, 1997, MAGNET RESON MED, V38, P852, DOI 10.1002/mrm.1910380524; De Santis S., 2011, MAGMA, V25, P267; Deshmane A, 2012, J MAGN RESON IMAGING, V36, P55, DOI 10.1002/jmri.23639; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fieremans E, 2010, NMR BIOMED, V23, P711, DOI 10.1002/nbm.1577; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Grinberg F, 2012, NMR BIOMED, V25, P1295, DOI 10.1002/nbm.2802; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hutton C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052075; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Kang XJ, 2012, MAGN RESON IMAGING, V30, P1111, DOI 10.1016/j.mri.2012.04.004; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Koay CG, 2009, J MAGN RESON, V197, P108, DOI 10.1016/j.jmr.2008.11.015; Kristoffersen A, 2012, J MAGN RESON IMAGING, V35, P181, DOI 10.1002/jmri.22826; Landman BA, 2009, MAGN RESON MED, V62, P500, DOI 10.1002/mrm.22013; Latt J, 2013, J MAGN RESON IMAGING, V37, P610, DOI 10.1002/jmri.23857; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Maggioni M., 2012, IEEE T IMAGE PROCESS; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Maximov II, 2012, MED IMAGE ANAL, V16, P536, DOI 10.1016/j.media.2011.12.002; Maximov II, 2011, J MAGN RESON, V213, P136, DOI 10.1016/j.jmr.2011.09.035; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Muller HP, 2009, MAGN RESON IMAGING, V27, P324, DOI 10.1016/j.mri.2008.07.003; Mulkern RV, 1999, NMR BIOMED, V12, P51, DOI 10.1002/(SICI)1099-1492(199902)12:1<51::AID-NBM546>3.0.CO;2-E; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Nowak RD, 1999, IEEE T IMAGE PROCESS, V8, P1408, DOI 10.1109/83.791966; Nunes RG, 2005, J MAGN RESON, V177, P102, DOI 10.1016/j.jmr.2005.07.005; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Prah DE, 2010, MAGN RESON MED, V64, P418, DOI 10.1002/mrm.22407; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Thompson MR, 1999, RADIOLOGY, V210, P253, DOI 10.1148/radiology.210.1.r99ja25253; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Veraart J, 2013, MAGN RESON MED, V70, P972, DOI 10.1002/mrm.24529; Veraart J, 2011, MAGN RESON MED, V66, P678, DOI 10.1002/mrm.22835; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Wirestam R, 2006, MAGN RESON MED, V56, P1114, DOI 10.1002/mrm.21036	66	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94531	10.1371/journal.pone.0094531	http://dx.doi.org/10.1371/journal.pone.0094531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722363	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100091
J	Faller, N; Gautschi, I; Schild, L				Faller, Nicolas; Gautschi, Ivan; Schild, Laurent			Functional Analysis of a Missense Mutation in the Serine Protease Inhibitor SPINT2 Associated with Congenital Sodium Diarrhea	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; XENOPUS-OOCYTES; TRANSMEMBRANE DOMAIN; IRON-DEFICIENCY; HUMAN TISSUES; CHANNEL ENAC; IN-VITRO; MATRIPTASE; EXPRESSION	Membrane-bound serine proteases play important roles in different biological processes. Their regulation by endogenous inhibitors is poorly understood. A Y163C mutation in the SPINT2 gene encoding the serine protease inhibitor Hepatocyte Growth Factor Inhibitor HAI-2 is associated with a congenital sodium diarrhea. The functional consequences of this mutation on HAI-2 activity and its physiological targets are unknown. We established a cellular assay in Xenopus laevis oocytes to study functional interactions between HAI-2 and candidate membrane-bound serine proteases expressed in the gastro-intestinal tract. We found that the wild-type form of HAI-2 is a potent inhibitor of nine gastro-intestinal serine proteases. The Y163C mutation in the second Kunitz domain of HAI-2 resulted in a complete loss of inhibitory activity on two intestinal proteases, prostasin and tmprss13. The effect of the mutation of the homologous Y68C in the first Kunitz domain of HAI-2 is consistent with a differential contribution of the two Kunitz domains of HAI-2 in the inhibition of serine proteases. By contrast to the Tyr to Cys, the Tyr to Ser substitution did not change the inhibitory potency of HAI-2, indicating that the thiol-group of the cysteine rather than the Tyr deletion is responsible for the HAI-2 loss of function. Our functional assay allowed us to identify membrane-bound serine proteases as cellular target for inhibition by HAI-2 wild type and mutants, and to better define the role of the Tyr in the second Kunitz domain in the inhibitory activity of HAI-2.	[Faller, Nicolas; Gautschi, Ivan; Schild, Laurent] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland	University of Lausanne	Schild, L (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	Laurent.Schild@unil.ch		, Nicolas/0000-0003-1647-9311	Swiss National Science Foundation [323530-128871]; Swiss Academy of Medical Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Academy of Medical Sciences	The work was supported by a grant from the Swiss National Science Foundation 323530-128871, MD-PhD Program of the Swiss Academy of Medical Sciences (to NF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hashimoto T, 2010, FEBS J, V277, P4888, DOI 10.1111/j.1742-4658.2010.07894.x; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim DR, 2001, BBA-GENE STRUCT EXPR, V1518, P204, DOI 10.1016/S0167-4781(01)00184-1; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Malsure S, 2014, J AM SOC NEPHROL; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muller-Pillasch F, 1998, BBA-GENE STRUCT EXPR, V1395, P88, DOI 10.1016/S0167-4781(97)00129-2; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Salomon J, 2014, HUM GENET, V133, P299, DOI 10.1007/s00439-013-1380-6; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; TSUJI A, 1991, J BIOL CHEM, V266, P16948; Vaarala MH, 2001, J PATHOL, V193, P134, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Yuan X, 1998, AM J PHYSIOL-GASTR L, V274, pG342, DOI 10.1152/ajpgi.1998.274.2.G342; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	53	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94267	10.1371/journal.pone.0094267	http://dx.doi.org/10.1371/journal.pone.0094267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722141	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100046
J	Shin, H; Kwon, S; Song, H; Lim, HJ				Shin, Hyejin; Kwon, Sojung; Song, Haengseok; Lim, Hyunjung Jade			The Transcription Factor Egr3 Is a Putative Component of the Microtubule Organizing Center in Mouse Oocytes	PLOS ONE			English	Article							MITOTIC SPINDLE; MEIOTIC SPINDLE; GAMMA-TUBULIN; MICE LACKING; MATURATION; PROTEIN; CELLS; MORPHOGENESIS; ORGANIZATION; CYTOSKELETON	The early growth response (Egr) family of zinc finger transcription factors consists of 4 members. During an investigation of Egr factor localization in mouse ovaries, we noted that Egr3 exhibits a subcellular localization that overlaps with the meiotic spindle in oocytes. Using Egr3-specific antibodies, we establish that Egr3 co-localizes with the spindle and cytosolic microtubule organizing centers (MTOCs) in oocytes during meiotic maturation. Notably, the Egr3 protein appears to accumulate around c-tubulin in MTOCs. Nocodazole treatment, which induces microtubule depolymerization, resulted in the disruption of spindle formation and Egr3 localization, suggesting that Egr3 localization is dependent on the correct configuration of the spindle. Shortly after warming of vitrified oocytes, growing arrays of microtubules were observed near large clusters of Egr3. An in vitro microtubule interaction assay showed that Egr3 does not directly interact with polymerized microtubules. Egr3 localization on the spindle was sustained in early preimplantation mouse embryos, but this pattern did not persist until the blastocyst stage. Collectively, our result shows for the first time that the Egr3 a transcription factor may play a novel non-transcriptional function during microtubule organization in mouse oocytes.	[Shin, Hyejin; Kwon, Sojung; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Song, Haengseok] CHA Univ, Coll Life Sci, Dept Biomed Sci, Seoul, South Korea	Konkuk University; Pochon Cha University	Lim, HJ (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea.	hlim@konkuk.ac.kr	Lim, Hyunjung J/D-5343-2011	Lim, Hyunjung J/0000-0003-2191-666X; Song, Haengseok/0000-0002-5027-7310	Konkuk University	Konkuk University	This paper resulted from the Konkuk University research support program in 2011 (www.konkuk.ac.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; Clary LM, 2010, DEVELOPMENT, V137, P3129, DOI 10.1242/dev.041616; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Eo J, 2008, J ENDOCRINOL, V198, P281, DOI 10.1677/JOE-08-0142; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Hogarth CA, 2010, DEV DYNAM, V239, P3106, DOI 10.1002/dvdy.22442; Honkaniemi J, 1999, EUR J NEUROSCI, V11, P10, DOI 10.1046/j.1460-9568.1999.00401.x; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; Inoue A, 2004, J MOL ENDOCRINOL, V32, P649, DOI 10.1677/jme.0.0320649; Jo JW, 2011, FERTIL STERIL, V96, P1239, DOI 10.1016/j.fertnstert.2011.08.023; Katche C, 2012, NEUROBIOL LEARN MEM, V98, P220, DOI 10.1016/j.nlm.2012.08.001; Kwon Sojung, 2011, Clin Exp Reprod Med, V38, P1, DOI 10.5653/cerm.2011.38.1.1; Kwon S, 2011, MOL HUM REPROD, V17, P317, DOI 10.1093/molehr/gaq088; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Li SL, 2012, IMMUNITY, V37, P685, DOI 10.1016/j.immuni.2012.08.001; Ma W, 2010, DEV BIOL, V339, P439, DOI 10.1016/j.ydbio.2010.01.009; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; Mora GR, 2004, MOL CANCER RES, V2, P115; O'Donovan KJ, 1999, MOL CELL BIOL, V19, P4711; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Quach DH, 2013, J NEUROSCI, V33, P4570, DOI 10.1523/JNEUROSCI.5481-12.2013; Schatten H, 2011, MOL REPROD DEV, V78, P757, DOI 10.1002/mrd.21380; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Soubry A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009203; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	37	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94708	10.1371/journal.pone.0094708	http://dx.doi.org/10.1371/journal.pone.0094708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722338	Green Submitted, gold, Green Published			2022-12-27	WOS:000336909100126
J	Wen, K; Tin, C; Wang, HF; Yang, XD; Li, GH; Giri-Rachman, E; Kocher, J; Bui, T; Clark-Deener, S; Yuan, LJ				Wen, Ke; Tin, Christine; Wang, Haifeng; Yang, Xingdong; Li, Guohua; Giri-Rachman, Ernawati; Kocher, Jacob; Bui, Tammy; Clark-Deener, Sherrie; Yuan, Lijuan			Probiotic Lactobacillus rhamnosus GG Enhanced Th1 Cellular Immunity but Did Not Affect Antibody Responses in a Human Gut Microbiota Transplanted Neonatal Gnotobiotic Pig Model	PLOS ONE			English	Article							HUMAN ROTAVIRUS INFECTION; FLORA-ASSOCIATED PIGLETS; WA HUMAN ROTAVIRUS; GERM-FREE; PROTECTIVE IMMUNITY; VACCINE; BACTERIA; DIARRHEA; DISEASE; IMMUNOGENICITY	This study aims to establish a human gut microbiota (HGM) transplanted gnotobiotic (Gn) pig model of human rotavirus (HRV) infection and diarrhea, and to verify the dose-effects of probiotics on HRV vaccine-induced immune responses. Our previous studies using the Gn pig model found that probiotics dose-dependently regulated both T cell and B cell immune responses induced by rotavirus vaccines. We generated the HGM transplanted neonatal Gn pigs through daily feeding of neonatal human fecal suspension to germ-free pigs for 3 days starting at 12 hours after birth. We found that attenuated HRV (AttHRV) vaccination conferred similar overall protection against rotavirus diarrhea and virus shedding in Gn pigs and HGM transplanted Gn pigs. HGM promoted the development of the neonatal immune system, as evidenced by the significantly enhanced IFN-gamma producing T cell responses and reduction of regulatory T cells and their cytokine production in the AttHRV-vaccinated pigs. The higher dose Lactobacillus rhamnosus GG (LGG) feeding (14 doses, up to 10(9) colony-forming-unit [CFU]/dose) effectively increased the LGG counts in the HGM Gn pig intestinal contents and significantly enhanced HRV-specific IFN-gamma producing T cell responses to the AttHRV vaccine. Lower dose LGG (9 doses, up to 10(6) CFU/dose) was ineffective. Neither doses of LGG significantly improved the protection rate, HRV-specific IgA and IgG antibody titers in serum, or IgA antibody titers in intestinal contents compared to the AttHRV vaccine alone, suggesting that an even higher dose of LGG is needed to overcome the influence of the microbiota to achieve the immunostimulatory effect in the HGM pigs. This study demonstrated that HGM Gn pig is an applicable animal model for studying immune responses to rotavirus vaccines and can be used for studying interventions (i.e., probiotics and prebiotics) that may enhance the immunogenicity and protective efficacy of vaccines through improving the gut microbiota.	[Wen, Ke; Tin, Christine; Wang, Haifeng; Yang, Xingdong; Li, Guohua; Giri-Rachman, Ernawati; Kocher, Jacob; Bui, Tammy; Yuan, Lijuan] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Clark-Deener, Sherrie] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Large Anim Clin Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Yuan, LJ (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	lyuan@vt.edu	Clark-Deener, Sherrie G/K-8181-2016; Yuan, Lijuan/A-2468-2008	Yuan, Lijuan/0000-0003-0709-5228; Giri-Rachman, Ernawati/0000-0002-1661-9073; Tin, Christine/0000-0002-2353-2582; Tin, Christine/0000-0003-0190-0636	National Center of Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD [R01AT004789]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004789] Funding Source: NIH RePORTER	National Center of Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant (R01AT004789) to Lijuan Yuan from the National Center of Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlroos T, 2009, J APPL MICROBIOL, V106, P506, DOI 10.1111/j.1365-2672.2008.04018.x; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Avershina E, 2013, FEMS MICROBIOL ECOL; Azevedo AS, 2005, J VIROL, V79, P5428, DOI 10.1128/JVI.79.9.5428-5436.2005; Che C, 2009, SCAND J IMMUNOL, V69, P223, DOI 10.1111/j.1365-3083.2008.02211.x; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hirayama K, 1999, EXP ANIM TOKYO, V48, P219, DOI 10.1538/expanim.48.219; ISOLAURI E, 1995, VACCINE, V13, P310, DOI 10.1016/0264-410X(95)93319-5; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kunisawa J, 2011, CELL HOST MICROBE, V9, P83, DOI 10.1016/j.chom.2011.01.012; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Levast B, 2013, VACCINE, V31, P2489, DOI 10.1016/j.vaccine.2012.11.089; Licciardi PV, 2011, DISCOV MED, V12, P525; Liu FN, 2014, J PEDIATR GASTR NUTR, V58, P169, DOI 10.1097/MPG.0000000000000197; Liu FN, 2013, J PEDIATR GASTR NUTR, V57, P750, DOI 10.1097/MPG.0b013e3182a356e1; Liu FN, 2010, VIRAL IMMUNOL, V23, P135, DOI 10.1089/vim.2009.0088; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; PLEASANTS JR, 1986, J NUTR, V116, P1949, DOI 10.1093/jn/116.10.1949; Saif LJ, 1996, ARCH VIROL, P153; Shen JA, 2010, ARCH MICROBIOL, V192, P959, DOI 10.1007/s00203-010-0628-y; Stepankova R, 1998, FOLIA MICROBIOL, V43, P531, DOI 10.1007/BF02820814; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; TLASKALOVAHOGENOVA H, 1983, ANN NY ACAD SCI, V409, P96, DOI 10.1111/j.1749-6632.1983.tb26862.x; To TL, 1998, J GEN VIROL, V79, P2661; Uchiyama R, 2014, J INFECT DIS, V210, P171, DOI 10.1093/infdis/jiu037; Ward LA, 1996, J GEN VIROL, V77, P1431, DOI 10.1099/0022-1317-77-7-1431; Wei H, 2008, J VET MED SCI, V70, P715, DOI 10.1292/jvms.70.715; Wen K, 2012, VACCINE, V30, P1198, DOI 10.1016/j.vaccine.2011.11.107; Yuan L, 2003, PERSP MED V, V9, P357; Yuan L, 2013, DOSE EFFECTS LAB MOD; Yuan LJ, 2008, VACCINE, V26, P3322, DOI 10.1016/j.vaccine.2008.03.085; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Yuan LJ, 2002, VET IMMUNOL IMMUNOP, V87, P147, DOI 10.1016/S0165-2427(02)00046-6; Zhang QS, 2013, GUT MICROBES, V4, P193, DOI 10.4161/gmic.23867; Zhang W, 2008, VACCINE, V26, P3655, DOI 10.1016/j.vaccine.2008.04.070; Zhang W, 2008, VET IMMUNOL IMMUNOP, V122, P175, DOI 10.1016/j.vetimm.2007.10.003; Zhang W, 2008, VET IMMUNOL IMMUNOP, V121, P222, DOI 10.1016/j.vetimm.2007.10.001; Zhu YH, 2014, APPL ENV MICROBIOL	40	54	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94504	10.1371/journal.pone.0094504	http://dx.doi.org/10.1371/journal.pone.0094504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722168	gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100085
J	Huo, XL; Min, JJ; Pan, CY; Zhao, CC; Pan, LL; Gui, FF; Jin, L; Wang, XT				Huo, Xin-long; Min, Jing-jing; Pan, Cai-yu; Zhao, Cui-cui; Pan, Lu-lu; Gui, Fei-fei; Jin, Lu; Wang, Xiao-tong			Efficacy of Lovastatin on Learning and Memory Deficits Caused by Chronic Intermittent Hypoxia-Hypercapnia: Through Regulation of NR2B-Containing NMDA Receptor-ERK Pathway	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; GLUTAMATE NEUROTOXICITY; COGNITIVE FUNCTION; CORTICAL-NEURONS; PROTEIN-KINASES; LIPID RAFTS; CELL-DEATH; CHOLESTEROL; TRAFFICKING; RAS	Background: Chronic intermittent hypoxia- hypercapnia (CIHH) exposure leads to learnning and memory deficits in rats. Overactivation of N-methyl-D-aspartate receptors(NMDARs) can lead to the death of neurons through a process termed excitotoxicity, which is involved in CIHH-induced cognitive deficits. Excessively activated NR2B (GluN2B)-containing NMDARs was reported as the main cause of excitotoxicity. The ERK1/2 (extracellular signal-regulated kinase 1/2) signaling cascade acts as a key component in NMDARs-dependent neuronal plasticity and survival. Ca2+/calmodulin-dependent protein kinase II (CaMKII), synapse-associated protein 102 ( SAP102) and Ras GTPase-activating protein (SynGAP) have been shown to be involved in the regulation of NMDAR-ERK signalling cascade. Recent studies revealed statins (the HMG-CoA reductase inhibitor) have effect on the expression of NMDARs. The present study intends to explore the potential effect of lovastatin on CIHH-induced cognitive deficits and the NR2B-ERK signaling pathway. Methods and Findings: Eighty male Sprague Dawley rats were randomly divided into five groups. Except for those in the control group, the rats were exposed to chronic intermittent hypoxia-hypercapnia (CIHH) ( 9,11% O-2, 5.5,6.5% CO2) for 4 weeks. After lovastatin administration, the rats performed better in the Morris water maze test. Electron microscopy showed alleviated hippocampal neuronal synaptic damage. Further observation suggested that either lovastatin or ifenprodil (a selective NR2B antagonist) administration similarly downregulated NR2B subunit expression leading to a suppression of CaMKII/SAP102/SynGAP signaling cascade, which in turn enhanced the phosphorylation of ERK1/2. The phosphorylated ERK1/2 induced signaling cascade involving cAMP-response element-binding protein (CREB) phosphorylation and brainderived neurotrophic factor (BDNF) activation, which is responsible for neuroprotection. Conclusions: These findings suggest that the ameliorative cognitive deficits caused by lovastatin are due to the downregulation of excessive NR2B expression accompanied by increased expression of ERK signaling cascade. The effect of NR2B in upregulating pERK1/2 maybe due, at least in part, to inactivation of CaMKII/SAP102/SynGAP signaling cascade.	[Huo, Xin-long; Min, Jing-jing; Pan, Cai-yu; Zhao, Cui-cui; Pan, Lu-lu; Gui, Fei-fei; Jin, Lu; Wang, Xiao-tong] Wenzhou Med Univ, Affiliated Hosp 2, Ctr Neurol & Rehabil, Wenzhou, Peoples R China		Wang, XT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Ctr Neurol & Rehabil, Wenzhou, Peoples R China.	doctorhxl@163.com			Medical Science Research Foundation of Zhejiang Province [Y205233]; Wenzhou City Science and Technology Bureau [Y2005A001]	Medical Science Research Foundation of Zhejiang Province; Wenzhou City Science and Technology Bureau	This research was supported by the Medical Science Research Foundation of Zhejiang Province grant (NO: Y205233) and by Wenzhou City Science and Technology Bureau grant (NO: Y2005A001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt S M, 1999, Adv Neurol, V79, P133; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Etnier J, 1999, CHEST, V116, P953, DOI 10.1378/chest.116.4.953; Follesa P, 1996, J NEUROSCI, V16, P2172; Frank C, 2008, EXP NEUROL, V212, P407, DOI 10.1016/j.expneurol.2008.04.019; Gambrill AC, 2011, J NEUROPHYSIOLX, V14, P2425; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harvey BH, 2012, PHARMACOL BIOCHEM BE, V100, P775, DOI 10.1016/j.pbb.2011.06.014; He X, 2006, J NEUROPATH EXP NEUR, V65, P652, DOI 10.1097/01.jnen.0000225906.82428.69; Hering H, 2003, J NEUROSCI, V23, P3262; Hetman M, 2006, CURR TOP MED CHEMX, V40, P775; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; Hindley A, 2002, J CELL SCI, V115, P1575; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Incalzi RA, 2003, J NEUROL, V250, P325, DOI 10.1007/s00415-003-1005-4; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Jonsson N, 2001, STROKE, V32, P1112, DOI 10.1161/01.STR.32.5.1112; Kannan M, 2010, NEUROBIOL AGING, V31, P1543, DOI 10.1016/j.neurobiolaging.2008.09.004; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kocsis B, 2012, BIOL PSYCHIAT, V71, P987, DOI 10.1016/j.biopsych.2011.10.002; Koudinov AR, 2001, FASEB J, V15, P1858, DOI 10.1096/fj.00-0815fje; Kozora E, 2000, CHEST, V117, p249S, DOI 10.1378/chest.117.5_suppl_1.249S; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Krysiak R, 2003, DRUGS, V63, P1821, DOI 10.2165/00003495-200363170-00005; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Liesker JJW, 2004, RESP MED, V98, P351, DOI 10.1016/j.rmed.2003.11.004; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; Makino K, 1997, ONCOGENE, V14, P2425, DOI 10.1038/sj.onc.1201087; Marti-Fabregas J, 2004, STROKE, V35, P1117, DOI 10.1161/01.STR.0000125863.93921.3f; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRISETT RA, 1990, EUR J PHARMACOL, V176, P103, DOI 10.1016/0014-2999(90)90138-V; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Gonzalez-Moro JMR, 2009, INT J CLIN PRACT, V63, P742, DOI 10.1111/j.1742-1241.2009.02040.x; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Wang CX, 2005, CNS NEUROL DISORD-DR, V4, P143, DOI 10.2174/1568007053544183; Wang XT, 2007, J WENZHOU MED COLL, V5, P003; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Yang Q, 2010, NEUROCHEM RES, V35, P1353, DOI 10.1007/s11064-010-0191-6; Yang XY, 2011, CHINESE J PATHOPHYSI, V3, P029; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zheng GQ, 2008, MED HYPOTHESES, V71, P111, DOI 10.1016/j.mehy.2008.01.025; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	63	22	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94278	10.1371/journal.pone.0094278	http://dx.doi.org/10.1371/journal.pone.0094278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718106	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000101
J	Liu, WN; Yu, WN; Hou, LY; Wang, XY; Zheng, F; Wang, WX; Liang, D; Yang, HL; Jin, Y; Xie, XM				Liu, Weina; Yu, Wangning; Hou, Lingyu; Wang, Xiaoyu; Zheng, Fei; Wang, Weixuan; Liang, Di; Yang, Hailun; Jin, Yi; Xie, Xiangming			Analysis of miRNAs and Their Targets during Adventitious Shoot Organogenesis of Acacia crassicarpa	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; APICAL MERISTEM; PLANT MICRORNAS; TRANSCRIPTION FACTORS; REGULATORY ROLES; LEAF DEVELOPMENT; DOWN-REGULATION; ZYGOTIC EMBRYO; SMALL RNAS; IN-VITRO	Organogenesis is an important process for plant regeneration by tissue or cell mass differentiation to regenerate a complete plant. MicroRNAs (miRNAs) play an essential role in regulating plant development by mediating target genes at transcriptional and post-transcriptional levels, but the diversity of miRNAs and their potential roles in organogenesis of Acacia crassicarpa have rarely been investigated. In this study, approximately 10 million sequence reads were obtained from a small RNA library, from which 189 conserved miRNAs from 57 miRNA families, and 7 novel miRNAs from 5 families, were identified from A. crassicarpa organogenetic tissues. Target prediction for these miRNAs yielded 237 potentially unique genes, of which 207 received target Gene Ontology annotations. On the basis of a bioinformatic analysis, one novel and 13 conserved miRNAs were selected to investigate their possible roles in A. crassicarpa organogenesis by qRT-PCR. The stage-specific expression patterns of the miRNAs provided information on their possible regulatory functions, including shoot bud formation, modulated function after transfer of the culture to light, and regulatory roles during induction of organogenesis. This study is the first to investigate miRNAs associated with A. crassicarpa organogenesis. The results provide a foundation for further characterization of miRNA expression profiles and roles in the regulation of diverse physiological pathways during adventitious shoot organogenesis of A. crassicarpa.	[Liu, Weina; Yu, Wangning; Hou, Lingyu; Wang, Xiaoyu; Zheng, Fei; Wang, Weixuan; Liang, Di; Yang, Hailun; Jin, Yi; Xie, Xiangming] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	Beijing Forestry University	Jin, Y (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	wizard.jin@163.com; xxm1005@126.com			National Natural Science Foundation of China [31070635]; Public Welfare Project from Ministry of Agriculture of the People's Republic of China [201103027]; Fundamental Research Funds for the Central University [TD2012-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Project from Ministry of Agriculture of the People's Republic of China; Fundamental Research Funds for the Central University	This work was supported by the National Natural Science Foundation of China (No. 31070635), Public Welfare Project from Ministry of Agriculture of the People's Republic of China (No. 201103027), and the Fundamental Research Funds for the Central University (No. TD2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Axtell MJ, 2008, BBA-GENE REGUL MECH, V1779, P725, DOI 10.1016/j.bbagrm.2008.02.007; Beilharz VC, 2004, STUD MYCOL, P471; Benson EE, 2000, IN VITRO CELL DEV-PL, V36, P141, DOI 10.1007/s11627-000-0029-z; Carraro N, 2006, PLANT MOL BIOL, V60, P811, DOI 10.1007/s11103-005-2761-6; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; DEWAN A, 1992, PLANT CELL REP, V12, P18, DOI 10.1007/BF00232415; Ehrenreich IM, 2008, PLANT SIGNAL BEHAV, V3, P829, DOI 10.4161/psb.3.10.5914; ENGELMANN F, 1991, EUPHYTICA, V57, P227, DOI 10.1007/BF00039669; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; HE L, 2004, NAT REV GENET, V5, P522; Irish VF, 2008, TRENDS PLANT SCI, V13, P430, DOI 10.1016/j.tplants.2008.05.006; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kinoshita N, 2012, PLANT CELL, V24, P3590, DOI 10.1105/tpc.112.097006; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Martin KP, 2003, PLANT CELL TISS ORG, V72, P79, DOI 10.1023/A:1021229422172; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; MIDGLEY S, 2000, AUSTR TREE RESOURCES, V6, P1; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Ong SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S13; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pan Zhigang, 1994, Forest Research, V7, P498; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Sugiyama M, 1999, CURR OPIN PLANT BIOL, V2, P61, DOI 10.1016/S1369-5266(99)80012-0; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; TRANTHANHVAN M, 1973, PLANTA, V115, P87, DOI 10.1007/BF00388609; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Yao DL, 2013, PROPAG ORNAM PLANTS, V13, P86; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	66	15	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93438	10.1371/journal.pone.0093438	http://dx.doi.org/10.1371/journal.pone.0093438			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718555	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000033
J	Sanchez-Bayo, F; Goka, K				Sanchez-Bayo, Francisco; Goka, Koichi			Pesticide Residues and Bees - A Risk Assessment	PLOS ONE			English	Article							HONEYBEES APIS-MELLIFERA; COLONY COLLAPSE DISORDER; NEONICOTINOID INSECTICIDES; HYMENOPTERA APIDAE; SYSTEMIC INSECTICIDES; POLLINATOR DECLINES; CONTAMINATED POLLEN; EXPOSURE; TOXICITY; BUMBLEBEES	Bees are essential pollinators of many plants in natural ecosystems and agricultural crops alike. In recent years the decline and disappearance of bee species in the wild and the collapse of honey bee colonies have concerned ecologists and apiculturalists, who search for causes and solutions to this problem. Whilst biological factors such as viral diseases, mite and parasite infections are undoubtedly involved, it is also evident that pesticides applied to agricultural crops have a negative impact on bees. Most risk assessments have focused on direct acute exposure of bees to agrochemicals from spray drift. However, the large number of pesticide residues found in pollen and honey demand a thorough evaluation of all residual compounds so as to identify those of highest risk to bees. Using data from recent residue surveys and toxicity of pesticides to honey and bumble bees, a comprehensive evaluation of risks under current exposure conditions is presented here. Standard risk assessments are complemented with new approaches that take into account time-cumulative effects over time, especially with dietary exposures. Whilst overall risks appear to be low, our analysis indicates that residues of pyrethroid and neonicotinoid insecticides pose the highest risk by contact exposure of bees with contaminated pollen. However, the synergism of ergosterol inhibiting fungicides with those two classes of insecticides results in much higher risks in spite of the low prevalence of their combined residues. Risks by ingestion of contaminated pollen and honey are of some concern for systemic insecticides, particularly imidacloprid and thiamethoxam, chlorpyrifos and the mixtures of cyhalothrin and ergosterol inhibiting fungicides. More attention should be paid to specific residue mixtures that may result in synergistic toxicity to bees.	[Sanchez-Bayo, Francisco] Univ Sydney, Fac Agr & Environm, Eveleigh, NSW, Australia; [Goka, Koichi] Natl Inst Environm Sci, Tsukuba, Ibaraki, Japan	University of Sydney; National Institute for Environmental Studies - Japan	Sanchez-Bayo, F (corresponding author), Univ Sydney, Fac Agr & Environm, Eveleigh, NSW, Australia.	sanchezbayo@mac.com						Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Biddinger DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072587; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blasco C, 2003, J AGR FOOD CHEM, V51, P8132, DOI 10.1021/jf034870m; Buczek K., 2009, Annales Universitatis Mariae Curie-Sklodowska. Sectio DD, Medicina Veterinaria, V64, P1; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Choudhary A, 2008, ENVIRON MONIT ASSESS, V144, P143, DOI 10.1007/s10661-007-9952-3; Choudhary A, 2008, B ENVIRON CONTAM TOX, V80, P417, DOI 10.1007/s00128-008-9426-5; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; EPA, 2012, WHIT PAP SUPP PROP R, P275; Fox DR, 2012, INTEGR ENVIRON ASSES, V8, P764, DOI 10.1002/ieam.1350; Geoghegan T., 2013, PREDICTING HONEYBEE, P174; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Goka K, 2006, POPUL ECOL, V48, P285, DOI 10.1007/s10144-006-0010-8; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; GREIGSMITH PW, 1994, CROP PROT, V13, P567, DOI 10.1016/0261-2194(94)90002-7; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; HELSON BV, 1994, ARCH ENVIRON CON TOX, V27, P107, DOI 10.1007/BF00203895; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Hsieh YN, 1998, PESTIC SCI, V53, P149, DOI 10.1002/(SICI)1096-9063(199806)53:2&lt;149::AID-PS758&gt;3.0.CO;2-Z; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; JOHANSEN CA, 1984, ENVIRON ENTOMOL, V13, P1386, DOI 10.1093/ee/13.5.1386; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kenta T, 2007, BIOL CONSERV, V134, P298, DOI 10.1016/j.biocon.2006.07.023; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kovac H, 2010, J INSECT PHYSIOL, V56, P1834, DOI 10.1016/j.jinsphys.2010.08.002; Landis Wayne G., 2011, Integrated Environmental Assessment and Management, V7, pVI, DOI 10.1002/ieam.249; Laurino D, 2013, B INSECTOL, V66, P119; Maini S, 2010, B INSECTOL, V63, P153; Marletto Franco, 2003, Bulletin of Insectology, V56, P155; Mattila HR, 2001, INSECT SOC, V48, P88, DOI 10.1007/PL00001764; Mineau P, 2008, ENVIRON ENTOMOL, V37, P546, DOI 10.1603/0046-225X(2008)37[546:UROBMI]2.0.CO;2; MOFFETT JO, 1970, J ECON ENTOMOL, V63, P475, DOI 10.1093/jee/63.2.475; Mommaerts V, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P507; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Jacob CRO, 2013, B ENVIRON CONTAM TOX, V90, P69, DOI 10.1007/s00128-012-0892-4; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Osborne JL, 2012, NATURE, V491, P43, DOI 10.1038/nature11637; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pilling D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093730; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rennich K., 2012, 2011 2012 NATL HONEY; Rissato SR, 2007, FOOD CHEM, V101, P1719, DOI 10.1016/j.foodchem.2005.10.034; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sanchez-Bayo F, 2009, ECOTOXICOLOGY, V18, P343, DOI 10.1007/s10646-008-0290-1; Schmuck R., 2001, Pflanzenschutz-Nachrichten Bayer, V54, P161; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Serra-Bonvehi J, 2010, PEST MANAG SCI, V66, P1230, DOI 10.1002/ps.1999; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Tasei JN, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P101, DOI 10.1201/9780203218655.ch7; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Teeters BS, 2012, ENVIRON TOXICOL CHEM, V31, P1349, DOI 10.1002/etc.1830; Tennekes HA, 2012, J ENV ANAL TOXICOL S, VS4, pS4; Tennekes HA, 2013, TOXICOLOGY, V309, P39, DOI 10.1016/j.tox.2013.04.007; Thompson Helen, 2003, Bulletin of Insectology, V56, P175; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; Thompson HM, 1999, ECOTOXICOLOGY, V8, P147, DOI 10.1023/A:1026444029579; Thompson HM, 2001, APIDOLOGIE, V32, P305, DOI 10.1051/apido:2001131; Tomlin C.D.S., 2009, E PESTICIDE MANUAL; Underwood R., 2007, BEE CULTURE, V35, P13; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; Van Wijngaarden RPA, 2005, ECOTOXICOLOGY, V14, P355, DOI 10.1007/s10646-004-6371-x; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Vieira RF, 1999, PESTIC SCI, V55, P412, DOI 10.1002/(SICI)1096-9063(199904)55:4&lt;412::AID-PS892&gt;3.0.CO;2-L; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	99	458	470	22	579	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94482	10.1371/journal.pone.0094482	http://dx.doi.org/10.1371/journal.pone.0094482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718419	Green Published, gold			2022-12-27	WOS:000334339000126
J	Boer, MC; van Meijgaarden, KE; Joosten, SA; Ottenhoff, THM				Boer, Mardi C.; van Meijgaarden, Krista E.; Joosten, Simone A.; Ottenhoff, Tom H. M.			CD8(+) Regulatory T Cells, and Not CD4(+) T Cells, Dominate Suppressive Phenotype and Function after In Vitro Live Mycobacterium bovis-BCG Activation of Human Cells	PLOS ONE			English	Article							IMMUNE-RESPONSES; ACTIVE TUBERCULOSIS; LATENT INFECTION; VACCINATION; BLOOD; TH17	Mycobacterium bovis bacillus Calmette-Guerin (M. bovis BCG), the only currently available vaccine against tuberculosis, has been reported to induce regulatory T cells in humans. The activity of regulatory T cells may not only dampen immunogenicity and protective efficacy of tuberculosis-vaccines, but also hamper diagnosis of infection of tuberculosis, when using immune (e.g. IFN gamma-release) assays. Still, in settings of infectious diseases and vaccination, most studies have focused on CD4(+) regulatory T cells, and not CD8(+) regulatory T-cells. Here, we present a comparative analysis of the suppressive phenotype and function of CD4(+) versus CD8(+) T cells after in vitro live BCG activation of human cells. Moreover, as BCG is administered as a (partly) live vaccine, we also compared the ability of live versus heatkilled BCG in activating CD4(+) and CD8(+) regulatory T cell responses. BCG-activated CD8(+) T cells consistently expressed higher levels of regulatory T cell markers, and after live BCG activation, density and (co-)expression of markers were significantly higher, compared to CD4(+) T cells. Furthermore, selection on CD25-expression after live BCG activation enriched for CD8(+) T cells, and selection on co-expression of markers further increased CD8(+) enrichment. Ultimately, only T cells activated by live BCG were functionally suppressive and this suppressive activity resided predominantly in the CD8(+) T cell compartment. These data highlight the important contribution of live BCG-activated CD8(+) Treg cells to immune regulation and emphasize their possible negative impact on immunity and protection against tuberculosis, following BCG vaccination.	[Boer, Mardi C.; van Meijgaarden, Krista E.; Joosten, Simone A.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	T.H.M.Ottenhoff@lumc.nl	Joosten, Simone A/F-1357-2011; Joosten, Simone/E-4731-2011	Joosten, Simone A/0000-0002-9878-0863; 	EC FP7 NEWTBVAC [HEALTH.F3.2009 241745]; EC FP7 ADITEC [HEALTH. 2011.1.4-4 280873]; EC FP7 EURIPRED [INFRASTRUCTURES.2012.1 312661]; Netherlands Organization for Scientific Research [916.86.115]; Gisela Thier Foundation of the Leiden University Medical Center; Netherlands Leprosy Foundation	EC FP7 NEWTBVAC; EC FP7 ADITEC; EC FP7 EURIPRED; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Gisela Thier Foundation of the Leiden University Medical Center; Netherlands Leprosy Foundation	The authors acknowledge EC FP7 NEWTBVAC contract no. HEALTH.F3.2009 241745, EC FP7 ADITEC contract no. HEALTH. 2011.1.4-4 280873, EC FP7 EURIPRED contract no. INFRASTRUCTURES.2012.1 312661 (the text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information), The Netherlands Organization for Scientific Research (VENI grant 916.86.115), the Gisela Thier Foundation of the Leiden University Medical Center and the Netherlands Leprosy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkoc T, 2010, PEDIAT ALLERG IMM-UK, V21, P1059, DOI 10.1111/j.1399-3038.2010.01051.x; Boer MC, 2013, EUR J IMMUNOL, V43, P1925, DOI 10.1002/eji.201243286; Boor PPC, 2011, EUR J IMMUNOL, V41, P1663, DOI 10.1002/eji.201041229; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Britten CM, 2012, IMMUNITY, V37, P1, DOI 10.1016/j.immuni.2012.07.010; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Chiacchio T, 2009, CLIN EXP IMMUNOL, V156, P463, DOI 10.1111/j.1365-2249.2009.03908.x; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; GELUK A, 1992, J IMMUNOL, V149, P2864; Griffiths KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023463; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Hussey GD, 2002, IMMUNOLOGY, V105, P314, DOI 10.1046/j.1365-2567.2002.01366.x; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Kapp JA, 2008, HUM IMMUNOL, V69, P715, DOI 10.1016/j.humimm.2008.07.018; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Li L, 2011, IMMUNOBIOLOGY, V216, P477, DOI 10.1016/j.imbio.2010.09.003; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lin MY, 2009, INFECT IMMUN, V77, P5071, DOI 10.1128/IAI.00457-09; Marchant A, 1999, J IMMUNOL, V163, P2249; Matsumiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067922; MODLIN RL, 1986, NATURE, V322, P459, DOI 10.1038/322459a0; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Neefjes J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00031; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Perreau M, 2013, EUR J IMMUNOL, V43, P939, DOI 10.1002/eji.201243090; Rozot V, 2013, EUR J IMMUNOL, V43, P1568, DOI 10.1002/eji.201243262; Semple PL, 2013, AM J RESP CRIT CARE, V187, P1249, DOI 10.1164/rccm.201210-1934OC; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Ye ZJ, 2011, CLIN VACCINE IMMUNOL, V18, P1608, DOI 10.1128/CVI.05214-11	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94192	10.1371/journal.pone.0094192	http://dx.doi.org/10.1371/journal.pone.0094192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714620	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900102
J	Chen, XP; Guo, XY; Huang, R; Chen, YP; Zheng, ZZ; Shang, HF				Chen, Xueping; Guo, Xiaoyan; Huang, Rui; Chen, Yongping; Zheng, Zhenzhen; Shang, Huifang			Serum Uric Acid Levels in Patients with Alzheimer's Disease: A Meta-Analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; VASCULAR RISK-FACTORS; 3RD NATIONAL-HEALTH; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; LIPID-PEROXIDATION; BLOOD-PRESSURE; PLASMA ANTIOXIDANTS; URATE	Background: Serum uric acid (UA) could exert neuro-protective effects against Alzheimer's disease (AD) via its antioxidant capacities. Many studies investigated serum UA levels in AD patients, but to date, results from these observational studies are conflicting. Methods: We conducted a meta-analysis to compare serum UA levels between AD patients and healthy controls by the random-effects model. Studies were identified by searching PubMed, ISI Web of Science, EMBASE, and the Cochrane library databases from 1966 through July 2013 using the Medical Subject Headings and keywords without restriction in languages. Only case-control studies were included if they had data on serum UA levels in AD patients and healthy controls. Begg's funnel plot and Egger's regression test were applied to assess the potential publication bias. Sensitivity analyses and metaregression were conducted to explore possible explanations for heterogeneity. Results: A total of 11 studies met the inclusion criteria including 2708 participants were abstracted. Serum UA levels were not significantly different in AD patients compared to healthy controls (standardized mean difference (SMD) = -0.50; 95% confidence interval (CI): -1.23 to 0.22). Little evidence of publication bias was observed. Sensitivity analyses showed that the combined SMD was consistent every time omitting any one study, except only one study which greatly influenced the overall results. Meta-regression showed that year of publication, race, sample size, and mean age were not significant sources of heterogeneity. Conclusion: Our meta-analysis of case-control studies suggests that serum UA levels do not differ significantly in AD patients, but there may be a trend toward decreased UA in AD after an appropriate interpretation. More well-designed investigations are needed to demonstrate the potential change of serum UA levels in AD patients.	[Chen, Xueping; Guo, Xiaoyan; Huang, Rui; Chen, Yongping; Zheng, Zhenzhen; Shang, Huifang] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Shang, HF (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Sichuan, Peoples R China.	hfshang@yahoo.com			National Natural Science Foundation of China [81301093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (grant number 81301093) (http://www.nsfc.gov.cn/Portal0/default166.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLSKOG JE, 1995, MOVEMENT DISORD, V10, P566, DOI 10.1002/mds.870100507; Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bobba A, 2010, INT J ALZHEIMERS DIS, V2010; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Butterfield DA, 2011, NEUROMOL MED, V13, P19, DOI 10.1007/s12017-010-8123-9; Can M, 2013, EUR NEUROL, V69, P377, DOI 10.1159/000339006; Cankurtaran M, 2013, J ALZHEIMERS DIS, V33, P1051, DOI 10.3233/JAD-2012-121630; Carantoni M, 2000, DEMENT GERIATR COGN, V11, P176, DOI 10.1159/000017232; Cascalheira JF, 2009, CLIN BIOCHEM, V42, P783, DOI 10.1016/j.clinbiochem.2009.02.006; Cervellati C, 2013, CURR ALZHEIMER RES, V10, P365, DOI 10.2174/1567205011310040003; Chen XQ, 2012, CURR NEUROL NEUROSCI, V12, P367, DOI 10.1007/s11910-012-0282-7; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; Clark Timothy A, 2010, Int J Biomed Sci, V6, P225; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; de la Torre Jack C, 2012, Cardiovasc Psychiatry Neurol, V2012, P367516, DOI 10.1155/2012/367516; de la Torre JC, 2010, J ALZHEIMERS DIS, V20, P687, DOI 10.3233/JAD-2010-091580; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; delaTorre JC, 1997, GERONTOLOGY, V43, P26; DESCHEERDER IK, 1991, AM J CARDIOL, V68, P392, DOI 10.1016/0002-9149(91)90838-C; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Euser SM, 2009, BRAIN, V132, P377, DOI 10.1093/brain/awn316; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Foy CJ, 1999, QJM-INT J MED, V92, P39, DOI 10.1093/qjmed/92.1.39; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Gao X, 2008, AM J EPIDEMIOL, V167, P831, DOI 10.1093/aje/kwm385; Gella A, 2009, CELL ADHES MIGR, V3, P88, DOI 10.4161/cam.3.1.7402; Gong L, 2012, J NEUROCHEM, V123, P876, DOI 10.1111/jnc.12038; Gu XM, 2012, NEUROSCI BULL, V28, P631, DOI 10.1007/s12264-012-1270-2; Hak AE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2519; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095; Ikeda K, 2011, NEURODEGENER DIS, V8, P252, DOI 10.1159/000323265; Irizarry MC, 2009, NEURODEGENER DIS, V6, P23, DOI 10.1159/000170883; Iuliano L, 2010, J ALZHEIMERS DIS, V21, P1383, DOI 10.3233/JAD-2010-100780; Jain S, 2011, NEUROEPIDEMIOLOGY, V36, P223, DOI 10.1159/000327748; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; Kawamoto R, 2013, HYPERTENS RES, V36, P634, DOI 10.1038/hr.2013.5; Kim KM, 2004, BRAIN RES BULL, V64, P47, DOI 10.1016/j.brainresbull.2004.04.016; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kumari Udhaya, 2010, Open Biochem J, V4, P29, DOI 10.2174/1874091X01004010029; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Kuzuya M, 2002, J GERONTOL A-BIOL, V57, pM660, DOI 10.1093/gerona/57.10.M660; Lee HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028033, 10.1371/journal.pone.0044670, 10.1371/journal.pone.0050296, 10.1186/1747-597X-7-11]; Liu B, 2012, NEUROL RES, V34, P163, DOI 10.1179/1743132811Y.0000000074; Logallo N, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-114; Lunnon K, 2012, J ALZHEIMERS DIS, V30, P685, DOI 10.3233/JAD-2012-111592; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; MAESAKA JK, 1993, J AM GERIATR SOC, V41, P501, DOI 10.1111/j.1532-5415.1993.tb01885.x; Maiese K, 2004, RESTOR NEUROL NEUROS, V22, P87; Mancuso M, 2006, J ALZHEIMERS DIS, V9, P111; Martinez-Finley EJ, 2011, METALLOMICS, V3, P271, DOI 10.1039/c0mt00064g; Matsumura K, 2006, CIRC J, V70, P885, DOI 10.1253/circj.70.885; Mecocci P, 2004, J ALZHEIMERS DIS, V6, P159; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Montine TJ, 2007, J MOL NEUROSCI, V33, P114, DOI 10.1007/s12031-007-0044-1; Montine TJ, 2011, NEUROMOL MED, V13, P37, DOI 10.1007/s12017-010-8126-6; Moreira PI, 2007, ANTIOXID REDOX SIGN, V9, P1621, DOI 10.1089/ars.2007.1703; Moreira PI, 2005, J NEURAL TRANSM, V112, P921, DOI 10.1007/s00702-004-0242-8; Muller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paganoni S, 2012, J NEUROL, V259, P1923, DOI 10.1007/s00415-012-6440-7; Polidori MC, 2002, J ALZHEIMERS DIS, V4, P517; Polidori MC, 2004, DEMENT GERIATR COGN, V18, P265, DOI 10.1159/000080027; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 2010, BBA-MOL CELL BIOL L, V1801, P930, DOI 10.1016/j.bbalip.2010.01.009; Puig JG, 1999, J HYPERTENS, V17, P869, DOI 10.1097/00004872-199917070-00001; Rinaldi P, 2003, NEUROBIOL AGING, V24, P915, DOI 10.1016/S0197-4580(03)00031-9; Rodrigues SL, 2012, ARQ BRAS CARDIOL, V98, P13, DOI 10.1590/S0066-782X2011005000116; Sayre LM, 2000, CELL MOL BIOL, V46, P731; Schrag M, 2013, NEUROBIOL DIS, V59, P100, DOI 10.1016/j.nbd.2013.07.005; Schretlen DJ, 2007, NEUROPSYCHOLOGY, V21, P136, DOI 10.1037/0894-4105.21.1.136; Scott GS, 2002, P NATL ACAD SCI USA, V99, P16303, DOI 10.1073/pnas.212645999; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Shen CH, 2013, CAN J NEUROL SCI, V40, P73, DOI 10.1017/S0317167100012981; Skoog I, 1996, LANCET, V347, P1141, DOI 10.1016/S0140-6736(96)90608-X; Smith MA, 2000, ANTIOXID REDOX SIGN, V2, P413, DOI 10.1089/15230860050192198; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stewart R, 2009, HYPERTENSION, V54, P233, DOI 10.1161/HYPERTENSIONAHA.109.128744; Stockl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032668; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sumino H, 1999, LANCET, V354, P650, DOI 10.1016/S0140-6736(99)92381-4; Tarumi T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00006; Torun M, 1998, J CLIN PHARM THER, V23, P25, DOI 10.1046/j.1365-2710.1998.00125.x; Villegas R, 2012, NUTR METAB CARDIOVAS, V22, P409, DOI 10.1016/j.numecd.2010.07.012; Villeneuve S, 2009, DEMENT GERIATR COGN, V27, P375, DOI 10.1159/000209965; Waring WS, 2000, QJM-INT J MED, V93, P707, DOI 10.1093/qjmed/93.11.707; Waring WS, 2001, J CARDIOVASC PHARM, V38, P365, DOI 10.1097/00005344-200109000-00005; Waugh WH, 2008, GERONTOLOGY, V54, P238, DOI 10.1159/000122618; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Zafrilla P, 2006, CURR MED CHEM, V13, P1075, DOI 10.2174/092986706776360978; Zhu XW, 2004, BRAIN RES, V1000, P32, DOI 10.1016/j.brainres.2004.01.012; Zoccolella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040608	100	28	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94084	10.1371/journal.pone.0094084	http://dx.doi.org/10.1371/journal.pone.0094084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714617	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900079
J	Jadhav, U; Hiremath, J; Namjoshi, DJ; Gujral, VK; Tripathi, KK; Siraj, M; Shamanna, P; Safar, M				Jadhav, Uday; Hiremath, Jagdish; Namjoshi, Deepak J.; Gujral, Vinod K.; Tripathi, Kamlakar K.; Siraj, Mohammad; Shamanna, Paramesh; Safar, Michel			Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study	PLOS ONE			English	Article							ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR EVENTS; CALCIUM; THERAPY; VALSARTAN/HYDROCHLOROTHIAZIDE; METAANALYSIS; MONOTHERAPY; PREVENTION; MANAGEMENT; REDUCTION	Objective: Despite antihypertensive treatment, most hypertensive patients still have high blood pressure (BP), notably high systolic blood pressure (SBP). The EFFICIENT study examines the efficacy and acceptability of a single-pill combination of sustained-release (SR) indapamide, a thiazide-like diuretic, and amlodipine, a calcium channel blocker (CCB), in the management of hypertension. Methods: Patients who were previously uncontrolled on CCB monotherapy (BP >= 140/90 mm Hg) or were previously untreated with grade 2 or 3 essential hypertension (BP >= 160/100 mm Hg) received a single-pill combination tablet containing indapamide SR 1.5 mg and amlodipine 5 mg daily for 45 days, in this multicenter prospective phase 4 study. The primary outcome was mean change in BP from baseline; percentage of patients achieving BP control (BP < 140/90 mm Hg) was a secondary endpoint. SBP reduction (triangle SBP) versus diastolic BP reduction (triangle DBP) was evaluated (triangle SBP/triangle DBP) from baseline to day 45. Safety and tolerability were also assessed. Results: Mean baseline BP of 196 patients (mean age 52.3 years) was 160.2/97.9 mm Hg. After 45 days, mean SBP decreased by 28.5 mm Hg (95% CI, 26.4 to 30.6), while diastolic BP decreased by 15.6 mm Hg (95% CI, 14.5 to 16.7). BP control (< 140/90 mm Hg) was achieved in 85% patients. triangle SBP/triangle DBP was 1.82 in the overall population. Few patients (n = 3 [ 2%]) reported side effects, and most (n = 194 [ 99%]) adhered to treatment. Conclusion: In patients who were previously uncontrolled on CCB monotherapy or untreated with grade 2 or 3 hypertension, single-pill combination indapamide SR/amlodipine reduced BP effectively-especially SBP-over 45 days, and was safe and well tolerated. Trial Registration: Clinical Trial Registry - India CTRI/2010/091/000114	[Jadhav, Uday] MGM New Bombay Hosp, Navi Mumbai, Maharashtra, India; [Hiremath, Jagdish] Poona Hosp & Res Ctr, Pune, Maharashtra, India; [Namjoshi, Deepak J.] Criti Care Multi Specialty Hosp & Res Ctr, Mumbai, Maharashtra, India; [Gujral, Vinod K.] Specialty Clin A, New Delhi, India; [Tripathi, Kamlakar K.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Siraj, Mohammad] Owaisi Hosp & Res Ctr, Deccan Coll Med Sci, Hyderabad, Andhra Pradesh, India; [Shamanna, Paramesh] Medisys Clinisearch India Pvt Ltd, Bangalore Diabet Ctr, Bangalore, Karnataka, India; [Safar, Michel] Univ Paris 05, AP HP, Paris, France	Banaras Hindu University (BHU); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite	Jadhav, U (corresponding author), MGM New Bombay Hosp, Navi Mumbai, Maharashtra, India.	drjadhav0512@gmail.com		S, Paramesh/0000-0002-0693-4483	Serdia Pharmaceuticals (India) Pvt. Ltd.	Serdia Pharmaceuticals (India) Pvt. Ltd.	A research grant was provided by Serdia Pharmaceuticals (India) Pvt. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguedas JA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008277.pub2; Baguet JP, 2007, CLIN DRUG INVEST, V27, P735, DOI 10.2165/00044011-200727110-00001; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Calhoun DA, 2008, CURR MED RES OPIN, V24, P2303, DOI 10.1185/03007990802271946; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Collins OR, 1994, TXB HYPERTENSION, P1156; Corrao G, 2011, HYPERTENSION, V58, P566, DOI 10.1161/HYPERTENSIONAHA.111.177592; Egan BM, 2012, HYPERTENSION, V59, P1124, DOI 10.1161/HYPERTENSIONAHA.112.194167; Ferrari R, 1997, EUR HEART J, V18, pA56; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; GUSTAFSSON D, 1987, J CARDIOVASC PHARM, V10, pS121, DOI 10.1097/00005344-198710001-00023; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Makani H, 2011, J HYPERTENS, V29, P1270, DOI 10.1097/HJH.0b013e3283472643; Mallion JM, 1996, ARCH MAL COEUR VAISS, V89, P27; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Matsuzaki M, 2011, J HYPERTENS, V29, P1649, DOI 10.1097/HJH.0b013e328348345d; McManus RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e181; Mohan V, 2007, J Assoc Physicians India, V55, P326; MOORE RA, 1977, CURR MED RES OPIN, V5, P25, DOI 10.1185/03007997709110220; Mulatero P, 2007, CLIN ENDOCRINOL, V67, P324, DOI 10.1111/j.1365-2265.2007.02898.x; Pool JL, 2007, CLIN THER, V29, P61, DOI 10.1016/j.clinthera.2007.01.007; Salerno Christina M, 2004, J Clin Hypertens (Greenwich), V6, P614, DOI 10.1111/j.1524-6175.2004.03808.x; SEIDEL CL, 1971, CIRC RES, V28, pII88; Taddei S, 2012, HIGH BLOOD PRESS CAR, V19, P55, DOI 10.2165/11632180-000000000-00000; Thomas F, 2012, J AM SOC HYPERTENS, V6, P405, DOI 10.1016/j.jash.2012.10.003; Tocci G, 2012, J HYPERTENS, V30, P1065, DOI 10.1097/HJH.0b013e3283535993; Turnbull F, 2003, LANCET, V362, P1527; van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075; Waeber B, 2012, EXPERT OPIN PHARMACO, V13, P1515, DOI 10.1517/14656566.2012.698611; Wang JG, 2007, HYPERTENSION, V50, P181, DOI 10.1161/HYPERTENSIONAHA.107.089763; Wheeler DC, 2013, KIDNEY INT, V83, P377, DOI 10.1038/ki.2012.425; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Zhang Y, 2011, HYPERTENSION, V58, P155, DOI 10.1161/HYPERTENSIONAHA.111.174383	37	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92955	10.1371/journal.pone.0092955	http://dx.doi.org/10.1371/journal.pone.0092955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714044	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900011
J	Lin, CW; Huang, YP; Chiu, YH; Ho, YT; Pan, SL				Lin, Chia-Wei; Huang, Ya-Ping; Chiu, Yueh-Hsia; Ho, Yu-Tsun; Pan, Shin-Liang			Increased Risk of Ischemic Stroke in Young Patients with Ankylosing Spondylitis: A Population-Based Longitudinal Follow-Up Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; ATHEROSCLEROSIS; PREVALENCE; RECOMMENDATIONS; MANIFESTATIONS; INFLAMMATION; MANAGEMENT; PROFILE; UPDATE	Background: Prospective data on the association between ischemic stroke and ankylosing spondylitis (AS) in the young are sparse. The purpose of this population-based, age- and sex-matched longitudinal follow-up study was to investigate the risk of developing ischemic stroke in young patients with AS. Methods: A total of 4562 patients aged 18- to 45-year-old with at least two ambulatory visits in 2001 with a principal diagnosis of AS were enrolled in the AS group. The non-AS group consisted of 22810 age- and sex-matched, randomly sampled subjects without AS. The two-year ischemic stroke-free survival rate for each group were calculated using the Kaplan-Meier method. Cox proportional hazards regression analysis was used to estimate the hazard ratio of ischemic stroke after adjusting for demographic and clinical covariates. Results: During follow-up, 21 patients in the AS group and 53 in the non-AS group developed ischemic stroke. The ischemic stroke-free survival rate over the 2 year follow-up was lower in the AS group than the non-AS group (p = 0.0021). The crude hazard ratio of ischemic stroke for the AS group was 1.98 (95% CI, 1.20-3.29; p = 0.0079) and the adjusted hazard ratio after controlling for demographic and comorbid medical disorders was 1.93 (95% CI, 1.16-3.20; p = 0.0110). Conclusion: Our study showed an increased risk of developing ischemic stroke in young patients with AS.	[Lin, Chia-Wei; Ho, Yu-Tsun; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Huang, Ya-Ping] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Yu Lin Branch, Yunlin, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Tao Yuan, Taiwan; [Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung University; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		lin, chiawei/0000-0002-6577-0116; Chiu, Sherry Yueh-Hsia/0000-0002-7207-7088; PAN, SHIN-LIANG/0000-0001-6451-4666	Department of Health (DOH), Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]; National Science Council, Executive Yuan, Republic of China [NSC101-2314-B-002-088]	Department of Health (DOH), Executive Yuan, Republic of China; National Science Council, Executive Yuan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health (DOH), Executive Yuan, Republic of China and grant NSC101-2314-B-002-088 from the National Science Council, Executive Yuan, Republic of China. This study used the complete National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health. The conclusions in our study are not necessarily those of the Department of Health, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bodnar N, 2011, J RHEUMATOL, V38, P723, DOI 10.3899/jrheum.100668; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; Cece H, 2011, CLIN INVEST MED, V34, pE225, DOI 10.25011/cim.v34i4.15364; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; CHOU CT, 1994, J RHEUMATOL, V21, P302; Cohen A, 1997, STROKE, V28, P1574, DOI 10.1161/01.STR.28.8.1574; Divecha H, 2005, CLIN SCI, V109, P171, DOI 10.1042/CS20040326; El Maghraoui A, 2011, EUR J INTERN MED, V22, P554, DOI 10.1016/j.ejim.2011.06.006; Gonzalez-Juanatey C, 2009, MEDICINE, V88, P358, DOI 10.1097/MD.0b013e3181c10773; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Hamdi W, 2012, J RHEUMATOL, V39, P322, DOI 10.3899/jrheum.110792; Han CL, 2006, J RHEUMATOL, V33, P2167; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064155; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Lange U, 2000, Eur J Med Res, V5, P507; Mathieu S, 2011, ARTHRIT CARE RES, V63, P557, DOI 10.1002/acr.20364; ONEILL TW, 1992, ANN RHEUM DIS, V51, P705, DOI 10.1136/ard.51.6.705; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peters MJL, 2010, J RHEUMATOL, V37, P161, DOI 10.3899/jrheum.090667; Peters MJ, 2004, SEMIN ARTHRITIS RHEU, V34, P585, DOI 10.1016/j.semarthrit.2004.07.010; RIBEIRO P, 1984, EUR HEART J, V5, P419, DOI 10.1093/oxfordjournals.eurheartj.a061676; Roman MJ, 2007, CIRCULATION, V116, P2346, DOI 10.1161/CIRCULATIONAHA.106.678334; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sari I, 2006, RHEUMATOLOGY, V45, P283, DOI 10.1093/rheumatology/kei145; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Szabo SM, 2011, ARTHRITIS RHEUM-US, V63, P3294, DOI 10.1002/art.30581; van den Berg R, 2012, RHEUMATOLOGY, V51, P1388, DOI 10.1093/rheumatology/kes066; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	33	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94027	10.1371/journal.pone.0094027	http://dx.doi.org/10.1371/journal.pone.0094027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714094	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900071
J	Wykowska, A; Wiese, E; Prosser, A; Muller, HJ				Wykowska, Agnieszka; Wiese, Eva; Prosser, Aaron; Mueller, Hermann J.			Beliefs about the Minds of Others Influence How We Process Sensory Information	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; COGNITIVE-PSYCHOLOGY; SELECTIVE ATTENTION; VISUAL-ATTENTION; JOINT ATTENTION; GAZE; REFLEXIVE; MODULATION; MECHANISM; BRAIN	Attending where others gaze is one of the most fundamental mechanisms of social cognition. The present study is the first to examine the impact of the attribution of mind to others on gaze-guided attentional orienting and its ERP correlates. Using a paradigm in which attention was guided to a location by the gaze of a centrally presented face, we manipulated participants' beliefs about the gazer: gaze behavior was believed to result either from operations of a mind or from a machine. In Experiment 1, beliefs were manipulated by cue identity (human or robot), while in Experiment 2, cue identity (robot) remained identical across conditions and beliefs were manipulated solely via instruction, which was irrelevant to the task. ERP results and behavior showed that participants' attention was guided by gaze only when gaze was believed to be controlled by a human. Specifically, the P1 was more enhanced for validly, relative to invalidly, cued targets only when participants believed the gaze behavior was the result of a mind, rather than of a machine. This shows that sensory gain control can be influenced by higher-order (task-irrelevant) beliefs about the observed scene. We propose a new interdisciplinary model of social attention, which integrates ideas from cognitive and social neuroscience, as well as philosophy in order to provide a framework for understanding a crucial aspect of how humans' beliefs about the observed scene influence sensory processing.	[Wykowska, Agnieszka; Wiese, Eva; Mueller, Hermann J.] Univ Munich, Dept Psychol, Munich, Germany; [Wykowska, Agnieszka] Tech Univ Munich, Inst Cognit Syst, D-80290 Munich, Germany; [Wiese, Eva] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Prosser, Aaron] Univ Munich, Neurocognit Psychol Master Program, Munich, Germany; [Prosser, Aaron] PET Ctr, Res Imaging Ctr, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mueller, Hermann J.] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England	University of Munich; Technical University of Munich; George Mason University; University of Munich; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of London; Birkbeck University London	Wykowska, A (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	agnieszka.wykowska@psy.lmu.de		Wykowska, Agnieszka/0000-0003-3323-7357	DFG-Excellence Cluster 'Cognition for Technical Systems' [EXC142, 435: SocGaze]; DFG [WY-122/1-1]	DFG-Excellence Cluster 'Cognition for Technical Systems'; DFG(German Research Foundation (DFG))	This work was supported by EXC142 grant (DFG-Excellence Cluster 'Cognition for Technical Systems', sub-project #435: SocGaze), awarded to HM; and a DFG individual grant awarded to AW (WY-122/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Dennett DC, 2003, PHILOS MIND CONT REA, P370; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; EIMER M, 1994, PERCEPT PSYCHOPHYS, V55, P667, DOI 10.3758/BF03211681; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hietanen JK, 1999, NEUROREPORT, V10, P3443, DOI 10.1097/00001756-199911080-00033; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; Kawai N, 2011, JPN PSYCHOL RES, V53, P292, DOI 10.1111/j.1468-5884.2011.00470.x; Lachat F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050499; Lins Otavio G., 1993, Brain Topography, V6, P51, DOI 10.1007/BF01234127; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1995, INT J NEUROSCI, V80, P281, DOI 10.3109/00207459508986105; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Lundqvist D., 1998, KAROLINSKA DIRECTED; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1993, ATTENTION PERFORM, V14, P219; MULLER HJ, 1987, PERCEPT PSYCHOPHYS, V42, P383, DOI 10.3758/BF03203097; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; Pfeiffer UJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027591; Poghosyan V, 2008, NEURON, V58, P802, DOI 10.1016/j.neuron.2008.04.013; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Schuller AM, 2001, NEUROREPORT, V12, P2381, DOI 10.1097/00001756-200108080-00019; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Senju A, 2005, VIS COGN, V12, P127, DOI 10.1080/13506280444000157; Stolarova M, 2006, CEREB CORTEX, V16, P876, DOI 10.1093/cercor/bhj031; Teufel C, 2010, TRENDS COGN SCI, V14, P376, DOI 10.1016/j.tics.2010.05.005; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tomasello M, 2009, WHY WE COOPERATE, P1; Tomasello M., 2010, ORIGINS HUMAN COMMUN; Townsend J.T., 1978, COGNITIVE THEORY, V3, P200; Wiese E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045391	47	89	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94339	10.1371/journal.pone.0094339	http://dx.doi.org/10.1371/journal.pone.0094339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714419	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000334160900118
J	Yu, HT; Jiang, W; Du, H; Xing, Y; Bai, GZ; Zhang, Y; Li, Y; Jiang, H; Zhang, Y; Wang, JP; Wang, PZ; Bai, XF				Yu, Haitao; Jiang, Wei; Du, Hong; Xing, Yuan; Bai, Guangzhen; Zhang, Ye; Li, Yu; Jiang, Hong; Zhang, Ying; Wang, Jiuping; Wang, Pingzhong; Bai, Xuefan			Involvement of the Akt/NF-kappa B Pathways in the HTNV-Mediated Increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC-FEVER; ANTIINFLAMMATORY ACTIVITY; INCREASED PERMEABILITY; HUMAN CYTOMEGALOVIRUS; RELA/P65 SUBUNIT; VIRUS-INFECTION; RENAL SYNDROME; IN-VITRO; EXPRESSION	Background: Hantaan virus (HTNV) infection causes a severe form of HFRS(hemorrhagic fever with renal syndrome) in Asia. Although HTNV has been isolated for nearly forty years, the pathogenesis of HFRS is still unknown, and little is known regarding the signaling pathway that is activated by the virus. Methodology/Principal Findings: Cardamonin was selected as a NF-kappa B inhibitor, and indirect immunofluorescence assays were used to detect the effect of cardamonin on HTNV-infected HUVECs. The effect of cardamonin on the HTNV-induced phosphorylation of Akt and DNA-binding activity of NF-kB were determined using Western blot analysis and electrophoretic mobility shift assays (EMSAs), respectively. Then, flow cytometric and quantitative real-time PCR analyses were performed to quantify the expression levels of the adhesion molecules ICAM-1 and VCAM-1, and the concentrations of IL-6, IL-8, and CCL5 in HUVEC supernatants were examined using ELISA. The results showed that cardamonin did not effect the proliferation of HUVECs or the replication of HTNV in HUVECs. Instead, cardamonin inhibited the phosphorylation of Akt and nuclear transduction of NF-kB and further reduced the expression of the adhesion molecules ICAM-1 and VCAM-1 in HTNV-infected HUVECs. Cardamonin also inhibited the secretion of IL-6 and CCL5, but not IL-8 Conclusion/Significance: HTNV replication may not be dependent upon the ability of the virus to activate NF-kB in HUVECs. The Akt/NF-kappa B pathways may be involved in the pathogenesis of HFRS; therefore, cardamonin may serve as a potential beneficial agent for HFRS therapy.	[Yu, Haitao; Jiang, Wei; Du, Hong; Zhang, Ye; Jiang, Hong; Zhang, Ying; Wang, Jiuping; Wang, Pingzhong; Bai, Xuefan] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Xing, Yuan] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Shaanxi Provinc, Peoples R China; [Bai, Guangzhen] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Li, Yu] Shaanxi Prov Peoples Hosp, Dept Infect Dis, Xian, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University	Wang, PZ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	wangpz63@126.com; xfbai@fmmu.edu.cn	Gaobo, Huang/AAP-9975-2020		National Basic Research Program of China (973 Program) [2012CB518905]; National Natural Science Foundation of China [30901346, 81071370]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2012CB518905) and National Natural Science Foundation of China (No. 30901346, No. 81071370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici C, 2001, J BIOL CHEM, V276, P28759, DOI 10.1074/jbc.M103408200; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Balwani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046528; Benedict CA, 2004, J VIROL, V78, P741, DOI 10.1128/JVI.78.2.741-750.2004; Bernasconi D, 2005, J BIOL CHEM, V280, P24127, DOI 10.1074/jbc.M413726200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caposio P, 2007, CELL MICROBIOL, V9, P2040, DOI 10.1111/j.1462-5822.2007.00936.x; COSGRIFF TM, 1991, REV INFECT DIS, V13, P97; Dai C, 2013, MOL CELL BIOCHEM, V374, P1, DOI 10.1007/s11010-012-1488-3; Gavrilovskaya IN, 2008, J VIROL, V82, P5797, DOI 10.1128/JVI.02397-07; Geimonen E, 2002, P NATL ACAD SCI USA, V99, P13837, DOI 10.1073/pnas.192298899; Gustems M, 2006, J VIROL, V80, P9899, DOI 10.1128/JVI.00640-06; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Han QY, 2010, EUR J CLIN MICROBIOL, V29, P1507, DOI 10.1007/s10096-010-1032-x; Hayasaka D, 2007, VIRUS RES, V123, P120, DOI 10.1016/j.virusres.2006.08.006; Jiang H, 2008, VIROLOGY, V380, P52, DOI 10.1016/j.virol.2008.07.002; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Kanerva M, 1998, REV MED VIROL, V8, P67, DOI 10.1002/(SICI)1099-1654(199804/06)8:2&lt;67::AID-RMV217&gt;3.0.CO;2-U; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kariwa H, 2007, COMP IMMUNOL MICROB, V30, P341, DOI 10.1016/j.cimid.2007.05.011; Kim YJ, 2010, INT IMMUNOPHARMACOL, V10, P1127, DOI 10.1016/j.intimp.2010.06.017; KITAMURA T, 1983, JPN J MED SCI BIOL, V36, P17, DOI 10.7883/yoken1952.36.17; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Lee JH, 2006, J PHARMACOL EXP THER, V316, P271, DOI 10.1124/jpet.105.092486; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; MacNeil A, 2011, VIRUS RES, V162, P138, DOI 10.1016/j.virusres.2011.09.017; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nakabayashi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-453; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Niikura M, 2004, ARCH VIROL, V149, P1279, DOI 10.1007/s00705-004-0306-y; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Qi BT, 2006, VIRAL IMMUNOL, V19, P565, DOI 10.1089/vim.2006.19.565; Ren GL, 2005, BIOCHEM BIOPH RES CO, V335, P1051, DOI 10.1016/j.bbrc.2005.07.170; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Saksida A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-142; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; SCHMALJOHN CS, 1985, SCIENCE, V227, P1041, DOI 10.1126/science.2858126; Sen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048770; Shah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052060; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sheikh AM, 2005, CARDIOVASC RES, V65, P263, DOI 10.1016/j.cardiores.2004.09.017; Sundstrom JB, 2001, J VIROL, V75, P6070, DOI 10.1128/JVI.75.13.6070-6085.2001; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tsoyi K, 2010, ATHEROSCLEROSIS, V213, P115, DOI 10.1016/j.atherosclerosis.2010.07.061; Vapalahti O, 1996, J GEN VIROL, V77, P3063, DOI 10.1099/0022-1317-77-12-3063; Wang PZ, 2012, J INT MED RES, V40, P648, DOI 10.1177/147323001204000227; Xu Zhe, 2007, J Infect, V55, pe1, DOI 10.1016/j.jinf.2007.01.003; Yu HT, 2012, VIRAL IMMUNOL, V25, P387, DOI 10.1089/vim.2012.0005; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zhang Y, 2008, APMIS, V116, P1089, DOI 10.1111/j.1600-0463.2008.01011.x	58	16	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93810	10.1371/journal.pone.0093810	http://dx.doi.org/10.1371/journal.pone.0093810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714064	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900051
J	Kabir, A; Merrill, RD; Shamim, AA; Klemn, RDW; Labrique, AB; Christian, P; West, KP; Nasser, M				Kabir, Alamgir; Merrill, Rebecca D.; Shamim, Abu Ahmed; Klemn, Rolf D. W.; Labrique, Alain B.; Christian, Parul; West, Keith P., Jr.; Nasser, Mohammed			Canonical Correlation Analysis of Infant's Size at Birth and Maternal Factors: A Study in Rural Northwest Bangladesh	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTATION; VITAMIN-A; ANTHROPOMETRIC MEASUREMENTS; INTRAUTERINE GROWTH; NUTRITIONAL-STATUS; WEIGHT; MORTALITY; NEWBORN; CIRCUMFERENCE; PREGNANCY	This analysis was conducted to explore the association between 5 birth size measurements ( weight, length and head, chest and mid-upper arm [MUAC] circumferences) as dependent variables and 10 maternal factors as independent variables using canonical correlation analysis (CCA). CCA considers simultaneously sets of dependent and independent variables and, thus, generates a substantially reduced type 1 error. Data were from women delivering a singleton live birth (n = 14506) while participating in a double-masked, cluster-randomized, placebo-controlled maternal vitamin A or b-carotene supplementation trial in rural Bangladesh. The first canonical correlation was 0.42 (P < 0.001), demonstrating a moderate positive correlation mainly between the 5 birth size measurements and 5 maternal factors (preterm delivery, early pregnancy MUAC, infant sex, age and parity). A significant interaction between infant sex and preterm delivery on birth size was also revealed from the score plot. Thirteen percent of birth size variability was explained by the composite score of the maternal factors (Redundancy, R-Y/(X) = 0.131). Given an ability to accommodate numerous relationships and reduce complexities of multiple comparisons, CCA identified the 5 maternal variables able to predict birth size in this rural Bangladesh setting. CCA may offer an efficient, practical and inclusive approach to assessing the association between two sets of variables, addressing the innate complexity of interactions.	[Kabir, Alamgir; Nasser, Mohammed] Rajshahi Univ, Dept Stat, Rajshahi 6205, Bangladesh; [Kabir, Alamgir] Icddr b, Dhaka, Bangladesh; [Merrill, Rebecca D.; Klemn, Rolf D. W.; Labrique, Alain B.; Christian, Parul; West, Keith P., Jr.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD USA; [Shamim, Abu Ahmed] JiVitA Maternal & Child Hlth & Nutr Res Project, Gaibandha, Bangladesh	University of Rajshahi; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kabir, A (corresponding author), Rajshahi Univ, Dept Stat, Rajshahi 6205, Bangladesh.	alamgir.kabir@icddrb.org	Kabir, Alamgir/H-3430-2019	Kabir, Alamgir/0000-0002-3762-8307; Abu Ahmed, Shamim/0000-0002-7071-8558; Labrique, Alain/0000-0003-2502-7819	Bill and Melinda Gates Foundation, Seattle, WA Global Control of Micronutrient Deficiency [614]; Micronutrients for Health Cooperative Agreement [HRN-A-00-97-00015]; Global Research Activity Cooperative Agreement [GHS-A-00-03-00019-00]; Johns Hopkins University; Office of Health, Infectious Diseases and Nutrition; US Agency for International Development, Washington, DC; Sight and Life Research Institute (Baltimore, MD); Nutrilite Health Institute (Nutrilite Division, Access Business Group, LLC, Buena Park, CA); Canadian International Development Agency (CIDA), Ottawa, Canada; Ministry of Health and Family Welfare of the Government of the People's Republic of Bangladesh	Bill and Melinda Gates Foundation, Seattle, WA Global Control of Micronutrient Deficiency; Micronutrients for Health Cooperative Agreement; Global Research Activity Cooperative Agreement; Johns Hopkins University(Johns Hopkins University); Office of Health, Infectious Diseases and Nutrition(United States Agency for International Development (USAID)); US Agency for International Development, Washington, DC(United States Agency for International Development (USAID)); Sight and Life Research Institute (Baltimore, MD); Nutrilite Health Institute (Nutrilite Division, Access Business Group, LLC, Buena Park, CA); Canadian International Development Agency (CIDA), Ottawa, Canada; Ministry of Health and Family Welfare of the Government of the People's Republic of Bangladesh	Supported by a grant from the Bill and Melinda Gates Foundation, Seattle, WA Global Control of Micronutrient Deficiency, grant 614); Micronutrients for Health Cooperative Agreement (HRN-A-00-97-00015); Global Research Activity Cooperative Agreement (GHS-A-00-03-00019-00) between Johns Hopkins University and the Office of Health, Infectious Diseases and Nutrition; and the US Agency for International Development, Washington, DC. Additional direct or in-kind support was provided by the Sight and Life Research Institute (Baltimore, MD); Nutrilite Health Institute (Nutrilite Division, Access Business Group, LLC, Buena Park, CA); the Canadian International Development Agency (CIDA), Ottawa, Canada; and the National Integrated Population and Health Program of the Ministry of Health and Family Welfare of the Government of the People's Republic of Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J DHAKA MEDI COLL; BAGGALEY AR, 1981, EVALUATION REV, V5, P123, DOI 10.1177/0193841X8100500106; Bartlett MS, 1941, BIOMETRIKA, V32, P29; Bhargava A, 2000, AM J PHYS ANTHROPOL, V111, P89, DOI 10.1002/(SICI)1096-8644(200001)111:1&lt;89::AID-AJPA6&gt;3.0.CO;2-X; Black J.T, 1992, MULTIVARIATE DATA AN; Bruguier A, 2008, NEUROIMAGE, V41, P35, DOI 10.1016/j.neuroimage.2008.01.062; Christian P, 2013, AM J CLIN NUTR, V97, P188, DOI 10.3945/ajcn.112.042275; Dhar B, 2002, J HEALTH POPUL NUTR, V20, P36; Elshibly EM, 2009, PEDIATR INT, V51, P326, DOI 10.1111/j.1442-200X.2008.02756.x; Feleke Y, 1999, E AFR MED J, V76, P468; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FISH LJ, 1988, MEAS EVAL COUNS DEV, V21, P130, DOI 10.1080/07481756.1988.12022895; FORNELL C, 1978, J MARKET RES SOC, V20, P166; Gonzalez I, 2008, J STAT SOFTW, V23, P1; Gunnsteinsson S, 2010, J HEALTH POPUL NUTR, V28, P509; Henson, 2000, MULTIPLE LINEAR REGR, V26, P11; Hosain GMM, 2006, J TROP PEDIATRICS, V52, P87, DOI 10.1093/tropej/fmi066; Institute of Medicine (Subcommittees on Nutritional Status and Weight Gain During Pregnancy and Dietary Intake and Nutrient Supplements During Pregnancy Committee on Nutritional Status During Pregnancy and Lactation Food and Nutrition Board), 1990, NUTR PREGN 1; Karim E, 1997, ANN HUM BIOL, V24, P387, DOI 10.1080/03014469700005152; Khatun S, 2008, J BIOSOC SCI, V40, P321, DOI 10.1017/S0021932007002532; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Labrique AB, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-102; LAMBERT ZV, 1975, J MARKETING RES, V12, P468, DOI 10.2307/3151100; Leal MDC, 2006, REV SAUDE PUBL, V40, P466, DOI 10.1590/S0034-89102006000300015; Lindley AA, 1999, EARLY HUM DEV, V56, P17, DOI 10.1016/S0378-3782(99)00033-X; Liu J, 2009, ENVIRON RES, V109, P193, DOI 10.1016/j.envres.2008.11.002; Maxwell S, 1992, ADV SOCIAL SCI METHO, V2, P137; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Naylor MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010395; NEGGERS Y, 1995, OBSTET GYNECOL, V85, P192, DOI 10.1016/0029-7844(94)00364-J; Ogbonna C, 2007, ACTA OBSTET GYN SCAN, V86, P26, DOI 10.1080/00016340600935664; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Raum E, 2001, INT J EPIDEMIOL, V30, P81, DOI 10.1093/ije/30.1.81; Sherry A, 2005, J PERS ASSESS, V84, P37, DOI 10.1207/s15327752jpa8401_09; Silva LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037356; STEWART D, 1968, PSYCHOL BULL, V70, P160, DOI 10.1037/h0026143; STOCH MB, 1963, ARCH DIS CHILD, V38, P546, DOI 10.1136/adc.38.202.546; Storms Michelle R, 2004, J Perinatol, V24, P236, DOI 10.1038/sj.jp.7211065; Thame M, 1997, EUR J CLIN NUTR, V51, P134, DOI 10.1038/sj.ejcn.1600357; THOMPSON B, 1991, MEAS EVAL COUNS DEV, V24, P80; Thompson B, 1998, ANNM AM ED RES ASS S, P102; Tripathi A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-111; West KP, 2011, JAMA-J AM MED ASSOC, V305, P1986, DOI 10.1001/jama.2011.656; Yunis KA, 2007, PAEDIATR PERINAT EP, V21, P387, DOI 10.1111/j.1365-3016.2007.00827.x	44	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94243	10.1371/journal.pone.0094243	http://dx.doi.org/10.1371/journal.pone.0094243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710082	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800127
J	Clark, CJ				Clark, Christopher James			Harmonic Hopping, and Both Punctuated and Gradual Evolution of Acoustic Characters in Selasphorus Hummingbird Tail-Feathers	PLOS ONE			English	Article							BLACK-CHINNED HUMMINGBIRD; AEROELASTIC FLUTTER; COURTSHIP DISPLAYS; SOUND PRODUCTION; WING FEATHERS; BIRD; TROCHILIDAE; SYSTEMATICS; PHONATION; SONATIONS	Models of character evolution often assume a single mode of evolutionary change, such as continuous, or discrete. Here I provide an example in which a character exhibits both types of change. Hummingbirds in the genus Selasphorus produce sound with fluttering tail-feathers during courtship. The ancestral character state within Selasphorus is production of sound with an inner tail-feather, R2, in which the sound usually evolves gradually. Calliope and Allen's Hummingbirds have evolved autapomorphic acoustic mechanisms that involve feather-feather interactions. I develop a source-filter model of these interactions. The 'source' comprises feather(s) that are both necessary and sufficient for sound production, and are aerodynamically coupled to neighboring feathers, which act as filters. Filters are unnecessary or insufficient for sound production, but may evolve to become sources. Allen's Hummingbird has evolved to produce sound with two sources, one with feather R3, another frequency-modulated sound with R4, and their interaction frequencies. Allen's R2 retains the ancestral character state, a similar to 1 kHz "ghost'' fundamental frequency masked by R3, which is revealed when R3 is experimentally removed. In the ancestor to Allen's Hummingbird, the dominant frequency has 'hopped' to the second harmonic without passing through intermediate frequencies. This demonstrates that although the fundamental frequency of a communication sound may usually evolve gradually, occasional jumps from one character state to another can occur in a discrete fashion. Accordingly, mapping acoustic characters on a phylogeny may produce misleading results if the physical mechanism of production is not known.	[Clark, Christopher James] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Clark, Christopher James] Yale Univ, Peabody Museum Nat Hist, New Haven, CT USA	University of California System; University of California Berkeley; Yale University	Clark, CJ (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	cclark@ucr.edu			Museum of Vertebrate Zoology; NSF [IOS-0920353]	Museum of Vertebrate Zoology; NSF(National Science Foundation (NSF))	Field work was funded by the Museum of Vertebrate Zoology, and by the author's personal funds. Funding during manuscript preparation was provided by NSF IOS-0920353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr PH, 1907, P ZOOL SOC LOND, V1907, P12; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Bostwick K., 2009, P ROYAL SOC BIOL S B, V227, P835; Bostwick KS, 2005, SCIENCE, V309, P736, DOI 10.1126/science.1111701; Bostwick KS, 2003, J EXP BIOL, V206, P3693, DOI 10.1242/jeb.00598; Clark CJ, 2013, J EXP BIOL, V216, P3395, DOI 10.1242/jeb.080317; Clark CJ, 2013, J EXP BIOL, V216, P3404, DOI 10.1242/jeb.085993; Clark CJ, 2012, CONDOR, V114, P329, DOI 10.1525/cond.2012.110058; Clark CJ, 2011, SCIENCE, V333, P1430, DOI 10.1126/science.1205222; Clark CJ, 2011, WILSON J ORNITHOL, V123, P218, DOI 10.1676/10-076.1; Clark CJ, 2010, AM NAT, V175, P27, DOI 10.1086/648560; Clark CJ, 2008, BIOL LETTERS, V4, P341, DOI 10.1098/rsbl.2008.0252; Clark CJ, 2008, P R SOC B, V275, P955, DOI 10.1098/rspb.2007.1619; Clark CJ, 2011, CURR ZOOL, V57, P187, DOI 10.1093/czoolo/57.2.187; Clark CJ, 2013, BIRS N AM ONLINE; Darwin C., 1871, P423; De Kort SR, 2004, ANIM BEHAV, V67, P549, DOI 10.1016/j.anbehav.2003.07.004; Delacour J., 1973, CURASSOWS RELATED BI; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; Felsenstein J, 2012, AM NAT, V179, P145, DOI 10.1086/663681; Feo TJ, 2010, AUK, V127, P787, DOI 10.1525/auk.2010.09263; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Gaunt AS, 1999, GUIDELINES USE WILD, P1; Hingee M, 2009, P ROY SOC B-BIOL SCI, V276, P4173, DOI 10.1098/rspb.2009.1110; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Lane DF, 2007, AUK, V124, P762, DOI 10.1642/0004-8038(2007)124[762:ADNSOT]2.0.CO;2; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McGuire JA, 2009, J ORNITHOL, V150, P155, DOI 10.1007/s10336-008-0330-x; NOWICKI S, 1986, J NEUROSCI, V6, P3595; Pearson OP, 1960, SPEED ALLEN HUMMINGB, P403; Peterson Roger, 2001, FIELD GUIDE BIRDS BR; Price JJ, 2002, EVOLUTION, V56, P1514; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647; Reddig V. E., 1978, J ORNITHOL, V119, P357; Robillard T, 2013, J EXP BIOL, V216, P2001, DOI 10.1242/jeb.083964; STILES FG, 1983, AUK, V100, P311, DOI 10.1093/auk/100.2.311; Suthers RA, 2004, NATURES MUSIC; ten Cate C, 2004, NATURES MUSIC SCI BI; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; TRAIL PW, 1991, WILSON BULL, V103, P539; Tuck L.M., 1972, SNIPES STUDY GENUS C, V5; Zyskowski Kristof, 1998, Bulletin of the British Ornithologists' Club, V118, P82	42	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93829	10.1371/journal.pone.0093829	http://dx.doi.org/10.1371/journal.pone.0093829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722049	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100025
J	Gianola, D; Weigel, KA; Kramer, N; Stella, A; Schon, CC				Gianola, Daniel; Weigel, Kent A.; Kraemer, Nicole; Stella, Alessandra; Schoen, Chris-Carolin			Enhancing Genome-Enabled Prediction by Bagging Genomic BLUP	PLOS ONE			English	Article							HILBERT-SPACES REGRESSION; QUANTITATIVE TRAITS; ASSISTED PREDICTION; BREEDING VALUES; GENETIC VALUE; ACCURACY; PEDIGREE; INFORMATION; SELECTION	We examined whether or not the predictive ability of genomic best linear unbiased prediction (GBLUP) could be improved via a resampling method used in machine learning: bootstrap aggregating sampling ("bagging''). In theory, bagging can be useful when the predictor has large variance or when the number of markers is much larger than sample size, preventing effective regularization. After presenting a brief review of GBLUP, bagging was adapted to the context of GBLUP, both at the level of the genetic signal and of marker effects. The performance of bagging was evaluated with four simulated case studies including known or unknown quantitative trait loci, and an application was made to real data on grain yield in wheat planted in four environments. A metric aimed to quantify candidate-specific cross-validation uncertainty was proposed and assessed; as expected, model derived theoretical reliabilities bore no relationship with cross-validation accuracy. It was found that bagging can ameliorate predictive performance of GBLUP and make it more robust against over-fitting. Seemingly, 25-50 bootstrap samples was enough to attain reasonable predictions as well as stable measures of individual predictive mean squared errors.	[Gianola, Daniel] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Gianola, Daniel; Weigel, Kent A.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Gianola, Daniel] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Kraemer, Nicole; Schoen, Chris-Carolin] Tech Univ Munich, Weihenstephan Ctr, Dept Plant Breeding, D-80290 Munich, Germany; [Stella, Alessandra] Parco Tecnol Padano, Bioinformat & Stat Unit, Lodi, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Technical University of Munich	Gianola, D (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	gianola@ansci.wisc.edu	stella, Alessandra/AAG-6401-2021; Guntinas-Lichius, Orlando/L-1871-2016; Schoen, Chris/G-1867-2011; stella, Alessandra/ABB-1952-2021; Stella, Alessandra/AAY-7322-2020	stella, Alessandra/0000-0003-2850-3964; Guntinas-Lichius, Orlando/0000-0001-9671-0784; Schoen, Chris/0000-0001-6067-7900; stella, Alessandra/0000-0003-2850-3964; Kramer, Nicole/0000-0002-8209-9141	Federal Ministry of Education and Research (BMBF, Germany) within the AgroClustEr 15 Synbreed-"Synergistic plan and animal breeding" [FKZ 03115528A]; U.S. Department of Agriculture Hatch Grant [142-PRJ63CV]; Wisconsin Agriculture Experiment Station	Federal Ministry of Education and Research (BMBF, Germany) within the AgroClustEr 15 Synbreed-"Synergistic plan and animal breeding"(Federal Ministry of Education & Research (BMBF)); U.S. Department of Agriculture Hatch Grant; Wisconsin Agriculture Experiment Station	Research was partially supported by the Federal Ministry of Education and Research (BMBF, Germany) within the AgroClustEr 15 Synbreed-"Synergistic plan and animal breeding" (FKZ 03115528A), by a U.S. Department of Agriculture Hatch Grant (142-PRJ63CV) to DG, and by the Wisconsin Agriculture Experiment Station. The funders had no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, MACH LEARN, V45, P261, DOI 10.1023/A:1017934522171; Bulmer MG, 1980, MATH THEORY QUANTITA; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2010, ANIM PROD SCI, V50, P1004, DOI 10.1071/AN10096; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2009, J ANIM SCI, V87, P1883, DOI 10.2527/jas.2008-1259; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Erbe M., 2010, 9 WORLD C GEN APPL L, P129; Erbe M, 2013, THESIS GEORGE AUGUST; Falconer D. S., 1996, Introduction to quantitative genetics.; FERNANDO RL, 1986, THEOR APPL GENET, V72, P822, DOI 10.1007/BF00266552; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Gianola D, 1999, GENET SEL EVOL, V22, P403; Gianola D, 2008, GENETICS, V178, P2289, DOI 10.1534/genetics.107.084285; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Gianola D, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-87; Goddard ME, 2008, GENETICA; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Henderson C. R., 1973, Proceedings of the Animal Breeding and Genetics Symposium in honor of Dr. Jay L. Lush, held July 29, 1972, at Virginia Polytechnic Institute and State University, Blacksburg, Virginia., P10; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; HENDERSON CR, 1977, J DAIRY SCI, V60, P783, DOI 10.3168/jds.S0022-0302(77)83935-0; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Janss L, 2012, GENETICS, V192, P693, DOI 10.1534/genetics.112.141143; Lehermeier C, 2013, STAT APPL GENET MOL, V12, P375, DOI 10.1515/sagmb-2012-0042; Long NY, 2011, GENETICA, V139, P843, DOI 10.1007/s10709-011-9588-7; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Meuwissen THE, 2001, GENETICS, V157, P1819; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Ogutu Joseph O, 2012, BMC Proc, V6 Suppl 2, pS10, DOI 10.1186/1753-6561-6-S2-S10; Suen YL, 2005, LECT NOTES ARTIF INT, V3720, P741, DOI 10.1007/11564096_76; Takezawa K, 2006, INTRODUCTION TO NONPARAMETRIC REGRESSION, P1; Valle C, 2007, LECT NOTES COMPUT SC, V4723, P130; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wimmer V, 2013, GENETICS, V195, P573, DOI 10.1534/genetics.113.150078	45	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91693	10.1371/journal.pone.0091693	http://dx.doi.org/10.1371/journal.pone.0091693			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722227	Green Published, gold			2022-12-27	WOS:000336909100009
J	Li, Q; Pogwizd, SM; Prabhu, SD; Zhou, LF				Li, Qince; Pogwizd, Steven M.; Prabhu, Sumanth D.; Zhou, Lufang			Inhibiting Na+/K+ ATPase Can Impair Mitochondrial Energetics and Induce Abnormal Ca2+ Cycling and Automaticity in Guinea Pig Cardiomyocytes	PLOS ONE			English	Article							COMPUTATIONAL MODEL; ELECTRICAL-ACTIVITY; INTRACELLULAR CA2+; REDOX BALANCE; CALCIUM; CONTRACTION; TRANSPORT; OSCILLATIONS; MICRODOMAINS; MECHANISMS	Cardiac glycosides have been used for the treatment of heart failure because of their capabilities of inhibiting Na+/K+ ATPase (NKA), which raises [Na+](i) and attenuates Ca2+ extrusion via the Na+/Ca2+ exchanger (NCX), causing [Ca2+](i) elevation. The resulting [Ca2+](i) accumulation further enhances Ca2+-induced Ca2+ release, generating the positive inotropic effect. However, cardiac glycosides have some toxic and side effects such as arrhythmogenesis, confining their extensive clinical applications. The mechanisms underlying the proarrhythmic effect of glycosides are not fully understood. Here we investigated the mechanisms by which glycosides could cause cardiac arrhythmias via impairing mitochondrial energetics using an integrative computational cardiomyocyte model. In the simulations, the effect of glycosides was mimicked by blocking NKA activity. Results showed that inhibiting NKA not only impaired mitochondrial Ca2+ retention (thus suppressed reactive oxygen species (ROS) scavenging) but also enhanced oxidative phosphorylation (thus increased ROS production) during the transition of increasing workload, causing oxidative stress. Moreover, concurrent blocking of mitochondrial Na+/Ca2+ exchanger, but not enhancing of Ca2+ uniporter, alleviated the adverse effects of NKA inhibition. Intriguingly, NKA inhibition elicited Ca2+ transient and action potential alternans under more stressed conditions such as severe ATP depletion, augmenting its proarrhythmic effect. This computational study provides new insights into the mechanisms underlying cardiac glycoside-induced arrhythmogenesis. The findings suggest that targeting both ion handling and mitochondria could be a very promising strategy to develop new glycoside-based therapies in the treatment of heart failure.	[Li, Qince; Pogwizd, Steven M.; Prabhu, Sumanth D.; Zhou, Lufang] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Pogwizd, Steven M.; Zhou, Lufang] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Li, Qince; Pogwizd, Steven M.; Prabhu, Sumanth D.; Zhou, Lufang] Univ Alabama Birmingham, Comprehens Cardiovasc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zhou, LF (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	lfzhou@uab.edu		Zhou, Lufang/0000-0002-1321-8442	NIH/NHLBI [R00HL095648]; University of Alabama at Birmingham Comprehensive Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL095648, R01HL121206] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham Comprehensive Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by NIH/NHLBI R00HL095648 and University of Alabama at Birmingham Comprehensive Cardiovascular Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371; BARRINGTON PL, 1988, J MOL CELL CARDIOL, V20, P1163, DOI 10.1016/0022-2828(88)90596-2; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; BASSANI RA, 1992, J PHYSIOL-LONDON, V453, P591, DOI 10.1113/jphysiol.1992.sp019246; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bers DM, 2001, EXCITATION CONTRACTI; Bers DM, 2009, IUBMB LIFE, V61, P215, DOI 10.1002/iub.163; Brandes R, 2002, BIOPHYS J, V83, P587, DOI 10.1016/S0006-3495(02)75194-1; Brandes R, 1997, CIRC RES, V80, P82, DOI 10.1161/01.RES.80.1.82; Brandes R, 1999, BIOPHYS J, V77, P1666, DOI 10.1016/S0006-3495(99)77014-1; Campia I, 2012, BIOCHEM J, V447, P301, DOI 10.1042/BJ20120200; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dedkova EN, 2008, CELL CALCIUM, V44, P77, DOI 10.1016/j.ceca.2007.11.002; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; FEDIDA D, 1987, J PHYSIOL-LONDON, V392, P523, DOI 10.1113/jphysiol.1987.sp016795; FERRIER GR, 1977, PROG CARDIOVASC DIS, V19, P459, DOI 10.1016/0033-0620(77)90010-X; Florea SM, 2012, AM J PHYSIOL-HEART C, V303, pH1047, DOI 10.1152/ajpheart.00384.2012; Florea SM, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00141; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Gauthier LD, 2013, BIOPHYS J, V105, P1045, DOI 10.1016/j.bpj.2013.07.006; Gauthier LD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00244; Gonano LA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P947, DOI 10.1161/CIRCEP.111.964908; Greenstein JL, 2006, BIOPHYS J, V90, P77, DOI 10.1529/biophysj.105.065169; Hashim T, 2013, AM J MED; Horackova M, 2000, CARDIOVASC RES, V47, P529, DOI 10.1016/S0008-6363(00)00088-2; Huser J, 2000, J BIOENERG BIOMEMBR, V32, P27, DOI 10.1023/A:1005556227425; ISHIDA H, 1988, J CLIN INVEST, V81, P1173, DOI 10.1172/JCI113432; Kajikawa M, 2002, DIABETES, V51, P2522, DOI 10.2337/diabetes.51.8.2522; Kembro JM, 2013, BIOPHYS J, V104, P332, DOI 10.1016/j.bpj.2012.11.3808; Li QC, 2012, BIOPHYS J, V102, P1471, DOI 10.1016/j.bpj.2012.03.007; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Liu T, 2010, J MOL CELL CARDIOL, V49, P728, DOI 10.1016/j.yjmcc.2010.06.012; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1158, DOI 10.1152/ajpcell.1998.274.4.C1158; Matsuoka S, 2004, PROG BIOPHYS MOL BIO, V85, P279, DOI 10.1016/j.pbiomolbio.2004.01.006; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Rahimtoola SH, 2004, CIRCULATION, V109, P2942, DOI 10.1161/01.CIR.0000132477.32438.03; Ramesh V, 1998, ANN NY ACAD SCI, V853, P341, DOI 10.1111/j.1749-6632.1998.tb08295.x; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; RIZZUTO R, 2004, SCI STKE; Roberts BN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002241; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Smith RM, 2013, AM J PHYSIOL-HEART C, V305, pH9, DOI 10.1152/ajpheart.00915.2012; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475; Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047; Zhou LF, 2011, J MOL CELL CARDIOL, V51, P632, DOI 10.1016/j.yjmcc.2011.05.007; Zhou L, 2009, BIOPHYS J, V97, P1843, DOI 10.1016/j.bpj.2009.07.029	55	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93928	10.1371/journal.pone.0093928	http://dx.doi.org/10.1371/journal.pone.0093928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722410	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100029
J	Li, R; Xu, W; Chen, Y; Qiu, W; Shu, YQ; Wu, AM; Dai, YQ; Bao, J; Lu, ZQ; Hu, XQ				Li, Rui; Xu, Wen; Chen, Ying; Qiu, Wei; Shu, Yaqing; Wu, Aimin; Dai, Yongqiang; Bao, Jian; Lu, Zhengqi; Hu, Xueqiang			Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-kappa B-Dependent CCL20 Expression in Reactive Astrocytes	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; PREGNANCY HORMONE ESTRIOL; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; SIGNALING PATHWAYS; SPINAL-CORD; IN-VITRO; T-CELLS; INHIBITION; MODULATORS	Recent clinical data have led to the consideration of sexual steroids as new potential therapeutic tools for multiple sclerosis. Selective estrogen receptor modulators can exhibit neuroprotective effects like estrogen, with fewer systemic estrogen side effects than estrogen, offering a more promising therapeutic modality for multiple sclerosis. The important role of astrocytes in a proinflammatory effect mediated by CCL20 signaling on inflammatory cells has been documented. Their potential contribution to selective estrogen receptor modulator-mediated protection is still unknown. Using a mouse model of chronic neuroinflammation, we report that raloxifene, a selective estrogen receptor modulator, alleviated experimental autoimmune encephalomyelitis-an animal model of multiple sclerosis-and decreased astrocytic production of CCL20. Enzyme-linked immunosorbent assay, immunohistochemistry imaging and transwell migration assays revealed that reactive astrocytes express CCL20, which promotes Th17 cell migration. In cultured rodent astrocytes, raloxifene inhibited IL-1 beta-induced CCL20 expression and chemotaxis ability for Th17 migration, whereas the estrogen receptor antagonist ICI 182,780 blocked this effect. Western blotting further indicated that raloxifene suppresses IL-1 beta-induced NF-kappa B activation (phosphorylation of p65) and translocation but does not affect phosphorylation of I kappa B. In conclusion, these data demonstrate that raloxifene provides robust neuroprotection against experimental autoimmune encephalomyelitis, partially via an inhibitory action on CCL20 expression and NF-kappa B pathways in reactive astrocytes. Our results contribute to a better understanding of the critical roles of raloxifene in treating experimental autoimmune encephalomyelitis and uncover reactive astrocytes as a new target for the inhibitory action of estrogen receptors on chemokine CCL20 expression.	[Li, Rui; Xu, Wen; Chen, Ying; Qiu, Wei; Shu, Yaqing; Wu, Aimin; Dai, Yongqiang; Bao, Jian; Lu, Zhengqi; Hu, Xueqiang] Sun Yat Sen Univ, Affiliated Hosp 3, Multiple Sclerosis Ctr, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Hu, XQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Multiple Sclerosis Ctr, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	huxueqiangzssy@qq.com	wei, qiu/M-7363-2015		National Science Foundation of China [81171126]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Science Foundation of China (No. 81171126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Bebo BF, 2009, GLIA, V57, P777, DOI 10.1002/glia.20805; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Dhandapani KM, 2007, EXP GERONTOL, V42, P70, DOI 10.1016/j.exger.2006.06.032; Elloso MM, 2005, J ENDOCRINOL, V185, P243, DOI 10.1677/joe.1.06063; Garidou L, 2004, J IMMUNOL, V173, P2435, DOI 10.4049/jimmunol.173.4.2435; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hosokawa Y, 2013, CELL IMMUNOL, V283, P8, DOI 10.1016/j.cellimm.2013.05.005; Islander U, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3371; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Liu HB, 2003, J IMMUNOL, V171, P6936, DOI 10.4049/jimmunol.171.12.6936; Luo XG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-9; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Morales LBJ, 2006, J NEUROSCI, V26, P6823, DOI 10.1523/JNEUROSCI.0453-06.2006; Nair A, 2008, CELL MOL LIFE SCI, V65, P2702, DOI 10.1007/s00018-008-8059-5; Nicot A, 2005, EUR J NEUROSCI, V21, P2660, DOI 10.1111/j.1460-9568.2005.04086.x; Nicot A, 2009, FRONT BIOSCI-LANDMRK, V14, P4477, DOI 10.2741/3543; Niino Masaaki, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P87; O'Neill EJ, 2006, J NEUROIMMUNOL, V178, P1, DOI 10.1016/j.jneuroim.2006.05.030; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; RUNMARKER B, 1995, BRAIN, V118, P253, DOI 10.1093/brain/118.1.253; Serafini B, 2000, AM J PATHOL, V157, P1991, DOI 10.1016/S0002-9440(10)64838-9; Sharma RV, 2001, J APPL PHYSIOL, V91, P2400, DOI 10.1152/jappl.2001.91.5.2400; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	43	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94320	10.1371/journal.pone.0094320	http://dx.doi.org/10.1371/journal.pone.0094320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722370	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100053
J	Li, W; Zhao, QJ; Deng, WY; Chen, T; Liu, MQ; Xie, JP				Li, Wu; Zhao, Quanju; Deng, Wanyan; Chen, Tian; Liu, Minqiang; Xie, Jianping			Mycobacterium tuberculosis Rv3402c Enhances Mycobacterial Survival within Macrophages and Modulates the Host Pro-Inflammatory Cytokines Production via NF-Kappa B/ERK/p38 Signaling	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TYROSINE-PHOSPHATASE PTPA; FACTOR-ALPHA; PROINFLAMMATORY CYTOKINES; SUPEROXIDE-DISMUTASE; PROMOTES SURVIVAL; HUMAN MONOCYTES; TNF-ALPHA; PROTEIN; GROWTH	Intracellular survival plays a central role in the pathogenesis of Mycobacterium tuberculosis, a process which depends on an array of virulence factors to colonize and replicate within the host. The M. tuberculosis iron regulated open reading frame (ORF) rv3402c, encoding a conserved hypothetical protein, was shown to be up-regulated upon infection in both human and mice macrophages. To explore the function of this ORF, we heterologously expressed the rv3402c gene in the nonpathogenic fast-growing Mycobacterium smegmatis strain, and demonstrated that Rv3402c, a cell envelope-associated protein, was able to enhance the intracellular survival of recombinant M. smegmatis. Enhanced growth was not found to be the result of an increased resistance to intracellular stresses, as growth of the Rv3402c expressing strain was unaffected by iron depletion, H2O2 exposure, or acidic conditions. Colonization of macrophages by M. smegmatis expressing Rv3402c was associated with substantial cell death and significantly greater amount of TNF-alpha and IL-1 beta compared with controls. Rv3402c-induced TNF-alpha and IL-1 beta production was found to be mediated by NF-kappa B, ERK and p38 pathway in macrophages. In summary, our study suggests that Rv3402c delivered in a live M. smegmatis vehicle can modify the cytokines profile of macrophage, promote host cell death and enhance the persistence of mycobacterium within host cells.	[Li, Wu; Zhao, Quanju; Deng, Wanyan; Chen, Tian; Liu, Minqiang; Xie, Jianping] Southwest Univ, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Minist Educ Ecoenvironm Gorges Reservoir, Inst Modern Biopharmaceut,Sch Life Sci, Chongqing, Peoples R China	Southwest University - China	Xie, JP (corresponding author), Southwest Univ, State Key Lab Breeding Base Ecoenvironm & Bioreso, Key Lab Minist Educ Ecoenvironm Gorges Reservoir, Inst Modern Biopharmaceut,Sch Life Sci, Chongqing, Peoples R China.	georgex@swu.edu.cn	xu, li/AAO-4684-2021; Li, Wu/K-3792-2019; xu, li/GNH-3667-2022	Li, Wu/0000-0002-0336-1843	National Natural Science Foundation [81371851, 81071316, 81271882]; National Megaprojects for Key Infectious Diseases [2008ZX10003-006, 2012ZX10003-003]; New Century Excellent Talents in Universities [NCET-11-0703]; Southwest University [kb2010017, ky2011003]; Fundamental Research Funds for the Central Universities [XDJK2011D006, XDJK2012D011, XDJK2012D007, XDJK2013D003]; Natural Science Foundation Project of CQ CSTC [CSTC 2010BB5002]; Chongqing Municipal Committee of Education for postgraduates excellence program [YJG123104]; undergraduates teaching reform program [2011JY052]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Megaprojects for Key Infectious Diseases; New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Southwest University(Southwest University - China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Chongqing Municipal Committee of Education for postgraduates excellence program; undergraduates teaching reform program	This work was supported by National Natural Science Foundation (grant numbers 81371851, 81071316, 81271882), National Megaprojects for Key Infectious Diseases (grant numbers 2008ZX10003-006, 2012ZX10003-003), New Century Excellent Talents in Universities (grant number NCET-11-0703), Excellent PhD thesis fellowship of Southwest University (grant numbers kb2010017, ky2011003), the Fundamental Research Funds for the Central Universities (Nos. XDJK2011D006, XDJK2012D011, XDJK2012D007 and XDJK2013D003), Natural Science Foundation Project of CQ CSTC (grant number CSTC 2010BB5002), the Chongqing Municipal Committee of Education for postgraduates excellence program (No. YJG123104), the undergraduates teaching reform program (No. 2011JY052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bashiri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045003; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Cowley SC, 2001, GENE, V264, P225, DOI 10.1016/S0378-1119(01)00336-5; Dahl JL, 2001, INFECT IMMUN, V69, P4295, DOI 10.1128/IAI.69.7.4295-4302.2001; Daim S, 2011, J MED MICROBIOL, V60, P582, DOI 10.1099/jmm.0.026047-0; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Dheenadhayalan V, 2006, MICROBES INFECT, V8, P262, DOI 10.1016/j.micinf.2005.06.021; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x; Huang Y, 2010, MOL CELL BIOCHEM, V340, P223, DOI 10.1007/s11010-010-0421-x; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Jacobs M, 2007, MICROBES INFECT, V9, P623, DOI 10.1016/j.micinf.2007.02.002; Ji L, 2011, INT J BIOL SCI, V7, P376, DOI 10.7150/ijbs.7.376; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jung SB, 2006, INFECT IMMUN, V74, P2686, DOI 10.1128/IAI.74.5.2686-2696.2006; Kengatharan M, 1996, BRIT J PHARMACOL, V117, P1163, DOI 10.1111/j.1476-5381.1996.tb16711.x; Kim KH, 2011, IMMUNE NETW, V11, P123, DOI DOI 10.4110/IN.2011.11.2.123; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Kuprash DV, 1999, J IMMUNOL, V163, P6575; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Lagier B, 1998, MOL MICROBIOL, V29, P465, DOI 10.1046/j.1365-2958.1998.00933.x; Lee JS, 2003, CLIN EXP IMMUNOL, V132, P443, DOI 10.1046/j.1365-2249.2003.02172.x; Li JM, 2008, CHINESE MED J-PEKING, V121, P1114, DOI 10.1097/00029330-200806020-00015; Li W, 2013, CELL PHYSIOL BIOCHEM, V31, P1, DOI 10.1159/000343343; Li W, 2011, J CELL BIOCHEM, V112, P2688, DOI 10.1002/jcb.23218; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; Miller J, 2010, NY TIMES BK REV, P6; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Pathak SK, 2004, J BIOL CHEM, V279, P55127, DOI 10.1074/jbc.M409885200; Pelosi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031788; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Rengarajan J, 2008, P NATL ACAD SCI USA, V105, P264, DOI 10.1073/pnas.0710601105; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Silver RF, 1998, J IMMUNOL, V160, P2408; Singh A, 2006, TUBERCULOSIS, V86, P28, DOI 10.1016/j.tube.2005.04.002; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wilson T, 1998, MICROBIOL-UK, V144, P2687, DOI 10.1099/00221287-144-10-2687; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	61	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94418	10.1371/journal.pone.0094418	http://dx.doi.org/10.1371/journal.pone.0094418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722253	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100068
J	Medina, DJ; Abass-Shereef, J; Walton, K; Goodell, L; Aviv, H; Strair, RK; Budak-Alpdogan, T				Medina, Daniel J.; Abass-Shereef, Jeneba; Walton, Kelly; Goodell, Lauri; Aviv, Hana; Strair, Roger K.; Budak-Alpdogan, Tulin			Cobblestone-Area Forming Cells Derived from Patients with Mantle Cell Lymphoma Are Enriched for CD133(+) Tumor-Initiating Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; STROMAL CELLS; NOD/SCID MICE; TRANSCRIPTION FACTORS; FREQUENCY-ANALYSIS; PROGENITOR CELLS; ENGRAFTMENT; SOX11; EXPRESSION	Mantle cell lymphoma (MCL) is associated with a significant risk of therapeutic failure and disease relapse, but the biological origin of relapse is poorly understood. Here, we prospectively identify subpopulations of primary MCL cells with different biologic and immunophenotypic features. Using a simple culture system, we demonstrate that a subset of primary MCL cells co-cultured with either primary human mesenchymal stromal cells (hMSC) or murine MS-5 cells form in cobblestone-areas consisting of cells with a primitive immunophenotype (CD19-CD133(+)) containing the chromosomal translocation t (11;14)(q13;q32) characteristic of MCL. Limiting dilution serial transplantation experiments utilizing immunodeficient mice revealed that primary MCL engraftment was only observed when either unsorted or CD19-CD133(+) cells were utilized. No engraftment was seen using the CD19(+)CD133(-) subpopulation. Our results establish that primary CD19-CD133(+) MCL cells are a functionally distinct subpopulation of primary MCL cells enriched for MCL-initiating activity in immunodeficient mice. This rare subpopulation of MCL-initiating cells may play an important role in the pathogenesis of MCL.	[Medina, Daniel J.; Abass-Shereef, Jeneba; Walton, Kelly; Strair, Roger K.; Budak-Alpdogan, Tulin] Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Goodell, Lauri; Aviv, Hana] Rutgers State Univ, Dept Pathol, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Medina, DJ (corresponding author), Rutgers State Univ, Dept Med, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.	medinadj@cinj.rutgers.edu			New Jersey Commission on Science and Technology; Two Guys Charity Golf Outing; The Century For The CURE; The Cancer Institute of New Jersey [P30CA072720]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	New Jersey Commission on Science and Technology; Two Guys Charity Golf Outing; The Century For The CURE; The Cancer Institute of New Jersey; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the New Jersey Commission on Science and Technology, Two Guys Charity Golf Outing and The Century For The CURE. This research was also supported by the Laboratory Support Services, Tissue Analytic Services and the Flow Cytometry Shared Resource(s) of The Cancer Institute of New Jersey (P30CA072720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bilwani FA, 2012, J IMMUNOL, V189, P4379, DOI 10.4049/jimmunol.1201176; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Brennan SK, 2010, BLOOD, V116, P4185, DOI 10.1182/blood-2010-02-268375; Brouard N, 1998, LEUKEMIA, V12, P1128, DOI 10.1038/sj.leu.2401081; Bruns I, 2009, LEUKEMIA, V23, P892, DOI 10.1038/leu.2008.392; Campo E, 1999, SEMIN HEMATOL, V36, P115; Carfi' M, 2010, TOXICOLOGY, V276, P33, DOI 10.1016/j.tox.2010.06.012; Chen Z, 2010, STEM CELL RES, V5, P212, DOI 10.1016/j.scr.2010.07.003; Choong ML, 2004, ANN HEMATOL, V83, P160, DOI 10.1007/s00277-003-0797-8; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; Daibata M, 1996, J VIROL, V70, P9003, DOI 10.1128/JVI.70.12.9003-9007.1996; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Durand C, 2006, HAEMATOLOGICA, V91, P1172; Ek S, 2008, BLOOD, V111, P800, DOI 10.1182/blood-2007-06-093401; Ferrando AA, 2013, BLOOD, V121, P2169, DOI 10.1182/blood-2013-02-480418; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Herrmann A, 2009, J CLIN ONCOL, V27, P511, DOI 10.1200/JCO.2008.16.8435; Hielscher A, 2013, STEM CELLS, V3, P167; Hielscher AC, 2009, THESIS U NEBRASKA; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hubin F, 2005, STEM CELLS, V23, P1626, DOI 10.1634/stemcells.2005-0041; ITOH K, 1989, EXP HEMATOL, V17, P145; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; Kvinlaug BT, 2007, EXPERT OPIN THER TAR, V11, P915, DOI 10.1517/14728222.11.7.915; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee MR, 2013, ACTA HAEMATOL-BASEL, V129, P10, DOI 10.1159/000341284; Leonard JP, 2009, CLIN LYMPHOMA MYELOM, V9, P267, DOI 10.3816/CLM.2009.n.055; Li ZM, 2013, CANC TREAT REV; Lu TX, 2013, LEUKEMIA RES, V37, P1412, DOI 10.1016/j.leukres.2013.07.039; Martinez-Climent JA, 2010, HAEMATOL-HEMATOL J, V95, P293, DOI 10.3324/haematol.2009.013318; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Medina DJ, 2012, HAEMATOL-HEMATOL J, V97, P1255, DOI 10.3324/haematol.2011.040659; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Nygren L, 2012, BLOOD, V119, P4215, DOI 10.1182/blood-2011-12-400580; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pileri SA, 2009, HAEMATOL-HEMATOL J, V94, P1488, DOI 10.3324/haematol.2009.013359; Ploemacher RE, 1997, BAILLIERE CLIN HAEM, V10, P429, DOI 10.1016/S0950-3536(97)80019-4; PLOEMACHER RE, 1989, BLOOD, V74, P2755; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Rasheed Z, 2010, J VIS EXP; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rehe K, 2013, EMBO MOL MED, V5, P38, DOI 10.1002/emmm.201201703; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schaumann DHS, 2007, MOL IMMUNOL, V44, P1606, DOI 10.1016/j.molimm.2006.08.021; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Smith MR, 2008, CURR OPIN HEMATOL, V15, P415, DOI 10.1097/MOH.0b013e328302c9c5; SUTHERLAND HJ, 1991, BLOOD, V78, P666, DOI 10.1182/blood.V78.3.666.bloodjournal783666; Teshima K, 2013, ONCOGENE; van Os Ronald P., 2008, V430, P143, DOI 10.1007/978-1-59745-182-6_10; Vegliante MC, 2013, BLOOD; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wang XM, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/465915; Wasik AM, 2013, SCI REP-UK, V3, DOI [10.1038/srep01400, 10.1038/srep02007]; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xu WR, 2011, J TRADIT CHIN MED, V31, P158, DOI 10.1016/S0254-6272(11)60032-0; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhang XB, 2002, BONE MARROW TRANSPL, V30, P557, DOI 10.1038/sj.bmt.1703714	67	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91042	10.1371/journal.pone.0091042	http://dx.doi.org/10.1371/journal.pone.0091042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722054	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100006
J	Samimi, P; Jenatabadi, HS				Samimi, Parisa; Jenatabadi, Hashem Salarzadeh			Globalization and Economic Growth: Empirical Evidence on the Role of Complementarities	PLOS ONE			English	Article							OPENNESS; LIBERALIZATION; TRADE	This study was carried out to investigate the effect of economic globalization on economic growth in OIC countries. Furthermore, the study examined the effect of complementary policies on the growth effect of globalization. It also investigated whether the growth effect of globalization depends on the income level of countries. Utilizing the generalized method of moments (GMM) estimator within the framework of a dynamic panel data approach, we provide evidence which suggests that economic globalization has statistically significant impact on economic growth in OIC countries. The results indicate that this positive effect is increased in the countries with better-educated workers and well-developed financial systems. Our finding shows that the effect of economic globalization also depends on the country's level of income. High and middle-income countries benefit from globalization whereas low-income countries do not gain from it. In fact, the countries should receive the appropriate income level to be benefited from globalization. Economic globalization not only directly promotes growth but also indirectly does so via complementary reforms.	[Samimi, Parisa] UTM, Fac Management, Johor Baharu, Malaysia; [Samimi, Parisa] Islamic Azad Univ, Dept Management, Mobarakeh Branch, Esfahan, Iran; [Jenatabadi, Hashem Salarzadeh] Univ Malaya, Econ & Adm Fac, Dept Appl Stat, Kuala Lumpur, Malaysia	Universiti Teknologi Malaysia; Islamic Azad University; Universiti Malaya	Samimi, P (corresponding author), UTM, Fac Management, Johor Baharu, Malaysia.	prs.samimi@gmail.com	Salarzadeh Jenatabadi, Hashem/P-9958-2016	Salarzadeh Jenatabadi, Hashem/0000-0002-9080-009X	Ministry of Higher Education of Malaysia, Malaysian International Scholarship (MIS)	Ministry of Higher Education of Malaysia, Malaysian International Scholarship (MIS)	The study is supported by the Ministry of Higher Education of Malaysia, Malaysian International Scholarship (MIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesina A., 1994, CAPITAL MOBILITY IMP, P289; Alfaro L., 2006, 12522 NBER, V12522, DOI [https://doi.org/10.3386/w12522, DOI 10.3386/W12522]; ANDERSON TW, 1981, J AM STAT ASSOC, V76, P598, DOI 10.2307/2287517; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Ates D, 2005, MIDDLE EAST POLICY, V12, P133, DOI 10.1111/j.1475-4967.2005.00230.x; Baldwin RE, 2000, J INT ECON, V50, P497, DOI 10.1016/S0022-1996(99)00008-2; Baltagi BH, 2009, J DEV ECON, V89, P285, DOI 10.1016/j.jdeveco.2008.06.006; Barro R., 2004, EC GROWTH, VSecond; Beck T., 2009, FINANCIAL I MARKETS; Berg A., 2003, IMF WORKING PAPERS, V1047; Bhandari A. K.., 2005, MEASUREMENT GLOBALIZ; Birdsall N., 2002, GLOBALISATION LIVING, P66; Borensztein E, 1998, J INT ECON, V45, P115, DOI 10.1016/S0022-1996(97)00033-0; Brunner A, 2003, IMF WORKING PAPERS; Calderon C, 2010, 5426 WORLD BANK; Chang CP, 2010, GLOBAL ECON REV, V39, P151, DOI 10.1080/1226508X.2010.483835; Chang R, 2009, J DEV ECON, V90, P33, DOI 10.1016/j.jdeveco.2008.06.011; Collins W, 1999, 7145 NBER; Dabour N., 2000, J EC COOPERATION, V21, P27; De Melo J., 2008, 3981 WORLD BANK; Dollar D, 2002, J ECON GROWTH, V7, P195, DOI 10.1023/A:1020139631000; DOLLAR D, 1992, ECON DEV CULT CHANGE, V40, P523, DOI 10.1086/451959; Dreher A, 2008, MEASURING GLOBALISAT, DOI 10.1007/978-0-387-74069-0; Dreher A, 2006, APPL ECON, V38, P1091, DOI 10.1080/00036840500392078; Edwards S, 1998, ECON J, V108, P383, DOI 10.1111/1468-0297.00293; Fischer S, 2003, AM ECON REV, V93, P1, DOI 10.1257/000282803321946750; GROSSMAN GM, 1990, AM ECON REV, V80, P86; GROSSMAN GM, 1991, ECON J, V101, P1214, DOI 10.2307/2234437; Gu XH, 2011, WORLD ECON, V34, P1106, DOI 10.1111/j.1467-9701.2011.01367.x; Guillaumin C, 2009, J ASIAN ECON, V20, P314, DOI 10.1016/j.asieco.2009.02.002; Haddad ME, 2010, POLICY RES WORKING P, V5222; Harrison A, 1996, J DEV ECON, V48, P419, DOI 10.1016/0304-3878(95)00042-9; Krugman P., 1993, FINANCE DEV ISSUES E, V4, P11; LEVINE R, 1992, AM ECON REV, V82, P942; Levine R., 2001, REV INT ECON, V9, P688, DOI [10.1111/1467-9396.00307, DOI 10.1111/1467-9396.00307]; Mammi I, 2012, ESSAYS GMM ESTIMATIO; Obstfeld M, 1997, NBER PROJECT REPORT, P353; Osang T, 1996, J PUBLIC ECON, V60, P45, DOI 10.1016/0047-2727(95)01510-8; Oyvat C, 2011, CAMB J REG ECON SOC, V4, P123, DOI 10.1093/cjres/rsq032; Rao BB, 2011, ECON MODEL, V28, P795, DOI 10.1016/j.econmod.2010.10.009; Rodriguez F, 2001, NBER MACROEC ANN-SER, V15, P261, DOI 10.1086/654419; Rodrik Dani, 1998, ESSAYS INT FINANC, P55; SACHS JD, 1995, BROOKINGS PAP ECO AC, P1; Samimi P, 2011, KNOWLEDGE MANAGEMENT, V1; Solt F, 2009, SOC SCI QUART, V90, P231, DOI 10.1111/j.1540-6237.2009.00614.x; Vamvakidis A, 1998, WORLD BANK ECON REV, V12, P251, DOI 10.1093/wber/12.2.251; Warner A, 2003, CTR GLOBAL DEV, V12, P1; Zeinelabdin AR, 1998, J EC COOPERATION ISL, V15, P1	48	48	48	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e87824	10.1371/journal.pone.0087824	http://dx.doi.org/10.1371/journal.pone.0087824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24721896	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100002
J	Buzatu, DA; Moskal, TJ; Williams, AJ; Cooper, WM; Mattes, WB; Wilkes, JG				Buzatu, Dan A.; Moskal, Ted J.; Williams, Anna J.; Cooper, Willie Mae; Mattes, William B.; Wilkes, Jon G.			An Integrated Flow Cytometry-Based System for RealTime, High Sensitivity Bacterial Detection and Identification	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; FOOD MATRIX INTERFERENCE; SAMPLE PREPARATION; PCR DETECTION; SAFETY; COMBINATION; SALMONELLA; PATHOGENS; ANTIBODY; CULTURE	Foodborne illnesses occur in both industrialized and developing countries, and may be increasing due to rapidly evolving food production practices. Yet some primary tools used to assess food safety are decades, if not centuries, old. To improve the time to result for food safety assessment a sensitive flow cytometer based system to detect microbial contamination was developed. By eliminating background fluorescence and improving signal to noise the assays accurately measure bacterial load or specifically identify pathogens. These assays provide results in minutes or, if sensitivity to one cell in a complex matrix is required, after several hours enrichment. Conventional assessments of food safety require 48 to 56 hours. The assays described within are linear over 5 orders of magnitude with results identical to culture plates, and report live and dead microorganisms. This system offers a powerful approach to real-time assessment of food safety, useful for industry self-monitoring and regulatory inspection.	[Buzatu, Dan A.; Williams, Anna J.; Cooper, Willie Mae; Wilkes, Jon G.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Moskal, Ted J.] Vivione Biosci, Pine Bluff, AR USA; [Mattes, William B.] PharmPoint Consulting, Poolesville, MD USA	US Food & Drug Administration (FDA)	Buzatu, DA (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	dan.buzatu@fda.hhs.gov		Mattes, William/0000-0001-8653-4289				ALHITI MMA, 1983, J APPL BACTERIOL, V55, P173, DOI 10.1111/j.1365-2672.1983.tb02662.x; ALSHARIF R, 2002, BACTERIAL DETECTION; American Society for Microbiology Center for Disease Control Association of Public Health Laboratories, 2011, SENT LAB GUID; Andrews W.H., 2011, BACTERIOLOGICAL ANAL; bioMerieux Inc, 2009, VIDAS ECO VIDAS ICE; Buzatu DA, 2013, FOOD MICROBIOL, V36, P416, DOI 10.1016/j.fm.2013.07.007; Center for Disease Control and Prevention, 2011, EST FOODB ILLN US; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Clarke RG, 1998, J APPL MICROBIOL, V84, P577, DOI 10.1046/j.1365-2672.1998.00384.x; DuPont, 2005, BAX ENR MED E COL, VO157, pH7; Food and Drug Administration (FDA), 2012, BACT AN MAN BAM; GarciadeLomas J, 1997, PEDIATR INFECT DIS J, V16, pS43, DOI 10.1097/00006454-199703001-00004; Holland JL, 2000, J CLIN MICROBIOL, V38, P4108, DOI 10.1128/JCM.38.11.4108-4113.2000; Jordan J, 2002, INSIDE LAB MANAGEMEN, V2002, P19; Kaferstein F, 1999, B WORLD HEALTH ORGAN, V77, P347; Lindqvist R, 1997, LETT APPL MICROBIOL, V24, P306, DOI 10.1046/j.1472-765X.1997.00069.x; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; MCCLELLAND RG, 1994, APPL ENVIRON MICROB, V60, P4255, DOI 10.1128/AEM.60.12.4255-4262.1994; McKillip JL, 2002, J FOOD PROTECT, V65, P1775, DOI 10.4315/0362-028X-65.11.1775; NABER SP, 1994, NEW ENGL J MED, V331, P1212, DOI 10.1056/NEJM199411033311808; Oliver JD, 2005, J MICROBIOL, V43, P93; Olson ED, 2011, HEALTH AFFAIR, V30, P915, DOI 10.1377/hlthaff.2010.1265; Pitcher DG, 2000, J INFECTION, V40, P116, DOI 10.1053/jinf.2000.0635; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; Seo KH, 1998, INT J FOOD MICROBIOL, V44, P115, DOI 10.1016/S0168-1605(98)00129-9; STEEN HB, 1979, SCIENCE, V204, P403, DOI 10.1126/science.441727; STEEN HB, 1982, CYTOMETRY, V2, P249; Stokstad E, 2011, SCIENCE, V331, P270, DOI 10.1126/science.331.6015.270; Taylor DA, 2011, ENVIRON HEALTH PERSP, V119, P119; Taylor MR, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1109388; Tetracore Inc, 2012, DOM PREP PROD BIOTHR; Toops D, 2012, 2012 FOOD IND OUTLOO; Vaisanen OM, 1998, J APPL MICROBIOL, V84, P1069; Wilkes JG, 2012, FOOD MICROBIOL, V30, P281, DOI 10.1016/j.fm.2011.11.002	34	34	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94254	10.1371/journal.pone.0094254	http://dx.doi.org/10.1371/journal.pone.0094254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718659	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000096
J	Duyvestyn, JM; Taylor, SJ; Dagger, SA; Orandle, M; Morse, HC; Thien, CBF; Langdon, WY				Duyvestyn, Johanna M.; Taylor, Samuel J.; Dagger, Samantha A.; Orandle, Marlene; Morse, Herbert C., III; Thien, Christine B. F.; Langdon, Wallace Y.			Dasatinib Targets B-Lineage Cells but Does Not Provide an Effective Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice	PLOS ONE			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACQUIRED UNIPARENTAL DISOMY; HEMATOPOIETIC STEM-CELLS; SRC-FAMILY KINASES; LYN-DEFICIENT MICE; INHIBITOR DASATINIB; AUTOIMMUNE-DISEASE; MYELOID NEOPLASMS; TYROSINE KINASES	This study aimed to determine whether the multi-kinase inhibitor dasatinib would provide an effective therapy for myeloproliferative diseases (MPDs) involving c-Cbl mutations. These mutations, which occur in the RING finger and linker domains, abolish the ability of c-Cbl to function as an E3 ubiquitin ligase and downregulate activated protein tyrosine kinases. Here we analyzed the effects of dasatinib in a c-Cbl RING finger mutant mouse that develops an MPD with a phenotype similar to the human MPDs. The mice are characterized by enhanced tyrosine kinase signaling resulting in an expansion of hematopoietic stem cells, multipotent progenitors and cells within the myeloid lineage. Since c-Cbl is a negative regulator of c-Kit and Src signaling we reasoned that dasatinib, which targets these kinases, would be an effective therapy. Furthermore, two recent studies showed dasatinib to be effective in inhibiting the in vitro growth of cells from leukemia patients with c-Cbl RING finger and linker domain mutations. Surprisingly we found that dasatinib did not provide an effective therapy for c-Cbl RING finger mutant mice since it did not suppress any of the hematopoietic lineages that promote MPD development. Thus we conclude that dasatinib may not be an appropriate therapy for leukemia patients with c-Cbl mutations. We did however find that dasatinib caused a marked reduction of pre-B cells and immature B cells which correlated with a loss of Src activity. This study is therefore the first to provide a detailed characterization of in vivo effects of dasatinib in a hematopoietic disorder that is driven by protein tyrosine kinases other than BCR-ABL.	[Duyvestyn, Johanna M.; Taylor, Samuel J.; Dagger, Samantha A.; Thien, Christine B. F.; Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Orandle, Marlene] NIAID, Infect Dis Pathogenesis Sect, Comparat Med Branch, NIH, Rockville, MD USA; [Morse, Herbert C., III] NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD USA	University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Langdon, WY (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia.	wally.langdon@uwa.edu.au	Thien, Christine/GQP-0424-2022	Morse, Herbert/0000-0002-9331-3705; Thien, Christine/0000-0003-3884-5546; Taylor, Samuel/0000-0002-9468-8752	National Health and Medical Research Council [572516, 634414]; Cancer Council of WA; Medical and the Health Research Infrastructure Fund; Intramural Research Program of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of WA(Cancer Council Western Australia); Medical and the Health Research Infrastructure Fund; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Health and Medical Research Council Project Grants 572516 and 634414, the Cancer Council of WA, and the Medical and the Health Research Infrastructure Fund, and in part by the Intramural Research Program of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein PC, 2011, CLIN CANCER RES, V17, P2977, DOI 10.1158/1078-0432.CCR-10-2879; Bunda S, 2013, CANCER RES, V73, P2540, DOI 10.1158/0008-5472.CAN-12-3425; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Dargart JL, 2012, ANTIVIR RES, V95, P49, DOI 10.1016/j.antiviral.2012.05.003; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Kuwahara K, 2012, J IMMUNOL, V189, P3472, DOI 10.4049/jimmunol.1200649; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Levis M, 2011, BLOOD, V117, P6987, DOI 10.1182/blood-2011-03-340273; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Makishima H, 2012, LEUKEMIA, V26, P1547, DOI 10.1038/leu.2012.7; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; McCaig AM, 2011, BRIT J HAEMATOL, V153, P199, DOI 10.1111/j.1365-2141.2010.08507.x; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; O'Laughlin-Bunner B, 2001, BLOOD, V98, P343, DOI 10.1182/blood.V98.2.343; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Robinson LJ, 2005, EXP HEMATOL, V33, P469, DOI 10.1016/j.exphem.2005.01.004; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Schnittger S, 2012, HAEMATOL-HEMATOL J, V97, P1890, DOI 10.3324/haematol.2012.065375; Taylor SJ, 2012, BLOOD, V120, P4049, DOI 10.1182/blood-2012-06-436675; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Vitali R, 2009, INT J CANCER, V125, P2547, DOI 10.1002/ijc.24606	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94717	10.1371/journal.pone.0094717	http://dx.doi.org/10.1371/journal.pone.0094717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718698	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000138
J	Kelley, JM; Kraft-Todd, G; Schapira, L; Kossowsky, J; Riess, H				Kelley, John M.; Kraft-Todd, Gordon; Schapira, Lidia; Kossowsky, Joe; Riess, Helen			The Influence of the Patient-Clinician Relationship on Healthcare Outcomes: A Systematic Review and MetaAnalysis of Randomized Controlled Trials	PLOS ONE			English	Review							INCREASE PHYSICAL-ACTIVITY; PRACTITIONER AGREEMENT; COMMUNICATION; INTERVENTION; BIAS	Objective: To determine whether the patient-clinician relationship has a beneficial effect on either objective or validated subjective healthcare outcomes. Design: Systematic review and meta-analysis. Data Sources: Electronic databases EMBASE and MEDLINE and the reference sections of previous reviews. Eligibility Criteria for Selecting Studies: Included studies were randomized controlled trials (RCTs) in adult patients in which the patient-clinician relationship was systematically manipulated and healthcare outcomes were either objective (e.g., blood pressure) or validated subjective measures (e.g., pain scores). Studies were excluded if the encounter was a routine physical, or a mental health or substance abuse visit; if the outcome was an intermediate outcome such as patient satisfaction or adherence to treatment; if the patient-clinician relationship was manipulated solely by intervening with patients; or if the duration of the clinical encounter was unequal across conditions. Results: Thirteen RCTs met eligibility criteria. Observed effect sizes for the individual studies ranged from d = 2.23 to.66. Using a random-effects model, the estimate of the overall effect size was small (d =.11), but statistically significant (p =.02). Conclusions: This systematic review and meta-analysis of RCTs suggests that the patient-clinician relationship has a small, but statistically significant effect on healthcare outcomes. Given that relatively few RCTs met our eligibility criteria, and that the majority of these trials were not specifically designed to test the effect of the patient-clinician relationship on healthcare outcomes, we conclude with a call for more research on this important topic.	[Kelley, John M.; Kraft-Todd, Gordon; Schapira, Lidia; Riess, Helen] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat,Empathy & Relat Sci Program, Boston, MA 02115 USA; [Kossowsky, Joe] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Placebo Studies & Therapeut Encounter, Boston, MA USA; [Kelley, John M.] Endicott Coll, Dept Psychol, Beverly, MA USA; [Schapira, Lidia] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kossowsky, Joe] Harvard Univ, Boston Childrens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Kossowsky, Joe] Univ Basel, Dept Clin Psychol & Psychotherapy, Basel, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Basel	Kelley, JM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat,Empathy & Relat Sci Program, Boston, MA 02115 USA.	johnkelley@post.harvard.edu	Schapira, Lidia/AAA-1293-2020; Kossowsky, Joe/AAO-1964-2021; Kraft-Todd, Gordon/O-5520-2016	Kossowsky, Joe/0000-0002-6272-6259; Kraft-Todd, Gordon/0000-0003-1220-9269	Arnold P. Gold Foundation [FI-11-004]; Swiss National Science Foundation [P2BSP1_148628]	Arnold P. Gold Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was made possible with a grant from the Arnold P. Gold Foundation (www.humanism-in-medicine.org; grant # FI-11-004). Joe Kossowsky's contributions to this study were supported by the Swiss National Science Foundation, grant project (P2BSP1_148628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiarzaguena JM, 2007, PSYCHOL MED, V37, P283, DOI 10.1017/S0033291706009536; Astrow AB, 2013, SOCIETY, V50; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bieber C, 2008, J PSYCHOSOM RES, V64, P13, DOI 10.1016/j.jpsychores.2007.05.009; Bolognesi M, 2006, ANN BEHAV MED, V31, P179, DOI 10.1207/s15324796abm3102_10; CALS JWL, 2009, BMJ-BRIT MED J, V338, P1112; Chassany O, 2006, J RHEUMATOL, V33, P1827; Christian JG, 2008, ARCH INTERN MED, V168, P141, DOI 10.1001/archinternmed.2007.13; Cleland Jennifer A, 2007, Prim Care Respir J, V16, P311; COCHRAN WG, 1950, BIOMETRIKA, V37, P256, DOI 10.1093/biomet/37.3-4.256; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper LA, 2001, J GEN INTERNAL MED, V26, P1297; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gabbay M, 2003, PSYCHOL MED, V33, P241, DOI 10.1017/S0033291702006992; Girgis A, 2009, PATIENT EDUC COUNS, V77, P456, DOI 10.1016/j.pec.2009.09.018; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Harrington J, 2004, PATIENT EDUC COUNS, V52, P7, DOI 10.1016/S0738-3991(03)00017-X; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Hojat M, 2011, ACAD MED, V86, P359, DOI 10.1097/ACM.0b013e3182086fe1; Kessler RC, 2001, ANN INTERN MED, V135, P262, DOI 10.7326/0003-4819-135-4-200108210-00011; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Kleinman A, 2013, NEW ENGL J MED, V368, P1376, DOI 10.1056/NEJMp1300678; Little P, 2001, BRIT MED J, V323, P908, DOI 10.1136/bmj.323.7318.908; MUMFORD E, 1982, AM J PUBLIC HEALTH, V72, P141, DOI 10.2105/AJPH.72.2.141; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; PUTNAM SM, 1985, MED CARE, V23, P74, DOI 10.1097/00005650-198501000-00008; Rosenthal R., 1984, EDUC RESEARCHER; Rutledge T, 2004, ANN BEHAV MED, V27, P138, DOI 10.1207/s15324796abm2702_9; Schapira L, 2013, CANCER; Sequist TD, 2010, ANN INTERN MED, V152, P40, DOI 10.7326/0003-4819-152-1-201001050-00009; STARFIELD B, 1981, AM J PUBLIC HEALTH, V71, P127, DOI 10.2105/AJPH.71.2.127; Stewart M A, 1979, J R Coll Gen Pract, V29, P77; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Street RL, 1997, MED DECISION MAKING, V17; Ward MM, 2003, ARTHRIT RHEUM-ARTHR, V49, P810, DOI 10.1002/art.11467; White P, 2011, PAIN; Williams JG, 2001, QUAL HEALTH CARE, V10, P159, DOI 10.1136/qhc.0100159..	43	415	418	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94207	10.1371/journal.pone.0094207	http://dx.doi.org/10.1371/journal.pone.0094207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718585	Green Published, gold			2022-12-27	WOS:000334339000090
J	Morfeld, KA; Lehnhardt, J; Alligood, C; Bolling, J; Brown, JL				Morfeld, Kari A.; Lehnhardt, John; Alligood, Christina; Bolling, Jeff; Brown, Janine L.			Development of a Body Condition Scoring Index for Female African Elephants Validated by Ultrasound Measurements of Subcutaneous Fat	PLOS ONE			English	Article							REPRODUCTIVE DISORDERS; BLUBBER THICKNESS; CONDITION SCORES; DAIRY-COW; OBESITY; HORSES; SYSTEM; RELIABILITY; PROVISION; AGREEMENT	Obesity-related health and reproductive problems may be contributing to non-sustainability of zoo African elephant (Loxodonta africana) populations. However, a major constraint in screening for obesity in elephants is lack of a practical method to accurately assess body fat. Body condition scoring (BCS) is the assessment of subcutaneous fat stores based on visual evaluation and provides an immediate appraisal of the degree of obesity of an individual. The objective of this study was to develop a visual BCS index for female African elephants and validate it using ultrasound measures of subcutaneous fat. To develop the index, standardized photographs were collected from zoo (n = 50) and free-ranging (n = 57) female African elephants for identifying key body regions and skeletal features, which were then used to visually determine body fat deposition patterns. This information was used to develop a visual BCS method consisting of a list of body regions and the physical criteria for assigning an overall score on a 5-point scale, with 1 representing the lowest and 5 representing the highest levels of body fat. Results showed that as BCS increased, ultrasound measures of subcutaneous fat thickness also increased (P<0.01), indicating the scores closely coincide with physical measures of fat reserves. The BCS index proved to be reliable and repeatable based on high intra- and inter-assessor agreement across three assessors. In comparing photographs of wild vs. captive African elephants, the median BCS in the free-ranging individuals (BCS = 3, range 1-5) was lower (P<0.001) than that of the zoo population (BCS = 4, range 2-5). In sum, we have developed the first validated BCS index for African elephants. This tool can be used to examine which factors impact body condition in zoo and free-ranging elephants, providing valuable information on how it affects health and reproductive potential of individual elephants.	[Morfeld, Kari A.; Brown, Janine L.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Roya, VA USA; [Lehnhardt, John; Bolling, Jeff] Natl Elephant Ctr, Fellsmere, FL USA; [Alligood, Christina] Disneys Anim Kingdom, Bay Lake, FL USA	Walt Disney Company	Morfeld, KA (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Roya, VA USA.	morfeldk@si.edu			Morris Animal Foundation; Shared Earth Foundation; FBB Capital Partners; Wolcott Fund; Siemens Medical Solutions Diagnostics	Morris Animal Foundation; Shared Earth Foundation; FBB Capital Partners; Wolcott Fund; Siemens Medical Solutions Diagnostics	Morris Animal Foundation, Shared Earth Foundation, FBB Capital Partners, Wolcott Fund, Siemens Medical Solutions Diagnostics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZA, 2011, AZA STAND EL MAN CAR; Bishop CJ, 2009, J WILDLIFE MANAGE, V73, P462, DOI 10.2193/2008-015; Bray George A., 1997, Human Reproduction (Oxford), V12, P26; Brown JL, 2004, ZOO BIOL, V23, P309, DOI 10.1002/zoo.20006; Burkholder WJ, 2000, J AM VET MED ASSOC, V217, P650, DOI 10.2460/javma.2000.217.650; Carter RA, 2009, VET J, V179, P204, DOI 10.1016/j.tvjl.2008.02.029; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; CLARK AM, 1995, HUM REPROD, V10, P2705, DOI 10.1093/oxfordjournals.humrep.a135772; Clingerman KJ, 2012, J AM ASSOC LAB ANIM, V51, P31; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cook RC, 2001, J WILDLIFE MANAGE, V65, P973, DOI 10.2307/3803046; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; Deurenberg P, 1999, BEST PRACT RES CL EN, V13, P1, DOI 10.1053/beem.1999.0003; DOMECQ JJ, 1995, J DAIRY SCI, V78, P2308, DOI 10.3168/jds.S0022-0302(95)76857-6; Dow TL, 2011, ZOO BIOL, V30, P699, DOI 10.1002/zoo.20377; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Ellis KJ, 2000, ENDOCRINOLOGIST, V10, p57S, DOI 10.1097/00019616-200010041-00012; FANELLI MT, 1984, AM J CLIN NUTR, V39, P703, DOI 10.1093/ajcn/39.5.703; Faust L., 2011, TECHNICAL REPORT ZOO; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Frank N, 2006, JAVMA-J AM VET MED A, V228, P1383, DOI 10.2460/javma.228.9.1383; Freeman EW, 2009, ZOO BIOL, V28, P1, DOI 10.1002/zoo.20187; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Gustine DD, 2010, RANGIFER, V27, P249; Hall AJ, 2007, MAR MAMMAL SCI, V23, P650, DOI 10.1111/j.1748-7692.2007.00132.x; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hile ME, 1997, J ZOO WILDLIFE MED, V28, P424; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Irvine L. M., 2003, CURR OBSTET GYNAECOL, V13, P179, DOI [DOI 10.1016/S0957-5847(03)00005-2, 10.1016/S0957-5847(03)00005-2]; Kearns CF, 2002, EQUINE VET J, V34, P485; Keele M., 2011, AZA PUBLICATION; Laflamme D, 1997, CANINE PRACT, V22, P10; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lassen J, 2003, J DAIRY SCI, V86, P4123, DOI 10.3168/jds.S0022-0302(03)74026-0; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Li G, 2012, VET MED-RES REP, V3, P71, DOI 10.2147/VMRR.S34665; Lievense AM, 2002, RHEUMATOLOGY, V41, P1155, DOI 10.1093/rheumatology/41.10.1155; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; Mellish JAE, 2004, J ZOO WILDLIFE MED, V35, P116, DOI 10.1638/03-028; Miller PB, 2008, J REPROD MED, V53, P315; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Norman RJ, 1998, REPROD FERT DEVELOP, V10, P55, DOI 10.1071/R98010; OTTO KL, 1991, J DAIRY SCI, V74, P852, DOI 10.3168/jds.S0022-0302(91)78234-9; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Phythian CJ, 2012, VET J, V193, P257, DOI 10.1016/j.tvjl.2011.12.006; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Schroder UJ, 2006, J DAIRY SCI, V89, P1, DOI 10.3168/jds.S0022-0302(06)72064-1; Speaker Kristin J., 2012, BMC Physiology, V12, P8, DOI 10.1186/1472-6793-12-8; Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717; Treiber K, 2012, 7 CRISS ZOOL NUTR S, P1; Vick MM, 2006, REPROD FERT DEVELOP, V18, P609, DOI 10.1071/RD06016; VOLZ PA, 1984, MED SCI SPORT EXER, V16, P97, DOI 10.1249/00005768-198401000-00020; WAGNER JJ, 1988, J ANIM SCI, V66, P603; Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099; WESTERVELT RG, 1976, J ANIM SCI, V43, P781, DOI 10.2527/jas1976.434781x; Wiese R. J., 2006, International Zoo Yearbook, V40, P80, DOI 10.1111/j.1748-1090.2006.00080.x; Wijeyamohan S, 2012, CURR SCI INDIA, V102, P26; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; WILKINSON MJA, 1991, J NUTR, V121, pS47, DOI 10.1093/jn/121.suppl_11.S47	68	33	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93802	10.1371/journal.pone.0093802	http://dx.doi.org/10.1371/journal.pone.0093802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718304	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000047
J	Blum, KS; Karaman, S; Proulx, ST; Ochsenbein, AM; Luciani, P; Leroux, JC; Wolfrum, C; Detmar, M				Blum, Katrin S.; Karaman, Sinem; Proulx, Steven T.; Ochsenbein, Alexandra M.; Luciani, Paola; Leroux, Jean-Christophe; Wolfrum, Christian; Detmar, Michael			Chronic High-Fat Diet Impairs Collecting Lymphatic Vessel Function in Mice	PLOS ONE			English	Article							LYMPHEDEMA; HYPERPLASIA; ADIPOSE; LYMPHANGIOGENESIS; DYNAMICS; TISSUE; MODEL; FLOW	Lymphatic vessels play an essential role in intestinal lipid uptake, and impairment of lymphatic vessel function leads to enhanced adipose tissue accumulation in patients with lymphedema and in genetic mouse models of lymphatic dysfunction. However, the effects of obesity on lymphatic function have been poorly studied. We investigated if and how adipose tissue accumulation influences lymphatic function. Using a lymphatic specific tracer, we performed in vivo near-infrared (NIR) imaging to assess the function of collecting lymphatic vessels in mice fed normal chow or high-fat diet (HFD). Histological and whole mount analyses were performed to investigate the morphological changes in initial and the collecting lymphatic vessels. HFD was associated with impaired collecting lymphatic vessel function, as evidenced by reduced frequency of contractions and diminished response to mechanostimulation. Moreover, we found a significant negative correlation between collecting lymphatic vessel function and body weight. Whole mount analyses showed an enlargement of contractile collecting lymphatic vessels of the hind limb. In K14-VEGF-C mice, HFD resulted in a reduced spreading of the tracer within dermal lymphatic vessels. These findings indicate that adipose tissue expansion due to HFD leads to a functional impairment of the lymphatic vasculature, predominantly in collecting lymphatic vessels.	[Blum, Katrin S.; Karaman, Sinem; Proulx, Steven T.; Ochsenbein, Alexandra M.; Luciani, Paola; Leroux, Jean-Christophe; Detmar, Michael] ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Wolfrum, Christian] ETH, Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Detmar, M (corresponding author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Karaman, Sinem/C-4428-2017; Luciani, Paola/M-3450-2018; Leroux, Jean-Christophe/N-4202-2015	Karaman, Sinem/0000-0002-0719-1773; Luciani, Paola/0000-0001-9664-0149; Leroux, Jean-Christophe/0000-0001-5601-1292; Wolfrum, Christian/0000-0002-3862-6805; Proulx, Steven/0000-0003-2154-8502	Swiss National Science Foundation [31003A_130627, 310030B_137087]; Advanced European Research Council Grant LYVICAM; Fondation Leducq Transatlantic Networks of Excellence in Cardiovascular Research; German Research Foundation [DFG: BL 1136/1-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced European Research Council Grant LYVICAM; Fondation Leducq Transatlantic Networks of Excellence in Cardiovascular Research; German Research Foundation(German Research Foundation (DFG))	This work was supported by Swiss National Science Foundation grants 31003A_130627 and 310030B_137087, Advanced European Research Council Grant LYVICAM, and Fondation Leducq Transatlantic Networks of Excellence in Cardiovascular Research (to MD). KSB received a research fellowship from the German Research Foundation (DFG: BL 1136/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; BILANCINI S, 1995, ANGIOLOGY, V46, P333, DOI 10.1177/000331979504600408; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Brorson Hakan, 2009, Lymphatic Research and Biology, V7, P3, DOI 10.1089/lrb.2008.1022; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Dixon JB, 2010, TRENDS ENDOCRIN MET, V21, P480, DOI 10.1016/j.tem.2010.04.003; Gogineni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068755; Greene AK, 2012, NEW ENGL J MED, V366, P2136, DOI 10.1056/NEJMc1201684; Harvey NL, 2008, ANN NY ACAD SCI, V1131, P82, DOI 10.1196/annals.1413.007; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Lim HY, 2009, AM J PATHOL, V175, P1328, DOI 10.2353/ajpath.2009.080963; Lohela M, 2008, AM J PATHOL, V173, P1891, DOI 10.2353/ajpath.2008.080378; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Proulx ST, 2013, ANGIOGENESIS; Proulx ST, 2013, BIOMATERIALS, V34, P5128, DOI 10.1016/j.biomaterials.2013.03.034; Quick CM, 2007, AM J PHYSIOL-REG I, V292, pR1510, DOI 10.1152/ajpregu.00258.2006; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Rutkowski JM, 2010, AM J PATHOL, V176, P1122, DOI 10.2353/ajpath.2010.090733; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Vasileiou AM, 2011, INT J OBESITY, V35, P1247, DOI 10.1038/ijo.2010.273; Weitman ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070703; Wittenberg T, 2011, EUR J VASC ENDOVASC, V41, P849, DOI 10.1016/j.ejvs.2011.02.015; Zawieja SD, 2012, AM J PHYSIOL-HEART C, V302, pH643, DOI 10.1152/ajpheart.00606.2011; Zhou QA, 2010, ARTHRITIS RHEUM-US, V62, P1881, DOI 10.1002/art.27464	26	91	95	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94713	10.1371/journal.pone.0094713	http://dx.doi.org/10.1371/journal.pone.0094713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714646	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900143
J	Boratynski, Z; Brito, JC; Campos, JC; Karala, M; Mappes, T				Boratynski, Zbyszek; Brito, Jose Carlos; Campos, Joao Carlos; Karala, Maija; Mappes, Tapio			Large Spatial Scale of the Phenotype-Environment Color Matching in Two Cryptic Species of African Desert Jerboas (Dipodidae: Jaculus)	PLOS ONE			English	Article							NATURAL-SELECTION; GENETIC-BASIS; EVOLUTION; ADAPTATION; CRYPSIS; HABITS; OWL	We tested the camouflage hypothesis, or the linkage between animal (Saharan rodent) and habitat coloration, on the largest geographical scale yet conducted. We aimed to determine whether phenotypic variation is explained by micro-habitat variation and/or genetic polymorphism to determine 1) the strength of linkage between fur color and local substrate color, and 2) the divergence in fur coloration between two genetic clades, representing cryptic species, throughout the complete range of the African desert jerboas (Jaculus jaculus). We used a combination of museum and field-collected specimens, remote sensing tools, satellite and digital photography and molecular genetic and phylogenetic methods to investigate the above hypotheses. Along with showing that the two divergent genetic clades of jerboas occur sympatrically throughout their African distribution, we showed significant covariation between dorsal fur coloration of the animals and the color of their habitat. We also described significant phenotypic divergence in fur color, consistent with genetic divergence between the sympatric clades. The linkage between environment and phenotype supports the idea that the selection promoting cryptic coloration is persistent in contemporary populations of jerboas, however the phenotypic divergence indicates that it has different strengths (or optima) in the two clades. The mosaic distribution of micro-habitats occupied by geographically sympatric clades suggests that it may influence both ecological and evolutionary dynamics between these two cryptic species.	[Boratynski, Zbyszek; Karala, Maija; Mappes, Tapio] Univ Jyvaskyla, Dept Biol & Environm Sci, Div Ecol & Evolutionary Biol, Jyvaskyla, Finland; [Boratynski, Zbyszek; Brito, Jose Carlos; Campos, Joao Carlos] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Brito, Jose Carlos; Campos, Joao Carlos] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal	University of Jyvaskyla; Universidade do Porto; Universidade do Porto	Boratynski, Z (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Div Ecol & Evolutionary Biol, Jyvaskyla, Finland.	boratyns@jyu.fi	Mappes, Tapio/B-9780-2013; Boratyński, Zbyszek/AAF-2389-2020; Campos, João/L-7901-2013; Brito, José C./A-7831-2010	Boratyński, Zbyszek/0000-0003-4668-4922; Campos, João/0000-0002-9144-4680; Brito, José C./0000-0001-5444-8132; Mappes, Tapio/0000-0002-5936-7355	National Geographic Society [7629-04, 8412-08]; Fundacao para a Ciencia e Tecnologia, through the EU program COMPETE [PTDC/BIA-BEC/099934/2008]; Academy of Finland [132190]; University of Jyvaskyla; Centre of Excellence in Evolutionary Research; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/84822/2012, SFRH/BD/87885/2012]; North Portugal Regional Operational Programme, under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF) [ON.2]	National Geographic Society(National Geographic Society); Fundacao para a Ciencia e Tecnologia, through the EU program COMPETE; Academy of Finland(Academy of Finland); University of Jyvaskyla; Centre of Excellence in Evolutionary Research; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); North Portugal Regional Operational Programme, under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF)	Fieldwork was supported by National Geographic Society (7629-04 and 8412-08) and Fundacao para a Ciencia e Tecnologia (PTDC/BIA-BEC/099934/2008), through the EU program COMPETE. Laboratory work was supported by the Academy of Finland (132190 to TM), the University of Jyvaskyla (mobility grant to ZB) and the Centre of Excellence in Evolutionary Research. Logistic support for fieldwork was given by Pedro Lopes Lda. (Trimble GPS), Off Road Power Shop and A. Araujo (P. N. Banc d'Arguin), and S.M.O. Lehlou (Ministry of Environment, Mauritania). Museum samples were kindly provided by the Smithsonian Institution, National Museum of Natural History, Division of Mammals, Washington D. C., USA. ZB and JCC are financed by Fundacao para a Ciencia e Tecnologia (SFRH/BPD/84822/2012 and SFRH/BD/87885/2012, respectively), and JCB by project "Biodiversity, Ecology and Global Change'' cofinanced by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Aviles JM, 2013, OECOLOGIA, V173; Ben Faleh A, 2012, BIOL J LINN SOC, V107, P27, DOI 10.1111/j.1095-8312.2012.01920.x; Blair W. F., 1947, Contributions from the Laboratory of Vertebrate Biology of the University of Michigan, V87, P1; Bond AB, 1998, NATURE, V395, P594, DOI 10.1038/26961; Boratynski Z, 2012, BIOL J LINN SOC, V105, P435, DOI 10.1111/j.1095-8312.2011.01791.x; Boratynski Z, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-355; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Coyne J.A., 2004, SPECIATION; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dice L, 1947, CONTRIBUTION LAB VER, P50115; ENDLER JA, 1988, PHILOS T R SOC B, V319, P505, DOI 10.1098/rstb.1988.0062; ESRI, 2008, ARCM 9 3 REDL; Gharaibeh, 1997, THESIS TEXAS TU, P354, DOI DOI 10.5281/ZENODO.4016016; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Hendrie CA, 1998, J ZOOL, V245, P439, DOI 10.1017/S0952836998008073; HETH G, 1988, OECOLOGIA, V74, P617, DOI 10.1007/BF00380062; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2005, HEREDITY, V94, P217, DOI 10.1038/sj.hdy.6800600; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HOOPER ET, 1972, J MAMMAL, V53, P574, DOI 10.2307/1379047; KAUFMAN DW, 1974, J MAMMAL, V55, P271, DOI 10.2307/1378997; Leonardi G, 2006, J ARID ENVIRON, V65, P677, DOI 10.1016/j.jaridenv.2005.10.007; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Merilaita S, 2001, P ROY SOC B-BIOL SCI, V268, P1925, DOI 10.1098/rspb.2001.1747; Mullen LM, 2009, P ROY SOC B-BIOL SCI, V276, P3809, DOI 10.1098/rspb.2009.1146; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Ng J, 2013, EVOLUTION, V67, P573, DOI 10.1111/j.1558-5646.2012.01795.x; NORRIS KS, 1964, ECOLOGY, V45, P565; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; RICE WR, 1990, EVOLUTION, V44, P1140, DOI 10.1111/j.1558-5646.1990.tb05221.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmidt DF, 2008, ANNOTATED GAZETTEER; Singaravelan N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008708; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; TURNER JOHN R. G., 1967, J LINN SOC LONDON ZOOL, V46, P255; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x	45	24	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94342	10.1371/journal.pone.0094342	http://dx.doi.org/10.1371/journal.pone.0094342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714509	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900119
J	Lahlali, R; McGregor, L; Song, T; Gossen, BD; Narisawa, K; Peng, G				Lahlali, Rachid; McGregor, Linda; Song, Tao; Gossen, Bruce D.; Narisawa, Kazuhiko; Peng, Gary			Heteroconium chaetospira Induces Resistance to Clubroot via Upregulation of Host Genes Involved in Jasmonic Acid, Ethylene, and Auxin Biosynthesis	PLOS ONE			English	Article							ROOT ENDOPHYTIC FUNGUS; PLASMODIOPHORA-BRASSICAE; CHINESE-CABBAGE; SYSTEMIC RESISTANCE; PIRIFORMOSPORA-INDICA; MUTUALISTIC SYMBIOSIS; PLANT; EXPRESSION; SUPPRESSION; ARABIDOPSIS	An endophytic fungus, Heteroconium chaetospira isolate BC2HB1 (Hc), suppressed clubroot (Plasmodiophora brassicae -Pb) on canola in growth-cabinet trials. Confocal microscopy demonstrated that Hc penetrated canola roots and colonized cortical tissues. Based on qPCR analysis, the amount of Hc DNA found in canola roots at 14 days after treatment was negatively correlated (r = 0.92, P<0.001) with the severity of clubroot at 5 weeks after treatment at a low (2x10(5) spores pot(-1)) but not high (2x10(5) spores pot(-1)) dose of pathogen inoculum. Transcript levels of nine B. napus (Bn) genes in roots treated with Hc plus Pb, Pb alone and a nontreated control were analyzed using qPCR supplemented with biochemical analysis for the activity of phenylalanine ammonia lyases (PAL). These genes encode enzymes involved in several biosynthetic pathways related potentially to plant defence. Hc plus Pb increased the activity of PAL but not that of the other two genes (BnCCR and BnOPCL) involved also in phenylpropanoid biosynthesis, relative to Pb inoculation alone. In contrast, expression of several genes involved in the jasmonic acid (BnOPR2), ethylene (BnACO), auxin (BnAAO1), and PR-2 protein (BnPR-2) biosynthesis were upregulated by 63, 48, 3, and 3 fold, respectively, by Hc plus Pb over Pb alone. This indicates that these genes may be involved in inducing resistance in canola by Hc against clubroot. The upregulation of BnAAO1 appears to be related to both pathogenesis of clubroot and induced defence mechanisms in canola roots. This is the first report on regulation of specific host genes involved in induced plant resistance by a non-mycorrhizal endophyte.	[Lahlali, Rachid; McGregor, Linda; Song, Tao; Gossen, Bruce D.; Peng, Gary] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Narisawa, Kazuhiko] Ibaraki Univ, Coll Agr, Ibaraki, Japan	Agriculture & Agri Food Canada; Ibaraki University	Peng, G (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	Gary.Peng@agr.gc.ca	Gossen, Bruce/W-3414-2019	Gossen, Bruce/0000-0001-5869-930X; Peng, Gary/0000-0002-9072-7187; Lahlali, Rachid/0000-0002-1299-5733	Canola Council of Canada/SaskCanola [CARP 2008-16]; Saskatchewan Agriculture Development Fund [20090359]	Canola Council of Canada/SaskCanola; Saskatchewan Agriculture Development Fund	Canola Council of Canada (http://www.canolacouncil.org/)/SaskCanola (http://www.saskcanola.com)(CARP 2008-16) and Saskatchewan Agriculture Development Fund (http://www.agriculture.gov.sk.ca/ADF) (Project 20090359) provided partial funding support to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2006, MOL PLANT PATHOL, V7, P223, DOI 10.1111/J.1364-3703.2006.00333.X; Martin-Rodriguez JA, 2011, NEW PHYTOL, V190, P193, DOI 10.1111/j.1469-8137.2010.03610.x; Arie Tsutomu, 1999, Pesticide Science, V55, P602, DOI 10.1002/(SICI)1096-9063(199905)55:5&lt;602::AID-PS964&gt;3.0.CO;2-C; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Chabannes M, 2001, PLANT J, V28, P257, DOI 10.1046/j.1365-313X.2001.01140.x; Clarke BB, 2006, PLANT DIS, V90, P994, DOI 10.1094/PD-90-0994; Cordier C, 1998, MOL PLANT MICROBE IN, V11, P1017, DOI 10.1094/MPMI.1998.11.10.1017; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doan TT, 2008, 5 INT S BRASS 16 INT, V867, P173; Donald EC, 2006, ACTA HORTIC, P283, DOI 10.17660/ActaHortic.2006.706.33; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Fracetto GGM, 2013, SYMBIOSIS, V60, P155, DOI 10.1007/s13199-013-0251-1; Garcia-Garrido JM, 2002, J EXP BOT, V53, P1377, DOI 10.1093/jexbot/53.373.1377; Grunwald U, 2004, PLANT MOL BIOL, V55, P553, DOI 10.1007/s11103-004-1303-y; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Hashiba T, 2005, FEMS MICROBIOL LETT, V252, P191, DOI 10.1016/j.femsle.2005.08.039; Hirai M, 2006, BREEDING SCI, V56, P223, DOI 10.1270/jsbbs.56.223; Howard RJ, 2010, CAN J PLANT PATHOL, V32, P43, DOI 10.1080/07060661003621761; Hwang SF, 2012, MOL PLANT PATHOL, V13, P105, DOI 10.1111/j.1364-3703.2011.00729.x; Jaschke D, 2010, PLANT PATHOL, V59, P100, DOI 10.1111/j.1365-3059.2009.02199.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Lahlali R., 2014, Plant Pathology, V63, P447, DOI 10.1111/ppa.12112; Lahlali R, 2013, PHYTOPATHOLOGY, V103, P245, DOI 10.1094/PHYTO-06-12-0123-R; Lahlali R, 2011, BIOCONTROL SCI TECHN, V21, P1351, DOI 10.1080/09583157.2011.618263; Lahlali R, 2012, CAN J PLANT PATHOL, V34, P320; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Lehtonen MJ, 2008, PHYTOPATHOLOGY, V98, P1190, DOI 10.1094/PHYTO-98-11-1190; Li J, 2005, PHYSIOL MOL PLANT P, V67, P220, DOI 10.1016/j.pmpp.2006.02.002; Liu JY, 2007, PLANT J, V50, P529, DOI 10.1111/j.1365-313X.2007.03069.x; Lovelock DA, 2013, AUSTRALAS PLANT PATH, V42, P141, DOI 10.1007/s13313-012-0167-x; Ludwig-Muller J, 2009, J PLANT GROWTH REGUL, V28, P229, DOI 10.1007/s00344-009-9089-4; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; McDonald MR, 2004, ACTA HORTIC, P25, DOI 10.17660/ActaHortic.2004.635.3; Morita Soichiro, 2003, Journal of General Plant Pathology, V69, P71, DOI 10.1007/s10327-002-0005-z; Narisawa K, 2005, PLANT DIS, V89, P285, DOI 10.1094/PD-89-0285; Narisawa K, 1998, PLANT PATHOL, V47, P206, DOI 10.1046/j.1365-3059.1998.00225.x; Narisawa K, 2000, PLANT PATHOL, V49, P141, DOI 10.1046/j.1365-3059.2000.00425.x; Narisawa Kazuhiko, 2007, Mycoscience, V48, P274, DOI 10.1007/s10267-007-0364-6; Ohki Takehiro, 2002, Mycoscience, V43, P191, DOI 10.1007/s102670200027; Peng G, 2011, PLANT PATHOL, V60, P566, DOI 10.1111/j.1365-3059.2010.02400.x; Peng G, 2014, CAN J PLANT PATHOL, V36, P99, DOI 10.1080/07060661.2013.860398; Petti C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-224; Pieterse CMJ, 2000, PHYSIOL MOL PLANT P, V57, P123, DOI 10.1006/pmpp.2000.0291; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Potlakayala SD, 2007, PHYTOPATHOLOGY, V97, P794, DOI 10.1094/PHYTO-97-7-0794; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; SCHREINER RP, 1993, NEW PHYTOL, V123, P99, DOI 10.1111/j.1469-8137.1993.tb04535.x; Sharma K, 2011, PHYTOPATHOLOGY, V101, P1424, DOI 10.1094/PHYTO-04-11-0124; Souza CD, 2008, NEW PHYTOL, V179, P987, DOI 10.1111/j.1469-8137.2008.02534.x; Strelkov SE, 2006, CAN J PLANT PATHOL, V28, P467, DOI 10.1080/07060660609507321; Sundelin T, 2010, PLANT DIS, V94, P432, DOI 10.1094/PDIS-94-4-0432; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Umamaheswari Chandrasekaran, 2009, Archives of Phytopathology and Plant Protection, V42, P1187, DOI 10.1080/03235400701652383; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Usuki Fumiaki, 2002, Journal of General Plant Pathology, V68, P326, DOI 10.1007/PL00013098; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Yonezawa Miho, 2004, Mycoscience, V45, P367, DOI 10.1007/s10267-004-0201-0; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]	68	44	52	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94144	10.1371/journal.pone.0094144	http://dx.doi.org/10.1371/journal.pone.0094144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714177	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900094
J	Vikhireva, O; Broda, G; Kubinova, R; Malyutina, S; Pajak, A; Tamosiunas, A; Skodova, Z; Simonova, G; Bobak, M; Pikhart, H				Vikhireva, Olga; Broda, Grazyna; Kubinova, Ruzena; Malyutina, Sofia; Pajak, Andrzej; Tamosiunas, Abdonas; Skodova, Zdena; Simonova, Galina; Bobak, Martin; Pikhart, Hynek			Does Inclusion of Education and Marital Status Improve SCORE Performance in Central and Eastern Europe and Former Soviet Union? Findings from MONICA and HAPIEE Cohorts	PLOS ONE			English	Article							CARDIOVASCULAR RISK PREDICTION; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; SOCIOECONOMIC-STATUS; FOLLOW-UP; MULTIPLE IMPUTATION; HEALTH; TRENDS; VALIDATION; RUSSIA	Background and Objective: The SCORE scale predicts the 10-year risk of fatal atherosclerotic cardiovascular disease (CVD), based on conventional risk factors. The high-risk version of SCORE is recommended for Central and Eastern Europe and former Soviet Union (CEE/FSU), due to high CVD mortality rates in these countries. Given the pronounced social gradient in cardiovascular mortality in the region, it is important to consider social factors in the CVD risk prediction. We investigated whether adding education and marital status to SCORE benefits its prognostic performance in two sets of population-based CEE/FSU cohorts. Methods: The WHO MONICA (MONItoring of trends and determinants in CArdiovascular disease) cohorts from the Czech Republic, Poland (Warsaw and Tarnobrzeg), Lithuania (Kaunas), and Russia (Novosibirsk) were followed from the mid-1980s (577 atherosclerotic CVD deaths among 14,969 participants with non-missing data). The HAPIEE (Health, Alcohol, and Psychosocial factors In Eastern Europe) study follows Czech, Polish (Krakow), and Russian (Novosibirsk) cohorts from 200205 (395 atherosclerotic CVD deaths in 19,900 individuals with non-missing data). Results: In MONICA and HAPIEE, the high-risk SCORE >= 5% at baseline strongly and significantly predicted fatal CVD both before and after adjustment for education and marital status. After controlling for SCORE, lower education and non-married status were significantly associated with CVD mortality in some samples. SCORE extension by these additional risk factors only slightly improved indices of calibration and discrimination (integrated discrimination improvement <5% in men and <= 1% in women). Conclusion: Extending SCORE by education and marital status failed to substantially improve its prognostic performance in population-based CEE/FSU cohorts.	[Vikhireva, Olga; Bobak, Martin; Pikhart, Hynek] UCL, Dept Epidemiol & Publ Hlth, London, England; [Broda, Grazyna] Cardinal Stefan Wyszynski Inst Cardiol, Dept CVD Epidemiol Prevent & Hlth Promot, Warsaw, Poland; [Kubinova, Ruzena] Natl Inst Publ Hlth, Prague, Czech Republic; [Malyutina, Sofia; Simonova, Galina] Russian Acad Med Sci, Siberian Branch, Inst Internal & Prevent Med, Novosibirsk, Russia; [Malyutina, Sofia] State Novosibirsk Med Univ, Novosibirsk, Russia; [Pajak, Andrzej] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Epidemiol & Populat Sci,Inst Publ Hlth, Krakow, Poland; [Tamosiunas, Abdonas] Lithuanian Univ Hlth Sci, Inst Cardiol, Lab Populat Res, Kaunas, Lithuania; [Skodova, Zdena] Inst Clin & Expt Med, Prevent Cardiol Dept, Prague, Czech Republic	University of London; University College London; National Institute of Public Health (SZU) - Czech Republic; Russian Academy of Medical Sciences; Russian Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University; Lithuanian University of Health Sciences; Institute for Clinical & Experimental Medicine (IKEM)	Vikhireva, O (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	o.vikhireva@ucl.ac.uk	Pikhart, Hynek/E-3074-2010; Tamosiunas, Abdonas/AAD-4274-2021; Simonova, Galina I./AAT-4345-2021; Malyutina, Sofia/J-1651-2018	Pikhart, Hynek/0000-0001-5277-4049; Malyutina, Sofia/0000-0001-6539-0466; Bobak, Martin/0000-0002-2633-6851	Czech and Polish Ministries of Health; Polish National Committee; Lithuanian Ministry of Education and Science; Russian Academy of Medical Sciences; Wellcome Trust [064947/Z/01/Z, 081081/Z/06/Z]; National Institute of Aging [1R01 AG23522]; MacArthur Foundation [71208]; NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER	Czech and Polish Ministries of Health; Polish National Committee; Lithuanian Ministry of Education and Science(Research Council of Lithuania (LMTLT)); Russian Academy of Medical Sciences(Russian Academy of Sciences); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The WHO MONICA Project in the Czech Republic, Poland, Lithuania, and Russia was supported by the Czech and Polish Ministries of Health, the Polish National Committee for Scientific Research, the Lithuanian Ministry of Education and Science, and the Russian Academy of Medical Sciences. The HAPIEE study has been supported by the Wellcome Trust (grant numbers 064947/Z/01/Z, 081081/Z/06/Z); the National Institute of Aging (1R01 AG23522); and the MacArthur Foundation (71208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; BENSHLOMO Y, 1993, J EPIDEMIOL COMMUN H, V47, P200, DOI 10.1136/jech.47.3.200; Bruthans J, 2012, EUR J PREV CARDIOL; Cifkova R, 2005, SUPPLEMENTUM COR VAS, V47, P3; Cifkova R, 2010, J HYPERTENS, V28, P2196, DOI 10.1097/HJH.0b013e32833d4451; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2010, EUR HEART J, V31, P2141, DOI 10.1093/eurheartj/ehq164; Cooney MT, 2009, EUR J CARDIOV PREV R, V16, P304, DOI 10.1097/HJR.0b013e3283213140; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; de la Iglesia B, 2011, HEART, V97, P491, DOI 10.1136/hrt.2010.203364; DELEON CFM, 1992, INT J EPIDEMIOL, V21, P460, DOI 10.1093/ije/21.3.460; DENNIS BH, 1993, INT J EPIDEMIOL, V22, P420, DOI 10.1093/ije/22.3.420; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fiscella K, 2004, ANN FAM MED, V2, P469, DOI 10.1370/afm.88; Fiscella K, 2009, AM HEART J, V157, P988, DOI 10.1016/j.ahj.2009.03.019; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Germano G, 2012, EUR HEART J, V33, P137; Grigoriev P, 2010, EUR J POPUL, V26, P245, DOI 10.1007/s10680-010-9210-1; Hajdu P., 1995, EUR J PUBLIC HEALTH, V5, P259, DOI [DOI 10.1093/EURPUB/5.4.259, 10.1093/eurpub/5.4.259]; Harper S, 2011, ANNU REV PUBL HEALTH, V32, P39, DOI 10.1146/annurev-publhealth-031210-101234; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hosmer DW, 1997, STAT MED, V16, P965; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Leinsalu M, 2009, INT J EPIDEMIOL, V38, P512, DOI 10.1093/ije/dyn248; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Macleod J, 2007, J EPIDEMIOL COMMUN H, V61, P833, DOI 10.1136/jech.2006.055921; Malyutina S, 2004, ANN EPIDEMIOL, V14, P244, DOI 10.1016/S1047-2797(03)00133-9; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Mendis S, 2011, J CLIN EPIDEMIOL, V64, P1451, DOI 10.1016/j.jclinepi.2011.02.001; Molloy GJ, 2009, SOC SCI MED, V69, P223, DOI 10.1016/j.socscimed.2009.05.010; Murphy M, 2006, AM J PUBLIC HEALTH, V96, P1293, DOI 10.2105/AJPH.2004.056929; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Podolec P, 2007, KARDIOL POL, V65, P100; Ramsay SE, 2011, EUR J CARDIOV PREV R, V18, P186, DOI 10.1177/1741826710389394; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Schottker B, 2013, DIABETOLOGIA, V56, P92, DOI 10.1007/s00125-012-2707-x; Sehestedt T, 2010, EUR HEART J, V31, P883, DOI 10.1093/eurheartj/ehp546; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; Sidorenkov O, 2012, ANN EPIDEMIOL, V22, P57, DOI 10.1016/j.annepidem.2011.08.008; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Ulmer H, 2005, EUR J CARDIOV PREV R, V12, P433, DOI 10.1097/01.hjr.0000174791.47059.80; United Nations, 2008, DEM YB 2006; Vikhireva O, 2014, EUR HEART J, V35, P571, DOI 10.1093/eurheartj/eht189; Vlismas K, 2011, HELL J CARDIOL, V52, P391; Whisman MA, 2010, J FAM PSYCHOL, V24, P367, DOI 10.1037/a0019547; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; World Health Organisation, 2011, GLOB INFOBASE; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2019, EUR HLTH ALL DAT; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160	72	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94344	10.1371/journal.pone.0094344	http://dx.doi.org/10.1371/journal.pone.0094344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714549	gold, Green Published			2022-12-27	WOS:000334160900120
J	Muller, S; Kaiser, H; Kruger, B; Fitzner, B; Lange, F; Bock, CN; Nizze, H; Ibrahim, SM; Fuellen, G; Wolkenhauer, O; Jaster, R				Mueller, Sarah; Kaiser, Hannah; Krueger, Burkhard; Fitzner, Brit; Lange, Falko; Bock, Cristin N.; Nizze, Horst; Ibrahim, Saleh M.; Fuellen, Georg; Wolkenhauer, Olaf; Jaster, Robert			Age-Dependent Effects of UCP2 Deficiency on Experimental Acute Pancreatitis in Mice	PLOS ONE			English	Article							ACUTE NECROTIZING PANCREATITIS; OXYGEN SPECIES PRODUCTION; UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; FREE-RADICALS; CONTROLLED-TRIAL; ACINAR-CELLS; INFLAMMATION; ACTIVATION; PATHOGENESIS	Reactive oxygen species (ROS) have been implicated in the pathogenesis of acute pancreatitis (AP) for many years but experimental evidence is still limited. Uncoupling protein 2 (UCP2)-deficient mice are an accepted model of age-related oxidative stress. Here, we have analysed how UCP2 deficiency affects the severity of experimental AP in young and older mice (3 and 12 months old, respectively) triggered by up to 7 injections of the secretagogue cerulein (50 mu g/kg body weight) at hourly intervals. Disease severity was assessed at time points from 3 hours to 7 days based on pancreatic histopathology, serum levels of alpha-amylase, intrapancreatic trypsin activation and levels of myeloperoxidase (MPO) in lung and pancreatic tissue. Furthermore, in vitro studies with pancreatic acini were performed. At an age of 3 months, UCP2(-/-) mice and wild-type (WT) C57BL/6 mice were virtually indistinguishable with respect to disease severity. In contrast, 12 months old UCP2(-/-) mice developed a more severe pancreatic damage than WT mice at late time points after the induction of AP (24 h and 7 days, respectively), suggesting retarded regeneration. Furthermore, a higher peak level of alpha-amylase activity and gradually increased MPO levels in pancreatic and lung tissue were observed in UCP2(-/-) mice. Interestingly, intrapancreatic trypsin activities (in vivo studies) and intraacinar trypsin and elastase activation in response to cerulein treatment (in vitro studies) were not enhanced but even diminished in the knockout strain. Finally, UCP2(-/-) mice displayed a diminished ratio of reduced and oxidized glutathione in serum but no increased ROS levels in pancreatic acini. Together, our data indicate an aggravating effect of UCP2 deficiency on the severity of experimental AP in older but not in young mice. We suggest that increased severity of AP in 12 months old UCP2(-/-) is caused by an imbalanced inflammatory response but is unrelated to acinar cell functions.	[Mueller, Sarah; Kaiser, Hannah; Fitzner, Brit; Lange, Falko; Bock, Cristin N.; Jaster, Robert] Univ Med Rostock, Dept Med 2, Div Gastroenterol, Rostock, Germany; [Krueger, Burkhard] Univ Med Rostock, Div Med Biol, Rostock, Germany; [Fitzner, Brit] Univ Med Rostock, Dept Neurol, Rostock, Germany; [Lange, Falko] Univ Med Rostock, Oscar Langendorff Inst Physiol, Rostock, Germany; [Nizze, Horst] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Ibrahim, Saleh M.] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Fuellen, Georg] Univ Med Rostock, Inst Biostatist & Informat Med & Ageing Res, Rostock, Germany; [Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany; [Wolkenhauer, Olaf] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study, ZA-7600 Stellenbosch, South Africa	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Lubeck; University of Rostock; University of Rostock; Stellenbosch University	Jaster, R (corresponding author), Univ Med Rostock, Dept Med 2, Div Gastroenterol, Rostock, Germany.	jaster@med.uni-rostock.de	Ibrahim, Saleh/AAO-9541-2020	Lange, Falko/0000-0001-8782-5205; Fitzner, Brit/0000-0003-3077-1351; Ibrahim, Saleh/0000-0001-7827-2290; Wolkenhauer, Olaf/0000-0001-6105-2937	Bundesministerium fur Bildung und Forschung [0315892A]; Bundesministerium fur Bildung und Forschung (GERONTOSYS program)	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung (GERONTOSYS program)	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (0315892A, GERONTOSYS program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bai Y, 2008, ALIMENT PHARM THER, V28, P557, DOI 10.1111/j.1365-2036.2008.03756.x; Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Bhardwaj P, 2009, GASTROENTEROLOGY, V136, P149, DOI 10.1053/j.gastro.2008.09.028; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Duval C, 2002, BIOCHEM CELL BIOL, V80, P757, DOI 10.1139/O02-158; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Emre Y, 2010, FEBS LETT, V584, P1437, DOI 10.1016/j.febslet.2010.03.014; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; HAYASHI Y, 1989, CLIN EXP IMMUNOL, V78, P120; Kruger B, 1998, LAB INVEST, V78, P763; Kuhla A, 2011, EXP GERONTOL, V46, P868, DOI 10.1016/j.exger.2011.07.008; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Lorentz K, 1998, CLIN CHEM LAB MED, V36, P185, DOI 10.1515/CCLM.1998.034; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Park BK, 2003, WORLD J GASTROENTERO, V9, P2266; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; RUTLEDGE PL, 1987, GASTROENTEROLOGY, V93, P41, DOI 10.1016/0016-5085(87)90311-8; Sah RP, 2013, CURR OPIN GASTROEN, V29, P523, DOI 10.1097/MOG.0b013e328363e399; SANFEY H, 1984, ANN SURG, V200, P405, DOI 10.1097/00000658-198410000-00003; Segersvard R, 2005, CELL TISSUE RES, V320, P251, DOI 10.1007/s00441-004-1024-1; Siriwardena AK, 2007, GUT, V56, P1439, DOI 10.1136/gut.2006.115873; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Sorg H, 2008, AM J PHYSIOL-GASTR L, V295, pG1274, DOI 10.1152/ajpgi.90341.2008; Telek G, 1999, J HISTOCHEM CYTOCHEM, V47, P1201, DOI 10.1177/002215549904700912; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Verlaan M, 2006, WORLD J GASTROENTERO, V12, P5705, DOI 10.3748/wjg.v12.i35.5705; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; Wu BU, 2013, GASTROENTEROLOGY, V144, P1272, DOI 10.1053/j.gastro.2013.01.075; Yasar M, 2002, HEPATO-GASTROENTEROL, V49, P1692; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; ZHOU WG, 1993, AM J PATHOL, V142, P1504	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94494	10.1371/journal.pone.0094494	http://dx.doi.org/10.1371/journal.pone.0094494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721982	gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100082
J	Wang, XX; Gao, Y; Feng, Y; Li, X; Wei, Q; Sheng, XY				Wang, Xiaoxia; Gao, Yuan; Feng, Yu; Li, Xue; Wei, Qian; Sheng, Xianyong			Cadmium Stress Disrupts the Endomembrane Organelles and Endocytosis during Picea wilsonii Pollen Germination and Tube Growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; METAL ACCUMULATION; HEAVY-METALS; ROOT-CELLS; TOXICITY; DYNAMICS; CHINA; CD; ULTRASTRUCTURE; BREFELDIN	As one of the most severe pollutants, cadmium has been reported to be harmful to plant cells, but the effects of cadmium on gymnosperm pollen germination and tube growth and the mechanism of this involvement are still unclear. Here, we report that cadmium not only strongly inhibited P. wilsonii pollen germination and tube growth, but also significantly altered tube morphology in a dose-dependent manner. Time-lapse images obtained with a laser scanning confocal microscope revealed that endocytosis was dramatically inhibited by cadmium stress. Further investigation with ER-Tracker dye indicated that cadmium stress reduced the number of the Golgi apparatus, and induced dilation of ER. Additionally, Lyso-Tracker staining showed that cadmium distinctly promoted the formation of acidic organelles in pollen tubes, likely derived from the dilated ER. Taken together, our studies indicated that P. wilsonii pollens were highly susceptible to cadmium stress, and that cadmium stress strongly inhibited pollen germination and tube growth by disrupting the endomembrane organelles, inhibiting endo/exocytosis, and forming acidic vacuoles, resulting in swollen tube tips and irregularly broadened tube diameters. These findings provide a new insight into the effects of cadmium toxicity on the tip growth of pollen tubes.	[Wang, Xiaoxia; Gao, Yuan; Feng, Yu; Li, Xue; Wei, Qian; Sheng, Xianyong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	Capital Normal University	Sheng, XY (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	xianyong.sheng@163.com			Natural Science Foundation of China [31371387]; Scientific Research Project of Beijing Educational Committee [KM201210028017]; Excellent Talent Training Project of Beijing [2012D005016000006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Beijing Educational Committee; Excellent Talent Training Project of Beijing	This work was supported by Natural Science Foundation of China (Grant No. 31371387), Scientific Research Project of Beijing Educational Committee (Grant No. KM201210028017), and Excellent Talent Training Project of Beijing (Grant No. 2012D005016000006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CHINA DAILY; Caijing, 2013, CHIN HAZ MOR HORR SA; Calzoni GL, 2007, ENVIRON POLLUT, V149, P239, DOI 10.1016/j.envpol.2006.12.023; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Cole L, 2000, J MICROSC-OXFORD, V197, P239, DOI 10.1046/j.1365-2818.2000.00664.x; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Gan HY, 2013, MAR POLLUT BULL, V66, P252, DOI 10.1016/j.marpolbul.2012.09.020; Gardarin A, 2010, MOL MICROBIOL, V76, P1034, DOI 10.1111/j.1365-2958.2010.07166.x; HOLUB Z, 1983, BIOLOGIA, V38, P393; Kalbande DM, 2008, ENVIRON MONIT ASSESS, V138, P233, DOI 10.1007/s10661-007-9793-0; Kitamura M, 2010, BIOMETALS, V23, P941, DOI 10.1007/s10534-010-9296-2; Kutik J, 2014, PHYSIOL PLANTARUM, V151, P423, DOI 10.1111/ppl.12124; Lin SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060815; Liu DH, 2003, J BIOSCIENCES, V28, P471, DOI 10.1007/BF02705121; Liu N, 2012, ECOTOXICOLOGY, V21, P2004, DOI 10.1007/s10646-012-0935-y; Luo L, 2009, J ENVIRON MANAGE, V90, P2524, DOI 10.1016/j.jenvman.2009.01.011; Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587; Niu LL, 2013, ENVIRON POLLUT, V176, P55, DOI 10.1016/j.envpol.2013.01.019; Oleksyn J, 1999, WATER AIR SOIL POLL, V110, P195, DOI 10.1023/A:1005064218004; Parton RM, 2001, J CELL SCI, V114, P2685; Perfus-Barbeoch L, 2002, PLANT J, V32, P539, DOI 10.1046/j.1365-313X.2002.01442.x; Sabrine H, 2010, SCI HORTIC-AMSTERDAM, V125, P551, DOI 10.1016/j.scienta.2010.05.031; Sawidis T, 2008, PROTOPLASMA, V233, P95, DOI 10.1007/s00709-008-0306-y; SAWIDIS T, 1995, PROTOPLASMA, V185, P113, DOI 10.1007/BF01272851; Sheng XY, 2010, CELL BIOCHEM FUNCT, V28, P420, DOI 10.1002/cbf.1672; Sheng XY, 2006, PLANT PHYSIOL, V141, P1578, DOI 10.1104/pp.106.081703; Sheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045673; Sheng XY, 2012, BIOL TRACE ELEM RES, V146, P86, DOI 10.1007/s12011-011-9212-9; Tuna A. Levent, 2002, Turkish Journal of Biology, V26, P109; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Xiong ZT, 2001, ECOTOX ENVIRON SAFE, V48, P51, DOI 10.1006/eesa.2000.2002; Zhang ZS, 2012, BIOL TRACE ELEM RES, V145, P403, DOI 10.1007/s12011-011-9199-2; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007; Zonia L, 2009, TRENDS PLANT SCI, V14, P318, DOI 10.1016/j.tplants.2009.03.008; 王崇臣, 2009, [环境化学, Environmental Chemistry], V28, P604	36	13	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94721	10.1371/journal.pone.0094721	http://dx.doi.org/10.1371/journal.pone.0094721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722362	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100128
J	Lopez, E; Domenech, A; Ferrandiz, MJ; Frias, MJ; Ardanuy, C; Ramirez, M; Garcia, E; Linares, J; de la Campa, AG				Lopez, Elena; Domenech, Arnau; Ferrandiz, Maria-Jose; Frias, Maria Joao; Ardanuy, Carmen; Ramirez, Mario; Garcia, Ernesto; Linares, Josefina; de la Campa, Adela G.			Induction of Prophages by Fluoroquinolones in Streptococcus pneumoniae: Implications for Emergence of Resistance in Genetically-Related Clones	PLOS ONE			English	Article							TOPOISOMERASE; BACTERIOPHAGE; DISEASE; GENES; DEATH; SUSCEPTIBILITY; PNEUMOCOCCUS; EVOLUTION; INFECTION; CARRIAGE	Antibiotic resistance in Streptococcus pneumoniae has increased worldwide by the spread of a few clones. Fluoroquinolone resistance occurs mainly by alteration of their intracellular targets, the type II DNA topoisomerases, which is acquired either by point mutation or by recombination. Increase in fluoroquinolone-resistance may depend on the balance between antibiotic consumption and the cost that resistance imposes to bacterial fitness. In addition, pneumococcal prophages could play an important role. Prophage induction by fluoroquinolones was confirmed in 4 clinical isolates by using Southern blot hybridization. Clinical isolates (105 fluoroquinolone-resistant and 160 fluoroquinolone-susceptible) were tested for lysogeny by using a PCR assay and functional prophage carriage was studied by mitomycin C induction. Fluoroquinoloneresistant strains harbored fewer inducible prophages (17/43) than fluoroquinolone-susceptible strains (49/70) (P= 0.0018). In addition, isolates of clones associated with fluoroquinolone resistance [CC156 (3/25); CC63 (2/20), and CC81 (1/19)], had lower frequency of functional prophages than isolates of clones with low incidence of fluoroquinolone resistance [CC30 (4/ 21), CC230 (5/20), CC62 (9/21), and CC180 (21/30)]. Likewise, persistent strains from patients with chronic respiratory diseases subjected to fluoroquinolone treatment had a low frequency of inducible prophages (1/11). Development of ciprofloxacin resistance was tested with two isogenic strains, one lysogenic and the other non-lysogenic: emergence of resistance was only observed in the non-lysogenic strain. These results are compatible with the lysis of lysogenic isolates receiving fluoroquinolones before the development of resistance and explain the inverse relation between presence of inducible prophages and fluoroquinolone-resistance.	[Lopez, Elena; Ferrandiz, Maria-Jose; de la Campa, Adela G.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Lopez, Elena; Domenech, Arnau; Ferrandiz, Maria-Jose; Ardanuy, Carmen; Garcia, Ernesto; Linares, Josefina; de la Campa, Adela G.] ISCIII, Ciber Enfermedades Resp, Madrid, Spain; [Domenech, Arnau; Ardanuy, Carmen; Linares, Josefina] Univ Barcelona, Hosp Univ Bellvitge, IDIBELL, Dept Microbiol, Barcelona, Spain; [Frias, Maria Joao; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Microbiol, Inst Mol Med, P-1699 Lisbon, Portugal; [Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [de la Campa, Adela G.] CSIC, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC)	de la Campa, AG (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	agcampa@isciii.es	Ferrandiz, Maria-Jose/K-2820-2014; Ramirez, Mario/B-4993-2008; de la Campa, Adela G/K-1654-2014; Liñares, Josefina/N-9450-2014; Ardanuy, Carmen/C-4463-2015	Ferrandiz, Maria-Jose/0000-0003-1428-9506; Ramirez, Mario/0000-0002-4084-6233; de la Campa, Adela G/0000-0002-3598-2548; Frias, Maria Joao/0000-0002-8060-1206; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; Domenech, Arnau/0000-0002-0829-511X; Ardanuy, Carmen/0000-0003-0225-607X	Plan Nacional [BIO2008-02154, SAF2009-10824, BIO2011-25343]; FIS of Ministerio de Economiy Competitividad [PI 0901904]; FPU of Ministerio de Educacion, Spain	Plan Nacional; FIS of Ministerio de Economiy Competitividad; FPU of Ministerio de Educacion, Spain(German Research Foundation (DFG))	This study was supported by grants BIO2008-02154, SAF2009-10824 and BIO2011-25343 from Plan Nacional and PI 0901904 by FIS of Ministerio de Economiy Competitividad. CIBER de Enfermedades Respiratorias (CIBERES) is an initiative of ISCIII. A. D. was supported by a grant from FPU of Ministerio de Educacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1; Balsalobre L, 2003, ANTIMICROB AGENTS CH, V47, P2072, DOI 10.1128/AAC.47.7.2072-2081.2003; Balsalobre L, 2008, ANTIMICROB AGENTS CH, V52, P822, DOI 10.1128/AAC.00731-07; Balsalobre L, 2013, ANTIMICROB AGENTS CH, V57, P254, DOI 10.1128/AAC.01357-12; Balsalobre L, 2011, ANTIMICROB AGENTS CH, V55, P1097, DOI 10.1128/AAC.00783-10; BERNHEIMER HP, 1979, J BACTERIOL, V138, P618, DOI 10.1128/JB.138.2.618-624.1979; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; de la Campa AG, 2004, EMERG INFECT DIS, V10, P1751, DOI 10.3201/eid1010.040382; Domenech A, 2012, J CLIN MICROBIOL, V50, P4047, DOI 10.1128/JCM.02056-12; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Ferrandiz MJ, 2014, ANTIMICROB AGENTS CH, V58, P247, DOI 10.1128/AAC.01706-13; Frias MJ, 2009, J BACTERIOL, V191, P5428, DOI 10.1128/JB.00477-09; Ingrey KT, 2003, INFECT IMMUN, V71, P3028, DOI 10.1128/IAI.71.6.3028-3033.2003; Jacobs MR, 2003, J ANTIMICROB CHEMOTH, V52, P229, DOI 10.1093/jac/dkg321; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Meessen-Pinard M, 2012, APPL ENVIRON MICROB, V78, P7662, DOI 10.1128/AEM.02275-12; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Ramirez M, 1999, J BACTERIOL, V181, P3618, DOI 10.1128/JB.181.12.3618-3625.1999; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Romero P, 2009, APPL ENVIRON MICROB, V75, P1642, DOI 10.1128/AEM.02155-08; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Stanhope MJ, 2005, ANTIMICROB AGENTS CH, V49, P4315, DOI 10.1128/AAC.49.10.4315-4326.2005; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09	32	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94358	10.1371/journal.pone.0094358	http://dx.doi.org/10.1371/journal.pone.0094358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718595	Green Published, gold			2022-12-27	WOS:000334339000110
J	Lubke, KT; Croy, I; Hoenen, M; Gerber, J; Pause, BM; Hummel, T				Luebke, Katrin T.; Croy, Ilona; Hoenen, Matthias; Gerber, Johannes; Pause, Bettina M.; Hummel, Thomas			Does Human Body Odor Represent a Significant and Rewarding Social Signal to Individuals High in Social Openness?	PLOS ONE			English	Article							CHEMOSENSORY CUES; ACTIVATION; RECOGNITION; EXPERT; COMMON; SKILLS	Across a wide variety of domains, experts differ from novices in their response to stimuli linked to their respective field of expertise. It is currently unknown whether similar patterns can be observed with regard to social expertise. The current study therefore focuses on social openness, a central social skill necessary to initiate social contact. Human body odors were used as social cues, as they inherently signal the presence of another human being. Using functional MRI, hemodynamic brain responses to body odors of women reporting a high (n = 14) or a low (n = 12) level of social openness were compared. Greater activation within the inferior frontal gyrus and the caudate nucleus was observed in high socially open individuals compared to individuals low in social openness. With the inferior frontal gyrus being a crucial part of the human mirror neuron system, and the caudate nucleus being implicated in social reward, it is discussed whether human body odor might constitute more of a significant and rewarding social signal to individuals high in social openness compared to individuals low in social openness process.	[Luebke, Katrin T.; Hoenen, Matthias; Pause, Bettina M.] Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany; [Croy, Ilona; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Dresden, Germany; [Gerber, Johannes] Univ Dresden, Sch Med, Dept Neuroradiol, Dresden, Germany	Heinrich Heine University Dusseldorf; Technische Universitat Dresden; Technische Universitat Dresden	Lubke, KT (corresponding author), Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany.	katrin.luebke@hhu.de	Gerber, Johannes/U-4918-2019; Hoenen, Matthias/I-1029-2019	Gerber, Johannes/0000-0001-7465-8700; Hoenen, Matthias/0000-0002-5791-9486; Croy, Ilona/0000-0002-0361-5559				Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Arsalidou M, 2012, HUM BRAIN MAPP; Ashbaugh AR, 2005, COGNITIVE THER RES, V29, P387, DOI 10.1007/s10608-005-2413-9; Baker SR, 2002, BRIT J CLIN PSYCHOL, V41, P243, DOI 10.1348/014466502760379118; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Bzdok D, 2011, BRAIN STRUCT FUNCT, V215, P209, DOI 10.1007/s00429-010-0287-4; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Caldu X, 2007, ANN NY ACAD SCI, V1118, P43, DOI 10.1196/annals.1412.007; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Croy I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009362; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; Dimoka A, 2011, NEUROIMAGE, V54, pS263, DOI 10.1016/j.neuroimage.2010.05.007; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; Duan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032532; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Focquaert F, 2010, BRAIN RES BULL, V83, P214, DOI 10.1016/j.brainresbull.2010.08.008; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Hampel S, 2011, J ANXIETY DISORD, V25, P545, DOI 10.1016/j.janxdis.2011.01.001; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00786; Kanning U. P, 2009, ISK; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kim J, 2008, NEUROSCI LETT, V445, P236, DOI 10.1016/j.neulet.2008.09.018; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kobal G., 2003, HDB OLFACTION GUSTAT, P229; Lebreton M, 2009, EUR J NEUROSCI, V29, P2247, DOI 10.1111/j.1460-9568.2009.06782.x; Lubke KT, 2012, BEHAV BRAIN RES, V228, P375, DOI 10.1016/j.bbr.2011.12.018; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2010, VITAM HORM, V83, P1, DOI 10.1016/S0083-6729(10)83001-8; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mallet P, 1998, J GEN PSYCHOL, V125, P47, DOI 10.1080/00221309809595576; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010342; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Pause BM, 2004, PHYSIOL BEHAV, V83, P21, DOI 10.1016/j.physbeh.2004.07.019; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Rilling JK, 2012, PSYCHONEUROENDOCRINO, V37, P447, DOI 10.1016/j.psyneuen.2011.07.013; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Semrud-Clikeman M, 2011, NEUROPSYCHOBIOLOGY, V64, P47, DOI 10.1159/000325075; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; SuÓ H.-M., 2005, HDB PERSONLICHKEITSP, P350; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wintermann GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074655; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Wyatt TD, 2004, SCENT HUMAN ATTRACTI, P270; Zhou W, 2011, NEUROIMAGE, V55, P1401, DOI 10.1016/j.neuroimage.2010.12.064; Zhou W, 2009, PSYCHOL SCI, V20, P1118, DOI 10.1111/j.1467-9280.2009.02413.x; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	60	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94314	10.1371/journal.pone.0094314	http://dx.doi.org/10.1371/journal.pone.0094314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718308	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000104
J	Prisco, AR; Bukowy, JD; Hoffmann, BR; Karcher, JR; Exner, EC; Greene, AS				Prisco, Anthony R.; Bukowy, John D.; Hoffmann, Brian R.; Karcher, Jamie R.; Exner, Eric C.; Greene, Andrew S.			Automated Quantification Reveals Hyperglycemia Inhibits Endothelial Angiogenic Function	PLOS ONE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; TUBE FORMATION; CLINICAL-RELEVANCE; BASEMENT-MEMBRANE; IN-VITRO; CELLS; DYSFUNCTION; ADIPONECTIN; SECRETION; MIGRATION	Objective: Diabetes Mellitus (DM) has reached epidemic levels globally. A contributing factor to the development of DM is high blood glucose (hyperglycemia). One complication associated with DM is a decreased angiogenesis. The Matrigel tube formation assay (TFA) is the most widely utilized in vitro assay designed to assess angiogeneic factors and conditions. In spite of the widespread use of Matrigel TFAs, quantification is labor-intensive and subjective, often limiting experiential design and interpretation of results. This study describes the development and validation of an open source software tool for high throughput, morphometric analysis of TFA images and the validation of an in vitro hyperglycemic model of DM. Approach and Results: Endothelial cells mimic angiogenesis when placed onto a Matrigel coated surface by forming tubelike structures. The goal of this study was to develop an open-source software algorithm requiring minimal user input (Pipeline v1.3) to automatically quantify tubular metrics from TFA images. Using Pipeline, the ability of endothelial cells to form tubes was assessed after culture in normal or high glucose for 1 or 2 weeks. A significant decrease in the total tube length and number of branch points was found when comparing groups treated with high glucose for 2 weeks versus normal glucose or 1 week of high glucose. Conclusions: Using Pipeline, it was determined that hyperglycemia inhibits formation of endothelial tubes in vitro. Analysis using Pipeline was more accurate and significantly faster than manual analysis. The Pipeline algorithm was shown to have additional applications, such as detection of retinal vasculature.	[Prisco, Anthony R.; Bukowy, John D.; Hoffmann, Brian R.; Karcher, Jamie R.; Exner, Eric C.; Greene, Andrew S.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Prisco, Anthony R.; Bukowy, John D.; Hoffmann, Brian R.; Karcher, Jamie R.; Exner, Eric C.; Greene, Andrew S.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Greene, AS (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	agreene@mcw.edu	Greene, Andrew S/B-9696-2015	Exner, Eric/0000-0003-0129-5536; Greene, Andrew/0000-0002-3191-2112	NIH [HL082798]; MSTP Institutional Training Fellowship from NIGMS [T32 GM80202]; NHLBI [T32 HL94273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL082798, T32HL094273, T32HL007852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP Institutional Training Fellowship from NIGMS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant HL082798 and a gift from the Kern Family Foundation. AP was supported in part by an MSTP Institutional Training Fellowship from NIGMS (T32 GM80202). BH was supported by a post-doctoral training fellowship from NHLBI (T32 HL94273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Alfred G, 1998, MODERN DIFFERENTIAL; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Bagley RG, 2003, CANCER RES, V63, P5866; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Bramich DM, 2008, MON NOT R ASTRON SOC, V386, pL77, DOI 10.1111/j.1745-3933.2008.00464.x; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chu LY, 2013, BLOOD, V122, P1822, DOI 10.1182/blood-2013-01-482315; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Devices M, 2010, USING ANGIOGENESIS T; Douma K, 2011, QUANTIFYING MICROVAS; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Esposito C, 2001, KIDNEY INT, V59, P1842, DOI 10.1046/j.1523-1755.2001.0590051842.x; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Feener EP, 1997, LANCET, V350, pSI9; Funk SD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/569654; Green PS, 2000, J NEUROCYTOL, V29, P419, DOI 10.1023/A:1007173509470; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kunimasa K, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep024; Luppi P, 2008, DIABETOLOGIA, V51, P1534, DOI 10.1007/s00125-008-1032-x; Matsumura T, 1997, J IMMUNOL, V158, P3408; Meerwaldt R, 2008, EUR J VASC ENDOVASC, V36, P125, DOI 10.1016/j.ejvs.2008.01.030; Meerwaldt R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-29; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Odstrcilik J, 2013, IET IMAGE PROCESS, V7, P373, DOI 10.1049/iet-ipr.2012.0455; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Potenza MA, 2009, CURR MED CHEM, V16, P94, DOI 10.2174/092986709787002853; Shen JS, 2007, MOL GENET METAB, V92, P137, DOI 10.1016/j.ymgme.2007.06.003; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang S, 2012, CURR DIABETES REP, V12, P355, DOI 10.1007/s11892-012-0289-0; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94599	10.1371/journal.pone.0094599	http://dx.doi.org/10.1371/journal.pone.0094599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718615	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000134
J	Sala, M; Casacci, LP; Balletto, E; Bonelli, S; Barbero, F				Sala, Marco; Casacci, Luca Pietro; Balletto, Emilio; Bonelli, Simona; Barbero, Francesca			Variation in Butterfly Larval Acoustics as a Strategy to Infiltrate and Exploit Host Ant Colony Resources	PLOS ONE			English	Article							LARGE-BLUE; SOCIAL PARASITE; MACULINEA-REBELI; POLYMORPHIC GROWTH; COMMUNICATION; SPECIFICITY; BEHAVIOR; ADOPTION; LEPIDOPTERA; CATERPILLARS	About 10,000 arthropods live as ants' social parasites and have evolved a number of mechanisms allowing them to penetrate and survive inside the ant nests. Many of them can intercept and manipulate their host communication systems. This is particularly important for butterflies of the genus Maculinea, which spend the majority of their lifecycle inside Myrmica ant nests. Once in the colony, caterpillars of Maculinea "predatory species'' directly feed on the ant larvae, while those of "cuckoo species'' are fed primarily by attendance workers, by trophallaxis. It has been shown that Maculinea cuckoo larvae are able to reach a higher social status within the colony's hierarchy by mimicking the acoustic signals of their host queen ants. In this research we tested if, when and how myrmecophilous butterflies may change sound emissions depending on their integration level and on stages of their life cycle. We studied how a Maculinea predatory species (M. teleius) can acoustically interact with their host ants and highlighted differences with respect to a cuckoo species (M. alcon). We recorded sounds emitted by Maculinea larvae as well as by their Myrmica hosts, and performed playback experiments to assess the parasites' capacity to interfere with the host acoustic communication system. We found that, although varying between and within butterfly species, the larval acoustic emissions are more similar to queens' than to workers' stridulations. Nevertheless playback experiments showed that ant workers responded most strongly to the sounds emitted by the integrated (i.e. post-adoption) larvae of the cuckoo species, as well as by those of predatory species recorded before any contact with the host ants (i.e. in pre-adoption), thereby revealing the role of acoustic signals both in parasite integration and in adoption rituals. We discuss our findings in the broader context of parasite adaptations, comparing effects of acoustical and chemical mimicry.	[Sala, Marco; Casacci, Luca Pietro; Balletto, Emilio; Bonelli, Simona; Barbero, Francesca] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Turin	Casacci, LP (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	luca.casacci@unito.it	Casacci, Luca Pietro/AAA-4295-2020; Barbero, Francesca/J-3555-2016	Casacci, Luca Pietro/0000-0003-3083-7357; Barbero, Francesca/0000-0003-2667-0435; BALLETTO, Emilio/0000-0003-1168-2791; Bonelli, Simona/0000-0001-5185-8136	DLR-BMBF (Germany); NERC (UK); DEFRA (UK); ANR (France); Formas (Sweden); Swedish EPA (Sweden); Italian Ministry of Education, University and Research (MIUR)	DLR-BMBF (Germany); NERC (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); DEFRA (UK)(Department for Environment, Food & Rural Affairs (DEFRA)); ANR (France)(French National Research Agency (ANR)); Formas (Sweden)(Swedish Research Council Formas); Swedish EPA (Sweden); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was carried out within the project CLIMIT (Climate Change Impacts on Insects and their Mitigation; Settele & Kuhn, 2009; Thomas, Simcox & Clarke, 2009) funded by DLR-BMBF (Germany), NERC and DEFRA (UK), ANR (France), Formas (Sweden), and Swedish EPA (Sweden) through the FP6 BiodivERsA Eranet, as well as by the project 'A multitaxa approach to study the impact of climate change on the biodiversity of Italian ecosystems' of the Italian Ministry of Education, University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Als TD, 2001, ANIM BEHAV, V62, P99, DOI 10.1006/anbe.2001.1716; Barbero F., 2012, Psyche (Cambridge), V2012, DOI 10.1155/2012/725237; Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Belt T, 1874, THE NATURALIST IN NI; Bonelli Simona, 2005, P65; Braune P, 2005, BEHAV ECOL SOCIOBIOL, V58, P587, DOI 10.1007/s00265-005-0944-4; Casacci LP, 2013, CURR BIOL, V23, P323, DOI 10.1016/j.cub.2013.01.010; DEVRIES PJ, 1991, ANT - PLANT INTERACTIONS, P143; DEVRIES PJ, 1993, BIOL J LINN SOC, V49, P229, DOI 10.1111/j.1095-8312.1993.tb00902.x; Donisthorpe H, 1927, THE GUESTS OF BRITIS; ELMES GW, 1991, J ZOOL, V223, P447, DOI 10.1111/j.1469-7998.1991.tb04775.x; Elmes GW, 2002, OECOLOGIA, V130, P525, DOI 10.1007/s00442-001-0857-5; Elmes GW, 1996, BIODIVERSITY RES ITS, P38; Fiedler K, 1990, NOTA LEPIDOPTEROLOGI, V12, P246; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; HILL CJ, 1993, J AUST ENTOMOL SOC, V32, P283; HOLLDOBLER B, 1985, BEHAV ECOL SOCIOBIOL, V18, P45; HOLLDOBLER B, 1985, Israel Journal of Entomology, V19, P89; Holldobler B, 2001, MG BEH ECOL, P92; Holldobler B., 1990, pi; Holldobler B, 2009, THE SUPERORGANISM TH; Hunt JH, 2013, INSECT SOC, V60, P403, DOI 10.1007/s00040-013-0311-9; Jang YW, 1996, ANIM BEHAV, V51, P1095, DOI 10.1006/anbe.1996.0111; Kirchner WH, 1997, EXS, V84, P273; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A., 1982, SOCIAL INSECTS TROPI, V1, P157; Manly B., 1994, MULTIVARIATE STATIST; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MARKL H, 1978, BEHAV ECOL SOCIOBIOL, V4, P183, DOI 10.1007/BF00354979; MARKL H, 1967, Z VERGL PHYSIOL, V57, P299, DOI 10.1007/BF00303001; Markl H., 1973, Proceedings Congr Int Un Study Soc Ins, V7, P258; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Patricelli D, 2010, SOCIOBIOLOGY, V55, P861; Roces F, 2001, J ACOUST SOC AM, V109, P3080, DOI 10.1121/1.1370085; Santos JC, 2005, SOCIOBIOLOGY, V46, P27; Schonrogge K, 2004, J CHEM ECOL, V30, P91, DOI 10.1023/B:JOEC.0000013184.18176.a9; Schurian Klaus G., 1994, Nachrichten des Entomologischen Vereins Apollo, V14, P339; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Settele J, 2011, J EXP BIOL, V214, P1407, DOI 10.1242/jeb.035329; TAYLOR RW, 1978, SCIENCE, V201, P979, DOI 10.1126/science.201.4360.979; THOMAS JA, 1992, OECOLOGIA, V91, P101, DOI 10.1007/BF00317247; THOMAS JA, 1984, BIOL CONSERV, V28, P325, DOI 10.1016/0006-3207(84)90040-5; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 1998, P ROY SOC B-BIOL SCI, V265, P1895, DOI 10.1098/rspb.1998.0517; Thomas JA, 1998, ECOL ENTOMOL, V23, P457, DOI 10.1046/j.1365-2311.1998.00153.x; Thomas JA, 2002, OECOLOGIA, V132, P531, DOI 10.1007/s00442-002-1002-9; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; Thomas Jeremy A., 2010, Communicative & Integrative Biology, V3, P169; WASMANN E., 1894, KRITISCHES VERZEICHN; Wheeler W, 1910, AM NAT, V91, P5927; Witek M, 2006, OECOLOGIA, V148, P729, DOI 10.1007/s00442-006-0404-5; Witek M, 2013, BIOL J LINN SOC, V109, P699, DOI 10.1111/bij.12074	57	30	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94341	10.1371/journal.pone.0094341	http://dx.doi.org/10.1371/journal.pone.0094341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718496	Green Published, gold			2022-12-27	WOS:000334339000107
J	Vannucci, M; Batool, I; Pelagatti, C; Mazzoni, G				Vannucci, Manila; Batool, Iram; Pelagatti, Claudia; Mazzoni, Giuliana			Modifying the Frequency and Characteristics of Involuntary Autobiographical Memories	PLOS ONE			English	Article							VOLUNTARY; MIND	Recent studies have shown that involuntary autobiographical memories (IAMs) can be elicited in the laboratory. Here we assessed whether the specific instructions given to participants can change the nature of the IAMs reported, in terms of both their frequency and their characteristics. People were either made or not made aware that the aim of the study was to examine IAMs. They reported mental contents either whenever they became aware of them or following a predetermined schedule. Both making people aware of the aim of the study and following a fixed schedule of interruptions increased significantly the number of IAMs reported. When aware of the aim of the study, participants reported more specific memories that had been retrieved and rehearsed more often in the past. These findings demonstrate that the number and characteristics of memories depend on the procedure used. Explanations of these effects and their implications for research on IAMs are discussed.	[Vannucci, Manila; Pelagatti, Claudia] Univ Florence, Dept NEUROFARBA, Psychol Sect, Florence, Italy; [Batool, Iram; Mazzoni, Giuliana] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Florence; University of Hull	Mazzoni, G (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.	g.mazzoni@hull.ac.uk	Pelagatti, Claudia/GXV-5654-2022	batool, iram/0000-0001-7230-9080; Vannucci, Manila/0000-0003-1782-0526; Pelagatti, Claudia/0000-0001-6350-1249				Ball C. T., 2007, INVOLUNTARY MEMORY, P127, DOI [DOI 10.1002/9780470774069.CH7, 10.1002/9780470774069.ch7]; Berntsen D, 2009, INVOLUNTARY AUTOBIOGRAPHICAL MEMORIES: AN INTRODUCTION TO THE UNBIDDEN PAST, P1, DOI 10.1017/CBO9780511575921; Berntsen D, 2004, MEM COGNITION, V32, P789, DOI 10.3758/BF03195869; Berntsen D, 1998, MEMORY, V6, P113, DOI 10.1080/741942071; Berntsen D, 2002, PSYCHOL AGING, V17, P636, DOI 10.1037//0882-7974.17.4.636; Berntsen D, 1996, APPL COGNITIVE PSYCH, V10, P435, DOI 10.1002/(SICI)1099-0720(199610)10:5<435::AID-ACP408>3.0.CO;2-L; Berntsen D, 2013, J EXP PSYCHOL GEN, V142, P426, DOI 10.1037/a0029128; Berntsen D, 2008, CONSCIOUS COGN, V17, P1093, DOI 10.1016/j.concog.2008.03.001; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Kvavilashvili L, 2004, COGNITIVE PSYCHOL, V48, P47, DOI 10.1016/S0010-0285(03)00115-4; Kvavilashvili L., 2007, INVOLUNTARY MEMORY, P87, DOI DOI 10.1002/9780470774069.CH5; Kvavilashvili L, 2011, MEMORY, V19, P331, DOI 10.1080/09658211.2011.568495; Mace JH, 2005, MEMORY, V13, P874, DOI 10.1080/09658210444000485; Mace JH, 2004, APPL COGNITIVE PSYCH, V18, P893, DOI 10.1002/acp.1020; Mace JH, 2003, AM J PSYCHOL, V116, P281, DOI 10.2307/1423581; Mace JH., 2007, INVOLUNTARY MEMORY N; Mazzoni G, 2009, 50 ANN M PSYCH SOC; Rasmussen AS, 2011, CONSCIOUS COGN, V20, P1842, DOI 10.1016/j.concog.2011.07.010; Schlagman S, 2008, MEM COGNITION, V36, P920, DOI 10.3758/MC.36.5.920; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Smallwood J, 2008, MEM COGNITION, V36, P1144, DOI 10.3758/MC.36.6.1144	22	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e89582	10.1371/journal.pone.0089582	http://dx.doi.org/10.1371/journal.pone.0089582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24717536	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000006
J	Kim, M; Kim, M				Kim, Minsung; Kim, Minki			Group-Wise Herding Behavior in Financial Markets: An Agent-Based Modeling Approach	PLOS ONE			English	Article							DYNAMICS	In this paper, we shed light on the dynamic characteristics of rational group behaviors and the relationship between monetary policy and economic units in the financial market by using an agent-based model (ABM), the Hurst exponent, and the Shannon entropy. First, an agent-based model is used to analyze the characteristics of the group behaviors at different levels of irrationality. Second, the Hurst exponent is applied to analyze the characteristics of the trend-following irrationality group. Third, the Shannon entropy is used to analyze the randomness and unpredictability of group behavior. We show that in a system that focuses on macro-monetary policy, steep fluctuations occur, meaning that the medium-level irrationality group has the highest Hurst exponent and Shannon entropy among all of the groups. However, in a system that focuses on micro-monetary policy, all group behaviors follow a stable trend, and the medium irrationality group thus remains stable, too. Likewise, in a system that focuses on both micro- and macro-monetary policies, all groups tend to be stable. Consequently, we find that group behavior varies across economic units at each irrationality level for micro- and macro-monetary policy in the financial market. Together, these findings offer key insights into monetary policy.	[Kim, Minsung] Korea Adv Inst Sci & Technol, Grad Sch Innovat & Technol Management, Taejon 305701, South Korea; [Kim, Minki] Korea Adv Inst Sci & Technol, Grad Sch Management, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, M (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Innovat & Technol Management, Taejon 305701, South Korea.	einestrella@naver.com	Kim, Minki/C-1851-2011					[Anonymous], 2009, NATURE, V460, P667, DOI 10.1038/460667a; [Anonymous], 2010, ECONOMIST; Avery C, 1998, AM ECON REV, V88, P724; Bernanke B, 2000, NATL BUREAU EC RES I, V7559; Bernanke BS, 2001, AM ECON REV, V91, P253, DOI 10.1257/aer.91.2.253; Bouchaud J. P., 2000, THEORY FINANCIAL RIS; Brunnermeier M. K., 2001, ASSET PRICING ASYMME; Caginalp G, 2008, J ECON BEHAV ORGAN, V66, P641, DOI 10.1016/j.jebo.2006.01.011; Caginalp G, 2007, PHYSICA D, V225, P43, DOI 10.1016/j.physd.2006.09.036; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chari VV, 2004, J ECON THEORY, V119, P128, DOI 10.1016/S0022-0531(03)00225-4; Christiano L, 2008, EUROPEAN CENTRAL BAN, V955; Cont R, 2000, MACROECON DYN, V4, P170; Corazza M., 2002, MULTINATL FINANC J, V6, P65, DOI [DOI 10.17578/6-2-1, 10.17578/6-2-1]; Curseu PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056454; da Silva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034371; Duran A, 2005, P IASTED INT C SOFTW, V467, P28; Duran A, 2011, APPL MATH LETT, V24, P471, DOI 10.1016/j.aml.2010.10.044; Gaballo G, 2012, GOOD LUCK GOOD POLIC; Gawronski P, 2011, COMPUT PHYS COMMUN, V182, P1924, DOI 10.1016/j.cpc.2011.03.005; Gilchrist S, 2002, J MONETARY ECON, V49, P75, DOI 10.1016/S0304-3932(01)00093-9; Graham C., 2002, HAPPINESS HARDSHIP O; Grech D, 2004, PHYSICA A, V336, P133, DOI 10.1016/j.physa.2004.01.018; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Henein CM, 2007, PHYSICA A, V373, P694, DOI 10.1016/j.physa.2006.06.023; Hertz H. R., 1887, ANN PHYS-NEW YORK, V267, P983, DOI [10.1002/andp.18872670827, DOI 10.1002/ANDP.18872670827]; Horvatic D, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18007; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Keynes John Maynard, 2007, GEN THEORY EMPLOYMEN; Kirkpatrick C., 2011, TECHNICAL ANAL COMPL; Loisel O, 2012, 413 BANQ FRANC; Mandelbrot B, 1997, FRACTALS SCALING FIN; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Minsky HymanPhilip., 1992, JEROME LEVY EC I WOR, Vvol. 74; Nicolis SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018901; Page S, 2008, NEW PALGRAVE DICT EC; Podobnik B, 2011, P NATL ACAD SCI USA, V108, P17883, DOI 10.1073/pnas.1113330108; Prechter R.R., 1999, WAVE PRINCIPLE HUMAN; Sales-Pardo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058989; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shao J, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/48001; Shefrin Hersh, 2000, GREED FEAR UNDERSTAN; Shiller R. J., 2000, IRRATIONAL EXUBERANC, DOI 10.1515/9781400865536; Solomon S, 1999, COMPUT PHYS COMMUN, V121, P161, DOI 10.1016/S0010-4655(99)00304-5; Tawney GA, 1905, PSYCHOL BULL, V2, P329, DOI 10.1037/h0072490; Testfatsion L, 2006, HDB COMPUTATIONAL EC, V2; Vissing-Jorgensen A, 2004, PERSPECTIVES BEHAV F; Yang JS, 2008, EUR PHYS J B, V61, P241, DOI 10.1140/epjb/e2008-00050-0; Zhou WX, 2007, EUR PHYS J B, V55, P175, DOI 10.1140/epjb/e2006-00391-6	50	2	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93661	10.1371/journal.pone.0093661	http://dx.doi.org/10.1371/journal.pone.0093661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714635	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900042
J	Wei, CY; Xiao, TF; Zhang, P; Wang, ZS; Chen, XW; Zhang, LH; Yao, MX; Chen, RS; Wang, H				Wei, Chunyan; Xiao, Tengfei; Zhang, Peng; Wang, Zhensheng; Chen, Xiaowei; Zhang, Lianhui; Yao, Meixue; Chen, Runsheng; Wang, Heng			Deep Profiling of the Novel Intermediate-Size Noncoding RNAs in Intraerythrocytic Plasmodium falciparum	PLOS ONE			English	Article							SYSTEMATIC IDENTIFICATION; COMPARATIVE GENOMICS; MALARIA PARASITES; ANTISENSE RNA; TRANSCRIPTOME; FEATURES; REVEALS; INTERFERENCE; EXPRESSION; SEQUENCES	Intermediate-size noncoding RNAs (is-ncRNAs) have been shown to play important regulatory roles in the development of several eukaryotic organisms. However, they have not been thoroughly explored in Plasmodium falciparum, which is the most virulent malaria parasite infecting human being. By using Illumina/Solexa paired-end sequencing of an is-ncRNA-specific library, we performed a systematic identification of novel is-ncRNAs in intraerythrocytic P. falciparum, strain 3D7. A total of 1,198 novel is-ncRNA candidates, including antisense, intergenic, and intronic is-ncRNAs, were identified. Bioinformatics analyses showed that the intergenic is-ncRNAs were the least conserved among different Plasmodium species, and antisense is-ncRNAs were more conserved than their sense counterparts. Twenty-two novel snoRNAs were identified, and eight potential novel classes of P. falciparum is-ncRNAs were revealed by clustering analysis. The expression of randomly selected novel is-ncRNAs was confirmed by RT-PCR and northern blotting assays. An obvious different expressional profile of the novel is-ncRNA between the early and late intraerythrocytic developmental stages of the parasite was observed. The expression levels of the antisense RNAs correlated with those of their cis-encoded sense RNA counterparts, suggesting that these is-ncRNAs are involved in the regulation of gene expression of the parasite. In conclusion, we accomplished a deep profiling analysis of novel is-ncRNAs in P. falciparum, analysed the conservation and structural features of these novel is-ncRNAs, and revealed their differential expression patterns during the development of the parasite. These findings provide important information for further functional characterisation of novel is-ncRNAs during the development of P. falciparum.	[Wei, Chunyan; Wang, Zhensheng; Zhang, Lianhui; Yao, Meixue; Wang, Heng] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100730, Peoples R China; [Wei, Chunyan; Wang, Zhensheng; Zhang, Lianhui; Yao, Meixue; Wang, Heng] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Xiao, Tengfei; Zhang, Peng; Chen, Xiaowei; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Lab Bioinformat & Noncoding RNA, Beijing 100080, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, RS (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Bioinformat & Noncoding RNA, Beijing 100080, Peoples R China.	crs@sun5.ibp.ac.cn; hengwang@pumc.edu.cn			National Basic Research Program of China [2007CB513100]; National Science Foundation of China [30700761]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China [2007CB513100] and the National Science Foundation of China [30700761]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Arisue N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017775; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chakrabarti K, 2007, RNA, V13, P1923, DOI 10.1261/rna.751807; Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206; Frazer KA, 2001, GENOME RES, V11, P1651, DOI 10.1101/gr.198201; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Gilmore SJ, 2012, AUSTRALAS J DERMATOL, V54, P1; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Goodrich JA, 2009, CRIT REV BIOCHEM MOL, V44, P3, DOI [10.1080/10409230802593995, 10.1080/10409230802593995 ]; Gunasekera AM, 2004, MOL BIOCHEM PARASIT, V136, P35, DOI 10.1016/j.molbiopara.2004.02.007; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Hertel J, 2008, BIOINFORMATICS, V24, P158, DOI 10.1093/bioinformatics/btm464; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee C, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-37; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li AQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048066; Li DD, 2011, NUCLEIC ACIDS RES, V39, P3792, DOI 10.1093/nar/gkq1317; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mishra PC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-68; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Mu JB, 2010, CURR GENOMICS, V11, P279, DOI 10.2174/138920210791233081; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Raabe CA, 2010, NUCLEIC ACIDS RES, V38, P608, DOI 10.1093/nar/gkp895; Radfar A, 2009, NAT PROTOC, V4, P1899, DOI 10.1038/nprot.2009.198; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Rathjen T, 2006, FEBS LETT, V580, P5185, DOI 10.1016/j.febslet.2006.08.063; Rougeulle C, 2002, TRENDS GENET, V18, P434, DOI 10.1016/S0168-9525(02)02749-X; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schattner P, 2004, NUCLEIC ACIDS RES, V32, P4281, DOI 10.1093/nar/gkh768; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silva JC, 2011, PARASITOLOGY, V138, P1737, DOI 10.1017/S0031182010001575; Sims JS, 2009, EUKARYOT CELL, V8, P327, DOI 10.1128/EC.00340-08; Spadafora C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-96; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang YF, 2011, NUCLEIC ACIDS RES, V39, P5203, DOI 10.1093/nar/gkr102; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Xiao TF, 2012, RNA, V18, P626, DOI 10.1261/rna.030965.111; Xue XY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-47; Yan DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021652; Zhang Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-61; Zhang Y, 2009, NUCLEIC ACIDS RES, V37, P6562, DOI 10.1093/nar/gkp704	60	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92946	10.1371/journal.pone.0092946	http://dx.doi.org/10.1371/journal.pone.0092946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713982	Green Published, gold			2022-12-27	WOS:000334160900010
J	Evans, DW; Kleinpeter, FL; Slane, MM; Boomer, KB				Evans, David W.; Kleinpeter, F. Lee; Slane, Mylissa M.; Boomer, K. B.			Adaptive and Maladaptive Correlates of Repetitive Behavior and Restricted Interests in Persons with Down Syndrome and Developmentally-Matched Typical Children: A Two-Year Longitudinal Sequential Design	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; PRADER-WILLI-SYNDROME; CHILDHOOD RITUALS; AUTISM; STEREOTYPIES; ANNOTATION; MODELS	We examined the course of repetitive behavior and restricted interests (RBRI) in children with and without Down syndrome (DS) over a two-year time period. Forty-two typically-developing children and 43 persons with DS represented two mental age (MA) levels: `` younger'' 2-4 years; `` older'' 5-11 years. For typically developing younger children some aspects of RBRI increased from Time 1 to Time 2. In older children, these aspects remained stable or decreased over the two-year period. For participants with DS, RBRI remained stable or increased over time. Time 1 RBRI predicted Time 2 adaptive behavior (measured by the Vineland Scales) in typically developing children, whereas for participants with DS, Time 1 RBRI predicted poor adaptive outcome (Child Behavior Checklist) at Time 2. The results add to the body of literature examining the adaptive and maladaptive nature of repetitive behavior.	[Evans, David W.; Slane, Mylissa M.] Geisinger Bucknell Autism & Dev Med Inst, Dev Neuropsychol Lab, Lewisburg, PA 17837 USA; [Evans, David W.] Bucknell Univ, Dept Neurosci, Lewisburg, PA 17837 USA; [Kleinpeter, F. Lee] River Parishes Community Coll, Dept Psychol, Sorrento, LA USA; [Boomer, K. B.] Bucknell Univ, Dept Math, Lewisburg, PA 17837 USA	Bucknell University; Bucknell University	Evans, DW (corresponding author), Geisinger Bucknell Autism & Dev Med Inst, Dev Neuropsychol Lab, Lewisburg, PA 17837 USA.	dwevans@bucknell.edu						Achenbach T. M., 1991, MANUAL SELF REPORT 1; [Anonymous], 1928, INFANCY HUMAN GROWTH; [Anonymous], 1974, INFANT CHILD CULTURE; Berkson G, 2002, AM J MENT RETARD, V107, P468, DOI 10.1352/0895-8017(2002)107<0468:EDOSAS>2.0.CO;2; Bishop SL, 2006, CHILD NEUROPSYCHOL, V12, P247, DOI 10.1080/09297040600630288; Bodfish JW, 2000, J AUTISM DEV DISORD, V30, P237, DOI 10.1023/A:1005596502855; Bolton D, 1996, J CHILD PSYCHOL PSYC, V37, P131, DOI 10.1111/j.1469-7610.1996.tb01384.x; Bolton D, 2002, BRIT J DEV PSYCHOL, V20, P479, DOI 10.1348/026151002760390819; Boyd BA, 2010, AUTISM RES, V3, P78, DOI 10.1002/aur.124; Boyd BA, 2009, RES AUTISM SPECT DIS, V3, P959, DOI 10.1016/j.rasd.2009.05.003; Cevikaslan A, 2013, CHILD PSYCHIAT HUMAN; CICCHETTI D, 1984, CHILD DEV, V55, P1, DOI 10.2307/1129830; DULANEY S, 1994, ETHOS, V22, P243, DOI 10.1525/eth.1994.22.3.02a00010; Dykens E, 2003, CNS DRUGS, V17, P167, DOI 10.2165/00023210-200317030-00003; Eilam D, 2006, NEUROSCI BIOBEHAV R, V30, P456, DOI 10.1016/j.neubiorev.2005.08.003; Esbensen AJ, 2009, J AUTISM DEV DISORD, V39, P57, DOI 10.1007/s10803-008-0599-x; Evans DA, 2000, S DAK REV, V38, P21; Evans DW, 2011, BEHAV BRAIN RES, V224, P174, DOI 10.1016/j.bbr.2011.05.025; Evans DW, 1997, CHILD DEV, V68, P58, DOI 10.2307/1131925; Evans DW, 2004, BRAIN COGNITION, V55, P220, DOI 10.1016/s0278-2626(03)00274-4; Evans DW, 2002, CHILD PSYCHIAT HUM D, V33, P43, DOI 10.1023/A:1016516205827; Evans DW, 1999, CHILD PSYCHIAT HUM D, V29, P261, DOI 10.1023/A:1021392931450; Evans DW, 2000, CHILD DEV, V71, P288, DOI 10.1111/1467-8624.00144; Evans DW, 2006, DEV PSYCHOPATHOL, P404; Fiske AP, 1997, J NERV MENT DIS, V185, P211, DOI 10.1097/00005053-199704000-00001; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; Garner JP, 2003, ANIM BEHAV, V66, P711, DOI 10.1006/anbe.2002.2254; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Glenn S, 2007, INTELLECT DEV DISAB, V45, P246, DOI 10.1352/1934-9556(2007)45[246:TOPRAC]2.0.CO;2; Greaves N, 2005, J INTELL DISABIL RES, V50, P92; Janowsky J, 1996, 5 7 YEAR SHIFT AGE R; Judge P, 2011, BEHAV BRAIN RES, V222, P54; Kagan J., 1981, 2 YEAR; King R, 1991, PATHWAYS GROWTH ESSE; Leekam S, 2007, J CHILD PSYCHOL PSYC, V48, P1131, DOI 10.1111/j.1469-7610.2007.01778.x; Leekam SR, 2011, PSYCHOL BULL, V137, P562, DOI 10.1037/a0023341; LEONARD HL, 1990, J AM ACAD CHILD PSY, V29, P17, DOI 10.1097/00004583-199001000-00004; Lewis M, 2009, J NEURODEV DISORD, V1, P114, DOI 10.1007/s11689-009-9019-6; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Marks I, 1987, FEARS PHOBIAS RITUAL; Militerni R, 2002, EUR CHILD ADOLES PSY, V11, P210, DOI 10.1007/s00787-002-0279-x; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Moss J, 2009, J AUTISM DEV DISORD, V39, P572, DOI 10.1007/s10803-008-0655-6; NILER ER, 1989, BEHAV RES THER, V27, P213, DOI 10.1016/0005-7967(89)90039-9; Piaget J., 1952, ORIGINS INTELLIGENCE; Pietrefesa AS, 2007, BRAIN COGNITION, V65, P36, DOI 10.1016/j.bandc.2006.02.007; Schultz RT, 1999, CHILD ADOL PSYCH CL, V8, P513; South M, 2007, AUTISM, V11, P437, DOI 10.1177/1362361307079606; Sparrow S. S., 2016, VINELAND ADAPTIVE BE, V3rd; Sparrow S.S., 1993, VINELAND SCREENER OV; THELEN E, 1979, ANIM BEHAV, V27, P699, DOI 10.1016/0003-3472(79)90006-X; Tregay J, 2009, BRIT J DEV PSYCHOL, V27, P283, DOI 10.1348/026151008X299737; Turner M, 1999, J CHILD PSYCHOL PSYC, V40, P839, DOI 10.1111/1469-7610.00502; Werner H., 1948, COMP PSYCHOL MENTAL; White SH, 1996, 5 7 YEAR SHIFT AGE R; Wigren M, 2003, J INTELL DISABIL RES, V47, P428, DOI 10.1046/j.1365-2788.2003.00515.x; Zelazo P., 1997, ANN CHILD DEV RES AN, V12, P119; ZIGLER E, 1967, SCIENCE, V155, P292, DOI 10.1126/science.155.3760.292; Zohar AH, 1997, J CHILD PSYCHOL PSYC, V38, P993, DOI 10.1111/j.1469-7610.1997.tb01616.x	60	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93951	10.1371/journal.pone.0093951	http://dx.doi.org/10.1371/journal.pone.0093951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710387	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800075
J	Souza-Silva, FA; Torres, LM; Santos-Alves, JR; Tang, ML; Sanchez, BAM; Sousa, TN; Fontes, CJF; Nogueira, PA; Rocha, RS; Brito, CFA; Adams, JH; Kano, FS; Carvalho, LH				Souza-Silva, Flavia A.; Torres, Leticia M.; Santos-Alves, Jessica R.; Tang, Michaelis Loren; Sanchez, Bruno A. M.; Sousa, Tais N.; Fontes, Cor J. F.; Nogueira, Paulo A.; Rocha, Roberto S.; Brito, Cristiana F. A.; Adams, John H.; Kano, Flora S.; Carvalho, Luzia H.			Duffy Antigen Receptor for Chemokine (DARC) Polymorphisms and Its Involvement in Acquisition of Inhibitory Anti-Duffy Binding Protein II (DBPII) Immunity	PLOS ONE			English	Article							PLASMODIUM-VIVAX; NEGATIVE INDIVIDUALS; MALARIA; ANTIBODIES; EXPRESSION; IDENTIFICATION; INVASION; GENE; TRANSMISSION; INFECTION	The Plasmodium vivax Duffy binding protein (PvDBP) and its erythrocytic receptor, the Duffy antigen receptor for chemokines (DARC), are involved in the major P. vivax erythrocyte invasion pathway. An open cohort study to analyze DARC genotypes and their relationship to PvDBP immune responses was carried out in 620 volunteers in an agricultural settlement of the Brazilian Amazon. Three cross-sectional surveys were conducted at 6-month intervals, comprising 395, 410, and 407 subjects, respectively. The incidence rates of P. vivax infection was 2.32 malaria episodes per 100 person-months under survey (95% confidence interval [CI] of 1.92-2.80/100 person-month) and, of P. falciparum, 0.04 per 100 person-months (95% CI of 0.007-0.14/100 person-month). The distribution of DARC genotypes was consistent with the heterogeneous ethnic origins of the Amazon population, with a predominance of non-silent DARC alleles:FY*A > FY*B. The 12-month follow-up study demonstrated no association between DARC genotypes and total IgG antibodies as measured by ELISA targeting PvDBP (region II, DBPII or regions II-IV, DBPII-IV). The naturally acquired DBPII specific binding inhibitory antibodies (BIAbs) tended to be more frequent in heterozygous individuals carrying a DARC-silent allele (FY*B-ES). These results provide evidence that DARC polymorphisms may influence the naturally acquired inhibitory anti-Duffy binding protein II immunity.	[Souza-Silva, Flavia A.; Torres, Leticia M.; Santos-Alves, Jessica R.; Tang, Michaelis Loren; Sousa, Tais N.; Rocha, Roberto S.; Brito, Cristiana F. A.; Kano, Flora S.; Carvalho, Luzia H.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [Sanchez, Bruno A. M.] Univ Fed Mato Grosso, Sinop, MT, Brazil; [Fontes, Cor J. F.] Univ Fed Mato Grosso, Julio Muller Univ Hosp, Cuiaba, MT, Brazil; [Nogueira, Paulo A.] FIOCRUZ Amazonia, Ctr Pesquisas Leonidas & Maria Deane, Manaus, AM, Brazil; [Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL USA	Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Fundacao Oswaldo Cruz; State University System of Florida; University of South Florida	Carvalho, LH (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.	lhcarvalho@cpqrr.fiocruz.br	Sanchez, Bruno A M/F-8543-2017; Fontes, Cor JF/G-7331-2018; Kano, Flora/N-7749-2017; Kano, Flora S./AAS-3215-2020; Nogueira, Paulo/AAK-8822-2020; Adams, John/G-1800-2015; de Sousa, Tais Nobrega/AAG-6225-2019; Carvalho, Luzia H/AAW-3461-2021; Adams, John H./ABB-8458-2020	Fontes, Cor JF/0000-0003-2756-0588; Kano, Flora/0000-0002-2364-9772; Nogueira, Paulo/0000-0001-9677-7225; Adams, John/0000-0003-3707-7979; de Sousa, Tais Nobrega/0000-0002-6874-9427; Adams, John H./0000-0003-3707-7979; Sanchez, Bruno Antonio Marinho/0000-0001-9097-0112	Research Foundation of Minas Gerais State (FAPEMIG); Research Foundation of Amazonas State (FAPEAM); Brazilian National Research Council (CNPq); Oswaldo Cruz Foundation (FIOCRUZ, PAPES VI); Malaria Network/Support Program for Centers of Excellence - Pronex Malaria/CNPq/DECIT/MS; CAPES; PIBIC/Fiocruz; CNPq; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478] Funding Source: NIH RePORTER	Research Foundation of Minas Gerais State (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Research Foundation of Amazonas State (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation (FIOCRUZ, PAPES VI); Malaria Network/Support Program for Centers of Excellence - Pronex Malaria/CNPq/DECIT/MS; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PIBIC/Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Research Foundation of Minas Gerais State (FAPEMIG), Research Foundation of Amazonas State (FAPEAM), The Brazilian National Research Council (CNPq), Oswaldo Cruz Foundation (FIOCRUZ, PAPES VI) and Malaria Network/Support Program for Centers of Excellence - Pronex Malaria/CNPq/DECIT/MS; scholarships from CAPES (FAS, LMT), PIBIC/Fiocruz (JRS, MLT), CNPq (LHC, CJFF, CFAB) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Afenyi-Annan A, 2008, TRANSFUSION, V48, P917, DOI 10.1111/j.1537-2995.2007.01622.x; Badakere S S, 1970, Indian J Med Sci, V24, P562; Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Ceravolo IP, 2005, AM J TROP MED HYG, V72, P675, DOI 10.4269/ajtmh.2005.72.675; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; FANG XD, 1991, MOL BIOCHEM PARASIT, V44, P125, DOI 10.1016/0166-6851(91)90228-X; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; IWAMOTO S, 1995, BLOOD, V85, P622, DOI 10.1182/blood.V85.3.622.bloodjournal853622; Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200; Kano FS, 2012, TROP MED INT HEALTH, V17, P989, DOI 10.1111/j.1365-3156.2012.03016.x; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; King CL, 2011, P NATL ACAD SCI USA, V108, P20113, DOI 10.1073/pnas.1109621108; Maestre A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011437; MALLINSON G, 1995, BRIT J HAEMATOL, V90, P823, DOI 10.1111/j.1365-2141.1995.tb05202.x; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Moise KJ, 2000, EUR J OBSTET GYN R B, V92, P75, DOI 10.1016/S0301-2115(00)00428-0; Ntumngia FB, 2012, INFECT IMMUN, V80, P1203, DOI 10.1128/IAI.05924-11; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Sampath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003420; Smolarek D, 2010, TRANSFUS CLIN BIOL, V17, P184, DOI 10.1016/j.tracli.2010.05.003; Sousa TN, 2007, VOX SANG, V92, P373, DOI 10.1111/j.1423-0410.2007.00902.x; Souza-Silva FA, 2010, AM J TROP MED HYG, V82, P185, DOI 10.4269/ajtmh.2010.08-0580; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Walton RT, 2008, CELL HOST MICROBE, V4, P3, DOI 10.1016/j.chom.2008.06.006; WEINSTEIN L, 1975, AM J OBSTET GYNECOL, V121, P643, DOI 10.1016/0002-9378(75)90467-6; Woolley I J, 2009, Immunohematology, V25, P63; Woolley IJ, 2000, TRANSFUSION, V40, P949, DOI 10.1046/j.1537-2995.2000.40080949.x; Xainli J, 2003, INFECT IMMUN, V71, P2508, DOI 10.1128/IAI.71.5.2508-2515.2003; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	49	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93782	10.1371/journal.pone.0093782	http://dx.doi.org/10.1371/journal.pone.0093782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710306	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800051
J	Tang, WF; Qiu, H; Jiang, HP; Sun, B; Wang, LX; Yin, J; Gu, HY				Tang, Weifeng; Qiu, Hao; Jiang, Heping; Sun, Bin; Wang, Lixin; Yin, Jun; Gu, Haiyong			Lack of Association between Cytotoxic T-lymphocyte Antigen 4 (CTLA-4)-1722T/C (rs733618) Polymorphism and Cancer Risk: From a Case-Control Study to a Meta-Analysis	PLOS ONE			English	Article							LUPUS-ERYTHEMATOSUS SLE; -1722T/C POLYMORPHISM; GENE VARIATIONS; CTLA4 GENE; SUSCEPTIBILITY; VARIANTS; PROMOTER	Background: The association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) gene -1722T/C polymorphism (rs733618) and cancer has been widely assessed, and a definitive conclusion remains elusive. We first performed a hospital based casecontrol study to measure this association of esophageal cancer with CTLA-4 -1722T/C polymorphism in Han Chinese population, and then carried out a meta-analysis to obtain a comprehensive evaluation for this issue. Methodology/Principal Findings: This case-control study involved 629 esophageal squamous cell carcinoma (ESCC) cases and 686 age and gender well matched cancer-free controls. PCR-LDR (polymerase chain reaction-ligase detection reactions) method was used to identify genotypes. Meta-analysis was conducted by STATA (v12.0) software. This case-control study showed no significant difference in the genotype and allele distributions of CTLA-4 -1722T/C polymorphism between esophageal cancer cases and control subjects, in accord with the findings of the further meta-analysis in all genetic models. Evidence of large heterogeneity was observed among all eligible studies in the recessive model. Further subgroup analyses by ethnicity, cancer type and system, detected null associations in this meta-analysis. Conclusion: This case-control study and the further meta-analysis, failed to identify the association between CTLA-4 -1722T/C polymorphism and cancer risk.	[Tang, Weifeng; Sun, Bin; Yin, Jun; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Qiu, Hao; Wang, Lixin] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Jiang, Heping] Jiangsu Univ, Affiliated Jintan Peoples Hosp, Dept Resp Dis, Jintan, Peoples R China	Jiangsu University; Southeast University - China; Jiangsu University	Yin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China.	yin912@126.com; haiyong_gu@hotmail.com	Qiu, Hao/HGU-4490-2022		Jiangsu University Clinical medicine science and technology development fund [JLY20120004]; National Natural Science Foundation of China [81370001, 81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; Social Development Foundation of Zhenjiang [SH2010017]; Changzhou Young Talents and Science-Technology Foundation of Health Bureau [QN201102]; Affiliated People's Hospital of Jiangsu University fund [Y200913]	Jiangsu University Clinical medicine science and technology development fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhenjiang; Changzhou Young Talents and Science-Technology Foundation of Health Bureau; Affiliated People's Hospital of Jiangsu University fund	This study was supported by Jiangsu University Clinical medicine science and technology development fund (JLY20120004), National Natural Science Foundation of China (81370001, 81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Social Development Foundation of Zhenjiang (SH2010017), Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102) and Affiliated People's Hospital of Jiangsu University fund (Y200913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti V, 2013, HUM IMMUNOL, V74, P348, DOI 10.1016/j.humimm.2012.12.008; Chen Shui-lian, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P1320; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Erfani N, 2006, CANCER GENET CYTOGEN, V165, P114, DOI 10.1016/j.cancergencyto.2005.07.020; Geng R, 2013, TUMOUR BIOL; Hadinia A, 2007, J GASTROEN HEPATOL, V22, P2283, DOI 10.1111/j.1440-1746.2007.04862.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu LM, 2010, HUM IMMUNOL, V71, P888, DOI 10.1016/j.humimm.2010.05.023; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang Li, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P313, DOI 10.3760/cma.j.issn.1003-9406.2011.03.017; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; Khaghanzadeh N, 2010, CANCER GENET CYTOGEN, V196, P171, DOI 10.1016/j.cancergencyto.2009.09.001; Li DL, 2012, MOL CELL BIOCHEM, V364, P283, DOI 10.1007/s11010-012-1228-8; Li Heng, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P282; Liu J, 2013, HUM IMMUNOL, V74, P341, DOI 10.1016/j.humimm.2012.12.009; Liu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027301; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Rahimifar S, 2010, GYNECOL ONCOL, V119, P136, DOI 10.1016/j.ygyno.2010.06.006; Reeves GK, 2012, INT J CANCER, V131, P930, DOI 10.1002/ijc.26460; Scheipers P, 1998, P NATL ACAD SCI USA, V95, P10083, DOI 10.1073/pnas.95.17.10083; [宋继权 SONG Jiquan], 2006, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V23, P1373; Sun T, 2008, CANCER RES, V68, P7025, DOI 10.1158/0008-5472.CAN-08-0806; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vandenborre K, 1999, IMMUNOLOGY, V98, P413, DOI 10.1046/j.1365-2567.1999.00888.x; Welsh MM, 2009, CANCER RES, V69, P6158, DOI 10.1158/0008-5472.CAN-09-0415; Yuqin Q, 2012, CHIN CLIN ONCOL, V17, P828; Zhai JX, 2013, MOL BIOL REP, V40, P5213, DOI 10.1007/s11033-012-2125-7; Zhang YG, 2011, CANCER-AM CANCER SOC, V117, P4312, DOI 10.1002/cncr.25979; Zhu JM, 2013, IMMUNOL INVEST, V42, P91, DOI 10.3109/08820139.2012.724752	29	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94039	10.1371/journal.pone.0094039	http://dx.doi.org/10.1371/journal.pone.0094039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710335	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800093
J	Zhang, N; Van Crombruggen, K; Holtappels, G; Lan, F; Katotomichelakis, M; Zhang, L; Hogger, P; Bachert, C				Zhang, Nan; Van Crombruggen, Koen; Holtappels, Gabriele; Lan, Feng; Katotomichelakis, Michail; Zhang, Luo; Hogger, Petra; Bachert, Claus			Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo	PLOS ONE			English	Article							HUMAN RECEPTOR KINETICS; ALLERGIC RHINITIS; INTRANASAL CORTICOSTEROIDS; STAPHYLOCOCCUS-AUREUS; PROPIONATE; SECRETION; AFFINITY; THERAPY; SPRAY; CELLS	Background: Topical glucocorticosteroids are the first line therapy for airway inflammation. Modern compounds with higher efficacy have been developed, but head-to-head comparison studies are sparse. Objective: To compare the activity of two intranasal glucocorticoids, fluticasone furoate (FF) and mometasone furoate (MF) with respect to the inhibition of T helper (Th)1, Th2 and Th17 cytokine release in airway mucosa. Methods: We used an ex-vivo human nasal mucosal tissue model and employed pre-and post-Staphylococcus aureus enterotoxin B (SEB)-challenge incubations with various time intervals and drug concentrations to mimic typical clinical situations of preventive or therapeutic use. Results: At a fixed concentration of 10(-10) M, FF had significantly higher suppressive effects on interferon (IFN)-gamma,interleukin (IL)-2 and IL-17 release, but not IL-5 or tumor necrosis factor (TNF)-alpha, vs. MF. While the maximal suppressive activity was maintained when FF was added before or after tissue stimulation, the cytokine suppression capacity of MF appeared to be compromised when SEB-induced cell activation preceded the addition of the drug. In a pre-challenge incubation setting with removal of excess drug concentrations, MF approached inhibition of IL-5 and TNF-alpha after 6 and 24 hours while FF maximally blocked the release of these cytokines right after pre-incubation. Furthermore, FF suppressed a wider range of T helper cytokines compared to MF. Conclusion: The study demonstrates the potential of our human mucosal model and shows marked differences in the ability to suppress the release of various cytokines in pre-and post-challenge settings between FF and MF mimicking typical clinical situations of preventive or therapeutic use.	[Zhang, Nan; Van Crombruggen, Koen; Holtappels, Gabriele; Lan, Feng; Bachert, Claus] Ghent Univ Hosp, Upper Airway Res Lab, Ghent, Belgium; [Katotomichelakis, Michail] Democritus Univ Thrace, Sch Med, Dept Otorhinolaryngol, Alexandroupolis, Greece; [Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Hogger, Petra] Univ Wurzburg, Inst Pharm & Food Chem, D-97070 Wurzburg, Germany; [Bachert, Claus] Karolinska Inst, Div ENT Dis, Stockholm, Sweden	Ghent University; Ghent University Hospital; Democritus University of Thrace; Capital Medical University; University of Wurzburg; Karolinska Institutet	Zhang, N (corresponding author), Ghent Univ Hosp, Upper Airway Res Lab, Ghent, Belgium.	nan.zhang@ugent.be	Katotomichelakis, Michael/AAL-7657-2021; Zhang, Nan/AAQ-3944-2020; Bachert, Claus/J-8825-2012	Zhang, Luo/0000-0002-0910-9884	GlaxoSmithKline Belgium; Flemish Scientific Research Board, FWO [G.0436.04, 3G.048.09, G.0642.10N, G.0641.10]; Global Allergy and Asthma European Network (GA2LEN); European Commission [260895]; Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy [IAP P7/30]	GlaxoSmithKline Belgium(GlaxoSmithKline); Flemish Scientific Research Board, FWO(FWO); Global Allergy and Asthma European Network (GA2LEN); European Commission(European CommissionEuropean Commission Joint Research Centre); Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by an investigator initiated grant from GlaxoSmithKline Belgium and by grants to Claus Bachert from the Flemish Scientific Research Board, FWO, projects G.0436.04, 3G.048.09, G.0642.10N, G.0641.10; by the Global Allergy and Asthma European Network (GA2LEN), the European Commission's Seventh Framework programme under grant agreement No 260895 (PREDICTA), and the Interuniversity Attraction Poles Program - Belgian State Belgian Science Policy, Nr. IAP P7/30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann D, 2009, CLIN EXP ALLERGY, V39, P1540, DOI 10.1111/j.1365-2222.2009.03306.x; Biggadike K, 2011, CLIN RESPIR J, V5, P183, DOI 10.1111/j.1752-699X.2011.00244.x; Bousquet J, 2003, ALLERGY, V58, P192, DOI 10.1034/j.1398-9995.2003.00054.x; Brattsand R., 2002, LUNG BIOL HEALTH DIS, P1; Carr W, 2012, J ALLERGY CLIN IMMUN, V129, P1282, DOI 10.1016/j.jaci.2012.01.077; Cato Andrew C B, 2002, Sci STKE, V2002, pre9, DOI 10.1126/stke.2002.138.re9; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Derendorf H, 2008, ALLERGY, V63, P1292, DOI 10.1111/j.1398-9995.2008.01750.x; Duitman EH, 2011, EUR J CELL BIOL, V90, P476, DOI 10.1016/j.ejcb.2011.01.010; European Medicines Agency, 2004, GUID CLIN DEV MED PR; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Food and Drug Administration, 2000, FDA DRAFT GUID IND A; Hellings PW, 2013, ALLERGY, V68, P1, DOI 10.1111/all.12040; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Jankowski R, 2009, ALLERGY, V64, P944, DOI 10.1111/j.1398-9995.2009.01938.x; Katial RK, 2009, ALLERGY ASTHMA PROC, V30, P595, DOI 10.2500/aap.2009.30.3291; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Lowenberg M, 2006, EMBO REP, V7, P1023, DOI 10.1038/sj.embor.7400775; Marttin E, 1998, ADV DRUG DELIVER REV, V29, P13, DOI 10.1016/S0169-409X(97)00059-8; MUNCK A, 1984, J BIOL CHEM, V259, P820; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Rodrigo GJ, 2011, CLIN EXP ALLERGY, V41, P160, DOI 10.1111/j.1365-2222.2010.03654.x; Rossios C, 2011, EUR J PHARMACOL, V670, P244, DOI 10.1016/j.ejphar.2011.08.022; Valotis A, 2004, J PHARM SCI-US, V93, P1337, DOI 10.1002/jps.20049; Valotis A, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-54; Van Crombruggen K, 2012, J ALLERGY CLIN IMMUN, V129, P1515, DOI 10.1016/j.jaci.2012.02.021; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	27	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93754	10.1371/journal.pone.0093754	http://dx.doi.org/10.1371/journal.pone.0093754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710117	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800049
J	Schneikert, J; Ruppert, JG; Behrens, J; Wenzel, EM				Schneikert, Jean; Ruppert, Jan Gustav; Behrens, Juergen; Wenzel, Eva Maria			Different Roles for the Axin Interactions with the SAMP versus the Second Twenty Amino Acid Repeat of Adenomatous Polyposis Coli	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; APC TUMOR-SUPPRESSOR; BETA-CATENIN PHOSPHORYLATION; MUTATION CLUSTER REGION; COLORECTAL TUMORS; GENE-PRODUCT; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; SOMATIC MUTATIONS; CRYSTAL-STRUCTURE	Wnt signalling is prevented by the proteosomal degradation of beta-catenin, which occurs in a destruction complex containing adenomatous polyposis coli (APC), APC-like (APCL), Axin and Axin2. Truncating mutations of the APC gene result in the constitutive stabilisation of beta-catenin and the initiation of colon cancer, although tumour cells tolerate the expression of wild-type APCL. Using the colocalisation of overexpressed Axin, APC and APCL constructs as a readout of interaction, we found that Axin interacted with the second twenty amino acid repeat (20R2) of APC and APCL. This interaction involved a domain adjacent to the C-terminal DIX domain of Axin. We identified serine residues within the 20R2 of APCL that were involved in Axin colocalisation, the phosphorylation of truncated APCL and the down-regulation of beta-catenin. Our results indicated that Axin, but not Axin2, displaced APC, but not APCL, from the cytoskeleton and stimulated its incorporation into bright cytoplasmic dots that others have recognised as beta-catenin destruction complexes. The SAMP repeats in APC interact with the N-terminal RGS domain of Axin. Our data showed that a short domain containing the first SAMP repeat in truncated APC was required to stimulate Axin oligomerisation. This was independent of Axin colocalisation with 20R2. Our data also suggested that the RGS domain exerted an internal inhibitory constraint on Axin oligomerisation. Considering our data and those from others, we discuss a working model whereby beta-catenin phosphorylation involves Axin and the 20R2 of APC or APCL and further processing of phospho-beta-catenin occurs upon the oligomerisation of Axin that is induced by binding the SAMP repeats in APC.	[Schneikert, Jean; Ruppert, Jan Gustav; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Wenzel, Eva Maria] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway	University of Erlangen Nuremberg; University of Oslo	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de		Wenzel, Eva Maria/0000-0002-5561-3344	Deutsche Forschungsgemeinschaft [SCHN 1189/1-2]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to JS [SCHN 1189/1-2]. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Day CL, 2000, J MOL BIOL, V301, P147, DOI 10.1006/jmbi.2000.3895; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Gaspar C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000547; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jarrett CR, 2001, CANCER RES, V61, P7978; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kadoya T, 2000, J BIOL CHEM, V275, P37030, DOI 10.1074/jbc.M005984200; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kohler EM, 2010, ONCOGENE, V29, P1663, DOI 10.1038/onc.2009.447; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li ZY, 2008, J CELL SCI, V121, P1916, DOI 10.1242/jcs.029470; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakagawa H, 1998, CANCER RES, V58, P5176; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1997, CANCER RES, V57, P4624; Schneikert J, 2013, PLOS ONE IN PRESS; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Schneikert J, 2011, HUM MOL GENET, V20, P3554, DOI 10.1093/hmg/ddr273; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Spink KE, 2001, EMBO J, V20, P6203, DOI 10.1093/emboj/20.22.6203; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Valvezan AJ, 2012, J BIOL CHEM, V287, P3823, DOI 10.1074/jbc.M111.323337; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vijaya-Chandra SH, 2012, PLOS ONE, V7; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94413	10.1371/journal.pone.0094413	http://dx.doi.org/10.1371/journal.pone.0094413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722208	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100067
J	Theunissen, SCPM; Rieffe, C; Netten, AP; Briaire, JJ; Soede, W; Kouwenberg, M; Frijns, JHM				Theunissen, Stephanie C. P. M.; Rieffe, Carolien; Netten, Anouk P.; Briaire, Jeroen J.; Soede, Wim; Kouwenberg, Maartje; Frijns, Johan H. M.			Self-Esteem in Hearing-Impaired Children: The Influence of Communication, Education, and Audiological Characteristics	PLOS ONE			English	Article							HARD-OF-HEARING; COCHLEAR IMPLANTS; PARENTING STRESS; DEAF ADOLESCENTS; LANGUAGE; BEHAVIOR; IMPAIRMENTS; PERFORMANCE; PREVALENCE; ADJUSTMENT	Objective: Sufficient self-esteem is extremely important for psychosocial functioning. It is hypothesized that hearing-impaired (HI) children have lower levels of self-esteem, because, among other things, they frequently experience lower language and communication skills. Therefore, the aim of this study was to compare HI children's self-esteem across different domains with those of normal hearing (NH) children and to investigate the influence of communication, type of education, and audiological characteristics. Methods: This large (N = 252) retrospective, multicenter study consisted of two age-and gender-matched groups: 123 HI children and 129 NH controls (mean age = 11.8 years). Self-reports were used to measure self-esteem across four domains: perceived social acceptance by peers, perceived parental attention, perceived physical appearance, and global self-esteem. Results: HI children experienced lower levels of self-esteem regarding peers and parents than NH controls. Particularly HI children who attended special education for the deaf were at risk, even after correcting for their language development and intelligence. Yet, levels of global self-esteem and self-esteem involving physical appearance in HI children equalled those of NH controls. Furthermore, younger age at implantation and longer duration of having cochlear implants (CIs) were related to higher levels of self-esteem. Conclusion: HI children experience lower levels of self-esteem in the social domains. Yet, due to the heterogeneity of the HI population, there is high variability in levels of self-esteem. Discussion: Clinicians must always be aware of the risk and protective factors related to self-esteem in order to help individual patients reach their full potential.	[Theunissen, Stephanie C. P. M.; Netten, Anouk P.; Briaire, Jeroen J.; Soede, Wim; Frijns, Johan H. M.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands; [Rieffe, Carolien; Kouwenberg, Maartje] Leiden Univ, Dept Dev Psychol, Leiden, Netherlands; [Rieffe, Carolien] Dutch Fdn Deaf & Hard Hearing Child, Amsterdam, Netherlands; [Frijns, Johan H. M.] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Theunissen, SCPM (corresponding author), Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands.	s.c.p.m.theunissen@lumc.nl	Briaire, Jeroen/A-7972-2008; Frijns, Johan H.M./H-6249-2011	Briaire, Jeroen/0000-0003-4302-817X; Frijns, Johan H.M./0000-0002-1180-3314; Rieffe, Carolien/0000-0002-7584-6698	Netherlands Organisation for Scientific Research (NWO) [452-07-004]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Innovational Research Incentives Scheme (a VIDI grant) by The Netherlands Organisation for Scientific Research (NWO), no. 452-07-004 to Carolien Rieffe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anmyr L, 2012, INT J PEDIATR OTORHI, V76, P1107, DOI 10.1016/j.ijporl.2012.04.009; ARMSDEN GC, 1987, J YOUTH ADOLESCENCE, V16, P427, DOI 10.1007/BF02202939; BATCHAVA Y, 1993, REHABIL PSYCHOL, V38, P221, DOI 10.1037/h0080303; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; BOND M, 2009, HLTH TECHNOLOGY ASSE, V13, P1; Calderon R, 2003, SOCIAL EMOTIONAL DEV; Cappelli M, 1995, VOLTA REV, V97, P197; CATES JA, 1991, AM ANN DEAF, V136, P354, DOI 10.1353/aad.2012.0499; Cohen M.S., 1999, FAM SYST HEALTH, V17, P149, DOI DOI 10.1037/H0089879; Cole DA, 2001, CHILD DEV, V72, P1723, DOI 10.1111/1467-8624.00375; Coleman JS, 1981, ADOLESCENT SOC; DAVIS JM, 1986, J SPEECH HEAR DISORD, V51, P53, DOI 10.1044/jshd.5101.53; Donnellan MB, 2005, PSYCHOL SCI, V16, P328, DOI 10.1111/j.0956-7976.2005.01535.x; Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149; Dumont M, 1999, J YOUTH ADOLESCENCE, V28, P343, DOI 10.1023/A:1021637011732; Eriks-Brophy A, 2012, VOLTA REV, V112, P5, DOI 10.17955/tvr.112.1.694; HARPER JF, 1991, ADOLESCENCE, V26, P799; Harter S., 2015, DEV PSYCHOPATHOL, V1, P370, DOI https://doi.org/10.1002/9780470939383.ch11; Harter S, 1985, MANUAL SELF PERCEPTI; Hermans D, 2010, J DEAF STUD DEAF EDU, V15, P107, DOI 10.1093/deafed/enp030; Hintermair M, 2008, J DEAF STUD DEAF EDU, V13, P278, DOI 10.1093/deafed/enm054; Keilmann A, 2007, INT J PEDIATR OTORHI, V71, P1747, DOI 10.1016/j.ijporl.2007.07.013; Kluwin TN, 2002, J DEAF STUD DEAF EDU, V71, P1747; Kort W., 2002, WISC 3 NL; Kort W., 2008, CELF4NL PEARS ASS IN; Kouwenberg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052174; Leigh IW, 2009, J DEAF STUD DEAF EDU, V14, P244, DOI 10.1093/deafed/enn038; LOEB R, 1986, VOLTA REV, V88, P89; Most T, 2012, J DEAF STUD DEAF EDU, V17, P259, DOI 10.1093/deafed/enr049; Nunes T., 2001, DEAF EDUC INT, P123, DOI DOI 10.1179/146431501790560972; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Percy-Smith L, 2008, INT J PEDIATR OTORHI, V72, P1113, DOI 10.1016/j.ijporl.2008.03.028; Pinquart M, 2013, J PEDIATR PSYCHOL, V38, P708, DOI 10.1093/jpepsy/jst020; Polat Filiz, 2003, J Deaf Stud Deaf Educ, V8, P325, DOI 10.1093/deafed/eng018; QUITTNER AL, 1990, J PERS SOC PSYCHOL, V59, P1266, DOI 10.1037/0022-3514.59.6.1266; Quittner AL, 2010, PARENT-SCI PRACT, V10, P136, DOI 10.1080/15295190903212851; Rieffe C, 2007, COGNITION EMOTION, V21, P1630, DOI 10.1080/02699930701238495; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; RUBIN KH, 1988, J CONSULT CLIN PSYCH, V56, P916, DOI 10.1037//0022-006X.56.6.916; Sach TH, 2005, INT J AUDIOL, V44, P400, DOI 10.1080/14992020500146500; Sahli S, 2006, INT J PEDIATR OTORHI, V70, P1601, DOI 10.1016/j.ijporl.2006.05.003; SEMEL EM, 1987, CELF CLIN EVALUATION; Stinson MS, 2000, TOP LANG DISORD, V20, P58, DOI 10.1097/00011363-200020020-00006; Tellegen P., 1993, EUROPEAN J PSYCHOL A, V9, P147, DOI DOI 10.1016/J.AJHG.2016.01.016; Theunissen SC, 2013, EUR CHILD ADOLESC PS; Tomaka J., 1991, MEASURES PERSONALITY, V1; Tomblin JB, 1999, J SPEECH LANG HEAR R, V42, P497, DOI 10.1044/jslhr.4202.497; Van Dijk P, 1999, SOMATIC COMPLAINTS C, P23; Van Eldik T, 2005, AM ANN DEAF, V150, P11, DOI 10.1353/aad.2005.0024; van Gent T, 2007, J CHILD PSYCHOL PSYC, V48, P950, DOI 10.1111/j.1469-7610.2007.01775.x; van Gent T, 2012, J DEAF STUD DEAF EDU, V17, P333, DOI 10.1093/deafed/ens002; Van Gurp S, 2001, J Deaf Stud Deaf Educ, V6, P54, DOI 10.1093/deafed/6.1.54; Veerman JW, 1997, COMPETENTIEBELVINGSS; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wolters N, 2011, RES DEV DISABIL, V32, P2553, DOI 10.1016/j.ridd.2011.07.003	59	38	39	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94521	10.1371/journal.pone.0094521	http://dx.doi.org/10.1371/journal.pone.0094521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722329	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100088
J	Yao, HM; Sun, TW; Zhang, XJ; Shen, DL; Du, YY; Wan, YD; Zhang, JY; Li, L; Zhao, LS				Yao, Hai-Mu; Sun, Tong-Wen; Zhang, Xiao-Juan; Shen, De-Liang; Du, You-You; Wan, You-Dong; Zhang, Jin-Ying; Li, Ling; Zhao, Luo-Sha			Red Blood Cell Distribution Width and Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stenting Era: A Two-Year Cohort Study	PLOS ONE			English	Article							PROGNOSTIC MARKER; MORTALITY; PREDICTOR; FRAILTY; ANEMIA; RISK	Background: Previous studies suggest the higher the red blood cell distribution width (RDW) the greater the risk of mortality in patients with coronary artery disease (CAD). However, the relationship between RDW and long-term outcome in CAD patients undergoing percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) remains unclear. This study was designed to evaluate the long-term effect of RDW in patients treated with drug-eluting stent for CAD. Methods: In total of 2169 non-anemic patients (1468 men, mean age 60.2 +/- 10.9 years) with CAD who had undergone successful PCI and had at least one drug-eluting stent were included in this study. Patients were grouped according to their baseline RDW: Quartile 1 (RDW<12.27%), Quartile 2 (12.27%<= RDW<13%), Quartile 3 (13%<= RDW<13.5%), and Quartile 4 (RDW >= 13.5). Results: The incidence of in-hospital mortality and death or myocardial infarction was significantly higher in Quartiles 3 and 4 compared with Quartile 1 (P<0.05). After a follow-up of 29 months, the incidence of all-cause death and stent thrombosis in Quartile 4 was higher than in Quartiles 1, 2, and 3 (P<0.05). The incidence of death/ myocardial infarction/ stroke and cardiac death in Quartile 4 was higher than in Quartiles 1 and 2 (P<0.05). Multivariate Cox regression analysis showed that RDW was an independent predictor of all-cause death (hazard ratio (HR) = 1.37, 95% confidence interval (CI) = 1.15-1.62, P<0.001) and outcomes of death/ myocardial infarction/ stroke (HR = 1.21, 95% CI = 1.04-1.39, P = 0.013). The cumulative survival rate of Quartile 4 was lower than that of Quartiles 1, 2, and 3 (P<0.05). Conclusion: High RDW is an independent predictor of long-term adverse clinical outcomes in non-anemic patients with CAD treated with DES.	[Yao, Hai-Mu; Shen, De-Liang; Du, You-You; Zhang, Jin-Ying; Li, Ling; Zhao, Luo-Sha] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Peoples R China; [Sun, Tong-Wen; Zhang, Xiao-Juan; Wan, You-Dong] Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated ICU, Zhengzhou 450052, Peoples R China	Zhengzhou University; Zhengzhou University	Sun, TW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Integrated ICU, Zhengzhou 450052, Peoples R China.	suntongwen@163.com	li, li/AAT-2097-2020; li, li/HII-4157-2022; li, li/GPX-3938-2022; Sun, Tongwen/AAQ-7741-2020; Li, Li/AEM-3636-2022; LI, LI QING/GRR-8855-2022; LI, LI/GVS-5344-2022	zhao, luosha/0000-0002-5785-3923	National Natural Science Foundation of China [81370364]; Program for Science and Technology Innovation of Henan Province [201203035]; Health Bureau of Henan Province; Program Grant for Science & Technology Innovation Talents in Universities of Henan Province [2012HASTIT001]; Henan Provincial Science and Technology Achievement Transformation Project [122102310581]; Henan Province of Medical Scientific Province & Ministry Research Project [201301005]; Henan Province of Medical Scientific Research Project, China [201203027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science and Technology Innovation of Henan Province; Health Bureau of Henan Province; Program Grant for Science & Technology Innovation Talents in Universities of Henan Province; Henan Provincial Science and Technology Achievement Transformation Project; Henan Province of Medical Scientific Province & Ministry Research Project; Henan Province of Medical Scientific Research Project, China	This study was supported by the National Natural Science Foundation of China (Grant No. 81370364), Program for Science and Technology Innovation of Henan Province (NO. 201203035), Innovative investigators project grant from the Health Bureau of Henan Province, Program Grant for Science & Technology Innovation Talents in Universities of Henan Province (2012HASTIT001), Henan Provincial Science and Technology Achievement Transformation Project (122102310581), Henan Province of Medical Scientific Province & Ministry Research Project (201301005), Henan Province of Medical Scientific Research Project (201203027), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Saleh H, 2009, CIRCULATION, V120, P2230, DOI 10.1161/CIRCULATIONAHA.109.894642; Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; [Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; Arbel Y, 2013, J THROMB THROMBOLYSI; Arbel Y, 2014, THROMB HAEMOSTASIS, V111, P300, DOI 10.1160/TH13-07-0567; Cavusoglu E, 2010, INT J CARDIOL, V141, P141, DOI 10.1016/j.ijcard.2008.11.187; Chen PC, 2010, AM J EPIDEMIOL, V171, P214, DOI 10.1093/aje/kwp360; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dabbah S, 2010, AM J CARDIOL, V105, P312, DOI 10.1016/j.amjcard.2009.09.027; Fatemi O, 2013, AM HEART J, V166, P104, DOI 10.1016/j.ahj.2013.04.006; Fatemi O, 2013, J THROMB THROMBOLYS, V35, P57, DOI 10.1007/s11239-012-0767-x; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Klein LW, 2012, J AM COLL CARDIOL, V59, P1760, DOI 10.1016/j.jacc.2012.01.042; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Lippi G, 2009, CLIN CHEM LAB MED, V47, P353, DOI 10.1515/CCLM.2009.066; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Minetti M, 2007, CARDIOVASC RES, V75, P21, DOI 10.1016/j.cardiores.2007.03.007; Moses JW, 2008, NEW ENGL J MED, V349, P1315; Nabais Sergio, 2009, Rev Port Cardiol, V28, P905; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Poludasu S, 2009, THROMB HAEMOSTASIS, V102, P581, DOI 10.1160/TH09-02-0127; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Veeranna V, 2013, INT J CARDIOL, V168, P5156, DOI 10.1016/j.ijcard.2013.07.109; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Wang YL, 2011, INTERNAL MED, V50, P2941, DOI 10.2169/internalmedicine.50.6407; Ward MJ, 2012, WORLD J EMERG MED, V3, P102, DOI 10.5847/wjem.j.issn.1920-8642.2012.02.004; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214	32	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94887	10.1371/journal.pone.0094887	http://dx.doi.org/10.1371/journal.pone.0094887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722190	Green Submitted, gold, Green Published			2022-12-27	WOS:000336909100143
J	Albertin, W; Chasseriaud, L; Comte, G; Panfili, A; Delcamp, A; Salin, F; Marullo, P; Bely, M				Albertin, Warren; Chasseriaud, Laura; Comte, Guillaume; Panfili, Aurelie; Delcamp, Adline; Salin, Franck; Marullo, Philippe; Bely, Marina			Winemaking and Bioprocesses Strongly Shaped the Genetic Diversity of the Ubiquitous Yeast Torulaspora delbrueckii	PLOS ONE			English	Article							NON-SACCHAROMYCES YEASTS; FROZEN SWEET DOUGH; MIXED CULTURES; SP NOV.; POPULATION-STRUCTURE; CEREVISIAE STRAINS; LEAVENING ABILITY; FREEZE TOLERANCE; SPOILAGE YEASTS; R-PACKAGE	The yeast Torulaspora delbrueckii is associated with several human activities including oenology, bakery, distillery, dairy industry, etc. In addition to its biotechnological applications, T. delbrueckii is frequently isolated in natural environments (plant, soil, insect). T. delbrueckii is thus a remarkable ubiquitous yeast species with both wild and anthropic habitats, and appears to be a perfect yeast model to search for evidence of human domestication. For that purpose, we developed eight microsatellite markers that were used for the genotyping of 110 strains from various substrates and geographical origins. Microsatellite analysis showed four genetic clusters: two groups contained most nature strains from Old World and Americas respectively, and two clusters were associated with winemaking and other bioprocesses. Analysis of molecular variance (AMOVA) confirmed that human activities significantly shaped the genetic variability of T. delbrueckii species. Natural isolates are differentiated on the basis of geographical localisation, as expected for wild population. The domestication of T. delbrueckii probably dates back to the Roman Empire for winemaking (, 1900 years ago), and to the Neolithic era for bioprocesses (, 4000 years ago). Microsatellite analysis also provided valuable data regarding the life-cycle of the species, suggesting a mostly diploid homothallic life. In addition to population genetics and ecological studies, the microsatellite tool will be particularly useful for further biotechnological development of T. delbrueckii strains for winemaking and other bioprocesses.	[Albertin, Warren; Chasseriaud, Laura; Comte, Guillaume; Panfili, Aurelie; Marullo, Philippe; Bely, Marina] Univ Bordeaux, ISVV, EA 4577, Unite Rech Enol, Villenave Dornon, France; [Albertin, Warren; Chasseriaud, Laura; Marullo, Philippe] Biolaffort, Bordeaux, France; [Delcamp, Adline; Salin, Franck] INRA, UMR Biodiversite Genes & Ecosyst, Cestas, France	UDICE-French Research Universities; Universite de Bordeaux; INRAE	Albertin, W (corresponding author), Univ Bordeaux, ISVV, EA 4577, Unite Rech Enol, Villenave Dornon, France.	warren.albertin@u-bordeaux.fr		Marullo, Philippe/0000-0002-3594-5173; Albertin, Warren/0000-0002-7385-9882	European commission [315065]	European commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by the Univ. de Bordeaux. This work was supported, in part, by the European commission in the framework of the FP7-SME project Wildwine grant agreement no 315065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2012, P ROY SOC B-BIOL SCI, V279, P2497, DOI 10.1098/rspb.2012.0434; Almeida MJ, 1996, APPL ENVIRON MICROB, V62, P4401, DOI 10.1128/AEM.62.12.4401-4404.1996; Alves-Araujo C, 2004, FEMS MICROBIOL LETT, V240, P7, DOI 10.1016/j.femsle.2004.09.008; Andrighetto C, 2000, LETT APPL MICROBIOL, V30, P5, DOI [10.1046/j.1472-765x.2000.00589.x, 10.1046/j.1472-765X.2000.00589.x]; [Anonymous], 2010, R LANG ENV STAT COMP; Azzolini M, 2012, EUR FOOD RES TECHNOL, V235, P303, DOI 10.1007/s00217-012-1762-3; Bely M, 2008, INT J FOOD MICROBIOL, V122, P312, DOI 10.1016/j.ijfoodmicro.2007.12.023; BONEKAMP FJ, 1994, APPL MICROBIOL BIOT, V41, P1, DOI [10.1007/s002530050097, 10.1007/BF00166072]; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; CAPRIOTTI A, 1957, ARCH MIKROBIOL, V28, P247, DOI 10.1007/BF00411496; CASTELLI T, 1954, ARCH MIKROBIOL, V20, P323, DOI 10.1007/BF00690877; Castelli T, 1940, ARCH MIKROBIOLOGIE, V11; Cavalieri D, 2003, J MOL EVOL, V57, pS226, DOI 10.1007/s00239-003-0031-2; Chen W-C., 2011, OVERLAPPING CODON MO; Ciani M, 1998, WORLD J MICROB BIOT, V14, P199, DOI 10.1023/A:1008825928354; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; CODON AC, 1995, APPL ENVIRON MICROB, V61, P1677; Comitini F, 2011, FOOD MICROBIOL, V28, P873, DOI 10.1016/j.fm.2010.12.001; Coton E, 2006, INT J FOOD MICROBIOL, V108, P130, DOI 10.1016/j.ijfoodmicro.2005.10.016; Douglas GL, 2010, ANNU REV FOOD SCI T, V1, P397, DOI 10.1146/annurev.food.102308.124134; Etchells JL, 1950, FARLOWIA, V4, P112; ETCHELLS JOHN L., 1952, FARLOWIA, V4, P249; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Frickmann H, 2012, MYCOSES, V55, P521, DOI 10.1111/j.1439-0507.2012.02214.x; Gadaga TH, 2000, INT DAIRY J, V10, P459, DOI 10.1016/S0958-6946(00)00070-4; Galbe M, 2002, APPL MICROBIOL BIOT, V59, P618, DOI 10.1007/s00253-002-1058-9; Gellissen G, 2005, HANSENULA POLYMORPHA; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; Gordon JL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002190; Granchi L, 1999, J APPL MICROBIOL, V87, P949, DOI 10.1046/j.1365-2672.1999.00600.x; Hernandez-Lopez MJ, 2007, INT J FOOD MICROBIOL, V116, P103, DOI 10.1016/j.ijfoodmicro.2006.12.006; Hernandez-Lopez MJ, 2003, ANTON LEEUW INT J G, V84, P125, DOI 10.1023/A:1025413520192; HERRAIZ T, 1990, AM J ENOL VITICULT, V41, P313; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; Kaygusuz I, 2003, CLIN MICROBIOL INFEC, V9, P319, DOI 10.1046/j.1469-0691.2003.00511.x; Kim YJ, 2005, J IND MICROBIOL BIOT, V32, P402, DOI 10.1007/s10295-005-0010-2; Kotzekidou P, 1997, FOOD MICROBIOL, V14, P609, DOI 10.1006/fmic.1997.0133; Kruglyak S, 1998, P NATL ACAD SCI USA, V95, P10774, DOI 10.1073/pnas.95.18.10774; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; KURTZMAN CP, 1991, YEAST, V7, P61, DOI 10.1002/yea.320070107; LACHANCE MA, 1995, ANTON LEEUW INT J G, V68, P151, DOI 10.1007/BF00873100; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Limtong S, 2008, FEMS YEAST RES, V8, P337, DOI 10.1111/j.1567-1364.2007.00324.x; Limtong S, 2012, WORLD J MICROB BIOT, V28, P3323, DOI 10.1007/s11274-012-1144-9; Loretan T, 2003, S AFR J SCI, V99, P92; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Nguyen NH, 2007, MYCOLOGIA, V99, P842, DOI 10.3852/mycologia.99.6.842; Nguyen NH, 2006, MYCOL RES, V110, P346, DOI 10.1016/j.mycres.2005.11.010; Nielsen DS, 2008, INT J FOOD MICROBIOL, V125, P133, DOI 10.1016/j.ijfoodmicro.2008.03.040; Nissen P, 2003, ARCH MICROBIOL, V180, P257, DOI 10.1007/s00203-003-0585-9; Nissen P, 2003, YEAST, V20, P331, DOI 10.1002/yea.965; Pacheco A, 2012, EMERGING ROLE YEAST; Paolocci F, 2006, APPL ENVIRON MICROB, V72, P2390, DOI 10.1128/AEM.72.4.2390-2393.2006; Papalexandratou Z, 2011, APPL ENVIRON MICROB, V77, P7698, DOI 10.1128/AEM.05523-11; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; PARLE JN, 1966, NEW ZEAL J AGR RES, V9, P98; Pataro C, 2000, J APPL MICROBIOL, V89, P24, DOI 10.1046/j.1365-2672.2000.01092.x; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; Primmer CR, 1998, MOL BIOL EVOL, V15, P997, DOI 10.1093/oxfordjournals.molbev.a026015; Pritchard JK, 2000, GENETICS, V155, P945; Renault PE, 2013, APPL MICROBIOL BIOT, V97, P4105, DOI 10.1007/s00253-012-4660-5; Renault P, 2009, INT J FOOD MICROBIOL, V134, P201, DOI 10.1016/j.ijfoodmicro.2009.06.008; Richards KD, 2009, ANTON LEEUW INT J G, V96, P355, DOI 10.1007/s10482-009-9346-3; Ros-Chumillas M, 2007, FOOD CONTROL, V18, P33, DOI 10.1016/j.foodcont.2005.08.004; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Saluja P, 2012, ANTON LEEUW INT J G, V101, P733, DOI 10.1007/s10482-011-9687-6; Samuel D, 1996, SCIENCE, V273, P488, DOI 10.1126/science.273.5274.488; Sangorrin MP, 2008, WORLD J MICROB BIOT, V24, P945, DOI 10.1007/s11274-007-9557-6; Santo DE, 2012, FOOD RES INT, V47, P45, DOI 10.1016/j.foodres.2012.01.009; SASAKI T, 1987, APPL ENVIRON MICROB, V53, P1504, DOI 10.1128/AEM.53.7.1504-1511.1987; Schlotterer C, 2001, GENET RES, V78, P209, DOI 10.1017/S0016672301005444; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schuller D, 2007, ANTON LEEUW INT J G, V91, P137, DOI 10.1007/s10482-006-9104-8; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Stringini M, 2008, INT J FOOD MICROBIOL, V127, P184, DOI 10.1016/j.ijfoodmicro.2008.07.017; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; TOKUOKA K, 1985, J GEN APPL MICROBIOL, V31, P411, DOI 10.2323/jgam.31.411; Ulloa M, 1978, BOL SOC MEX MICOL, V12, P5; VALDES AM, 1993, GENETICS, V133, P737; van Breda V, 2013, INT J FOOD MICROBIOL, V163, P80, DOI 10.1016/j.ijfoodmicro.2013.02.011; Valdez AV, 2011, ANTON LEEUW INT J G, V100, P497, DOI 10.1007/s10482-011-9605-y; Vrancken G, 2010, FEMS YEAST RES, V10, P471, DOI 10.1111/j.1567-1364.2010.00621.x; Wang QM, 2009, FEMS YEAST RES, V9, P1322, DOI 10.1111/j.1567-1364.2009.00567.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welthagen JJ, 1998, INT J FOOD MICROBIOL, V41, P185, DOI 10.1016/S0168-1605(98)00042-7; Westall S, 1998, FOOD MICROBIOL, V15, P243, DOI 10.1006/fmic.1997.0162; Zott K, 2010, FOOD MICROBIOL, V27, P559, DOI 10.1016/j.fm.2010.01.006	97	49	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94246	10.1371/journal.pone.0094246	http://dx.doi.org/10.1371/journal.pone.0094246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718638	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000095
J	Holand, K; Boller, D; Hagel, C; Dolski, S; Treszl, A; Pardo, OE; Cwiek, P; Salm, F; Leni, Z; Shepherd, PR; Styp-Rekowska, B; Djonov, V; von Bueren, AO; Frei, K; Arcaro, A				Hoeland, Katrin; Boller, Danielle; Hagel, Christian; Dolski, Silvia; Treszl, Andras; Pardo, Olivier E.; Cwiek, Paulina; Salm, Fabiana; Leni, Zaira; Shepherd, Peter R.; Styp-Rekowska, Beata; Djonov, Valentin; von Bueren, Andre O.; Frei, Karl; Arcaro, Alexandre			Targeting Class I-A PI3K Isoforms Selectively Impairs Cell Growth, Survival, and Migration in Glioblastoma	PLOS ONE			English	Article							BRAIN-TUMORS; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; ANTITUMOR-ACTIVITY; MALIGNANT GLIOMAS; PATIENT SURVIVAL; KINASE-B; MUTATIONS; PATHWAY	The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is frequently activated in human cancer and plays a crucial role in glioblastoma biology. We were interested in gaining further insight into the potential of targeting PI3K isoforms as a novel anti-tumor approach in glioblastoma. Consistent expression of the PI3K catalytic isoform PI3K p11 alpha was detected in a panel of glioblastoma patient samples. In contrast, PI3K p11 beta expression was only rarely detected in glioblastoma patient samples. The expression of a module comprising the epidermal growth factor receptor (EGFR)/PI3K p110 alpha/phosphorylated ribosomal S6 protein (p-S6) was correlated with shorter patient survival. Inhibition of PI3K p11 alpha activity impaired the anchorage-dependent growth of glioblastoma cells and induced tumor regression in vivo. Inhibition of PI3K p11 alpha or PI3K p110 alpha also led to impaired anchorage-independent growth, a decreased migratory capacity of glioblastoma cells, and reduced the activation of the Akt/mTOR pathway. These effects were selective, because targeting of PI3K p11 delta d did not result in a comparable impairment of glioblastoma tumorigenic properties. Together, our data reveal that drugs targeting PI3K p110a can reduce growth in a subset of glioblastoma tumors characterized by the expression of EGFR/PI3K p110 alpha/p-S6.	[Hoeland, Katrin; Cwiek, Paulina; Salm, Fabiana; Leni, Zaira; Arcaro, Alexandre] Univ Bern, Dept Clin Res, Bern, Switzerland; [Boller, Danielle; Arcaro, Alexandre] Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, Zurich, Switzerland; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Dolski, Silvia; Frei, Karl] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Treszl, Andras] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Pardo, Olivier E.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Shepherd, Peter R.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Styp-Rekowska, Beata; Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [von Bueren, Andre O.] Univ Med Ctr Goettingen, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Gottingen, Germany	University of Bern; University Children's Hospital Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Imperial College London; University of Auckland; University of Bern; University of Gottingen	Arcaro, A (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	Pardo, Oliver/AEM-2071-2022; von Bueren, Andre/AAF-2065-2020; Arcaro, Alexandre/G-1711-2010	Pardo, Oliver/0000-0003-2223-1435; Arcaro, Alexandre/0000-0001-9107-2947; Bronnimann, Paulina/0000-0001-7574-8214; Djonov, Valentin/0000-0002-5062-1169; Cwiek, Paulina/0000-0002-0964-6364; von Bueren, Andre/0000-0003-4197-6264	Oncosuisse [OCS-01501-02-2004]; Krebsliga Zurich; European Union [259348]	Oncosuisse; Krebsliga Zurich; European Union(European Commission)	Oncosuisse (OCS-01501-02-2004); Krebsliga Zurich; European Union's Seventh Framework Programme (FP7/2007-2013, grant agreement no259348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Arcaro A, 2007, BIOCHEM J, V406, P57, DOI 10.1042/BJ20070309; Belkaid A, 2006, FEBS LETT, V580, P3746, DOI 10.1016/j.febslet.2006.05.071; Bowers DC, 2000, CANCER RES, V60, P4277; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; CBTRUS, CENTR BRAIN TUM REG; Chakravarti A, 2002, CANCER RES, V62, P200; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choe G, 2003, CANCER RES, V63, P2742; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Hartmann C, 2005, ACTA NEUROPATHOL, V109, P639, DOI 10.1007/s00401-005-1000-1; Holand K, 2011, CURR CANCER DRUG TAR, V11, P894, DOI 10.2174/156800911797264743; Hui ABY, 2001, LAB INVEST, V81, P717, DOI 10.1038/labinvest.3780280; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Janku F, 2012, CANC RES; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kim B, 2010, J NEUROL SCI, V294, P112, DOI 10.1016/j.jns.2010.03.019; Knobbe CB, 2005, NEUROPATH APPL NEURO, V31, P486, DOI 10.1111/j.1365-2990.2005.00660.x; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lino MM, 2011, J NEURO-ONCOL, V103, P417, DOI 10.1007/s11060-010-0442-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luk SK, 2012, EUR J CANCER, V48, P149, DOI 10.1016/j.ejca.2011.09.006; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; McBride SM, 2010, J NEURO-ONCOL, V97, P33, DOI 10.1007/s11060-009-0004-4; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Mueller W, 2005, ACTA NEUROPATHOL, V109, P654, DOI 10.1007/s00401-005-1001-0; Mure H, 2010, NEURO-ONCOLOGY, V12, P221, DOI 10.1093/neuonc/nop026; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nilsson KPR, 2010, AM J PATHOL, V176, P563, DOI 10.2353/ajpath.2010.080797; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Rodak R, 2005, J NEUROSURG, V102, P1055, DOI 10.3171/jns.2005.102.6.1055; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; VAN MEIR E, 1990, CANCER RES, V50, P6683; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Weigelt B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00109; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	59	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94132	10.1371/journal.pone.0094132	http://dx.doi.org/10.1371/journal.pone.0094132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718026	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000080
J	Kim, TN; Lee, JE; Lee, EJ; Won, JC; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Kim, Tae Nyun; Lee, Joo Eun; Lee, Eun Ju; Won, Jong Chul; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Prevalence of and Factors Associated with Lens Opacities in a Korean Adult Population with and without Diabetes: The 2008-2009 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							POSTERIOR SUBCAPSULAR CATARACTS; AGE-RELATED CATARACT; CLASSIFICATION-SYSTEM-III; TANJONG-PAGAR SURVEY; ANGELES-LATINO-EYE; RISK-FACTORS; BARBADOS EYE; NUCLEAR; EPIDEMIOLOGY; SINGAPORE	Objective: We examined the prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes. Research Design and Methods: Among the 11,163 adults (>= 19 years old) from the fourth Korea National Health and Nutrition Examination Survey in 2008-2009, the data from laboratory tests, nutritional surveys, and slit-lamp examinations of 10,248 persons (4,397 men, 5,851 women) were examined. Cataract was defined as the presence of any nuclear, cortical, subcapsular, or mixed cataract in at least one eye, using the Lens Opacities Classification System III. Results: The weighted prevalence of cataracts were 23.5% [ 95% confidence interval (CI), 21.7-25.4] in a Korean adult population (19-39 years old, 1.8% [ 1.3-2.5], 40-64 years old, 25.2% [ 22.5-28.1],>= 65 years old, 87.8% [ 85.4-89.9]) and 54.7% [ 50.1-59.2] in a diabetic population(19-39 years old, 11.6% [ 4.5-26.5], 40-64 years old, 41.1% [ 35.4-47.0], >= 65 years old, 88.3% [ 83.5-91.8]). In a logistic regression analysis, age, myopia, and the presence of diabetes were independent risk factors. For young (age 19-39 years) and middle aged (age 40-65 years) adults with diabetes, the OR of having a lens opacity is 5.04 [ 1.41-17.98] and 1.47 [ 1.11-1.94], respectively, as those without diabetes, whereas for adults aged 65 and older, there was no difference in the prevalence of cataract. Conclusions: According to these national survey data, similar to 24% of Korean adults and similar to 55% of people with diabetes have cataracts. The presence of diabetes was independently associated with cataracts in young and middle aged adults.	[Kim, Tae Nyun; Lee, Eun Ju] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Internal Med, Pusan, South Korea; [Kim, Tae Nyun; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Cardiovasc & Metab Dis Ctr, Pusan, South Korea; [Lee, Joo Eun] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Ophthalmol, Pusan, South Korea; [Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, South Korea; [Won, Jong Chul; Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Internal Med, Seoul, South Korea	Inje University; Inje University; Inje University; Inje University; Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, South Korea.	djkim@paik.ac.kr	Kim, Tae Nyun/AAV-5521-2020; Noh, Junghyun/AAU-8113-2020	Kim, Tae Nyun/0000-0001-6568-2469; Won, Jong Chul/0000-0002-2219-4083; Noh, Junghyun/0000-0002-7964-0515	Inje University research grant	Inje University research grant	This work was supported by a 2010 Inje University research grant. The relevant grant number is one. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; Chen SJ, 2008, ACTA DIABETOL, V45, P7, DOI 10.1007/s00592-007-0012-9; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Foster PJ, 2003, BRIT J OPHTHALMOL, V87, P1112, DOI 10.1136/bjo.87.9.1112; HILLER R, 1986, AM J EPIDEMIOL, V124, P916, DOI 10.1093/oxfordjournals.aje.a114481; HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; KARBASSI M, 1993, OPTOMETRY VISION SCI, V70, P923, DOI 10.1097/00006324-199311000-00009; Kim Seong Il, 2006, Korean J Ophthalmol, V20, P201; Klein B E, 1995, Ophthalmic Epidemiol, V2, P49, DOI 10.3109/09286589509071451; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; Leske MC, 1999, OPHTHALMOLOGY, V106, P35, DOI 10.1016/S0161-6420(99)90003-9; Leske MC, 1997, ARCH OPHTHALMOL-CHIC, V115, P105, DOI 10.1001/archopht.1997.01100150107018; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Miglior S, 1994, Ophthalmic Epidemiol, V1, P93, DOI 10.3109/09286589409052365; Murtha T, 2007, CURR OPIN OPHTHALMOL, V18, P13, DOI 10.1097/ICU.0b013e32801129fc; Negahban Kambiz, 2002, Curr Opin Ophthalmol, V13, P419, DOI 10.1097/00055735-200212000-00013; Obrosova IG, 2010, DIABETES-METAB RES, V26, P172, DOI 10.1002/dmrr.1075; Pan CW, 2013, OPHTHALMOLOGY, V120, P284, DOI 10.1016/j.ophtha.2012.07.065; Park S, 2013, OPTOMETRY VISION SCI, V90, P1019, DOI 10.1097/OPX.0b013e31829cae62; Park Y, 2006, ANN NY ACAD SCI, V1079, P31, DOI 10.1196/annals.1375.005; Pierscionek BK, 1996, OPHTHALMIC RES, V28, P88, DOI 10.1159/000267879; Raman R, 2010, INVEST OPHTH VIS SCI, V51, P6253, DOI 10.1167/iovs.10-5414; Richter GM, 2012, OPHTHALMOLOGY, V119, P2040, DOI 10.1016/j.ophtha.2012.05.001; Richter GM, 2012, OPHTHALMOLOGY, V119, P547, DOI 10.1016/j.ophtha.2011.09.005; Rotimi Charles, 2003, Ethnicity & Disease, V13; Rowe N G, 2000, Ophthalmic Epidemiol, V7, P103; Seah SKL, 2002, OPHTHALMOLOGY, V109, P2058, DOI 10.1016/S0161-6420(02)01221-6; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94189	10.1371/journal.pone.0094189	http://dx.doi.org/10.1371/journal.pone.0094189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718421	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000086
J	Zhou, YF; Ueda, T; Muller, M				Zhou, Yufan; Ueda, Takuya; Mueller, Matthias			Signal Recognition Particle and SecA Cooperate during Export of Secretory Proteins with Highly Hydrophobic Signal Sequences	PLOS ONE			English	Article							ESCHERICHIA-COLI; MEMBRANE-PROTEINS; DEPENDENT TRANSLOCATION; INNER MEMBRANE; PURIFIED COMPONENTS; IN-VITRO; SRP; INSERTION; PATHWAY; SECYEG	The Sec translocon of bacterial plasma membranes mediates the linear translocation of secretory proteins as well as the lateral integration of membrane proteins. Integration of many membrane proteins occurs co-translationally via the signal recognition particle (SRP)-dependent targeting of ribosome-associated nascent chains to the Sec translocon. In contrast, translocation of classical secretory proteins across the Sec translocon is a post-translational event requiring no SRP but the motor protein SecA. Secretory proteins were, however, reported to utilize SRP in addition to SecA, if the hydrophobicity of their signal sequences exceeds a certain threshold value. Here we have analyzed transport of this subgroup of secretory proteins across the Sec translocon employing an entirely defined in vitro system. We thus found SecA to be both necessary and sufficient for translocation of secretory proteins with hydrophobic signal sequences, whereas SRP and its receptor improved translocation efficiency. This SRP-mediated boost of translocation is likely due to the early capture of the hydrophobic signal sequence by SRP as revealed by site-specific photo cross-linking of ribosome nascent chain complexes.	[Zhou, Yufan; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79106 Freiburg, Germany; [Zhou, Yufan] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Ueda, Takuya] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba, Japan	University of Freiburg; University of Freiburg; University of Tokyo	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, Hugstetter Str 55, D-79106 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de	Zhou, Yufan/AFR-9024-2022; Ueda, Takuya/K-5217-2014	Ueda, Takuya/0000-0002-7760-8271	Deutsche Forschungsgemeinschaft [Forschergruppe 967]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Forschergruppe 967 of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bibi E, 2012, TRENDS BIOCHEM SCI, V37, P1, DOI 10.1016/j.tibs.2011.09.004; Braig D, 2011, MOL BIOL CELL, V22, P2309, DOI 10.1091/mbc.E11-02-0152; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Deitermann S, 2005, J BIOL CHEM, V280, P39077, DOI 10.1074/jbc.M509647200; DEUTSCHE.MP, 1974, J BACTERIOL, V118, P621, DOI 10.1128/JB.118.2.621-627.1974; Eisner G, 2003, J CELL BIOL, V163, P35, DOI 10.1083/jcb.200306069; Holzapfel E, 2009, BIOCHEMISTRY-US, V48, P5096, DOI 10.1021/bi900520d; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Kuruma Y, 2005, BIOTECHNOL PROGR, V21, P1243, DOI 10.1021/bp049553u; Moser Michael, 2007, V390, P63; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nishiyama K, 2010, BIOCHEM BIOPH RES CO, V394, P733, DOI 10.1016/j.bbrc.2010.03.061; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimohata N, 2005, J BACTERIOL, V187, P3997, DOI 10.1128/JB.187.12.3997-4004.2005; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; WOOD H, 1992, NUCLEIC ACIDS RES, V20, P5919, DOI 10.1093/nar/20.22.5919; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743	31	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92994	10.1371/journal.pone.0092994	http://dx.doi.org/10.1371/journal.pone.0092994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717922	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000023
J	Keefe, CC; Goldman, MM; Zhang, K; Clarke, N; Reitz, RE; Welt, CK				Keefe, Candace C.; Goldman, Mildred M.; Zhang, Ke; Clarke, Nigel; Reitz, Richard E.; Welt, Corrine K.			Simultaneous Measurement of Thirteen Steroid Hormones in Women with Polycystic Ovary Syndrome and Control Women Using Liquid Chromatography-Tandem Mass Spectrometry	PLOS ONE			English	Article							ANDROGEN OVERPRODUCTION; THECA CELLS; TESTOSTERONE; CATHETERIZATION; RESPONSES; EXCESS	Background: The measurement of adrenal and ovarian androgens in women with PCOS has been difficult based on poor specificity and sensitivity of assays in the female range. Methods: Women with PCOS (NIH criteria; n = 52) and control subjects with 25-35 day menstrual cycles, no evidence of hyperandrogenism and matched for BMI (n = 42) underwent morning blood sampling. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to simultaneously measure 13 steroids from a single blood sample to measure adrenal and ovarian steroids. Androgen and progesterone results were compared in the same samples using RIA. Results: Testosterone, androstenedione, progesterone and 17OH progesterone levels were higher when measured using RIA compared to LC-MS/MS, although the testosterone RIA demonstrated the best agreement with the LC-MS/MS using a Bland-Altman analysis. Results using LC-MS/MS demonstrated that the concentration of androgens and their precursors were higher in women with PCOS than controls [median (2.5, 97.5th % ile); 1607 (638, 3085) vs. 1143 (511, 4784) ng/dL; p = 0.03]. Women with PCOS had higher testosterone [49 (16, 125) vs. 24 (10, 59) ng/dL], androstenedione [203 (98, 476) vs. 106 (69, 223) ng/dL] and 17OH progesterone levels [80 (17, 176) vs. 44 (17, 142) ng/dL] compared to controls (all P<0.02), but no differences in serum concentrations of the adrenal steroids DHEAS, cortisol, corticosterone and their 11 deoxy precursors. Women with PCOS also had an increase in the product: precursor ratio for 3 beta-hydroxysteroid dehydrogenase [22% (6, 92) vs. 20% (4, 43); p = 0.009]. Conclusion: LC-MS/MS was superior to RIA in measuring androstenedione, progesterone and 17OH progesterone levels, while testosterone measurements were better matched in the two assays. Androgen levels were higher in women with PCOS in the absence of a difference in adrenal-predominant steroids. These data support previous findings that the ovary is an important source for the androgen excess in women with PCOS.	[Keefe, Candace C.; Welt, Corrine K.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Goldman, Mildred M.; Zhang, Ke; Clarke, Nigel; Reitz, Richard E.] Quest Diagnost Nichols Inst, Steroids Dept, San Juan Capistrano, CA USA	Harvard University; Massachusetts General Hospital; Nichols Institute	Welt, CK (corresponding author), Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA.	cwelt@partners.org		Welt, Corrine/0000-0002-8219-5504	National Institutes of Health [1R01HD065029, ADA 1-10-CT-57, 1 UL1 RR025758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065029] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding came from the National Institutes of Health 1R01HD065029 (CKW), ADA 1-10-CT-57 (CKW) and the 1 UL1 RR025758 Harvard Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; BARNES RB, 1989, NEW ENGL J MED, V320, P559, DOI 10.1056/NEJM198903023200904; Fanelli F, 2011, STEROIDS, V76, P244, DOI 10.1016/j.steroids.2010.11.005; GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; Hamdine O, 2013, FERTIL STERIL, V100, P867, DOI 10.1016/j.fertnstert.2013.05.031; ISAACS D, 1983, J CLIN PATHOL, V36, P1193, DOI 10.1136/jcp.36.10.1193; Janse F, 2011, EUR J ENDOCRINOL, V165, P925, DOI 10.1530/EJE-11-0482; Jaque J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-5; Kasum M, 2013, GYNECOL ENDOCRINOL, V29, P744, DOI 10.3109/09513590.2013.798280; KIRSCHNER MA, 1971, J CLIN ENDOCR METAB, V33, P199, DOI 10.1210/jcem-33-2-199; Kumar A, 2005, CLIN ENDOCRINOL, V62, P644, DOI 10.1111/j.1365-2265.2005.02256.x; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5305, DOI 10.1210/jc.2010-1123; Naessen T, 2010, FERTIL STERIL, V94, P2228, DOI 10.1016/j.fertnstert.2009.12.081; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; Pasquali R, 2011, CLIN ENDOCRINOL, V74, P424, DOI 10.1111/j.1365-2265.2010.03956.x; RODIN A, 1994, NEW ENGL J MED, V330, P460, DOI 10.1056/NEJM199402173300703; Rosencrantz MA, 2011, J CLIN ENDOCR METAB, V96, P1106, DOI 10.1210/jc.2010-2200; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Simon JA, 2002, FERTIL STERIL, V77, pS77; Taylor AE, 1997, J CLIN ENDOCR METAB, V82, P2248, DOI 10.1210/jc.82.7.2248; Vassiliadi DA, 2009, J CLIN ENDOCR METAB, V94, P3558, DOI 10.1210/jc.2009-0837; Vogeser M, 2007, EXP CLIN ENDOCR DIAB, V115, P559, DOI 10.1055/s-2007-981458; WAJCHENBERG BL, 1986, J CLIN ENDOCR METAB, V63, P1204, DOI 10.1210/jcem-63-5-1204; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4361, DOI 10.1210/jc.2006-1191; Welt CK, 1999, J CLIN ENDOCR METAB, V84, P2163, DOI 10.1210/jc.84.6.2163; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377	28	67	72	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93805	10.1371/journal.pone.0093805	http://dx.doi.org/10.1371/journal.pone.0093805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713888	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900049
J	Kitsera, N; Gasteiger, K; Luhnsdorf, B; Allgayer, J; Epe, B; Carell, T; Khobta, A				Kitsera, Nataliya; Gasteiger, Karola; Luehnsdorf, Bork; Allgayer, Julia; Epe, Bernd; Carell, Thomas; Khobta, Andriy			Cockayne Syndrome: Varied Requirement of Transcription-Coupled Nucleotide Excision Repair for the Removal of Three Structurally Different Adducts from Transcribed DNA	PLOS ONE			English	Article							UV-SENSITIVE SYNDROME; RNA-POLYMERASE-II; MOLECULAR-BASIS; DAMAGE; PROTEINS; LESION; CELLS; AAF; CSA	Hereditary defects in the transcription-coupled nucleotide excision repair (TC-NER) pathway of damaged DNA cause severe neurodegenerative disease Cockayne syndrome (CS) however the origin and chemical nature of the underlying DNA damage had remained unknown. To find out to which degree the structural properties of DNA lesions determine the extent of transcription arrest in human CS cells we performed quantitative host cell reactivation analyses of expression vectors containing various synthetic adducts. We found that a single 3-(deoxyguanosin-N-2-yl)-2- acetylaminofluorene adduct (dG(N-2)-AAF) constitutes an unsurmountable obstacle to transcription in both CS-A and CS-B cells and is removed exclusively by the CSA and CSB-dependent pathway. In contrast contribution of the CS proteins to the removal of two other transcription-blocking DNA lesions - N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG(C8)-AAF) and cyclobutane thymine-thymine (TT) dimer - is only minor (TT dimer) or none (dG(C8)-AAF). The unique properties of dG(N-2)-AAF identify this adduct as a prototype for a new class of DNA lesions that escape the alternative global genome repair and could be critical for the CS pathogenesis.	[Kitsera, Nataliya; Luehnsdorf, Bork; Allgayer, Julia; Epe, Bernd; Khobta, Andriy] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Gasteiger, Karola; Carell, Thomas] Univ Munich, Dept Chem & Biochem, Munich, Germany	Johannes Gutenberg University of Mainz; University of Munich	Khobta, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany.	khobta@uni-mainz.de	Carell, Thomas/G-4799-2012; Khobta, Andriy/B-6622-2014	Carell, Thomas/0000-0001-7898-2831; Khobta, Andriy/0000-0001-9165-3557	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [KH 263/1, KH 263/2]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (KH 263/1 and KH 263/2). The funder's website:www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer J, 2013, NUCLEIC ACIDS RES, V41, P8559, DOI 10.1093/nar/gkt620; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bonala RR, 2005, CHEM RES TOXICOL, V18, P457, DOI 10.1021/tx0497907; Cleaver JE, 2013, MECH AGEING DEV, V134, P284, DOI 10.1016/j.mad.2013.02.005; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cui XS, 1999, MUTAT RES-GEN TOX EN, V442, P9, DOI 10.1016/S1383-5718(99)00053-4; Donahue BA, 1996, J BIOL CHEM, V271, P10588, DOI 10.1074/jbc.271.18.10588; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gillet LCJ, 2005, NUCLEIC ACIDS RES, V33, P1961, DOI 10.1093/nar/gki335; Gillet LCJ, 2002, ORG LETT, V4, P4205, DOI 10.1021/ol026474f; Gool AJ, 1997, EMBO J, V16, P5955; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hess MT, 1997, P NATL ACAD SCI USA, V94, P6664, DOI 10.1073/pnas.94.13.6664; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Khobta A, 2013, MECH AGEING DEV, V134, P253, DOI 10.1016/j.mad.2013.03.001; Khobta A, 2010, NUCLEIC ACIDS RES, V38, P4285, DOI 10.1093/nar/gkq170; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; Luhnsdorf B, 2012, ANAL BIOCHEM, V425, P47, DOI 10.1016/j.ab.2012.03.001; MAYNE LV, 1982, CANCER RES, V42, P1473; Mu H, 2012, NUCLEIC ACIDS RES, V40, P9675, DOI 10.1093/nar/gks788; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; OHANDLEY SF, 1993, BIOCHEMISTRY-US, V32, P2481, DOI 10.1021/bi00061a005; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Wang ZW, 2001, ORG LETT, V3, P565, DOI 10.1021/ol006968h; Yeo JE, 2012, CHEM RES TOXICOL, V25, P2462, DOI 10.1021/tx3003033; Zaliznyak T, 2006, CHEM RES TOXICOL, V19, P745, DOI 10.1021/tx060002i	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94405	10.1371/journal.pone.0094405	http://dx.doi.org/10.1371/journal.pone.0094405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713864	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900129
J	Park, YJ; Baek, JH; Lee, S; Kim, C; Rhee, H; Kim, H; Seo, JS; Park, HR; Yoon, DE; Nam, JY; Kim, HI; Kim, JG; Yoon, H; Kang, HW; Cho, JY; Song, ES; Sung, GH; Yoo, YB; Lee, CS; Lee, BM; Kong, WS				Park, Young-Jin; Baek, Jeong Hun; Lee, Seonwook; Kim, Changhoon; Rhee, Hwanseok; Kim, Hyungtae; Seo, Jeong-Sun; Park, Hae-Ran; Yoon, Dae-Eun; Nam, Jae-Young; Kim, Hong-Il; Kim, Jong-Guk; Yoon, Hyeokjun; Kang, Hee-Wan; Cho, Jae-Yong; Song, Eun-Sung; Sung, Gi-Ho; Yoo, Young-Bok; Lee, Chang-Soo; Lee, Byoung-Moo; Kong, Won-Sik			Whole Genome and Global Gene Expression Analyses of the Model Mushroom Flammulina velutipes Reveal a High Capacity for Lignocellulose Degradation	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; FRUITING BODY DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; ALCOHOL-DEHYDROGENASE; ASPERGILLUS-NIDULANS; MITOCHONDRIAL GENOME; PROTEIN EXPRESSION; HYPHAL WALL; RNA GENES; SEQUENCE	Flammulina velutipes is a fungus with health and medicinal benefits that has been used for consumption and cultivation in East Asia. F. velutipes is also known to degrade lignocellulose and produce ethanol. The overlapping interests of mushroom production and wood bioconversion make F. velutipes an attractive new model for fungal wood related studies. Here, we present the complete sequence of the F. velutipes genome. This is the first sequenced genome for a commercially produced edible mushroom that also degrades wood. The 35.6-Mb genome contained 12,218 predicted protein-encoding genes and 287 tRNA genes assembled into 11 scaffolds corresponding with the 11 chromosomes of strain KACC42780. The 88.4-kb mitochondrial genome contained 35 genes. Well-developed wood degrading machinery with strong potential for lignin degradation (69 auxiliary activities, formerly FOLymes) and carbohydrate degradation (392 CAZymes), along with 58 alcohol dehydrogenase genes were highly expressed in the mycelium, demonstrating the potential application of this organism to bioethanol production. Thus, the newly uncovered wood degrading capacity and sequential nature of this process in F. velutipes, offer interesting possibilities for more detailed studies on either lignin or (hemi-) cellulose degradation in complex wood substrates. The mutual interest in wood degradation by the mushroom industry and (ligno-) cellulose biomass related industries further increase the significance of F. velutipes as a new model.	[Park, Young-Jin; Park, Hae-Ran; Yoon, Dae-Eun; Nam, Jae-Young; Kim, Hong-Il; Lee, Chang-Soo] Konkuk Univ, Dept Biomed Chem, Chungju, South Korea; [Baek, Jeong Hun; Lee, Seonwook; Kim, Changhoon; Rhee, Hwanseok; Kim, Hyungtae; Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea; [Kim, Jong-Guk; Yoon, Hyeokjun] Kyungpook Natl Univ, Dept Life Sci & Biotechnol, Taegu 702701, South Korea; [Kang, Hee-Wan] Hankyong Natl Univ, Grad Sch Biotechnol & Informat Technol, Ansung, South Korea; [Cho, Jae-Yong] Sangji Univ, Dept Pharmaceut Engn, Wonju, South Korea; [Song, Eun-Sung; Lee, Byoung-Moo] Natl Acad Agr Sci, Rural Dev Adm, Suwon, South Korea; [Sung, Gi-Ho; Yoo, Young-Bok; Kong, Won-Sik] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Mushroom Res Div, Eumsung, South Korea; [Seo, Jeong-Sun] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea	Konkuk University; Macrogen, Inc.; Kyungpook National University; Hankyong National University; Sangji University; Rural Development Administration (RDA), Republic of Korea; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Lee, CS (corresponding author), Konkuk Univ, Dept Biomed Chem, Chungju, South Korea.	cslee@kku.ac.kr; lbmoo@korea.kr; wskong@korea.kr	Seo, Jeong-Sun/J-2763-2012	Kong, Won-Sik/0000-0001-6800-2545	next generation Biogreen 21 Program [PJ008216]; Rural Development Administration, Republic of Korea	next generation Biogreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the next generation Biogreen 21 Program (Grant number PJ008216), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Ando A, 2001, CURR GENET, V39, P190, DOI 10.1007/s002940100193; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Bao DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058294; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOTTOM CB, 1979, CARBOHYD RES, V77, P169, DOI 10.1016/S0008-6215(00)83803-3; BRUNS TD, 1992, MOL BIOL EVOL, V9, P836; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058780; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; de Smidt O, 2008, FEMS YEAST RES, V8, P967, DOI 10.1111/j.1567-1364.2008.00387.x; Dequard-Chablat M, 2011, MOL BIOL EVOL, V28, P2063, DOI 10.1093/molbev/msr025; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; FELDMANN H, 1994, EMBO J, V13, P5795, DOI 10.1002/j.1460-2075.1994.tb06923.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; Frijters ACJ, 1997, THEOR APPL GENET, V94, P390, DOI 10.1007/s001220050428; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Haridas S, 2010, FEMS MICROBIOL LETT, V308, P29, DOI 10.1111/j.1574-6968.2010.01979.x; HYNES MJ, 1977, MOL GEN GENET, V150, P193, DOI 10.1007/BF00695399; Joh JH, 2009, J MICROBIOL BIOTECHN, V19, P774, DOI 10.4014/jmb.0809.548; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kong Won-Sik, 2004, Mycobiology, V32, P11; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Larroy C, 2002, EUR J BIOCHEM, V269, P5738, DOI 10.1046/j.1432-1033.2002.03296.x; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lockington RA, 2001, MOL MICROBIOL, V40, P1311, DOI 10.1046/j.1365-2958.2001.02474.x; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUTSTORF U, 1968, ARCH BIOCHEM BIOPHYS, V126, P933, DOI 10.1016/0003-9861(68)90487-6; Maehara T, 2013, FUNGAL BIOL-UK, V117, P220, DOI 10.1016/j.funbio.2013.02.002; Maehara T, 2010, BIOSCI BIOTECH BIOCH, V74, P1126, DOI 10.1271/bbb.100021; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mizuno R, 2009, BIOSCI BIOTECH BIOCH, V73, P2240, DOI 10.1271/bbb.90332; Mizuno R, 2009, BIOSCI BIOTECH BIOCH, V73, P1671, DOI 10.1271/bbb.90099; MOL PC, 1990, MYCOL RES, V94, P472, DOI 10.1016/S0953-7562(10)80006-1; Moore D., 1998, FUNGAL MORPHOGENESIS; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Mouhamadou B, 2008, FUNGAL GENET BIOL, V45, P1219, DOI 10.1016/j.fgb.2008.06.006; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Okamura, 2009, MUSHROOM SCI BIOTECH, V8, P109; Okamura T, 2001, BIOSCI BIOTECH BIOCH, V65, P1596, DOI 10.1271/bbb.65.1596; PAL M, 1995, WORLD J MICROB BIOT, V11, P541, DOI 10.1007/BF00286370; Park YJ, 2010, MICROBIOL RES, V165, P321, DOI 10.1016/j.micres.2009.06.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Psurtseva NV, 2005, INT J MED MUSHROOMS, V7, P449, DOI DOI 10.1615/INTJMEDMUSHROOMS.V7.I3.870; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; Sakamoto Y, 2002, MYCOL RES, V106, P222, DOI 10.1017/S095375620100541X; Sakamoto Y, 2007, FUNGAL GENET BIOL, V44, P14, DOI 10.1016/j.fgb.2006.06.002; Sakamoto Y, 2010, MYCOSCIENCE, V51, P163, DOI 10.1007/s10267-010-0032-0; Santana MF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-720; SHIDA M, 1981, J BIOCHEM, V90, P1093, DOI 10.1093/oxfordjournals.jbchem.a133561; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Todd RB, 2000, MOL GEN GENET, V263, P561, DOI 10.1007/s004380051202; van Peer AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022249; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; van Zyl WH, 2007, ADV BIOCHEM ENG BIOT, V108, P205, DOI 10.1007/10_2007_061; vanIersel MFM, 1997, APPL ENVIRON MICROB, V63, P4079, DOI 10.1128/AEM.63.10.4079-4082.1997; WALTON JD, 1986, CELL, V46, P857, DOI 10.1016/0092-8674(86)90067-X; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2008, FEMS MICROBIOL LETT, V280, P34, DOI 10.1111/j.1574-6968.2007.01048.x; WEHNER EP, 1993, MOL GEN GENET, V237, P351, DOI 10.1007/BF00279438; WESSELS JGH, 1993, ADV MICROB PHYSIOL, V34, P147, DOI 10.1016/S0065-2911(08)60029-6; WESSELS JGH, 1972, BIOCHIM BIOPHYS ACTA, V273, P346, DOI 10.1016/0304-4165(72)90226-7; Yamada M, 2005, APPL MICROBIOL BIOT, V67, P240, DOI 10.1007/s00253-004-1776-2; Yamada M, 2008, FEMS MICROBIOL LETT, V289, P130, DOI 10.1111/j.1574-6968.2008.01361.x; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoon H, 2012, J GEN APPL MICROBIOL, V58, P331	93	81	112	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93560	10.1371/journal.pone.0093560	http://dx.doi.org/10.1371/journal.pone.0093560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714189	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900034
J	Swedish, KA; Goldstone, SE				Swedish, Kristin A.; Goldstone, Stephen E.			Prevention of Anal Condyloma with Quadrivalent Human Papillomavirus Vaccination of Older Men Who Have Sex with Men	PLOS ONE			English	Article							HPV INFECTION; RISK-FACTORS; DISEASE; WOMEN; RECURRENCE; CLEARANCE; ACUMINATA; NEOPLASIA; EFFICACY; COHORT	Background: The quadrivalent human papillomavirus vaccine (qHPV) is FDA-approved for use in males 9 to 26 years old to prevent anogenital condyloma. The objective of this study is to determine if qHPV is effective at preventing anal condyloma among men who have sex with men (MSM) aged 26 years and older. Methods: This post-hoc analysis of a nonconcurrent cohort study evaluated 210 patients without history of anal condyloma and 103 patients with previously-treated anal condyloma recurrence-free for at least 12 months prior to vaccination/time zero. We determined the rate of anal condyloma development in vaccinated versus unvaccinated patients. Results: 313 patients with mean age 42 years were followed for median 981 days. During 773.6 person-years follow-up, condyloma developed in 10 (8.6%) vaccinated patients (incidence of 3.7 per 100 person-years) and 37 (18.8%) unvaccinated patients (incidence 7.3 per 100 person-years; p = 0.05). Multivariable hazards ratio showed that qHPV was associated with decreased risk of anal condyloma development (HR 0.45; 95% CI 0.22-0.92; p = 0.03). History of anal condyloma was associated with increased risk of anal condyloma development (HR 2.28; 95% CI 1.28-4.05; p = 0.005), as was infection with oncogenic HPV (HR 3.87; 95% CI 1.66-9.03; p = 0.002). Conclusions: Among MSM 26 years of age and older with and without history of anal condyloma, qHPV reduces the risk of anal condyloma development. A randomized controlled trial is needed to confirm these findings in this age group.	[Swedish, Kristin A.] Montefiore Med Ctr, Dept Internal Med, Bronx, NY 10467 USA; [Goldstone, Stephen E.] Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Goldstone, SE (corresponding author), Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA.	goldstone.stephen@gmail.com						Anic GM, 2012, J INFECT DIS, V205, P789, DOI 10.1093/infdis/jir851; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; D'Ambrogio A, 2009, SEX TRANSM DIS, V36, P536, DOI 10.1097/OLQ.0b013e3181a866a3; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Goldstone SE, 2013, VACCINE, V31, P3849, DOI 10.1016/j.vaccine.2013.06.057; Goodman MT, 2008, J INFECT DIS, V197, P957, DOI 10.1086/529207; Howley PM, 2007, FIELDS VIROLOGY, V2, P2299; Jin F, 2007, SEX TRANSM DIS, V34, P488, DOI 10.1097/01.olq.0000245960.52668.e5; Joura EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1401; Lee Mortensen Gitte, 2010, BMC Res Notes, V3, P280, DOI 10.1186/1756-0500-3-280; Mistrangelo M, 2010, COLORECTAL DIS, V12, P799, DOI 10.1111/j.1463-1318.2009.01960.x; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Shvetsov YB, 2009, CLIN INFECT DIS, V48, P536, DOI 10.1086/596758; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; Swedish KA, 2011, DIS COLON RECTUM, V54, P1003, DOI 10.1097/DCR.0b013e31821d6cb9; Thomas EA, 2011, VACCINE, V29, P570, DOI 10.1016/j.vaccine.2010.09.101; Van den Eeden SK, 1998, SEX TRANSM DIS, V25, P278, DOI 10.1097/00007435-199807000-00002	19	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93393	10.1371/journal.pone.0093393	http://dx.doi.org/10.1371/journal.pone.0093393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714693	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900025
J	Yang, CY; Li, F; Du, BW; Chen, B; Wang, F; Wang, MK				Yang, Chunyan; Li, Fu; Du, Baowen; Chen, Bin; Wang, Fei; Wang, Mingkui			Isolation and Characterization of New Phenolic Compounds with Estrogen Biosynthesis-Inhibiting and Antioxidation Activities from Broussonetia papyrifera Leaves	PLOS ONE			English	Article							AROMATASE INHIBITORS; LIQUID-CHROMATOGRAPHY; CELL-LINE; IDENTIFICATION; ALPHA; CONSTITUENTS; GLYCOSIDES; EXTRACT	Broussonetia papyrifera leaves (BPL) as a traditional Chinese medicine are also used in livestock feed for stimulating reproduction, adipose tissue and muscle development; however, the mechanism of their action is still unknown. Through estrogen biosynthesis-guided fractionation in human ovarian granulosa-like KGN cells, five new phenolic glycosides, broussoside A-E(1-5), along with fifteen known dietary phenolic compounds, were isolated from the n-butanol extract of BPL, and their structures were elucidated on the basis of NMR spectra analysis and chemical evidence. New compounds 3, 4, 5 and the known compounds 9 and 10 were found to potently inhibit estrogen biosynthesis in KGN cells. In addition, compounds 9, 17, 18, and 20 showed strong antioxidant activity against ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6sulfonic acid) diammonium salt) and DPPH (1, 1'-diphenyl-2-picryl-hydrazyl radical) assays. These findings suggest that BPL may improve meat quality through the regulation of estrogen biosynthesis. Furthermore, they may be useful for the discovery of potential aromatase modulators from natural products. Finally, they could be considered as a new source for natural antioxidants.	[Yang, Chunyan; Li, Fu; Du, Baowen; Chen, Bin; Wang, Fei; Wang, Mingkui] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Peoples R China; [Yang, Chunyan; Li, Fu; Du, Baowen; Chen, Bin; Wang, Fei; Wang, Mingkui] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Sichuan Prov, Chengdu, Peoples R China; [Yang, Chunyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, F (corresponding author), Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Peoples R China.	wangfei@cib.ac.cn; wangmk@cib.ac.cn		Wang, Fei/0000-0002-2513-502X	National New Drug Innovation 441 Major Project of 442 China [2011ZX09307-002-02]; National Natural Science Foundation of China 443 [20932007, 21372214]	National New Drug Innovation 441 Major Project of 442 China; National Natural Science Foundation of China 443	This work was supported by the National New Drug Innovation 441 Major Project of 442 China (2011ZX09307-002-02) and National Natural Science Foundation of China 443 (Grants 20932007 and 21372214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alu'datt MH, 2013, FOOD CHEM, V139, P93, DOI 10.1016/j.foodchem.2012.12.061; Bao L, 2010, NAT PROD RES DEV, V22, P939; [鲍玲 Bao Ling], 2010, [天然产物研究与开发, Natural Product R & D], V22, P934; Bhattacharya P, 2013, REV BRAS FARMACOGN, V23, P342, DOI 10.1590/S0102-695X2013005000020; BHAUMIK PK, 1987, PHYTOCHEMISTRY, V26, P3090, DOI 10.1016/S0031-9422(00)84606-3; Bonfield K, 2012, BIOORGAN MED CHEM, V20, P2603, DOI 10.1016/j.bmc.2012.02.042; Cooke PS, 2004, EXP BIOL MED, V229, P1127, DOI 10.1177/153537020422901107; Dawidowicz AL, 2013, EUR FOOD RES TECHNOL, V236, P1099, DOI 10.1007/s00217-013-1982-1; Du QZ, 2012, FOOD CHEM, V131, P1181, DOI 10.1016/j.foodchem.2011.09.095; Gao DF, 2011, FOOD CHEM, V124, P432, DOI 10.1016/j.foodchem.2010.06.048; Gerothanassis IP, 1998, J AGR FOOD CHEM, V46, P4185, DOI 10.1021/jf9804591; GOLLAPUDI SR, 1989, PHYTOCHEMISTRY, V28, P3556, DOI 10.1016/0031-9422(89)80394-2; KIM SY, 1994, J AM OIL CHEM SOC, V71, P633, DOI 10.1007/BF02540592; Kisiel W, 2000, FITOTERAPIA, V71, P269, DOI 10.1016/S0367-326X(99)00158-6; Krafczyk N, 2008, J AGR FOOD CHEM, V56, P3368, DOI 10.1021/jf703701n; Lee D, 2001, J NAT PROD, V64, P1286, DOI 10.1021/np010288l; Lee JH, 2013, FOOD CHEM, V136, P843, DOI 10.1016/j.foodchem.2012.08.057; Liu YB, 2012, J FUNCT FOODS, V4, P116, DOI 10.1016/j.jff.2011.08.006; Lu DF, 2012, J AGR FOOD CHEM, V60, P8411, DOI 10.1021/jf3022817; McInnes KJ, 2008, BREAST CANCER RES TR, V112, P429, DOI 10.1007/s10549-007-9883-2; Minglu X, 2011, J HENAN I SCI TECHNO, P51; Mun'im A, 2003, BIOSCI BIOTECH BIOCH, V67, P410, DOI 10.1271/bbb.67.410; Nair VD, 2013, IND CROP PROD, V45, P406, DOI 10.1016/j.indcrop.2013.01.008; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Ouyang MA, 2007, J AGR FOOD CHEM, V55, P6460, DOI 10.1021/jf0709808; Pineda B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053902; Reyes JM, 2012, SMALL RUMINANT RES, V106, P178, DOI 10.1016/j.smallrumres.2012.03.017; Ryu HW, 2010, J AGR FOOD CHEM, V58, P202, DOI 10.1021/jf903068k; Sarkar A, 2012, J MOL MODEL, V18, P2621, DOI 10.1007/s00894-011-1274-2; Sashidhara KV, 2013, EUR J MED CHEM, V60, P497, DOI 10.1016/j.ejmech.2012.12.019; Shi J, 2010, MOLECULES, V15, P3556, DOI 10.3390/molecules15053556; Shibano M, 2008, J NAT MED-TOKYO, V62, P349, DOI 10.1007/s11418-008-0244-1; Shoeb M, 2007, J NAT MED, V61, P164, DOI 10.1007/s11418-006-0117-4; Stauffer F, 2012, BIOORG MED CHEM LETT, V22, P1860, DOI 10.1016/j.bmcl.2012.01.076; Suvannang N, 2011, MOLECULES, V16, P3597, DOI 10.3390/molecules16053597; Tang WW, 2012, FITOTERAPIA, V83, P513, DOI 10.1016/j.fitote.2011.12.016; Tarola AM, 2013, FOOD ANAL METHOD, V6, P227, DOI 10.1007/s12161-012-9431-5; ter Veld MGR, 2006, J AGR FOOD CHEM, V54, P4407, DOI 10.1021/jf052864f; Xiong Y, 2009, CHINA FOREST SCI TEC, V23, P42; Xu ML, 2010, FOOD SCI BIOTECHNOL, V19, P677, DOI 10.1007/s10068-010-0095-x; Yang CY, 2013, NAT PROD RES, V27, P2055, DOI 10.1080/14786419.2013.811660; Yang CY, 2012, J SEP SCI, V35, P977, DOI 10.1002/jssc.201101104; Yang LJ, 2013, J ETHNOPHARMACOL, V145, P715, DOI 10.1016/j.jep.2012.11.031; Yang YH, 2012, AQUACULTURE, V350, P1, DOI 10.1016/j.aquaculture.2012.04.031; Yao Y, 2011, INT J MOL SCI, V12, P6445, DOI 10.3390/ijms12106445; Yi B, 2011, MOLECULES, V16, P10157, DOI 10.3390/molecules161210157; Zheng ZP, 2008, FOOD CHEM, V106, P529, DOI 10.1016/j.foodchem.2007.06.037; Zhu LF, 2012, J AGR FOOD CHEM, V60, P12170, DOI 10.1021/jf302726t	48	9	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94198	10.1371/journal.pone.0094198	http://dx.doi.org/10.1371/journal.pone.0094198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714659	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900104
J	Gentle, BN; Pillsworth, EG; Goetz, AT				Gentle, Brooke N.; Pillsworth, Elizabeth G.; Goetz, Aaron T.			Changes in Sleep Time and Sleep Quality across the Ovulatory Cycle as a Function of Fertility and Partner Attractiveness	PLOS ONE			English	Article							MENSTRUAL-CYCLE; SCENT; YOUNG; MEN	Research suggests that near ovulation women tend to consume fewer calories and engage in more physical activity; they are judged to be more attractive, express greater preferences for masculine and symmetrical men, and experience increases in sexual desire for men other than their primary partners. Some of these cycle phase shifts are moderated by partner attractiveness and interpreted as strategic responses to women's current reproductive context. The present study investigated changes in sleep across the ovulatory cycle, based on the hypothesis that changes in sleep may reflect ancestral strategic shifts of time and energy toward reproductive activities. Participants completed a 32-day daily diary in which they recorded their sleep time and quality for each day, yielding over 1,000 observations of sleep time and quality. Results indicated that, when the probability of conception was high, women partnered with less attractive men slept more, while women with more attractive partners slept less.	[Gentle, Brooke N.] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92717 USA; [Pillsworth, Elizabeth G.] Calif State Univ Fullerton, Dept Anthropol, Fullerton, CA 92634 USA; [Goetz, Aaron T.] Calif State Univ Fullerton, Dept Psychol, Fullerton, CA 92634 USA	University of California System; University of California Irvine; California State University System; California State University Fullerton; California State University System; California State University Fullerton	Gentle, BN (corresponding author), Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA 92717 USA.	bgentle@uci.edu	Pillsworth, Elizabeth G/C-3327-2011					Abu-Lughod Lila, 1986, VEILED SENTIMENTS HO; Acerbi A, 2011, ANIM BEHAV, V81, P801, DOI 10.1016/j.anbehav.2011.01.015; Baker FC, 2004, J PSYCHOSOM RES, V56, P239, DOI 10.1016/S0022-3999(03)00067-9; Baker FC, 2007, SLEEP MED, V8, P613, DOI 10.1016/j.sleep.2006.09.011; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; Bryant GA, 2009, BIOL LETTERS, V5, P12, DOI 10.1098/rsbl.2008.0507; Chavanne TJ, 1998, EVOL HUM BEHAV, V19, P27, DOI 10.1016/S1090-5138(98)00016-6; Descola P, 1993, SPEARS TWILIGHT LIFE; Diamond J., 1998, WHY IS SEX FUN EVOLU; Driver HS, 1996, J CLIN ENDOCR METAB, V81, P728, DOI 10.1210/jc.81.2.728; Durante KM, 2008, PERS SOC PSYCHOL B, V34, P1451, DOI 10.1177/0146167208323103; Fehring RJ, 2006, JOGNN-J OBST GYN NEO, V35, P376, DOI 10.1111/j.1552-6909.2006.00051.x; Fessler D. M., 2003, SEXUALITIES EVOLUTIO, V5, P127, DOI [10.1080/14616660410001662361, DOI 10.1080/14616660410001662361]; Fessler DMT, 2003, EVOL HUM BEHAV, V24, P406, DOI 10.1016/S1090-5138(03)00054-0; Fessler DMT, 2003, Q REV BIOL, V78, P3, DOI 10.1086/367579; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gangestad SW, 2005, CURR DIR PSYCHOL SCI, V14, P312, DOI 10.1111/j.0963-7214.2005.00388.x; Gildersleeve KA, 2012, HORM BEHAV, V61, P157, DOI 10.1016/j.yhbeh.2011.11.005; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Haselton MG, 2011, CURR DIR PSYCHOL SCI, V20, P87, DOI 10.1177/0963721411402668; Haselton MG, 2006, HORM BEHAV, V49, P509, DOI 10.1016/j.yhbeh.2005.10.006; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hua C., 2001, SOC FATHERS HUSBANDS; Kruger D. J., 2011, J SOCIAL EVOLUTIONAR, V5, P239, DOI [10.1037/h0099259, DOI 10.1037/H0099259]; Larson CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044456; Larson CM, 2012, HORM BEHAV, V63, P128; Lieberman D, 2011, PSYCHOL SCI, V22, P13, DOI 10.1177/0956797610390385; Marlowe F. W., 2010, HADZA HUNTER GATHERE, V3; Miller G, 2007, EVOL HUM BEHAV, V28, P375, DOI 10.1016/j.evolhumbehav.2007.06.002; Murdock G. P., 1981, ATLAS WORLD CULTURES; Petralia SM, 2002, EVOL HUM BEHAV, V23, P3, DOI 10.1016/S1090-5138(01)00085-X; Pillsworth E. G., 2006, ANN REV SEX RES, V17, P59, DOI DOI 10.1080/10532528.2006.10559837; Pillsworth EG, 2006, EVOL HUM BEHAV, V27, P247, DOI 10.1016/j.evolhumbehav.2005.10.002; Pipitone RN, 2008, EVOL HUM BEHAV, V29, P268, DOI 10.1016/j.evolhumbehav.2008.02.001; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Scharf MT, 2008, PROG NEUROBIOL, V86, P264, DOI 10.1016/j.pneurobio.2008.08.003; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Shostak M., 1981, NISA LIFE WORDS KUNG; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3	44	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92796	10.1371/journal.pone.0092796	http://dx.doi.org/10.1371/journal.pone.0092796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710508	Green Published, gold			2022-12-27	WOS:000334159800017
J	Konarev, PV; Kachalova, GS; Ryazanova, AY; Kubareva, EA; Karyagina, AS; Bartunik, HD; Svergun, DI				Konarev, Petr V.; Kachalova, Galina S.; Ryazanova, Alexandra Yu; Kubareva, Elena A.; Karyagina, Anna S.; Bartunik, Hans D.; Svergun, Dmitri I.			Flexibility of the Linker between the Domains of DNA Methyltransferase SsoII Revealed by Small-Angle X-Ray Scattering: Implications for Transcription Regulation in SsoII Restriction-Modification System	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROMOTER REGION; BIOLOGICAL MACROMOLECULES; HHAI METHYLTRANSFERASE; MOLECULAR-BIOLOGY; EXPRESSION; BINDING; METHYLATION; PROTEINS; COMPLEX	Cytosine-5)-DNA methyltransferase SsoII (M. SsoII) consists of a methyltransferase domain (residues 72-379) and an N-terminal region (residues 1-71) which regulates transcription in SsoII restriction-modification system. Small-angle X-ray scattering (SAXS) is employed here to study the low resolution structure of M.SsoII and its complex with DNA containing the methylation site. The shapes reconstructed ab initio from the SAXS data reveal two distinct protein domains of unequal size. The larger domain matches the crystallographic structure of a homologous DNA methyltransferase HhaI (M.HhaI), and the cleft in this domain is occupied by DNA in the model of the complex reconstructed from the SAXS data. This larger domain can thus be identified as the methyltransferase domain whereas the other domain represents the N-terminal region. Homology modeling of the M.SsoII structure is performed by using the model of M.HhaI for the methyltransferase domain and representing the N-terminal region either as a flexible chain of dummy residues or as a rigid structure of a homologous protein (phage 434 repressor) connected to the methyltransferase domain by a short flexible linker. Both models are compatible with the SAXS data and demonstrate high mobility of the N-terminal region. The linker flexibility might play an important role in the function of M.SsoII as a transcription factor.	[Konarev, Petr V.; Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstat, Hamburg, Germany; [Kachalova, Galina S.; Bartunik, Hans D.] Russian Acad Sci, Bach Inst Biochem, Moscow, Russia; [Ryazanova, Alexandra Yu; Kubareva, Elena A.; Karyagina, Anna S.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Karyagina, Anna S.] NF Gamalei Inst Epidemiol & Microbiol, Moscow, Russia; [Karyagina, Anna S.] Russian Acad Sci, Inst Agr Biotechnol, Moscow, Russia	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences	Svergun, DI (corresponding author), DESY, European Mol Biol Lab, Hamburg Outstat, Hamburg, Germany.	svergun@embl-hamburg.de	kachalova, galina/AAD-9742-2019; Kubareva, Elena A/I-3184-2012; Kachalova, Galina S/J-9437-2015; Ryazanova, Alexandra/E-9427-2012; Karyagina, Anna/I-7159-2012; Konarev, Petr V/W-1380-2017	Kachalova, Galina S/0000-0002-8240-6287; Ryazanova, Alexandra/0000-0002-3503-779X; Karyagina, Anna/0000-0002-2580-3489; Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696	Max-Planck-Gesellschaft zur Forderung der Wissenschaften; Russian Foundation for Basic Research [13-04-00615_a, 12-04-32103]; Max-Planck fellowship; German Ministry of Education and Science (BMBF) project BIOSCAT [05K20912]	Max-Planck-Gesellschaft zur Forderung der Wissenschaften(Max Planck Society); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Max-Planck fellowship(Max Planck Society); German Ministry of Education and Science (BMBF) project BIOSCAT(Federal Ministry of Education & Research (BMBF))	This work was supported by Max-Planck-Gesellschaft zur Forderung der Wissenschaften and by Russian Foundation for Basic Research (grant nos. 13-04-00615_a and 12-04-32103). A.Yu.R. was a recipient of a Max-Planck fellowship. D. I. S. and P. V. K. acknowledge support from the German Ministry of Education and Science (BMBF) project BIOSCAT, Grant 05K20912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball N, 2009, ACTA CRYSTALLOGR D, V65, P900, DOI 10.1107/S0907444909020514; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beletskaya IV, 2000, NUCLEIC ACIDS RES, V28, P3817, DOI 10.1093/nar/28.19.3817; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Burenina OY, 2013, ACTA NATURAE, V5, P70, DOI 10.32607/20758251-2013-5-2-70-80; Butler D, 2001, J BACTERIOL, V183, P4668, DOI 10.1128/JB.183.15.4668-4673.2001; Dong AP, 2004, BIOL CHEM, V385, P373, DOI 10.1515/bchm.385.13.373.57208; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P1579, DOI 10.1093/nar/20.7.1579; FRIEDMAN S, 1993, J BACTERIOL, V175, P6293, DOI 10.1128/JB.175.19.6293-6298.1993; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Karyagina A, 1997, NUCLEIC ACIDS RES, V25, P2114, DOI 10.1093/nar/25.11.2114; Karyagina A. S., 2003, Biophysics, V48, pS45; KARYAGINA AS, 1995, GENE, V157, P93, DOI 10.1016/0378-1119(94)00667-H; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kobayashi I, 2004, NUCL ACID M, V14, P19; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kubareva EA, 2002, BIOTECHNIQUES, V33, P526, DOI 10.2144/02333st02_11839a; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; McGeehan JE, 2011, J MOL BIOL, V409, P177, DOI 10.1016/j.jmb.2011.03.033; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; Nagornykh M O, 2008, Genetika, V44, P606; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; NARDONE G, 1984, J BIOL CHEM, V259, P357; NIKOLSKAYA II, 1984, BIOCHEM INT, V9, P771; O'Driscoll J, 2005, MOL MICROBIOL, V57, P1532, DOI 10.1111/j.1365-2958.2005.04769.x; O'Gara M, 1999, J MOL BIOL, V287, P201, DOI 10.1006/jmbi.1999.2608; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Protsenko A, 2009, NUCLEIC ACIDS RES, V37, P5322, DOI 10.1093/nar/gkp579; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; RODGERS DW, 1993, STRUCTURE, V1, P227, DOI 10.1016/0969-2126(93)90012-6; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Ryazanova AY, 2011, ANALYST, V136, P1227, DOI 10.1039/c0an00545b; Ryazanova AY, 2010, MOL BIOL+, V44, P807, DOI 10.1134/S0026893310050183; Ryazanova AY, 2011, NUCLEOS NUCLEOT NUCL, V30, P632, DOI 10.1080/15257770.2011.584339; Ryazanova AY, 2012, METHYLATION DNA RNA, P29; Sawaya MR, 2005, STRUCTURE, V13, P1837, DOI 10.1016/j.str.2005.08.017; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Shilov I, 1998, NUCLEIC ACIDS RES, V26, P2659, DOI 10.1093/nar/26.11.2659; SOM S, 1993, EMBO J, V12, P4297, DOI 10.1002/j.1460-2075.1993.tb06114.x; Som S, 1997, J BACTERIOL, V179, P964, DOI 10.1128/jb.179.3.964-967.1997; Streeter SD, 2004, NUCLEIC ACIDS RES, V32, P6445, DOI 10.1093/nar/gkh975; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thomas CB, 2006, NUCLEIC ACIDS RES, V34, P806, DOI 10.1093/nar/gkj486; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorob'eva OV, 2002, RUSS J BIOORG CHEM+, V28, P363, DOI 10.1023/A:1020463810179; Vorob'eva OV, 2000, MOL BIOL+, V34, P921, DOI 10.1023/A:1026640212498	56	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93453	10.1371/journal.pone.0093453	http://dx.doi.org/10.1371/journal.pone.0093453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710319	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800034
J	Miyagawa, K; Yamazaki, M; Kawai, M; Nishino, J; Koshimizu, T; Ohata, Y; Tachikawa, K; Mikuni-Takagaki, Y; Kogo, M; Ozono, K; Michigami, T				Miyagawa, Kazuaki; Yamazaki, Miwa; Kawai, Masanobu; Nishino, Jin; Koshimizu, Takao; Ohata, Yasuhisa; Tachikawa, Kanako; Mikuni-Takagaki, Yuko; Kogo, Mikihiko; Ozono, Keiichi; Michigami, Toshimi			Dysregulated Gene Expression in the Primary Osteoblasts and Osteocytes Isolated from Hypophosphatemic Hyp Mice	PLOS ONE			English	Article							X-LINKED HYPOPHOSPHATEMIA; VITAMIN-D METABOLISM; PHOSPHATE HOMEOSTASIS; INORGANIC-PHOSPHATE; MINERAL METABOLISM; TARGETED ABLATION; DIETARY PHOSPHATE; FGF23 EXPRESSION; IN-VITRO; PEX GENE	Osteocytes express multiple genes involved in mineral metabolism including PHEX, FGF23, DMP1 and FAM20C. In Hyp mice, a murine model for X-linked hypophosphatemia (XLH),Phex deficiency results in the overproduction of FGF23 in osteocytes, which leads to hypophosphatemia and impaired vitamin D metabolism. In this study, to further clarify the abnormality in osteocytes of Hyp mice, we obtained detailed gene expression profiles in osteoblasts and osteocytes isolated from the long bones of 20-week-old Hyp mice and wild-type (WT) control mice. The expression of Fgf23, Dmp1, and Fam20c was higher in osteocytic cells than in osteoblastic cells in both genotypes, and was up-regulated in Hyp cells. Interestingly, the up-regulation of these genes in Hyp bones began before birth. On the other hand, the expression of Slc20a1 encoding the sodium/phosphate (Na+/Pi) co-transporter Pit1 was increased in osteoblasts and osteocytes from adult Hyp mice, but not in Hyp fetal bones. The direct effects of extracellular Pi and 1,25-dihydroxyvitamin D-3 [ 1,25( OH) D-2(3)] on isolated osteoblastic and osteocytic cells were also investigated. Twenty-four-hour treatment with 10(-8) M 1,25(OH)(2)D-3 increased the expression of Fgf23 in WT osteoblastic cells but not in osteocytic cells. Dmp1 expression in osteocytic cells was increased due to the 24-hour treatment with 10 mM Pi and was suppressed by 10(-8) M 1,25(OH)(2)D-3 in WT osteocytic cells. We also found the up-regulation of the genes for FGF1, FGF2, their receptors, and Egr-1 which is a target of FGF signaling, in Hyp osteocytic cells, suggesting the activation of FGF/FGFR signaling. These results implicate the complex gene dysregulation in osteoblasts and osteocytes of Hyp mice, which might contribute to the pathogenesis.	[Miyagawa, Kazuaki; Yamazaki, Miwa; Kawai, Masanobu; Nishino, Jin; Koshimizu, Takao; Ohata, Yasuhisa; Tachikawa, Kanako; Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Osaka, Japan; [Miyagawa, Kazuaki; Yamazaki, Miwa; Kawai, Masanobu; Nishino, Jin; Koshimizu, Takao; Ohata, Yasuhisa; Tachikawa, Kanako; Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka, Japan; [Ohata, Yasuhisa; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan; [Miyagawa, Kazuaki; Nishino, Jin; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Mikuni-Takagaki, Yuko] Kanagawa Dent Coll, Dept Mol & Cellular Biol Mineralized Tissues, Yokosuka, Kanagawa 238, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka University; Kanagawa Dental College	Michigami, T (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, Osaka, Japan.	michigami@mch.pref.osaka.jp	Kogo, Mikihiko/ABD-7080-2020; Ohata, Yasuhisa/AAJ-4615-2020; Michigami, Toshimi/AAU-2326-2021	Kogo, Mikihiko/0000-0002-4556-2491; Ohata, Yasuhisa/0000-0001-6084-6620; Kawai, Masanobu/0000-0003-4466-1559; Miyagawa, Kazuaki/0000-0003-4014-1847	Japan Society for the Promotion of Science [23591227]; Grants-in-Aid for Scientific Research [23791216, 23591227] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (No. 23591227). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for the study.	Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Beck L, 1997, J CLIN INVEST, V99, P1200, DOI 10.1172/JCI119276; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cornet A, 1998, J NEUROSCI RES, V53, P742, DOI 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#; Endo I, 2008, BONE, V42, P1235, DOI 10.1016/j.bone.2008.02.014; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Ito N, 2007, J BONE MINER METAB, V25, P419, DOI 10.1007/s00774-007-0779-3; Ito N, 2013, J STEROID BIOCHEM, V136, P183, DOI 10.1016/j.jsbmb.2012.09.029; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Kyono A, 2012, J BONE MINER METAB, V30, P19, DOI 10.1007/s00774-011-0288-2; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; REINHARDT TA, 1990, ENDOCRINOLOGY, V127, P942, DOI 10.1210/endo-127-2-942; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sabbagh Y, 2000, HUM MUTAT, V16, P1; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Ubaidus S, 2009, J ELECTRON MICROSC, V58, P381, DOI 10.1093/jmicro/dfp032; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738	51	38	37	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93840	10.1371/journal.pone.0093840	http://dx.doi.org/10.1371/journal.pone.0093840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710520	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800056
J	Prager, SM; Esquivel, I; Trumble, JT				Prager, Sean M.; Esquivel, Isaac; Trumble, John T.			Factors Influencing Host Plant Choice and Larval Performance in Bactericera cockerelli	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; HEMIPTERA TRIOZIDAE; LIFE-HISTORY; POTATO; SELECTION; PREFERENCE; LEPIDOPTERA; HOMOPTERA; MEMORY; TOMATO	Among the many topics of interest to ecologists studying associations between phytophagous insects and their host plants are the influence of natal host plant on future oviposition decisions and the mechanisms of generalist versus specialist host selection behavior. In this study, we examined the oviposition preferences, behavior and larval development of the tomato/potato psyllid, Bactericera cockerelli. By rearing psyllids with two distinct geographically-linked haplotypes on different host plants, we were able to examine the role of natal host plant and potential local adaptation on host plant usage. Choice bioassays among three host species demonstrated that psyllids from California had clear preferences that were influenced by natal plant. We further found that patterns in choice bioassays corresponded to observed feeding and movement responses. No-choice bioassays demonstrated that there is little to no association between development and host-plant choice for oviposition, while also indicating that host choice varies between haplotypes. These findings support the concept that mothers do not always choose oviposition sites optimally and also add support for the controversial Hopkins' host selection principle.	[Prager, Sean M.; Esquivel, Isaac; Trumble, John T.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Prager, SM (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	sprager@ucr.edu		Esquivel, Isaac/0000-0002-2242-0466	USDA SCRI [2009-34381-20036]; California Department of Food and Agriculture (CDFA) Speciality Crop Block [SCB11052]	USDA SCRI(United States Department of Agriculture (USDA)); California Department of Food and Agriculture (CDFA) Speciality Crop Block	This research was partially funded by a USDA SCRI grant (2009-34381-20036) and a California Department of Food and Agriculture (CDFA) Speciality Crop Block Grant SCB11052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Berdegue M, 1996, ENTOMOL EXP APPL, V78, P253, DOI 10.1111/j.1570-7458.1996.tb00789.x; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Blackiston DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001736; Butler Casey D., 2012, Terrestrial Arthropod Reviews, V5, P87, DOI 10.1163/187498312X634266; Butler CD, 2012, ENTOMOL EXP APPL, V142, P247, DOI 10.1111/j.1570-7458.2012.01219.x; Butler CD, 2011, J ECON ENTOMOL, V104, P586, DOI 10.1603/EC10285; Casteel CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035191; Clark KE, 2011, ECOL ENTOMOL, V36, P117, DOI 10.1111/j.1365-2311.2010.01248.x; CORBET SA, 1985, ECOL ENTOMOL, V10, P143, DOI 10.1111/j.1365-2311.1985.tb00543.x; Crawley M. J., 1983, Herbivory. The dynamics of animal--plant interactions.; Crosslin JM, 2009, AM J POTATO RES, V86, P183, DOI 10.1007/s12230-009-9070-6; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; Dunlap AS, 2012, BEHAV PROCESS, V89, P86, DOI 10.1016/j.beproc.2011.10.005; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Forister ML, 2013, OIKOS, V122, P657, DOI 10.1111/j.1600-0706.2013.00251.x; Fox J., 2018, R COMPANION APPL REG, VThird; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Futuyma D.J., 1983, COEVOLUTION; Gao F, 2009, INSECT SCI, V16, P399, DOI 10.1111/j.1744-7917.2009.01261.x; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Hansen AK, 2013, MOL ECOL; HODKINSON ID, 1974, B ENTOMOL RES, V64, P325, DOI 10.1017/S0007485300031217; Hopkins AD, 1916, EC INVESTIGATIONS SC, P353; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Janz N, 2005, J INSECT BEHAV, V18, P767, DOI 10.1007/s10905-005-8739-z; Johnson SN, 2006, ECOL ENTOMOL, V31, P395, DOI 10.1111/j.1365-2311.2006.00776.x; KAROWE DN, 1990, EVOLUTION, V44, P1637, DOI 10.1111/j.1558-5646.1990.tb03852.x; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; Liu D, 2006, B ENTOMOL RES, V96, P197, DOI 10.1079/BER2005416; Liu D, 2007, ENTOMOL EXP APPL, V123, P35, DOI 10.1111/j.1570-7458.2007.00521.x; Liu DG, 2005, CROP PROT, V24, P111, DOI 10.1016/j.cropro.2004.07.001; Liu DG, 2004, J ECON ENTOMOL, V97, P1078, DOI 10.1603/0022-0493(2004)097[1078:TPBRTT]2.0.CO;2; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Martin Nicholas A., 2008, Weta, V35, P12; Matkin OA, 1957, UC TYPE SOIL MIXES; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MOPPER S, 1995, EVOLUTION, V49, P810, DOI [10.2307/2410404, 10.1111/j.1558-5646.1995.tb02317.x]; Munyaneza JE, 2013, PLANT DIS, V97, P1654, DOI 10.1094/PDIS-06-13-0641-PDN; Munyaneza JE, 2013, PLANT DIS, V97, P1244, DOI 10.1094/PDIS-03-13-0247-PDN; MUNYANEZA JE, 2007, SUBTROPICAL PLANT SC, V59, P30; NANTHAGOPAL R, 1989, CROP PROT, V8, P133, DOI 10.1016/0261-2194(89)90089-6; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oksanen J., 2011, MULTIVARIATE ANAL EC; PHILLIPS WM, 1977, ENTOMOL EXP APPL, V21, P71, DOI 10.1007/BF00300343; PLETSCH D. J., 1947, Bull. Mont. agric. Exp. Stn., V446; Prager SM, 2013, PEST MANAG SCI, V69, P1131, DOI 10.1002/ps.3475; Price PW, 2011, INSECT ECOLOGY; Ray S, 1999, NEUROSCI LETT, V259, P37, DOI 10.1016/S0304-3940(98)00892-1; Rietdorf K, 2002, PHYSIOL ENTOMOL, V27, P223, DOI 10.1046/j.1365-3032.2002.00289.x; Scheirs J, 2000, P ROY SOC B-BIOL SCI, V267, P2065, DOI 10.1098/rspb.2000.1250; Scheirs J, 2002, OIKOS, V96, P187, DOI 10.1034/j.1600-0706.2002.960121.x; SMITH MA, 1979, ANIM BEHAV, V27, P365, DOI 10.1016/0003-3472(79)90170-2; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Thomas K. L., 2011, New Zealand Plant Protection, V64, P259; Thoming G, 2013, ECOLOGY, V94, P1744, DOI 10.1890/12-0907.1; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; TULLY T, 1994, J NEUROSCI, V14, P68; Underwood NC, 1998, OECOLOGIA, V114, P376, DOI 10.1007/s004420050460; VALLADARES G, 1991, J ANIM ECOL, V60, P227, DOI 10.2307/5456; Van Klinken RD, 2000, ECOL ENTOMOL, V25, P413, DOI 10.1046/j.1365-2311.2000.00274.x; vanEmden HF, 1996, PHYSIOL ENTOMOL, V21, P325, DOI 10.1111/j.1365-3032.1996.tb00873.x; Venables WN., 2002, MODERN APPL STAT S, V4; Wallis CM, 2013, PHYTOPATHOLOGY, V103, P154; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; WALLIS RL, 1951, J ECON ENTOMOL, V44, P815, DOI 10.1093/jee/44.5.815; White I.M., 1985, Bulletin of the British Museum (Natural History) Entomology, V50, P153; WIKLUND C, 1981, OIKOS, V36, P163, DOI 10.2307/3544441; WIKLUND C, 1975, OECOLOGIA, V18, P185, DOI 10.1007/BF00345421; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yang XB, 2010, J ECON ENTOMOL, V103, P1729, DOI 10.1603/EC10083; Yang XB, 2009, ENVIRON ENTOMOL, V38, P1661, DOI 10.1603/022.038.0619; ZHANG ML, 1993, J CHEM ECOL, V19, P1109, DOI 10.1007/BF00987372	89	24	26	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94047	10.1371/journal.pone.0094047	http://dx.doi.org/10.1371/journal.pone.0094047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710468	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800095
J	Calbet, A; Sazhin, AF; Nejstgaard, JC; Berger, SA; Tait, ZS; Olmos, L; Sousoni, D; Isari, S; Martinez, RA; Bouquet, JM; Thompson, EM; Bamstedt, U; Jakobsen, HH				Calbet, Albert; Sazhin, Andrey F.; Nejstgaard, Jens C.; Berger, Stella A.; Tait, Zachary S.; Olmos, Lorena; Sousoni, Despoina; Isari, Stamatina; Martinez, Rodrigo A.; Bouquet, Jean-Marie; Thompson, Eric M.; Bamstedt, Ulf; Jakobsen, Hans H.			Future Climate Scenarios for a Coastal Productive Planktonic Food Web Resulting in Microplankton Phenology Changes and Decreased Trophic Transfer Efficiency	PLOS ONE			English	Article							OCEAN ACIDIFICATION; MARINE-PHYTOPLANKTON; INCREASED TEMPERATURE; NUTRIENT ENRICHMENT; COMMUNITY STRUCTURE; INCREASED PCO(2); GRAZING IMPACT; SPRING BLOOM; GROWTH; CO2	We studied the effects of future climate change scenarios on plankton communities of a Norwegian fjord using a mesocosm approach. After the spring bloom, natural plankton were enclosed and treated in duplicates with inorganic nutrients elevated to pre-bloom conditions (N, P, Si; eutrophication), lowering of 0.4 pH units (acidification), and rising 3 degrees C temperature (warming). All nutrient-amended treatments resulted in phytoplankton blooms dominated by chain-forming diatoms, and reached 13-16 mu g chlorophyll (chl) a l(-1). In the control mesocosms, chl a remained below 1 mu g l(-1). Acidification and warming had contrasting effects on the phenology and bloom-dynamics of autotrophic and heterotrophic microplankton. Bacillariophyceae, prymnesiophyceae, cryptophyta, and Protoperidinium spp. peaked earlier at higher temperature and lower pH. Chlorophyta showed lower peak abundances with acidification, but higher peak abundances with increased temperature. The peak magnitude of autotrophic dinophyceae and ciliates was, on the other hand, lowered with combined warming and acidification. Over time, the plankton communities shifted from autotrophic phytoplankton blooms to a more heterotrophic system in all mesocosms, especially in the control unaltered mesocosms. The development of mass balance and proportion of heterotrophic/autotrophic biomass predict a shift towards a more autotrophic community and less-efficient food web transfer when temperature, nutrients and acidification are combined in a future climate-change scenario. We suggest that this result may be related to a lower food quality for microzooplankton under acidification and warming scenarios and to an increase of catabolic processes compared to anabolic ones at higher temperatures.	[Calbet, Albert; Olmos, Lorena; Isari, Stamatina; Martinez, Rodrigo A.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Sazhin, Andrey F.] PP Shirshov Inst Oceanol RAS, Moscow, Russia; [Nejstgaard, Jens C.; Berger, Stella A.; Tait, Zachary S.] Univ Georgia, Skidaway Inst Oceanog, Savannah, GA USA; [Berger, Stella A.; Bouquet, Jean-Marie; Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway; [Olmos, Lorena] CSIC, Inst Invest Marinas, Vigo, Spain; [Sousoni, Despoina] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Isari, Stamatina] Hellen Ctr Marine Res, Inst Oceanog, Athens, Greece; [Bouquet, Jean-Marie; Thompson, Eric M.] Univ Bergen, Sars Int Ctr, Uni Res, Bergen, Norway; [Bamstedt, Ulf] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Jakobsen, Hans H.] Aarhus Univ, Dept Biosci, Roskilde, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Russian Academy of Sciences; Shirshov Institute of Oceanology; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; University of Bergen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Crete; Hellenic Centre for Marine Research; University of Bergen; Umea University; Aarhus University	Calbet, A (corresponding author), CSIC, Inst Ciencies Mar, Barcelona, Spain.	acalbet@icm.csic.es	Isari, Stamatina/J-6987-2014; Nejstgaard, Jens/ABB-8903-2020; Jakobsen, Hans/I-7200-2013; Calbet, Albert/A-7779-2008	Isari, Stamatina/0000-0003-3457-0274; Nejstgaard, Jens/0000-0003-1236-0647; Jakobsen, Hans/0000-0001-9590-2362; Calbet, Albert/0000-0003-1069-212X; Sousoni, Despoina/0000-0002-5426-7881	MESOAQUA -EU [FP7-INFRA-2008-1, 228224]; Norwegian Research Council [NFR-HK 2024040/E40]; Ministry of Science and Innovation [CTM2009-08783, CTM2011-23480]; VELUX foundation [VKR022608]	MESOAQUA -EU; Norwegian Research Council(Research Council of NorwayEuropean Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); VELUX foundation(Velux Fonden)	This research was funded through the projects BIOPUMP (EMT) and CYCLE from MESOAQUA -EU FP7-INFRA-2008-1, 228224 to (M. Winder & group members), the Norwegian Research Council grant NFR-HK 2024040/E40 (EMT), the project PROTOS (CTM2009-08783), and TopCop (CTM2011-23480) from the Ministry of Science and Innovation (AC). HHJ received financial support from the VELUX foundation (grant VKR022608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2007, OECOLOGIA, V150, P668, DOI 10.1007/s00442-006-0540-y; Aberle N, 2013, BIOGEOSCIENCES, V10, P1471, DOI 10.5194/bg-10-1471-2013; Aberle N, 2012, MAR BIOL, V159, P2441, DOI 10.1007/s00227-012-1947-0; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Berge T, 2010, MAR ECOL PROG SER, V416, P79, DOI 10.3354/meps08780; Berger SA, 2010, GLOBAL CHANGE BIOL, V16, P1954, DOI 10.1111/j.1365-2486.2009.02134.x; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Calbet A, 1996, J PLANKTON RES, V18, P2329, DOI 10.1093/plankt/18.12.2329; Calbet A, 2008, ICES J MAR SCI, V65, P325, DOI 10.1093/icesjms/fsn013; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CARON DA, 1983, APPL ENVIRON MICROB, V46, P491, DOI 10.1128/AEM.46.2.491-498.1983; CARON DA, 1986, APPL ENVIRON MICROB, V52, P1340, DOI 10.1128/AEM.52.6.1340-1347.1986; Chen BZ, 2012, LIMNOL OCEANOGR, V57, P519, DOI 10.4319/lo.2012.57.2.0519; Chi YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056482; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Grasshoff K., 1983, METHODS SEA WATER AN, V2nd; GREBECKI A., 1962, BULL ACAD POLON SCI SER SCI BIOL, V10, P483; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Hutchins DA, 2003, LIMNOL OCEANOGR-METH, V1, P82; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jakobsen HH, 2011, AQUAT MICROB ECOL, V65, P75, DOI 10.3354/ame01539; Kemp WM, 2001, MAR ECOL PROG SER, V223, P73, DOI 10.3354/meps223073; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Lewandowska A, 2010, MAR ECOL PROG SER, V405, P101, DOI 10.3354/meps08520; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Mackas DL, 1998, CAN J FISH AQUAT SCI, V55, P1878, DOI 10.1139/cjfas-55-8-1878; Meakin NG, 2011, ISME J, V5, P1397, DOI 10.1038/ismej.2011.18; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Mitchell JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059548; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Paulino AI, 2008, BIOGEOSCIENCES, V5, P739, DOI 10.5194/bg-5-739-2008; Pedersen MF, 2003, MAR ECOL PROG SER, V260, P33, DOI 10.3354/meps260033; Regaudie-De-Gioux A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003907; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riegman R, 1995, WATER SCI TECHNOL, V32, P63, DOI 10.1016/0273-1223(95)00682-6; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; Rose JM, 2009, MAR ECOL PROG SER, V388, P27, DOI 10.3354/meps08134; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Sazhin AF, 2007, BIOGEOCHEMISTRY, V83, P137, DOI 10.1007/s10533-007-9086-2; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; Smith WO, 2003, DEEP-SEA RES PT II, V50, P605, DOI 10.1016/S0967-0645(02)00586-6; Sommer U, 2007, OECOLOGIA, V150, P655, DOI 10.1007/s00442-006-0539-4; Sommer U, 2012, MAR BIOL, V159, P2479, DOI [10.1007/s00227-012-2085-4, 10.1007/s00227-012-1897-6]; STOECKER DK, 1994, MAR ECOL PROG SER, V110, P293, DOI 10.3354/meps110293; Straile D, 1997, LIMNOL OCEANOGR, V42, P1375, DOI 10.4319/lo.1997.42.6.1375; Suffrian K, 2008, BIOGEOSCIENCES, V5, P1145, DOI 10.5194/bg-5-1145-2008; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Taraldsvik M, 2000, EUR J PHYCOL, V35, P189, DOI 10.1017/S0967026200002687; THORESEN SS, 1984, J EXP MAR BIOL ECOL, V83, P149, DOI 10.1016/0022-0981(84)90042-X; Troedsson C, 2013, MAR BIOL, V160, P2175, DOI 10.1007/s00227-012-2137-9; Verschoor AM, 2013, FRESHWATER BIOL, V58, P597, DOI 10.1111/j.1365-2427.2012.02833.x; WEISSE T, 1990, LIMNOL OCEANOGR, V35, P781, DOI 10.4319/lo.1990.35.4.0781; Winder M, 2012, MAR BIOL, V159, P2491, DOI 10.1007/s00227-012-1964-z; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222	73	43	44	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94388	10.1371/journal.pone.0094388	http://dx.doi.org/10.1371/journal.pone.0094388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721992	Green Published, gold			2022-12-27	WOS:000336909100063
J	Law, C; Paquet, M; Kania, A				Law, Chris; Paquet, Michel; Kania, Artur			Emergence of Motor Circuit Activity	PLOS ONE			English	Article							ISOLATED SPINAL-CORD; METHYL-D-ASPARTATE; CHICK-EMBRYO; ACTIVATION PATTERNS; ELECTRICAL-ACTIVITY; NETWORK ACTIVITY; SYNAPTIC DRIVE; CALCIUM WAVES; HIND-LIMB; MOTONEURONS	In the developing nervous system, ordered neuronal activity patterns can occur even in the absence of sensory input and to investigate how these arise, we have used the model system of the embryonic chicken spinal motor circuit, focusing on motor neurons of the lateral motor column (LMC). At the earliest stages of their molecular differentiation, we can detect differences between medial and lateral LMC neurons in terms of expression of neurotransmitter receptor subunits, including CHRNA5, CHRNA7, GRIN2A, GRIK1, HTR1A and HTR1B, as well as the KCC2 transporter. Using patch-clamp recordings we also demonstrate that medial and lateral LMC motor neurons have subtly different activity patterns that reflect the differential expression of neurotransmitter receptor subunits. Using a combination of patch-clamp recordings in single neurons and calcium-imaging of motor neuron populations, we demonstrate that inhibition of nicotinic, muscarinic or GABA-ergic activity, has profound effects of motor circuit activity during the initial stages of neuromuscular junction formation. Finally, by analysing the activity of large populations of motor neurons at different developmental stages, we show that the asynchronous, disordered neuronal activity that occurs at early stages of circuit formation develops into organised, synchronous activity evident at the stage of LMC neuron muscle innervation. In light of the considerable diversity of neurotransmitter receptor expression, activity patterns in the LMC are surprisingly similar between neuronal types, however the emergence of patterned activity, in conjunction with the differential expression of transmitter systems likely leads to the development of near-mature patterns of locomotor activity by perinatal ages.	[Law, Chris; Paquet, Michel; Kania, Artur] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Kania, Artur] McGill Univ, Dept Anat & Cell Biol, Div Expt Med, Montreal, PQ, Canada; [Kania, Artur] McGill Univ, Dept Biol, Div Expt Med, Montreal, PQ H3A 1B1, Canada; [Kania, Artur] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; Universite de Montreal	Kania, A (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	artur.kania@ircm.qc.ca		Kania, Artur/0000-0002-5209-2520	Canadian Institutes of Health Research [MOP-77556]; Natural Sciences and Engineering Research Council of Canada; Brain Canada; W. Garfield Weston Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Brain Canada; W. Garfield Weston Foundation	This work is funded by grants to Artur Kania from the Canadian Institutes of Health Research (Operating Grant MOP-77556), the Natural Sciences and Engineering Research Council of Canada, Brain Canada and the W. Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Benjumeda I, 2013, J NEUROSCI, V33, P18208, DOI 10.1523/JNEUROSCI.1931-13.2013; Borda T, 1998, J NEURAL TRANSM, V105, P193, DOI 10.1007/s007020050048; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briz V, 2013, J NEUROSCI, V33, P4317, DOI 10.1523/JNEUROSCI.4907-12.2013; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chub N, 1998, J NEUROSCI, V18, P294; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; COWLEY KC, 1994, NEUROSCI LETT, V171, P147, DOI 10.1016/0304-3940(94)90626-2; Croteau LP, 2011, J NEUROSCI METH, V201, P381, DOI 10.1016/j.jneumeth.2011.08.012; CULLHEIM S, 1977, BRAIN RES, V132, P1, DOI 10.1016/0006-8993(77)90702-8; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Dhande OS, 2012, J COMP NEUROL, V520, P1562, DOI 10.1002/cne.23000; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMBURGER V, 1963, DEV BIOL, V7, P533, DOI 10.1016/0012-1606(63)90140-4; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HOLLEY JA, 1982, J COMP NEUROL, V207, P314, DOI 10.1002/cne.902070403; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Jablonski AM, 2013, ANN NY ACAD SCI, V1279, P54, DOI 10.1111/nyas.12053; Kao TJ, 2009, J NEUROSCI, V29, P5690, DOI 10.1523/JNEUROSCI.0265-09.2009; Karim N, 2013, AMINO ACIDS, V44, P1139, DOI 10.1007/s00726-012-1456-y; Kastanenka KV, 2010, J NEUROSCI, V30, P10575, DOI 10.1523/JNEUROSCI.2773-10.2010; Koch Christof, 1999, P1; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1975, J PHYSIOL-LONDON, V249, P301, DOI 10.1113/jphysiol.1975.sp011017; LANDMESSER LT, 1984, J PHYSIOL-LONDON, V347, P189, DOI 10.1113/jphysiol.1984.sp015061; LANDMESSER LT, 1986, J PHYSIOL-LONDON, V380, P157, DOI 10.1113/jphysiol.1986.sp016278; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; MENDELSON B, 1992, NEUROSCI LETT, V138, P72, DOI 10.1016/0304-3940(92)90475-M; Mendez J, 1999, J NEUROCHEM, V73, P162, DOI 10.1046/j.1471-4159.1999.0730162.x; Milner LD, 1999, J NEUROSCI, V19, P3007; Mire E, 2013, NAT NEUROSCI, V15, P1134; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Ni XL, 2010, NEUROPHARMACOLOGY, V58, P593, DOI 10.1016/j.neuropharm.2009.11.016; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; ODONOVAN M, 1992, J EXP ZOOL, V261, P261, DOI 10.1002/jez.1402610306; ODONOVAN M, 1994, J NEUROSCI, V14, P6354; ODONOVAN MJ, 1987, J NEUROSCI, V7, P3256; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; PERRINS R, 1995, J NEUROPHYSIOL, V73, P1005, DOI 10.1152/jn.1995.73.3.1005; Plazas PV, 2013, P NATL ACAD SCI USA, V110, P1524, DOI 10.1073/pnas.1213048110; PROVINE RR, 1970, P NATL ACAD SCI USA, V65, P508, DOI 10.1073/pnas.65.3.508; Ravary A, 2003, J NEUROSCI, V23, P2228; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; SERNAGOR E, 1991, NEUROSCI LETT, V128, P211, DOI 10.1016/0304-3940(91)90263-S; SERNAGOR E, 1995, J NEUROSCI, V15, P7452; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Temkin R, 1997, MOL BRAIN RES, V52, P38, DOI 10.1016/S0169-328X(97)00249-0; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VOGEL MW, 1995, J NEUROBIOL, V26, P537, DOI 10.1002/neu.480260407; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang S, 2009, J NEUROSCI, V29, P15232, DOI 10.1523/JNEUROSCI.3809-09.2009; Warp E, 2011, CURR BIOL, V22, P93; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Wolfram V, 2012, NEURON, V75, P663, DOI 10.1016/j.neuron.2012.06.015; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	74	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93836	10.1371/journal.pone.0093836	http://dx.doi.org/10.1371/journal.pone.0093836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722186	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100027
J	Linnerth-Petrik, NM; Santry, LA; Petrik, JJ; Wootton, SK				Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Petrik, James J.; Wootton, Sarah K.			Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; JAAGSIEKTE SHEEP; MOUSE MODEL; PROGNOSTIC-SIGNIFICANCE; CELL-PROLIFERATION; NEVER-SMOKERS; CANCER; RETROVIRUS; SURVIVAL; PROTEIN	Background: The phosphatidylinositol 3-kinase-regulated protein kinase, Akt, plays an important role in the initiation and progression of human cancer. Mammalian cells express three Akt isoforms (Akt1-3), which are encoded by distinct genes. Despite sharing a high degree of amino acid identity, phenotypes observed in knockout mice suggest that Akt isoforms are not functionally redundant. The relative contributions of the different Akt isoforms to oncogenesis, and the effect of their deficiencies on tumor development, are not well understood. Methods: Here we demonstrate that Akt isoforms have non-overlapping and sometimes opposing functions in tumor initiation and progression using a viral oncogene-induced mouse model of lung cancer and Akt isoform-specific knockout mice. Results: Akt1 ablation significantly delays initiation of lung tumor growth, whereas Akt2 deficiency dramatically accelerates tumorigenesis in this mouse model. Ablation of Akt3 had a small, not statistically significant, stimulatory effect on tumor induction and growth by the viral oncogene. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling and Ki67 immunostaining of lung tissue sections revealed that the delayed tumor induction in Akt1(-/-) mice was due to the inhibitory effects of Akt1 ablation on cell growth and survival. Conversely, the accelerated growth rate of lung tumors in Akt2(-/-) and Akt3(-/-) mice was due to increased cell proliferation and reduced tumor cell apoptosis. Investigation of Akt signaling in tumors from Akt knockout mice revealed that the lack of Akt1 interrupted the propagation of signaling in tumors to the critical downstream targets, GSK-3 alpha/beta and mTOR. Conclusions: These results demonstrate that the degree of functional redundancy between Akt isoforms in the context of lung tumor initiation is minimal. Given that this mouse model exhibits considerable similarities to human lung cancer, these findings have important implications for the design and use of Akt inhibitors for the treatment of lung cancer.	[Linnerth-Petrik, Nicolle M.; Santry, Lisa A.; Wootton, Sarah K.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Petrik, James J.] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Wootton, SK (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	kwootton@uoguelph.ca			Cancer Research Society; Ontario Veterinary College MSc Fellowship	Cancer Research Society; Ontario Veterinary College MSc Fellowship	This work was supported by funding from the Cancer Research Society. LAS was supported by an Ontario Veterinary College MSc Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Caporale M, 2006, J VIROL, V80, P8030, DOI 10.1128/JVI.00474-06; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Ferguson RD, 2013, ENDOCR-RELAT CANCER, V20, P391, DOI 10.1530/ERC-12-0333; Ferguson RD, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3089; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Greenaway J, 2008, GYNECOL ONCOL, V108, P385, DOI 10.1016/j.ygyno.2007.10.035; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hollander MC, 2011, ONCOGENE, V30, P1812, DOI 10.1038/onc.2010.556; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Li YW, 2009, BIOORG MED CHEM LETT, V19, P834, DOI 10.1016/j.bmcl.2008.12.017; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; Linnerth-Petrik NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051400; Liu SL, 2007, ONCOGENE, V26, P789, DOI 10.1038/sj.onc.1209850; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Mornex JF, 2003, CURR TOP MICROBIOL, V275, P225; Mukohara T, 2004, ANTICANCER RES, V24, P11; MUSCAT JE, 1995, CANCER LETT, V88, P1, DOI 10.1016/0304-3835(94)03608-L; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Palmarini M, 1997, TRENDS MICROBIOL, V5, P478, DOI 10.1016/S0966-842X(97)01162-1; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rosenberg N, 2001, P NATL ACAD SCI USA, V98, P4285, DOI 10.1073/pnas.091097698; Saji M, 2011, ONCOGENE, V30, P4307, DOI 10.1038/onc.2011.136; Sciacca L, 2013, NUTR METAB CARDIOVAS; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Tsurutani J, 2007, LUNG CANCER, V55, P115, DOI 10.1016/j.lungcan.2006.09.026; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Watson KL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-375; Wootton SK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-94; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CX, 2008, AM J RESP CRIT CARE, V178, P60, DOI 10.1164/rccm.200707-1022OC; Xu PZ, 2012, ONCOGENE, V31, P518, DOI 10.1038/onc.2011.243; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	64	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94595	10.1371/journal.pone.0094595	http://dx.doi.org/10.1371/journal.pone.0094595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722238	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100105
J	Truppel, JH; Otomura, F; Teodoro, U; Massafera, R; da Costa-Ribeiro, MCV; Catarino, CM; Dalagrana, L; Ferreira, MEMC; Thomaz-Soccol, V				Truppel, Jesse Henrique; Otomura, Flavio; Teodoro, Ueslei; Massafera, Rubens; Vieira da Costa-Ribeiro, Magda Clara; Catarino, Carolina Motter; Dalagrana, Luana; Moreira Costa Ferreira, Maria Eugenia; Thomaz-Soccol, Vanete			Can Equids Be a Reservoir of Leishmania braziliensis in Endemic Areas?	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; VIANNIA BRAZILIENSIS; EQUUS-CABALLUS; STATE; HORSE; EPIDEMIOLOGY; INFECTION; VENEZUELA; CANINE; HOSTS	In this study, we detected Leishmania (Viannia) braziliensis infection in equids living in endemic regions of cutaneous leishmaniasis. To determine the role of these animals in the Leishmania cycle, we used two approaches: serological and molecular methods. Antibodies to the parasite were assayed using the Enzyme Linked Immunosorbent Assay (ELISA). Blood samples were collected and tested by polymerase chain reaction (PCR), and the positive products were sequenced. The results showed that 11.0% (25/227) of the equids were seropositive for Leishmania sp, and 16.3% (37/227) were PCR positive. Antibodies were detected in 20 horses, 3 donkeys, and 2 mules, and the parasite DNA was detected in 30 horses, 5 donkeys, and 2 mules. Sequencing the amplified DNA revealed 100% similarity with sequences for Viannia complex, corroborating the results of PCR for L. braziliensis. Our results show that equids are infected with L. braziliensis, which could be food sources for phlebotomines in the peridomiciliary environment and consequently play a role in the cutaneous leishmaniasis cycle.	[Truppel, Jesse Henrique] Ctr Zoonoses Control, Dept Hlth Surveillance, Municipal Hlth Dept, Araucaria, Parana, Brazil; [Truppel, Jesse Henrique; Vieira da Costa-Ribeiro, Magda Clara; Catarino, Carolina Motter; Dalagrana, Luana; Thomaz-Soccol, Vanete] Fed Univ Parana UFPR, Postgraduat Program Microbiol Parasitol & Pathol, Dept Pathol, Curitiba, Parana, Brazil; [Otomura, Flavio; Teodoro, Ueslei] Maringa State Univ UEM, Postgraduat Program Hlth Sci, Maringa, Parana, Brazil; [Moreira Costa Ferreira, Maria Eugenia] Maringa State Univ UEM, Dept Geog, Maringa, Parana, Brazil	Universidade Federal do Parana; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Thomaz-Soccol, V (corresponding author), Fed Univ Parana UFPR, Postgraduat Program Microbiol Parasitol & Pathol, Dept Pathol, Curitiba, Parana, Brazil.	vanete.soccol@pq.cnpq.br	Soccol, Vanete Thomaz/F-2392-2015; Soccol, Vanete Thomaz/N-9887-2019	Soccol, Vanete Thomaz/0000-0001-9301-541X; Soccol, Vanete Thomaz/0000-0001-9301-541X	CAPES; CNPq [410550-2006-0, 301906/2008-4]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was co-funded by CAPES and CNPq (Grant number 410550-2006-0, Process number: 301906/2008-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso Margarete Martins dos Santos, 2005, Cad. Saúde Pública, V21, P1816, DOI 10.1590/S0102-311X2005000600030; AGUILAR C M, 1984, Memorias do Instituto Oswaldo Cruz, V79, P181, DOI 10.1590/S0074-02761984000200005; AGUILAR C M, 1987, Memorias do Instituto Oswaldo Cruz, V82, P143, DOI 10.1590/S0074-02761987000100024; AGUILAR C M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P471, DOI 10.1590/S0074-02761986000400015; AGUILAR CM, 1989, MEM I OSWALDO CRUZ, V84, P19, DOI 10.1590/S0074-02761989000100005; BONFANTEGARRIDO R, 1992, T ROY SOC TROP MED H, V86, P141, DOI 10.1016/0035-9203(92)90544-M; Brandao SP, 2003, T ROY SOC TROP MED H, V97, P291, DOI 10.1016/S0035-9203(03)90146-5; Castro EA, 2007, EXP PARASITOL, V117, P13, DOI 10.1016/j.exppara.2007.03.003; Costa-Ribeiro MCV, 2006, THESIS I O CRUZ RIO; CRONIN T M, 1987, Paleontological Society Memoir, P1; Cupolillo E, 2003, J CLIN MICROBIOL, V41, P3126, DOI 10.1128/JCM.41.7.3126-3132.2003; Cupolillo E, 1998, MEM I OSWALDO CRUZ, V93, P663, DOI 10.1590/S0074-02761998000500018; de Castro EA, 2005, ACTA TROP, V93, P141, DOI 10.1016/j.actatropica.2004.10.004; Castro Edilene Alcântara de, 2002, Rev. Soc. Bras. Med. Trop., V35, P445; Falqueto A, 2003, MEM I OSWALDO CRUZ, V98, P1003, DOI 10.1590/S0074-02762003000800004; FALQUETO A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P443, DOI 10.1590/S0074-02761987000300020; Follador I, 1999, Rev Soc Bras Med Trop, V32, P497, DOI 10.1590/S0037-86821999000500005; Ishikawa EAY., 2002, T R SOC TROP MED HYG, V96, P111, DOI DOI 10.1016/S0035-9203(02)90061-1; Koehler K, 2002, VET PARASITOL, V109, P9, DOI 10.1016/S0304-4017(02)00246-7; Lainson R, 2005, TOPLEY WILSONS MICRO, P313; Mazza S., 1927, B U B AIRES, V3, P462; Membrive Norberto Assis, 2004, Entomologia y Vectores, V11, P673, DOI 10.1590/S0328-03812004000400009; Meneses CRV, 2002, J VECTOR ECOL, V27, P207; OLIVEIRA-NETO M P, 1988, Memorias do Instituto Oswaldo Cruz, V83, P427, DOI 10.1590/S0074-02761988000400006; RamosVara JA, 1996, VET PATHOL, V33, P731, DOI 10.1177/030098589603300619; Reuss SM, 2012, EMERG INFECT DIS, V18, P1545, DOI 10.3201/eid1809.120184; Rotureau B, 2006, MED HYPOTHESES, V67, P1235, DOI 10.1016/j.mehy.2006.02.056; Sambrook J., 2001, MOL CLONING LAB MANU; Soares IR, 2013, VET PARASITOL, V197, P665, DOI 10.1016/j.vetpar.2013.06.014; Soccol VT, 2009, ACTA TROP, V111, P308, DOI 10.1016/j.actatropica.2009.05.013; Solano-Gallego L, 2003, EQUINE VET J, V35, P320, DOI 10.2746/042516403776148336; Teodoro U, 2006, REV SAUDE PUBL, V40, P327, DOI 10.1590/S0034-89102006000200022; Teodoro Ueslei, 2010, Revista de Patologia Tropical, V39, P322; THOMAZSOCCOL V, 1993, ANN PARASIT HUM COMP, V68, P104; Vedovello D, 2008, ZOONOSES PUBLIC HLTH, V55, P149, DOI 10.1111/j.1863-2378.2008.01106.x; WHO, 1990, WHO TECHN REP SER, V793; YOSHIDA ELA, 1990, MEM I OSWALDO CRUZ, V85, P133, DOI 10.1590/S0074-02761990000100026	37	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93731	10.1371/journal.pone.0093731	http://dx.doi.org/10.1371/journal.pone.0093731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721908	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100022
J	Gazeau, F; van Rijswijk, P; Pozzato, L; Middelburg, JJ				Gazeau, Frederic; van Rijswijk, Pieter; Pozzato, Lara; Middelburg, Jack J.			Impacts of Ocean Acidification on Sediment Processes in Shallow Waters of the Arctic Ocean	PLOS ONE			English	Article							SEAWATER ACIDIFICATION; CARBON; CO2; NITROGEN; ALKALINITY; RATES; UNDERSATURATION; NITRIFICATION; PHYSIOLOGY	Despite the important roles of shallow-water sediments in global biogeochemical cycling, the effects of ocean acidification on sedimentary processes have received relatively little attention. As high-latitude cold waters can absorb more CO2 and usually have a lower buffering capacity than warmer waters, acidification rates in these areas are faster than those in sub-tropical regions. The present study investigates the effects of ocean acidification on sediment composition, processes and sediment-water fluxes in an Arctic coastal system. Undisturbed sediment cores, exempt of large dwelling organisms, were collected, incubated for a period of 14 days, and subject to a gradient of pCO(2) covering the range of values projected for the end of the century. On five occasions during the experimental period, the sediment cores were isolated for flux measurements (oxygen, alkalinity, dissolved inorganic carbon, ammonium, nitrate, nitrite, phosphate and silicate). At the end of the experimental period, denitrification rates were measured and sediment samples were taken at several depth intervals for solid-phase analyses. Most of the parameters and processes (i.e. mineralization, denitrification) investigated showed no relationship with the overlying seawater pH, suggesting that ocean acidification will have limited impacts on the microbial activity and associated sediment-water fluxes on Arctic shelves, in the absence of active bio-irrigating organisms. Only following a pH decrease of 1 pH unit, not foreseen in the coming 300 years, significant enhancements of calcium carbonate dissolution and anammox rates were observed. Longer-term experiments on different sediment types are still required to confirm the limited impact of ocean acidification on shallow Arctic sediment processes as observed in this study.	[Gazeau, Frederic] Sorbonne Univ, Univ Paris 06, Lab Oceanog Villefranche, Observ Oceanol, Villefranche Sur Mer, France; [Gazeau, Frederic] CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Observ Oceanol, Villefranche Sur Mer, France; [van Rijswijk, Pieter; Pozzato, Lara; Middelburg, Jack J.] Royal Netherlands Inst Sea Res, Dept Ecosyst Studies, Yerseke, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Gazeau, F (corresponding author), Sorbonne Univ, Univ Paris 06, Lab Oceanog Villefranche, Observ Oceanol, Villefranche Sur Mer, France.	f.gazeau@obs-vlfr.fr	Gazeau, Frédéric/G-3050-2011; Middelburg, Jack/B-4951-2011	Gazeau, Frédéric/0000-0001-8807-4597; Middelburg, Jack/0000-0003-3601-9072	Netherlands Organization of Scientific Research; Darwin Centre for Biogeosciences; European Community [211384]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Darwin Centre for Biogeosciences; European Community(European Commission)	This research has received support from the Netherlands Organization of Scientific Research, the Darwin Centre for Biogeosciences and is a contribution to the "European Project on Ocean Acidification" (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2006, CORAL REEFS, V25, P123, DOI 10.1007/s00338-005-0069-2; Andersson AJ, 2003, GEOLOGY, V31, P513, DOI 10.1130/0091-7613(2003)031<0513:SOSCAI>2.0.CO;2; Andersson AJ, 2014, NAT CLIM CHANGE, V4, P56, DOI 10.1038/NCLIMATE2050; BARNES DJ, 2000, P 9 INT COR REEF S; Barry J. P., 2010, GUIDE BEST PRACTICES; Bates NR, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004862; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Berner R.A., 1980, EARLY DIAGENESIS THE; Burdige DJ, 2006, GEOCHEMISTRY MARINE, DOI DOI 10.2307/J.CTV131BW7S; Caldeira K, 2007, GEOPHYS RES LETT, V34, P3; Chierici M, 2009, BIOGEOSCIENCES, V6, P2421, DOI 10.5194/bg-6-2421-2009; Cyronak T, 2013, LIMNOL OCEANOGR, V58, P131, DOI 10.4319/lo.2013.58.1.0131; Darby DA, 1990, ARCTICS SEAS CLIMATO, P657; Dashfield SL, 2008, J EXP MAR BIOL ECOL, V365, P46, DOI 10.1016/j.jembe.2008.07.039; den Camp HJMO, 2006, BIOCHEM SOC T, V34, P174, DOI 10.1042/BST0340174; Dickson A.G., 2007, GUIDE BEST PRACTICES; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donohue PJC, 2012, AQUAT BIOL, V15, P73, DOI 10.3354/ab00408; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Forster S, 2003, J MAR RES, V61, P335, DOI 10.1357/002224003322201223; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; Gattuso J.-P., 2011, OCEAN ACIDIFICATION, P1; Gihring TM, 2010, LIMNOL OCEANOGR, V55, P740, DOI 10.4319/lo.2009.55.2.0740; Gribsholt B, 2005, LIMNOL OCEANOGR, V50, P1945, DOI 10.4319/lo.2005.50.6.1945; Hauck J, 2013, GLOBAL BIOGEOCHEM CY, V27, P11, DOI 10.1029/2011GB004211; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hu XP, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003859; Huesemann MH, 2002, MAR POLLUT BULL, V44, P142, DOI 10.1016/S0025-326X(01)00194-1; Kitidis V, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049095; Knap A., 1996, 19 JGOFS UNESCO; Krumins V, 2013, BIOGEOSCIENCES, V10, P371, DOI 10.5194/bg-10-371-2013; Meysman FJR, 2006, LIMNOL OCEANOGR, V51, P142, DOI 10.4319/lo.2006.51.1.0142; Middelburg JJ, 2009, BIOGEOSCIENCES, V6, P1273, DOI 10.5194/bg-6-1273-2009; Middelburg JJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049725; NIEUWENHUIZE J, 1994, MAR CHEM, V45, P217, DOI 10.1016/0304-4203(94)90005-1; Olafsson J, 2009, BIOGEOSCIENCES, V6, P2661, DOI 10.5194/bg-6-2661-2009; Orr J. C., 2011, RECENT FUTURE CHANGE, P41; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pempkowiak J., 2006, ANN ENV PROT, V8, P79; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Rao AMF, 2012, LIMNOL OCEANOGR, V57, P809, DOI 10.4319/lo.2012.57.3.0809; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Soetaert K, 2007, MAR CHEM, V105, P30, DOI 10.1016/j.marchem.2006.12.012; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Tait K, 2013, ESTUAR COAST, P1; Thomas H, 2009, BIOGEOSCIENCES, V6, P267, DOI 10.5194/bg-6-267-2009; Van den Meersche K, 2004, LIMNOL OCEANOGR, V49, P862, DOI 10.4319/lo.2004.49.3.0862; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Widdicombe S, 2007, MAR ECOL PROG SER, V341, P111, DOI 10.3354/meps341111; Widdicombe S, 2009, MAR ECOL PROG SER, V379, P59, DOI 10.3354/meps07894; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006; Wood HL, 2009, BIOGEOSCIENCES, V6, P2015, DOI 10.5194/bg-6-2015-2009; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Yates KK, 2006, ESTUARIES COASTS, V29, P24, DOI 10.1007/BF02784696	56	26	26	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94068	10.1371/journal.pone.0094068	http://dx.doi.org/10.1371/journal.pone.0094068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718610	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000074
J	Kooij, PW; Liberti, J; Giampoudakis, K; Schiott, M; Boomsma, JJ				Kooij, Pepijn W.; Liberti, Joanito; Giampoudakis, Konstantinos; Schiott, Morten; Boomsma, Jacobus J.			Differences in Forage-Acquisition and Fungal Enzyme Activity Contribute to Niche Segregation in Panamanian Leaf-Cutting Ants	PLOS ONE			English	Article							ATTA-CEPHALOTES L; L HYMENOPTERA-FORMICIDAE; HABITAT SEGREGATION; INSECT HERBIVORES; WASTE MANAGEMENT; SUBSTRATE; SELECTION; DIET; RETICULITERMES; DEGRADATION	The genera Atta and Acromyrmex are often grouped as leaf-cutting ants for pest management assessments and ecological surveys, although their mature colony sizes and foraging niches may differ substantially. Few studies have addressed such interspecific differences at the same site, which prompted us to conduct a comparative study across six sympatric leafcutting ant species in Central Panama. We show that foraging rates during the transition between dry and wet season differ about 60 fold between genera, but are relatively constant across species within genera. These differences appear to match overall differences in colony size, especially when Atta workers that return to their nests without leaves are assumed to carry liquid food. We confirm that Panamanian Atta specialize primarily on tree-leaves whereas Acromyrmex focus on collecting flowers and herbal leaves and that species within genera are similar in these overall foraging strategies. Species within genera tended to be spaced out over the three habitat categories that we distinguished (forest, forest edge, open grassland), but each of these habitats normally had only a single predominant Atta and Acromyrmex species. We measured activities of twelve fungus garden decomposition enzymes, belonging to the amylases, cellulases, hemicellulases, pectinases and proteinases, and show that average enzyme activity per unit of fungal mass in Atta gardens is lower than in Acromyrmex gardens. Expression profiles of fungal enzymes in Atta also appeared to be more specialized than in Acromyrmex, possibly reflecting variation in forage material. Our results suggest that species-and genus-level identities of leaf-cutting ants and habitat-specific foraging profiles may give predictable differences in the expression of fungal genes coding for decomposition enzymes.	[Kooij, Pepijn W.; Liberti, Joanito; Giampoudakis, Konstantinos; Schiott, Morten; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark	University of Copenhagen	Kooij, PW (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	pkooij@bio.ku.dk	Schiøtt, Morten/H-4118-2012; Boomsma, Jacobus J/M-2785-2014; Kooij, Pepijn W/E-3755-2019; Liberti, Joanito/AFT-0264-2022; Schiøtt, Morten/AAJ-8945-2021	Schiøtt, Morten/0000-0002-4309-8090; Boomsma, Jacobus J/0000-0002-3598-1609; Kooij, Pepijn W/0000-0002-2619-0813; Liberti, Joanito/0000-0002-4158-2591; Schiøtt, Morten/0000-0002-4309-8090	Danish National Research Foundation [DNRF57]	Danish National Research Foundation(Danmarks Grundforskningsfond)	Funding was provided by the Danish National Research Foundation (DNRF57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Aylward FO, 2013, APPL ENVIRON MICROB, V79, P3770, DOI 10.1128/AEM.03833-12; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; BERISH CW, 1986, AM MIDL NAT, V115, P268, DOI 10.2307/2425863; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; CHERRETT JM, 1972, J ANIM ECOL, V41, P647, DOI 10.2307/3200; CHERRETT JM, 1968, J ANIM ECOL, V37, P387, DOI 10.2307/2955; CHERRETT JM, 1976, ANN APPL BIOL, V84, P124, DOI 10.1111/j.1744-7348.1976.tb01741.x; CREWE RM, 1972, J INSECT PHYSIOL, V18, P31, DOI 10.1016/0022-1910(72)90062-5; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DEVASCONCELOS HL, 1990, INSECT SOC, V37, P131, DOI 10.1007/BF02224026; Farji-Brener AG, 2000, STUD NEOTROP FAUNA E, V35, P131, DOI 10.1076/0165-0521(200008)35:2;1-9;FT131; Farji-Brener AG, 2001, OIKOS, V92, P169, DOI 10.1034/j.1600-0706.2001.920120.x; Florencio M, 2013, FRESHW SCI, V32, P650, DOI 10.1899/12-105.1; FOWLER HG, 1989, ENVIRON MANAGE, V13, P671, DOI 10.1007/BF01868306; Grell MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-928; Guo ZQ, 2012, FUND APPL LIMNOL, V181, P241, DOI 10.1127/1863-9135/2012/0397; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Holldobler B, 2011, LEAFCUTTER ANTS; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Houseman RM, 2001, ENVIRON ENTOMOL, V30, P673, DOI 10.1603/0046-225X-30.4.673; HOWARD JJ, 1988, ECOLOGY, V69, P250, DOI 10.2307/1943180; Husson F, 2013, FACTOMINER MULTIVARI; Ibanez R, 2002, ENVIRON MONIT ASSESS, V80, P65, DOI 10.1023/A:1020378926399; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kambara K, 2009, SOCIOBIOLOGY, V54, P65; Kooij PW, 2011, INSECT SOC, V58, P145, DOI 10.1007/s00040-010-0127-9; Kooij PW, FUNGAL ADAPTAT UNPUB; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; Licht HHD, 2010, ECOL ENTOMOL, V35, P259, DOI 10.1111/j.1365-2311.2010.01193.x; LITTLEDYKE M, 1976, B ENTOMOL RES, V66, P205, DOI 10.1017/S0007485300006647; Mayhe-Nunes Antonio, 1998, Ecotropicos, V11, P45; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Mendes Thais D., 2012, Insects, V3, P228, DOI 10.3390/insects3010228; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; Moller IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017506; Murakami T, 2000, BEHAV ECOL SOCIOBIOL, V48, P276, DOI 10.1007/s002650000243; Nagamoto NS, 2011, J BIOL RES-THESSALON, V16, P308; North RD, 1999, PHYSIOL ENTOMOL, V24, P127, DOI 10.1046/j.1365-3032.1999.00122.x; ORTEGA S, 1987, J EXP MAR BIOL ECOL, V113, P247, DOI 10.1016/0022-0981(87)90104-3; Pinheiro J, 2020, R PACKAGE VERSION 31; PORTER SD, 1980, BIOTROPICA, V12, P232, DOI 10.2307/2387983; QUINLAN RJ, 1979, ECOL ENTOMOL, V4, P151, DOI 10.1111/j.1365-2311.1979.tb00570.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rohde K, 2006, NONEQUILIBRIUM ECOLO; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Suzuki R, 2011, PVCLUST HIERARCHICAL; TYRRELL HF, 1975, J DAIRY SCI, V58, P1151, DOI 10.3168/jds.S0022-0302(75)84694-7; Villesen P, 2002, P ROY SOC B-BIOL SCI, V269, P1541, DOI 10.1098/rspb.2002.2044; Warnes G, 2016, R PACKAGE VERSION 3; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1969, ECOLOGY, V50, P141; WEBER NA, 1972, AM ZOOL, V12, P577; Weber NA, 1958, P 10 INT C ENT, V2, P459; Wetterer JK, 1998, FLA ENTOMOL, V81, P61, DOI 10.2307/3495996; WETTERER JK, 1995, OECOLOGIA, V104, P409, DOI 10.1007/BF00341337; Wirth R, 2003, HERBIVORY LEAF CUTTI	61	19	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94284	10.1371/journal.pone.0094284	http://dx.doi.org/10.1371/journal.pone.0094284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718261	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000102
J	Liu, XP; Tu, XY; He, HM; Chen, C; Xue, FS				Liu, XingPing; Tu, XiaoYun; He, HaiMin; Chen, Chao; Xue, FangSen			Evidence for Inbreeding Depression and Pre-Copulatory, but Not Post Copulatory Inbreeding Avoidance in the Cabbage Beetle Colaphellus bowringi	PLOS ONE			English	Article							MATE CHOICE; NO EVIDENCE; CALLOSOBRUCHUS-MACULATUS; MATING-BEHAVIOR; FEMALE FITNESS; FIELD CRICKET; LIFE-SPAN; EVOLUTION; FERTILIZATION; COLEOPTERA	Inbreeding is known to have adverse effects on fitness-related traits in a range of insect species. A series of theoretical and experimental studies have suggested that polyandrous insects could avoid the cost of inbreeding via pre-copulatory mate choice and/or post-copulatory mechanisms. We looked for evidence of pre-copulatory inbreeding avoidance using female mate preference trials, in which females were given the choice of mating with either of two males, a sibling and a nonsibling. We also tested for evidence of post- copulatory inbreeding avoidance by conducting double mating experiments, in which four sibling females were mated with two males sequentially, either two siblings, two non-siblings or a sibling and a non-sibling in either order. We identified substantial inbreeding depression: offspring of females mated to full siblings had lower hatching success, slower development time from egg to adult, lower survival of larval and pupal stages, and lower adult body mass than the offspring of females mated to non-sibling males. We also found evidence of pre-copulatory inbreeding avoidance, as females preferred to mate with non-sibling males. However, we did not find any evidence of postcopulatory inbreeding avoidance: egg hatching success of females mating to both sibling and non- sibling males were consistent with sperm being used without bias in relation to mate relatedness. Our results suggest that this cabbage beetle has evolved a pre-copulatory mechanism to avoid matings between close relative, but that polyandry is apparently not an inbreeding avoidance mechanism in C. bowringi.	[Liu, XingPing; He, HaiMin; Chen, Chao; Xue, FangSen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China; [Tu, XiaoYun] Jiangxi Normal Univ, Life & Sci Coll, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Xue, FS (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	xue_fangsen@hotmail.com			National Natural Science Foundation of of P.R. China [31000173, 30460074]	National Natural Science Foundation of of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of of P.R. China to XPL (Project no. 31000173) and to FSX (Project no. 30460074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Honkola O, 2011, EVOLUTION, V65, P2699, DOI 10.1111/j.1558-5646.2011.01317.x; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Bechsgaard JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051176; BOORMAN E, 1976, ECOL ENTOMOL, V1, P145, DOI 10.1111/j.1365-2311.1976.tb01217.x; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cook PA, 1997, PHILOS T R SOC B, V352, P771, DOI 10.1098/rstb.1997.0061; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; Drayton JM, 2011, BEHAV ECOL, V22, P486, DOI 10.1093/beheco/arr005; Edvardsson M, 2008, ANIM BEHAV, V75, P1519, DOI 10.1016/j.anbehav.2007.10.005; Fox CW, 2007, B ENTOMOL RES, V97, P49, DOI 10.1017/S0007485307004737; Fox CW, 2013, J EVOLUTION BIOL, V26, P88, DOI 10.1111/jeb.12027; Fox CW, 2012, J EVOLUTION BIOL, V25, P29, DOI 10.1111/j.1420-9101.2011.02400.x; Fox CW, 2009, HEREDITY, V103, P62, DOI 10.1038/hdy.2009.31; Fox CW, 2006, ENTOMOL EXP APPL, V121, P137, DOI 10.1111/j.1570-8703.2006.00465.x; Fox CW, 2011, EVOL ECOL, V25, P25, DOI 10.1007/s10682-010-9376-3; Haikola S, 2004, EVOL ECOL, V18, P113, DOI 10.1023/B:EVEC.0000021062.97769.66; Harano T, 2011, ECOL RES, V26, P327, DOI 10.1007/s11284-010-0787-y; Jennions MD, 2004, EVOLUTION, V58, P2472; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kuriwada T, 2011, ETHOLOGY, V117, P822, DOI 10.1111/j.1439-0310.2011.01937.x; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Liu XP, 2013, ENTOMOL EXP APPL, V146, P379, DOI 10.1111/eea.12037; Liu XP, 2014, INSECT SCI, V21, P515, DOI 10.1111/1744-7917.12051; Liu XP, 2011, J INSECT BEHAV, V24, P83, DOI 10.1007/s10905-010-9237-5; Liu XP, 2010, ANIM BEHAV, V79, P1391, DOI 10.1016/j.anbehav.2010.03.019; Liu XP, 2010, INSECT SCI, V17, P61, DOI 10.1111/j.1744-7917.2009.01285.x; Messina FJ, 2013, ANN ENTOMOL; Michalczyk L, 2011, SCIENCE, V333, P1739, DOI 10.1126/science.1207314; Michalczyk L, 2010, P ROY SOC B-BIOL SCI, V277, P3483, DOI 10.1098/rspb.2010.0514; Okada K, 2011, J EVOLUTION BIOL, V24, P363, DOI 10.1111/j.1420-9101.2010.02170.x; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Polkki M, 2012, BIOL LETTERS, V8, P423, DOI 10.1098/rsbl.2011.1135; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Ruf D, 2010, BEHAV ECOL, V21, P1301, DOI 10.1093/beheco/arq148; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; SIMMONS LW, 1991, ANIM BEHAV, V41, P493, DOI 10.1016/S0003-3472(05)80852-8; Tabadkani SM, 2012, NATURWISSENSCHAFTEN, V99, P779, DOI 10.1007/s00114-012-0961-x; Teng ZQ, 2007, EVOLUTION, V61, P470, DOI 10.1111/j.1558-5646.2007.00030.x; Thornhill R., 1983, pi; Tien NSH, 2011, EXP APPL ACAROL, V54, P119, DOI 10.1007/s10493-011-9431-y; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Valtonen TM, 2011, GENETICA, V139, P525, DOI 10.1007/s10709-011-9574-0; Welke K, 2009, BEHAV ECOL, V20, P1056, DOI 10.1093/beheco/arp097; Xue Fang-Sen, 2002, Acta Entomologica Sinica, V45, P494; Xue FS, 2002, J INSECT PHYSIOL, V48, P279, DOI 10.1016/S0022-1910(01)00172-X; XUE FS, 1993, J APPL ENTOMOL, V116, P170; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	52	16	16	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94389	10.1371/journal.pone.0094389	http://dx.doi.org/10.1371/journal.pone.0094389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718627	gold, Green Published			2022-12-27	WOS:000334339000113
J	Grayson, KL; Mitchell, NJ; Monks, JM; Keall, SN; Wilson, JN; Nelson, NJ				Grayson, Kristine L.; Mitchell, Nicola J.; Monks, Joanne M.; Keall, Susan N.; Wilson, Joanna N.; Nelson, Nicola J.			Sex Ratio Bias and Extinction Risk in an Isolated Population of Tuatara (Sphenodon punctatus)	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; CONSERVATION; VIABILITY; DYNAMICS; ISLAND; CONSEQUENCES; GENERATIONS; DIMORPHISM; ALLOCATION	Understanding the mechanisms underlying population declines is critical for preventing the extinction of endangered populations. Positive feedbacks can hasten the process of collapse and create an 'extinction vortex,' particularly in small, isolated populations. We provide a case study of a male-biased sex ratio creating the conditions for extinction in a natural population of tuatara (Sphenodon punctatus) on North Brother Island in the Cook Strait of New Zealand. We combine data from long term mark-recapture surveys, updated model estimates of hatchling sex ratio, and population viability modeling to measure the impacts of sex ratio skew. Results from the mark-recapture surveys show an increasing decline in the percentage of females in the adult tuatara population. Our monitoring reveals compounding impacts on female fitness through reductions in female body condition, fecundity, and survival as the male-bias in the population has increased. Additionally, we find that current nest temperatures are likely to result in more male than female hatchlings, owing to the pattern of temperature-dependent sex determination in tuatara where males hatch at warmer temperatures. Anthropogenic climate change worsens the situation for this isolated population, as projected temperature increases for New Zealand are expected to further skew the hatchling sex ratio towards males. Population viability models predict that without management intervention or an evolutionary response, the population will ultimately become entirely comprised of males and functionally extinct. Our study demonstrates that sex ratio bias can be an underappreciated threat to population viability, particularly in populations of long-lived organisms that appear numerically stable.	[Grayson, Kristine L.; Keall, Susan N.; Wilson, Joanna N.; Nelson, Nicola J.] Victoria Univ Wellington, Allan Wilson Ctr Mol Ecol & Evolut, Sch Biol Sci, Wellington, New Zealand; [Mitchell, Nicola J.] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, WA, Australia; [Monks, Joanne M.] Dept Conservat, Sci & Capabil Grp, Christchurch, New Zealand	Victoria University Wellington; University of Western Australia	Grayson, KL (corresponding author), Victoria Univ Wellington, Allan Wilson Ctr Mol Ecol & Evolut, Sch Biol Sci, Wellington, New Zealand.	klg8y@virginia.edu	Mitchell, Nicola J/K-5277-2012; Mitchell, Nicola/AAE-4132-2020	Mitchell, Nicola J/0000-0003-0744-984X; Nelson, Nicola/0000-0002-1641-6030; Monks, Jo/0000-0001-9391-380X; Grayson, Kristine/0000-0003-1710-0457	Allan Wilson Centre for Molecular Ecology and Evolution; School of Biological Sciences at Victoria University of Wellington; US National Science Foundation [OISE-0965096]	Allan Wilson Centre for Molecular Ecology and Evolution; School of Biological Sciences at Victoria University of Wellington; US National Science Foundation(National Science Foundation (NSF))	This work was supported by the Allan Wilson Centre for Molecular Ecology and Evolution and the School of Biological Sciences at Victoria University of Wellington. Funding was also provided by grants from the US National Science Foundation (International Research Fellowship OISE-0965096 to KLG), Dallas Zoo, (http://www.dallaszoo.com/), Toledo Zoo (http://www.toledozoo.org/), and St. Louis Zoo (http://www.stlzoo.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AC, 1994, ZOO BIOL, V13, P479, DOI 10.1002/zoo.1430130510; Armbruster P, 1999, ANIM CONSERV, V2, P69, DOI 10.1111/j.1469-1795.1999.tb00050.x; Arnqvist Goran, 2005, pUnpaginated; Bernardo J, 1996, AM ZOOL, V36, P83; Brook BW, 2002, CONSERV ECOL, V6; BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cree A., 1991, Tuatara, V31, P9; CREE A, 1994, NEW ZEAL J ZOOL, V21, P351, DOI 10.1080/03014223.1994.9518005; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Doody JS, 2006, EVOL ECOL, V20, P307, DOI 10.1007/s10682-006-0003-2; Ewen JG, 2011, J ANIM ECOL, V80, P448, DOI 10.1111/j.1365-2656.2010.01774.x; Freed LA, 2009, EVOL ECOL RES, V11, P731; Freedberg S, 2006, EVOL ECOL RES, V8, P1499; GAZE P, 2001, TUATARA RECOVERY PLA; Gilpin M.E., 1986, P19; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gruber MAM, 2007, CONSERVATION TUATARA; Herrel A, 2010, BIOL J LINN SOC, V100, P287, DOI 10.1111/j.1095-8312.2010.01433.x; Hoare JM, 2006, ANIM CONSERV, V9, P456, DOI 10.1111/j.1469-1795.2006.00061.x; Hu JH, 2013, BIOL CONSERV, V166, P23, DOI 10.1016/j.biocon.2013.06.011; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Kendall WL, 1997, ECOLOGY, V78, P563; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lopez-Sepulcre A, 2009, J ANIM ECOL, V78, P219, DOI 10.1111/j.1365-2656.2008.01475.x; MacAvoy ES, 2007, CONSERV GENET, V8, P305, DOI 10.1007/s10592-006-9170-5; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Mitchell Nicola J, 2006, Front Zool, V3, P9, DOI 10.1186/1742-9994-3-9; Mitchell NJ, 2010, GLOBAL CHANGE BIOL, V16, P60, DOI 10.1111/j.1365-2486.2009.01964.x; Moore JA, 2008, CONSERV GENET, V9, P1243, DOI 10.1007/s10592-007-9452-6; Moore JA, 2009, J HERPETOL, V43, P570, DOI 10.1670/08-290.1; MROSOVSKY N, 1982, BIOL CONSERV, V23, P309, DOI 10.1016/0006-3207(82)90087-8; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nelson NJ, 2010, HERPETOL CONSERV BIO, V5, P324; Nelson NJ, 2004, INT CONGR SER, V1275, P250, DOI 10.1016/j.ics.2004.08.093; Nelson NJ, 2002, J BIOGEOGR, V29, P633, DOI 10.1046/j.1365-2699.2002.00712.x; O'Grady JJ, 2008, ANIM CONSERV, V11, P442, DOI 10.1111/j.1469-1795.2008.00201.x; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; Rankin DJ, 2011, AM NAT, V177, P780, DOI 10.1086/659947; Reisinger A., 2010, GLOBAL LOCAL CLIMATE; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Schwanz LE, 2008, PHYSIOL BIOCHEM ZOOL, V81, P826, DOI 10.1086/590220; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; THOMPSON MB, 1992, J ROY SOC NEW ZEAL, V22, P123, DOI 10.1080/03036758.1992.10420810; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Wapstra E, 2009, J ANIM ECOL, V78, P84, DOI 10.1111/j.1365-2656.2008.01470.x; Wedekind C, 2002, ANIM CONSERV, V5, P13, DOI 10.1017/S1367943002001026; Woerner LLB, 2009, AGGRESSION COMPETITI; Wratt D.S., 2004, CLIMATE CHANGE EFFEC	62	47	47	1	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94214	10.1371/journal.pone.0094214	http://dx.doi.org/10.1371/journal.pone.0094214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714691	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900106
J	Zhang, YF; Yu, B; Sui, YJ; Gao, X; Yang, H; Ma, TH				Zhang, Yaofang; Yu, Bo; Sui, Yujie; Gao, Xin; Yang, Hong; Ma, Tonghui			Identification of Resveratrol Oligomers as Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator by High-Throughput Screening of Natural Products from Chinese Medicinal Plants	PLOS ONE			English	Article							CFTR CHLORIDE CHANNEL; EPSILON-VINIFERIN; STILBENE DERIVATIVES; TRANS-RESVERATROL; CHOLERA-TOXIN; PHARMACOKINETICS; MECHANISM; DISCOVERY; GROWTH	Inhibitors of cystic fibrosis transmembrane conductance regulator (CFTR) have been widely used for characterizing CFTR function in epithelial fluid transport and in diseases such as secretory diarrhea, polycystic kidney disease and cystic fibrosis. Few small molecule CFTR inhibitors have been discovered so far from combinatorial compound library. In the present study, we used a high throughput screening (HTS)-based natural product discovery strategy to identify new CFTR inhibitors from Chinese medicinal herbs. By screening 40,000 small molecule fractions from 500 herbal plants, we identified 42 positive fractions from 5 herbs and isolated two compounds that inhibited CFTR conductance from Chinese wild grapevine (Vitis amurensis Rupr). Mass spectrometry (MS) and nuclear magnetic resonance (NMR) studies determined the two active compounds as trans-epsilon-viniferin (TV) and r-2-viniferin (RV), respectively. Both compounds dose-dependently blocked CFTR-mediated iodide influx with IC50 around 20 mu M. Further analysis by excised inside-out patch-clamp indicated strong inhibition of protein kinase A (PKA)-activated CFTR chloride currents by TV and RV. In ex vivo studies, TV and RV inhibited CFTR-mediated short-circuit CI- currents in isolated rat colonic mucosa in a dose-dependent manner. In a closed-loop mouse model, intraluminal applications of TV (2.5 mu g) and RV (4.5 mu g) significantly reduced cholera toxin-induced intestinal fluid secretion. The present study identified two resveratrol oligomers as new CFTR inhibitors and validates our high-throughput screening method for discovery of bioactive compounds from natural products with complex chemical ingredients such as herbal plants.	[Zhang, Yaofang; Yu, Bo; Yang, Hong] Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China; [Sui, Yujie; Ma, Tonghui] Dalian Med Univ, Coll Basic Med Sci, Dalian, Peoples R China; [Gao, Xin] Yanbian Univ, Sch Med, Yanji, Peoples R China	Liaoning Normal University; Dalian Medical University; Yanbian University	Yang, H (corresponding author), Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China.	hyanglnnu@gmail.com; tonghuima@dlmedu.edu.cn		Ma, Tonghui/0000-0001-9338-1030	National Natural Science Fund [81173109, 30973577]; Special Fund for Doctorate Disciplines Construction in Universities [20112136110002]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Special Fund for Doctorate Disciplines Construction in Universities	This work was supported by National Natural Science Fund (No. 81173109; 30973577), Special Fund for Doctorate Disciplines Construction in Universities (20112136110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bavaresco L, 1999, DRUG EXP CLIN RES, V25, P57; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gonzalez-Sarrias A, 2011, J AGR FOOD CHEM, V59, P8632, DOI 10.1021/jf201561e; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; He CY, 2004, CHEM RES CHINESE U, V20, P334; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Kim JY, 2012, PHYTOMEDICINE, V19, P150, DOI 10.1016/j.phymed.2011.06.015; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; la Porte C, 2010, CLIN PHARMACOKINET, V49, P449, DOI 10.2165/11531820-000000000-00000; Landrault N, 2002, J AGR FOOD CHEM, V50, P2046, DOI 10.1021/jf010794g; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Luzhetskyy A, 2007, CURR OPIN INVEST DR, V8, P608; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Privat C, 2002, J AGR FOOD CHEM, V50, P1213, DOI 10.1021/jf010676t; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Vitrac X, 2005, J AGR FOOD CHEM, V53, P5664, DOI 10.1021/jf050122g; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang XF, 2004, EXP PHYSIOL, V89, P417, DOI 10.1113/expphysiol.2003.027003; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yang S, 2013, PHARMAZIE, V68, P772, DOI 10.1691/ph.2013.3548; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zghonda N, 2011, BIOSCI BIOTECH BIOCH, V75, P1259, DOI 10.1271/bbb.110022; Zhang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081589	41	18	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94302	10.1371/journal.pone.0094302	http://dx.doi.org/10.1371/journal.pone.0094302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714160	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900113
J	Bertolusso, R; Tian, B; Zhao, Y; Vergara, L; Sabree, A; Iwanaszko, M; Lipniacki, T; Brasier, AR; Kimmel, M				Bertolusso, Roberto; Tian, Bing; Zhao, Yingxin; Vergara, Leoncio; Sabree, Aqeeb; Iwanaszko, Marta; Lipniacki, Tomasz; Brasier, Allan R.; Kimmel, Marek			Dynamic Cross Talk Model of the Epithelial Innate Immune Response to Double-Stranded RNA Stimulation: Coordinated Dynamics Emerging from Cell-Level Noise	PLOS ONE			English	Article							NF-KAPPA-B; INDUCIBLE GENE-I; INTERFERON ANTIVIRAL RESPONSE; RIG-I; TRANSCRIPTION FACTOR; UBIQUITIN LIGASE; ACTIVATION; RECOGNITION; EXPRESSION; ADAPTER	We present an integrated dynamical cross-talk model of the epithelial innate immune reponse (IIR) incorporating RIG-I and TLR3 as the two major pattern recognition receptors (PRR) converging on the RelA and IRF3 transcriptional effectors. bioPN simulations reproduce biologically relevant gene-and protein abundance measurements in response to time course, gene silencing and dose-response perturbations both at the population and single cell level. Our computational predictions suggest that RelA and IRF3 are under auto-and cross-regulation. We predict, and confirm experimentally, that RIG-I mRNA expression is controlled by IRF7. We also predict the existence of a TLR3-dependent, IRF3-independent transcription factor (or factors) that control(s) expression of MAVS, IRF3 and members of the IKK family. Our model confirms the observed dsRNA dose-dependence of oscillatory patterns in single cells, with periods of 1-3 hr. Model fitting to time series, matched by knockdown data suggests that the NF-kB module operates in a different regime (with different coefficient values) than in the TNF alpha-stimulation experiments. In future studies, this model will serve as a foundation for identification of virus-encoded IIR antagonists and examination of stochastic effects of viral replication. Our model generates simulated time series, which reproduce the noisy oscillatory patterns of activity (with 1-3 hour period) observed in individual cells. Our work supports the hypothesis that the IIR is a phenomenon that emerged by evolution despite highly variable responses at an individual cell level.	[Bertolusso, Roberto; Sabree, Aqeeb; Kimmel, Marek] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Tian, Bing; Zhao, Yingxin; Brasier, Allan R.] UTMB, Dept Internal Med, Galveston, TX USA; [Zhao, Yingxin; Brasier, Allan R.] UTMB, Sealy Ctr Mol Med, Galveston, TX USA; [Zhao, Yingxin; Brasier, Allan R.] UTMB, Inst Translat Sci, Galveston, TX USA; [Vergara, Leoncio] UTMB, Ctr Biomed Engn, Galveston, TX USA; [Iwanaszko, Marta; Kimmel, Marek] Silesian Tech Univ, Syst Engn Grp, Gliwice, Poland; [Lipniacki, Tomasz] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland	Rice University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Silesian University of Technology; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Kimmel, M (corresponding author), Rice Univ, Dept Stat, Houston, TX 77251 USA.	kimmel@rice.edu	Lipniacki, Tomasz/AAC-6744-2019	Lipniacki, Tomasz/0000-0002-3488-2561; Brasier, Allan/0000-0002-5012-4090	National Institutes of Health [GM086885, AI062885]; National Science Center (Poland) [DEC-2012/04/A/ST7/00353]; EPSRC; Institute for Advanced Study at the Warwick University, UK; EPSRC [EP/J006653/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J006653/1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center (Poland)(National Science Centre, Poland); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Institute for Advanced Study at the Warwick University, UK; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM086885 (RB, TL, AS, MI, ARB, MK) and AI062885 (ARB). MK was partly supported by DEC-2012/04/A/ST7/00353 grant from the National Science Center (Poland), and by EPSRC and the Institute for Advanced Study at the Warwick University, UK, grants supporting his stay as a Fellow of the IAS at the Systems Biology Center at WU in the fall of 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Bertolusso R, 2011, COMPUTATIONAL MODELS; Brasier A.R., 2008, CELLULAR SIGNALING I, P119; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Chkrebtii O, 2013, BAYESIAN UNCERTAINTY; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Du CJ, 2010, CYTOM PART A, V77A, P1137, DOI 10.1002/cyto.a.20993; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Fujita PA, 2011, NUCL ACIDS RES; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Girolami M, 2008, THEOR COMPUT SCI, V408, P4, DOI 10.1016/j.tcs.2008.07.005; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Gutenkunst RN, 2007, ANN NY ACAD SCI, V1115, P203, DOI 10.1196/annals.1407.003; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Imaizumi T, 2004, LIFE SCI, V75, P1171, DOI 10.1016/j.lfs.2004.01.030; Iwanaszko M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-182; Jaksik R, 2012, GENE, V492, P375, DOI 10.1016/j.gene.2011.10.050; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Liu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008079; Lu RQ, 2002, J BIOL CHEM, V277, P16592, DOI 10.1074/jbc.M111440200; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; mieja J, 2008, BIOINFORMATICS, V24, P2363; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sandelin A, 2004, NUCLEIC ACIDS RES, V1, P32; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seckute J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt540; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Su ZZ, 2007, J CELL PHYSIOL, V213, P502, DOI 10.1002/jcp.21128; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2013, J VIROL, V87, P7075, DOI 10.1128/JVI.03399-12; Waterfall JJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150601; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu T, 2010, SCI SIGNALLING, V3; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299; Zhao YX, 2013, METHODS, V61, P313, DOI 10.1016/j.ymeth.2013.02.001; Zhao YX, 2013, MOL CELL PROTEOMICS, V12, P1513, DOI 10.1074/mcp.M112.023465	69	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93396	10.1371/journal.pone.0093396	http://dx.doi.org/10.1371/journal.pone.0093396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710104	Green Published, gold			2022-12-27	WOS:000334159800030
J	Hofstede, SN; van Bodegom-Vos, L; Wentink, MM; Vleggeert-Lankamp, CLA; Vlieland, TPMV; Marang-van de Mheen, PJ				Hofstede, Stefanie N.; van Bodegom-Vos, Leti; Wentink, Manon M.; Vleggeert-Lankamp, Carmen L. A.; Vlieland, Thea P. M. Vliet; Marang-van de Mheen, Perla J.		DISC Study Grp	Most Important Factors for the Implementation of Shared Decision Making in Sciatica Care: Ranking among Professionals and Patients	PLOS ONE			English	Article							SURGERY; DISC; FACILITATORS; MANAGEMENT; BARRIERS	Introduction: Due to the increasing specialization of medical professionals, patients are treated by multiple disciplines. To ensure that delivered care is patient-centered, it is crucial that professionals and the patient together decide on treatment (shared decision making (SDM)). However, it is not known how SDM should be integrated in multidisciplinary practice. This study determines the most important factors for SDM implementation in sciatica care, as it is known that a prior inventory of factors is crucial to develop a successful implementation strategy. Methods: 246 professionals (general practitioners, physical therapists, neurologists, neurosurgeons, orthopedic surgeons) (30% response) and 155 patients (96% response) responded to an internet-based survey. Respondents ranked barriers and facilitators identified in previous interviews, on their importance using Maximum Difference Scaling. Feeding back the personal top 5 most important factors, each respondent indicated whether these factors were barriers or facilitators. Hierarchical Bayes estimation was used to estimate the relative importance (RI) of each factor. Results: Professionals assigned the highest importance to: quality of professional-patient relationship (RI 4.87; CI 4.75-4.99); importance of quick recovery of patient (RI 4.83; CI 4.69-4.97); and knowledge about treatment options (RI 6.64; CI 4.534.74), which were reported as barrier and facilitator. Professionals working in primary care had a different ranking than those working in hospital care. Patients assigned the highest importance to: correct diagnosis by professionals (barrier, RI 8.19; CI 7.99-8.38); information provision about treatment options and potential harm and benefits (RI 7.87; CI 7.65-8.08); and explanation of the professional about the care trajectory (RI 7.16; CI 6.94-7.38), which were reported as barrier and facilitator. Conclusions: Knowledge, information provision and a good relationship are the most important conditions for SDM perceived by both patients and professionals. These conditions are not restricted to one specific disease or health care system, because they are mostly professional or patient dependent and require healthcare professional training.	[Hofstede, Stefanie N.; van Bodegom-Vos, Leti; Wentink, Manon M.; Marang-van de Mheen, Perla J.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Vleggeert-Lankamp, Carmen L. A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Vlieland, Thea P. M. Vliet] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Marang-van de Mheen, PJ (corresponding author), Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands.	p.j.marang@lumc.nl	assendelft, willem/AAW-1854-2021; Assendelft, W.J.J./H-8008-2014; Vleggeert-Lankamp, Carmen/AGX-9660-2022; de Mheen, Perla J. Marang-van/I-2783-2015; van Bodegom-Vos, Leti/J-8087-2015; Vlieland, Thea Vliet/AAJ-8119-2020	assendelft, willem/0000-0002-2966-3778; Assendelft, W.J.J./0000-0002-2966-3778; Vleggeert-Lankamp, Carmen/0000-0001-9597-7225; de Mheen, Perla J. Marang-van/0000-0003-1439-0989; van Bodegom-Vos, Leti/0000-0002-8486-6404; Vlieland, Thea Vliet/0000-0001-6322-3859; Hofstede, Stefanie/0000-0002-7181-9959	Netherlands Organization for Health Research and Development [171203003]; Netherlands Organization for Scientific Research (NWO) Incentive Fund Open Access Publications	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO) Incentive Fund Open Access Publications	This research project is supported by a grant from the Netherlands Organization for Health Research and Development (grant number 171203003). Funding was obtained from the Netherlands Organization for Scientific Research (NWO) Incentive Fund Open Access Publications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; Cohen S, 2004, MARK RES, V16, P32; Cohen Steven H., 2002, C P AMST NETH; DEGNER LF, 1992, J CLIN EPIDEMIOL, V45, P941, DOI 10.1016/0895-4356(92)90110-9; Dobrow MJ, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1090; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Hofstede SN, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-95; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; Jessup RL, 2007, AUST HEALTH REV, V31, P330, DOI 10.1071/AH070330; Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2; Legare F, 2011, J EVAL CLIN PRACT, V17, P554, DOI 10.1111/j.1365-2753.2010.01515.x; Legare F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub2; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Lurie JD, 2008, SPINE, V33, P2663, DOI 10.1097/BRS.0b013e31818cb0db; McIntosh E, 2002, HLTH EC STUD GROUP M; OCONNOR A, 2009, COCHRANE DB SYST REV, V10; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Quality Institute for Health Care CBO, 2008, GUID LUMB RAD SYNDR; Rajakumar R., 2014, PRIM HLTH CARE RES D, P1; Sawtooth Software, 2009, CBC HB SYSTEM HIERAR; Sawtooth Software I, 2013, MAXDIFF SYST VERS 8; Sawtooth Software I, 2012, SSI WEB V8 1 SOFTW W; Van Beek E, 2010, REDUCTION VARIATION; Veroff D, 2013, HEALTH AFFAIR, V32, P285, DOI 10.1377/hlthaff.2011.0941; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; Webster BS, 2005, J GEN INTERN MED, V20, P1132, DOI 10.1111/j.1525-1497.2005.0230.x; Wiebe ER, 2012, CAN FAM PHYSICIAN, V58, pE225; Wirth R, 2011, USING MAXDIFF EVALUA	30	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94176	10.1371/journal.pone.0094176	http://dx.doi.org/10.1371/journal.pone.0094176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710328	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800112
J	Shiheido, H; Chen, C; Hikida, M; Watanabe, T; Shimizu, J				Shiheido, Hirokazu; Chen, Chen; Hikida, Masaki; Watanabe, Takeshi; Shimizu, Jun			Modulation of the Human T Cell Response by a Novel Non-Mitogenic Anti-CD3 Antibody	PLOS ONE			English	Article							OKT3 MONOCLONAL-ANTIBODY; ANTIGEN RECEPTOR; IN-VITRO; IMMUNOSUPPRESSIVE PROPERTIES; ACTIVATION; RECIPIENTS; REJECTION; PROLIFERATION; EXPANSION; RELEASE	The agonistic anti-human CD3 epsilon antibody ( Ab), OKT3, has been used to control acute transplant rejection. The in vivo administration of OKT3 was previously shown to induce the partial depletion of T cells and unresponsiveness ( anergy) in the remaining CD4(+) T cells. However, this therapy is also associated with the systemic release of several cytokines, which leads to a series of adverse side effects. We established a novel anti-human CD3 epsilon Ab, 20-2b2, which recognized a close, but different determinant on the CD epsilon molecule from that recognized by OKT3. 20-2b2 was non-mitogenic for human CD4(+) T cells, could inhibit the activation of T cells in vitro, and induced T cell anergy in in vivo experiments using humanized mice. Cytokine release in humanized mice induced by the administration of 20-2b2 was significantly less than that induced by OKT3. Our results indicated that the CD epsilon molecule is still an attractive, effective, and useful target for the modulation of T cell responses. The establishment of other Abs that recognize CD3e, even though the determinant recognized by those Abs may be close to or different from that recognized by OKT3, may represent a novel approach for the development of safer Ab therapies using anti-CD3 Abs, in addition to the modification of OKT3 in terms of the induction of cytokine production.	[Shiheido, Hirokazu; Chen, Chen; Hikida, Masaki; Watanabe, Takeshi; Shimizu, Jun] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Kyoto University	Shimizu, J (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.	jun@ak.med.kyoto-u.ac.jp		Shimizu, Jun/0000-0002-6461-4648; Shiheido, Hirokazu/0000-0002-1415-2019	Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Grants-in-Aid for Scientific Research [24111009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Special Coordination Funds by the Ministry of Education, Culture, Sports, Science and Technology of Japan and Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; ALEGRE ML, 1994, TRANSPLANTATION, V57, P1537; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; BOLT S, 1993, EUR J IMMUNOL, V23, P403, DOI 10.1002/eji.1830230216; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; Chatenoud L, 2004, CURR OPIN PHARMACOL, V4, P403, DOI 10.1016/j.coph.2004.03.012; CHATENOUD L, 1990, TRANSPLANTATION, V49, P697, DOI 10.1097/00007890-199004000-00009; Cole MS, 1999, TRANSPLANTATION, V68, P563, DOI 10.1097/00007890-199908270-00020; COSIMI AB, 1981, NEW ENGL J MED, V305, P308, DOI 10.1056/NEJM198108063050603; COSIMI AB, 1981, TRANSPLANTATION, V32, P535, DOI 10.1097/00007890-198112000-00018; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Fleischer B, 1996, INFECT IMMUN, V64, P987, DOI 10.1128/IAI.64.3.987-994.1996; Friend PJ, 1999, TRANSPLANTATION, V68, P1632, DOI 10.1097/00007890-199912150-00005; Grakoui A, 1998, INT IMMUNOL, V10, P969, DOI 10.1093/intimm/10.7.969; Herold KC, 2003, J CLIN INVEST, V111, P409, DOI 10.1172/JCI200316090; HIRSCH R, 1989, J IMMUNOL, V142, P737; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Kaufman A, 2009, DIABETES-METAB RES, V25, P302, DOI 10.1002/dmrr.933; Kuhn C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001830; Li J, 2006, INT IMMUNOPHARMACOL, V6, P880, DOI 10.1016/j.intimp.2005.12.009; LUTON F, 1994, J IMMUNOL, V153, P63; Martin A, 2013, CLIN IMMUNOL, V148, P136, DOI 10.1016/j.clim.2013.04.011; Nishida E, 2011, IMMUNOL LETT, V136, P163, DOI 10.1016/j.imlet.2011.01.006; Nishioka T, 2008, IMMUNOL LETT, V121, P97, DOI 10.1016/j.imlet.2008.09.003; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Popma SH, 2005, INT IMMUNOPHARMACOL, V5, P155, DOI 10.1016/j.intimp.2004.09.023; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Shiheido H, 2014, EUR J IMMUNOL, V44, P1770, DOI 10.1002/eji.201344146; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; VIGERAL P, 1986, TRANSPLANTATION, V41, P730, DOI 10.1097/00007890-198606000-00013; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; 1985, N ENGL J MED, V313, P337	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94324	10.1371/journal.pone.0094324	http://dx.doi.org/10.1371/journal.pone.0094324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710513	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800135
J	Naqvi, T; Warden, AC; French, N; Sugrue, E; Carr, PD; Jackson, CJ; Scott, C				Naqvi, Tatheer; Warden, Andrew C.; French, Nigel; Sugrue, Elena; Carr, Paul D.; Jackson, Colin J.; Scott, Colin			A 5000-Fold Increase in the Specificity of a Bacterial Phosphotriesterase for Malathion through Combinatorial Active Site Mutagenesis	PLOS ONE			English	Article							ORGANOPHOSPHORUS HYDROLASE; PSEUDOMONAS-DIMINUTA; DIRECTED EVOLUTION; NERVE AGENTS; HYDROLYSIS; MECHANISM; ENZYME; IDENTIFICATION; DEGRADATION; MANAGEMENT	Phosphotriesterases (PTEs) have been isolated from a range of bacterial species, including Agrobcaterium radiobacter (PTEAr), and are efficient enzymes with broad substrate ranges. The turnover rate of PTEAr for the common organophosphorous insecticide malathion is lower than expected based on its physical properties; principally the pk(a) of its leaving group. In this study, we rationalise the turnover rate of PTEAr for malathion using computational docking of the substrate into a high resolution crystal structure of the enzyme, suggesting that malathion is too large for the PTEAr binding pocket. Protein engineering through combinatorial active site saturation testing (CASTing) was then used to increase the rate of malathion turnover. Variants from a CASTing library in which Ser308 and Tyr309 were mutated yielded variants with increased activity towards malathion. The most active PTEAr variant carried Ser308Leu and Tyr309Ala substitutions, which resulted in a ca. 5000-fold increase in k(cat)/K-M for malathion. X-ray crystal structures for the PTEAr Ser308Leu\Tyr309Ala variant demonstrate that the access to the binding pocket was enhanced by the replacement of the bulky Tyr309 residue with the smaller alanine residue.	[Naqvi, Tatheer] COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad, Pakistan; [Naqvi, Tatheer; Warden, Andrew C.; French, Nigel; Scott, Colin] CSIRO, Ecosyst Sci, Canberra, ACT, Australia; [Sugrue, Elena; Carr, Paul D.; Jackson, Colin J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	COMSATS University Islamabad (CUI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Scott, C (corresponding author), CSIRO, Ecosyst Sci, Canberra, ACT, Australia.	colin.scott@csiro.au	Scott, Colin/A-4682-2009; Naqvi, Tatheer Alam/GSO-2098-2022; French, Nigel/B-5501-2011; Alam, Tatheer/I-5443-2019; Warden, Andrew C/C-1484-2008; Jackson, Colin J/C-1500-2008	Scott, Colin/0000-0001-6110-6982; Naqvi, Tatheer Alam/0000-0003-4538-6317; Alam, Tatheer/0000-0003-4538-6317; Warden, Andrew C/0000-0003-2683-9798; Jackson, Colin J/0000-0001-6150-3822; Sugrue, Elena/0000-0001-5014-9522	Australian Department of Industry Endeavour Fellowship	Australian Department of Industry Endeavour Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science)	TN was supported by an Australian Department of Industry Endeavour Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert SD, 2004, BIOCHEMISTRY-US, V43, P5707, DOI 10.1021/bi0497805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bird SB, 2008, TOXICOLOGY, V247, P88, DOI 10.1016/j.tox.2008.02.005; Bonner MR, 2007, AM J EPIDEMIOL, V166, P1023, DOI 10.1093/aje/kwm182; CALDWELL SR, 1991, BIOCHEMISTRY-US, V30, P7438, DOI 10.1021/bi00244a010; Cho CMH, 2002, APPL ENVIRON MICROB, V68, P2026, DOI 10.1128/AEM.68.4.2026-2030.2002; Cho CMH, 2004, APPL ENVIRON MICROB, V70, P4681, DOI 10.1128/AEM.70.8.4681-4685.2004; Dawson RM, 2008, J HAZARD MATER, V157, P308, DOI 10.1016/j.jhazmat.2007.12.099; DUMAS DP, 1989, J BIOL CHEM, V264, P19659; Eddleston M, 2008, LANCET, V371, P597, DOI 10.1016/S0140-6736(07)61202-1; Edwards JW, 2007, ENVIRON RES, V103, P38, DOI 10.1016/j.envres.2006.06.001; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hilal SH, 1995, QUANT STRUCT-ACT REL, V14, P348, DOI 10.1002/qsar.19950140405; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horne I, 2002, APPL ENVIRON MICROB, V68, P3371, DOI 10.1128/AEM.68.7.3371-3376.2002; Jackson C, 2005, BBA-PROTEINS PROTEOM, V1752, P56, DOI 10.1016/j.bbapap.2005.06.008; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; Jackson CJ, 2005, ORG BIOMOL CHEM, V3, P4343, DOI 10.1039/b512399b; Jackson CJ, 2008, J MOL BIOL, V375, P1189, DOI 10.1016/j.jmb.2007.10.061; Jackson CJ, 2006, BIOCHEM J, V397, P501, DOI 10.1042/BJ20060276; Jackson CJ, 2013, P NATL ACAD SCI USA, V110, P10177, DOI 10.1073/pnas.1304097110; Jackson CJ, 2010, BIOCHEM PHARMACOL, V80, P1079, DOI 10.1016/j.bcp.2010.06.008; Jackson CJ, 2009, APPL ENVIRON MICROB, V75, P5153, DOI 10.1128/AEM.00629-09; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Paudyal BP, 2008, J NEPAL MED ASSOC, V47, P251; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; Schleier JJ, 2012, SCI TOTAL ENVIRON, V438, P72, DOI 10.1016/j.scitotenv.2012.07.059; Scott C, 2011, ACS S SERIES; Scott C, 2008, INDIAN J MICROBIOL, V48, P65, DOI 10.1007/s12088-008-0007-4; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; Watkins LM, 1997, J BIOL CHEM, V272, P25596, DOI 10.1074/jbc.272.41.25596; Weston DP, 2009, ENVIRON SCI TECHNOL, V43, P5514, DOI 10.1021/es900434z; Wille T, 2012, BIOCATALYSIS BIOTRAN, V30; Yang H, 2003, PROTEIN ENG, V16, P135, DOI 10.1093/proeng/gzg013	37	28	28	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94177	10.1371/journal.pone.0094177	http://dx.doi.org/10.1371/journal.pone.0094177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721933	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336909100042
J	Nigmatullin, RR; Osokin, SI; Baleanu, D; Al-Amri, S; Azam, A; Memic, A				Nigmatullin, Raoul R.; Osokin, Sergey I.; Baleanu, Dumitru; Al-Amri, Sawsan; Azam, Ameer; Memic, Adnan			The First Observation of Memory Effects in the InfraRed (FT-IR) Measurements: Do Successive Measurements Remember Each Other?	PLOS ONE			English	Article							OXIDE THIN-FILMS; FIELD-EMISSION; CUO NANOPARTICLES; CUPROUS-OXIDE; TRANSITION	Over the past couple of decades there have been major advances in the field of nanoscience and nanotechnology. Many applications have sprouted from these fields of research. It is essential, given the scale of the materials, to attain accurate, valid and reproducible measurements. Material properties have shown to be a function of their size and composition. Physiochemical properties of the nanomaterials can significantly alter material behavior compared to bulk counterparts. For example, metal oxide nanoparticles have found broad applications ranging from photo-catalysis to antibacterial agents. In our study, we synthesized CuO nanoparticles using well established sol-gel based methods with varying levels of Ni doping. However, upon analysis of measured infrared data, we discovered the presence of quasi-periodic (QP) processes. Such processes have previously been reported to be tightly associated with measurement memory effects. We were able to detect the desired QP process in these measurements from three highly accurate repetitive experiments performed on each Ni (1-7%) doped CuO sample. In other words, successive measurements performed in a rather short period of time remember each other at least inside a group of neighboring measurements.	[Nigmatullin, Raoul R.; Osokin, Sergey I.] Kazan Fed Univ, Dept Theoret Phys, Kazan, Russia; [Baleanu, Dumitru] King Abdulaziz Univ, Chem & Mat Engn Dept, Jeddah 21413, Saudi Arabia; [Baleanu, Dumitru] Cankaya Univ, Dept Math & Comp Sci, Ankara, Turkey; [Baleanu, Dumitru] Inst Space Sci, Magurele, Romania; [Al-Amri, Sawsan; Azam, Ameer; Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21413, Saudi Arabia; [Al-Amri, Sawsan] King Abdulaziz Univ, Dept Biochem, Jeddah 21413, Saudi Arabia	Kazan Federal University; King Abdulaziz University; Cankaya University; Institute of Space Science; King Abdulaziz University; King Abdulaziz University	Nigmatullin, RR (corresponding author), Kazan Fed Univ, Dept Theoret Phys, Kazan, Russia.	renigmat@gmail.com; memic@mit.edu	Baleanu, Dumitru/B-9936-2012; Nigmatullin, Raoul/AAO-5504-2020; Memić, Adnan/I-6138-2013; Azam, Ameer/C-3346-2011	Baleanu, Dumitru/0000-0002-0286-7244; Nigmatullin, Raoul/0000-0003-2931-4428; Memić, Adnan/0000-0003-4639-8168; 	Kazan Federal University; Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [363-903-1433]; DSR	Kazan Federal University; Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	R.R.N. and S.I.O. want to express their acknowledgments to the authorities of the Kazan Federal University for the financial support of this research in the frame of the program "Top-100" that was adopted by the university for the period of the years 2014-2018. The publication of this paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 363-903-1433. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AS, 2011, J LUMIN, V131, P1, DOI 10.1016/j.jlumin.2010.07.017; Allen SE, 2013, CHEM REV, V113, P6234, DOI 10.1021/cr300527g; Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347; Azam A, 2012, INT J NANOMED, V7, P3527, DOI 10.2147/IJN.S29020; Baco-Carles V, 2011, ISRN NANOTECHNOLOGY, V2011, P7; Baleanu CM, 2011, CENT EUR J PHYS, V9, P729, DOI 10.2478/s11534-010-0068-y; Borgohain K, 2000, PHYS REV B, V61, P11093, DOI 10.1103/PhysRevB.61.11093; Chen J, 2003, APPL PHYS LETT, V83, P746, DOI 10.1063/1.1595156; Chowdhuri A, 2004, APPL PHYS LETT, V84, P1180, DOI 10.1063/1.1646760; Das K, 2010, J APPL PHYS, V107, DOI 10.1063/1.3295910; Eliseev AA, 2000, MATER RES INNOV, V3, P308, DOI 10.1007/PL00010877; Gao XP, 2004, J PHYS CHEM B, V108, P5547, DOI 10.1021/jp037075k; GRIFFITHS PR, 1983, SCIENCE, V222, P297, DOI 10.1126/science.6623077; HERION J, 1980, SOL ENERG MATER, V4, P101, DOI 10.1016/0165-1633(80)90022-2; Jayatissa AH, 2009, APPL SURF SCI, V255, P9474, DOI 10.1016/j.apsusc.2009.07.072; Kumar RV, 2000, CHEM MATER, V12, P2301, DOI 10.1021/cm000166z; Nigmatullin RR, 2006, J INSTRUM, V1, DOI 10.1088/1748-0221/1/10/P10002; Nigmatullin R.R., 2012, SIGNAL IMAGE VIDEO P, P1, DOI [10.1007/s11760-012-0386-1, DOI 10.1007/S11760-012-0386-1]; Nigmatullin RR, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/01/015201; Ogwu AA, 2005, J PHYS D APPL PHYS, V38, P266, DOI 10.1088/0022-3727/38/2/011; Ott HR, 2003, PHYSICS OF SUPERCONDUCTORS, VOL I, P385; RAKHSHANI AE, 1986, SOLID STATE ELECTRON, V29, P7, DOI 10.1016/0038-1101(86)90191-7; Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374; Switzer JA, 2003, NATURE, V425, P490, DOI 10.1038/nature01990; TANAKA T, 1990, THIN SOLID FILMS, V189, P9, DOI 10.1016/0040-6090(90)90021-5; Wang C, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145506; Wu DX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235206; Xu JF, 1999, J SOLID STATE CHEM, V147, P516, DOI 10.1006/1999.8409; Yeon SC, 2006, J VAC SCI TECHNOL B, V24, P940, DOI 10.1116/1.2183788; Zhu YW, 2005, NANOTECHNOLOGY, V16, P88, DOI 10.1088/0957-4484/16/1/018	30	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94305	10.1371/journal.pone.0094305	http://dx.doi.org/10.1371/journal.pone.0094305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722337	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100051
J	Roland, WSU; Gouka, RJ; Gruppen, H; Driesse, M; van Buren, L; Smit, G; Vincken, JP				Roland, Wibke S. U.; Gouka, Robin J.; Gruppen, Harry; Driesse, Marianne; van Buren, Leo; Smit, Gerrit; Vincken, Jean-Paul			6-Methoxyflavanones as Bitter Taste Receptor Blockers for hTAS2R39	PLOS ONE			English	Article							STRUCTURAL REQUIREMENTS; ACTIVATE; PEPTIDES; SUBUNITS	Many (dietary) bitter compounds, e. g. flavonoids, activate bitter receptor hTAS2R39 in cell-based assays. Several flavonoids, amongst which some flavanones, are known not to activate this receptor. As certain flavanones are known to mask bitter taste sensorially, flavanones might act as bitter receptor antagonists. Fourteen flavanones were investigated for their potential to reduce activation of hTAS2R39 by epicatechin gallate (ECG), one of the main bitter compounds occurring in green tea. Three flavanones showed inhibitory behavior towards the activation of hTAS2R39 by ECG: 49-fluoro-6-methoxyflavanone, 6,39-dimethoxyflavanone, and 6-methoxyflavanone (in order of decreasing potency). The 6-methoxyflavanones also inhibited activation of hTAS2R14 (another bitter receptor activated by ECG), though to a lesser extent. Dose-response curves of ECG at various concentrations of the full antagonist 49-fluoro-6-methoxyflavanone and wash-out experiments indicated reversible insurmountable antagonism. The same effect was observed for the structurally different agonist denatonium benzoate.	[Roland, Wibke S. U.; Gruppen, Harry; Driesse, Marianne; Smit, Gerrit; Vincken, Jean-Paul] Wageningen Univ, Food Chem Lab, NL-6700 AP Wageningen, Netherlands; [Gouka, Robin J.; van Buren, Leo] Unilever R&D, Vlaardingen, Netherlands	Wageningen University & Research; Unilever	Vincken, JP (corresponding author), Wageningen Univ, Food Chem Lab, NL-6700 AP Wageningen, Netherlands.	jean-paul.vincken@wur.nl		Vincken, Jean-Paul/0000-0001-8540-4327	Food & Nutrition Delta of the Ministry of Economic Affairs, the Netherlands [FND 08019]	Food & Nutrition Delta of the Ministry of Economic Affairs, the Netherlands	This work was financially supported by the Food & Nutrition Delta of the Ministry of Economic Affairs, the Netherlands (FND 08019, http://www.agentschapnl.nl/subsidies-regelingen/innovatieprogramma-food-nutrition). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Brockhoff A, 2011, J NEUROSCI, V31, P14775, DOI 10.1523/JNEUROSCI.2923-11.2011; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Drewnowski A, 2000, AM J CLIN NUTR, V72, P1424; Fletcher JN, 2011, J AGR FOOD CHEM, V59, P13117, DOI 10.1021/jf204359q; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Kenakin T., 2006, PHARM PRIMER THEORY; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; Kohl S, 2013, J AGR FOOD CHEM, V61, P53, DOI 10.1021/jf303146h; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Ley JP, 2008, CHEMOSENS PERCEPT, V1, P58, DOI 10.1007/s12078-008-9008-2; Ley JP, 2012, J AGR FOOD CHEM, V60, P6303, DOI 10.1021/jf301335z; Ley JP, 2005, J AGR FOOD CHEM, V53, P6061, DOI 10.1021/jf0505170; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Narukawa M, 2011, BIOCHEM BIOPH RES CO, V405, P620, DOI 10.1016/j.bbrc.2011.01.079; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Roland WSU, 2011, J AGR FOOD CHEM, V59, P11764, DOI 10.1021/jf202816u; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Thalmann S, 2013, BIOCHEM BIOPH RES CO, V435, P267, DOI 10.1016/j.bbrc.2013.04.066; Ueda T, 2003, J NEUROSCI, V23, P7376; Ueno Y, 2011, BIOSCI BIOTECH BIOCH, V75, P1188, DOI 10.1271/bbb.100893; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	26	71	73	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94451	10.1371/journal.pone.0094451	http://dx.doi.org/10.1371/journal.pone.0094451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722342	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100071
J	Singh, NJ; Leonardsson, K				Singh, Navinder J.; Leonardsson, Kjell			Partial Migration and Transient Coexistence of Migrants and Residents in Animal Populations	PLOS ONE			English	Article							MOOSE ALCES-ALCES; ENVIRONMENTAL-CHANGE; DENSITY-DEPENDENCE; EVOLUTION; CONSEQUENCES; SELECTION; ECOLOGY; BIRDS; SIZE	Partial migration, whereby a proportion of the population migrates, is common across the animal kingdom. Much of the focus in the literature has been on trying to explain the underlying mechanisms for the coexistence of migrants and residents. In addition, there has been an increasing number of reports on the prevalence and frequency of partially migratory populations. One possible explanation for the occurrence of partial migration, which has received no attention in the literature, is that of 'transient coexistence' during the invasion phase of a superior behaviour. In this study we develop a theoretical basis for explaining partial migration as a transient coexistence and derive a method to predict the frequency of residents and migrants in partially migrating populations. This method is useful to predict the frequencies of migrants and residents in a small set of populations as a complementing hypothesis to 'an Evolutionary Stable Strategy (ESS)'. We use the logistic growth equation to derive a formula for predicting the frequencies of residents and migrants. We also use simulations and empirical data from white perch (Morone americana), moose (Alces alces) and red deer (Cervus elaphus) to demonstrate our approach. We show that the probability of detecting partial migration due to transient coexistence depends upon a minimum number of tracked or marked individuals for a given number of populations. Our approach provides a starting point in searching for explanations to the observed frequencies, by contrasting the observed pattern with both the predicted transient and the uniform random pattern. Aggregating such information on observed patterns (proportions of migrants and residents) may eventually lead to the development of a quantitative theory for the equilibrium (ESS) populations as well.	[Singh, Navinder J.; Leonardsson, Kjell] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences	Singh, NJ (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	navinder.singh@slu.se; kjell.leonardsson@slu.se			Thematic Programme in Wildlife and forestry at the Swedish University of Agricultural Sciences	Thematic Programme in Wildlife and forestry at the Swedish University of Agricultural Sciences	NS was supported by the Thematic Programme in Wildlife and forestry at the Swedish University of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; [Anonymous], 2020, ECONOMIST 0326; Bateson P, 2004, BIOL PHILOS, V19, P283, DOI 10.1023/B:BIPH.0000024468.12161.83; BERTHOLD P, 1982, EXPERIENTIA, V38, P805, DOI 10.1007/BF01972282; Berthold P, 1999, OSTRICH, V70, P1, DOI 10.1080/00306525.1999.9639744; BERTHOLD P, 1984, RING, V10, P253; BIEBACH H, 1983, AUK, V100, P601, DOI 10.1093/auk/100.3.601; Brodersen J, 2008, OIKOS, V117, P40, DOI 10.1111/j.2007.0030-1299.16118.x; Brusewitz G, 1996, SWEDISH GAME BIOL MA, P40; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Chevin LM, 2011, BIOL LETTERS, V7, P210, DOI 10.1098/rsbl.2010.0580; Ducatez S, 2013, ANIM COGN, V16, P525, DOI 10.1007/s10071-013-0612-4; Ericsson G, 1999, WILDLIFE BIOL, V5, P177, DOI 10.2981/wlb.1999.022; Fryxell JM, 2013, ECOLOGY, V94, P1274, DOI 10.1890/12-0668.1; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Griswold CK, 2011, OIKOS, V120, P1847, DOI 10.1111/j.1600-0706.2011.19435.x; Griswold CK, 2010, P ROY SOC B-BIOL SCI, V277, P2711, DOI 10.1098/rspb.2010.0550; KAITALA A, 1993, AM NAT, V142, P59, DOI 10.1086/285529; Kerr LA, 2012, ESTUAR COAST, V35, P227, DOI 10.1007/s12237-011-9434-2; Kokko H, 2001, AM NAT, V157, P188, DOI 10.1086/318632; Kokko H, 2011, OIKOS, V120, P1826, DOI 10.1111/j.1600-0706.2011.19438.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; LUNDBERG P, 1987, J THEOR BIOL, V125, P351, DOI 10.1016/S0022-5193(87)80067-X; LUNDBERG P, 1988, TRENDS ECOL EVOL, V3, P172, DOI 10.1016/0169-5347(88)90035-3; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Rooney AP, 1999, J MOL EVOL, V49, P682, DOI 10.1007/PL00006589; Rosvold J, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-191; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Solberg EJ, 2005, WILDLIFE BIOL, V11, P163, DOI 10.2981/0909-6396(2005)11[163:CRAAEO]2.0.CO;2; Taylor CM, 2007, BIOLOGY LETT, V3, P280, DOI 10.1098/rsbl.2007.0053; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	35	5	5	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94750	10.1371/journal.pone.0094750	http://dx.doi.org/10.1371/journal.pone.0094750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722396	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100129
J	Song, YK; Liu, KJ; Wang, TH				Song, Yunke; Liu, Kelvin J.; Wang, Tza-Huei			Elimination of Ligation Dependent Artifacts in T4 RNA Ligase to Achieve High Efficiency and Low Bias MicroRNA Capture	PLOS ONE			English	Article							MIRNA EXPRESSION; RT-PCR; OLIGONUCLEOTIDE; MICROARRAY; QUANTIFICATION; IDENTIFICATION; DISCOVERY; PLATFORM	Adapter ligation is a critical first step in many microRNA analysis methods including microarray, qPCR, and sequencing. Previous studies have shown that ligation bias can have dramatic effects on both the fidelity of expression profiles and reproducibility across samples. We have developed a method for high efficiency and low bias microRNA capture by 3' adapter ligation using T4 RNA ligase that does not require pooled adapters. Using a panel of 20 microRNA, we investigated the effects of ligase type, PEG concentration, ligase amount, adapter concentration, incubation time, incubation temperature, and adapter design on capture efficiency and bias. Of these factors, high PEG% was found to be critical in suppressing ligation bias. We obtained high average capture efficiency and low CV across the 20 microRNA panel, both in idealized buffer conditions (86% +/- 10%) and total RNA spiking conditions (64% +/- 17%). We demonstrate that this method is reliable across microRNA species that previous studies have had difficulty capturing and that our adapter design performs significantly better than the common adapter designs. Further, we demonstrate that the optimization methodology must be specifically designed for minimizing bias in order to obtain the ideal reaction parameters.	[Song, Yunke; Wang, Tza-Huei] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Liu, Kelvin J.; Wang, Tza-Huei] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Liu, Kelvin J.] Circulomics Inc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Liu, KJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	kliu@circulomics.com; thwang@jhu.edu	Wang, Tza-Huei/A-3337-2010; Liu, Kelvin/F-5432-2010	Liu, Kelvin/0000-0002-1164-582X; Wang, Tza-Huei/0000-0002-3540-9354	National Institutes of Health [R21CA173390, R43GM103360, R01CA155305, U54CA151838]; Maryland Technology Development Corporation [2012- MTTCF-0291-00]; NATIONAL CANCER INSTITUTE [R01CA155305, U54CA151838, R21CA173390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM103360, R44GM103360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Technology Development Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health [R21CA173390, R43GM103360, R01CA155305, U54CA151838]; and the Maryland Technology Development Corporation [2012- MTTCF-0291-00]. Funding for open access charge: National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; HARRISON B, 1984, NUCLEIC ACIDS RES, V12, P8235, DOI 10.1093/nar/12.21.8235; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Kilburn D, 2013, J AM CHEM SOC, V135, P10055, DOI 10.1021/ja4030098; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyoshi D, 2008, BIOCHIMIE, V90, P1040, DOI 10.1016/j.biochi.2008.02.009; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pfeffer Sebastien, 2005, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2604s72; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Sorefan Karim, 2012, Silence, V3, P4, DOI 10.1186/1758-907X-3-4; Sun GH, 2011, RNA, V17, P2256, DOI 10.1261/rna.028621.111; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; TESSIER DC, 1986, ANAL BIOCHEM, V158, P171, DOI 10.1016/0003-2697(86)90606-8; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Van Nieuwerburgh F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026969; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vigneault F, 2008, NAT METHODS, V5, P777, DOI 10.1038/NMETH.1244; Viollet S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-72; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yin SM, 2003, J BIOL CHEM, V278, P17601, DOI 10.1074/jbc.M300817200; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang ZJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r109; Zhuang FL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1263	55	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94619	10.1371/journal.pone.0094619	http://dx.doi.org/10.1371/journal.pone.0094619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722341	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100108
J	Agrawal, G; Keshri, K				Agrawal, Gopal; Keshri, Kunal			Morbidity Patterns and Health Care Seeking Behavior among Older Widows in India	PLOS ONE			English	Article							MARITAL-STATUS; SEX-DIFFERENCES; MORTALITY; GENDER; WOMEN; POPULATION; EGYPT; AGE	In the process of health transition, India is facing rapid pace of demographic aging. Rapid increase in older adult population posed serious concerns regarding health and health care utilization for them. However, very limited research documented resultant implications of demographic aging for health and health care use in the nexus of marital status and gender. With this perspective, the present study examined patterns in morbidity prevalence and health seeking behaviour among older widows in India. Multivariate logistic regression models were estimated to examine the effects of socio-demographic conditions on morbidity prevalence among older widows and their health care seeking behavior. Data from the latest 60(th) round of National Sample Survey (NSS), 2004 was used. Overall, morbidity prevalence was 13% greater among older widows compared to older widowers. Adjusted prevalence of communicable and non- communicable diseases was found 74 and 192 per 1000 older widows respectively. At the same time, likelihood of seeking health care services for reported morbidities was substantially lower among older widows. The findings of this study are important to support policy makers and health care providers in identifying individuals `at risk' and could be integrated into the current programs of social, economic and health security for the older persons.	[Agrawal, Gopal] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Keshri, Kunal] GB Pant Social Sci Inst, Allahabad, Uttar Pradesh, India	International Institute for Population Sciences; University of Allahabad	Keshri, K (corresponding author), GB Pant Social Sci Inst, Allahabad, Uttar Pradesh, India.	keshri.kunal@gmail.com	Keshri, Kunal/ADE-3613-2022	Keshri, Kunal/0000-0002-2969-2552				Agrawal G, 2009, MIDDLE E J AGE AGEIN, V6, P21; Agrawal G, 2010, J APPL GERONTOL, V29, P155, DOI 10.1177/0733464809339622; [Anonymous], STAT MODELS CAUSAL A; Arokiasamy P, 2010, J PRIM CARE COMMUNIT, V1, P192, DOI 10.1177/2150131910378527; Case A, 2002, AM ECON REV, V92, P1308, DOI 10.1257/000282802762024520; CHEN M, 1992, ECON POLIT WEEKLY, V27, pWS81; Cheung YB, 2000, INT J EPIDEMIOL, V29, P93, DOI 10.1093/ije/29.1.93; Cockerham WC, 1997, THIS AGING SOC; Cutler DM, 2008, 14333 NAT BUR EC RES; Dhak B, 2009, J BIOSOC SCI, V41, P625, DOI 10.1017/S002193200999006X; Dreze J, 1997, J DEV ECON, V54, P217, DOI 10.1016/S0304-3878(97)00041-2; FENWICK R, 1981, J HEALTH SOC BEHAV, V22, P106, DOI 10.2307/2136287; Grundy E, 2003, SOC SCI MED, V56, P935, DOI 10.1016/S0277-9536(02)00093-X; Gubhaju B, 2008, ASIA PACIFIC POPULAT, V23, P55; Gulati L, 1999, ECON POLIT WEEKLY, V34, pWS46; Gulati L, 1998, WIDOWS INDIA SOCIAL; HAHN BA, 1993, J MARRIAGE FAM, V55, P495, DOI 10.2307/352818; Hallerod B, 2011, SOC SCI MED, V72, P116, DOI 10.1016/j.socscimed.2010.09.036; Harper S., 2006, AGEING SOC MYTHS CHA; Hoffman R, 2008, SOCIOECONOMIC DIFFER; HU YR, 1990, DEMOGRAPHY, V27, P233, DOI 10.2307/2061451; Karkal M, 1999, ECON POLIT WEEKLY, V34, pWS54; Krochalk PC, 2008, AUSTRALAS J AGEING, V27, P26, DOI 10.1111/j.1741-6612.2007.00269.x; Kumar Vinod, 2003, J Aging Soc Policy, V15, P67, DOI 10.1300/J031v15n02_05; Liang J, 2002, J GERONTOL B-PSYCHOL, V57, pS294, DOI 10.1093/geronb/57.5.S294; Manzoli L, 2007, SOC SCI MED, V64, P77, DOI 10.1016/j.socscimed.2006.08.031; Martin L. G., 1994, DEMOGRAPHY AGING; Mazumder B., 2008, EC PERSPECTIVES, V33, P2; NPOP, 1999, NAT POL OLD PERS; Pandey MK, 2008, MUNICH PERSONAL REPE; Park SM, 2010, J BIOSOC SCI, V42, P99, DOI 10.1017/S0021932009990204; Prakash IJ, 1997, INDIAN J MED RES, V106, P396; Prakash IJ, 2003, AGEING INDIA PERSPEC; Rajan SI., 2006, POPULATION AGEING HL; Reddy P H, 1996, Health Transit Rev, V6 Suppl, P233; Redondo-Sendino Guallar-Castillon P, 2006, BMC PUBLIC HEALTH, V6, P1; Registrar General of India, 2001, CENS IND PRIM CENS A; Registrar General of India, 2011, CENS IND PRIM CENS A; Sengupta M., 2003, ASIA PAC POPULAT J, V18, P53; Sengupta Manisha, 2002, J Cross Cult Gerontol, V17, P313, DOI 10.1023/A:1023079219538; Shah B, 1997, INDIAN J MED RES, V106, P265; Smith KR, 1996, SOC BIOL, V43, P59; Strauss J, 1998, J ECON LIT, V36, P766; Swarnalatha N., 2007, J INDIAN ACAD GERIAT, V3, P15; United Nations, 2007, WORLD POP AG 1950 20; VERBRUGGE LM, 1989, J HEALTH SOC BEHAV, V30, P282, DOI 10.2307/2136961; Visaria Pravin, 2001, ECON POLIT WEEKLY, V36, P1967; WHO, 2007, WOM AG HLTH FRAM ACT; Williams K, 2004, J HEALTH SOC BEHAV, V45, P81, DOI 10.1177/002214650404500106; Yount KM, 2005, DEMOGRAPHY, V42, P169, DOI 10.1353/dem.2005.0009; Yount KM, 2004, SOC SCI MED, V59, P2479, DOI 10.1016/j.socscimed.2004.04.004	51	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94295	10.1371/journal.pone.0094295	http://dx.doi.org/10.1371/journal.pone.0094295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718291	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000103
J	Anderson, LG; White, PCL; Stebbing, PD; Stentiford, GD; Dunn, AM				Anderson, Lucy G.; White, Piran C. L.; Stebbing, Paul D.; Stentiford, Grant D.; Dunn, Alison M.			Biosecurity and Vector Behaviour: Evaluating the Potential Threat Posed by Anglers and Canoeists as Pathways for the Spread of Invasive Non-Native Species and Pathogens	PLOS ONE			English	Article							CRAYFISH PLAGUE; GYRODACTYLUS-SALARIS; MEDIATED DISPERSAL; OVERLAND DISPERSAL; RISK-ASSESSMENT; GREAT-BRITAIN; WATER; TRANSMISSION; ZOOPLANKTON; SURVIVAL	Invasive non-native species ( INNS) endanger native biodiversity and are a major economic problem. The management of pathways to prevent their introduction and establishment is a key target in the Convention on Biological Diversity's Aichi biodiversity targets for 2020. Freshwater environments are particularly susceptible to invasions as they are exposed to multiple introduction pathways, including non-native fish stocking and the release of boat ballast water. Since many freshwater INNS and aquatic pathogens can survive for several days in damp environments, there is potential for transport between water catchments on the equipment used by recreational anglers and canoeists. To quantify this biosecurity risk, we conducted an online questionnaire with 960 anglers and 599 canoeists to investigate their locations of activity, equipment used, and how frequently equipment was cleaned and/or dried after use. Anglers were also asked about their use and disposal of live bait. Our results indicate that 64% of anglers and 78.5% of canoeists use their equipment/boat in more than one catchment within a fortnight, the survival time of many of the INNS and pathogens considered in this study and that 12% of anglers and 50% of canoeists do so without either cleaning or drying their kit between uses. Furthermore, 8% of anglers and 28% of canoeists had used their equipment overseas without cleaning or drying it after each use which could facilitate both the introduction and secondary spread of INNS in the UK. Our results provide a baseline against which to evaluate the effectiveness of future biosecurity awareness campaigns, and identify groups to target with biosecurity awareness information. Our results also indicate that the biosecurity practices of these groups must improve to reduce the likelihood of inadvertently spreading INNS and pathogens through these activities.	[Anderson, Lucy G.; Dunn, Alison M.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Stebbing, Paul D.; Stentiford, Grant D.] Ctr Environm Fisheries & Aquaculture Sci Cefas, Weymouth, England	University of Leeds; University of York - UK; Centre for Environment Fisheries & Aquaculture Science	Dunn, AM (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	a.dunn@leeds.ac.uk	Stentiford, Grant/I-5567-2019; White, Piran Crawfurd Limond/AAH-6851-2021	Stentiford, Grant/0000-0001-6597-5413; White, Piran Crawfurd Limond/0000-0002-7496-5775; Dunn, Alison/0000-0002-4855-1077; Anderson, Lucy/0000-0002-9744-0349	CASE-Studentship from Biotechnology and Biological Sciences Research Council; Centre for Environment, Fisheries and Aquaculture Science; BBSRC	CASE-Studentship from Biotechnology and Biological Sciences Research Council; Centre for Environment, Fisheries and Aquaculture Science; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a CASE-Studentship from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) and the Centre for Environment, Fisheries and Aquaculture Science (www.cefas.defra.gov.uk) awarded to LA. The major funder (BBSRC) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors PS and GS are employed by the case-partner, Cefas.	AHNE W, 1982, ZBL VET MED B, V29, P457; Ahne W., 1976, FISCH UMWELT, V2, P121; Baruch-Mordo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015681; Briski E, 2012, J APPL ECOL, V49, P1124, DOI 10.1111/j.1365-2664.2012.02186.x; British Canoe Union, 2011, WAT LEIS PART SURV; Caplat P, 2011, ENVIRON MANAGE, V48, P878, DOI 10.1007/s00267-011-9747-8; Chan FT, 2012, BIOL INVASIONS; CSIRO, 2009, BIOS INV SPEC; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Dresser C, 2013, BIOL INVASIONS, V15, P1049, DOI 10.1007/s10530-012-0349-z; E.S.R.I, 2012, ARCGIS; Environment Agency, 2004, OUR NAT FISH MIGR FR; Environment Agency, 2011, BIOD MOST WANT; Fielding N, 2011, FRESHWATER BIOL ASS, V54; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; Gates KK, 2009, FISHERIES MANAG ECOL, V16, P448, DOI 10.1111/j.1365-2400.2009.00694.x; Gatlin MR, 2012, BIOL INVASIONS; GB Non Native Species Secretariat, 2011, GB NONN ORG RISK ASS; Gozlan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053200; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Havel JE, 2004, LIMNOL OCEANOGR, V49, P1229, DOI 10.4319/lo.2004.49.4_part_2.1229; Jacobs MJ, 2007, HYDROBIOLOGIA, V583, P119, DOI 10.1007/s10750-006-0487-3; Jerde CL, 2012, AQUAT INVASIONS, V7, P135, DOI 10.3391/ai.2012.7.1.015; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Keller RP, 2007, AM MIDL NAT, V158, P321, DOI 10.1674/0003-0031(2007)158[321:FBSTTF]2.0.CO;2; Keller RP, 2009, CONSERV BIOL, V23, P1526, DOI 10.1111/j.1523-1739.2009.01249.x; Kelly NE, 2013, BIOL INVASIONS, V15, P509, DOI 10.1007/s10530-012-0303-0; Kilian JV, 2012, BIOL INVASIONS; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacNeil C, 2010, AQUAT INVASIONS, V5, P441, DOI 10.3391/ai.2010.5.4.15; Madgwick G, 2011, BRIT WILDLIFE; Martens Andreas, 2008, Lauterbornia, V62, P41; Ministry for Primary Industries, 2008, CHECK CLEAN DRY; Nakano H, 1998, FISH PATHOL, V33, P65, DOI 10.3147/jsfp.33.65; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; Oidtmann B, 2002, DIS AQUAT ORGAN, V52, P159, DOI 10.3354/dao052159; Oidtmann B, 2000, DIS FRESHWATER CRAYF, P9; Oidtmann BC, 2011, AQUACULTURE, V320, P22, DOI 10.1016/j.aquaculture.2011.07.032; Okamura B, 2011, FRESHWATER BIOL, V56, P627, DOI 10.1111/j.1365-2427.2011.02578.x; Olstad K, 2006, PARASITOLOGY, V133, P33, DOI 10.1017/S0031182006009966; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Peeler EJ, 2011, FRESHWATER BIOL, V56, P705, DOI 10.1111/j.1365-2427.2011.02572.x; Peeler EJ, 2004, PREV VET MED, V64, P175, DOI 10.1016/j.prevetmed.2004.05.005; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poznanska M, 2013, HYDROBIOLOGIA, V700, P47, DOI 10.1007/s10750-012-1218-6; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; R Core Team, 2018, R LANG ENV STAT COMP; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; REYNOLDS JD, 1988, BIOL CONSERV, V45, P279, DOI 10.1016/0006-3207(88)90059-6; RICCIARDI A, 1995, CAN J FISH AQUAT SCI, V52, P470, DOI 10.1139/f95-048; Secretariat of the Convention on Biological Diversity, 2011, STRAT PLAN BIOD 2011; Shimizu T, 2006, FISH PATHOL, V41, P153, DOI 10.3147/jsfp.41.153; Stasko AD, 2012, AQUAT ECOL, V46, P9, DOI 10.1007/s10452-011-9378-4; Strayer DL, 2010, AQUAT SCI, V72, P127, DOI 10.1007/s00027-010-0128-9; TAUGBOL T, 1993, BIOL CONSERV, V63, P75, DOI 10.1016/0006-3207(93)90076-D; University of Bristol, 2013, BRIST ONL SURV; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Williams AE, 2001, AQUAT CONSERV, V11, P357, DOI 10.1002/aqc.466; Williams F., 2010, EC COST INVASIVE NON; Winfield IJ, 2011, HYDROBIOLOGIA, V660, P93, DOI 10.1007/s10750-010-0397-2	63	63	66	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92788	10.1371/journal.pone.0092788	http://dx.doi.org/10.1371/journal.pone.0092788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717714	Green Published, gold			2022-12-27	WOS:000334339000020
J	Boudarham, J; Roche, N; Pradon, D; Delouf, E; Bensmail, D; Zory, R				Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Delouf, Eric; Bensmail, Djamel; Zory, Raphael			Effects of Quadriceps Muscle Fatigue on Stiff-Knee Gait in Patients with Hemiparesis	PLOS ONE			English	Article							BOTULINUM TOXIN INJECTION; MOTONEURON FIRING RATES; RECTUS FEMORIS ACTIVITY; CEREBRAL-PALSY; SPASTIC PARESIS; STROKE PATIENTS; VOLUNTARY CONTRACTIONS; HEMIPLEGIC PATIENTS; LOWER-EXTREMITY; STRETCH REFLEX	The relationship between neuromuscular fatigue and locomotion has never been investigated in hemiparetic patients despite the fact that, in the clinical context, patients report to be more spastic or stiffer after walking a long distance or after a rehabilitation session. The aim of this study was to evaluate the effects of quadriceps muscle fatigue on the biomechanical gait parameters of patients with a stiff-knee gait (SKG). Thirteen patients and eleven healthy controls performed one gait analysis before a protocol of isokinetic quadriceps fatigue and two after (immediately after and after 10 minutes of rest). Spatiotemporal parameters, sagittal knee and hip kinematics, rectus femoris (RF) and vastus lateralis (VL) kinematics and electromyographic (EMG) activity were analyzed. The results showed that quadriceps muscle weakness, produced by repetitive concentric contractions of the knee extensors, induced an improvement of spatiotemporal parameters for patients and healthy subjects. For the patient group, the increase in gait velocity and step length was associated with i) an increase of sagittal hip and knee flexion during the swing phase, ii) an increase of the maximal normalized length of the RF and VL and of the maximal VL lengthening velocity during the pre-swing and swing phases, and iii) a decrease in EMG activity of the RF muscle during the initial pre-swing phase and during the latter 2/3 of the initial swing phase. These results suggest that quadriceps fatigue did not alter the gait of patients with hemiparesis walking with a SKG and that neuromuscular fatigue may play the same functional role as an anti-spastic treatment such as botulinum toxin-A injection. Strength training of knee extensors, although commonly performed in rehabilitation, does not seem to be a priority to improve gait of these patients.	[Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Delouf, Eric; Bensmail, Djamel; Zory, Raphael] CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France; [Zory, Raphael] Univ Nice Sophia Antipolis, LAMHESS, EA 6309, F-06189 Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Cote d'Azur	Boudarham, J (corresponding author), CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France.	julien.boudarham@yahoo.fr	roche, nicolas/R-6080-2018; Bensmail, Djamel/R-6035-2018	Bensmail, Djamel/0000-0001-9360-9330				Amann M, 2011, J PHYSIOL-LONDON, V589, P5299, DOI 10.1113/jphysiol.2011.213769; Annaswamy TM, 1999, ARCH PHYS MED REHAB, V80, P930, DOI 10.1016/S0003-9993(99)90085-0; Arif M., 2010, ENG INTELL SYST ELEC, V2, P93; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; BIGLANDRITCHIE BR, 1986, J PHYSIOL-LONDON, V379, P451, DOI 10.1113/jphysiol.1986.sp016263; Biro A, 2007, EXP BRAIN RES, V177, P157, DOI 10.1007/s00221-006-0656-7; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boudarham J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066421; Byrne CA, 2005, J ELECTROMYOGR KINES, V15, P564, DOI 10.1016/j.jelekin.2005.03.002; Caty GD, 2008, ARCH PHYS MED REHAB, V89, P284, DOI 10.1016/j.apmr.2007.08.155; CRENNA P, 1999, PATHOPHYSIOLOGY, V5, P283; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Goldberg SR, 2006, J BIOMECH, V39, P689, DOI 10.1016/j.jbiomech.2005.01.015; Granacher U, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-56; Helbostad JL, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-56; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hu M, 2006, BIOL SPORT, V23, P327; Hunter SK, 2004, EXERC SPORT SCI REV, V32, P44, DOI 10.1097/00003677-200404000-00002; Hutin E, 2012, GAIT POSTURE, V36, P205, DOI 10.1016/j.gaitpost.2012.02.016; Hutin E, 2010, NEUROREHAB NEURAL RE, V24, P442, DOI 10.1177/1545968309354535; Jackson ND, 2009, J ELECTROMYOGR KINES, V19, P75, DOI 10.1016/j.jelekin.2007.06.016; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kalezic I, 2004, J PHYSIOL-LONDON, V556, P283, DOI 10.1113/jphysiol.2003.053249; KERRIGAN DC, 1991, AM J PHYS MED REHAB, V70, P294; Knorr S, 2012, DISABIL REHABIL, V34, P2291, DOI 10.3109/09638288.2012.683233; Knuppe AE, 2013, GAIT POSTURE, V37, P345, DOI 10.1016/j.gaitpost.2012.07.034; KNUTSSON E, 1980, SCAND J REHABIL MED, V12, P93; Lampire N, 2013, CLIN BIOMECH, V28, P164, DOI 10.1016/j.clinbiomech.2012.12.006; Lelas JL, 2003, GAIT POSTURE, V17, P106, DOI 10.1016/S0966-6362(02)00060-7; Lewek MD, 2007, J NEUROPHYSIOL, V98, P3153, DOI 10.1152/jn.00726.2007; Longpre HS, 2013, CLIN BIOMECH, V28, P441, DOI 10.1016/j.clinbiomech.2013.02.010; Lukacs M, 2008, CLIN NEUROPHYSIOL, V119, P2555, DOI 10.1016/j.clinph.2008.08.005; Marque P, 2001, J NEUROL NEUROSUR PS, V70, P36, DOI 10.1136/jnnp.70.1.36; Martin PG, 2006, J NEUROSCI, V26, P4796, DOI 10.1523/JNEUROSCI.5487-05.2006; Merletti R., 1999, J ELECTROMYOGR KINES, V9, P1; Moore BD, 2002, J ELECTROMYOGR KINES, V12, P351, DOI 10.1016/S1050-6411(02)00032-9; Moreau NG, 2008, ARCH PHYS MED REHAB, V89, P2011, DOI 10.1016/j.apmr.2008.03.012; Moreau NG, 2009, CLIN BIOMECH, V24, P355, DOI 10.1016/j.clinbiomech.2009.01.012; Murdock GH, 2012, EUR J APPL PHYSIOL, V112, P439, DOI 10.1007/s00421-011-1990-4; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; NAKAMURA R, 1988, TOHOKU J EXP MED, V154, P111, DOI 10.1620/tjem.154.111; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Parijat P, 2008, GAIT POSTURE, V28, P568, DOI 10.1016/j.gaitpost.2008.04.001; Perry J., 1992, GAIT ANAL NORMAL PAT; Piazza SJ, 1996, J BIOMECH, V29, P723, DOI 10.1016/0021-9290(95)00144-1; Pincivero DM, 2001, MED SCI SPORT EXER, V33, P334; Poulain B., 2003, Annales de Readaptation et de Medecine Physique, V46, P265, DOI 10.1016/S0168-6054(03)00114-4; Reinbolt JA, 2008, J BIOMECH, V41, P2362, DOI 10.1016/j.jbiomech.2008.05.030; Robertson JVG, 2009, GAIT POSTURE, V29, P108, DOI 10.1016/j.gaitpost.2008.07.005; Rosales RL, 1996, MUSCLE NERVE, V19, P488, DOI 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8; Rossi A, 2003, CLIN NEUROPHYSIOL, V114, P279, DOI 10.1016/S1388-2457(02)00334-6; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Shiavi R, 1987, J Rehabil Res Dev, V24, P24; Sibley KM, 2008, GAIT POSTURE, V27, P387, DOI 10.1016/j.gaitpost.2007.05.007; Stampacchia G, 2004, ARCH ITAL BIOL, V142, P265; Staszkiewicz R, 2010, ACTA BIOENG BIOMECH, V12, P13; Stoquart GG, 2008, ARCH PHYS MED REHAB, V89, P56, DOI 10.1016/j.apmr.2007.08.131; Sung DH, 2000, ARCH PHYS MED REHAB, V81, P910, DOI 10.1053/apmr.2000.5615; Tok F, 2012, AM J PHYS MED REHAB, V91, P321, DOI 10.1097/PHM.0b013e3182465feb; Trompetto C, 2006, MOVEMENT DISORD, V21, P777, DOI 10.1002/mds.20801; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; van der Krogt MM, 2010, J REHABIL MED, V42, P656, DOI 10.2340/16501977-0579; VANINGENSCHENAU GJ, 1995, J PHYSIOL-LONDON, V484, P247, DOI 10.1113/jphysiol.1995.sp020662	70	21	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94138	10.1371/journal.pone.0094138	http://dx.doi.org/10.1371/journal.pone.0094138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718087	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000081
J	Jimenez-Franco, MV; Martinez, JE; Calvo, JF				Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.			Lifespan Analyses of Forest Raptor Nests: Patterns of Creation, Persistence and Reuse	PLOS ONE			English	Article							BUZZARD BUTEO-BUTEO; TERRITORIAL OCCUPANCY; HIERAAETUS-PENNATUS; CONSERVATION; COMPETITION; POPULATION; DEMOGRAPHY; FIDELITY; DENSITY; EAGLES	Structural elements for breeding such as nests are key resources for the conservation of bird populations. This is especially true when structural elements require a specific and restricted habitat, or if the construction of nests is costly in time and energy. The availability of nesting-platforms is influenced by nest creation and persistence. In a Mediterranean forest in southeastern Spain, nesting-platforms are the only structural element for three forest-dwelling raptor species: booted eagle Aquila pennata, common buzzard Buteo buteo and northern goshawk Accipiter gentilis. From 1998 to 2013, we tracked the fate of 157 nesting-platforms built and reused by these species with the aim of determining the rates of creation and destruction of nesting-platforms, estimating nest persistence by applying two survival analyses, describing the pattern of nest reuse and testing the effects of nest use on breeding success. Nest creation and destruction rates were low (0.14 and 0.05, respectively). Using Kaplan Meier survival estimates and Cox proportional-hazards regression models we found that median nest longevity was 12 years and that this was not significantly affected by nest characteristics, nest-tree dimensions, nest-builder species, or frequency of use of the platform. We also estimated a transition matrix, considering the different stages of nest occupation (vacant or occupied by one of the focal species), to obtain the fundamental matrix and the average life expectancies of nests, which varied from 17.9 to 19.7 years. Eighty six percent of nests were used in at least one breeding attempt, 67.5% were reused and 17.8% were successively occupied by at least two of the study species. The frequency of nest use had no significant effects on the breeding success of any species. We conclude that nesting-platforms constitute an important resource for forest raptors and that their longevity is sufficiently high to allow their reuse in multiple breeding attempts.	[Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.] Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain; [Martinez, Jose E.] Bonellis Eagle Study & Conservat Grp, Murcia, Spain	University of Murcia	Jimenez-Franco, MV (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain.	mvjimenez@um.es	Jiménez-Franco, Maria Victoria/M-2041-2014; Calvo, José Francisco/C-7076-2009	Jiménez-Franco, Maria Victoria/0000-0002-7254-0431; Calvo, José Francisco/0000-0002-3813-4333; Martinez, Jose Enrique/0000-0002-1200-5795	Spanish Ministerio de Educacion y Ciencia [REN2002-324 01884/GLO]; FEDER funds; Consejeria de Agricultura y Agua of the Region of Murcia; FPU grant from the Spanish Ministerio de Educacion y Ciencia [AP2009-2073]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); FEDER funds(European Commission); Consejeria de Agricultura y Agua of the Region of Murcia; FPU grant from the Spanish Ministerio de Educacion y Ciencia(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG))	This work was funded by the Spanish Ministerio de Educacion y Ciencia (project REN2002-324 01884/GLO, partially financed by FEDER funds) and the Consejeria de Agricultura y Agua of the Region of Murcia. MVJF is supported by a FPU grant from the Spanish Ministerio de Educacion y Ciencia (reference AP2009-2073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund H, 2013, ANIM CONSERV, V16, P546, DOI 10.1111/acv.12028; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Brostrom G., 2011, GLMMML GEN LINEAR MO; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KK, 2009, IBIS, V151, P514, DOI 10.1111/j.1474-919X.2009.00939.x; Caswell, 2000, MATRIX POPULATION MO; Caswell H., 2004, Animal Biodiversity and Conservation, V27, P471; Caswell H, 2009, OIKOS, V118, P1763, DOI 10.1111/j.1600-0706.2009.17620.x; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Edworthy AB, 2013, J WILDLIFE MANAGE, V77, P770, DOI 10.1002/jwmg.526; Edworthy AB, 2012, ECOL APPL, V22, P1733, DOI 10.1890/11-1594.1; ERCKMANN WJ, 1990, CONDOR, V92, P113, DOI 10.2307/1368389; Fergusson-Lees J, 2001, RAPTORS BIRDS PREY W; Ferreira M, 2013, BIOL CONSERV, V165, P179, DOI 10.1016/j.biocon.2013.05.029; Fox G.A., 2001, DESIGN ANAL ECOLOGIC, V2nd, P253; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Fuller MR., 1987, RAPTOR MANAGEMENT TE, P37; Hakkarainen H, 2004, OECOLOGIA, V141, P420, DOI 10.1007/s00442-004-1656-6; HICKEY JOSEPH J., 1942, AUK, V59, P176; Jimenez-Franco MV, 2014, J ZOOL, V292, P64, DOI 10.1111/jzo.12085; Jimenez-Franco MV, 2013, J ORNITHOL, V154, P311, DOI 10.1007/s10336-012-0895-2; Jimenez-Franco MV, 2011, OECOLOGIA, V166, P507, DOI 10.1007/s00442-010-1857-0; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kochert MN, 2012, J RAPTOR RES, V46, P239, DOI 10.3356/JRR-12-00001.1; KOSTRZEWA A, 1991, ETHOL ECOL EVOL, V3, P127, DOI 10.1080/08927014.1991.9525379; Kruger O, 2002, OIKOS, V96, P441, DOI 10.1034/j.1600-0706.2002.960306.x; Kruger O, 2002, ECOGRAPHY, V25, P523, DOI 10.1034/j.1600-0587.2002.250502.x; Lebreton JD, 1995, J APPL STAT, V22, P1009, DOI 10.1080/02664769524766; Libois E, 2012, BIOL CONSERV, V155, P39, DOI 10.1016/j.biocon.2012.05.020; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lohmus Asko, 2006, Proceedings of the Estonian Academy of Sciences Biology Ecology, V55, P31; Margalida A, 1999, BIRD STUDY, V46, P224, DOI 10.1080/00063659909461134; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Martinez JE, 2006, RAPACES DIURNAS NOCT; Martinez JE, 2002, THESIS U MURCIA; Martinez JE, 2007, BIODIVERS CONSERV, V16, P3481, DOI 10.1007/s10531-006-9053-6; Martinez JE, 2006, J ORNITHOL, V147, P612, DOI 10.1007/s10336-006-0086-0; Martinez JE, 2006, IBIS, V148, P807, DOI 10.1111/j.1474-919X.2006.00586.x; Martinez JE, 2013, ACTA OECOL, V48, P47, DOI 10.1016/j.actao.2013.01.017; McCulloch C. E., 2000, GEN LINEAR MIXED MOD; Mitsopoulos ID, 2014, EUR J FOREST RES, V133, P73, DOI 10.1007/s10342-013-0740-z; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1979, POPULATION ECOLOGY R; Ontiveros D, 2008, J ORNITHOL, V149, P253, DOI 10.1007/s10336-007-0268-4; Pagan I, 2009, J ZOOL, V279, P36, DOI 10.1111/j.1469-7998.2009.00587.x; Penteriani V, 2002, AUK, V119, P1132, DOI 10.1642/0004-8038(2002)119[1132:ISRTCN]2.0.CO;2; Penteriani Vincenzo, 2011, P126; PETTY SJ, 1998, FORESTRY COMMISSION, V118; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redmond LJ, 2007, CONDOR, V109, P463, DOI 10.1650/0010-5422(2007)109[463:NRBEKA]2.0.CO;2; Rendell WB, 1996, CONDOR, V98, P142, DOI 10.2307/1369517; Robledano F., 2006, LIBRO ROJO VERTEBRAD; Santangeli A, 2012, ANIM CONSERV, V15, P571, DOI 10.1111/j.1469-1795.2012.00551.x; Sergio F, 2011, SCIENCE, V331, P327, DOI 10.1126/science.1199422; Steenhof K., 1987, RAPTOR MANAGEMENT TE, P157; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Wesolowski T, 2012, BIOL CONSERV, V153, P118, DOI 10.1016/j.biocon.2012.04.017; White C.M., 1994, NEW WORLD VULTURES G; Zhou T, 2009, PROG NAT SCI-MATER, V19, P1253, DOI 10.1016/j.pnsc.2009.03.006; [No title captured]; [No title captured]	62	16	16	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93628	10.1371/journal.pone.0093628	http://dx.doi.org/10.1371/journal.pone.0093628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717935	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000041
J	Li, LJ; Li, N; Pang, W; Zhang, X; Hammock, BD; Ai, D; Zhu, Y				Li, Lijuan; Li, Nan; Pang, Wei; Zhang, Xu; Hammock, Bruce D.; Ai, Ding; Zhu, Yi			Opposite Effects of Gene Deficiency and Pharmacological Inhibition of Soluble Epoxide Hydrolase on Cardiac Fibrosis	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLISM; BLOOD-PRESSURE REGULATION; HUMAN NEUTROPHIL FUNCTION; NITRIC-OXIDE SYNTHASE; ANGIOTENSIN-II; COLLAGEN DEPOSITION; CELLS; HYPERTROPHY; MODULATION; PROTECTS	Arachidonic acid-derived epoxyeicosatrienoic acids (EETs) are important regulators of cardiac remodeling; manipulation of their levels is a potentially useful pharmacological strategy. EETs are hydrolyzed by soluble epoxide hydrolase (sEH) to form the corresponding diols, thus altering and reducing the activity of these oxylipins. To better understand the phenotypic impact of sEH disruption, we compared the effect of EPHX2 gene knockout (EPHX2(-/-)) and sEH inhibition in mouse models. Measurement of plasma oxylipin profiles confirmed that the ratio of EETs/DHETs was increased in EPHX2(-/-) and sEH-inhibited mice. However, plasma concentrations of 9, 11, 15, 19-HETE were elevated in EPHX2(-/-) but not sEH-inhibited mice. Next, we investigated the role of this difference in cardiac dysfunction induced by Angiotensin II (AngII). Both EPHX2 gene deletion and inhibition protected against AngII-induced cardiac hypertrophy. Interestingly, cardiac dysfunction was attenuated by sEH inhibition rather than gene deletion. Histochemical staining revealed that compared with pharmacological inhibition, EPHX2 deletion aggravated AngII-induced myocardial fibrosis; the mRNA levels of fibrotic-related genes were increased. Furthermore, cardiac inflammatory response was greater in EPHX2(-/-) than sEH-inhibited mice with AngII treatment, as evidenced by increased macrophage infiltration and expression of MCP-1 and IL-6. In vitro, AngII-upregulated MCP-1 and IL-6 expression was significantly attenuated by sEH inhibition but promoted by EPHX2 deletion in cardiofibroblasts. Thus, compared with pharmacological inhibition of sEH, EPHX2 deletion caused the shift in arachidonic acid metabolism, which may led to pathological cardiac remodeling, especially cardiac fibrosis.	[Li, Lijuan; Li, Nan; Pang, Wei; Zhu, Yi] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Zhang, Xu; Ai, Ding; Zhu, Yi] Tianjin Med Univ, Dept Physiol, Tianjin, Peoples R China; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA	Peking University; Tianjin Medical University; University of California System; University of California Davis; University of California System; University of California Davis	Ai, D (corresponding author), Tianjin Med Univ, Dept Physiol, Tianjin, Peoples R China.	edin2000cn@gmail.com; zhuyi@tijmu.edu.cn	li, li/GPX-3938-2022; Li, Li/AEM-3636-2022; li, li/AAT-2097-2020; LI, LI/GVS-5344-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022	Ai, Ding/0000-0001-5992-9904; , Xu/0000-0002-8103-8486	Major National Basic Research Grant of China [2010CB912504, 2012CB517504]; National Natural Science Foundation of China [81130002, 81322006, 81370396]; NIEH [RO1 ES002710]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER	Major National Basic Research Grant of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIEH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the Major National Basic Research Grant of China [No. 2010CB912504; 2012CB517504] and the National Natural Science Foundation of China [81130002, 81322006, 81370396]. Bruce D. Hammock is a George and Judy Marcus Senior Fellow of the American Asthma Society. Partial support was provided by NIEH RO1 ES002710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2009, P NATL ACAD SCI USA, V106, P564, DOI 10.1073/pnas.0811022106; Althurwi HN, 2013, BRIT J PHARMACOL, V168, P1794, DOI 10.1111/bph.12066; Anwar-mohamed A, 2010, PHARMACOL RES, V61, P410, DOI 10.1016/j.phrs.2009.12.015; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BRILLA CG, 1995, AM J CARDIOL, V76, pD8, DOI 10.1016/S0002-9149(99)80485-8; Burlew BS, 2002, HERZ, V27, P92, DOI 10.1007/s00059-002-2354-y; CAPDEVILA J, 1982, P NATL ACAD SCI-BIOL, V79, P767, DOI 10.1073/pnas.79.3.767; Chiamvimonvat N, 2007, J CARDIOVASC PHARM, V50, P225, DOI 10.1097/FJC.0b013e3181506445; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Ding WY, 2012, INT J BIOCHEM CELL B, V44, P1031, DOI 10.1016/j.biocel.2012.03.013; Dixon IMC, 2011, HYPERTENSION, V58, P142, DOI 10.1161/HYPERTENSIONAHA.111.174748; EnayetAllah AE, 2008, J BIOL CHEM, V283, P36592, DOI 10.1074/jbc.M806315200; Francois H, 2005, CELL METAB, V2, P201, DOI 10.1016/j.cmet.2005.08.005; Gobeil F, 2003, J BIOL CHEM, V278, P38875, DOI 10.1074/jbc.M212481200; GOETZL EJ, 1980, PROSTAGLANDINS, V19, P71, DOI 10.1016/0090-6980(80)90155-0; GOETZL EJ, 1980, IMMUNOLOGY, V39, P491; Gomez GA, 2004, BIOCHEMISTRY-US, V43, P4716, DOI 10.1021/bi036189j; Harding P, 2011, PROSTAG LEUKOTR ESS, V84, P147, DOI 10.1016/j.plefa.2011.01.003; Hayashidani S, 2003, CIRCULATION, V108, P2134, DOI 10.1161/01.CIR.0000092890.29552.22; HINGLAIS N, 1994, LAB INVEST, V70, P286; Hoff U, 2011, KIDNEY INT, V79, P57, DOI 10.1038/ki.2010.377; Honeck H, 2000, HYPERTENSION, V36, P610, DOI 10.1161/01.HYP.36.4.610; Hou HH, 2012, CARDIOVASC RES, V93, P120, DOI 10.1093/cvr/cvr267; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; KALKMAN EAJ, 1995, J MOL CELL CARDIOL, V27, P2483, DOI 10.1006/jmcc.1995.0236; Kenchaiah S, 2004, MED CLIN N AM, V88, P115, DOI 10.1016/S0025-7125(03)00168-8; Levick SP, 2007, J IMMUNOL, V178, P641, DOI 10.4049/jimmunol.178.2.641; Lopez B, 2006, J AM COLL CARDIOL, V48, P89, DOI 10.1016/j.jacc.2006.01.077; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; Luria A, 2009, AM J PHYSIOL-ENDOC M, V297, pE375, DOI 10.1152/ajpendo.00131.2009; Morisseau C, 2012, BIOCHEM BIOPH RES CO, V419, P796, DOI 10.1016/j.bbrc.2012.02.108; Nie XW, 2012, PROSTAG OTH LIPID M, V97, P50, DOI 10.1016/j.prostaglandins.2011.11.003; NISHIMURA M, 1989, PROSTAGLANDINS, V38, P413, DOI 10.1016/0090-6980(89)90124-X; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Ratcliffe NR, 2000, J AUTOIMMUN, V15, P359, DOI 10.1006/jaut.2000.0432; Rossaint J, 2012, CRIT CARE, V16, DOI 10.1186/cc11518; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Sirish P, 2013, P NATL ACAD SCI USA, V110, P5618, DOI 10.1073/pnas.1221972110; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Tejera N, 2012, J LIPID RES, V53, P87, DOI 10.1194/jlr.M017822; Tunctan Bahar, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P121; van Kesteren CAM, 1999, CARDIOVASC RES, V43, P148, DOI 10.1016/S0008-6363(99)00057-7; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103; Zein CO, 2012, HEPATOLOGY, V56, P1291, DOI 10.1002/hep.25778	48	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94092	10.1371/journal.pone.0094092	http://dx.doi.org/10.1371/journal.pone.0094092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718617	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000075
J	Xie, SB; Chen, M; Yan, B; He, XF; Chen, XW; Li, DW				Xie, Songbo; Chen, Miao; Yan, Bing; He, Xianfei; Chen, Xiwen; Li, Dengwen			Identification of a Role for the PI3K/AKT/mTOR Signaling Pathway in Innate Immune Cells	PLOS ONE			English	Article							TISSUE-RESIDENT MACROPHAGES; CYTOKINE PRODUCTION; INDUCED IL-12; PI3K; RECEPTOR; KINASE; CANCER; ACCUMULATION; MIGRATION; RESPONSES	The innate immune system is the first line of host defense against infection and involves several different cell types. Here we investigated the role of the phosphatidylinositol 3 kinase (PI3K) signaling pathway in innate immune cells. By blocking this pathway with pharmacological inhibitors, we found that the production of proinflammatory cytokines was drastically suppressed in monocytes and macrophages. Further study revealed that the suppression was mainly related to the mammalian target of rapamycin (mTOR)/p70(S6K) signaling. In addition, we found that the PI3K pathway was involved in macrophage motility and neovascularization. Our data provide a rationale that inhibition of the PI3K signaling pathway could be an attractive approach for the management of inflammatory disorders.	[Xie, Songbo; Chen, Miao; Yan, Bing; He, Xianfei; Chen, Xiwen; Li, Dengwen] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University	Chen, XW (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	xiwenchen@nankai.edu.cn; dwli@nankai.edu.cn	Xie, Songbo/AAD-9850-2020		National Natural Science Foundation of China [31171334, 31371382]; Tianjin Natural Science Foundation [13JCZDJC30300]; 111 project of the Ministry of Education of China [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); 111 project of the Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Natural Science Foundation of China (31171334 and 31371382), the Tianjin Natural Science Foundation (13JCZDJC30300), and the 111 project of the Ministry of Education of China (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, ANTI-CANCER AGENT ME, V13, P1014, DOI 10.2174/18715206113139990117; Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; CERAMI A, 1992, CLIN IMMUNOL IMMUNOP, V62, pS3, DOI 10.1016/0090-1229(92)90035-M; Chanput W, 2013, FOOD FUNCT, V4, P266, DOI 10.1039/c2fo30156c; Chiba T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/759103; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Desmedt M, 1998, J IMMUNOL, V160, P5300; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Goldbach-Mansky R, 2012, CLIN EXP IMMUNOL, V167, P391, DOI 10.1111/j.1365-2249.2011.04533.x; Hammond MD, 2012, TRANSL STROKE RES, V3, pS125, DOI 10.1007/s12975-012-0174-9; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Li DW, 2011, PROTEIN CELL, V2, P150, DOI 10.1007/s13238-011-1015-4; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236; Reale M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-13; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Shi XJ, 2012, CELL CYCLE, V11, P1554, DOI 10.4161/cc.19954; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Trifilo MJ, 2003, J VIROL, V77, P4004, DOI 10.1128/JVI.77.7.4004-4014.2003; Utsugi M, 2009, J IMMUNOL, V182, P5225, DOI 10.4049/jimmunol.0801352; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie C, 2007, INT IMMUNOL, V19, P509, DOI 10.1093/intimm/dxm017; Xie SB, 2014, ATHEROSCLEROSIS, V233, P403, DOI 10.1016/j.atherosclerosis.2014.01.009; Zajac E, 2013, BLOOD, V122, P4054, DOI 10.1182/blood-2013-05-501494	42	146	146	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94496	10.1371/journal.pone.0094496	http://dx.doi.org/10.1371/journal.pone.0094496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718556	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000128
J	Talati, M; West, J; Zaynagetdinov, R; Hong, CC; Han, W; Blackwell, T; Robinson, L; Blackwell, TS; Lane, K				Talati, Megha; West, James; Zaynagetdinov, Rinat; Hong, Charles C.; Han, Wei; Blackwell, Tom; Robinson, Linda; Blackwell, Timothy S.; Lane, Kirk			BMP Pathway Regulation of and by Macrophages	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; RECEPTOR; INFLAMMATION; MUTATIONS; GENE	Pulmonary arterial hypertension (PAH) is a disease of progressively increasing pulmonary vascular resistance, associated with mutations of the type 2 receptor for the BMP pathway, BMPR2. The canonical signaling pathway for BMPR2 is through the SMAD family of transcription factors. BMPR2 is expressed in every cell type, but the impact of BMPR2 mutations affecting SMAD signaling, such as Bmpr2(delx4+), had only previously been investigated in smooth muscle and endothelium. In the present study, we created a mouse with universal doxycycline-inducible expression of Bmpr2(delx4+) in order to determine if broader expression had an impact relevant to the development of PAH. We found that the most obvious phenotype was a dramatic, but patchy, increase in pulmonary inflammation. We crossed these double transgenic mice onto an NF-kB reporter strain, and by luciferase assays on live mice, individual organs and isolated macrophages, we narrowed down the origin of the inflammatory phenotype to constitutive activation of tissue macrophages. Study of bone marrow-derived macrophages from mutant and wild-type mice suggested a baseline difference in differentiation state in Bmpr2 mutants. When activated with LPS, both mutant and wild-type macrophages secrete BMP pathway inhibitors sufficient to suppress BMP pathway activity in smooth muscle cells (SMC) treated with conditioned media. Functionally, co-culture with macrophages results in a BMP signaling-dependent increase in scratch closure in cultured SMC. We conclude that SMAD signaling through BMP is responsible, in part, for preventing macrophage activation in both live animals and in cells in culture, and that activated macrophages secrete BMP inhibitors in sufficient quantity to cause paracrine effect on vascular smooth muscle.	[Talati, Megha; West, James; Zaynagetdinov, Rinat; Hong, Charles C.; Han, Wei; Blackwell, Tom; Robinson, Linda; Blackwell, Timothy S.; Lane, Kirk] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Hong, Charles C.] Vet Affairs Tennessee Valley Healthcare Syst, Dept Med Res, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	West, J (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA.	j.west@vanderbilt.edu	West, James/E-2960-2010	West, James/0000-0002-6004-0202	National Institutes of Health [HL82694, HL095797]; Vanderbilt Allergy, Pulmonary, and Critical Care Division; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040, R01HL082694, R01HL095797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Allergy, Pulmonary, and Critical Care Division; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health RO1 Grants HL82694 and HL095797 and Vanderbilt Allergy, Pulmonary, and Critical Care Division internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Austin Eric D, 2011, Pulm Circ, V1, P389, DOI 10.4103/2045-8932.87308; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Burton VJ, 2010, BLOOD; Chamoto K, 2011, J CELL PHYSL; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Davies RJ, 2012, AM J PHYSL LUNG CELL; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Hagen M, 2007, AM J PHYSIOL-LUNG C, V292, pL1473, DOI 10.1152/ajplung.00197.2006; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Johnson JA, 2011, AM J PHYSL LUNG CELL; Konstantinidis G, 2011, CELL PHYSIOL BIOCHEM, V28, P1031, DOI 10.1159/000335790; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lane Kirk L, 2011, Pulm Circ, V1, P72; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Majka SM, 2008, AM J PHYSIOL-LUNG C, V295, pL1028, DOI 10.1152/ajplung.90449.2008; Majka S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-84; Menon S, 2011, INT J CLIN PRACT, V65, P19, DOI 10.1111/j.1742-1241.2010.02604.x; Price LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075415; Sadikot RT, 2003, J IMMUNOL, V170, P1091, DOI 10.4049/jimmunol.170.2.1091; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; Yull FE, 2003, J HISTOCHEM CYTOCHEM, V51, P741, DOI 10.1177/002215540305100605	29	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94119	10.1371/journal.pone.0094119	http://dx.doi.org/10.1371/journal.pone.0094119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713633	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900087
J	Wang, LY; Liu, Y; Wang, HM; Liu, X; Chen, J; Wang, MH; Wang, JF; Huang, H				Wang, Luyun; Liu, Yang; Wang, Huamin; Liu, Xun; Chen, Jie; Wang, Mong-Heng; Wang, Jingfeng; Huang, Hui			Epoxyeicosatrienoic Acids Attenuating Hypotonic-Induced Apoptosis of IMCD Cells via gamma-ENaC Inhibition	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; ACTIVATED PROTEIN-KINASE; COLLECTING DUCT CELLS; ENDOTHELIAL-CELLS; MEDIATED REGULATION; ARACHIDONIC-ACID; HEME OXYGENASE-1; APICAL MEMBRANE; CATION CHANNEL; BETA-ENAC	Inner medulla collecting duct (IMCD) cells are the key part for urinary concentration. Hypotonic stress may trigger apoptosis of IMCD cells and induce renal injury. Epoxyeicosatrienoic acids (EETs) play an important role in anti-apoptosis, but their roles in hypotonic-induced apoptosis of IMCD cells are still unclear. Here we found increasing exogenous 11, 12-EET or endogenous EETs with Ad-CMV-CYP2C23-EGFP transfection decreased apoptosis of IMCD cells induced by hypotonic stress. Moreover, up-regulation of c-ENaC induced by hypotonic stress was abolished by elevation of exogenous or endogenous EETs. Collectively, this study illustrated that EETs attenuated hypotonic-induced apoptosis of IMCD cells, and that regulation of gamma-ENAC may be a possible mechanism contributing to the anti-apoptotic effect of EETs in response to hypotonic stress.	[Wang, Luyun; Liu, Yang; Chen, Jie; Wang, Jingfeng; Huang, Hui] Guangdong Prov Key Lab Arrhythmia & Elect, Guangzhou, Guangdong, Peoples R China; [Liu, Yang; Wang, Jingfeng; Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Luyun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Crit Care Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Huamin] Guangzhou Univ Chinese Med, Affiliated Hosp, Zhongshan City Hosp Chinese Med, Zhongshan, Peoples R China; [Liu, Xun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mong-Heng] Georgia Regents Univ, Dept Physiol, Augusta, GA USA	Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Sun Yat Sen University; University System of Georgia; Augusta University	Huang, H (corresponding author), Guangdong Prov Key Lab Arrhythmia & Elect, Guangzhou, Guangdong, Peoples R China.	huanghui765@hotmail.com	wang, jing/GRS-7509-2022		NSFC [91029742, 81170647, 81370837, 81370866, 81070612]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [132030]; Yat-sen Scholarship for Young Scientists, the Science & technology star of Zhujiang (Guangzhou) [2011016]; AHA [AHASE0054]	NSFC(National Natural Science Foundation of China (NSFC)); Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); Yat-sen Scholarship for Young Scientists, the Science & technology star of Zhujiang (Guangzhou); AHA(American Heart Association)	This work was supported in part by NSFC [91029742, 81170647 and 81370837 to HH], Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [132030], Yat-sen Scholarship for Young Scientists, the Science & technology star of Zhujiang (Guangzhou)[2011016] to HH, NSFC [81370866 and 81070612] to XL, AHA Grant-in-Aid grant (AHASE0054) to MHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1995, INVEST OPHTH VIS SCI, V36, P2202; Bi Y, 2013, ARCH MED SCI, V9, P314, DOI 10.5114/aoms.2012.31410; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Bortner CD, 2011, CELL PHYSIOL BIOCHEM, V28, P1079, DOI 10.1159/000335864; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Bouvry D, 2006, AM J RESP CELL MOL, V35, P519, DOI 10.1165/rcmb.2005-0478OC; Capdevila J, 2013, CURR OPIN NEPHROL HY, V22, P163, DOI 10.1097/MNH.0b013e32835d911e; Chen GZ, 2012, AM J PHYSIOL-ENDOC M, V303, pE563, DOI 10.1152/ajpendo.00591.2011; Chen LD, 2013, PROSTAG OTH LIPID M, V104, P42, DOI 10.1016/j.prostaglandins.2012.12.001; Ecelbarger CA, 2000, AM J PHYSIOL-RENAL, V279, pF46, DOI 10.1152/ajprenal.2000.279.1.F46; Fauci Braunwald, HARRISONS PRINCIPLES, VII, P2738; Feng WJ, 2013, INT J MOL MED, V32, P685, DOI 10.3892/ijmm.2013.1435; Gao CJ, 2012, J TRAUMA ACUTE CARE, V72, P150, DOI 10.1097/TA.0b013e318230e25d; GRUNEWALD JM, 1993, KIDNEY INT, V44, P509, DOI 10.1038/ki.1993.275; Hager H, 2001, AM J PHYSIOL-RENAL, V280, pF1093, DOI 10.1152/ajprenal.2001.280.6.F1093; Husted RF, 1996, AM J PHYSIOL-RENAL, V271, pF433, DOI 10.1152/ajprenal.1996.271.2.F433; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P595, DOI 10.1161/01.ATV.0000116219.09040.8c; Kultz D, 1998, J EXP BIOL, V201, P3015; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, pH491, DOI 10.1152/ajpheart.00927.2005; LIGHT DB, 1988, AM J PHYSIOL, V255, pF278, DOI 10.1152/ajprenal.1988.255.2.F278; LIGHT DB, 1989, J CLIN INVEST, V84, P352, DOI 10.1172/JCI114162; Liu XL, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-8; Liu YM, 2013, MOL PHARMACOL, V84, P925, DOI 10.1124/mol.113.088302; Marunaka Y, 1997, JPN J PHYSIOL, V47, P499, DOI 10.2170/jjphysiol.47.499; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Miyazaki H, 2008, BIOCHEM BIOPH RES CO, V366, P506, DOI 10.1016/j.bbrc.2007.11.144; Niisato N, 2007, BIOCHEM BIOPH RES CO, V358, P819, DOI 10.1016/j.bbrc.2007.04.192; Niisato N, 2012, AM J PHYSIOL-RENAL, V303, pF240, DOI 10.1152/ajprenal.00198.2011; Ohsawa R, 2010, J CELL PHYSIOL, V223, P764, DOI 10.1002/jcp.22088; Orlov SN, 2013, AM J PHYSIOL-CELL PH, V305, pC361, DOI 10.1152/ajpcell.00040.2013; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Quan S, 2004, KIDNEY INT, V65, P1628, DOI 10.1111/j.1523-1755.2004.00562.x; Saito T, 2008, EXP PHYSIOL, V93, P1147, DOI 10.1113/expphysiol.2008.042663; STOKES JB, 1987, AM J PHYSIOL, V253, pF251, DOI 10.1152/ajprenal.1987.253.2.F251; Sun P, 2012, HYPERTENSION, V59, P339, DOI 10.1161/HYPERTENSIONAHA.111.178475; Taniguchi J, 2005, VASC PHARMACOL, V43, P47, DOI 10.1016/j.vph.2005.03.005; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Taruno A, 2007, AM J PHYSIOL-RENAL, V293, pF128, DOI 10.1152/ajprenal.00011.2007; Volk KA, 1995, J CLIN INVEST, V96, P2748, DOI 10.1172/JCI118344; Wang XX, 2014, MOL PHARMACOL, V85, P105, DOI 10.1124/mol.113.087122; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Ye Q, 2003, HYPERTENSION, V41, P675, DOI 10.1161/01.HYP.0000047204.72286.34; Yin JJ, 2013, INT J ENDOCRINOL MET, V11, P184, DOI 10.5812/ijem.8088; Zhang Wei, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P385; Zhao G, 2012, HUM GENE THER, V23, P688, DOI 10.1089/hum.2011.135	49	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94400	10.1371/journal.pone.0094400	http://dx.doi.org/10.1371/journal.pone.0094400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713619	gold, Green Submitted, Green Published			2022-12-27	WOS:000334160900127
J	Wang, YY; Zhao, J; Yang, JH; Zhou, ZX; Chen, GL; Liu, Y				Wang, Yingyong; Zhao, Jian; Yang, Jianhuan; Zhou, Zhixin; Chen, Guoling; Liu, Yang			Morphology, Molecular Genetics, and Bioacoustics Support Two New Sympatric Xenophrys Toads ( Amphibia: Anura: Megophryidae) in Southeast China	PLOS ONE			English	Article							PHYLOGENY; DIVERSITY; EVOLUTION; IDENTITY; FROGS	Given their recent worldwide declines and extinctions, characterization of species-level diversity is of critical importance for large-scale biodiversity assessments and conservation of amphibians. This task is made difficult by the existence of cryptic species complexes, species groups comprising closely related and morphologically analogous species. The combination of morphology, genetic, and bioacoustic analyses permits robust and accurate species identification. Using these methods, we discovered two undescribed Xenophrys species, namely Xenophrys lini sp. nov. and Xenophrys cheni sp. nov. from the middle range of Luoxiao Mountains, southeast China. These two new species can be reliably distinguished from other known congeners by morphological and morphometric differences, distinctness in male advertisement calls, and substantial genetic distances (> 3.6%) based on the mitochondrial 16s and 12s rRNA genes. The two new species, together with X. jinggangensis, are sympatric in the middle range of Luoxiao Mountains but may be isolated altitudinally and ecologically. Our study provides a first step to help resolve previously unrecognized cryptic biodiversity and provides insights into the understanding of Xenophrys diversification in the mountain complexes of southeast China.	[Wang, Yingyong; Zhao, Jian; Chen, Guoling; Liu, Yang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Jianhuan] Kadoorie Farm & Bot Garden, Hong Kong, Hong Kong, Peoples R China; [Zhou, Zhixin] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	liuy353@mail.sysu.edu.cn	Zhou, Zhixin/GSD-7016-2022; Zhou, Zhixin/AAK-6744-2020	Zhou, Zhixin/0000-0002-4055-9672	Chinese National Science AMP; Technology Basic Work Program; The Comprehensive Scientific Survey of Biodiversity from Luoxiao Range Region in China [2013FY111500]; Hundred Talent Program ("Bai Ren Ji Hua") from Sun Yat-sen University	Chinese National Science AMP; Technology Basic Work Program; The Comprehensive Scientific Survey of Biodiversity from Luoxiao Range Region in China; Hundred Talent Program ("Bai Ren Ji Hua") from Sun Yat-sen University	This work was partially supported by the Chinese National Science & Technology Basic Work Program, "The Comprehensive Scientific Survey of Biodiversity from Luoxiao Range Region in China (2013FY111500)" to Y.Y. Wang and the Hundred Talent Program ("Bai Ren Ji Hua") from Sun Yat-sen University to Y. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aowphol A, 2013, ZOOTAXA, V3702, P101, DOI 10.11646/zootaxa.3702.2.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Delorme Magali, 2006, Alytes (Paris), V24, P6; Fei L, 2009, FAUNA SINICA AMPHIBI; Felsenstein J, 2004, INFERRING PHYLOGENIE; Frost DR, 2011, AMPHIBIAN SPECIES WO; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gosner K. L., 1960, Herpetologica, V16, P183; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanken J, 1999, TRENDS ECOL EVOL, V14, P7, DOI 10.1016/S0169-5347(98)01534-1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hu JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084529, 10.1371/journal.pone.0108582]; Hu JH, 2012, ASIAN HERPETOL RES, V3, P163, DOI 10.3724/SP.J.1245.2012.00163; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019817; Huang ZH, 2007, JIANGXI SCI, V25, P643; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jiang JP, 2005, HERPETOL J, V15, P1; Karraker NE, 2010, BIOL CONSERV, V143, P1079, DOI 10.1016/j.biocon.2010.01.020; Lehtinen RM, 2011, J ZOOL, V283, P117, DOI 10.1111/j.1469-7998.2010.00752.x; Li Cheng, 2008, Acta Zootaxonomica Sinica, V33, P104; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mahony S, 2013, ZOOTAXA, V3722, P143, DOI 10.11646/zootaxa.3722.2.2; Mahony Stephen, 2011, Zootaxa, V2734, P23; Mayr E., 1942, P1; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mo XY, 2010, CURR ZOOL, V56, P432, DOI 10.1093/czoolo/56.4.432; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rao Ding-Qi, 1997, Asiatic Herpetological Research, V7, P93; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vredenburg VT, 2007, J ZOOL, V271, P361, DOI 10.1111/j.1469-7998.2006.00258.x; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wang Ying-Yong, 2012, Zootaxa, V3546, P53; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zou DL, 1985, J NANCHANG U NATURAL, V1, P51	52	34	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93075	10.1371/journal.pone.0093075	http://dx.doi.org/10.1371/journal.pone.0093075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714161	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900013
J	Olden, A; Ovaskainen, O; Kotiaho, JS; Laaka-Lindberg, S; Halme, P				Olden, Anna; Ovaskainen, Otso; Kotiaho, Janne S.; Laaka-Lindberg, Sanna; Halme, Panu			Bryophyte Species Richness on Retention Aspens Recovers in Time but Community Structure Does Not	PLOS ONE			English	Article							BOREAL FOREST; EPIPHYTIC BRYOPHYTES; MICROCLIMATIC GRADIENTS; TREE RETENTION; GROWTH; DIVERSITY; CONSERVATION; FINLAND; EDGES; REPRODUCTION	Green-tree retention is a forest management method in which some living trees are left on a logged area. The aim is to offer `lifeboats' to support species immediately after logging and to provide microhabitats during and after forest re-establishment. Several studies have shown immediate decline in bryophyte diversity after retention logging and thus questioned the effectiveness of this method, but longer term studies are lacking. Here we studied the epiphytic bryophytes on European aspen (Populus tremula L.) retention trees along a 30-year chronosequence. We compared the bryophyte flora of 102 `retention aspens' on 14 differently aged retention sites with 102 `conservation aspens' on 14 differently aged conservation sites. We used a Bayesian community-level modelling approach to estimate the changes in bryophyte species richness, abundance (area covered) and community structure during 30 years after logging. Using the fitted model, we estimated that two years after logging both species richness and abundance of bryophytes declined, but during the following 20-30 years both recovered to the level of conservation aspens. However, logging-induced changes in bryophyte community structure did not fully recover over the same time period. Liverwort species showed some or low potential to benefit from lifeboating and high potential to re-colonise as time since logging increases. Most moss species responded similarly, but two cushion-forming mosses benefited from the logging disturbance while several weft- or mat-forming mosses declined and did not re-colonise in 20-30 years. We conclude that retention trees do not function as equally effective lifeboats for all bryophyte species but are successful in providing suitable habitats for many species in the long-term. To be most effective, retention cuts should be located adjacent to conservation sites, which may function as sources of re-colonisation and support the populations of species that require old-growth forests.	[Olden, Anna; Kotiaho, Janne S.; Halme, Panu] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Ovaskainen, Otso] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Laaka-Lindberg, Sanna] Univ Helsinki, Bot Unit, Finnish Nat Hist Museum LUOMUS, Helsinki, Finland	University of Jyvaskyla; University of Helsinki; University of Helsinki	Olden, A (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	anna.m.olden@jyu.fi	Ovaskainen, Otso/D-9119-2012; Ovaskainen, Otso/AGN-4838-2022	Ovaskainen, Otso/0000-0001-9750-4421; Ovaskainen, Otso/0000-0001-9750-4421; Kotiaho, Janne/0000-0002-4732-784X; Olden, Anna/0000-0003-0570-5002	Koneen Saatio foundation [27-6152]; Metsamiesten Saatio; Societas pro Fauna et Flora Fennica; Suomen Biologian Seura Vanamo ry; Academy of Finland [250444]; European Research Council [205905]	Koneen Saatio foundation; Metsamiesten Saatio; Societas pro Fauna et Flora Fennica; Suomen Biologian Seura Vanamo ry; Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	This study was funded by Koneen Saatio foundation (http://www.koneensaatio.fi/en/, grant 27-6152 to A.O.), Metsamiesten Saatio (http://mmsaatio.fi/www/fi/index.php, small grant to A.O), Societas pro Fauna et Flora Fennica (http://www.societasfff.fi/?lang = en, small grant to A.O), Suomen Biologian Seura Vanamo ry (http://www.vanamo.fi/, small grant to A.O), Academy of Finland (http://www.aka.fi/en-GB/A/, grant 250444 to O.O.) and the European Research Council (http://erc.europa.eu/, ERC Starting Grant 205905 to O.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Bates JW, 1998, OIKOS, V82, P223, DOI 10.2307/3546962; Beese WJ, 1999, FOREST ECOL MANAG, V115, P231, DOI 10.1016/S0378-1127(98)00402-2; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Berg D.R., 1997, CREATING FORESTRY 21, P111; Brosofske KD, 1997, ECOL APPL, V7, P1188, DOI 10.1890/1051-0761(1997)007[1188:HEOMGF]2.0.CO;2; Brown JH, 2001, OECOLOGIA, V126, P321, DOI 10.1007/s004420000536; BUSBY JR, 1978, ECOL MONOGR, V48, P95, DOI 10.2307/2937294; CAJANDER A. K., 1926, ADA FORESTALIA FENNICA, V29, P1; Caners RT, 2013, FOREST ECOL MANAG, V303, P184, DOI 10.1016/j.foreco.2013.04.019; Caners RT, 2010, BOTANY, V88, P315, DOI 10.1139/B09-089; Caruso A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027936; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; FAO, 2010, 163 FAO; Franklin J.F., 1989, AM FORESTS, V95, P37; Gignac LD, 2005, BRYOLOGIST, V108, P50, DOI 10.1639/0007-2745(2005)108[50:EOFSAH]2.0.CO;2; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; HUNTER ML, 1993, BIOL CONSERV, V65, P115, DOI 10.1016/0006-3207(93)90440-C; Hylander K, 2005, J APPL ECOL, V42, P518, DOI 10.1111/j.1365-2664.2005.01033.x; Hylander K, 2012, J APPL ECOL, V49, P1316, DOI 10.1111/j.1365-2664.2012.02218.x; Jairus K, 2009, J APPL ECOL, V46, P930, DOI 10.1111/j.1365-2664.2009.01672.x; Jalonen J, 2001, FOREST ECOL MANAG, V146, P25, DOI 10.1016/S0378-1127(00)00446-1; Johansson Tord, 1996, Silva Fennica, V30, P437; Kouki Jari, 2004, Journal for Nature Conservation (Jena), V12, P41, DOI 10.1016/j.jnc.2003.08.002; Kuuluvainen T, 2012, CAN J FOREST RES, V42, P1185, DOI [10.1139/X2012-064, 10.1139/x2012-064]; Kuusinen M, 1996, LICHENOLOGIST, V28, P443, DOI 10.1006/lich.1996.0043; Kuusinen M, 1999, ECOGRAPHY, V22, P729, DOI 10.1111/j.1600-0587.1999.tb00522.x; Lankia H, 2012, J VEG SCI, V23, P1159, DOI 10.1111/j.1654-1103.2012.01426.x; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lobel S, 2012, J APPL ECOL, V49, P1334, DOI 10.1111/j.1365-2664.2012.02201.x; Lobel S, 2009, J ECOL, V97, P176, DOI 10.1111/j.1365-2745.2008.01459.x; Lohmus A, 2010, BIOL CONSERV, V143, P891, DOI 10.1016/j.biocon.2009.12.036; Lohmus P, 2006, CAN J FOREST RES, V36, P1319, DOI 10.1139/X06-032; Lundstrom J, 2013, FOREST ECOL MANAG, V293, P49, DOI 10.1016/j.foreco.2012.12.027; Martikainen Petri, 2001, Ecological Bulletins, V49, P205; Nelson CR, 2005, CAN J BOT, V83, P610, DOI [10.1139/B05-036, 10.1139/b05-036]; Ojala E, 2000, CAN J BOT, V78, P529, DOI 10.1139/cjb-78-4-529; Ovaskainen O, 2011, ECOLOGY, V92, P289, DOI 10.1890/10-1251.1; Perhans K, 2009, BIOL CONSERV, V142, P1125, DOI 10.1016/j.biocon.2008.12.033; Proctor MCF, 2007, BRYOLOGIST, V110, P595, DOI 10.1639/0007-2745(2007)110[595:DIBAR]2.0.CO;2; Roberge JM, 2011, J APPL ECOL, V48, P650, DOI 10.1111/j.1365-2664.2011.01963.x; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Syrjanen K., 2010, 2010 RED LIST FINNIS, P208; Syrjanen K, 2009, SUOMEN UNHANALAISET, P183; Ulvinen T., 2002, SUOMEN SAMMALET LEVI; Ulvinen T., 2009, SUOMEN UHANALAISET S, P309	50	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93786	10.1371/journal.pone.0093786	http://dx.doi.org/10.1371/journal.pone.0093786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710329	Green Published, gold			2022-12-27	WOS:000334159800052
J	Qiu, L; Na, R; Xu, R; Wang, SY; Sheng, HG; Wu, WL; Qu, Y				Qiu, Ling; Na, Risu; Xu, Rong; Wang, Siyang; Sheng, Hongguang; Wu, Wanling; Qu, Yi			Quantitative Assessment of the Effect of KCNJ11 Gene Polymorphism on the Risk of Type 2 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; SENSITIVE POTASSIUM CHANNEL; COMMON VARIANTS; E23K POLYMORPHISM; SUSCEPTIBILITY LOCI; KIR6.2 KCNJ11; SUR1 ABCC8; METAANALYSIS; POPULATION	To clarify the role of potassium inwardly-rectifying-channel, subfamily-J, member 11 (KCNJ11) variation in susceptibility to type 2 diabetes (T2D), we performed a systematic meta-analysis to investigate the association between the KCNJ11 E23K polymorphism (rs5219) and the T2D in different genetic models. Databases including PubMed, Medline, EMBASE, and ISI Web of Science were searched to identify relevant studies. A total of 48 published studies involving 56,349 T2D cases, 81,800 controls, and 483 family trios were included in this meta-analysis. Overall, the E23K polymorphism was significantly associated with increased T2D risk with per-allele odds ratio (OR) of 1.12 ( 95% CI: 1.09-1.16; P < 10(-5)). The summary OR for T2D was 1.09 (95% CI: 1.03-1.14; P < 10(-5)), and 1.26 (95% CI: 1.17-1.35; P < 10(-5)), for heterozygous and homozygous, respectively. Similar results were also detected under dominant and recessive genetic models. When stratified by ethnicity, significantly increased risks were found for the polymorphism in Caucasians and East Asians. However, no such associations were detected among Indian and other ethnic populations. Significant associations were also observed in the stratified analyses according to different mean BMI of cases and sample size. Although significant between study heterogeneity was identified, meta-regression analysis suggested that the BMI of controls significantly correlated with the magnitude of the genetic effect. The current meta-analysis demonstrated that a modest but statistically significant effect of the 23K allele of rs5219 polymorphism in susceptibility to T2D. But the contribution of its genetic variants to the epidemic of T2D in Indian and other ethnic populations appears to be relatively low.	[Qiu, Ling; Xu, Rong; Wang, Siyang; Qu, Yi] Chinese Acad Sci, Shanghai Xuhui Cent Hosp, Shanghai Clin Ctr, Dept Geriatr, Shanghai, Peoples R China; [Na, Risu; Sheng, Hongguang] Chinese Acad Sci, Shanghai Xuhui Cent Hosp, Shanghai Clin Ctr, Dept Endocrinol, Shanghai, Peoples R China; [Wu, Wanling] Shanghai Jiao Tong Univ, Peoples Hosp Attach 9, Sch Med, Dept Endocrinol, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Jiao Tong University	Qu, Y (corresponding author), Chinese Acad Sci, Shanghai Xuhui Cent Hosp, Shanghai Clin Ctr, Dept Geriatr, Shanghai, Peoples R China.	yi_qu001@163.com			research foundation of Shanghai Municipal Health Bureau [20124276]	research foundation of Shanghai Municipal Health Bureau	This work was supported by the research foundation of Shanghai Municipal Health Bureau (No. 20124276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Gamboa-Melendez MA, 2012, DIABETES, V61, P3314, DOI 10.2337/db11-0550; Alsmadi O, 2008, DIABETES-METAB RES, V24, P137, DOI 10.1002/dmrr.777; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bronstein M, 2008, HUM GENET, V124, P101, DOI 10.1007/s00439-008-0520-x; Cauchi S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-45; Cejkova P, 2007, FOLIA BIOL-PRAGUE, V53, P173; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Chavali S, 2011, J HUM GENET, V56, P695, DOI 10.1038/jhg.2011.83; Cheung CYY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028598; Chistiakov DA, 2009, ACTA DIABETOL, V46, P43, DOI 10.1007/s00592-008-0056-5; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Cugino D, 2012, NUTR METAB CARDIOVAS, V22, P619, DOI 10.1016/j.numecd.2010.11.010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doi Y, 2007, DIABETES, V56, P2829, DOI 10.2337/db06-1709; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Gloyn AL, 2001, DIABETIC MED, V18, P206, DOI 10.1046/j.1464-5491.2001.00449.x; Gonen MS, 2012, ARCH MED RES, V43, P317, DOI 10.1016/j.arcmed.2012.06.001; Gupta V, 2010, ANN HUM GENET, V74, P361, DOI 10.1111/j.1469-1809.2010.00580.x; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hansen SK, 2005, J CLIN ENDOCR METAB, V90, P3629, DOI 10.1210/jc.2004-1942; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Koo BK, 2007, DIABETIC MED, V24, P178, DOI 10.1111/j.1464-5491.2006.02050.x; Laukkanen O, 2004, J CLIN ENDOCR METAB, V89, P6286, DOI 10.1210/jc.2004-1204; Li YY, 2013, MOL BIOL REP, V40, P141, DOI 10.1007/s11033-012-2042-9; Liu Zhuo, 2006, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V28, P124; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Moue H, 1997, DIABETES, V46, P502; Neuman RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009903; Nichols CG, 2007, DIABETES OBES METAB, V9, P81, DOI 10.1111/j.1463-1326.2007.00778.x; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Peng SB, 2008, YUEYANG ZHI YE JI SH, V23, P77; Qi L, 2007, DIABETIC MED, V24, P1187, DOI 10.1111/j.1464-5491.2007.02255.x; Qin LJ, 2013, GENET MOL RES, V12, P2990, DOI 10.4238/2013.August.20.1; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Riedel MJ, 2005, DIABETES, V54, P2070, DOI 10.2337/diabetes.54.7.2070; Sakamoto Y, 2007, J HUM GENET, V52, P781, DOI 10.1007/s10038-007-0190-x; Sakura H, 1996, DIABETOLOGIA, V39, P1233, DOI 10.1007/BF02658512; Sale MM, 2007, DIABETES, V56, P2638, DOI 10.2337/db07-0012; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith Andrew J., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000403; Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tabara Y, 2009, DIABETES, V58, P493, DOI 10.2337/db07-1785; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Thorsby PM, 2009, SCAND J CLIN LAB INV, V69, P282, DOI 10.1080/00365510802538188; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; van Dam RM, 2005, DIABETIC MED, V22, P590, DOI 10.1111/j.1464-5491.2005.01465.x; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Wang F, 2009, CHINESE MED J-PEKING, V122, P2477, DOI 10.3760/cma.j.issn.0366-6999.2009.20.015; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009153; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yamada Y, 2001, DIABETES-METAB RES, V17, P213, DOI 10.1002/dmrr.193; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang LJ, 2012, MOL BIOL REP, V39, P645, DOI 10.1007/s11033-011-0782-6; Yokoi N, 2006, DIABETES, V55, P2379, DOI 10.2337/db05-1203; Zhou DZ, 2009, J HUM GENET, V54, P433, DOI 10.1038/jhg.2009.54	70	30	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93961	10.1371/journal.pone.0093961	http://dx.doi.org/10.1371/journal.pone.0093961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710510	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800077
J	Yang, M; Geng, XM; Grace, J; Lu, C; Zhu, Y; Zhou, Y; Lei, GC				Yang, Meng; Geng, Xuemeng; Grace, John; Lu, Cai; Zhu, Yi; Zhou, Yan; Lei, Guangchun			Spatial and Seasonal CH4 Flux in the Littoral Zone of Miyun Reservoir near Beijing: The Effects of Water Level and Its Fluctuation	PLOS ONE			English	Article							METHANE EMISSIONS; EMERGENT MACROPHYTES; BOREAL LAKES; SOIL REDOX; WETLANDS; OXIDATION; HYDROPOWER; EFFLUX; STANDS; RICE	Wetlands, and especially their littoral zones, are considered to be CH4 emissions hotspots. The recent creation of reservoirs has caused a rapid increase in the area of the world's littoral zones. To investigate the effects of water depth and water level fluctuation on CH4 fluxes, and how these are coupled with vegetation and nutrients, we used static closed chamber and gas chromatography techniques to measure CH4 fluxes in the littoral zone of a large reservoir near Beijing, China, from November 2011 to October 2012. We found that CH4 flux decreased significantly along a transect from open water to dry land, from 3.1 mg m (-2) h (-1) at the deep water site to approximately 1.3 mg m (-2) h (-1) at the shallow water site, and less than 0.01 mg m 22 h 21 in the non-flooded area. Water level influenced CH4 flux by affecting soil properties including soil redox potential, soil carbon and nitrogen, and bulk density. The largest emission of all was from the seasonally flooded site after a flooding event ( up to 21.1 mg m (-2) h (-1)), which may have been caused by vegetation decomposition. Submerged sites had greater emissions, while the driest site had lower emissions. Immediately after the monthly measurements had been made, we removed the aboveground vegetation to enable an assessment of the gas transportation per unit of biomass. Removal of biomass decreased emissions by up to 53%. These results indicated the dominant effect of water depth on CH4 flux through effects of soil conditions, plant species composition and distribution. This study suggests that temporally flooded wetlands, including littoral zones, contribute significantly to the global CH4 burden. However, the current challenge is to capture their spatial extent and temporal variation in the fluxes.	[Yang, Meng; Geng, Xuemeng; Lu, Cai; Zhu, Yi; Zhou, Yan; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Grace, John] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland	Beijing Forestry University; University of Edinburgh	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	guangchun.lei@foxmail.com	Guangchun, Lei/ABC-8081-2021; Grace, John/N-9280-2013		China National Forestry Public Welfare Fund [200804005]	China National Forestry Public Welfare Fund	This research was supported by China National Forestry Public Welfare Fund (No. 200804005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2013, J S AM EARTH SCI, V44, P104, DOI 10.1016/j.jsames.2012.11.007; Allaire SE, 2008, J ENVIRON MONITOR, V10, P1326, DOI 10.1039/b809461f; [Anonymous], 2011, CHINAS LARGEST INLAN; Bergier I., 2011, OECOL AUST, V15, P666, DOI [10.4257/oeco.2011.1503.17, DOI 10.4257/0EC0.2011.1503.17, DOI 10.4257/OECO.2011.1503.17]; Bergstrom I, 2007, ATMOS ENVIRON, V41, P339, DOI 10.1016/j.atmosenv.2006.08.014; Bernal B, 2013, BIOGEOCHEMISTRY, V115, P77, DOI 10.1007/s10533-012-9819-8; Bhullar GS, 2013, J PLANT ECOL, V6, P298, DOI 10.1093/jpe/rts045; Boon PI, 1997, HYDROBIOLOGIA, V357, P73, DOI 10.1023/A:1003126601466; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; [曹荣龙 CAO Ronglong], 2008, [测绘科学, Science of Surveying and Mapping], V33, P158; Chaudhari P.R., 2013, INT J SCI RES PUBLIC, V3, P1; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen X, 2009, GAZETTE MINISTRY WAT; Cheng HL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078838, 10.1371/journal.pone.0053878]; Chowdhury TR, 2013, APPL SOIL ECOL, V65, P8, DOI 10.1016/j.apsoil.2012.12.014; Cunha-Santino Marcela Bianchessi da, 2010, Acta Limnol. Bras., V22, P237, DOI 10.4322/actalb.02202012; Demarty M, 2011, BIOGEOSCIENCES, V8, P41, DOI 10.5194/bg-8-41-2011; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Duan XN, 2006, J FRESHWATER ECOL, V21, P139, DOI 10.1080/02705060.2006.9664106; Fazli H.C., 2013, ASIA PAC J MOL BIOL, V21, P3; Gao Z. Q., 1989, BEIJING CHRONICLES W, VIII; Gauci V, 2010, ATMOS ENVIRON, V44, P2157, DOI 10.1016/j.atmosenv.2010.02.034; Gorres CM, 2013, FEMS MICROBIOL ECOL, V85, P227, DOI 10.1111/1574-6941.12115; Gunkel G, 2009, CLEAN-SOIL AIR WATER, V37, P726, DOI 10.1002/clen.200900062; Haynes WM, 2012, CRC HDB CHEM PHYS 20; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; Hu YA, 2013, NAT CLIM CHANGE, V3, P708, DOI 10.1038/NCLIMATE1831; [黄佳芳 Huang Jiafang], 2011, [植物学报, Chinese Bulletin of Botany], V46, P534; Huang Y, 2002, NUTR CYCL AGROECOSYS, V64, P157, DOI 10.1023/A:1021132330268; Juutinen S, 2003, GLOBAL CHANGE BIOL, V9, P413, DOI 10.1046/j.1365-2486.2003.00595.x; Juutinen S, 2004, METHANE FLUXES THEIR; Kammann C, 2001, ENVIRON POLLUT, V115, P261, DOI 10.1016/S0269-7491(01)00103-8; Kankaala P, 2005, GLOBAL CHANGE BIOL, V11, P145, DOI 10.1111/j.1365-2486.2004.00888.x; KLUDZE HK, 1995, SOIL SCI SOC AM J, V59, P939, DOI 10.2136/sssaj1995.03615995005900030045x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Koh HS, 2009, HYDROBIOLOGIA, V630, P271, DOI 10.1007/s10750-009-9821-x; Kolka RK, 2007, ECOLOGY FRESHWATER E; Kundzewicz ZW, 2007, CONTRIBUTION WORKING; Laanbroek HJ, 2010, ANN BOT-LONDON, V105, P141, DOI 10.1093/aob/mcp201; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li SY, 2012, NAT HAZARDS, V62, P1343, DOI 10.1007/s11069-012-0127-3; Light HM, 1993, HYDROLOGY VEGETATION; Liu DY, 2011, BIOGEOSCIENCES, V8, P329, DOI 10.5194/bg-8-329-2011; Makinen K., 2010, Water Alternatives, V3, P91; Mander U, 2011, WETLANDS, V31, P1023, DOI 10.1007/s13157-011-0218-z; MOORE TR, 1991, ATMOS OCEAN, V29, P102, DOI 10.1080/07055900.1991.9649395; Petrescu AMR, 2008, BIOGEOSCIENCES, V5, P111, DOI 10.5194/bg-5-111-2008; Petrescu AMR, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003610; Pierobon E, 2010, J LIMNOL, V69, P225, DOI 10.4081/jlimnol.2010.225; Sakin E., 2012, African Journal of Biotechnology, V11, P1373; Schimel J, 2000, NATURE, V403, P375, DOI 10.1038/35000325; Solomon S., 2007, PHYS SCI BASIS WORKI; Swamy YV, 2012, ATMOSFERA, V25, P107; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382, DOI 10.2136/sssaj1993.03615995005700020016x; Wildi W., 2010, TERRE ENV, V88, P187; Yamamoto A, 2009, LIMNOLOGY, V10, P228, DOI 10.1007/s10201-009-0284-6; [杨萌 YANG Meng], 2011, [湿地科学, Wetland Science], V9, P191; Zheng H, 2011, HYDROL PROCESS, V25, P1391, DOI 10.1002/hyp.7903	59	20	23	6	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94275	10.1371/journal.pone.0094275	http://dx.doi.org/10.1371/journal.pone.0094275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710279	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800130
J	Miao, HS; Choi, BD; Suryadevara, CM; Sanchez-Perez, L; Yang, SC; De Leon, G; Sayour, EJ; McLendon, R; Herndon, JE; Healy, P; Archer, GE; Bigner, DD; Johnson, LA; Sampson, JH				Miao, Hongsheng; Choi, Bryan D.; Suryadevara, Carter M.; Sanchez-Perez, Luis; Yang, Shicheng; De Leon, Gabriel; Sayour, Elias J.; McLendon, Roger; Herndon, James E., II; Healy, Patrick; Archer, Gary E.; Bigner, Darell D.; Johnson, Laura A.; Sampson, John H.			EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODIES; CLINICAL-TRIAL; ADVERSE EVENT; GLIOMA; CANCER; GENE; IMMUNOTHERAPY; THERAPY; RECOGNITION	Glioblastoma (GBM) is the most common primary malignant brain tumor in adults and is uniformly lethal. T-cell-based immunotherapy offers a promising platform for treatment given its potential to specifically target tumor tissue while sparing the normal brain. However, the diffuse and infiltrative nature of these tumors in the brain parenchyma may pose an exceptional hurdle to successful immunotherapy in patients. Areas of invasive tumor are thought to reside behind an intact blood brain barrier, isolating them from effective immunosurveillance and thereby predisposing the development of "immunologically silent" tumor peninsulas. Therefore, it remains unclear if adoptively transferred T cells can migrate to and mediate regression in areas of invasive GBM. One barrier has been the lack of a preclinical mouse model that accurately recapitulates the growth patterns of human GBM in vivo. Here, we demonstrate that D-270 MG xenografts exhibit the classical features of GBM and produce the diffuse and invasive tumors seen in patients. Using this model, we designed experiments to assess whether T cells expressing third-generation chimeric antigen receptors (CARs) targeting the tumor-specific mutation of the epidermal growth factor receptor, EGFRvIII, would localize to and treat invasive intracerebral GBM. EGFRvIII-targeted CAR (EGFRvIII(+) CAR) T cells demonstrated in vitro EGFRvIII antigen-specific recognition and reactivity to the D-270 MG cell line, which naturally expresses EGFRvIII. Moreover, when administered systemically, EGFRvIII(+) CAR T cells localized to areas of invasive tumor, suppressed tumor growth, and enhanced survival of mice with established intracranial D-270 MG tumors. Together, these data demonstrate that systemically administered T cells are capable of migrating to the invasive edges of GBM to mediate antitumor efficacy and tumor regression.	[Miao, Hongsheng; Choi, Bryan D.; Suryadevara, Carter M.; Sanchez-Perez, Luis; Yang, Shicheng; De Leon, Gabriel; Sayour, Elias J.; Archer, Gary E.; Bigner, Darell D.; Johnson, Laura A.; Sampson, John H.] Duke Univ, Med Ctr, Dept Surg, Duke Brain Tumor Immunotherapy Program,Div Neuros, Durham, NC 27710 USA; [Choi, Bryan D.; Sayour, Elias J.; McLendon, Roger; Archer, Gary E.; Bigner, Darell D.; Sampson, John H.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [De Leon, Gabriel] Duke Univ, Med Ctr, Dept Mol Canc Biol, Durham, NC USA; [McLendon, Roger; Archer, Gary E.; Bigner, Darell D.; Johnson, Laura A.; Sampson, John H.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA; [Herndon, James E., II; Healy, Patrick] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Sampson, JH (corresponding author), Duke Univ, Med Ctr, Dept Surg, Duke Brain Tumor Immunotherapy Program,Div Neuros, Durham, NC 27710 USA.	john.sampson@duke.edu		Sampson, John/0000-0002-0104-7658	National Institutes of Health [1R01CA177476-01, 5R01-CA135272-05, 5P50-NS020023- 30, 3R25-NS065731-03S1, 1F30CA177152-01]; Pediatric Brain Tumor Foundation; Ben and Catherine Ivy Foundation; Against Brain Cancer; American Brain Tumor Association; Duke Cancer Institute; NATIONAL CANCER INSTITUTE [F30CA177152, R01CA135272, P30CA014236, R01CA177476, DP2CA174502, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023, R25NS065731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Ben and Catherine Ivy Foundation; Against Brain Cancer; American Brain Tumor Association; Duke Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health: 1R01CA177476-01 (J.H. Sampson), 5R01-CA135272-05 (J.H. Sampson), 5P50-NS020023- 30 (D. D. Bigner and J.H. Sampson), 3R25-NS065731-03S1 (J.H. Sampson), 1F30CA177152-01 (B. D. Choi). Additional support was provided by the Pediatric Brain Tumor Foundation (D. D. Bigner and J.H. Sampson), Ben and Catherine Ivy Foundation (J.H. Sampson), Voices Against Brain Cancer (L. A. Johnson), American Brain Tumor Association (L. A. Johnson), and Duke Cancer Institute (J.H. Sampson and B. D. Choi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Ajay Divya, 2012, Curr Drug Discov Technol, V9, P237; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; BIGNER SH, 1990, CANCER RES, V50, P8017; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Choi BD, 2014, J CLIN NEUROSCI, V21, P189, DOI 10.1016/j.jocn.2013.03.012; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hashizume R, 2010, J NEURO-ONCOL, V96, P151, DOI 10.1007/s11060-009-9954-9; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hong JJ, 2010, CLIN CANCER RES, V16, P4892, DOI 10.1158/1078-0432.CCR-10-1507; Hughes MS, 2005, HUM GENE THER, V16, P457, DOI 10.1089/hum.2005.16.457; IMPERATO JP, 1990, ANN NEUROL, V28, P818, DOI 10.1002/ana.410280614; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Lal A, 2002, CANCER RES, V62, P3335; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miura FK, 2010, CLINICS, V65, P305, DOI 10.1590/S1807-59322010000300011; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2012, HUM GENE THER, V23, P1043, DOI 10.1089/hum.2012.041; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2003, J IMMUNOTHER, V26, P385, DOI 10.1097/00002371-200309000-00001; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sampson JH, 2013, CLIN CANC RES; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Till BG, 2012, BLOOD, V119, P3940, DOI 10.1182/blood-2011-10-387969; Vauleon E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/689171; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	51	74	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94281	10.1371/journal.pone.0094281	http://dx.doi.org/10.1371/journal.pone.0094281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722266	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100049
J	Tung, EWY; Boudreau, A; Wade, MG; Atlas, E				Tung, Emily W. Y.; Boudreau, Adele; Wade, Michael G.; Atlas, Ella			Induction of Adipocyte Differentiation by Polybrominated Diphenyl Ethers (PBDEs) in 3T3-L1 Cells	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; LIVER-X-RECEPTORS; POLYCHLORINATED-BIPHENYLS; HUMAN EXPOSURE; IN-VITRO; ACCUMULATION; DISRUPTORS; EXPRESSION; MILK	Polybrominated diphenyl ethers (PBDEs) are a class of brominated flame retardants that were extensively used in commercial products. PBDEs are ubiquitous environmental contaminants that are both lipophilic and bioaccumulative. Effects of PBDEs on adipogenesis were studied in the 3T3-L1 preadipocyte cell model in the presence and absence of a known adipogenic agent, dexamethasone (DEX). A PBDE mixture designed to mimic body burden of North Americans was tested, in addition to the technical mixture DE-71 and the individual congener BDE-47. The mixture, DE-71, and BDE-47 all induced adipocyte differentiation as assessed by markers for terminal differentiation [ fatty acid binding protein 4 (aP2) and perilipin] and lipid accumulation. Characterization of the differentiation process in response to PBDEs indicated that adipogenesis induced by a minimally effective dose of DEX was enhanced by these PBDEs. Moreover, C/EBP alpha, PPAR gamma, and LXR alpha were induced late in the differentiation process. Taken together, these data indicate that adipocyte differentiation is induced by PBDEs; they act in the absence of glucocorticoid and enhance glucocorticoid-mediated adipogenesis.	[Tung, Emily W. Y.; Boudreau, Adele; Wade, Michael G.; Atlas, Ella] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada	Health Canada	Atlas, E (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	ella.atlas@hc-sc.gc.ca		Wade, Michael/0000-0002-7331-3839	Health Canada Chemicals Management Plan	Health Canada Chemicals Management Plan	E.A. is funded by the Health Canada Chemicals Management Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birnbaum LS, 2004, ENVIRON HEALTH PERSP, V112, P9, DOI 10.1289/ehp.6559; Chen D, 2010, ENVIRON INT, V36, P800, DOI 10.1016/j.envint.2010.05.013; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; ERNEST SR, TOXICOL SCI, V127, P496; FORTE TM, 1981, LIPIDS, V16, P240, DOI 10.1007/BF02535023; Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005; Hale RC, 2003, ENVIRON INT, V29, P771, DOI 10.1016/S0160-4120(03)00113-2; Hoppe AA, 2007, OBESITY, V15, P2942, DOI 10.1038/oby.2007.351; Hummasti S, 2004, J LIPID RES, V45, P616, DOI 10.1194/jlr.M300312-JLR200; Johnson-Restrepo B, 2005, ENVIRON SCI TECHNOL, V39, P5177, DOI 10.1021/es050399x; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kelly BC, 2008, SCI TOTAL ENVIRON, V401, P60, DOI 10.1016/j.scitotenv.2008.03.045; Lim JS, 2008, DIABETES CARE, V31, P1802, DOI 10.2337/dc08-0850; Malarvannan G, 2013, ENVIRON INT, V55, P33, DOI 10.1016/j.envint.2013.02.012; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Mercado-Feliciano M, 2008, ENVIRON HEALTH PERSP, V116, P1315, DOI 10.1289/ehp.11343; Montano M, 2012, TOXICOL SCI, V130, P94, DOI 10.1093/toxsci/kfs228; Mundy WR, 2004, TOXICOL SCI, V82, P164, DOI 10.1093/toxsci/kfh239; Pacyniak E, 2011, TOXICOL APPL PHARM, V257, P23, DOI 10.1016/j.taap.2011.08.014; Pereira-Fernandes A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077481; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schecter A, 2003, ENVIRON HEALTH PERSP, V111, P1723, DOI 10.1289/ehp.6466; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; She JW, 2007, CHEMOSPHERE, V67, pS307, DOI 10.1016/j.chemosphere.2006.05.154; Sjodin A, 2003, ENVIRON INT, V29, P829, DOI 10.1016/S0160-4120(03)00108-9; Steffensen KR, 2002, BIOCHEM BIOPH RES CO, V293, P1333, DOI 10.1016/S0006-291X(02)00390-X; Suvorov A, 2009, TOXICOLOGY, V260, P126, DOI 10.1016/j.tox.2009.03.018; Teta D, 2005, NEPHROL DIAL TRANSPL, V20, P1329, DOI 10.1093/ndt/gfh812; Walther RF, 2005, J BIOL CHEM, V280, P17549, DOI 10.1074/jbc.M501548200; Wu N, 2007, ENVIRON SCI TECHNOL, V41, P1584, DOI 10.1021/es0620282	33	36	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94583	10.1371/journal.pone.0094583	http://dx.doi.org/10.1371/journal.pone.0094583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722056	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100102
J	Zhao, HG; Luo, FL; Li, HZ; Zhang, L; Yi, YF; Wan, JY				Zhao, Hengguang; Luo, Fuling; Li, Hongzhong; Zhang, Li; Yi, Yongfen; Wan, Jingyuan			Antinociceptive Effect of Tetrandrine on LPS-Induced Hyperalgesia via the Inhibition of IKK beta Phosphorylation and the COX-2/PGE(2) Pathway in Mice	PLOS ONE			English	Article							NF-KAPPA-B; PROSTAGLANDIN E-2; ACTIVATION; EXPRESSION; KINASE; ALPHA; AKT; HYPERSENSITIVITY; CYCLOOXYGENASE-2; ENDOTOXEMIA	Tetrandrine (TET) is a bisbenzylisoquinoline alkaloid that is isolated from the Stephania Tetrandra. It is known to possess anti-inflammatory and immunomodulatory effects. We have shown that TET can effectively suppress the production of bacterial lipopolysaccharide (LPS)-induced inflammatory mediators, including cyclooxygenases (COXs), in macrophages. However, whether TET has an antinociceptive effect on LPS-induced hyperalgesia is unknown. In the present study, we investigated the potential antinociceptive effects of TET and the mechanisms by which it elicits its effects on LPS-induced hyperalgesia. LPS effectively evoked hyperalgesia and induced the production of PGE(2) in the sera, brain tissues, and cultured astroglia. TET pretreatment attenuated all of these effects. LPS also activated inhibitor of kappa B (I kappa B) kinase beta (IKK beta) and its downstream components in the I kappa B/nuclear factor (NF)-kappa B signaling pathway, including COX-2; the increase in expression levels of these components was significantly abolished by TET. Furthermore, in primary astroglia, knockdown of IKK beta, but not IKK alpha, reversed the effects of TET on the LPS-induced increase in I kappa B phosphorylation, P65 phosphorylation, and COX-2. Our results suggest that TET can effectively exert antinociceptive effects on LPS-induced hyperalgesia in mice by inhibiting IKK beta phosphorylation, which leads to the reduction in the production of important pain mediators, such as PGE(2) and COX-2, via the IKK beta/I kappa B/NF-kappa B pathway.	[Zhao, Hengguang] Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China; [Luo, Fuling] Chongqing Med Univ, Affiliated Hosp 1, Dept Pharm, Chongqing, Peoples R China; [Li, Hongzhong] Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China; [Zhang, Li] Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China; [Yi, Yongfen] Chongqing Med Univ, Dept Pathol, Mol Med & Tumor Ctr, Chongqing, Peoples R China; [Wan, Jingyuan] Chongqing Med Univ, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Yi, YF (corresponding author), Chongqing Med Univ, Dept Pathol, Mol Med & Tumor Ctr, Chongqing, Peoples R China.	yiyongfen1953@aliyun.com; jywan@cqmu.edu.cn			National Natural Science Foundation of China [81072650, 81373870]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81072650 and 81373870). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou LR, 2000, P NATL ACAD SCI USA, V97, P10272, DOI 10.1073/pnas.180319297; Benson S, 2012, PAIN, V153, P794, DOI 10.1016/j.pain.2011.12.001; Berenbaum F, 2004, JOINT BONE SPINE, V71, P451, DOI 10.1016/j.jbspin.2004.02.003; Cao L, 2009, NEUROSCIENCE, V158, P896, DOI 10.1016/j.neuroscience.2008.10.004; Dajani R, 2007, AM J PHYSIOL-GASTR L, V292, pG242, DOI 10.1152/ajpgi.00043.2006; Gao F, 2013, J SURG RES, V184, P944, DOI 10.1016/j.jss.2013.03.034; Gong X, 2010, INT IMMUNOPHARMACOL, V10, P357, DOI 10.1016/j.intimp.2009.12.010; Haddad JJ, 2011, CELL IMMUNOL, V271, P5, DOI 10.1016/j.cellimm.2011.06.021; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu CC, 2013, BIOCHEM PHARMACOL, V85, P385, DOI 10.1016/j.bcp.2012.11.002; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; Islam S, 2004, MICROBIOL IMMUNOL, V48, P729, DOI 10.1111/j.1348-0421.2004.tb03598.x; Iturriaga-Vasquez P, 2003, J NAT PROD, V66, P954, DOI 10.1021/np030022+; Johann S, 2008, J MOL NEUROSCI, V34, P177, DOI 10.1007/s12031-007-9028-4; Kanngiesser M, 2012, J PAIN, V13, P485, DOI 10.1016/j.jpain.2012.02.010; Kaushik D, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/245431; Koppula S, 2013, AM J CHINESE MED, V41, P927, DOI 10.1142/S0192415X13500626; Kovacs KJ, 2008, PAIN, V136, P75, DOI 10.1016/j.pain.2007.06.017; Lee YS, 2012, FOODBORNE PATHOG DIS, V9, P686, DOI 10.1089/fpd.2011.1119; Li XD, 2011, J SURG RES, V166, pE45, DOI 10.1016/j.jss.2010.10.034; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Miyachi T, 2001, NEUROSCI RES, V40, P53, DOI 10.1016/S0168-0102(01)00208-5; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Nasrallah R, 2007, CLIN SCI, V113, P297, DOI 10.1042/CS20070089; Ndengele MM, 2008, FASEB J, V22, P3154, DOI 10.1096/fj.08-108159; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Park EJ, 2011, PHYTOCHEM LETT, V4, P426, DOI 10.1016/j.phytol.2011.07.009; Saito O, 2010, BRIT J PHARMACOL, V160, P1754, DOI 10.1111/j.1476-5381.2010.00811.x; Shao D, 2008, INFLAMM RES, V57, P601, DOI 10.1007/s00011-008-8053-2; Shen DF, 2010, BRIT J PHARMACOL, V159, P970, DOI 10.1111/j.1476-5381.2009.00605.x; Shishodia S, 2004, J IMMUNOL, V173, P2011, DOI 10.4049/jimmunol.173.3.2011; Southall MD, 2001, J BIOL CHEM, V276, P16083, DOI 10.1074/jbc.M011408200; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Thomsen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072110; Wang TH, 2012, ONCOL REP, V28, P1681, DOI 10.3892/or.2012.1999; Xiang Y, 2013, J MOL NEUROSCI; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yu XC, 2004, J PHARM PHARMACOL, V56, P115, DOI 10.1211/0022357022458	39	24	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94586	10.1371/journal.pone.0094586	http://dx.doi.org/10.1371/journal.pone.0094586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722146	gold, Green Published, Green Submitted			2022-12-27	WOS:000336909100103
J	Abraham, G; Inouye, M				Abraham, Gad; Inouye, Michael			Fast Principal Component Analysis of Large-Scale Genome-Wide Data	PLOS ONE			English	Article							ASSOCIATION; POPULATIONS; COMMON	Principal component analysis (PCA) is routinely used to analyze genome-wide single-nucleotide polymorphism (SNP) data, for detecting population structure and potential outliers. However, the size of SNP datasets has increased immensely in recent years and PCA of large datasets has become a time consuming task. We have developed flashpca, a highly efficient PCA implementation based on randomized algorithms, which delivers identical accuracy in extracting the top principal components compared with existing tools, in substantially less time. We demonstrate the utility of flashpca on both HapMap3 and on a large Immunochip dataset. For the latter, flashpca performed PCA of 15,000 individuals up to 125 times faster than existing tools, with identical results, and PCA of 150,000 individuals using flashpca completed in 4 hours. The increasing size of SNP datasets will make tools such as flashpca essential as traditional approaches will not adequately scale. This approach will also help to scale other applications that leverage PCA or eigen-decomposition to substantially larger datasets.	[Abraham, Gad] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne	Abraham, G (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.	gad.abraham@unimelb.edu.au		Inouye, Michael/0000-0001-9413-6520; Abraham, Gad/0000-0003-4853-0118	NHMRC grant [1062227]; NHMRC Early Career Fellowship [637400]	NHMRC grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge support and funding from NHMRC grant no. 1062227. MI was supported by an NHMRC Early Career Fellowship (no. 637400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Guennebaud G., 2010, EIGEN V3; Halko N, 2011, SIAM REV, V53, P217, DOI 10.1137/090771806; Halko N, 2011, SIAM J SCI COMPUT, V33, P2580, DOI 10.1137/100804139; Johnstone IM, 2009, J AM STAT ASSOC, V104, P682, DOI 10.1198/jasa.2009.0121; Lee S, 2012, GENET EPIDEMIOL, V36, P293, DOI 10.1002/gepi.21621; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rakitsch B, 2013, BIOINFORMATICS, V29, P206, DOI 10.1093/bioinformatics/bts669; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	17	159	160	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93766	10.1371/journal.pone.0093766	http://dx.doi.org/10.1371/journal.pone.0093766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718290	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000046
J	Bastiaans, E; Bastiaans, MJ; Morinaga, G; Gaytan, JGC; Marshall, JC; Bane, B; de la Cruz, FM; Sinervo, B				Bastiaans, Elizabeth; Jane Bastiaans, Mary; Morinaga, Gen; Castaneda Gaytan, Jose Gamaliel; Marshall, Jonathon C.; Bane, Brendan; Mendez de la Cruz, Fausto; Sinervo, Barry			Female Preference for Sympatric vs. Allopatric Male Throat Color Morphs in the Mesquite Lizard (Sceloporus grammicus) Species Complex	PLOS ONE			English	Article							2 CHROMOSOME RACES; KEELED EARLESS LIZARDS; VISUAL MATE CHOICE; MALE TREE LIZARDS; SEXUAL SELECTION; HYBRID ZONE; IGUANID LIZARD; BEHAVIORAL-RESPONSES; GEOGRAPHIC-VARIATION; COURTSHIP REJECTION	Color polymorphic sexual signals are often associated with alternative reproductive behaviors within populations, and the number, frequency, or type of morphs present often vary among populations. When these differences lead to assortative mating by population, the study of such polymorphic taxa may shed light on speciation mechanisms. We studied two populations of a lizard with polymorphic throat color, an important sexual signal. Males in one population exhibit orange, yellow, or blue throats; whereas males in the other exhibit orange, yellow, or white throats. We assessed female behavior when choosing between allopatric and sympatric males. We asked whether females discriminated more when the allopatric male was of an unfamiliar morph than when the allopatric male was similar in coloration to the sympatric male. We found that female rejection of allopatric males relative to sympatric males was more pronounced when males in a pair were more different in throat color. Our findings may help illuminate how behavioral responses to color morph differences between populations with polymorphic sexual signals contribute to reproductive isolation.	[Bastiaans, Elizabeth; Morinaga, Gen; Bane, Brendan; Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Jane Bastiaans, Mary] Nanoopt Mat Inc, Carson, CA USA; [Castaneda Gaytan, Jose Gamaliel] Univ Juarez Estado Durango, Fac Ciencias Biol, Durango, Mexico; [Marshall, Jonathon C.] Weber State Univ, Dept Zool, Ogden, UT 84408 USA; [Mendez de la Cruz, Fausto] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Lab Herpetol, Mexico City 04510, DF, Mexico	University of California System; University of California Santa Cruz; Utah System of Higher Education; Weber State University; Universidad Nacional Autonoma de Mexico	Bastiaans, E (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, Falcon Hts, MN 55108 USA.	ejbastiaans@gmail.com	DURANGO, UNIVERSIDAD J/F-1212-2018; Mendez, Fausto/HGD-1205-2022; Mendez, Fausto R./O-3512-2018; Marshall, Jonathon C./AGG-8101-2022	DURANGO, UNIVERSIDAD J/0000-0002-1896-0937; Mendez, Fausto R./0000-0002-5084-1276; Bastiaans, Elizabeth/0000-0002-7322-1088; Marshall, Jonathon/0000-0003-0955-4889	National Science Foundation [IOS-1110497]; Science, Technology, Engineering, Society, and Policy Institute, UC Santa Cruz	National Science Foundation(National Science Foundation (NSF)); Science, Technology, Engineering, Society, and Policy Institute, UC Santa Cruz	This work was funded by the National Science Foundation (www.nsf.gov) Doctoral Dissertation Improvement Grant IOS-1110497 to EB. Research fellowship from the Science, Technology, Engineering, Society, and Policy Institute, UC Santa Cruz, to EB (www.ucsc.edu).	Abell AJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P217, DOI 10.1007/s002650050382; Alonzo SH, 2010, J EVOLUTION BIOL, V23, P2614, DOI 10.1111/j.1420-9101.2010.02130.x; Andrews RM, 1997, COPEIA, P108, DOI 10.2307/1447845; AREVALO E, 1993, COPEIA, P352; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bastiaans E., 2013, THESIS U CALIFORNIA; Bastiaans E, 2013, BEHAV ECOL, V24, P968, DOI 10.1093/beheco/art010; Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Bleay C, 2007, BEHAV ECOL, V18, P304, DOI 10.1093/beheco/arl101; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Calsbeek R, 2002, P NATL ACAD SCI USA, V99, P14897, DOI 10.1073/pnas.242645199; CARPENTER C C, 1978, Milwaukee Public Museum Contributions in Biology and Geology, P1; COOPER WE, 1987, ANIM BEHAV, V35, P1177, DOI 10.1016/S0003-3472(87)80174-4; COOPER WE, 1988, ETHOLOGY, V77, P265; COOPER WE, 1987, ANIM BEHAV, V35, P526, DOI 10.1016/S0003-3472(87)80277-4; Corl A, 2012, COPEIA, P593, DOI 10.1643/CH-11-166; Corl A, 2010, P NATL ACAD SCI USA, V107, P4254, DOI 10.1073/pnas.0909480107; Coyne J.A., 2004, SPECIATION; DENARDO DF, 1993, HORM BEHAV, V27, P184, DOI 10.1006/hbeh.1993.1014; Dijkstra PD, 2009, BEHAV ECOL, V20, P593, DOI 10.1093/beheco/arp036; Downes SJ, 2002, BEHAV ECOL SOCIOBIOL, V52, P444, DOI 10.1007/s00265-002-0538-3; DUVALL D, 1979, J EXP ZOOL, V210, P321, DOI 10.1002/jez.1402100215; Egger B, 2008, HYDROBIOLOGIA, V615, P37, DOI 10.1007/s10750-008-9564-0; Elmer KR, 2009, EVOLUTION, V63, P2750, DOI 10.1111/j.1558-5646.2009.00736.x; Encina-Dominguez JA, 2008, B SOC BOT MEX, V83, P13; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Ersts PJ, 2012, GEOGRAPHIC DISTANCE; Feldman CR, 2011, MOL PHYLOGENET EVOL, V61, P714, DOI 10.1016/j.ympev.2011.08.008; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; GARLAND T, 1990, FUNCT ECOL, V4, P243, DOI 10.2307/2389343; Gonzalez-Voyer A, 2013, J EVOLUTION BIOL, V26, P647, DOI 10.1111/jeb.12084; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; HALL W., 1973, THESIS HARVARD U CAM; Hall WP, 2009, CYTOGENET GENOME RES, V127, P143, DOI 10.1159/000304050; Hamilton PS, 2005, ANIM BEHAV, V69, P219, DOI 10.1016/j.anbehav.2004.03.011; Hardwick KM, 2013, CURR ZOOL, V59, P20, DOI 10.1093/czoolo/59.1.20; Healey M, 2007, ANIM BEHAV, V74, P337, DOI 10.1016/j.anbehav.2006.09.017; Hernandez-Salinas U, 2010, HERPETOLOGICA, V66, P12, DOI 10.1655/08-053.1; Hews DK, 2004, ANIM BEHAV, V68, P1201, DOI 10.1016/j.anbehav.2003.11.024; Hochberg ME, 2003, EVOLUTION, V57, P154, DOI 10.1554/0014-3820(2003)057[0154:SMS]2.0.CO;2; HOVER EL, 1985, COPEIA, P933; Huyghe K, 2007, INTEGR COMP BIOL, V47, P211, DOI 10.1093/icb/icm043; Jimenez-Cruz E, 2005, SOUTHWEST NAT, V50, P178, DOI 10.1894/0038-4909(2005)050[0178:RCOSGS]2.0.CO;2; Korzan WJ, 2007, BEHAV ECOL, V18, P318, DOI 10.1093/beheco/arl093; Kozak GM, 2013, J EVOLUTION BIOL, V26, P130, DOI 10.1111/jeb.12034; Kraaijeveld K, 2011, BIOL REV, V86, P367, DOI 10.1111/j.1469-185X.2010.00150.x; Lancaster LT, 2007, ECOL LETT, V10, P798, DOI 10.1111/j.1461-0248.2007.01069.x; Lancaster LT, 2010, EVOLUTION, V64, P1607, DOI 10.1111/j.1558-5646.2010.00941.x; Lancaster LT, 2009, BEHAV ECOL, V20, P993, DOI 10.1093/beheco/arp088; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LARA-GONGORA G., 1983, B MARYLAND HERPETOLO, V19, P1; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Lemos-Espinal JA, 1998, GREAT BASIN NAT, V58, P375; Lopez P, 2003, BEHAV ECOL SOCIOBIOL, V55, P73, DOI 10.1007/s00265-003-0675-3; Lukhtanov VA, 2005, NATURE, V436, P385, DOI 10.1038/nature03704; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; Marshall JC, 2006, EVOLUTION, V60, P1050; Marshall JC, 2001, MOL ECOL, V10, P435, DOI 10.1046/j.1365-294x.2001.01232.x; MARTINS EP, 1991, ANIM BEHAV, V41, P403, DOI 10.1016/S0003-3472(05)80841-3; MARTINS EP, 1993, AM NAT, V142, P994, DOI 10.1086/285585; Martins EP, 1998, ANIM BEHAV, V56, P1113, DOI 10.1006/anbe.1998.0872; McLean CA, 2014, BIOL REV, V89, P860, DOI 10.1111/brv.12083; Mendelson TC, 2012, TRENDS ECOL EVOL, V27, P421, DOI 10.1016/j.tree.2012.04.001; Mendez de la Cruz F, 1989, THESIS U NACL AUTONO; Miles DB, 2007, FUNCT ECOL, V21, P653, DOI 10.1111/j.1365-2435.2007.01304.x; Neff BD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0045; NOBLE G. K., 1933, ANN NEW YORK ACAD SCI, V35, P25, DOI 10.1111/j.1749-6632.1933.tb55365.x; Norman GR, 2008, BIOSTATISTICS BARE E, V3rd; Olsson M, 2013, SEMIN CELL DEV BIOL, V24, P529, DOI 10.1016/j.semcdb.2013.04.001; Perez i de Lanuza G, 2012, BEHAV ECOL; Pizzatto L, 2012, BIOL J LINN SOC, V107, P210, DOI 10.1111/j.1095-8312.2012.01936.x; Pryke SR, 2010, EVOLUTION, V64, P1301, DOI 10.1111/j.1558-5646.2009.00897.x; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Quinn VS, 2000, P ROY SOC B-BIOL SCI, V267, P755, DOI 10.1098/rspb.2000.1067; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ramirez-Bautista A, 2004, WEST N AM NATURALIST, V64, P175; Ramirez-Bautista A, 2012, ECOL EVOL, V2, P1903, DOI 10.1002/ece3.310; RAND MS, 1990, AM MIDL NAT, V124, P352, DOI 10.2307/2426184; RAND MS, 1988, AM ZOOL, V28, pA153; REED KM, 1995, EVOLUTION, V49, P37, DOI 10.1111/j.1558-5646.1995.tb05956.x; REED KM, 1995, EVOLUTION, V49, P61, DOI 10.1111/j.1558-5646.1995.tb05958.x; REED KM, 1995, EVOLUTION, V49, P48, DOI 10.1111/j.1558-5646.1995.tb05957.x; Reynolds RG, 2007, EVOLUTION, V61, P2253, DOI 10.1111/j.1558-5646.2007.00174.x; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Robertson JM, 2009, BIOL J LINN SOC, V98, P243, DOI 10.1111/j.1095-8312.2009.01291.x; Ronald KL, 2012, ANIM BEHAV, V84, P1283, DOI 10.1016/j.anbehav.2012.09.015; Runemark A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-269; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, ECOL LETT, V2, P367; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Simmons LW, 2001, EVOLUTION, V55, P1386, DOI 10.1111/j.0014-3820.2001.tb00660.x; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; SITES JW, 1983, EVOLUTION, V37, P54, DOI 10.1111/j.1558-5646.1983.tb05513.x; SITES JW, 1995, EVOLUTION, V49, P9, DOI 10.1111/j.1558-5646.1995.tb05955.x; SITES JW, 1983, EVOLUTION, V37, P38, DOI 10.1111/j.1558-5646.1983.tb05512.x; SITES JW, 1981, J HERPETOL, V15, P59, DOI 10.2307/1563647; Speck F. G., 1924, Copeia Northampton, V128, P35; Sullivan BK, 2007, FUNCT ECOL, V21, P666, DOI 10.1111/j.1365-2435.2007.01244.x; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; Swierk L, 2013, ANIM BEHAV; Swierk L, 2012, BEHAV ECOL SOCIOBIOL, V66, P1033, DOI 10.1007/s00265-012-1351-2; Templeton JJ, 2012, BIOL LETTERS, V8, P924, DOI 10.1098/rsbl.2012.0830; THOEN C, 1986, ANIM BEHAV, V34, P1805, DOI 10.1016/S0003-3472(86)80266-4; THOMPSON CW, 1991, ANIM BEHAV, V42, P745, DOI 10.1016/S0003-3472(05)80120-4; THOMPSON CW, 1991, COPEIA, P493; TOKARZ RR, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P17, DOI 10.2307/1466994; Uetz GW, 2009, ANIM BEHAV, V78, P299, DOI 10.1016/j.anbehav.2009.04.023; van der Sluijs I, 2008, PHILOS T R SOC B, V363, P2871, DOI 10.1098/rstb.2008.0045; van der Sluijs I, 2008, BEHAV ECOL, V19, P177, DOI 10.1093/beheco/arm120; Vercken E, 2008, ECOSCIENCE, V15, P320, DOI 10.2980/15-3-3135; Vercken E, 2008, HERPETOL J, V18, P223; Villanueva-Diaz J, 2007, CLIMATIC CHANGE, V83, P117, DOI 10.1007/s10584-006-9144-0; VINEGAR MB, 1972, COPEIA, P660; WESTEBERHARD MJ, 1986, P NATL ACAD SCI USA, V83, P1388, DOI 10.1073/pnas.83.5.1388; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Zoppoth P, 2013, J EVOLUTION BIOL, V26, P577, DOI 10.1111/jeb.12074; Zuniga-Vega JJ, 2008, AMPHIBIA-REPTILIA, V29, P127, DOI 10.1163/156853808783431550	124	30	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93197	10.1371/journal.pone.0093197	http://dx.doi.org/10.1371/journal.pone.0093197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718297	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000028
J	DelGiorno, KE; Tam, JW; Hall, JC; Thotakura, G; Crawford, HC; van der Velden, AWM				DelGiorno, Kathleen E.; Tam, Jason W.; Hall, Jason C.; Thotakura, Gangadaar; Crawford, Howard C.; van der Velden, Adrianus W. M.			Persistent Salmonellosis Causes Pancreatitis in a Murine Model of Infection	PLOS ONE			English	Article							TO-DUCTAL METAPLASIA; NF-KAPPA-B; TYPHOID CARRIERS; CANCER; TYPHIMURIUM; CELLS; CARCINOMA; EPIDEMIOLOGY; MACROPHAGE; GALLSTONES	Pancreatitis, a known risk factor for the development of pancreatic ductal adenocarcinoma, is a serious, widespread medical condition usually caused by alcohol abuse or gallstone-mediated ductal obstruction. However, many cases of pancreatitis are of an unknown etiology. Pancreatitis has been linked to bacterial infection, but causality has yet to be established. Here, we found that persistent infection of mice with the bacterial pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) was sufficient to induce pancreatitis reminiscent of the human disease. Specifically, we found that pancreatitis induced by persistent S. Typhimurium infection was characterized by a loss of pancreatic acinar cells, acinar-toductal metaplasia, fibrosis and accumulation of inflammatory cells, including CD11b(+) F4/80(+), CD11b(+) Ly6C(int) Ly6G(+) and CD11b(+) Ly6C(hi) Ly6G(-) cells. Furthermore, we found that S. Typhimurium colonized and persisted in the pancreas, associated with pancreatic acinar cells in vivo, and could invade cultured pancreatic acinar cells in vitro. Thus, persistent infection of mice with S. Typhimurium may serve as a useful model for the study of pancreatitis as it relates to bacterial infection. Increased knowledge of how pathogenic bacteria can cause pancreatitis will provide a more integrated picture of the etiology of the disease and could lead to the development of new therapeutic approaches for treatment and prevention of pancreatitis and pancreatic ductal adenocarcinoma.	[DelGiorno, Kathleen E.; Tam, Jason W.; Crawford, Howard C.; van der Velden, Adrianus W. M.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [DelGiorno, Kathleen E.; Hall, Jason C.; Crawford, Howard C.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [van der Velden, Adrianus W. M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Tam, Jason W.; van der Velden, Adrianus W. M.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [DelGiorno, Kathleen E.; Hall, Jason C.; Thotakura, Gangadaar; Crawford, Howard C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Mayo Clinic	Crawford, HC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	a.vandervelden@stonybrook.edu; crawford.howard@mayo.edu	DelGiorno, Kathy/AAJ-9911-2021	DelGiorno, Kathy/0000-0002-5749-8394	NIH [R21AI092165, R01AI101221, P01AI055621-Benach, R01CA159222, R01CA136754, T32AI007539]; NATIONAL CANCER INSTITUTE [R01CA159222, R01CA136754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092165, P01AI055621, R01AI101221, T32AI007539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants awarded to AWMvdV (R21AI092165, R01AI101221 and P01AI055621-Benach) and HCC (R01CA159222 and R01CA136754). JWT was supported by the NIH under award number T32AI007539. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAWADHI NZ, 1989, AM J GASTROENTEROL, V84, P1570; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; ANDRENSANDBERG A, 1994, INT J PANCREATOL, V15, P229; Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Blank A, 2003, DIGEST DIS SCI, V48, P1472, DOI 10.1023/A:1024795202768; CAYGILL CPJ, 1995, EUR J CANCER PREV, V4, P187, DOI 10.1097/00008469-199504000-00010; CAYGILL CPJ, 1994, LANCET, V343, P83, DOI 10.1016/S0140-6736(94)90816-8; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Delrue LJ, 2010, ABDOM IMAGING, V35, P349, DOI 10.1007/s00261-009-9522-y; Deng SX, 2008, WORLD J GASTROENTERO, V14, P782, DOI 10.3748/wjg.14.782; Ding SP, 2003, WORLD J GASTROENTERO, V9, P584, DOI 10.3748/wjg.v9.i3.584; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Dutta U, 2000, AM J GASTROENTEROL, V95, P784, DOI 10.1111/j.1572-0241.2000.01860.x; EDWARDS CN, 1991, AM J GASTROENTEROL, V86, P1665; ELZAYADI A, 1991, HEPATO-GASTROENTEROL, V38, P337; EZPELETA C, 1992, CLIN INFECT DIS, V15, P1050, DOI 10.1093/clind/15.6.1050; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; FILIPE MI, 1994, INT J CANCER, V57, P324, DOI 10.1002/ijc.2910570306; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fortunato F, 2006, AM J PHYSIOL-GASTR L, V290, pG232, DOI 10.1152/ajpgi.00040.2005; Frey CF, 2006, PANCREAS, V33, P336, DOI 10.1097/01.mpa.0000236727.16370.99; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; GARG P, 1992, POSTGRAD MED J, V68, P294, DOI 10.1136/pgmj.68.798.294; GIBB AP, 1991, J ANTIMICROB CHEMOTH, V28, P318, DOI 10.1093/jac/28.2.318; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; HALEVY A, 1987, BRIT J SURG, V74, P150, DOI 10.1002/bjs.1800740227; Hamaguchi H, 1999, INT J PANCREATOL, V26, P189, DOI 10.1385/IJGC:26:3:189; HERMANS P, 1991, SCAND J INFECT DIS, V23, P201, DOI 10.3109/00365549109023401; Kadappu Krishna Kishor, 2002, Indian J Gastroenterol, V21, P32; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; KUNE GA, 1972, MED J AUSTRALIA, V1, P417, DOI 10.5694/j.1326-5377.1972.tb106538.x; Lambotte O, 2001, J INFECTION, V42, P161, DOI 10.1053/jinf.2000.0783; LINDHOLT J, 1985, ACTA CHIR SCAND, V151, P703; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; MURPHY S, 1991, LANCET, V338, P571, DOI 10.1016/0140-6736(91)91134-G; Parenti DM, 1996, PANCREAS, V13, P356, DOI 10.1097/00006676-199611000-00005; PETTERSSON T, 1970, Annals of Clinical Research, V2, P157; Pezzilli Raffaele, 2003, JOP, V4, P200; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; RENNER F, 1991, LANCET, V337, P1611, DOI 10.1016/0140-6736(91)93310-6; RUSSELL IJ, 1976, JAMA-J AM MED ASSOC, V235, P753, DOI 10.1001/jama.235.7.753; Schmid SW, 1999, GUT, V45, P311, DOI 10.1136/gut.45.2.311; Sevastos N, 2001, AM J GASTROENTEROL, V96, P3450, DOI 10.1111/j.1572-0241.2001.05348.x; Shukla VK, 2000, DIGEST DIS SCI, V45, P900, DOI 10.1023/A:1005564822630; STRAND CL, 1978, AM SURGEON, V44, P174; Tenner S, 1997, GASTROENTEROLOGY, V113, P899, DOI 10.1016/S0016-5085(97)70185-9; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaccaro MI, 2000, DIGEST DIS SCI, V45, P915, DOI 10.1023/A:1005521007609; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; van der Velden AWM, 2000, INFECT IMMUN, V68, P5702, DOI 10.1128/IAI.68.10.5702-5709.2000; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wang F, 2013, CANC LETT; WESTBLOM TU, 1988, SOUTH MED J, V81, P1200, DOI 10.1097/00007611-198809000-00036; Whitcomb DC, 2004, AM J PHYSIOL-GASTR L, V287, pG315, DOI 10.1152/ajpgi.00115.2004; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004	63	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92807	10.1371/journal.pone.0092807	http://dx.doi.org/10.1371/journal.pone.0092807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717768	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000021
J	Holden, AR; Koch, JB; Griswold, T; Erwin, DM; Hall, J				Holden, Anna R.; Koch, Jonathan B.; Griswold, Terry; Erwin, Diane M.; Hall, Justin			Leafcutter Bee Nests and Pupae from the Rancho La Brea Tar Pits of Southern California: Implications for Understanding the Paleoenvironment of the Late Pleistocene	PLOS ONE			English	Article							MIDDLE EOCENE; HYMENOPTERA; LEAF; COLEOPTERA; FOSSIL; EVOLUTION; BEETLES; CLIMATE; APOIDEA	The Rancho La Brea Tar Pits is the world's richest and most important Late Pleistocene fossil locality and best renowned for numerous fossil mammals and birds excavated over the past century. Less researched are insects, even though these specimens frequently serve as the most valuable paleoenvironemental indicators due to their narrow climate restrictions and life cycles. Our goal was to examine fossil material that included insect-plant associations, and thus an even higher potential for significant paleoenviromental data. Micro-CT scans of two exceptionally preserved leafcutter bee nest cells from the Rancho La Brea Tar Pits in Los Angeles, California reveal intact pupae dated between, similar to 23,000-40,000 radiocarbon years BP. Here identified as best matched to Megachile (Litomegachile) gentilis Cresson (Hymenoptera: Megachilidae) based on environmental niche models as well as morphometrics, the nest cells (LACMRLP 388E) document rare preservation and life-stage. The result of complex plant-insect interactions, they offer new insights into the environment of the Late Pleistocene in southern California. The remarkable preservation of the nest cells suggests they were assembled and nested in the ground where they were excavated. The four different types of dicotyledonous leaves used to construct the cells were likely collected in close proximity to the nest and infer a wooded or riparian habitat with sufficient pollen sources for larval provisions. LACMRLP 388E is the first record of fossil Megachile Latreille cells with pupae. Consequently, it provides a pre-modern age location for a Nearctic group, whose phylogenetic relationships and biogeographic history remain poorly understood. Megachile gentilis appears to respond to climate change as it has expanded its distribution across elevation gradients over time as estimated by habitat suitability comparisons between low and high elevations; it currently inhabits mesic habitats which occurred at a lower elevation during the Last Glacial Maximum,21,000 years ago. Nevertheless, the broad ecological niche of M. gentilis appears to have remained stable.	[Holden, Anna R.] Nat Hist Museum Los Angeles Cty, Entomol Sect, Los Angeles, CA 90007 USA; [Koch, Jonathan B.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Koch, Jonathan B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Griswold, Terry] Utah State Univ, USDA ARS, Pollinating Insect Res Unit, Logan, UT 84322 USA; [Erwin, Diane M.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Hall, Justin] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; University of California System; University of California Berkeley	Holden, AR (corresponding author), Nat Hist Museum Los Angeles Cty, Entomol Sect, Los Angeles, CA 90007 USA.	aholden@nhm.org	Koch, Jonathan/AAH-4591-2020	Koch, Jonathan/0000-0002-6654-7370; Griswold, Terry/0000-0003-3952-9393	Annie M. Alexander Endowment	Annie M. Alexander Endowment	The Annie M. Alexander Endowment provided funding for Diane M. Erwin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOTT HJ, 1963, AM J BOT, V50, P821, DOI 10.2307/2440201; ARNOTT HOWARD J., 1964, BOT GAZ, V125, P13, DOI 10.1086/336238; Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; Berry E. W., 1916, 91 US GEOL SURV, V91, P1, DOI [DOI 10.3133/PP91, 10.3133/pp91]; Berry EW, 1931, AM J SCI, V21, P301; Bischoff JL, 2001, QUATERNARY RES, V55, P14, DOI 10.1006/qres.2000.2183; BROOKS H. K., 1955, PSYCHE, V62, P1, DOI 10.1155/1955/76727; Bzdyk EL, 2012, ZOOKEYS, P31, DOI 10.3897/zookeys.221.3234; Cane JH, 2007, ANN ENTOMOL SOC AM, V100, P350, DOI 10.1603/0013-8746(2007)100[350:SAMUFN]2.0.CO;2; CANE JH, 1983, J KANSAS ENTOMOL SOC, V56, P199; CANE JH, 1984, COMP BIOCHEM PHYS B, V78, P769, DOI 10.1016/0305-0491(84)90132-9; Cockerell TDA, 1908, B AM MUS NAT HIST, V24, P59; Coltrain JB, 2004, PALAEOGEOGR PALAEOCL, V205, P199, DOI 10.1016/j.palaeo.2003.12.008; Coope GR, 2004, PHILOS T R SOC B, V359, P209, DOI 10.1098/rstb.2003.1393; DOYEN JT, 1980, PAN-PAC ENTOMOL, V56, P1; Engel Michael S., 1999, American Museum Novitates, V3276, P1; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Engel MS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)506[0001:AEBIRA]2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Friscia AR, 2008, PALAIOS, V23, P35, DOI 10.2110/palo.2005.p05-143r; Gustafsson MH, 1955, BOT J LINN SOC, V118, P1; Heusser L, 1998, PALEOCEANOGRAPHY, V13, P252, DOI 10.1029/98PA00670; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holden AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067119; Hurd PD, 1955, B CALIFORNIA INSECT, V3, P1; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Kim JY, 2007, NATURWISSENSCHAFTEN, V94, P981, DOI 10.1007/s00114-007-0277-4; KIM JY, 1992, ANN ENTOMOL SOC AM, V85, P85, DOI 10.1093/aesa/85.1.85; Krombein K. V., 1967, TRAP NESTING WASPS B, Vvi; Latreille P. A., 1802, HIST NATURELLE GEN P; LEWIS SE, 1994, J PALEONTOL, V68, P172, DOI 10.1017/S0022336000025713; Litman JR, 2011, P ROY SOC B-BIOL SCI, V278, P3593, DOI 10.1098/rspb.2011.0365; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CHARLES D., 1953, UNIV KANSAS SCI BULL, V35, P1659; Michez Denis, 2012, Systematics Association Special Volume Series, V81, P103; MILLER SE, 1981, P ENTOMOL SOC WASH, V83, P625; MITCHELL THEODORE B., 1935, TRANS AMER ENT SOC, V61, P1; Munz P., 1959, CALIFORNIA FLORA; O'Toole C., 1991, BEES OF THE WORLD; PACKER L, 1987, J KANSAS ENTOMOL SOC, V60, P280; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2012, R LANG ENV STAT COMP; Robert C, 2004, QUATERNARY SCI REV, V23, P1029, DOI 10.1016/j.quascirev.2003.11.005; Sarzetti LC, 2008, PALAEONTOLOGY, V51, P933, DOI 10.1111/j.1475-4983.2008.00787.x; Shaw C.A., 1982, Curator, V25, P63; Shaw C.A., 1986, CALIFORNIA GEOLOGY U, V39, p123; Sheffield Cory S., 2013, Journal of Melittology, V19, P1; Stock C, 1992, RANCHO LA BREA RECOR; Strickler K, 1991, J KANSAS ENTOMOL SOC, V69, P26; Wappler T, 2003, J PALEONTOL, V77, P908, DOI 10.1666/0022-3360(2003)077<0908:TMEBFO>2.0.CO;2; Warter JK, 1979, ABS ANN M S CA ACAD, V87, P44; Wedmann S, 2009, NATURWISSENSCHAFTEN, V96, P703, DOI 10.1007/s00114-009-0525-x	54	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94724	10.1371/journal.pone.0094724	http://dx.doi.org/10.1371/journal.pone.0094724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718701	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000139
J	Li, YJ; Lu, JP; Peng, ZK; Tan, GJ; Liu, N; Huang, DM; Zhang, ZL; Duan, CJ; Tang, XW; Tang, FQ				Li, Yuejin; Lu, Jinping; Peng, Zhengke; Tan, Gongjun; Liu, Na; Huang, Damao; Zhang, Zhenlin; Duan, Chaojun; Tang, Xiaowei; Tang, Faqing			N,N '-Dinitrosopiperazine-Mediated AGR2 Is Involved in Metastasis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CATHEPSIN-B PROMOTES; BREAST-CANCER; SALTED FISH; PANCREATIC-CANCER; NITROSO-COMPOUNDS; NODE METASTASIS; EXPRESSION; CHINESE; RISK; BIOMARKER	Nasopharyngeal carcinoma (NPC) has a high metastatic character in the clinic, but its mechanism is not clear. As a carcinogen with organ specificity for the nasopharyngeal epithelium, N,N '-Dinitrosopiperazine (DNP) is involved in NPC metastasis. Herein, our data revealed that anterior gradient 2 (AGR2) was overexpressed in human NPC tissues, particularly in cervical lymph node metastatic NPC (LMNPC). High AGR2 expression was associated with NPC metastasis. Importantly, DNP induced AGR2 expression, and increased cell motility and invasion in the NPC cell line 6-10B. However, DNP-mediated cell motility and invasion was dramatically decreased when transfected with siRNA-AGR2. Further, AGR2 directly regulated cathepsin (CTS) B and D by binding them in vitro. These results indicate that DNP induces AGR2 expression, regulates CTSB and CTSD, increases cell motility and invasion, and promotes NPC tumor metastasis. Therefore, DNP-mediated AGR2 expression may be an important factor in prolific NPC metastasis.	[Li, Yuejin; Lu, Jinping; Peng, Zhengke; Tan, Gongjun; Zhang, Zhenlin; Tang, Faqing] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Clin Lab, Zhuhai, Guangdong, Peoples R China; [Li, Yuejin; Lu, Jinping; Peng, Zhengke; Tan, Gongjun; Zhang, Zhenlin; Tang, Faqing] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Med Res Ctr, Zhuhai, Guangdong, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun] Cent South Univ, Xiangya Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun] Cent South Univ, Xiangya Hosp, Clin Lab, Changsha, Hunan, Peoples R China; [Tang, Xiaowei] Cent South Univ, Changsha, Hunan, Peoples R China	Jinan University; Jinan University; Central South University; Central South University; Central South University	Tang, FQ (corresponding author), Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Clin Lab, Zhuhai, Guangdong, Peoples R China.	tangfaqing33@hotmail.com	LI, Yue/GRS-8071-2022		National Natural Science Foundation of China [81372282, 81071718, 30973400, 30670990]; Program for New Century Excellent Talents in University, NCET [NCET-06-0685]; Guangdong Natural Science Foundation [S2013010013360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University, NCET(Program for New Century Excellent Talents in University (NCET)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported in part by the National Natural Science Foundation of China (81372282, 81071718, 30973400 30670990), Program for New Century Excellent Talents in University, NCET (NCET-06-0685), Guangdong Natural Science Foundation (S2013010013360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DE, 2010, CANCER BIOL THER, V9, P23, DOI 10.4161/cbt.9.1.10378; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; [Anonymous], BREAST CANC RES, V12, pR32; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; BARTSCH H, 1992, PHARMACOGENETICS, V2, P272, DOI 10.1097/00008571-199212000-00005; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Bu HJ, 2011, PROSTATE, V71, P575, DOI 10.1002/pros.21273; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chen Z C, 1991, IARC Sci Publ, P434; Cheng AL, 2008, J PROTEOME RES, V7, P2415, DOI 10.1021/pr7008548; Chew MMS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-574; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Chung Kyukwang, 2012, Osaka City Med J, V58, P13; Czyzewska J, 2008, FOLIA HISTOCHEM CYTO, V46, P57, DOI 10.2478/v10042-008-0007-6; del Casar JM, 2008, J CANCER RES CLIN, V134, P153, DOI 10.1007/s00432-007-0264-3; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Gan Y, 2008, CELL DEATH DIFFER, V15, P1481, DOI 10.1038/cdd.2008.73; Henderson B E, 1978, IARC Sci Publ, P251; Herszenyi L, 2008, EUR J CANCER PREV, V17, P438, DOI 10.1097/CEJ.0b013e328305a130; Huang D P, 1978, IARC Sci Publ, P315; Jakszyn P, 2006, WORLD J GASTROENTERO, V12, P4296, DOI 10.3748/wjg.v12.i27.4296; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Kaneko I, 2007, WORLD J GASTROENTERO, V13, P3829; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Li CS, 2011, ONCOL REP, V26, P869, DOI 10.3892/or.2011.1344; Li YM, 2012, CHINA FOUNDRY, V9, P6; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; LIJINSKY W, 1993, CANCER LETT, V74, P101, DOI 10.1016/0304-3835(93)90050-J; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Lodillinsky C, 2009, J UROLOGY, V182, P749, DOI 10.1016/j.juro.2009.03.076; Malla RR, 2013, MOL CARCINOGEN, V52, P777, DOI 10.1002/mc.21915; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Ohri SS, 2008, INT J ONCOL, V32, P491; Paksoy M, 2011, J CANCER RES CLIN, V137, P1371, DOI 10.1007/s00432-011-1007-z; Park K, 2011, EXP MOL MED, V43, P91, DOI 10.3858/emm.2011.43.2.011; Peng ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062908; Pizzi M, 2012, APPL IMMUNOHISTO M M, V20, P31, DOI 10.1097/PAI.0b013e3182233f9f; Poirier S, 1987, IARC Sci Publ, P415; PRESTONMARTIN S, 1989, CANCER SURV, V8, P459; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Salmans ML, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3408; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Simons Malcolm J, 2011, Chin J Cancer, V30, P79; Szajda SD, 2008, HEPATO-GASTROENTEROL, V55, P388; Szajda Slawomir Dariusz, 2006, Pol Arch Med Wewn, V116, P1150; Tang F, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P125; Tang FQ, 2009, CANCER SCI, V100, P216, DOI 10.1111/j.1349-7006.2008.01028.x; Tang FQ, 2011, J BIOL CHEM, V286, P36956, DOI 10.1074/jbc.M111.259234; Wang X, 2008, RADIOTHER ONCOL, V89, P28, DOI 10.1016/j.radonc.2008.07.014; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wickramasinghe NS, 2005, ARCH BIOCHEM BIOPHYS, V436, P187, DOI 10.1016/j.abb.2005.01.023; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Wu D, 2012, HISTOL HISTOPATHOL, V27, P79, DOI 10.14670/HH-27.79; Wu Dan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1330; Yu B, 2004, ZHONGHUA WEI CHANG W, V8, P507; Yu M C, 1990, FEMS Microbiol Immunol, V2, P235; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1989, BRIT J CANCER, V60, P198, DOI 10.1038/bjc.1989.250; YU MC, 1986, CANCER RES, V46, P956; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; ZHENG X, 1994, ACTA OTO-LARYNGOL, V114, P98, DOI 10.3109/00016489409126024; Zou J, 2000, J Radiat Res, V41 Suppl, P53; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202; Zweitzig DR, 2007, MOL CELL BIOCHEM, V306, P255, DOI 10.1007/s11010-007-9562-y	67	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92081	10.1371/journal.pone.0092081	http://dx.doi.org/10.1371/journal.pone.0092081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717913	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000013
J	Nie, HY; Liu, C; Cheng, TC; Li, QY; Wu, YQ; Zhou, MT; Zhang, YX; Xia, QY				Nie, Hongyi; Liu, Chun; Cheng, Tingcai; Li, Qiongyan; Wu, Yuqian; Zhou, Mengting; Zhang, Yinxia; Xia, Qingyou			Transcriptome Analysis of Integument Differentially Expressed Genes in the Pigment Mutant (quail) during Molting of Silkworm, Bombyx mori	PLOS ONE			English	Article							TRANSLUCENT LARVAL SKIN; CUTICULAR PROTEIN GENES; OMMOCHROME BIOSYNTHESIS; TOBACCO HORNWORM; TRANSPORTER GENE; ABC TRANSPORTER; MELANIN; IDENTIFICATION; MUTATIONS; YELLOW	In the silkworm Bombyx mori, pigment mutants with diverse body colors have been maintained throughout domestication for about 5000 years. The silkworm larval body color is formed through the mutual interaction of melanin, ommochromes, pteridines and uric acid. These pigments/compounds are synthesized by the cooperative action of various genes and enzymes. Previous reports showed that melanin, ommochrome and pteridine are increased in silkworm quail (q) mutants. To understand the pigment increase and alterations in pigment synthesis in q mutant, transcriptome profiles of the silkworm integument were investigated at 16 h after head capsule slippage in the fourth molt in q mutants and wild-type (Dazao). Compared to the wild-type, 1161 genes were differentially expressed in the q mutant. Of these modulated genes, 62.4% (725 genes) were upregulated and 37.6% (436 genes) were downregulated in the q mutant. The molecular function of differently expressed genes was analyzed by Blast2GO. The results showed that upregulated genes were mainly involved in protein binding, small molecule binding, transferase activity, nucleic acid binding, specific DNA-binding transcription factor activity and chromatin binding, while exclusively down-expressed genes functioned in oxidoreductase activity, cofactor binding, tetrapyrrole binding, peroxidase activity and pigment binding. We focused on genes related to melanin, pteridine and ommochrome biosynthesis; transport of uric acid; and juvenile hormone metabolism because of their importance in integument coloration during molting. This study identified differently expressed genes implicated in silkworm integument formation and pigmentation using silkworm q mutant. The results estimated the number and types of genes that drive new integument formation.	[Nie, Hongyi; Liu, Chun; Cheng, Tingcai; Li, Qiongyan; Wu, Yuqian; Zhou, Mengting; Zhang, Yinxia; Xia, Qingyou] State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Nie, Hongyi; Liu, Chun; Cheng, Tingcai; Li, Qiongyan; Wu, Yuqian; Zhou, Mengting; Zhang, Yinxia; Xia, Qingyou] Southwest Univ, Minist Agr, Key Sericultural Lab, Chongqing, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China	Xia, QY (corresponding author), State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2012CB114600]; Program for New Century Excellent Talents [110699]; National Natural Science Foundation of China [31372380]; Fundamental Research Funds for the Central Universities of China [XDJK2013A026]; Doctorial Innovation Fund of Southwest University [ky2010001]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Doctorial Innovation Fund of Southwest University	Funding provided by the National Basic Research Program of China (No. 2012CB114600); Program for New Century Excellent Talents (No. NCET-110699); the National Natural Science Foundation of China (No. 31372380); the Fundamental Research Funds for the Central Universities of China (No. XDJK2013A026); the Doctorial Innovation Fund of Southwest University (No. ky2010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2012, DEV GENES EVOL, V222, P89, DOI 10.1007/s00427-012-0392-x; Andersen S.O., 2005, P145; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; Chen L, 2013, INT J MOL SCI, V14, P17055, DOI 10.3390/ijms140817055; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071984; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; FUKAMIZO T, 1985, INSECT BIOCHEM, V15, P141, DOI 10.1016/0020-1790(85)90001-0; Futahashi R, 2006, INSECT BIOCHEM MOLEC, V36, P63, DOI 10.1016/j.ibmb.2005.11.002; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Futahashi R, 2012, P NATL ACAD SCI USA, V109, P12626, DOI 10.1073/pnas.1207114109; Futahashi R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-46; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Han D, 2002, BIOCHEM J, V368, P333; HAYASHI Y, 1960, NATURE, V186, P1053, DOI 10.1038/1861053a0; HORI M, 1982, J COMP PHYSIOL, V147, P1, DOI 10.1007/BF00689284; Hu YG, 2013, ARCH INSECT BIOCHEM, V83, P41, DOI 10.1002/arch.21096; Ito K, 2010, J BIOL CHEM, V285, P5624, DOI 10.1074/jbc.M109.035741; Kato T, 2006, PIGM CELL RES, V19, P337, DOI 10.1111/j.1600-0749.2006.00316.x; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kiuchi T, 2011, INSECT BIOCHEM MOLEC, V41, P680, DOI 10.1016/j.ibmb.2011.04.011; Komoto N, 2003, INSECT BIOCHEM MOLEC, V33, P417, DOI 10.1016/S0965-1748(03)00006-7; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Kozlova T, 2009, DEV DYNAM, V238, P701, DOI 10.1002/dvdy.21860; Li S, 2005, INSECT BIOCHEM MOLEC, V35, P1235, DOI 10.1016/j.ibmb.2005.06.005; Linzen B., 1974, ADV INSECT PHYSL, P117, DOI DOI 10.1016/S0065-2806(08)60130-7; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OHASHI M, 1983, INSECT BIOCHEM, V13, P123, DOI 10.1016/0020-1790(83)90074-4; Ohashi M, 1983, J SERICULTURAL SCI J, P52; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Phillips J. P., 1980, GENET BIOL DROSOPHIL, P542; RETTENMEYER CW, 1970, ANNU REV ENTOMOL, V15, P43, DOI 10.1146/annurev.en.15.010170.000355; SAFRANEK L, 1975, J INSECT PHYSIOL, V21, P1931, DOI 10.1016/0022-1910(75)90225-5; Sato K, 2008, GENETICS, V179, P875, DOI 10.1534/genetics.107.082784; Sawada H, 1997, J SERICULTURAL SCI J, P66; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; Sugumaran M, 2009, PIGM CELL MELANOMA R, V22, P523, DOI 10.1111/j.1755-148X.2009.00608.x; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; tenHave JFM, 1995, MOL GEN GENET, V249, P673, DOI 10.1007/BF00418037; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Wang L, 2013, INSECT BIOCH MOL BIO; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WATT WB, 1969, P NATL ACAD SCI USA, V63, P767, DOI 10.1073/pnas.63.3.767; WIERNASZ DC, 1989, EVOLUTION, V43, P1672, DOI 10.1111/j.1558-5646.1989.tb02617.x; Wiernasz DC, 1995, ANIMAL BEHAV; Willis J.H., 2005, P79; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Yamada M, 2000, DEVELOPMENT, V127, P5083; Yao QO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014058	62	20	24	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94185	10.1371/journal.pone.0094185	http://dx.doi.org/10.1371/journal.pone.0094185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718369	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000085
J	Bhuiyan, TR; Islam, MMT; Uddin, T; Chowdhury, MI; Janzon, A; Adamsson, J; Lundin, SB; Qadri, F; Lundgren, A				Bhuiyan, Taufiqur R.; Islam, M. M. Towhidul; Uddin, Taher; Chowdhury, Mohiul I.; Janzon, Anders; Adamsson, Jenni; Lundin, Samuel B.; Qadri, Firdausi; Lundgren, Anna			Th1 and Th17 Responses to Helicobacter pylori in Bangladeshi Infants, Children and Adults	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNE-RESPONSES; GASTRITIS; EXPRESSION; IL-17; CD4(+); INTERLEUKIN-17; INFECTION; SPECIFICITY; VACCINATION	Both Th1 and Th17 cells are important components of the immune response to Helicobacter pylori (Hp) in adults, but less is known about T cell responses to Hp during early childhood, when the infection is often acquired. We investigated Th1 and Th17 type responses to Hp in adults, children and infants in Bangladesh, where Hp is highly endemic. IL-17 and IFN-gamma mRNA levels in gastric biopsies from Hp-infected Bangladeshi adults were analyzed and compared to levels in infected and uninfected Swedish controls. Since biopsies could not be collected from infants and children, cytokine responses in Bangladeshi infants (6-12 months), children (3-5 years) and adults (> 19 years) were instead compared by stimulating peripheral blood mononuclear cells (PBMCs) with a Hp membrane preparation (MP) and analyzing culture supernatants by ELISA and cytometric bead array. We found significantly higher expression of IL-17 and IFN-gamma mRNA in gastric mucosa of Hp-infected Bangladeshi and Swedish adults compared to uninfected Swedish controls. PBMCs from all age groups produced IL-17 and IFN-gamma after MP stimulation, but little Th2 cytokines. IL-17 and IFN-gamma were primarily produced by CD4(+) T cells, since CD4(+) T cell depleted PBMCs produced reduced amounts of these cytokines. Infant cells produced significantly more IL-17, but similar levels of IFN-gamma, compared to adult cells after MP stimulation. In contrast, polyclonal stimulation induced lower levels IL-17 and IFN-gamma in infant compared to adult PBMCs and CD4(+) T cells. The strong IL-17 production in infants after MP stimulation was paralleled by significantly higher production of the IL-17 promoting cytokine IL-1 beta from infant compared to adult PBMCs and monocytes. In conclusion, these results show that T cells can produce high levels of IL-17 and IFN-gamma in response to Hp from an early age and indicate a potential role for IL-1 beta in promoting Th17 responses to Hp during infancy.	[Bhuiyan, Taufiqur R.; Islam, M. M. Towhidul; Uddin, Taher; Chowdhury, Mohiul I.; Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Bangladesh Icddr, Dhaka 1000, Bangladesh; [Janzon, Anders; Adamsson, Jenni; Lundin, Samuel B.; Lundgren, Anna] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg	Lundgren, A (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	anna.lundgren@microbio.gu.se	UDDIN, TAHER/AAX-8663-2021; Qadri, Firdausi/AAF-4583-2019; Al, Mamun M./AAF-5850-2019	, Mohiul/0000-0001-5534-2161	Swedish Agency for Research and Economic Cooperation (SAREC) [INT-ICDDR,B-HN-01-AV]; Marianne and Markus Wallenberg Foundation; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)	Swedish Agency for Research and Economic Cooperation (SAREC); Marianne and Markus Wallenberg Foundation; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)	This work was supported by the Swedish Agency for Research and Economic Cooperation (SAREC) (grant INT-ICDDR,B-HN-01-AV), the Marianne and Markus Wallenberg Foundation through the support to GUVAX as well as the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1978, MOL GEN GENET, V164, P171, DOI 10.1007/BF00267382; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bhuiyan TR, 2008, FEMS IMMUNOL MED MIC, V54, P70, DOI 10.1111/j.1574-695X.2008.00449.x; Bhuiyan TR, 2010, J INFECT DIS, V202, P1676, DOI 10.1086/657085; Bhuiyan TR, 2009, PEDIATR INFECT DIS J, V28, P79, DOI 10.1097/INF.0b013e31818a5d9d; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; de Melo FF, 2012, MICROBES INFECT, V14, P341, DOI 10.1016/j.micinf.2011.11.008; DElios MM, 1997, EUR J IMMUNOL, V27, P1751, DOI 10.1002/eji.1830270723; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; DITOMMASO A, 1995, INFECT IMMUN, V63, P1102, DOI 10.1128/IAI.63.3.1102-1106.1995; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Gray BM, 2013, INFECT IMMUN, V81, P740, DOI 10.1128/IAI.01269-12; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Janzon A, 2009, HELICOBACTER, V14, P237, DOI 10.1111/j.1523-5378.2009.00692.x; KARTTUNEN R, 1990, CLIN EXP IMMUNOL, V82, P485; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Kindlund B, 2009, HELICOBACTER, V14, P192, DOI 10.1111/j.1523-5378.2009.00673.x; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051718; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lindgren A, 2010, J INNATE IMMUN, V2, P294, DOI 10.1159/000286238; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P5612, DOI 10.1128/IAI.73.9.5612-5619.2005; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Lundin BS, 2007, CLIN IMMUNOL, V125, P205, DOI 10.1016/j.clim.2007.07.011; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Luzza F, 2001, DIGEST LIVER DIS, V33, P14, DOI 10.1016/S1590-8658(01)80130-4; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Mattsson A, 1998, CLIN DIAGN LAB IMMUN, V5, P288, DOI 10.1128/CDLI.5.3.288-293.1998; Mizuno T, 2005, WORLD J GASTROENTERO, V11, P6305, DOI 10.3748/wjg.v11.i40.6305; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Keeffe J, 2008, HELICOBACTER, V13, P1, DOI 10.1111/j.1523-5378.2008.00559.x; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; Ottsjo LS, 2013, INFECT IMMUN, V81, P1532, DOI 10.1128/IAI.01407-12; Quiding-Jarbrink M, 2001, CLIN EXP IMMUNOL, V123, P81, DOI 10.1046/j.1365-2249.2001.01427.x; Rahman M, 2003, J CLIN MICROBIOL, V41, P2008, DOI 10.1128/JCM.41.5.2008-2014.2003; Robinson K, 2010, ADV M C M, P94, DOI 10.1079/9781845935948.0094; Schaub B, 2008, ALLERGY, V63, P1438, DOI 10.1111/j.1398-9995.2008.01685.x; Serelli-Lee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039199; Serrano C, 2013, MUCOSAL IMMUNOL, V6, P950, DOI 10.1038/mi.2012.133; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Sundquist M, 2010, EXPERT REV GASTROENT, V4, P733, DOI 10.1586/EGH.10.71; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Zu YL, 2000, ULTRASTRUCT PATHOL, V24, P319, DOI 10.1080/019131200750035049	52	24	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93943	10.1371/journal.pone.0093943	http://dx.doi.org/10.1371/journal.pone.0093943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714675	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900064
J	Dijkstra, AE; Smolonska, J; van den Berge, M; Wijmenga, C; Zanen, P; Luinge, MA; Platteel, M; Lammers, JW; Dahlback, M; Tosh, K; Hiemstra, PS; Sterk, PJ; Spira, A; Vestbo, J; Nordestgaard, BG; Benn, M; Nielsen, SF; Dahl, M; Verschuren, WM; Picavet, HSJ; Smit, HA; Owsijewitsch, M; Kauczor, HU; de Koning, HJ; Nizankowska-Mogilnicka, E; Mejza, F; Nastalek, P; van Diemen, CC; Cho, MH; Silverman, EK; Crapo, JD; Beaty, TH; Lomas, DA; Bakke, P; Gulsvik, A; Bosse, Y; Obeidat, MA; Loth, DW; Lahousse, L; Rivadeneira, F; Uitterlinden, AG; Hofman, A; Stricker, BH; Brusselle, GG; van Duijn, C; Brouwer, U; Koppelman, GH; Vonk, JM; Nawijn, MC; Groen, HJM; Timens, W; Boezen, HM; Postma, DS				Dijkstra, Akkelies E.; Smolonska, Joanna; van den Berge, Maarten; Wijmenga, Ciska; Zanen, Pieter; Luinge, Marjan A.; Platteel, Mathieu; Lammers, Jan-Willem; Dahlback, Magnus; Tosh, Kerrie; Hiemstra, Pieter S.; Sterk, Peter J.; Spira, Avi; Vestbo, Jorgen; Nordestgaard, Borge G.; Benn, Marianne; Nielsen, Sune F.; Dahl, Morten; Verschuren, W. Monique; Picavet, H. Susan J.; Smit, Henriette A.; Owsijewitsch, Michael; Kauczor, Hans U.; de Koning, Harry J.; Nizankowska-Mogilnicka, Eva; Mejza, Filip; Nastalek, Pawel; van Diemen, Cleo C.; Cho, Michael H.; Silverman, Edwin K.; Crapo, James D.; Beaty, Terri H.; Lomas, David A.; Bakke, Per; Gulsvik, Amund; Bosse, Yohan; Obeidat, M. A.; Loth, Daan W.; Lahousse, Lies; Rivadeneira, Fernando; Uitterlinden, Andre G.; Hofman, Andre; Stricker, Bruno H.; Brusselle, Guy G.; van Duijn, CorneliaM.; Brouwer, Uilke; Koppelman, Gerard H.; Vonk, Judith M.; Nawijn, Martijn C.; Groen, Harry J. M.; Timens, Wim; Boezen, H. Marike; Postma, Dirkje S.		LifeLines Cohort Study	Susceptibility to Chronic Mucus Hypersecretion, a Genome Wide Association Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC-BRONCHITIS; GENETIC EPIDEMIOLOGY; BINDING-PROTEIN; RISK-FACTORS; COPD; CHROMATIN; SATB1; EXPRESSION; MANAGEMENT	Background: Chronic mucus hypersecretion (CMH) is associated with an increased frequency of respiratory infections, excess lung function decline, and increased hospitalisation and mortality rates in the general population. It is associated with smoking, but it is unknown why only a minority of smokers develops CMH. A plausible explanation for this phenomenon is a predisposing genetic constitution. Therefore, we performed a genome wide association (GWA) study of CMH in Caucasian populations. Methods: GWA analysis was performed in the NELSON-study using the Illumina 610 array, followed by replication and metaanalysis in 11 additional cohorts. In total 2,704 subjects with, and 7,624 subjects without CMH were included, all current or former heavy smokers (>= 20 pack-years). Additional studies were performed to test the functional relevance of the most significant single nucleotide polymorphism (SNP). Results: A strong association with CMH, consistent across all cohorts, was observed with rs6577641 (p = 4.25610(-6), OR = 1.17), located in intron 9 of the special AT-rich sequence-binding protein 1 locus (SATB1) on chromosome 3. The risk allele (G) was associated with higher mRNA expression of SATB1 (4.3610 29) in lung tissue. Presence of CMH was associated with increased SATB1 mRNA expression in bronchial biopsies from COPD patients. SATB1 expression was induced during differentiation of primary human bronchial epithelial cells in culture. Conclusions: Our findings, that SNP rs6577641 is associated with CMH in multiple cohorts and is a cis-eQTL for SATB1, together with our additional observation that SATB1 expression increases during epithelial differentiation provide suggestive evidence that SATB1 is a gene that affects CMH.	[Dijkstra, Akkelies E.; van den Berge, Maarten; Groen, Harry J. M.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Dijkstra, Akkelies E.; Smolonska, Joanna; van den Berge, Maarten; Brouwer, Uilke; Koppelman, Gerard H.; Vonk, Judith M.; Nawijn, Martijn C.; Boezen, H. Marike; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Smolonska, Joanna; Wijmenga, Ciska; Platteel, Mathieu; van Diemen, Cleo C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Zanen, Pieter; Lammers, Jan-Willem] Univ Utrecht, Dept Pulmonol, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Luinge, Marjan A.; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Dahlback, Magnus] AstraZeneca, R&D Molndal, Molndal, Sweden; [Tosh, Kerrie] AstraZeneca, Alderley Pk, Macclesfield, Cheshire, England; [Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Sterk, Peter J.] Univ Amsterdam, Dept Resp Med, Amsterdam, Netherlands; [Spira, Avi] Boston Univ, Med Ctr, Sect Computat Biomed, Dept Med, Boston, MA USA; [Vestbo, Jorgen] Odense Univ Hosp, Dept Resp Med J, DK-5000 Odense, Denmark; [Vestbo, Jorgen] Univ Southern Denmark, Inst Clin, Odense, Denmark; [Vestbo, Jorgen] Univ Hosp South Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Resp & Allergy Res Grp, Manchester, Lancs, England; [Nordestgaard, Borge G.; Nielsen, Sune F.] Univ Copenhagen, Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Nordestgaard, Borge G.; Benn, Marianne] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Dahl, Morten] Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Verschuren, W. Monique; Picavet, H. Susan J.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Smit, Henriette A.] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Owsijewitsch, Michael; Kauczor, Hans U.] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Owsijewitsch, Michael; Kauczor, Hans U.] Translat Lung Res Ctr TLRC H, Heidelberg, Germany; [de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Nizankowska-Mogilnicka, Eva; Mejza, Filip; Nastalek, Pawel] Jagiellonian Univ, Coll Med, Dept Resp Dis, Krakow, Poland; [Cho, Michael H.; Silverman, Edwin K.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.] Harvard Univ, Sch Med, Boston, MA USA; [Crapo, James D.] Natl Jewish Hlth, Div Pulm & Crit Care Med, Denver, CO USA; [Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Lomas, David A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Bakke, Per; Gulsvik, Amund] Univ Bergen, Hosp & Inst Med, Haukeland Univ, Dept Thorac Med, Bergen, Norway; [Bosse, Yohan] Univ Laval, Dept Mol Med, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Obeidat, M. A.] Univ British Columbia, St Pauls Hosp, James Hogg Res Ctr, Div Respirol,Dept Med, Vancouver, BC V5Z 1M9, Canada; [Loth, Daan W.; Lahousse, Lies; Hofman, Andre; Stricker, Bruno H.; Brusselle, Guy G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Loth, Daan W.; Stricker, Bruno H.] Netherlands Healthcare Inspectorate, The Hague, Netherlands; [Lahousse, Lies; Brusselle, Guy G.] Univ Hosp Ghent, Dept Resp Med, Ghent, Belgium; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, Fernando; Uitterlinden, Andre G.; Hofman, Andre] NCHA, Rotterdam, Netherlands; [van Duijn, CorneliaM.] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Genet Epidemiol Unit, Rotterdam, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Ctr Med Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Groningen; AstraZeneca; AstraZeneca; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Boston University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Ruprecht Karls University Heidelberg; Erasmus University Rotterdam; Erasmus MC; Jagiellonian University; Collegium Medicum Jagiellonian University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Jewish Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cambridge; University of Bergen; Haukeland University Hospital; Laval University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen	Postma, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands.	d.s.postma@umcg.nl	/V-8478-2019; Koppelman, Gerard/AAG-9187-2020; Vonk, Judith/K-8477-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Hiemstra, Pieter S/K-8587-2018; Wijmenga, Cisca/AAE-7719-2019; Vestbo, Jorgen/Y-2912-2019; Lahousse, Lies/O-9426-2019; NAstałek, Paweł/AAK-9098-2020; Dahl, Morten/F-4219-2014; Sterk, P.J./AAK-8175-2020; Wijmenga, Cisca/D-2173-2009; Alizadeh, Behrooz Z Ziad/J-2921-2017; Groen, Harry/AAP-2242-2021; de+Koning, Harry/AAF-9062-2019; Kauczor, HU/AAX-6033-2021; Timens, Wim/K-5570-2013; Rivadeneira, Fernando/O-5385-2015; Ormel, Johan/C-6094-2013; Benn, Marianne/O-4164-2019; Vonk, Judith M/ABA-3009-2020; Kauczor, Hans-Ulrich/AAU-5955-2021; Franke, Lude/P-7036-2016	Vonk, Judith/0000-0001-7531-4547; Hiemstra, Pieter S/0000-0002-0238-5982; Wijmenga, Cisca/0000-0002-5635-1614; Lahousse, Lies/0000-0002-3494-4363; Dahl, Morten/0000-0002-6686-312X; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; de+Koning, Harry/0000-0003-4682-3646; Timens, Wim/0000-0002-4146-6363; Rivadeneira, Fernando/0000-0001-9435-9441; Benn, Marianne/0000-0002-1701-595X; Vonk, Judith M/0000-0001-7531-4547; Stolk, Ronald/0000-0002-0518-1205; Vestbo, Jorgen/0000-0001-6355-6362; Nordestgaard, Borge/0000-0002-1954-7220; Picavet, Susan/0000-0002-6895-165X; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; van den Berge, Maarten/0000-0002-9336-7340; Franke, Lude/0000-0002-5159-8802; Brusselle, Guy/0000-0001-7021-8505; Loth, Daan/0000-0003-1260-9326; zanen, pieter/0000-0002-5318-8276; Koppelman, Gerard/0000-0001-8567-3252; Nawijn, Martijn/0000-0003-3372-6521; Van Duijn, Cornelia/0000-0002-2374-9204; van Diemen, Cleo/0000-0001-9283-2207; Groen, Harry J.M./0000-0002-2978-5265	EU FP7 [201379]; 'Zorg Onderzoek Nederland-Medische Wetenschappen (ZONMW)'; KWF Kankerbestrijiding; 'Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen' (RvvZ); Netherlands Organization for Scientific Research; Netherlands Asthma Foundation; University of Groningen; Leiden University Medical Center; GlaxoSmithKline; Dutch ministry of Health, Welfare and Sport; ministry of Economic Affairs, Agriculture and Innovation; province of Groningen; European Union (regional development fund); Northern Netherlands Provinces (SNN); Netherlands Organisation for Scientific Research (NWO); University Medical Center Groningen (UMCG); de Nierstichting (the Dutch Kidney Foundation); Diabetes Fonds (the Diabetic Foundation); GSK; NIH [RO I HL089897, RO I HL089856]; COPD foundation; Dutch Lung Foundation; MRC [G0901786] Funding Source: UKRI; Medical Research Council [G0901786] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089856, R01HL089897] Funding Source: NIH RePORTER	EU FP7(European Commission); 'Zorg Onderzoek Nederland-Medische Wetenschappen (ZONMW)'(Netherlands Organization for Health Research and Development); KWF Kankerbestrijiding; 'Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen' (RvvZ); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation; University of Groningen; Leiden University Medical Center; GlaxoSmithKline(GlaxoSmithKline); Dutch ministry of Health, Welfare and Sport; ministry of Economic Affairs, Agriculture and Innovation; province of Groningen; European Union (regional development fund)(European Commission); Northern Netherlands Provinces (SNN); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); University Medical Center Groningen (UMCG); de Nierstichting (the Dutch Kidney Foundation); Diabetes Fonds (the Diabetic Foundation); GSK(GlaxoSmithKline); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPD foundation; Dutch Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The COPACETIC study was funded by EU FP7 grant 201379. The NELSON study was supported by 'Zorg Onderzoek Nederland-Medische Wetenschappen (ZONMW),' KWF Kankerbestrijiding,' and 'Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen' (RvvZ). The GLUCOLD study was supported by the Netherlands Organization for Scientific Research, Netherlands Asthma Foundation, University of Groningen, Leiden University Medical Center, and GlaxoSmithKline. The LifeLines cohort study was sponsored by the Dutch ministry of Health, Welfare and Sport, the ministry of Economic Affairs, Agriculture and Innovation, the province of Groningen, the European Union (regional development fund), the Northern Netherlands Provinces (SNN), the Netherlands Organisation for Scientific Research (NWO), University Medical Center Groningen (UMCG), University of Groningen, de Nierstichting (the Dutch Kidney Foundation), and the Diabetes Fonds (the Diabetic Foundation). The ECLIPSE study was funded by GSK and NIH grants RO I HL089897 and by a grant from GlaxoSmithKline. The COPDGene study was funded by NIH grants RO I HL089856 and by the COPD foundation through contributions made to an Industry Advisory Board comprised of AstraZeneca, Boehringer Ingelheim, Novartis, Pfizer, and Sunovion. Data sampling for the Norway study was funded by GlaxoSmithKline. The Dutch Lung Foundation supported the cell culture work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguma-Nibasheka M, 2007, HISTOL HISTOPATHOL, V22, P483, DOI 10.14670/HH-22.483; Becker N, 2008, ONKOLOGIE, V31; Cai C, 2010, CHINESE MED J-PEKING, V123, P1720, DOI 10.3760/cma.j.issn.0366-6999.2010.13.020; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Cho MH, 2011, HUM MOL GENET; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Ekberg-Aronsson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-98; Ferre A, 2012, RESP MED, V106, P467, DOI 10.1016/j.rmed.2011.12.002; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Hallberg J, 2008, AM J RESP CRIT CARE, V177, P486, DOI 10.1164/rccm.200704-565OC; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Lange P, 2003, AGE AGEING, V32, P636, DOI 10.1093/ageing/afg108; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Nizankowska-Mogilnicka Ewa, 2007, Pol Arch Med Wewn, V117, P402; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; RIJCKEN B, 1993, AM REV RESPIR DIS, V147, P1447, DOI 10.1164/ajrccm/147.6_Pt_1.1447; Selinger CI, 2011, J THORAC ONCOL, V6, P1179, DOI 10.1097/JTO.0b013e31821b4ce0; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; van Diemen CC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-89; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; VESTBO J, 1989, EUR RESPIR J, V2, P710; VIEGI G, 1994, EUR J EPIDEMIOL, V10, P725, DOI 10.1007/BF01719289; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhu G, 2009, EUR RESP J	35	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e91621	10.1371/journal.pone.0091621	http://dx.doi.org/10.1371/journal.pone.0091621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714607	Green Published, Green Accepted, gold			2022-12-27	WOS:000334160900002
J	Duncan, MJ; Kline, CE; Vandelanotte, C; Sargent, C; Rogers, NL; Di Milia, L				Duncan, Mitch J.; Kline, Christopher E.; Vandelanotte, Corneel; Sargent, Charli; Rogers, Naomi L.; Di Milia, Lee			Cross-Sectional Associations between Multiple Lifestyle Behaviors and Health-Related Quality of Life in the 10,000 Steps Cohort	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SELF-RATED HEALTH; PHYSICAL-ACTIVITY; SLEEP DURATION; CARDIOVASCULAR-DISEASE; SITTING TIME; NATIONAL-HEALTH; HEART-DISEASE; RISK; WOMEN	Background: The independent and combined influence of smoking, alcohol consumption, physical activity, diet, sitting time, and sleep duration and quality on health status is not routinely examined. This study investigates the relationships between these lifestyle behaviors, independently and in combination, and health-related quality of life (HRQOL). Methods: Adult members of the 10,000 Steps project (n = 159,699) were invited to participate in an online survey in November-December 2011. Participant socio-demographics, lifestyle behaviors, and HRQOL (poor self-rated health; frequent unhealthy days) were assessed by self-report. The combined influence of poor lifestyle behaviors were examined, independently and also as part of two lifestyle behavior indices, one excluding sleep quality (Index 1) and one including sleep quality (Index 2). Adjusted Cox proportional hazard models were used to examine relationships between lifestyle behaviors and HRQOL. Results: A total of 10,478 participants provided complete data for the current study. For Index 1, the Prevalence Ratio (p value) of poor self-rated health was 1.54 (p = 0.001), 2.07 (p <= 0.001), 3.00 (p <= 0.001), 3.61 (p <= 0.001) and 3.89 (p <= 0.001) for people reporting two, three, four, five and six poor lifestyle behaviors, compared to people with 0-1 poor lifestyle behaviors. For Index 2, the Prevalence Ratio (p value) of poor self-rated health was 2.26 (p = 0.007), 3.29 (p <= 0.001), 4.68 (p <= 0.001), 6.48 (p <= 0.001), 7.91 (p <= 0.001) and 8.55 (p <= 0.001) for people reporting two, three, four, five, six and seven poor lifestyle behaviors, compared to people with 0-1 poor lifestyle behaviors. Associations between the combined lifestyle behavior index and frequent unhealthy days were statistically significant and similar to those observed for poor self-rated health. Conclusions: Engaging in a greater number of poor lifestyle behaviors was associated with a higher prevalence of poor HRQOL. This association was exacerbated when sleep quality was included in the index.	[Duncan, Mitch J.; Vandelanotte, Corneel] Cent Queensland Univ, Ctr Phys Act Studies, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia; [Kline, Christopher E.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Sargent, Charli] Cent Queensland Univ, Appleton Inst Behav Sci, Adelaide, SA, Australia; [Rogers, Naomi L.; Di Milia, Lee] Cent Queensland Univ, Sch Business & Law, Rockhampton, Qld 4702, Australia; [Di Milia, Lee] Cent Queensland Univ, Sch Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia	Central Queensland University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central Queensland University; Central Queensland University; Central Queensland University	Duncan, MJ (corresponding author), Cent Queensland Univ, Ctr Phys Act Studies, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia.	m.duncan@cqu.edu.au	Vandelanotte, Corneel/ABF-5580-2020; Kline, Christopher/B-1477-2012; Di Milia, Lee/A-6810-2008; Sargent, Charli/U-7393-2019; Duncan, Mitch/V-1708-2019	Kline, Christopher/0000-0003-1025-9430; Di Milia, Lee/0000-0001-7681-5589; Duncan, Mitch/0000-0002-9166-6195; Sargent, Charli/0000-0001-5340-4701; Vandelanotte, Corneel/0000-0002-4445-8094	Queensland Health; CQUniversity Health CRN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL082610] Funding Source: NIH RePORTER	Queensland Health; CQUniversity Health CRN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Queensland Health provided funding to Central Queensland University for the development of 10,000 Steps. 10,000 is a joint Australian, State, and Territory Government Initiative under the National Partnership Agreement on Preventive Health. This manuscript was supported by the CQUniversity Health CRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1175; [Anonymous], 2000, MEAS HLTH DAYS; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Byles J, 2006, J AM GERIATR SOC, V54, P1341, DOI 10.1111/j.1532-5415.2006.00837.x; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chau JY, 2011, BRIT J SPORT MED, V45, P1216, DOI 10.1136/bjsports-2011-090214; Chee MWL, 2013, ANN ACAD MED SINGAP, V42, P105; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davies CA, 2012, PREV MED, V55, P46, DOI 10.1016/j.ypmed.2012.05.003; Ding D, PREVENTIVE IN PRESS; Duncan MJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-16; Eguchi E, 2012, EUR HEART J, V33, P467, DOI 10.1093/eurheartj/ehr429; Ernstsen L, 2011, AGE AGEING, V40, P105, DOI 10.1093/ageing/afq141; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; Grandner MA, 2010, SLEEP MED REV, V14, P191, DOI 10.1016/j.smrv.2009.07.006; Haseli-Mashhadi N, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-130, 10.1186/1471-2458-9-368]; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Hoevenaar-Blom MP, 2013, EUR J PREV CARDIOL; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Hyman DJ, 2007, ARCH INTERN MED, V167, P1152, DOI 10.1001/archinte.167.11.1152; King AC, 2013, ANN BEHAV MED, V46, P157, DOI 10.1007/s12160-013-9501-y; Kline CE, 2013, SLEEP, V36, P1279, DOI 10.5665/sleep.2946; Li CY, 2008, VALUE HEALTH, V11, P689, DOI 10.1111/j.1524-4733.2007.00307.x; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Magee CA, 2012, J SLEEP RES, V21, P441, DOI 10.1111/j.1365-2869.2011.00993.x; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Magee CA, 2010, J AGING HEALTH, V22, P1235, DOI 10.1177/0898264310372780; Martinez-Gomez D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-47; Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37; Mummery W, 2008, 10 INT C BEH MED TOK; National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH; Newschaffer C. J., 1998, VALIDATION BEHAV RIS; Noar SM, 2008, PREV MED, V46, P275, DOI 10.1016/j.ypmed.2007.08.001; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Parekh S, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-108; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Prochaska JJ, 2008, PREV MED, V46, P260, DOI 10.1016/j.ypmed.2007.07.035; Prochaska JJ, 2008, PREV MED, V46, P181, DOI 10.1016/j.ypmed.2008.02.001; Rabin BA, 2006, AM J PREV MED, V31, pS24, DOI 10.1016/j.amepre.2006.06.009; Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071; Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037; Smith KJ, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-29; Sodergren M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-551; Tsai J, 2010, PREV MED, V51, P268, DOI 10.1016/j.ypmed.2010.07.010; Vallance JK, 2013, MENTAL HLTH PHYS ACT; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Vandelanotte C, 2008, PREV MED, V46, P232, DOI 10.1016/j.ypmed.2007.07.008	60	55	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94184	10.1371/journal.pone.0094184	http://dx.doi.org/10.1371/journal.pone.0094184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714564	Green Published, gold, Green Accepted			2022-12-27	WOS:000334160900100
J	Hira, SK; Mishra, AK; Ray, B; Manna, PP				Hira, Sumit Kumar; Mishra, Avnish Kumar; Ray, Biswajit; Manna, Partha Pratim			Targeted Delivery of Doxorubicin-Loaded Poly (epsilon-caprolactone)-b-Poly (N-vinylpyrrolidone) Micelles Enhances Antitumor Effect in Lymphoma	PLOS ONE			English	Article							DRUG-DELIVERY; INTRACELLULAR RELEASE; BLOCK-COPOLYMERS; CELLS; POLYMERIZATION; NANOPARTICLES; COMBINATION; APOPTOSIS; TISSUE	Background: The present study was motivated by the need to design a safe nano-carrier for the delivery of doxorubicin which could be tolerant to normal cells. PCL63-b-PNVP90 was loaded with doxorubicin (6 mg/ml), and with 49.8% drug loading efficiency; it offers a unique platform providing selective immune responses against lymphoma. Methods: In this study, we have used micelles of amphiphilic PCL63-b-PNVP90 block copolymer as nano-carrier for controlled release of doxorubicin (DOX). DOX is physically entrapped and stabilized in the hydrophobic cores of the micelles and biological roles of these micelles were evaluated in lymphoma. Results: DOX loaded PCL63-b-PNVP90 block copolymer micelles (DOX-PCL63-b-PNVP90) shows enhanced growth inhibition and cytotoxicity against human (K-562, JE6.1 and Raji) and mice lymphoma cells (Dalton's lymphoma, DL). DOX-PCL63-b-PNVP90 demonstrates higher levels of tumoricidal effect against DOX-resistant tumor cells compared to free DOX. DOX-PCL63- b-PNVP90 demonstrated effective drug loading and a pH-responsive drug release character besides exhibiting sustained drug release performance in in-vitro and intracellular drug release experiments. Conclusion: Unlike free DOX, DOX-PCL63-b-PNVP90 does not show cytotoxicity against normal cells. DOX-PCL63-b-PNVP90 prolonged the survival of tumor (DL) bearing mice by enhancing the apoptosis of the tumor cells in targeted organs like liver and spleen.	[Hira, Sumit Kumar; Manna, Partha Pratim] Banaras Hindu Univ, Dept Zool, Fac Sci, Immunobiol Lab, Varanasi 221005, Uttar Pradesh, India; [Mishra, Avnish Kumar; Ray, Biswajit] Banaras Hindu Univ, Dept Chem, Fac Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Ray, B (corresponding author), Banaras Hindu Univ, Dept Chem, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	biswajitray2003@yahoo.co.in; pp_manna@yahoo.com	Ray, Biswajit/I-9968-2018; HIRA, SUMIT KUMAR/J-9271-2014	HIRA, SUMIT KUMAR/0000-0001-6113-4721; Manna, Partha Pratim/0000-0003-2939-0818	Department of Biotechnology (DBT), New Delhi, India [BT/PR11490/BRB/10/675/2008]; Department of Science and Technology, Government of India [SR/S1/PC-25/2006]; CSIR, New Delhi, India	Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Present work is supported by a grant from Department of Biotechnology (DBT), New Delhi, India, No. BT/PR11490/BRB/10/675/2008(PPM). BR gratefully acknowledges the financial support from the Department of Science and Technology, Government of India, through grant no. SR/S1/PC-25/2006. SKH and AKM are recipients of junior & senior research fellowship from CSIR, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Chaudhuri P, 2009, ACS NANO, V3, P2505, DOI 10.1021/nn900318y; Chung TW, 2004, POLYMER, V45, P1591, DOI 10.1016/j.polymer.2003.12.074; Dash TK, 2012, MOL PHARMACEUT, V9, P2365, DOI 10.1021/mp3001952; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gamen S, 2000, EXP CELL RES, V258, P223, DOI 10.1006/excr.2000.4924; Gao Y, 2011, ACS NANO, V5, P9788, DOI 10.1021/nn2033105; GOLDIE H, 1951, CANCER RES, V11, P73; Jeon HJ, 2009, J POLYM SCI POL CHEM, V47, P3078, DOI 10.1002/pola.23396; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; KLEIN E, 1954, CANCER RES, V14, P139; Leiva A, 2007, J COLLOID INTERF SCI, V310, P136, DOI 10.1016/j.jcis.2007.01.013; Lele BS, 2002, MACROMOLECULES, V35, P6714, DOI 10.1021/ma020433h; Li Y, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055106; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; Matsumura Y, 2004, BRIT J CANCER, V91, P1775, DOI 10.1038/sj.bjc.6602204; Mishra AK, 2011, MACROMOLECULES, V44, P2465, DOI 10.1021/ma102453h; Patel VK, 2010, POLYM BULL, V65, P97, DOI 10.1007/s00289-009-0185-1; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Reddy LH, 2007, J CONTROL RELEASE, V124, P20, DOI 10.1016/j.jconrel.2007.08.018; Rihova B, 2003, J CONTROL RELEASE, V91, P1, DOI 10.1016/S0168-3659(03)00235-9; Sun HL, 2010, BIOMACROMOLECULES, V11, P848, DOI 10.1021/bm1001069; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Tolcher AW, 1999, J CLIN ONCOL, V17, P478, DOI 10.1200/JCO.1999.17.2.478; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; Wang YC, 2011, BIOCONJUGATE CHEM, V22, P1939, DOI 10.1021/bc200139n; Weiss B, 2007, BIOCONJUGATE CHEM, V18, P1087, DOI 10.1021/bc060342f; Xu G, 2002, CLIN CANCER RES, V8, P2605	30	55	56	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94309	10.1371/journal.pone.0094309	http://dx.doi.org/10.1371/journal.pone.0094309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714166	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900114
J	Itahashi, T; Yamada, T; Watanabe, H; Nakamura, M; Jimbo, D; Shioda, S; Toriizuka, K; Kato, N; Hashimoto, R				Itahashi, Takashi; Yamada, Takashi; Watanabe, Hiromi; Nakamura, Motoaki; Jimbo, Daiki; Shioda, Seiji; Toriizuka, Kazuo; Kato, Nobumasa; Hashimoto, Ryuichiro			Altered Network Topologies and Hub Organization in Adults with Autism: A Resting-State fMRI Study	PLOS ONE			English	Article							BRAIN FUNCTIONAL NETWORKS; SUPERIOR TEMPORAL SULCUS; MIRROR NEURON SYSTEM; SPECTRUM QUOTIENT AQ; GRAY-MATTER VOLUME; INHIBITORY CONTROL; MODULAR ORGANIZATION; ANATOMICAL NETWORKS; DEFAULT MODE; CONNECTIVITY	Recent functional magnetic resonance imaging (fMRI) studies on autism spectrum condition (ASC) have identified dysfunctions in specific brain networks involved in social and non-social cognition that persist into adulthood. Although increasing numbers of fMRI studies have revealed atypical functional connectivity in the adult ASC brain, such functional alterations at the network level have not yet been fully characterized within the recently developed graph-theoretical framework. Here, we applied a graph-theoretical analysis to resting-state fMRI data acquired from 46 adults with ASC and 46 age- and gender-matched controls, to investigate the topological properties and organization of autistic brain network. Analyses of global metrics revealed that, relative to the controls, participants with ASC exhibited significant decreases in clustering coefficient and characteristic path length, indicating a shift towards randomized organization. Furthermore, analyses of local metrics revealed a significantly altered organization of the hub nodes in ASC, as shown by analyses of hub disruption indices using multiple local metrics and by a loss of '' hubness '' in several nodes (e. g., the bilateral superior temporal sulcus, right dorsolateral prefrontal cortex, and precuneus) that are critical for social and non-social cognitive functions. In particular, local metrics of the anterior cingulate cortex consistently showed significant negative correlations with the Autism-Spectrum Quotient score. Our results demonstrate altered patterns of global and local topological properties that may underlie impaired social and non-social cognition in ASC.	[Itahashi, Takashi; Toriizuka, Kazuo] Showa Univ, Sch Med, Dept Pharmacognosy & Phytochem, Tokyo 142, Japan; [Yamada, Takashi; Watanabe, Hiromi; Nakamura, Motoaki; Kato, Nobumasa; Hashimoto, Ryuichiro] Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan; [Nakamura, Motoaki] Kinko Hosp, Kanagawa Psychiat Ctr, Kanagawa, Japan; [Jimbo, Daiki; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Hashimoto, Ryuichiro] Tokyo Metropolitan Univ, Grad Sch Humanities, Dept Language Sci, Tokyo 158, Japan	Showa University; Showa University; Showa University	Hashimoto, R (corresponding author), Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan.	dbridges50@gmail.com		Itahashi, Takashi/0000-0001-7606-7090; Hashimoto, Ryu-ichiro/0000-0002-9661-3412	Japan Society for the Promotion of Science (JSPS) [25870738]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23118003]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A part of this study is the result of "Development of BMI Technologies for Clinical Application" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) (25870738 to T. I.) and by a Grant-in-Aid for Scientific Research on Innovative Areas (23118003; Adolescent Mind & Self-Regulation to R. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2013, P NATL ACAD SCI USA, V110, P12060, DOI 10.1073/pnas.1302982110; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen G, 2004, BIOL PSYCHIAT, V56, P269, DOI 10.1016/j.biopsych.2004.06.005; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aoki Y, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-25; Arons MH, 2012, J NEUROSCI, V32, P14966, DOI 10.1523/JNEUROSCI.2215-12.2012; Ashburner J, 2008, AM J OCCUP THER, V62, P564, DOI 10.5014/ajot.62.5.564; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Bakhtiari R, 2012, NEUROIMAGE-CLIN, V1, P48, DOI 10.1016/j.nicl.2012.09.001; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Barttfeld P, 2012, NEUROPSYCHOLOGIA, V50, P3653, DOI 10.1016/j.neuropsychologia.2012.09.047; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bruno J, 2012, NEUROBIOL DIS, V48, P329, DOI 10.1016/j.nbd.2012.07.009; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao H, 2014, NEUROIMAGE, V84, P888, DOI 10.1016/j.neuroimage.2013.09.013; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Christ SE, 2007, J AUTISM DEV DISORD, V37, P1155, DOI 10.1007/s10803-006-0259-y; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Dickstein DP, 2013, J AM ACAD CHILD PSY, V52, P279, DOI 10.1016/j.jaac.2012.12.012; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dowell LR, 2009, NEUROPSYCHOLOGY, V23, P563, DOI 10.1037/a0015640; Duerden EG, 2013, BRAIN RES, V1533, P80, DOI 10.1016/j.brainres.2013.08.021; Dunn MA, 2008, J AUTISM DEV DISORD, V38, P52, DOI 10.1007/s10803-007-0359-3; Dziuk MA, 2007, DEV MED CHILD NEUROL, V49, P734, DOI 10.1111/j.1469-8749.2007.00734.x; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; GAYMARD B, 1993, ANN NEUROL, V34, P404, DOI 10.1002/ana.410340317; Greimel E, 2012, NEUROPSYCHOLOGIA, V50, P3440, DOI 10.1016/j.neuropsychologia.2012.09.029; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Hua X, 2013, HUM BRAIN MAPP, V34, P425, DOI 10.1002/hbm.21441; Hwang K, 2013, CEREB CORTEX, V23, P2380, DOI 10.1093/cercor/bhs227; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kana RK, 2012, SOCIAL COGNITIVE AFF; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Lai MC, 2010, BIOL PSYCHIAT, V68, P1092, DOI 10.1016/j.biopsych.2010.06.027; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Li H, 2012, HUM BRAIN MAPP; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuzaki J, 2012, NEUROREPORT, V23, P113, DOI 10.1097/WNR.0b013e32834ebf44; Menon V, 2013, TRENDS COGN SCI, V17, P627, DOI 10.1016/j.tics.2013.09.015; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mosconi MW, 2009, PSYCHOL MED, V39, P1559, DOI 10.1017/S0033291708004984; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Muller RA, 2007, MENT RETARD DEV D R, V13, P85, DOI 10.1002/mrdd.20141; Muller RA, 2004, BIOL PSYCHIAT, V56, P323, DOI 10.1016/j.biopsych.2004.06.007; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakano M, 2014, PROG NEURO-PSYCHOPH, V48, P51, DOI 10.1016/j.pnpbp.2013.09.011; Nebel MB, 2012, HUM BRAIN MAPP; Nelson HE., 1982, NATL ADULT READING T; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Peters JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-54; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Redcay E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00573; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Rudie JD, 2012, CEREB CORTEX, V22, P1025, DOI 10.1093/cercor/bhr171; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Shih P, 2011, BIOL PSYCHIAT, V70, P270, DOI 10.1016/j.biopsych.2011.03.040; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Takarae Y, 2007, PSYCHIAT RES-NEUROIM, V156, P117, DOI 10.1016/j.pscychresns.2007.03.008; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; Uddin Lucina Q, 2013, Front Hum Neurosci, V7, P458, DOI 10.3389/fnhum.2013.00458; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watanabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039561; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams DL, 2013, AUTISM RES, V6, P288, DOI 10.1002/aur.1291; Yamasaki S, 2010, BIOL PSYCHIAT, V68, P1141, DOI 10.1016/j.biopsych.2010.07.012; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	121	91	96	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94115	10.1371/journal.pone.0094115	http://dx.doi.org/10.1371/journal.pone.0094115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714805	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900086
J	Kim, HJ; Jin, Y; Kim, HJ				Kim, Hyoung Jin; Jin, Yingji; Kim, Hong-Jin			The Concentration of Carbon Source in the Medium Affects the Quality of Virus-Like Particles of Human Papillomavirus Type 16 Produced in Saccharomyces cerevisiae	PLOS ONE			English	Article							L1 PROTEIN; IMMUNOGENICITY; VACCINES; MANUFACTURE; PSEUDOVIRUS; GLUTATHIONE; EXPRESSION; REACTIVITY; SYSTEMS; STRESS	There is accumulating evidence that virus-like particles (VLPs) recombinantly produced in Saccharomyces cerevisiae (S. cerevisiae) are characterized by low structural stability, and that this is associated with reduced antigenicity and immunogenicity. However, little attention has been devoted to methods of improving the quality of the VLPs. Here, we investigated the effect of carbon source concentration in the medium on the antigenicity and immunogenicity of human papillomavirus (HPV) type 16 L1 VLPs expressed in S. cerevisiae from the galactose promoter. Media containing 2, 4, 6, and 8% carbon source, composed of both glucose and galactose in equal proportion, were used. VLP antigenicity was enhanced in cultures grown on media with 6 or 8% carbon source, compared to those from cultures with less than 6% carbon source. Moreover, the VLPs obtained from these cultures induced higher anti-HPV16 L1 IgG titers and neutralizing antibody titers in immunized mice than those purified from cultures with less than 6% carbon source. Our results indicate that the concentration of the carbon source in the medium plays a crucial role in determining the antigenicity and immunogenicity of HPV type16 L1 VLPs.	[Kim, Hyoung Jin; Jin, Yingji; Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea.	hongjink@cau.ac.kr			National Research Foundation of Korea; Korean Government [NRF-2009-353-E00026]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by a National Research Foundation of Korea Grant funded by the Korean Government [NRF-2009-353-E00026], http://www.nrf.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2007, J PEPT SCI, V13, P776, DOI 10.1002/psc.896; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Chang DY, 2012, BIOTECHNOL BIOPROC E, V17, P755, DOI 10.1007/s12257-012-0067-5; Choi YR, 2013, PROTEIN EXPRES PURIF, V89, P162, DOI 10.1016/j.pep.2013.03.007; Cobbold C, 2007, J GEN VIROL, V88, P77, DOI 10.1099/vir.0.82257-0; Crisci E, 2012, VET IMMUNOL IMMUNOP, V148, P211, DOI 10.1016/j.vetimm.2012.04.026; Foged C, 2011, THER DELIV, V2, P1057, DOI 10.4155/TDE.11.68; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Kim HJ, 2013, BIOTECHNOL LETT, V35, P413, DOI 10.1007/s10529-012-1097-y; Kim HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035893; Kim HJ, 2011, PROTEIN EXPRES PURIF, V80, P52, DOI 10.1016/j.pep.2011.06.010; Kim HJ, 2010, J BIOTECHNOL, V150, P31, DOI 10.1016/j.jbiotec.2010.07.032; Kim HJ, 2010, PROTEIN EXPRES PURIF, V70, P68, DOI 10.1016/j.pep.2009.08.005; Kim SY, 2011, PROTEIN EXPRES PURIF, V76, P103, DOI 10.1016/j.pep.2010.11.003; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Kwag HL, 2012, J MICROBIOL, V50, P813, DOI 10.1007/s12275-012-2292-1; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Mulder AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033235; MURRAY K, 1988, VACCINE, V6, P164, DOI 10.1016/S0264-410X(88)80022-7; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011; Peixoto C, 2007, J BIOTECHNOL, V127, P452, DOI 10.1016/j.jbiotec.2006.08.002; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Rizk RZ, 2008, J GEN VIROL, V89, P117, DOI 10.1099/vir.0.83145-0; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; SILBER R, 1992, BLOOD, V80, P2038; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Tanyalcin T, 2000, HEPATOL RES, V18, P104, DOI 10.1016/S1386-6346(99)00088-1; Thones N, 2008, J VIROL, V82, P5472, DOI 10.1128/JVI.02482-07; Xie XX, 2013, ARCH VIROL, V158, P193, DOI 10.1007/s00705-012-1465-x; Zhao QJ, 2013, TRENDS BIOTECHNOL, V31, P654, DOI 10.1016/j.tibtech.2013.09.002; Zhao YP, 2003, BIOTECHNOL LETT, V25, P1151, DOI 10.1023/A:1024577414157	32	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94467	10.1371/journal.pone.0094467	http://dx.doi.org/10.1371/journal.pone.0094467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714383	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900136
J	Haase, N; Rugor, J; Przybyl, L; Qadri, F; Muller, DN; Dechend, R				Haase, Nadine; Rugor, Julianna; Przybyl, Lukasz; Qadri, Fatimunnisa; Mueller, Dominik N.; Dechend, Ralf			Relaxin Does Not Improve Angiotensin II-Induced Target-Organ Damage	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; INDUCED CARDIAC INJURY; EMERGING ROLE; HORMONE RELAXIN; HEART-FAILURE; PREGNANT RATS; NITRIC-OXIDE; HUMAN RENIN; FIBROSIS; DISEASE	Relaxin is a corpus-luteum produced protein hormone with vasodilatatory, anti-fibrotic, and angiogenic properties that are opposite to angiotensin (Ang) II. We investigated whether or not relaxin ameliorates Ang II-induced target-organ damage. We used double transgenic rats harboring both human renin and angiotensinogen genes (dTGR) that develop severe hypertension, target-organ damage, and die untreated within 7-8 weeks. Recombinant relaxin at a low (26 mu g/kg/d) and a high dose (240 mu g/kg/d) was given to 4 week-old dTGR and age-matched Sprague-Dawley rats (SD). Systolic blood pressure increased progressively in untreated dTGRs from 162 +/- 3 mmHg at week 5 to 225 +/- 5 mmHg at week 7. Relaxin had no effect on blood pressure whereas SD rats were normotensive (106 +/- 1 mmHg). Untreated and relaxin-treated dTGR had similarly severe cardiac hypertrophy indices. Relaxin did not ameliorate albuminuria and did not prevent matrix-protein deposition in the heart and kidney in dTGR. Finally, relaxin treatment did not reduce mortality. These data suggest that pharmacological doses of relaxin do not reverse severe effects of Ang II.	[Haase, Nadine; Rugor, Julianna; Przybyl, Lukasz; Qadri, Fatimunnisa; Mueller, Dominik N.; Dechend, Ralf] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Haase, Nadine; Rugor, Julianna; Przybyl, Lukasz; Qadri, Fatimunnisa; Mueller, Dominik N.; Dechend, Ralf] Fac Med Charite, Berlin, Germany; [Dechend, Ralf] HELIOS Klin, Dept Cardiol & Nephrol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken	Dechend, R (corresponding author), Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany.	ralf.dechend@charite.de	Bader, Michael/K-2124-2013; Przybyl, Lukasz/GYA-0002-2022	Muller, Dominik N/0000-0003-3650-5644; Przybyl, Lukasz/0000-0001-9777-8879; Haase, Nadine/0000-0003-0727-1738	Novartis	Novartis(Novartis)	The work was funded by grant in aid by Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Chan SL, 2013, FASEB J, V27, P3917, DOI 10.1096/fj.13-230797; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Conrad KP, 2011, SEMIN NEPHROL, V31, P15, DOI 10.1016/j.semnephrol.2010.10.003; Conrad KP, 2004, AM J PHYSIOL-REG I, V287, pR250, DOI 10.1152/ajpregu.00672.2003; Danielson LA, 2003, J APPL PHYSIOL, V95, P1509, DOI 10.1152/japplphysiol.00545.2003; Debrah DO, 2005, HYPERTENSION, V46, P745, DOI 10.1161/01.HYP.0000184230.52059.33; Dechend R, 2001, CIRCULATION, V104, P576, DOI 10.1161/hc3001.092039; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Fiebeler A, 2001, HYPERTENSION, V37, P787, DOI 10.1161/01.HYP.37.2.787; Fischer R, 2008, HYPERTENSION, V51, P540, DOI 10.1161/HYPERTENSIONAHA.107.103143; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; GRIGGS KC, 1993, AM J PHYSIOL, V265, pF309, DOI 10.1152/ajprenal.1993.265.2.F309; Hernandez-Montfort Jaime A, 2013, Curr Heart Fail Rep, V10, P198, DOI 10.1007/s11897-013-0148-6; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hewitson TD, 2009, ANN NY ACAD SCI, V1160, P289, DOI 10.1111/j.1749-6632.2008.03795.x; Hultstrom M, 2012, J HYPERTENS, V30, P1087, DOI 10.1097/HJH.0b013e328352b89a; Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Luft FC, 1999, HYPERTENSION, V33, P212, DOI 10.1161/01.HYP.33.1.212; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; McGuane JT, 2011, HYPERTENSION, V57, P1151, DOI 10.1161/HYPERTENSIONAHA.110.165027; Mervaala EMA, 2001, HYPERTENSION, V37, P414, DOI 10.1161/01.HYP.37.2.414; Muller DN, 2000, AM J PATHOL, V157, P111, DOI 10.1016/S0002-9440(10)64523-3; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8; OLSON JL, 1986, KIDNEY INT, V29, P849, DOI 10.1038/ki.1986.76; Parikh A, 2013, CIRC RES, V113, P313, DOI 10.1161/CIRCRESAHA.113.301646; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2009, CURR OPIN NEPHROL HY, V18, P9, DOI 10.1097/MNH.0b013e32831b7096; Samuel CS, 2006, KIDNEY INT, V69, P1498, DOI 10.1038/sj.ki.5000264; Sasser JM, 2011, HYPERTENSION, V58, P197, DOI 10.1161/HYPERTENSIONAHA.110.164392; Shagdarsuren E, 2005, CIRC RES, V97, P716, DOI 10.1161/01.RES.0000182677.89816.38; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Unemori E, 2009, ANN NY ACAD SCI, V1160, P381, DOI 10.1111/j.1749-6632.2009.03838.x; van Drongelen J, 2013, PEPTIDES, V49, P41, DOI 10.1016/j.peptides.2013.08.020; Wellner M, 2005, PHYSIOL GENOMICS, V20, P256, DOI 10.1152/physiolgenomics.00165.2004; Wenzel K, 2011, HYPERTENSION, V58, P77, DOI 10.1161/HYPERTENSIONAHA.111.171348; Wong SE, 2013, PROTEIN PEPTIDE LETT, V20, P1029; Xu Q, 2008, ENDOCRINOLOGY, V149, P476, DOI 10.1210/en.2007-1220; Yoshida T, 2013, AM J PHYSIOL-RENAL, V305, pF1169, DOI 10.1152/ajprenal.00654.2012	44	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93743	10.1371/journal.pone.0093743	http://dx.doi.org/10.1371/journal.pone.0093743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710077	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000334159800047
J	Tan, XL; Wang, S; Ridsdill-Smith, J; Liu, TX				Tan, Xiao-Ling; Wang, Su; Ridsdill-Smith, James; Liu, Tong-Xian			Direct and Indirect Impacts of Infestation of Tomato Plant by Myzus persicae ( Hemiptera: Aphididae) on Bemisia tabaci ( Hemiptera: Aleyrodidae)	PLOS ONE			English	Article							INDUCED VOLATILE EMISSIONS; PHLOEM-FEEDING INSECTS; MEDIATED INTERACTIONS; INTERSPECIFIC COMPETITION; MACROSIPHUM-EUPHORBIA; INDUCED RESISTANCE; SPODOPTERA-EXIGUA; DEFENSE RESPONSES; NATURAL ENEMIES; ORAL SECRETION	The impacts of infestation by the green peach aphid (Myzus persicae) on sweetpotato whitefly (Bemisia tabaci) settling on tomato were determined in seven separate experiments with whole plants and with detached leaves through manipulation of four factors: durations of aphid infestation, density of aphids, intervals between aphid removal after different durations of infestation and the time of whitefly release, and leaf positions on the plants. The results demonstrated that B. tabaci preferred to settle on the plant leaves that had not been infested by aphids when they had a choice. The plant leaves on which aphids were still present ( direct effect) had fewer whiteflies than those previously infested by aphids ( indirect effect). The whiteflies were able to settle on the plant which aphids had previously infested, and also could settle on leaves with aphids if no uninfested plants were available. Tests of direct factors revealed that duration of aphid infestation had a stronger effect on whitefly landing preference than aphid density; whitefly preference was the least when 20 aphids fed on the leaves for 72 h. Tests of indirect effects revealed that the major factor that affected whitefly preference for a host plant was the interval between the time of aphid removal after infestation and the time of whitefly release. The importance of the four factors that affected the induced plant defense against whiteflies can be arranged in the following order: time intervals between aphid removal and whitefly release. durations of aphid infestation > density of aphids > leaf positions on the plants. In conclusion, the density of aphid infestation and time for which they were feeding influenced the production of induced compounds by tomatoes, the whitefly responses to the plants, and reduced interspecific competition.	[Tan, Xiao-Ling; Ridsdill-Smith, James; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Tan, Xiao-Ling; Ridsdill-Smith, James; Liu, Tong-Xian] Northwest A&F Univ, Key Lab Crop Pest Management Losses Plateau, Minist Agr, Yangling, Shaanxi, Peoples R China; [Wang, Su] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Ridsdill-Smith, James] Univ Western Australia M092, Crawley, WA, Australia	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Beijing Academy of Agriculture & Forestry; University of Western Australia	Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn	wang, su/AAC-6313-2019; tan, xiao/GZL-0264-2022	Ridsdill-Smith, James/0000-0003-0660-1934	National Basic Research Program of China [2012CB114105, 2013CB127600]; China Agriculture Research System [CARS-25-B-06]	National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	Funding of this research was partially supported by each of the following grants: the National Basic Research Program of China (973 Projects No. 2012CB114105 and No. 2013CB127600), China Agriculture Research System (CARS-25-B-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, OIKOS, V89, P70, DOI 10.1034/j.1600-0706.2000.890108.x; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Anderson KE, 2009, OIKOS, V118, P1633, DOI 10.1111/j.1600-0706.2009.17437.x; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; BERLINGER MJ, 1986, AGR ECOSYST ENVIRON, V17, P69, DOI 10.1016/0167-8809(86)90028-9; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Botha CEJ, 2004, S AFR J BOT, V70, P249, DOI 10.1016/S0254-6299(15)30242-8; Brunissen L, 2009, ENTOMOL EXP APPL, V132, P30, DOI 10.1111/j.1570-7458.2009.00862.x; Choh Y, 2004, J CHEM ECOL, V30, P1305, DOI 10.1023/B:JOEC.0000037741.13402.19; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; de Vos M, 2010, CURR OPIN PLANT BIOL, V13, P366, DOI 10.1016/j.pbi.2010.05.001; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Dugravot S, 2007, ENTOMOL EXP APPL, V123, P271, DOI 10.1111/j.1570-7458.2007.00542.x; Elliot SL, 2000, ECOL LETT, V3, P228; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Erb M, 2011, J ECOL, V99, P7, DOI 10.1111/j.1365-2745.2010.01757.x; Gianoli E, 1997, J CHEM ECOL, V23, P2695, DOI 10.1023/A:1022554708782; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Goggin FL, 2001, ENVIRON ENTOMOL, V30, P101, DOI 10.1603/0046-225X-30.1.101; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P81, DOI 10.1046/j.1461-9563.2002.00138.x; Inbar M, 1999, ENVIRON ENTOMOL, V28, P353, DOI 10.1093/ee/28.3.353; Inbar M, 2001, OIKOS, V94, P228, DOI 10.1034/j.1600-0706.2001.940203.x; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Kaplan I, 2011, OECOLOGIA, V166, P627, DOI 10.1007/s00442-010-1885-9; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; LIU TX, 1994, J ENTOMOL SCI, V29, P55, DOI 10.18474/0749-8004-29.1.55; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Luo C, 2010, CROP PROT, V29, P429, DOI 10.1016/j.cropro.2009.10.001; Ma DY, 2007, CROP PROT, V26, P612, DOI 10.1016/j.cropro.2006.04.027; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; McAuslane HJ, 2000, ENTOMOL EXP APPL, V97, P283, DOI 10.1023/A:1004051527347; MCCALL PJ, 1994, J CHEM ECOL, V20, P3039, DOI 10.1007/BF02033709; Messina FJ, 2002, OECOLOGIA, V131, P43, DOI 10.1007/s00442-001-0859-3; MORAN NA, 1990, ECOLOGY, V71, P1050, DOI 10.2307/1937373; Murugan M., 2006, Journal of Vegetable Science, V12, P43, DOI 10.1300/J484v12n03_05; Naranjo SE, 2009, BIOL CONTROL, V51, P458, DOI 10.1016/j.biocontrol.2009.08.006; Nombela G, 2009, B ENTOMOL RES, V99, P183, DOI 10.1017/S0007485308006214; Nombela G, 1987, BEMISIA BIONOMICS MA, P357; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Orians C, 2005, J CHEM ECOL, V31, P2231, DOI 10.1007/s10886-005-7099-7; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Quiroz A, 1997, J CHEM ECOL, V23, P2599, DOI 10.1023/B:JOEC.0000006669.34845.0d; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Rodriguez-Saona C, 2003, J CHEM ECOL, V29, P2539, DOI 10.1023/A:1026314102866; Sarmento RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023757; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Sauge MH, 2002, ENTOMOL EXP APPL, V102, P29, DOI 10.1023/A:1015282702657; Shiojiri K, 2006, OECOLOGIA, V149, P214, DOI 10.1007/s00442-006-0441-0; Smith CM, 2007, ENTOMOL EXP APPL, V122, P1, DOI 10.1111/j.1570-7458.2006.00503.x; Stratmann JW, 2003, TRENDS PLANT SCI, V8, P247, DOI 10.1016/S1360-1385(03)00106-7; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; Turlings TCJ, 2000, J CHEM ECOL, V26, P189, DOI 10.1023/A:1005449730052; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Wise MJ, 2009, EVOL ECOL, V23, P347, DOI 10.1007/s10682-007-9230-4; Wool D, 1996, PHYTOPARASITICA, V24, P39, DOI 10.1007/BF02981452; Xue M, 2010, ENVIRON ENTOMOL, V39, P883, DOI 10.1603/EN09307; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Zhang LP, 2005, J APPL ENTOMOL, V129, P443, DOI 10.1111/j.1439-0418.2005.00991.x; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhang SZ, 2013, ENTOMOL EXP APPL, V147, P293, DOI 10.1111/eea.12067; Zhang ZP, 1997, PLANTA, V203, P436, DOI 10.1007/s004250050211; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177; Zhu-Salzman Keyan, 2005, Insect Science, V12, P3, DOI 10.1111/j.1672-9609.2005.00002.x	72	9	12	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94310	10.1371/journal.pone.0094310	http://dx.doi.org/10.1371/journal.pone.0094310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710393	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800133
J	Frentz, D; van de Vijver, D; Abecasis, A; Albert, J; Hamouda, O; Jorgensen, L; Kucherer, C; Struck, D; Schmit, JC; Vercauteren, J; Asjo, B; Balotta, C; Bergin, C; Beshkov, D; Camacho, R; Clotet, B; Griskevicius, A; Grossman, Z; Horban, A; Kolupajeva, T; Korn, K; Kostrikis, L; Linka, KLM; Nielsen, C; Otelea, D; Paraskevis, D; Paredes, R; Poljak, M; Puchhammer-Stockl, E; Sonnerborg, A; Stanekova, D; Stanojevic, M; Vandamme, AM; Boucher, C; Wensing, A				Frentz, Dineke; van de Vijver, David; Abecasis, Ana; Albert, Jan; Hamouda, Osamah; Jorgensen, Louise; Kucherer, Claudia; Struck, Daniel; Schmit, Jean-Claude; Vercauteren, Jurgen; Asjo, Birgitta; Balotta, Claudia; Bergin, Colm; Beshkov, Danail; Camacho, Ricardo; Clotet, Bonaventura; Griskevicius, Algirdas; Grossman, Zehava; Horban, Andrzej; Kolupajeva, Tatjana; Korn, Klaus; Kostrikis, Leondios; Linka, Kirsi Liitsola Marek; Nielsen, Claus; Otelea, Dan; Paraskevis, Dimitrios; Paredes, Roger; Poljak, Mario; Puchhammer-Stoeckl, Elisabeth; Sonnerborg, Anders; Stanekova, Danica; Stanojevic, Maja; Vandamme, Anne-Mieke; Boucher, Charles; Wensing, Annemarie		SPREAD Programme	Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TRANSMISSION; PREVALENCE; MUTATIONS; EPIDEMIOLOGY; INDIVIDUALS; POPULATIONS; APPEARANCE; ACCESS; HAART	Background: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations (TDRM) in relation to the risk behaviour reported. Methods: HIV-1 patients newly diagnosed in 27 countries from 2002 through 2007 were included. Inclusion was representative for risk group and geographical distribution in the participating countries in Europe. Trends over time were calculated by logistic regression. Results: From the 4317 patients included, the majority was men-having-sex-with-men -MSM (2084, 48%), followed by heterosexuals (1501, 35%) and injection drug users (IDU) (355, 8%). MSM were more often from Western Europe origin, infected with subtype B virus, and recently infected (<1 year) (p<0.001). The prevalence of TDRM was highest in MSM (prevalence of 11.1%), followed by heterosexuals (6.6%) and IDU (5.1%, p<0.001). TDRM was predominantly ascribed to nucleoside reverse transcriptase inhibitors (NRTI) with a prevalence of 6.6% in MSM, 3.3% in heterosexuals and 2.0% in IDU (p = 0.001). A significant increase in resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) and a decrease in resistance to protease inhibitors was observed in MSM (p = 0.008 and p = 0.006, respectively), but not in heterosexual patients (p = 0.68 and p = 0.14, respectively). Conclusions: MSM showed to have significantly higher TDRM prevalence compared to heterosexuals and IDU. The increasing NNRTI resistance in MSM is likely to negatively influence the therapy response of first-line therapy, as most include NNRTI drugs.	[Frentz, Dineke; van de Vijver, David; Boucher, Charles] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Abecasis, Ana; Camacho, Ricardo] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan; Sonnerborg, Anders] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Hamouda, Osamah; Kucherer, Claudia; Nielsen, Claus] Robert Koch Inst, Berlin, Germany; [Jorgensen, Louise] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Struck, Daniel; Schmit, Jean-Claude] CRP Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Schmit, Jean-Claude] Ctr Hosp Luxembourg, Luxembourg, Luxembourg; [Vercauteren, Jurgen; Vandamme, Anne-Mieke] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium; [Asjo, Birgitta] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Balotta, Claudia] Univ Milan, Milan, Italy; [Bergin, Colm] St James Hosp, Dept GU Med & Infect Dis, Dublin 8, Ireland; [Beshkov, Danail; Paredes, Roger] Natl Ctr Infect & Parasit Dis, Dept Virol, Sofia, Bulgaria; [Camacho, Ricardo] Ctr Hosp Lisboa Ocidental, Hosp Egas Moniz, Lisbon, Portugal; [Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst, Badalona, Spain; [Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Lluita SIDA Fdn, Badalona, Spain; [Griskevicius, Algirdas] Natl Publ Hlth Surveillance Lab, Vilnius, Lithuania; [Grossman, Zehava] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Horban, Andrzej] Med Univ Warsaw, Warsaw, Poland; [Horban, Andrzej] Hosp Infect Dis, Warsaw, Poland; [Kolupajeva, Tatjana] Infectol Ctr Latvia, Riga, Latvia; [Korn, Klaus] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Kostrikis, Leondios] Univ Cyprus, Nicosia, Cyprus; [Linka, Kirsi Liitsola Marek] Natl Inst Hlth & Welf, Helsinki, Finland; [Linka, Kirsi Liitsola Marek] Natl Inst Publ Hlth, Prague, Czech Republic; [Otelea, Dan] Prof Dr Matei Bals Inst Infect Dis, Bucharest, Romania; [Paraskevis, Dimitrios] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Poljak, Mario] Univ Ljubljana, Ljubljana, Slovenia; [Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Vienna, Austria; [Sonnerborg, Anders] Karolinska Inst, Div Infect Dis, Stockholm, Sweden; [Sonnerborg, Anders] Karolinska Inst, Div Clin Virol, Stockholm, Sweden; [Stanekova, Danica] Slovak Med Univ, Bratislava, Slovakia; [Stanojevic, Maja] Univ Belgrade, Sch Med, Belgrade, Serbia; [Wensing, Annemarie] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Robert Koch Institute; Statens Serum Institut; Luxembourg Institute of Health; Luxembourg Hospital Center; KU Leuven; University of Bergen; University of Milan; Trinity College Dublin; Bulgarian Academy of Sciences; Medical University Sofia; Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Centro Hospitalar de Lisboa Ocidental, EPE; Egas Moniz Hospital; Universidade de Lisboa; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Chaim Sheba Medical Center; Medical University of Warsaw; University of Erlangen Nuremberg; University of Cyprus; Finland National Institute for Health & Welfare; National Institute of Public Health (SZU) - Czech Republic; National Institute for Infectious Diseases "Matei Bals"; Athens Medical School; National & Kapodistrian University of Athens; University of Ljubljana; Medical University of Vienna; Karolinska Institutet; Karolinska Institutet; Slovak Medical University Bratislava; University of Belgrade; Utrecht University; Utrecht University Medical Center	Wensing, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	A.M.J.Wensing@umcutrecht.nl	Vandekerckhove, Linos/J-6420-2013; rezza, giovanni/D-4393-2016; Paraskevis, Dimitrios/H-5835-2019; Magiorkinis, Emmanouil/B-1530-2010; Abecasis, Ana/ABF-6657-2020; Van Laethem, Kristel/R-6282-2016; Wiercińska-Drapało, Alicja/V-5930-2018; Vandamme, Anne-Mieke/I-4127-2012; Abecasis, Ana/B-6295-2009; Ciccozzi, Massimo/AAC-3271-2022; Sakka, Vissaria/GLN-7705-2022; Otelea, Dan/AAV-6467-2021; Sönnerborg, Anders/W-2011-2019; KOSTRIKIS, LEONDIOS G/A-5330-2016; Camacho, Ricardo J/I-7629-2012; Van Ranst, Marc/P-7522-2017; Vercauteren, Jurgen/P-7676-2019; Gisslen, Magnus/D-7454-2015; Balotta, Claudia/L-7295-2017	Vandekerckhove, Linos/0000-0002-8600-1631; rezza, giovanni/0000-0003-0268-6790; Paraskevis, Dimitrios/0000-0001-6167-7152; Magiorkinis, Emmanouil/0000-0001-8883-7275; Abecasis, Ana/0000-0002-3903-5265; Van Laethem, Kristel/0000-0001-6036-2271; Wiercińska-Drapało, Alicja/0000-0001-5921-1409; Vandamme, Anne-Mieke/0000-0002-6594-2766; Abecasis, Ana/0000-0002-3903-5265; Ciccozzi, Massimo/0000-0003-3866-9239; Sönnerborg, Anders/0000-0001-8928-3374; KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Camacho, Ricardo J/0000-0002-9129-3237; Van Ranst, Marc/0000-0002-1674-4157; Vercauteren, Jurgen/0000-0003-0698-4736; Otelea, Dan/0000-0002-0821-6346; Duque, Vitor/0000-0003-0000-4004; Ristola, Matti/0000-0001-5115-2811; Gisslen, Magnus/0000-0002-2357-1020; Ribera, Esteban/0000-0002-3752-8808; Stanojevic, Maja/0000-0002-4643-4272; van de Vijver, David/0000-0001-5877-8526; Korn, Klaus/0000-0003-1891-2107; Lunar, Maja/0000-0003-1262-338X; Balotta, Claudia/0000-0002-1107-9119; Walter, Henrik/0000-0002-9403-6121	European Commission [QLK2-CT-2001-01344, LSHP-CT-2006-518211, 233847, 223131]; Belgian AIDS Reference Laboratory Fund, Belgian Fonds voor Wetenschappelijk Onderzoek [G. 0611.09]; Interuniversitaire Attractiepolen (Belgium) [P6/41]; Cyprus Research Promotion Foundation [Health/0104/22]; Danish AIDS Foundation; Ministry of Health (Germany) [1502-686-18]; Ministry of Education and Research (Germany) [01KI501]; Fifth National Program on HIV/AIDS, Istituto Superiore di Sanita (Italy) [N 40F.56, 20D.1.6]; Fondation Recherche sur le SiDA; Ministry of Health (Luxembourg); Swedish Research Council; Swedish Civil Contingencies Agency; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network [223131]; European Commission; Ministry of Education and Science (Republic of Serbia) [175024]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/65605/2009]; Slovak Ministry of Health [2005/37-SZU-15]	European Commission(European CommissionEuropean Commission Joint Research Centre); Belgian AIDS Reference Laboratory Fund, Belgian Fonds voor Wetenschappelijk Onderzoek; Interuniversitaire Attractiepolen (Belgium); Cyprus Research Promotion Foundation; Danish AIDS Foundation; Ministry of Health (Germany); Ministry of Education and Research (Germany); Fifth National Program on HIV/AIDS, Istituto Superiore di Sanita (Italy); Fondation Recherche sur le SiDA(ANRS); Ministry of Health (Luxembourg); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Civil Contingencies Agency; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education and Science (Republic of Serbia); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Slovak Ministry of Health	This work was supported by the European Commission (grant QLK2-CT-2001-01344, fifth framework; grant LSHP-CT-2006-518211, sixth framework, grant DynaNets no. 233847, grant CHAIN no. 223131, seventh framework); Belgian AIDS Reference Laboratory Fund, Belgian Fonds voor Wetenschappelijk Onderzoek (grant G. 0611.09); Interuniversitaire Attractiepolen (Belgium; grant P6/41); Cyprus Research Promotion Foundation (grant Health/0104/22); Danish AIDS Foundation; Ministry of Health (Germany; grant 1502-686-18); Ministry of Education and Research (Germany; grant 01KI501); Fifth National Program on HIV/AIDS, Istituto Superiore di Sanita (Italy; grants N 40F.56 and 20D.1.6); Fondation Recherche sur le SiDA; Ministry of Health (Luxembourg); Swedish Research Council; Swedish Civil Contingencies Agency; CHAIN, Collaborative HIV and Anti-HIV Drug Resistance Network, (Integrated Project no. 223131, funded by the European Commission Framework 7 Program); and Ministry of Education and Science (Republic of Serbia; grant 175024). ABA is supported by Fundacao para a Ciencia e Tecnologia (grant no. SFRH/BPD/65605/2009), and Slovak Ministry of Health-project (No. 2005/37-SZU-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Bannister WP, 2008, JAIDS-J ACQ IMM DEF, V48, P324, DOI 10.1097/QAI.0b013e31817ae5c0; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V41, P323; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Bollerup AR, 2008, SCAND J PUBLIC HEALT, V36, P183, DOI 10.1177/1403494807085191; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P517, DOI 10.1093/jac/dkl501; BOUCHER CAB, 1992, J INFECT DIS, V165, P105, DOI 10.1093/infdis/165.1.105; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Donoghoe MC, 2007, INT J DRUG POLICY, V18, P271, DOI 10.1016/j.drugpo.2007.02.010; Frentz D, 2012, AIDS REV, V14, P17; Gorbach PM, 2004, SEX TRANSM INFECT, V80, P512, DOI 10.1136/sti.2004.010918; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hurt CB, 2009, ANTIVIR THER, V14, P673; Jain V, 2011, J INFECT DIS, V203, P1174, DOI 10.1093/infdis/jiq167; Karlsson A, 2012, PLOS ONE, V7, P33484, DOI DOI 10.1371/JOURNAL.PONE.0033484; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Luber Andrew D, 2005, MedGenMed, V7, P69, DOI 10.1186/1758-2652-7-3-69; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Morrison SD, 2011, CENT EUR J PUBL HEAL, V19, P91, DOI 10.21101/cejph.a3644; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pingen M, 2011, J ANTIMICROB CHEMOTH; Routy JP, 2004, AIDS, V18, P2305, DOI 10.1097/00002030-200411190-00011; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Shoptaw S, 2009, J URBAN HEALTH, V86, pS77, DOI 10.1007/s11524-009-9372-5; *UNAIDS, 2002, REP GLOB HIV AIDS EP; Van Asten LC, 2003, EUR J PUBLIC HEALTH, V13, P347, DOI 10.1093/eurpub/13.4.347; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; WHO, 2011, HIV DRUG RES FACT SH; Wittkop L, 2011, LANCET INFECT DIS; Wood E, 2003, CAN MED ASSOC J, V169, P656; Xiridou M, 2010, AIDS, V24, P2081, DOI 10.1097/QAD.0b013e32833a6071; Yebra G, 2013, ARCH VIROL; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	43	29	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94495	10.1371/journal.pone.0094495	http://dx.doi.org/10.1371/journal.pone.0094495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721998	Green Published, gold			2022-12-27	WOS:000336909100083
J	Gassowska, M; Czapski, GA; Pajak, B; Cieslik, M; Lenkiewicz, AM; Adamczyk, A				Gassowska, Magdalena; Czapski, Grzegorz A.; Pajak, Beata; Cieslik, Magdalena; Lenkiewicz, Anna M.; Adamczyk, Agata			Extracellular alpha-Synuclein Leads to Microtubule Destabilization via GSK-3 beta-Dependent Tau Phosphorylation in PC12 Cells	PLOS ONE			English	Article							SYNTHASE KINASE-3 GSK3; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CONTRIBUTES; SER(396); PROTEIN; MODEL	alpha-Synuclein (ASN) plays an important role in pathogenesis of Parkinson's disease (PD) and other neurodegenerative disorders. Novel and most interesting data showed elevated tauopathy in PD and suggested relationship between ASN and Tau protein. However, the mechanism of ASN-evoked Tau protein modification is not fully elucidated. In this study we investigated the role of extracellular ASN in Tau hyperphosphorylation in rat pheochromocytoma (PC12) cells and the involvement of glycogen synthase kinase-3 beta (GSK-3 beta) and cyclin-dependent kinase 5 (CDK5) in ASN-dependent Tau modification. Our results indicated that exogenously added ASN increases Tau phosphorylation at Ser396. Accordingly, the GSK-3 beta inhibitor (SB-216763) prevented ASN-evoked Tau hyperphosphorylation, but the CDK5 inhibitor had no effect. Moreover, western blot analysis showed that ASN affected GSK-3 beta via increasing of protein level and activation of this enzyme. GSK-3 beta activity evaluated by its phosphorylation status assay showed that ASN significantly increased the phosphorylation of this enzyme at Tyr216 with parallel decrease in phosphorylation at Ser9, indicative of stimulation of GSK-3 beta activity. Moreover, the effect of ASN on microtubule (MT) destabilization and cell death with simultaneous the involvement of GSK-3 beta in these processes were analyzed. ASN treatment increased the amount of free tubulin and concomitantly reduced the amount of polymerized tubulin and SB-216763 suppressed these ASN-induced changes in tubulin, indicating that GSK-3 beta is involved in ASN-evoked MT destabilization. ASN-induced apoptotic processes lead to decrease in PC12 cells viability and SB-216763 protected those cells against ASN-evoked cytotoxicity. Concluding, extracellular ASN is involved in GSK-3 beta-dependent Tau hyperphosphorylation, which leads to microtubule destabilization. GSK-3 beta inhibition may be an effective strategy for protecting against ASN-induced cytotoxicity.	[Gassowska, Magdalena; Czapski, Grzegorz A.; Cieslik, Magdalena; Lenkiewicz, Anna M.; Adamczyk, Agata] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Cellular Signalling, Warsaw, Poland; [Pajak, Beata] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Adamczyk, A (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Cellular Signalling, Warsaw, Poland.	agataadamczyk72@gmail.com	Lenkiewicz, Anna Magdalena/V-9419-2018; Czapski, Grzegorz/D-6151-2016	Lenkiewicz, Anna Magdalena/0000-0003-2358-8372; Pajak, Beata/0000-0002-3565-8860; Gassowska-Dobrowolska, Magdalena/0000-0001-9777-1378; Czapski, Grzegorz/0000-0002-7541-1571; Cieslik, Magdalena/0000-0002-7604-4371	National Science Centre [2012/05/B/NZ3/02047]	National Science Centre(National Science Centre, Poland)	This project was funded by a grant from The National Science Centre (2012/05/B/NZ3/02047) for AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk A, 2005, J PHYSIOL PHARMACOL, V56, P29; Adamczyk A, 2007, FOLIA NEUROPATHOL, V45, P230; Arai Y, 2001, BRAIN RES, V888, P287, DOI 10.1016/S0006-8993(00)03082-1; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brown DR, 2010, IUBMB LIFE, V62, P334, DOI 10.1002/iub.316; Chen L, 2007, BIOCHEM BIOPH RES CO, V356, P548, DOI 10.1016/j.bbrc.2007.02.163; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Ciofani G, 2013, PHARM RES-DORDR, V30, P2133, DOI 10.1007/s11095-013-1071-y; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Czapski GA, 2013, FEBS LETT, V587, P3135, DOI 10.1016/j.febslet.2013.07.053; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; Fornai F, 2007, BRAIN RES, V1129, P174, DOI 10.1016/j.brainres.2006.10.071; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geddes JW, 2005, EXP NEUROL, V192, P244, DOI 10.1016/j.expneurol.2004.12.002; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haggerty T, 2011, EUR J NEUROSCI, V33, P1598, DOI 10.1111/j.1460-9568.2011.07660.x; Hongo H, 2012, BIOCHEM BIOPH RES CO, V426, P94, DOI 10.1016/j.bbrc.2012.08.042; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kawakami F, 2011, FEBS J, V278, P4895, DOI 10.1111/j.1742-4658.2011.08389.x; Kazmierczak A, 2008, NEUROCHEM INT, V53, P263, DOI 10.1016/j.neuint.2008.08.004; Khandelwal PJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-47; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lee SJ, 2008, J MOL NEUROSCI, V34, P17, DOI 10.1007/s12031-007-0012-9; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liu GW, 2013, J NEURAL TRANSM, V120, P1331, DOI 10.1007/s00702-013-0999-8; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	40	43	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94259	10.1371/journal.pone.0094259	http://dx.doi.org/10.1371/journal.pone.0094259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722055	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100045
J	Attard, MRG; Parr, WCH; Wilson, LAB; Archer, M; Hand, SJ; Rogers, TL; Wroe, S				Attard, Marie R. G.; Parr, William C. H.; Wilson, Laura A. B.; Archer, Michael; Hand, Suzanne J.; Rogers, Tracey L.; Wroe, Stephen			Virtual Reconstruction and Prey Size Preference in the Mid Cenozoic Thylacinid, Nimbacinus dicksoni (Thylacinidae, Marsupialia)	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; QUOLL DASYURUS-MACULATUS; ESTIMATED BITING FORCES; PREDATORY BEHAVIOR; FEEDING-BEHAVIOR; DNA PHYLOGENY; BITE FORCE; SKULL; DIET; BIOMECHANICS	Thylacinidae is an extinct family of Australian and New Guinean marsupial carnivores, comprizing 12 known species, the oldest of which are late Oligocene (similar to 24 Ma) in age. Except for the recently extinct thylacine (Thylacinus cynocephalus), most are known from fragmentary craniodental material only, limiting the scope of biomechanical and ecological studies. However, a particularly well-preserved skull of the fossil species Nimbacinus dicksoni, has been recovered from middle Miocene (similar to 16-11.6 Ma) deposits in the Riversleigh World Heritage Area, northwestern Queensland. Here, we ask whether N. dicksoni was more similar to its recently extinct relative or to several large living marsupials in a key aspect of feeding ecology, i.e., was N. dicksoni a relatively small or large prey specialist. To address this question we have digitally reconstructed its skull and applied three-dimensional Finite Element Analysis to compare its mechanical performance with that of three extant marsupial carnivores and T. cynocephalus. Under loadings adjusted for differences in size that simulated forces generated by both jaw closing musculature and struggling prey, we found that stress distributions and magnitudes in the skull of N. dicksoni were more similar to those of the living spotted-tailed quoll (Dasyurus maculatus) than to its recently extinct relative. Considering the Finite Element Analysis results and dental morphology, we predict that N. dicksoni likely occupied a broadly similar ecological niche to that of D. maculatus, and was likely capable of hunting vertebrate prey that may have exceeded its own body mass.	[Attard, Marie R. G.; Parr, William C. H.; Wilson, Laura A. B.; Rogers, Tracey L.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Attard, Marie R. G.; Wroe, Stephen] Univ New England, Sch Environm & Rural Sci, Funct Evolut & Anat Res Lab, Armidale, NSW 2351, Australia; [Archer, Michael; Hand, Suzanne J.] Univ New S Wales, Evolut Earth & Life Sci Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney; University of New England; University of New South Wales Sydney	Attard, MRG (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	marie.attard@une.edu.au	Wilson, Laura AB/A-4881-2012; Rogers, Tracey L/C-3419-2008; Attard, Marie/AAT-9996-2021; Hand, Suzanne J/C-3853-2008	Wilson, Laura AB/0000-0002-3779-8277; Attard, Marie/0000-0002-8509-3677; Wroe, Stephen/0000-0002-6365-5915; Hand, Suzanne/0000-0002-4940-3391; Rogers, Tracey/0000-0002-7141-4177; Archer, Michael/0000-0002-0304-4039	Australian Research Council [DP0666374, DP0987985, LP100200486, DP1094569]; Postgraduate Writing and Skills Transfer Award; Evolution and Ecology Research Centre, University of New South Wales; Swiss National Science Foundation [PBZHP3_141470]	Australian Research Council(Australian Research Council); Postgraduate Writing and Skills Transfer Award; Evolution and Ecology Research Centre, University of New South Wales; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was funded by Australian Research Council grants to S. Wroe (DP0666374 and DP0987985), and to M. Archer, and S .J. Hand (LP100200486 and DP1094569). M. Attard is supported by the Postgraduate Writing and Skills Transfer Award sponsored by the Evolution and Ecology Research Centre, University of New South Wales. L. Wilson is supported by the Swiss National Science Foundation (PBZHP3_141470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	ARCHER M, 1991, RIVERSLEIGH STORY AN; ARCHER M, 2002, EVOLUTION AUSTR 110; Archer M., 2006, ALCHERINGA AUSTRALAS, V30, P1, DOI DOI 10.1080/03115510609506851; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; Bailey C, 2003, TIGER TALES STORIES; BELCHER CA, 1995, WILDLIFE RES, V22, P341, DOI 10.1071/WR9950341; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; Benazzi S, 2011, J HUM EVOL, V61, P75, DOI 10.1016/j.jhevol.2011.02.005; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bradshaw CJA, 2005, ECOGRAPHY, V28, P181, DOI 10.1111/j.0906-7590.2005.04088.x; Braithwaite RW, 1995, MAMMALS AUSTR NATL P, P65; Breul R, 1999, ANN ANAT, V181, P55, DOI 10.1016/S0940-9602(99)80090-9; Chamoli U, 2011, THESIS U NEW S WALES; Chamoli U, 2011, J THEOR BIOL, V283, P217, DOI 10.1016/j.jtbi.2011.05.020; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Clausen P, 2008, J BIOMECH, V41, P3184, DOI 10.1016/j.jbiomech.2008.08.019; COOK SD, 1982, J DENT RES, V61, P25, DOI 10.1177/00220345820610010501; Dawson JP, 2007, WILDLIFE RES, V34, P342, DOI 10.1071/WR05101; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Edgar R., 1995, MAMMALS AUSTR, P67; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Figueirido B, 2013, EVOLUTION, V67, P1975, DOI 10.1111/evo.12059; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; FLEAY DAVID, 1932, VICTORIAN NAT, V49, P63; Glen AS, 2006, J ZOOL, V269, P241, DOI 10.1111/j.1469-7998.2006.00046.x; Goswami A, 2011, P ROY SOC B-BIOL SCI, V278, P1831, DOI 10.1098/rspb.2010.2031; Greaves GN, 2011, NAT MATER, V10, P823, DOI [10.1038/NMAT3134, 10.1038/nmat3134]; Groves C. P., 2005, MAMMAL SPECIES WORLD, P23; GUILER E R, 1970, Australian Journal of Zoology, V18, P49, DOI 10.1071/ZO9700049; Guiler ER, 1985, THYLACINE TRAGEDY TA; Hickman DM, 1998, ORAL SURG ORAL MED O, V85, P18, DOI 10.1016/S1079-2104(98)90392-4; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; Jones M, 1997, ECOLOGY, V78, P2569; Jones M., 1995, THESIS U TASMANIA HO; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones Menna E., 2003, P285; Krajewski C, 1997, P ROY SOC B-BIOL SCI, V264, P911, DOI 10.1098/rspb.1997.0126; KRAJEWSKI C, 1992, P ROY SOC B-BIOL SCI, V250, P19, DOI 10.1098/rspb.1992.0125; LOWENSTEIN JM, 1981, NATURE, V291, P409, DOI 10.1038/291409a0; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; MUIRHEAD J, 1990, Memoirs of the Queensland Museum, V28, P203; Muirhead J, 1998, J VERTEBR PALEONTOL, V18, P612, DOI 10.1080/02724634.1998.10011088; Muirhead Jeanette, 1997, Memoirs of the Queensland Museum, V41, P367; Murray Peter, 2000, Beagle, V16, P145; Murray Peter F., 1997, Records of the South Australian Museum (Adelaide), V30, P43; Myers TJ, 2001, AUST J ZOOL, V49, P99, DOI 10.1071/ZO01009; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Oakwood M., 1997, THESIS AUSTR NATL U; Oldfield CC, 2012, J ZOOL, V286, P163, DOI 10.1111/j.1469-7998.2011.00862.x; Owen D, 2005, TASMANIAN DEVIL UNIQ; Paddle R., 2000, LAST TASMANIAN TIGER; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; PELLIS S M, 1984, Australian Mammalogy, V7, P5; PELLIS SM, 1987, ETHOLOGY, V75, P177; Pollock A. B., 1999, Australian Zoologist, V31, P388; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ross CF, 2005, ANAT REC PART A, V283A, P253, DOI 10.1002/ar.a.20177; SARICH V, 1982, CARNIVOROUS MARSUPIA, P445; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Strahan R., 1995, MAMMALS AUSTR, V2nd; Strait DS, 2010, ANAT REC, V293, P583, DOI 10.1002/ar.21122; Szalay F.S., 1982, P621; TAYLOR R J, 1986, Papers and Proceedings of the Royal Society of Tasmania, V120, P7; THOMAS RH, 1989, NATURE, V340, P465, DOI 10.1038/340465a0; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; THRESHER RW, 1973, J BIOMECH, V6, P443, DOI 10.1016/0021-9290(73)90003-1; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Tsafnat N, 2011, J ANAT, V218, P40, DOI 10.1111/j.1469-7580.2010.01289.x; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 1996, J PALEONTOL, V70, P1032, DOI 10.1017/S0022336000038737; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2001, AUST J ZOOL, V49, P603, DOI 10.1071/ZO01044; Wroe S, 2001, AUST J ZOOL, V49, P487, DOI 10.1071/ZO00032; Wroe S, 1999, AUST J ZOOL, V47, P489, DOI 10.1071/ZO99006; Wroe S, 1998, J PALEONTOL, V72, P738, DOI 10.1017/S0022336000040439; Wroe S, 2006, EVOLUTION BIOGEOGRAP, P517; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; Wroe Stephen, 2003, P102; Wroe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066888; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zar J. H., 1996, BIOSTAT ANAL, P353	92	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93088	10.1371/journal.pone.0093088	http://dx.doi.org/10.1371/journal.pone.0093088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718109	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000026
J	Canto, E; Planella, EG; Zamora-Atenza, C; Nieto, JC; Gordillo, J; Ortiz, MA; Meton, I; Serrano, E; Vegas, E; Garcia-Bosch, O; Juarez, C; Vidal, S				Canto, Elisabet; Garcia Planella, Esther; Zamora-Atenza, Carlos; Camilo Nieto, Juan; Gordillo, Jordi; Angels Ortiz, Ma; Meton, Isidoro; Serrano, Elena; Vegas, Esteban; Garcia-Bosch, Orlando; Juarez, Candido; Vidal, Silvia			Interleukin-19 Impairment in Active Crohn's Disease Patients	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; CUTTING EDGE; POTENTIAL ROLE; TH2 CYTOKINES; TNF-ALPHA; IL-19; EXPRESSION; CELLS; IL-20; MICE	The exact function of interleukin-19 (IL-19) on immune response is poorly understood. In mice, IL-19 up-regulates TNF alpha and IL-6 expression and its deficiency increases susceptibility to DSS-induced colitis. In humans, IL-19 favors a Th2 response and is elevated in several diseases. We here investigate the expression and effects of IL-19 on cells from active Crohn's disease (CD) patient. Twenty-three active CD patients and 20 healthy controls (HC) were included. mRNA and protein IL-19 levels were analyzed in monocytes. IL-19 effects were determined in vitro on the T cell phenotype and in the production of cytokines by immune cells. We observed that unstimulated and TLR-activated monocytes expressed significantly lower IL-19 mRNA in active CD patients than in HC (logFC = -1.97 unstimulated; -1.88 with Pam3CSK4; and -1.91 with FSL-1; p< 0.001). These results were confirmed at protein level. Exogenous IL-19 had an anti-inflammatory effect on HC but not on CD patients. IL-19 decreased TNF alpha production in PBMC (850.7 +/- 75.29 pg/ml vs 2626.0 +/- 350 pg/ml; p<0.01) and increased CTLA4 expression (22.04 +/- 1.55% vs 13.98 +/- 2.05%; p<0.05) and IL-4 production (32.5 +/- 8.9 pg/ml vs 13.5 +/- 2.9 pg/ml; p< 0.05) in T cells from HC. IL-10 regulated IL-19 production in both active CD patients and HC. We observed that three of the miRNAs that can modulate IL-19 mRNA expression, were up-regulated in monocytes from active CD patients. These results suggested that IL-19 had an anti-inflammatory role in this study. Defects in IL-19 expression and the lack of response to this cytokine could contribute to inflammatory mechanisms in active CD patients.	[Canto, Elisabet; Zamora-Atenza, Carlos; Camilo Nieto, Juan; Angels Ortiz, Ma; Vidal, Silvia] IIB St Pau, Biomed Res Inst St Pau, Dept Immunol, Barcelona, Spain; [Garcia Planella, Esther; Gordillo, Jordi] Hosp Santa Creu & Sant Pau, Dept Digest Pathol, Barcelona, Spain; [Meton, Isidoro] Univ Barcelona, Fac Pharm, Dept Biochem & Mol Biol, Barcelona, Spain; [Serrano, Elena] IIB St Pau, Biomed Res Inst St Pau, PSCT Platforms, Barcelona, Spain; [Vegas, Esteban] Univ Barcelona, Fac Biol, Dept Stat, Barcelona, Spain; [Garcia-Bosch, Orlando] Hosp St Joan Despi Moises Broggi, Dept Digest, Barcelona, Spain; [Juarez, Candido] Hosp Santa Creu & Sant Pau, Dept Immunol, Barcelona, Spain; [Juarez, Candido; Vidal, Silvia] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Canto, E (corresponding author), IIB St Pau, Biomed Res Inst St Pau, Dept Immunol, Barcelona, Spain.	ecanto@santpau.cat	Vegas, Esteban/G-4231-2015; Metón, Isidoro/G-9027-2015	Vegas, Esteban/0000-0002-6869-4075; Metón, Isidoro/0000-0003-2301-2365; zamora, carlos/0000-0003-2962-678X; Vidal, Silvia/0000-0002-3909-6682; CANTO, ELISABET/0000-0002-1782-1855; Nieto Sachica, Juan Camilo/0000-0002-3400-1488	Ministerio de Economia i competitividad, Instituto de Salud Carlos III [PS09/132]; Fondo Investigaciones Sanitarias	Ministerio de Economia i competitividad, Instituto de Salud Carlos III; Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III)	Ministerio de Economia i competitividad PS09/132 Instituto de Salud Carlos III. Silvia Vidal was supported by "Fondo Investigaciones Sanitarias" and participant in the Program for Stabilization of Investigators of the "Direccio d'Estrategia i Coordinacio del Departament Salut de la Generalitat de Catalunya". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara T, 2010, SCAND J RHEUMATOL, V39, P118, DOI 10.3109/03009740903170823; Azuma YT, 2010, INFLAMM BOWEL DIS, V16, P1017, DOI 10.1002/ibd.21151; Beltran CJ, 2009, EUR CYTOKINE NETW, V20, P94, DOI [10.1684/ecn.2009.0142, 10.1684/ecn.2009.0151]; Bianchini R, 2011, EUR J IMMUNOL, V41, P2269, DOI 10.1002/eji.201040943; Canto E, 2006, CLIN IMMUNOL, V119, P156, DOI 10.1016/j.clim.2005.12.005; Chen YY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/294320; De Tena JG, 2006, J CLIN IMMUNOL, V26, P233, DOI 10.1007/s10875-006-9016-4; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; England RN, 2013, AM J PHYSL CELL PHYS; England RN, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/253583; Gabunia K, 2011, AM J PHYSIOL-CELL PH, V300, pC896, DOI 10.1152/ajpcell.00439.2010; Gallagher G, 2004, INT IMMUNOPHARMACOL, V4, P615, DOI 10.1016/j.intimp.2004.01.005; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Gallagher G, 2010, CYTOKINE GROWTH F R, V21, P345, DOI 10.1016/j.cytogfr.2010.08.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; Hofmann SR, 2012, KLIN PADIATR, V224, P53, DOI 10.1055/s-0031-1291359; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2007, NEPHROL DIAL TRANSPL, V22, P2230, DOI 10.1093/ndt/gfm179; Hsing CH, 2008, CYTOKINE, V44, P221, DOI 10.1016/j.cyto.2008.06.007; Hsu YH, 2012, RHEUMATOLOGY, V51, P434, DOI 10.1093/rheumatology/ker127; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Oral HB, 2006, EUR J IMMUNOL, V36, P380, DOI 10.1002/eji.200425523; Pace E, 2012, ALLERGY, V67, P878, DOI 10.1111/j.1398-9995.2012.02842.x; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Strober W, 1998, ANN INTERN MED, V128, P848, DOI 10.7326/0003-4819-128-10-199805150-00009; Sun DP, 2013, CYTOKINE, V62, P360, DOI 10.1016/j.cyto.2013.03.017; Wahl C, 2009, J IMMUNOL, V182, P802, DOI 10.4049/jimmunol.182.2.802; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Yeh CH, 2011, ANN THORAC SURG, V92, P1252, DOI 10.1016/j.athoracsur.2011.04.061; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003	41	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93910	10.1371/journal.pone.0093910	http://dx.doi.org/10.1371/journal.pone.0093910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718601	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000056
J	Gruninger, RJ; Thibault, J; Capeness, MJ; Till, R; Mosimann, SC; Sockett, RE; Selinger, BL; Lovering, AL				Gruninger, Robert J.; Thibault, John; Capeness, Michael J.; Till, Robert; Mosimann, Steven C.; Sockett, R. Elizabeth; Selinger, Brent L.; Lovering, Andrew L.			Structural and Biochemical Analysis of a Unique Phosphatase from Bdellovibrio bacteriovorus Reveals Its Structural and Functional Relationship with the Protein Tyrosine Phosphatase Class of Phytase	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INOSITOL POLYPHOSPHATASE; SUBSTRATE-BINDING; SPECIFICITY; DIVERSITY; STEREOSPECIFICITY	Bdellovibrio bacteriovorus is an unusual delta-proteobacterium that invades and preys on other Gram-negative bacteria and is of potential interest as a whole cell therapeutic against pathogens of man, animals and crops. PTPs (protein tyrosine phosphatases) are an important class of enzyme involved in desphosphorylating a variety of substrates, often with implications in cell signaling. The B. bacteriovorus open reading frame Bd1204 is predicted to encode a PTP of unknown function. Bd1204 is both structurally and mechanistically related to the PTP- like phytase (PTPLP) class of enzymes and possesses a number of unique properties not observed in any other PTPLPs characterized to date. Bd1204 does not display catalytic activity against some common protein tyrosine phosphatase substrates but is highly specific for hydrolysis of phosphomonoester bonds of inositol hexakisphosphate. The structure reveals that Bd1204 has the smallest and least electropositive active site of all characterized PTPLPs to date yet possesses a unique substrate specificity characterized by a strict preference for inositol hexakisphosphate. These two active site features are believed to be the most significant contributors to the specificity of phytate degrading enzymes. We speculate that Bd1204 may be involved in phosphate acquisition outside of prey.	[Gruninger, Robert J.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Capeness, Michael J.; Till, Robert; Sockett, R. Elizabeth] Univ Nottingham, Sch Med, Sch Life Sci, Ctr Genet & Genom,QMC, Nottingham, England; [Thibault, John; Selinger, Brent L.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Mosimann, Steven C.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Lovering, Andrew L.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Lovering, Andrew L.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Agriculture & Agri Food Canada; University of Nottingham; University of Lethbridge; University of Lethbridge; University of Birmingham; University of Birmingham	Lovering, AL (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.	a.lovering@bham.ac.uk		Lovering, Andrew/0000-0002-1856-7975	NSERC; BBSRC [BB/G013632/1, BB/J015229/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G013632/1, BB/J015229/1] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LBS and SBM are supported by funding from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohm K, 2010, FEBS J, V277, P1284, DOI 10.1111/j.1742-4658.2010.07559.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gruninger RJ, 2008, FEBS J, V275, P3783, DOI 10.1111/j.1742-4658.2008.06524.x; Gruninger RJ, 2012, J BIOL CHEM, V287, P9722, DOI 10.1074/jbc.M111.309872; Gruninger RJ, 2009, J MOL BIOL, V392, P75, DOI 10.1016/j.jmb.2009.05.079; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang HQ, 2011, ENVIRON MICROBIOL, V13, P747, DOI 10.1111/j.1462-2920.2010.02379.x; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karunker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061850; Kostrewa D, 1999, J MOL BIOL, V288, P965, DOI 10.1006/jmbi.1999.2736; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lim BL, 2007, ISME J, V1, P321, DOI 10.1038/ismej.2007.40; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Nakashima BA, 2007, MICROB ECOL, V53, P82, DOI 10.1007/s00248-006-9147-4; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Pasternak Z, 2013, ISME J, V7, P756, DOI 10.1038/ismej.2012.149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puhl AA, 2008, BIOCHEM CELL BIOL, V86, P322, DOI 10.1139/o08-095; Puhl AA, 2008, INT J BIOCHEM CELL B, V40, P2053, DOI 10.1016/j.biocel.2008.02.003; Puhl AA, 2007, PROTEIN SCI, V16, P1368, DOI 10.1110/ps.062738307; Puhl AA, 2009, APPL MICROBIOL BIOT, V82, P95, DOI 10.1007/s00253-008-1734-5; Rao DECS, 2009, CRIT REV BIOTECHNOL, V29, P182, DOI 10.1080/07388550902919571; Shapland EB, 2011, J BACTERIOL, V193, P4361, DOI 10.1128/JB.00185-11; Sockett RE, 2004, NAT REV MICROBIOL, V2, P669, DOI 10.1038/nrmicro959; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	34	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94403	10.1371/journal.pone.0094403	http://dx.doi.org/10.1371/journal.pone.0094403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718691	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000119
J	Sabir, JSM; Arasappan, D; Bahieldin, A; Abo-Aba, S; Bafeel, S; Zari, TA; Edris, S; Shokry, AM; Gadalla, NO; Ramadan, AM; Atef, A; Al-Kordy, MA; El-Domyati, FM; Jansen, RK				Sabir, Jamal S. M.; Arasappan, Dhivya; Bahieldin, Ahmed; Abo-Aba, Salah; Bafeel, Sameera; Zari, Talal A.; Edris, Sherif; Shokry, Ahmed M.; Gadalla, Nour O.; Ramadan, Ahmed M.; Atef, Ahmed; Al-Kordy, Magdy A.; El-Domyati, Fotoh M.; Jansen, Robert K.			Whole Mitochondrial and Plastid Genome SNP Analysis of Nine Date Palm Cultivars Reveals Plastid Heteroplasmy and Close Phylogenetic Relationships among Cultivars	PLOS ONE			English	Article							BIPARENTAL INHERITANCE; CHLOROPLAST GENOME; CYTOPLASMIC INHERITANCE; L. CULTIVARS; DNA; GENERATION; FRUIT; AFLP; IDENTIFICATION; INSERTIONS	Date palm is a very important crop in western Asia and northern Africa, and it is the oldest domesticated fruit tree with archaeological records dating back 5000 years. The huge economic value of this crop has generated considerable interest in breeding programs to enhance production of dates. One of the major limitations of these efforts is the uncertainty regarding the number of date palm cultivars, which are currently based on fruit shape, size, color, and taste. Whole mitochondrial and plastid genome sequences were utilized to examine single nucleotide polymorphisms (SNPs) of date palms to evaluate the efficacy of this approach for molecular characterization of cultivars. Mitochondrial and plastid genomes of nine Saudi Arabian cultivars were sequenced. For each species about 60 million 100 bp paired-end reads were generated from total genomic DNA using the Illumina HiSeq 2000 platform. For each cultivar, sequences were aligned separately to the published date palm plastid and mitochondrial reference genomes, and SNPs were identified. The results identified cultivar-specific SNPs for eight of the nine cultivars. Two previous SNP analyses of mitochondrial and plastid genomes identified substantial intra-cultivar (= intra-varietal) polymorphisms in organellar genomes but these studies did not properly take into account the fact that nearly half of the plastid genome has been integrated into the mitochondrial genome. Filtering all sequencing reads that mapped to both organellar genomes nearly eliminated mitochondrial heteroplasmy but all plastid SNPs remained heteroplasmic. This investigation provides valuable insights into how to deal with interorganellar DNA transfer in performing SNP analyses from total genomic DNA. The results confirm recent suggestions that plastid heteroplasmy is much more common than previously thought. Finally, low levels of sequence variation in plastid and mitochondrial genomes argue for using nuclear SNPs for molecular characterization of date palm cultivars.	[Sabir, Jamal S. M.; Bahieldin, Ahmed; Abo-Aba, Salah; Bafeel, Sameera; Zari, Talal A.; Edris, Sherif; Shokry, Ahmed M.; Gadalla, Nour O.; Ramadan, Ahmed M.; Atef, Ahmed; Al-Kordy, Magdy A.; El-Domyati, Fotoh M.; Jansen, Robert K.] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia; [Arasappan, Dhivya; Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Bahieldin, Ahmed; Edris, Sherif; El-Domyati, Fotoh M.] Ain Shams Univ, Dept Genet, Cairo, Egypt; [Abo-Aba, Salah] Natl Res Ctr, Dept Microbial Genet, Giza, Egypt; [Shokry, Ahmed M.; Ramadan, Ahmed M.] Agr Res Ctr, Agr Genet Engn Res Inst, Giza, Egypt; [Gadalla, Nour O.; Al-Kordy, Magdy A.] Natl Res Ctr, Dept Genet & Cytol, Dokki, Egypt	King Abdulaziz University; University of Texas System; University of Texas Austin; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Jansen, RK (corresponding author), King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia.	jansen@austin.utexas.edu	Zari, Talal/E-9398-2014; Edris, Sherif/GXZ-9995-2022; atef, ahmed/B-7842-2013; Sabir, Jamal S M/C-8102-2014; Edris, Sherif/I-8070-2012; bahieldin, ahmed/I-9186-2012; Ramadan, Ahmed/I-8241-2012; Bafeel, Sameera Omar/ABB-9694-2020; gadalla, nour eldin o/J-3140-2012	Zari, Talal/0000-0002-7333-5034; Edris, Sherif/0000-0002-2810-3736; Edris, Sherif/0000-0002-2810-3736; Ramadan, Ahmed/0000-0002-2502-9921; Bafeel, Sameera/0000-0002-7912-1993; Bahieldin, Ahmed/0000-0002-6496-7881; Atef, Ahmed/0000-0001-7530-2060; Al-kordy, Magdy/0000-0002-0838-0445; Gadalla, Nour/0000-0002-1622-6763	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [1-3-1432/HiCi]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under Grant no. (1-3-1432/HiCi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla M, 2010, AUST J CROP SCI, V4, P23; Adawy S.S., 2005, ARAB J BIOTECHNOL, V8, P99; Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Mahmoud ME, 2012, AM J BOT, V99, pE7, DOI 10.3732/ajb.1100425; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Al-Mssallem IS, 1996, DATE PALM PHOENIX DA, V7; Al-Shahib W, 2003, INT J FOOD SCI NUTR, V54, P247, DOI [10.1080/09637480120091982, 10.1080/096374803766666120]; Arrieta-Montiel MP, 2011, ADVAN PL BIO, V1, P65; BIRKY CW, 1983, SCIENCE, V222, P468, DOI 10.1126/science.6353578; Cao BR, 2002, HORTSCIENCE, V37, P966, DOI 10.21273/HORTSCI.37.6.966; Chat J, 2002, J HERED, V93, P293, DOI 10.1093/jhered/93.4.293; CHIU WL, 1988, CURR GENET, V13, P181, DOI 10.1007/BF00365653; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Diaz S, 2003, CELL MOL BIOL LETT, V8, P891; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; El Hadrami Ismail, 2009, P191, DOI 10.1007/978-0-387-71201-7_6; El-Hadrami A., 2012, Emirates Journal of Food and Agriculture, V24, P371; Elkhishin D. A., 2003, ARAB J BIOTECH, V6, P223; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Frey JE, 1999, THEOR APPL GENET, V99, P578, DOI 10.1007/s001220051271; Garcia MA, 2004, J MOL EVOL, V58, P322, DOI 10.1007/s00239-003-2554-y; Gawel NJ, 1991, MOL BIOL REP, V9, P262, DOI DOI 10.1007/BF02672076; Hagemann R, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P93, DOI 10.1007/978-1-4020-3166-3_4; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; Jaradat AA, 2011, ENCY LIFE SUPPORT SY, P1; JOHNSON LB, 1989, PLANT MOL BIOL, V12, P3, DOI 10.1007/BF00017442; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khan A, 2012, PLANT MOL BIOL REP, V30, P666, DOI 10.1007/s11105-011-0373-7; Kmiec B, 2006, CURR GENET, V50, P149, DOI 10.1007/s00294-006-0082-1; LAX AR, 1987, J HERED, V78, P147, DOI 10.1093/oxfordjournals.jhered.a110347; LEE DJ, 1988, THEOR APPL GENET, V76, P545, DOI 10.1007/BF00260905; MASON RJ, 1994, J HERED, V85, P171, DOI 10.1093/oxfordjournals.jhered.a111430; McPherson H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-8; Melodelima C, 2013, META GENE, V1, P65, DOI 10.1016/j.mgene.2013.10.004; MICHAELIS P., 1962, BIOL ZENTRALBL, V81, P91; Michalovova M, 2013, HEREDITY, V111, P314, DOI 10.1038/hdy.2013.51; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Moghaieb REA, 2010, ARAB J BIOTECH, V132, P143; MOON E, 1987, NUCLEIC ACIDS RES, V15, P611, DOI 10.1093/nar/15.2.611; Mower J.P., 2012, PLANT GENOME DIVERSI, P123, DOI DOI 10.1007/978-3-7091-1130-7_9; Noutsos C, 2005, GENOME RES, V15, P616, DOI 10.1101/gr.3788705; Popenoe P., 1973, The date palm.; Sabir JSM, 2014, CR BIOL, V337, P6, DOI 10.1016/j.crvi.2013.11.003; Sharma R., 2012, SCI RES IMPACT, V1, P29; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; TILNEYBASSETT RAE, 1981, THEOR APPL GENET, V60, P43, DOI 10.1007/BF00275177; Vayalil PK, 2002, J AGR FOOD CHEM, V50, P610, DOI 10.1021/jf010716t; Vayalil PK, 2012, CRIT REV FOOD SCI, V52, P249, DOI 10.1080/10408398.2010.499824; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Younis R. A. A., 2008, Research Journal of Agriculture and Biological Sciences, V4, P278; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	55	32	33	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94158	10.1371/journal.pone.0094158	http://dx.doi.org/10.1371/journal.pone.0094158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718264	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000083
J	Gaiad, TP; Araujo, KPC; Serrao, JC; Miglino, MA; Ambrosio, CE				Gaiad, Thais P.; Araujo, Karla P. C.; Serrao, Julio C.; Miglino, Maria A.; Ambrosio, Carlos Eduardo			Motor Physical Therapy Affects Muscle Collagen Type I and Decreases Gait Speed in Dystrophin-Deficient Dogs	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; FIBROSIS; MODELS; RANGE; GENE	Golden Retriever Muscular Dystrophy (GRMD) is a dystrophin-deficient canine model genetically homologous to Duchenne Muscular Dystrophy (DMD) in humans. Muscular fibrosis secondary to cycles of degeneration/regeneration of dystrophic muscle tissue and muscular weakness leads to biomechanical adaptation that impairs the quality of gait. Physical therapy (PT) is one of the supportive therapies available for DMD, however, motor PT approaches have controversial recommendations and there is no consensus regarding the type and intensity of physical therapy. In this study we investigated the effect of physical therapy on gait biomechanics and muscular collagen deposition types I and III in dystrophin-deficient dogs. Two dystrophic dogs (treated dogs-TD) underwent a PT protocol of active walking exercise, 3 x/week, 40 minutes/day, 12 weeks. Two dystrophic control dogs (CD) maintained their routine of activities of daily living. At t0 (pre) and t1 (post-physical therapy), collagen type I and III were assessed by immunohistochemistry and gait biomechanics were analyzed. Angular displacement of shoulder, elbow, carpal, hip, stifle and tarsal joint and vertical (Fy), mediolateral (Fz) and craniocaudal (Fx) ground reaction forces (GRF) were assessed. Wilcoxon test was used to verify the difference of biomechanical variables between t0 and t1, considering p<.05. Type I collagen of endomysium suffered the influence of PT, as well as gait speed that had decreased from t0 to t1 (p<.000). The PT protocol employed accelerates morphological alterations on dystrophic muscle and promotes a slower velocity of gait. Control dogs which maintained their routine of activities of daily living seem to have found a better balance between movement and preservation of motor function.	[Gaiad, Thais P.] Univ Jequitinhonha & Mucuri Valley UFVJM, Fac Biol Sci & Hlth, Dept Phys Therapy, Diamantina, MG, Brazil; [Araujo, Karla P. C.; Miglino, Maria A.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, BR-09500900 Sao Paulo, Brazil; [Serrao, Julio C.] Univ Sao Paulo, Sch Phys Educ & Sports, Dept Biodynam, BR-09500900 Sao Paulo, Brazil; [Ambrosio, Carlos Eduardo] Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade de Sao Paulo	Ambrosio, CE (corresponding author), Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil.	ceambrosio@usp.br	SERRÃO, JULIO CERCA/G-8499-2015; Ambrosio, Carlos Eduardo/F-3402-2010; Miglino, Maria Angelica/B-9519-2012	SERRÃO, JULIO CERCA/0000-0002-3646-3387; Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Miglino, Maria Angelica/0000-0003-4979-115X	FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo) [06/61561-6]	FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo) process no 06/61561-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052202; Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Ambrosio CE, 2009, GENET MOL RES, V8, P389, DOI 10.4238/vol8-2gmr581; Ansved T, 2003, CURR OPIN CLIN NUTR, V6, P435, DOI 10.1097/00075197-200307000-00013; Araujo KPC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061367; Barthelemy I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048478; Barthelemy I, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-75; Barthelemy I, 2009, NEUROMUSCULAR DISORD, V19, P788, DOI 10.1016/j.nmd.2009.07.014; Besancon MF, 2004, AM J VET RES, V65, P1497, DOI 10.2460/ajvr.2004.65.1497; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Carter GT, 2008, AM J PHYS MED RE S11, V81, P151; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Cozzi F, 2001, ACTA NEUROPATHOL, V101, P469; Cup EH, 2007, ARCH PHYS MED REHAB, V88, P1452, DOI 10.1016/j.apmr.2007.07.024; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Doglio L, 2011, EUR J PHYS REHAB MED, V47, P587; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Gaiad TP, 2009, BRAZ J PHYS THER, V13, P244, DOI 10.1590/S1413-35552009005000032; Gaiad TP, 2011, RES VET SCI, V91, P188, DOI 10.1016/j.rvsc.2011.01.007; Gaiad TP, 2012, MUSCULAR DYSTROPHY, P535, DOI [10.5772/30329, DOI 10.5772/30329]; Ganea R, 2012, J CHILD NEUROL, V27, P30, DOI 10.1177/0883073811413581; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Huebner KD, 2008, AM J PHYSIOL-HEART C, V294, pH1550, DOI 10.1152/ajpheart.01253.2007; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Lee DV, 2004, J EXP BIOL, V207, P1715, DOI 10.1242/jeb.00947; Marsh AP, 2010, NEUROMUSCULAR DISORD, V20, P16, DOI 10.1016/j.nmd.2009.10.007; McLoon LK, 2008, AM J PHYSIOL-HEART C, V294, pH1505, DOI 10.1152/ajpheart.00176.2008; Meij BP, 2006, VET SURG, V35, P168, DOI 10.1111/j.1532-950X.2006.00128.x; Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; Shin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059875; Shin JH, 2013, MOL THER, V21, P750, DOI 10.1038/mt.2012.283; Strober Jonathan B, 2006, NeuroRx, V3, P225; Thibaud JL, 2007, NEUROMUSCULAR DISORD, V17, P575, DOI 10.1016/j.nmd.2007.03.013; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; van der Walt AM, 2008, J S AFR VET ASSOC, V79, P175; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	41	10	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93500	10.1371/journal.pone.0093500	http://dx.doi.org/10.1371/journal.pone.0093500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713872	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900029
J	King, K; Ogle, C				King, Katherine; Ogle, Christin			Negative Life Events Vary by Neighborhood and Mediate the Relation between Neighborhood Context and Psychological Well-Being	PLOS ONE			English	Article							POTENTIALLY TRAUMATIC EVENTS; PHYSICAL HEALTH; SOCIAL-CLASS; DISORDER; STRESS; ENVIRONMENT; EXPOSURE; IMPACT; CRIME; EPIDEMIOLOGY	Researchers have speculated that negative life events are more common in troubled neighborhoods, amplifying adverse effects on health. Using a clustered representative sample of Chicago residents (2001-03; n = 3,105) from the Chicago Community Adult Health Survey, we provide the first documentation that negative life events are highly geographically clustered compared to health outcomes. Associations between neighborhood context and negative life events were also found to vary by event type. We then demonstrate the power of a contextualized approach by testing path models in which life events mediate the relation between neighborhood characteristics and health outcomes, including self-rated health, anxiety, and depression. The indirect paths between neighborhood conditions and health through negative life event exposure are highly significant and large compared to the direct paths from neighborhood conditions to health. Our results indicate that neighborhood conditions can have acute as well as chronic effects on health, and that negative life events are a powerful mechanism by which context may influence health.	[King, Katherine] US EPA, Environm Publ Hlth Div, Chapel Hill, NC USA; [King, Katherine] Duke Univ, Durham, NC USA; [Ogle, Christin] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	United States Environmental Protection Agency; Duke University; Duke University	King, K (corresponding author), US EPA, Environm Publ Hlth Div, Chapel Hill, NC USA.	keking@umich.edu			Duke University Medical Center (King, Ogle); U.S. Environmental Protection Agency; Office of Research and Development; Oak Ridge Institute for Science and Education;  [2T32 AG000029-35]; NATIONAL INSTITUTE ON AGING [T32AG000029] Funding Source: NIH RePORTER	Duke University Medical Center (King, Ogle); U.S. Environmental Protection Agency(United States Environmental Protection Agency); Office of Research and Development; Oak Ridge Institute for Science and Education(General Electric); ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by grant 2T32 AG000029-35 to the Center for the Study of Aging and Human Development, Duke University Medical Center (King, Ogle) and in part by an appointment (King) to the Research Participation Program for the U.S. Environmental Protection Agency, Office of Research and Development, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U. S. Department of Energy and EPA. This work does not represent the official policies of the Environmental Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; BLAZER D, 1987, AM J PSYCHIAT, V144, P1178; Burton LM, 2006, AGING GLOBALIZATION; Chilcoat HD, 1998, ARCH GEN PSYCHIAT, V55, P913, DOI 10.1001/archpsyc.55.10.913; CRANE J, 1991, AM J SOCIOL, V96, P1226, DOI 10.1086/229654; Cutrona CE, 2000, J PERS SOC PSYCHOL, V79, P1088, DOI 10.1037/0022-3514.79.6.1088; Durkheim E., 1997, SUICIDE STUDY SOCIOL; Earls F. J., 2007, PROJECT HUMAN DEV CH; Entwisle B, 2007, DEMOGRAPHY, V44, P687, DOI 10.1353/dem.2007.0045; EPA US, 2003, FRAM CUM RISK ASS; Finch BK, 2010, HEALTH PLACE, V16, P1058, DOI 10.1016/j.healthplace.2010.05.009; Fremont AM., 2000, HDB MED SOCIOLOGY, V5; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Hatch SL, 2007, AM J COMMUN PSYCHOL, V40, P313, DOI 10.1007/s10464-007-9134-z; HUGHES DC, 1988, INT J AGING HUM DEV, V27, P207, DOI 10.2190/F9RP-8V9D-CGH7-2F0N; Hunte HER, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1084; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Kilpatrick D. G., 1998, DSM 4 SOURCEBOOK, V4, P803; King K, 2013, PREV MED, V57, P850, DOI 10.1016/j.ypmed.2013.09.019; King K, 2013, URBAN STUD, V50, P2407, DOI 10.1177/0042098013477698; King K, 2012, SOC SCI MED, V75, P2258, DOI 10.1016/j.socscimed.2012.08.027; King KE, 2011, PSYCHOSOM MED, V73, P572, DOI 10.1097/PSY.0b013e318227b062; Krause N, 2004, PSYCHOL AGING, V19, P637, DOI 10.1037/0882-7974.19.4.637; Krause N, 2004, GERONTOLOGIST, V44, P615, DOI 10.1093/geront/44.5.615; Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Mair C, 2010, HLTH PLACE, V16; MASSEY DS, 1981, AM SOCIOL REV, V46, P641, DOI 10.2307/2094945; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Morello-Frosch R, 2006, ENVIRON RES, V102, P181, DOI 10.1016/j.envres.2006.05.007; Morenoff J.D., 2008, MAKING AM HLTH SOCIA, P309; Morenoff JD, 2007, SOC SCI MED, V65, P1853, DOI 10.1016/j.socscimed.2007.05.038; Moudon Anne Vernez, 2006, J Phys Act Health, V3, pS99, DOI 10.1123/jpah.3.s1.s99; Muthen B., 2010, MPLUS USERS GUIDE; Norris F. H., 2002, J CLIN GEROPSYCHOLOG, V8, P153, DOI DOI 10.1023/A:1015940126474; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; O'Donovan A, 2012, BRAIN BEHAV IMMUN, V26, P642, DOI 10.1016/j.bbi.2012.02.003; Oakes JM, 2006, INT J EPIDEMIOL, V35, P643, DOI 10.1093/ije/dyl054; Ogle CM, 2013, CLIN PSYCHOL SCI, V1, P426, DOI 10.1177/2167702613485076; Ogle CM, 2013, DEV PSYCHOL, V49, P2191, DOI 10.1037/a0031985; Ogle CM, AGING MENTAL HLTH; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; PERKINS DD, 1992, J ENVIRON PSYCHOL, V12, P21, DOI 10.1016/S0272-4944(05)80294-4; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Porter AS, 1999, IMECHE SEM, V1999, P1; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Sampson RJ, 1999, AM J SOCIOL, V105, P603, DOI 10.1086/210356; Sampson RJ, 1999, AM SOCIOL REV, V64, P633, DOI 10.2307/2657367; Sampson RJ, 2004, SOC PSYCHOL QUART, V67, P319, DOI 10.1177/019027250406700401; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schnurr P, 2002, J CLIN GEROPSYCHOL, V8, P175, DOI [DOI 10.1023/A:1015992110544, 10.1023/A:1015992110544]; Shmotkin D, 2009, SOC PSYCH PSYCH EPID, V44, P989, DOI 10.1007/s00127-009-0020-x; Skrondal A., 2004, GEN LATENT VARIABLE; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stansfeld SA, 1998, SOC PSYCH PSYCH EPID, V33, P1; Sternthal MJ, 2010, J HEALTH SOC BEHAV, V51, P343, DOI 10.1177/0022146510378237; Taylor SE, 1997, ANNU REV PSYCHOL, V48, P411, DOI 10.1146/annurev.psych.48.1.411; Taylor SE, 2004, J PERS, V72, P1365, DOI 10.1111/j.1467-6494.2004.00300.x; Terracciano A, 2005, PSYCHOL AGING, V20, P493, DOI 10.1037/0882-7974.20.3.493; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Viruell-Fuentes EA, 2010, AM J PUBLIC HEALTH, pe1; Woldoff RA, 2006, CRIME PREV COMMUNITY, V8, P228, DOI 10.1057/palgrave.cpcs.8150028	66	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93539	10.1371/journal.pone.0093539	http://dx.doi.org/10.1371/journal.pone.0093539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714115	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900032
J	Natoli, C; Brocco, D; Sperduti, I; Nuzzo, A; Tinari, N; De Tursi, M; Grassadonia, A; Mazzilli, L; Iacobelli, S; Gamucci, T; Vici, P				Natoli, Clara; Brocco, Davide; Sperduti, Isabella; Nuzzo, Antonio; Tinari, Nicola; De Tursi, Michele; Grassadonia, Antonino; Mazzilli, Lorenzo; Iacobelli, Stefano; Gamucci, Teresa; Vici, Patrizia		Follow-UP Study Grp	Breast Cancer '' Tailored Follow-up '' in Italian Oncology Units: A Web-Based Survey	PLOS ONE			English	Article							AMERICAN-SOCIETY; ADJUVANT THERAPY; CARE; GUIDELINES; WOMEN; SURVEILLANCE; RECURRENCE; DISEASE; UPDATE; EXPERIENCE	Purpose: Breast cancer follow-up procedures after primary treatment are still a controversial issue. Aim of this study was to investigate, through a web-based survey, surveillance methodologies selected by Italian oncologists in everyday clinical practice. Methods: Referents of Italian medical oncology units were invited to participate to the study via e-mail through the SurveyMonkey website. Participants were asked how, in their institution, exams of disease staging and follow-up are planned in asymptomatic women and if surveillance continues beyond the 5th year. Results: Between February and May 2013, 125 out of 233 (53.6%) invited referents of Italian medical oncology units agreed to participate in the survey. Ninety-seven (77.6%) referents state that modalities of breast cancer follow-up are planned according to the risk of disease progression at diagnosis and only 12 (9.6%) oncology units apply the minimal follow-up procedures according to international guidelines. Minimal follow-up is never applied in high risk asymptomatic women. Ninety-eight (78.4%) oncology units continue follow-up in all patients beyond 5 years. Conclusions: Our survey shows that 90.4% of participating Italian oncology units declare they do not apply the minimal breast cancer follow-up procedures after primary treatment in asymptomatic women, as suggested by national and international guidelines. Interestingly, about 80.0% of interviewed referents performs the so called '' tailored follow-up '', high intensity for high risk, low intensity for low risk patients. There is an urgent need of randomized clinical trials able to determine the effectiveness of risk-based follow-up modalities, their ideal frequency and persistence in time.	[Natoli, Clara; Brocco, Davide; Tinari, Nicola; De Tursi, Michele; Grassadonia, Antonino; Iacobelli, Stefano] Univ G Dannunzio, Dept Expt & Clin Sci, Chieti, Italy; [Sperduti, Isabella] Regina Elena Inst Canc Res, Unit Biostat, Rome, Italy; [Nuzzo, Antonio] Floraspe Renzetti Hosp, Dept Oncol, Lanciano, Italy; [Mazzilli, Lorenzo] SS Annunziata Hosp, Clin Governance Unit, Chieti, Italy; [Gamucci, Teresa] SS Trinita Hosp, Dept Oncol, Sora, Italy; [Vici, Patrizia] Regina Elena Inst Canc Res, Div Med Oncol B, Rome, Italy	G d'Annunzio University of Chieti-Pescara; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Natoli, C (corresponding author), Univ G Dannunzio, Dept Expt & Clin Sci, Chieti, Italy.	natoli@unich.it	DE TURSI, MICHELE/L-3427-2016; Natoli, Clara/E-1378-2013; Biglia, Nicoletta/F-8801-2013; Brunello, Antonella/F-4224-2014; Brocco, Davide/ABC-5304-2021; Ferro, Antonella/AAA-8241-2020; Madeddu, Clelia/C-2347-2014; Sperduti, Isabella/K-8902-2016; GORI, Stefania/AAB-4802-2022; GORI, Stefania/N-8827-2016; riccardi, ferdinando/K-7370-2016	DE TURSI, MICHELE/0000-0002-1411-1946; Natoli, Clara/0000-0001-7295-0230; Biglia, Nicoletta/0000-0003-1009-5309; Brunello, Antonella/0000-0003-2583-5226; Ferro, Antonella/0000-0003-4109-6769; Sperduti, Isabella/0000-0001-5115-3099; GORI, Stefania/0000-0001-6320-405X; GORI, Stefania/0000-0001-6320-405X; Tonini, Giuseppe/0000-0003-4442-8677; riccardi, ferdinando/0000-0002-2852-2770; Vici, Patrizia/0000-0001-7528-9783; Tinari, Nicola/0000-0001-8449-5407; Landriscina, Matteo/0000-0003-0591-9799; ORDITURA, Michele/0000-0001-9105-8563	Consorzio Interuniversitario Nazionale per Bio-Oncologia (CINBO); Gruppo Interdisciplinare Cure Oncologiche (GICO), ASL Lanciano-Vasto-Chieti, Italy	Consorzio Interuniversitario Nazionale per Bio-Oncologia (CINBO); Gruppo Interdisciplinare Cure Oncologiche (GICO), ASL Lanciano-Vasto-Chieti, Italy	Supported by the Consorzio Interuniversitario Nazionale per Bio-Oncologia (CINBO) and by the Gruppo Interdisciplinare Cure Oncologiche (GICO), ASL Lanciano-Vasto-Chieti, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Associazione Italiana Oncologia Medica, LIN GUID TUM MAMM; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Barni S, 2011, TUMORI J, V97, P559, DOI 10.1700/989.10711; Bell RJ, 2013, INTERN MED J; Bell RJ, 2013, ANZ J SURG, V83, P129, DOI 10.1111/j.1445-2197.2012.06229.x; Brennan ME, 2010, ASIA-PAC J CLIN ONCO, V6, P116, DOI 10.1111/j.1743-7563.2010.01286.x; Ciatto S, 2004, EUR J CANCER, V40, P1496, DOI 10.1016/j.ejca.2004.03.010; Collins RF, 2004, CANCER TREAT REV, V30, P19, DOI 10.1016/S0305-7372(03)00141-5; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; de Bock GH, 2004, BRIT J CANCER, V90, P1144, DOI 10.1038/sj.bjc.6601655; Del Barco S, 2013, CLIN TRANSL ONCOL; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; Donnelly P, 2007, ANN ONCOL, V18, P1467, DOI 10.1093/annonc/mdm193; Gamucci T, 2013, J CANCER RES CLIN, V139, P853, DOI 10.1007/s00432-013-1388-2; GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587, DOI 10.1001/jama.1994.03510440047031; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Grandjean I, 2012, EUR J ONCOL NURS, V16, P281, DOI 10.1016/j.ejon.2011.07.004; Grunfeld E, 2005, CAN MED ASSOC J, V172, P1319, DOI 10.1503/cmaj.045062; Grunfeld E, 2010, J ONCOL PRACT, V6, P174, DOI 10.1200/JOP.200009; Hahn EE, 2013, CANCER; Hall PS, 2011, PHARMACOECONOMICS, V29, P415, DOI 10.2165/11588340-000000000-00000; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hayes DF, 2007, NEW ENGL J MED, V356, P2505, DOI 10.1056/NEJMcp067260; Jatoi I, 2011, J CLIN ONCOL, V29, P2301, DOI 10.1200/JCO.2010.32.3550; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Kobayashi T, 2012, BREAST CANCER-TOKYO, V19, P218, DOI 10.1007/s12282-012-0347-0; Kokko R, 2005, BREAST CANCER RES TR, V93, P255, DOI 10.1007/s10549-005-5199-2; Leoni M, 2013, TUMORI, V99, P30, DOI 10.1700/1248.13784; Margenthaler JA, 2013, ANN SURG ONCOL; Margenthaler JA, 2012, J ONCOL PRACT, V8, P79, DOI 10.1200/JOP.2011.000289; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Minicozzi P, 2013, J CANCER RES CLIN, V139, P1569, DOI 10.1007/s00432-013-1478-1; Montgomery DA, 2007, BRIT J CANCER, V96, P1625, DOI 10.1038/sj.bjc.6603771; Nabholtz Jean-Marc A, 2008, Ther Clin Risk Manag, V4, P189; National Comprehensive Cancer Network, 2013, BREAST CANC; Neuman HB, 2013, ANN SURG ONCOL; NICE, EARL LOC ADV BREAST; Ogawa Y, 2013, INT J CLIN ONCOL, V18, P447, DOI 10.1007/s10147-012-0401-0; Ohno S, 2012, BREAST CANCER-TOKYO, V19, P212, DOI 10.1007/s12282-011-0277-2; Palli D, 1999, JAMA-J AM MED ASSOC, V281, P1586, DOI 10.1001/jama.281.17.1586; Rojas MP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001768.pub2; Mendoza ESR, 2013, J CANCER RES CLIN, V139, P645, DOI 10.1007/s00432-012-1367-z; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Schaapveld M, 2008, BREAST CANCER RES TR, V110, P189, DOI 10.1007/s10549-007-9709-2; Senkus E, 2013, ANN ONCOL; Smith TJ, 1999, J CLIN ONCOL, V17, P1080, DOI 10.1200/JCO.1999.17.3.1080; Somerfield MR, 1997, J CLIN ONCOL, V15, P2149; Stopeck AT, 2012, CLIN EXP METASTAS, V29, P807, DOI 10.1007/s10585-012-9496-y; Strasser-Weippl K, 2013, BREAST, V22, pS171, DOI 10.1016/j.breast.2013.07.033; Taggart F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-238; van Hezewijk M, 2011, EJSO-EUR J SURG ONC, V37, P217, DOI 10.1016/j.ejso.2011.01.001	52	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94063	10.1371/journal.pone.0094063	http://dx.doi.org/10.1371/journal.pone.0094063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714591	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900078
J	Wang, XL; Luo, FL; Zhao, HG				Wang, Xiaolong; Luo, Fuling; Zhao, Hengguang			Paraquat-Induced Reactive Oxygen Species Inhibit Neutrophil Apoptosis via a p38 MAPK/NF-kappa B-IL-6/TNF-alpha Positive-Feedback Circuit	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; ACTIVATION; LUNG; SUPPRESSION; HYPOXIA; KINASE	Paraquat (PQ), a widely used herbicide and potent reactive oxygen species (ROS) inducer, can injure multiple tissues and organs, especially the lung. However, the underlying mechanism is still poorly understood. According to previous reports, neutrophil aggregation and excessive ROS production might play pivotal pathogenetic roles. In the present study, we found that PQ could prolong neutrophil lifespan and induce ROS generation in a concentration-independent manner. Activated nuclear factor-kappa B (NF-kappa B), p38 mitogen-activated kinase (p38 MAPK), and myeloid cell leukemia sequence 1 (Mcl-1) but not Akt signaling pathways were involved in this process, as well as increasing levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and IL-1 beta. Furthermore, the proinflammatory mediators IL-6 and TNF-alpha could in turn promote ROS generation, creating a vicious cycle. The existence of such a feedback loop is supported by our finding that neutrophil apoptosis is attenuated by PQ in a concentration-independent manner and could partially explain the clinical dilemma why oxygen therapy will exacerbate PQ induced tissue injury.	[Wang, Xiaolong] Chongqing Med Univ, Affiliated Hosp 2, Emergency Dept, Chongqing, Peoples R China; [Luo, Fuling] Chongqing Med Univ, Affiliated Hosp 1, Dept Pharm, Chongqing, Peoples R China; [Zhao, Hengguang] Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhao, HG (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China.	zhgdoc@hotmail.com			Natural Science Foundation Project of CQ CSTC [cstc2012jjA0315]; Sanitary Science Foundation of CQ [2013-2-036]	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Sanitary Science Foundation of CQ	This study was supported by Natural Science Foundation Project of CQ CSTC (to Hengguang Zhao, No. cstc2012jjA0315) and Sanitary Science Foundation of CQ (to Xiaolong Wang, No. 2013-2-036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirshahrokhi K, 2013, INT IMMUNOPHARMACOL, V17, P210, DOI 10.1016/j.intimp.2013.06.005; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Choi M, 2003, BLOOD, V102, P2259, DOI 10.1182/blood-2002-09-2960; Corasaniti MT, 1998, PHARMACOL TOXICOL, V83, P1, DOI 10.1111/j.1600-0773.1998.tb01434.x; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dinis-Oliveira RJ, 2006, XENOBIOTICA, V36, P724, DOI 10.1080/00498250600790331; Dinis-Oliveira RJ, 2006, PEDIATR EMERG CARE, V22, P537, DOI 10.1097/01.pec.0000223179.07633.8a; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hashimoto S, 2000, AM J RESP CRIT CARE, V161, P237, DOI 10.1164/ajrccm.161.1.9810007; Haslett C, 1997, BRIT MED BULL, V53, P669; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hoffer E, 1996, TOXICOL LETT, V84, P7, DOI 10.1016/0378-4274(95)03446-3; Holland JA, 1998, ENDOTHELIUM-NEW YORK, V6, P113, DOI 10.3109/10623329809072198; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Leuenroth SJ, 2000, SURGERY, V128, P171, DOI 10.1067/msy.2000.107609; Lundqvist-Gustafsson H, 1999, J LEUKOCYTE BIOL, V65, P196, DOI 10.1002/jlb.65.2.196; Maianski NA, 2003, ACTA HAEMATOL-BASEL, V111, P56, DOI 10.1159/000074486; Martin TR, 2003, CRIT CARE MED, V31, pS184, DOI 10.1097/01.CCM.0000057841.33876.B1; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Miskolci V, 2007, MOL MED, V13, P134, DOI 10.2119/2006-00072.Miskolci; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Parsey MV, 1999, CLIN IMMUNOL, V91, P219, DOI 10.1006/clim.1999.4693; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; SLATER AFG, 1995, BBA-MOL BASIS DIS, V1271, P59, DOI 10.1016/0925-4439(95)00010-2; Strassheim D, 2004, AM J PHYSIOL-CELL PH, V286, pC683, DOI 10.1152/ajpcell.00296.2003; Tesoriere L., 2013, BR J NUTR, P1; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200	39	40	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93837	10.1371/journal.pone.0093837	http://dx.doi.org/10.1371/journal.pone.0093837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714343	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900055
J	Yi, N; Ma, WZ; Pei, JF; Ouyang, Q; Tang, C; Lai, LH				Yi, Ning; Ma, Wenzhe; Pei, Jianfeng; Ouyang, Qi; Tang, Chao; Lai, Luhua			Synergistic and Antagonistic Drug Combinations Depend on Network Topology	PLOS ONE			English	Article							DISCOVERY; IDENTIFICATION; INHIBITION; TARGET	Drug combinations may exhibit synergistic or antagonistic effects. Rational design of synergistic drug combinations remains a challenge despite active experimental and computational efforts. Because drugs manifest their action via their targets, the effects of drug combinations should depend on the interaction of their targets in a network manner. We therefore modeled the effects of drug combinations along with their targets interacting in a network, trying to elucidate the relationships between the network topology involving drug targets and drug combination effects. We used three-node enzymatic networks with various topologies and parameters to study two-drug combinations. These networks can be simplifications of more complex networks involving drug targets, or closely connected target networks themselves. We found that the effects of most of the combinations were not sensitive to parameter variation, indicating that drug combinational effects largely depend on network topology. We then identified and analyzed consistent synergistic or antagonistic drug combination motifs. Synergistic motifs encompass a diverse range of patterns, including both serial and parallel combinations, while antagonistic combinations are relatively less common and homogenous, mostly composed of a positive feedback loop and a downstream link. Overall our study indicated that designing novel synergistic drug combinations based on network topology could be promising, and the motifs we identified could be a useful catalog for rational drug combination design in enzymatic systems.	[Yi, Ning; Pei, Jianfeng; Ouyang, Qi; Tang, Chao; Lai, Luhua] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS, Beijing 100871, Peoples R China; [Ouyang, Qi; Tang, Chao; Lai, Luhua] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Ouyang, Qi; Tang, Chao] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Ma, Wenzhe] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Peking University; Chinese Academy of Sciences; Peking University; Peking University; Peking University; Harvard University; Harvard Medical School	Lai, LH (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China.	lhlai@pku.edu.cn	Ma, Wenzhe/N-3320-2017; Pei, Jianfeng/U-9790-2019	Pei, Jianfeng/0000-0002-8482-1185; Tang, Chao/0000-0003-1474-3705	Ministry of Science and Technology of China [2012AA020308, 2012AA020301]; National Natural Science Foundation of China [90913021, 91313302, 81273436]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Ministry of Science and Technology of China (No. 2012AA020308, 2012AA020301) National Natural Science Foundation of China (No. 90913021, 91313302, 81273436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381; BLACK ML, 1963, J MED CHEM, V6, P145, DOI 10.1021/jm00338a014; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Galassi M., 2011, GNU SCI LIB REFERENC; GRECO WR, 1995, PHARMACOL REV, V47, P331; Jansen G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.95; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kraatz BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012838; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Morita M, 2007, INT J ONCOL, V30, P187; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391; VOGT MW, 1987, SCIENCE, V235, P1376, DOI 10.1126/science.2435003; Wang HS, 2011, CANCER RES, V71, P5535, DOI 10.1158/0008-5472.CAN-10-4351; Xu S, 2013, MOL CANC THER; Yan H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-50; YAN L, 2012, PLOS ONE, V0007; Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zou J, 2012, MOL BIOSYST, V8, P3185, DOI 10.1039/c2mb25267h	35	42	47	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93960	10.1371/journal.pone.0093960	http://dx.doi.org/10.1371/journal.pone.0093960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713621	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900067
J	Nakamura, I; Zakharia, K; Banini, BA; Mikhail, DS; Kim, TH; Yang, JD; Moser, CD; Shaleh, HM; Thornburgh, SR; Walters, I; Roberts, LR				Nakamura, Ikuo; Zakharia, Kais; Banini, Bubu A.; Mikhail, Dalia S.; Kim, Tae Hyo; Yang, Ju Dong; Moser, Catherine D.; Shaleh, Hassan M.; Thornburgh, Sarah R.; Walters, Ian; Roberts, Lewis R.			Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; LIVER FIBROSIS; TGF-BETA; INCREASED EXPRESSION; FACTOR RECEPTOR-2; BASIC FIBROBLAST; DUAL INHIBITOR; DISCOVERY	Background and Aims: Brivanib is a selective inhibitor of vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) tyrosine kinases, which are both involved in mechanisms of liver fibrosis. We hypothesized that inhibition of VEGFR and FGFR by brivanib would inhibit liver fibrosis. We therefore examined the effect of brivanib on liver fibrosis in three mouse models of fibrosis. Methods: In vivo, we induced liver fibrosis by bile duct ligation (BDL), chronic carbon tetrachloride (CCl4), and chronic thioacetamide (TAA) administration. Liver fibrosis was examined by immunohistochemistry and Western immunoblotting. In vitro, we used LX-2 human hepatic stellate cells (HSCs) to assess the effect of brivanib on stellate cell proliferation and activation. Results: After in vivo induction with BDL, CCl4, and TAA, mice treated with brivanib showed reduced liver fibrosis and decreased expression of collagen I alpha 1 and alpha-smooth muscle actin in the liver. In vitro, brivanib decreased proliferation of HSCs induced by platelet-derived growth factor (PDGF), VEGF, and FGF. Brivanib also decreased stellate cell viability and inhibited PDGFBB-induced phosphorylation of its cognate receptor. Conclusion: Brivanib reduces liver fibrosis in three different animal models and decreases human hepatic stellate cell activation. Brivanib may represent a novel therapeutic approach to treatment of liver fibrosis and prevention of liver cancer.	[Nakamura, Ikuo; Zakharia, Kais; Banini, Bubu A.; Mikhail, Dalia S.; Kim, Tae Hyo; Yang, Ju Dong; Moser, Catherine D.; Shaleh, Hassan M.; Thornburgh, Sarah R.; Roberts, Lewis R.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Walters, Ian] Bristol Myers Squibb, Wallingford, CT USA	Mayo Clinic; Bristol-Myers Squibb	Roberts, LR (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	roberts.lewis@mayo.edu		Roberts, Lewis/0000-0001-7885-8574	Bristol Myers Squibb; NATIONAL CANCER INSTITUTE [R01CA165076] Funding Source: NIH RePORTER	Bristol Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support was received from Bristol Myers Squibb. Dr Ian Walters (employee of Bristol Myers Squibb) played a role in study design and in review/editing of the manuscript, but had no role in data collection and analysis or in the decision to publish.	Ayers M, 2007, CANCER RES, V67, P6899, DOI 10.1158/0008-5472.CAN-06-4555; BARTOK I, 1981, HUM PATHOL, V12, P794; Bhide RS, 2010, MOL CANCER THER, V9, P369, DOI 10.1158/1535-7163.MCT-09-0472; Bhide RS, 2006, J MED CHEM, V49, P2143, DOI 10.1021/jm051106d; Cai ZW, 2008, J MED CHEM, V51, P1976, DOI 10.1021/jm7013309; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; Fibbi G, 1999, HEPATOLOGY, V29, P868, DOI 10.1002/hep.510290343; Finn RS, 2012, CLIN CANCER RES, V18, P2090, DOI 10.1158/1078-0432.CCR-11-1991; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Huynh H, 2008, CLIN CANCER RES, V14, P6146, DOI 10.1158/1078-0432.CCR-08-0509; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Kim SO, 1996, CANCER RES, V56, P3831; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Liu YQ, 2009, LAB INVEST, V89, P209, DOI 10.1038/labinvest.2008.127; Mise M, 1996, HEPATOLOGY, V23, P455; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Pinzani M, 1998, LIVER, V18, P2; Pinzani M, 2002, FRONT BIOSCI-LANDMRK, V7, pD1720, DOI 10.2741/pinzani; Sokolovic A, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-3; Torimura T, 1998, HUM PATHOL, V29, P986, DOI 10.1016/S0046-8177(98)90205-2; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5	27	43	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92273	10.1371/journal.pone.0092273	http://dx.doi.org/10.1371/journal.pone.0092273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710173	Green Published, gold			2022-12-27	WOS:000334159800012
J	Wang, LM; Li, LH; Chen, X; Tian, X; Wang, XK; Luo, GP				Wang, Limei; Li, Longhui; Chen, Xi; Tian, Xin; Wang, Xiaoke; Luo, Geping			Biomass Allocation Patterns across China's Terrestrial Biomes	PLOS ONE			English	Article							ORGANIC-MATTER; ROOT BIOMASS; SHOOT RATIOS; CARBON; FORESTS; GROWTH; PLANTS; WATER	Root to shoot ratio (RS) is commonly used to describe the biomass allocation between below-and aboveground parts of plants. Determining the key factors influencing RS and interpreting the relationship between RS and environmental factors is important for biological and ecological research. In this study, we compiled 2088 pairs of root and shoot biomass data across China's terrestrial biomes to examine variations in the RS and its responses to biotic and abiotic factors including vegetation type, soil texture, climatic variables, and stand age. The median value of RS (RSm) for grasslands, shrublands, and forests was 6.0, 0.73, and 0.23, respectively. The range of RS was considerably wide for each vegetation type. RS values for all three major vegetation types were found to be significantly correlated to mean annual precipitation (MAP) and potential water deficit index (PWDI). Mean annual temperature (MAT) also significantly affect the RS for forests and grasslands. Soil texture and forest origin altered the response of RS to climatic factors as well. An allometric formula could be used to well quantify the relationship between aboveground and belowground biomass, although each vegetation type had its own inherent allometric relationship.	[Wang, Limei; Li, Longhui; Chen, Xi; Luo, Geping] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Tian, Xin] Chinese Acad Forestry, Inst Forest Informat Resource Tech, Beijing, Peoples R China; [Wang, Xiaoke] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing Urban Ecosyst Res Stn, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Forestry; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Li, LH (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.	lhli@ms.xjb.ac.cn; tianxin@caf.ac.cn	Li, Longhui/I-5797-2018; Li, L./C-7214-2013	Li, Longhui/0000-0001-9983-6681; 	National Natural Science Foundation of China [41171094, 41101379]; "Hundred Talent" Project of the Chinese Academy of Sciences [Y174051001]; one of National Basic Research Program of China [2013CB733404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talent" Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); one of National Basic Research Program of China	This study was funded by the National Natural Science Foundation of China (grant number 41171094), the "Hundred Talent" Project of the Chinese Academy of Sciences (grant number Y174051001), one of National Basic Research Program of China (grant number 2013CB733404), and the National Natural Science Foundation of China (grant number 41101379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2003, ANN BOT-LONDON, V92, P795, DOI 10.1093/aob/mcg203; Binkley D, 2004, FOREST ECOL MANAG, V193, P5, DOI 10.1016/j.foreco.2004.01.019; BROWN S, 1982, BIOTROPICA, V14, P161, DOI 10.2307/2388024; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Camila AC, 2011, PLOS ONE, V6; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Crawley M. J, 2002, STAT COMPUTING INTRO; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Ericsson T, 1996, BIOMASS BIOENERG, V11, P115, DOI 10.1016/0961-9534(96)00032-3; FAO Food and Agriculture Organization of the United Nations, 1998, CROP EVAPOTRANSPIRAT; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; GHOLZ HL, 1991, ECOL MONOGR, V61, P33, DOI 10.2307/1942998; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Kang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069561; Kellomaki S, 2001, TREE PHYSIOL, V16, P765; Li LH, 2006, FIELD CROP RES, V96, P133, DOI 10.1016/j.fcr.2005.06.003; Li LH, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002038; Luo YJ, 2013, ANN FOREST SCI, V70, P589, DOI 10.1007/s13595-013-0296-6; Luo YJ, 2012, FOREST ECOL MANAG, V269, P19, DOI 10.1016/j.foreco.2012.01.005; Matsui Y, 2003, WATER RES, V37, P4413, DOI 10.1016/S0043-1354(03)00423-8; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Read JJ, 1996, ANN BOT-LONDON, V77, P487, DOI 10.1006/anbo.1996.0059; Reich PB, 2002, PLANT ROOTS HIDDEN H, V3rd, P205; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Snowdon P., 2000, 17 NCAS AUSTR GREENH; Stearns S.C., 1992, pi; Vogt KA, 1998, PLANT SOIL, V200, P71, DOI 10.1023/A:1004313515294; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]	37	24	33	11	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93566	10.1371/journal.pone.0093566	http://dx.doi.org/10.1371/journal.pone.0093566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710503	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800038
J	Wu, ZJ; Li, MM; Qu, L; Ye, HM; Liu, B; Yang, Q; Sheng, J; Xiao, L; Lv, C; Yang, B; Gao, X; Gao, XF; Xu, CL; Hou, JG; Sun, YH; Wang, LH				Wu, Zhenjie; Li, Mingmin; Qu, Le; Ye, Huamao; Liu, Bing; Yang, Qing; Sheng, Jing; Xiao, Liang; Lv, Chen; Yang, Bo; Gao, Xu; Gao, Xiaofeng; Xu, Chuanliang; Hou, Jianguo; Sun, Yinghao; Wang, Linhui			A Propensity-Score Matched Comparison of Perioperative and Early Renal Functional Outcomes of Robotic versus Open Partial Nephrectomy	PLOS ONE			English	Article							ASSISTED PARTIAL NEPHRECTOMY; CHRONIC KIDNEY-DISEASE; RADICAL NEPHRECTOMY; SURGICAL OUTCOMES; MULTICENTER; ISCHEMIA; IMPACT; INDEX	Objectives: To compare the perioperative and early renal functional outcomes of RPN with OPN for kidney tumors. Materials and Methods: A total of 209 RPN or OPN patients with availability of preoperative cross- sectional imaging since 2009 at our center were included. To adjust for potential baseline confounders propensity-score matching was performed, which resulted in 94 OPNs matched to 51 RPNs. Perioperative and early renal functional outcomes were compared. Results: In propensity-score matched analysis, RPN procedures were well tolerated and resulted in significant decreases in postoperative analgesic time (24 vs. 48 hr, p<0.001) and visual analog pain scale (3 vs. 4, p<0.001). Besides, the RPN patients had a significantly shorter LOS (9 vs. 11 days, p = 0.008) and less EBL (100 vs. 200 ml, p, 0.001), but median operative time was significantly longer (229 vs. 182 min, p<0.001). Ischemia time, transfusion rates, complication rates, percentage eGFR decline and CKD upstaging were equivalent after RPN versus OPN. In multivariable logistic regression analysis, RPN patients were less likely to have a prolonged LOS (odds ratio [ OR]: 0.409; p = 0.016), while more likely to experience a longer operative time (OR: 4.296; p = 0.001). However, the statistical significance for the protective effect of RPN versus OPN in EBL was not confirmed by examining the risk of EBL >= 400 ml (OR: 0.488; p = 0.212). Conclusions: When adjusted for potential selection biases, RPN offers comparable perioperative and early renal functional outcomes to those of OPN, with the added advantage of improved postoperative pain control and a shorter LOS.	[Wu, Zhenjie; Qu, Le; Ye, Huamao; Liu, Bing; Yang, Qing; Xiao, Liang; Lv, Chen; Yang, Bo; Gao, Xu; Gao, Xiaofeng; Xu, Chuanliang; Hou, Jianguo; Sun, Yinghao; Wang, Linhui] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Li, Mingmin; Sheng, Jing] Second Mil Med Univ, Changhai Hosp, Dept Radiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Sun, YH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China.	sunyh@medmail.com.cn; wlhui_chh@163.com	Wu, Zhenjie/GRJ-0184-2022; wang, lin/GSE-3040-2022; Lü, Chen/R-4089-2018	Wu, Zhenjie/0000-0002-6487-5207; Lü, Chen/0000-0001-6390-7636	National Natural Science Foundation of China [81272817, 81172447]; Talents Project of Shanghai Health System [XBR2011027]; Scientific and Technological Talents Project of Shanghai [13XD1400100]; Natural Science Foundation of Shanghai [11ZR1447800]; "Leading Talent" Project of Shanghai [2013046]; Hospital "1255" Discipline Construction Projects [CH125520300]; Hospital's Youth Initiation Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents Project of Shanghai Health System; Scientific and Technological Talents Project of Shanghai; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); "Leading Talent" Project of Shanghai; Hospital "1255" Discipline Construction Projects; Hospital's Youth Initiation Fund	This study has been supported by National Natural Science Foundation of China (81272817, 81172447), the Talents Project of Shanghai Health System (XBR2011027), the Scientific and Technological Talents Project of Shanghai (13XD1400100), Natural Science Foundation of Shanghai (11ZR1447800), The "Leading Talent" Project of Shanghai (2013046), and Hospital "1255" Discipline Construction Projects (CH125520300), Hospital's Youth Initiation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001943; Autorino R, 2013, BJU INT; Ficarra V, 2013, BJU INT; Ficarra V, 2012, EUR UROL, V61, P395, DOI 10.1016/j.eururo.2011.10.046; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Gong EM, 2008, J ENDOUROL, V22, P953, DOI 10.1089/end.2007.0300; Hemal AK, 2007, J UROLOGY, V177, P862, DOI 10.1016/j.juro.2006.10.053; Isac WE, 2012, BJU INT, V110, pE997, DOI 10.1111/j.1464-410X.2012.11318.x; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Laydner H, 2012, BJU INT, V109, P274, DOI 10.1111/j.1464-410X.2011.10319.x; Lee S, 2011, J ENDOUROL, V25, P1181, DOI 10.1089/end.2010.0670; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Ljungberg B., 2013, GUIDELINES RENAL CEL; MacLennan S, 2012, EUR UROL, V61, P972, DOI 10.1016/j.eururo.2012.02.039; Masson-Lecomte A, 2013, UROL ONCOL-SEMIN ORI, V31, P924, DOI 10.1016/j.urolonc.2011.08.004; Mottrie A, 2010, EUR UROL, V58, P127, DOI 10.1016/j.eururo.2010.03.045; Ng SSM, 2008, ANN SURG ONCOL, V15, P2418, DOI 10.1245/s10434-008-9895-0; Rogers CG, 2013, EUR UROL, V63, P573, DOI 10.1016/j.eururo.2012.11.029; Roscigno M, 2013, EUR UROL; Simhan J, 2012, J UROLOGY, V187, P2000, DOI 10.1016/j.juro.2012.01.064; Simmons MN, 2012, J UROLOGY, V188, P384, DOI 10.1016/j.juro.2012.03.123; Sun M, 2012, EUR UROL, V62, P696, DOI 10.1016/j.eururo.2012.03.051; Tan HJ, 2012, JAMA-J AM MED ASSOC, V307, P1629, DOI 10.1001/jama.2012.475; Vittori G, 2014, WORLD J UROL, V32, P287, DOI 10.1007/s00345-013-1136-x; Wang LH, 2013, BJU INT, V111, P1191, DOI 10.1111/bju.12108; White MA, 2011, UROLOGY, V77, P809, DOI 10.1016/j.urology.2010.12.005	27	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94195	10.1371/journal.pone.0094195	http://dx.doi.org/10.1371/journal.pone.0094195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710511	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800115
J	Sen, P; Dharmadhikari, AV; Majewski, T; Mohammad, MA; Kalin, TV; Zabielska, J; Ren, XM; Bray, M; Brown, HM; Welty, S; Thevananther, S; Langston, C; Szafranski, P; Justice, MJ; Kalinichenko, VV; Gambin, A; Belmont, J; Stankiewicz, P				Sen, Partha; Dharmadhikari, Avinash V.; Majewski, Tadeusz; Mohammad, Mahmoud A.; Kalin, Tanya V.; Zabielska, Joanna; Ren, Xiaomeng; Bray, Molly; Brown, Hannah M.; Welty, Stephen; Thevananther, Sundararajah; Langston, Claire; Szafranski, Przemyslaw; Justice, Monica J.; Kalinichenko, Vladimir V.; Gambin, Anna; Belmont, John; Stankiewicz, Pawel			Comparative Analyses of Lung Transcriptomes in Patients with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins and in Foxf1 Heterozygous Knockout Mice	PLOS ONE			English	Article							FORKHEAD BOX F1; GENE-EXPRESSION; CHRONIC HYPOXIA; HYPERTENSION; VASCULATURE; VARIANTS; NULL	Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) is a developmental disorder of the lungs, primarily affecting their vasculature. FOXF1 haploinsufficiency due to heterozygous genomic deletions and point mutations have been reported in most patients with ACDMPV. The majority of mice with heterozygous loss-of-function of Foxf1 exhibit neonatal lethality with evidence of pulmonary hemorrhage in some of them. By comparing transcriptomes of human ACDMPV lungs with control lungs using expression arrays, we found that several genes and pathways involved in lung development, angiogenesis, and in pulmonary hypertension development, were deregulated. Similar transcriptional changes were found in lungs of the postnatal day 0.5 Foxf1(-/-) mice when compared to their wildtype littermate controls; 14 genes, COL15A1, COL18A1, COL6A2, ESM1, FSCN1, GRINA, IGFBP3, IL1B, MALL, NOS3, RASL11B, MATN2, PRKCDBP, and SIRPA, were found common to both ACDMPV and Foxf1 heterozygous lungs. Our results advance knowledge toward understanding of the molecular mechanism of ACDMPV, lung development, and its vasculature pathology. These data may also be useful for understanding etiologies of other lung disorders, e. g. pulmonary hypertension, bronchopulmonary dysplasia, or cancer.	[Sen, Partha; Mohammad, Mahmoud A.; Welty, Stephen; Thevananther, Sundararajah; Belmont, John] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Dharmadhikari, Avinash V.; Brown, Hannah M.; Szafranski, Przemyslaw; Justice, Monica J.; Belmont, John; Stankiewicz, Pawel] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dharmadhikari, Avinash V.; Thevananther, Sundararajah; Justice, Monica J.; Stankiewicz, Pawel] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Majewski, Tadeusz] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Kalin, Tanya V.; Ren, Xiaomeng; Kalinichenko, Vladimir V.] Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Cincinnati, OH USA; [Zabielska, Joanna; Gambin, Anna] Univ Warsaw, Inst Informat, Warsaw, Poland; [Bray, Molly] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Brown, Hannah M.] Univ Adelaide, Sch Pediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Langston, Claire] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Gambin, Anna] Polish Acad Sci, Mossakowski Med Res Ctr, Warsaw, Poland	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Warsaw; University of Alabama System; University of Alabama Birmingham; Robinson Research Institute; University of Adelaide; Baylor College of Medicine; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Sen, P (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	psen@msn.com; pawels@bcm.edu	Mohammad, Mahmoud/GNO-9940-2022; Welty, Stephen/AAZ-4307-2021; Belmont, John/AAH-6084-2021; Welty, Stephen/AGS-7454-2022; Ren, Xiaomeng/U-1751-2019; Stankiewicz, Paweł/AAP-7906-2021; Dharmadhikari, Avinash Vijay/AAA-1514-2021; Belmont, John W/AAI-2494-2019; Gambin, Anna/I-3580-2012	Mohammad, Mahmoud/0000-0002-6535-5529; Welty, Stephen/0000-0002-6321-8440; Stankiewicz, Paweł/0000-0002-6456-7490; Dharmadhikari, Avinash Vijay/0000-0003-4182-4543; Belmont, John W/0000-0001-7409-3578; Gambin, Anna/0000-0003-3476-3017	Texas Children's Hospital, Houston TX; NIH [1RO1HL101975-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101975] Funding Source: NIH RePORTER	Texas Children's Hospital, Houston TX; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Part of this work was supported by a NORD grant and Pilot Project Award from the Texas Children's Hospital, Houston TX to P. Sen, and NIH grant 1RO1HL101975-01 to P. Stankiewicz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLAH HI, 1993, CRIT CARE MED, V21, P628, DOI 10.1097/00003246-199304000-00026; Al-Hathlol K, 2000, EARLY HUM DEV, V57, P85, DOI 10.1016/S0378-3782(99)00065-1; Alameh J, 2002, EUR J PEDIATR, V161, P262, DOI 10.1007/s00431-002-0927-7; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, P1; Armeanu-Ebinger S, 2011, INT J ONCOL, V38, P993, DOI 10.3892/ijo.2011.921; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Bhattacharya S, 2012, AM J RESP CRIT CARE, V186, P349, DOI 10.1164/rccm.201203-0406OC; Bishop NB, 2011, AM J RESP CRIT CARE, V184, P172, DOI 10.1164/rccm.201010-1697CI; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Hardie WD, 2007, AM J RESP CELL MOL, V37, P309, DOI 10.1165/rcmb.2006-0455OC; JANNEY CG, 1981, AM J CLIN PATHOL, V76, P722; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joza S, 2012, AM J PATHOL, V181, P2003, DOI 10.1016/j.ajpath.2012.08.037; Kalin TV, 2008, AM J RESP CELL MOL, V39, P390, DOI 10.1165/rcmb.2008-0044OC; Kalinichenko VV, 2004, AM J PHYSIOL-LUNG C, V286, pL521, DOI 10.1152/ajplung.00212.2003; Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322; Kitayama Y, 1997, J PEDIATR SURG, V32, P99, DOI 10.1016/S0022-3468(97)90105-6; LANGSTON C, 1991, Pediatric Pathology, V11, P163; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640; Levine DM, 2013, NAT GENET, V45, P1487, DOI 10.1038/ng.2796; Licht C, 2004, EUR J PEDIATR, V163, P181, DOI 10.1007/s00431-003-1385-6; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lo PK, 2013, EXP MOL PATHOL, V94, P262, DOI 10.1016/j.yexmp.2012.10.014; Lo PK, 2010, CANCER RES, V70, P6047, DOI 10.1158/0008-5472.CAN-10-1576; MACMAHON HE, 1948, PEDIATRICS, V2, P43; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; MANSOOR AM, 1995, BIOCHEM BIOPH RES CO, V215, P981, DOI 10.1006/bbrc.1995.2560; Plat G, 2007, ARCH MAL COEUR VAISS, V100, P458; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Sen P, 2004, J PEDIATR-US, V145, P646, DOI 10.1016/j.jpeds.2004.06.081; Sen P, 2013, HUM MUTAT, V34, P801, DOI 10.1002/humu.22313; Sen P, 2013, EUR J HUM GENET, V21, P474, DOI 10.1038/ejhg.2012.171; Shankar V, 2006, PEDIATR CRIT CARE ME, V7, P177, DOI 10.1097/01.PCC.0000202570.58016.67; SHOHET I, 1984, ARCH DIS CHILD, V59, P783, DOI 10.1136/adc.59.8.783; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Su Z, 2012, NAT GENET, V44, P1131, DOI 10.1038/ng.2408; Szafranski P, 2013, GENOME RES, V23, P23, DOI 10.1101/gr.141887.112; Tamura M, 2014, ONCOGENE, V33, P4837, DOI 10.1038/onc.2013.427; Thibeault DW, 1999, J PEDIATR-US, V134, P661, DOI 10.1016/S0022-3476(99)70264-7; Umesh A, 2011, J VASC RES, V48, P525, DOI 10.1159/000329593; van der Heul-Nieuwenhuijsen L, 2009, BJU INT, V103, P1574, DOI 10.1111/j.1464-410X.2009.08351.x; Wendling DS, 2008, INT J MOL MED, V22, P787, DOI 10.3892/ijmm_00000086; Young KC, 2010, EXP LUNG RES, V36, P111, DOI 10.3109/01902140903171610	48	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94390	10.1371/journal.pone.0094390	http://dx.doi.org/10.1371/journal.pone.0094390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722050	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100064
J	Wiese, E; Wykowska, A; Muller, HJ				Wiese, Eva; Wykowska, Agnieszka; Mueller, Hermann J.			What We Observe Is Biased by What Other People Tell Us: Beliefs about the Reliability of Gaze Behavior Modulate Attentional Orienting to Gaze Cues	PLOS ONE			English	Article							VISUAL-ATTENTION; EYE GAZE; SOCIAL COGNITION; REFLEXIVE; OTHERS; ARROWS; BRAIN	For effective social interactions with other people, information about the physical environment must be integrated with information about the interaction partner. In order to achieve this, processing of social information is guided by two components: a bottom-up mechanism reflexively triggered by stimulus-related information in the social scene and a top-down mechanism activated by task-related context information. In the present study, we investigated whether these components interact during attentional orienting to gaze direction. In particular, we examined whether the spatial specificity of gaze cueing is modulated by expectations about the reliability of gaze behavior. Expectations were either induced by instruction or could be derived from experience with displayed gaze behavior. Spatially specific cueing effects were observed with highly predictive gaze cues, but also when participants merely believed that actually non-predictive cues were highly predictive. Conversely, cueing effects for the whole gazed-at hemifield were observed with non-predictive gaze cues, and spatially specific cueing effects were attenuated when actually predictive gaze cues were believed to be non-predictive. This pattern indicates that (i) information about cue predictivity gained from sampling gaze behavior across social episodes can be incorporated in the attentional orienting to social cues, and that (ii) beliefs about gaze behavior modulate attentional orienting to gaze direction even when they contradict information available from social episodes.	[Wiese, Eva; Wykowska, Agnieszka; Mueller, Hermann J.] Univ Munich, Dept Gen & Expt Psychol, Munich, Germany; [Wiese, Eva] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Wykowska, Agnieszka] Tech Univ Munich, Inst Cognit Syst, D-80290 Munich, Germany; [Mueller, Hermann J.] Univ London Birkbeck Coll, Dept Psychol Sci, London WC1E 7HX, England	University of Munich; George Mason University; Technical University of Munich; University of London; Birkbeck University London	Wiese, E (corresponding author), Univ Munich, Dept Gen & Expt Psychol, Munich, Germany.	wiese@psy.lmu.de		Wykowska, Agnieszka/0000-0003-3323-7357	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [WY-122/1-1]; Graduate School of Systemic Neurosciences (GSN) Munich	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Graduate School of Systemic Neurosciences (GSN) Munich	This work was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) within the Excellence Cluster 'Cognition for Technical Systems' (CoTeSys) and based on the individual grant awarded to AW (WY-122/1-1). The authors also thank the Graduate School of Systemic Neurosciences (GSN) Munich for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Liuzza MT, 2011, PLOS ONE, V6, P1; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Nummenmaa L, 2009, J EXP PSYCHOL HUMAN, V35, P1738, DOI 10.1037/a0016472; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ristic J, 2005, COGNITION, V94, pB55, DOI 10.1016/j.cognition.2004.04.005; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Ristic J, 2006, Q J EXP PSYCHOL, V59, P1921, DOI 10.1080/17470210500416367; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Teufel C, 2010, ATTEN PERCEPT PSYCHO, V72, P695, DOI 10.3758/APP.72.3.695; Teufel C, 2009, CURR BIOL, V19, P1274, DOI 10.1016/j.cub.2009.05.069; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287; Vecera SP, 2006, NEUROPSYCHOLOGIA, V44, P150, DOI 10.1016/j.neuropsychologia.2005.04.010; Wiese E, 2013, ATTEN PERCEPT PSYCHO, V75, P967, DOI 10.3758/s13414-013-0444-y; Wiese E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045391; Wykowska A, PLOS ONE IN PRESS	29	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94529	10.1371/journal.pone.0094529	http://dx.doi.org/10.1371/journal.pone.0094529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722348	gold, Green Published, Green Accepted			2022-12-27	WOS:000336909100090
J	Ge, H; Liu, G; Xiang, YF; Wang, Y; Guo, CW; Chen, NH; Zhang, YJ; Wang, YF; Kitazato, K; Xu, J				Ge, Hu; Liu, Ge; Xiang, Yang-Fei; Wang, Yu; Guo, Chao-Wan; Chen, Nan-Hao; Zhang, Ying-Jun; Wang, Yi-Fei; Kitazato, Kaio; Xu, Jun			The Mechanism of Poly-Galloyl-Glucoses Preventing Influenza A Virus Entry into Host Cells	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; MOLECULAR-DYNAMICS; HUMAN INFECTION; HEMAGGLUTININ; FUSION; ORIGIN; AMBER	Hemagglutinin (HA) is essential for Influenza A virus infection, but its diversity of subtypes presents an obstacle to developing broad-spectrum HA inhibitors. In this study, we investigated the molecular mechanisms by which poly-galloyl glucose (pGG) analogs inhibit influenza hemagglutinin (HA) in vitro and in silico. We found that (1) star-shaped pGG analogs exhibit HA-inhibition activity by interacting with the conserved structural elements of the receptor binding domain (RBD); (2) HA inhibition depends on the number of galloyl substituents in a pGG analog; the best number is four; and when PGG binds with two HA trimers at their conserved receptor binding domains (loop 130, loop 220, and 190-alpha-helix), PGG acts as a molecular glue by aggregating viral particles so as to prevent viral entry into host cells (this was revealed via an in silico simulation on the binding of penta- galloyl-glucose (PGG) with HA). pGGs are also effective on a broad-spectrum influenza A subtypes (including H1, H3, H5, H7); this suggests that pGG analogs can be applied to most influenza A subtypes as a prophylactic against influenza viral infections.	[Ge, Hu; Wang, Yu; Chen, Nan-Hao; Xu, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ge, Hu; Wang, Yu; Chen, Nan-Hao; Xu, Jun] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Ge; Guo, Chao-Wan; Kitazato, Kaio] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Mol Pharmacol Infect Agents, Nagasaki 852, Japan; [Xiang, Yang-Fei; Wang, Yi-Fei] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med, Div Biomed,Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China; [Xiang, Yang-Fei] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Zhang, Ying-Jun] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Nagasaki University; Jinan University; Jinan University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Wang, YF (corresponding author), Jinan Univ, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med, Div Biomed,Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China.	twang-yf@163.com; kkholi@nagasaki-u.ac.jp; junxu@biochemomes.com	Guo, Chaowan/AAF-3876-2022; Guo, Chaowan/AFI-6708-2022	Wang, Yi-fei/0000-0002-9918-2865	National High Technology Research and Development Program of China (863 Program) [2012AA020307]; Guangdong Recruitment Program of Creative Research Groups; National Natural Science Foundation of China [81173470, 81274170]; Special Funding Program for the National Supercomputer Center in Guangzhou [2012Y2-00048/2013Y2-00045, 201200000037]; Tokyo Biochemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [22590274]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Guangdong Recruitment Program of Creative Research Groups; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funding Program for the National Supercomputer Center in Guangzhou; Tokyo Biochemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program) (No. 2012AA020307), Guangdong Recruitment Program of Creative Research Groups, and the National Natural Science Foundation of China (No. 81173470, 81274170), and the Special Funding Program for the National Supercomputer Center in Guangzhou (2012Y2-00048/2013Y2-00045, 201200000037). This study was also supported partly by Grant-in-aid from the Tokyo Biochemical Research Foundation and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 22590274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Frisch G. W., 2013, GAUSSIAN 09; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ge H, 2010, NAT PROD REP, V27, P1758, DOI 10.1039/c0np00005a; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gu QO, 2010, MOLECULES, V15, P5031, DOI 10.3390/molecules15075031; Gyemant G, 2009, BBA-PROTEINS PROTEOM, V1794, P291, DOI 10.1016/j.bbapap.2008.10.012; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; He Q, 2006, FOOD CHEM, V95, P250, DOI 10.1016/j.foodchem.2004.11.055; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Ichiki H, 2007, J NAT MED-TOKYO, V61, P146, DOI 10.1007/s11418-006-0111-x; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kageyama-Yahara N, 2010, FEBS LETT, V584, P111, DOI 10.1016/j.febslet.2009.11.007; Kato S, 2010, BIOL PHARM BULL, V33, P1878, DOI 10.1248/bpb.33.1878; Knipe DM, 2007, FIELDS VIROLOGY; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XQ, 2011, J NANOMATER, V2011, DOI 10.1155/2011/270974; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Luo GX, 1996, VIROLOGY, V226, P66, DOI 10.1006/viro.1996.0628; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Nandi T, 2008, BIOINFORMATION, V2, P240, DOI 10.6026/97320630002240; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Pan DB, 2012, J MOL MODEL, V18, P4355, DOI 10.1007/s00894-012-1423-2; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Richard T, 2005, BBA-GEN SUBJECTS, V1726, P238, DOI 10.1016/j.bbagen.2005.07.017; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Watanabe T, 2011, J VIROL, V85, P13195, DOI 10.1128/JVI.00859-11; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO/GIP, 2013, CUM NUMB CONF HUM CA; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu J, 2013, SCI CHINA CHEM, V56, P71, DOI 10.1007/s11426-012-4761-0; Yamada K, 2009, ANTIVIR RES, V83, P35, DOI 10.1016/j.antiviral.2009.03.002; Yen HL, 2012, NATURE, V486, P332, DOI 10.1038/nature11192; Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhou RH, 2001, J CHEM PHYS, V115, P2348, DOI 10.1063/1.1385159	56	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94392	10.1371/journal.pone.0094392	http://dx.doi.org/10.1371/journal.pone.0094392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718639	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000114
J	Gervais, WM				Gervais, Will M.			Everything Is Permitted? People Intuitively Judge Immorality as Representative of Atheists	PLOS ONE			English	Article							RELIGION; DISTRUST; PROSOCIALITY; PSYCHOLOGY; EVOLUTION; GOD	Scientific research yields inconsistent and contradictory evidence relating religion to moral judgments and outcomes, yet most people on earth nonetheless view belief in God (or gods) as central to morality, and many view atheists with suspicion and scorn. To evaluate intuitions regarding a causal link between religion and morality, this paper tested intuitive moral judgments of atheists and other groups. Across five experiments (N = 1,152), American participants intuitively judged a wide variety of immoral acts (e. g., serial murder, consensual incest, necrobestiality, cannibalism) as representative of atheists, but not of eleven other religious, ethnic, and cultural groups. Even atheist participants judged immoral acts as more representative of atheists than of other groups. These findings demonstrate a prevalent intuition that belief in God serves a necessary function in inhibiting immoral conduct, and may help explain persistent negative perceptions of atheists.	Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA	University of Kentucky	Gervais, WM (corresponding author), Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA.	will.gervais@uky.edu			University of Kentucky	University of Kentucky	These experiments were funded by a University of Kentucky startup grant to W. M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Atran S, 2012, SCIENCE, V336, P855, DOI 10.1126/science.1216902; Banerjee K, 2010, J COGN CULT, V10, P253, DOI 10.1163/156853710X531186; Bloom P, 2012, ANNU REV PSYCHOL, V63, P179, DOI 10.1146/annurev-psych-120710-100334; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Boyer P, 2008, NATURE, V455, P1038, DOI 10.1038/4551038a; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chudek M, 2012, EVOL HUM BEHAV, V33, P46, DOI 10.1016/j.evolhumbehav.2011.05.005; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; De Waal F., 2013, BONOBO ATHEIST SEARC; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; de Waal FBM, 2012, SCIENCE, V336, P874, DOI 10.1126/science.1220999; Edgell P, 2006, AM SOCIOL REV, V71, P211, DOI 10.1177/000312240607100203; Gervais WM, 2013, SOC PERSONAL PSYCHOL, V7, P366, DOI 10.1111/spc3.12035; Gervais WM, 2012, PSYCHOL SCI, V23, P483, DOI 10.1177/0956797611429711; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Gervais WM, 2011, J PERS SOC PSYCHOL, V101, P1189, DOI 10.1037/a0025882; Gervais WM, 2011, PERS SOC PSYCHOL B, V37, P543, DOI 10.1177/0146167211399583; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greene J, 2003, NAT REV NEUROSCI, V4, P846, DOI 10.1038/nrn1224; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; Laurin K, 2012, J PERS SOC PSYCHOL, V102, P4, DOI 10.1037/a0025971; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Norenzayan A, RELIG BRAIN IN PRESS; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Pew Research Global Attitudes Project, 2007, VIEWS REL MOR; Pichon I, 2007, EUR J SOC PSYCHOL, V37, P1032, DOI 10.1002/ejsp.416; Preston JL, 2010, SOC PERSONAL PSYCHOL, V4, P574, DOI 10.1111/j.1751-9004.2010.00286.x; R Core Team, 2012, R LANG ENV STAT COMP; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Randolph-Seng Brandon, 2007, INT J PSYCHOL RELIG, V17, P303, DOI [DOI 10.1080/10508610701572812, 10.1080/10508610701572812]; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Ritter RS, 2011, J EXP SOC PSYCHOL, V47, P1225, DOI 10.1016/j.jesp.2011.05.006; Rounding K, 2012, PSYCHOL SCI, V23, P635, DOI 10.1177/0956797611431987; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; TVERSKY A, 1983, PSYCHOL REV, V90, P293, DOI 10.1037/0033-295X.90.4.293	44	70	70	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92302	10.1371/journal.pone.0092302	http://dx.doi.org/10.1371/journal.pone.0092302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AE9PC	24717972	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000014
J	Lovati, AB; Romano, CL; Monti, L; Vassena, C; Previdi, S; Drago, L				Lovati, Arianna B.; Romano, Carlo L.; Monti, Lorenzo; Vassena, Christian; Previdi, Sara; Drago, Lorenzo			Does PGE1 Vasodilator Prevent Orthopaedic Implant-Related Infection in Diabetes? Preliminary Results in a Mouse Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROSTAGLANDIN E-1; PERIPHERAL-BLOOD; FOOT INFECTIONS; BONE-FORMATION; FACTOR-ALPHA; ANGIOGENESIS; STIMULATION; DISEASE; OSTEOMYELITIS	Background: Implant-related infections are characterized by bacterial colonization and biofilm formation on the prosthesis. Diabetes represents one of the risk factors that increase the chances of prosthetic infections because of related severe peripheral vascular disease. Vasodilatation can be a therapeutic option to overcome diabetic vascular damages and increase the local blood supply. In this study, the effect of a PGE(1) vasodilator on the incidence of surgical infections in diabetic mice was investigated. Methodology: A S. aureus implant-related infection was induced in femurs of diabetic mice, then differently treated with a third generation cephalosporin alone or associated with a PGE(1) vasodilator. Variations in mouse body weight were evaluated as index of animal welfare. The femurs were harvested after 28 days and underwent both qualitative and quantitative analysis as micro-CT, histological and microbiological analyses. Results: The analysis performed in this study demonstrated the increased host response to implant-related infection in diabetic mice treated with the combination of a PGE(1) and antibiotic. In this group, restrained signs of infections were identified by micro-CT and histological analysis. On the other hand, the diabetic mice treated with the antibiotic alone showed a severe infection and inability to successfully respond to the standard antimicrobial treatment. Conclusions: The present study revealed interesting preliminary results in the use of a drug combination of antibiotic and vasodilator to prevent implant-related Staphylococcus aureus infections in a diabetic mouse model.	[Lovati, Arianna B.] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Romano, Carlo L.; Monti, Lorenzo] IRCCS Galeazzi Orthopaed Inst, Dipartimento Chirurg Ricostrutt & Infez Osteoarti, Milan, Italy; [Vassena, Christian; Drago, Lorenzo] IRCCS Galeazzi Orthopaed Inst, Lab Clin Chem & Microbiol, Milan, Italy; [Previdi, Sara] Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Canc Cachexia AIRC Start Up, Milan, Italy; [Drago, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Lovati, AB (corresponding author), IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposandonato.it	Lovati, Arianna Barbara/J-8213-2016; Monti, Lorenzo/AAB-2967-2020; ROMANO, CARLO LUCA/C-4310-2017	Lovati, Arianna Barbara/0000-0002-5230-9718; ROMANO, CARLO LUCA/0000-0001-6726-0593; Lorenzo, Drago/0000-0002-5206-540X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The entire work was funded by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMINE T, 1992, BONE, V13, P11, DOI 10.1016/8756-3282(92)90356-2; Akbari CM, 1999, J VASC SURG, V30, P373, DOI 10.1016/S0741-5214(99)70154-0; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573; Clover AJP, 2003, BRIT J PLAST SURG, V56, P314, DOI 10.1016/S0007-1226(03)00230-3; CREUTZIG A, 1991, THERAPIE, V46, P241; Cross SE, 1996, ANTIMICROB AGENTS CH, V40, P1703, DOI 10.1128/AAC.40.7.1703; Dooper MMBW, 2002, IMMUNOLOGY, V107, P152, DOI 10.1046/j.1365-2567.2002.01474.x; Eneroth M, 1999, J DIABETES COMPLICAT, V13, P254, DOI 10.1016/S1056-8727(99)00065-3; Faries PL, 2004, AM J SURG, V187, p34S, DOI 10.1016/S0002-9610(03)00302-7; Farrokhnia F, 2012, WORLD J GASTRO SURG, V4, P284, DOI 10.4240/wjgs.v4.i12.284; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; GEE MH, 1987, CIRC RES, V61, P420, DOI 10.1161/01.RES.61.3.420; GOODSON WH, 1977, J SURG RES, V22, P221, DOI 10.1016/0022-4804(77)90137-8; HIGH WB, 1987, BONE, V8, P363, DOI 10.1016/8756-3282(87)90068-8; Iino G, 2008, INT J ORAL MAX IMPL, V23, P835; Ishikawa O, 1998, EUR J PHARMACOL, V344, P95, DOI 10.1016/S0014-2999(97)01575-6; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; JEE WSS, 1985, CALCIFIED TISSUE INT, V37, P148, DOI 10.1007/BF02554834; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; Jung CJ, 2012, J INFECT DIS, V205, P1066, DOI 10.1093/infdis/jis021; King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8; Kuss M, 2003, VASA-J VASCULAR DIS, V32, P145, DOI 10.1024/0301-1526.32.3.145; Lankinen P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-41; Lipsky BA, 1997, CLIN INFECT DIS, V25, P1318, DOI 10.1086/516148; Lipsky BA, 2007, DIABETES CARE, V30, P2171, DOI 10.2337/dc07-0935; Lovati AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067628; Makino H, 2004, HYPERTENS RES, V27, P85, DOI 10.1291/hypres.27.85; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; Mehrabi MR, 2003, BIOMED PHARMACOTHER, V57, P173, DOI 10.1016/S0753-3322(03)00026-X; Mehrabi MR, 2001, J HEART LUNG TRANSPL, V20, P465, DOI 10.1016/S1053-2498(00)00317-X; Miller SC, 2008, PHARM RES-DORDR, V25, P2889, DOI 10.1007/s11095-008-9706-0; MILLER SC, 1993, BONE, V14, P143, DOI 10.1016/8756-3282(93)90241-2; Moreschi Jr. Dorival, 2007, J. vasc. bras., V6, P316, DOI 10.1590/S1677-54492007000400004; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; PASCH AR, 1984, SURGERY, V95, P724; Pawar P, 2004, J IMMUNOL, V173, P1258, DOI 10.4049/jimmunol.173.2.1258; Pineda Carlos, 2009, Semin Plast Surg, V23, P80, DOI 10.1055/s-0029-1214160; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; RICHMAN CM, 1987, BLOOD, V70, P1792; Romano CL, 2010, J ORTHOP TRAUMATOL, V11, P167, DOI 10.1007/s10195-010-0106-y; Rubinstein R, 2008, CLIN EXP IMMUNOL, V154, P235, DOI 10.1111/j.1365-2249.2008.03742.x; SCHEFFLER P, 1994, CIRCULATION, V90, P818, DOI 10.1161/01.CIR.90.2.818; Shiga K, 2002, ANN OTO RHINOL LARYN, V111, P783, DOI 10.1177/000348940211100904; Silvestre JS, 2006, CIRC RES, V98, P4, DOI 10.1161/01.RES.0000200396.90220.41; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Spatz M, 2003, CELL IMMUNOL, V221, P15, DOI 10.1016/S0008-8749(03)00043-1; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Suponitzky I, 1998, J ENDOCRINOL, V156, P51, DOI 10.1677/joe.0.1560051; TATER D, 1987, HORM METAB RES, V19, P642, DOI 10.1055/s-2007-1011899; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Trampuz A, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000087324.60612.93; ULICH TR, 1987, J IMMUNOL, V139, P3406; van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019; VANDERPOLL T, 1992, BLOOD, V79, P693; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; Widomski D, 1997, IMMUNOPHARM IMMUNOT, V19, P165, DOI 10.3109/08923979709007656	62	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94758	10.1371/journal.pone.0094758	http://dx.doi.org/10.1371/journal.pone.0094758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718359	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000144
J	McCallum, JW; Rowcliffe, JM; Cuthill, IC				McCallum, Jamie W.; Rowcliffe, J. Marcus; Cuthill, Innes C.			Conservation on International Boundaries: The Impact of Security Barriers on Selected Terrestrial Mammals in Four Protected Areas in Arizona, USA	PLOS ONE			English	Article							LARGE CARNIVORES; BIODIVERSITY; FRAGMENTATION; FORESTS; BORDER; IMMIGRATION; REDUCTION; PREDATORS; DEER	Several thousand terrestrial protected areas (PAs) lie on international boundaries. Because international boundaries can be focal points for trade, illegal activity and development, such PAs can be vulnerable to a range of anthropogenic threats. There is an increasing trend towards the erection of international boundary infrastructure (including fences, barriers and ditches) in many parts of the world, which may reduce the risk of these anthropogenic threats to some PAs. However this may restrict home range and access to resources for some native species. We sought to understand the impacts of these two different types of threat by using camera traps to measure the activity level of humans, native and invasive mammals in four US PAs on the Mexican international boundary. Comparisons were made between treatment areas with barriers and those without. Results showed that puma and coati were more likely to appear in treatment areas without barriers, whereas humans were not observed more frequently in one treatment area over another. The suggestion is that the intermittent fencing present in this part of the world does affect some native species, but does not necessarily restrict the movement of humans (including illegal migrants), who may negatively impact native species.	[McCallum, Jamie W.; Cuthill, Innes C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Rowcliffe, J. Marcus] Zool Soc London, Inst Zool, London NW1 4RY, England; [McCallum, Jamie W.] Zool Soc London, Conservat Programmes, London, England	University of Bristol; Zoological Society of London; Zoological Society of London	McCallum, JW (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	jamie.mccallum@zsl.org	Rowcliffe, Marcus/G-3713-2018	Rowcliffe, Marcus/0000-0002-4286-6887				Abbas F, 2011, OECOLOGIA, V167, P401, DOI 10.1007/s00442-011-1994-0; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andreas P, 2003, INT SECURITY, V28, P78, DOI 10.1162/016228803322761973; Bailey R, 1989, ECOREGIONS, P1650; Bozarth CA, 2011, J MAMMAL, V92, P1070, DOI 10.1644/10-MAMM-A-223.1; Brockington Dan, 2002, FORTRESS CONSERVATIO; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Busch J, 2008, ECOL ECON, V67, P394, DOI 10.1016/j.ecolecon.2007.12.012; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Cornelius WA, 2007, REGUL GOV, V1, P139, DOI 10.1111/j.1748-5991.2007.00007.x; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Creel S, 2014, ECOL LETT IN PRESS; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Ewers RM, 2000, P R SOC LOND, V366, P3292; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Hamilton LS, 1996, BIODIVERS CONSERV; Hanks J., 2010, FENCING IMPACTS REV; Harris G., 2010, B ECOL SOC AM, V91, P352, DOI DOI 10.1890/0012-9623-91.3.352; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kapos V, 2009, ORYX, V43, P336, DOI 10.1017/S0030605309990275; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karki SM, 2007, J WILDLIFE MANAGE, V71, P2707, DOI 10.2193/2006-275; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; Lasky JR, 2011, DIVERS DISTRIB, V17, P673, DOI 10.1111/j.1472-4642.2011.00765.x; Lysenko I, 2007, GLOBAL LIST TRANSBOU; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; McDonald W, 2004, J APPL ECOL, V41, P82, DOI 10.1111/j.1365-2664.2004.00877.x; McDonald WR, 2004, OIKOS, V105, P397; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McIntyre DL, 2002, PROF GEOGR, V54, P392, DOI 10.1111/0033-0124.00338; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Moya H, 2007, POSSIBLE IMPACTS BOR; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Newman D., 2006, EUR J SOC THEORY, V9, P171, DOI [10.1177/1368431006063331, DOI 10.1177/1368431006063331]; Novosseloff A., 2007, MURS ENTRE HOMMES; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Peers MJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051488; R Core Team, 2021, R LANGUAGE ENV STAT; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Smallwood KS, 1999, ENVIRON CONSERV, V26, P102, DOI 10.1017/S0376892999000156; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; Sundberg J, 2007, ENVIRON PLANN D, V25, P727, DOI 10.1068/d75j; Valenzuela D, 2002, J ZOOL, V258, P247, DOI 10.1017/S0952836902001358; Van Schoik DR, 2007, MONOGRAPH SW CONSORT, V15; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Waller DM, 1997, WILDLIFE SOC B, V25, P217; Wang H, 2003, MAMMALIA, V67, P513; Wolff JO, 1997, CONSERV BIOL, V11, P945, DOI 10.1046/j.1523-1739.1997.96136.x; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x	61	9	9	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93679	10.1371/journal.pone.0093679	http://dx.doi.org/10.1371/journal.pone.0093679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717982	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000042
J	Bergouignan, A; Kealey, EH; Schmidt, SL; Jackman, MR; Bessesen, DH				Bergouignan, Audrey; Kealey, Elizabeth H.; Schmidt, Stacy L.; Jackman, Matthew R.; Bessesen, Daniel H.			Twenty-Four Hour Total and Dietary Fat Oxidation in Lean, Obese and Reduced-Obese Adults with and without a Bout of Exercise	PLOS ONE			English	Article							TYPE-2 DIABETIC SUBJECTS; SKELETAL-MUSCLE; ACID-METABOLISM; WEIGHT-LOSS; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; LIPID OXIDATION; METAANALYSIS; REGAIN; MEAL	Background: It has been hypothesized that obese and reduced-obese individuals have decreased oxidative capacity, which contributes to weight gain and regain. Recent data have challenged this concept. Objective: To determine (1) whether total and dietary fat oxidation are decreased in obese and reduced-obese adults compared to lean but increase in response to an acute exercise bout and (2) whether regular physical activity attenuates these metabolic alterations. Design: We measured 24-hr total (whole-room calorimetry) and dietary fat (C-14-oleate) oxidation in Sedentary Lean (BMI = 21.5 = 1.6; n = 10), Sedentary Obese (BMI = 33.6 = 2.5; n = 9), Sedentary Reduced-Obese (RED-SED; BMI = 26.9 = 3.7; n = 7) and in Physically Active Reduced-Obese (RED-EX; BMI = 27.3 = 2.8; n = 12) men and women with or without an acute exercise bout where energy expended during exercise was not replaced. Results: Although Red-SED and Red-EX had a similar level of fatness, aerobic capacity and metabolic profiles were better in Red-EX only compared to Obese subjects. No significant between-group differences were seen in 24-hr respiratory quotient (RQ, Lean: 0.831 +/- 0.044, Obese: 0.852 +/- 0.023, Red-SED: 0.864 +/- 0.037, Red-EX: 0.842 +/- 0.039), total and dietary fat oxidation. A single bout of exercise increased total (+27.8%, p<0.0001) and dietary (+6.6%, p = 0.048) fat oxidation across groups. Although exercise did not impact RQ during the day, it decreased RQ during sleep (p = 0.01) in all groups. Red-EX oxidized more fat overnight than Red-SED subjects under both resting (p = 0.036) and negative energy balance (p = 0.003) conditions, even after adjustment for fat-free mass. Conclusion: Obese and reduced-obese individuals oxidize as much fat as lean both under eucaloric and negative energy balance conditions, which does not support the hypothesis of reduced oxidative capacity in these groups. Reduced-obese individuals who exercise regularly have markers of metabolic health similar to those seen in lean adults. Both the acute and chronic effects of exercise were primarily observed at night suggesting an important role of sleep in the regulation of lipid metabolism.	[Bergouignan, Audrey; Kealey, Elizabeth H.; Schmidt, Stacy L.; Bessesen, Daniel H.] Univ Colorado, Anschutz Hlth & Wellness Ctr, Aurora, CO 80045 USA; [Jackman, Matthew R.] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Bessesen, Daniel H.] Denver Hlth Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Bessesen, DH (corresponding author), Univ Colorado, Anschutz Hlth & Wellness Ctr, Anschutz Med Campus, Aurora, CO 80045 USA.	Daniel.Bessesen@ucdenver.edu	Bergouignan, Audrey/A-2750-2016	Bergouignan, Audrey/0000-0002-1266-5144	National Institutes of Health [K24DK002935]; NIH/NCRR Colorado CTSI [UL 1 RR025780]; Colorado Nutrition Obesity Research Center [P30DK048520]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, K24DK002935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition Obesity Research Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DHB received support from the National Institutes of Health through K24DK002935. The study was further supported by the NIH/NCRR Colorado CTSI Grant: UL 1 RR025780 and the Colorado Nutrition Obesity Research Center: P30DK048520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; ASTRUP A, 1994, AM J PHYSIOL, V266, pE592, DOI 10.1152/ajpendo.1994.266.4.E592; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bergouignan A, 2010, PLOS ONE, V7; Bergouignan A, 2009, PROG LIPID RES, V48, P128, DOI 10.1016/j.plipres.2009.02.004; Bergouignan A, 2009, DIABETES, V58, P367, DOI 10.2337/db08-0263; BESSESEN DH, 1995, OBES RES, V3, P179, DOI 10.1002/j.1550-8528.1995.tb00134.x; Binnert C, 1998, AM J CLIN NUTR, V67, P595, DOI 10.1093/ajcn/67.4.595; Blaak EE, 2004, P NUTR SOC, V63, P323, DOI 10.1079/PNS2004361; Blaak EE, 2000, DIABETES, V49, P2102, DOI 10.2337/diabetes.49.12.2102; Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554; Hansen K, 2005, SPORTS MED, V35, P363, DOI 10.2165/00007256-200535050-00001; Hawkins KR, 2012, EUR J APPL PHYSIOL, V112, P3775, DOI 10.1007/s00421-012-2360-6; Hodson L, 2010, AM J PHYSIOL-ENDOC M, V299, pE584, DOI 10.1152/ajpendo.00272.2010; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Horton TJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1192, DOI 10.1152/ajpendo.00164.2002; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Jackman MR, 2006, AM J PHYSIOL-ENDOC M, V291, pE1083, DOI 10.1152/ajpendo.00159.2006; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Larson-Meyer DE, 2010, MED SCI SPORT EXER, V42, P152, DOI 10.1249/MSS.0b013e3181ad7f17; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; MacLean PS, 2011, AM J PHYSIOL-REG I, V301, pR581, DOI 10.1152/ajpregu.00755.2010; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Melanson EL, 2009, J APPL PHYSIOL, V107, P1847, DOI 10.1152/japplphysiol.00958.2009; Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Ogden LG, 2012, OBESITY, V20, P2039, DOI 10.1038/oby.2012.79; RABEN A, 1994, AM J PHYSIOL-ENDOC M, V267, pE549, DOI 10.1152/ajpendo.1994.267.4.E549; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Santosa S, 2008, AM J CLIN NUTR, V88, P1134, DOI 10.1093/ajcn/88.4.1134; Sidossis LS, 1997, AM J PHYSIOL-ENDOC M, V272, pE1065, DOI 10.1152/ajpendo.1997.272.6.E1065; Sonko BJ, 2005, J NUTR, V135, P2159, DOI 10.1093/jn/135.9.2159; Votruba SB, 2005, INT J OBESITY, V29, P100, DOI 10.1038/sj.ijo.0802779; Votruba SB, 2002, MED SCI SPORT EXER, V34, P1757, DOI 10.1097/00005768-200211000-00011; Wadden TA, 2003, ENDOCRIN METAB CLIN, V32, P981, DOI 10.1016/S0889-8529(03)00072-0; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Westerterp KR, 2008, AM J CLIN NUTR, V87, P132, DOI 10.1093/ajcn/87.1.132	43	16	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94181	10.1371/journal.pone.0094181	http://dx.doi.org/10.1371/journal.pone.0094181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714529	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900099
J	Dettmer, S; Peters, L; de Wall, C; Schaefer-Prokop, C; Schmidt, M; Warnecke, G; Gottlieb, J; Wacker, F; Shin, HO				Dettmer, Sabine; Peters, Lars; de Wall, Claudia; Schaefer-Prokop, Cornelia; Schmidt, Michael; Warnecke, Gregor; Gottlieb, Jens; Wacker, Frank; Shin, Hoen-oh			Bronchial Wall Measurements in Patients after Lung Transplantation: Evaluation of the Diagnostic Value for the Diagnosis of Bronchiolitis Obliterans Syndrome	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; AIRWAY DIMENSIONS; CT; STANDARDIZATION	Objectives: To prospectively evaluate quantitative airway wall measurements of thin-section CT for the diagnosis of Bronchiolitis Obliterans Syndrome (BOS) following lung transplantation. Materials and Methods: In 141 CT examinations, bronchial wall thickness (WT), the wall area percentage (WA%) calculated as the ratio of the bronchial wall area and the total area (sum of bronchial wall area and bronchial lumen area) and the difference of the WT on inspiration and expiration (WTdiff) were automatically measured in different bronchial generations. The measurements were correlated with the lung function parameters. WT and WA% in CT examinations of patients with (n = 25) and without (n = 116) BOS, were compared using the unpaired t-test and univariate analysis of variance, while also considering the differing lung volumes. Results: Measurements could be performed in 2,978 bronchial generations. WT, WA%, and WTdiff did not correlate with the lung function parameters (r<0.5). The WA% on inspiration was significantly greater in patients with BOS than in patients without BOS, even when considering the dependency of the lung volume on the measurements. WT on inspiration and expiration and WA% on expiration did not show significant differences between the groups. Conclusion: WA% on inspiration was significantly greater in patients with than in those without BOS. However, WA% measurements were significantly dependent on lung volume and showed a high variability, thus not allowing the sole use of bronchial wall measurements to differentiate patients with from those without BOS.	[Dettmer, Sabine; Peters, Lars; Wacker, Frank; Shin, Hoen-oh] Hannover Med Sch, Dept Radiol, Hannover, Germany; [de Wall, Claudia; Gottlieb, Jens] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Schaefer-Prokop, Cornelia] Meander Med Ctr, Amersfoort, Netherlands; [Schaefer-Prokop, Cornelia] Radboud Univ Nijmegen Med Ctr, DIAG, Nijmegen, Netherlands; [Schmidt, Michael] Fraunhofer MEVIS, Bremen, Germany; [Warnecke, Gregor] Hannover Med Sch, Dept Thorac & Cardiovasc Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Meander Medisch Centrum; Radboud University Nijmegen; Hannover Medical School	Dettmer, S (corresponding author), Hannover Med Sch, Dept Radiol, Hannover, Germany.	dettmer.sabine@mh-hannover.de		Gottlieb, Prof. Jens/0000-0002-9540-9022	German Federal Ministry of Education and Research [01EO0802]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work (Dettmer and de Wall) was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 2008, EUR RADIOL, V18, P2731, DOI 10.1007/s00330-008-1089-4; Al-Githmi I, 2006, EUR J CARDIO-THORAC, V30, P846, DOI 10.1016/j.ejcts.2006.09.027; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; Bankier AA, 2001, RADIOLOGY, V218, P533, DOI 10.1148/radiology.218.2.r01fe09533; Berstad AE, 2006, EUR J RADIOL, V58, P124, DOI 10.1016/j.ejrad.2005.11.013; Boehler A, 1998, CHEST, V114, P1411, DOI 10.1378/chest.114.5.1411; Brillet PY, 2007, EUR RADIOL, V17, P1483, DOI 10.1007/s00330-006-0496-7; Chae EJ, 2011, ALLERGY ASTHMA IMMUN, V3, P111, DOI 10.4168/aair.2011.3.2.111; CHAMBERLAIN D, 1994, J HEART LUNG TRANSPL, V13, P963; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P940, DOI 10.1513/pats.200806-057QC; de Jong PA, 2006, THORAX, V61, P799, DOI 10.1136/thx.2005.053249; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Gottlieb J, 2008, TRANSPLANTATION, V85, P36, DOI 10.1097/01.tp.0000295981.84633.bc; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Kim N, 2008, KOREAN J RADIOL, V9, P226, DOI 10.3348/kjr.2008.9.3.226; Konen E, 2004, RADIOLOGY, V231, P467, DOI 10.1148/radiol.2312030563; Kuhnigk JM, 2005, RADIOGRAPHICS, V25, P525, DOI 10.1148/rg.252045070; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miller WT, 2001, J THORAC IMAG, V16, P76, DOI 10.1097/00005382-200104000-00002; Montaudon M, 2007, RADIOLOGY, V242, P573, DOI 10.1148/radiol.2422060030; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; MORRISH WF, 1991, RADIOLOGY, V179, P487, DOI 10.1148/radiology.179.2.2014297; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Nakano Y, 2002, PROC SPIE, V4683, P460, DOI 10.1117/12.463615; Ng YL, 2009, AM J ROENTGENOL, V192, pS1, DOI 10.2214/AJR.07.7061; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Reinhardt JM, 1997, IEEE T MED IMAGING, V16, P820, DOI 10.1109/42.650878; Schmidt M, 2010, PROC SPIE, V7624, DOI 10.1117/12.844453; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Zach JA, 2012, INVEST RADIOL, V47, P596, DOI 10.1097/RLI.0b013e318262292e	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93783	10.1371/journal.pone.0093783	http://dx.doi.org/10.1371/journal.pone.0093783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713820	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900048
J	Harris, R; de Jong, BM				Harris, Robert; de Jong, Bauke M.			Cerebral Activations Related to Audition-Driven Performance Imagery in Professional Musicians	PLOS ONE			English	Article							PARIETAL LOBE ACTIVATION; INTRAPARIETAL SULCUS; BROCAS AREA; BRAIN; PERCEPTION; CORTEX; PREMOTOR; SPACE; NETWORKS; PIANISTS	Functional Magnetic Resonance Imaging (fMRI) was used to study the activation of cerebral motor networks during auditory perception of music in professional keyboard musicians (n = 12). The activation paradigm implied that subjects listened to two-part polyphonic music, while either critically appraising the performance or imagining they were performing themselves. Two-part polyphonic audition and bimanual motor imagery circumvented a hemisphere bias associated with the convention of playing the melody with the right hand. Both tasks activated ventral premotor and auditory cortices, bilaterally, and the right anterior parietal cortex, when contrasted to 12 musically unskilled controls. Although left ventral premotor activation was increased during imagery (compared to judgment), bilateral dorsal premotor and right posterior-superior parietal activations were quite unique to motor imagery. The latter suggests that musicians not only recruited their manual motor repertoire but also performed a spatial transformation from the vertically perceived pitch axis (high and low sound) to the horizontal axis of the keyboard. Imagery-specific activations in controls were seen in left dorsal parietal-premotor and supplementary motor cortices. Although these activations were less strong compared to musicians, this overlapping distribution indicated the recruitment of a general 'mirror-neuron' circuitry. These two levels of sensori-motor transformations point towards common principles by which the brain organizes audition-driven music performance and visually guided task performance.	[Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Harris, Robert] Hanze Hsch Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	de Jong, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	b.m.de.jong@umcg.nl		de Jong, Bauke M./0000-0002-6568-5739	Gratama Foundation, Harlingen; Hanze University; Prince Claus Conservatoire; Lectorate Lifelong Learning in Music, Groningen	Gratama Foundation, Harlingen; Hanze University; Prince Claus Conservatoire; Lectorate Lifelong Learning in Music, Groningen	Financial support was obtained from The Gratama Foundation, Harlingen (NL), the Hanze University, Prince Claus Conservatoire, and the Lectorate Lifelong Learning in Music, Groningen (NL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Angula-Perkins A, 2011, 17 ANN M ORG HUM BRA; Balter M, 2004, SCIENCE, V306, P1120, DOI 10.1126/science.306.5699.1120; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Baumgart F, 1998, MED PHYS, V25, P2068, DOI 10.1118/1.598368; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Beudel M, 2011, HUM BRAIN MAPP, V32, P564, DOI 10.1002/hbm.21044; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Camurri A, 2009, ACII 2009 3 INT C AF, V364, P2369; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cupchik GC, 2001, BRAIN COGNITION, V46, P373, DOI 10.1006/brcg.2001.1295; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Dick F, 2011, CEREB CORTEX, V21, P938, DOI 10.1093/cercor/bhq166; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dissanayake E, 2000, ORIGINS OF MUSIC, P389; Foster NEV, 2010, CEREB CORTEX, V20, P1350, DOI 10.1093/cercor/bhp199; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Goodale MA, 1998, CURR BIOL, V8, pR489, DOI 10.1016/S0960-9822(98)70314-8; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Itoh K, 2001, NEUROSCI LETT, V309, P41, DOI 10.1016/S0304-3940(01)02024-9; James CE, 2008, NEUROIMAGE, V42, P1597, DOI 10.1016/j.neuroimage.2008.06.025; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Koelsch S, 2006, CORTEX, V42, P518, DOI 10.1016/S0010-9452(08)70390-3; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Kokotsaki D., 2007, MUSIC EDUC RES, V9, P93, DOI [DOI 10.1080/14613800601127577, 10.1080/14613800601127577]; Kornysheva K, 2010, HUM BRAIN MAPP, V31, P48, DOI 10.1002/hbm.20844; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144; LEMAN M, 2008, EMBODIED MUSIC COGNI; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; McNeill W. H., 1995, KEEPING TOGETHER TIM; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; Nan Y, 2006, BRAIN RES, V1094, P179, DOI 10.1016/j.brainres.2006.03.115; Osnes B, 2011, BRAIN LANG, V116, P97, DOI 10.1016/j.bandl.2010.10.001; Parsons LM, 2001, ANN NY ACAD SCI, V930, P211, DOI 10.1111/j.1749-6632.2001.tb05735.x; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 2005, ANN NY ACAD SCI, V1060, P59, DOI 10.1196/annals.1360.005; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; Pressing J, 2005, GENERATIVE PROCESSES; RAUSCHER FH, 1995, NEUROSCI LETT, V185, P44, DOI 10.1016/0304-3940(94)11221-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rusconi E, 2005, ANN NY ACAD SCI, V1060, P195, DOI 10.1196/annals.1360.056; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sammler D, 2011, CORTEX, V47, P659, DOI 10.1016/j.cortex.2010.04.007; Satoh M, 2001, COGNITIVE BRAIN RES, V12, P101, DOI 10.1016/S0926-6410(01)00044-1; Schachner Adena, 2010, Communicative & Integrative Biology, V3, P290; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; SERGENT J, 1992, SCIENCE, V257, P106, DOI 10.1126/science.1621084; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Stewart L, 2003, NEUROIMAGE, V20, P71, DOI 10.1016/S1053-8119(03)00248-9; Tervaniemi M, 2003, COGNITIVE NEUROSCIEN; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Trainor LJ, 2002, J COGNITIVE NEUROSCI, V14, P430, DOI 10.1162/089892902317361949; Vesia M, 2006, J NEUROPHYSIOL, V96, P3016, DOI 10.1152/jn.00411.2006; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	89	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93681	10.1371/journal.pone.0093681	http://dx.doi.org/10.1371/journal.pone.0093681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714661	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900043
J	Jiang, L; Wallerman, O; Younis, S; Rubin, CJ; Gilbert, ER; Sundstrom, E; Ghazal, A; Zhang, XL; Wang, L; Mikkelsen, TS; Andersson, G; Andersson, L				Jiang, Lin; Wallerman, Ola; Younis, Shady; Rubin, Carl-Johan; Gilbert, Elizabeth R.; Sundstrom, Elisabeth; Ghazal, Awaisa; Zhang, Xiaolan; Wang, Li; Mikkelsen, Tarjei S.; Andersson, Goran; Andersson, Leif			ZBED6 Modulates the Transcription of Myogenic Genes in Mouse Myoblast Cells	PLOS ONE			English	Article							HELIX-LOOP-HELIX; GROWTH; METHYLATIONS; DOMAIN; MYOD	ZBED6 is a recently discovered transcription factor, unique to placental mammals, that has evolved from a domesticated DNA transposon. It acts as a repressor at the IGF2 locus. Here we show that ZBED6 acts as a transcriptional modulator in mouse myoblast cells, where more than 700 genes were differentially expressed after Zbed6-silencing. The most significantly enriched GO term was muscle protein and contractile fiber, which was consistent with increased myotube formation. Twenty small nucleolar RNAs all showed increased expression after Zbed6-silencing. The co-localization of histone marks and ZBED6 binding sites and the effect of Zbed6-silencing on distribution of histone marks was evaluated by ChIP-seq analysis. There was a strong association between ZBED6 binding sites and the H3K4me3, H3K4me2 and H3K27ac modifications, which are usually found at active promoters, but no association with the repressive mark H3K27me3. Zbed6-silencing led to increased enrichment of active marks at myogenic genes, in agreement with the RNA-seq findings. We propose that ZBED6 preferentially binds to active promoters and modulates transcriptional activity without recruiting repressive histone modifications.	[Jiang, Lin; Wallerman, Ola; Younis, Shady; Rubin, Carl-Johan; Gilbert, Elizabeth R.; Sundstrom, Elisabeth; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Younis, Shady] Ain Shams Univ, Dept Anim Prod, Cairo, Egypt; [Ghazal, Awaisa; Andersson, Goran; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Zhang, Xiaolan; Wang, Li; Mikkelsen, Tarjei S.] Broad Inst, Cambridge, MA USA; [Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Mikkelsen, Tarjei S.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Uppsala University; Egyptian Knowledge Bank (EKB); Ain Shams University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	leif.andersson@imbim.uu.se	Andersson, Goran/AAK-6564-2020; Mikkelsen, Tarjei S/A-1306-2007	Andersson, Goran/0000-0001-5131-3144; Mikkelsen, Tarjei S/0000-0002-8133-3135; Rubin, Carl-Johan/0000-0001-8238-5052; Jiang, Lin/0000-0001-9123-5988; Wallerman, Ola/0000-0003-1037-7904; Younis, Shady/0000-0002-4319-1738	Swedish Research Council; Swedish Foundation for Strategic Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	The work was supported by grants from the Swedish Research Council and Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Andersson L, 2010, TRANSCR-AUSTIN, V1, P144, DOI 10.4161/trns.1.3.13343; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; CALVI BR, 1991, CELL, V66, P465, DOI 10.1016/0092-8674(81)90010-6; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Michal B, 2007, FLEXARRAY STAT DATA, P69; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Van Laere AS, 2005, QTL QTN IDENTIFICATI; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	32	15	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94187	10.1371/journal.pone.0094187	http://dx.doi.org/10.1371/journal.pone.0094187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714595	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900101
J	Jung, Y; Ng, JH; Keating, CP; Senthil-Kumar, P; Zhao, J; Randolph, MA; Winograd, JM; Evans, CL				Jung, Yookyung; Ng, Joanna H.; Keating, Cameron P.; Senthil-Kumar, Prabhu; Zhao, Jie; Randolph, Mark A.; Winograd, Jonathan M.; Evans, Conor L.			Comprehensive Evaluation of Peripheral Nerve Regeneration in the Acute Healing Phase Using Tissue Clearing and Optical Microscopy in a Rodent Model	PLOS ONE			English	Article							IN-VIVO; INJURIES; IMPROVES; REPAIR; ORGANS	Peripheral nerve injury (PNI), a common injury in both the civilian and military arenas, is usually associated with high healthcare costs and with patients enduring slow recovery times, diminished quality of life, and potential long-term disability. Patients with PNI typically undergo complex interventions but the factors that govern optimal response are not fully characterized. A fundamental understanding of the cellular and tissue-level events in the immediate postoperative period is essential for improving treatment and optimizing repair. Here, we demonstrate a comprehensive imaging approach to evaluate peripheral nerve axonal regeneration in a rodent PNI model using a tissue clearing method to improve depth penetration while preserving neural architecture. Sciatic nerve transaction and end-to-end repair were performed in both wild type and thy-1 GFP rats. The nerves were harvested at time points after repair before undergoing whole mount immunofluorescence staining and tissue clearing. By increasing the optic depth penetration, tissue clearing allowed the visualization and evaluation of Wallerian degeneration and nerve regrowth throughout entire sciatic nerves with subcellular resolution. The tissue clearing protocol did not affect immunofluorescence labeling and no observable decrease in the fluorescence signal was observed. Large-area, high-resolution tissue volumes could be quantified to provide structural and connectivity information not available from current gold-standard approaches for evaluating axonal regeneration following PNI. The results are suggestive of observed behavioral recovery in vivo after neurorrhaphy, providing a method of evaluating axonal regeneration following repair that can serve as an adjunct to current standard outcomes measurements. This study demonstrates that tissue clearing following whole mount immunofluorescence staining enables the complete visualization and quantitative evaluation of axons throughout nerves in a PNI model. The methods developed in this study could advance PNI research allowing both researchers and clinicians to further understand the individual events of axonal degeneration and regeneration on a multifaceted level.	[Jung, Yookyung; Zhao, Jie; Evans, Conor L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA; [Ng, Joanna H.; Keating, Cameron P.; Senthil-Kumar, Prabhu; Randolph, Mark A.; Winograd, Jonathan M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Plast & Reconstruct Surg,Plast Surg Res Lab, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Evans, CL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	Evans.Conor@mgh.harvard.edu	Senthil-kumar, Prabhu/AAE-2147-2019	Jung, Yookyung/0000-0003-2790-6016	American Society for Surgery of the Hand (Basic Science Grant); Department of Defense "Center for Integration of Medicine and Innovative Technology" (CIMIT) [W81XWH-09-2-0001]; National Institutes of Heath (NIH) Innovative Molecular Analysis Technologies (IMAT) program [R21 CA155535]; NIH Director's New Innovator Award [DP2 OD007096]; NATIONAL CANCER INSTITUTE [R21CA155535] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007096] Funding Source: NIH RePORTER	American Society for Surgery of the Hand (Basic Science Grant); Department of Defense "Center for Integration of Medicine and Innovative Technology" (CIMIT); National Institutes of Heath (NIH) Innovative Molecular Analysis Technologies (IMAT) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the American Society for Surgery of the Hand (Basic Science Grant, www.assh.org), the Department of Defense "Center for Integration of Medicine and Innovative Technology" (CIMIT, www.cimit.org) Grant Award #W81XWH-09-2-0001, the National Institutes of Heath (NIH) Innovative Molecular Analysis Technologies (IMAT, imat.cancer.gov) program, grant number R21 CA155535, and the NIH Director's New Innovator Award, grant number DP2 OD007096. Information on the New Innovator Award Program is at http://nihroadmap.nih.gov/newinnovator/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arous JB, 2011, J BIOMEDICAL OPTICS, V16; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Belanger E, 2011, BIOMED OPT EXPRESS, V2, P2698, DOI 10.1364/BOE.2.002698; Belanger E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021107; Birch R, 2012, J BONE JOINT SURG BR, V94B, P523, DOI 10.1302/0301-620X.94B4.28483; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Chlebicki CA, 2010, LASER SURG MED, V42, P306, DOI 10.1002/lsm.20915; Dagum A B, 1998, J Hand Ther, V11, P111; Erturk A, 2013, EXP NEUROL, V242, P57, DOI 10.1016/j.expneurol.2012.10.018; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; FU SY, 1995, J NEUROSCI, V15, P3876; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gordon T, 1997, Adv Neurol, V72, P185; Henry FP, 2009, PLAST RECONSTR SURG, V123, p123S, DOI 10.1097/PRS.0b013e318191c5b8; Henry FP, 2009, SURGERY, V145, P313, DOI 10.1016/j.surg.2008.11.005; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018; Isaacs J, 2010, J HAND SURG-AM, V35A, P491, DOI 10.1016/j.jhsa.2009.12.009; Kelly Patrick, ZPROJECT PLUGIN; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Liu YA, 2011, NEUROGASTROENT MOTIL, V23, pE446, DOI 10.1111/j.1365-2982.2011.01773.x; Magill CK, 2010, ARCH FACIAL PLAST S, V12, P315, DOI 10.1001/archfacial.2010.71; Maricevic A, 1997, MIL MED, V162, P808, DOI 10.1093/milmed/162.12.808; Mathes SJ, 2005, PLASTIC SURG; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Moore AM, 2012, J NEUROSCI METH, V204, P19, DOI 10.1016/j.jneumeth.2011.10.011; O'Neill AC, 2009, J SURG RES, V151, P33, DOI 10.1016/j.jss.2008.01.025; Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Sevrain D, 2013, EXP DERMATOL, V22, P290, DOI 10.1111/exd.12108; Shi YZ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3641988; Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6; Tapia JC, 2012, NEURON, V74, P816, DOI 10.1016/j.neuron.2012.04.017; Turney SG, 2012, COLD SPRING HARBOR P, V2012; Turney SG, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001352; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008	45	32	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94054	10.1371/journal.pone.0094054	http://dx.doi.org/10.1371/journal.pone.0094054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714405	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900076
J	Lutz, P; Parcina, M; Bekeredjian-Ding, I; Nischalke, HD; Nattermann, J; Sauerbruch, T; Hoerauf, A; Strassburg, CP; Spengler, U				Lutz, Philipp; Parcina, Marijo; Bekeredjian-Ding, Isabelle; Nischalke, Hans Dieter; Nattermann, Jacob; Sauerbruch, Tilman; Hoerauf, Achim; Strassburg, Christian P.; Spengler, Ulrich			Impact of Rifaximin on the Frequency and Characteristics of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis and Ascites	PLOS ONE			English	Article							PASTEURELLA-MULTOCIDA; RISK-FACTORS; INFECTIONS; PREVALENCE; RESISTANT	Background: Rifaximin is a non-absorbable antibiotic used to prevent relapses of hepatic encephalopathy which may also be a candidate for prophylaxis of spontaneous bacterial peritonitis (SBP). Aim: To detect the impact of rifaximin on the occurrence and characteristics of SBP. Methods: We prospectively studied all hospitalized patients that underwent a diagnostic paracentesis in our department from March 2012 to April 2013 for SBP and recorded all clinical data including type of SBP prophylaxis, prior use of rifaximin, concomitant complications of cirrhosis, as well as laboratory results and bacteriological findings. Patients were divided into the following three groups: no antibiotic prophylaxis, prophylaxis with rifaximin or with systemically absorbed antibiotic prophylaxis. Results: Our study cohort comprised 152 patients with advanced liver cirrhosis, 32 of whom developed SBP during the study period. As expected, our study groups differed regarding a history of hepatic encephalopathy and SBP before inclusion into the study. None of the 17 patients on systemic antibiotic prophylaxis developed SBP while 8/27 patients on rifaximin and 24/108 without prophylaxis had SBP (p = 0.02 and p = 0.04 versus systemic antibiotics, respectively). In general, episodes of SBP were similar for patients treated with rifaximin and those without any prophylaxis. However, Escherichia coli and enterococci were dominant in the ascites of patients without any prophylaxis, while mostly klebsiella species were recovered from the ascites samples in the rifaximin group. Conclusion: Rifaximin pretreatment did not lead to a reduction of SBP occurrence in hospitalized patients with advanced liver disease. However, the bacterial species causing SBP were changed by rifaximin.	[Lutz, Philipp; Nischalke, Hans Dieter; Nattermann, Jacob; Sauerbruch, Tilman; Strassburg, Christian P.; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Parcina, Marijo; Bekeredjian-Ding, Isabelle; Hoerauf, Achim] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany	University of Bonn; University of Bonn	Lutz, P (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	philipp.lutz@ukb.uni-bonn.de	Parcina, Marijo/ABG-4659-2020; Bekeredjian-Ding, Isabelle/I-6197-2013	Bekeredjian-Ding, Isabelle/0000-0001-6646-5888; Lutz, Philipp/0000-0002-4921-200X; Nischalke, Hans Dieter/0000-0002-3457-0023	German Center for Infection Research	German Center for Infection Research	This study was supported by a clinical leave stipend to PL by the German Center for Infection Research (DZIF, http://www.dzif.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; AVRIL JL, 1990, J CLIN MICROBIOL, V28, P1438, DOI 10.1128/JCM.28.6.1438-1440.1990; Bajaj JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060042; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Bunchorntavakul C, 2012, WORLD J HEPATOL, V4, P158, DOI 10.4254/wjh.v4.i5.158; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; DELEO C, 1986, DRUG EXP CLIN RES, V12, P979; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; DuPont HL, 2004, CLIN MICROBIOL INFEC, V10, P1009, DOI 10.1111/j.1469-0691.2004.00997.x; Eltawil KM, 2012, WORLD J GASTROENTERO, V18, P767, DOI 10.3748/wjg.v18.i8.767; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580; GILLIS JC, 1995, DRUGS, V49, P467, DOI 10.2165/00003495-199549030-00009; GINES P, 1990, HEPATOLOGY, V12, P716, DOI 10.1002/hep.1840120416; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Gustot T, 2009, HEPATOLOGY, V50, P2022, DOI 10.1002/hep.23264; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Hanouneh MA, 2012, J CLIN GASTROENTEROL, V46, P709, DOI 10.1097/MCG.0b013e3182506dbb; Harputluoglu MMM, 2012, INFLAMMATION, V35, P1512, DOI 10.1007/s10753-012-9465-2; HOOVER WW, 1993, DIAGN MICR INFEC DIS, V16, P111, DOI 10.1016/0732-8893(93)90004-Q; Jiang ZD, 2000, ANTIMICROB AGENTS CH, V44, P2205, DOI 10.1128/AAC.44.8.2205-2206.2000; Kothary V, 2013, ANTIMICROB AGENTS CH, V57, P811, DOI 10.1128/AAC.02163-12; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; PELLETIER G, 1990, J HEPATOL, V10, P327, DOI 10.1016/0168-8278(90)90140-M; Rogers GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074884; Scarpignato C, 2006, DIGESTION, V73, P13, DOI 10.1159/000089776; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Tamaskar I, 2004, SOUTH MED J, V97, P1113, DOI 10.1097/01.SMJ.0000144616.66917.8A; Tandon P, 2012, CLIN GASTROENTEROL H, V10, P1291, DOI 10.1016/j.cgh.2012.08.017; TANNER A, 2000, PERIODONTOL, V5, P26; Thuluvath PJ, 2001, AM J GASTROENTEROL, V96, P1232, DOI 10.1111/j.1572-0241.2001.03708.x; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Umgelter A, 2009, INFECTION, V37, P2, DOI 10.1007/s15010-008-8060-9; Valentin T, 2011, J INFECTION, V62, P34, DOI 10.1016/j.jinf.2010.11.004; Vlachogiannakos J, 2013, J GASTROEN HEPATOL, V28, P450, DOI 10.1111/jgh.12070; Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779; Yakar T, 2010, DIGEST DIS SCI, V55, P1149, DOI 10.1007/s10620-009-0825-1; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	39	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93909	10.1371/journal.pone.0093909	http://dx.doi.org/10.1371/journal.pone.0093909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714550	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900059
J	Oskarsson, H; Wiklund, AKE; Thorsen, G; Danielsson, G; Kumblad, L				Oskarsson, Hanna; Wiklund, Ann-Kristin Eriksson; Thorsen, Gunnar; Danielsson, Gabriela; Kumblad, Linda			Community Interactions Modify the Effects of Pharmaceutical Exposure: A Microcosm Study on Responses to Propranolol in Baltic Sea Coastal Organisms	PLOS ONE			English	Article							MYTILUS-EDULIS; RISK-ASSESSMENT; BETA-BLOCKERS; ECOSYSTEM; BIODIVERSITY; CONTAMINANTS; ECOTOXICITY; POPULATIONS; PESTICIDES; FILTRATION	This study investigated the uptake and effects of a common human pharmaceutical, propranolol, on the structure and function of a coastal Baltic Sea model community consisting of macroalga (Ceramium tenuicorne), mussels (Mytilus edulis trossulus), amphipods (Gammarus spp.), water and sediment. The most sensitive species, the mussel, was affected to the same extent as in previous single species studies, while the effects on the amphipod and alga were smaller or even positive compared to experiments performed in less complex test systems. The observed cascade of beneficial effects was a result of inter-specific species interactions that buffered for more severe effects. The poor condition of the mussel led to a feeding shift from alga to mussel by the amphipods. The better food quality, due to the dietary shift, counteracted the effects of the exposure. Less amphipod grazing, together with increased levels of nutrients in the water was favourable for the alga, despite the negative effects of propranolol. This microcosm study showed effects on organisms on different organizational levels as well as interactions among the different components resulting in indirect exposure effects of both functional and structural nature. The combination of both direct and indirect effects would not have been detected using simpler single- or even two-species study designs. The observed structural changes would in the natural environment have a long-term influence on ecosystem function, especially in a low-biodiversity ecosystem like the Baltic Sea.	[Oskarsson, Hanna; Kumblad, Linda] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Wiklund, Ann-Kristin Eriksson] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Thorsen, Gunnar] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden; [Danielsson, Gabriela] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University; Stockholm University; Stockholm University	Oskarsson, H (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	hanna.oskarsson@su.se		Thorsen, Gunnar/0000-0002-0387-901X	Stockholm University Baltic Sea Center	Stockholm University Baltic Sea Center	The field sampling was financed by an Asko grant from Stockholm University Baltic Sea Center (http://www.su.se/ostersjocentrum/english/) to H. Oskarsson. Employees of the funder at the Asko Laboratory assisted with the collection of organisms. The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Adamo Shelley A., 2008, ISJ, V5, P12; ALEXANDER BS, 1987, J PHARM PHARMACOL, V39, P664, DOI 10.1111/j.2042-7158.1987.tb03452.x; Alsterberg C, 2013, P NATL ACAD SCI USA, V110, P8603, DOI 10.1073/pnas.1303797110; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andreozzi R, 2003, CHEMOSPHERE, V50, P1319, DOI 10.1016/S0045-6535(02)00769-5; Ankar S, 1978, CONTRIBUTIONS ASKO L, V11; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Bengtsson B-E, 2005, LAKEMEDEL MILJO; Bonsdorff E, 1999, AUST J ECOL, V24, P312, DOI 10.1046/j.1442-9993.1999.00986.x; Calabrese EJ, 2008, ENVIRON TOXICOL CHEM, V27, P1451, DOI 10.1897/07-541; Clausen I, 1996, MAR ECOL PROG SER, V141, P37, DOI 10.3354/meps141037; Clements WH, 2009, ENVIRON TOXICOL CHEM, V28, P1789, DOI 10.1897/09-140.1; Cleuvers M, 2003, TOXICOL LETT, V142, P185, DOI 10.1016/S0378-4274(03)00068-7; Elmgren R, 1997, MARINE BIODIVERSITY-BOOK, P319, DOI 10.1017/CBO9780511752360.015; Elmgren R, 2001, AMBIO, V30, P222, DOI 10.1639/0044-7447(2001)030[0222:UHIOTB]2.0.CO;2; Ericson H, 2010, AQUAT TOXICOL, V99, P223, DOI 10.1016/j.aquatox.2010.04.017; Escher BI, 2006, ENVIRON SCI TECHNOL, V40, P7402, DOI 10.1021/es052572v; Falas P, 2012, WATER SCI TECHNOL, V66, P783, DOI 10.2166/wst.2012.243; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Ferrari B, 2004, ENVIRON TOXICOL CHEM, V23, P1344, DOI 10.1897/03-246; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Forbes VE, 2012, ENVIRON TOXICOL CHEM, V31, P2663, DOI 10.1002/etc.2009; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huggett DB, 2002, ARCH ENVIRON CON TOX, V43, P229, DOI 10.1007/s00244-002-1182-7; Hughes A., 2012, NAT ED KNOWL, V3, P48; Jansson B-O, 1977, CONTRIBUTIONS ASKO L, V18; JANSSON BO, 1980, AMBIO, V9, P128; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Kautsky H, 1989, CONTRIBUTIONS ASKO L, V35; KAUTSKY N, 1987, MAR ECOL PROG SER, V38, P201, DOI 10.3354/meps038201; KAUTSKY U, 1995, THESIS STOCKHOLM U S; Koivisto M, 2011, MAR BIOL, V158, P945, DOI 10.1007/s00227-010-1621-3; KOLDING S, 1981, OIKOS, V37, P167, DOI 10.2307/3544461; KOLDING S, 1981, OIKOS, V37, P173, DOI 10.2307/3544462; Lacoste A, 2001, GEN COMP ENDOCR, V122, P252, DOI 10.1006/gcen.2001.7643; Lora-Vilchis MC, 2004, AQUAC RES, V35, P1086, DOI 10.1111/j.1365-2109.2004.01123.x; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; Maire O, 2007, MAR BIOL, V152, P1293, DOI 10.1007/s00227-007-0778-x; Massarsky A, 2011, J EXP ZOOL PART A, V315A, P251, DOI 10.1002/jez.672; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Norling P, 2009, THESIS STOCKHOLM U S; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; Norling P, 2008, AQUAT BIOL, V4, P75, DOI 10.3354/ab00096; Oskarsson H, 2012, MAR ENVIRON RES, V74, P1, DOI 10.1016/j.marenvres.2011.11.001; Prevodnik A, 2007, AQUAT TOXICOL, V82, P63, DOI 10.1016/j.aquatox.2007.01.006; Relyea RA, 2005, ECOL APPL, V15, P1125, DOI 10.1890/04-0559; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Ronnback P, 2007, AMBIO, V36, P534, DOI 10.1579/0044-7447(2007)36[534:EGASFS]2.0.CO;2; Ruist E, 2008, FOSFOR KVAVEFRAKTION; Sheehan P. J., 1984, EFFECTS POLLUTANTS E, P51; SHURE DJ, 1971, ECOLOGY, V52, P271, DOI 10.2307/1934585; SMITH R. L., 2003, ELEMENTS ECOLOGY; Stanley JK, 2006, ENVIRON TOXICOL CHEM, V25, P1780, DOI 10.1897/05-298R1.1; Wahlberg C., 2010, LAKEMEDELSRESTER STO; Widdows J., 1985, P3; Wiklund AKE, 2011, AQUAT BIOL, V14, P29, DOI 10.3354/ab00380; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wulff F, 2001, AMBIO, V30, P254, DOI 10.1639/0044-7447(2001)030[0254:GAOCEM]2.0.CO;2; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640	64	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93774	10.1371/journal.pone.0093774	http://dx.doi.org/10.1371/journal.pone.0093774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713620	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900047
J	Xue, G; Wang, XJ; Yang, Y; Liu, DG; Cheng, Y; Zhou, J; Cao, YK				Xue, Gang; Wang, Xiaojuan; Yang, Yong; Liu, Degui; Cheng, Ying; Zhou, Jun; Cao, Yongkuan			Colon Cancer-Specific Antigen-2 May Be Used as a Detecting and Prognostic Marker in Colorectal Cancer: A Preliminary Observation	PLOS ONE			English	Article							SERUM CARCINOEMBRYONIC ANTIGEN; UNITED-STATES; DIAGNOSIS; SURVEILLANCE; GUIDELINES; SOCIETY; CEA	Background: A specific and sensitive serum marker for colorectal cancer (CRC) detection and surveillance is central to effective treatment. It was preliminarily reported that some nuclear matrix proteins may be served as a specific blood based marker for colon cancer. The objective of this study is to evaluate the value of serum CCSA-2 detection in diagnosis, prognostic estimation and surveillance for CRC. Method: Serum CCSA-2 protein was measured in 181 various patient populations and 20 healthy donors before surgery. For 106 CRC patients, it was also measured on day 7 after surgery. Among them, 49 CRC patients' CCSA-2 protein were measured during the follow-up period according to NCCN Guideline. Results: The serum CCSA-2 concentration in CRC patients was significantly higher than which in other patients and healthy individuals. Serum CCSA-2, at the cut-off point of 64.10 ng/ mL, had a sensitivity of 98.10% and a specificity of 97.90% in separating CRC populations from all other individuals. The CCSA-2 assay was significantly more sensitive than CEA and CA19-9 assay in CRC detection. After surgery, the serum CCSA-2 level of CRC patients declined significantly, but it rebounded to a high level when recurrences occurred. The pre-operative serum CCSA-2 level in patients who had a relapse within the follow-up period was significantly higher than which in patients without relapse. Conclusions: Serum CCSA-2 not only may be a potential biomarker using in screening and surveillance of CRC, but also may be an independent prognostic marker for CRC patients. Further clinical trials need to be performed in a larger population of patients to ulteriorly confirm these results.	[Xue, Gang; Wang, Xiaojuan; Yang, Yong; Liu, Degui] Chengdu Mil Gen Hosp, Dept Breast & Thyroid Surg, Chengdu, Peoples R China; [Cheng, Ying] Chengdu Mil Gen Hosp, Dept Endocrinol, Chengdu, Peoples R China; [Zhou, Jun; Cao, Yongkuan] Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China		Xue, G (corresponding author), Chengdu Mil Gen Hosp, Dept Breast & Thyroid Surg, Chengdu, Peoples R China.	kpardan@163.com			elite training foundation of Chengdu Military General Hospital; foundation of Sichuan Provincial Health Bureau [080009]	elite training foundation of Chengdu Military General Hospital; foundation of Sichuan Provincial Health Bureau	This work was supported by the elite training foundation of Chengdu Military General Hospital and the foundation of Sichuan Provincial Health Bureau (080009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Brunagel G, 2002, CANCER RES, V62, P2437; Carpelan-Holmstrom M, 2004, TUMOR BIOL, V25, P228, DOI 10.1159/000081385; Di Cristofaro L, 2012, ACTA CHIR BELG, V112, P24, DOI 10.1080/00015458.2012.11680791; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; FEY EG, 1988, P NATL ACAD SCI USA, V85, P121, DOI 10.1073/pnas.85.1.121; Ghesani M, 2003, CLIN NUCL MED, V28, P608, DOI 10.1097/00003072-200307000-00021; Hara M, 2011, SURG TODAY, V41, P1357, DOI 10.1007/s00595-010-4519-2; Hawk ET, 2005, J CLIN ONCOL, V23, P378, DOI 10.1200/JCO.2005.08.097; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Knychalski Bartlomiej, 2012, Pol Przegl Chir, V84, P86, DOI 10.2478/v10035-012-0014-3; Labianca R, 2010, TUMORI, V96, P889, DOI 10.1177/548.6506; Leman ES, 2007, CANCER RES, V67, P5600, DOI 10.1158/0008-5472.CAN-07-0649; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Mandel JS, 2007, JNCI-J NATL CANCER I, V99, P1424, DOI 10.1093/jnci/djm166; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Smith RA, 2011, CA-CANCER J CLIN, V61, P8, DOI 10.3322/caac.20096; Walgenbach-Brunagel G, 2008, J CELL BIOCHEM, V104, P286, DOI 10.1002/jcb.21619; Yang XQ, 2011, ASIAN PAC J CANCER P, V12, P1251; Yeh CY, 2011, HEPATO-GASTROENTEROL, V58, P1171, DOI 10.5754/hge10564	23	2	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94252	10.1371/journal.pone.0094252	http://dx.doi.org/10.1371/journal.pone.0094252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710115	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800128
J	Bachanek-Bankowska, K; Maan, S; Castillo-Olivares, J; Manning, NM; Maan, NS; Potgieter, AC; Di Nardo, A; Sutton, G; Batten, C; Mertens, PPC				Bachanek-Bankowska, Katarzyna; Maan, Sushila; Castillo-Olivares, Javier; Manning, Nicola M.; Maan, Narender Singh; Potgieter, Abraham C.; Di Nardo, Antonello; Sutton, Geoff; Batten, Carrie; Mertens, Peter P. C.			Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RECOMBINANT CANARYPOX VIRUS; BLUETONGUE-VIRUS; HORSESICKNESS-VIRUS; COMPETITIVE ELISA; COMPLETE SET; VP2 GENES; ORBIVIRUS; SEROTYPES; IDENTIFICATION	Although African horse sickness (AHS) can cause up to 95% mortality in horses, naive animals can be protected by vaccination against the homologous AHSV serotype. Genome segment 2 (Seg-2) encodes outer capsid protein VP2, the most variable of the AHSV proteins. VP2 is also a primary target for AHSV specific neutralising antibodies, and consequently determines the identity of the nine AHSV serotypes. In contrast VP1 (the viral polymerase) and VP3 (the sub-core shell protein), encoded by Seg-1 and Seg-3 respectively, are highly conserved, representing virus species/orbivirus-serogroup-specific antigens. We report development and evaluation of real-time RT-PCR assays targeting AHSV Seg-1 or Seg-3, that can detect any AHSV type (virus species/serogroup-specific assays), as well as type-specific assays targeting Seg-2 of the nine AHSV serotypes. These assays were evaluated using isolates of different AHSV serotypes and other closely related orbiviruses, from the 'Orbivirus Reference Collection' (ORC) at The Pirbright Institute. The assays were shown to be AHSV virus-species-specific, or type-specific (as designed) and can be used for rapid, sensitive and reliable detection and identification (typing) of AHSV RNA in infected blood, tissue samples, homogenised Culicoides, or tissue culture supernatant. None of the assays amplified cDNAs from closely related heterologous orbiviruses, or from uninfected host animals or cell cultures.	[Bachanek-Bankowska, Katarzyna; Maan, Sushila; Castillo-Olivares, Javier; Manning, Nicola M.; Maan, Narender Singh; Di Nardo, Antonello; Batten, Carrie; Mertens, Peter P. C.] Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England; [Potgieter, Abraham C.] Deltamune Pty Ltd, Lyttelton, Centurion, South Africa; [Potgieter, Abraham C.] North West Univ, Dept Biochem, Ctr Human Metabon, Potchefstroom, South Africa; [Sutton, Geoff] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; North West University - South Africa; University of Oxford; Wellcome Centre for Human Genetics	Mertens, PPC (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England.	Peter.mertens@pirbright.ac.uk	Castillo-Olivares, Javier/AAA-7603-2019; Castillo-Olivares, Javier/AAA-8837-2019	Castillo-Olivares, Javier/0000-0003-3453-8557; Batten, Carrie/0000-0003-4274-7375; Mertens, Peter/0000-0002-3438-3738	Defra; Biotechnology and Biological Sciences Research Council; European Commission [245266, 222633-2, K1303206]; Biotechnology and Biological Sciences Research Council [BB/H531478/1, BB/L004690/1, BB/I017259/1, BBS/E/I/00001144, BBS/E/I/00001446] Funding Source: researchfish; BBSRC [BB/L004690/1, BB/H531478/1, BB/I017259/1, BBS/E/I/00001446] Funding Source: UKRI	Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge funding from Defra, Biotechnology and Biological Sciences Research Council, and the European Commission (OrbiVac - Grant no.: 245266; WildTech - Grant no.: 222633-2; EMIDA grant OrbiNet - K1303206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero M, 2008, J VET DIAGN INVEST, V20, P325, DOI 10.1177/104063870802000310; Aklilu N, 2012, TRANSBOUNDARY EMERGI; Aradaib IE, 2009, J VIROL METHODS, V159, P1, DOI 10.1016/j.jviromet.2009.02.012; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Bachanek-Bankowska K, 2012, GENETIC STUDIES AFRI; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belaganahalli MN, 2012, PLOS ONE, V7; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Bremer CW, 1998, ONDERSTEPOORT J VET, V65, P1; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Chiam R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005997; Coetzer J. A. W., 2004, Infectious diseases of livestock. Volume Two, P1231; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; El Garch H, 2012, VET IMMUNOL IMMUNOP, V149, P76, DOI 10.1016/j.vetimm.2012.06.009; Fernandez-Pinero J, 2009, RES VET SCI, V86, P353, DOI 10.1016/j.rvsc.2008.07.015; Gibbens N, 2012, VET REC, V170, P58, DOI 10.1136/vr.e292; Guthrie AJ, 2013, J VIROL METHODS, V189, P30, DOI 10.1016/j.jviromet.2012.12.014; Guthrie AJ, 2009, VACCINE, V27, P4434, DOI 10.1016/j.vaccine.2009.05.044; Hamblin C, 1998, ARCH VIROL, P37; HAMBLIN C, 1991, J VIROL METHODS, V31, P285, DOI 10.1016/0166-0934(91)90166-W; HAMBLIN C, 1990, EPIDEMIOL INFECT, V104, P303, DOI 10.1017/S0950268800059483; Hoffmann B, 2009, J CLIN MICROBIOL, V47, P2992, DOI 10.1128/JCM.00599-09; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; House C, 1990, J Vet Diagn Invest, V2, P44; HOWELL P. G., 1962, ONDERSTEPOORT JOUR VET RES, V29, P139; Jimenez-Clavero MA, 2006, J VET DIAGN INVEST, V18, P7, DOI 10.1177/104063870601800103; Koekemoer JJO, 2000, J VIROL METHODS, V88, P135, DOI 10.1016/S0166-0934(00)00191-9; Koekemoer JJO, 2004, J VIROL METHODS, V122, P49, DOI 10.1016/j.jviromet.2004.08.002; Kweon CH, 2003, J VIROL METHODS, V113, P13, DOI 10.1016/S0166-0934(03)00217-9; LAVIADA MD, 1992, J VIROL METHODS, V38, P229, DOI 10.1016/0166-0934(92)90113-R; LeBlanc N, 2010, J VIROL METHODS, V167, P165, DOI 10.1016/j.jviromet.2010.03.032; Lubroth J., 1988, Equine Practice, V10, P26; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025686; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; McINTOSH B. M., 1958, ONDERSTEPOORT JOUR VET RES, V27, P465; McINTOSH B. M., 1956, ONDERSTEPOORT JOUR VET RES, V27, P165; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Mertens P. P. C., 2014, REOID PHYLOGENETIC S; Mertens PPC, 2009, BIOL ANIM INFECT, P101, DOI 10.1016/B978-012369368-6.50010-1; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 2011, RNAS PROTEINS DSRNA; MIZUKOSHI N, 1994, J VET MED SCI, V56, P347, DOI 10.1292/jvms.56.347; Monaco F, 2011, MOL CELL PROBE, V25, P87, DOI 10.1016/j.mcp.2011.01.006; O'Hara RS, 1998, ARCH VIROL, P259; OIE, 2008, SUMM IMM NOT FOLL UP; OIE, 2007, SUMM IMM NOT FOLL UP; OIE, 2011, TERR AN HLTH COD; Portas M, 1999, EPIDEMIOL INFECT, V123, P337, DOI 10.1017/S0950268899002897; Potgieter AC, 2003, J GEN VIROL, V84, P1317, DOI 10.1099/vir.0.18919-0; ProMED-mail, 2008, AFR HORS SICKN ETH 0; ProMED-mail, 2007, AFR HORS SICKN SEN S; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quan M, 2010, J VIROL METHODS, V167, P45, DOI 10.1016/j.jviromet.2010.03.009; R Core Team, 2021, R LANGUAGE ENV STAT; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; RODRIGUEZ M, 1992, VET MICROBIOL, V33, P129, DOI 10.1016/0378-1135(92)90041-Q; Rodriguez-Sanchez B, 2008, J VIROL METHODS, V151, P87, DOI 10.1016/j.jviromet.2008.03.029; Saeed MF, 2001, J GEN VIROL, V82, P2173, DOI 10.1099/0022-1317-82-9-2173; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Sailleau C, 2000, J GEN VIROL, V81, P831, DOI 10.1099/0022-1317-81-3-831; Sanchez-Vizcaino JM, 2004, DEV BIOLOGICALS, V119, P255; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; STONEMARSCHAT M, 1994, J CLIN MICROBIOL, V32, P697, DOI 10.1128/JCM.32.3.697-700.1994; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Veronesi E, 2012, TEMPERATURE STRAIN R; von Teichman BF, 2010, VACCINE, V28, P6505, DOI 10.1016/j.vaccine.2010.06.105; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988; Yin HQ, 2010, J VIROL METHODS, V168, P237, DOI 10.1016/j.jviromet.2010.04.018; ZIENTARA S, 1993, VET RES, V24, P385	78	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93758	10.1371/journal.pone.0093758	http://dx.doi.org/10.1371/journal.pone.0093758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721971	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100023
J	Wang, J; Zhang, HZ; Su, CL; Chen, JJ; Zhu, BL; Zhang, HD; Xiao, H; Zhang, JS				Wang, Jun; Zhang, Huazhong; Su, Chenglei; Chen, Junjie; Zhu, Baoli; Zhang, Hengdong; Xiao, Hang; Zhang, Jinsong			Dexamethasone Ameliorates H2S-Induced Acute Lung Injury by Alleviating Matrix Metalloproteinase-2 and-9 Expression	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; HYDROGEN-SULFIDE TOXICITY; BRONCHOALVEOLAR LAVAGE FLUID; SPRAGUE-DAWLEY RATS; DOXYCYCLINE; INHIBITION; CELLS; EXPOSURE; LIPOPOLYSACCHARIDE; CORTICOSTEROIDS	Acute lung injury (ALI) is one of the fatal outcomes after exposure to high levels of hydrogen sulfide (H2S), and the matrix metalloproteinases (MMPs) especially MMP-2 and MMP-9 are believed to be involved in the development of ALI by degrading the extracellular matrix (ECM) of blood-air barrier. However, the roles of MMP-2 and MMP-9 in H2S-induced ALI and the mechanisms of dexamethasone (DXM) in treating ALI in clinical practice are still largely unknown. The present work was aimed to investigate the roles of MMP-2 and MMP-9 in H2S-induced ALI and the protective effects of DXM. In our study, SD rats were exposed to H2S to establish the ALI model and in parallel, A549 cells were incubated with NaHS (a H2S donor) to establish cell model. The lung HE staining, immunohistochemisty, electron microscope assay and wet/dry ratio were used to identify the ALI induced by H2S, then the MMP-2 and MMP-9 expression in both rats and A549 cells were detected. Our results revealed that MMP-2 and MMP-9 were obviously increased in both mRNA and protein level after H2S exposure, and they could be inhibited by MMP inhibitor doxycycline (DOX) in rat model. Moreover, DXM significantly ameliorated the symptoms of H2S-induced ALI including alveolar edema, infiltration of inflammatory cells and the protein leakage in BAFL via up-regulating glucocorticoid receptor(GR) to mediate the suppression of MMP-2 and MMP-9. Furthermore, the protective effects of DXM in vivo and vitro study could be partially blocked by co-treated with GR antagonist mifepristone (MIF). Our results, taken together, demonstrated that MMP-2 and MMP-9 were involved in the development of H2S-induced ALI and DXM exerted protective effects by alleviating the expression of MMP-2 and MMP-9. Therefore, MMP-2 and MMP-9 might represent novel pharmacological targets for the treatment of H2S and other hazard gases induced ALI.	[Zhang, Huazhong; Su, Chenglei; Chen, Junjie; Zhang, Jinsong] Nanjing Med Univ, Affiliated Hosp 1, Dept Emergency Med, Nanjing, Jiangsu, Peoples R China; [Wang, Jun; Xiao, Hang] Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhu, Baoli; Zhang, Hengdong] Jiangsu Prov Ctr Dis Prevent & Control, Dept Occupat Dis Prophylacticotherapet Inst, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xiao, H (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China.	hxiao@njmu.edu.cn; zhangjsojz@163.com			Medical Innovation Team Foundation of Jiangsu Province [LJ201122]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Medical Innovation Team Foundation of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Medical Innovation Team Foundation of Jiangsu Province (LJ201122) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bertorelli G, 2008, PULM PHARMACOL THER, V21, P214, DOI 10.1016/j.pupt.2007.03.001; Coimbra R, 2006, J TRAUMA, V60, P115, DOI 10.1097/01.ta.0000200075.12489.74; Corbel M, 1999, PULM PHARMACOL THER, V12, P165, DOI 10.1006/pupt.1999.0178; Corbel M, 2000, BRAZ J MED BIOL RES, V33, P749, DOI 10.1590/S0100-879X2000000700004; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; Dong M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039695; Dongo K, 2012, ENVIRON SCI POLLUT R, V19, P3192, DOI 10.1007/s11356-012-0823-2; Dorman DC, 2000, NEUROTOXICOL TERATOL, V22, P71, DOI 10.1016/S0892-0362(99)00055-0; Dorman DC, 2002, TOXICOL SCI, V65, P18, DOI 10.1093/toxsci/65.1.18; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Fligiel SEG, 2006, HUM PATHOL, V37, P422, DOI 10.1016/j.humpath.2005.11.023; Fujita M, 2007, PULM PHARMACOL THER, V20, P669, DOI 10.1016/j.pupt.2006.08.006; Garvican ER, 2010, J ORTHOP RES, V28, P370, DOI 10.1002/jor.21001; Guney S, 2007, AM J PHYSIOL-LUNG C, V293, pL1332, DOI 10.1152/ajplung.00338.2006; Gushima Y, 2001, EUR RESPIR J, V18, P827, DOI 10.1183/09031936.01.00049201; Hanemaaijer R, 1998, Adv Dent Res, V12, P114; Haouzi P, 2012, RESP PHYSIOL NEUROBI, V184, P170, DOI 10.1016/j.resp.2012.05.002; He Dai-Kun, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P289; Kanno S, 2013, ARCH TOXICOL, V87, P1245, DOI 10.1007/s00204-013-1027-3; KHAN AA, 1990, TOXICOL APPL PHARM, V103, P482, DOI 10.1016/0041-008X(90)90321-K; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL848, DOI 10.1152/ajplung.2000.278.4.L848; Liu XJ, 2008, BRAIN RES, V1207, P237, DOI 10.1016/j.brainres.2008.01.106; LOPEZ A, 1988, VET PATHOL, V25, P376, DOI 10.1177/030098588802500507; Maghni K, 2010, ALLERGY, V65, P722, DOI 10.1111/j.1398-9995.2009.02256.x; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Moon A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-31; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Nogue S, 2011, OCCUP MED-OXFORD, V61, P212, DOI 10.1093/occmed/kqr021; Oesterhelweg L, 2008, INT J LEGAL MED, V122, P101, DOI 10.1007/s00414-007-0172-8; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Pirrone F, 2009, VET RES COMMUN, V33, pS121, DOI 10.1007/s11259-009-9255-y; PRIOR M, 1990, TOXICOL PATHOL, V18, P279, DOI 10.1177/019262339001800206; PRIOR MG, 1988, CAN J VET RES, V52, P375; Prota LFM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047405; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Shivanthan MC, 2013, J OCCUP MED TOXICOL, V8, DOI 10.1186/1745-6673-8-9; Smith GN, 1999, ARTHRITIS RHEUM, V42, P1140, DOI 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7; Struve MF, 2001, NEUROTOXICOLOGY, V22, P375, DOI 10.1016/S0161-813X(01)00021-3; TAMAOKI J, 1995, AM J RESP CRIT CARE, V151, P1582, DOI 10.1164/ajrccm.151.5.7735618; Torii K, 1997, AM J RESP CRIT CARE, V155, P43, DOI 10.1164/ajrccm.155.1.9001287; Truong DH, 2006, DRUG METAB REV, V38, P733, DOI 10.1080/03602530600959607; Tsushima K, 2009, INTERNAL MED, V48, P621, DOI 10.2169/internalmedicine.48.1741; Umberto Meduri Gianfranco, 2011, Presse Med, V40, pe543, DOI 10.1016/j.lpm.2011.04.023; Wang DL, 2011, BRAIN BEHAV IMMUN, V25, P706, DOI 10.1016/j.bbi.2011.01.011; Warner RL, 2001, AM J PATHOL, V158, P2139, DOI 10.1016/S0002-9440(10)64685-8; Warner RL, 2001, AM J RESP CELL MOL, V24, P537, DOI 10.1165/ajrcmb.24.5.4160; Wei N, 2013, J ORTHOP RES, V31, P760, DOI 10.1002/jor.22298; Xu J, 2001, J NEUROSCI, V21, P92, DOI 10.1523/JNEUROSCI.21-01-00092.2001; Yalamanchili C, 2008, AM J EMERG MED, V26; Yang Zhi-hui, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P466	55	20	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94701	10.1371/journal.pone.0094701	http://dx.doi.org/10.1371/journal.pone.0094701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722316	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100125
J	Dominy, SS; Brown, JN; Ryder, MI; Gritsenko, M; Jacobs, JM; Smith, RD				Dominy, Stephen S.; Brown, Joseph N.; Ryder, Mark I.; Gritsenko, Marina; Jacobs, Jon M.; Smith, Richard D.			Proteomic Analysis of Saliva in HIV-Positive Heroin Addicts Reveals Proteins Correlated with Cognition	PLOS ONE			English	Article							IL-1 RECEPTOR ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; NEURODEGENERATIVE DISEASES; TRANSMISSION EFFICIENCY; MAINTENANCE PATIENTS; ALZHEIMERS-DISEASE; QUALITY-CONTROL; ACCURATE MASS; BRAIN	The prevalence of HIV-associated neurocognitive disorders (HAND) remains high despite effective antiretroviral therapies. Multiple etiologies have been proposed over the last several years to account for this phenomenon, including the neurotoxic effects of antiretrovirals and co-morbid substance abuse; however, no underlying molecular mechanism has been identified. Emerging evidence in several fields has linked the gut to brain diseases, but the effect of the gut on the brain during HIV infection has not been explored. Saliva is the most accessible gut biofluid, and is therefore of great scientific interest for diagnostic and prognostic purposes. This study presents a longitudinal, liquid chromatography-mass spectrometry-based quantitative proteomics study investigating saliva samples taken from 8 HIV-positive (HIV+), 11 -negative (HIV-) heroin addicts. In addition, saliva samples were investigated from 11 HIV-, non-heroin addicted healthy controls. In the HIV+ group, 58 proteins were identified that show significant correlations with cognitive scores, implicating disruption of protein quality control pathways by HIV. Notably, only one protein from the HIV 2 heroin addict cohort showed a significant correlation with cognitive scores, and no proteins correlated with cognitive scores in the healthy control group. In addition, the majority of correlated proteins have been shown to be associated with exosomes, allowing us to propose that the salivary glands and/or oral epithelium may modulate brain function during HIV infection through the release of discrete packets of proteins in the form of exosomes.	[Dominy, Stephen S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Brown, Joseph N.; Gritsenko, Marina; Jacobs, Jon M.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA USA; [Ryder, Mark I.] Univ Calif San Francisco, Dept Orofacial Sci, Div Periodontol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California San Francisco	Dominy, SS (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	stephen.dominy@ucsf.edu; rds@pnnl.gov	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349	NIH [P01 DA026134, P41GM103493]; National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research [P30-AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The majority of the research was funded through NIH grant P01 DA026134, including proteomics measurements from capabilities developed at PNNL under NIH grant P41GM103493. The IL1RA ELISA research was supported by a grant from the National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research, P30-AI027763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Becker JT, 1999, J INT NEUROPSYCH SOC, V5, P41, DOI 10.1017/S1355617799511065; Bell JE, 2006, J NEUROIMMUNE PHARM, V1, P182, DOI 10.1007/s11481-006-9018-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermejo-Pareja F, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-108; Brown JN, 2012, MOL CELL PROTEOMICS, V11, P605, DOI 10.1074/mcp.M111.016121; Byrd DA, 2013, J INT NEUROPSYCH SOC, V19, P463, DOI 10.1017/S1355617712001634; Cheng GLF, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.36; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cockburn Andrew F, 2012, Investig Genet, V3, P19, DOI 10.1186/2041-2223-3-19; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; Coren LV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-64; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Darke S, 2012, DRUG ALCOHOL DEPEN, V126, P309, DOI 10.1016/j.drugalcdep.2012.05.032; Denier Niklaus, 2013, Front Psychiatry, V4, P135, DOI 10.3389/fpsyt.2013.00135; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Diamond B, 2011, BIOESSAYS, V33, P588, DOI 10.1002/bies.201100042; Diez-Revuelta N, 2010, J CELL SCI, V123, P671, DOI 10.1242/jcs.058198; Dolan PJ, 2011, FEBS LETT, V585, P3424, DOI 10.1016/j.febslet.2011.09.032; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Fernandes SP, 2010, J NEUROCHEM, V114, P1527, DOI 10.1111/j.1471-4159.2010.06869.x; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Gelman BB, 2010, J NEUROIMMUNE PHARM, V5, P92, DOI 10.1007/s11481-009-9168-0; Gomes I, 2010, AAPS J, V12, P658, DOI 10.1208/s12248-010-9217-x; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Gruber VA, 2012, CLIN INFECT DIS, V54, P414, DOI 10.1093/cid/cir799; GUTIERREZ EG, 1994, J NEUROIMMUNOL, V55, P153, DOI 10.1016/0165-5728(94)90005-1; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114; Jackrel ME, 2011, J CLIN INVEST, V121, P2972, DOI 10.1172/JCI59190; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jaitly N, 2006, ANAL CHEM, V78, P7397, DOI 10.1021/ac052197p; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jeffers L, 2011, Adv Dent Res, V23, P79, DOI 10.1177/0022034510396882; Johnson JL, 2011, BIOCH BIOPHYS ACTA; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Kelly RT, 2008, ANAL CHEM, V80, P143, DOI 10.1021/ac701647s; Kiebel GR, 2006, PROTEOMICS, V6, P1783, DOI 10.1002/pmic.200500500; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kragh CL, 2012, BRAIN PATHOL, V22, P99, DOI 10.1111/j.1750-3639.2011.00545.x; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Lazzeri G, 2006, ANN NY ACAD SCI, V1074, P174, DOI 10.1196/annals.1369.017; Marginean I, 2009, J AM SOC MASS SPECTR, V20, P682, DOI 10.1016/j.jasms.2008.12.004; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matzke MM, 2013, PROTEOMICS, V13, P493, DOI 10.1002/pmic.201200269; MCLEOD DR, 1982, BEHAV RES METH INSTR, V14, P463, DOI 10.3758/BF03203313; Mintzer MZ, 2002, DRUG ALCOHOL DEPEN, V67, P41, DOI 10.1016/S0376-8716(02)00013-3; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nam JW, 2007, ORAL DIS, V13, P187, DOI 10.1111/j.1601-0825.2006.01265.x; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Oh YS, 2006, AM J PHYSIOL-CELL PH, V291, pC76, DOI 10.1152/ajpcell.00508.2005; Ojha J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016550; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Page JS, 2007, J AM SOC MASS SPECTR, V18, P1582, DOI 10.1016/j.jasms.2007.05.018; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Papandreou MJ, 2010, J BIOL CHEM, V285, P13788, DOI 10.1074/jbc.M109.066670; Park IW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-234; Petritis K, 2006, ANAL CHEM, V78, P5026, DOI 10.1021/ac060143p; Proctor CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022038; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Rimaniol AC, 1997, J ACQ IMMUN DEF SYND, V16, P340, DOI 10.1097/00042560-199712150-00005; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rozek W, 2008, PROTEOM CLIN APPL, V2, P1498, DOI 10.1002/prca.200780114; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; SALTHOUSE TA, 1992, J GERONTOL, V47, pP121, DOI 10.1093/geronj/47.3.P121; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Shi M, 2011, J ALZHEIMERS DIS, V27, P299, DOI 10.3233/JAD-2011-110731; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Spulber S, 2009, BRAIN BEHAV IMMUN, V23, P573, DOI 10.1016/j.bbi.2009.02.015; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Stanley JR, 2011, ANAL CHEM, V83, P6135, DOI 10.1021/ac2009806; Stockton SD, 2014, NEUROPSYCHOPHARMACOL, V39, P88, DOI 10.1038/npp.2013.227; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taverner T, 2012, BIOINFORMATICS; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Theodoraki MA, 2011, BIOCH BIOPHYS ACTA; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Toro-Nieves DM, 2009, J NEUROVIROL, V15, P36, DOI 10.1080/13550280802385505; Verdejo A, 2005, DRUG ALCOHOL DEPEN, V78, P283, DOI 10.1016/j.drugalcdep.2004.11.006; Wang Chih-Hong, 2010, Open Hypertens J, V3, P1; Wang J, 2011, MOL NEUROBIOL, V44, P269, DOI 10.1007/s12035-011-8202-4; Wang WX, 2010, J CELL BIOCHEM, V111, P343, DOI 10.1002/jcb.22698; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2011, CURR ALZHEIMER RES, V8, P252; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Williams JL, 2013, CLIN IMMUNOL, V149, P236, DOI 10.1016/j.clim.2013.04.005; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yasuhara O, 1997, ACTA NEUROPATHOL, V93, P414, DOI 10.1007/s004010050633; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; ZAVALA F, 1995, J IMMUNOL, V155, P2784; Zhou L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-27; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164; Zill P, 2011, EUR ARCH PSY CLIN N, V261, P121, DOI 10.1007/s00406-010-0129-7	105	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e89366	10.1371/journal.pone.0089366	http://dx.doi.org/10.1371/journal.pone.0089366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717448	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000004
J	Herlemann, DPR; Manecki, M; Meeske, C; Pollehne, F; Labrenz, M; Schulz-Bull, D; Dittmar, T; Jurgens, K				Herlemann, Daniel P. R.; Manecki, Marcus; Meeske, Christian; Pollehne, Falk; Labrenz, Matthias; Schulz-Bull, Detlef; Dittmar, Thorsten; Juergens, Klaus			Uncoupling of Bacterial and Terrigenous Dissolved Organic Matter Dynamics in Decomposition Experiments	PLOS ONE			English	Article							MARINE BACTERIOPLANKTON; MASS-SPECTROMETRY; SURFACE WATERS; BOREAL RIVER; ARCTIC-OCEAN; SEA-ICE; CARBON; DIVERSITY; COMMUNITIES; EXTRACTION	The biodegradability of terrigenous dissolved organic matter (tDOM) exported to the sea has a major impact on the global carbon cycle, but our understanding of tDOM bioavailability is fragmentary. In this study, the effects of preparative tDOM isolation on microbial decomposition were investigated in incubation experiments consisting of mesocosms containing mesohaline water from the Baltic Sea. Dissolved organic carbon (DOC) consumption, molecular DOM composition, bacterial activities, and shifts in bacterial community structure were compared between mesocosms supplemented with riverine tDOM, either as filtered, particle-free river water or as a concentrate obtained by lyophilization/tangential ultrafiltration, and those containing only Baltic Sea water or river water. As shown using ultra-high-resolution mass spectrometry (15 Tesla Fourier-transform ion cyclotron resonance mass spectrometry, FT-ICR-MS) covering approximately 4600 different DOM compounds, the three DOM preparation protocols resulted in distinct patterns of molecular DOM composition. However, despite DOC losses of 4-16% and considerable bacterial production, there was no significant change in DOM composition during the 28-day experiment. Moreover, tDOM addition affected neither DOC degradation nor bacterial dynamics significantly, regardless of the tDOM preparation. This result suggested that the introduced tDOM was largely not bioavailable, at least on the temporal scale of our experiment, and that the observed bacterial activity and DOC decomposition mainly reflected the degradation of unknown, labile, colloidal and low-molecular weight DOM, both of which escape the analytical window of FT-ICR-MS. In contrast to the different tDOM preparations, the initial bacterial inoculum and batch culture conditions determined bacterial community succession and superseded the effects of tDOM addition. The uncoupling of tDOM and bacterial dynamics suggests that mesohaline bacterial communities cannot efficiently utilize tDOM and that in subarctic estuaries other factors are responsible for the removal of imported tDOM.	[Herlemann, Daniel P. R.; Manecki, Marcus; Meeske, Christian; Pollehne, Falk; Labrenz, Matthias; Schulz-Bull, Detlef; Juergens, Klaus] Warnemunde IOW, Leibniz Inst Balt Sea Res, Rostock, Germany; [Manecki, Marcus; Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Res Grp Marine Geochem, ICBM MPI Bridging Grp, D-26111 Oldenburg, Germany	Leibniz Institut fur Ostseeforschung Warnemunde; Carl von Ossietzky Universitat Oldenburg	Jurgens, K (corresponding author), Warnemunde IOW, Leibniz Inst Balt Sea Res, Rostock, Germany.	klaus.juergens@io-warnemuende.de	Dittmar, Thorsten/L-7796-2013; Herlemann, Daniel/AAL-2569-2020	Dittmar, Thorsten/0000-0002-3462-0107; Herlemann, Daniel/0000-0002-8100-4649; Jurgens, Klaus/0000-0002-7999-9368; Pollehne, Falk/0000-0003-4419-6351	WGL PAKT ATKiM Project from the Leibnitz Society; Leibnitz Institute for Baltic Sea Research, Warnemunde	WGL PAKT ATKiM Project from the Leibnitz Society; Leibnitz Institute for Baltic Sea Research, Warnemunde	This work was supported by the WGL PAKT ATKiM Project from the Leibnitz Society and the Leibnitz Institute for Baltic Sea Research, Warnemunde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD K, 1989, J GEOPHYS RES-OCEANS, V94, P14485, DOI 10.1029/JC094iC10p14485; Alling V, 2008, LIMNOL OCEANOGR, V53, P2594, DOI 10.4319/lo.2008.53.6.2594; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amon RMW, 2004, MAR CHEM, V92, P311, DOI 10.1016/j.marchem.2004.06.034; Amon RMW, 2001, LIMNOL OCEANOGR, V46, P287, DOI 10.4319/lo.2001.46.2.0287; Anderson LG, 1998, GLOBAL BIOGEOCHEM CY, V12, P455, DOI 10.1029/98GB01372; Baltar F, 2012, MICROBIOLOGYOPEN, V1, P214, DOI 10.1002/mbo3.25; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Brockmeyer B., 2013, INT J ORG CHEM, V3, P17; Brown JM, 2012, AQUAT MICROB ECOL, V66, P33, DOI 10.3354/ame01550; Cauwet G, 2002, MAR CHEM, V79, P193, DOI 10.1016/S0304-4203(02)00064-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cooper LW, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000031; Deutsch B, 2012, BIOGEOSCIENCES, V9, P4465, DOI 10.5194/bg-9-4465-2012; Dinasquet J, 2013, ENV MICROBIOL; Dittmar T, 2001, GEOCHIM COSMOCHIM AC, V65, P4103, DOI 10.1016/S0016-7037(01)00688-3; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Eckert EM, 2012, ENVIRON MICROBIOL, V14, P794, DOI 10.1111/j.1462-2920.2011.02639.x; Elifantz H, 2007, AQUAT MICROB ECOL, V50, P39, DOI 10.3354/ame01145; Fellman JB, 2010, MAR CHEM, V121, P112, DOI 10.1016/j.marchem.2010.03.009; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Gomez-Consarnau L, 2012, ENVIRON MICROBIOL, V14, P2361, DOI 10.1111/j.1462-2920.2012.02804.x; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Humborg C, 2004, LIMNOL OCEANOGR, V49, P1871, DOI 10.4319/lo.2004.49.5.1871; Ingri J, 2000, CHEM GEOL, V166, P23, DOI 10.1016/S0009-2541(99)00178-3; Ingri J, 2005, AQUAT GEOCHEM, V11, P57, DOI 10.1007/s10498-004-2248-0; Ingri J, 1997, APPL GEOCHEM, V12, P483, DOI 10.1016/S0883-2927(97)00026-7; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Jurgens K, 2000, J EXP MAR BIOL ECOL, V245, P127, DOI 10.1016/S0022-0981(99)00156-2; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; Koch J, 2007, ANAL BIOANAL CHEM, V387, P149, DOI 10.1007/s00216-006-0918-z; Kohler H., 2003, P MAR SCI, V6, P281, DOI DOI 10.1016/S1568-2692(03)80042-6; Kujawinski EB, 2002, MAR CHEM, V77, P133, DOI 10.1016/S0304-4203(01)00082-2; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Landa M, 2013, AQUAT MICROB ECOL, V69, P157, DOI 10.3354/ame01632; Langenheder S, 2003, FEMS MICROBIOL ECOL, V45, P189, DOI 10.1016/S0168-6496(03)00149-1; Letscher RT, 2011, MAR CHEM, V123, P78, DOI 10.1016/j.marchem.2010.10.002; Lo Giudice A, 2010, POLAR BIOL, V33, P929, DOI 10.1007/s00300-010-0770-7; Lobbes JM, 2000, GEOCHIM COSMOCHIM AC, V64, P2973, DOI 10.1016/S0016-7037(00)00409-9; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181; Massana R, 2003, AQUAT MICROB ECOL, V32, P11, DOI 10.3354/ame032011; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; MEYER JL, 1987, MICROB ECOL, V13, P13, DOI 10.1007/BF02014960; Mopper K, 2007, CHEM REV, V107, P419, DOI 10.1021/cr050359b; Moran MA, 1999, ESTUARIES, V22, P55, DOI 10.2307/1352927; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; Moran MA, 2000, LIMNOL OCEANOGR, V45, P1254, DOI 10.4319/lo.2000.45.6.1254; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Oh KH, 2011, INT J SYST EVOL MICR, V61, P1382, DOI 10.1099/ijs.0.023994-0; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raisanen J, 2004, CLIM DYNAM, V22, P13, DOI 10.1007/s00382-003-0365-x; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ray JL, 2012, FEMS MICROBIOL ECOL, V82, P713, DOI 10.1111/j.1574-6941.2012.01443.x; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; RIEMANN B, 1987, LIMNOL OCEANOGR, V32, P471, DOI 10.4319/lo.1987.32.2.0471; Robinson C, 1999, MAR ECOL PROG SER, V180, P23, DOI 10.3354/meps180023; Rohde K.-H., 1979, AUSGEWAHLTE METHODEN; Schafer H, 2000, ARCH MICROBIOL, V173, P138, DOI 10.1007/s002039900121; SHOLKOVITZ ER, 1976, GEOCHIM COSMOCHIM AC, V40, P831, DOI 10.1016/0016-7037(76)90035-1; Sjostedt J, 2012, APPL ENVIRON MICROB, V78, P1361, DOI 10.1128/AEM.05542-11; Smedberg E, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002567; Stein R, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P315; Strady E, 2008, CHEMOSPHERE, V70, P1309, DOI 10.1016/j.chemosphere.2007.07.051; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Topper B, 2013, FEMS MICROBIOL ECOL, V83, P202, DOI 10.1111/j.1574-6941.2012.01463.x; van Dongen BE, 2008, MAR CHEM, V112, P203, DOI 10.1016/j.marchem.2008.08.002; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Weber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041970; Weinbauer MG, 2002, APPL ENVIRON MICROB, V68, P1082, DOI 10.1128/AEM.68.3.1082-1087.2002; Wikner J, 1999, AQUAT MICROB ECOL, V17, P289, DOI 10.3354/ame017289; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	92	43	43	5	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93945	10.1371/journal.pone.0093945	http://dx.doi.org/10.1371/journal.pone.0093945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718626	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000059
J	Mengel, F				Mengel, Friederike			Computer Games and Prosocial Behaviour	PLOS ONE			English	Article							PLAYING VIOLENT VIDEO; COOPERATION; DILEMMA; AGGRESSION	We relate different self-reported measures of computer use to individuals' propensity to cooperate in the Prisoner's dilemma. The average cooperation rate is positively related to the self-reported amount participants spend playing computer games. None of the other computer time use variables (including time spent on social media, browsing internet, working etc.) are significantly related to cooperation rates.	[Mengel, Friederike] Univ Essex, Dept Econ, Colchester CO4 3SQ, Essex, England; [Mengel, Friederike] Maastricht Univ, Dept Econ AE 1, Maastricht, Limburg, Netherlands	University of Essex; Maastricht University	Mengel, F (corresponding author), Univ Essex, Dept Econ, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	fr.mengel@gmail.com			European Union [PERG08-GA-2010-277026]	European Union(European Commission)	Funding was obtained from a research grant from the European Union (grant PERG08-GA-2010-277026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; [Anonymous], 2008, PEW INTERNET AM LIFE; Bereby-Meyer Y, 2006, AM ECON REV, V96, P1029, DOI 10.1257/aer.96.4.1029; Bluemke M, 2010, AGGRESSIVE BEHAV, V36, P1, DOI 10.1002/ab.20329; Colwell J, 2000, BRIT J PSYCHOL, V91, P295, DOI 10.1348/000712600161844; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; Ewoldsen DR, 2012, CYBERPSYCH BEH SOC N, V15, P277, DOI 10.1089/cyber.2011.0308; Ferguson CJ, 2011, COMPUT HUM BEHAV, V27, P770, DOI 10.1016/j.chb.2010.10.026; Friedman D, 2012, AM ECON REV, V102, P337, DOI 10.1257/aer.102.1.337; Funk JB, 1996, J COMMUN, V46, P19, DOI 10.1111/j.1460-2466.1996.tb01472.x; Gentile DA, 2009, PERS SOC PSYCHOL B, V35, P752, DOI 10.1177/0146167209333045; Granic I, 2014, AM PSYCHOL, V69, P66, DOI 10.1037/a0034857; Greitemeyer T, 2011, CURR DIR PSYCHOL SCI, V20, P251, DOI 10.1177/0963721411415229; Grimm V, 2009, GAME ECON BEHAV, V66, P202, DOI 10.1016/j.geb.2008.05.005; Grusser SM, 2007, CYBERPSYCHOL BEHAV, V10, P290, DOI 10.1089/cpb.2006.9956; Konrath S, 2013, HDB RES TECHNOSELF I; Lemola S, 2011, PERS INDIV DIFFER, V51, P117, DOI 10.1016/j.paid.2011.03.024; Lo SK, 2005, CYBERPSYCHOL BEHAV, V8, P15, DOI 10.1089/cpb.2005.8.15; Schmidt D, 2001, J ECON BEHAV ORGAN, V46, P357, DOI 10.1016/S0167-2681(01)00158-5; Wiegman O, 1998, BRIT J SOC PSYCHOL, V37, P367, DOI 10.1111/j.2044-8309.1998.tb01177.x; Williamson P. A., 1987, J APPLIED DEV PSYCHO, V8, P453, DOI [10.1016/0193-3973(87)90033-5, DOI 10.1016/0193-3973(87)90033-5]	23	7	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94099	10.1371/journal.pone.0094099	http://dx.doi.org/10.1371/journal.pone.0094099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718635	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000334339000076
J	Riedl, M; Muller, A; Kraemer, JF; Penzel, T; Kurths, J; Wessel, N				Riedl, Maik; Mueller, Andreas; Kraemer, Jan F.; Penzel, Thomas; Kurths, Juergen; Wessel, Niels			Cardio-Respiratory Coordination Increases during Sleep Apnea	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; HEART-RATE; SYNCHRONIZATION; PHASE; OSCILLATIONS; VENTILATION; HUMANS; EVENT	Cardiovascular diseases are the main source of morbidity and mortality in the United States with costs of more than $ 170 billion. Repetitive respiratory disorders during sleep are assumed to be a major cause of these diseases. Therefore, the understanding of the cardio-respiratory regulation during these events is of high public interest. One of the governing mechanisms is the mutual influence of the cardiac and respiratory oscillations on their respective onsets, the cardio-respiratory coordination (CRC). We analyze this mechanism based on nocturnal measurements of 27 males suffering from obstructive sleep apnea syndrome. Here we find, by using an advanced analysis technique, the coordigram, not only that the occurrence of CRC is significantly more frequent during respiratory sleep disturbances than in normal respiration (p-value<10(-51)) but also more frequent after these events (p-value<10(-15)). Especially, the latter finding contradicts the common assumption that spontaneous CRC can only be observed in epochs of relaxed conditions, while our newly discovered epochs of CRC after disturbances are characterized by high autonomic stress. Our findings on the connection between CRC and the appearance of sleep-disordered events require a substantial extension of the current understanding of obstructive sleep apneas and hypopneas.	[Riedl, Maik; Mueller, Andreas; Kraemer, Jan F.; Kurths, Juergen; Wessel, Niels] Humboldt Univ, Dept Phys, Berlin, Germany; [Penzel, Thomas] Charite, Dept Cardiol, Sleep Med Ctr, D-13353 Berlin, Germany; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Potsdam Institut fur Klimafolgenforschung	Wessel, N (corresponding author), Humboldt Univ, Dept Phys, Invalidenstr 110, Berlin, Germany.	niels.wessel@physik.hu-berlin.de	Penzel, Thomas/M-2344-2014	Penzel, Thomas/0000-0002-4304-0112; Wessel, Niels/0000-0003-0922-9971	Deutsche Forschungsgemeinschaft [RI2916/2-1, WE2834/5-1, PE628/4-1, KU837/23-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MR, NW, AM, TP and JK acknowledge financial support from RI2916/2-1, WE2834/5-1, PE628/4-1, and KU837/23-1 (Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.054102; Bartsch RP, 2012, P NATL ACAD SCI USA, V109, P10181, DOI 10.1073/pnas.1204568109; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; CHERNIACK NS, 1984, J CLIN INVEST, V73, P1501, DOI 10.1172/JCI111355; Cysarz D, 2004, AM J PHYSIOL-HEART C, V287, pH579, DOI 10.1152/ajpheart.01131.2003; Cysarz D, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-44; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Galletly DC, 1997, BRIT J ANAESTH, V79, P35, DOI 10.1093/bja/79.1.35; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Iber C., 2007, AASM MANUAL SCORING; Kabir MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010602; Kotani K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051923; Larsen PD, 1999, BRIT J ANAESTH, V82, P685, DOI 10.1093/bja/82.5.685; MOSER M, 1995, BIOL RHYTHM RES, V26, P100, DOI 10.1080/09291019509360328; Niizeki K, 2012, AM J PHYSIOL-HEART C, V302, pH359, DOI 10.1152/ajpheart.00746.2011; PESSENHOFER H, 1975, PFLUG ARCH EUR J PHY, V355, P77, DOI 10.1007/BF00584801; Porta A, 2004, BIOL CYBERN, V91, P258, DOI 10.1007/s00422-004-0513-3; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2012, COMPUT BIOL MED, V42, P298, DOI 10.1016/j.compbiomed.2011.04.019; Raschke F, 1986, TEMPORAL DISORDER HU; Raschke F, 1991, RHYTHMUS PHYSL SYSTE; SALAMONE JA, 1983, J APPL PHYSIOL, V55, P61, DOI 10.1152/jappl.1983.55.1.61; Schafer C, 1998, NATURE, V392, P239, DOI 10.1038/32567; Silverman B.W., 1986, DENSITY ESTIMATION S; SOMERS D, 1993, BIOL CYBERN, V68, P393, DOI 10.1007/BF00198772; Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology, 1996, EUR HEART J, V17; Toledo E, 2002, MED ENG PHYS, V24, P45, DOI 10.1016/S1350-4533(01)00114-X; Wallois F, 2008, AUTON NEUROSCI-BASIC, V143, P79, DOI 10.1016/j.autneu.2008.07.012; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105	31	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93866	10.1371/journal.pone.0093866	http://dx.doi.org/10.1371/journal.pone.0093866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718564	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000052
J	Tsou, A; Thelwall, M; Mongeon, P; Sugimoto, CR				Tsou, Andrew; Thelwall, Mike; Mongeon, Philippe; Sugimoto, Cassidy R.			A Community of Curious Souls: An Analysis of Commenting Behavior on TED Talks Videos	PLOS ONE			English	Article							SCIENCE; YOUTUBE; COMMUNICATION; SCIENTISTS	The TED (Technology, Entertainment, Design) Talks website hosts video recordings of various experts, celebrities, academics, and others who discuss their topics of expertise. Funded by advertising and members but provided free online, TED Talks have been viewed over a billion times and are a science communication phenomenon. Although the organization has been derided for its populist slant and emphasis on entertainment value, no previous research has assessed audience reactions in order to determine the degree to which presenter characteristics and platform affect the reception of a video. This article addresses this issue via a content analysis of comments left on both the TED website and the YouTube platform (on which TED Talks videos are also posted). It was found that commenters were more likely to discuss the characteristics of a presenter on YouTube, whereas commenters tended to engage with the talk content on the TED website. In addition, people tended to be more emotional when the speaker was a woman (by leaving comments that were either positive or negative). The results can inform future efforts to popularize science amongst the public, as well as to provide insights for those looking to disseminate information via Internet videos.	[Tsou, Andrew; Sugimoto, Cassidy R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Thelwall, Mike] Wolverhampton Univ, Sch Technol, Wolverhampton WV1 1DJ, W Midlands, England; [Mongeon, Philippe] Univ Montreal, Ecole Bibliothecon & Sci Informat, Quebec City, PQ, Canada	Indiana University System; Indiana University Bloomington; University of Wolverhampton; Universite de Montreal	Tsou, A (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	atsou@umail.iu.edu	Thelwall, Mike/C-1449-2013; Sugimoto, Cassidy R/AAV-2705-2021; Mongeon, Philippe/H-1446-2012	Thelwall, Mike/0000-0001-6065-205X; Sugimoto, Cassidy R/0000-0001-8608-3203; Mongeon, Philippe/0000-0003-1021-059X	international funding initiative Digging into Data; National Science Foundation in the United States [1208804]; Joint Information Systems Committee (JISC) in the United Kingdom; Social Sciences and Humanities Research Council of Canada	international funding initiative Digging into Data; National Science Foundation in the United States(National Science Foundation (NSF)); Joint Information Systems Committee (JISC) in the United Kingdom; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This manuscript is based upon work supported by the international funding initiative Digging into Data. Specifically, funding comes from the National Science Foundation in the United States (Grant No. 1208804) (URL: http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 501084), Joint Information Systems Committee (JISC) in the United Kingdom, and the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa, 2013, TOP SIT; Bentley P, 2011, PUBLIC UNDERST SCI, V20, P48, DOI 10.1177/0963662510384461; Berk R. A., 2009, INT J TECHNOL TEACH, V5, P1; Brossard D, 2013, P NATL ACAD SCI US; Brossard D, 2013, NY TIMES; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Chowdhury SA, 2012, 2012 SEVENTH INTERNATIONAL CONFERENCE ON BROADBAND, WIRELESS COMPUTING, COMMUNICATION AND APPLICATIONS (BWCCA 2012), P244, DOI 10.1109/BWCCA.2012.47; Clifton A, 2011, NURS EDUC TODAY, V31, P311, DOI 10.1016/j.nedt.2010.10.004; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222; Desmet Christy, 2009, ENGL J, V99, P65; DUNWOODY S, 1985, J COMMUN, V35, P26, DOI 10.1111/j.1460-2466.1985.tb01882.x; Frank A, 2013, NY TIMES; Gascoigne T, 1997, SCI COMMUN, V18, P265, DOI 10.1177/1075547097018003005; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Jaffar AA, 2012, ANAT SCI EDUC, V5, P158, DOI 10.1002/ase.1268; Jones T, 2011, COMPUT SCH, V28, P75, DOI 10.1080/07380569.2011.553149; Juhasz A, 2009, CINEMA J, V48, P145; Jurgenson N, 2012, TED; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Kling R, 2007, INFORM SOC, V23, P205, DOI 10.1080/01972240701441556; Knosel M, 2011, J DENT EDUC, V75, P1558; LaBarre S., 2013, POPULAR SCI; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Martin-Sempere MJ, 2008, PUBLIC UNDERST SCI, V17, P349, DOI 10.1177/0963662506067660; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; National Science Board, 2012, SCI ENG IND; O'Brien C, 2012, LOS ANGELES TIMES; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Robbins Martin, 2012, TROUBLE TED TALKS; Steyaert J, 2011, J SOCIAL INTERVENTIO, V20, P79; Sugimoto CR, 2013, J AM SOC INF SCI TEC, V64, P663, DOI 10.1002/asi.22764; Sugimoto CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062403; Taleb N. N., 2010, BLACK SWAN 2 EDITION; TED, 2012, TED; TED Blog, 2012, WHAT TALKS HAV RES M; Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P616, DOI 10.1002/asi.21679; Tsfati Y, 2011, SCI COMMUN, V33, P143, DOI 10.1177/1075547010380385; Vogel L, 2011, CAN MED ASSOC J, V183, P647, DOI 10.1503/cmaj.109-3812; Weigold MF, 2001, SCI COMMUN, V23, P164, DOI 10.1177/1075547001023002005	43	44	44	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93609	10.1371/journal.pone.0093609	http://dx.doi.org/10.1371/journal.pone.0093609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718634	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000038
J	Zels, S; Verlinden, H; Dillen, S; Vleugels, R; Nachman, RJ; Vanden Broeck, J				Zels, Sven; Verlinden, Heleen; Dillen, Senne; Vleugels, Rut; Nachman, Ronald J.; Vanden Broeck, Jozef			Signaling Properties and Pharmacological Analysis of Two Sulfakinin Receptors from the Red Flour Beetle, Tribolium castaneum	PLOS ONE			English	Article							SULFATED INSECT NEUROPEPTIDE; FOOD-INTAKE; DROSOPHILA-MELANOGASTER; FUNCTIONAL-CHARACTERIZATION; ALLATOTROPIN RECEPTOR; NEOBELLIERIA-BULLATA; AMERICAN COCKROACH; PROTEIN HORMONES; NERVOUS-SYSTEM; CHOLECYSTOKININ	Sulfakinin is an insect neuropeptide that constitutes an important component of the complex network of hormonal and neural factors that regulate feeding and digestion. The key modulating functions of sulfakinin are mediated by binding and signaling via G-protein coupled receptors. Although a substantial amount of functional data have already been reported on sulfakinins in different insect species, only little information is known regarding the properties of their respective receptors. In this study, we report on the molecular cloning, functional expression and characterization of two sulfakinin receptors in the red flour beetle, Tribolium castaneum. Both receptor open reading frames show extensive sequence similarity with annotated sulfakinin receptors from other insects. Comparison of the sulfakinin receptor sequences with homologous vertebrate cholecystokinin receptors reveals crucial conserved regions for ligand binding and receptor activation. Quantitative reverse transcriptase PCR shows that transcripts of both receptors are primarily expressed in the central nervous system of the beetle. Pharmacological characterization using 29 different peptide ligands clarified the essential requirements for efficient activation of these sulfakinin receptors. Analysis of the signaling pathway in multiple cell lines disclosed that the sulfakinin receptors of T. castaneum can stimulate both the Ca2+ and cyclic AMP second messenger pathways. This in depth characterization of two insect sulfakinin receptors may provide useful leads for the further development of receptor ligands with a potential applicability in pest control and crop protection.	[Zels, Sven; Verlinden, Heleen; Dillen, Senne; Vleugels, Rut; Vanden Broeck, Jozef] Katholieke Univ Leuven, Dept Biol, Louvain, Vlaams Brabant, Belgium; [Nachman, Ronald J.] USDA, Areawide Pest Management Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA	KU Leuven; United States Department of Agriculture (USDA)	Vanden Broeck, J (corresponding author), Katholieke Univ Leuven, Dept Biol, Louvain, Vlaams Brabant, Belgium.	Jozef.VandenBroeck@bio.kuleuven.be	Verlinden, Heleen/D-1033-2011	Verlinden, Heleen/0000-0001-6721-3973; Vanden Broeck, Jozef/0000-0001-7653-0516	Interuniversity Attraction Poles program [P7/40]; KU Leuven Research Foundation [GOA/11/02]; Agency for Innovation by Science and Technology (IWT); Research Foundation of Flanders (FWO)	Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); KU Leuven Research Foundation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation of Flanders (FWO)(FWO)	The authors thank the Interuniversity Attraction Poles program (Belgian Science Policy Grant P7/40) and the KU Leuven Research Foundation (GOA/11/02) for financial support. SZ and RV were supported by the Agency for Innovation by Science and Technology (IWT). HV was supported by the Research Foundation of Flanders (FWO). The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Audsley N, 2011, PEPTIDES, V32, P434, DOI 10.1016/j.peptides.2010.08.028; Beeman RW, 2009, BEETLE BEETLE WRANGL; Chen X, 2012, FLY, V6, P290, DOI 10.4161/fly.21534; Chen X, 2012, J CELL BIOL, V196, P529, DOI 10.1083/jcb.201109044; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Downer KE, 2007, J INSECT PHYSIOL, V53, P106, DOI 10.1016/j.jinsphys.2006.10.013; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; DUVE H, 1995, EUR J BIOCHEM, V232, P633, DOI 10.1111/j.1432-1033.1995.tb20854.x; East PD, 1997, TISSUE CELL, V29, P347, DOI 10.1016/S0040-8166(97)80010-9; FONAGY A, 1992, COMP BIOCHEM PHYS C, V103, P135, DOI 10.1016/0742-8413(92)90242-Y; Fourmy D, 2002, PHARMACOL TOXICOL, V91, P313, DOI 10.1034/j.1600-0773.2002.910608.x; Gigoux V, 1999, PROTEIN SCI, V8, P2347; Gigoux V, 1998, J BIOL CHEM, V273, P14380, DOI 10.1074/jbc.273.23.14380; Harshini S, 2002, PEPTIDES, V23, P1759, DOI 10.1016/S0196-9781(02)00152-3; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Janssen T, 2008, ENDOCRINOLOGY, V149, P2826, DOI 10.1210/en.2007-1772; Kiss B, 2013, GEN COMP ENDOCR, V191, P137, DOI 10.1016/j.ygcen.2013.05.023; Kubiak TM, 2002, BIOCHEM BIOPH RES CO, V291, P313, DOI 10.1006/bbrc.2002.6459; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Maestro JL, 2001, EUR J BIOCHEM, V268, P5824, DOI 10.1046/j.0014-2956.2001.02527.x; Marciniak P, 2011, J COMP PHYSIOL B, V181, P721, DOI 10.1007/s00360-011-0563-5; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Miller LJ, 2008, PHARMACOL THERAPEUT, V119, P83, DOI 10.1016/j.pharmthera.2008.05.001; Nachman R J, 1988, Peptides, V9 Suppl 1, P137, DOI 10.1016/0196-9781(88)90237-9; Nachman RJ, 1997, ANN NY ACAD SCI, V814, P335, DOI 10.1111/j.1749-6632.1997.tb46178.x; Nachman RJ, 2005, PEPTIDES, V26, P115, DOI 10.1016/j.peptides.2004.07.018; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V140, P357, DOI 10.1016/0006-291X(86)91098-3; NACHMAN RJ, 1986, SCIENCE, V234, P71, DOI 10.1126/science.3749893; Nachman RJ, 1997, PEPTIDES, V18, P53, DOI 10.1016/S0196-9781(96)00233-1; Nichols R, 2007, PEPTIDES, V28, P767, DOI 10.1016/j.peptides.2007.01.009; NICHOLS R, 1988, J BIOL CHEM, V263, P12167; Nichols R, 1997, ANN NY ACAD SCI, V814, P315, DOI 10.1111/j.1749-6632.1997.tb46173.x; Nichols R, 2009, FRONT BIOSCI-LANDMRK, V14, P4035, DOI 10.2741/3510; Nichols R, 2008, PEPTIDES, V29, P2128, DOI 10.1016/j.peptides.2008.08.010; Ons S, 2009, PROTEOMICS, V9, P788, DOI 10.1002/pmic.200800499; Palmer GC, 2007, J INSECT PHYSIOL, V53, P1125, DOI 10.1016/j.jinsphys.2007.06.001; Predel R, 1999, EUR J BIOCHEM, V263, P552, DOI 10.1046/j.1432-1327.1999.00532.x; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Schoofs L., 2013, HDB BIOL ACTIVE PEPT, P310; Shi Y, 2011, J BIOL CHEM, V286, P42390, DOI 10.1074/jbc.M111.275602; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VEENSTRA JA, 1989, NEUROPEPTIDES, V14, P145, DOI 10.1016/0143-4179(89)90038-3; VEENSTRA JA, 1995, HISTOCHEM CELL BIOL, V104, P337, DOI 10.1007/BF01458127; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V316, P763, DOI 10.1016/j.bbrc.2004.02.115; Verlinden H, 2013, GEN COMP ENDOCR, V193, P193, DOI 10.1016/j.ygcen.2013.08.006; Vleugels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065052; Vuerinckx K, 2011, INSECT BIOCHEM MOLEC, V41, P815, DOI 10.1016/j.ibmb.2011.06.003; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Wicher D, 2007, FRONT CELL NEUROSCI, V1, DOI [10.3389/neuro.03.003/2007, 10.3389/neuro.03.003.2007]; Yu N, 2013, PEPTIDES, pS0196; Yu N, 2013, GEN COMP ENDOCR, V188, P196, DOI 10.1016/j.ygcen.2013.03.006; Yu N, 2013, PEPTIDES, V41, P107, DOI 10.1016/j.peptides.2012.12.005; Zoephel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041543	58	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94502	10.1371/journal.pone.0094502	http://dx.doi.org/10.1371/journal.pone.0094502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718573	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000129
J	Fan, SL; Meng, YY; Song, MZ; Pang, CY; Wei, HL; Liu, J; Zhan, XJ; Lan, JY; Feng, CH; Zhang, SX; Yu, SX				Fan, Shuli; Meng, Yanyan; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Ji; Zhan, Xianjin; Lan, Jiayang; Feng, Changhui; Zhang, Shengxi; Yu, Shuxun			Quantitative Phosphoproteomics Analysis of Nitric Oxide-Responsive Phosphoproteins in Cotton Leaf	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION ANALYSIS; SERINE/ARGININE-RICH PROTEINS; ACID SIGNAL-TRANSDUCTION; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; IN-VIVO; PLASMA-MEMBRANE; BINDING-PROTEIN; EXPRESSION; REVEALS	Knowledge of phosphorylation events and their regulation is crucial to understanding the functional biology of plant proteins, but very little is currently known about nitric oxide-responsive phosphorylation in plants. Here, we report the first large-scale, quantitative phosphoproteome analysis of cotton (Gossypium hirsutum) treated with sodium nitroprusside (nitric oxide donor) by utilizing the isobaric tag for relative and absolute quantitation (iTRAQ) method. A total of 1315 unique phosphopeptides, spanning 1528 non-redundant phosphorylation sites, were detected from 1020 cotton phosphoproteins. Among them, 183 phosphopeptides corresponding to 167 phosphoproteins were found to be differentially phosphorylated in response to sodium nitroprusside. Several of the phosphorylation sites that we identified, including RQxS, DSxE, TxxxxSP and SPxT, have not, to our knowledge, been reported to be protein kinase sites in other species. The phosphoproteins identified are involved in a wide range of cellular processes, including signal transduction, RNA metabolism, intracellular transport and so on. This study reveals unique features of the cotton phosphoproteome and provides new insight into the biochemical pathways that are regulated by nitric oxide.	[Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Ji; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan Province, Peoples R China; [Meng, Yanyan; Zhan, Xianjin; Lan, Jiayang; Feng, Changhui; Zhang, Shengxi] Hubei Acad Agr Sci, Crop Inst Econ, Key Lab Cotton Biol & Breeding Middle Reaches Cha, Wuhan, Hubei Province, Peoples R China; [Liu, Ji] Northwest A&F Univ, Coll Agron, Wuhan, Hubei Province, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Hubei Academy of Agricultural Sciences; Northwest A&F University - China	Zhang, SX (corresponding author), Hubei Acad Agr Sci, Crop Inst Econ, Key Lab Cotton Biol & Breeding Middle Reaches Cha, Wuhan, Hubei Province, Peoples R China.	zhangsx01@126.com; yu@cricaas.com.cn	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022		National Basic Research Program of China (973 Program) [2010CB126006]; State Key Laboratory of Cotton Biology Open Fund [CB2013A01]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Laboratory of Cotton Biology Open Fund	This research was sponsored by the National Basic Research Program of China (973 Program; 2010CB126006) and supported by the State Key Laboratory of Cotton Biology Open Fund (CB2013A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Ahlfors R, 2009, PLANT J, V58, P1, DOI 10.1111/j.1365-313X.2008.03756.x; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Chou MF, 2011, CURR PROTOC BIOINFOR, V13.5, P24; Chou MF, 2011, CURR PROTOC BIOINFOR, V13.6, P8; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; van Bentem SDF, 2006, NUCLEIC ACIDS RES, V34, P3267, DOI 10.1093/nar/gkl429; del Giudice J, 2011, NEW PHYTOL, V191, P405, DOI 10.1111/j.1469-8137.2011.03693.x; Delbarre A, 1998, PLANT PHYSIOL, V116, P833, DOI 10.1104/pp.116.2.833; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Elliott DJ, 2000, HUM MOL GENET, V9, P2117, DOI 10.1093/hmg/9.14.2117; Farley AR, 2011, J PROTEOME RES, V10, P1481, DOI 10.1021/pr100877m; Ferrarini A, 2008, MOL PLANT MICROBE IN, V21, P781, DOI 10.1094/MPMI-21-6-0781; Gao JJ, 2009, NUCLEIC ACIDS RES, V37, pD960, DOI 10.1093/nar/gkn733; Garcia-Mata C, 2007, NITRIC OXIDE-BIOL CH, V17, P143, DOI 10.1016/j.niox.2007.08.001; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grimsrud PA, 2010, PLANT PHYSIOL, V152, P19, DOI 10.1104/pp.109.149625; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; He HQ, 2008, BIOCHEM BIOPH RES CO, V371, P883, DOI 10.1016/j.bbrc.2008.05.001; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; Huang X, 2002, PLANTA, V215, P914, DOI 10.1007/s00425-002-0828-z; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kline KG, 2010, P NATL ACAD SCI USA, V107, P15986, DOI 10.1073/pnas.1007879107; Koizumi N, 1996, PLANT CELL PHYSIOL, V37, P862, DOI 10.1093/oxfordjournals.pcp.a029023; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lopato S, 1996, P NATL ACAD SCI USA, V93, P3074, DOI 10.1073/pnas.93.7.3074; Lopato S, 1999, GENE DEV, V13, P987, DOI 10.1101/gad.13.8.987; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; Ma FF, 2012, J EXP BOT, V63, P4835, DOI 10.1093/jxb/ers161; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Mata CG, 2001, PLANT PHYSIOL, V126, P1196, DOI 10.1104/pp.126.3.1196; Meng YY, 2011, J PROTEOME RES, V10, P5416, DOI 10.1021/pr200671d; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Mishina TE, 2007, PLANT CELL ENVIRON, V30, P39, DOI 10.1111/j.1365-3040.2006.01604.x; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Niu YH, 2012, J INTEGR PLANT BIOL, V54, P516, DOI 10.1111/j.1744-7909.2012.01140.x; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pagnussat GC, 2002, PLANT PHYSIOL, V129, P954, DOI 10.1104/pp.004036; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Palmieri MC, 2008, J EXP BOT, V59, P177, DOI 10.1093/jxb/erm345; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Parani M, 2004, PLANT BIOTECHNOL J, V2, P359, DOI 10.1111/j.1467-7652.2004.00085.x; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reddy ASN, 2004, TRENDS PLANT SCI, V9, P541, DOI 10.1016/j.tplants.2004.09.007; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Romanov GA, 2008, FEBS LETT, V582, P874, DOI 10.1016/j.febslet.2008.02.016; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Sandberg A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.016998; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanou G, 2010, J PROTEOME RES, V9, P5994, DOI 10.1021/pr100782h; Tran HNN, 2012, MOL CELL PROTEOMICS, V11, P1140, DOI 10.1074/mcp.M112.018028; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; Wang X, 2013, J PROTEOMICS, V78, P486, DOI 10.1016/j.jprot.2012.10.018; Whiteman SA, 2008, PLANT J, V56, P146, DOI 10.1111/j.1365-313X.2008.03578.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wunsche H, 2011, J EXP BOT, V62, P4605, DOI 10.1093/jxb/err171; Yang LM, 2013, J PROTEOME RES, V12, P1316, DOI 10.1021/pr300971n; Yao QM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00186; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang AY, 2011, PLANT CELL PHYSIOL, V52, P181, DOI 10.1093/pcp/pcq187; Zhang Y, 2013, NUCLEIC ACIDS RES, V41, P1343, DOI 10.1093/nar/gks1097; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996; ZHENG CC, 1993, PLANT MOL BIOL, V23, P813, DOI 10.1007/BF00021536; Zhuang YL, 2003, MOL BIOL EVOL, V20, P1978, DOI 10.1093/molbev/msg203	83	28	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94261	10.1371/journal.pone.0094261	http://dx.doi.org/10.1371/journal.pone.0094261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714030	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900110
J	Gitsioudis, G; Hosch, W; Iwan, J; Voss, A; Atsiatorme, E; Hofmann, NP; Buss, SJ; Siebert, S; Kauczor, HU; Giannitsis, E; Katus, HA; Korosoglou, G				Gitsioudis, Gitsios; Hosch, Waldemar; Iwan, Johannes; Voss, Andreas; Atsiatorme, Edem; Hofmann, Nina P.; Buss, Sebastian J.; Siebert, Stefan; Kauczor, Hans-Ulrich; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios			When Do We Really Need Coronary Calcium Scoring Prior to Contrast-Enhanced Coronary Computed Tomography Angiography? Analysis by Age, Gender and Coronary Risk Factors	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; APPROPRIATE USE CRITERIA; CT ANGIOGRAPHY; DIAGNOSTIC-ACCURACY; ARTERY-DISEASE; RADIATION-EXPOSURE; IMAGE QUALITY; TUBE VOLTAGE; CALCIFICATION; PROTECTION	Aims: To investigate the value of coronary calcium scoring ( CCS) as a filter scan prior to coronary computed tomography angiography ( CCTA). Methods and Results: Between February 2008 and April 2011, 732 consecutive patients underwent clinically indicated CCTA. During this 'control phase', CCS was performed in all patients. In patients with CCS >= 800, CCTA was not performed. During a subsequent 'CCTA phase' ( May 2011-May 2012) another 200 consecutive patients underwent CCTA, and CCS was performed only in patients with increased probability for severe calcification according to age, gender and atherogenic risk factors. In patients where CCS was not performed, calcium scoring was performed in contrast-enhanced CCTA images. Significant associations were noted between CCS and age ( r = 0.30, p < 0.001) and coronary risk factors ( x(2) = 37.9; HR = 2.2; 95% CI = 1.7- 2.9, p < 0.001). Based on these associations, a <= 3% pre-test probability for CCS >= 800 was observed for males,61 yrs. and females < 79 yrs. According to these criteria, CCS was not performed in 106 of 200 ( 53%) patients during the 'CCTA phase', including 47 ( 42%) males and 59 ( 67%) females. This resulted in absolute radiation saving of similar to 1 mSv in 75% of patients younger than 60 yrs. Of 106 patients where CCS was not performed, estimated calcium scoring was indeed < 800 in 101 ( 95%) cases. Non-diagnostic image quality due to calcification was similar between the 'control phase' and the 'CCTA' group ( 0.25% versus 0.40%, p = NS). Conclusion: The value of CCS as a filter for identification of a high calcium score is limited in younger patients with intermediate risk profile. Omitting CCS in such patients can contribute to further dose reduction with cardiac CT studies.	[Gitsioudis, Gitsios; Iwan, Johannes; Atsiatorme, Edem; Hofmann, Nina P.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Hosch, Waldemar; Siebert, Stefan; Kauczor, Hans-Ulrich] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Voss, Andreas] Heidelberg Univ, Inst Psychol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Gitsioudis, G (corresponding author), Heidelberg Univ, Dept Cardiol, Heidelberg, Germany.	gitsiosg@web.de	Gitsioudis, Gitsios/GSJ-4171-2022; Kauczor, Hans-Ulrich/AAU-5955-2021; Kauczor, HU/AAX-6033-2021; Voss, Andreas/F-5087-2011	Voss, Andreas/0000-0002-4499-3660				Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; Bauer RW, 2009, AM J ROENTGENOL, V193, P410, DOI 10.2214/AJR.08.1277; Bischoff B, EUR HEART J CARDIOVA, V13, P468; Bischoff B, 2009, JACC-CARDIOVASC IMAG, V2, P940, DOI 10.1016/j.jcmg.2009.02.015; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Chao SP, 2010, EUR HEART J, V31, P1916, DOI 10.1093/eurheartj/ehq072; de Graaf FR, 2010, EUR HEART J, V31, P1908, DOI 10.1093/eurheartj/ehp571; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; den Dekker MAM, 2012, EUR RADIOL, V22, P2688, DOI 10.1007/s00330-012-2551-x; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2009, JAMA-J AM MED ASSOC, V301, P545, DOI 10.1001/jama.2009.53; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Gopal A, 2009, INT J CARDIOL, V132, P435, DOI 10.1016/j.ijcard.2007.08.072; Gottlieb I, 2010, J AM COLL CARDIOL, V55, P627, DOI 10.1016/j.jacc.2009.07.072; Guo SL, 2011, INT J CARDIOVAS IMAG, V27, P755, DOI 10.1007/s10554-010-9690-4; Hadamitzky M, 2011, CIRC-CARDIOVASC IMAG, V4, P16, DOI 10.1161/CIRCIMAGING.110.955351; Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Hosch W, 2013, EUR J RADIO IN PRESS; Hosch W, 2011, EUR J RADIOL; Hosch W, 2010, EUR J RADIOL; Hosch W, 2012, EUR J RADIOL, V81, P3568, DOI 10.1016/j.ejrad.2011.06.055; Hosch W, 2011, EUR J RADIOL, V80, P127, DOI 10.1016/j.ejrad.2010.07.011; Husmann L, 2008, EUR HEART J, V29, P191, DOI 10.1093/eurheartj/ehm613; Joshi PH, 2012, J NUCL CARDIOL, V19, P1226, DOI 10.1007/s12350-012-9626-6; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Korosoglou G, 2010, EUR RADIOL, V20, P1841, DOI 10.1007/s00330-010-1753-3; Kuettner A, 2004, J AM COLL CARDIOL, V43, P831, DOI 10.1016/j.jacc.2003.05.015; Kwon SW, 2011, RADIOLOGY, V259, P92, DOI 10.1148/radiol.10100886; Litt HI, 2012, NEW ENGL J MED, V366, P1393, DOI 10.1056/NEJMoa1201163; Ong TK, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.12.027; Palumbo AA, 2009, EUR RADIOL, V19, P2127, DOI 10.1007/s00330-009-1398-2; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Raggi P, 2005, CIRCULATION, V112, P563, DOI 10.1161/CIRCULATIONAHA.104.512681; Stevens NA, 1999, J AM COLL CARDIOL, V33, P403; Stolzmann P, 2008, AM J ROENTGENOL, V191, P1684, DOI 10.2214/AJR.07.4040; Stolzmann P, 2008, EUR RADIOL, V18, P592, DOI 10.1007/s00330-007-0786-8; Taylor AJ, 2010, J CARDIOVASC COMPUT, V4, P407, DOI 10.1016/j.jcct.2010.11.001; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Truong Quynh, 2010, Rev Cardiovasc Med, V11, P271, DOI 10.3909/ricm0568; Ueda H, 2011, HEART VESSELS; Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851; Zimmermann E, 2011, ROFO-FORTSCHR RONTG, V183, P54, DOI 10.1055/s-0029-1245629	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92396	10.1371/journal.pone.0092396	http://dx.doi.org/10.1371/journal.pone.0092396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714677	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900006
J	Lin, Y; Liu, XR; Shan, B; Wu, J; Sharma, S; Sun, Y				Lin, Yi; Liu, Xiaorui; Shan, Bin; Wu, Ji; Sharma, Surendra; Sun, Yun			Prevention of CpG-Induced Pregnancy Disruption by Adoptive Transfer of In Vitro-Induced Regulatory T Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; UTERINE NK CELLS; WILD-TYPE; TOLERANCE; EFFECTOR; MICE; ACTIVATION; CONVERSION; EXPRESSION; FAILURE	Objective: To elucidate the mechanism by which embryo-resorption and preterm birth were enhanced by pathogenic CpG motif and to develop a counter strategy for normal pregnancy outcome. Methods: This is an animal model-based study. In pregnant nonobese diabetic (NOD) mice and wild-type (WT) mice in the same strain background, an infection was mimicked by toll-like receptor 9 (TLR9) activation through CpG1826-injection. In vivo inactivation of IL-10 was performed to enhance pregnancy loss. Regulatory T cells induced by FTY720 in vitro from splenic CD4(+)CD25(-)Foxp3(-) cells (iTreg cells) were transferred to improve pregnancy outcomes in NOD mice. Results: Embryo-resorption and preterm birth were readily induced by CpG1826 in NOD mice, but not in WT mice. However, inactivation of IL-10 using neutralizing antibody injections enhanced pregnancy loss in WT mice exposed to CpG, while adoptive transfer of iTreg cells increased decidual Foxp3(+) Treg cells and IL-10(+) cell number and rescued pregnancy. Conclusions: NOD mice are prone to abortion and preterm birth. This can be attributed to lacking Treg cells and insufficient IL-10 expression. Adoptive transfer of iTreg cells can rescue CpG-mediated pregnancy failure.	[Lin, Yi; Liu, Xiaorui] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai 200030, Peoples R China; [Shan, Bin] Washington State Univ, Spokane, WA USA; [Wu, Ji] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Sharma, Surendra] Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02912 USA; [Sun, Yun] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Reprod Med, Shanghai 200030, Peoples R China; [Sun, Yun] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China	Shanghai Jiao Tong University; Washington State University; Shanghai Jiao Tong University; Brown University; Women & Infants Hospital Rhode Island; Shanghai Jiao Tong University	Sun, Y (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Reprod Med, Shanghai 200030, Peoples R China.	syun163@163.com		Shan, Bin/0000-0002-6869-2678	National Basic Research Program of China [2014CB943300, 2013CB967404]; National Natural Science Foundation of China [81370762, 81125004, 31171439]; Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China [12JC1405800]; Shanghai Jiao Tong University Medicine-Engineering Fund [YG2013ZD04, YG2013MS68]; Superfund Program Research National Institute of Environmental Health Sciences, USA (SPR NIEHS) [P42ES013660]; Fund for Outstanding Academic Leaders in Shanghai, China [12XD1406600, 2013-049]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China; Shanghai Jiao Tong University Medicine-Engineering Fund; Superfund Program Research National Institute of Environmental Health Sciences, USA (SPR NIEHS); Fund for Outstanding Academic Leaders in Shanghai, China	This work was supported by the National Basic Research Program of China (2014CB943300 and 2013CB967404), the National Natural Science Foundation of China (81370762, 81125004 and 31171439), the Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China (12JC1405800), Shanghai Jiao Tong University Medicine-Engineering Fund (YG2013ZD04 and YG2013MS68), the Superfund Program Research National Institute of Environmental Health Sciences, USA (SPR NIEHS grant P42ES013660), and the Fund for Outstanding Academic Leaders in Shanghai, China (12XD1406600 and 2013-049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arck PC, 1999, CELL IMMUNOL, V196, P71, DOI 10.1006/cimm.1999.1535; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fischer K, 2002, J IMMUNOL METHODS, V259, P159, DOI 10.1016/S0022-1759(01)00507-5; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Havla J, 2013, J NEUROL, V260, P1382, DOI 10.1007/s00415-012-6808-8; Higuma-Myojo S, 2005, AM J REPROD IMMUNOL, V54, P21, DOI 10.1111/j.1600-0897.2005.00279.x; Kalkunte SS, 2009, J IMMUNOL, V182, P4085, DOI 10.4049/jimmunol.0803769; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Li C, 2009, J CELL BIOCHEM, V108, P447, DOI 10.1002/jcb.22271; Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628; Lin Y, 2005, J REPROD IMMUNOL, V68, P39, DOI 10.1016/j.jri.2005.05.002; Lin Y, 2008, CLIN IMMUNOL, V126, P104, DOI 10.1016/j.clim.2007.09.006; Lin Y, 2006, J IMMUNOL, V176, P4147, DOI 10.4049/jimmunol.176.7.4147; Lin Y, 2011, AM J PATHOL, V178, P506, DOI 10.1016/j.ajpath.2010.10.005; Lin Y, 2009, J REPROD IMMUNOL, V82, P12, DOI 10.1016/j.jri.2009.03.004; Lin Y, 2009, FERTIL STERIL, V91, P2687, DOI 10.1016/j.fertnstert.2008.01.109; Lin Y, 2009, FERTIL STERIL, V91, P2676, DOI 10.1016/j.fertnstert.2007.08.087; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Murphy SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.043; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Parsons CH, 2006, J CLIN INVEST, V116, P1963, DOI 10.1172/JCI27249; Pedersen G, 2005, CLIN EXP IMMUNOL, V141, P298, DOI 10.1111/j.1365-2249.2005.02848.x; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Rocha-Campos AC, 2006, DIABETES, V55, P1163, DOI 10.2337/diabetes.55.04.06.db05-0908; Saito S, 2007, SEMIN IMMUNOPATHOL, V29, P115, DOI 10.1007/s00281-007-0067-2; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Serpero LD, 2013, J NEUROIMMUNE PHARM, V8, P1106, DOI 10.1007/s11481-013-9465-5; Shigeru S, 2008, J REPROD IMMUNOL, V77, P14, DOI 10.1016/j.jri.2007.04.007; Sun Y, 2013, FERTIL STERIL, V99, P1759, DOI 10.1016/j.fertnstert.2013.01.121; Sun Y, 2011, AM J REPROD IMMUNOL, V66, P349, DOI 10.1111/j.1600-0897.2011.01010.x; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Wang WJ, 2009, REPROD BIOMED ONLINE, V18, P95, DOI 10.1016/S1472-6483(10)60430-0; Yin GJ, 2011, J CELL BIOCHEM, V112, P773, DOI 10.1002/jcb.22893; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	44	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94702	10.1371/journal.pone.0094702	http://dx.doi.org/10.1371/journal.pone.0094702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714634	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900142
J	Minamino, R; Tateno, M				Minamino, Ryoko; Tateno, Masaki			Tree Branching: Leonardo da Vinci's Rule versus Biomechanical Models	PLOS ONE			English	Article							CONSTANT-STRESS; HEIGHT GROWTH; SIZE; HYPOTHESIS; DIAMETER; SAFETY; SHOOT	This study examined Leonardo da Vinci's rule (i.e., the sum of the cross-sectional area of all tree branches above a branching point at any height is equal to the cross-sectional area of the trunk or the branch immediately below the branching point) using simulations based on two biomechanical models: the uniform stress and elastic similarity models. Model calculations of the daughter/mother ratio (i.e., the ratio of the total cross-sectional area of the daughter branches to the cross-sectional area of the mother branch at the branching point) showed that both biomechanical models agreed with da Vinci's rule when the branching angles of daughter branches and the weights of lateral daughter branches were small; however, the models deviated from da Vinci's rule as the weights and/or the branching angles of lateral daughter branches increased. The calculated values of the two models were largely similar but differed in some ways. Field measurements of Fagus crenata and Abies homolepis also fit this trend, wherein models deviated from da Vinci's rule with increasing relative weights of lateral daughter branches. However, this deviation was small for a branching pattern in nature, where empirical measurements were taken under realistic measurement conditions; thus, da Vinci's rule did not critically contradict the biomechanical models in the case of real branching patterns, though the model calculations described the contradiction between da Vinci's rule and the biomechanical models. The field data for Fagus crenata fit the uniform stress model best, indicating that stress uniformity is the key constraint of branch morphology in Fagus crenata rather than elastic similarity or da Vinci's rule. On the other hand, mechanical constraints are not necessarily significant in the morphology of Abies homolepis branches, depending on the number of daughter branches. Rather, these branches were often in agreement with da Vinci's rule.	[Minamino, Ryoko; Tateno, Masaki] Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan	University of Tokyo	Minamino, R (corresponding author), Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan.	ryokominamino@gmail.com			Japan Science Society [22-523]; Yamaguchi Educational and Scholarship Foundation	Japan Science Society; Yamaguchi Educational and Scholarship Foundation	Financial support for this study was provided by the Sasakawa Scientific Research Grant from The Japan Science Society [grant number 22-523] (http://www.jss.or.jp/ikusei/sasakawa/) and Yamaguchi Educational and Scholarship Foundation (http://yamaguchi-esf.or.jp/). No individuals employed or contracted by the funders (other than the named authors) played any role in this study.	Bertram JEA, 1989, TREES-STRUCT FUNCT, V3, P241, DOI 10.1007/BF00225358; da Vinci Leonardo, 1970, COURIER CORPORATION, P2; Dahle GA, 2010, TREES-STRUCT FUNCT, V24, P321, DOI 10.1007/s00468-009-0401-5; DEAN TJ, 1986, ANN BOT-LONDON, V58, P833, DOI 10.1093/oxfordjournals.aob.a087265; Dean TJ, 2002, TREES-STRUCT FUNCT, V16, P559, DOI 10.1007/s00468-002-0208-0; Evans LS, 2008, TREES-STRUCT FUNCT, V22, P283, DOI 10.1007/s00468-007-0182-7; Horn HS, 2000, SFI S SCI C, P199; KING D, 1981, OECOLOGIA, V51, P351, DOI 10.1007/BF00540905; KING D, 1978, RADIAT ENVIRON BIOPH, V15, P141, DOI 10.1007/BF01323263; KOZAK A, 1993, FOREST CHRON, V69, P438, DOI 10.5558/tfc69438-4; MATTHECK C, 1993, J THEOR BIOL, V165, P185, DOI 10.1006/jtbi.1993.1184; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; Meng SX, 2006, J EXP BOT, V57, P3175, DOI 10.1093/jxb/erl079; Nikinmaa Eero, 1992, Acta Forestalia Fennica, V235, P1; Niklas KJ, 2000, TREES-STRUCT FUNCT, V14, P230, DOI 10.1007/s004680050008; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; Niklas KJ, 2000, J EXP BOT, V51, P797, DOI 10.1093/jexbot/51.345.797; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Sone K, 2005, TREE PHYSIOL, V25, P39, DOI 10.1093/treephys/25.1.39; Sone K, 2009, J PLANT RES, V122, P41, DOI 10.1007/s10265-008-0177-5; Taneda H, 2004, AM J BOT, V91, P1949, DOI 10.3732/ajb.91.12.1949; Timoshenko S., 1955, STRENGTH MAT 1, V3; Watt MS, 2011, ECOL MODEL, V222, P3910, DOI 10.1016/j.ecolmodel.2011.10.011; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; WILSON BF, 1977, ANNU REV PLANT PHYS, V28, P23, DOI 10.1146/annurev.pp.28.060177.000323	26	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93535	10.1371/journal.pone.0093535	http://dx.doi.org/10.1371/journal.pone.0093535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714065	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900031
J	Tucholski, J; Pinner, AL; Simmons, MS; Meador-Woodruff, JH				Tucholski, Janusz; Pinner, Anita L.; Simmons, Micah S.; Meador-Woodruff, James H.			Evolutionarily Conserved Pattern of AMPA Receptor Subunit Glycosylation in Mammalian Frontal Cortex	PLOS ONE			English	Article							N-GLYCOSYLATION; PREFRONTAL CORTEX; ELDERLY-PATIENTS; LIGAND-BINDING; TOPOGRAPHY; REVEALS; GLYCANS; SITES	Protein glycosylation may contribute to the evolution of mammalian brain complexity by adapting excitatory neurotransmission in response to environmental and social cues. Balanced excitatory synaptic transmission is primarily mediated by glutamatergic neurotransmission. Previous studies have found that subunits of the AMPA subtype of glutamate receptor are N-glycosylated, which may play a critical role in AMPA receptor trafficking and function at the cell membrane. Studies have predominantly used rodent models to address altered glycosylation in human pathological conditions. Given the rate of mammalian brain evolution and the predicted rate of change in the brain-specific glycoproteome, we asked if there are species-specific changes in glycoprotein expression, focusing on the AMPA receptor. N-glycosylation of AMPA receptor subunits was investigated in rat (Rattus norvegicus), tree shrew (Tupaia glis belangeri), macaque (Macaca nemestrina), and human frontal cortex tissue using a combination of enzymatic deglycosylation and Western blot analysis, as well as lectin binding assays. We found that two AMPA receptor subunits, GluA2 and GluA4, are sensitive to deglycosylation with Endo H and PNGase F. When we enriched for glycosylated proteins using lectin binding assays, we found that all four AMPA receptor subunits are glycosylated, and were predominantly recognized by lectins that bind to glucose or mannose, N-acetylglucosamine (GlcNAc), or 1-6 alpha fucose. We found differences in glycosylation between different subunits, as well as modest differences in glycosylation of homologous subunits between different species.	[Tucholski, Janusz; Pinner, Anita L.; Simmons, Micah S.; Meador-Woodruff, James H.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Tucholski, J (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	jtuchol@uab.edu			NIH [MH53327]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NIH grant - MH53327 (JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bauer D, 2008, SCHIZOPHR RES, V104, P108, DOI 10.1016/j.schres.2008.06.012; Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Clark RAC, 1998, J NEUROCHEM, V70, P2594; Dingledine R, 1999, PHARMACOL REV, V51, P7; Drummond JB, 2013, SCHIZOPHR RES, V147, P32, DOI 10.1016/j.schres.2013.03.010; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; Freeze HH, 2001, CURR PROTOC MOL BIOL; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Mueller TM, 2014, NEUROPSYCHOPHARMACOL, V39, P528, DOI 10.1038/npp.2013.190; Pasternack A, 2003, J NEUROCHEM, V84, P1184, DOI 10.1046/j.1471-4159.2003.01611.x; Standley S, 1998, J NEUROCHEM, V70, P2434; Standley S, 2000, CELL MOL LIFE SCI, V57, P1508, DOI 10.1007/PL00000635; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Tucholski J, 2013, SCHIZOPHR RES, V146, P177, DOI 10.1016/j.schres.2013.01.031; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94255	10.1371/journal.pone.0094255	http://dx.doi.org/10.1371/journal.pone.0094255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713873	Green Submitted, Green Published			2022-12-27	WOS:000334160900109
J	Wallner, S; Grandl, M; Konovalova, T; Sigruner, A; Kopf, T; Peer, M; Orso, E; Liebisch, G; Schmitz, G				Wallner, Stefan; Grandl, Margot; Konovalova, Tatiana; Sigruener, Alexander; Kopf, Thomas; Peer, Markus; Orso, Evelyn; Liebisch, Gerhard; Schmitz, Gerd			Monocyte to Macrophage Differentiation Goes along with Modulation of the Plasmalogen Pattern through Transcriptional Regulation	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PARTIAL LEAST-SQUARES; OXIDATIVE STRESS; MICROARRAY DATA; FACTOR EGR-1; CHOLESTEROL; PROTEIN; HSP70; INFLAMMATION; LIPOPROTEIN	Background: Dysregulation of monocyte-macrophage differentiation is a hallmark of vascular and metabolic diseases and associated with persistent low grade inflammation. Plasmalogens represent ether lipids that play a role in diabesity and previous data show diminished plasmalogen levels in obese subjects. We therefore analyzed transcriptomic and lipidomic changes during monocyte-macrophage differentiation in vitro using a bioinformatic approach. Methods: Elutriated monocytes from 13 healthy donors were differentiated in vitro to macrophages using rhM-CSF under serum-free conditions. Samples were taken on days 0, 1, 4 and 5 and analyzed for their lipidomic and transcriptomic profiles. Results: Gene expression analysis showed strong regulation of lipidome-related transcripts. Enzymes involved in fatty acid desaturation and elongation were increasingly expressed, peroxisomal and ER stress related genes were induced. Total plasmalogen levels remained unchanged, while the PE plasmalogen species pattern became more similar to circulating granulocytes, showing decreases in PUFA and increases in MUFA. A partial least squares discriminant analysis (PLS/DA) revealed that PE plasmalogens discriminate the stage of monocyte-derived macrophage differentiation. Partial correlation analysis could predict novel potential key nodes including DOCK1, PDK4, GNPTAB and FAM126A that might be involved in regulating lipid and especially plasmalogen homeostasis during differentiation. An in silico transcription analysis of lipid related regulation revealed known motifs such as PPAR-gamma and KLF4 as well as novel candidates such as NFY, RNF96 and Zinc-finger proteins. Conclusion: Monocyte to macrophage differentiation goes along with profound changes in the lipid-related transcriptome. This leads to an induction of fatty-acid desaturation and elongation. In their PE-plasmalogen profile macrophages become more similar to granulocytes than monocytes, indicating terminal phagocytic differentiation. Therefore PE plasmalogens may represent potential biomarkers for cell activation. For the underlying transcriptional network we were able to predict a range of novel central key nodes and underlying transcription factors using a bioinformatic approach.	[Wallner, Stefan; Grandl, Margot; Konovalova, Tatiana; Sigruener, Alexander; Kopf, Thomas; Peer, Markus; Orso, Evelyn; Liebisch, Gerhard; Schmitz, Gerd] Univ Regensburg, Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany	University of Regensburg	Schmitz, G (corresponding author), Univ Regensburg, Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany.	gerd.schmitz@ukr.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811	European Community [202272]; Deutsche Forschungsgemeinschaft [SFB-TR 13/A3]; Federal Ministry of Education and Research [FKZ01KU1216J]; European Lipidomics Initiative by EC [013032]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Lipidomics Initiative by EC	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet. The project was also supported by the Deutsche Forschungsgemeinschaft (SFB-TR 13/A3), related to "The European Lipidomics Initiative; shaping the life sciences" a specific support action subsidized by the EC 2006-2007 (proposal number 013032). The results upon which this publication is based were partly funded by the Federal Ministry of Education and Research under the Project Number FKZ01KU1216J. The responsibility for the content of this publication lies with the author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Bakhle YS, 1999, DRUGS TODAY, V35, P237, DOI 10.1358/dot.1999.35.4-5.552200; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Berbee JFP, 2006, FASEB J, V20, P2162, DOI 10.1096/fj.05-5639fje; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUDDECKE E, 1959, H-S Z PHYSIOL CHEM, V314, P38, DOI 10.1515/bchm2.1959.314.1.38; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Castelo R, 2006, J MACH LEARN RES, V7, P2621; Castelo R, 2012, METHODS MOL BIOL, V802, P215, DOI 10.1007/978-1-61779-400-1_14; Castelo R, 2009, J COMPUT BIOL, V16, P213, DOI 10.1089/cmb.2008.08TT; Colas R, 2011, DIABETOLOGIA, V54, P2931, DOI 10.1007/s00125-011-2272-8; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Doherty GJ, 2011, MOL BIOL CELL, V22, P4380, DOI 10.1091/mbc.E10-12-0936; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Farooqui AA, 1999, METH MOL B, V109, P39; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gautier EL, 2009, CIRCULATION, V119, P1795, DOI 10.1161/CIRCULATIONAHA.108.806158; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gelissen IC, 1998, BIOCHEM J, V331, P231, DOI 10.1042/bj3310231; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTTA Y, 1995, ADV BIOPHYS, V31, P101, DOI 10.1016/0065-227X(95)99386-4; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kondrakhin Yury V, 2008, In Silico Biol, V8, P383; KRISHNARAJU K, 1995, MOL CELL BIOL, V15, P5499; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Lessig J, 2009, CURR MED CHEM, V16, P2021; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Matsuzaka T, 2002, J LIPID RES, V43, P911; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; MULLER G, 1993, ARTERIOSCLER THROMB, V13, P1317, DOI 10.1161/01.ATV.13.9.1317; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Piao L, 2011, GENE CHROMOSOME CANC, V50, P13, DOI 10.1002/gcc.20828; R Core Team, 2021, R LANGUAGE ENV STAT; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Schroder O, 2003, CRIT CARE MED, V31, P73, DOI 10.1097/01.CCM.0000037972.16578.2B; Seo HS, 1997, ARTERIOSCL THROM VAS, V17, P3593, DOI 10.1161/01.ATV.17.12.3593; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stenvinkel P, 2004, NEPHROL DIAL TRANSPL, V19, P972, DOI 10.1093/ndt/gfh035; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Tsutsumi K., 2003, Current Vascular Pharmacology, V1, P11, DOI 10.2174/1570161033386673; VAN DS, 2012, BMC GENOMICS, V13, P535; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wang Y, 2008, J LIPID RES, V49, P1538, DOI 10.1194/jlr.M800123-JLR200; WATERBEEMD HVD, 1995, CHEMOMETRIC METHODS, P2; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Westerterp Marit, 2007, Atherosclerosis, V195, pe9, DOI 10.1016/j.atherosclerosis.2007.01.015; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	83	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94102	10.1371/journal.pone.0094102	http://dx.doi.org/10.1371/journal.pone.0094102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714687	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900083
J	Kurtz, KH; Souza-Smith, FM; Moor, AN; Breslin, JW				Kurtz, Kristine H.; Souza-Smith, Flavia M.; Moor, Andrea N.; Breslin, Jerome W.			Rho Kinase Enhances Contractions of Rat Mesenteric Collecting Lymphatics	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; MYOSIN PHOSPHATASE; PUMP FUNCTION; INHIBITION; PHOSPHORYLATION; CA2+; PATHWAY; INFLAMMATION; FORCE	The mechanisms that control phasic and tonic contractions of lymphatic vessels are poorly understood. We hypothesized that rho kinase ROCK, previously shown to increase calcium ( Ca2+) sensitivity in vascular smooth muscle, enhances lymphatic contractile activity in a similar fashion. Contractions of isolated rat mesenteric lymphatic vessels were observed at a luminal pressure of 2 cm H2O in a 37 degrees C bath. The expression of ROCK in isolated rat mesenteric lymphatic vessels was assessed by Western blotting and confocal microscopy. The role of ROCK in contractile function was tested using two specific yet structurally distinct inhibitors: H1152 (0.1-10 mu M) and Y-27632 (0.5-50 mu M). In addition, lymphatics were transfected with constitutively active (ca)-ROCK protein (2 mu g/ml) to assess gain of contractile function. Vessel diameter and the concentration of intracellular free Ca2+ ([Ca2+](i)) were simultaneously measured in a subset of isolated lymphatics loaded with the Ca2+-sensing dye fura-2. The results show expression of both the ROCK1 and ROCK2 isoforms in lymphatic vessels. Inhibition of ROCK increased lymphatic end diastolic diameter and end systolic diameter in a concentration-dependent manner. Significant reductions in lymphatic tone and contraction amplitude were observed after treatment 1-10 mu M H1152 or 25-50 mu M Y-27632. H1152 (10 mu M) also significantly reduced contraction frequency. Transient increases in [ Ca2+] i preceded each phasic contraction, however this pattern was disrupted by either 10 mu M H1152 or 50 mM Y-27632 in the majority of lymphatics studied. The significant decrease in tone caused by H1152 or Y-27632 was not associated with a significant change in the basal [ Ca2+](i) between transients. Transfection with ca-ROCK protein enhanced lymphatic tone, but was not associated with a significant change in basal [ Ca2+](i). Our data suggest that ROCK mediates normal tonic constriction and influences phasic contractions in lymphatics. We propose that ROCK modulates Ca2+ sensitivity of contractile proteins in lymphatics.	[Kurtz, Kristine H.; Souza-Smith, Flavia M.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA USA; [Moor, Andrea N.; Breslin, Jerome W.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; State University System of Florida; University of South Florida	Breslin, JW (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	jbreslin@health.usf.edu			National Institutes of Health [P20RR018766, R01HL098215, F32AA021049]; American Heart Association [0835388N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants P20RR018766, R01HL098215, and F32AA021049, and American Heart Association grant number 0835388N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406; BENOIT JN, 1991, AM J PHYSIOL, V261, pH1970, DOI 10.1152/ajpheart.1991.261.6.H1970; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Bridenbaugh EA, 2013, LYMPHAT RES BIOL, V11, P155, DOI 10.1089/lrb.2013.0023; Dougherty PJ, 2008, AM J PHYSIOL-REG I, V294, pR1524, DOI 10.1152/ajpregu.00888.2007; Dougherty PJ, 2014, AM J PHYSL HEART CIR; Fowler CJ, 1997, CLIN CHIM ACTA, V265, P247, DOI 10.1016/S0009-8981(97)00139-3; Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033; Gashev AA, 2013, LYMPHAT RES BIOL, V11, P2, DOI 10.1089/lrb.2013.0003; Hosaka K, 2003, AM J PHYSIOL-HEART C, V284, pH2015, DOI 10.1152/ajpheart.00763.2002; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Imtiaz MS, 2007, BIOPHYS J, V92, P3843, DOI 10.1529/biophysj.106.095687; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Lund AW, 2010, J MAMMARY GLAND BIOL, V15, P341, DOI 10.1007/s10911-010-9193-x; Nepiyushchikh ZV, 2011, J PHYSIOL-LONDON, V589, P5415, DOI 10.1113/jphysiol.2011.218446; Nobe K, 2001, CIRC RES, V88, P1283, DOI 10.1161/hh1201.092035; NOBLE D, 1991, P ROY SOC B-BIOL SCI, V246, P167, DOI 10.1098/rspb.1991.0140; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Si YH, 2013, SHOCK, V40, P49, DOI 10.1097/SHK.0b013e31829635cf; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Souza-Smith FM, 2011, JOVE-J VIS EXP, DOI 10.3791/3438; Souza-Smith FM, 2013, MICROCIRCULATION, V20, P377, DOI 10.1111/micc.12032; Souza-Smith FM, 2010, MICROCIRCULATION, V17, P514, DOI 10.1111/j.1549-8719.2010.00050.x; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Von Der Weid PY, 2001, ALIMENT PHARM THER, V15, P1115, DOI 10.1046/j.1365-2036.2001.01037.x; Wang W, 2009, AM J PHYSIOL-HEART C, V297, pH726, DOI 10.1152/ajpheart.00312.2009; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Wetzel P, 2002, AM J PHYSIOL-CELL PH, V283, pC1242, DOI 10.1152/ajpcell.00106.2002; Zhou H, 2012, CURR PHARM DESIGN, V18, P2964, DOI 10.2174/138161212800672688; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986; ZWEIFACH BW, 1975, AM J PHYSIOL, V228, P1326, DOI 10.1152/ajplegacy.1975.228.5.1326	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94082	10.1371/journal.pone.0094082	http://dx.doi.org/10.1371/journal.pone.0094082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710574	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800098
J	Roxworthy, BJ; Johnston, MT; Lee-Montiel, FT; Ewoldt, RH; Imoukhuede, PI; Toussaint, KC				Roxworthy, Brian J.; Johnston, Michael T.; Lee-Montiel, Felipe T.; Ewoldt, Randy H.; Imoukhuede, Princess I.; Toussaint, Kimani C., Jr.			Plasmonic Optical Trapping in Biologically Relevant Media	PLOS ONE			English	Article							PROTEIN; DNA	We present plasmonic optical trapping of micron-sized particles in biologically relevant buffer media with varying ionic strength. The media consist of 3 cell-growth solutions and 2 buffers and are specifically chosen due to their widespread use and applicability to breast-cancer and angiogenesis studies. High-precision rheological measurements on the buffer media reveal that, in all cases excluding the 8.0 pH Stain medium, the fluids exhibit Newtonian behavior, thereby enabling straightforward measurements of optical trap stiffness from power-spectral particle displacement data. Using stiffness as a trapping performance metric, we find that for all media under consideration the plasmonic nanotweezers generate optical forces 3-4x a conventional optical trap. Further, plasmonic trap stiffness values are comparable to those of an identical water-only system, indicating that the performance of a plasmonic nanotweezer is not degraded by the biological media. These results pave the way for future biological applications utilizing plasmonic optical traps.	[Roxworthy, Brian J.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA; [Johnston, Michael T.; Ewoldt, Randy H.; Toussaint, Kimani C., Jr.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Lee-Montiel, Felipe T.; Imoukhuede, Princess I.] Univ Illinois, Dept Bioengn, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Toussaint, KC (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.	ktoussai@illinois.edu	Imoukhuede, P I/T-7580-2017; Toussaint, Kimani/A-4611-2014; Ewoldt, Randy/N-9067-2013	Imoukhuede, P I/0000-0002-4257-1085; Toussaint, Kimani/0000-0002-6701-4541; Ewoldt, Randy/0000-0003-2720-9712; Roxworthy, Brian/0000-0002-6361-6203	National Science Foundation [NSF ECCS 10-25868]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF ECCS 10-25868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Baffou G, 2013, LASER PHOTONICS REV, V7, P171, DOI 10.1002/lpor.201200003; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53; Burckhardt P, 2010, NUTR INFLUENCES BONE; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Grigorenko AN, 2008, NAT PHOTONICS, V2, P365, DOI 10.1038/nphoton.2008.78; Huang L, 2009, OPT EXPRESS, V17, P6018, DOI 10.1364/OE.17.006018; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Imoukhuede PI, 2013, CANC MED IN PRESS; Imoukhuede PI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044791; Johnston MT, 2013, J RHEOL, V57, P1515, DOI 10.1122/1.4819914; Juan ML, 2011, NAT PHOTONICS, V5, P349, DOI [10.1038/nphoton.2011.56, 10.1038/NPHOTON.2011.56]; Kang JH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1592; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; KRISHNAN GP, 1995, PHYS FLUIDS, V7, P2538, DOI 10.1063/1.868755; Liu Y, 1996, BIOPHYS J, V71, P2158, DOI 10.1016/S0006-3495(96)79417-1; Marchington RF, 2008, OPT EXPRESS, V16, P3712, DOI 10.1364/OE.16.003712; Martinez IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061630; Miao XY, 2007, IEEE J SEL TOP QUANT, V13, P1655, DOI 10.1109/JSTQE.2007.910996; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Ploschner M, 2010, J NANOPHOTONICS, V4, DOI 10.1117/1.3332850; Righini M, 2009, NANO LETT, V9, P3387, DOI 10.1021/nl803677x; Roxworthy BJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00660; Roxworthy BJ, 2012, OPT EXPRESS, V20, DOI 10.1364/OE.20.009591; Roxworthy BJ, 2012, NANO LETT, V12, P796, DOI 10.1021/nl203811q; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Shoji T, 2013, J AM CHEM SOC, V135, P6643, DOI 10.1021/ja401657j; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Tolic-Norrelykke IM, 2004, COMPUT PHYS COMMUN, V159, P225, DOI 10.1016/j.cpc.2004.02.012; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Watanabe TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012224; Zhang WH, 2010, NANO LETT, V10, P1006, DOI 10.1021/nl904168f	34	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93929	10.1371/journal.pone.0093929	http://dx.doi.org/10.1371/journal.pone.0093929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710326	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800073
J	Liu, J; Ren, YG; Kang, L; Zhang, LH				Liu, Jun; Ren, Yingang; Kang, Li; Zhang, Lihua			Overexpression of CCN3 Inhibits Inflammation and Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; IMMEDIATE-EARLY GENE; EXPRESSION; NOV; RECEPTOR; ATHEROGENESIS; MACROPHAGES; PLAQUES; DISEASE; LESIONS	Background: Cysteine-rich 61/connective tissue growth factor/nephroblastoma overexpressed (CCN) 3 has been recently reported to play a role in regulating inflammation of vascular endothelial cells. However, the role of CCN3 in atherosclerosis, which is characterized by vascular inflammation, remains unclear. Hypothesis and Objectives: Overexpression of CCN3 may relieve the inflammation response in and inhibit the progress of atherosclerosis. We aimed to explore the potential roles of CCN3 in inflammation in atherosclerosis. Strategy and Main Results: In in vitro studies using cultured human aortic endothelial cells and human umbilical vein endothelial cells, CCN3 mRNA and protein expression significantly decreased in response to tumor necrosis factor-a and interleukin-1 beta treatments (p<0.05), when analyzed by quantitative real-time polymerase chain reaction and Western blot. Using a mouse model of atherosclerosis, the mRNA and protein levels of CCN3 decreased by 72.2% (p = 0.041) and 86.4% (p = 0.036), respectively, compared with levels in wild-type control mice, respectively. Overexpression of CCN3 by adenovirus-mediated gene overexpression decreased low-density lipoprotein cholesterol by 48.9% (p = 0.017), total cholesterol by 58.9% (p = 0.031), and triglycerides by 56.8% (p = 0.022), and it increased high-density lipoprotein cholesterol level by 2.16-fold (p = 0.039), compared with control groups. Additionally, a reduced plaque area and increased fibrous cap were observed (p<0.05). Furthermore, CCN3 overexpression decreased cell adhesion molecule-1 mRNA expression by 84.7% (p = 0.007) and intercellular adhesion molecule-1 mRNA expression by 61.2% (p = 0.044). Inflammatory factors, including matrix metalloproteinases, cyclooxygenase 2, and tissue factor also significantly (p<0.05) decreased with CCN3 overexpression in the atherosclerotic mouse model. Additionally, CCN1 and CCN2, which have been reported to be highly expressed in aortic atherosclerotic plaques, were significantly downregulated (p<0.05) by CCN3 overexpression. Conclusion: CCN3 overexpression is associated with control of inflammatory processes and reversion of dyslipidemia in the process of atherosclerosis, which implies that CCN3 may be a promising target in the treatment of atherosclerosis.	[Liu, Jun; Ren, Yingang; Kang, Li; Zhang, Lihua] Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Peoples R China	Air Force Military Medical University	Zhang, LH (corresponding author), Fourth Mil Med Univ, Dept Geriatr, Tangdu Hosp, Xian 710032, Peoples R China.	lihuazhangcn@163.com						Boden WE, 2000, AM J CARDIOL, V86, p19L; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; Fiorucci S, 2001, DIGEST LIVER DIS, V33, pS2, DOI 10.1016/S1590-8658(01)80152-3; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hilfiker A, 2002, CIRCULATION, V106, P254, DOI 10.1161/01.CIR.0000021426.87274.62; Iiyama K, 1999, CIRC RES, V85, P199, DOI 10.1161/01.RES.85.2.199; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Ito T, 2004, EXP ANIM TOKYO, V53, P339, DOI 10.1538/expanim.53.339; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Jude B, 2005, ARCH MAL COEUR VAISS, V98, P667; Karger A, 2008, CELL SIGNAL, V20, P1865, DOI 10.1016/j.cellsig.2008.06.016; Kim KK, 2013, ENDOCRINOL METAB, V28, P214, DOI 10.3803/EnM.2013.28.3.214; Kocialkowski S, 2001, ANAT EMBRYOL, V203, P417, DOI 10.1007/s004290100177; Kok SH, 2011, ARTHRITIS RHEUM-US, V63, P1010, DOI 10.1002/art.27433; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Kular L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-36; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin ZY, 2010, J CELL COMMUN SIGNAL, V4, P141, DOI 10.1007/s12079-010-0095-x; Liuzzo G, 2001, Rays, V26, P221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus IM, 2001, EUR J VASC ENDOVASC, V21, P17, DOI 10.1053/ejvs.2000.1278; Lwaleed BA, 2007, BIOL RES NURS, V9, P97, DOI 10.1177/1099800407305733; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Morancho A, 2010, ANN NY ACAD SCI, V1207, P123, DOI 10.1111/j.1749-6632.2010.05734.x; Moritani Norifumi H, 2005, Cell Commun Signal, V3, P6, DOI 10.1186/1478-811X-3-6; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Nozawa K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2863; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Oemar BS, 1997, ARTERIOSCL THROM VAS, V17, P1483, DOI 10.1161/01.ATV.17.8.1483; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal Bernard, 2006, Cell Commun Signal, V4, P6, DOI 10.1186/1478-811X-4-6; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; SHAH PK, 1995, CIRCULATION, V92, P1565; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; Sigala F, 2006, EUR J VASC ENDOVASC, V32, P238, DOI 10.1016/j.ejvs.2006.01.026; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; WATANABE T, 1985, LAB INVEST, V53, P80; Yan XL, 2006, ENDOCRINOLOGY, V147, P5268, DOI 10.1210/en.2005-1568; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6	44	19	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94912	10.1371/journal.pone.0094912	http://dx.doi.org/10.1371/journal.pone.0094912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722330	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100146
J	Bannink, R; Broeren, S; van de Looij-Jansen, PM; de Waart, FG; Raat, H				Bannink, Rienke; Broeren, Suzanne; van de Looij-Jansen, Petra M.; de Waart, Frouwkje G.; Raat, Hein			Cyber and Traditional Bullying Victimization as a Risk Factor for Mental Health Problems and Suicidal Ideation in Adolescents	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE SDQ; FOLLOW-UP; PEER VICTIMIZATION; SELF-HARM; CHILDHOOD; ADULTHOOD; POPULATION; DISORDERS; STRENGTHS; SYMPTOMS	Purpose: To examine whether traditional and cyber bullying victimization were associated with adolescent's mental health problems and suicidal ideation at two-year follow-up. Gender differences were explored to determine whether bullying affects boys and girls differently. Methods: A two-year longitudinal study was conducted among first-year secondary school students (N = 3181). Traditional and cyber bullying victimization were assessed at baseline, whereas mental health status and suicidal ideation were assessed at baseline and follow-up by means of self-report questionnaires. Logistic regression analyses were conducted to assess associations between these variables while controlling for baseline problems. Additionally, we tested whether gender differences in mental health and suicidal ideation were present for the two types of bullying. Results: There was a significant interaction between gender and traditional bullying victimization and between gender and cyber bullying victimization on mental health problems. Among boys, traditional and cyber bullying victimization were not related to mental health problems after controlling for baseline mental health. Among girls, both traditional and cyber bullying victimization were associated with mental health problems after controlling for baseline mental health. No significant interaction between gender and traditional or cyber bullying victimization on suicidal ideation was found. Traditional bullying victimization was associated with suicidal ideation, whereas cyber bullying victimization was not associated with suicidal ideation after controlling for baseline suicidal ideation. Conclusions: Traditional bullying victimization is associated with an increased risk of suicidal ideation, whereas traditional, as well as cyber bullying victimization is associated with an increased risk of mental health problems among girls. These findings stress the importance of programs aimed at reducing bullying behavior, especially because early-onset mental health problems may pose a risk for the development of psychiatric disorders in adulthood.	[Bannink, Rienke; Broeren, Suzanne; Raat, Hein] Erasmus Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [van de Looij-Jansen, Petra M.; de Waart, Frouwkje G.] Municipal Publ Hlth Serv Rotterdam Area, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Raat, H (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl			Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The publication of this study was supported by the Netherlands Organization for Scientific Research (NWO). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldry AC, 2004, AGGRESSIVE BEHAV, V30, P343, DOI 10.1002/ab.20043; Bhat CS, 2008, AUST J GUID COUNS, V18, P53, DOI 10.1375/ajgc.18.1.53; Bonanno RA, 2013, J YOUTH ADOLESC; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; Cash SJ, 2009, CURR OPIN PEDIATR, V21, P613, DOI 10.1097/MOP.0b013e32833063e1; Centraal Bureau voor de Statistiek, ALL; Copeland WE, 2013, JAMA PSYCHIAT, P1; Crick NR, 1998, J CONSULT CLIN PSYCH, V66, P337, DOI 10.1037/0022-006X.66.2.337; Cullerton-Sen C, 2005, SCHOOL PSYCHOL REV, V34, P147; Fergusson DM, 2002, ARCH GEN PSYCHIAT, V59, P225, DOI 10.1001/archpsyc.59.3.225; Fisher HL, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2683; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Haavisto A, 2004, J AFFECT DISORDERS, V83, P143, DOI 10.1016/j.jad.2004.06.008; Heikkila HK, 2013, EUR CHILD ADOLES PSY, V22, P95, DOI 10.1007/s00787-012-0327-0; Hofstra MB, 2002, J AM ACAD CHILD PSY, V41, P182, DOI 10.1097/00004583-200202000-00012; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Klomek AB, 2008, J AFFECT DISORDERS, V109, P47, DOI 10.1016/j.jad.2007.12.226; Klomek AB, 2007, J AM ACAD CHILD PSY, V46, P40, DOI 10.1097/01.chi.0000242237.84925.18; Klomek AB, 2010, CAN J PSYCHIAT, V55, P282, DOI 10.1177/070674371005500503; Klomek AB, 2009, J AM ACAD CHILD PSY, V48, P254, DOI 10.1097/CHI.0b013e318196b91f; Kowalski RM, 2007, J ADOLESCENT HEALTH, V41, pS22, DOI 10.1016/j.jadohealth.2007.08.017; Lereya ST, 2013, J AM ACAD CHILD PSY, V52, P608, DOI 10.1016/j.jaac.2013.03.012; Levy N., 2012, BULLYING NETWORKED E, V2012-17; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Olweus D., 1993, AGGRESSIVE BEHAV CUR; Raskauskas J, 2007, DEV PSYCHOL, V43, P564, DOI 10.1037/0012-1649.43.3.564; Reijntjes A, 2010, CHILD ABUSE NEGLECT, V34, P244, DOI 10.1016/j.chiabu.2009.07.009; Rutter M., 1986, DEPRESSION YOUNG PEO; Schneider SK, 2012, AM J PUBLIC HEALTH, V102, P171, DOI 10.2105/AJPH.2011.300308; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Schultze-Krumbholz A, 2012, EMOT BEHAV DIFFIC, V17, P329, DOI 10.1080/13632752.2012.704317; Scoring the SDQ, INSTR ENGL SCOR SELF; Smith PK, 2008, J CHILD PSYCHOL PSYC, V49, P376, DOI 10.1111/j.1469-7610.2007.01846.x; Smith PK, 2003, CAN J PSYCHIAT, V48, P591, DOI 10.1177/070674370304800905; Sourander A, 2000, CHILD ABUSE NEGLECT, V24, P873, DOI 10.1016/S0145-2134(00)00146-0; Sourander A, 2007, PEDIATRICS, V120, P397, DOI 10.1542/peds.2006-2704; Sourander A, 2009, ARCH GEN PSYCHIAT, V66, P1005, DOI 10.1001/archgenpsychiatry.2009.122; Suzuki Keita, 2012, Int J Adolesc Med Health, V24, P27, DOI 10.1515/ijamh.2012.005; Ttofi MM, 2011, J EXP CRIMINOL, V7; Twisk J.W.R., 2006, PRACTICAL GUIDES BIO; van de Looij-Jansen PM, 2009, PUBLIC HEALTH, V123, P686, DOI 10.1016/j.puhe.2009.07.015; van Dorsselaer S, 2009, GEZONDHEID WELZIJN O; Ybarra ML, 2012, COMPLEMENTAR PEDIAT	43	123	131	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94026	10.1371/journal.pone.0094026	http://dx.doi.org/10.1371/journal.pone.0094026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718563	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000070
J	Hinton, L; Locock, L; Knight, M				Hinton, Lisa; Locock, Louise; Knight, Marian			Partner Experiences of "Near-Miss" Events in Pregnancy and Childbirth in the UK: A Qualitative Study	PLOS ONE			English	Article							BIRTH TRAUMA; FATHERS; RESUSCITATION; NARRATIVES; DEATH; WOMEN; LIFE; CARE	Objective: Severe life-threatening complications in pregnancy that require urgent medical intervention are commonly known as "near-miss" events. Although these complications are rare (1 in 100 births), there are potentially 8,000 women and their families in the UK each year who live through a life-threatening emergency and its aftermath. Near-miss obstetric emergencies can be traumatic and frightening for women, and their impact can last for years. There is little research that has explored how these events impact on partners. The objective of this interview study was to explore the impact of a near-miss obstetric emergency, focusing particularly on partners. Design: Qualitative study based on narrative interviews, video and audio recorded and transcribed for analysis. A qualitative interpretative approach was taken, combining thematic analysis with constant comparison. The analysis presented here focuses on the experiences of partners. Participants: Maximum variation sample included 35 women, 10 male partners, and one lesbian partner who had experienced a life-threatening obstetric emergency. Setting: Interviews were conducted in participants' own homes. Results: In the hospital, partner experiences were characterized by powerlessness and exclusion. Partners often found witnessing the emergency shocking and distressing. Support (from family or staff) was very important, and clear, honest communication from medical staff highly valued. The long-term emotional effects for some were profound; some experienced depression, flashbacks and post-traumatic stress disorder months and years after the emergency. These, in turn, affected the whole family. Little support was felt to be available, nor acknowledgement of their ongoing distress. Conclusion: Partners, as well as women giving birth, can be shocked to experience a life-threatening illness in childbirth. While medical staff may view a near-miss as a positive outcome for a woman and her baby, there can be long-term mental health consequences that can have profound impacts on the individual, but also their families.	[Hinton, Lisa; Locock, Louise] Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Hlth Experiences Res Grp, Oxford, England; [Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford; University of Oxford	Hinton, L (corresponding author), Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Hlth Experiences Res Grp, Oxford, England.	lisa.hinton@phc.ox.ac.uk	Knight, Marian/B-6225-2009; Hinton, Lisa/AAA-2266-2019	Knight, Marian/0000-0002-1984-4575; Hinton, Lisa/0000-0002-6082-3151	National Institute for Health Research (NIHR) [RP-PG-0608-10038]; National Institute for Health Research [NIHR-RP-011-032, RP-PG-0608-10038] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under the "Beyond maternal death: Improving the quality of maternity care through national studies of 'near-miss' maternal morbidity" programme (Programme Grant RP-PG-0608-10038). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayers Susan, 2006, Psychol Health Med, V11, P389, DOI 10.1080/13548500600708409; Beck CT, 2008, NURS RES, V57, P228, DOI 10.1097/01.NNR.0000313494.87282.90; Beck CT, 2004, NURS RES, V53, P28, DOI 10.1097/00006199-200401000-00005; Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Dellmann T., 2004, AUST J MIDWIFERY, V17, P20, DOI DOI 10.1016/S1448-8272(04)80014-2; Department of Health, 2007, MAT MATT CHOIC ACC C; Dolan A, 2011, SOCIOL HEALTH ILL, V33, P1019, DOI 10.1111/j.1467-9566.2011.01349.x; Draper Jan, 2003, Nurs Inq, V10, P66, DOI 10.1046/j.1440-1800.2003.00157.x; Elmir R, 2012, MIDWIFERY, V28, P228, DOI 10.1016/j.midw.2010.11.008; Erlandsson K, 2007, BIRTH-ISS PERINAT C, V34, P105, DOI 10.1111/j.1523-536X.2007.00162.x; Erlandsson K, 2011, J PERINAT EDUC, V20, P91, DOI 10.1891/1058-1243.20.2.91; Fagerskiold A, 2008, SCAND J CARING SCI, V22, P64, DOI 10.1111/j.1471-6712.2007.00585.x; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; Gamble J, 2004, AUSTR MIDWIFERY, V17, P12; Glaser B.G., 1968, DISCOV GROUNDED THEO; Green J., 2018, QUALITATIVE METHODS, VFourth; Hanson S, 2009, J PERINAT EDUC, V18, P12, DOI 10.1624/105812409X474672; Harvey ME, 2012, ARCH DIS CHILD-FETAL, V97, pF439, DOI 10.1136/archdischild-2011-301482; Hodge AN, 2009, COLLEGIAN, V16, P101, DOI 10.1016/j.colegn.2009.04.003; Jessop E, 2011, J REPROD INFANT PSYC, V29, pe25; Lewis GE, 2007, SAVING MOTHERS LIVES; Locock L, 2006, SOC SCI MED, V62, P1349, DOI 10.1016/j.socscimed.2005.08.011; Longworth HL, 2011, MIDWIFERY, V27, P588, DOI 10.1016/j.midw.2010.06.013; Mander R., 2004, MEN MATERNITY; McCreight BS, 2004, SOCIOL HEALTH ILL, V26, P326, DOI 10.1111/j.1467-9566.2004.00393.x; Miller T., 2011, MAKING SENSE FATHERH; National Institute for Health and Clinical Excellence, 2006, ROUT POSTN CAR WOM T; New South Wales Department of Health, 2007, SUPP FAM EARL PACK S; Nilsson C, 2009, MIDWIFERY, V25, pE1, DOI 10.1016/j.midw.2007.01.017; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Patton M. Q., 1990, QUALITATIVE EVALUATI; Perinatal and Maternal Mortality Review Committee (PMMRC), 2006, PER MAT MORT NZ; Premberg A, 2011, MIDWIFERY, V27, P848, DOI 10.1016/j.midw.2010.09.002; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Redshaw M, 2013, BMC PREGNANCY CHILDB, V13; Snowdon C, 2012, MIDWIFERY, V28, P791, DOI 10.1016/j.midw.2011.12.012; Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x; Steen M, 2012, MIDWIFERY, V28, P422, DOI 10.1016/j.midw.2011.06.009; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056; TNS System Three, 2005, NHS MAT SERV QUANT R; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; White G, 2007, BRIT J MIDWIFERY, V15, P39, DOI DOI 10.12968/BJOM.2007.15.1.22679; Wolfberg AJ, 2004, AM J OBSTET GYNECOL, V191, P708, DOI 10.1016/j.ajog.2004.05.019	45	22	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e91735	10.1371/journal.pone.0091735	http://dx.doi.org/10.1371/journal.pone.0091735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24717799	Green Published, gold			2022-12-27	WOS:000334339000011
J	Fa, R; Roberts, DJ; Nandi, AK				Fa, Rui; Roberts, David J.; Nandi, Asoke K.			SMART: Unique Splitting-While-Merging Framework for Gene Clustering	PLOS ONE			English	Article							EXPRESSION DATA; COMMUNITY STRUCTURE; CLASS DISCOVERY; MICROARRAY; ALGORITHMS; CRITERIA; NUMBER	Successful clustering algorithms are highly dependent on parameter settings. The clustering performance degrades significantly unless parameters are properly set, and yet, it is difficult to set these parameters a priori. To address this issue, in this paper, we propose a unique splitting-while-merging clustering framework, named '' splitting merging awareness tactics '' (SMART), which does not require any a priori knowledge of either the number of clusters or even the possible range of this number. Unlike existing self-splitting algorithms, which over-cluster the dataset to a large number of clusters and then merge some similar clusters, our framework has the ability to split and merge clusters automatically during the process and produces the the most reliable clustering results, by intrinsically integrating many clustering techniques and tasks. The SMART framework is implemented with two distinct clustering paradigms in two algorithms: competitive learning and finite mixture model. Nevertheless, within the proposed SMART framework, many other algorithms can be derived for different clustering paradigms. The minimum message length algorithm is integrated into the framework as the clustering selection criterion. The usefulness of the SMART framework and its algorithms is tested in demonstration datasets and simulated gene expression datasets. Moreover, two real microarray gene expression datasets are studied using this approach. Based on the performance of many metrics, all numerical results show that SMART is superior to compared existing self-splitting algorithms and traditional algorithms. Three main properties of the proposed SMART framework are summarized as: (1) needing no parameters dependent on the respective dataset or a priori knowledge about the datasets, (2) extendible to many different applications, (3) offering superior performance compared with counterpart algorithms.	[Fa, Rui; Nandi, Asoke K.] Brunel Univ, Dept Elect & Comp Engn, Uxbridge UB8 3PH, Middx, England; [Roberts, David J.] Natl Hlth Serv Blood & Transplant, Oxford, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Nandi, Asoke K.] Univ Jyvaskyla, Dept Math Informat, Jyvaskyla, Finland	Brunel University; NHS Blood & Transplant (NHSBT); University of Oxford; University of Jyvaskyla	Fa, R (corresponding author), Brunel Univ, Dept Elect & Comp Engn, Uxbridge UB8 3PH, Middx, England.	Rui.Fa@brunel.ac.uk; asoke.nandi@brunel.ac.uk		Fa, Rui/0000-0003-4588-7971	National Institute for Health Research (NIHR), UK [NIHR-RP-PG-0310-1004-AN]; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Institute for Health Research (NIHR), UK(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors are thankful for the financial support from National Institute for Health Research (NIHR), UK. The project reference is NIHR-RP-PG-0310-1004-AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Jamous B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056432; Abu-Jamous B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0990; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baek J, 2011, BIOINFORMATICS, V27, P1269, DOI 10.1093/bioinformatics/btr112; Baek J, 2010, IEEE T PATTERN ANAL, V32, P1298, DOI 10.1109/TPAMI.2009.149; Bandyopadhyay S, 2007, BIOINFORMATICS, V23, P2859, DOI 10.1093/bioinformatics/btm418; Bishop CM, 2006, PATTERN RECOGN, P2006; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Celeux G, 1999, 4 INRIA RHON ALP FRA; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fa R, 2011, 2 INT WORKSH GEN SIG; Fa R, 2014, IEEE T COMP IN PRESS; Fa R, 2012, 5 INT IEEE S COMM CO; Fa R, 2011, IEEE INT WORKS MACH; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FRALEY C, 1998, 329 U WASH DEP STAT; FRITZKE B, 1994, NEURAL NETWORKS, V7, P1441, DOI 10.1016/0893-6080(94)90091-4; Fritzke B., 1995, Advances in Neural Information Processing Systems 7, P625; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Halkidi M, 2002, SIGMOD REC, V31, P19, DOI 10.1145/601858.601862; Halkidi M, 2002, SIGMOD RECORD, V31, P40, DOI 10.1145/565117.565124; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lam BSY, 2007, SOFT COMPUT, V11, P341, DOI 10.1007/s00500-006-0087-1; Lanterman AD, 2001, INT STAT REV, V69, P185, DOI 10.2307/1403813; Lin CR, 2005, IEEE T KNOWL DATA EN, V17, P145, DOI 10.1109/TKDE.2005.21; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; Mavridis L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-213; McLachlan G., 2000, WILEY SER PROB STAT; MCLACHLAN G. J, 2007, EM ALGORITHM EXTENSI; McLachlan GJ, 2002, BIOINFORMATICS, V18, P413, DOI 10.1093/bioinformatics/18.3.413; McNicholas PD, 2010, BIOINFORMATICS, V26, P2705, DOI 10.1093/bioinformatics/btq498; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oliver J. J., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P364; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Qin J, 2003, BIOINFORMATICS, V19, P2097, DOI 10.1093/bioinformatics/btg288; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rousseeuw PJ, 1990, FINDING GROUPS DATA; Salem SA, 2009, PATTERN ANAL APPL, V12, P79, DOI 10.1007/s10044-007-0099-1; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Teschendorff AE, 2005, BIOINFORMATICS, V21, P3025, DOI 10.1093/bioinformatics/bti466; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Wallace CS, 1999, COMPUT J, V42, P270, DOI 10.1093/comjnl/42.4.270; Wu SH, 2004, IEEE T INF TECHNOL B, V8, P5, DOI 10.1109/TITB.2004.824724; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Xu Rui, 2010, IEEE Rev Biomed Eng, V3, P120, DOI 10.1109/RBME.2010.2083647; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhang YJ, 2002, IEEE T NEURAL NETWOR, V13, P369, DOI 10.1109/72.991422; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198	67	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94141	10.1371/journal.pone.0094141	http://dx.doi.org/10.1371/journal.pone.0094141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714159	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900093
J	Gray, SA; Reeve, RA				Gray, Sarah A.; Reeve, Robert A.			Preschoolers' Dot Enumeration Abilities Are Markers of Their Arithmetic Competence	PLOS ONE			English	Article							BASIC NUMERICAL CAPACITIES; WORKING-MEMORY; EXECUTIVE FUNCTIONS; DEVELOPMENTAL DYSCALCULIA; INDIVIDUAL-DIFFERENCES; OBJECT-FILES; NUMBER WORDS; CHILDREN; MATHEMATICS; SKILLS	The abilities to enumerate small sets of items (e. g., dots) and to compare magnitudes are claimed to be indexes of core numerical competences that scaffold early math development. Insofar as this is correct, these abilities may be diagnostic markers of math competence in preschoolers. However, unlike magnitude comparison abilities, little research has examined preschoolers' ability to enumerate small sets, or its significance for emerging math abilities; which is surprising since dot enumeration is a marker of school-aged children's math competence. It is nevertheless possible that general cognitive functions (working memory, response inhibition in particular) are associated with preschoolers' math abilities and underlie nascent dot enumeration abilities. We investigated whether preschoolers' dot enumeration abilities predict their non-verbal arithmetic ability, over and above the influence of working memory and response inhibition. Two measures of dot enumeration ability were examined-inverse efficiency and paradigm specific (response time profiles) measures-to determine which has the better diagnostic utility as a marker of math competence. Seventy-eight 42-to-57 month-olds completed dot enumeration, working memory, response inhibition, and non-verbal addition and subtraction tasks. Dot enumeration efficiency predicted arithmetic ability over and above the influence of general cognitive functions. While dot enumeration efficiency was a better predictor of arithmetic ability than paradigm specific response time profiles; the response time profile displaying the smallest subitizing range and steepest subitizing slope, also displayed poor addition abilities, suggesting a weak subitizing profile may have diagnostic significance in preschoolers. Overall, the findings support the claim that dot enumeration abilities and general cognitive functions are markers of preschoolers' math ability.	[Gray, Sarah A.; Reeve, Robert A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	Reeve, RA (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	r.reeve@unimelb.edu.au		Gray, Sarah/0000-0002-2491-2368	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	SAG is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroody AJ, 2009, MATH THINK LEARN, V11, P41, DOI 10.1080/10986060802583956; Baroody AJ, 2009, EARLY EDUC DEV, V20, P80, DOI 10.1080/10409280802206619; Bartelet D, 2014, J EXP CHILD PSYCHOL, V117, P12, DOI 10.1016/j.jecp.2013.08.010; Benoit L, 2004, COGNITIVE DEV, V19, P291, DOI 10.1016/j.cogdev.2004.03.005; Bonny JW, 2013, J EXP CHILD PSYCHOL, V114, P375, DOI 10.1016/j.jecp.2012.09.015; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Bull R, 2011, DEVELOPMENTAL SCI, V14, P679, DOI 10.1111/j.1467-7687.2010.01012.x; Butterworth B., 2003, DYSCALCULIA SCREENER; Butterworth B, 2010, TRENDS COGN SCI, V14, P534, DOI 10.1016/j.tics.2010.09.007; Canobi KH, 2005, J EXP CHILD PSYCHOL, V92, P220, DOI 10.1016/j.jecp.2005.06.001; Carey S, 2001, MIND LANG, V16, P37, DOI 10.1111/1468-0017.00155; CHI MTH, 1975, J EXP CHILD PSYCHOL, V19, P434, DOI 10.1016/0022-0965(75)90072-7; Clark CAC, 2013, CHILD DEV, V84, P662, DOI 10.1111/j.1467-8624.2012.01854.x; Clements D., 1999, TEACHING CHILDREN MA, V5, P400; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; Desoete A, 2009, EDUC RES REV-NETH, V4, P55, DOI 10.1016/j.edurev.2008.11.003; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; Eigsti IM, 2006, PSYCHOL SCI, V17, P478, DOI 10.1111/j.1467-9280.2006.01732.x; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2003, DEVELOPMENTAL SCI, V6, P568, DOI 10.1111/1467-7687.00313; Fuchs LS, 2010, DEV PSYCHOL, V46, P1731, DOI 10.1037/a0020662; Fuchs LS, 2010, CHILD DEV, V81, P1520, DOI 10.1111/j.1467-8624.2010.01489.x; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Hunting R., 2003, J MATH BEHAV, V22, P217, DOI DOI 10.1016/S0732-3123(03)00021-X; HUTTENLOCHER J, 1994, J EXP PSYCHOL GEN, V123, P284, DOI 10.1037/0096-3445.123.3.284; Hyde DC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00150; Hyde DC, 2011, DEVELOPMENTAL SCI, V14, P360, DOI 10.1111/j.1467-7687.2010.00987.x; Iuculano T, 2008, DEVELOPMENTAL SCI, V11, P669, DOI 10.1111/j.1467-7687.2008.00716.x; Jordan NC, 2006, CHILD DEV, V77, P153, DOI 10.1111/j.1467-8624.2006.00862.x; Klein JS, 2000, CAN J EXP PSYCHOL, V54, P105, DOI 10.1037/h0087333; Koontz K. L., 1996, MATH COGNITION, V2, P1, DOI [10.1080/135467996387525, DOI 10.1080/135467996387525]; Kroesbergen EH, 2009, J PSYCHOEDUC ASSESS, V27, P226, DOI 10.1177/0734282908330586; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00459; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; LEVINE SC, 1992, J EXP CHILD PSYCHOL, V53, P72, DOI 10.1016/S0022-0965(05)80005-0; Libertus ME, 2013, J EXP CHILD PSYCHOL, V116, P829, DOI 10.1016/j.jecp.2013.08.003; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lonnemann J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00783; Magidson J., 2003, DMA RES COUNCIL J; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; McAuley T, 2011, J EXP CHILD PSYCHOL, V108, P453, DOI 10.1016/j.jecp.2010.08.009; Melcher D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029296; Ostergren R, 2013, J EXP CHILD PSYCHOL, V115, P405, DOI 10.1016/j.jecp.2013.03.007; Penner-Wilger M., 2007, P 29 ANN C COGNITIVE, P1385; Piazza M, 2011, COGNITION, V121, P147, DOI 10.1016/j.cognition.2011.05.007; Purpura DJ, 2013, AM EDUC RES J, V50, P178, DOI 10.3102/0002831212465332; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; Reeve R, 2012, J EXP PSYCHOL GEN, V141, P649, DOI 10.1037/a0027520; Reigosa-Crespo V, 2012, DEV PSYCHOL, V48, P123, DOI 10.1037/a0025356; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; Schleifer P, 2011, DEVELOPMENTAL SCI, V14, P280, DOI 10.1111/j.1467-7687.2010.00976.x; Shimomura T, 2011, ATTEN PERCEPT PSYCHO, V73, P1694, DOI 10.3758/s13414-011-0135-5; Shinskey JL, 2009, J EXP CHILD PSYCHOL, V103, P409, DOI 10.1016/j.jecp.2009.01.012; SILVERMAN IW, 1980, DEV PSYCHOL, V16, P539, DOI 10.1037/0012-1649.16.5.539; Simpson A, 2006, J EXP CHILD PSYCHOL, V94, P18, DOI 10.1016/j.jecp.2005.10.003; STARKEY P, 1995, BRIT J DEV PSYCHOL, V13, P399, DOI 10.1111/j.2044-835X.1995.tb00688.x; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Traff U, 2013, J EXP CHILD PSYCHOL, V116, P139, DOI 10.1016/j.jecp.2013.04.007; Trezise K, 2014, J EXP CHILD PSYCHOL, V121, P120, DOI 10.1016/j.jecp.2013.12.001; Trick LM, 2003, MEM COGNITION, V31, P1229, DOI 10.3758/BF03195806; Tuholski SW, 2001, MEM COGNITION, V29, P484, DOI 10.3758/BF03196399; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Vermunt J., 2016, TECHNICAL GUIDE LATE; Vermunt J.K., 2005, LATENT GOLD 40 USERS; von Aster MG, 2007, DEV MED CHILD NEUROL, V49, P868, DOI 10.1111/j.1469-8749.2007.00868.x; Wiebe SA, 2012, CHILD DEV, V83, P1245, DOI 10.1111/j.1467-8624.2012.01765.x; Wiebe SA, 2011, J EXP CHILD PSYCHOL, V108, P436, DOI 10.1016/j.jecp.2010.08.008; Wutz A, 2013, ATTEN PERCEPT PSYCHO, V75, P921, DOI 10.3758/s13414-013-0454-9; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P	78	29	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94428	10.1371/journal.pone.0094428	http://dx.doi.org/10.1371/journal.pone.0094428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714052	Green Published, gold			2022-12-27	WOS:000334160900131
J	Pappalardo, P; Rodriguez-Serrano, E; Fernandez, M				Pappalardo, Paula; Rodriguez-Serrano, Enrique; Fernandez, Miriam			Correlated Evolution between Mode of Larval Development and Habitat in Muricid Gastropods	PLOS ONE			English	Article							PROSOBRANCH EGG CAPSULES; REPRODUCTIVE STRATEGIES; SPECIES RICHNESS; LIFE-HISTORY; MARINE; PATTERNS; PHYLOGENY; DISPERSAL; ECOLOGY; SIZE	Larval modes of development affect evolutionary processes and influence the distribution of marine invertebrates in the ocean. The decrease in pelagic development toward higher latitudes is one of the patterns of distribution most frequently discussed in marine organisms (Thorson's rule), which has been related to increased larval mortality associated with long pelagic durations in colder waters. However, the type of substrate occupied by adults has been suggested to influence the generality of the latitudinal patterns in larval development. To help understand how the environment affects the evolution of larval types we evaluated the association between larval development and habitat using gastropods of the Muricidae family as a model group. To achieve this goal, we collected information on latitudinal distribution, sea water temperature, larval development and type of substrate occupied by adults. We constructed a molecular phylogeny for 45 species of muricids to estimate the ancestral character states and to assess the relationship between traits using comparative methods in a Bayesian framework. Our results showed high probability for a common ancestor of the muricids with nonpelagic (and nonfeeding) development, that lived in hard bottoms and cold temperatures. From this ancestor, a pelagic feeding larva evolved three times, and some species shifted to warmer temperatures or sand bottoms. The evolution of larval development was not independent of habitat; the most probable evolutionary route reconstructed in the analysis of correlated evolution showed that type of larval development may change in soft bottoms but in hard bottoms this change is highly unlikely. Lower sea water temperatures were associated with nonpelagic modes of development, supporting Thorson's rule. We show how environmental pressures can favor a particular mode of larval development or transitions between larval modes and discuss the reacquisition of feeding larva in muricids gastropods.	[Pappalardo, Paula] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Rodriguez-Serrano, Enrique] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Concepcion, Chile; [Pappalardo, Paula; Fernandez, Miriam] Pontificia Univ Catolica Chile, Ctr Conservac Marina, Dept Ecol, Santiago, Chile	University System of Georgia; University of Georgia; Universidad de Concepcion; Pontificia Universidad Catolica de Chile	Pappalardo, P (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	paulapappalardo@gmail.com	Pappalardo, Paula/AFK-4906-2022	Pappalardo, Paula/0000-0003-0853-7681; Rodriguez-Serrano, Enrique/0000-0002-5049-8500	Fondecyt [1100592]; ICM [P10-033F]; CONICYT scholarship; LERNER GRAY fund for marine research; FIC of Ministerio de Economia, Fomento y Turismo of Chile;  [DIUC-213.113.085-1 AP]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM; CONICYT scholarship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); LERNER GRAY fund for marine research; FIC of Ministerio de Economia, Fomento y Turismo of Chile; 	This study was supported by Fondecyt 1100592 (http://www.conicyt.cl/fondecyt/) and the ICM P10-033F, developed with funds FIC of Ministerio de Economia, Fomento y Turismo of Chile granted to the Center for Marine Conservation (http://www.conservacionmarinauc.cl/). P. Pappalardo was supported through a CONICYT (http://www.conicyt.cl/) scholarship and also thanks a LERNER GRAY fund for marine research. E. Rodriguez-Serrano thanks grant DIUC-213.113.085-1 AP (http://www.udec.cl/vrid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco A, 2010, MOL PHYLOGENET EVOL, V56, P1025, DOI 10.1016/j.ympev.2010.03.008; CASWELL H, 1981, AM NAT, V117, P529, DOI 10.1086/283733; CHAMBERS RJ, 1994, J MOLLUS STUD, V60, P415, DOI 10.1093/mollus/60.4.415; Chaparro OR, 2002, BIOL BULL, V203, P80, DOI 10.2307/1543460; CHRISTIANSEN FB, 1979, THEOR POPUL BIOL, V16, P267, DOI 10.1016/0040-5809(79)90017-0; Claremont M, 2008, J MOLLUS STUD, V74, P215, DOI 10.1093/mollus/eyn005; CLARK KB, 1978, J MOLLUS STUD, V44, P283; Collin R, 2004, EVOLUTION, V58, P1488; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; Collin R, 2007, BIOL BULL-US, V212, P83, DOI 10.2307/25066586; Cunha RL, 2005, SYST BIOL, V54, P634, DOI 10.1080/106351591007471; Cunningham CW, 1999, SYST BIOL, V48, P665, DOI 10.1080/106351599260238; DAsaro CN, 1997, OPHELIA, V46, P83, DOI 10.1080/00785326.1997.10432578; DASARO CN, 1991, OPHELIA, V35, P1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez M, 2009, ECOL LETT, V12, P601, DOI 10.1111/j.1461-0248.2009.01315.x; Fortunato H, 2004, INVERTEBR REPROD DEV, V46, P139, DOI 10.1080/07924259.2004.9652617; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gallardo Carlos S., 1994, Gayana Zoologia, V58, P79; Gallardo CS, 2001, MAR BIOL, V138, P547, DOI 10.1007/s002270000477; Grantham BA, 2003, ECOL APPL, V13, pS108; HANSEN TA, 1983, SCIENCE, V220, P501, DOI 10.1126/science.220.4596.501; HANSEN TA, 1980, PALEOBIOLOGY, V6, P193, DOI 10.1017/S0094837300006758; Hart M, 2000, SEMIN CELL DEV BIOL, V11, P411, DOI 10.1006/scdb.2000.0194; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; Jeffery CH, 2003, MOL PHYLOGENET EVOL, V28, P99, DOI 10.1016/S1055-7903(03)00030-7; Leiva GE, 1998, REV CHIL HIST NAT, V71, P157; Levin L.A., 1995, ECOLOGY MARINE INVER, P464; LEVIN LA, 1984, ECOLOGY, V65, P1185, DOI 10.2307/1938326; Maddison WP, 2009, MESQUITE MODULAR SYS; Marshall DJ, 2012, ANNU REV ECOL EVOL S, V43, P97, DOI 10.1146/annurev-ecolsys-102710-145004; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Moran AL, 1999, BIOL BULL, V196, P229, DOI 10.2307/1542948; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M., 2007, BAYESTRAITS VERSION; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pagel Mark, 2002, VVolume 64, P269; Pappalardo P, 2014, GLOBAL ECOL BIOGEOGR, V23, P12, DOI 10.1111/geb.12115; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Pringle JM, 2013, ECOLOGY IN PRESS; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 5; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; SHUTO T, 1974, LETHAIA, V7, P239, DOI 10.1111/j.1502-3931.1974.tb00899.x; SPIGHT T M, 1977, Nautilus, V91, P67; SPIGHT TM, 1976, BIOL BULL, V150, P491, DOI 10.2307/1540687; STOCKMANNBOSBACH R, 1989, MAR BIOL, V102, P283, DOI 10.1007/BF00428479; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Tamura K, 2011, MOL BIOL EVOLUTION; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; VANCE RR, 1973, AM NAT, V107, P353, DOI 10.1086/282839; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P19, DOI 10.1666/0094-8373(2000)026<0019:TMGSRP>2.0.CO;2; Zou SM, 2011, MOL PHYLOGENET EVOL, V61, P425, DOI 10.1016/j.ympev.2011.07.014	61	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94104	10.1371/journal.pone.0094104	http://dx.doi.org/10.1371/journal.pone.0094104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714732	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900084
J	Song, Y; Bian, Y; Petzold, M; Ung, COL				Song, Yan; Bian, Ying; Petzold, Max; Ung, Carolina Oi Lam			Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; B-VIRUS; RESIDUAL RISK; VACCINATION; IMPACT; HIV	Background: The prevalence of transfusion-transmissible infections (TTIs) in blood donations is important for evaluating blood safety and potential risks to the population. This study investigated the prevalence of TTIs among blood donors in Western China and suggested measures for policy-makers. Methods: The screening results of 66,311 donations between 2005 and 2010 from a central blood center in Western China were analyzed. The prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and syphilis infections were expressed in percentages for the entire study group as well as groups by demographic characteristics and donation frequency, with differences analyzed using Fisher's exact or Chi-square test. Logistic regression was performed to identify the influencing factors of the detected results. Results: 1,769 (2.67%, 95% Cl 2.55-2.79%) of the donated blood had serological evidence of infection with at least one pathogen and 44 (0.07%, 95% Cl 0.05-0.09%) showed evidence of multiple infections. The seroprevalence of HBV, HCV, HIV, and syphilis infections was 0.87% (95% Cl 0.80-0.94%), 0.86% (95% Cl 0.79-0.93%), 0.31% (95% Cl 0.26-0.35%), and 0.70% (95% Cl 0.64-0.76%) respectively. Trend analysis for the prevalence of TTIs showed a significant increase from 2.44% to 3.71% (chi(2) = 100.72, p = 0.00) over this 6-year period. The positive rates for TTIs varied along demographic lines. The top three risk factors in test-positive donors were identified as age, education level and donation frequency. The older age group and lower educated group were linked to a higher prevalence of TTIs. A decreasing prevalence was associated with an increasing frequency of blood donations (chi(2) = 562.78, p = 0.00). Conclusions: Hepatitis B and C were found most, and often in conjunction with syphilis. These were the primary threats to blood safety. The high positivity rate and the increasing prevalence of TTIs among blood donors in Western China call for further actions.	[Song, Yan; Bian, Ying; Ung, Carolina Oi Lam] Univ Macau, Inst Chinese Med Sci, Taipa, Macau, Peoples R China; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden	University of Macau; University of Gothenburg	Bian, Y (corresponding author), Univ Macau, Inst Chinese Med Sci, Taipa, Macau, Peoples R China.	bianying@umac.mo	Ung, Carolina Oi Lam/AAR-2672-2020; bian, ying/ABI-8040-2020	bian, ying/0000-0002-1716-2925; Ung, Carolina Oi Lam/0000-0003-1915-5099				Adams V, 2009, SOC SCI MED, V68, P410, DOI 10.1016/j.socscimed.2008.11.006; Ameen R, 2005, TRANSFUSION, V45, P1973, DOI 10.1111/j.1537-2995.2005.00635.x; Chiavetta JA, 2003, CAN MED ASSOC J, V169, P767; China MoH WHO UNAIDS, 2006, 2005 UPD HIV AIDS EP; ChinaWindow, 2013, W REG DEV; Christensen PB, 1999, TRANSFUSION, V39, P188, DOI 10.1046/j.1537-2995.1999.39299154734.x; Dong RL, 2011, BIOMED ENVIRON SCI, V24, P207, DOI 10.3967/0895-3988.2011.03.001; Erwin K, 2006, MED ANTHROPOL Q, V20, P139, DOI 10.1525/maq.2006.20.2.139; Gao XF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-88; Guo XC, 1999, BIOMED ENVIRON SCI, V12, P227; Kafi-Abad SA, 2009, TRANSFUSION, V49, P2214, DOI 10.1111/j.1537-2995.2009.02245.x; Kim MJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-160; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Mathai Jaisy, 2002, Indian J Pathol Microbiol, V45, P319; National Bureau of Statistics of China, 2012, REP NAT POP CENS; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Soldan K, 2005, Euro Surveill, V10, P9, DOI 10.2807/esm.10.02.00520-en; Soldan K, 2003, VOX SANG, V84, P274, DOI 10.1046/j.1423-0410.2003.00296.x; Wang DeWen, 2008, China Tropical Medicine, V8, P822; WHO, 2009, 100 VOL NONR DON BLO; World Health Organization, 2009, SCREEN DON BLOOD TRA; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Zou SM, 2004, TRANSFUSION, V44, P1640, DOI 10.1111/j.0041-1132.2004.04153.x; 文国新, 2010, [中国输血杂志, Chinese Journal of Blood Transfusion], V23, P937	30	30	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94528	10.1371/journal.pone.0094528	http://dx.doi.org/10.1371/journal.pone.0094528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714490	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900138
J	Blackledge, MD; Collins, DJ; Tunariu, N; Orton, MR; Padhani, AR; Leach, MO; Koh, DM				Blackledge, Matthew D.; Collins, David J.; Tunariu, Nina; Orton, Matthew R.; Padhani, Anwar R.; Leach, Martin O.; Koh, Dow-Mu			Assessment of Treatment Response by Total Tumor Volume and Global Apparent Diffusion Coefficient Using Diffusion-Weighted MRI in Patients with Metastatic Bone Disease: A Feasibility Study	PLOS ONE			English	Article							PROSTATE-CANCER	We describe our semi-automatic segmentation of whole-body diffusion-weighted MRI (WBDWI) using a Markov random field (MRF) model to derive tumor total diffusion volume (tDV) and associated global apparent diffusion coefficient (gADC); and demonstrate the feasibility of using these indices for assessing tumor burden and response to treatment in patients with bone metastases. WBDWI was performed on eleven patients diagnosed with bone metastases from breast and prostate cancers before and after anti-cancer therapies. Semi-automatic segmentation incorporating a MRF model was performed in all patients below the C4 vertebra by an experienced radiologist with over eight years of clinical experience in body DWI. Changes in tDV and gADC distributions were compared with overall response determined by all imaging, tumor markers and clinical findings at serial follow up. The segmentation technique was possible in all patients although erroneous volumes of interest were generated in one patient because of poor fat suppression in the pelvis, requiring manual correction. Responding patients showed a larger increase in gADC (median change = +0.18, range = -0.07 to +0.78x10(-3) mm(2/s)) after treatment compared to non-responding patients (median change = -0.02, range = -0.10 to +0.05x10(-3) mm (2/s), p = 0.05, Mann-Whitney test), whereas non-responding patients showed a significantly larger increase in tDV (median change = +26%, range = +3 to +284%) compared to responding patients (median change = -50%, range = -85 to +27%, p = 0.02, Mann-Whitney test). Semi-automatic segmentation of WBDWI is feasible for metastatic bone disease in this pilot cohort of 11 patients, and could be used to quantify tumor total diffusion volume and median global ADC for assessing response to treatment.	[Blackledge, Matthew D.; Collins, David J.; Tunariu, Nina; Orton, Matthew R.; Leach, Martin O.; Koh, Dow-Mu] Canc Res UK, Radiotherapy & Imaging Div, Sutton, Surrey, England; [Blackledge, Matthew D.; Collins, David J.; Tunariu, Nina; Orton, Matthew R.; Leach, Martin O.; Koh, Dow-Mu] Engn & Phys Sci Res Council Canc Imaging Ctr, Inst Canc Res, Sutton, Surrey, England; [Blackledge, Matthew D.; Collins, David J.; Tunariu, Nina; Orton, Matthew R.; Leach, Martin O.; Koh, Dow-Mu] Royal Marsden Natl Hlth Serv Fdn, Sutton, Surrey, England; [Padhani, Anwar R.] Mt Vernon Canc Ctr, Paul Strickland Scanner Ctr, Northwood, Middx, England	Cancer Research UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Mount Vernon Cancer Centre	Leach, MO (corresponding author), Canc Res UK, Radiotherapy & Imaging Div, Sutton, Surrey, England.	Martin.Leach@icr.ac.uk	leach, martin o/C-2248-2008	leach, martin o/0000-0002-0756-5368; Collins, David/0000-0001-8281-1496; Padhani, Anwar/0000-0002-5830-5777; Koh, Dow-Mu/0000-0001-7654-8011; Blackledge, Matthew/0000-0001-8117-9003	CRUK; EPSRC Cancer Imaging Centre; MRC; Department of Health (England) grant [C10060/A10334]; NHS; EPSRC Platform Grant [EP/H046526/1]; NIHR [NHR011X]; National Institute for Health Research (NIHR); EPSRC [EP/H046526/1] Funding Source: UKRI; Cancer Research UK [16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046526/1] Funding Source: researchfish; National Institute for Health Research [PDF-2012-05-441, NF-SI-0512-10162] Funding Source: researchfish	CRUK(Cancer Research UK); EPSRC Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England) grant; NHS; EPSRC Platform Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the support received from the CRUK and EPSRC Cancer Imaging Centre in association with the MRC and Department of Health (England) grant C10060/A10334, NHS funding to the NIHR Biomedical Research Centre and the NIHR Clinical Research Facility. Support was also received from EPSRC Platform Grant EP/H046526/1 and NIHR postdoctoral fellowship NHR011X. MOL is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Ballon D, 2000, NMR BIOMED, V13, P321, DOI 10.1002/1099-1492(200010)13:6<321::AID-NBM651>3.0.CO;2-P; Blackledge MD, 2011, RADIOLOGY, V261, P573, DOI 10.1148/radiol.11101919; Blackledge MD, 2012, P INT SOC MAGN RES M, P255; Collins DJ, 2010, DIFFUSION WEIGHTED M; Gutzeit A, 2010, SKELETAL RADIOL, V39, P333, DOI 10.1007/s00256-009-0789-4; Heusner TA, 2011, BRIT J RADIOL, V84, P126, DOI 10.1259/bjr/93330765; Komori T, 2007, ANN NUCL MED, V21, P209, DOI 10.1007/s12149-007-0010-6; Nakanishi Katsuyuki, 2007, Magn Reson Med Sci, V6, P147, DOI 10.2463/mrms.6.147; Ohno Y, 2008, RADIOLOGY, V248, P643, DOI 10.1148/radiol.2482072039; Perez-Lopez R, 2014, P INT SOC MAGN RES M; Reischauer C, 2010, RADIOLOGY, V257, P523, DOI 10.1148/radiol.10092469; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Takahara Taro, 2004, Radiat Med, V22, P275; Thoeny HC, 2005, RADIOLOGY, V234, P756, DOI 10.1148/radiol.2343031721; Vezhnevets V., 2005, P GRAPH, V1, P150, DOI DOI 10.1016/J.AJ0D0.2004.07.036	16	81	84	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e91779	10.1371/journal.pone.0091779	http://dx.doi.org/10.1371/journal.pone.0091779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710083	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800010
J	Geng, Q; Zhang, T; Ding, YF; Tao, YZ; Lin, YZ; Wang, YZ; Black, S; Zhao, GM				Geng, Qian; Zhang, Tao; Ding, Yunfang; Tao, Yunzhen; Lin, Yuzun; Wang, Yunzhong; Black, Steven; Zhao, Genming			Molecular Characterization and Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Children Hospitalized with Respiratory Infections in Suzhou, China	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; MACROLIDE RESISTANCE MECHANISMS; SEROTYPE DISTRIBUTION; PEDIATRIC-PATIENTS; ANTIBIOTIC-RESISTANCE; INVASIVE DISEASE; CHANGING TRENDS; PCR; 19A; EPIDEMIOLOGY	Background: Dissemination of antibiotic resistant clones is recognized as an important factor in the emergence and prevalence of resistance in pneumococcus. This study was undertaken to survey the antimicrobial susceptibility and serotypes distribution of pneumococci and to explore the circulating clones in hospitalized children in Suzhou, China. Methods: The pneumococci were isolated from the nasopharyngeal aspirates of children less than 5 years of age admitted to Soochow-University-Affiliated-Children's-Hospital with respiratory infections. The capsular serotypes were identified by multiplex polymerase chain reaction (PCR). Antimicrobial susceptibility was tested by E-test. The presence of ermB, mefA/E genes were detected by PCR and the genotypes were explored by Multilocus sequence typing (MLST). Results: From July 2012 to July 2013, a total of 175 pneumococcal isolates were collected and all strains were resistant to erythromycin and clindamycin, about 39.4% strains were non-susceptible to penicillin G. Overall, 174 (99.4%) isolates were resistant to >= 3 types of antibiotics. Serotypes 19F (28.1%), 6B (19.7%), 19A (18.0%), and 23F (17.4%) were the most common serotypes in all identified strains. The serotypes coverage of PCV7 and PCV13 were 71.9% and 89.9%, respectively. Four international antibiotic-resistant clones, including Taiwan(19F)-14(n=79), Spain(23F)-1(n=25), Taiwan(23F)-15(n=7) and Spain(6B)-2(n=7), were identified. The Taiwan(19F)-14 clones have a higher non-susceptibility rate in beta-lactams than other clones and non-clone isolates (p < 0.001). In addition, 98.7% Taiwan(19F)-14 clones were positive of both ermB and mefA/E genes, compare to 33.3% in other clones and non-clone strains. Conclusions: The spread of international antibiotic-resistant clones, especially Taiwan(19F)-14 clones, played a predominant role in the dissemination of antimicrobial resistant isolates in Suzhou, China. Considering the high prevalence of PCV7 serotypes and serotype 19A, the introduction of PCV13 may be a promising preventive strategy to control the increasing trend of clonal spread in China.	[Geng, Qian; Zhang, Tao; Lin, Yuzun; Zhao, Genming] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [Ding, Yunfang; Tao, Yunzhen; Wang, Yunzhong] Soochow Univ, Affiliated Childrens Hosp, Suzhou, Peoples R China; [Black, Steven] Cincinnati Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA	Fudan University; Soochow University - China; Cincinnati Children's Hospital Medical Center	Zhang, T (corresponding author), Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China.	tzhang@shmu.edu.cn			National Natural Science Foundation of China [81102166]; SINO-US collaborative program on Emerging and Re-emerging Infectious Diseases [5U2GGH000018]; Shanghai Leading Public Health Discipline Project [12GWZX0101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SINO-US collaborative program on Emerging and Re-emerging Infectious Diseases; Shanghai Leading Public Health Discipline Project	This work was funded by National Natural Science Foundation of China (81102166), SINO-US collaborative program on Emerging and Re-emerging Infectious Diseases (5U2GGH000018) and Shanghai Leading Public Health Discipline Project (12GWZX0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Chen R, 2010, J TROP PEDIATRICS, V56, P204, DOI 10.1093/tropej/fmp078; CLSI, 2011, M100S20 CLSI, P172; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Farrell DJ, 2002, J ANTIMICROB CHEMOTH, V50, P39, DOI 10.1093/jac/dkf806; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hsieh YC, 2013, J INFECT DIS, V208, P203, DOI 10.1093/infdis/jit145; Jones RN, 2013, DIAGN MICR INFEC DIS, V75, P107, DOI 10.1016/j.diagmicrobio.2012.08.024; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Ladhani SN, 2013, CLIN INFECT DIS, V56, P633, DOI 10.1093/cid/cis934; Lawrence ER, 2003, J CLIN MICROBIOL, V41, P601, DOI 10.1128/JCM.41.2.601-607.2003; Li CF, 2012, J MICROBIOL IMMUNOL, V45, P305, DOI 10.1016/j.jmii.2011.12.012; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067507; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Siira L, 2012, EUR J CLIN MICROBIOL, V31, P867, DOI 10.1007/s10096-011-1386-8; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Techasaensiri C, 2010, PEDIATR INFECT DIS J, V29, P294, DOI 10.1097/INF.0b013e3181c2a229; Tyrrell GJ, 2011, J INFECT DIS, V203, P1345, DOI 10.1093/infdis/jir056; WHO, 2007, WKLY EPIDEMIOL REC, V82, P93; Wierzbowski AK, 2007, J ANTIMICROB CHEMOTH, V60, P733, DOI 10.1093/jac/dkm273; Wierzbowski AK, 2013, J ANTIMICROB CHEMOTH; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yang F, 2008, INT J ANTIMICROB AG, V32, P386, DOI 10.1016/j.ijantimicag.2008.05.004; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; Zhang T, 2010, EPIDEMIOLOGY CHILDRE; Zhang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015885; Zhou L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-228; Zhou L, 2011, VACCINE, V29, P7704, DOI 10.1016/j.vaccine.2011.07.137	36	34	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93752	10.1371/journal.pone.0093752	http://dx.doi.org/10.1371/journal.pone.0093752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710108	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800048
J	Lin, CH; Kang, CJ; Tsao, CK; Wallace, CG; Lee, LY; Lin, CY; Wang, HM; Ng, SH; Yen, TC; Liao, CT				Lin, Chih-Hung; Kang, Chung-Jan; Tsao, Chung-Kan; Wallace, Christopher Glenn; Lee, Li-Yu; Lin, Chien-Yu; Wang, Hung-Ming; Ng, Shu-Hang; Yen, Tzu-Chen; Liao, Chun-Ta			Priority of Fibular Reconstruction in Patients with Oral Cavity Cancer Undergoing Segmental Mandibulectomy	PLOS ONE			English	Article							NECK LYMPH-NODES; BONE INVASION; CARCINOMA; RESECTION; DEFECTS; EXTENT	Background: The fibula osteoseptocutaneous free flap is generally used for segmental mandibular reconstructions following resection of oral cavity squamous cell carcinoma (OSCC). However, less complex reconstructions may be feasible for patients with predicted poor survival. Herein, we sought to identify the main risk factors (RFs) associated with poor prognosis in OSCC patients undergoing segmental mandibulectomy to help decide between fibular and non-fibular reconstructions. Methods: Between 1996 and 2011, we examined the 5-year control, distant metastases, and survival rates in 310 consecutive, previously untreated patients with primary OSCC who underwent segmental mandibulectomy. Results: Margin status was the only independent RF for 5-year local control. Level IV/V metastases, extracapsular spread, and tumor depth >= 15 mm were independent RFs for poor 5-year survival. In the entire study cohort, 23% of the patients had 2 or 3 adverse RFs; such a high-risk group was characterized by a poor prognosis and may be suitable for non-fibular reconstructions. Overall, 70% of the study patients were cT1-4N0, cT1N2, cT2N1, or had tumor depth <15 mm; less than 5% of patients in this subgroup had 2 or 3 adverse RFs and were thus candidates for fibular reconstructions. Among the remaining 30% of patients who showed both advanced clinical stage (cT2N2, cT3-4N1-2) and tumor depth >= 15 mm, 70% exhibited 2 or 3 adverse RFs. Conclusions: Level IV/V metastases, extracapsular spread, and tumor depth >15 mm were independent predictors of poor prognosis in OSCC patients undergoing segmental mandibulectomy. The preoperative or intraoperative identification of adverse RFs may help decide between fibular and non-fibular mandibular reconstruction. High-risk patients bearing 2 or 3 adverse RFs have poor prognosis and should not be considered as candidates for fibular reconstructions.	[Lin, Chih-Hung; Tsao, Chung-Kan; Wallace, Christopher Glenn] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Lin, Chih-Hung; Kang, Chung-Jan; Tsao, Chung-Kan; Wallace, Christopher Glenn; Lee, Li-Yu; Lin, Chien-Yu; Wang, Hung-Ming; Ng, Shu-Hang; Yen, Tzu-Chen; Liao, Chun-Ta] Chang Gung Univ, Taoyuan, Taiwan; [Lin, Chih-Hung; Kang, Chung-Jan; Tsao, Chung-Kan; Wallace, Christopher Glenn; Lee, Li-Yu; Lin, Chien-Yu; Wang, Hung-Ming; Ng, Shu-Hang; Yen, Tzu-Chen; Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Head & Neck, Oncol Grp, Taoyuan, Taiwan; [Kang, Chung-Jan; Wallace, Christopher Glenn; Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Lee, Li-Yu] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan; [Lin, Chien-Yu] Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Med Oncol, Taoyuan, Taiwan; [Ng, Shu-Hang] Chang Gung Mem Hosp, Dept Diagnost Radiol, Taoyuan, Taiwan; [Yen, Tzu-Chen] Chang Gung Mem Hosp, Nucl Med & Mol Imaging Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Liao, CT (corresponding author), Chang Gung Mem Hosp, Dept Head & Neck, Oncol Grp, Taoyuan, Taiwan.	liaoct@adm.cgmh.org.tw	Li-yu, Lee/G-5055-2010		Chang Gung Memorial Hospital [CMRPG1B0591]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grant no. CMRPG1B0591, Chang Gung Memorial Hospital. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1997, AJCC CANC STAGING MA; [Anonymous], 2010, TAIW CANC REG ANN RE; Edge SB, 2010, AJCC CANC STAGING MA; Guerra MFM, 2003, J ORAL MAXIL SURG, V61, P1289, DOI 10.1016/S0278-2391(03)00730-4; Johnson RE, 1997, HEAD NECK-J SCI SPEC, V19, P281, DOI 10.1002/(SICI)1097-0347(199707)19:4<281::AID-HED6>3.0.CO;2-X; Liao CT, 2006, CANCER, V107, P337, DOI 10.1002/cncr.21984; Liao CT, 2013, ORAL ONCOL, V49, P230, DOI 10.1016/j.oraloncology.2012.09.010; Liao CT, 2011, INT J RADIAT ONCOL, V81, P930, DOI 10.1016/j.ijrobp.2010.07.1988; Liao CT, 2011, J NUCL MED, V52, P180, DOI 10.2967/jnumed.110.082370; Liao CT, 2009, EUR J NUCL MED MOL I, V36, P1783, DOI 10.1007/s00259-009-1180-3; O'Brien CJ, 2003, INT J ORAL MAX SURG, V32, P492, DOI 10.1054/ijom.2003.0420; Patel RS, 2008, LARYNGOSCOPE, V118, P780, DOI 10.1097/MLG.0b013e31816422bb; Saber Tarek K, 2009, J Egypt Natl Canc Inst, V21, P219; Wei FC, 2002, PLAST RECONSTR SURG, V109, P45, DOI 10.1097/00006534-200201000-00008; Wei FC, 1999, PLAST RECONSTR SURG, V103, P39, DOI 10.1097/00006534-199901000-00008	15	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94315	10.1371/journal.pone.0094315	http://dx.doi.org/10.1371/journal.pone.0094315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722353	Green Submitted, gold, Green Published			2022-12-27	WOS:000336909100052
J	Sacre, K; Escoubet, B; Pasquet, B; Chauveheid, MP; Zennaro, MC; Tubach, F; Papo, T				Sacre, Karim; Escoubet, Brigitte; Pasquet, Blandine; Chauveheid, Marie-Paule; Zennaro, Maria-Christina; Tubach, Florence; Papo, Thomas			Increased Arterial Stiffness in Systemic Lupus Erythematosus (SLE) Patients at Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ACCELERATED ATHEROSCLEROSIS; WOMEN; CLASSIFICATION; CRITERIA	Cardiovascular disease (CVD) is a major cause of death in systemic lupus erythematosus (SLE) patients. Although the risk for cardiovascular events in patients with SLE is significant, the absolute number of events per year in any given cohort remains small. Thus, CVD risks stratification in patients with SLE focuses on surrogate markers for atherosclerosis at an early stage, such as reduced elasticity of arteries. Our study was designed to determine whether arterial stiffness is increased in SLE patients at low risk for CVD and analyze the role for traditional and non-traditional CVD risk factors on arterial stiffness in SLE. Carotid-femoral pulse wave velocity (PWV) was prospectively assessed as a measure of arterial stiffness in 41 SLE patients and 35 controls (CTL). Adjustment on age or Framingham score was performed using a logistic regression model. Factors associated with PWV were identified separately in SLE patients and in controls using Pearson's correlation coefficient for univariate analysis and multiple linear regression for multivariate analysis. SLE patients and controls displayed a low 10-year risk for CVD according to Framingham score (1.8 +/- 3.6% in SLE vs 1.6 +/- 2.8% in CTL, p = 0.46). Pulse wave velocity was, however, higher in SLE patients (7.1 +/- 1.6 m/s) as compared to controls (6.3 +/- 0.8 m/s; p = 0.01, after Framingham score adjustment) and correlated with internal carotid wall thickness (p = 0.0017). In multivariable analysis, only systolic blood pressure (p = 0.0005) and cumulative dose of glucocorticoids (p = 0.01) were associated with PWV in SLE patients. Interestingly, the link between systolic blood pressure (SBP) and arterial stiffness was also confirmed in SLE patients with normal systolic blood pressure. In conclusion, arterial stiffness is increased in SLE patients despite a low risk for CVD according to Framingham score and is associated with systolic blood pressure and glucocorticoid therapy.	[Sacre, Karim; Chauveheid, Marie-Paule; Papo, Thomas] Univ Paris Diderot, Hop Bichat, AP HP, Dept Med Interne,PRES Sorbonne Paris Cite, Paris, France; [Sacre, Karim; Papo, Thomas] INSERM, U1149, Paris, France; [Sacre, Karim; Papo, Thomas] Dept Hosp Univ FIRE Fibrosis Inflammat & Remodell, Paris, France; [Escoubet, Brigitte] Univ Paris Diderot, Hop Bichat, AP HP,PRES Sorbonne Paris Cite, Dept Physiol,INSERM,U1138, Paris, France; [Pasquet, Blandine; Tubach, Florence] Univ Paris Diderot, Hop Bichat, AP HP,PRES Sorbonne Paris Cite, Dept Epidemiol & Rech Clin,INSERM,CIE 801, Paris, France; [Zennaro, Maria-Christina] Univ Paris Diderot, Hop Europeen Georges Pompidou, AP HP,PRES Sorbonne Paris Cite, Dept Cardiol,INSERM,UMRS 970, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sacre, K (corresponding author), Univ Paris Diderot, Hop Bichat, AP HP, Dept Med Interne,PRES Sorbonne Paris Cite, Paris, France.	karim.sacre@bch.aphp.fr	Zennaro, Maria-Christina/G-2841-2013	Zennaro, Maria-Christina/0000-0001-5449-9191; Sacre, Karim/0000-0002-6544-234X				Aranow C, 2000, LUPUS, V9, P166, DOI 10.1191/096120300678828208; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Bjornadal L, 2004, J RHEUMATOL, V31, P713; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Cacciapaglia F, 2009, LUPUS, V18, P249, DOI 10.1177/0961203308097571; Chin CWL, 2013, CLIN EXP RHEUMATOL, V31, P295; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Doria A, 2003, ANN RHEUM DIS, V62, P1071, DOI 10.1136/ard.62.11.1071; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Goldberg RJ, 2009, J RHEUMATOL, V36, P2454, DOI 10.3899/jrheum.090011; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; HARRIS M, 1979, DIABETES, V28, P1039; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Karp I, 2008, ARTHRIT RHEUM-ARTHR, V59, P169, DOI 10.1002/art.23352; Kullo IJ, 2007, J AM COLL CARDIOL, V49, P1413, DOI 10.1016/j.jacc.2006.11.039; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Sabio JM, 2009, J RHEUMATOL, V36, P2204, DOI 10.3899/jrheum.081253; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Parker B, 2013, ANN RHEUM DIS, V72, P1308, DOI 10.1136/annrheumdis-2012-202106; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Rahman P, 2000, LUPUS, V9, P672, DOI 10.1191/096120300669204787; Roman MJ, 2005, HYPERTENSION, V46, P194, DOI 10.1161/01.HYP.0000168055.89955.db; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ruyssen-Witrand A, 2011, JOINT BONE SPINE, V78, P23, DOI 10.1016/j.jbspin.2010.02.040; Selzer F, 2001, HYPERTENSION, V37, P1075, DOI 10.1161/01.HYP.37.4.1075; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAQUET A, 1993, EUR J EPIDEMIOL, V9, P298, DOI 10.1007/BF00146267; Valero-Gonzalez S, 2014, SCAND J RHEUMATOL, V43, P54, DOI 10.3109/03009742.2013.803150; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D	32	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94511	10.1371/journal.pone.0094511	http://dx.doi.org/10.1371/journal.pone.0094511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722263	Green Published, gold			2022-12-27	WOS:000336909100087
J	Fiz, JA; Jane, R; Lozano, M; Gomez, R; Ruiz, J				Antonio Fiz, Jose; Jane, Raimon; Lozano, Manuel; Gomez, Rosa; Ruiz, Juan			Detecting Unilateral Phrenic Paralysis by Acoustic Respiratory Analysis	PLOS ONE			English	Article							NORMAL LUNG SOUNDS; DIAPHRAGMATIC PARALYSIS; BIOACOUSTIC METHOD; PULMONARY-FUNCTION; SLEEP-APNEA; FLOW; VISUALIZATION; WAKEFULNESS; VENTILATION; DYSFUNCTION	The consequences of phrenic nerve paralysis vary from a considerable reduction in respiratory function to an apparently normal state. Acoustic analysis of lung sound intensity (LSI) could be an indirect non-invasive measurement of respiratory muscle function, comparing activity on the two sides of the thoracic cage. Lung sounds and airflow were recorded in ten males with unilateral phrenic paralysis and ten healthy subjects (5 men/5 women), during progressive increasing airflow maneuvers. Subjects were in sitting position and two acoustic sensors were placed on their back, on the left and right sides. LSI was determined from 1.2 to 2.4 L/s between 70 and 2000 Hz. LSI was significantly greater on the normal (19.3 +/- 4.0 dB) than the affected (5.7 +/- 3.5 dB) side in all patients (p = 0.0002), differences ranging from 9.9 to 21.3 dB (13.5 +/- 3.5 dB). In the healthy subjects, the LSI was similar on both left (15.1 +/- 6.3 dB) and right (17.4 +/- 5.7 dB) sides (p = 0.2730), differences ranging from 0.4 to 4.6 dB (2.3 +/- 1.6 dB). There was a positive linear relationship between the LSI and the airflow, with clear differences between the slope of patients (about 5 dB/L/s) and healthy subjects (about 10 dB/L/s). Furthermore, the LSI from the affected side of patients was close to the background noise level, at low airflows. As the airflow increases, the LSI from the affected side did also increase, but never reached the levels seen in healthy subjects. Moreover, the difference in LSI between healthy and paralyzed sides was higher in patients with lower FEV1 (%). The acoustic analysis of LSI is a relevant non-invasive technique to assess respiratory function. This method could reinforce the reliability of the diagnosis of unilateral phrenic paralysis, as well as the monitoring of these patients.	[Antonio Fiz, Jose; Gomez, Rosa; Ruiz, Juan] Hosp Badalona Germans Trias & Pujol, Serv Pneumol, Badalona, Spain; [Antonio Fiz, Jose; Jane, Raimon; Lozano, Manuel] Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Antonio Fiz, Jose; Jane, Raimon] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Jane, Raimon] Univ Politecn Cataluna, Dept ESAII, Barcelona, Spain; [Lozano, Manuel] Germans Trias & Pujol Fdn IGTP, Hlth Sci Res Inst, Innovat Grp, Badalona, Spain	Hospital Germans Trias i Pujol; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP)	Jane, R (corresponding author), Inst Bioengn Catalonia IBEC, Barcelona, Spain.	rjane@ibecbarcelona.eu	García, Manuel Lozano/S-2482-2018	García, Manuel Lozano/0000-0002-4146-9839; Jane, Raimon/0000-0002-6541-8729	Spanish Ministry of Economy and Competitiveness [TEC2010-21703-C03-01]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was made possible thanks to a collaboration agreement, between IBEC and IGTP, to create a joint research Unit, and it was supported in part by the Spanish Ministry of Economy and Competitiveness under grant TEC2010-21703-C03-01. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaer H, 2011, J CLIN MONIT COMPUT, V25, P285, DOI 10.1007/s10877-011-9307-z; AMIS TC, 1980, CLIN SCI, V59, P485, DOI 10.1042/cs0590485; BALAJI S, 1990, BRIT HEART J, V64, P20; Boudarham J, 2013, CHEST, V144, P887, DOI 10.1378/chest.12-2317; BROCHARD L, 1989, AM REV RESPIR DIS, V139, P513, DOI 10.1164/ajrccm/139.2.513; Chetta A, 2005, RESP MED, V99, P39, DOI 10.1016/j.rmed.2004.04.016; Dellinger RP, 2008, RESPIRATION, V75, P60, DOI 10.1159/000103558; Dernaika TA, 2008, RESP CARE, V53, P351; DEVITA MA, 1993, CHEST, V103, P850, DOI 10.1378/chest.103.3.850; DiMarco AF, 2004, J APPL PHYSIOL, V96, P2120, DOI 10.1152/japplphysiol.00628.2003; EPSTEIN SW, 1979, CAN MED ASSOC J, V120, P1360; Fiz JA, 2008, CHEST, V133, P729, DOI 10.1378/chest.07-1102; Freilich S, 2011, THORAX, V66, P133, DOI 10.1136/thx.2010.145144; GAVRIELY N, 1994, EUR RESPIR J, V7, P35, DOI 10.1183/09031936.94.07010035; Gayan-Ramirez G, 2008, RESP MED, V102, P690, DOI 10.1016/j.rmed.2008.01.001; GHARAGOZLOO F, 1995, SURG ENDOSC-ULTRAS, V9, P1204; GIBSON GJ, 1989, THORAX, V44, P960, DOI 10.1136/thx.44.11.960; Golabbakhsh M, 2004, CAN C ELECT COMPUT E, V2, P751; Gross V, 2000, AM J RESP CRIT CARE, V162, P905, DOI 10.1164/ajrccm.162.3.9905104; Habib GS, 2012, J MED CASES, V3, P164; Hossain I, 2004, P ANN INT IEEE EMBS, V26, P3852; Hult P, 2000, MED ENG PHYS, V22, P425, DOI 10.1016/S1350-4533(00)00050-3; Kim SH, 2010, ANESTH ANALG, V110, P1349, DOI 10.1213/ANE.0b013e3181d5e4d8; Kompis M, 1997, P ANN INT IEEE EMBS, V19, P2047, DOI 10.1109/IEMBS.1997.758750; LISBOA C, 1986, AM REV RESPIR DIS, V134, P488; McCool FD, 2012, NEW ENGL J MED, V366, P932, DOI 10.1056/NEJMra1007236; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montazeri A, 2012, ANN BIOMED ENG, V40, P916, DOI 10.1007/s10439-011-0456-5; Morice RC, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-81; Oud M, 2000, IEEE T BIO-MED ENG, V47, P1450, DOI 10.1109/10.880096; Pasterkamp H, 1997, MED BIOL ENG COMPUT, V35, P103, DOI 10.1007/BF02534138; Pasterkamp H, 1997, AM J RESP CRIT CARE, V156, P974, DOI 10.1164/ajrccm.156.3.9701115; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; ROUSSOS CS, 1977, AM REV RESPIR DIS, V116, P457, DOI 10.1164/arrd.1977.116.3.457; Scillia P, 2004, J APPL PHYSIOL, V96, P96, DOI 10.1152/japplphysiol.00761.2003; SHYKOFF BE, 1988, AM REV RESPIR DIS, V137, P872, DOI 10.1164/ajrccm/137.4.872; Sokolowska B, 2003, JPN J PHYSIOL, V53, P301, DOI 10.2170/jjphysiol.53.301; Tejman-Yarden S, 2006, ANESTH ANALG, V103, P1489, DOI 10.1213/01.ane.0000240909.48774.49; Torres-Jimenez A, 2008, IEEE ENG MED BIO, P4797, DOI 10.1109/IEMBS.2008.4650286; Watson AC, 2001, CRIT CARE MED, V29, P1325, DOI 10.1097/00003246-200107000-00005; Xu WD, 2005, J NEUROSURG, V103, P464, DOI 10.3171/jns.2005.103.3.0464; Yadollahi A, 2013, ANN BIOMED ENG, V41, P537, DOI 10.1007/s10439-012-0692-3; Yi LC, 2011, ARCH BRONCONEUMOL, V47, P310, DOI 10.1016/j.arbres.2010.12.011	43	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93595	10.1371/journal.pone.0093595	http://dx.doi.org/10.1371/journal.pone.0093595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718599	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000036
J	Chinier, E; N'Guyen, S; Lignon, G; Ter Minassian, A; Richard, I; Dinomais, M				Chinier, Eva; N'Guyen, Sylvie; Lignon, Gregoire; Ter Minassian, Aram; Richard, Isabelle; Dinomais, Mickael			Effect of Motor Imagery in Children with Unilateral Cerebral Palsy: fMRI Study	PLOS ONE			English	Article							CONGENITAL HEMIPARESIS; BRAIN; SELECTION; MOVEMENT; NETWORK; LATERALIZATION; REORGANIZATION; NORMALIZATION; ACTIVATION; EXECUTION	Background: Motor imagery is considered as a promising therapeutic tool for rehabilitation of motor planning problems in patients with cerebral palsy. However motor planning problems may lead to poor motor imagery ability. Aim: The aim of this functional magnetic resonance imaging study was to examine and compare brain activation following motor imagery tasks in patients with hemiplegic cerebral palsy with left or right early brain lesions. We tested also the influence of the side of imagined hand movement. Method: Twenty patients with clinical hemiplegic cerebral palsy (sixteen males, mean age 12 years and 10 months, aged 6 years 10 months to 20 years 10 months) participated in this study. Using block design, brain activations following motor imagery of a simple opening-closing hand movement performed by either the paretic or nonparetic hand was examined. Results: During motor imagery tasks, patients with early right brain damages activated bilateral fronto-parietal network that comprise most of the nodes of the network well described in healthy subjects. Inversely, in patients with left early brain lesion brain activation following motor imagery tasks was reduced, compared to patients with right brain lesions. We found also a weak influence of the side of imagined hand movement. Conclusion: Decreased activations following motor imagery in patients with right unilateral cerebral palsy highlight the dominance of the left hemisphere during motor imagery tasks. This study gives neuronal substrate to propose motor imagery tasks in unilateral cerebral palsy rehabilitation at least for patients with right brain lesions.	[Chinier, Eva; N'Guyen, Sylvie; Ter Minassian, Aram; Dinomais, Mickael] LUNAM, Nantes, France; [Chinier, Eva; N'Guyen, Sylvie; Ter Minassian, Aram; Dinomais, Mickael] Univ Angers, Lab Ingn Syst Automatise, Nantes, France; [Chinier, Eva; Richard, Isabelle; Dinomais, Mickael] Univ Angers, LUNAM, Dept Med Phys & Readaptat, Nantes, France; [N'Guyen, Sylvie] Univ Angers, LUNAM, CHU Angers, Dept Neuropediat, Nantes, France; [Lignon, Gregoire] Univ Angers, LUNAM, CHU Angers, Pole Imagerie, Nantes, France; [Ter Minassian, Aram] Univ Angers, LUNAM, CHU Angers, Pole Anesthesie Reanimat, Nantes, France	Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Chinier, E (corresponding author), LUNAM, Nantes, France.	eva.chinier@hotmail.fr			university hospital of Angers; Societe Francaise de Medecine Physique et Readaptation (SOFMER); Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance (SFERHE)	university hospital of Angers; Societe Francaise de Medecine Physique et Readaptation (SOFMER); Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance (SFERHE)	The research was supported by the university hospital of Angers, the Societe Francaise de Medecine Physique et Readaptation (SOFMER) and the Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance (SFERHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Craje C, 2010, RES DEV DISABIL, V31, P1039, DOI 10.1016/j.ridd.2010.04.007; Craje C, 2009, BRAIN RES, V1261, P54, DOI 10.1016/j.brainres.2008.12.074; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dinomais M, 2013, RES DEV DISABIL, V34, P3487, DOI 10.1016/j.ridd.2013.07.008; Dinomais M, 2013, RES DEV DISABIL, V34, P1928, DOI 10.1016/j.ridd.2013.03.020; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; HEIL M, 1993, J EXP PSYCHOL HUMAN, V19, P1313, DOI 10.1037/0096-1523.19.6.1313; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Holmes P, 2008, J MOTOR BEHAV, V40, P433, DOI 10.3200/JMBR.40.5.433-445; Houwink A, 2011, RES DEV DISABIL, V32, P2157, DOI 10.1016/j.ridd.2011.07.012; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Janssen L, 2011, RES DEV DISABIL, V32, P963, DOI 10.1016/j.ridd.2011.02.002; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Johnson SH, 2002, J COGNITIVE NEUROSCI, V14, P841, DOI 10.1162/089892902760191072; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Lebon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037850; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P1317, DOI 10.1016/S0028-3932(99)00016-0; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mutsaarts M, 2007, NEUROPSYCHOLOGIA, V45, P853, DOI 10.1016/j.neuropsychologia.2006.08.020; Mutsaarts M, 2006, EXP BRAIN RES, V172, P151, DOI 10.1007/s00221-005-0327-0; Sabate M, 2004, NEUROPSYCHOLOGIA, V42, P1041, DOI 10.1016/j.neuropsychologia.2003.12.015; Saito K, 2013, EXP BRAIN RES, V227, P333, DOI 10.1007/s00221-013-3513-5; Sakzewski L, 2009, PEDIATRICS, V123, pE1111, DOI 10.1542/peds.2008-3335; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Sharma N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00564; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; SIRIGU A, 1995, NEUROREPORT, V6, P997, DOI 10.1097/00001756-199505090-00012; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Staudt M, 2004, ANN NEUROL, V56, P854, DOI 10.1002/ana.20297; Staudt M, 2002, BRAIN, V125, P2222, DOI 10.1093/brain/awf227; Steenbergen B, 2004, COGNITIVE BRAIN RES, V19, P145, DOI 10.1016/j.cogbrainres.2003.11.008; Steenbergen B, 2007, NEUROPSYCHOLOGIA, V45, P3324, DOI 10.1016/j.neuropsychologia.2007.07.002; Steenbergen B, 2007, DISABIL REHABIL, V29, P13, DOI 10.1080/09638280600947591; Steenbergen B, 2009, DEV MED CHILD NEUROL, V51, P690, DOI 10.1111/j.1469-8749.2009.03371.x; Steenbergen B, 2006, DEV MED CHILD NEUROL, V48, P780, DOI 10.1017/S0012162206001666; Stinear CM, 2007, CLIN NEUROPHYSIOL, V118, P1794, DOI 10.1016/j.clinph.2007.05.008; van Elk M, 2010, BRAIN RES, V1349, P56, DOI 10.1016/j.brainres.2010.06.055; Williams J, 2011, RES DEV DISABIL, V32, P740, DOI 10.1016/j.ridd.2010.11.006; Zimmermann-Schlatter A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-8	53	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93378	10.1371/journal.pone.0093378	http://dx.doi.org/10.1371/journal.pone.0093378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718311	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000029
J	Shannon, G; Cordes, LS; Hardy, AR; Angeloni, LM; Crooks, KR				Shannon, Graeme; Cordes, Line S.; Hardy, Amanda R.; Angeloni, Lisa M.; Crooks, Kevin R.			Behavioral Responses Associated with a Human-Mediated Predator Shelter	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; GROUP-SIZE; TEMPORAL VARIATION; PREY INTERACTIONS; HUMAN DISTURBANCE; TROPHIC CASCADE; GRIZZLY BEARS; RISK; WOLVES; ELK	Human activities in protected areas can affect wildlife populations in a similar manner to predation risk, causing increases in movement and vigilance, shifts in habitat use and changes in group size. Nevertheless, recent evidence indicates that in certain situations ungulate species may actually utilize areas associated with higher levels of human presence as a potential refuge from disturbance-sensitive predators. We now use four-years of behavioral activity budget data collected from pronghorn 9Antilocapra americana) and elk (Cervus elephus) in Grand Teton National Park, USA to test whether predictable patterns of human presence can provide a shelter from predatory risk. Daily behavioral scans were conducted along two parallel sections of road that differed in traffic volume - with the main Teton Park Road experiencing vehicle use that was approximately thirty-fold greater than the River Road. At the busier Teton Park Road, both species of ungulate engaged in higher levels of feeding 927% increase in the proportion of pronghorn feeding and 21% increase for elk), lower levels of alert behavior 918% decrease for pronghorn and 9% decrease for elk) and formed smaller groups. These responses are commonly associated with reduced predatory threat. Pronghorn also exhibited a 30% increase in the proportion of individuals moving at the River Road as would be expected under greater exposure to predation risk. Our findings concur with the 'predator shelter hypothesis', suggesting that ungulates in GTNP use human presence as a potential refuge from predation risk, adjusting their behavior accordingly. Human activity has the potential to alter predator-prey interactions and drive trophic-mediated effects that could ultimately impact ecosystem function and biodiversity.	[Shannon, Graeme; Cordes, Line S.; Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hardy, Amanda R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Angeloni, Lisa M.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Shannon, G (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	graeme.shannon@colostate.edu	Shannon, Graeme/A-5790-2011	Shannon, Graeme/0000-0002-5039-4904	Federal Highway Administration	Federal Highway Administration	The National Park Service funded this study through a grant from the Federal Highway Administration, administered by the Cooperative Ecosystems Study Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni L, 2008, ANIM BEHAV, V75, P731, DOI 10.1016/j.anbehav.2007.08.007; [Anonymous], 1990, URSUS; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Brown CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040505; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Frid A, 2002, CONSERV ECOL, V6; Gavin SD, 2006, CAN J ZOOL, V84, P1775, DOI 10.1139/Z06-175; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Halofsky JS, 2008, OECOLOGIA, V155, P869, DOI 10.1007/s00442-007-0956-z; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Kaartinen S, 2005, ANN ZOOL FENN, V42, P523; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Manor R, 2003, ECOL APPL, V13, P1830, DOI 10.1890/01-5354; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Musiani M, 2010, ECOL MODEL, V221, P2374, DOI 10.1016/j.ecolmodel.2010.06.019; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Whittington J, 2004, ECOL SOC, V9; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; [No title captured]	52	41	44	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94630	10.1371/journal.pone.0094630	http://dx.doi.org/10.1371/journal.pone.0094630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718624	gold, Green Published			2022-12-27	WOS:000334339000135
J	Bosnjak, M; Ristic, B; Arsikin, K; Mircic, A; Suzin-Zivkovic, V; Perovic, V; Bogdanovic, A; Paunovic, V; Markovic, I; Bumbasirevic, V; Trajkovic, V; Harhaji-Trajkovic, L				Bosnjak, Mihajlo; Ristic, Biljana; Arsikin, Katarina; Mircic, Aleksandar; Suzin-Zivkovic, Violeta; Perovic, Vladimir; Bogdanovic, Andrija; Paunovic, Verica; Markovic, Ivanka; Bumbasirevic, Vladimir; Trajkovic, Vladimir; Harhaji-Trajkovic, Ljubica			Inhibition of mTOR-Dependent Autophagy Sensitizes Leukemic Cells to Cytarabine-Induced Apoptotic Death	PLOS ONE			English	Article							OXIDATIVE STRESS; TARGETING AUTOPHAGY; RESISTANCE; PHOSPHORYLATION; ACTIVATION; MECHANISM; PATHWAY	The present study investigated the role of autophagy, a cellular self-digestion process, in the cytotoxicity of antileukemic drug cytarabine towards human leukemic cell lines (REH, HL-60, MOLT-4) and peripheral blood mononuclear cells from leukemic patients. The induction of autophagy was confirmed by acridine orange staining of intracellular acidic vesicles, electron microscopy visualization of autophagic vacuoles, as well as by the increase in autophagic proteolysis and autophagic flux, demonstrated by immunoblot analysis of p62 downregulation and LC3-I conversion to autophagosome-associated LC3-II in the presence of proteolysis inhibitors, respectively. Moreover, the expression of autophagy-related genes Atg4, Atg5 and Atg7 was stimulated by cytarabine in REH cells. Cytarabine reduced the phosphorylation of the major negative regulator of autophagy, mammalian target of rapamycin (mTOR), and its downstream target p70S6 kinase in REH cells, which was associated with downregulation of mTOR activator Akt and activation of extracellular signal-regulated kinase. Cytarabine had no effect on the activation of mTOR inhibitor AMP-activated protein kinase. Leucine, an mTOR activator, reduced both cytarabine-induced autophagy and cytotoxicity. Accordingly, pharmacological downregulation of autophagy with bafilomycin A1 and chloroquine, or RNA interference-mediated knockdown of LC3 beta or p62, markedly increased oxidative stress, mitochondrial depolarization, caspase activation and subsequent DNA fragmentation and apoptotic death in cytarabine-treated REH cells. Cytarabine also induced mTOR-dependent cytoprotective autophagy in HL-60 and MOLT-4 leukemic cell lines, as well as primary leukemic cells, but not normal leukocytes. These data suggest that the therapeutic efficiency of cytarabine in leukemic patients could be increased by the inhibition of the mTOR-dependent autophagic response.	[Bosnjak, Mihajlo; Mircic, Aleksandar; Suzin-Zivkovic, Violeta; Bumbasirevic, Vladimir] Univ Belgrade, Sch Med, Inst Histol & Embryol, Belgrade, Serbia; [Ristic, Biljana; Arsikin, Katarina; Perovic, Vladimir; Paunovic, Verica; Trajkovic, Vladimir] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Bogdanovic, Andrija] Univ Belgrade, Sch Med, Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia; [Markovic, Ivanka] Univ Belgrade, Sch Med, Inst Med & Clin Biochem, Belgrade, Serbia; [Harhaji-Trajkovic, Ljubica] Univ Belgrade, Inst Biol Res, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Belgrade; University of Belgrade	Trajkovic, V (corresponding author), Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Dr Subotica 1, Belgrade, Serbia.	vtrajkovic@med.bg.ac.rs; buajk@yahoo.com	Markovic, Ivanka/AAJ-1243-2020; Bogdanovic, Andrija/AAF-2505-2020	Bogdanovic, Andrija/0000-0002-8288-7308; Harhaji-Trajkovic, Ljubica/0000-0001-8757-555X; Trajkovic, Vladimir/0000-0002-8061-2968; Perovic, Vladimir/0000-0002-1994-1738; bosnjak, mihajlo/0000-0002-5973-8275; Markovic, Ivanka/0000-0002-7961-3752; Paunovic, Verica/0000-0002-4912-7761; Ristic, Biljana/0000-0002-7255-6556	Ministry of Science and Technological Development of the Republic of Serbia [173053, 41025]	Ministry of Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	The study was supported by the grants 173053 and 41025 from the Ministry of Science and Technological Development of the Republic of Serbia (http://www.mpn.gov.rs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Banerji V., 2012, INT J CELL BIOL, V2012, DOI [10.1155/2012/59597622829831, DOI 10.1155/2012/59597622829831]; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bezombes C, 2001, FASEB J, V15, P1583, DOI 10.1096/fj.00-0787fje; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Calabretta B, 2011, LEUKEMIA LYMPHOMA, V52, P54, DOI 10.3109/10428194.2010.546913; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cheng J, 2012, TOXICOL MECH METHOD, V22, P512, DOI 10.3109/15376516.2012.686534; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; Cros E, 2004, LEUKEMIA LYMPHOMA, V45, P1123, DOI 10.1080/1042819032000159861; Evangelisti C, 2011, J CELL PHYSIOL, V226, P822, DOI 10.1002/jcp.22407; Fimia GM, 2010, CELL MOL LIFE SCI, V67, P1581, DOI 10.1007/s00018-010-0284-z; Grander D, 2009, AUTOPHAGY, V5, P1198, DOI 10.4161/auto.5.8.10122; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Huang Y, 2011, AUTOPHAGY, V7, P1132, DOI 10.4161/auto.7.10.16636; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishdorj G, 2012, LEUKEMIA LYMPHOMA, V53, P26, DOI 10.3109/10428194.2011.604752; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaludjerovic GN, 2005, INT J CANCER, V116, P479, DOI 10.1002/ijc.21080; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Kobayashi T, 1998, CELL DEATH DIFFER, V5, P584, DOI 10.1038/sj.cdd.4400382; Lamba JK, 2009, PHARMACOGENOMICS, V10, P1657, DOI [10.2217/pgs.09.118, 10.2217/PGS.09.118]; Li JY, 2010, AUTOPHAGY, V6, P711, DOI 10.4161/auto.6.6.12397; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Martelli AM, 2012, EXPERT OPIN THER TAR, V16, P729, DOI 10.1517/14728222.2012.694869; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Novotny L, 2009, NEOPLASMA, V56, P177; Ohtomo T, 2010, BIOCHEM BIOPH RES CO, V391, P310, DOI 10.1016/j.bbrc.2009.11.055; Pham NA, 2001, EXP CELL RES, V264, P345, DOI 10.1006/excr.2000.5148; Puissant A, 2010, CELL CYCLE, V9, P3470, DOI 10.4161/cc.9.17.13048; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sadowski-Debbing K, 2002, ARCH IMMUNOL THER EX, V50, P19; Schnekenburger M, 2011, BIOCHEM PHARMACOL, V81, P364, DOI 10.1016/j.bcp.2010.10.013; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; STENTOFT J, 1990, DRUG SAFETY, V5, P7, DOI 10.2165/00002018-199005010-00003; TETT SE, 1988, BRIT J CLIN PHARMACO, V26, P303, DOI 10.1111/j.1365-2125.1988.tb05281.x; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	53	44	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94374	10.1371/journal.pone.0094374	http://dx.doi.org/10.1371/journal.pone.0094374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714637	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900123
J	Jarajapu, YPR; Hazra, S; Segal, M; LiCalzi, S; Jhadao, C; Qian, K; Mitter, SK; Raizada, MK; Boulton, ME; Grant, MB				Jarajapu, Yagna P. R.; Hazra, Sugata; Segal, Mark; LiCalzi, Sergio; Jhadao, Chandra; Qian, Kevin; Mitter, Sayak K.; Raizada, Mohan K.; Boulton, Michael E.; Grant, Maria B.			Vasoreparative Dysfunction of CD34(+) Cells in Diabetic Individuals Involves Hypoxic Desensitization and Impaired Autocrine/Paracrine Mechanisms	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR-BETA; MYOCARDIAL-INFARCTION; CEREBRAL-ARTERIES; CLONAL ANALYSIS; MYOGENIC TONE; NITRIC-OXIDE; STEM-CELLS; ANGIOGENESIS; ACTIVATION	We hypothesized that endothelial progenitor cells derived from individuals with diabetes would exhibit functional defects including inability to respond to hypoxia and altered paracrine/autocrine function that would impair the angiogenic potential of these cells. Circulating mononuclear cells isolated from diabetic (n = 69) and nondiabetic (n = 46) individuals were used to grow endothelial colony forming cells (ECFC), early endothelial progenitor cells (eEPCs) and isolate CD34(+) cells. ECFCs and eEPCs were established from only 15% of the diabetic individuals tested thus directing our main effort toward examination of CD34(+) cells. CD34(+) cells were plated in basal medium to obtain cell-free conditioned medium (CM). In CM derived from CD34(+) cells of diabetic individuals (diabetic-CM), the levels of stem cell factor, hepatocyte growth factor, and thrombopoietin were lower, and IL-1 beta and tumor necrosis factor (TNF alpha) levels were higher than CM derived from nondiabetic individuals (nondiabetic-CM). Hypoxia did not upregulate HIF1 alpha in CD34(+) cells of diabetic origin. Migration and proliferation of nondiabetic CD34(+) cells toward diabetic-CM were lower compared to nondiabetic-CM. Attenuation of pressure-induced constriction, potentiation of bradykinin relaxation, and generation of cGMP and cAMP in arterioles were observed with nondiabetic-CM, but not with diabetic-CM. Diabetic-CM failed to induce endothelial tube formation from vascular tissue. These results suggest that diabetic subjects with microvascular complications exhibit severely limited capacity to generate ex-vivo expanded endothelial progenitor populations and that the vasoreparative dysfunction observed in diabetic CD34(+) cells is due to impaired autocrine/paracrine function and reduced sensitivity to hypoxia.	[Jarajapu, Yagna P. R.] N Dakota State Univ, Coll Pharm Nursing & Allied Sci, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Jarajapu, Yagna P. R.; Hazra, Sugata; Jhadao, Chandra; Grant, Maria B.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Segal, Mark] Univ Florida, Coll Med, Dept Nephrol, Gainesville, FL USA; [LiCalzi, Sergio; Qian, Kevin; Mitter, Sayak K.; Boulton, Michael E.; Grant, Maria B.] Indiana Univ, Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Raizada, Mohan K.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA	North Dakota State University Fargo; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida	Grant, MB (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.	mabgrant@iupui.edu			NIH [EY007739, EY012601, DK090730-02, U01HL087366, EY018358]; NATIONAL EYE INSTITUTE [R01EY012601, R01EY007739, R01EY018358, R29EY007739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366, UM1HL087366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding Sources include NIH - EY007739, EY012601, DK090730-02, and U01HL087366 to MBG and EY018358 to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; Ali H, 1997, MED CLIN N AM, V81, P1, DOI 10.1016/S0025-7125(05)70503-4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Awad O, 2006, ARTERIOSCL THROM VAS, V26, P758, DOI 10.1161/01.ATV.0000203513.29227.6f; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Bhatwadekar AD, 2010, DIABETES, V59, P2010, DOI 10.2337/db10-0287; Brizzi MF, 1999, CIRC RES, V84, P785; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Dempsey RJ, 2003, J NEUROCHEM, V87, P586, DOI 10.1046/j.1471-4159.2003.02022.x; Eguchi M, 2008, J MOL CELL CARDIOL, V45, P661, DOI 10.1016/j.yjmcc.2008.08.002; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Goldschmidt-Clermont Pascal J, 2005, Rev Cardiovasc Med, V6 Suppl 3, pS22; Harraz M, 2001, STEM CELLS, V19, P304, DOI 10.1634/stemcells.19-4-304; He T, 2008, CIRC RES, V103, P80, DOI 10.1161/CIRCRESAHA.108.176057; He TR, 2005, AM J PHYSIOL-HEART C, V289, pH968, DOI 10.1152/ajpheart.01166.2004; Jarajapu YPR, 2008, EUR J PHARMACOL, V579, P298, DOI 10.1016/j.ejphar.2007.10.028; Jarajapu YPR, 2011, INVEST OPHTH VIS SCI, V52, P5093, DOI 10.1167/iovs.10-70911; Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140; Jarajapu YPR, 2002, AM J PHYSIOL-HEART C, V283, pH2234, DOI 10.1152/ajpheart.00624.2002; Jarajapu YPR, 2001, J PHARMACOL EXP THER, V299, P729; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Katakam PVG, 2009, AM J PHYSIOL-REG I, V296, pR289, DOI 10.1152/ajpregu.90656.2008; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Krenning G, 2009, J CELL MOL MED, V13, P2521, DOI 10.1111/j.1582-4934.2008.00479.x; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Mackie AR, 2011, TEX HEART I J, V38, P474; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Meng S, 2012, J MOL CELL CARDIOL, V53, P64, DOI 10.1016/j.yjmcc.2012.04.003; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Mohty M, 2011, EXP HEMATOL; Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016; Nakagawa T, 2006, J AM SOC NEPHROL, V17, P736, DOI 10.1681/ASN.2005070759; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Orlandi A, 2010, BASIC RES CARDIOL, V105, P703, DOI 10.1007/s00395-010-0109-0; Ramos AL, 2010, CIRC RES, V107, P1460, DOI 10.1161/CIRCRESAHA.110.223669; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Santhanam AVR, 2007, CIRC RES, V100, P1379, DOI 10.1161/01.RES.0000265848.55035.5d; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Schatteman GC, 2010, AM J PATHOL, V177, P2002, DOI 10.2353/ajpath.2010.091232; Schroder K, 2010, ANTIOXID REDOX SIGNA; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Semenza GL, 1999, ANN NY ACAD SCI, V874, P262, DOI 10.1111/j.1749-6632.1999.tb09241.x; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Smith G, 1999, BRIT J OPHTHALMOL, V83, P486, DOI 10.1136/bjo.83.4.486; Tan K, 2010, EXP EYE RES, V91, P229, DOI 10.1016/j.exer.2010.05.012; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Zhu GX, 2010, INT J CARDIOL, V138, P70, DOI 10.1016/j.ijcard.2008.10.042	67	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93965	10.1371/journal.pone.0093965	http://dx.doi.org/10.1371/journal.pone.0093965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713821	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900068
J	Oppel, S; Marczakiewicz, P; Lachmann, L; Grzywaczewski, G				Oppel, Steffen; Marczakiewicz, Piotr; Lachmann, Lars; Grzywaczewski, Grzegorz			Improving Aquatic Warbler Population Assessments by Accounting for Imperfect Detection	PLOS ONE			English	Article							ACROCEPHALUS-PALUDICOLA; ESTIMATING ABUNDANCE; WESTERN MARGIN; COUNTS; MODELS; SONGBIRDS; TRENDS	Monitoring programs designed to assess changes in population size over time need to account for imperfect detection and provide estimates of precision around annual abundance estimates. Especially for species dependent on conservation management, robust monitoring is essential to evaluate the effectiveness of management. Many bird species of temperate grasslands depend on specific conservation management to maintain suitable breeding habitat. One such species is the Aquatic Warbler (Acrocephalus paludicola), which breeds in open fen mires in Central Europe. Aquatic Warbler populations have so far been assessed using a complete survey that aims to enumerate all singing males over a large area. Because this approach provides no estimate of precision and does not account for observation error, detecting moderate population changes is challenging. From 2011 to 2013 we trialled a new line transect sampling monitoring design in the Biebrza valley, Poland, to estimate abundance of singing male Aquatic Warblers. We surveyed Aquatic Warblers repeatedly along 50 randomly placed 1-km transects, and used binomial mixture models to estimate abundances per transect. The repeated line transect sampling required 150 observer days, and thus less effort than the traditional `full count' approach (175 observer days). Aquatic Warbler abundance was highest at intermediate water levels, and detection probability varied between years and was influenced by vegetation height. A power analysis indicated that our line transect sampling design had a power of 68% to detect a 20% population change over 10 years, whereas raw count data had a 9% power to detect the same trend. Thus, by accounting for imperfect detection we increased the power to detect population changes. We recommend to adopt the repeated line transect sampling approach for monitoring Aquatic Warblers in Poland and in other important breeding areas to monitor changes in population size and the effects of habitat management.	[Oppel, Steffen; Lachmann, Lars] Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Marczakiewicz, Piotr] Ogolnopolskie Towarzystwo Ochrony Ptakow, Marki, Poland; [Marczakiewicz, Piotr] Biebrzanski Pk Narodowy, Goniadz, Poland; [Grzywaczewski, Grzegorz] Univ Life Sci, Dept Zool Anim Ecol & Wildlife Management, Lublin, Poland	Royal Society for Protection of Birds	Oppel, S (corresponding author), Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England.	steffen.oppel@rspb.org.uk	Oppel, Steffen/H-2771-2019	Oppel, Steffen/0000-0002-8220-3789; Grzywaczewski, Grzegorz/0000-0003-1136-0768	RSPB; Biebrza National Park;  [LIFE05 NAT/PL/000101]	RSPB; Biebrza National Park; 	Funding was provided by the project LIFE05 NAT/PL/000101 (http://ec.europa.eu/environment/life/), the RSPB (www.rspb.org.uk), and the Biebrza National Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2007, J WILDLIFE MANAGE, V71, P2759, DOI 10.2193/2006-161; Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; [Anonymous], 2010, R LANG ENV STAT COMP; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; Buchanan GM, 2011, OSTRICH, V82, P81, DOI 10.2989/00306525.2011.603461; Buckland S.T., 2001, pi; Buckland ST, 2008, BIRD CONSERV INT, V18, pS91, DOI 10.1017/S0959270908000294; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; DYRCZ A, 1993, IBIS, V135, P181, DOI 10.1111/j.1474-919X.1993.tb02830.x; Etterson MA, 2009, ECOL APPL, V19, P2049, DOI 10.1890/08-1317.1; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Flade M, 2008, INT SPECIES ACTION P, P74; Flade M, 2011, J ORNITHOL, V152, P129, DOI 10.1007/s10336-011-0666-5; Gelman A., 2004, BAYESIAN DATA ANAL; Gottschalk TK, 2011, J ORNITHOL, V152, P421, DOI 10.1007/s10336-010-0601-1; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kloskowski Janusz, 1999, Vogelwelt, V120, P113; Kotowski W, 2013, BIOL CONSERV, V167, P292, DOI 10.1016/j.biocon.2013.08.021; Kozulin A, 2004, ACTA ORNITHOL, V39, P35, DOI 10.3161/068.039.0109; Kozulin Alexander, 1999, Vogelwelt, V120, P97; Krogulec J., 2003, Ornis Hungarica, V12-13, P191; Kubacka J, 2014, BIRD CONSERV INT, V24, P45, DOI 10.1017/S0959270913000154; Laake JL, 2011, J AGR BIOL ENVIR ST, V16, P389, DOI 10.1007/s13253-011-0059-5; Lachmann L., 2010, Grassland in a changing world. Proceedings of the 23rd General Meeting of the European Grassland Federation, Kiel, Germany, 29th August - 2nd September 2010, P711; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Nichols JD, 2009, ENVIRON ECOL STAT SE, V3, P201, DOI 10.1007/978-0-387-78151-8_9; Norvell RE, 2003, AUK, V120, P1013, DOI 10.1642/0004-8038(2003)120[1013:ASCORA]2.0.CO;2; Oppel S, 2011, J AVIAN BIOL, V42, P342, DOI 10.1111/j.1600-048X.2011.05252.x; Plummer M., 2012, JAGS VERSION 3 3 0; Reynolds JH, 2011, BIOL CONSERV, V144, P1278, DOI 10.1016/j.biocon.2010.12.002; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Salewski V, 2013, J ORN IN PRESS; Schaefer HM, 2000, J ORNITHOL, V141, P418, DOI 10.1007/BF01651571; Schmeller DS, 2012, NAT CONSERV-BULGARIA, P41, DOI 10.3897/natureconservation.2.3644; Schmidt JH, 2013, BIOL CONSERV, V160, P130, DOI 10.1016/j.biocon.2013.01.007; Schulze-Hagen K., 1991, HDB VOGEL MITTELEURO; Schulze-Hagen Karl, 1999, Vogelwelt, V120, P87; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Tanneberger F, 2009, BIODIVERS CONSERV, V18, P1475, DOI 10.1007/s10531-008-9495-0; Tanneberger F, 2008, J ORNITHOL, V149, P105, DOI 10.1007/s10336-007-0241-2; Tanneberger F, 2010, IBIS, V152, P347, DOI 10.1111/j.1474-919X.2010.01016.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118	56	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94406	10.1371/journal.pone.0094406	http://dx.doi.org/10.1371/journal.pone.0094406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713994	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900130
J	Wang, T; Chen, BB; Kim, MS; Xie, Y; Xiao, GH				Wang, Tao; Chen, Beibei; Kim, MinSoo; Xie, Yang; Xiao, Guanghua			A Model-Based Approach to Identify Binding Sites in CLIP-Seq Data	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; RNA; PROTEIN; NETWORKS; TARGETS; REVEALS; GALAXY; DNA	Cross-linking immunoprecipitation coupled with high-throughput sequencing (CLIP-Seq) has made it possible to identify the targeting sites of RNA-binding proteins in various cell culture systems and tissue types on a genome-wide scale. Here we present a novel model-based approach (MiClip) to identify high-confidence protein-RNA binding sites from CLIP-seq datasets. This approach assigns a probability score for each potential binding site to help prioritize subsequent validation experiments. The MiClip algorithm has been tested in both HITS-CLIP and PAR-CLIP datasets. In the HITS-CLIP dataset, the signal/noise ratios of miRNA seed motif enrichment produced by the MiClip approach are between 17% and 301% higher than those by the ad hoc method for the top 10 most enriched miRNAs. In the PAR-CLIP dataset, the MiClip approach can identify similar to 50% more validated binding targets than the original ad hoc method and two recently published methods. To facilitate the application of the algorithm, we have released an R package, MiClip (http://cran.r-project.org/web/packages/MiClip/index.html), and a public web-based graphical user interface software (http://galaxy.qbrc.org/tool_runner?tool_id=mi_clip) for customized analysis.	[Wang, Tao; Chen, Beibei; Kim, MinSoo; Xie, Yang; Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Clin Sci, Dallas, TX 75390 USA; [Chen, Beibei; Kim, MinSoo; Xie, Yang] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xiao, GH (corresponding author), Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Clin Sci, Dallas, TX 75390 USA.	Guanghua.Xiao@UTSouthwestern.edu	Wang, Tao/K-3518-2016		National Institutes of Health [1R01CA172211, 5R01CA152301]; Cancer Prevention Research Institute of Texas [RP101251]; NATIONAL CANCER INSTITUTE [R01CA172211, R01CA152301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (http://www.nih.gov/) [1R01CA172211, 5R01CA152301]; and the Cancer Prevention Research Institute of Texas (http://www.cprit.state.tx.us/) [RP101251]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chou CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S2; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, J VIS EXP; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; HARTER SP, 1975, J AM SOC INFORM SCI, V26, P197, DOI 10.1002/asi.4630260402; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hu JJ, 2005, NUCLEIC ACIDS RES, V33, P4899, DOI 10.1093/nar/gki791; Iengar P, 2012, NUCLEIC ACIDS RES, V40, P6401, DOI 10.1093/nar/gks290; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; R Development Core Team, 2012, R LANG ENV STAT COMP; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210; Sievers C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks697; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Xing HP, 2012, JOVE-J VIS EXP, DOI 10.3791/4273; Youn A, 2010, BIOINFORMATICS, V26, P1879, DOI 10.1093/bioinformatics/btq289; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93248	10.1371/journal.pone.0093248	http://dx.doi.org/10.1371/journal.pone.0093248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714572	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900019
J	Yang, JT; Li, ZL; Wu, JY; Lu, FJ; Chen, CH				Yang, Jen-Tsung; Li, Zih-Ling; Wu, Jin-Yi; Lu, Fung-Jou; Chen, Ching-Hsein			An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells	PLOS ONE			English	Article							ROS PRODUCTION; CYCLE ARREST; APOPTOSIS; GROWTH; PERMEABILIZATION; EXPRESSION; INDUCTION; CASPASES; DAMAGE; DEATH	Shikonin is a quinone-containing natural product that induces the apoptotic death of some cancer cell lines in culture through increasing intracellular reactive oxygen species (ROS). Quinone-based drugs have shown potential in the clinic, making shikonin an interesting compound to study. Our previous study found that shikonin induces apoptosis in neuroblastoma by induction of ROS, but its mechanism of action and scope of activity are unknown. In this study, we investigated the mode of oxidative stress of shikonin in human glioma cells. ROS induction by shikonin was of mitochondrial origin, as demonstrated by detection of superoxide with MitoSOX Red. Pre-incubation of shikonin with inhibitors of different complexes of the respiratory chain suggested that shikonin-induced ROS production occurred via complex II. In addition, NADPH oxidase and lipooxygenase are two other main ROS-generated sites in shikonin treatment. ROS production by shikonin resulted in the inhibition of nuclear translocation of Nrf2. Stable overexpression of Nrf2 in glioma cells inhibited ROS generation by shikonin. ROS generation from mitochondrial complex II, NADPH oxidase and lipooxygenase is likely the primary mechanism by which shikonin induces apoptosis in glioma cells. These findings also have relevance to the development of certain ROS producers as anti-cancer agents. These, along with shikonin have potential as novel chemotherapeutic agents on human glioma.	[Yang, Jen-Tsung; Li, Zih-Ling] Chang Gung Univ, Chang Gung Mem Hosp Chiayi, Coll Med, Dept Neurosurg, Tao Yuan, Taiwan; [Li, Zih-Ling; Wu, Jin-Yi; Chen, Ching-Hsein] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Lu, Fung-Jou] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Chiayi University; Chung Shan Medical University	Chen, CH (corresponding author), Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	chench@mail.ncyu.edu.tw			Chang Gung Memorial Hospital, R.O.C. [CMRPG6A0252]; National Science Council, Taiwan [NSC 102-2320-B-415-005-MY3]	Chang Gung Memorial Hospital, R.O.C.(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Chang Gung Memorial Hospital, R.O.C. (CMRPG6A0252, J.T.Y.) and in part by National Science Council, Taiwan (NSC 102-2320-B-415-005-MY3; National Science Council's, C.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaba-Muruato LR, 2012, CAN J PHYSIOL PHARM, V90, P1469, DOI 10.1139/y2012-125; Bobba A, 2013, MITOCHONDRION, V13, P298, DOI 10.1016/j.mito.2013.03.008; Byun JY, 2009, MOL PHARMACOL, V76, P734, DOI 10.1124/mol.109.056259; Chen CH, 2003, PLANTA MED, V69, P1119, DOI 10.1055/s-2003-45193; Chen CH, 2012, ANN SURG ONCOL, V19, P3097, DOI 10.1245/s10434-012-2324-4; Conklin KA, 2004, J NUTR, V134, p3201S, DOI 10.1093/jn/134.11.3201S; Gao S, 2013, CANCER LETT, V333, P36, DOI 10.1016/j.canlet.2012.12.029; Garcia-Escudero V, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/162152; Garcia-Perez C, 2012, P NATL ACAD SCI USA, V109, P4497, DOI 10.1073/pnas.1118244109; Jaburek M, 2013, INT J BIOCHEM CELL B, V45, P816, DOI 10.1016/j.biocel.2013.01.010; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Kim HJ, 2003, ARCH PHARM RES, V26, P405, DOI 10.1007/BF02976698; Klaus V, 2010, ARCH BIOCHEM BIOPHYS, V496, P93, DOI 10.1016/j.abb.2010.02.002; Kuo HM, 2007, ANTICANCER RES, V27, P395; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7; Nguyen MVC, 2013, BIOCHEM PHARMACOL, V85, P1644, DOI 10.1016/j.bcp.2013.03.023; Okayasu H, 2001, ANTICANCER RES, V21, P2387; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Paletta-Silva R, 2013, INT J MOL SCI, V14, P3683, DOI 10.3390/ijms14023683; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rincheval V, 2012, CELL BIOL TOXICOL, V28, P239, DOI 10.1007/s10565-012-9219-9; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; WU FYH, 1993, ONCOGENE, V8, P2237; Xu KH, 2010, LEUKEMIA RES, V34, P658, DOI 10.1016/j.leukres.2009.08.017	29	52	53	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94180	10.1371/journal.pone.0094180	http://dx.doi.org/10.1371/journal.pone.0094180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714453	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900098
J	Yimer, G; Gry, M; Amogne, W; Makonnen, E; Habtewold, A; Petros, Z; Aderaye, G; Schuppe-Koistinen, I; Lindquist, L; Aklillu, E				Yimer, Getnet; Gry, Marcus; Amogne, Wondwossen; Makonnen, Eyasu; Habtewold, Abiy; Petros, Zelalem; Aderaye, Getachew; Schuppe-Koistinen, Ina; Lindquist, Lars; Aklillu, Eleni			Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TERM EFAVIRENZ AUTOINDUCTION; HIV-POSITIVE PATIENTS; INDUCED HEPATOTOXICITY; PLASMA EXPOSURE; THERAPY; TUBERCULOSIS; INJURY; PHARMACOGENETICS; EXPERIENCE	Objectives: To evaluate the incidence, type, severity and predictors of antiretroviral and/or anti-tuberculosis drugs induced liver injury (DILI). Methods: A total of 1,060 treatment naive patients were prospectively enrolled into four treatment groups: HIV patients receiving efavirenz based HAART alone (Arm-1); TB-HIV co-infected patients with CD4 <= 200 cells/mu L, receiving concomitant rifampicin based anti-TB and efavirenz based HAART (Arm-2); TB-HIV co-infected patients with CD4>200 cells/mu L, receiving anti-TB alone (Arm-3); TB patients taking rifampicin based anti-TB alone (Arm-4). Liver enzyme levels were monitored at baseline, 1st, 2nd, 4th, 8th, 12th and 24th weeks during treatment. CD4 and HIV viral load was measured at baseline, 24th and 48th weeks. Data were analyzed using multivariate Cox Proportional Hazards Model. Results: A total of 159 patients (15%) developed DILI with severity grades 1, 2, 3 and 4 of 53.5%, 32.7%, 11.3% and 2.5% respectively. The incidence of cholestatic, hepatocellular or mixed pattern was 61%, 15% and 24%, respectively. Incidence of DILI was highest in Arm-2 (24.2%)>Arm-3 (10.8%)>Arm-1 (8.8%)>Arm-4 (2.9%). Concomitant anti-TB-HIV therapy increased the risk of DILI by 10-fold than anti-TB alone (p<0.0001). HIV co-infection increased the risk of anti-TB DILI by 4-fold (p = 0.004). HAART associated DILI was 3-fold higher than anti-TB alone, (p = 0.02). HAART was associated with cholestatic and grade 1 DILI whereas anti-TB therapy was associated with hepatocellular and grade >= 2. Treatment type, lower CD4, platelet, hemoglobin, higher serum AST and direct bilirubin levels at baseline were significant DILI predictors. There was no effect of DILI on immunologic recovery or virologic suppression rate of HAART. Conclusion: HAART associated DILI is mainly cholestatic and mild whereas hepatocellular or mixed pattern with high severity grade is more common in anti-tuberculosis DILI. TB-HIV co-infection, disease severity and concomitant treatment exacerbates the risk of DILI.	[Yimer, Getnet; Habtewold, Abiy; Aklillu, Eleni] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Pharmacol,Dept Lab Med, Stockholm, Sweden; [Yimer, Getnet; Makonnen, Eyasu; Habtewold, Abiy; Petros, Zelalem] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Dept Pharmacol, Addis Ababa, Ethiopia; [Gry, Marcus] Former AstraZeneca R&D, Global Safety Assessment Mol Toxicol, Sodertalje, Sweden; [Amogne, Wondwossen; Aderaye, Getachew] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia; [Schuppe-Koistinen, Ina] AstraZeneca, Innovat Med Personalised Healthcare & Biomarkers, Solna, Sweden; [Amogne, Wondwossen; Lindquist, Lars] Karolinska Univ, Hosp Huddinge I 73, Karolinska Inst, Dept Med,Div Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Addis Ababa University; AstraZeneca; Addis Ababa University; AstraZeneca; Karolinska Institutet; Karolinska University Hospital	Aklillu, E (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Pharmacol,Dept Lab Med, C1 68, Stockholm, Sweden.	Eleni.Aklillu@ki.se	Aklillu, Eleni/ABG-3461-2021; Degu, Wondwossen Amogne/GON-3590-2022; Amogne, Wondwossen/AGM-9855-2022; Yimer, Getnet/A-9436-2015	Aklillu, Eleni/0000-0002-9788-0790; Makonnen, Eyasu/0000-0002-9259-5288; Yimer, Getnet/0000-0002-1469-837X; Schuppe-Koistinen, Ina/0000-0002-1423-3089	European & Developing Countries Clinical Trials Partnership [CG_TA.05.40204_005, CT.2005.32030.001]; SIDA [HIV-2006-031, SWE 2007-270]; Swedish research council [VR 521-2011-3437]	European & Developing Countries Clinical Trials Partnership; SIDA; Swedish research council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from European & Developing Countries Clinical Trials Partnership (grant numbers CG_TA.05.40204_005, CT.2005.32030.001) and SIDA (grant numbers HIV-2006-031, SWE 2007-270), Swedish research council (grant number VR 521-2011-3437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIDS CLIN TRIALS, 1996, TABL GRAD SEV AD ADV; Aithal GP, 2011, CLIN PHARMACOL THER, V89, P806, DOI 10.1038/clpt.2011.58; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Daly AK, 2010, PHARMACOGENOMICS, V11, P607, DOI [10.2217/pgs.10.24, 10.2217/PGS.10.24]; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Devarbhavi H, 2010, AM J GASTROENTEROL, V105, P2396, DOI 10.1038/ajg.2010.287; Dore GJ, 1999, J INFECT DIS, V180, P607, DOI 10.1086/314942; Elsharkawy AM, 2013, J CLIN VIROL, V58, P331, DOI 10.1016/j.jcv.2013.05.003; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Inductivo-Yu I, 2008, CURR DRUG SAF, V3, P4, DOI 10.2174/157488608783333916; Jones M, 2012, SEMIN LIVER DIS, V32, P167, DOI 10.1055/s-0032-1316472; Kalyesubula R, 2011, AFR HEALTH SCI, V11, P16; Karvellas CJ, 2010, LIVER INT, V30, P826, DOI 10.1111/j.1478-3231.2010.02243.x; Lamar Zanetta S, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P183, DOI 10.1177/1545109711401411; Lee LSU, 2012, ANN ACAD MED SINGAP, V41, P559; M'Kada H, 2011, REGUL TOXICOL PHARM, V60, P290, DOI 10.1016/j.yrtph.2011.04.002; McRae MP, 2006, J PHARMACOL EXP THER, V318, P1068, DOI 10.1124/jpet.106.102657; Mugusi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040180; Mugusi SF, 2012, ANTIVIR THER, V17, P265, DOI 10.3851/IMP1956; Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261; Nelson M, 2003, AIDS, V17, pF7, DOI 10.1097/00002030-200301030-00002; Neukam K, 2011, J ANTIMICROB CHEMOTH, V66, P2605, DOI 10.1093/jac/dkr357; Ngaimisi E, 2011, CLIN PHARMACOL THER, V90, P406, DOI 10.1038/clpt.2011.129; Ngaimisi E, 2010, CLIN PHARMACOL THER, V88, P676, DOI 10.1038/clpt.2010.172; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Stine JG, 2011, EXPERT OPIN DRUG MET, V7, P875, DOI 10.1517/17425255.2011.577415; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Tostmann A, 2007, TROP MED INT HEALTH, V12, P852, DOI 10.1111/j.1365-3156.2007.01871.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Tostmann A, 2010, TROP MED INT HEALTH, V15, P268, DOI 10.1111/j.1365-3156.2009.02449.x; Walker UA, 2007, CURR OPIN HIV AIDS, V2, P293, DOI 10.1097/COH.0b013e328122dbaa; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; WHO, ANT THER HIV INF AD; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	41	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94271	10.1371/journal.pone.0094271	http://dx.doi.org/10.1371/journal.pone.0094271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714066	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900111
J	Menon, M; Askinazi, OL; Schafer, DA				Menon, Manisha; Askinazi, Olga L.; Schafer, Dorothy A.			Dynamin2 Organizes Lamellipodial Actin Networks to Orchestrate Lamellar Actomyosin	PLOS ONE			English	Article							CLATHRIN-COATED PITS; FOCAL ADHESIONS; STRESS FIBERS; ALPHA-ACTININ; MIGRATING CELLS; RETROGRADE FLOW; CYTOSKELETON; BUNDLES; GTPASE; ENDOCYTOSIS	Actin networks in migrating cells exist as several interdependent structures: sheet-like networks of branched actin filaments in lamellipodia; arrays of bundled actin filaments co-assembled with myosin II in lamellae; and actin filaments that engage focal adhesions. How these dynamic networks are integrated and coordinated to maintain a coherent actin cytoskeleton in migrating cells is not known. We show that the large GTPase dynamin2 is enriched in the distal lamellipod where it regulates lamellipodial actin networks as they form and flow in U2-OS cells. Within lamellipodia, dynamin2 regulated the spatiotemporal distributions of a-actinin and cortactin, two actin-binding proteins that specify actin network architecture. Dynamin2's action on lamellipodial F-actin influenced the formation and retrograde flow of lamellar actomyosin via direct and indirect interactions with actin filaments and a finely tuned GTP hydrolysis activity. Expression in dynamin2-depleted cells of a mutant dynamin2 protein that restores endocytic activity, but not activities that remodel actin filaments, demonstrated that actin filament remodeling by dynamin2 did not depend of its functions in endocytosis. Thus, dynamin2 acts within lamellipodia to organize actin filaments and regulate assembly and flow of lamellar actomyosin. We hypothesize that through its actions on lamellipodial F-actin, dynamin2 generates F-actin structures that give rise to lamellar actomyosin and for efficient coupling of F-actin at focal adhesions. In this way, dynamin2 orchestrates the global actin cytoskeleton.	[Menon, Manisha; Askinazi, Olga L.; Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Schafer, DA (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	das9w@virginia.edu			NIGMS [GM067222]; Department of Biology, University of Virginia; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067222] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Biology, University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS (www.nih.gov) GM067222 to D. A. S. and by interim funds from the Department of Biology, University of Virginia (www.bio.virginia.edu). The funders had no role in study design, data collection and analysis, decidio to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Aratyn-Schaus Y, 2011, MOL BIOL CELL, V22, P1330, DOI 10.1091/mbc.E10-11-0891; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; CHOI CK, 2008, NAT CELL BIOL; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chua J, 2009, P NATL ACAD SCI US; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Destaing O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077956; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hamao K, 2009, EXP CELL RES, V315, P1336, DOI 10.1016/j.yexcr.2009.01.025; HEATH JP, 1983, J CELL SCI, V60, P331; Henmi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028603; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; MACIVER SK, 1991, J CELL BIOL, V115, P1621, DOI 10.1083/jcb.115.6.1621; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Menon M, 2013, INT REV CEL MOL BIO, V302, P187, DOI 10.1016/B978-0-12-407699-0.00003-0; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Razidlo GL, 2013, DEV CELL, V24, P573, DOI 10.1016/j.devcel.2013.02.010; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Risca VI, 2012, P NATL ACAD SCI USA, V109, P2913, DOI 10.1073/pnas.1114292109; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Stricker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070652; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	64	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94330	10.1371/journal.pone.0094330	http://dx.doi.org/10.1371/journal.pone.0094330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710573	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800137
J	Rasala, BA; Chao, SS; Pier, M; Barrera, DJ; Mayfield, SP				Rasala, Beth A.; Chao, Syh-Shiuan; Pier, Matthew; Barrera, Daniel J.; Mayfield, Stephen P.			Enhanced Genetic Tools for Engineering Multigene Traits into Green Algae	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; SYNTHETIC BIOLOGY; ENDOPLASMIC-RETICULUM; BIOFUEL PRODUCTION; MICROALGAE; BIOTECHNOLOGY; MITOCHONDRIA; CHLOROPLAST; EXPRESSION; PROTEINS	Transgenic microalgae have the potential to impact many diverse biotechnological industries including energy, human and animal nutrition, pharmaceuticals, health and beauty, and specialty chemicals. However, major obstacles to sophisticated genetic and metabolic engineering in algae have been the lack of well-characterized transformation vectors to direct engineered gene products to specific subcellular locations, and the inability to robustly express multiple nuclear-encoded transgenes within a single cell. Here we validate a set of genetic tools that enable protein targeting to distinct subcellular locations, and present two complementary methods for multigene engineering in the eukaryotic green microalga Chlamydomonas reinhardtii. The tools described here will enable advanced metabolic and genetic engineering to promote microalgae biotechnology and product commercialization.	[Mayfield, Stephen P.] Univ Calif San Diego, Calif Ctr Algae Biotechnol, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Mayfield, SP (corresponding author), Univ Calif San Diego, Calif Ctr Algae Biotechnol, La Jolla, CA 92093 USA.	smayfield@ucsd.edu	Serrano-Ruiz, Juan Carlos/U-6297-2018	Serrano-Ruiz, Juan Carlos/0000-0002-9078-7390	Department of Energy [DE-EE0003373]; California Energy Commission (CILMSF) [500-10-039]; Life Technologies	Department of Energy(United States Department of Energy (DOE)); California Energy Commission (CILMSF); Life Technologies	This work was supported the by the Department of Energy (DE-EE0003373), the California Energy Commission (CILMSF # 500-10-039) and Life Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes D, 2005, MOL GENET GENOMICS, V274, P625, DOI 10.1007/s00438-005-0055-y; Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Christaki E, 2011, INT J FOOD SCI NUTR, V62, P794, DOI 10.3109/09637486.2011.582460; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; DEHOSTOS EL, 1988, J CELL BIOL, V106, P29, DOI 10.1083/jcb.106.1.29; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; DUMAS P, 1994, EMBO J, V13, P2483, DOI 10.1002/j.1460-2075.1994.tb06535.x; EHARA T, 1995, J CELL SCI, V108, P499; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Gimpel JA, 2013, CURR OPIN CHEM BIOL, V17, P489, DOI 10.1016/j.cbpa.2013.03.038; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gong YM, 2011, J IND MICROBIOL BIOT, V38, P1879, DOI 10.1007/s10295-011-1032-6; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Heinig U, 2013, CURR OPIN BIOTECH, V24, P239, DOI 10.1016/j.copbio.2012.11.006; Hiramatsu T, 2006, J PHYCOL, V42, P1048, DOI 10.1111/j.1529-8817.2006.00259.x; Jones CS, 2012, CURR OPIN BIOTECH, V23, P346, DOI 10.1016/j.copbio.2011.10.013; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; MORRIS GJ, 1985, J CELL SCI, V76, P145; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Olaizola M, 2003, BIOMOL ENG, V20, P459, DOI 10.1016/S1389-0344(03)00076-5; Oyler GA, 2008, CURR OPIN BIOTECHNOL, V19, P430; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Purton S, 2005, PLANT CELL REP, V24, P629; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Raja R, 2008, CRIT REV MICROBIOL, V34, P77, DOI [10.1080/10408410802086783, 10.1080/10408410802086783 ]; Rasala BA, 2013, PLANT J, V74, P545, DOI 10.1111/tpj.12165; Rasala BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043349; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Sweetlove LJ, 2013, ANNU REV PLANT BIOL, V64, P723, DOI 10.1146/annurev-arplant-050312-120233; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wijffels RH, 2013, CURR OPIN BIOTECH, V24, P405, DOI 10.1016/j.copbio.2013.04.004; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	46	83	87	8	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94028	10.1371/journal.pone.0094028	http://dx.doi.org/10.1371/journal.pone.0094028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710110	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800089
J	van Dalen, MT; Suijker, JJ; MacNeil-Vroomen, J; van Rijn, M; van Charante, EPM; de Rooij, SE; Buurman, BM				van Dalen, Marlies T.; Suijker, Jacqueline J.; MacNeil-Vroomen, Janet; van Rijn, Marjon; van Charante, Eric P. Moll; de Rooij, Sophia E.; Buurman, Bianca M.			Self-Report of Healthcare Utilization among Community-Dwelling Older Persons: A Prospective Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL DECLINE; PHYSICIAN UTILIZATION; PREDICTIVE-VALIDITY; SERVICES; DISABILITY; VISITS; PEOPLE; NURSE; RISK	Background: Self-reported data are often used for estimates on healthcare utilization in cost-effectiveness studies. Objective: To analyze older adults' self-report of healthcare utilization compared to data obtained from the general practitioners' (GP) electronic medical record (EMR) and to study the differences in healthcare utilization between those who completed the study, those who did not respond, and those lost to follow-up. Methods: A prospective cohort study was conducted among community-dwelling persons aged 70 years and above, without dementia and not living in a nursing home. Self-reporting questionnaires were compared to healthcare utilization data extracted from the EMR at the GP-office. Results: Overall, 790 persons completed questionnaires at baseline, median age 75 years (IQR 72-80), 55.8% had no disabilities in (instrumental) activities of daily living. Correlations between self-report data and EMR data on healthcare utilization were substantial for 'hospitalizations' and 'GP home visits' at 12 months intraclass correlation coefficient 0.63 (95% CI; 0.58-0.68). Compared to the EMR, self-reported healthcare utilization was generally slightly over-reported. Nonrespondents received more GP home visits (p < 0.05). Of the participants who died or were institutionalized 62.2% received 2 or more home visits (p<0.001) and 18.9% had 2 or more hospital admissions (p<0.001) versus respectively 18.6% and 3.9% of the participants who completed the study. Of the participants lost to follow-up for other reasons 33.0% received 2 or more home visits (p<0.01) versus 18.6 of the participants who completed the study. Conclusions: Self-report of hospitalizations and GP home visits in a broadly 'healthy' community-dwelling older population seems adequate and efficient. However, as people become older and more functionally impaired, collecting healthcare utilization data from the EMR should be considered to avoid measurement bias, particularly if the data will be used to support economic evaluation.	[van Dalen, Marlies T.; Suijker, Jacqueline J.; van Charante, Eric P. Moll] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [MacNeil-Vroomen, Janet; van Rijn, Marjon; de Rooij, Sophia E.; Buurman, Bianca M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Sect, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Suijker, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.suijker@amc.uva.nl	Vroomen, Janet MacNeil/M-5358-2017; van Charante, Eric Moll/L-4856-2019	Vroomen, Janet MacNeil/0000-0001-6400-7189; van Charante, Eric Moll/0000-0002-1489-5218	Netherlands Organisation for Health Research and development [313020201]	Netherlands Organisation for Health Research and development(Netherlands Organization for Health Research and Development)	This study is funded by The Netherlands Organisation for Health Research and development (no. 313020201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellon JA, 2000, J EPIDEMIOL COMMUN H, V54, P544, DOI 10.1136/jech.54.7.544; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x; BOWNS I, 1991, BRIT J GEN PRACT, V41, P100; Buskens E, 2008, MINIMALE DATA SET AA; Buurman BM, 2011, EUR J EMERG MED, V18, P215, DOI 10.1097/MEJ.0b013e328344597e; Byles JE, 2004, MED J AUSTRALIA, V181, P186, DOI 10.5694/j.1326-5377.2004.tb06233.x; CARSJO K, 1994, J GERONTOL, V49, pS156, DOI 10.1093/geronj/49.3.S156; CLEARY PD, 1984, MED CARE, V22, P796, DOI 10.1097/00005650-198409000-00003; Daniels R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-69; Dendukuri N, 2005, MED CARE, V43, P266, DOI 10.1097/00005650-200503000-00009; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; GLANDON GL, 1992, J GERONTOL, V47, pS245, DOI 10.1093/geronj/47.5.S245; Goossens MEJB, 2000, J CLIN EPIDEMIOL, V53, P688, DOI 10.1016/S0895-4356(99)00177-8; Hebert R, 1996, AGE AGEING, V25, P159; Hebert R, 1997, AM J EPIDEMIOL, V145, P935; Hebert R, 1996, J CLIN EPIDEMIOL, V49, P373, DOI 10.1016/0895-4356(95)00527-7; Hogan DB, 2001, CAN MED ASSOC J, V165, P537; Hoogendoorn M, 2009, INT J TECHNOL ASSESS, V25, P588, DOI 10.1017/S0266462309990432; Huisman M, 2011, INT J EPIDEMIOL, V40, P868, DOI 10.1093/ije/dyq219; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P791, DOI 10.1016/j.jclinepi.2005.12.008; Kjoller M, 2005, EUR J PUBLIC HEALTH, V15, P528, DOI 10.1093/eurpub/cki023; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lutomski JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081673; Mihelic AH, 1997, J GERONTOL B-PSYCHOL, V52, pS37, DOI 10.1093/geronb/52B.1.S37; Oostenbrink JB, 2002, PHARMACOECONOMICS, V20, P443, DOI 10.2165/00019053-200220070-00002; Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Schellevis FG, 2005, J PUBLIC HEALTH-HEID, V13, P265, DOI 10.1007/s10389-005-0124-z; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Stalenhoef PA, 2002, J CLIN EPIDEMIOL, V55, P1088, DOI 10.1016/S0895-4356(02)00502-4; Suijker JJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-85; Tas U, 2007, PREV MED, V44, P272, DOI 10.1016/j.ypmed.2006.11.007; Tas U, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-22; van Hout HPJ, 2010, J GERONTOL A-BIOL, V65, P734, DOI 10.1093/gerona/glq037; Wallihan DB, 1999, MED CARE, V37, P662, DOI 10.1097/00005650-199907000-00006; Wolinsky FD, 2007, MED CARE, V45, P300, DOI 10.1097/01.mlr.0000254576.26353.09	42	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93372	10.1371/journal.pone.0093372	http://dx.doi.org/10.1371/journal.pone.0093372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710075	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800029
J	Yang, WJ; Yuan, GR; Cong, L; Xie, YF; Wang, JJ				Yang, Wen-Jia; Yuan, Guo-Rui; Cong, Lin; Xie, Yi-Fei; Wang, Jin-Jun			De novo Cloning and Annotation of Genes Associated with Immunity, Detoxification and Energy Metabolism from the Fat Body of the Oriental Fruit Fly, Bactrocera dorsalis	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; TREHALOSE-PHOSPHATE-SYNTHASE; MOLECULAR CHARACTERIZATION; DROSOPHILA-MELANOGASTER; BROWN PLANTHOPPER; RNA INTERFERENCE; TRANSCRIPTOME; EXPRESSION; IDENTIFICATION; RESISTANCE	The oriental fruit fly, Bactrocera dorsalis, is a destructive pest in tropical and subtropical areas. In this study, we performed transcriptome-wide analysis of the fat body of B. dorsalis and obtained more than 59 million sequencing reads, which were assembled into 27,787 unigenes with an average length of 591 bp. Among them, 17,442 (62.8%) unigenes matched known proteins in the NCBI database. The assembled sequences were further annotated with gene ontology, cluster of orthologous group terms, and Kyoto encyclopedia of genes and genomes. In depth analysis was performed to identify genes putatively involved in immunity, detoxification, and energy metabolism. Many new genes were identified including serpins, peptidoglycan recognition proteins and defensins, which were potentially linked to immune defense. Many detoxification genes were identified, including cytochrome P450s, glutathione S-transferases and ATP-binding cassette (ABC) transporters. Many new transcripts possibly involved in energy metabolism, including fatty acid desaturases, lipases, alpha amylases, and trehalose-6-phosphate synthases, were identified. Moreover, we randomly selected some genes to examine their expression patterns in different tissues by quantitative real-time PCR, which indicated that some genes exhibited fat body-specific expression in B. dorsalis. The identification of a numerous transcripts in the fat body of B. dorsalis laid the foundation for future studies on the functions of these genes.	[Yang, Wen-Jia; Yuan, Guo-Rui; Cong, Lin; Xie, Yi-Fei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	jjwang7008@yahoo.com			Natural Science Foundation of Chongqing (CSTC) [2013jjB0176]; Program for Changjiang Scholars and Innovative Research Teams in Universities [IRT0976]; Modern Agro-industry (Citrus) Technology Research System; Fundamental Research Funds for the Central Universities of China [XDJK2013A017]	Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Program for Changjiang Scholars and Innovative Research Teams in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Modern Agro-industry (Citrus) Technology Research System; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This research was funded in part by the Natural Science Foundation of Chongqing (CSTC, 2013jjB0176), the Program for Changjiang Scholars and Innovative Research Teams in Universities (IRT0976), the earmarked fund for Modern Agro-industry (Citrus) Technology Research System, and the Fundamental Research Funds for the Central Universities (XDJK2013A017) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Attardo GM, 2006, INSECT MOL BIOL, V15, P411, DOI 10.1111/j.1365-2583.2006.00649.x; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; CABIB E, 1958, J BIOL CHEM, V231, P259; Chamankhah A, 2003, INSECT BIOCHEM MOLEC, V33, P355, DOI 10.1016/S0965-1748(02)00263-1; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Cong L, 2012, FLA ENTOMOL, V95, P650, DOI 10.1653/024.095.0316; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; DUNN PE, 1986, ANNU REV ENTOMOL, V31, P321, DOI 10.1146/annurev.en.31.010186.001541; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feitosa FM, 2006, J INSECT SCI, V6; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; FRIEDMAN S, 1978, ANNU REV ENTOMOL, V23, P389, DOI 10.1146/annurev.en.23.010178.002133; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILBY AR, 1965, ANNU REV ENTOMOL, V10, P141, DOI 10.1146/annurev.en.10.010165.001041; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guz N, 2012, INSECT MOL BIOL, V21, P139, DOI 10.1111/j.1365-2583.2011.01129.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Huang Y, 2013, PESTIC BIOCHEM PHYS, V106, P1, DOI 10.1016/j.pestbp.2013.03.001; Huang YF, 2011, J INSECT PHYSIOL, V57, P1033, DOI 10.1016/j.jinsphys.2011.05.001; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jiang ZH, 2005, OBES RES, V13, P1898, DOI 10.1038/oby.2005.233; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065931; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-491; Liu Y, 2009, ARCH INSECT BIOCHEM, V71, P16, DOI 10.1002/arch.20290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; MATSUI I, 1994, BIOCHEMISTRY-US, V33, P451, DOI 10.1021/bi00168a009; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; PROUDLOCK J W, 1971, Journal of Bioenergetics, V2, P327, DOI 10.1007/BF01963829; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Shen GM, 2013, INSECT MOL BIOL, V22, P354, DOI 10.1111/imb.12026; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Suwanchaichinda C, 2013, INSECT BIOCHEM MOLEC, V43, P555, DOI 10.1016/j.ibmb.2013.03.015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang B, 2010, J INSECT PHYSIOL, V56, P813, DOI 10.1016/j.jinsphys.2010.02.009; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wicker-Thomas C, 1997, INSECT BIOCHEM MOLEC, V27, P963, DOI 10.1016/S0965-1748(97)00077-5; Xie W, 2012, INT J BIOL SCI, V8, P1142, DOI 10.7150/ijbs.4588; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; YU SM, 1991, J BIOL CHEM, V266, P21131; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	59	30	33	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94470	10.1371/journal.pone.0094470	http://dx.doi.org/10.1371/journal.pone.0094470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710118	gold, Green Submitted, Green Published			2022-12-27	WOS:000334159800149
J	Oluka, OC; Nie, SF; Sun, Y				Oluka, Obiageli Crystal; Nie, Shaofa; Sun, Yi			Quality Assessment of TPB-Based Questionnaires: A Systematic Review	PLOS ONE			English	Article							PLANNED BEHAVIOR; PHYSICAL-ACTIVITY; REASONED ACTION; VALIDATION; INSTRUMENT	Objective: This review is aimed at assessing the quality of questionnaires and their development process based on the theory of planned behavior (TPB) change model. Methods: A systematic literature search for studies with the primary aim of TPB-based questionnaire development was conducted in relevant databases between 2002 and 2012 using selected search terms. Ten of 1,034 screened abstracts met the inclusion criteria and were assessed for methodological quality using two different appraisal tools: one for the overall methodological quality of each study and the other developed for the appraisal of the questionnaire content and development process. Both appraisal tools consisted of items regarding the likelihood of bias in each study and were eventually combined to give the overall quality score for each included study. Results: 8 of the 10 included studies showed low risk of bias in the overall quality assessment of each study, while 9 of the studies were of high quality based on the quality appraisal of questionnaire content and development process. Conclusion: Quality appraisal of the questionnaires in the 10 reviewed studies was successfully conducted, highlighting the top problem areas (including: sample size estimation; inclusion of direct and indirect measures; and inclusion of questions on demographics) in the development of TPB-based questionnaires and the need for researchers to provide a more detailed account of their development process.	[Oluka, Obiageli Crystal; Nie, Shaofa; Sun, Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Hubei Province, Peoples R China.	sf_nie@mails.tjmu.edu.cn; sunyi_shyx@163.com						Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Akbayrak B., 2000, HACET U EGIT FAK DER, V18, P1; [Anonymous], 2009, METH DEV NICE PUBL H; Boileau C, 2008, AIDS EDUC PREV, V20, P203, DOI 10.1521/aeap.2008.20.3.203; Cornelio ME, 2009, REV LAT-AM ENFERM, V17, P701, DOI 10.1590/S0104-11692009000500017; COURNEYA KS, 1995, J BEHAV MED, V18, P499, DOI 10.1007/BF01904776; Everitt B, 1996, CAMBRIDGE; Francis J., 2004, CONSTRUCTING QUESTIO, V5th ed.; Francis JJ, 2004, MEASUREMENT ISSUES; French DP, 2003, BRIT J HEALTH PSYCH, V8, P37, DOI 10.1348/135910703762879192; Ghazanfari Z, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-104; Giles M, 2007, J PUBLIC HEALTH-UK, V29, P17, DOI 10.1093/pubmed/fdl083; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Hausenblas HA, 1997, J SPORT EXERCISE PSY, V19, P36, DOI 10.1123/jsep.19.1.36; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Husebo AML, 2013, J CLIN NURS, V22, P4, DOI 10.1111/j.1365-2702.2012.04322.x; Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004; Jalalian M, 2010, SE ASIAN J TROPICAL, V41; Jansen H, 2010, FORUM QUAL SOC RES, V11; Key JP, 1997, QUESTIONNAIRES INTER; Lopez-McKee G, 2010, ONLINE J ISSUES NURS, V16; McColl E, 2001, Health Technol Assess, V5, P1; Mendez RD, 2010, REV ESC ENFERM USP, V44, P584, DOI 10.1590/S0080-62342010000300006; Mulero-Portela AL, 2012, PHYSIOTHER THEORY PR, V1; Steele S, 2005, J NURS MEAS, V13, P23, DOI 10.1891/106137405780954541; Gonzalez ST, 2012, SPAN J PSYCHOL, V15, P801, DOI 10.5209/rev_SJOP.2012.v15.n2.38892	27	25	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94419	10.1371/journal.pone.0094419	http://dx.doi.org/10.1371/journal.pone.0094419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722323	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100069
J	Shin, EH; Roh, JY; Park, WI; Song, BG; Chang, KS; Lee, WG; Lee, HI; Park, C; Park, MY; Shin, EH				Shin, Eun Hee; Roh, Jong Yul; Park, Won Il; Song, Bong Gu; Chang, Kyu-Sik; Lee, Wook-Gyo; Lee, Hee Il; Park, Chan; Park, Mi-Yeoun; Shin, E-Hyun			Transovarial Transmission of Orientia tsutsugamushi in Leptotrombidium palpale (Acari: Trombiculidae)	PLOS ONE			English	Article							RICKETTSIA-TSUTSUGAMUSHI; VERTICAL TRANSMISSION; PALLIDUM; IMPHALUM	Transovarial transmission of Orientia tsutsugamushi in colonies of Leptotrombidium palpale was studied in the parent and F-1 and F2 generations. Both transovarial transmission and filial infection rates were 100% in the parent and F-1 generations of Leptotrombidium palpale. The filial infection rate in the F-1 generation was 100%, but it declined to 94.3% in the F-2 progeny. The sex ratio of the F-1 generation from infected L. palpale was 1:0.8 (male:female) and the proportion of males was relatively high. This study is the first to report on the transovarial transmission of O. tsutsugamushi in L. palpale. High transovarial transmission rates in L. palpale suggest that this species might be one of the major vectors of tsutsugamushi disease in Korea.	[Shin, Eun Hee; Roh, Jong Yul; Park, Won Il; Song, Bong Gu; Chang, Kyu-Sik; Lee, Wook-Gyo; Park, Mi-Yeoun; Shin, E-Hyun] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongwon, South Korea; [Lee, Hee Il] Korea Natl Inst Hlth, Div Biosafety Evaluat & Control, Cheongwon, South Korea; [Park, Chan] Korea Natl Inst Hlth, Div Arboviruses, Ctr Immunol & Pathol, Cheongwon, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Division of Biosafety Evaluation & Control; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Shin, EH (corresponding author), Korea Natl Inst Hlth, Ctr Immunol & Pathol, Div Med Entomol, Cheongwon, South Korea.	ehshin@nih.go.kr	Chang, Kyu-Sik/R-6752-2019; Shin, Eun-Hee/D-5757-2012		Research of Korea Centers for Disease Control and Prevention [211-N55002-22]	Research of Korea Centers for Disease Control and Prevention	This research was supported by a fund (211-N55002-22) by Research of Korea Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Asanuma K., 1959, Japanese Journal of Sanitary Zoology, V10, P232; BURGDORFER W, 1967, ANNU REV ENTOMOL, V12, P347, DOI 10.1146/annurev.en.12.010167.002023; Frances SP, 2001, J MED ENTOMOL, V38, P17, DOI 10.1603/0022-2585-38.1.17; FURUYA Y, 1993, J CLIN MICROBIOL, V31, P1637, DOI 10.1128/JCM.31.6.1637-1640.1993; Kawamura A., 1995, TSUTSUGAMUSHI DIS; Lee HI, 2011, VECTOR-BORNE ZOONOT, V11, P209, DOI 10.1089/vbz.2009.0180; MUNRO-FAURE A D, 1951, J R Army Med Corps, V97, P227; Phasomkusolsil S, 2012, J MED ENTOMOL, V49, P1270, DOI 10.1603/ME12100; Phasomkusolsil S, 2009, J MED ENTOMOL, V46, P1442, DOI 10.1603/033.046.0628; RAPMUND G, 1984, J INFECT DIS, V149, P330, DOI 10.1093/infdis/149.3.330; RAPMUND G, 1972, J MED ENTOMOL, V9, P71, DOI 10.1093/jmedent/9.1.71; REE H-I, 1991, Korean Journal of Parasitology, V29, P87, DOI 10.3347/kjp.1991.29.1.87; Ree Han-Il, 1992, Korean Journal of Parasitology, V30, P341, DOI 10.3347/kjp.1992.30.4.341; Ree HI, 1997, J MED ENTOMOL, V48, P13; ROBERTS LW, 1977, J MED ENTOMOL, V14, P89, DOI 10.1093/jmedent/14.1.89; Takahashi M., 1990, Japanese Journal of Sanitary Zoology, V41, P389; TAKAHASHI M, 1988, JPN J EXP MED, V58, P213; URAKAMI H, 1994, AM J TROP MED HYG, V50, P219, DOI 10.4269/ajtmh.1994.50.219; URAKAMI H, 1994, JPN J MED SCI BIOL, V47, P127, DOI 10.7883/yoken1952.47.127; Wormersley H, 1951, REC S AUSTR MUS, V10, P1	20	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e88453	10.1371/journal.pone.0088453	http://dx.doi.org/10.1371/journal.pone.0088453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721932	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100003
J	Du, XJ; Tang, LL; Mao, YP; Sun, Y; Zeng, MS; Kang, TB; Jia, WH; Lin, AH; Ma, J				Du, Xiao-Jing; Tang, Ling-Long; Mao, Yan-Ping; Sun, Ying; Zeng, Mu-Sheng; Kang, Tie-Bang; Jia, Wei-Hua; Lin, Ai-Hua; Ma, Jun			The Pretreatment Albumin to Globulin Ratio Has Predictive Value for Long-Term Mortality in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							SERUM-ALBUMIN; ANTIINFLAMMATORY DRUGS; CANCER; INFLAMMATION; SURVIVAL; NEUTROPHILS; MANAGEMENT; NUTRITION; PROGNOSIS; PROTEIN	Background: Low serum albumin is predictive of poor survival in nasopharyngeal carcinoma (NPC). We evaluated the ability of the pretreatment albumin/ globulin ratio (AGR) to predict long- term mortality in patients with NPC. Methods: This retrospective study examined an unselected cohort of 694 patients with NPC who had documented pretreatment total serum protein and serum albumin levels (ALB). AGR was calculated as [AGR = ALB/(total serum protein ALB)]. Survival analysis was used to evaluate the predictive value of AGR. Results: Multivariate analysis demonstrated that a low pretreatment serum AGR (< 1.4) was an independent predictor of poor OS (P = 0.029) and DMFS (P = 0.033). A low AGR was significantly associated with advanced stage disease ( P < 0.001), high white blood cell count (P = 0.033), high neutrophil count (P = 0.047), high total serum protein (P < 0.001) and low ALB (P < 0.001). Conclusion: The pretreatment AGR may represent a simple, potentially useful predictive biomarker for evaluating the longterm prognosis of patients with undifferentiated NPC.	[Du, Xiao-Jing; Tang, Ling-Long; Mao, Yan-Ping; Sun, Ying; Ma, Jun] Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Mu-Sheng; Kang, Tie-Bang; Jia, Wei-Hua] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	drmajun@hotmail.com		zeng, musheng/0000-0003-3509-5591	Innovation Team Development Plan of the Ministry of Education of China [IRT1297]; Cultivating Foundation of Education-bureau of Guangdong Province [LYM11001]; Key Laboratory Construction Project of Guangzhou City, China [121800085]	Innovation Team Development Plan of the Ministry of Education of China; Cultivating Foundation of Education-bureau of Guangdong Province; Key Laboratory Construction Project of Guangzhou City, China	This work was supported by grants from the Innovation Team Development Plan of the Ministry of Education of China (IRT1297), the Cultivating Foundation of Education-bureau of Guangdong Province (LYM11001) and the Key Laboratory Construction Project of Guangzhou City, China (No. 121800085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2011, TUMOR BIOL, V32, P317, DOI 10.1007/s13277-010-0124-7; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.007; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Edge SB, 2010, AJCC CANC STAGING MA; Gourzones C, 2012, SEMIN CANCER BIOL, V22, P127, DOI 10.1016/j.semcancer.2012.01.002; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Igarashi T, 2001, JPN J CLIN ONCOL, V31, P13, DOI 10.1093/jjco/hye004; Jin Y, 2013, HEAD NECK IN PRESS; KWONG D, 1994, INT J RADIAT ONCOL, V30, P1029, DOI 10.1016/0360-3016(94)90306-9; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; LAURSEN I, 1990, ANTICANCER RES, V10, P343; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Li G, 2013, HEAD NECK IN PRESS; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Maltoni M, 2002, HEMATOL ONCOL CLIN N, V16, P715, DOI 10.1016/S0889-8588(02)00024-2; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Muir C, 1987, IARC SCI PUBL, V5, P1; Muliawati Yanti, 2012, Acta Med Indones, V44, P154; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Seaton K, 2001, J NATL MED ASSOC, V93, P490; Sonnenschein C, 1996, J STEROID BIOCHEM, V59, P147, DOI 10.1016/S0960-0760(96)00112-4; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057; Xia WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076958; Xia WX, 2013, EUR J CANCER, V49, P2152, DOI 10.1016/j.ejca.2013.03.003	36	97	101	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94473	10.1371/journal.pone.0094473	http://dx.doi.org/10.1371/journal.pone.0094473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718309	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000124
J	Moon, S; Cho, SB				Moon, Seongwuk; Cho, Seong Beom			Differential Impact of Science Policy on Subfields of Human Embryonic Stem Cell Research	PLOS ONE			English	Article							LINES	In this research, we examine how restrictive policy influenced performance in human embryonic stem cell research (hESC) between 1998 and 2008. In previous research, researchers argued whether restrictive policy decreased the performance of stem cell research in some nations, especially in the US. Here, we hypothesize that this policy influenced specific subfields of the hESC research. To investigate the selective policy effects, we categorize hESC research publications into three subfields-derivation, differentiation, and medical application research. Our analysis shows that restrictive policy had different effects on different subfields. In general, the US outperformed in overall hESC research throughout these periods. In the derivation of hESC, however, the US almost lost its competence under restrictive policy. Interestingly, the US scientific community showed prominent resilience in hESC research through international collaboration. We concluded that the US resilience and performance stemmed from the wide breadth of research portfolio of US scientists across the hESC subfields, combined with their strategic efforts to collaborate internationally on derivation research.	[Moon, Seongwuk] Sogang Univ, Grad Sch Management Technol, Seoul, South Korea; [Cho, Seong Beom] KCDC, Natl Inst Hlth, Ctr Genome Sci, Div Biomed Informat, Chungcheongbuk Do, South Korea	Sogang University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Moon, S (corresponding author), Sogang Univ, Grad Sch Management Technol, Seoul, South Korea.	seongwuk@gmail.com; sbcho@korea.kr			KDI School of Public Policy and Management, Seoul, Korea; Sogang University [201310008.01]	KDI School of Public Policy and Management, Seoul, Korea; Sogang University	Seongwuk Moon is grateful for the financial support from KDI School of Public Policy and Management, Seoul, Korea. This work was supported by the Sogang University Research Grant of 2013 (201310008.01). Seongwuk Moon is grateful for this financial support from Sogang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furman JL, 2012, J POLICY ANAL MANAG, V31, P661, DOI 10.1002/pam.21644; Guhr A, 2006, STEM CELLS, V24, P2187, DOI 10.1634/stemcells.2006-0053; Korobkin Russell, 2007, STEM CELL CENTURY LA; Levine AD, 2008, CELL STEM CELL, V2, P521, DOI 10.1016/j.stem.2008.05.008; Loser P, 2010, STEM CELLS, V28, P240, DOI 10.1002/stem.286; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Scott CT, 2006, STEM CELL NOW FORM E; Smith JO, 2006, NAT BIOTECHNOL, V24, P391, DOI 10.1038/nbt0406-391; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	10	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e86395	10.1371/journal.pone.0086395	http://dx.doi.org/10.1371/journal.pone.0086395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717403	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000003
J	Rehman, SU; Yaseen, Z; Husain, MA; Sarwar, T; Ishqi, HM; Tabish, M				Rehman, Sayeed Ur; Yaseen, Zahid; Husain, Mohammed Amir; Sarwar, Tarique; Ishqi, Hassan Mubarak; Tabish, Mohammad			Interaction of 6 Mercaptopurine with Calf Thymus DNA - Deciphering the Binding Mode and Photoinduced DNA Damage	PLOS ONE			English	Article							MIXED-LIGAND COMPLEXES; CIRCULAR-DICHROISM; NUCLEIC-ACIDS; FLUORESCENCE-SPECTRA; METAL-COMPLEXES; GROOVE BINDING; TARGETS; RUTHENIUM(II); INTERCALATION; HOECHST-33258	DNA is one of the major intracellular targets for a wide range of anticancer and antibiotic drugs. Elucidating the binding between small molecules and DNA provides great help in understanding drug-DNA interactions and in designing of new and promising drugs for clinical use. The ability of small molecules to bind and interfere with DNA replication and transcription provides further insight into how the drugs control the expression of genes. Interaction of an antimetabolite anticancer drug 6mercaptopurine (6MP) with calf thymus DNA was studied using various approaches like UV-visible spectroscopy, fluorescence spectroscopy, CD, viscosity and molecular docking. UV-visible spectroscopy confirmed 6MP-DNA interaction. Steady state fluorescence experiments revealed a moderate binding constant of 7.48x10(3) M-1 which was consistent with an external binding mode. Competitive displacement assays further confirmed a non-intercalative binding mode of 6MP which was further confirmed by CD and viscosity experiments. Molecular docking further revealed the minimum energy conformation (-119.67 kJ/mole) of the complex formed between DNA and 6MP. Hence, the biophysical techniques and in-silico molecular docking approaches confirmed the groove binding/electrostatic mode of interaction between 6MP and DNA. Further, photo induced generation of ROS by 6MP was studied spectrophotometrically and DNA damage was assessed by plasmid nicking and comet assay. There was a significant increase in ROS generation and consequent DNA damage in the presence of light.	[Rehman, Sayeed Ur; Husain, Mohammed Amir; Sarwar, Tarique; Ishqi, Hassan Mubarak; Tabish, Mohammad] AM Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India; [Yaseen, Zahid] AM Univ, Fac Sci, Dept Chem, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Tabish, M (corresponding author), AM Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India.	tabish.bcmlab@gmail.com	Husain, Mohammed/E-3246-2017	Husain, Mohammed Amir/0000-0003-3488-2710; Ishqi, Hassan Mubarak/0000-0003-0939-0271	Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	The authors are thankful to the Council of Scientific and Industrial Research, New Delhi, for the award of CSIR-SRF fellowship to SUR and A.M.U., Aligarh for providing the necessary facilities. They also thank University Grants Commission, New Delhi for providing financial assistance to their department under the DRS-III program and Advance Instrumentation Research Facility, Jawaharlal Nehru University, New Delhi, where CD experiments were performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonincontro A, 2008, LANGMUIR, V24, P1973, DOI 10.1021/la701730h; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; Chen QG, 1999, ANALYST, V124, P901, DOI 10.1039/a901174i; Ding YH, 2010, J PHYS CHEM B, V114, P2033, DOI 10.1021/jp9104757; Dong C, 2003, SPECTROCHIM ACTA A, V59, P3131, DOI 10.1016/S1386-1425(03)00121-5; Elder RM, 2011, BIOMACROMOLECULES, V12, P3870, DOI 10.1021/bm201113y; Guan Y, 2006, ANAL CHIM ACTA, V570, P21, DOI 10.1016/j.aca.2006.03.106; HILLEN W, 1980, NUCLEIC ACIDS RES, V8, P5427, DOI 10.1093/nar/8.22.5427; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; Jain SS, 2003, NUCLEIC ACIDS RES, V31, P4608, DOI 10.1093/nar/gkg648; Kakkar R, 2002, J MOL STRUC-THEOCHEM, V579, P109, DOI 10.1016/S0166-1280(01)00721-7; Kashanian S, 2010, EUR FOOD RES TECHNOL, V230, P821, DOI 10.1007/s00217-010-1226-6; Kim Hyung-Lae, 2006, Genomics & Informatics, V4, P16; KUMAR CV, 1992, J CHEM SOC CHEM COMM, P470, DOI 10.1039/c39920000470; KUMAR CV, 1993, J PHOTOCH PHOTOBIO A, V74, P231, DOI 10.1016/1010-6030(93)80121-O; Kypr J, 2002, BIOPOLYMERS, V67, P275, DOI 10.1002/bip.10112; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Li JF, 2009, TALANTA, V77, P1043, DOI 10.1016/j.talanta.2008.08.012; Liu HK, 2011, ACCOUNTS CHEM RES, V44, P349, DOI 10.1021/ar100140e; Liu YJ, 2008, SPECTROCHIM ACTA A, V70, P171, DOI 10.1016/j.saa.2007.07.029; Maheswari PU, 2004, J INORG BIOCHEM, V98, P219, DOI 10.1016/j.jinorgbio.2003.09.003; Maniatis T., 1982, MOL CLONING; MERGNY JL, 1992, SCIENCE, V256, P1681, DOI 10.1126/science.256.5064.1681; NAKAYAMA T, 1983, CARCINOGENESIS, V4, P765, DOI 10.1093/carcin/4.6.765; Nejedly K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni008; Onoue S, 2009, CURR DRUG SAF, V4, P123, DOI 10.2174/157488609788173044; PILCH DS, 1995, BIOCHEMISTRY-US, V34, P9962, DOI 10.1021/bi00031a019; POOLZOBEL BL, 1993, FOOD CHEM TOXICOL, V31, P271, DOI 10.1016/0278-6915(93)90077-C; PYLE AM, 1989, J AM CHEM SOC, V111, P3051, DOI 10.1021/ja00190a046; Rafique B, 2013, BIOSENS BIOELECTRON, V44, P21, DOI 10.1016/j.bios.2012.12.028; Rahban M, 2010, J PHYS CHEM C, V114, P5798, DOI 10.1021/jp910656g; Rauf S, 2005, J PHARMACEUT BIOMED, V37, P205, DOI 10.1016/j.jpba.2004.10.037; SATYANARAYANA S, 1993, BIOCHEMISTRY-US, V32, P2573, DOI 10.1021/bi00061a015; SATYANARAYANA S, 1992, BIOCHEMISTRY-US, V31, P9319, DOI 10.1021/bi00154a001; Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w; Singh N.P., 1998, EXP CELL RES, V17, P184, DOI DOI 10.1016/0014-4827(88)90265-0; Song YM, 2000, SPECTROCHIM ACTA A, V56, P2491, DOI 10.1016/S1386-1425(00)00340-1; SPRECHER CA, 1979, BIOPOLYMERS, V18, P1009, DOI 10.1002/bip.1979.360180418; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Taki K, 2013, J TOXICOL SCI, V38, P159, DOI 10.2131/jts.38.159; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tsiliki P, 2013, POLYHEDRON, V53, P215, DOI 10.1016/j.poly.2013.01.049; Vorlickova M, 1995, BIOPHYS J, V69, P2033, DOI 10.1016/S0006-3495(95)80073-1; Wang Y, 2009, INORG CHIM ACTA, V362, P377, DOI 10.1016/j.ica.2008.04.017	48	107	108	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93913	10.1371/journal.pone.0093913	http://dx.doi.org/10.1371/journal.pone.0093913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718609	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000057
J	Backfisch, B; Kozin, VV; Kirchmaier, S; Tessmar-Raible, K; Raible, F				Backfisch, Benjamin; Kozin, Vitaly V.; Kirchmaier, Stephan; Tessmar-Raible, Kristin; Raible, Florian			Tools for Gene-Regulatory Analyses in the Marine Annelid Platynereis dumerilii	PLOS ONE			English	Article							TRANSPOSON MEDIATED TRANSGENESIS; IN-SITU HYBRIDIZATION; ENHANCER DETECTION; GERM-LINE; CIONA-INTESTINALIS; CELL-TYPES; EVOLUTION; GENOME; TRANSFORMATION; REGISTRATION	The advent of high-throughput sequencing technology facilitates the exploration of a variety of reference species outside the few established molecular genetic model systems. Bioinformatic and gene expression analyses provide new ways for comparative analyses between species, for instance, in the field of evolution and development. Despite these advances, a critical bottleneck for the exploration of new model species remains the establishment of functional tools, such as the ability to experimentally express genes in specific cells of an organism. We recently established a first transgenic strain of the annelid Platynereis, using a Tc1/mariner-type Mos1 transposon vector. Here, we compare Mos1 with Tol2, a member of the hAT family of transposons. In Platynereis, Tol2-based constructs showed a higher frequency of nuclear genome insertion and sustained gene expression in the G0 generation. However, in contrast to Mos1-mediated transgenes, Tol2-mediated insertions failed to retain fluorescence in the G1 generation, suggesting a germ line-based silencing mechanism. Furthermore, we present three novel expression constructs that were generated by a simple fusion-PCR approach and allow either ubiquitous or cell-specific expression of a reporter gene. Our study indicates the versatility of Tol2 for transient transgenesis, and provides a template for transgenesis work in other emerging reference species.	[Backfisch, Benjamin; Kozin, Vitaly V.; Kirchmaier, Stephan; Tessmar-Raible, Kristin; Raible, Florian] Univ Vienna, MFPL, Vienna, Austria; [Backfisch, Benjamin; Tessmar-Raible, Kristin; Raible, Florian] Univ Vienna, Res Platform Marine Rhythms Life, Vienna, Austria; [Kozin, Vitaly V.] St Petersburg State Univ, Dept Embryol, St Petersburg 199034, Russia	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; Saint Petersburg State University	Raible, F (corresponding author), Univ Vienna, MFPL, Vienna, Austria.	florian.raible@mfpl.ac.at	Raible, Florian/G-6019-2011; Tessmar-Raible, Kristin/F-9642-2011; Kozin, Vitaly V./J-5047-2012	Tessmar-Raible, Kristin/0000-0002-8038-1741; Kozin, Vitaly V./0000-0003-1109-3508; Raible, Florian/0000-0002-4515-6485; Kirchmaier, Stephan/0000-0002-3870-8624	Research Platform "Marine Rhythms of Life"; University of Vienna; Research the Austrian Science Fund [(FWF): AY0041321]; European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC [260304]; Austrian Science Fund (FWF) [Y 413] Funding Source: researchfish	Research Platform "Marine Rhythms of Life"; University of Vienna; Research the Austrian Science Fund; European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Our work was supported by the Research Platform "Marine Rhythms of Life" as well as start-up funds of the University of Vienna (to F. R. and K.T.-R.), and the Research the Austrian Science Fund (FWF): AY0041321 (to K.T.-R.). The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 260304 (to F. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Allende ML, 2006, METHODS, V39, P212, DOI 10.1016/j.ymeth.2005.12.005; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Asadulina A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-27; Backfisch B, 2013, P NATL ACAD SCI USA, V110, P193, DOI 10.1073/pnas.1209657109; Bannister S, 2014, GENETICS, V197, P77, DOI 10.1534/genetics.113.161091; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Bolker J, 2012, NATURE, V491, P31, DOI 10.1038/491031a; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cuypers MG, 2013, NUCLEIC ACIDS RES, V41, P2020, DOI 10.1093/nar/gks1295; Davidson EH, 2006, REG GEN GEN REG; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hauenschild C., 1969, PLATYNEREIS DUMERILI; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Hozumi A, 2013, DEV DYNAM, V242, P30, DOI 10.1002/dvdy.23891; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Jaillet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043365; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Kerner P, 2009, EVOL DEV, V11, P513, DOI 10.1111/j.1525-142X.2009.00359.x; Kines KJ, 2008, FASEB J, V22, P2936, DOI 10.1096/fj.08-108308; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mates L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S1; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Mongin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019747; Nam JM, 2010, P NATL ACAD SCI USA, V107, P3930, DOI 10.1073/pnas.1000147107; Pavlopoulos A, 2005, P NATL ACAD SCI USA, V102, P7888, DOI 10.1073/pnas.0501101102; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; RASSOULZADEGAN M, 1986, CELL, V46, P513, DOI 10.1016/0092-8674(86)90876-7; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Sasakura Y, 2008, DEV DYNAM, V237, P39, DOI 10.1002/dvdy.21333; Sasakura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S3; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Simakov O, 2013, BRIEF FUNCT GENOMICS, V12, P430, DOI 10.1093/bfgp/els049; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Veedin-Rajan VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075811; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	56	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93076	10.1371/journal.pone.0093076	http://dx.doi.org/10.1371/journal.pone.0093076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714200	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900014
J	Davila, JL; Goff, LA; Ricupero, CL; Camarillo, C; Oni, EN; Swerdel, MR; Toro-Ramos, AJ; Li, JL; Hart, RP				Davila, Jonathan L.; Goff, Loyal A.; Ricupero, Christopher L.; Camarillo, Cynthia; Oni, Eileen N.; Swerdel, Mavis R.; Toro-Ramos, Alana J.; Li, Jiali; Hart, Ronald P.			A Positive Feedback Mechanism That Regulates Expression of miR-9 during Neurogenesis	PLOS ONE			English	Article							II HISTONE DEACETYLASES; LONG NONCODING RNAS; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTOR; MICRORNA EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; MEF2	MiR-9, a neuron-specific miRNA, is an important regulator of neurogenesis. In this study we identify how miR-9 is regulated during early differentiation from a neural stem-like cell. We utilized two immortalized rat precursor clones, one committed to neurogenesis (L2.2) and another capable of producing both neurons and non-neuronal cells (L2.3), to reproducibly study early neurogenesis. Exogenous miR-9 is capable of increasing neurogenesis from L2.3 cells. Only one of three genomic loci capable of encoding miR-9 was regulated during neurogenesis and the promoter region of this locus contains sufficient functional elements to drive expression of a luciferase reporter in a developmentally regulated pattern. Furthermore, among a large number of potential regulatory sites encoded in this sequence, Mef2 stood out because of its known pro-neuronal role. Of four Mef2 paralogs, we found only Mef2C mRNA was regulated during neurogenesis. Removal of predicted Mef2 binding sites or knockdown of Mef2C expression reduced miR-9-2 promoter activity. Finally, the mRNA encoding the Mef2C binding partner HDAC4 was shown to be targeted by miR-9. Since HDAC4 protein could be co-immunoprecipitated with Mef2C protein or with genomic Mef2 binding sequences, we conclude that miR-9 regulation is mediated, at least in part, by Mef2C binding but that expressed miR-9 has the capacity to reduce inhibitory HDAC4, stabilizing its own expression in a positive feedback mechanism.	[Hart, Ronald P.] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08855 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Hart, RP (corresponding author), Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08855 USA.	rhart@rci.rutgers.edu	li, Jiali/HGF-2395-2022; Hart, Ronald P/D-5219-2009; Hart, Ronald P/G-6530-2019	li, Jiali/0000-0001-6202-7741; Hart, Ronald P/0000-0003-4836-8712; Hart, Ronald P/0000-0003-4836-8712; Goff, Loyal/0000-0003-2875-451X; Li, Jiali/0000-0002-0039-3671	National Institutes of Health (NIH) [R21 MH085088]; New Jersey Commission for Science and Technology; New Jersey Commission on Spinal Cord Research; National Science Foundation (NSF) IGERT training grant; NIH Pipeline Grant [5R25GM055145]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission for Science and Technology; New Jersey Commission on Spinal Cord Research; National Science Foundation (NSF) IGERT training grant(National Science Foundation (NSF)); NIH Pipeline Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institutes of Health (NIH) (R21 MH085088) and the New Jersey Commission for Science and Technology. JD and CC were supported by fellowships from the New Jersey Commission on Spinal Cord Research; CLR was supported by a National Science Foundation (NSF) IGERT training grant; EO was supported by an NIH Pipeline Grant (5R25GM055145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00014; Annibali D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040269; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bonev B, 2012, CELL REPORTS, V2, P10, DOI 10.1016/j.celrep.2012.05.017; Bonev B, 2011, DEV CELL, V20, P19, DOI 10.1016/j.devcel.2010.11.018; Campbell GRO, 2011, MOL CELL NEUROSCI, V46, P548, DOI 10.1016/j.mcn.2010.12.012; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cho EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024027; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Coolen M, 2012, DEV CELL, V22, P1052, DOI 10.1016/j.devcel.2012.03.003; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Goff Loyal A, 2007, J Biomol Tech, V18, P205; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Han R, 2012, NEUROSCI LETT, V515, P147, DOI 10.1016/j.neulet.2012.03.032; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li HD, 2004, DEV BIOL, V271, P225, DOI 10.1016/j.ydbio.2004.02.028; Li H, 2008, GLIA, V56, P646, DOI 10.1002/glia.20643; Li HD, 2008, DEV NEUROBIOL, V68, P1549, DOI 10.1002/dneu.20679; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Lin X, 1996, MOL BRAIN RES, V42, P307, DOI 10.1016/S0169-328X(96)00135-0; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Skreka K, 2012, NUCLEIC ACIDS RES, V40, P6001, DOI 10.1093/nar/gks311; Smith B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011109; Tan SL, 2012, GENES CELLS, V17, P952, DOI 10.1111/gtc.12009; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhao CN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01329; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200	62	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94348	10.1371/journal.pone.0094348	http://dx.doi.org/10.1371/journal.pone.0094348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714615	gold, Green Submitted, Green Published			2022-12-27	WOS:000334160900122
J	Pan, T; Wu, SX; He, X; Luo, HH; Zhang, YJ; Fan, MM; Geng, GN; Clarke Ruiz, V; Zhang, J; Mills, L; Bai, C; Zhang, H				Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Clarke Ruiz, Vivian; Zhang, Jim; Mills, Lisa; Bai, Chuan; Zhang, Hui			Necroptosis Takes Place in Human Immunodeficiency Virus Type-1 (HIV-1)-Infected CD4(+) T Lymphocytes	PLOS ONE			English	Article							HTLV-III/LAV ENVELOPE; MIXED LINEAGE KINASE; CELL-DEATH; HIV-1 TAT; PROGRAMMED NECROSIS; CHEMOKINE RECEPTORS; SIGNALING PATHWAYS; DOMAIN-LIKE; APOPTOSIS; MECHANISMS	Human immunodeficiency virus type 1 (HIV-1) infection is characterized by progressive depletion of CD4(+) T lymphocytes and dysfunction of the immune system. The numbers of CD4(+) T lymphocytes in the human body are maintained constantly by homeostatic mechanisms that failed during HIV-1 infection, resulting in progressive loss of CD4(+) T cells mainly via apoptosis. Recently, a non-apoptotic form of necrotic programmed cell death, named necroptosis, has been investigated in many biological and pathological processes. We then determine whether HIV-1-infected cells also undergo necroptosis. In this report, we demonstrate that HIV-1 not only induces apoptosis, but also mediates necroptosis in the infected primary CD4(+) T lymphocytes and CD4(+) T-cell lines. Necroptosis-dependent cytopathic effects are significantly increased in HIV-1-infected Jurkat cells that is lack of Fas-associated protein-containing death domain (FADD), indicating that necroptosis occurs as an alternative cell death mechanism in the absence of apoptosis. Unlike apoptosis, necroptosis mainly occurs in HIV-infected cells and spares bystander damage. Treatment with necrostatin-1(Nec-1), a RIP1 inhibitor that specifically blocks the necroptosis pathway, potently restrains HIV-1-induced cytopathic effect and interestingly, inhibits the formation of HIV-induced syncytia in CD4(+) T-cell lines. This suggests that syncytia formation is mediated, at least partially, by necroptosis-related processes. Furthermore, we also found that the HIV-1 infection-augmented tumor necrosis factor-alpha (TNF-alpha) plays a key role in inducing necroptosis and HIV-1 Envelope and Tat proteins function as its co-factors. Taken together, necroptosis can function as an alternative cell death pathway in lieu of apoptosis during HIV-1 infection, thereby also contributing to HIV-1-induced cytopathic effects. Our results reveal that in addition to apoptosis, necroptosis also plays an important role in HIV-1-induced pathogenesis.	[Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Bai, Chuan; Zhang, Hui] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Bai, Chuan; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Clarke Ruiz, Vivian; Zhang, Jim; Mills, Lisa] Thomas Jefferson Univ, Ctr Human Virol, Dept Med, Div Infect Dis, Philadelphia, PA 19107 USA	Sun Yat Sen University; Sun Yat Sen University; Jefferson University	Bai, C (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China.	baichuan@mail.sysu.edu.cn; hz08043@gmail.com	Zhang, Yijun/J-5485-2017; Pan, Ting/AAX-1933-2021	Zhang, Yijun/0000-0001-7971-2200; He, Xin/0000-0002-2131-2092; Pan, Ting/0000-0002-7106-7312	Guangdong Recruitment Program of Creative Research Groups [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; Natural Science Foundation of China [30972620]; Natural Science Foundation of Guangdong [9251008901000022]	Guangdong Recruitment Program of Creative Research Groups; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was funded by the grants from Guangdong Recruitment Program of Creative Research Groups (NO. 2009010058), National Basic Research Program of China (973 Program) (No. 2010CB912202), Natural Science Foundation of China (No. 30972620), Natural Science Foundation of Guangdong (No. 9251008901000022) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Bennasser Y, 2002, VIROLOGY, V303, P174, DOI 10.1006/viro.2002.1676; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BRODER CC, 1995, P NATL ACAD SCI USA, V92, P9004, DOI 10.1073/pnas.92.19.9004; Chan FKM, 2012, CELL, V148, P17, DOI 10.1016/j.cell.2011.12.020; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Chu WM, 2012, CANC LETT; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huerta L, 2009, THESCIENTIFICWORLDJO, V9, P746, DOI 10.1100/tsw.2009.90; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; MELLORS JW, 1991, J INFECT DIS, V163, P78, DOI 10.1093/infdis/163.1.78; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Miao BC, 2009, METHODS MOL BIOL, V559, P79, DOI 10.1007/978-1-60327-017-5_6; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; PUMAROLASUNE T, 1987, ANN NEUROL, V21, P490, DOI 10.1002/ana.410210513; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Scheinberg MA, 2012, NAT REV RHEUMATOL, V8, P430, DOI 10.1038/nrrheum.2012.84; SHARER LR, 1986, HUM PATHOL, V17, P271, DOI 10.1016/S0046-8177(83)80220-2; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Teng X, 2005, BIOORG MED CHEM LETT, V15, P5039, DOI 10.1016/j.bmcl.2005.07.077; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; WESSELINGH SL, 1993, ANN NEUROL, V33, P576, DOI 10.1002/ana.410330604; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Zhou ZR, 2012, PROTEIN CELL, V3, P811, DOI 10.1007/s13238-012-2083-9	62	45	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93944	10.1371/journal.pone.0093944	http://dx.doi.org/10.1371/journal.pone.0093944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714696	Green Submitted, gold, Green Published			2022-12-27	WOS:000334160900065
J	Raykova, D; Klar, J; Azhar, A; Khan, TN; Malik, NA; Iqbal, M; Tariq, M; Baig, SM; Dahl, N				Raykova, Doroteya; Klar, Joakim; Azhar, Aysha; Khan, Tahir Naeem; Malik, Naveed Altaf; Iqbal, Muhammad; Tariq, Muhammad; Baig, Shahid Mahmood; Dahl, Niklas			Autosomal Recessive Transmission of a Rare KRT74 Variant Causes Hair and Nail Ectodermal Dysplasia: Allelism with Dominant Woolly Hair/Hypotrichosis	PLOS ONE			English	Article							PURE HAIR; GENE; KERATINS; EXPRESSION; HOXC13; MUTATIONS; MATRIX; UNIT	Pure hair and nail ectodermal dysplasia (PHNED) comprises a heterogeneous group of rare heritable disorders characterized by brittle hair, hypotrichosis, onychodystrophy and micronychia. Autosomal recessive (AR) PHNED has previously been associated with mutations in either KRT85 or HOXC13 on chromosome 12p11.1-q14.3. We investigated a consanguineous Pakistani family with AR PHNED linked to the keratin gene cluster on 12p11.1 but without detectable mutations in KRT85 and HOXC13. Whole exome sequencing of affected individuals revealed homozygosity for a rare c.821T> C variant (p.Phe274Ser) in the KRT74 gene that segregates AR PHNED in the family. The transition alters the highly conserved Phe274 residue in the coil 1B domain required for long-range dimerization of keratins, suggesting that the mutation compromises the stability of intermediate filaments. Immunohistochemical (IHC) analyses confirmed a strong keratin-74 expression in the nail matrix, the nail bed and the hyponychium of mouse distal digits, as well as in normal human hair follicles. Furthermore, hair follicles and epidermis of an affected family member stained negative for Keratin-74 suggesting a loss of function mechanism mediated by the Phe274Ser substitution. Our observations show for the first time that homozygosity for a KRT74 missense variant may be associated with AR PHNED. Heterozygous KRT74 mutations have previously been associated with autosomal dominant woolly hair/ hypotrichosis simplex (ADWH). Thus, our findings expand the phenotypic spectrum associated with KRT74 mutations and imply that a subtype of AR PHNED is allelic with ADWH.	[Raykova, Doroteya; Klar, Joakim; Dahl, Niklas] Uppsala Univ, Biomed Ctr, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Azhar, Aysha; Khan, Tahir Naeem; Malik, Naveed Altaf; Tariq, Muhammad; Baig, Shahid Mahmood] Natl Inst Biotechnol & Genet Engn, Hlth Biotechnol Div, Human Mol Genet Lab, Faisalabad, Pakistan; [Iqbal, Muhammad] Nucl Med Hosp, Punjab Inst, Dept Nucl Med, Faisalabad, Pakistan	Uppsala University; Pakistan Institute of Engineering & Applied Science	Dahl, N (corresponding author), Uppsala Univ, Biomed Ctr, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	Niklas.Dahl@igp.uu.se	Klar, Joakim/H-2900-2019; Tariq, Muhammad/I-4992-2013; BAig, Shahid Mahmood/AAS-8365-2020; Baig, Shahid Mahmood/I-7309-2015	Klar, Joakim/0000-0003-4185-7409; Tariq, Muhammad/0000-0002-5334-403X; Khan, Tahir/0000-0003-3096-8795; Iqbal, Muhammad/0000-0001-7202-6670	Swedish Research Council [K2013-66X-10829-20-3]; Uppsala University Hospital, funds at Uppsala University; Science for Life Laboratory; Swedish Society for Medical Reserach	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University Hospital, funds at Uppsala University; Science for Life Laboratory; Swedish Society for Medical Reserach	This work was supported by grants from the Swedish Research Council (K2013-66X-10829-20-3), Uppsala University Hospital, funds at Uppsala University and the Science for Life Laboratory. JK is supported by the Swedish Society for Medical Reserach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbareschi M, 1997, AM J MED GENET, V72, P91, DOI 10.1002/(SICI)1096-8628(19971003)72:1<91::AID-AJMG19>3.0.CO;2-P; Barthelemy NR, 2012, ANAL BIOCHEM, V421, P43, DOI 10.1016/j.ab.2011.10.011; CALZAVARAPINTON P, 1991, DERMATOLOGICA, V182, P184, DOI 10.1159/000247779; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Cui CY, 2013, J INVEST DERMATOL, V133, P1990, DOI 10.1038/jid.2013.84; Farooq M, 2013, HUM MUTAT, V34, P578, DOI 10.1002/humu.22271; Gauster M, 2013, HISTOL HISTOPATHOL, V28, P817, DOI 10.14670/HH-28.817; Harrison Shannon, 2004, Australas J Dermatol, V45, P103, DOI 10.1111/j.1440-0960.2004.00055.x; Irvine AD, 2009, AM J MED GENET A, V149A, P1970, DOI 10.1002/ajmg.a.32852; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lin ZM, 2012, AM J HUM GENET, V91, P906, DOI 10.1016/j.ajhg.2012.08.029; Maity B, 2012, METHOD CELL BIOL, V113, P81, DOI 10.1016/B978-0-12-407239-8.00005-7; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; Naeem M, 2006, J MED GENET, V43, P274, DOI 10.1136/jmg.2005.033381; Naeem M, 2006, BRIT J DERMATOL, V155, P1184, DOI 10.1111/j.1365-2133.2006.07509.x; Perrin C, 2004, BRIT J DERMATOL, V151, P362, DOI 10.1111/j.1365-2133.2004.06108.x; PINHEIRO M, 1992, CLIN GENET, V41, P296; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Rasool M, 2010, EUR J DERMATOL, V20, P443, DOI 10.1684/ejd.2010.0962; Rice RH, 2011, J COSMET SCI, V62, P229; Shimomura Y, 2010, AM J HUM GENET, V86, P632, DOI 10.1016/j.ajhg.2010.02.025; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Talas U, 2000, J INVEST DERMATOL, V114, P165, DOI 10.1046/j.1523-1747.2000.00825.x; Wasif N, 2011, HUM GENET, V129, P419, DOI 10.1007/s00439-010-0938-9; Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539	31	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93607	10.1371/journal.pone.0093607	http://dx.doi.org/10.1371/journal.pone.0093607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714551	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900039
J	Shi, YJ; Frost, P; Hoang, B; Yang, YH; Bardeleben, C; Gera, J; Lichtenstein, A				Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan			MNK1-Induced eIF-4E Phosphorylation in Myeloma Cells: A Pathway Mediating IL-6-Induced Expansion and Expression of Genes Involved in Metabolic and Proteotoxic Responses	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MULTIPLE-MYELOMA; BINDING-PROTEIN; IN-VIVO; MNK1; TRANSLATION; INITIATION; EIF4E; TRANSFORMATION; INHIBITORS	Because multiple myeloma (MM) cells are at risk for endoplasmic reticulum (ER) stress, they require a carefully regulated mechanism to promote protein translation of selected transcripts when proliferation is stimulated. MAPK-interacting kinases (MNKs) may provide this mechanism by enhancing cap-dependent translation of a small number of critical transcripts. We, thus, tested whether MNKs played a role in MM responses to the myeloma growth factor interleukin-6 (IL-6). IL-6 activated MNK1 phosphorylation and induced phosphorylation of its substrate, eIF-4E, in MM lines and primary specimens. MNK paralysis, achieved pharmacologically or by shRNA, prevented MM expansion stimulated by IL-6. A phosphodefective eIF-4E mutant also prevented the IL-6 response, supporting the notion that MNK's role was via phosphorylation of eIF-4E. Both pharmacological MNK inhibition and expression of the phosphodefective eIF-4E mutant inhibited MM growth in mice. Although critical for IL-6-induced expansion, eIF-4E phosphorylation had no significant effect on global translation or Ig expression. Deep sequencing of ribosome-protected mRNAs revealed a repertoire of genes involved in metabolic processes and ER stress modulation whose translation was regulated by eIF-4E phosphorylation. These data indicate MM cells exploit the MNK/eIF-4E pathway for selective mRNA translation without enhancing global translation and risking ER stress.	[Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan] Greater Los Angeles VA Healthcare Ctr, Dept Med Hematol Oncol, Los Angeles, CA 90073 USA; [Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Lichtenstein, A (corresponding author), Greater Los Angeles VA Healthcare Ctr, Dept Med Hematol Oncol, Los Angeles, CA 90073 USA.	alan.lichtenstein@med.va.gov		Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [2RO1CA111448, 1RO1CA132778, 1R21CA168491]; Veteran's Administration; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R21CA168491, R01CA168700, R01CA132778, R01CA111448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health grants 2RO1CA111448, 1RO1CA132778 and 1R21CA168491; research funds of the Veteran's Administration; The Multiple Myeloma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BILLADEAU D, 1995, CANCER RES, V55, P3640; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Clendening JW, 2010, BLOOD, V115, P4787, DOI 10.1182/blood-2009-07-230508; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Frost P, 2007, ONCOGENE, V26, P2255, DOI 10.1038/sj.onc.1210019; Frost P, 2004, BLOOD, V104, P4181, DOI 10.1182/blood-2004-03-1153; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JERNBERGWIKLUND H, 1992, LEUKEMIA, V6, P310; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Munshi NC, 2004, BLOOD, V103, P1799, DOI 10.1182/blood-2003-02-0402; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogata A, 1997, J IMMUNOL, V159, P2212; Parra JL, 2005, J BIOL CHEM, V280, P37623, DOI 10.1074/jbc.M508356200; Paulin FEM, 1996, ONCOGENE, V13, P505; Pellagatti A, 2003, CANCER RES, V63, P3940; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Suzuki A, 2005, ONCOGENE, V24, P6936, DOI 10.1038/sj.onc.1208844; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wen XY, 1999, INT J ONCOL, V15, P173; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Worch J, 2004, ONCOGENE, V23, P9162, DOI 10.1038/sj.onc.1208164; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986	42	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94011	10.1371/journal.pone.0094011	http://dx.doi.org/10.1371/journal.pone.0094011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714040	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900070
J	Wang, X; Huang, Y; Niu, SB; Jiang, BG; Jia, N; van der Geest, L; Ni, XB; Sun, Y; Cao, WC				Wang, Xin; Huang, Yong; Niu, Si-bo; Jiang, Bao-Gui; Jia, Na; van der Geest, Leo; Ni, Xue-bing; Sun, Yi; Cao, Wu-Chun			Genetic Diversity of Salp15 in the Ixodes ricinus Complex (Acari: Ixodidae)	PLOS ONE			English	Article							TICK SALIVA IMMUNOSUPPRESSOR; LYME-DISEASE SPIROCHETE; RHIPICEPHALUS-APPENDICULATUS; ANTICOAGULANT PEPTIDE; BINDING-PROTEINS; GLAND PROTEIN; SENSU-LATO; IDENTIFICATION; VECTOR; IMMUNOGLOBULIN	Salp15, a 15-kDa tick salivary gland protein, is both essential for ticks to successfully obtain host blood and also facilitates transmission of Lyme borreliosis. To determine whether the Salp15 gene is expressed in Ixodes persulcatus and Ixodes sinensis, principle vectors of Lyme borreliosis in China, we studied transcriptions of this gene in semi-engorged larvae, nymph and adults of these two species. A total of eight Salp15 homologues, five in I. persulcatus and three in I. sinensis, were identified by reverse transcriptase-polymerase chain reaction (RT-PCR). Interestingly, the intra-species similarity of Salp15 is approximately equal to its interspecies similarity and more than one Salp15 protein is expressed in a certain tick developmental stage. Comparison of DNA and proteins with other available tick Salp15 homologues suggests that the Salp15 superfamily is genetically conserved and diverse in the Ixodes ricinus complex. These findings indicate that Salp15 proteins in the I. ricinus complex may play an essential role in interacting with the host immune system and transmission of Borrelia genospecies.	[Wang, Xin; Huang, Yong; Jiang, Bao-Gui; Jia, Na; Ni, Xue-bing; Sun, Yi; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Xin; Sun, Yi] Wenzhou Ctr Dis Control & Prevent, Wenzhou, Peoples R China; [Niu, Si-bo] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [van der Geest, Leo] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Ecol, Amsterdam, Netherlands	Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Amsterdam	Sun, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	sunyi73@gmail.com	Jiang, Baogui/ABE-5439-2021	Yi, Sun/0000-0002-6871-6975	National Nature Foundation of P.R. China [30872196, 81271878]; Special Fund of the Ministry of Health of P. R. China [201202019]; National Critical Project for Science and Technology on Infectious Disease of P. R. China [2012ZX10004219]	National Nature Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Special Fund of the Ministry of Health of P. R. China; National Critical Project for Science and Technology on Infectious Disease of P. R. China	This work was supported by the National Nature Foundation of P.R. China (No. 30872196; 81271878); Special Fund of the Ministry of Health of P. R. China (Grant No. 201202019), National Critical Project for Science and Technology on Infectious Disease of P. R. China (Grant No. 2012ZX10004219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao OR, 2012, DM-DIS MON, V58, P335, DOI 10.1016/j.disamonth.2012.03.005; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; BURGDORFER W, 1989, RHEUM DIS CLIN N AM, V15, P775; Cavassani KA, 2005, IMMUNOLOGY, V114, P235, DOI 10.1111/j.1365-2567.2004.02079.x; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; Filippova N.A., 1991, P109; Garg R, 2006, J IMMUNOL, V177, P6579, DOI 10.4049/jimmunol.177.10.6579; Gillespie RD, 2001, J IMMUNOL, V166, P4319, DOI 10.4049/jimmunol.166.7.4319; Hannier S, 2004, IMMUNOLOGY, V113, P401, DOI 10.1111/j.1365-2567.2004.01975.x; Hao Q, 2011, J CLIN MICROBIOL, V49, P647, DOI 10.1128/JCM.00725-10; Hojgaard A, 2009, J MED ENTOMOL, V46, P1458, DOI 10.1603/033.046.0631; Hovius JW, 2008, J INFECT DIS, V198, P1189, DOI 10.1086/591917; Hovius JWR, 2007, VECTOR-BORNE ZOONOT, V7, P296, DOI 10.1089/vbz.2006.0624; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JORDAN SP, 1990, BIOCHEMISTRY-US, V29, P11095, DOI 10.1021/bi00502a012; Juncadella IJ, 2007, FEMS IMMUNOL MED MIC, V49, P433, DOI 10.1111/j.1574-695X.2007.00223.x; Juncadella IJ, 2008, THESIS U MASS AMHERS; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu L, 2011, EMBO REP, V12, P1196, DOI 10.1038/embor.2011.177; Liu XQ, 2009, NUCLEIC ACIDS RES, V37, pW33, DOI 10.1093/nar/gkp428; Mori A, 2010, INSECT MOL BIOL, V19, P359, DOI 10.1111/j.1365-2583.2010.00994.x; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Nene V, 2004, INSECT BIOCHEM MOLEC, V34, P1117, DOI 10.1016/j.ibmb.2004.07.002; Oliver JH, 1996, J PARASITOL, V82, P926, DOI 10.2307/3284201; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Rechav Y, 2000, EXP APPL ACAROL, V24, P569, DOI 10.1023/A:1026531926109; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; Schwarz RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015788; Sun Y, 2003, VECTOR-BORNE ZOONOT, V3, P39, DOI 10.1089/153036603765627442; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; WANG H, 1994, PARASITOLOGY, V109, P525, DOI 10.1017/S0031182000080781; WANG H, 1995, PARASITOLOGY, V111, P161, DOI 10.1017/S0031182000064908; WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510; Wu J, 2006, PROTEINS, V65, P808, DOI 10.1002/prot.21218; Xu G, 2003, J PARASITOL, V89, P452, DOI 10.1645/0022-3395(2003)089[0452:MPAITT]2.0.CO;2	44	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94131	10.1371/journal.pone.0094131	http://dx.doi.org/10.1371/journal.pone.0094131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714063	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900091
J	Zhang, YF; Zhou, L; Zhang, HW; Hou, AJ; Gao, HF; Zhou, YH				Zhang, Yu-Fei; Zhou, Li; Zhang, Hong-Wei; Hou, An-Ji; Gao, Hong-Fang; Zhou, Yu-Hao			Association between Folate Intake and the Risk of Lung Cancer: A Dose-Response Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							B-VITAMINS; VEGETABLE CONSUMPTION; TREND ESTIMATION; POOLED ANALYSIS; DIETARY-INTAKE; POLYMORPHISMS; MULTIVITAMINS; METABOLISM; METHIONINE; SMOKERS	Background: Studies have reported inconsistent results regarding the existence of an association between folate intake and the risk of lung cancer. The purpose of this study was to summarize the evidence from prospective cohort studies regarding this relationship by using a dose-response meta-analytic approach. Methodology and Principal Findings: In September 2013, we performed electronic searches in PubMed, Embase, and the Cochrane Library to identify studies examining the effect of folate intake on the incidence of lung cancer. Only prospective cohort studies that reported the effect estimates about the incidence of lung cancer with 95% confidence intervals (CIs) for more than 2 categories of folate intake were included. Overall, we examined 9 cohort studies reporting the data of 566,921 individuals. High folate intake had little effect on the risk of lung cancer (risk ratio [RR], 0.92; 95% CI, 0.84-1.01; P = 0.076). Dose-response meta-analysis also suggested that a 100 mu g/day increase in folate intake had no significant effect on the risk of lung cancer (RR, 0.99; 95% CI, 0.97-1.01; P = 0.318). Subgroup analysis suggested that the potential protective effect of low folate intake (100-299 mu g/day) was more evident in women than men, while the opposite was true of high folate intake (>400 mu g/day). Finally, subgroup analyses of a 100 mu g/day increment in folate intake indicated that its potential protective effect was more evident in men than in women. Conclusion/Significance: Our study revealed that folate intake had little or no effect on the risk of lung cancer. Subgroup analyses indicated that an increased folate intake was associated with a reduced risk of lung cancer in men. Furthermore, low folate intake may be a protective factor for women, and high folate intake for men.	[Zhang, Yu-Fei; Zhou, Li; Zhang, Hong-Wei; Hou, An-Ji; Gao, Hong-Fang] Shanghai Seventh Peoples Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	zhou_ly@126.com	Zhang, yufei/HHC-7375-2022		Shanghai Natural Science Foundation [12ZR1422800]; Talents Training program of Shanghai Seventh People's Hospital [QMX2014-01]	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Talents Training program of Shanghai Seventh People's Hospital	This study was funded by Shanghai Natural Science Foundation (Grant No. 12ZR1422800) and Talents Training program of Shanghai Seventh People's Hospital (Grant No. QMX2014-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Bandera EV, 1997, CANCER CAUSE CONTROL, V8, P828, DOI 10.1023/A:1018456127018; Bassett JK, 2012, EUR J CLIN NUTR, V66, P182, DOI 10.1038/ejcn.2011.157; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cho E, 2006, INT J CANCER, V118, P970, DOI 10.1002/ijc.21441; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hung RJ, 2007, CARCINOGENESIS, V28, P1334, DOI 10.1093/carcin/bgm067; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; LEMARCHAND L, 1989, JNCI-J NATL CANCER I, V81, P1158, DOI 10.1093/jnci/81.15.1158; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Roswall N, 2010, LUNG CANCER, V67, P275, DOI 10.1016/j.lungcan.2009.11.010; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; Shen HB, 2003, CANCER EPIDEM BIOMAR, V12, P980; Shi QL, 2005, CARCINOGENESIS, V26, P649, DOI 10.1093/carcin/bgh351; Slatore CG, 2008, AM J RESP CRIT CARE, V177, P524, DOI 10.1164/rccm.200709-1398OC; Smith-Warner SA, 2003, INT J CANCER, V107, P1001, DOI 10.1002/ijc.11490; Suzuki T, 2007, CARCINOGENESIS, V28, P1718, DOI 10.1093/carcin/bgm104; Takata Y, 2013, NUTR CANCER, V65, P51, DOI 10.1080/01635581.2013.741757; Takata Y, 2012, CANCER CAUSE CONTROL, V23, P1965, DOI 10.1007/s10552-012-0074-z; Vaissiere T, 2009, CANCER RES, V69, P243, DOI 10.1158/0008-5472.CAN-08-2489; Voorrips LE, 2000, CANCER EPIDEM BIOMAR, V9, P357; Wells G.A., 2000, VIS COMMUN Q; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yuan JM, 2003, CANCER EPIDEM BIOMAR, V12, P890	36	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93465	10.1371/journal.pone.0093465	http://dx.doi.org/10.1371/journal.pone.0093465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713625	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900027
J	Hao, XW; Liu, SG; Dong, Q; Zhang, H; Zhao, J; Su, L				Hao, Xiwei; Liu, Shiguo; Dong, Qian; Zhang, Hong; Zhao, Jing; Su, Lin			Whole Exome Sequencing Identifies Recessive PKHD1 Mutations in a Chinese Twin Family with Caroli Disease	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; CONGENITAL HEPATIC-FIBROSIS; PRENATAL-DIAGNOSIS; ARPKD; GENE; EXPERIENCE; PROTEIN	Background: Mutations in PKHD1 cause autosomal recessive Caroli disease, which is a rare congenital disorder involving cystic dilatation of the intrahepatic bile ducts. However, the mutational spectrum of PKHD1 and the phenotype-genotype correlations have not yet been fully established. Methods: Whole exome sequencing (WES) was performed on one twin sample with Caroli disease from a Chinese family from Shandong province. Routine Sanger sequencing was used to validate the WES and to carry out segregation studies. We also described the PKHD1 mutation associated with the genotype-phenotype of this twin. Results: A combination of WES and Sanger sequencing revealed the genetic defect to be a novel compound heterozygous genotype in PKHD1, including the missense mutation c.2507 T>C, predicted to cause a valine to alanine substitution at codon 836 (c.2507T>C, p.Val836Ala), and the nonsense mutation c.2341C>T, which is predicted to result in an arginine to stop codon at codon 781 (c.2341C>T, p.Arg781*). This compound heterozygous genotype co-segregates with the Caroli disease-affected pedigree members, but is absent in 200 normal chromosomes. Conclusions: Our findings indicate exome sequencing can be useful in the diagnosis of Caroli disease patients and associate a compound heterozygous genotype in PKHD1 with Caroli disease, which further increases our understanding of the mutation spectrum of PKHD1 in association with Caroli disease.	[Hao, Xiwei; Dong, Qian; Zhang, Hong; Zhao, Jing; Su, Lin] Qingdao Univ, Affiliated Hosp, Coll Med, Qingdao 266071, Peoples R China; [Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Coll Med, Genet Lab, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Dong, Q (corresponding author), Qingdao Univ, Affiliated Hosp, Coll Med, Qingdao 266071, Peoples R China.	13608968352@163.com	hao, xiwei/AAT-7623-2020		National "Twelfth Five-Year" Plan for Science & Technology Support [2013BAI01B00]	National "Twelfth Five-Year" Plan for Science & Technology Support	The project is supported by the National "Twelfth Five-Year" Plan for Science & Technology Support (2013BAI01B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann C, 2005, HUM MUTAT, V25, P225, DOI 10.1002/humu.20145; Bergmann C, 2005, KIDNEY INT, V67, P829, DOI 10.1111/j.1523-1755.2005.00148.x; Bergmann C, 2003, J AM SOC NEPHROL, V14, P76, DOI 10.1097/01.ASN.0000039578.55705.6E; Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; Denamur E, 2010, KIDNEY INT, V77, P350, DOI 10.1038/ki.2009.440; DESMET VJ, 1992, HISTOPATHOLOGY, V20, P465; Desmet VJ, 1998, MAYO CLIN PROC, V73, P80; Foo JN, 2012, NAT REV NEUROL, V8, P508, DOI 10.1038/nrneurol.2012.148; Gunay-Aygun M, 2006, J PEDIATR-US, V149, P159, DOI 10.1016/j.jpeds.2006.03.014; Gunay-Aygun M, 2013, GASTROENTEROLOGY, V144, P112, DOI 10.1053/j.gastro.2012.09.056; Gunay-Aygun M, 2010, MOL GENET METAB, V99, P160, DOI 10.1016/j.ymgme.2009.10.010; Kassahun WT, 2005, SURGERY, V138, P888, DOI 10.1016/j.surg.2005.05.002; Keane F, 1997, ARCH DIS CHILD-FETAL, V77, pF145, DOI 10.1136/fn.77.2.F145; Lens XM, 1997, GENOMICS, V41, P463, DOI 10.1006/geno.1997.4671; Mousson C, 1997, NEPHROL DIAL TRANSPL, V12, P1481, DOI 10.1093/ndt/12.7.1481; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Rossetti S, 2003, KIDNEY INT, V64, P391, DOI 10.1046/j.1523-1755.2003.00111.x; Sgro M, 2004, ULTRASOUND OBST GYN, V23, P73, DOI 10.1002/uog.943; Sharp AM, 2005, J MED GENET, V42, P336, DOI 10.1136/jmg.2004.024489; Taylor ACF, 1998, EUR J GASTROEN HEPAT, V10, P105, DOI 10.1097/00042737-199802000-00001; Totkas S, 2000, EUR J SURG ONCOL, V26, P520, DOI 10.1053/ejso.1999.0936; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; ZERRES K, 1994, NAT GENET, V7, P429, DOI 10.1038/ng0794-429; Zerres K, 1998, AM J MED GENET, V76, P137, DOI 10.1002/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.0.CO;2-Q	27	7	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92661	10.1371/journal.pone.0092661	http://dx.doi.org/10.1371/journal.pone.0092661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710345	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800015
J	Lee, K; Hoti, K; Hughes, JD; Emmerton, LM				Lee, Kenneth; Hoti, Kreshnik; Hughes, Jeffery D.; Emmerton, Lynne M.			Interventions to Assist Health Consumers to Find Reliable Online Health Information: A Comprehensive Review	PLOS ONE			English	Review							LITERACY; INTERNET; SKILLS; PREFERENCES; CITIZENS; CANCER; PEOPLE; ACCESS	Background: Health information on the Internet is ubiquitous, and its use by health consumers prevalent. Finding and understanding relevant online health information, and determining content reliability, pose real challenges for many health consumers. Purpose: To identify the types of interventions that have been implemented to assist health consumers to find reliable online health information, and where possible, describe and compare the types of outcomes studied. Data Sources: PubMed, PsycINFO, CINAHL Plus and Cochrane Library databases; WorldCat and Scirus 'gray literature' search engines; and manual review of reference lists of selected publications. Study Selection: Publications were selected by firstly screening title, abstract, and then full text. Data Extraction: Seven publications met the inclusion criteria, and were summarized in a data extraction form. The form incorporated the PICOS (Population Intervention Comparators Outcomes and Study Design) Model. Two eligible gray literature papers were also reported. Data Synthesis: Relevant data from included studies were tabulated to enable descriptive comparison. A brief critique of each study was included in the tables. This review was unable to follow systematic review methods due to the paucity of research and humanistic interventions reported. Limitations: While extensive, the gray literature search may have had limited reach in some countries. The paucity of research on this topic limits conclusions that may be drawn. Conclusions: The few eligible studies predominantly adopted a didactic approach to assisting health consumers, whereby consumers were either taught how to find credible websites, or how to use the Internet. Common types of outcomes studied include knowledge and skills pertaining to Internet use and searching for reliable health information. These outcomes were predominantly self-assessed by participants. There is potential for further research to explore other avenues for assisting health consumers to find reliable online health information, and to assess outcomes via objective measures.	[Lee, Kenneth; Hoti, Kreshnik; Hughes, Jeffery D.; Emmerton, Lynne M.] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia	Curtin University	Emmerton, LM (corresponding author), Curtin Univ, Sch Pharm, Perth, WA 6845, Australia.	lynne.emmerton@curtin.edu.au	Hoti, Kreshnik/AAA-4562-2021; Lee, Kenneth/A-3406-2016	Lee, Kenneth/0000-0003-3022-4868; Hoti, Kreshnik/0000-0001-7652-6074; Hughes, Jeffery David/0000-0003-0040-4753; Emmerton, Lynne/0000-0002-0806-6691	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	KL is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2010, INT J MED INFORM, V79, pE89, DOI 10.1016/j.ijmedinf.2008.06.009; Alpay L, 2004, PAPER PRESENTED AT T; Andreassen HK, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-53; Attfield Simon J, 2006, Health Informatics J, V12, P165, DOI 10.1177/1460458206063811; Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Bell RA, 2011, PATIENT EDUC COUNS, V85, P525, DOI 10.1016/j.pec.2011.01.015; Bergeson SC, 2006, JAMA-J AM MED ASSOC, V296, P2848, DOI 10.1001/jama.296.23.2848; Car J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007092.pub2; Carter Ernest L, 2011, Perspect Health Inf Manag, V8, p1b; Chandler J, 2012, METHODOLOGICAL EXPEC; Cook TD., 1979, QUASI EXPERIMENTAL D; Cutilli CC, 2009, ORTHOP NURS, V28, P27, DOI 10.1097/01.NOR.0000345852.22122.d6; Davison BJ, 2002, CANCER NURS, V25, P42, DOI 10.1097/00002820-200202000-00009; Diaz JA, 2002, J GEN INTERN MED, V17, P180, DOI 10.1046/j.1525-1497.2002.10603.x; Donald M, 2011, PATIENT EDUC COUNS, V83, P217, DOI 10.1016/j.pec.2010.05.031; Eberlein T, 2008, BIOCHEM MOL BIOL EDU, V36, P262, DOI 10.1002/bmb.20204; Ekberg J, 2010, J MED SYST, V34, P107, DOI 10.1007/s10916-008-9222-0; European Commission, 2003, SURVEY OF ONLINE HEA; Ferguson LA., 2011, J NURSE PRACT, V7, P123, DOI [10.1016/j.nurpra.2010.11.020, DOI 10.1016/J.NURPRA.2010.11.020]; Fox S., 2011, REPORT FROM THE PEW; Gray K, 2013, INFORM HEALTH SOC CA, V38, P171, DOI 10.3109/17538157.2012.705201; Gross VA, 2007, J CONS HLTH INTERNET, V11, P1, DOI [10.1300/J381v11n02_01, 10.1300/J381vlln02_01]; Halpert A, 2008, DIGEST DIS SCI, V53, P3184, DOI 10.1007/s10620-008-0280-4; Johnes F., 2006, ED RES REV, V1, P23; Kalichman SC, 2006, J CONSULT CLIN PSYCH, V74, P545, DOI 10.1037/0022-006X.74.3.545; Kennedy A, 2005, HEALTH EDUC RES, V20, P567, DOI 10.1093/her/cyh018; Kim P, 1999, BMJ-BRIT MED J, V318, P647, DOI 10.1136/bmj.318.7184.647; Kurtz-Rossi S, 2010, J CONS HLTH INTERNET, V14, P325, DOI 10.1080/15397734.2010.524089; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Manning DL, 2006, EUR J CANCER CARE, V15, P448, DOI 10.1111/j.1365-2354.2006.00687.x; Masse LC, 2012, J PHYS ACT HEALTH, V9, pS44, DOI 10.1123/jpah.9.s1.s44; McDaid D, 2010, ONLINE HEALTH UNTANG; McNutt RA, 2004, JAMA-J AM MED ASSOC, V292, P2516, DOI 10.1001/jama.292.20.2516; Metzger MJ, 2011, J HEALTH COMMUN, V16, P45, DOI 10.1080/10810730.2011.589881; MILES MB, 1988, CURRICULUM INQ, V18, P157, DOI 10.2307/1179456; Nielsen-Bohlman L, 2004, HEALTH LITERACY A PR; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Raats CJI, 2008, PATIENT EDUC COUNS, V73, P413, DOI 10.1016/j.pec.2008.07.038; Rice RE, 2006, INT J MED INFORM, V75, P8, DOI 10.1016/j.ijmedinf.2005.07.032; Sandholtz JH, 1997, TEACHING WITH TECHNO; Susic J, 2009, J CONS HLTH INTERNET, V13, P417, DOI 10.1080/15398280903341226; World Health Organization, 2011, HEALTH LITERACY AND; Xie B, 2011, J AM SOC INF SCI TEC, V62, P933, DOI 10.1002/asi.21507	46	28	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94186	10.1371/journal.pone.0094186	http://dx.doi.org/10.1371/journal.pone.0094186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710348	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800113
J	Shentu, XP; Liu, WP; Zhan, XH; Xu, YP; Xu, JF; Yu, XP; Zhang, CX				Shentu, Xu-Ping; Liu, Wei-Ping; Zhan, Xiao-Huan; Xu, Yi-Peng; Xu, Jian-Feng; Yu, Xiao-Ping; Zhang, Chuan-Xi			Transcriptome Sequencing and Gene Expression Analysis of Trichoderma brevicompactum under Different Culture Conditions	PLOS ONE			English	Article							TRICHOTHECENE BIOSYNTHESIS; FUSARIUM; MYCOTOXINS; EVOLUTION; CLUSTER; GENOME	Background: Trichoderma brevicompactum is the Trichoderma species producing simple trichothecenes-trichodermin, a potential antifungal antibiotic and a protein synthesis inhibitor. However, the biosynthetic pathway of trichodermin in Trichoderma is not completely clarified. Therefore, transcriptome and gene expression profiling data for this species are needed as an important resource to better understand the mechanism of the trichodermin biosynthesis and provide a blueprint for further study of T. brevicompactum. Results: In this study, de novo assembly of the T. brevicompactum transcriptome using the short-read sequencing technology (Illumina) was performed. In addition, two digital gene expression (DGE) libraries of T. brevicompactum under the trichodermin-producing and trichodermin-nonproducing culture conditions, respectively, were constructed to identify the differences in gene expression. A total of 23,351 unique transcripts with a mean length of 856 bp were obtained by a new Trinity de novo assembler. The variations of the gene expression under different culture conditions were also identified. The expression profiling data revealed that 3,282 unique transcripts had a significantly differential expression under the trichodermin-producing condition, as compared to the trichodermin-nonproducing condition. This study provides a large amount of transcript sequence data that will contribute to the study of the trichodermin biosynthesis in T. brevicompactum. Furthermore, quantitative real-time PCR (qRT-PCR) was found to be useful to confirm the differential expression of the unique transcripts. Conclusion: Our study provides considerable gene expression information of T. brevicompactum at the transcriptional level, which will help accelerate the research on the trichodermin biosynthesis. Additionally, we have demonstrated the feasibility of using the Illumina sequencing based DGE system for gene expression profiling, and have shed new light on functional studies of the genes involved in T. brevicompactum biosynthesis.	[Shentu, Xu-Ping; Liu, Wei-Ping; Zhan, Xiao-Huan; Xu, Yi-Peng; Yu, Xiao-Ping] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China; [Shentu, Xu-Ping; Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Jian-Feng] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA; [Xu, Jian-Feng] Arkansas State Univ, Coll Agr, Jonesboro, AR USA	China Jiliang University; Zhejiang University; Arkansas State University; Arkansas State University	Yu, XP (corresponding author), China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China.	yuxiaoping19630306@163.com; chxzhang@zju.edu.cn	Liu, Weiping/E-9208-2010; Zhang, Chuan-Xi/K-7978-2019	Liu, Weiping/0000-0002-1173-892X; Zhang, Chuan-Xi/0000-0002-7784-1188	National Basic Research Development Program of China [2011CB111602]; National Natural Science Foundation of China [31171860]; Zhejiang Province Natural Science Foundation [LY12C14012]; Zhejiang Province Programs for Science and Technology Development [2010C32063, 2013C32008]; Office Of The Director [1003970] Funding Source: National Science Foundation	National Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Province Programs for Science and Technology Development; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Basic Research Development Program of China (2011CB111602), the National Natural Science Foundation of China (31171860), the Zhejiang Province Natural Science Foundation (LY12C14012) and the Zhejiang Province Programs for Science and Technology Development (2010C32063, 2013C32008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Beremand M.N., 1992, HDB APPL MYCOLOGY, V5, P360; Brown DW, 2004, FUNGAL GENET BIOL, V41, P454, DOI 10.1016/j.fgb.2003.12.002; Cardoza RE, 2011, APPL ENVIRON MICROB, V77, P4867, DOI 10.1128/AEM.00595-11; Cardoza RE, 2007, FUNGAL GENET BIOL, V44, P269, DOI 10.1016/j.fgb.2006.11.013; CARRASCO L, 1973, BIOCHIM BIOPHYS ACTA, V312, P368, DOI 10.1016/0005-2787(73)90381-X; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Degenkolb T, 2008, MYCOL PROG, V7, P177, DOI 10.1007/s11557-008-0563-3; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grove J F, 2007, Fortschr Chem Org Naturst, V88, P63, DOI 10.1007/978-3-211-49389-2_2; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kraus GF, 2004, MYCOLOGIA, V96, P1059, DOI 10.2307/3762089; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Nielsen KF, 2005, J AGR FOOD CHEM, V53, P8190, DOI 10.1021/jf051279b; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; [申屠旭萍 SHENTU Xuping], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P1755; TATE WP, 1973, J BIOL CHEM, V248, P7970; Tijerino A, 2011, FUNGAL GENET BIOL, V48, P285, DOI 10.1016/j.fgb.2010.11.012; UENO Y, 1984, FUND APPL TOXICOL, V4, pS124, DOI 10.1016/0272-0590(84)90144-1; UENO Y, 1985, CRC CR REV TOXICOL, V14, P99, DOI 10.3109/10408448509089851; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233	31	13	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94203	10.1371/journal.pone.0094203	http://dx.doi.org/10.1371/journal.pone.0094203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710600	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800117
J	Bailey, K; Balaei, MR; Mannan, A; Del Bigio, MR; Marzban, H				Bailey, Karen; Balaei, Maryam Rahimi; Mannan, Ashraf; Del Bigio, Marc R.; Marzban, Hassan			Purkinje Cell Compartmentation in the Cerebellum of the Lysosomal Acid Phosphatase 2 Mutant Mouse (Nax - Naked-Ataxia Mutant Mouse)	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; LOPEZ-HERNANDEZ-SYNDROME; ZEBRIN-II; PHOSPHOLIPASE-C-BETA-4 EXPRESSION; ANTIGEN-EXPRESSION; RAT; REVEALS; TOPOGRAPHY; CORTEX; VERMIS	The Acp2 gene encodes the beta subunit of lysosomal acid phosphatase, which is an isoenzyme that hydrolyzes orthophosphoric monoesters. In mice, a spontaneous mutation in Acp2 results in severe cerebellar defects. These include a reduced size, abnormal lobulation, and an apparent anterior cerebellar disorder with an absent or hypoplastic vermis. Based on differential gene expression in the cerebellum, the mouse cerebellar cortex can normally be compartmentalized anteroposteriorly into four transverse zones and mediolaterally into parasagittal stripes. In this study, immunohistochemistry was performed using various Purkinje cell compartmentation markers to examine their expression patterns in the Acp2 mutant. Despite the abnormal lobulation and anterior cerebellar defects, zebrin II and PLC beta 4 showed similar expression patterns in the nax mutant and wild type cerebellum. However, fewer stripes were found in the anterior zone of the nax mutant, which could be due to a lack of Purkinje cells or altered expression of the stripe markers. HSP25 expression was uniform in the central zone of the nax mutant cerebellum at around postnatal day (P) 18-19, suggesting that HSP25 immunonegative Purkinje cells are absent or delayed in stripe pattern expression compared to the wild type. HSP25 expression became heterogeneous around P22-23, with twice the number of parasagittal stripes in the nax mutant compared to the wild type. Aside from reduced size and cortical disorganization, both the posterior zone and nodular zone in the nax mutant appeared less abnormal than the rest of the cerebellum. From these results, it is evident that the anterior zone of the nax mutant cerebellum is the most severely affected, and this extends beyond the primary fissure into the rostral central zone/vermis. This suggests that ACP2 has critical roles in the development of the anterior cerebellum and it may regulate anterior and central zone compartmentation.	[Bailey, Karen; Balaei, Maryam Rahimi; Del Bigio, Marc R.; Marzban, Hassan] Univ Manitoba, Fac Med, MICH, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Mannan, Ashraf] Univ Gottingen, Inst Human Genet, Univ Med Ctr Goettingen, Gottingen, Germany; [Del Bigio, Marc R.] Univ Manitoba, Fac Med, Dept Pathol, Winnipeg, MB, Canada	University of Manitoba; University of Gottingen; University of Manitoba	Marzban, H (corresponding author), Univ Manitoba, Fac Med, MICH, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.	hassan.marzban@med.umanitoba.ca	Hawkes, Richard/F-7971-2011	Marzban, Hassan/0000-0001-6885-2590; Del Bigio, Marc/0000-0001-8366-0394	Manitoba Health Research Council (MHRC); University of Manitoba	Manitoba Health Research Council (MHRC); University of Manitoba	This work is supported by funds from the Manitoba Health Research Council (MHRC) Operating Award and University of Manitoba Research Grants Program (URGP) to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Armstrong C, 2001, J COMP NEUROL, V439, P151, DOI 10.1002/cne.1339; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Armstrong CL, 2001, J COMP NEUROL, V429, P7, DOI 10.1002/1096-9861(20000101)429:1<7::AID-CNE2>3.0.CO;2-Q; Armstrong CL, 2005, J COMP NEUROL, V491, P69, DOI 10.1002/cne.20703; Bailey K, 2013, CEREBELLUM, V12, P870, DOI 10.1007/s12311-013-0502-y; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Beierbach E, 2001, J COMP NEUROL, V436, P42; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Carletti B, 2008, DEV BIOL, V317, P147, DOI 10.1016/j.ydbio.2008.02.005; Chakrabarti L, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-24; Chung SH, 2008, NEUROSCIENCE, V153, P721, DOI 10.1016/j.neuroscience.2008.01.090; Consalez GG, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00123; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; DECAMILLI P, 1984, NEUROSCIENCE, V11, P761, DOI 10.1016/0306-4522(84)90193-3; EDWARDS MA, 1994, ANAT EMBRYOL, V190, P417; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Feng LB, 2009, MOL CELL BIOL, V29, P324, DOI 10.1128/MCB.00663-08; Fernandez-Jaen A, 2009, PEDIATR NEUROL, V40, P58, DOI 10.1016/j.pediatrneurol.2008.10.001; Fortin M, 1998, NEUROSCI RES, V30, P155, DOI 10.1016/S0168-0102(97)00124-7; GEIER C, 1992, J HISTOCHEM CYTOCHEM, V40, P1275, DOI 10.1177/40.9.1506664; Goldowitz D, 1997, J NEUROSCI, V17, P8767; GOTTSCHALK S, 1989, EMBO J, V8, P3215, DOI 10.1002/j.1460-2075.1989.tb08480.x; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Ji ZQ, 1996, J COMP NEUROL, V371, P578; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kemp K, 2012, BRAIN, V135, P2962, DOI 10.1093/brain/aws226; Krishnamurthy S, 2008, INDIAN J PEDIATR, V75, P1178, DOI 10.1007/S12098-008-0183-6; Kuwamura M, 1997, ACTA NEUROPATHOL, V94, P549, DOI 10.1007/s004010050749; Larouche M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001653; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Makrypidi G, 2012, MOL CELL BIOL, V32, P774, DOI 10.1128/MCB.06195-11; Mannan AU, 2004, NEUROGENETICS, V5, P229, DOI 10.1007/s10048-004-0197-9; Marzban H, 2008, NEUROSCIENCE, V153, P1190, DOI 10.1016/j.neuroscience.2008.02.036; Marzban H, 2007, J COMP NEUROL, V502, P857, DOI 10.1002/cne.21352; Marzban H, 2007, BRAIN RES, V1141, P25, DOI 10.1016/j.brainres.2007.01.031; Melquist S, 2007, AM J HUM GENET, V80, P769, DOI 10.1086/513320; Namba K, 2011, J COMP NEUROL, V519, P2594, DOI 10.1002/cne.22640; Ozol K, 1999, J COMP NEUROL, V412, P95; Pohl S, 2007, J NEUROCHEM, V103, P2177, DOI 10.1111/j.1471-4159.2007.04920.x; Ramaekers VT, 1997, BRAIN, V120, P1739, DOI 10.1093/brain/120.10.1739; Saftig P, 1997, J BIOL CHEM, V272, P18628, DOI 10.1074/jbc.272.30.18628; Sarna JR, 2006, J COMP NEUROL, V496, P303, DOI 10.1002/cne.20912; SATO H, 1987, J NEUROCHEM, V48, P1823, DOI 10.1111/j.1471-4159.1987.tb05742.x; SEIL FJ, 1995, J COMP NEUROL, V356, P398, DOI 10.1002/cne.903560307; Sillitoe RV, 2010, J NEUROSCI, V30, P10015, DOI 10.1523/JNEUROSCI.0653-10.2010; Sillitoe RV, 2002, J HISTOCHEM CYTOCHEM, V50, P235, DOI 10.1177/002215540205000211; Sillitoe RV, 2012, BRAIN STRUCT FUNCT; TANO D, 1992, J COMP NEUROL, V323, P128, DOI 10.1002/cne.903230111; Vastagh C, 2005, ANAT EMBRYOL, V209, P471, DOI 10.1007/s00429-005-0458-x; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; WASSEF M, 1990, J COMP NEUROL, V294, P223, DOI 10.1002/cne.902940207; Whetsell W, 2006, PEDIATR RADIOL, V36, P552, DOI 10.1007/s00247-006-0150-1	61	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94327	10.1371/journal.pone.0094327	http://dx.doi.org/10.1371/journal.pone.0094327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722417	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100054
J	de Vrij, EL; Vogelaar, PC; Goris, M; Houwertjes, MC; Herwig, A; Dugbartey, GJ; Boerema, AS; Strijkstra, AM; Bouma, HR; Henning, RH				de Vrij, Edwin L.; Vogelaar, Pieter C.; Goris, Maaike; Houwertjes, Martin C.; Herwig, Annika; Dugbartey, George J.; Boerema, Ate S.; Strijkstra, Arjen M.; Bouma, Hjalmar R.; Henning, Robert H.			Platelet Dynamics during Natural and Pharmacologically Induced Torpor and Forced Hypothermia	PLOS ONE			English	Article							HIBERNATING GROUND-SQUIRRELS; ISCHEMIA-REPERFUSION INJURY; LOW-TEMPERATURE; SYRIAN-HAMSTER; COLD-STORAGE; BLOOD-FLOW; ACTIVATION; MECHANISM; AGGREGATION; COAGULATION	Hibernation is an energy-conserving behavior in winter characterized by two phases: torpor and arousal. During torpor, markedly reduced metabolic activity results in inactivity and decreased body temperature. Arousal periods intersperse the torpor bouts and feature increased metabolism and euthermic body temperature. Alterations in physiological parameters, such as suppression of hemostasis, are thought to allow hibernators to survive periods of torpor and arousal without organ injury. While the state of torpor is potentially procoagulant, due to low blood flow, increased viscosity, immobility, hypoxia, and low body temperature, organ injury due to thromboembolism is absent. To investigate platelet dynamics during hibernation, we measured platelet count and function during and after natural torpor, pharmacologically induced torpor and forced hypothermia. Splenectomies were performed to unravel potential storage sites of platelets during torpor. Here we show that decreasing body temperature drives thrombocytopenia during torpor in hamster with maintained functionality of circulating platelets. Interestingly, hamster platelets during torpor do not express P-selectin, but expression is induced by treatment with ADP. Platelet count rapidly restores during arousal and rewarming. Platelet dynamics in hibernation are not affected by splenectomy before or during torpor. Reversible thrombocytopenia was also induced by forced hypothermia in both hibernating (hamster) and non-hibernating (rat and mouse) species without changing platelet function. Pharmacological torpor induced by injection of 5'-AMP in mice did not induce thrombocytopenia, possibly because 5'-AMP inhibits platelet function. The rapidness of changes in the numbers of circulating platelets, as well as marginal changes in immature platelet fractions upon arousal, strongly suggest that storage-and-release underlies the reversible thrombocytopenia during natural torpor. Possibly, margination of platelets, dependent on intrinsic platelet functionality, governs clearance of circulating platelets during torpor.	[de Vrij, Edwin L.; Goris, Maaike; Dugbartey, George J.; Strijkstra, Arjen M.; Bouma, Hjalmar R.; Henning, Robert H.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Vogelaar, Pieter C.] Sulfateq BV, Groningen, Netherlands; [Houwertjes, Martin C.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Herwig, Annika] Univ Hamburg, Inst Zool, Hamburg, Germany; [Boerema, Ate S.; Strijkstra, Arjen M.] Univ Groningen, Dept Chronobiol, Ctr Behav & Neurosci, Groningen, Netherlands; [Boerema, Ate S.] Univ Groningen, Dept Mol Neurobiol, Ctr Behav & Neurosci, Groningen, Netherlands; [Boerema, Ate S.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Bouma, Hjalmar R.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Hamburg; University of Groningen; University of Groningen; University of Groningen; University of Groningen	de Vrij, EL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	E.L.de.Vrij@umcg.nl	Henning, Robert H/AAY-5222-2020; Bouma, Hjalmar/F-9737-2015; Boerema, A.S./W-9810-2018	Bouma, Hjalmar/0000-0003-1032-321X; Boerema, A.S./0000-0002-4771-5156; Vogelaar, Pieter/0000-0001-8271-3204; Herwig, Annika/0000-0003-3048-0618; Dugbartey, George/0000-0001-8161-7202; Henning, Robert/0000-0002-5135-4621	University Medical Center Groningen	University Medical Center Groningen	An MD/PhD grant was provided by the University Medical Center Groningen on behalf of Hjalmar Bouma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombeli T, 1998, J EXP MED, V187, P329, DOI 10.1084/jem.187.3.329; Bouma HR, 2010, VET IMMUNOL IMMUNOP, V136, P319, DOI 10.1016/j.vetimm.2010.03.016; Bouma HR, 2013, J LEUKOCYTE BIOL, V94, P89, DOI 10.1189/jlb.1212613; Bouma HR, 2011, P NATL ACAD SCI USA, V108, P2052, DOI 10.1073/pnas.1008823108; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; BULLARD RW, 1962, AM J PHYSIOL, V203, P266, DOI 10.1152/ajplegacy.1962.203.2.266; Carey HV, 2012, CIRC RES, V110, P915, DOI 10.1161/CIRCRESAHA.111.255398; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Cooper ST, 2012, AM J PHYSIOL-REG I, V302, pR1202, DOI 10.1152/ajpregu.00018.2012; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Egidi MG, 2010, BLOOD TRANSFUS-ITALY, V8, pS73, DOI 10.2450/2010.012S; Fuentes E, 2014, THROMB HAEMOSTASIS, V111, P491, DOI 10.1160/TH13-05-0386; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Ghasemzadeh M, 2013, THROMB RES, V131, P191, DOI 10.1016/j.thromres.2012.11.028; Hampton M, 2010, AM J PHYSIOL-REG I, V299, pR1478, DOI 10.1152/ajpregu.00273.2010; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Henning RH, 2002, LIFE SCI, V70, P2071, DOI 10.1016/S0024-3205(02)01505-9; HEYNS ADP, 1980, BRIT J HAEMATOL, V44, P269, DOI 10.1111/j.1365-2141.1980.tb01209.x; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Hoffmeister KM, 2001, J BIOL CHEM, V276, P24751, DOI 10.1074/jbc.M011642200; Hut RA, 2002, J COMP PHYSIOL B, V172, P47; Ishikawa M, 2004, J CEREBR BLOOD F MET, V24, P907, DOI 10.1097/01.WCB.0000132690.96836.7F; Jinka TR, 2011, J NEUROSCI, V31, P10752, DOI 10.1523/JNEUROSCI.1240-11.2011; KLONIZAKIS I, 1981, J CLIN PATHOL, V34, P377, DOI 10.1136/jcp.34.4.377; Kortner G, 2000, CHRONOBIOL INT, V17, P103, DOI 10.1081/CBI-100101036; Krause S, 2001, PLATELETS, V12, P423, DOI 10.1080/09537100120071040; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; LECHLER E, 1963, AM J PHYSIOL, V205, P985, DOI 10.1152/ajplegacy.1963.205.5.985; Leng XH, 2004, ARTERIOSCL THROM VAS, V24, P376, DOI 10.1161/01.ATV.0000110445.95304.91; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; Miglis M, 2002, PLATELETS, V13, P5, DOI 10.1080/09537100120112558; Milsom WK, 1999, COMP BIOCHEM PHYS A, V124, P383, DOI 10.1016/S1095-6433(99)00130-0; Miyazawa S, 2008, AM J PHYSIOL-REG I, V295, pR991, DOI 10.1152/ajpregu.00142.2008; Moran N, 2006, ANAL BIOCHEM, V357, P77, DOI 10.1016/j.ab.2006.06.037; Pinsky DJ, 1996, J CLIN INVEST, V97, P493, DOI 10.1172/JCI118440; PIVORUN EB, 1981, CRYOBIOLOGY, V18, P515, DOI 10.1016/0011-2240(81)90212-1; Reasor D., 2012, ANN BIOMED ENG; REDDICK RL, 1973, LAB INVEST, V28, P270; Rittiner JE, 2012, J BIOL CHEM, V287, P5301, DOI 10.1074/jbc.M111.291666; Russell J, 2003, AM J PHYSIOL-GASTR L, V284, pG123, DOI 10.1152/ajpgi.00303.2002; Ruzicka K, 2001, ARCH PATHOL LAB MED, V125, P391; Sandovici M, 2004, NITRIC OXIDE-BIOL CH, V11, P194, DOI 10.1016/j.niox.2004.08.002; Saunders DK, 2000, J EXP ZOOL, V287, P459, DOI 10.1002/1097-010X(20001201)287:7<459::AID-JEZ1>3.3.CO;2-Y; SCHAFFNER A, 1985, ARCH INTERN MED, V145, P651, DOI 10.1001/archinte.145.4.651; Scharbert G, 2010, PLATELETS, V21, P44, DOI 10.3109/09537100903420269; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Straub A, 2011, ARTERIOSCL THROM VAS, V31, P1607, DOI 10.1161/ATVBAHA.111.226373; Tailor A, 2005, MICROCIRCULATION, V12, P275, DOI 10.1080/10739680590925691; Talaei F, 2012, J EXP BIOL, V215, P2912, DOI 10.1242/jeb.067363; Thon JN, 2008, TRANSFUS MED REV, V22, P268, DOI 10.1016/j.tmrv.2008.05.004; TILLES AW, 1987, MICROVASC RES, V33, P211, DOI 10.1016/0026-2862(87)90018-5; Tupone D, 2013, J NEUROSCI, V33, P14512, DOI 10.1523/JNEUROSCI.1980-13.2013; Vostal JG, 1997, TRANSFUS MED REV, V11, P286, DOI 10.1016/S0887-7963(97)80094-6; Wandall HH, 2008, BLOOD, V111, P3249, DOI 10.1182/blood-2007-06-097295; Yasuma Yoshihide, 1997, American Journal of Physiology, V273, pR1861; ZUCKER MB, 1954, BLOOD, V9, P602, DOI 10.1182/blood.V9.6.602.602	56	26	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93218	10.1371/journal.pone.0093218	http://dx.doi.org/10.1371/journal.pone.0093218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722364	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100014
J	Lin, HH; Hwang, SM; Wu, SJ; Hsu, LF; Liao, YH; Sheen, YS; Chuang, WH; Huang, SY				Lin, Hsiu-Hsia; Hwang, Shiaw-Min; Wu, Shang-Ju; Hsu, Lee-Feng; Liao, Yi-Hua; Sheen, Yi-Shuan; Chuang, Wen-Hui; Huang, Shang-Yi			The Osteoblastogenesis Potential of Adipose Mesenchymal Stem Cells in Myeloma Patients Who Had Received Intensive Therapy	PLOS ONE			English	Article							MULTIPLE-MYELOMA; BONE-DISEASE; OSTEOGENIC DIFFERENTIATION; TISSUE; MARROW; PROLIFERATION; PATHOGENESIS; LESIONS	Multiple myeloma (MM) is characterized by advanced osteolytic lesions resulting from the activation of osteoclasts (OCs) and inhibition of osteoblasts (OBs). OBs are derived from mesenchymal stem cells (MSCs) from the bone marrow (BM), however the pool and function of BMMSCs in MM patients (MM-BMMSCs) are reduced by myeloma cells (MCs) and cytokines secreted from MCs and related anti-MM treatment. Such reduction in MM-BMMSCs currently cannot be restored by any means. Recently, genetic aberrations of MM-BMMSCs have been noted, which further impaired their differentiation toward OBs. We hypothesize that the MSCs derived from adipose tissue (ADMSCs) can be used as alternative MSC sources to enhance the pool and function of OBs. Therefore, the purpose of this study was to compare the osteogenesis ability of paired ADMSCs and BMMSCs in MM patients who had completed intensive therapy. Fifteen MM patients who had received bortezomib-based induction and autologous transplantation were enrolled. At the third month after the transplant, the paired ADMSCs and BMMSCs were obtained and cultured. Compared with the BMMSCs, the ADMSCs exhibited a significantly higher expansion capacity (100% vs 13%, respectively; P=.001) and shorter doubling time (28 hours vs 115 hours, respectively; P=.019). After inducing osteogenic differentiation, although the ALP activity did not differ between the ADMSCs and BMMSCs (0.78 U/mu g vs 0.74+/-0.14 U/mg, respectively; P=.834), the ADMSCs still exhibited higher calcium mineralization, which was determined using Alizarin red S (1029 nmole vs 341 nmole, respectively; P=.001) and von Kossa staining (2.6 E+05 mu m(2) vs 5 E+04 mu m(2), respectively; P=.042), than the BMMSCs did. Our results suggested that ADMSCs are a feasible MSC source for enhancing the pool and function of OBs in MM patients who have received intensive therapy.	[Lin, Hsiu-Hsia; Wu, Shang-Ju; Chuang, Wen-Hui; Huang, Shang-Yi] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hwang, Shiaw-Min; Hsu, Lee-Feng] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu, Taiwan; [Liao, Yi-Hua; Sheen, Yi-Shuan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Huang, SY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	syhuang55@ntuh.gov.tw	Sheen, Yi-Shuan/HGA-1172-2022	Huang, Shang-Yi/0000-0001-5688-3410; LIAO, YI-HUA/0000-0002-4434-3780; Sheen, Yi-Shuan/0000-0002-8743-7496	National Science Council [NSC97-2314-B-002-036-MY3, NSC101-2314-B-002-086, NSC102-2628-B-002-052-MY3]; National Taiwan University Hospital [NTUH 94A19-1, 99-S0131, 100-S1659, 101-S1801, 102-S2161]; Department of Health, Taiwan, Republic of China [DOH100-TD-C-111-001]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); Department of Health, Taiwan, Republic of China	This study was supported by grants from the National Science Council (NSC97-2314-B-002-036-MY3; NSC101-2314-B-002-086; NSC102-2628-B-002-052-MY3) and National Taiwan University Hospital (NTUH 94A19-1, 99-S0131, 100-S1659, 101-S1801, 102-S2161) and Department of Health (DOH100-TD-C-111-001), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059756; Cao YR, 2010, EXP HEMATOL, V38, P860, DOI 10.1016/j.exphem.2010.06.012; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Charbord P, 2011, STEM CELL REV REP, V7, P32, DOI 10.1007/s12015-010-9125-6; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Choi YS, 2012, BIOMATERIALS, V33, P2482, DOI 10.1016/j.biomaterials.2011.12.004; Christoulas D, 2009, EXPERT REV HEMATOL, V2, P385, DOI 10.1586/ehm.09.36; Cocco C, 2010, CLIN CANCER RES, V16, P4188, DOI 10.1158/1078-0432.CCR-10-0173; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Cournil-Henrionnet C, 2008, BIORHEOLOGY, V45, P513, DOI 10.3233/BIR-2008-0487; Garayoa M, 2009, LEUKEMIA, V23, P1515, DOI 10.1038/leu.2009.65; Garderet L, 2007, LEUKEMIA LYMPHOMA, V48, P2032, DOI 10.1080/10428190701593644; Ginis I, 2012, TISSUE ENG PART C-ME, V18, P453, DOI [10.1089/ten.TEC.2011.0395, 10.1089/ten.tec.2011.0395]; Giuliani N, 2009, EXP HEMATOL, V37, P879, DOI 10.1016/j.exphem.2009.04.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Konno M, 2013, DEV GROWTH DIFFER, V55, P309, DOI 10.1111/dgd.12049; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Li X, 2012, J BONE MINER RES, V27, P1635, DOI 10.1002/jbmr.1620; Lin TM, 2005, STEM CELLS DEV, V14, P92, DOI 10.1089/scd.2005.14.92; Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K; Moroni L, 2013, J CELL PHYSIOL, V228, P680, DOI 10.1002/jcp.24223; Naito H, 2011, TISSUE ENG PT A, V17, P2321, DOI [10.1089/ten.tea.2011.0099, 10.1089/ten.TEA.2011.0099]; Nery AA, 2013, CYTOM PART A, V83A, P48, DOI 10.1002/cyto.a.22205; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Papadopoulou EC, 2010, HIPPOKRATIA, V14, P76; Pevsner-Fischer M, 2012, STEM CELL REV REP, V8, P343, DOI 10.1007/s12015-011-9310-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Reagan MR, 2012, CLIN CANCER RES, V18, P342, DOI 10.1158/1078-0432.CCR-11-2212; Roodman G David, 2008, Hematology Am Soc Hematol Educ Program, P313, DOI 10.1182/asheducation-2008.1.313; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b; Xu S, 2012, LEUKEMIA, V26, P2546, DOI 10.1038/leu.2012.126; Zhang HT, 2012, CYTOTHERAPY, V14, P1203, DOI 10.3109/14653249.2012.711470; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	42	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94395	10.1371/journal.pone.0094395	http://dx.doi.org/10.1371/journal.pone.0094395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722177	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100066
J	Wu, WF; Sun, LY; Pan, XD; Yang, SW; Wang, LY				Wu, Wen-Feng; Sun, Li-Yuan; Pan, Xiao-Dong; Yang, Shi-Wei; Wang, Lv-Ya			Use of Targeted Exome Sequencing in Genetic Diagnosis of Chinese Familial Hypercholesterolemia	PLOS ONE			English	Article							LDL-RECEPTOR GENE; SHORT READ ALIGNMENT; MUTATIONS; REARRANGEMENTS; SIMVASTATIN; POPULATION; EXPRESSION; EFFICACY; DISEASE; TOOL	Familial hypercholesterolemia is an autosomal dominant inherited disease characterized by elevated plasma low-density lipoprotein cholesterol (LDL-C). It is mainly caused by mutations of the low-density lipoprotein receptor (LDLR) gene. Currently, the methods of whole genome sequencing or whole exome sequencing for screening mutations in familial hypercholesterolemia are not applicable in China due to high cost. We performed targeted exome sequencing of 167 genes implicated in the homozygous phenotype of a proband pedigree to identify candidate mutations, validated them in the family of the proband, studied the functions of the mutant protein, and followed up serum lipid levels after treatment. We discovered that exon 9 c. 1268 T>C and exon 8 c. 1129 T>G compound heterozygous mutations in the LDLR gene in the proband derived from the mother and father, respectively, in which the mutation of c. 1129 T>G has not been reported previously. The mutant LDL-R protein had 57% and 52% binding and internalization functions, respectively, compared with that of the wild type. After 6 months of therapy, the LDL-C level of the proband decreased by more than 50% and the LDL-C of the other family members with heterozygous mutation also reduced to normal. Targeted exome sequencing is an effective method for screening mutation genes in familial hypercholesterolemia. The exon 8 and 9 mutations of the LDLR gene were pedigree mutations. The functions of the mutant LDL-R protein were decreased significantly compared with that of the wild type. Simvastatin plus ezetimibe was proven safe and effective in this preschool-age child.	[Wu, Wen-Feng; Sun, Li-Yuan; Yang, Shi-Wei] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Wu, Wen-Feng; Pan, Xiao-Dong; Yang, Shi-Wei; Wang, Lv-Ya] Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China	Capital Medical University	Wang, LY (corresponding author), Beijing Inst Heart Lung & Blood Vessel Dis, Dept Atherosclerosis, Beijing, Peoples R China.	wanglvya2012@163.com			Natural Science Foundation of Beijing [7112040]; National Natural Science Foundation of China [81170810, 81271923]	Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of Beijing (No. 7112040) and National Natural Science Foundation of China (No. 81170810 and 81271923). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonsol R, 2013, EXPERT REV CARDIOVAS, V11, P327, DOI [10.1586/ERC.13.7, 10.1586/erc.13.7]; Amsellem S, 2002, HUM GENET, V111, P501, DOI 10.1007/s00439-002-0813-4; Ballantyne CM, 2005, AM HEART J, V149, P464, DOI 10.1016/j.ahj.2004.11.023; Bertolini S, 1999, ARTERIOSCL THROM VAS, V19, P408, DOI 10.1161/01.ATV.19.2.408; Catapano AL, 2006, CURR MED RES OPIN, V22, P2041, DOI 10.1185/030079906X132721; Chang JH, 2003, J LIPID RES, V44, P1850, DOI 10.1194/jlr.M200470-JLR200; Chiou KR, 2010, AM J CARDIOL, V105, P1752, DOI 10.1016/j.amjcard.2010.01.356; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; EKSTROM U, 1995, HUM GENET, V96, P147, DOI 10.1007/BF00207370; Ekstrom U, 1998, EUR J CLIN INVEST, V28, P740; Elis A, 2013, CARDIOL YOUNG, V10, P1; Espinheira MC, 2013, REV PORT CARDIOL, V32, P379, DOI 10.1016/j.repc.2012.09.008; Futema M, 2012, J MED GENET, V49, P644, DOI 10.1136/jmedgenet-2012-101189; He J, 2011, ONCOTARGET, V2, P178; Hou HB, 2010, NUCLEIC ACIDS RES, V38, pW732, DOI 10.1093/nar/gkq302; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Kastelein JJP, 2007, NEW ENGL J MED, V356, P1620, DOI 10.1056/NEJMoa071359; Khoo KL, 2000, CLIN GENET, V58, P98, DOI 10.1034/j.1399-0004.2000.580202.x; Kim YR, 2013, KOREAN CIRC J, V43, P363, DOI 10.4070/kcj.2013.43.6.363; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Motazacker MM, 2012, EUR HEART J, V33, P1360, DOI 10.1093/eurheartj/ehs010; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vandrovcova J, 2013, GENET MED, V15, P948, DOI 10.1038/gim.2013.55; Wang L, 2009, NUTR METAB CARDIOVAS, V19, P391, DOI 10.1016/j.numecd.2008.07.011; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Wu WF, 2013, CLIN BIOCHEM, V46, P993, DOI 10.1016/j.clinbiochem.2013.04.003	30	89	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94697	10.1371/journal.pone.0094697	http://dx.doi.org/10.1371/journal.pone.0094697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722143	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100122
J	Zhang, J; Wang, WD; Geng, QR; Wang, L; Chen, XQ; Liu, CC; Lv, Y				Zhang, Jing; Wang, Wei-da; Geng, Qi-rong; Wang, Liang; Chen, Xiao-qin; Liu, Cheng-cheng; Lv, Yue			Serum Levels of Interleukin-9 Correlate with Negative Prognostic Factors in Extranodal NK/T-Cell Lymphoma	PLOS ONE			English	Article							LETHAL MIDLINE GRANULOMA; T-CELLS; IN-VIVO; MALIGNANT-LYMPHOMAS; IL-9 RECEPTOR; NASAL-TYPE; GROWTH; EXPRESSION; ASTHMA; ACTIVATION	Interleukin-9 (IL-9) is more functionally diverse than previously expected, especially with regards to lymphomagenesis. However, the relationship between IL-9 and the clinicopathological features of extranodal NK/T-cell lymphoma is less well established. Patients with this lymphoma in Sun Yat-Sen University Cancer Center between January 2003 and March 2013 were systematically reviewed in an intention-to-treat analysis. Baseline serum IL-9 levels were determined using sandwich enzyme-linked immunosorbent assays. A total of seventy-four patients were enrolled in this study. The mean concentration of serum IL-9 for all patients was 6.48 pg/mL (range: 1.38-51.87 pg/mL). Age, B symptoms and local lymph node involvement were found to be related to high serum IL-9 levels. Patients with low IL-9 levels tended to have higher rates of complete remission. Notably, the median progression-free survival (PFS) and overall survival (OS) were longer in the low IL-9 level group than in the high IL-9 level group (PFS: 68.7 months vs. 28.3 months, P < 0.001; OS: 86 months vs. 42.8 months, P = 0.001). Multivariate analysis revealed independent prognostic factors for PFS. Similarly, high IL-9 levels (P = 0.003) and old age (P = 0.007) were independently predictive of shorter OS. Serum IL-9 is closely related to several clinical features, such as age, B symptoms and local lymph node involvement. It can also be a significant independent prognostic factor for extranodal NK/T-cell lymphoma, which suggests a role for IL-9 in the pathogenesis of this disease and offers new insight into potential therapeutic strategies.	[Zhang, Jing; Wang, Wei-da; Geng, Qi-rong; Wang, Liang; Chen, Xiao-qin; Liu, Cheng-cheng; Lv, Yue] Sun Yat Sen Univ, Dept Hematol Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jing; Wang, Wei-da; Geng, Qi-rong; Wang, Liang; Chen, Xiao-qin; Liu, Cheng-cheng; Lv, Yue] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Jing] Hubei Canc Hosp, Dept Med Oncol, Wuhan, Hubei, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China	Lv, Y (corresponding author), Sun Yat Sen Univ, Dept Hematol Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	lvyue@sysucc.org.cn	Wang, Weida/HGV-1933-2022		National Natural Science Foundation of China [30471976, 81272620]; Science and Technology projects of Guangdong Province [2010B031600233, 2010A090200019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology projects of Guangdong Province	This work was supported by the following funds: National Natural Science Foundation of China (contract/grant numbers 30471976 and 81272620) and Science and Technology projects of Guangdong Province (contract/grant numbers 2010B031600233 and 2010A090200019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WY, 2009, BLOOD, V113, P3931, DOI 10.1182/blood-2008-10-185256; Bouchekioua A, 2014, LEUKEMIA, V28, P338, DOI 10.1038/leu.2013.157; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 2001, CELL GROWTH DIFFER, V12, P169; EICHEL BS, 1966, AM J SURG, V112, P597, DOI 10.1016/0002-9610(66)90328-X; Fischer M, 2003, LEUKEMIA, V17, P2513, DOI 10.1038/sj.leu.2403123; HARRIS NL, 1994, BLOOD, V84, P1361; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Jaffe ES, 1996, AM J SURG PATHOL, V20, P103, DOI 10.1097/00000478-199601000-00012; KASSEL SH, 1969, CANCER-AM CANCER SOC, V23, P920, DOI 10.1002/1097-0142(196904)23:4<920::AID-CNCR2820230430>3.0.CO;2-M; KELLEHER K, 1991, BLOOD, V77, P1436; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Lange K, 2003, ONCOGENE, V22, P517, DOI 10.1038/sj.onc.1206076; Lee J, 2006, J CLIN ONCOL, V24, P612, DOI 10.1200/JCO.2005.04.1384; Levitt RC, 1999, J ALLERGY CLIN IMMUN, V103, pS485, DOI 10.1016/S0091-6749(99)70165-X; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Lv X, 2013, LEUKEMIA LYMPHOMA, V54, P1367, DOI 10.3109/10428194.2012.745072; Lv X, 2013, INT J CLIN EXP PATHO, V6, P911; MERZ H, 1991, BLOOD, V78, P1311; Moriai S, 2009, CLIN CANCER RES, V15, P6771, DOI 10.1158/1078-0432.CCR-09-1052; Nagato T, 2005, CLIN CANCER RES, V11, P8250, DOI 10.1158/1078-0432.CCR-05-1426; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Qiu L, 2006, BLOOD, V108, P2407, DOI 10.1182/blood-2006-04-020305; RENAULD JC, 1995, BLOOD, V85, P1300, DOI 10.1182/blood.V85.5.1300.bloodjournal8551300; Shang Y, 2008, IN VIVO, V22, P713; Shimbara A, 2000, J ALLERGY CLIN IMMUN, V105, P108, DOI 10.1016/S0091-6749(00)90185-4; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Sun J, 2012, AM J CLIN PATHOL, V138, P429, DOI 10.1309/AJCP7YLTQPUSDQ5C; TeruyaFeldstein J, 1997, BLOOD, V90, P4099, DOI 10.1182/blood.V90.10.4099; Wang L, 2013, CANCER-AM CANCER SOC, V119, P348, DOI 10.1002/cncr.27752; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733; Yang XR, 2009, INT J CANCER, V125, P2912, DOI 10.1002/ijc.24622	39	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94637	10.1371/journal.pone.0094637	http://dx.doi.org/10.1371/journal.pone.0094637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722378	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100110
J	De Roo, ML; Miccinesi, G; Onwuteaka-Philipsen, BD; Van Den Noortgate, N; Van den Block, L; Bonacchi, A; Donker, GA; Alonso, JEL; Moreels, S; Deliens, L; Francke, AL				De Roo, Maaike L.; Miccinesi, Guido; Onwuteaka-Philipsen, Bregje D.; Van Den Noortgate, Nele; Van den Block, Lieve; Bonacchi, Andrea; Donker, Ge A.; Alonso, Jose E. Lozano; Moreels, Sarah; Deliens, Luc; Francke, Anneke L.		EURO IMPACT	Actual and Preferred Place of Death of Home-Dwelling Patients in Four European Countries: Making Sense of Quality Indicators	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE-CARE; CANCER-PATIENTS; GENERAL-PRACTITIONERS; PATIENTS PREFERENCES; HEALTH-CARE; PEOPLE DIE; NETHERLANDS; CONGRUENCE; AWARENESS	Background: Dying at home and dying at the preferred place of death are advocated to be desirable outcomes of palliative care. More insight is needed in their usefulness as quality indicators. Our objective is to describe whether " the percentage of patients dying at home'' and "the percentage of patients who died in their place of preference'' are feasible and informative quality indicators. Methods and Findings: A mortality follow-back study was conducted, based on data recorded by representative GP networks regarding home-dwelling patients who died non-suddenly in Belgium (n = 1036), the Netherlands (n = 512), Italy (n = 1639) or Spain (n = 565). "The percentage of patients dying at home'' ranged between 35.3% (Belgium) and 50.6% (the Netherlands) in the four countries, while "the percentage of patients dying at their preferred place of death'' ranged between 67.8% (Italy) and 86.0% (Spain). Both indicators were strongly associated with palliative care provision by the GP (odds ratios of 1.55-13.23 and 2.30-6.63, respectively). The quality indicator concerning the preferred place of death offers a broader view than the indicator concerning home deaths, as it takes into account all preferences met in all locations. However, GPs did not know the preferences for place of death in 39.6% (the Netherlands) to 70.3% (Italy), whereas the actual place of death was known in almost all cases. Conclusion: GPs know their patients' actual place of death, making the percentage of home deaths a feasible indicator for collection by GPs. However, patients' preferred place of death was often unknown to the GP. We therefore recommend using information from relatives as long as information from GPs on the preferred place of death is lacking. Timely communication about the place where patients want to be cared for at the end of life remains a challenge for GPs.	[De Roo, Maaike L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc; Francke, Anneke L.] Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care, EMGO Inst Hlth & Care Res,Dept Publ & Occupat Hlt, Amsterdam, Netherlands; [Miccinesi, Guido; Bonacchi, Andrea] Canc Prevent & Res Inst, ISPO, Clin & Descript Epidemiol Unit, Florence, Italy; [Van Den Noortgate, Nele] Ghent Univ Hosp, Dept Geriatr, Ghent, Belgium; [Van den Block, Lieve; Deliens, Luc] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Van den Block, Lieve; Deliens, Luc] Univ Ghent, Vrije Univ Brussel, Brussels, Belgium; [Donker, Ge A.; Francke, Anneke L.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Alonso, Jose E. Lozano] Govt Castilla & Leon, Reg Minist Hlth, Publ Hlth Directorate Gen, Valladolid, Spain; [Moreels, Sarah] WIV ISP, Sci Inst Publ Hlth Publ Hlth & Surveillance, Hlth Serv Res, Brussels, Belgium	Vrije Universiteit Amsterdam; Ghent University; Ghent University Hospital; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Netherlands Institute for Health Services Research	De Roo, ML (corresponding author), Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care, EMGO Inst Hlth & Care Res,Dept Publ & Occupat Hlt, Amsterdam, Netherlands.	eol@vumc.nl	Donker, Gé/AAX-8564-2021; Van den Block, Lieve/D-1247-2011; Caraceni, Augusto/C-1012-2017; miccinesi, guido/AAB-5476-2022	Van den Block, Lieve/0000-0002-7770-348X; Caraceni, Augusto/0000-0002-0375-6204; miccinesi, guido/0000-0002-7452-9594; De Roo, Maaike/0000-0002-2972-0867; Deliens, Luc/0000-0002-8158-2422; Lozano Alonso, Jose Eugenio/0000-0003-2589-0671; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248; Moreels, Sarah/0000-0002-4020-9533; Bonacchi, Andrea/0000-0003-4703-4067; Harding, Richard/0000-0001-9653-8689; Donker, Ge/0000-0001-6314-9249	Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project [SBO IWT 050158]; Vrije Universiteit Brussel; Ghent University; Antwerp University; Scientific Institute for Public Health, Belgium; VU University Medical Centre Amsterdam, the Netherlands; Italian Ministry of Health; Massimo Costantini (IRCCS AOU San Martino-IST, Genoa); Autonomous Community of Castilla y Leon; Comunitat Valenciana; EUROIMPACT: European Intersectorial; Multidisciplinary Palliative Care Research Training; European Union [264697]	Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project; Vrije Universiteit Brussel; Ghent University(Ghent University); Antwerp University; Scientific Institute for Public Health, Belgium; VU University Medical Centre Amsterdam, the Netherlands(Netherlands Government); Italian Ministry of Health(Ministry of Health, Italy); Massimo Costantini (IRCCS AOU San Martino-IST, Genoa); Autonomous Community of Castilla y Leon; Comunitat Valenciana; EUROIMPACT: European Intersectorial; Multidisciplinary Palliative Care Research Training; European Union(European Commission)	Funding for the study came from the Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO) (contract SBO IWT 050158) (2006-2010), as part of the "Monitoring Quality of End-of-Life Care (MELC) Study'', a collaboration between the Vrije Universiteit Brussel, Ghent University, Antwerp University, the Scientific Institute for Public Health, Belgium, and VU University Medical Centre Amsterdam, the Netherlands. Funding also came from the Italian Ministry of Health through the "Evaluation, testing and implementation of supportive care, care interventions, integrated programs and improving the quality of care for cancer patients'' program ("Integrated Oncology Project no6, years 2008-2011''), led by Massimo Costantini (IRCCS AOU San Martino-IST, Genoa), from the annual budgets of the Autonomous Community of Castilla y Leon and Comunitat Valenciana and from EUROIMPACT: European Intersectorial and Multidisciplinary Palliative Care Research Training, funded by the European Union Seventh Framework Programme (FP7/2007-2013, under grant agreement no [264697]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabom B, 2005, BRIT J GEN PRACT, V55, P684; Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Abarshi E, 2009, J PAIN SYMPTOM MANAG, V38, P568, DOI 10.1016/j.jpainsymman.2008.12.007; Abel J, 2013, BMJ SUPPORT PALLIAT, V3, P168, DOI 10.1136/bmjspcare-2012-000327; Agar M, 2008, PALLIATIVE MED, V22, P787, DOI 10.1177/0269216308092287; Barbera L, 2005, PALLIATIVE MED, V19, P435, DOI 10.1177/026921630501900515; Barclay S, 2009, BRIT J GEN PRACT, V59, P642, DOI 10.3399/bjgp09X454052; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Bell CL, 2009, PALLIATIVE MED, V23, P482, DOI 10.1177/0269216309106318; Bell CL, 2010, J PAIN SYMPTOM MANAG, V39, P591, DOI 10.1016/j.jpainsymman.2009.07.007; Billingham MJ, 2013, BMJ SUPPORT PALLIAT, V3, P144, DOI 10.1136/bmjspcare-2012-000292; Brazil K, 2005, PALLIATIVE MED, V19, P492, DOI 10.1191/0269216305pm1050oa; Brogaard T, 2013, PALLIATIVE MED, V27, P155, DOI 10.1177/0269216312438468; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Claessen SJJ, 2011, J PAIN SYMPTOM MANAG, V42, P169, DOI 10.1016/j.jpainsymman.2010.10.267; Cohen J, 2008, PALLIATIVE MED, V22, P702, DOI 10.1177/0269216308092285; Cohen J, 2006, HEALTH POLICY, V78, P319, DOI 10.1016/j.healthpol.2005.11.003; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Costantini M, 1999, J PAIN SYMPTOM MANAG, V18, P243, DOI 10.1016/S0885-3924(99)00084-6; Currow DC, 2008, J PALLIAT CARE, V24, P144, DOI 10.1177/082585970802400303; Davies E, 2004, SOLID FACTS PALLIATI; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; Deckers JGM, 2006, FAM PRACT, V23, P151, DOI 10.1093/fampra/cmi118; Department of Health, 2009, END LIF CAR STRAT QU; Desmedt M, 2002, SUPPORT CARE CANCER, V10, P343, DOI 10.1007/s00520-002-0345-4; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Fukui S, 2003, PALLIATIVE MED, V17, P445, DOI 10.1191/0269216303pm782oa; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gott M, 2008, SOC SCI MED, V67, P1113, DOI 10.1016/j.socscimed.2008.05.024; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Hannon KL, 2012, PALLIATIVE MED, V26, P336, DOI 10.1177/0269216311406990; Higginson IJ, 2013, PALLIATIVE MED, V27, P918, DOI 10.1177/0269216313487940; Hoek JF, 2003, INT J GERIATR PSYCH, V18, P244, DOI 10.1002/gps.816; Holdsworth L, 2010, INT J PALLIAT NURS, V16, P424, DOI 10.12968/ijpn.2010.16.9.78634; Houttekier D, 2010, J PALLIAT MED, V13, P1461, DOI 10.1089/jpm.2010.0279; Howat A, 2007, PALLIATIVE MED, V21, P41, DOI 10.1177/0269216306072383; IIS, 2009, AT CUID PAL ORG COM; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Ko W, 2013, EUR J CANCER, V49, P1967, DOI 10.1016/j.ejca.2013.01.006; Macleod U, 2011, BRIT J HOSP MED, V72, P441, DOI 10.12968/hmed.2011.72.8.441; Meeussen K, 2011, J CLIN ONCOL, V29, P4327, DOI 10.1200/JCO.2011.34.9498; Meeussen K, 2009, BRIT J GEN PRACT, V59, P665, DOI 10.3399/bjgp09X454124; Ministerie van Volksgezondheid WeS, 2011, VER PALL ZORG PRAKT; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Paddy Miranda, 2011, Nurs Stand, V26, P33; Pasman HRW, 2009, J PAIN SYMPTOM MANAG, V38, P145, DOI 10.1016/j.jpainsymman.2008.07.008; Peruselli C, 1997, J PALLIAT CARE, V13, P34, DOI 10.1177/082585979701300306; Petkova H., 2012, UNDERSTANDING PLACE; Saugo M, 2008, TUMORI J, V94, P87; Sbanotto A, 1998, SUPPORT CARE CANCER, V6, P426, DOI 10.1007/s005200050189; Seale C, 1997, SOC SCI MED, V45, P477, DOI 10.1016/S0277-9536(96)00379-6; Tang ST, 2010, J PAIN SYMPTOM MANAG, V40, P566, DOI 10.1016/j.jpainsymman.2010.01.020; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Thomas C, 2004, SOC SCI MED, V58, P2431, DOI 10.1016/j.socscimed.2003.09.005; Van den Block Lieve, 2007, BMC Palliat Care, V6, P6; Van den Block L, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-73; van Gestel YRBM, 2012, MED CARE, V50, P662, DOI 10.1097/MLR.0b013e31824ebd9f; Vega Alonso Agustin Tomas, 2006, Gac Sanit, V20 Suppl 3, P52, DOI 10.1157/13101090	62	96	97	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93762	10.1371/journal.pone.0093762	http://dx.doi.org/10.1371/journal.pone.0093762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714736	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900046
J	Dhaliwal, SS; Welborn, TA; Goh, LGH; Howat, PA				Dhaliwal, Satvinder S.; Welborn, Timothy A.; Goh, Louise G. H.; Howat, Peter A.			Obesity as Assessed by Body Adiposity Index and Multivariable Cardiovascular Disease Risk	PLOS ONE			English	Article							CARDIOMETABOLIC RISK; MASS INDEX; FAT; ASSOCIATION; HEALTH; BMI; SEX; AGE	To assess the role of body adiposity index (BAI) in predicting cardiovascular disease (CVD) and coronary heart disease (CHD) mortality, in comparison with body mass index (BMI), waist circumference (WC), and the waist circumference to hip circumference ratio (WHR). This study was a prospective 15 year mortality follow-up of 4175 Australian males, free of heart disease, diabetes and stroke. The Framingham Risk Scores (FRS) for CHD and CVD death were calculated at baseline for all subjects. Multivariable logistic regression was used to assess the effects of the measures of obesity on CVD and CHD mortality, before adjustment and after adjustment for FRS. The predictive ability of BAI, though present in the unadjusted analyses, was generally not significant after adjustment for age and FRS for both CVD and CHD mortality. BMI behaved similarly to BAI in that its predictive ability was generally not significant after adjustments. Both WC and WHR were significant predictors of CVD and CHD mortality and remained significant after adjustment for covariates. BAI appeared to be of potential interest as a measure of % body fat and of obesity, but was ineffective in predicting CVD and CHD.	[Dhaliwal, Satvinder S.; Goh, Louise G. H.; Howat, Peter A.] Curtin Univ, Perth, WA 6845, Australia; [Welborn, Timothy A.] Sir Charles Gairdner Hosp, Perth, WA, Australia	Curtin University; University of Western Australia	Dhaliwal, SS (corresponding author), Curtin Univ, Perth, WA 6845, Australia.	S.Dhaliwal@curtin.edu.au			Healthway, the Western Australian Health Promotion Foundation	Healthway, the Western Australian Health Promotion Foundation	This study was originally supported by a competitive grant from Healthway, the Western Australian Health Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER H, 1990, MED J AUSTRALIA, V153, P367, DOI 10.5694/j.1326-5377.1990.tb136975.x; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Risk Factor Prevalence Study Management Committee, 1990, SURV 3 1989; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Barzi F, 2010, OBES REV, V11, P127, DOI 10.1111/j.1467-789X.2009.00605.x; Bennasar-Veny M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063999; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; de Lima JG, 2012, OBESITY, V20, P1140, DOI 10.1038/oby.2012.3; Dhaliwal SS, 2009, PREV MED, V49, P148, DOI 10.1016/j.ypmed.2009.06.023; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; Elisha B, 2013, EUR J NUTR, V52, P145, DOI 10.1007/s00394-011-0296-y; Freedman DZ, 2012, SUPERGRAVITY, P1, DOI 10.1017/CBO9781139026833; Freedman DS, 2013, OBESITY, V21, pE64, DOI 10.1002/oby.20054; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Godoy-Matos AF, 2012, OBESITY, V20, P440, DOI 10.1038/oby.2011.343; Goh LGH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004702; Hung CS, 2012, OBESITY, V20, P1141, DOI 10.1038/oby.2012.86; Huxley R, 2008, J HYPERTENS, V26, P169, DOI 10.1097/HJH.0b013e3282f16ad3; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Johnson W, 2012, OBESITY, V20, P900, DOI 10.1038/oby.2011.346; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Lichtash CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065954; Lopez AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035281; Melmer A, 2013, OBESITY, V21, P775, DOI 10.1002/oby.20289; Moliner-Urdiales D, 2013, OBESITY; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Schulze MB, 2011, OBESITY, V19, P1729, DOI 10.1038/oby.2011.153; Snijder MB, 2012, OBESITY, V20, P1138, DOI 10.1038/oby.2011.338; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; World Health Organization, 1998, INT CLASS DIS MAN IN; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang Z-Q, 2013, CLIN ENDOCRINOLOGY	32	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94560	10.1371/journal.pone.0094560	http://dx.doi.org/10.1371/journal.pone.0094560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714547	gold, Green Published			2022-12-27	WOS:000334160900139
J	El Emam, K; Arbuckle, L; Essex, A; Samet, S; Eze, B; Middleton, G; Buckeridge, D; Jonker, E; Moher, E; Earle, C				El Emam, Khaled; Arbuckle, Luk; Essex, Aleksander; Samet, Saeed; Eze, Benjamin; Middleton, Grant; Buckeridge, David; Jonker, Elizabeth; Moher, Ester; Earle, Craig			Secure Surveillance of Antimicrobial Resistant Organism Colonization or Infection in Ontario Long Term Care Homes	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; RESIDENTS; FACILITIES; PREVALENCE; STAFF; MRSA	long term care homes, yet there is a need to collect data about their prevalence for public health surveillance and intervention purposes. Objective: We conducted a point prevalence study to assess ARO rates in long term care homes in Ontario using a secure data collection system. Methods: All long term care homes in the province were asked to provide colonization or infection counts for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and extended-spectrum beta-lactamase (ESBL) as recorded in their electronic medical records, and the number of current residents. Data was collected online during the October-November 2011 period using a Paillier cryptosystem that allows computation on encrypted data. Results: A provably secure data collection system was implemented. Overall, 82% of the homes in the province responded. MRSA was the most frequent ARO identified at 3 cases per 100 residents, followed by ESBL at 0.83 per 100 residents, and VRE at 0.56 per 100 residents. The microbiological findings and their distribution were consistent with available provincial laboratory data reporting test results for AROs in hospitals. Conclusions: We describe an ARO point prevalence study which demonstrated the feasibility of collecting data from long term care homes securely across the province and providing strong privacy and confidentiality assurances, while obtaining high response rates.	[El Emam, Khaled; Arbuckle, Luk; Jonker, Elizabeth; Moher, Ester] Childrens Hosp, Eastern Ontario Res Inst, Elect Hlth Informat Lab, Ottawa, ON, Canada; [El Emam, Khaled] Univ Ottawa, Ottawa, ON, Canada; [Essex, Aleksander] Western Univ, London, ON, Canada; [Samet, Saeed] Mem Univ Newfoundland, St John, NF, Canada; [Eze, Benjamin; Middleton, Grant] Privacy Analyt Inc, Ottawa, ON, Canada; [Buckeridge, David] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Earle, Craig] Inst Clin Evaluat Sci, Canc Res Program, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Western University (University of Western Ontario); Memorial University Newfoundland; McGill University; University of Toronto	El Emam, K (corresponding author), Childrens Hosp, Eastern Ontario Res Inst, Elect Hlth Informat Lab, Ottawa, ON, Canada.	kelemam@uottawa.ca		Samet, Saeed/0000-0002-5116-5484	Canada Research Chairs program; Ontario Institute for Cancer Research	Canada Research Chairs program(Canada Research Chairs); Ontario Institute for Cancer Research	The funders for this project were: (1) The Canada Research Chairs program through a research grant. (2) The Ontario Institute for Cancer Research through a research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti A, 2012, J MARKETING RES, V49, P160, DOI 10.1509/jmr.09.0215; Bryce EA, 2000, INFECT CONT HOSP EP, V21, P270, DOI 10.1086/501757; Canadian Healthcare Technology, 2013, CBC CLAIMS PROV BLOC; Conchie SM, 2008, RISK ANAL, V28, P141, DOI 10.1111/j.1539-6924.2008.01006.x; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; El Emam K, 2013, J LAW MED ETHICS; El Emam K., 2013, GUIDE DE IDENTIFICAT; El Emam K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-454; El Emam K, 2011, J AM MED INFORM ASSN, V18, P212, DOI 10.1136/amiajnl-2011-000100; Gravely Steve D, 2009, J Healthc Inf Manag, V23, P33; Jackson Virginia, 2008, Biotechnol Healthc, V5, P57; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Koch AM, 2009, J HOSP INFECT, V71, P269, DOI 10.1016/j.jhin.2008.10.032; Kreman T, 2005, INFECT CONT HOSP EP, V26, P811, DOI 10.1086/502498; Kress A, 2004, MORB MORTAL WKLY R S, V53, P247; Lindner J.R., 2001, J AGR ED, V42, P43, DOI [DOI 10.5032/JAE.2001.04043, https://doi.org/10.5032/jae.2001.04043]; Lober William B, 2004, MMWR Suppl, V53, P203; Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470; Manly BFJ, 1997, RANDOMIZATION BOOTST; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P867, DOI 10.1111/j.1469-0691.2008.02060.x; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; McGeer A, 2011, ANTIMICROBIAL RESIST; Muller M, 2002, Can Commun Dis Rep, V28, P113; MYLOTTE JM, 1992, INFECT CONT HOSP EP, V13, P711; O'Fallon E, 2009, INFECT CONT HOSP EP, V30, P1172, DOI 10.1086/648453; Paillier P, 1999, LECT NOTES COMPUT SC, V1592, P223; Public Health Ontario Provincial Infectious Diseases Advisory Committee, 2011, ANN A SCREEN TEST SU; Schwaber MJ, 2011, CLIN INFECT DIS, V53, P910, DOI 10.1093/cid/cir607; Standing Committee on Public Accounts, 2011, INF PREV CONTR LONG; Stone ND, 2008, INFECT CONT HOSP EP, V29, P143, DOI 10.1086/526437; THURN JR, 1991, J AM GERIATR SOC, V39, P1105, DOI 10.1111/j.1532-5415.1991.tb02877.x; Trick WE, 2001, J AM GERIATR SOC, V49, P270, DOI 10.1046/j.1532-5415.2001.4930270.x; Tsai J, 2009, THESIS CARNEGIE MELL; Wojcik R, 2007, OBTAINING DATA DIS S	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93285	10.1371/journal.pone.0093285	http://dx.doi.org/10.1371/journal.pone.0093285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714643	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900022
J	Marin, C; Palomeque, MD; Marco-Jimenez, F; Vega, S				Marin, Clara; Palomeque, Maria-Dolores; Marco-Jimenez, Francisco; Vega, Santiago			Wild Griffon Vultures (Gyps fulvus) as a Source of Salmonella and Campylobacter in Eastern Spain	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; GULLS LARUS-RIDIBUNDUS; THERMOPHILIC CAMPYLOBACTER; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; DISEASE BURDEN; AVIAN WILDLIFE; PIG PRODUCTION; FOOD-PRODUCTS; BIRDS	The existence of Campylobacter and Salmonella reservoirs in wildlife is a potential hazard to animal and human health; however, the prevalence of these species is largely unknown. Until now, only a few studies have evaluated the presence of Campylobacter and Salmonella in wild griffon vultures and based on a small number of birds. The aim of this study was to evaluate the presence of Campylobacter and Salmonella in wild griffon vultures (n = 97) during the normal ringing programme at the Cinctorres Observatory in Eastern Spain. In addition, the effect of ages of individuals (juveniles, subadult and adult) on the presence were compared. Campylobacter was isolated from 1 of 97 (1.0%) griffon vultures and identified as C. jejuni. Salmonella was isolated from 51 of 97 (52.6%) griffon vultures. No significant differences were found between the ages of individuals for the presence of Salmonella. Serotyping revealed 6 different serovars among two Salmonella enterica subspecies; S. enterica subsp. enterica (n = 49, 96.1%) and S. enterica subsp. salamae (n = 2, 3.9%). No more than one serovar was isolated per individual. The serovars isolated were S. Typhimurium (n = 42, 82.3%), S. Rissen (n = 4, 7.8%), S. Senftenberg (n = 3, 5.9%) and S. 4,12: b[-] (n = 2, 3.9%). Our results imply that wild griffon vultures are a risk factor for Salmonella transmission, but do not seem to be a reservoir for Campylobacter. We therefore rule out vultures as a risk factor for human campylobacteriosis. Nevertheless, further studies should be undertaken in other countries to confirm these results.	[Marin, Clara; Palomeque, Maria-Dolores; Vega, Santiago] Univ CEU Cardenal Herrera, Fac Vet, Dept Prod Anim, Inst Ciencias Biomed, Valencia, Spain; [Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46071 Valencia, Spain	Universidad CEU Cardenal Herrera; Universitat Politecnica de Valencia	Marin, C (corresponding author), Univ CEU Cardenal Herrera, Fac Vet, Dept Prod Anim, Inst Ciencias Biomed, Valencia, Spain.	clara.marin@uch.ceu.es	Marin, Clara/S-1396-2016; Vega, Santiago/K-8172-2019; Vega, Santiago/AAI-3813-2021; Jiménez, Francisco Marco/I-7126-2012	Marin, Clara/0000-0001-6152-3778; Vega, Santiago/0000-0002-4220-6029; Jiménez, Francisco Marco/0000-0002-5226-4118	Conselleria de Infraestructuras, Territorio y Medio Ambiente (Regional Government/Generalitat Valenciana)	Conselleria de Infraestructuras, Territorio y Medio Ambiente (Regional Government/Generalitat Valenciana)	Funding for this project came from the Conselleria de Infraestructuras, Territorio y Medio Ambiente (Regional Government/Generalitat Valenciana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TECHN M SALM CAMP CH; Arguello H, 2013, RES VET SCI, V95, P334, DOI 10.1016/j.rvsc.2013.04.001; Arguello H, 2013, J FOOD PROTECT, V76, P899, DOI 10.4315/0362-028X.JFP-12-404; Astorga Marquez RJ, 2007, J FOOD PROTECT, V70, P1502; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bergmire-Sweat D., 2008, Morbidity and Mortality Weekly Report, V57, P69; Botti V, 2013, VET ITAL, V49, P195, DOI 10.12834/VetIt.2013.492.201.208; Broman T, 2002, J CLIN MICROBIOL, V40, P4594, DOI 10.1128/JCM.40.12.4594-4602.2002; Camina A, 2006, ACTA ORNITHOL, V41, P7, DOI 10.3161/068.041.0106; Camina Alvaro, 2004, P45; Chuma T, 2000, J VET MED SCI, V62, P1291, DOI 10.1292/jvms.62.1291; Clemente L, 2013, INT J FOOD MICROBIOL, V167, P221, DOI 10.1016/j.ijfoodmicro.2013.08.009; COOPER J E, 1975, Journal of Wildlife Diseases, V11, P389; COULSON JC, 1983, J HYG-CAMBRIDGE, V91, P437, DOI 10.1017/S0022172400060472; Davies RH, 2013, VET MICROBIOL, V166, P543, DOI 10.1016/j.vetmic.2013.07.003; Del Moral JC, 2001, BRUITRE LEONADS PENI; Denis M, 2013, VET REC, V173, P370, DOI 10.1136/vr.101901; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FERRER M, 1987, COMP BIOCHEM PHYS A, V87, P1123, DOI 10.1016/0300-9629(87)90049-1; French NP, 2009, APPL ENVIRON MICROB, V75, P779, DOI 10.1128/AEM.01979-08; GIRDWOOD RWA, 1985, J HYG-CAMBRIDGE, V95, P229, DOI 10.1017/S0022172400062665; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Hamemeijer WJM, 1997, EBCC ATLAS EUROPEAN; Handeland K, 2002, EPIDEMIOL INFECT, V128, P523, DOI 10.1017/S0950268802007021; Hatch Jeremy J., 1996, International Journal of Environmental Health Research, V6, P5, DOI 10.1080/09603129609356867; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; HAWKEY C, 1985, AVIAN PATHOL, V14, P251, DOI 10.1080/03079458508436226; Hendriksen RS, 2008, FOODBORNE PATHOG DIS, V5, P605, DOI 10.1089/fpd.2007.0075; Hernandez J, 2003, EMERG INFECT DIS, V9, P753; Hughes LA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-4; HUMPHREY TJ, 1988, VET REC, V123, P160, DOI 10.1136/vr.123.6.160; Jijon S, 2007, J ZOO WILDLIFE MED, V38, P409, DOI 10.1638/1042-7260(2007)38[409:SEIFWA]2.0.CO;2; Jong BC, 2005, EMERG INFECT DIS, V11, P398, DOI 10.3201/eid1103.040694; Kapperud G, 1998, AM J EPIDEMIOL, V147, P774, DOI 10.1093/oxfordjournals.aje.a009522; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Keller JI, 2011, J WILDLIFE DIS, V47, P750, DOI 10.7589/0090-3558-47.3.750; KEYMER IF, 1972, VET REC, V90, P579, DOI 10.1136/vr.90.21.579; KIRKPATRICK CE, 1986, J AM VET MED ASSOC, V189, P997; Kocabiyik AL, 2006, J WILDLIFE DIS, V42, P696, DOI 10.7589/0090-3558-42.3.696; Lafuente S, 2013, ENFERM INFEC MICR CL, V31, P32, DOI 10.1016/j.eimc.2012.05.013; Lopez B, 2012, 22 EUR C CLIN MICR I, P1578; Marin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072350; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; Millan J, 2004, REV SCI TECH OIE, V23, P905, DOI 10.20506/rst.23.3.1529; Molina-Lopez RA, 2011, VET REC, V168, DOI 10.1136/vr.c7123; Nakadai A, 2005, J VET MED SCI, V67, P97, DOI 10.1292/jvms.67.97; Padungtod P, 2006, INT J FOOD MICROBIOL, V108, P346, DOI 10.1016/j.ijfoodmicro.2005.11.020; Palmgren H, 2006, EPIDEMIOL INFECT, V134, P635, DOI 10.1017/S0950268805005261; Palmgren H, 2004, J WILDLIFE DIS, V40, P583, DOI 10.7589/0090-3558-40.3.583; Petersen L, 2001, APPL ENVIRON MICROB, V67, P3115, DOI 10.1128/AEM.67.7.3115-3121.2001; Pezzoli L., 2007, EURO SURVEILL, V12, pii; Reche MP, 2003, J VET MED B, V50, P42, DOI 10.1046/j.1439-0450.2003.00623.x; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5595, DOI 10.1128/AEM.68.11.5595-5599.2002; Reilly WJ, 1891, VET REC, V108, P553; Stepan RM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-153; Tauni MA, 2000, J SMALL ANIM PRACT, V41, P339, DOI 10.1111/j.1748-5827.2000.tb03214.x; Thompson SA, 2000, CAMPYLOBACTER, P321; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Waldenstrom J, 2002, APPL ENVIRON MICROB, V68, P5911, DOI 10.1128/AEM.68.12.5911-5917.2002; Waldenstrom J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009082; Whiley H, 2013, INT J ENV RES PUB HE, V10, P5886, DOI 10.3390/ijerph10115886; WILSON JE, 1967, BRIT VET J, V123, P212, DOI 10.1016/S0007-1935(17)40005-4; YOGASUNDRAM K, 1989, AVIAN DIS, V33, P664, DOI 10.2307/1591142	66	31	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94191	10.1371/journal.pone.0094191	http://dx.doi.org/10.1371/journal.pone.0094191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710464	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800114
J	Okuno, M; Kano, H; Fujii, K; Bito, K; Naito, S; Leproux, P; Couderc, V; Hamaguchi, H				Okuno, Masanari; Kano, Hideaki; Fujii, Kenkichi; Bito, Kotatsu; Naito, Satoru; Leproux, Philippe; Couderc, Vincent; Hamaguchi, Hiro-o			Surfactant Uptake Dynamics in Mammalian Cells Elucidated with Quantitative Coherent Anti-Stokes Raman Scattering Microspectroscopy	PLOS ONE			English	Article							SODIUM LAURYL SULFATE; MAXIMUM-ENTROPY METHOD; CARS MICROSCOPY; CONTACT-DERMATITIS; IN-VIVO; ENDOCYTOSIS; IRRITATION; TRANSPORT; MEMBRANE; ENZYMES	The mechanism of surfactant-induced cell lysis has been studied with quantitative coherent anti-Stokes Raman scattering (CARS) microspectroscopy. The dynamics of surfactant molecules as well as intracellular biomolecules in living Chinese Hamster Lung (CHL) cells has been examined for a low surfactant concentration (0.01 w%). By using an isotope labeled surfactant having CD bonds, surfactant uptake dynamics in living cells has been traced in detail. The simultaneous CARS imaging of the cell itself and the internalized surfactant has shown that the surfactant molecules is first accumulated inside a CHL cell followed by a sudden leak of cytosolic components such as proteins to the outside of the cell. This finding indicates that surfactant uptake occurs prior to the cell lysis, contrary to what has been believed: surface adsorption of surfactant molecules has been thought to occur first with subsequent disruption of cell membranes. Quantitative CARS microspectroscopy enables us to determine the molecular concentration of the surfactant molecules accumulated in a cell. We have also investigated the effect of a drug, nocodazole, on the surfactant uptake dynamics. As a result of the inhibition of tubulin polymerization by nocodazole, the surfactant uptake rate is significantly lowered. This fact suggests that intracellular membrane trafficking contributes to the surfactant uptake mechanism.	[Okuno, Masanari; Kano, Hideaki; Hamaguchi, Hiro-o] Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo 113, Japan; [Fujii, Kenkichi] Kao Corp, Safety Sci Res Labs, Haga, Tochigi, Japan; [Bito, Kotatsu; Naito, Satoru] Kao Corp, Analyt Sci Res Labs, Haga, Tochigi, Japan; [Leproux, Philippe; Couderc, Vincent] UMR CNRS, Inst Rech XLIM, Limoges, France; [Hamaguchi, Hiro-o] Natl Chiao Tung Univ, Inst Mol Sci, Hsinchu, Taiwan; [Hamaguchi, Hiro-o] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan	University of Tokyo; KAO Corporation; KAO Corporation; Centre National de la Recherche Scientifique (CNRS); National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hamaguchi, H (corresponding author), Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	hhama@nctu.edu.tw	Leproux, Philippe/ABA-6725-2020; Masanari, Okuno/AGU-4731-2022; Okuno, Masanari/D-8465-2018; FUJII, Kenkichi/F-9108-2017	Leproux, Philippe/0000-0002-3854-413X; Okuno, Masanari/0000-0002-3682-9350; Kano, Hideaki/0000-0003-3682-7627; FUJII, Kenkichi/0000-0003-3442-025X	SENTAN project (Program-S) of the Japan Science and Technology Agency (JST); MEXT [477]; Global COE Program for "Chemistry Innovation"	SENTAN project (Program-S) of the Japan Science and Technology Agency (JST); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program for "Chemistry Innovation"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by the SENTAN project (Program-S) of the Japan Science and Technology Agency (JST). H. Kano gratefully acknowledges financial support by Grand-Aid for Scientific Research on Priority "Molecular Science for Supra Functional Systems" [477] from MEXT, and the Global COE Program for "Chemistry Innovation." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNER T, 1990, J INVEST DERMATOL, V95, P543, DOI 10.1111/1523-1747.ep12504896; Bonn M, 2009, J RAMAN SPECTROSC, V40, P763, DOI 10.1002/jrs.2253; Castillo C, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P292, DOI 10.1079/9781845933913.0292; Cheng JX, 2002, J PHYS CHEM B, V106, P8493, DOI 10.1021/jp025771z; Day JPR, 2011, J PHYS CHEM B, V115, P7713, DOI 10.1021/jp200606e; Day JPR, 2010, J AM CHEM SOC, V132, P8433, DOI 10.1021/ja102069d; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P7603; diNardo A, 1996, CONTACT DERMATITIS, V35, P86, DOI 10.1111/j.1600-0536.1996.tb02296.x; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Kano H, 2007, ANAL CHEM, V79, P8967, DOI 10.1021/ac071416z; Kee TW, 2004, OPT LETT, V29, P2701, DOI 10.1364/OL.29.002701; Kokyama H, 1970, GANN, V61, P161; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Moore PN, 2003, J COSMET SCI, V54, P29; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Okuno M, 2010, ANGEW CHEM INT EDIT, V49, P6773, DOI 10.1002/anie.201001560; PARKER FS, 1983, APPL INFRARED RAMAN; PARTEARROYO MA, 1990, BIOCHEM PHARMACOL, V40, P1323, DOI 10.1016/0006-2952(90)90399-6; Petrov GI, 2007, P NATL ACAD SCI USA, V104, P7776, DOI 10.1073/pnas.0702107104; Potma EO, 2005, CHEMPHYSCHEM, V6, P77, DOI 10.1002/cphc.200400390; Rinia HA, 2007, CHEMPHYSCHEM, V8, P279, DOI 10.1002/cphc.200600481; SALTON MRJ, 1951, J GEN MICROBIOL, V5, P391, DOI 10.1099/00221287-5-2-391; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Smith ARW, 2008, J APPL MICROBIOL, V105, P2161, DOI 10.1111/j.1365-2672.2008.03963.x; Tupker RA, 1997, CONTACT DERMATITIS, V37, P53, DOI 10.1111/j.1600-0536.1997.tb00041.x; van Manen HJ, 2008, ANAL CHEM, V80, P9576, DOI 10.1021/ac801841y; van Manen HJ, 2004, J PHYS CHEM B, V108, P18762, DOI 10.1021/jp046955b; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vieira DB, 2006, J ANTIMICROB CHEMOTH, V58, P760, DOI 10.1093/jac/dkl312	32	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93401	10.1371/journal.pone.0093401	http://dx.doi.org/10.1371/journal.pone.0093401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710120	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800031
J	Sterling, JT; Springer, AM; Iverson, SJ; Johnson, SP; Pelland, NA; Johnson, DS; Lea, MA; Bond, NA				Sterling, Jeremy T.; Springer, Alan M.; Iverson, Sara J.; Johnson, Shawn P.; Pelland, Noel A.; Johnson, Devin S.; Lea, Mary-Anne; Bond, Nicholas A.			The Sun, Moon, Wind, and Biological Imperative-Shaping Contrasting Wintertime Migration and Foraging Strategies of Adult Male and Female Northern Fur Seals (Callorhinus ursinus)	PLOS ONE			English	Article							MIXED-LAYER DEPTH; ARCTOCEPHALUS-GAZELLA; ZOOPLANKTON DISTRIBUTION; SEXUAL SEGREGATION; VERTICAL MIGRATION; MARINE PREDATOR; ELEPHANT SEALS; COASTAL ORIGIN; PACIFIC EDDY; NE PACIFIC	Adult male and female northern fur seals (Callorhinus ursinus) are sexually segregated in different regions of the North Pacific Ocean and Bering Sea during their winter migration. Explanations for this involve interplay between physiology, predator-prey dynamics, and ecosystem characteristics, however possible mechanisms lack empirical support. To investigate factors influencing the winter ecology of both sexes, we deployed five satellite-linked conductivity, temperature, and depth data loggers on adult males, and six satellite-linked depth data loggers and four satellite transmitters on adult females from St. Paul Island (Bering Sea, Alaska, USA) in October 2009. Males and females migrated to different regions of the North Pacific Ocean: males wintered in the Bering Sea and northern North Pacific Ocean, while females migrated to the Gulf of Alaska and California Current. Horizontal and vertical movement behaviors of both sexes were influenced by wind speed, season, light (sun and moon), and the ecosystem they occupied, although the expression of the behaviors differed between sexes. Male dive depths were aligned with the depth of the mixed layer during daylight periods and we suspect this was the case for females upon their arrival to the California Current. We suggest that females, because of their smaller size and physiological limitations, must avoid severe winters typical of the northern North Pacific Ocean and Bering Sea and migrate long distances to areas of more benign environmental conditions and where prey is shallower and more accessible. In contrast, males can better tolerate often extreme winter ocean conditions and exploit prey at depth because of their greater size and physiological capabilities. We believe these contrasting winter behaviors 1) are a consequence of evolutionary selection for large size in males, important to the acquisition and defense of territories against rivals during the breeding season, and 2) ease environmental/physiological constraints imposed on smaller females.	[Sterling, Jeremy T.; Johnson, Devin S.] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Springer, Alan M.] Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK USA; [Iverson, Sara J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Johnson, Shawn P.] Johnson Vet Serv, Marine Mammal Ctr, Sausalito, CA USA; [Pelland, Noel A.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Lea, Mary-Anne] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Bond, Nicholas A.] Univ Washington, JISAO, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; Dalhousie University; University of Washington; University of Washington Seattle; University of Tasmania; University of Washington; University of Washington Seattle	Sterling, JT (corresponding author), NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	Jeremy.Sterling@noaa.gov	Lea, Mary-Anne/E-9054-2013	Lea, Mary-Anne/0000-0001-8318-9299; Iverson, Sara/0000-0003-2842-4094	NOAA's Undersea Research Program; NOAA's National Cooperative Research Program	NOAA's Undersea Research Program; NOAA's National Cooperative Research Program	Principal financial support for this study was provided by NOAA's Undersea Research Program (http://www.nurp.noaa.gov). Additional crucial support was provided by the National Marine Fisheries Service (http://www.nmfs.noaa.gov), Alaska Sea Life Center (http://www.alaskasealife.org), and the TEMPEST project funded by NOAA's National Cooperative Research Program (http://www.st.nmfs.noaa.gov/ cooperative-research/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JC, 2006, J COASTAL RES, V22, P511, DOI 10.2112/03-0108.1; [Anonymous], 2004, MARINE FISHERIES REV; Atwood E, 2010, FISH OCEANOGR, V19, P493, DOI 10.1111/j.1365-2419.2010.00559.x; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Beamish RJ, 1999, PROG OCEANOGR, V43, P399, DOI 10.1016/S0079-6611(99)00017-8; Bigg DM, 1987, KILLER WHALES STUDY; Bigg MA, 1990, CANADIAN TECHNICAL R; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Boyd IL, 1998, CAN J FISH AQUAT SCI, V55, P845, DOI 10.1139/cjfas-55-4-845; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Crawford W, 2007, PROG OCEANOGR, V75, P161, DOI 10.1016/j.pocean.2007.08.017; Dalton AJM, MARINE MAMM IN PRESS; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Frost B, 1979, FISHERY B, V76, P717; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Godo OR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030161; Graham NE, 2001, B AM METEOROL SOC, V82, P1869, DOI 10.1175/1520-0477(2001)082<1869:EFIONP>2.3.CO;2; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; Hindell MA, 2000, PHYSIOL BIOCHEM ZOOL, V73, P790, DOI 10.1086/318104; Hooper CL, 1895, REPORT HOOPER DATED, P228; ISAACS JD, 1974, DEEP-SEA RES, V21, P651, DOI 10.1016/0011-7471(74)90049-7; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Jordan David Starr, 1898, FUR SEALS FUR SEAL I; Kajimura H, 1984, SSRF779 NOAA NMFS, P49; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Ladd C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001157; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Le Boeuf Burney J., 1994, P237; Lea MA, 2010, MAR ECOL PROG SER, V419, P233, DOI 10.3354/meps08758; Lea MA, 2009, BIOL LETTERS, V5, P252, DOI 10.1098/rsbl.2008.0643; Loughlin TR, 1999, DYNAMICS BERING SEA, P615; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P1011, DOI 10.1016/j.dsr2.2005.02.008; Mackas DL, 2002, J OCEANOGR, V58, P725, DOI 10.1023/A:1022802625242; MCGOWAN J A, 1973, Journal of Experimental Marine Biology and Ecology, V12, P187, DOI 10.1016/0022-0981(73)90013-0; Nesis KN, 1997, ADV MAR BIOL, V32, P243; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Page B, 2006, MAR ECOL PROG SER, V323, P263, DOI 10.3354/meps323263; PEARCY WG, 1977, DEEP-SEA RES, V24, P223, DOI 10.1016/S0146-6291(77)80002-7; PEREZ MA, 1986, FISH B-NOAA, V84, P957; Peterson R.S., 1965, THESIS J HOPKINS U; Pinheiro J., 2008, LINEAR NONLINEAR MIX; Pitman RL, 2001, MAR MAMMAL SCI, V17, P494, DOI 10.1111/j.1748-7692.2001.tb01000.x; Polovina JJ, 1995, DEEP-SEA RES PT I, V42, P1701, DOI 10.1016/0967-0637(95)00075-H; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Ream RR, 2005, DEEP-SEA RES PT II, V52, P823, DOI 10.1016/j.dsr2.2004.12.021; Roper FE, 1975, VERTICAL DISTRIBUTIO; Rosen DAS, MARINE MAMM IN PRESS; Rutishauser MR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P669, DOI 10.1086/421749; SCHEFFER VB, 1953, GROWTH, V17, P129; Schumacher J.D., 1994, Fisheries Oceanography, V3, P182, DOI 10.1111/j.1365-2419.1994.tb00095.x; Schumacher JD, P 5 N PAC RIM FISH C; Sherman K, 2007, NMFSNE208 NOAA; Sherman K., 1992, LARGE MARINE ECOSYST; Spalding DJ, 1964, B FISHERIES RES BOAR, V146, P52; Staniland IJ, 2008, ANIM BEHAV, V75, P1581, DOI 10.1016/j.anbehav.2007.10.012; Sterling J.T., 2009, NO SEAL FORAGING BEH; Stewart BS, 1997, J MAMMAL, V78, P1101, DOI 10.2307/1383053; Suga T, 2004, J PHYS OCEANOGR, V34, P3, DOI 10.1175/1520-0485(2004)034<0003:TNPCOW>2.0.CO;2; TABATA S, 1978, J PHYS OCEANOGR, V8, P970, DOI 10.1175/1520-0485(1978)008<0970:AEOTQO>2.0.CO;2; Tont S. A., 1976, CALIFORNIA COOPERATI, V18, P112, DOI DOI 10.1046/J.1365-2419.1999.00103.X.; Towell RG, 2008, NMFSAFSC188 NOAA, P8; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Villegas-Amtmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023166; Watanabe H, 2006, MAR ECOL PROG SER, V315, P187, DOI 10.3354/meps315187; Weise MJ, 2007, J EXP BIOL, V210, P278, DOI 10.1242/jeb.02643; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Whitehead H., 2003, SPERM WHALES SOCIAL	74	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93068	10.1371/journal.pone.0093068	http://dx.doi.org/10.1371/journal.pone.0093068			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722344	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100013
J	Geldsetzer, P; Williams, TC; Kirolos, A; Mitchell, S; Ratcliffe, LA; Kohli-Lynch, MK; Bischoff, EJL; Cameron, S; Campbell, H				Geldsetzer, Pascal; Williams, Thomas Christie; Kirolos, Amir; Mitchell, Sarah; Ratcliffe, Louise Alison; Kohli-Lynch, Maya Kate; Bischoff, Esther Jill Laura; Cameron, Sophie; Campbell, Harry			The Recognition of and Care Seeking Behaviour for Childhood Illness in Developing Countries: A Systematic Review	PLOS ONE			English	Review							ACUTE RESPIRATORY-INFECTIONS; MALARIA TREATMENT PRACTICES; ORAL REHYDRATION THERAPY; THAN 5 YEARS; HEALTH-CARE; YOUNG-CHILDREN; FEBRILE CHILDREN; CASE-MANAGEMENT; MATERNAL PERCEPTION; DIARRHEAL DISEASES	Background: Pneumonia, diarrhoea, and malaria are among the leading causes of death in children. These deaths are largely preventable if appropriate care is sought early. This review aimed to determine the percentage of caregivers in low-and middle-income countries (LMICs) with a child less than 5 years who were able to recognise illness in their child and subsequently sought care from different types of healthcare providers. Methods and Findings: We conducted a systematic literature review of studies that reported recognition of, and/or care seeking for episodes of diarrhoea, pneumonia or malaria in LMICs. The review is registered with PROSPERO (registration number: CRD42011001654). Ninety-one studies met the inclusion criteria. Eighteen studies reported data on caregiver recognition of disease and seventy-seven studies on care seeking. The median sensitivity of recognition of diarrhoea, malaria and pneumonia was low (36.0%, 37.4%, and 45.8%, respectively). A median of 73.0% of caregivers sought care outside the home. Care seeking from community health workers (median: 5.4% for diarrhoea, 4.2% for pneumonia, and 1.3% for malaria) and the use of oral rehydration therapy (median: 34%) was low. Conclusions: Given the importance of this topic to child survival programmes there are few published studies. Recognition of diarrhoea, malaria and pneumonia by caregivers is generally poor and represents a key factor to address in attempts to improve health care utilisation. In addition, considering that oral rehydration therapy has been widely recommended for over forty years, its use remains disappointingly low. Similarly, the reported levels of care seeking from community health workers in the included studies are low even though global action plans to address these illnesses promote community case management. Giving greater priority to research on care seeking could provide crucial evidence to inform child mortality programmes.	[Geldsetzer, Pascal] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Williams, Thomas Christie; Kirolos, Amir; Mitchell, Sarah; Ratcliffe, Louise Alison; Kohli-Lynch, Maya Kate; Bischoff, Esther Jill Laura; Cameron, Sophie; Campbell, Harry] Univ Edinburgh, Div Community Hlth Sci, Publ Hlth Sci Sect, Edinburgh, Midlothian, Scotland	Harvard University; Harvard T.H. Chan School of Public Health; University of Edinburgh	Geldsetzer, P (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	pag395@mail.harvard.edu	Williams, Thomas Christie/AFM-7862-2022; Campbell, Harry/E-2959-2010	Williams, Thomas Christie/0000-0002-3866-1344; Campbell, Harry/0000-0002-6169-6262; Kirolos, Amir/0000-0003-2995-330X; Geldsetzer, Pascal/0000-0002-8878-5505	Centre for Population Health Sciences, University of Edinburgh	Centre for Population Health Sciences, University of Edinburgh	Funding was provided by the Centre for Population Health Sciences, University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akogun OB, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-13; Ali M, 2000, J HEALTH POPUL NUTR, V18, P103; Amofah GK, 1995, E AFR MED J, V72, P619; [Anonymous], PUBMED; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; BABANIYI OA, 1991, J TROP PEDIATRICS, V37, P57, DOI 10.1093/tropej/37.2.57; BABANIYI OA, 1994, E AFR MED J, V71, P531; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Baume C, 2000, SOC SCI MED, V51, P1491, DOI 10.1016/S0277-9536(00)00049-6; Beiersmann C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-106; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Biritwum RB, 2004, J HEALTH POPUL NUTR, V22, P182; Breiman RF, 2011, J HEALTH POPUL NUTR, V29, P123; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; CAMPBELL H, 1990, ANN TROP PAEDIATR, V10, P45, DOI 10.1080/02724936.1990.11747408; COGSWELL ME, 1991, SOC SCI MED, V33, P1209, DOI 10.1016/0277-9536(91)90237-7; DABIS F, 1989, B WORLD HEALTH ORGAN, V67, P675; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; de Silva MWA, 2001, SOC SCI MED, V53, P1363, DOI 10.1016/S0277-9536(00)00425-1; DECLERQUE J, 1992, SOC SCI MED, V34, P687, DOI 10.1016/0277-9536(92)90196-W; DEMING MS, 1989, B WORLD HEALTH ORGAN, V67, P695; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Desai MR, 2002, TROP MED INT HEALTH, V7, P831, DOI 10.1046/j.1365-3156.2002.00942.x; DEZOYSA I, 1984, SOC SCI MED, V19, P727, DOI 10.1016/0277-9536(84)90245-4; Diallo AB, 2001, B WORLD HEALTH ORGAN, V79, P28; Ellis AA, 2007, SOC SCI MED, V64, P701, DOI 10.1016/j.socscimed.2006.10.011; Ene-Obong HN, 2000, J HEALTH POPUL NUTR, V18, P97; Foster D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-240; Fourn L, 2001, Sante Publique, V13, P161; GADOMSKI AM, 1993, INT J EPIDEMIOL, V22, P1166, DOI 10.1093/ije/22.6.1166; Gálvez Cesar Augusto, 2002, Rev Panam Salud Publica, V11, P99, DOI 10.1590/S1020-49892002000200006; Gao WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043103; GLIK DC, 1989, J HEALTH SOC BEHAV, V30, P421, DOI 10.2307/2136990; Global Health Workforce Alliance, 2010, GLOBAL EXPERIENCE CO; Gombojav N, 2009, ARCH DIS CHILD, V94, P849, DOI 10.1136/adc.2008.157115; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Gupta N, 2007, INDIAN J PEDIATR, V74, P471, DOI 10.1007/s12098-007-0080-4; Hamel MJ, 2001, B WORLD HEALTH ORGAN, V79, P1014; Hanson K, 1998, HEALTH POLICY PLANN, V13, P195, DOI 10.1093/heapol/13.3.195; HARRISON LH, 1995, INT J EPIDEMIOL, V24, P1058, DOI 10.1093/ije/24.5.1058; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Holtz TH, T R SOC TROP MED HYG, V97, P491; Hussain R, 1997, SOC SCI MED, V45, P991, DOI 10.1016/S0277-9536(97)00012-9; Jordan HT, 2009, INT J INFECT DIS, V13, P355, DOI 10.1016/j.ijid.2008.07.014; Kaatano G M, 2006, Tanzan Health Res Bull, V8, P155; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kaljee LM, 2004, J HEALTH POPUL NUTR, V22, P139; KALTER HD, 1991, INT J EPIDEMIOL, V20, P193, DOI 10.1093/ije/20.1.193; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Kambarami R. A., 1996, Central African Journal of Medicine, V42, P291; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Kapoor SK, INDIAN J PEDIAT, V57, P533; LANGSTEN R, 1995, SOC SCI MED, V40, P989, DOI 10.1016/0277-9536(94)00163-N; Lassi ZS, 2012, J DEV EFFECT, V4, P151, DOI 10.1080/19439342.2012.655911; Lassi ZS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub2; Lindblade KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-885; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Lubanga RGN, 1997, ACTA TROP, V68, P53, DOI 10.1016/S0001-706X(97)00071-5; Luque JS, 2008, MATERN CHILD HLTH J, V12, P287, DOI 10.1007/s10995-007-0249-5; MCNEE A, 1995, SOC SCI MED, V40, P1279, DOI 10.1016/0277-9536(94)00242-L; Mobley CC, 1996, J TROP PEDIATRICS, V42, P365, DOI 10.1093/tropej/42.6.365; Mukanga D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-121; MULL DS, 1994, SOC SCI MED, V38, P973, DOI 10.1016/0277-9536(94)90429-4; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Njama D, 2003, TROP MED INT HEALTH, V8, P685, DOI 10.1046/j.1365-3156.2003.01060.x; Oguonu T, 2005, PUBLIC HEALTH, V119, P409, DOI 10.1016/j.puhe.2004.05.008; Okeke TA, 2010, J BIOSOC SCI, V42, P325, DOI 10.1017/S0021932009990484; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; OLANGO P, 1990, SOC SCI MED, V31, P1245, DOI 10.1016/0277-9536(90)90131-B; Olson CK, 2011, AM J TROP MED HYG, V85, P1134, DOI 10.4269/ajtmh.2011.11-0178; Oreagba A. I., 2004, Tropical Journal of Pharmaceutical Research, V3, P299; Othero Doreen M, 2008, East Afr J Public Health, V5, P142; Page AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-389; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; PerezCuevas R, 1996, J DIARRHOEAL DIS RES, V14, P260; Prohmmo A, 2006, ASIA-PAC J PUBLIC HE, V18, P26, DOI 10.1177/10105395060180020501; QURESHI AF, 1994, J TROP PEDIATRICS, V40, P378, DOI 10.1093/tropej/40.6.378; Ringsted FM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-111; Rudan I, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001099; Rutebemberwa E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-45; Rutebemberwa E, 2009, TROP MED INT HEALTH, V14, P472, DOI 10.1111/j.1365-3156.2009.02237.x; Saini N K, 1992, J Commun Dis, V24, P75; Samosornsuki S, 2004, J HEALTH POPUL NUTR, V22, P113; Shah MS, 2012, J INFECT DEV COUNTR, V6, P137, DOI 10.3855/jidc.1374; Simanjuntak CH, 2004, J HEALTH POPUL NUTR, V22, P119; Simiyu D E, 2003, East Afr Med J, V80, P303; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-333; Sodemann M, 1996, ACTA PAEDIATR, V85, P1062, DOI 10.1111/j.1651-2227.1996.tb14218.x; Sodemann M, 1997, B WORLD HEALTH ORGAN, V75, P205; Sur D, 2004, J HEALTH POPUL NUTR, V22, P130; SUTRISNA B, 1993, LANCET, V342, P787, DOI 10.1016/0140-6736(93)91545-W; Talani P, 2003, Sante Publique, V15, P485; Teka T, 1995, E AFR MED J, V72, P623; Theodoratou E, 2010, INT J EPIDEMIOL, V39, P155, DOI 10.1093/ije/dyq032; Thera MA, 2000, TROP MED INT HEALTH, V5, P876, DOI 10.1046/j.1365-3156.2000.00652.x; THOMAS J C, 1989, Journal of Diarrhoeal Diseases Research, V7, P63; TUPASI TE, 1989, ANN TROP PAEDIATR, V9, P82, DOI 10.1080/02724936.1989.11748603; UNICEF, 2003, COMM FAM IMPR KNOWL; UNICEF, 2012, UNICEF STAT MON MULT; UNICEF WHO World Bank UN population division, 2012, LEV TRENDS CHILD MOR; US AID The DHS Program, MEASURE DHS QUAL INF; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; VATHANOPHAS K, 1988, Journal of the Medical Association of Thailand, V71, P177; Wang XY, 2004, J HEALTH POPUL NUTR, V22, P104; Williams T, 2012, SYSTEMATIC LIT REV R; Wilson SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033273; World Health Organization, INT MAN CHILDH ILLN; Yadav SP, 2010, J VECTOR DIS, V47, P235; Ye Y, 2007, ANN TROP MED PARASIT, V101, P297, DOI 10.1179/136485907X176391; YODER PS, 1994, J TROP MED HYG, V97, P1	113	130	131	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93427	10.1371/journal.pone.0093427	http://dx.doi.org/10.1371/journal.pone.0093427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718483	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000032
J	McClanahan, TR; Ateweberhan, M; Darling, ES; Graham, NAJ; Muthiga, NA				McClanahan, Timothy R.; Ateweberhan, Mebrahtu; Darling, Emily S.; Graham, Nicholas A. J.; Muthiga, Nyawira A.			Biogeography and Change among Regional Coral Communities across the Western Indian Ocean	PLOS ONE			English	Article							MARINE PROTECTED AREAS; CLIMATE-CHANGE; REEF; RESILIENCE; DIVERSITY; RECOVERY; SUSCEPTIBILITY; CONSERVATION; MANAGEMENT; MORTALITY	Coral reefs are biodiverse ecosystems structured by abiotic and biotic factors operating across many spatial scales. Regional-scale interactions between climate change, biogeography and fisheries management remain poorly understood. Here, we evaluated large-scale patterns of coral communities in the western Indian Ocean after a major coral bleaching event in 1998. We surveyed 291 coral reef sites in 11 countries and over 30 degrees of latitude between 2004 and 2011 to evaluate variations in coral communities post 1998 across gradients in latitude, mainland-island geography and fisheries management. We used linear mixed-effect hierarchical models to assess total coral cover, the abundance of four major coral families (acroporids, faviids, pocilloporids and poritiids), coral genus richness and diversity, and the bleaching susceptibility of the coral communities. We found strong latitudinal and geographic gradients in coral community structure and composition that supports the presence of a high coral cover and diversity area that harbours temperature-sensitive taxa in the northern Mozambique Channel between Tanzania, northern Mozambique and northern Madagascar. Coral communities in the more northern latitudes of Kenya, Seychelles and the Maldives were generally composed of fewer bleaching-tolerant coral taxa and with reduced richness and diversity. There was also evidence for continued declines in the abundance of temperature-sensitive taxa and community change after 2004. While there are limitations of our regional dataset in terms of spatial and temporal replication, these patterns suggest that large-scale interactions between biogeographic factors and strong temperature anomalies influence coral communities while smaller-scale factors, such as the effect of fisheries closures, were weak. The northern Mozambique Channel, while not immune to temperature disturbances, shows continued signs of resistance to climate disturbances and remains a priority for future regional conservation and management actions.	[McClanahan, Timothy R.; Ateweberhan, Mebrahtu; Muthiga, Nyawira A.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [Ateweberhan, Mebrahtu] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Darling, Emily S.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Wildlife Conservation Society; University of Warwick; Simon Fraser University; James Cook University	McClanahan, TR (corresponding author), Wildlife Conservat Soc, Marine Programs, Bronx, NY USA.	tmcclanahan@wcs.org	McClanahan, Tim/K-4998-2019; Graham, Nicholas AJ/C-8360-2014	Graham, Nicholas AJ/0000-0002-0304-7467; McClanahan, Timothy/0000-0001-5821-3584; Darling, Emily/0000-0002-1048-2838	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management Program (MASMA) program; John D. and Catherine T. MacArthur Foundation; Coral Reef Targeted Research Group (World Bank); UK Department for International Development; Leverhulme Trust	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management Program (MASMA) program; John D. and Catherine T. MacArthur Foundation; Coral Reef Targeted Research Group (World Bank); UK Department for International Development; Leverhulme Trust(Leverhulme Trust)	This work was supported by the Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management Program (MASMA) program, the John D. and Catherine T. MacArthur Foundation, the Coral Reef Targeted Research Group (World Bank), UK Department for International Development and Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; de Ruijter WPM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013714; FAURE G, 1984, CR ACAD SCI III-VIE, V299, P637; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Hardman E., 2007, ATOLL RES BULL, V555, P1; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jennings S, 1995, CORAL REEFS, V14, P225, DOI 10.1007/BF00334346; Jimenez H, 2012, J SEA RES, V72, P77, DOI 10.1016/j.seares.2012.04.011; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; McClanahan TR, 2009, MAR ECOL PROG SER, V380, P117, DOI 10.3354/meps07879; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2005, MAR ECOL PROG SER, V305, P301, DOI 10.3354/meps305301; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Penven P, 2006, GEOPHYS RES LETT, V33; R Development Core Team, 2012, R LANG ENV STAT COMP; Sebastian CR, 2009, MAR BIOL, V156, P2049, DOI 10.1007/s00227-009-1236-8; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tompkins EL, 2004, ECOL SOC, V9; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; West J, 2003, COMMENTARY, V115, P17; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; Wooldridge S, 2005, MAR ECOL PROG SER, V295, P157, DOI 10.3354/meps295157; Zuur Alain F., 2009, P1	48	55	56	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93385	10.1371/journal.pone.0093385	http://dx.doi.org/10.1371/journal.pone.0093385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718371	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000334339000030
J	Duong, NT; Morris, GE; Lam, LT; Zhang, QP; Sewry, CA; Shanahan, CM; Holt, I				Nguyen Thuy Duong; Morris, Glenn E.; Le Thanh Lam; Zhang, Qiuping; Sewry, Caroline A.; Shanahan, Catherine M.; Holt, Ian			Nesprins: Tissue-Specific Expression of Epsilon and Other Short Isoforms	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-MEMBRANE PROTEIN; REAL-TIME PCR; LAMIN A/C; ACTIN CYTOSKELETON; SKELETAL-MUSCLE; SUN PROTEINS; ENVELOPE; CELLS; ROLES	Nesprin-1-giant and nesprin-2-giant regulate nuclear positioning by the interaction of their C-terminal KASH domains with nuclear membrane SUN proteins and their N- terminal calponin-homology domains with cytoskeletal actin. A number of short isoforms lacking the actin-binding domains are produced by internal promotion. We have evaluated the significance of these shorter isoforms using quantitative RT-PCR and western blotting with site-specific monoclonal antibodies. Within a complete map of nesprin isoforms, we describe two novel nesprin-2 epsilon isoforms for the first time. Epsilon isoforms are similar in size and structure to nesprin-1-alpha. Expression of nesprin isoforms was highly tissue-dependent. Nesprin-2-epsilon- 1 was found in early embryonic cells, while nesprin-2-epsilon-2 was present in heart and other adult tissues, but not skeletal muscle. Some cell lines lack shorter isoforms and express only one of the two nesprin genes, suggesting that either of the giant nesprins is sufficient for basic cell functions. For the first time, localisation of endogenous nesprin away from the nuclear membrane was shown in cells where removal of the KASH domain by alternative splicing occurs. By distinguishing between degradation products and true isoforms on western blots, it was found that previously-described beta and gamma isoforms are expressed either at only low levels or with a limited tissue distribution. Two of the shortest alpha isoforms, nesprin-1-alpha-2 and nesprin-2-alpha-1, were found almost exclusively in cardiac and skeletal muscle and a highly conserved and alternatively- spliced exon, available in both nesprin genes, was always included in these tissues. These "muscle-specific'' isoforms are thought to form a complex with emerin and lamin A/C at the inner nuclear membrane and mutations in all three proteins cause Emery-Dreifuss muscular dystrophy and/or inherited dilated cardiomyopathy, disorders in which only skeletal muscle and/or heart are affected.	[Nguyen Thuy Duong; Morris, Glenn E.; Le Thanh Lam; Sewry, Caroline A.; Holt, Ian] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England; [Nguyen Thuy Duong] Vietnam Acad Sci & Technol VAST, Inst Genome Res, Hanoi, Vietnam; [Morris, Glenn E.; Holt, Ian] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Zhang, Qiuping; Shanahan, Catherine M.] Kings Coll London, James Black Ctr, Div Cardiovasc, London, England; [Sewry, Caroline A.] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Sewry, Caroline A.] Great Ormond St Hosp Sick Children, London, England	Keele University; Vietnam Academy of Science & Technology (VAST); Keele University; University of London; King's College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Holt, I (corresponding author), RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England.	ian.holt@rjah.nhs.uk	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Shanahan, Catherine/0000-0002-8352-8171; Nguyen, Thuy Duong/0000-0001-8691-9138	British Heart Foundation [PG/11/71/29091]; Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.06-2010.62]; British Heart Foundation [PG/11/58/29004] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); British Heart Foundation(British Heart Foundation)	We thank the British Heart Foundation for grant support (PG/11/71/29091 to IH and GEM). NTD received funding from the Vietnam National Foundation for Science and Technology Development (NAFOSTED) (106.06-2010.62). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, LAB INVEST, V50, P147; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Bastien P, 2008, J CLIN MICROBIOL, V46, P1897, DOI 10.1128/JCM.02258-07; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; GEY GO, 1952, CANCER RES, V12, P264; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Holt I, 2006, NEUROMUSCULAR DISORD, V16, P368, DOI 10.1016/j.nmd.2006.03.014; Lam LT, 2011, BIOCHEM BIOPH RES CO, V412, P291, DOI 10.1016/j.bbrc.2011.07.085; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi ML, 2011, BIOCHEM SOC T, V39, P1729, DOI 10.1042/BST20110686; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Manilal S, 1997, NEUROMUSCULAR DISORD, V7, P63, DOI 10.1016/S0960-8966(96)00405-1; Meinke P, 2011, BIOCHEM SOC T, V39, P1693, DOI 10.1042/BST20110658; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; Morris GE, 2010, BIOCHEM SOC T, V38, P278, DOI 10.1042/BST0380278; Morris-Stiff GJ, 2010, EUR J GASTROEN HEPAT, V22, P886, DOI 10.1097/MEG.0b013e3283392a62; Nguyen TM, 2010, PROTEIN PROTOCOLS HD, P1961; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Pereboev A, 1996, Methods Mol Biol, V66, P195; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Randles KN, 2010, DEV DYNAM, V239, P998, DOI 10.1002/dvdy.22229; Rashmi RN, 2012, NUCLEUS-PHILA, V3, P172, DOI 10.4161/nucl.19090; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Zhang JL, 2010, HUM MOL GENET, V19, P329, DOI 10.1093/hmg/ddp499; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543	48	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94380	10.1371/journal.pone.0094380	http://dx.doi.org/10.1371/journal.pone.0094380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718612	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000334339000112
J	O'Daly, OG; Joyce, D; Tracy, DK; Azim, A; Stephan, KE; Murray, RM; Shergill, SS				O'Daly, Owen G.; Joyce, Daniel; Tracy, Derek K.; Azim, Adnan; Stephan, Klaas E.; Murray, Robin M.; Shergill, Sukhwinder S.			Amphetamine Sensitization Alters Reward Processing in the Human Striatum and Amygdala	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INDUCED DOPAMINE RELEASE; COCAINE-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; ORBITOFRONTAL CORTEX; INCENTIVE-SENSITIZATION; EXTRACELLULAR DOPAMINE; MESENCEPHALIC DOPAMINE; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX	Dysregulation of mesolimbic dopamine transmission is implicated in a number of psychiatric illnesses characterised by disruption of reward processing and goal-directed behaviour, including schizophrenia, drug addiction and impulse control disorders associated with chronic use of dopamine agonists. Amphetamine sensitization (AS) has been proposed to model the development of this aberrant dopamine signalling and the subsequent dysregulation of incentive motivational processes. However, in humans the effects of AS on the dopamine-sensitive neural circuitry associated with reward processing remains unclear. Here we describe the effects of acute amphetamine administration, following a sensitising dosage regime, on blood oxygen level dependent (BOLD) signal in dopaminoceptive brain regions during a rewarded gambling task performed by healthy volunteers. Using a randomised, double-blind, parallel-groups design, we found clear evidence for sensitization to the subjective effects of the drug, while rewarded reaction times were unchanged. Repeated amphetamine exposure was associated with reduced dorsal striatal BOLD signal during decision making, but enhanced ventromedial caudate activity during reward anticipation. The amygdala BOLD response to reward outcomes was blunted following repeated amphetamine exposure. Positive correlations between subjective sensitization and changes in anticipation-and outcome-related BOLD signal were seen for the caudate nucleus and amygdala, respectively. These data show for the first time in humans that AS changes the functional impact of acute stimulant exposure on the processing of reward-related information within dopaminoceptive regions. Our findings accord with pathophysiological models which implicate aberrant dopaminergic modulation of striatal and amygdala activity in psychosis and drug-related compulsive disorders.	[O'Daly, Owen G.; Joyce, Daniel; Tracy, Derek K.; Azim, Adnan; Shergill, Sukhwinder S.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Cognit Schizophrenia & Imaging Lab, London, England; [O'Daly, Owen G.] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Sci, Dept Neuroimaging, London, England; [Tracy, Derek K.] Oxleas NHS Fdn Trust, London, England; [Stephan, Klaas E.] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Stephan, Klaas E.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Murray, Robin M.] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England; [Shergill, Sukhwinder S.] South London & Maudsley NHS Fdn, Natl Psychosis Unit, London, England	University of London; King's College London; University of London; King's College London; University of Zurich; University of London; University College London; University of London; King's College London	O'Daly, OG (corresponding author), Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Cognit Schizophrenia & Imaging Lab, London, England.	o.o'daly@kcl.ac.uk	Tracy, Derek/AAE-1155-2021; murray, robin/F-8658-2012	shergill, sukhi/0000-0003-4928-9100; Tracy, Derek/0000-0002-3609-9407; Stephan, Klaas Enno/0000-0002-8594-9092; murray, robin/0000-0003-0829-0519; Azim, Adnan/0000-0001-5960-1159	Wellcome grant; MRC [G0901868] Funding Source: UKRI; Medical Research Council [G0901868] Funding Source: researchfish; National Institute for Health Research [ACF-2012-17-001] Funding Source: researchfish	Wellcome grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Wellcome grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Angrist B M, 1970, Biol Psychiatry, V2, P95; ANTELMAN SM, 1980, SCIENCE, V207, P329, DOI 10.1126/science.7188649; Anticevic A, 2010, SCHIZOPHR B; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2013, CURR OPIN NEUROBIOL, V23, P564, DOI 10.1016/j.conb.2013.01.025; Boileau I, 2007, J NEUROSCI, V27, P3998, DOI 10.1523/JNEUROSCI.4370-06.2007; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Booij L, 2009, 50 ANN C SCAND COLL; Bozarth, 1987, METHODS ASSESSING RE, P489, DOI DOI 10.1007/978-1-4612-4812-5_24; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brotons O, 2010, MOL PSYCHIAT; Castner SA, 2003, BIOL PSYCHIAT, V54, P105, DOI 10.1016/S0006-3223(03)00292-0; Castner SA, 1999, NEUROPSYCHOPHARMACOL, V20, P10, DOI 10.1016/S0893-133X(98)00050-5; Castner SA, 2000, NEUROPSYCHOPHARMACOL, V22, P4, DOI 10.1016/S0893-133X(99)00080-9; Chambers RA, 2004, BIOL PSYCHIAT, V56, P308, DOI 10.1016/j.biopsych.2004.05.019; De Vries TJ, 1998, EUR J NEUROSCI, V10, P3565, DOI 10.1046/j.1460-9568.1998.00368.x; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Evans AH, 2006, ANN NEUROL, V59, P852, DOI 10.1002/ana.20822; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Featherstone RE, 2007, PROG NEURO-PSYCHOPH, V31, P1556, DOI 10.1016/j.pnpbp.2007.08.025; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Goldstein RZ, 2007, AM J PSYCHIAT, V164, P43, DOI 10.1176/appi.ajp.164.1.43; Goldstein RZ, 2007, DRUG ALCOHOL DEPEN, V87, P233, DOI 10.1016/j.drugalcdep.2006.08.022; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Haber SN, 2000, J NEUROSCI, V20, P2369; HAERTZEN CA, 1963, PSYCHOPHARMACOLOGIA, V4, P155, DOI 10.1007/BF02584088; HAERTZEN CA, 1963, J CLIN PSYCHOL, V19, P407, DOI 10.1002/1097-4679(196310)19:4<407::AID-JCLP2270190410>3.0.CO;2-N; Homayoun H, 2006, J NEUROSCI, V26, P8025, DOI 10.1523/JNEUROSCI.0842-06.2006; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Jonkman Sietse, 2006, J Neurosci, V26, P7319, DOI 10.1523/JNEUROSCI.2236-06.2006; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KALIVAS PW, 1993, J NEUROSCI, V13, P276; KALIVAS PW, 1986, BIOL PSYCHIAT, V21, P939, DOI 10.1016/0006-3223(86)90268-4; KALIVAS PW, 1990, SYNAPSE, V5, P48, DOI 10.1002/syn.890050104; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kilts C D, 2001, Psychopharmacol Bull, V35, P84; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kosson DS, 2006, NEUROIMAGE, V29, P1161, DOI 10.1016/j.neuroimage.2005.07.060; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kumari V, 1998, BEHAV PHARMACOL, V9, P567, DOI 10.1097/00008877-199811000-00012; Lapish CC, 2006, ALCOHOL CLIN EXP RES, V30, P1451, DOI 10.1111/j.1530-0277.2006.00176.x; Laruelle M, 2000, BRAIN RES REV, V31, P371, DOI 10.1016/S0165-0173(99)00054-5; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Laruelle M, 1999, BIOL PSYCHIAT, V46, P56, DOI 10.1016/S0006-3223(99)00067-0; Malison RT, 1999, J NUCL MED, V40, p110P; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; McNair DM., 1992, EDITS MANUAL PROFILE; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris RW, 2011, MOL PSYCHIAT; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Murray GK, 2010, SCHIZOPHRENIA BULL, V36, P465, DOI 10.1093/schbul/sbq005; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nordquist RE, 2007, EUR NEUROPSYCHOPHARM, V17, P532, DOI 10.1016/j.euroneuro.2006.12.005; O'Daly O. G., 2005, J DUAL DIAGN, V1, P11; O'Daly OG, 2014, J PSYCH IN PRESS JAN; O'Daly OG, 2011, ARCH GEN PSYCHIAT, V68, P545, DOI 10.1001/archgenpsychiatry.2011.3; PIAZZA PV, 1990, BRAIN RES, V514, P22, DOI 10.1016/0006-8993(90)90431-A; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROBINSON TE, 1987, NEUROPHARMACOLOGY, V26, P679, DOI 10.1016/0028-3908(87)90228-0; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Roesch MR, 2007, J NEUROSCI, V27, P245, DOI 10.1523/JNEUROSCI.4080-06.2007; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Schmidt WJ, 2006, NEUROTOX RES, V10, P161, DOI 10.1007/BF03033244; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; Schoenbaum G, 2004, EUR J NEUROSCI, V19, P1997, DOI 10.1111/j.1460-9568.2004.03274.x; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1993, PROG BRAIN RES, V99, P227; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; See RE, 2003, ANN NY ACAD SCI, V985, P294; Stalnaker TA, 2007, NAT NEUROSCI, V10, P949, DOI 10.1038/nn1931; Stalnaker TA, 2006, EUR J NEUROSCI, V24, P2643, DOI 10.1111/j.1460-9568.2006.05128.x; Steeves TDL, 2009, BRAIN, V132, P1376, DOI 10.1093/brain/awp054; Strakowski SM, 2001, NEUROPSYCHOPHARMACOL, V25, P548, DOI 10.1016/S0893-133X(01)00253-6; Strakowski SM, 1998, BIOL PSYCHIAT, V44, P1171, DOI 10.1016/S0006-3223(97)00454-X; Strakowski SM, 1996, BIOL PSYCHIAT, V40, P872, DOI 10.1016/0006-3223(95)00497-1; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Takahashi Y, 2007, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.011.2007; Tse MTL, 2011, J NEUROSCI, V31, P11282, DOI 10.1523/JNEUROSCI.1810-11.2011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 2008, NEUROIMAGE, V39, P1266, DOI 10.1016/j.neuroimage.2007.09.059; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Waltz JA, 2010, NEUROPSYCHOPHARMACOL, V35, P2427, DOI 10.1038/npp.2010.126; WISE RA, 1980, PHARMACOL BIOCHEM BE, V13, P213, DOI 10.1016/S0091-3057(80)80033-5; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; YOUNG IR, 1988, MAGN RESON IMAGING, V6, P585, DOI 10.1016/0730-725X(88)90133-6; Zack Martin, 2009, Curr Drug Abuse Rev, V2, P11; Ziauddeen H, 2010, CURR OPIN PSYCHIATR, V23, P91, DOI 10.1097/YCO.0b013e328336661b	116	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93955	10.1371/journal.pone.0093955	http://dx.doi.org/10.1371/journal.pone.0093955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717936	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000334339000060
J	Thompson, JJ; Blair, MR; Henrey, AJ				Thompson, Joseph J.; Blair, Mark R.; Henrey, Andrew J.			Over the Hill at 24: Persistent Age-Related CognitiveMotor Decline in Reaction Times in an Ecologically Valid Video Game Task Begins in Early Adulthood	PLOS ONE			English	Article							EXPERTISE; PERFORMANCE; ATTENTION; PERCEPTION; COGNITION; SKILL	Typically studies of the effects of aging on cognitive-motor performance emphasize changes in elderly populations. Although some research is directly concerned with when age-related decline actually begins, studies are often based on relatively simple reaction time tasks, making it impossible to gauge the impact of experience in compensating for this decline in a real world task. The present study investigates age-related changes in cognitive motor performance through adolescence and adulthood in a complex real world task, the real-time strategy video game StarCraft 2. In this paper we analyze the influence of age on performance using a dataset of 3,305 players, aged 16-44, collected by Thompson, Blair, Chen & Henrey [ 1]. Using a piecewise regression analysis, we find that age-related slowing of within-game, self-initiated response times begins at 24 years of age. We find no evidence for the common belief expertise should attenuate domainspecific cognitive decline. Domain-specific response time declines appear to persist regardless of skill level. A second analysis of dual-task performance finds no evidence of a corresponding age-related decline. Finally, an exploratory analyses of other age-related differences suggests that older participants may have been compensating for a loss in response speed through the use of game mechanics that reduce cognitive load.	[Thompson, Joseph J.; Blair, Mark R.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Henrey, Andrew J.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Thompson, JJ (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	jjthomps@sfu.ca			Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was supported by funding from the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; BOSMAN EA, 1993, PSYCHOL AGING, V8, P87, DOI 10.1037/0882-7974.8.1.87; CHARNESS N, 1983, J VERB LEARN VERB BE, V22, P406, DOI 10.1016/S0022-5371(83)90264-5; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Hastie T., 2009, UNSUPERVISED LEARNIN; Horner K L, 1986, Psychol Aging, V1, P319, DOI 10.1037/0882-7974.1.4.319; Jastrzembski TS, 2006, PSYCHOL AGING, V21, P401, DOI 10.1037/0882-7974.21.2.401; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Kennedy Q, 2010, AVIAT SPACE ENVIR MD, V81, P489, DOI 10.3357/ASEM.2684.2010; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee H, 2012, ACTA PSYCHOL, V139, P146, DOI 10.1016/j.actpsy.2011.11.003; Lewis JM, 2011, P 33 ANN C COGN SCI, P687; MANE A, 1989, ACTA PSYCHOL, V71, P17, DOI 10.1016/0001-6918(89)90003-6; Meinz EJ, 2000, PSYCHOL AGING, V15, P297, DOI 10.1037/0882-7974.15.2.297; MORROW D, 1994, PSYCHOL AGING, V9, P134, DOI 10.1037/0882-7974.9.1.134; Palmeri TJ, 1997, J EXP PSYCHOL LEARN, V23, P324, DOI 10.1037/0278-7393.23.2.324; REITMAN JS, 1976, COGNITIVE PSYCHOL, V8, P336, DOI 10.1016/0010-0285(76)90011-6; SALTHOUSE TA, 1984, J EXP PSYCHOL GEN, V113, P345, DOI 10.1037/0096-3445.113.3.345; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Schroeder DH, 2004, PERS INDIV DIFFER, V36, P393, DOI 10.1016/S0191-8869(03)00104-1; Shinoda H, 2001, VISION RES, V41, P3535, DOI 10.1016/S0042-6989(01)00199-7; Thompson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072540; Tsang PS, 1998, PSYCHOL AGING, V13, P323, DOI 10.1037/0882-7974.13.2.323; Tun PA, 2008, DEV PSYCHOL, V44, P1421, DOI 10.1037/a0012845; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443	28	53	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94215	10.1371/journal.pone.0094215	http://dx.doi.org/10.1371/journal.pone.0094215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718593	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000091
J	He, Z; Tian, T; Guo, D; Wu, HJ; Chen, Y; Zhang, YC; Wan, Q; Zhao, HZ; Wang, CY; Shen, HJ; Zhao, L; Bu, XD; Wan, ML; Shen, CL				He, Ze; Tian, Tian; Guo, Dan; Wu, Huijuan; Chen, Yang; Zhang, Yongchen; Wan, Qing; Zhao, Huzi; Wang, Congyang; Shen, Hongjing; Zhao, Lei; Bu, Xiaodong; Wan, Meiling; Shen, Chuanlu			Cytoplasmic Retention of a Nucleocytoplasmic Protein TBC1D3 by Microtubule Network Is Required for Enhanced EGFR Signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; C-CBL; NUCLEAR TRANSPORT; UBIQUITINATION; DEGRADATION; ENDOCYTOSIS; ONCOGENE; INTERNALIZATION; UBIQUITYLATION	The hominoid oncogene TBC1D3 enhances epidermal growth factor receptor (EGFR) signaling and induces cell transformation. However, little is known regarding its spatio-temporal regulation and mechanism of tumorigenesis. In the current study, we identified the microtubule subunit beta-tubulin as a potential interaction partner for TBC1D3 using affinity purification combined with mass spectrometry analysis. The interaction between TBC1D3 and beta-tubulin was confirmed by co-immunoprecipitation. Using the same method, we also revealed that TBC1D3 co-precipitated with endogenous alpha-tubulin, another subunit of the microtubule. In agreement with these results, microtubule cosedimentation assays showed that TBC1D3 associated with the microtubule network. The beta-tubulin-interacting site of TBC1D3 was mapped to amino acids 286,353 near the C-terminus of the TBC domain. Deletion mutation within these amino acids was shown to abolish the interaction of TBC1D3 with beta-tubulin. Interestingly, the deletion mutation caused a complete loss of TBC1D3 from the cytoplasmic filamentous and punctate structures, and TBC1D3 instead appeared in the nucleus. Consistent with this, wild-type TBC1D3 exhibited the same nucleocytoplasmic distribution in cells treated with the microtubule depolymerizing agent nocodazole, suggesting that the microtubule network associates with and retains TBC1D3 in the cytoplasm. We further found that deficiency in beta-tubulin-interacting resulted in TBC1D3's inability to inhibit c-Cbl recruitment and EGFR ubiquitination, ultimately leading to dysregulation of EGFR degradation and signaling. Taken together, these studies indicate a novel model by which the microtubule network regulates EGFR stability and signaling through tubulin dimer/oligomer interaction with the nucleocytoplasmic protein TBC1D3.	[He, Ze; Tian, Tian; Guo, Dan; Wu, Huijuan; Chen, Yang; Zhang, Yongchen; Wan, Qing; Zhao, Huzi; Wang, Congyang; Zhao, Lei; Bu, Xiaodong; Wan, Meiling; Shen, Chuanlu] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [He, Ze] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Shen, Hongjing] SUNY Buffalo, Dept Biomed Sci, Buffalo, NY 14260 USA	Southeast University - China; Southeast University - China; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shen, CL (corresponding author), Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China.	shencl37@163.com	Chen, Yang/L-7304-2018; Chen, Yang/AFL-4729-2022	Chen, Yang/0000-0001-7661-5923; 	National Natural Science Foundation of China [81272261, 81071803, 30971144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (No. 81272261, No. 81071803, and No. 30971144) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Campbell EA, 2003, ADV DRUG DELIVER REV, V55, P761, DOI 10.1016/S0169-409X(03)00049-8; Carbonaro M, 2012, J BIOL CHEM, V287, P11859, DOI 10.1074/jbc.M112.345587; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034919; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Eden ER, 2012, TRAFFIC, V13, P329, DOI 10.1111/j.1600-0854.2011.01305.x; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haller K, 2004, J BIOL CHEM, V279, P49384, DOI 10.1074/jbc.M406046200; Hatanaka H, 2010, CANCER SCI, V101, P54, DOI 10.1111/j.1349-7006.2009.01348.x; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kong C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046485; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Malki S, 2005, EXP CELL RES, V309, P468, DOI 10.1016/j.yexcr.2005.07.005; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; Okur MN, 2012, MOL CELL BIOL, V32, P817, DOI 10.1128/MCB.05647-11; Pareja F, 2012, ONCOGENE, V31, P4599, DOI 10.1038/onc.2011.587; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pei L, 2002, CANCER RES, V62, P5420; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Wainszelbaum MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031225; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Ziegler Elizabeth C, 2005, Sci STKE, V2005, pre6, DOI 10.1126/stke.2842005re6	53	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94134	10.1371/journal.pone.0094134	http://dx.doi.org/10.1371/journal.pone.0094134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714105	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900092
J	Krause, TA; Alex, AF; Engel, DR; Kurts, C; Eter, N				Krause, Torsten A.; Alex, Anne F.; Engel, Daniel R.; Kurts, Christian; Eter, Nicole			VEGF-Production by CCR2-Dependent Macrophages Contributes to Laser-Induced Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; MACULAR DEGENERATION; DENDRITIC CELLS; BLOOD-VESSELS; AGE; MICROGLIA; RECEPTOR; EXPRESSION; MONOCYTES	Age-related macular degeneration (AMD) is the most prevalent cause of blindness in the elderly, and its exsudative subtype critically depends on local production of vascular endothelial growth factor A (VEGF). Mononuclear phagocytes, such as macrophages and microglia cells, can produce VEGF. Their precursors, for example monocytes, can be recruited to sites of inflammation by the chemokine receptor CCR2, and this has been proposed to be important in AMD. To investigate the role of macrophages and CCR2 in AMD, we studied intracellular VEGF content in a laser-induced murine model of choroidal neovascularisation. To this end, we established a technique to quantify the VEGF content in cell subsets from the laser-treated retina and choroid separately. 3 days after laser, macrophage numbers and their VEGF content were substantially elevated in the choroid. Macrophage accumulation was CCR2-dependent, indicating recruitment from the circulation. In the retina, microglia cells were the main VEGF(+) phagocyte type. A greater proportion of microglia cells contained VEGF after laser, and this was CCR2-independent. On day 6, VEGF-expressing macrophage numbers had already declined, whereas numbers of VEGF(+) microglia cells remained increased. Other sources of VEGF detectable by flow cytometry included in dendritic cells and endothelial cells in both retina and choroid, and Muller cells/astrocytes in the retina. However, their VEGF content was not increased after laser. When we analyzed flatmounts of laser-treated eyes, CCR2-deficient mice showed reduced neovascular areas after 2 weeks, but this difference was not evident 3 weeks after laser. In summary, CCR2-dependent influx of macrophages causes a transient VEGF increase in the choroid. However, macrophages augmented choroidal neovascularization only initially, presumably because VEGF production by CCR2-independent eye cells prevailed at later time points. These findings identify macrophages as a relevant source of VEGF in laser-induced choroidal neovascularization but suggest that the therapeutic efficacy of CCR2-inhibition might be limited.	[Krause, Torsten A.; Engel, Daniel R.; Kurts, Christian] Rhein Freidrich Wilhelms Univ Bonn, Inst Expt Immunol, D-53113 Bonn, Germany; [Alex, Anne F.; Eter, Nicole] Univ Munster, Dept Ophthalmol, D-48149 Munster, Germany	University of Bonn; University of Munster	Kurts, C (corresponding author), Rhein Freidrich Wilhelms Univ Bonn, Inst Expt Immunol, D-53113 Bonn, Germany.	ckurts@web.de	Engel, Daniel Robert/C-5945-2013	Engel, Daniel Robert/0000-0001-7301-353X	Deutsche Forschungsgemeinschaft [SFBTR57, KU1063/8, ET 29/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (SFBTR57, KU1063/8 and ET 29/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Berardi S, 2013, J ONCOL, V2013, DOI 10.1155/2013/183602; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Eter N, 2008, INVEST OPHTH VIS SCI, V49, P3649, DOI 10.1167/iovs.07-1322; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Granata F, 2010, J IMMUNOL, V184, P5232, DOI 10.4049/jimmunol.0902501; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Horster R, 2011, GRAEF ARCH CLIN EXP, V249, P645, DOI 10.1007/s00417-010-1588-2; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jais A, 2011, VET IMMUNOL IMMUNOP, V140, P207, DOI 10.1016/j.vetimm.2010.12.005; Kezic J, 2008, J LEUKOCYTE BIOL, V84, P721, DOI 10.1189/jlb.0308166; Kezic JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068570; Kezic JM, 2013, INVEST OPHTH VIS SCI, V54, P854, DOI 10.1167/iovs.12-10876; Lewis GP, 2007, BRIT J OPHTHALMOL, V91, P1234, DOI 10.1136/bjo.2006.104612; Liu J, 2013, ACTA GEOL SIN-ENGL, V87, P1501, DOI 10.1111/1755-6724.12154; Luna G, 2010, MOL VIS, V16, P2511; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Nagineni CN, 2012, J CELL PHYSIOL, V227, P116, DOI 10.1002/jcp.22708; Nakai K, 2008, INVEST OPHTH VIS SCI, V49, P3666, DOI 10.1167/iovs.07-1640; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Portillo JAC, 2009, MOL VIS, V15, P1383; Riazy M, 2009, ATHEROSCLEROSIS, V204, P47, DOI 10.1016/j.atherosclerosis.2008.08.004; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Scheef E, 2005, MOL VIS, V11, P613; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Wu WK, 2010, IMMUNOBIOLOGY, V215, P796, DOI 10.1016/j.imbio.2010.05.025; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933; Yanni SE, 2010, EXP EYE RES, V91, P34, DOI 10.1016/j.exer.2010.03.019	49	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94313	10.1371/journal.pone.0094313	http://dx.doi.org/10.1371/journal.pone.0094313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714223	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900115
J	Kizis, D; Natskoulis, P; Nychas, GJE; Panagou, EZ				Kizis, Dimosthenis; Natskoulis, Pantelis; Nychas, George-John E.; Panagou, Efstathios Z.			Biodiversity and ITS-RFLP Characterisation of Aspergillus Section Nigri Isolates in Grapes from Four Traditional Grape-Producing Areas in Greece	PLOS ONE			English	Article							WINE-PRODUCING VINEYARDS; OCHRATOXIN-A PRODUCTION; DRIED VINE FRUITS; POPULATION COMPOSITION; BLACK ASPERGILLI; SOUTHERN EUROPE; CONTAMINATION; FUNGI; FOOD; CARBONARIUS	A study on the occurrence of Aspergillus section Nigri species on grapes from four traditional grape-producing areas in Greece during the 2011/ 2012 vintage, and their capability to produce OTA was conducted. One hundred and twenty-eight black aspergilli isolates were characterised at the species level initially by the use of morphological criteria in accordance with appropriate keys, followed by molecular characterisation performed with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) of the 5.8 ribosomal RNA gene Internal Transcribed Spacer region (5.8 rRNA ITS). Restriction enzyme digestion of the ITS amplicons using the HhaI, HinfI and RsaI, endonucleases distinguished eleven different patterns of restriction fragment length polymorphism (RFLP), four for each of the HhaI and RsaI digests and three for HinfI. From a total number of 128 individual isolates, 124 were classified into four Aspergillus species corresponding to A. carbonarius, A. tubingensis, A. japonicus and A. ibericus, and the remaining 4 were classified as members of the A. niger aggregate. A. carbonarius and A. tubingensis being the main representative species were equally counted, with higher geographical representation of the former in southern and the latter in northern regions, respectively. All isolates were tested for their ochratoxigenic potential by use of High Performance Liquid Chromatography (HPLC) and Enzyme Linked Immuno Sorbent Assay (ELISA), resulting in significant interspecies differences in OTA production.	[Kizis, Dimosthenis; Natskoulis, Pantelis; Nychas, George-John E.; Panagou, Efstathios Z.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece	Agricultural University of Athens	Kizis, D (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece.	dimosthenis_kizis@yahoo.gr	Panagou, Efstathios/I-6537-2019; Nychas, George/B-2734-2009; Natskoulis, Pantelis/AAX-4254-2021	Panagou, Efstathios/0000-0002-0317-1177; Nychas, George/0000-0002-2673-6425; Natskoulis, Pantelis/0000-0002-8121-5606	project 'Design and development of innovative tools for the detection of ochratoxigenic fungi in wine and table grapes FungalPrognosis 242'; European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: ARISTEIA-I	project 'Design and development of innovative tools for the detection of ochratoxigenic fungi in wine and table grapes FungalPrognosis 242'; European Union (European Social Fund ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: ARISTEIA-I	This work has been supported by the project 'Design and development of innovative tools for the detection of ochratoxigenic fungi in wine and table grapes FungalPrognosis 242' that is co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: ARISTEIA-I, (www.fungalprognosis.gr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca ML, 2004, ANTON LEEUW INT J G, V86, P33, DOI 10.1023/B:ANTO.0000024907.85688.05; Abouzied MM, 2002, FOOD ADDIT CONTAM A, V19, P755, DOI 10.1080/02652030210145036; Accensi F, 2001, ANTON LEEUW INT J G, V79, P365, DOI 10.1023/A:1012003813985; Astoreca AL, 2010, TOXINS, V2, P2593, DOI 10.3390/toxins2112593; Battilani P, 2006, INT J FOOD MICROBIOL, V111, pS72, DOI 10.1016/j.ijfoodmicro.2006.03.014; Battilani P, 2003, J FOOD PROTECT, V66, P633, DOI 10.4315/0362-028X-66.4.633; Bau M, 2006, INT J FOOD MICROBIOL, V111, pS18, DOI 10.1016/j.ijfoodmicro.2006.03.008; Bau M, 2005, RES MICROBIOL, V156, P375, DOI 10.1016/j.resmic.2004.12.003; Bau M, 2005, INT J FOOD MICROBIOL, V98, P125, DOI 10.1016/j.ijfoodmicro.2004.05.015; Bau M, 2006, INT J FOOD MICROBIOL, V1, P111; Belli N, 2006, INT J FOOD MICROBIOL, V111, pS40, DOI 10.1016/j.ijfoodmicro.2006.03.011; Borman AM, 2007, J ANTIMICROB CHEMOTH, V61, pI7, DOI 10.1093/jac/dkm425; Bragulat MR, 2001, INT J FOOD MICROBIOL, V71, P139, DOI 10.1016/S0168-1605(01)00581-5; Cary JW, 2006, MYCOPATHOLOGIA, V162, P167, DOI 10.1007/s11046-006-0051-8; Chiotta ML, 2011, INT J FOOD MICROBIOL, V149, P171, DOI 10.1016/j.ijfoodmicro.2011.06.002; Chiotta ML, 2009, INT J FOOD MICROBIOL, V136, P137, DOI 10.1016/j.ijfoodmicro.2009.08.013; Communities T., 2005, OFFICIAL J EUROPEAN, V25, P3; de Cerain AL, 2002, FOOD ADDIT CONTAM A, V19, P1058, DOI 10.1080/02652030210145928; Diaz GA, 2009, INT J FOOD MICROBIOL, V133, P195, DOI 10.1016/j.ijfoodmicro.2009.04.018; Duarte SC, 2010, FOOD MICROBIOL, V27, P187, DOI 10.1016/j.fm.2009.11.016; El Khoury A, 2008, FOOD CHEM TOXICOL, V46, P2244, DOI 10.1016/j.fct.2008.02.026; el Khoury A, 2010, TOXINS, V2, P461, DOI 10.3390/toxins2040461; Esteban A, 2008, CURR MICROBIOL, V57, P348, DOI 10.1007/s00284-008-9201-1; European Commission, 2006, OFF J EUR UNION L, V1365, P6; European Commission (EC), 2012, RAP AL SYST FOOD FEE; Fuchs R, 2005, FOOD ADDIT CONTAM A, V22, P53, DOI 10.1080/02652030500309368; Kapetanakou AE, 2009, FOOD CONTROL, V20, P725, DOI 10.1016/j.foodcont.2008.09.008; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Labrinea EP, 2011, FOOD ADDIT CONTAM B, V4, P61, DOI 10.1080/19393210.2010.539707; Lasram S, 2007, INT J FOOD MICROBIOL, V114, P376, DOI 10.1016/j.ijfoodmicro.2006.09.027; Lasram S, 2012, FOOD CONTROL, V25, P75, DOI 10.1016/j.foodcont.2011.10.006; Leong SL, 2007, LETT APPL MICROBIOL, V45, P301, DOI 10.1111/j.1472-765X.2007.02189.x; Leong SLL, 2006, J AGR FOOD CHEM, V54, P6460, DOI 10.1021/jf061669d; Levin RE, 2012, INT J FOOD MICROBIOL, V156, P1, DOI 10.1016/j.ijfoodmicro.2012.03.001; Ponsone ML, 2012, TOXINS, V4, P364, DOI 10.3390/toxins4050364; Magan N, 2006, MYCOPATHOLOGIA, V162, P245, DOI 10.1007/s11046-006-0057-2; Magnoli C, 2003, LETT APPL MICROBIOL, V37, P179, DOI 10.1046/j.1472-765X.2003.01376.x; Martinez-Culebras PV, 2007, INT J FOOD MICROBIOL, V113, P147, DOI 10.1016/j.ijfoodmicro.2006.06.023; Martinez-Culebras PV, 2009, INT J FOOD MICROBIOL, V132, P33, DOI 10.1016/j.ijfoodmicro.2009.03.015; Mateo R, 2007, INT J FOOD MICROBIOL, V119, P79, DOI 10.1016/j.ijfoodmicro.2007.07.029; Matsuda Y, 2013, WORLD J GASTROENTERO, V19, P2587, DOI 10.3748/wjg.v19.i17.2587; Medina A, 2005, APPL ENVIRON MICROB, V71, P4696, DOI 10.1128/AEM.71.8.4696-4702.2005; Nugroho A.D., 2013, J FOOD SCI ENG, V3, P472; Oliveri C, 2008, INT J FOOD MICROBIOL, V127, P147, DOI 10.1016/j.ijfoodmicro.2008.06.021; Otteneder H, 2000, FOOD ADDIT CONTAM A, V17, P793, DOI 10.1080/026520300415345; Palencia ER, 2010, TOXINS, V2, P399, DOI 10.3390/toxins2040399; Palumbo JD, 2011, LETT APPL MICROBIOL, V52, P330, DOI 10.1111/j.1472-765X.2011.03004.x; Perrone G, 2007, STUD MYCOL, P53, DOI 10.3114/sim.2007.59.07; Perrone G, 2006, INT J FOOD MICROBIOL, V111, pS22, DOI 10.1016/j.ijfoodmicro.2006.03.009; Perrone G, 2013, FOOD ADDIT CONTAM A, V30, P1339, DOI 10.1080/19440049.2013.796594; Perrone G, 2011, FUNGAL BIOL-UK, V115, P1138, DOI 10.1016/j.funbio.2011.07.008; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Pietri A, 2001, FOOD ADDIT CONTAM A, V18, P647, DOI 10.1080/02652030110028353; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P1, DOI 10.1007/978-0-387-92207-2; Reddy L, 2010, TOXINS, V2, P771, DOI 10.3390/toxins2040771; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samson R. A., 2000, INTRO FOOD AIRBORNE, P389; Schmidt H, 2005, Mycotoxin Res, V21, P61, DOI 10.1007/BF02954820; Serra R, 2005, RES MICROBIOL, V156, P515, DOI 10.1016/j.resmic.2004.12.005; Serra R, 2003, INT J FOOD MICROBIOL, V88, P63, DOI 10.1016/S0168-1605(03)00085-0; Serra R, 2006, MYCOLOGIA, V98, P295, DOI 10.3852/mycologia.98.2.295; Spadaro D, 2012, TOXINS, V4, P42, DOI 10.3390/toxins4020042; Stefanovic V, 2009, NEPHRON CLIN PRACT, V112, pC51, DOI 10.1159/000213081; Susca A, 2013, INT J FOOD MICROBIOL, V165, P163, DOI 10.1016/j.ijfoodmicro.2013.04.027; Tittlemier SA, 2011, FOOD ADDIT CONTAM A, V28, P775, DOI 10.1080/19440049.2011.559278; Tjamos SE, 2006, INT J FOOD MICROBIOL, V111, pS61, DOI 10.1016/j.ijfoodmicro.2006.01.044; Tjamos SE, 2004, J PHYTOPATHOL, V152, P250, DOI 10.1111/j.1439-0434.2004.00838.x; Valero A, 2006, FOOD MICROBIOL, V23, P753, DOI 10.1016/j.fm.2006.01.005; Varga J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.69.01; Varga J, 2010, INT J FOOD MICROBIOL, V143, P143, DOI 10.1016/j.ijfoodmicro.2010.08.008; Velmourougane K, 2010, FOODBORNE PATHOG DIS, V7, P1279, DOI 10.1089/fpd.2010.0571; Visconti A, 2008, FOOD ADDIT CONTAM A, V25, P193, DOI 10.1080/02652030701744546; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	73	31	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93923	10.1371/journal.pone.0093923	http://dx.doi.org/10.1371/journal.pone.0093923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710283	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800072
J	Nobs, JB; Maerkl, SJ				Nobs, Jean-Bernard; Maerkl, Sebastian J.			Long-Term Single Cell Analysis of S. pombe on a Microfluidic Microchemostat Array	PLOS ONE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; BUDDING YEAST; GENE-EXPRESSION; CYCLE; GENOME; DEVICE; SIZE; VARIABILITY; INTEGRATION	Although Schyzosaccharomyces pombe is one of the principal model organisms for studying the cell cycle, surprisingly few methods have characterized S. pombe growth on the single cell level, and no methods exist capable of analyzing thousands of cells and tens of thousands of cell division events. We developed an automated microfluidic platform permitting S. pombe to be grown on-chip for several days under defined and changeable conditions. We developed an image processing pipeline to extract and quantitate several physiological parameters including cell length, time to division, and elongation rate without requiring synchronization of the culture. Over a period of 50 hours our platform analyzed over 100000 cell division events and reconstructed single cell lineages up to 10 generations in length. We characterized cell lengths and division times in a temperature shift experiment in which cells were initially grown at 30 degrees C and transitioned to 25 degrees C. Although cell length was identical at both temperatures at steady-state, we observed transient changes in cell length if the temperature shift took place during a critical phase of the cell cycle. We further show that cells born with normal length do divide over a wide range of cell lengths and that cell length appears to be controlled in the second generation, were large newly born cells have a tendency to divide more rapidly and thus at a normalized cell size. The platform is thus applicable to measure fine-details in cell cycle dynamics, should be a useful tool to decipher the molecular mechanism underlying size homeostasis, and will be generally applicable to study processes on the single cell level that require large numbers of precision measurements and single cell lineages.	[Nobs, Jean-Bernard; Maerkl, Sebastian J.] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Maerkl, SJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland.	sebastian.maerkl@epfl.ch	Maerkl, Sebastian J. J/C-5438-2008	Maerkl, Sebastian J. J/0000-0003-1917-5268	SystemsX.ch Grant DynamiX-RTD [2008/005]; Ecole Polytechnique Federale de Lausanne	SystemsX.ch Grant DynamiX-RTD; Ecole Polytechnique Federale de Lausanne	This work was supported by a SystemsX.ch Grant DynamiX-RTD (2008/005) and the Ecole Polytechnique Federale de Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Blomberg A, 2011, CURR OPIN BIOTECH, V22, P94, DOI 10.1016/j.copbio.2010.10.013; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Denervaud N, 2013, P NATL ACAD SCI USA, V110, P15842, DOI 10.1073/pnas.1308265110; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Falconnet D, 2011, LAB CHIP, V11, P466, DOI [10.1039/c0lc00228c, 10.1039/c01c00228c]; Hachet O, 2012, CURR OPIN CELL BIOL, V24, P858, DOI 10.1016/j.ceb.2012.10.001; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; LEE SW, 1985, GENE, V39, P173, DOI 10.1016/0378-1119(85)90311-7; Leung K, 2012, P NATL ACAD SCI USA, V109, P7665, DOI 10.1073/pnas.1106752109; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Maerkl SJ, 2009, INTEGR BIOL-UK, V1, P19, DOI 10.1039/b819762h; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MITCHISON JM, 1985, J CELL SCI, V75, P357; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Rajkumar AS, 2013, NAT GENET, V45, P1207, DOI 10.1038/ng.2729; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ricicova M, 2013, P NATL ACAD SCI USA, V110, P11403, DOI 10.1073/pnas.1215850110; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tian Y, 2013, LAB CHIP, V13, P4071, DOI 10.1039/c3lc50639h; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048275	39	49	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93466	10.1371/journal.pone.0093466	http://dx.doi.org/10.1371/journal.pone.0093466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710337	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800035
J	Sun, JM; Gong, ZY; Lv, HK; Chen, ZP; Chai, CL; Liu, SL; Ling, F; Lu, Y; Cai, J; Yu, Z; Miao, ZP; Ren, JP; Chen, EF				Sun, Jimin; Gong, Zhenyu; Lv, Huakun; Chen, Zhiping; Chai, Chengliang; Liu, Shelan; Ling, Feng; Lu, Ye; Cai, Jian; Yu, Zhao; Miao, Ziping; Ren, Jiangping; Chen, Enfu			Comparison of Characteristics between Patients with H7N9 Living in Rural and Urban Areas of Zhejiang Province, China: A Preliminary Report	PLOS ONE			English	Article							INFLUENZA-A H7N9; HUMAN INFECTIONS; VIRUS; CANCER	A total of 134 cases of H7N9 influenza infection were identified in 12 provinces of China between March 25 and September 31, 2013. Of these, 46 cases occurred in Zhejiang Province. We carried out a preliminary comparison of characteristics between rural and urban H7N9 cases from Zhejiang Province, China. Field investigations were conducted for each confirmed H7N9 case. A standardized questionnaire was used to collect information about demographics, exposure history, clinical signs and symptoms, timelines of medical visits and care after onset of illness. Of the 46 H7N9 cases in Zhejiang Province identified between March 25 and September 31, 2013, there were 16 rural cases and 30 urban cases. Compared to urban cases, there was a higher proportion of females among the rural cases [11/16 (69%) vs. 6/30 (20%), P=0.001]. Among the rural cases, 14/15 (93%) with available data had a history of recent poultry exposure, which was significantly higher than that among urban cases (64%, P=0.038). More patients from the rural group had a history of breeding poultry compared with those from the urban group [38% (6/16) vs. 10% (3/30), respectively; P=0.025]. Interestingly, the median number of medical visits of patients from rural areas was higher than that of patients from urban areas (P=0.046). There was no difference between the two groups in terms of age distribution, fatality rate, incubation period, symptoms, and underlying medical conditions. In conclusion, compared to patients from urban areas, more patients from rural areas were female, had an exposure history, had a history of breeding poultry, and had a higher number of medical visits. These findings indicate that there are different exposure patterns between patients living in rural and urban areas and that more rural cases were infected through backyard poultry breeding.	[Sun, Jimin; Gong, Zhenyu; Lv, Huakun; Chen, Zhiping; Chai, Chengliang; Liu, Shelan; Ling, Feng; Lu, Ye; Cai, Jian; Yu, Zhao; Miao, Ziping; Ren, Jiangping; Chen, Enfu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Chen, EF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	zjcdccfs@126.com		Lv, Huakun/0000-0002-3420-6942	Provincial Medical Research Fund of Zhejiang, China [wkj2013-2-008]; Zhejiang Leading Team of Science and Technology Innovation [2011R50021]	Provincial Medical Research Fund of Zhejiang, China; Zhejiang Leading Team of Science and Technology Innovation	This work was supported by grants from Provincial Medical Research Fund of Zhejiang, China (wkj2013-2-008), and Zhejiang Leading Team of Science and Technology Innovation (grant number 2011R50021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; FARLEY TA, 1989, AM J PUBLIC HEALTH, V79, P1508, DOI 10.2105/AJPH.79.11.1508; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; HORNER RD, 1987, INT J EPIDEMIOL, V16, P184, DOI 10.1093/ije/16.2.184; Jie ZJ, 2013, AM J RESP CRIT CARE, V188, P114, DOI 10.1164/rccm.201304-0797LE; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu SL, 2013, J INFECTION, V67, P595, DOI 10.1016/j.jinf.2013.08.007; Lu SH, 2013, BIOSCI TRENDS, V7, P109, DOI 10.5582/bst.2013.v7.2.109; MERRILL JM, 1991, CANCER, V67, P1750, DOI 10.1002/cncr.2820671810; Miller M K, 1987, J Rural Health, V3, P23, DOI 10.1111/j.1748-0361.1987.tb00165.x; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430	15	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93775	10.1371/journal.pone.0093775	http://dx.doi.org/10.1371/journal.pone.0093775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710171	Green Submitted, gold, Green Published			2022-12-27	WOS:000334159800050
J	Ye, H; Mandal, R; Catherman, A; Thomas, PM; Kelleher, NL; Ikonomidou, C; Li, LJ				Ye, Hui; Mandal, Rakesh; Catherman, Adam; Thomas, Paul M.; Kelleher, Neil L.; Ikonomidou, Chrysanthy; Li, Lingjun			Top-Down Proteomics with Mass Spectrometry Imaging: A Pilot Study towards Discovery of Biomarkers for Neurodevelopmental Disorders	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; CYTOCHROME-C; TISSUE-SECTIONS; PROTEINS; IDENTIFICATION; PEPTIDES; CANCER; ALZHEIMERS; APOPTOSIS; CALCIUM	In the developing mammalian brain, inhibition of NMDA receptor can induce widespread neuroapoptosis, inhibit neurogenesis and cause impairment of learning and memory. Although some mechanistic insights into adverse neurological actions of these NMDA receptor antagonists exist, our understanding of the full spectrum of developmental events affected by early exposure to these chemical agents in the brain is still limited. Here we attempt to gain insights into the impact of pharmacologically induced excitatory/inhibitory imbalance in infancy on the brain proteome using mass spectrometric imaging (MSI). Our goal was to study changes in protein expression in postnatal day 10 (P10) rat brains following neonatal exposure to the NMDA receptor antagonist dizocilpine (MK801). Analysis of rat brains exposed to vehicle or MK801 and comparison of their MALDI MS images revealed differential relative abundances of several proteins. We then identified these markers such as ubiquitin, purkinje cell protein 4 (PEP-19), cytochrome c oxidase subunits and calmodulin, by a combination of reversed-phase (RP) HPLC fractionation and top-down tandem MS platform. More in-depth large scale study along with validation experiments will be carried out in the future. Overall, our findings indicate that a brief neonatal exposure to a compound that alters excitatory/inhibitory balance in the brain has a long term effect on protein expression patterns during subsequent development, highlighting the utility of MALDI-MSI as a discovery tool for potential biomarkers.	[Ye, Hui] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Ye, Hui] China Pharmaceut Univ, Dept Pharmaceut Anal, Nanjing, Jiangsu, Peoples R China; [Ye, Hui; Li, Lingjun] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Mandal, Rakesh; Ikonomidou, Chrysanthy] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Catherman, Adam; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Evanston, IL USA; [Li, Lingjun] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	China Pharmaceutical University; China Pharmaceutical University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; University of Wisconsin System; University of Wisconsin Madison	Ikonomidou, C (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	ikonomidou@neurology.wisc.edu; lli@pharmacy.wisc.edu	Thomas, Paul M/A-6233-2011	Thomas, Paul M/0000-0003-2887-4765	University of Wisconsin [PRJ-26CH, PRJ-23FA, PRJ-25AH, PRJ 233-23CK]; National Institute of Child Health and Human Development [P30 HD03352]; National Institutes of Health (NIH) [R01DK071801]; NIH shared instrument program [S10 RR029531]; NIH [R01 GM067193, P30 DA018310]; Searle Funds at the Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	University of Wisconsin; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH shared instrument program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Funds at the Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by University of Wisconsin grants PRJ-26CH, PRJ-23FA, PRJ-25AH and Waisman grant PRJ 233-23CK to CI, a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P30 HD03352), the National Institutes of Health (NIH) grant (R01DK071801 to LL). The authors would also like to acknowledge NIH shared instrument program for funding the instrument purchase (S10 RR029531 to LL). NLK thanks support from NIH grants R01 GM067193 and P30 DA018310 and the Searle Funds at the Chicago Community Trust (to Chicago Biomedical Consortium). LL acknowledges an H. I. Romnes Faculty Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badamchian M, 2003, INT IMMUNOPHARMACOL, V3, P1225, DOI 10.1016/S1567-5769(03)00024-9; Balluff B, 2011, AM J PATHOL, V179, P2720, DOI 10.1016/j.ajpath.2011.08.032; Beckingham K, 1998, BIOMETALS, V11, P359, DOI 10.1023/A:1009201824806; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaze MTM, 2012, ANALYST, V137, P5018, DOI 10.1039/c2an35922g; Bora A, 2008, J PROTEOME RES, V7, P4992, DOI 10.1021/pr800394e; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chaurand P, 2002, CURR OPIN CHEM BIOL, V6, P676, DOI 10.1016/S1367-5931(02)00370-8; Chen RB, 2009, J AM SOC MASS SPECTR, V20, P1068, DOI 10.1016/j.jasms.2009.01.017; Chughtai K, 2013, J LIPID RES, V54, P333, DOI 10.1194/jlr.M027961; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Debois D, 2013, TOP CURR CHEM, V331, P117, DOI 10.1007/128_2012_363; Debois D, 2010, ANAL CHEM, V82, P4036, DOI 10.1021/ac902875q; Deininger SO, 2008, J PROTEOME RES, V7, P5230, DOI 10.1021/pr8005777; DeKeyser SS, 2007, J PROTEOME RES, V6, P1782, DOI 10.1021/pr060603v; Delbosc S, 2008, MOL MED, V14, P383, DOI 10.2119/2008-00030.Delbosc; Elsner M, 2012, J PROTEOMICS, V75, P4693, DOI 10.1016/j.jprot.2012.02.012; Feldkirchner S, 2012, PROTEOMICS, V12, P3598, DOI 10.1002/pmic.201100559; Ferguson JT, 2009, J AM SOC MASS SPECTR, V20, P1743, DOI 10.1016/j.jasms.2009.05.014; Fergusson J, 2000, NEUROSCI LETT, V279, P69, DOI 10.1016/S0304-3940(99)00917-9; Flint MS, 2010, J PROTEOME RES, V9, P509, DOI 10.1021/pr900861j; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Groseclose MR, 2007, J MASS SPECTROM, V42, P254, DOI 10.1002/jms.1177; Hanrieder J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009308; Hardesty WM, 2011, J PROTEOMICS, V74, P1002, DOI 10.1016/j.jprot.2011.04.013; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Huttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ishimura R, 2002, TOXICOL APPL PHARM, V185, P197, DOI 10.1006/taap.2002.9539; Johanson RA, 2000, J NEUROSCI, V20, P2860; Joshi B, 1999, CANCER RES, V59, P4343; Kaindl AM, 2006, CELL MOL LIFE SCI, V63, P399, DOI 10.1007/s00018-005-5348-0; Kaindl AM, 2007, NEUROTOX RES, V11, P203, DOI 10.1007/BF03033568; Kaindl AM, 2008, MOL CELL PROTEOMICS, V7, P2293, DOI 10.1074/mcp.M800030-MCP200; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Lagarrigue M, 2012, J PROTEOME RES, V11, P5453, DOI 10.1021/pr3006974; Lagarrigue M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005991; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Li HH, 2011, ANAL CHEM, V83, P8794, DOI 10.1021/ac202356g; Li TA, 2011, MOL PLANT, V4, P361, DOI 10.1093/mp/ssq078; Lowenthal MS, 2005, CLIN CHEM, V51, P1933, DOI 10.1373/clinchem.2005.052944; MacAleese L, 2009, PROTEOMICS, V9, P819, DOI 10.1002/pmic.200800363; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Meistermann H, 2006, MOL CELL PROTEOMICS, V5, P1876, DOI 10.1074/mcp.M500399-MCP200; Michalski A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.013698; Minerva L, 2008, PROTEOMICS, V8, P3763, DOI 10.1002/pmic.200800237; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; Philp D, 2010, ANN NY ACAD SCI, V1194, P81, DOI 10.1111/j.1749-6632.2010.05479.x; Pierson J, 2004, J PROTEOME RES, V3, P289, DOI 10.1021/pr0499747; Pirman DA, 2013, ANAL CHEM, V85, P1081, DOI 10.1021/ac302960j; Popoli P, 2007, ANN NY ACAD SCI, V1112, P219, DOI 10.1196/annals.1415.033; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135; Sampson JS, 2009, J AM SOC MASS SPECTR, V20, P667, DOI 10.1016/j.jasms.2008.12.003; Sanchez-Alcazar JA, 2001, CANCER RES, V61, P1038; Schey KL, 2013, ANAL CHEM, V85, P6767, DOI 10.1021/ac400832w; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Skold K, 2006, J PROTEOME RES, V5, P262, DOI 10.1021/pr050281f; SLEMMON JR, 1994, J NEUROSCI, V14, P2225; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Stefovska VG, 2008, ANN NEUROL, V64, P434, DOI 10.1002/ana.21463; Stella DR, 2010, INVEST OPHTH VIS SCI, V51, P5153, DOI 10.1167/iovs.10-5302; Teng PN, 2011, J PROTEOME RES, V10, P1333, DOI 10.1021/pr101074p; Utal AK, 1999, NEUROSCIENCE, V88, P993; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Wang Z, 2008, J PROTEOME RES, V7, P2696, DOI 10.1021/pr700737h; Xu BGJ, 2002, J AM SOC MASS SPECTR, V13, P1292, DOI 10.1016/S1044-0305(02)00644-X; Zhang JA, 2010, J AM SOC MASS SPECTR, V21, P940, DOI 10.1016/j.jasms.2010.02.005	75	31	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92831	10.1371/journal.pone.0092831	http://dx.doi.org/10.1371/journal.pone.0092831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710523	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800018
J	Andrews, KR; Moriwake, VN; Wilcox, C; Grau, EG; Kelley, C; Pyle, RL; Bowen, BW				Andrews, Kimberly R.; Moriwake, Virginia N.; Wilcox, Christie; Grau, E. Gordon; Kelley, Christopher; Pyle, Richard L.; Bowen, Brian W.			Phylogeographic Analyses of Submesophotic Snappers Etelis coruscans and Etelis "marshi" (Family Lutjanidae) Reveal Concordant Genetic Structure across the Hawaiian Archipelago	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; JOHNSTON ATOLL; SOFTWARE; PATTERNS; ECOLOGY; DIFFERENTIATION; CONNECTIVITY; NEUTRALITY; HISTORIES	The Hawaiian Archipelago has become a natural laboratory for understanding genetic connectivity in marine organisms as a result of the large number of population genetics studies that have been conducted across this island chain for a wide taxonomic range of organisms. However, population genetic studies have been conducted for only two species occurring in the mesophotic or submesophotic zones (30+m) in this archipelago. To gain a greater understanding of genetic connectivity in these deepwater habitats, we investigated the genetic structure of two submesophotic fish species (occurring similar to 200-360 m) in this archipelago. We surveyed 16 locations across the archipelago for submesophotic snappers Etelis coruscans (N = 787) and E. "marshi'' (formerly E. carbunculus; N = 770) with 436-490 bp of mtDNA cytochrome b and 10-11 microsatellite loci. Phylogeographic analyses reveal no geographic structuring of mtDNA lineages and recent coalescence times that are typical of shallow reef fauna. Population genetic analyses reveal no overall structure across most of the archipelago, a pattern also typical of dispersive shallow fishes. However some sites in the mid-archipelago (Raita Bank to French Frigate Shoals) had significant population differentiation. This pattern of no structure between ends of the Hawaiian range, and significant structure in the middle, was previously observed in a submesophotic snapper (Pristipomoides filamentosus) and a submesophotic grouper (Hyporthodus quernus). Three of these four species also have elevated genetic diversity in the mid-archipelago. Biophysical larval dispersal models from previous studies indicate that this elevated diversity may result from larval supplement from Johnston Atoll,similar to 800 km southwest of Hawaii. In this case the boundaries of stocks for fishery management cannot be defined simply in terms of geography, and fishery management in Hawaii may need to incorporate external larval supply into management plans.	[Andrews, Kimberly R.; Moriwake, Virginia N.; Wilcox, Christie; Grau, E. Gordon; Kelley, Christopher; Bowen, Brian W.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Andrews, Kimberly R.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3HP, England; [Moriwake, Virginia N.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Wilcox, Christie] Univ Hawaii, Cell & Mol Biol Grad Program, Honolulu, HI 96822 USA; [Kelley, Christopher] Univ Hawaii, Hawaii Undersea Res Lab, Honolulu, HI 96822 USA; [Pyle, Richard L.] Bernice P Bishop Museum, Honolulu, HI USA	University of Hawaii System; Durham University; University of Hawaii System; University of Hawaii System; University of Hawaii System	Andrews, KR (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	kimandrews@gmail.com		Wilcox, Christie/0000-0002-7356-2552	National Oceanic and Atmospheric Administration [R/FM-18]; University of Hawaii Sea Grant College Program; SOEST under NOAA Office of Sea Grant, Department of Commerce [NA05OAR4171048]; Seaver Institute; NOAA Pacific Island Fisheries Science Center [NA10NMF4520121]; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant [NA07NOS4780188]; NOAA National Marine Sanctuaries Program; MOA [2005-008/66882]; National Science Foundation [OIA0554657, OCE-0929031]; NOAA Coral Reef Conservation Program; Hawai'i Undersea Research Laboratory [NA05OAR4301108]; Western Pacific Regional Fisheries Management Council [05-WPC-033]; Hawai'i Division of Aquatic Resources	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii Sea Grant College Program; SOEST under NOAA Office of Sea Grant, Department of Commerce; Seaver Institute; NOAA Pacific Island Fisheries Science Center; NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant; NOAA National Marine Sanctuaries Program(National Oceanic Atmospheric Admin (NOAA) - USA); MOA; National Science Foundation(National Science Foundation (NSF)); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Hawai'i Undersea Research Laboratory; Western Pacific Regional Fisheries Management Council; Hawai'i Division of Aquatic Resources	This paper is funded in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project R/FM-18, which is sponsored by the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant No. NA05OAR4171048 (B. W. B) from NOAA Office of Sea Grant, Department of Commerce. This paper is also funded in part by generous support from the Seaver Institute (B. W. B. and R. L. P.), NOAA Pacific Island Fisheries Science Center (http://www.pifsc.noaa.gov/) Grant NA10NMF4520121, NOAA National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies Grant (http://ccma.nos.noaa.gov/ecosystems/coralreef/coral_grant.aspx) NA07NOS4780188 (R. L. P.), NOAA National Marine Sanctuaries Program (http://sanctuaries.noaa.gov/) MOA grant No. 2005-008/66882 (R.J. Toonen), National Science Foundation (http://www.nsf.gov/) grants No. OIA0554657, and OCE-0929031 (B. W. B.), NOAA Coral Reef Conservation Program and Hawai'i Undersea Research Laboratory (http://www.soest.hawaii.edu/HURL/) Grant NA05OAR4301108, Western Pacific Regional Fisheries Management Council (http://www.wpcouncil.org/; contract No. 05-WPC-033), and Hawai'i Division of Aquatic Resources (http://hawaii.gov/dlnr/dar/). The views expressed herein are those of the author(s) and do not necessarily reflect the views of NOAA or any of its subagencies. UNIHI-SEAGRANT-JC-05-53. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 2011, MAR FRESHWATER RES, V62, P1259, DOI 10.1071/MF11080; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J, 2004, MOL MARKERS NATURAL; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Brodziak J., 2011, NOAATMNMFSPIFSC29; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Craig MT, 2007, MAR ECOL PROG SER, V334, P245, DOI 10.3354/meps334245; Craig MT, 2010, J BIOGEOGR, V37, P2125, DOI 10.1111/j.1365-2699.2010.02358.x; CUMMINGS SA, 1994, BIOTECHNIQUES, V17, P426; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; DeMartini EE, 1999, FISH B-NOAA, V97, P449; DiBattista JD, 2011, J MAR BIOL, DOI DOI 10.1155/2011/839134; DiBattista JD, 2012, J HERED, V103, P617, DOI 10.1093/jhered/ess056; Eble Jeff A., 2011, Journal of Marine Biology, V2011, P1; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Gaither MR, 2010, CONSERV GENET RESOUR, V2, P169, DOI 10.1007/s12686-009-9119-3; Gaither MR, 2010, MOL ECOL, V19, P1107, DOI 10.1111/j.1365-294X.2010.04535.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GRIGG RW, 1981, PAC SCI, V35, P1; GRIGG RW, 1981, PAC SCI, V35, P15; HOSPITAL J, 2009, NOAATMNMFSPIFSC20; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karl SA, 2012, MOL ECOL, V21, P4171, DOI 10.1111/j.1365-294X.2012.05576.x; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; Leis J.M., 1987, P189; LEIS JM, 1994, B MAR SCI, V55, P46; Leray M, 2010, EVOLUTION, V64, P1218, DOI 10.1111/j.1558-5646.2009.00917.x; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Ludt WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038042; MARAGOS JE, 1986, CORAL REEFS, V4, P141, DOI 10.1007/BF00427935; MARTEL SJD, 2011, SSTATUS TRENS UNPUB; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; MEYER A, 1993, EVOLUTION GENTICS AQ; Moffitt Robert B., 1996, Pacific Science, V50, P371; Mundy B.C, 2005, CHECKLIST FISHES HAW; Ovenden JR, 2004, MOL ECOL, V13, P1991, DOI 10.1111/j.1365-294X.2004.02210.x; Park S.D.E., 2001, THESIS; Pooley SG, 1987, TROPICAL SNAPPERS GR, P605; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Ralston S, 1979, DESCRIPTION BOTTOMFI; Ramon ML, 2008, MAR BIOL, V153, P1207, DOI 10.1007/s00227-007-0894-7; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RANDALL JE, 2007, REFF SHORE FISHES HA; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reece JS, 2011, MAR ECOL PROG SER, V437, P269, DOI 10.3354/meps09248; Reece JS, 2010, MOL PHYLOGENET EVOL, V57, P829, DOI 10.1016/j.ympev.2010.07.013; Rivera M.A.J., 2011, J MAR BIOL; Rivera MAJ, 2004, BIOL J LINN SOC, V81, P449, DOI 10.1111/j.1095-8312.2003.00304.x; RIVERA MAJ, 2002, THESIS U CALIFORNIA; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Skillings Derek J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/783030; Taberlet P, 1992, MOL ECOL, V1, P27, DOI 10.1111/j.1365-294X.1992.tb00152.x; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Timmers MA, 2011, J MARINE BIOL; Toonen RJ, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/460173; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 2008, EVOL APPL, V1, P183, DOI 10.1111/j.1752-4571.2008.00035.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; *WPRFMC, 2012, FIN FISH MAN PLAN CO, V3	79	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e91665	10.1371/journal.pone.0091665	http://dx.doi.org/10.1371/journal.pone.0091665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722193	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000336909100008
J	Fu, SP; He, SY; Xu, B; Hu, CJ; Lu, SF; Shen, WX; Huang, Y; Hong, H; Li, Q; Wang, N; Liu, XL; Liang, FR; Zhu, BM				Fu, Shu-Ping; He, Su-Yun; Xu, Bin; Hu, Chen-Jun; Lu, Sheng-Feng; Shen, Wei-Xing; Huang, Yan; Hong, Hao; Li, Qian; Wang, Ning; Liu, Xuan-Liang; Liang, Fanrong; Zhu, Bing-Mei			Acupuncture Promotes Angiogenesis after Myocardial Ischemia through H3K9 Acetylation Regulation at VEGF Gene	PLOS ONE			English	Article							RNA-SEQ; ELECTROACUPUNCTURE; RATS; PRETREATMENT; REPERFUSION; INJURY; HEART; INVOLVEMENT; HYPOXIA; KINASE	Background: Acupuncture exerts cardioprotective effects on several types of cardiac injuries, especially myocardial ischemia (MI), but the mechanisms have not yet been well elucidated. Angiogenesis mediated by VEGF gene expression and its modification through histone acetylation has been considered a target in treating myocardial ischemia. This study aims to exam whether modulation of angiogenesis through H3K9 acetylation regulation at VEGF gene is one possible cardioprotective mechanism of acupuncture. Results: We generated rat MI models by ligating the left anterior descending coronary artery and applied electroacupuncture (EA) treatment at the Neiguan (PC6) acupoint. Our results showed that acupuncture reversed the S-T segment change, reduced Q-wave area, decreased CK, CK-MB, LDH levels, mitigated myocardial remodeling, and promoted microvessel formation in the MI heart. RNA-seq analysis showed that VEGF-induced angiogenesis signaling was involved in the modulation of EA. Western blot results verified that the protein expressions of VEGF, Ras, phospho-p44/42 MAPK, phospho-p38 MAPK, phospho-SAPK/JNK and Akt, were all elevated significantly by EA treatment in the MI heart. Furthermore, increased H3K9 acetylation was also observed according with the VEGF. ChIP assay confirmed that EA treatment could notably stimulate the recruitment of H3K9ace at the VEGF promoter. Conclusions: Our study demonstrates for the first time that acupuncture can effectively up-regulate VEGF expression through H3K9 acetylation modification directly at the VEGF promoter and hence activate VEGF-induced angiogenesis in rat MI models. We employed high throughput sequencing in this study and, for the first time, generated genome-wide gene expression profiles both in the rat MI model and in acupuncture treatment.	[Fu, Shu-Ping; He, Su-Yun; Xu, Bin; Lu, Sheng-Feng; Shen, Wei-Xing; Huang, Yan; Hong, Hao; Li, Qian; Wang, Ning; Liu, Xuan-Liang; Zhu, Bing-Mei] Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing, Jiangsu, Peoples R China; [Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Tuina, Chengdu, Sichuan, Peoples R China; [Hu, Chen-Jun] Nanjing Univ Chinese Med, Sch Informat Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Chengdu University of Traditional Chinese Medicine; Nanjing University of Chinese Medicine	Liang, FR (corresponding author), Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Tuina, Chengdu, Sichuan, Peoples R China.	0001170@cdutcm.edu.cn; zhubm64@hotmail.com		huang, yan/0000-0002-5588-0274; Liang, Fanrong/0000-0003-2210-2027	national basic research program of China (973 program) [2012CB518501]; National Natural Science Foundation of China [81273838]; Natural Science Foundation of the Jiangsu Hager Education Institutions of China [12KJB360005]; Natural Science Foundation of the Jiangsu Province of China [BK20130956]; Scientific and Technological Innovation Group of "Qinglan-Project" of Jiangsu Province	national basic research program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Hager Education Institutions of China; Natural Science Foundation of the Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Scientific and Technological Innovation Group of "Qinglan-Project" of Jiangsu Province	This work was supported by grants from the national basic research program of China (973 program, No. 2012CB518501), the National Natural Science Foundation of China (No. 81273838), the Natural Science Foundation of the Jiangsu Hager Education Institutions of China (No. 12KJB360005), the Natural Science Foundation of the Jiangsu Province of China (No. BK20130956) and the Scientific and Technological Innovation Group of "Qinglan-Project" of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YH, 2010, BLOOD, V115, P2336, DOI 10.1182/blood-2009-12-256933; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Dasgupta Piyali, 2007, V383, P135, DOI 10.1007/978-1-59745-335-6_9; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gao JH, 2006, J PHYSIOL SCI, V56, P275, DOI 10.2170/physiolsci.RP006606; Gao JH, 2008, J PHYSIOL SCI, V58, P389, DOI 10.2170/physiolsci.RP007108; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Hu Jinsheng, 2008, J Tradit Chin Med, V28, P228; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Lorier G, 2011, ARQ BRAS CARDIOL, V97, pE140, DOI 10.1590/S0066-782X2011001500019; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; Lujan HL, 2007, AM J PHYSIOL-HEART C, V292, pH2550, DOI 10.1152/ajpheart.00979.2006; Meng Jingbi, 2004, J Tradit Chin Med, V24, P16; Ni XL, 2012, PEDIATR ANESTH, V22, P805, DOI 10.1111/j.1460-9592.2012.03822.x; Park SI, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/464586; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sun XC, 2010, EXP NEUROL, V224, P347, DOI 10.1016/j.expneurol.2010.04.009; Tjen-A-Looi SC, 2003, AUTON NEUROSCI-BASIC, V106, P119, DOI 10.1016/S1566-0702(03)00076-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tseng A, 2010, CARDIOVASC RES, V87, P704, DOI 10.1093/cvr/cvq110; Tsou MT, 2004, AM J CHINESE MED, V32, P951, DOI 10.1142/S0192415X04002557; Wang SB, 2008, WORLD J GASTROENTERO, V14, P6496, DOI 10.3748/wjg.14.6496; Xu Feng-hua, 2005, Zhongguo Zhen Jiu, V25, P89; Yang LF, 2010, ANN THORAC SURG, V89, P781, DOI 10.1016/j.athoracsur.2009.12.003; Zhang F, 2011, BRAIN INJURY, V25, P895, DOI 10.3109/02699052.2011.581639; Zhang HX, 2009, CAN J CARDIOL, V25, P359, DOI 10.1016/S0828-282X(09)70095-9; Zhao L, 2013, BRAIN RES, V1503, P78, DOI 10.1016/j.brainres.2013.01.051	33	51	68	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94604	10.1371/journal.pone.0094604	http://dx.doi.org/10.1371/journal.pone.0094604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722278	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100106
J	Bazin, P; Jouenne, F; Friedl, T; Deton-Cabanillas, AF; Le Roy, B; Veron, B				Bazin, Pauline; Jouenne, Fabien; Friedl, Thomas; Deton-Cabanillas, Anne-Flore; Le Roy, Bertrand; Veron, Benoit			Phytoplankton Diversity and Community Composition along the Estuarine Gradient of a Temperate Macrotidal Ecosystem: Combined Morphological and Molecular Approaches	PLOS ONE			English	Article							SSU RIBOSOMAL-RNA; MICROBIAL EUKARYOTES; PROTIST DIVERSITY; GENETIC DIVERSITY; ENGLISH-CHANNEL; COASTAL SITE; SP-NOV; MARINE; PCR; SEQUENCES	Microscopical and molecular analyses were used to investigate the diversity and spatial community structure of spring phytoplankton all along the estuarine gradient in a macrotidal ecosystem, the Baie des Veys (eastern English Channel). Taxa distribution at high tide in the water column appeared to be mainly driven by the tidal force which superimposed on the natural salinity gradient, resulting in a two-layer flow within the channel. Lowest taxa richness and abundance were found in the bay where Teleaulax-like cryptophytes dominated. A shift in species composition occurred towards the mouth of the river, with the diatom Asterionellopsis glacialis dramatically accumulating in the bottom waters of the upstream brackish reach. Small thalassiosiroid diatoms dominated the upper layer river community, where taxa richness was higher. Through the construction of partial 18S rDNA clone libraries, the microeukaryotic diversity was further explored for three samples selected along the surface salinity gradient (freshwater-brackish-marine). Clone libraries revealed a high diversity among heterotrophic and/or small-sized protists which were undetected by microscopy. Among them, a rich variety of Chrysophyceae and other lineages (e. g. novel marine stramenopiles) are reported here for the first time in this transition area. However, conventional microscopy remains more efficient in revealing the high diversity of phototrophic taxa, low in abundances but morphologically distinct, that is overlooked by the molecular approach. The differences between microscopical and molecular analyses and their limitations are discussed here, pointing out the complementarities of both approaches, for a thorough phytoplankton community description.	[Bazin, Pauline; Deton-Cabanillas, Anne-Flore; Le Roy, Bertrand; Veron, Benoit] Univ Caen Basse Normandie, UMR BOREA Biol Organismes & Ecosyst Aquat, Caen, France; [Bazin, Pauline; Deton-Cabanillas, Anne-Flore; Le Roy, Bertrand; Veron, Benoit] CNRS, Inst Ecol & Environm INEE, UMR BOREA, Caen, France; [Jouenne, Fabien; Veron, Benoit] Univ Caen Basse Normandie, Algobank Caen, Caen, France; [Friedl, Thomas] Univ Gottingen, Dept Expt Phykol & Sammlung Algenkulturen EPSAG, D-37073 Gottingen, Germany	UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Universite de Caen Normandie	Veron, B (corresponding author), Univ Caen Basse Normandie, UMR BOREA Biol Organismes & Ecosyst Aquat, Caen, France.	benoit.veron@unicaen.fr	Friedl, Thomas/AAQ-4606-2021; Friedl, Thomas/AAS-4403-2021	Friedl, Thomas/0000-0002-4070-776X; 	University of Caen Basse-Normandie	University of Caen Basse-Normandie(Region Normandie)	This work was funded by the University of Caen Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPINE AE, 1988, MAR ECOL PROG SER, V44, P167, DOI 10.3354/meps044167; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminot A., 2007, DOSAGE AUTOMATIQUE N; Andersen RA, 1999, PROTIST, V150, P71, DOI 10.1016/S1434-4610(99)70010-6; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bachvaroff TR, 2012, APPL ENVIRON MICROB, V78, P334, DOI 10.1128/AEM.06678-11; Bazin P, 2014, HYDROBIOLOGIA, V726, P155, DOI 10.1007/s10750-013-1761-9; Behnke A, 2010, FEMS MICROBIOL ECOL, V72, P89, DOI 10.1111/j.1574-6941.2010.00836.x; Boenigk J, 2005, ENVIRON MICROBIOL, V7, P685, DOI 10.1111/j.1462-2920.2005.00743.x; Bourrelly P, 1981, ALGUES EAU DOUCE, V2, P577; Bourrelly P, 1981, ALGUES EAU DOUCE, V1, P572; Bourrelly P, 1981, ALGUES EAU DOUCE, V3; Caron DA, 2004, J EUKARYOT MICROBIOL, V51, P38, DOI 10.1111/j.1550-7408.2004.tb00159.x; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; CHAO A, 1984, SCAND J STAT, V11, P265; Charvet S, 2012, POLAR BIOL, V35, P733, DOI 10.1007/s00300-011-1118-7; Clay BL, 1999, PROTIST, V150, P297, DOI 10.1016/S1434-4610(99)70031-3; Deane JA, 2002, J PHYCOL, V38, P1236, DOI 10.1046/j.1529-8817.2002.01250.x; del Campo J, 2011, PROTIST, V162, P435, DOI 10.1016/j.protis.2010.10.003; DESPREZ M, 1986, HYDROBIOLOGIA, V142, P249, DOI 10.1007/BF00026763; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; *EN, 2006, 15204 EN EUR COMM ST; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; Hepperle D., 2004, SEQASSEM SEQUENCE AN; Herfort L, 2011, MAR ECOL PROG SER, V438, P19, DOI 10.3354/meps09303; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; John DM., 2002, FRESHWATER ALGAL FLO; Jouenne F, 2005, ESTUAR COAST SHELF S, V65, P421, DOI 10.1016/j.ecss.2005.05.023; Jouenne F, 2007, MAR BIOL, V151, P805, DOI 10.1007/s00227-006-0440-z; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klein C, 2010, HARMFUL ALGAE, V9, P218, DOI 10.1016/j.hal.2009.10.004; Kolodziej K, 2007, APPL ENVIRON MICROB, V73, P2718, DOI 10.1128/AEM.02158-06; Laza-Martinez A, 2012, J PHYCOL, V48, P423, DOI 10.1111/j.1529-8817.2012.01130.x; Lionard M, 2008, ESTUAR COAST SHELF S, V79, P694, DOI 10.1016/j.ecss.2008.06.013; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; Luo W, 2011, HYDROBIOLOGIA, V661, P133, DOI 10.1007/s10750-010-0510-6; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2002, APPL ENVIRON MICROB, V68, P4554, DOI 10.1128/AEM.68.9.4554-4558.2002; Massana R, 2004, FEMS MICROBIOL ECOL, V50, P231, DOI 10.1016/j.femsec.2004.07.001; Massana R, 2006, ENVIRON MICROBIOL, V8, P1515, DOI 10.1111/j.1462-2920.2006.01042.x; McLusky D.S., 1993, NETHERLANDJ AQUAT, P489, DOI [DOI 10.1007/BF02334809, 10.1007/BF02334809]; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Muylaert K, 2000, HYDROBIOLOGIA, V432, P25, DOI 10.1023/A:1004017018702; Muylaert K, 2009, ESTUAR COAST SHELF S, V82, P335, DOI 10.1016/j.ecss.2009.01.024; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Potvin M, 2009, J EUKARYOT MICROBIOL, V56, P174, DOI 10.1111/j.1550-7408.2008.00386.x; Pritchard D.W., 1989, ESTUARINE CIRCULATIO, P1; Quinlan EL, 2007, J PLANKTON RES, V29, P401, DOI 10.1093/plankt/fbm024; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seoane S, 2006, ESTUAR COAST SHELF S, V67, P343, DOI 10.1016/j.ecss.2005.10.020; Shalchian-Tabrizi K, 2008, ENVIRON MICROBIOL, V10, P2635, DOI 10.1111/j.1462-2920.2008.01685.x; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Slapeta J, 2005, P ROY SOC B-BIOL SCI, V272, P2073, DOI 10.1098/rspb.2005.3195; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Tomas CR, 1997, IDENTIFYING MARINE P; Trigueros JM, 2000, J PLANKTON RES, V22, P969, DOI 10.1093/plankt/22.5.969; Ubertini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044155; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Vigil P, 2009, AQUAT MICROB ECOL, V54, P83, DOI 10.3354/ame01252; Viprey M, 2008, ENVIRON MICROBIOL, V10, P1804, DOI 10.1111/j.1462-2920.2008.01602.x; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wylezich C, 2011, ENVIRON MICROBIOL, V13, P2939, DOI 10.1111/j.1462-2920.2011.02569.x; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zuendorf A, 2006, FEMS MICROBIOL ECOL, V58, P476, DOI 10.1111/j.1574-6941.2006.00171.x	72	31	34	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94110	10.1371/journal.pone.0094110	http://dx.doi.org/10.1371/journal.pone.0094110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718653	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000077
J	Careaga, M; Rose, D; Tassone, F; Berman, RF; Hagerman, R; Ashwood, P				Careaga, Milo; Rose, Destanie; Tassone, Flora; Berman, Robert F.; Hagerman, Randi; Ashwood, Paul			Immune Dysregulation as a Cause of Autoinflammation in Fragile X Premutation Carriers: Link between FMRI CGG Repeat Number and Decreased Cytokine Responses	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; PRIMARY IMMUNODEFICIENCY; TREMOR/ATAXIA SYNDROME; AUTOIMMUNITY LESSONS; EXPANDED ALLELES; TREMOR; GENE; IDENTIFICATION; ASSOCIATION; DYSFUNCTION	Background: Increased rates of autoinflammatory and autoimmune disorders have been observed in female premutation carriers of CGG repeat expansion alleles of between 55-200 repeats in the fragile X mental retardation 1 (FMR1) gene. To determine whether an abnormal immune profile was present at a cellular level that may predispose female carriers to autoinflammatory conditions, we investigated dynamic cytokine production following stimulation of blood cells. In addition, splenocyte responses were examined in an FMR1 CGG knock-in mouse model of the fragile X premutation. Methods: Human monocyte and peripheral blood leukocytes (PBLs) were isolated from the blood of 36 female FMR1 premutation carriers and 15 age-matched controls. Cells were cultured with media alone, LPS or PHA. In the animal model, splenocytes were isolated from 32 CGG knock-in mice and 32 wild type littermates. Splenocytes were cultured with media alone or LPS or PMA/ Ionomycin. Concentrations of cytokines (GM-CSF, IL-1 beta, IL-6, IL-10, IL-13, IL-17, IFN gamma, TNF alpha, and MCP- 1) were determined from the supernatants of cellular cultures via Luminex multiplex assay. Additionally, phenotypic cellular markers were assessed on cells isolated from human subjects via flow cytometry. Results: We found decreases in cytokine production in human premutation carriers as well as in the FMR1 knock-in mice when compared with controls. Levels of cytokines were found to be associated with CGG repeat length in both human and mouse. Furthermore, T cells from human premutation carriers showed decreases in cell surface markers of activation when compared with controls. Conclusions: In this study, FMR1 CGG repeat expansions are associated with decreased immune responses and immune dysregulation in both humans and mice. Deficits in immune responses in female premutation carriers may lead to increased susceptibility to autoimmunity and further research is warranted to determine the link between FMR1 CGG repeat lengths and onset of autoinflammatory conditions.	[Careaga, Milo; Rose, Destanie; Ashwood, Paul] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Careaga, Milo; Rose, Destanie; Tassone, Flora; Berman, Robert F.; Hagerman, Randi; Ashwood, Paul] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Hagerman, Randi] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ashwood, P (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	pashwood@ucdavis.edu			National Institutes of Health (NIH) [HD036071, HD02274, RL1 AG032115, RL1 NS062411, R01 NS079775]; Jane Botsford Johnson Foundation; Peter Emch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125, P30HD002274, R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RL1NS062411, R01NS079775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RL1AG032115] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Botsford Johnson Foundation; Peter Emch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants HD036071, HD02274, RL1 AG032115, RL1 NS062411, R01 NS079775, the Jane Botsford Johnson Foundation and Peter Emch Foundation. The above-mentioned funding agencies were not responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Alleva DG, 1998, J IMMUNOL, V161, P6878; Arason GJ, 2010, SCAND J IMMUNOL, V71, P317, DOI 10.1111/j.1365-3083.2010.02386.x; Ashwood P, 2004, J CLIN IMMUNOL, V24, P664, DOI 10.1007/s10875-004-6241-6; Berman RF, 2009, J INVEST MED, V57, P837, DOI 10.2310/JIM.0b013e3181af59d6; Bourgeois JA, 2011, J CLIN PSYCHIAT, V72, P175, DOI 10.4088/JCP.09m05407blu; Chen YC, 2010, HUM MOL GENET, V19, P196, DOI 10.1093/hmg/ddp479; Coffey SM, 2008, AM J MED GENET A, V146A, P1009, DOI 10.1002/ajmg.a.32060; CONWAY GS, 1995, LANCET, V346, P309, DOI 10.1016/S0140-6736(95)92194-X; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Graber JJ, 2011, J NEUROL SCI, V305, P1, DOI 10.1016/j.jns.2011.03.026; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; Gupta S, 2013, CLIN REV ALLERG IMMU, V45, P162, DOI 10.1007/s12016-012-8345-8; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hamlin AA, 2012, AM J MED GENET A, V158A, P1304, DOI 10.1002/ajmg.a.35323; Hessl D, 2011, BIOL PSYCHIAT, V70, P859, DOI 10.1016/j.biopsych.2011.05.033; Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S; Houssiau FA, 1997, CLIN EXP IMMUNOL, V108, P375, DOI 10.1046/j.1365-2249.1997.d01-1009.x; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Mackay IR, 2010, J AUTOIMMUN, V35, P199, DOI 10.1016/j.jaut.2010.06.008; Marek D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-238; Roberts JE, 2009, AM J MED GENET B, V150B, P130, DOI 10.1002/ajmg.b.30786; Rodriguez-Revenga L, 2009, EUR J HUM GENET, V17, P1359, DOI 10.1038/ejhg.2009.51; Rodriguez-Revenga L, 2009, MENOPAUSE, V16, P944, DOI 10.1097/gme.0b013e3181a06a37; Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Sleasman J W, 1996, Adv Dent Res, V10, P57; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tassone F, 2010, FRAGILE X-ASSOCIATED TREMOR ATAXIA SYNDROME (FXTAS), P1, DOI 10.1007/978-1-4419-5805-1; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Tassone F, 2012, RESULTS PROBL CELL D, V54, P337, DOI 10.1007/978-3-642-21649-7_18; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Uzielli MLG, 1999, AM J MED GENET, V84, P300, DOI 10.1002/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.3.CO;2-X; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Winarni TI, 2012, AM J MED GENET A, V158A, P2473, DOI 10.1002/ajmg.a.35569	38	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94475	10.1371/journal.pone.0094475	http://dx.doi.org/10.1371/journal.pone.0094475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718368	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000125
J	Sun, CQ; Hubl, U; Hoefakker, P; Vasudevamurthy, MK; Johnson, KD				Sun, Cynthia Q.; Hubl, Ulrike; Hoefakker, Petra; Vasudevamurthy, Madhusudan K.; Johnson, Keryn D.			A New Assay for Determining Ganglioside Sialyltransferase Activities Lactosylceramide-2,3-Sialyltransferase (SAT I) and Monosialylganglioside-2,3-Sialyltransferase ( SATIV)	PLOS ONE			English	Article							N-ACETYLNEURAMINIC ACID; RAT-LIVER; ALPHA-2-3 SIALYLTRANSFERASE; GAL-BETA-1,3GALNAC ALPHA-2,3-SIALYLTRANSFERASE; KINETIC-PROPERTIES; LABELED ACCEPTORS; SIALIC-ACID; BRAIN; GM3; LACTOSYLCERAMIDE	A new assay for the determination of lactosylceramide-2,3-sialyltransferase (SAT I, EC 2.4.99.9) and monosialoganglioside sialyltransferase (SAT IV, EC 2.4.99.2) is described. The assay utilised the commercially available fluorophore labelled sphingolipids, boron dipyrromethene difluoride (BODIPY) lactosylceramide (LacCer), and BODIPY-monosialotetrahexosylganglioside (GM1) as the acceptor substrates, for SAT I and SAT IV, respectively. HPLC coupled with fluorescence detection was used to analyse product formation. The analysis was performed in a quick and automated fashion. The assay showed good linearity for both BODIPY sphingolipids with a quantitative detection limit of 0.05 pmol. The high sensitivity enabled the detection of SAT I and SAT IV activities as low as 0.001 mu U, at least 200 fold lower than that of most radiometric assays. This new assay was applied to the screening of SAT I and SAT IV activities in ovine and bovine organs (liver, heart, kidney, and spleen). The results provided evidence that young animals, such as calves, start to produce ganglioside sialyltransferases as early as 7 days after parturition and that levels change during maturation. Among the organs tested from a bovine source, spleen had the highest specific ganglioside sialyltransferase activity. Due to the organ size, the greatest total ganglioside sialyltransferase activities (SAT I and SAT IV) were detected in the liver of both bovine and ovine origin.	[Sun, Cynthia Q.; Hubl, Ulrike; Hoefakker, Petra; Vasudevamurthy, Madhusudan K.; Johnson, Keryn D.] Callaghan Innovat Res Ltd, Lower Hutt, New Zealand	Callaghan Innovation	Hubl, U (corresponding author), Callaghan Innovat Res Ltd, Lower Hutt, New Zealand.	ulrike.hubl@callaghaninnovation.govt.nz			New Zealand Meat Biologics Research Consortium (MBRC)	New Zealand Meat Biologics Research Consortium (MBRC)	The research was funded by the New Zealand Meat Biologics Research Consortium (MBRC). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Fleischer S, 1974, Methods Enzymol, V31, P3; Furukawa K, 2008, EXPT GLYCOSCIENCE, P56; GROSS HJ, 1990, ANAL BIOCHEM, V186, P127, DOI 10.1016/0003-2697(90)90585-W; GU TJ, 1990, FEBS LETT, V275, P83, DOI 10.1016/0014-5793(90)81444-S; Hubl U, 2000, ANAL BIOCHEM, V285, P92, DOI 10.1006/abio.2000.4727; Huwiler A, 2000, BBA-MOL CELL BIOL L, V1485, P63, DOI 10.1016/S1388-1981(00)00042-1; IBER H, 1991, EUR J BIOCHEM, V195, P115, DOI 10.1111/j.1432-1033.1991.tb15683.x; IZUMI T, 1993, PEDIATR NEUROL, V9, P293, DOI 10.1016/0887-8994(93)90066-L; KADOWAKI H, 1994, J BIOL CHEM, V269, P14931; Kajihara Y, 2001, CARBOHYD RES, V331, P455, DOI 10.1016/S0008-6215(01)00056-8; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; KOJIMA N, 1994, BIOCHEMISTRY-US, V33, P5772, DOI 10.1021/bi00185a014; Kok JW, 1999, FLUORESCENT LUMINESC, P136; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; LEE YC, 1994, J BIOL CHEM, V269, P10028; Limberg G, 1996, LIEBIGS ANN-RECL, P1773; MELKERSONWATSON LJ, 1990, BIOCHEM BIOPH RES CO, V172, P165, DOI 10.1016/S0006-291X(05)80188-3; Molecular Probes Inc, 2003, NBD BODIPY DYE LAB S, V2003, P1; NOJIRI H, 1986, P NATL ACAD SCI USA, V83, P782, DOI 10.1073/pnas.83.3.782; Pagano RE, 2000, METHOD ENZYMOL, V312, P523; PREUSS U, 1993, J BIOL CHEM, V268, P26273; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; PUKEL CS, 1982, J EXP MED, V155, P1133, DOI 10.1084/jem.155.4.1133; RICHARDSON CL, 1977, BIOCHIM BIOPHYS ACTA, V488, P88, DOI 10.1016/0005-2760(77)90125-4; Roseman S., 1966, METHOD ENZYMOL, V8, P354; SCHACHTE.H, 1970, J BIOL CHEM, V245, P1090; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Suzuki Y, 2012, J LIPID RES, V53, P599, DOI 10.1194/jlr.D020545; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; TRINCHERA M, 1990, J BIOL CHEM, V265, P18242; Walkley SU, 2000, CEREB CORTEX, V10, P1028, DOI 10.1093/cercor/10.10.1028; Wang B, 2003, AM J CLIN NUTR, V78, P1024, DOI 10.1093/ajcn/78.5.1024; Washiya K, 2000, ANAL BIOCHEM, V283, P39, DOI 10.1006/abio.2000.4632; Watanabe R, 2002, CANCER RES, V62, P3850; WILLIAMS MA, 1995, GLYCOCONJUGATE J, V12, P755, DOI 10.1007/BF00731235; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94206	10.1371/journal.pone.0094206	http://dx.doi.org/10.1371/journal.pone.0094206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718572	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000089
J	Toth, AB; Lyons, SK; Behrensmeyer, AK				Toth, Aniko B.; Lyons, S. Kathleen; Behrensmeyer, Anna K.			A Century of Change in Kenya's Mammal Communities: Increased Richness and Decreased Uniqueness in Six Protected Areas	PLOS ONE			English	Article							SPATIALLY EXPLICIT; HABITAT LOSS; HYDE 3.1; CONSERVATION; DYNAMICS; DISTRIBUTIONS; ASSEMBLAGES; POPULATION; EXTINCTION; SERENGETI	The potential for large-scale biodiversity losses as a result of climate change and human impact presents major challenges for ecology and conservation science. Governments around the world have established national parks and wildlife reserves to help protect biodiversity, but there are few studies on the long-term consequences of this strategy. We use Kenya as a case study to investigate species richness and other attributes of mammal communities in 6 protected areas over the past century. Museum records from African expeditions that comprehensively sampled mammals from these same areas in the early 1900's provide a baseline for evaluating changes in species richness and community structure over time. We compare species lists assembled from archived specimens (1896-1950) to those of corresponding modern protected areas (19502013). Species richness in Kenya was stable or increased at 5 out of 6 sites from historical to modern times. Beta-diversity, in contrast, decreased across all sites. Potential biases such as variable historical vs. modern collection effort and detection of small-bodied, rare, and low-visibility species do not account for the observed results. We attribute the pattern of decreased beta diversity primarily to increased site occupancy by common species across all body size classes. Despite a decrease in land area available to wildlife, our data do not show the extinctions predicted by species-area relationships. Moreover, the results indicate that species-area curves based solely on protected areas could underestimate diversity because they do not account for mammal species whose ranges extend beyond protected area boundaries. We conclude that the 6 protected areas have been effective in preserving species richness in spite of continuing conversion of wild grasslands to cropland, but the overall decrease in beta diversity indicates a decline in the uniqueness of mammal communities that historically characterized Kenya's varied landscape.	[Toth, Aniko B.; Lyons, S. Kathleen; Behrensmeyer, Anna K.] Smithsonian Inst Washington, Natl Museum Nat Hist, Dept Paleobiol, Evolut Terr Ecosyst Program, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Toth, AB (corresponding author), Smithsonian Inst Washington, Natl Museum Nat Hist, Dept Paleobiol, Evolut Terr Ecosyst Program, Washington, DC 20560 USA.	totha@si.edu	Tóth, Anikó/AAT-6084-2021	Tóth, Anikó/0000-0002-3063-1917; Lyons, S. Kathleen/0000-0001-5112-2508	National Museum of Natural History internal grant; Direct For Biological Sciences [1257625] Funding Source: National Science Foundation	National Museum of Natural History internal grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by a National Museum of Natural History internal grant to the Evolution of Terrestrial Ecosystems Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, AFR MAMM DAT; [Anonymous], 2014, ASS AFR PROT AR; [Anonymous], 2013, GLOBAL BIODIVERSITY; Bakker VJ, 2000, ECOLOGY, V81, P3530, DOI 10.1890/0012-9658(2000)081[3530:SDPIBS]2.0.CO;2; Becht R, 2002, HYDROBIOLOGIA, V488, P1, DOI 10.1023/A:1023318007715; Bleher A, 2006, KENYA BIODIV CONS, V15, P1159; Bouwman AF., 2006, INTEGRATED MODELLING, P1; Calix M., 2018, EUROPEAN RED LIST SA; East R., 1999, AFRICAN ANTELOPE DAT; ESRI, 2011, ARCGIS DESKT REL 10; Fashing PJ, 2002, AFRICAN ZOOLOGY, V37, P2; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Goldson J, 1993, LAKE NAIVASHA RIPARI, P109; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Harper DM, 2003, LAKE NAIVASHA; Heller E, 1909, SMITHSONIAN AFRICAN; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; IUCN and UNEP-WCMC, 2013, WORLD DAT PROT AR WD; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kenya Wildlife Service, 2012, OV PARKS RES; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kingdon J., 1971, E AFRICAN MAMMALS AT; Kingdon J, 1988, E AFRICAN MAMMALS AT, V3; Kingdon J, 1974, E AFRICAN MAMMALS AT, V2; Kingdon J., 1982, E AFRICAN MAMMALS AT, V3; KOKWARO JO, 1988, MONOGRAPH SYSTEMATIC, V25, P471; Loring JA, 1909, SMITHSONIAN AFRICAN; Lyons SK, 2013, MACROECOLOGICAL PATT, P114; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Marquet PA, 1999, OIKOS, V85, P299, DOI 10.2307/3546496; Mearns EA, 1909, SMITHSONIAN AFRICAN; Mitchell N, 2009, BIOTA E AFRICA REPOR; Ngigi T.G., 2004, INT J ENVIRON STUD, V61, P281, DOI [10.1080/0020723032000170959, DOI 10.1080/0020723032000170959]; NMNH Collections, NMNH COLL; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Roosevelt T, 1927, AFRICAN GAME TRAILS; ROOSEVELT T, 1914, LIFE HIST AFRICAN GA; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair A.R.E., 1995, SERENGETI DYNAMICS E; Sinclair AR, 2008, DYNAMICS; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Songa JM, 2002, INT J PEST MANAGE, V48, P1, DOI 10.1080/09670870110052077; Waithaka J, 2012, KENYA WILDLIFE SERVI, V29, P21; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Western D, 2009, SCIENCE, V324, P1061, DOI 10.1126/science.1171155; Wilson AE, 2005, MAMMAL SPECIES WORLD; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; World Resources Institute, 2014, KEN GIS DAT	52	10	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93092	10.1371/journal.pone.0093092	http://dx.doi.org/10.1371/journal.pone.0093092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718262	Green Published, gold			2022-12-27	WOS:000334339000027
J	Zhang, XH; Qiao, GJ; Lu, PF				Zhang, Xiaohong; Qiao, Guijuan; Lu, Pengfei			Modulation of Fibroblast Growth Factor Signaling Is Essential for Mammary Epithelial Morphogenesis	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; RECEPTOR SPECIFICITY; DISTINCT ROLES; BREAST-CANCER; STEM-CELLS; GLAND; GENE; EXPRESSION; PATHWAY; MECHANISMS	Fibroblast growth factor (FGF) signaling is essential for vertebrate organogenesis, including mammary gland development. The mechanism whereby FGF signaling is regulated in the mammary gland, however, has remained unknown. Using a combination of mouse genetics and 3D ex vivo models, we tested the hypothesis that Spry2 gene, which encodes an inhibitor of signaling via receptor tyrosine kinases (RTKs) in certain contexts, regulates FGF signaling during mammary branching. We found that Spry2 is expressed at various stages of the developing mammary gland. Targeted removal of Spry2 function from mammary epithelium leads to accelerated epithelial invasion. Spry2 is up-regulated by FGF signaling activities and its loss sensitizes mammary epithelium to FGF stimulation, as indicated by increased expression of FGF target genes and epithelia invasion. By contrast, Spry2 gain-of-function in the mammary epithelium results in reduced FGF signaling, epithelial invasion, and stunted branching. Furthermore, reduction of Spry2 expression is correlated with tumor progression in the MMTV-PyMT mouse model. Together, the data show that FGF signaling modulation by Spry2 is essential for epithelial morphogenesis in the mammary gland and it functions to protect the epithelium against tumorigenesis.	[Zhang, Xiaohong; Qiao, Guijuan; Lu, Pengfei] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	University of Manchester	Lu, PF (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	paul.pf.lu@gmail.com			National Institutes of Health [R03 HD060807]; Breakthrough Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breakthrough Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by grants from the National Institutes of Health (R03 HD060807) and Breakthrough Breast Cancer to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2012, COLD SPRING HARBOR P, V4; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kim EJ, 2013, J MAMMARY GLAND BIOL, V18, P139, DOI 10.1007/s10911-013-9278-4; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; Lu PF, 2006, DEVELOPMENT, V133, P33, DOI 10.1242/dev.02172; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Moraes RC, 2009, DEVELOPMENT, V136, P1423, DOI 10.1242/dev.023994; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; Pond AC, 2013, STEM CELLS, V31, P178, DOI 10.1002/stem.1266; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Sigurdsson V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060798; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhu WT, 2013, DEV BIOL, V379, P235, DOI 10.1016/j.ydbio.2013.04.029	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92735	10.1371/journal.pone.0092735	http://dx.doi.org/10.1371/journal.pone.0092735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718286	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000018
J	Che, RB; Sun, YY; Sun, DQ; Xu, TJ				Che, Rongbo; Sun, Yueyan; Sun, Dianqiao; Xu, Tianjun			Characterization of the Miiuy Croaker (Miichthys miiuy) Transcriptome and Development of Immune-Relevant Genes and Molecular Markers	PLOS ONE			English	Article							CC-CHEMOKINE GENE; EXPRESSION ANALYSIS; RAINBOW-TROUT; SSR-MARKERS; SEQUENCE; CLONING; ANNOTATION; BACTERIA; TOOL	Background: The miiuy croaker (Miichthys miiuy) is an important species of marine fish that supports capture fisheries and aquaculture. At present commercial scale aquaculture of this species is limited due to diseases caused by pathogens and parasites which restrict production and limit commercial value. The lack of transcriptomic and genomic information for the miiuy croaker limits the ability of researchers to study the pathogenesis and immune system of this species. In this study we constructed a cDNA library from liver, spleen and kidney which was sequenced using Illumina paired-end sequencing to enable gene discovery and molecular marker development. Principal Findings: In our study, a total of 69,071 unigenes with an average length of 572 bp were obtained. Of these, 45,676 (66.13%) were successfully annotated in public databases. The unigenes were also annotated with Gene Ontology, Clusters of Orthologous Groups and KEGG pathways. Additionally, 498 immune-relevant genes were identified and classified. Furthermore, 14,885 putative simple sequence repeats (cSSRs) and 8,510 putative single nucleotide polymorphisms (SNPs) were identified from the 69,071 unigenes. Conclusion: The miiuy croaker (Miichthys miiuy) transcriptome data provides a large resource to identify new genes involved in many processes including those involved in the response to pathogens and diseases. Furthermore, the thousands of potential cSSR and SNP markers found in this study are important resources with respect to future development of molecular marker assisted breeding programs for the miiuy croaker.	[Che, Rongbo; Sun, Yueyan; Sun, Dianqiao; Xu, Tianjun] Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China	Zhejiang Ocean University	Xu, TJ (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China.	tianjunxu@163.com			Nation Nature Science Foundation of China [31370049]; Important Science and Technology Specific Projects of Zhejiang Province [2011C14012]	Nation Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important Science and Technology Specific Projects of Zhejiang Province	This study was supported by Nation Nature Science Foundation of China (31370049) and Important Science and Technology Specific Projects of Zhejiang Province (2011C14012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bajgain P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-370; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bondad-Reantaso MG, 2007, ASSESSMENT FRESHWATE; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Cheng YZ, 2011, FISH SHELLFISH IMMUN, V31, P439, DOI 10.1016/j.fsi.2011.06.016; Cheng YZ, 2011, FISH SHELLFISH IMMUN, V31, P148, DOI 10.1016/j.fsi.2011.02.024; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dumetz F, 2006, APPL ENVIRON MICROB, V72, P4845, DOI 10.1128/AEM.00279-06; Gong YF, 2009, J IMMUNOL, V182, P7749, DOI 10.4049/jimmunol.0804370; Grisez L., 2005, DIS ASIAN AQUACULTUR, P483; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacob NM, 2010, BIOTECHNOL BIOENG, V105, P1002, DOI 10.1002/bit.22588; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin AF, 2009, J IMMUNOL, V183, P7398, DOI 10.4049/jimmunol.0803955; Liu XZ, 2012, FISH SHELLFISH IMMUN, V32, P464, DOI 10.1016/j.fsi.2011.11.033; Lou B., 2004, CHIN J MOD FISH, V6, P11; Meng FX, 2012, FISH SHELLFISH IMMUN, V32, P1171, DOI 10.1016/j.fsi.2012.02.010; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller HC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-439; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Shan LZ, 2010, CHINA MAR SCI, V34, P75; Shan Xiu-Juan, 2009, Oceanologia et Limnologia Sinica, V40, P714; Sun YN, 2011, FISH PHYSIOL BIOCHEM, V37, P761, DOI 10.1007/s10695-011-9475-2; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang RX, 2010, GENET MOL RES, V9, P931, DOI 10.4238/vol9-2gmr806; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xu TJ, 2011, AQUACULTURE, V318, P25, DOI 10.1016/j.aquaculture.2011.04.034; Xu TJ, 2011, DEV COMP IMMUNOL, V35, P483, DOI 10.1016/j.dci.2010.12.003; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; Xu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035449; Xu TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023823; Xu TJ, 2011, INT J MOL SCI, V12, P4021, DOI 10.3390/ijms12064021; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	54	52	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94046	10.1371/journal.pone.0094046	http://dx.doi.org/10.1371/journal.pone.0094046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714210	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900074
J	Huang, QL; Zhang, R; Hu, XH; Ding, SW; Qian, JG; Lei, T; Cao, X; Tao, L; Qian, ZY; Liu, HY				Huang, Qingling; Zhang, Rui; Hu, Xinhua; Ding, Shangwen; Qian, Jingguang; Lei, Ting; Cao, Xuan; Tao, Ling; Qian, Zhiyu; Liu, Hongyi			Disturbed Small-World Networks and Neurocognitive Function in Frontal Lobe Low-Grade Glioma Patients	PLOS ONE			English	Article							BRAIN-TUMOR PATIENTS; CORTICAL NETWORKS; CONNECTIVITY; INJECTION; IMAGES	Background: Brain tumor patients often associated with losses of the small-world configuration and neurocognitive functions before operations. However, few studies were performed on the impairments of frontal lobe low-grade gliomas (LGG) after tumor resection using small-world network features. Methodology/Principal Findings: To detect differences in the whole brain topology among LGG patients before and after operation, a combined study of neurocognitive assessment and graph theoretical network analysis of fMRI data was performed. We collected resting-state fMRI data of 12 carefully selected frontal lobe LGG patients before and after operation. We calculated the topological properties of brain functional networks in the 12 LGG, and compared with 12 healthy controls (HCs). We also applied Montreal Cognitive Assessment (MoCA) in a subset of patients (n = 12, including before and after operation groups) and HCs (n = 12). The resulting functional connectivity matrices were constructed for all 12 patients, and binary network analysis was performed. In the range of 0.05 <= K-cost <= 0.35, the functional networks in preoperative LGG and postoperative one both fitted the definition of small-worldness. We proposed K-net = 0.20 as small-world network interval, and the results showed that the topological properties were found to be disrupted in the two LGG groups, meanwhile the global efficiency increased and the local efficiency decreased. L-net in the two LGG groups both were longer than HCs. C-net in the LGG groups were smaller than HCs. Compared with the Hcs, MoCA in the two LGG groups were lower than HCs with significant difference, and the disturbed networks in the LGG were negatively related to worse MoCA scores. Conclusions: Disturbed small-worldness preperty in the two LGG groups was found and widely spread in the strength and spatial organization of brain networks, and the alterated small-world network may be responsible for cognitive dysfunction in frontal lobe LGG patients.	[Huang, Qingling] Nanjing Med Univ, Nanjing Brain Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhang, Rui; Hu, Xinhua; Lei, Ting; Liu, Hongyi] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Ding, Shangwen; Tao, Ling; Qian, Zhiyu] Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China; [Qian, Jingguang] Nanjing Sport Inst, Dept Sci Res, Nanjing, Jiangsu, Peoples R China; [Cao, Xuan] Univ Florida, Dept Stat, Gainesville, FL 32611 USA	Nanjing Medical University; Nanjing Medical University; Nanjing University of Aeronautics & Astronautics; Nanjing Sport Institute; State University System of Florida; University of Florida	Qian, ZY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China.	zhiyu@nuaa.edu.cn; hyl18@126.com			Natural Scientific Foundation of China [31270998]; Science and Technology Development Program of Jiangsu Province [BL2012041]; Science and Technology Program of Nanjing [QRX11115]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Jiangsu Province; Science and Technology Program of Nanjing	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 31270998 for Jingguang Qian], the Science and Technology Development Program of Jiangsu Province [Grant No. BL2012041 for Hongyi Liu], and the Science and Technology Program of Nanjing [Grant No. QRX11115 for Qingling Huang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BOSMA I, 2009, NONLINEAR BIOMED PHY, V1, P3; Bosma I, 2008, NEURO-ONCOLOGY, V10, P734, DOI 10.1215/15228517-2008-034; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Douw L, 2008, EXP NEUROL, V212, P285, DOI 10.1016/j.expneurol.2008.03.013; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Douw L, 2009, NEUROIMAGE, V46, P584, DOI 10.1016/j.neuroimage.2009.02.034; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Nudo RJ, 1996, J NEUROSCI, V16, P785; Ramasco JJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066106; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Shaw E G, 1993, Oncology (Williston Park), V7, P97; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stephan KE, 2008, NEUROIMAGE, V42, P1, DOI 10.1016/j.neuroimage.2008.04.167; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	33	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94095	10.1371/journal.pone.0094095	http://dx.doi.org/10.1371/journal.pone.0094095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714669	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900082
J	Lunze, K; Yeboah-Antwi, K; Marsh, DR; Kafwanda, SN; Musso, A; Semrau, K; Waltensperger, KZ; Hamer, DH				Lunze, Karsten; Yeboah-Antwi, Kojo; Marsh, David R.; Kafwanda, Sarah Ngolofwana; Musso, Austen; Semrau, Katherine; Waltensperger, Karen Z.; Hamer, Davidson H.			Prevention and Management of Neonatal Hypothermia in Rural Zambia	PLOS ONE			English	Article							NEWBORN CARE PRACTICES; MORTALITY; PRETERM; INFANTS; BABIES; HEALTH	Background: Neonatal hypothermia is increasingly recognized as a risk factor for newborn survival. The World Health Organization recommends maintaining a warm chain and skin-to-skin care for thermoprotection of newborn children. Since little is known about practices related to newborn hypothermia in rural Africa, this study's goal was to characterize relevant practices, attitudes, and beliefs in rural Zambia. Methods and Findings: We conducted 14 focus group discussions with mothers and grandmothers and 31 in-depth interviews with community leaders and health officers in Lufwanyama District, a rural area in the Copperbelt Province, Zambia, enrolling a total of 171 participants. We analyzed data using domain analysis. In rural Lufwanyama, community members were aware of the danger of neonatal hypothermia. Caregivers' and health workers' knowledge of thermoprotective practices included birthplace warming, drying and wrapping of the newborn, delayed bathing, and immediate and exclusive breastfeeding. However, this warm chain was not consistently maintained in the first hours postpartum, when newborns are at greatest risk. Skin-to-skin care was not practiced in the study area. Having to assume household and agricultural labor responsibilities in the immediate postnatal period was a challenge for mothers to provide continuous thermal care to their newborns. Conclusions: Understanding and addressing community-based practices on hypothermia prevention and management might help improve newborn survival in resource-limited settings. Possible interventions include the implementation of skin-to-skin care in rural areas and the use of appropriate, low-cost newborn warmers to prevent hypothermia and support families in their provision of newborn thermal protection. Training family members to support mothers in the provision of thermoprotection for their newborns could facilitate these practices.	[Lunze, Karsten; Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Lunze, Karsten; Yeboah-Antwi, Kojo; Semrau, Katherine; Hamer, Davidson H.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA USA; [Lunze, Karsten; Yeboah-Antwi, Kojo; Musso, Austen; Semrau, Katherine; Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Marsh, David R.; Waltensperger, Karen Z.] Save Children US, Westport, CT USA; [Kafwanda, Sarah Ngolofwana] Trop Dis Res Ctr, Ndola, Zambia; [Hamer, Davidson H.] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia	Boston University; Boston University; Boston University; Save the Children; University of Zambia	Lunze, K (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	karsten.lunze@post.harvard.edu	Yeboah-Antwi, Kojo/AAI-8519-2020; Lunze, Karsten/AAL-7240-2021; Hamer, Davidson Howes/J-2020-2019	Lunze, Karsten/0000-0001-8495-0350; Hamer, Davidson Howes/0000-0002-4700-1495; Semrau, Katherine/0000-0002-8360-1391; Yeboah-Antwi, Kojo/0000-0002-3516-9266	United States Agency for International Development [GHS A-00-09-00013-00]	United States Agency for International Development(United States Agency for International Development (USAID))	The authors would like to acknowledge the United States Agency for International Development, the support of which - through Cooperative Agreement Number: GHS A-00-09-00013-00 - made this project and study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013783; Ayaz S, 2008, EUR J CONTRACEP REPR, V13, P282, DOI 10.1080/13625180802049427; Central Statistical Office, 2012, 2010 CENS POP HOUS; Choudhary S. P., 2000, Indian Journal of Pediatrics, V67, P491, DOI 10.1007/BF02760474; CHRISTENSSON K, 1995, J TROP PEDIATRICS, V41, P210, DOI 10.1093/tropej/41.4.210; CHRISTENSSON K, 1988, J TROP PEDIATRICS, V34, P208, DOI [10.1093/tropej/34.5.208-a, 10.1093/tropej/34.5.208]; Clark J, 2003, QUALITATIVE RES REV; Corbin Juliet M., 2007, BASICS QUALITATIVE R; Darmstadt GL, 2006, J PERINATOL, V26, P597, DOI 10.1038/sj.jp.7211569; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dragovich D, 1997, ACTA PAEDIATR, V86, P645, DOI 10.1111/j.1651-2227.1997.tb08949.x; Embrace, 2013, EMBR GLOB INF THERM; Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Hill Z, 2010, TROP MED INT HEALTH, V15, P1118, DOI 10.1111/j.1365-3156.2010.02593.x; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leadford AE, 2013, PEDIATRICS, V132, pE128, DOI 10.1542/peds.2012-2030; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lunze K, 2012, J PERINATOL, V32, P317, DOI 10.1038/jp.2012.11; Lunze K, 2012, BMC MED IN PRESS; Moran AC, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-54; Mullany LC, 2010, SEMIN PERINATOL, V34, P426, DOI 10.1053/j.semperi.2010.09.007; Mullany LC, 2010, ARCH PEDIAT ADOL MED, V164, P650, DOI 10.1001/archpediatrics.2010.103; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Osrin D, 2002, BMJ-BRIT MED J, V325, P1063, DOI 10.1136/bmj.325.7372.1063; QSR International, 2013, NVIVO 10 RES SOFTW A; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; Thairu L, 2013, Trop Med Int Health, V18, P117, DOI 10.1111/tmi.12021; Thairu L, 2008, MATERN CHILD NUTR, V4, P194, DOI 10.1111/j.1740-8709.2008.00135.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; Waiswa P, 2010, TROP MED INT HEALTH, V15, P1140, DOI 10.1111/j.1365-3156.2010.02603.x; Wirth M, 2012, GLOBAL HLTH DIPLOMAC, V2, P5; World Health Organization. Maternal and Newborn Health/Safe Motherhood, 1997, THERM PROT NEWB PRAC; Zupan J., 2005, PERINATAL MORTALITY	36	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92006	10.1371/journal.pone.0092006	http://dx.doi.org/10.1371/journal.pone.0092006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714630	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900003
J	Yokoyama, S; Kitamoto, S; Higashi, M; Goto, Y; Hara, T; Ikebe, D; Yamaguchi, T; Arisaka, Y; Niihara, T; Nishimata, H; Tanaka, S; Takaori, K; Batra, SK; Yonezawa, S				Yokoyama, Seiya; Kitamoto, Sho; Higashi, Michiyo; Goto, Yuko; Hara, Taro; Ikebe, Dai; Yamaguchi, Taketo; Arisaka, Yoshifumi; Niihara, Toru; Nishimata, Hiroto; Tanaka, Sadao; Takaori, Kyoichi; Batra, Surinder K.; Yonezawa, Suguru			Diagnosis of Pancreatic Neoplasms Using a Novel Method of DNA Methylation Analysis of Mucin Expression in Pancreatic Juice	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER-CELLS; TUMORS; HYPERMETHYLATION; CLASSIFICATION; MUC5AC; IPMN	Mucins (MUC) play crucial roles in carcinogenesis and tumor invasion in pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasms (IPMNs). Our immunohistochemistry (IHC) studies have shown a consensus position on mucin expression profiles in pancreatic neoplasms as follows: MUC1-positive but MUC2-negative expression in PDACs; MUC1-negative but MUC2-positive expression in intestinal-type IPMNs (dangerous type); MUC1-negative and MUC2-negative expression in gastric-type IPMNs (safe type); High MUC4 expression in PDAC patients with a poor outcome; and MUC4-positive expression in intestinal-type IPMNs. We also showed that three mucin genes (MUC1, MUC2 and MUC4) expression in cancer cell line was regulated by DNA methylation. We have developed a novel ' methylation-specific electrophoresis (MSE)' method to analyze the DNA methylation status of mucin genes by high sensitivity and resolution. By using the MSE method, we evaluated pancreatic juice samples from 45 patients with various pancreatic lesions. The results were compared with final diagnosis of the pancreatic lesions including IHC of mucin expression in the paired pancreatic tissues. The results indicated that the DNA methylation status of MUC1, MUC2 and MUC4 in pancreatic juice matched with the mucin expression in tissue. Analyses of the DNA methylation status of MUC1, MUC2 and MUC4 were useful for differential diagnosis of human pancreatic neoplasms, with specificity and sensitivity of 87% and 80% for PDAC; 100% and 88% for intestinal-type IPMN; and 88% and 77% for gastric-type IPMN, respectively. In conclusion, MSE analysis of human pancreatic juice may provide useful information for selection of treatment for pancreatic neoplasms.	[Yokoyama, Seiya; Kitamoto, Sho; Higashi, Michiyo; Goto, Yuko; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 890, Japan; [Hara, Taro] Chiba Canc Ctr, Div Endoscopy, Chiba 2608717, Japan; [Ikebe, Dai] Chiba Canc Ctr, Div Surg Pathol, Chiba 2608717, Japan; [Yamaguchi, Taketo] Chiba Canc Ctr, Div Gastroenterol, Chiba 2608717, Japan; [Arisaka, Yoshifumi] Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 657, Japan; [Niihara, Toru] Nanpuh Hosp, Div Gastroenterol, Kagoshima, Japan; [Tanaka, Sadao] Nanpuh Hosp, Div Surg Pathol, Kagoshima, Japan; [Takaori, Kyoichi] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Batra, Surinder K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE USA	Kagoshima University; Chiba Cancer Center; Chiba Cancer Center; Chiba Cancer Center; Kobe University; Kyoto University; University of Nebraska System; University of Nebraska Medical Center	Yonezawa, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 890, Japan.	syoneza@m2.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647	Princess Takamatsu Cancer Research Fund [11-24319]; Ministry of Education, Science, Sports, Culture and Technology, Japan [23390085, 24590447, 24701008]; Kodama Memorial Foundation, Japan; USPHS from the National Institutes of Health [CA78590]; NATIONAL CANCER INSTITUTE [R01CA078590] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24701008] Funding Source: KAKEN	Princess Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kodama Memorial Foundation, Japan; USPHS from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant from the Princess Takamatsu Cancer Research Fund (11-24319) to S. Yonezawa; Grants-in-Aid for Scientific Research on Scientific Research (B) 23390085 to S. Yonezawa, Scientific Research (C) 24590447 to MH and Young Scientists (B) 24701008 to S. Yokoyama from the Ministry of Education, Science, Sports, Culture and Technology, Japan; by the Kodama Memorial Foundation, Japan (S. Yokoyama & MH); and by USPHS grant CA78590 from the National Institutes of Health to SKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2002, CANCER, V94, P62, DOI 10.1002/cncr.10203; Adsay NV., 2010, PATHOLOGY GENETICS T, P304; Begum S, 2011, CLIN CANCER RES, V17, P4494, DOI 10.1158/1078-0432.CCR-10-3436; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Fawcett T, 2006, PATTERN RECOGN, V27, P4; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Hara T, 2013, ANN SURG, V257, P1103, DOI 10.1097/SLA.0b013e318281b824; Horinouchi M, 2003, ACTA HISTOCHEM CYTOC, V36, P443, DOI 10.1267/ahc.36.443; Hruban RH, 2010, WHO CLASSIFICATION T, P281; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Ihaka R, 1996, J COMPUT GRAPH STAT, V5, P16; Kitazono I, 2013, PANCREAS, V42, P1120, DOI 10.1097/MPA.0b013e3182965915; Longnecker DS, 2000, WHO CLASSIFICATION T, P237; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Nagata S, 2012, CANCER-AM CANCER SOC, V118, P4298, DOI 10.1002/cncr.27417; Nakamura A, 2002, J PATHOL, V197, P201, DOI 10.1002/path.1109; OSAKO M, 1993, CANCER, V71, P2191, DOI 10.1002/1097-0142(19930401)71:7<2191::AID-CNCR2820710705>3.0.CO;2-X; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Shinozuka N, 2007, J HEPATO-BILIARY-PAN, V14, P569, DOI 10.1007/s00534-006-1203-4; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Venables WN., 2002, MODERN APPL STAT S 4; Yamada N, 2009, BRIT J CANCER, V100, P344, DOI 10.1038/sj.bjc.6604845; Yamada N, 2011, CLIN EPIGENET; Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Yamada N, 2006, INT J CANCER, V119, P1850, DOI 10.1002/ijc.22047; Yao F, 2013, AM J MED SCI, V346, P175, DOI 10.1097/MAJ.0b013e31827b94b6; Yokoyama S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-67; Yonezawa S, 1999, PATHOL INT, V49, P45, DOI 10.1046/j.1440-1827.1999.00823.x; Yonezawa S, 1997, HUM PATHOL, V28, P344, DOI 10.1016/S0046-8177(97)90134-9; Yonezawa S, 1998, PATHOL INT, V48, P319, DOI 10.1111/j.1440-1827.1998.tb03913.x; Yonezawa S, 2012, GASTRIC CANC; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Yonezawa S, 2010, J HEPATO-BIL-PAN SCI, V17, P108, DOI 10.1007/s00534-009-0174-7; Yonezawa S, 2008, GUT LIVER, V2, P137, DOI 10.5009/gnl.2008.2.3.137	37	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93760	10.1371/journal.pone.0093760	http://dx.doi.org/10.1371/journal.pone.0093760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714692	gold, Green Submitted, Green Published			2022-12-27	WOS:000334160900045
J	Zhang, H; Wang, XY; Lin, XH; Liu, CX				Zhang, Hao; Wang, Xing-yuan; Lin, Xiao-hui; Liu, Chong-xin			Stability and Synchronization for Discrete-Time Complex-Valued Neural Networks with Time-Varying Delays	PLOS ONE			English	Article								In this paper, the synchronization problem for a class of discrete-time complex-valued neural networks with time-varying delays is investigated. Compared with the previous work, the time delay and parameters are assumed to be time-varying. By separating the real part and imaginary part, the discrete-time model of complex-valued neural networks is derived. Moreover, by using the complex-valued Lyapunov-Krasovskii functional method and linear matrix inequality as tools, sufficient conditions of the synchronization stability are obtained. In numerical simulation, examples are presented to show the effectiveness of our method.	[Zhang, Hao; Wang, Xing-yuan; Lin, Xiao-hui] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China; [Liu, Chong-xin] Xi An Jiao Tong Univ, Inst Elect Engn, Xian 710049, Peoples R China	Dalian University of Technology; Xi'an Jiaotong University	Zhang, H (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China.	wangxy@dlut.edu.cn; zhangh545@yahoo.com.cn	Wang, Xing-yuan/I-6353-2015		National Natural Science Foundation of China [61370145, 61173183, 60973152]; Doctoral Program Foundation of Institution of Higher Education of China [20070141014]; Program for Liaoning Excellent Talents in University [LR2012003]; National Natural Science Foundation of Liaoning province [20082165]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institution of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Liaoning Excellent Talents in University; National Natural Science Foundation of Liaoning province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (Nos: 61370145, 61173183, and 60973152), the Doctoral Program Foundation of Institution of Higher Education of China (No: 20070141014), Program for Liaoning Excellent Talents in University (No: LR2012003), the National Natural Science Foundation of Liaoning province (No: 20082165) and the Fundamental Research Funds for the Central Universities (No: DUT12JB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arik S, 2000, IEEE T CIRCUITS-I, V47, P568, DOI 10.1109/81.841858; Boyd S., 1994, LINEAR MATRIX INEQUA; Chapelle O, 1999, IEEE T NEURAL NETWOR, V10, P1055, DOI 10.1109/72.788646; Chen DY, 2012, CHAOS, V22, DOI 10.1063/1.4721996; Duan CJ, 2010, DISCRETE DYN NAT SOC, V2010, DOI 10.1155/2010/368379; Georgieva A, 2009, IEEE T NEURAL NETWOR, V20, P675, DOI 10.1109/TNN.2008.2011903; Gong DW, 2012, NEUROCOMPUTING, V82, P14, DOI 10.1016/j.neucom.2011.09.026; Gonzalez-Miranda JM, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.047202; Hu J, 2012, IEEE T NEUR NET LEAR, V23, P853, DOI 10.1109/TNNLS.2012.2195028; Lin SH, 1997, IEEE T NEURAL NETWOR, V8, P114, DOI 10.1109/72.554196; Liu YR, 2008, IEEE T SYST MAN CY B, V38, P1314, DOI 10.1109/TSMCB.2008.925745; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Rudin W., 1987, REAL COMPLEX ANAL, DOI DOI 10.1007/BFB0084190; SANGER TD, 1989, NEURAL NETWORKS, V2, P459, DOI 10.1016/0893-6080(89)90044-0; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P124, DOI 10.1016/j.cnsns.2009.03.035; Zhang H, 2007, IEEE T NEURAL NETWOR, V18, P1841, DOI 10.1109/TNN.2007.902958; Zhang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039355; Zhou B, 2013, IEEE T NEUR NET LEAR, V24, P1227, DOI 10.1109/TNNLS.2013.2247626; Zhou W, 2009, IEEE T CIRCUITS-II, V56, P669, DOI 10.1109/TCSII.2009.2025625	19	22	22	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93838	10.1371/journal.pone.0093838	http://dx.doi.org/10.1371/journal.pone.0093838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714386	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900056
J	Diaz, D; Esteban, FJ; Hernandez, P; Caballero, JA; Guevara, A; Dorado, G; Galvez, S				Diaz, David; Esteban, Francisco J.; Hernandez, Pilar; Caballero, Juan Antonio; Guevara, Antonio; Dorado, Gabriel; Galvez, Sergio			MC64-ClustalWP2: A Highly-Parallel Hybrid Strategy to Align Multiple Sequences in Many-Core Architectures	PLOS ONE			English	Article							CLUSTAL-W; SMITH-WATERMAN; LINEAR-SPACE; ALGORITHM; EFFICIENT; PROGRAM; SENSITIVITY; GENERATION; GENOMES; SEARCH	We have developed the MC64-ClustalWP2 as a new implementation of the Clustal W algorithm, integrating a novel parallelization strategy and significantly increasing the performance when aligning long sequences in architectures with many cores. It must be stressed that in such a process, the detailed analysis of both the software and hardware features and peculiarities is of paramount importance to reveal key points to exploit and optimize the full potential of parallelism in many-core CPU systems. The new parallelization approach has focused into the most time-consuming stages of this algorithm. In particular, the so-called progressive alignment has drastically improved the performance, due to a fine-grained approach where the forward and backward loops were unrolled and parallelized. Another key approach has been the implementation of the new algorithm in a hybrid-computing system, integrating both an Intel Xeon multi-core CPU and a Tilera Tile64 many-core card. A comparison with other Clustal W implementations reveals the high-performance of the new algorithm and strategy in many-core CPU architectures, in a scenario where the sequences to align are relatively long (more than 10 kb) and, hence, a many-core GPU hardware cannot be used. Thus, the MC64-ClustalWP2 runs multiple alignments more than 18x than the original Clustal W algorithm, and more than 7x than the best x86 parallel implementation to date, being publicly available through a web service. Besides, these developments have been deployed in cost-effective personal computers and should be useful for life-science researchers, including the identification of identities and differences for mutation/polymorphism analyses, biodiversity and evolutionary studies and for the development of molecular markers for paternity testing, germplasm management and protection, to assist breeding, illegal traffic control, fraud prevention and for the protection of the intellectual property (identification/traceability), including the protected designation of origin, among other applications.	[Diaz, David; Guevara, Antonio; Galvez, Sergio] Univ Malaga, Dep Lenguajes & Ciencias Computac, E-29071 Malaga, Spain; [Esteban, Francisco J.] Univ Cordoba, Serv Informat, Cordoba, Spain; [Hernandez, Pilar] CSIC, IAS, Cordoba, Spain; [Caballero, Juan Antonio] Univ Cordoba, Dep Estadist, Cordoba, Spain; [Dorado, Gabriel] Univ Cordoba, Dept Bioquim & Biol Mol, Cordoba, Spain	Universidad de Malaga; Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad de Cordoba; Universidad de Cordoba	Galvez, S (corresponding author), Univ Malaga, Dep Lenguajes & Ciencias Computac, E-29071 Malaga, Spain.	galvez@uma.es	Rojas, Sergio Gálvez/K-7733-2014; Guevara-Plaza, Antonio A/I-4707-2017; Hernandez, Pilar/B-5996-2016	Rojas, Sergio Gálvez/0000-0003-4743-2807; Guevara-Plaza, Antonio A/0000-0002-2400-0668; Hernandez, Pilar/0000-0001-5166-4454	Ministerio de Economia y Competitividad (MINECO) [AGL2010-17316, BIO2011-15237-E]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (MINECO); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria [INIA RF2012-00002-C02-02]; Consejeria de Agricultura y Pesca [041/C/2007, 75/C/2009, 56/C/2010]; Consejeria de Economia, Innovacion y Ciencia [AGR-7322, AGR-482]; "Consejeria de Economia, Innovacion y Ciencia'' of "Junta de Andalucia"; "Consejeria de Economia, Innovacion y Ciencia'' of "Grupo PAI" [AGR-248]; "Consejeria de Economia, Innovacion y Ciencia'' of "Universidad de Cordoba'' ("Ayuda a Grupos''), Spain	Ministerio de Economia y Competitividad (MINECO); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (MINECO); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA)); Consejeria de Agricultura y Pesca(Junta de Andalucia); Consejeria de Economia, Innovacion y Ciencia; "Consejeria de Economia, Innovacion y Ciencia'' of "Junta de Andalucia"; "Consejeria de Economia, Innovacion y Ciencia'' of "Grupo PAI"; "Consejeria de Economia, Innovacion y Ciencia'' of "Universidad de Cordoba'' ("Ayuda a Grupos''), Spain	This work was supported by "Ministerio de Economia y Competitividad'' (MINECO grants AGL2010-17316 and BIO2011-15237-E) and "Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria'' (MINECO and INIA RF2012-00002-C02-02); "Consejeria de Agricultura y Pesca'' (041/C/2007, 75/C/2009 and 56/C/2010) and "Consejeria de Economia, Innovacion y Ciencia'' (AGR-7322 and AGR-482) of "Junta de Andalucia''; "Grupo PAI'' (AGR-248); and "Universidad de Cordoba'' ("Ayuda a Grupos''), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapteva, 2011, EP MULT IP; Agrifood Biotechnology (Biotecnologia Agroalimentaria) Research Group, 2009, MAN COR BIOINF ALG D; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, INT TER RES CHIP; BAINS W, 1986, NUCLEIC ACIDS RES, V14, P159, DOI 10.1093/nar/14.1.159; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chaichoompu K., 2006, Proceedings. 20th International Parallel and Distributed Processing Symposium (IEEE Cat. No.06TH8860); Chain Patrick, 2003, Briefings in Bioinformatics, V4, P105, DOI 10.1093/bib/4.2.105; Cheetham J, 2003, LECT NOTES COMPUT SC, V2668, P300; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dewey Colin N., 2007, V395, P221; Diaz D, 2011, PARALLEL COMPUT, V37, P244, DOI 10.1016/j.parco.2011.03.003; Driga A, 2006, ALGORITHMICA, V45, P337, DOI 10.1007/s00453-006-1217-y; Du ZH, 2006, PARALLEL COMPUT, V32, P441, DOI 10.1016/j.parco.2006.05.001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esteban FJ, 2013, ADV INTELL SYST, V206, P819, DOI 10.1007/978-3-642-36981-0_76; Esteban FJ, 2013, FUTURE GENER COMP SY, V29, P15, DOI 10.1016/j.future.2012.03.018; Galvez S, 2010, BIOINFORMATICS, V26, P683, DOI 10.1093/bioinformatics/btq017; Goetzmann JF, 2007, THESIS U MAINZ; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Higgins DG, 2005, P NATL ACAD SCI USA, V102, P10411, DOI 10.1073/pnas.0504801102; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HIRSCHBERG DS, 1975, COMMUN ACM, V18, P341, DOI 10.1145/360825.360861; Hohl Michael, 2002, Bioinformatics, V18 Suppl 1, pS312; Intel, 2010, SCC PLATF OV; Isaza S, 2010, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPLEX, INTELLIGENT AND SOFTWARE INTENSIVE SYSTEMS (CISIS 2010), P889, DOI 10.1109/CISIS.2010.149; Katoh K, 2007, BIOINFORMATICS, V23, P372, DOI 10.1093/bioinformatics/btl592; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P9061, DOI 10.1167/iovs.11-7812; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu Y, 2009, 2009 IEEE INT S PAR, P1, DOI [DOI 10.1109/IPDPS.2009.5160988, 10.1109/IPDPS.2009.5160923, DOI 10.1109/IPDPS.2009.5160923]; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Liu YC, 2009, IEEE INT CONF ASAP, P121, DOI 10.1109/ASAP.2009.14; Manavski SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S10; MATTSON TG, 2008, P 2008 ACM IEEE C SU, P1, DOI DOI 10.1109/SC.2008.5213921; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Mirto M, 2008, FUTURE GENER COMP SY, V24, P752, DOI 10.1016/j.future.2008.02.001; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Notredame C, 2007, PLOS COMPUT BIOL, V3, P1405, DOI 10.1371/journal.pcbi.0030123; Paten B, 2011, GENOME RES, V21, P1512, DOI 10.1101/gr.123356.111; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Perez-Jimenez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070507; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shah M, 2007, IEEE ASIAN SOLID STA, P22; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stone JE, 2010, COMPUT SCI ENG, V12, P66, DOI 10.1109/MCSE.2010.69; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tilera, 2011, PROD BRIEF TILE GX 8; Vandierendonck H, 2008, LECT NOTES COMPUT SC, V4917, P161, DOI 10.1007/978-3-540-77560-7_12; Vandierendonck H, 2010, COMPUT J, V53, P814, DOI 10.1093/comjnl/bxp086; WATERMAN MS, 1986, NUCLEIC ACIDS RES, V14, P9095, DOI 10.1093/nar/14.22.9095; Wentzlaff D, 2007, IEEE MICRO, V27, P15, DOI 10.1109/MM.2007.4378780	58	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94044	10.1371/journal.pone.0094044	http://dx.doi.org/10.1371/journal.pone.0094044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710354	Green Submitted, Green Published, gold			2022-12-27	WOS:000334159800094
J	Baumgartner, S; Tolic, IM				Baumgaertner, Stephan; Tolic, Iva M.			Astral Microtubule Pivoting Promotes Their Search for Cortical Anchor Sites during Mitosis in Budding Yeast	PLOS ONE			English	Article							MITOTIC SPINDLE; DYNEIN; ORIENTATION; MECHANISM; KAR9	Positioning of the mitotic spindle is crucial for proper cell division. In the budding yeast Saccharomyces cerevisiae, two mechanisms contribute to spindle positioning. In the Kar9 pathway, astral microtubules emanating from the daughter-bound spindle pole body interact via the linker protein Kar9 with the myosin Myo2, which moves the microtubule along the actin cables towards the neck. In the dynein pathway, astral microtubules off-load dynein onto the cortical anchor protein Num1, which is followed by dynein pulling on the spindle. Yet, the mechanism by which microtubules target cortical anchor sites is unknown. Here we quantify the pivoting motion of astral microtubules around the spindle pole bodies, which occurs during spindle translocation towards the neck and through the neck. We show that this pivoting is largely driven by the Kar9 pathway. The microtubules emanating from the daughter-bound spindle pole body pivot faster than those at the mother-bound spindle pole body. The Kar9 pathway reduces the time needed for an astral microtubule inside the daughter cell to start pulling on the spindle. Thus, we propose a new role for microtubule pivoting: By pivoting around the spindle pole body, microtubules explore the space laterally, which helps them search for cortical anchor sites in the context of spindle positioning in budding yeast.	[Baumgaertner, Stephan; Tolic, Iva M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Tolic, Iva M.] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia	Max Planck Society; Rudjer Boskovic Institute	Tolic, IM (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	tolic@mpi-cbg.de	Tolić, Iva/F-1704-2014	Tolić, Iva/0000-0003-1305-7922	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max Planck Society, http://www.mpg.de/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Ananthanarayanan V, 2013, CELL, V153, P1526, DOI 10.1016/j.cell.2013.05.020; Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X; Berg, 2018, RANDOM WALKS BIOL; BROERSMA S, 1960, J CHEM PHYS, V32, P1626, DOI 10.1063/1.1730994; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; Gerson-Gurwitz A, 2009, CELL MOL LIFE SCI, V66, P301, DOI 10.1007/s00018-008-8479-2; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Kalinina I, 2013, NAT CELL BIOL, V15, P82, DOI 10.1038/ncb2640; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lee WL, 2005, J CELL BIOL, V168, P201, DOI 10.1083/jcb.200407036; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; Liakopoulos D, 2003, CELL, V112, P561, DOI 10.1016/S0092-8674(03)00119-3; Markus SM, 2012, EXP CELL RES, V318, P1400, DOI 10.1016/j.yexcr.2012.04.006; Markus SM, 2009, CURR BIOL, V19, P196, DOI 10.1016/j.cub.2008.12.047; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Pavin N, 2014, SYST SYNTH BIOL; Pavin N, 2013, BIOCHEM SOC T, V41, P1731, DOI 10.1042/BST20130235; R Core Team, 2021, R LANGUAGE ENV STAT; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; TIRADO MM, 1979, J CHEM PHYS, V71, P2581, DOI 10.1063/1.438613; Tolic-Norrelykke IM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.078102; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Yin HW, 2000, NATURE, V406, P1013, DOI 10.1038/35023024	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93781	10.1371/journal.pone.0093781	http://dx.doi.org/10.1371/journal.pone.0093781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24721997	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100024
J	Thomson, DR; Shitole, S; Shitole, T; Sawant, K; Subbaraman, R; Bloom, DE; Patil-Deshmukh, A				Thomson, Dana R.; Shitole, Shrutika; Shitole, Tejal; Sawant, Kiran; Subbaraman, Ramnath; Bloom, David E.; Patil-Deshmukh, Anita			A System for Household Enumeration and Re-identification in Densely Populated Slums to Facilitate Community Research, Education, and Advocacy	PLOS ONE			English	Article							SETTLEMENTS; HEALTH; INDIA; WATER	Background: We devised and implemented an innovative Location-Based Household Coding System (LBHCS) appropriate to a densely populated informal settlement in Mumbai, India. Methods and Findings: LBHCS codes were designed to double as unique household identifiers and as walking directions; when an entire community is enumerated, LBHCS codes can be used to identify the number of households located per road (or lane) segment. LBHCS was used in community-wide biometric, mental health, diarrheal disease, and water poverty studies. It also facilitated targeted health interventions by a research team of youth from Mumbai, including intensive door-to-door education of residents, targeted follow-up meetings, and a full census. In addition, LBHCS permitted rapid and low-cost preparation of GIS mapping of all households in the slum, and spatial summation and spatial analysis of survey data. Conclusion: LBHCS was an effective, easy-to-use, affordable approach to household enumeration and re-identification in a densely populated informal settlement where alternative satellite imagery and GPS technologies could not be used.	[Thomson, Dana R.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02163 USA; [Shitole, Shrutika; Shitole, Tejal; Sawant, Kiran; Subbaraman, Ramnath; Patil-Deshmukh, Anita] Partners Urban Knowledge Act & Res, Bombay, Maharashtra, India; [Subbaraman, Ramnath] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Bloom, David E.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Thomson, DR (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02163 USA.	dana_thomson@hms.harvard.edu		Thomson, Dana Renee/0000-0002-9507-9123; Subbaraman, Ramnath/0000-0002-2063-943X	Rockefeller Foundation; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University [R24 TW007988]; Harvard University T32 Post-Doctoral Fellowship [NIAID AI 007433]; Weatherhead Center for International Affairs at Harvard University; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER	Rockefeller Foundation; Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University; Harvard University T32 Post-Doctoral Fellowship; Weatherhead Center for International Affairs at Harvard University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the Rockefeller Foundation. RS's contribution was funded by the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and more recently by a Harvard University T32 Post-Doctoral Fellowship (NIAID AI 007433). Financial support was also provided by The Weatherhead Center for International Affairs at Harvard University. No funding bodies had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appadurai A, 2008, MUMBAIS BAREFOOT RES; Curtis A, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-21; GORTER AC, 1991, INT J EPIDEMIOL, V20, P527, DOI 10.1093/ije/20.2.527; Howard G., 2003, DOMESTIC WATER QUANT; Karanja I, 2010, ENVIRON URBAN, V22, P217, DOI 10.1177/0956247809362642; Kretzmann J, 2007, NATL CIVIC REV, V85, P23; Livengood A, 2012, ENVIRON URBAN, V24, P77, DOI 10.1177/0956247811434360; Makau J, 2012, ENVIRON URBAN, V24, P31, DOI 10.1177/0956247812438368; Militino AF, 2013, J GEODESY, V87, P675, DOI 10.1007/s00190-013-0638-z; Municipal Corporation of Greater Mumbai, 2010, MUMB HUM DEV REP 200; Navstar Global Positioning System, 2008, GLOB POS SYST STAND; Patel S, 2012, ENVIRON URBAN, V24, P13, DOI 10.1177/0956247812438366; Sharma Kalpana, 2000, REDISCOVERING DHARAV; Subbaraman R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-173; Subbaraman R, 2012, ENVIRON URBAN, V24, P643, DOI 10.1177/0956247812456356; *UNFPA, 2007, STAT WORLD POP 2007; Vuksanovic-Macura Z, 2012, ENVIRON URBAN, V24, P685, DOI 10.1177/0956247812451809; WELL, 1998, GUID MAN WAT SUPPL S	18	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e93925	10.1371/journal.pone.0093925	http://dx.doi.org/10.1371/journal.pone.0093925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5LS	24722369	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000336909100028
J	Zou, J; Yue, F; Li, WJ; Song, K; Jiang, XH; Yi, JL; Liu, LY				Zou, Jing; Yue, Fei; Li, Wenjiao; Song, Kun; Jiang, Xianhan; Yi, Jinglin; Liu, Leyuan			Autophagy Inhibitor LRPPRC Suppresses Mitophagy through Interaction with Mitophagy Initiator Parkin	PLOS ONE			English	Article							IN-VIVO; MITOCHONDRIAL; MICROTUBULE; PROTEIN; BCL-2; DISEASE; CANCER; RASSF1; DEGRADATION; MODULATION	Autophagy plays an important role in tumorigenesis. Mitochondrion-associated protein LRPPRC interacts with MAP1S that interacts with LC3 and bridges autophagy components with microtubules and mitochondria to affect autophagy flux. Dysfunction of LRPPRC and MAP1S is associated with poor survival of ovarian cancer patients. Furthermore, elevated levels of LRPPRC predict shorter overall survival in patients with prostate adenocarcinomas or gastric cancer. To understand the role of LRPPRC in tumor development, previously we reported that LRPPRC forms a ternary complex with Beclin 1 and Bcl-2 to inhibit autophagy. Here we further show that LRPPRC maintains the stability of Parkin that mono-ubiquitinates Bcl-2 to increase Bcl-2 stability to inhibit autophagy. Under mitophagy stress, Parkin translocates to mitochondria to cause rupture of outer mitochondrial membrane and bind with exposed LRPPRC. Consequently, LRPPRC and Parkin help mitochondria being engulfed in autophagosomes to be degraded. In cells under long-term mitophagy stress, both LRPPRC and Parkin become depleted coincident with disappearance of mitochondria and final autophagy inactivation due to depletion of ATG5-ATG12 conjugates. LRPPRC functions as a checkpoint protein that prevents mitochondria from autophagy degradation and impact tumorigenesis.	[Zou, Jing; Yue, Fei; Li, Wenjiao; Song, Kun; Jiang, Xianhan; Liu, Leyuan] Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Zou, Jing; Yi, Jinglin] Nanchang Univ, Jiangxi Res Inst Ophthalmol & Visual Sci, Affiliated Eye Hosp, Nanchang, Jiangxi, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Nanchang University	Liu, LY (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA.	lliu@ibt.tamhsc.edu	Li, Wenjiao/J-2198-2019; Yue, Fei/N-1891-2018	Li, Wenjiao/0000-0003-1308-8489; Zou, Jing/0000-0002-0976-7078; Song, Kun/0000-0003-3822-2891	DOD [W81XWH]; NCI [R01CA142862]; NATIONAL CANCER INSTITUTE [R01CA142862, P30CA016672] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DOD New Investigator Award W81XWH and NCI R01CA142862 to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Davison EJ, 2009, PROTEOMICS, V9, P4284, DOI 10.1002/pmic.200900126; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Galindo MF, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/131058; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461; Jiang XH, 2014, CANCER-AM CANCER SOC, V120, P1228, DOI 10.1002/cncr.28551; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kayaba H, 2000, J ALLERGY CLIN IMMUN, V106, pS40, DOI 10.1067/mai.2000.106060; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Li XS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0818-y; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LY, 2009, CELL ONCOL, V31, P393, DOI 10.3233/CLO-2009-0484; Liu LY, 2009, CELL CYCLE, V8, P1616, DOI 10.4161/cc.8.10.8577; Liu LY, 2005, BIOCHEM BIOPH RES CO, V332, P670, DOI 10.1016/j.bbrc.2005.05.006; Liu LY, 2005, CANCER RES, V65, P1830, DOI 10.1158/0008-5472.CAN-04-3896; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Parr R, 2013, DISCOV MED, V15, P213; Plun-Favreau H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001257; Rakovic A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/153979; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Terman A, 2006, CHEM-BIOL INTERACT, V163, P29, DOI 10.1016/j.cbi.2006.04.013; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zanon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078648; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	48	26	28	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94903	10.1371/journal.pone.0094903	http://dx.doi.org/10.1371/journal.pone.0094903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722279	Green Submitted, gold, Green Published			2022-12-27	WOS:000336909100145
J	Crowl, AA; Mavrodiev, E; Mansion, G; Haberle, R; Pistarino, A; Kamari, G; Phitos, D; Borsch, T; Cellinese, N				Crowl, Andrew A.; Mavrodiev, Evgeny; Mansion, Guilhem; Haberle, Rosemarie; Pistarino, Annalaura; Kamari, Georgia; Phitos, Dimitrios; Borsch, Thomas; Cellinese, Nico			Phylogeny of Campanuloideae (Campanulaceae) with Emphasis on the Utility of Nuclear Pentatricopeptide Repeat (PPR) Genes	PLOS ONE			English	Article							SOUTHERN BLUEBELLS WAHLENBERGIA; HISTORICAL BIOGEOGRAPHY; TESTING HYBRIDIZATION; MOLECULAR PHYLOGENY; PLEISTOCENE REFUGIA; MAXIMUM-LIKELIHOOD; SEQUENCES; TREES; EVOLUTION; INFERENCE	Background: The Campanuloideae (Campanulaceae) are a highly diverse clade of angiosperms found mostly in the Northern Hemisphere, with the highest diversity in temperate areas of the Old World. Chloroplast markers have greatly improved our understanding of this clade but many relationships remain unclear primarily due to low levels of molecular evolution and recent and rapid divergence. Furthermore, focusing solely on maternally inherited markers such as those from the chloroplast genome may obscure processes such as hybridization. In this study we explore the phylogenetic utility of two low-copy nuclear loci from the pentatricopeptide repeat gene family (PPR). Rapidly evolving nuclear loci may provide increased phylogenetic resolution in clades containing recently diverged or closely related taxa. We present results based on both chloroplast and low-copy nuclear loci and discuss the utility of such markers to resolve evolutionary relationships and infer hybridization events within the Campanuloideae clade. Results: The inclusion of low-copy nuclear genes into the analyses provides increased phylogenetic resolution in two species-rich clades containing recently diverged taxa. We also obtain support for the placement of two early diverging lineages (Jasione and Musschia-Gadellia clades) that have previously been unresolved. Furthermore, phylogenetic analyses of PPR loci revealed potential hybridization events for a number of taxa (e. g., Campanula pelviformis and Legousia species). These loci offer greater overall topological support than obtained with plastid DNA alone. Conclusion: This study represents the first inclusion of low-copy nuclear genes for phylogenetic reconstruction in Campanuloideae. The two PPR loci were easy to sequence, required no cloning, and the sequence alignments were straightforward across the entire Campanuloideae clade. Although potentially complicated by incomplete lineage sorting, these markers proved useful for understanding the processes of reticulate evolution and resolving relationships at a wide range of phylogenetic levels. Our results stress the importance of including multiple, independent loci in phylogenetic analyses.	[Crowl, Andrew A.; Mavrodiev, Evgeny; Cellinese, Nico] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Crowl, Andrew A.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Mansion, Guilhem; Borsch, Thomas] Free Univ Berlin, Bot Garten, Berlin, Germany; [Mansion, Guilhem; Borsch, Thomas] Free Univ Berlin, Bot Museum, Berlin, Germany; [Haberle, Rosemarie] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98447 USA; [Pistarino, Annalaura] Museo Reg Sci Nat, Turin, Italy; [Kamari, Georgia; Phitos, Dimitrios] Univ Patras, Dept Biol, Patras, Greece	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Free University of Berlin; Pacific Lutheran University; University of Patras	Crowl, AA (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	andy.crowl@ufl.edu		Cellinese, Nico/0000-0002-7157-9414	National Science Foundation [DEB-0953677]	National Science Foundation(National Science Foundation (NSF))	The authors thank the National Science Foundation (DEB-0953677) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; [Anonymous], 2002, SE AL SEQUENCE ALIGN; Antonelli A, 2008, MOL PHYLOGENET EVOL, V46, P1, DOI 10.1016/j.ympev.2007.06.015; Antonelli A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-82; Avise John C., 1994, pi; Becker M, 2013, NAT CLIM CHANGE, V3, P1039, DOI 10.1038/NCLIMATE2027; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Boissier E., 1875, FLORA ORIENTALIS, V3, P884, DOI [10.5962/bhl.title.20323, DOI 10.5962/BHL.TITLE.20323]; Borsch Thomas, 2009, Willdenowia, V39, P7, DOI 10.3372/wi.39.39101; Carlstrom A., 1986, WILLDENOWIA, V15, P375; Cellinese N, 2009, J BIOGEOGR, V36, P1253, DOI 10.1111/j.1365-2699.2008.02077.x; COSNER M E, 1991, American Journal of Botany, V78, P92; Cosner Mary Elizabeth, 1993, American Journal of Botany, V80, P140; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; de Candolle AP, 1839, CAMPANULACEAE PRODRO, P784; Doyle J. J., 1987, PHYTOCHEM B, P11; Doyle JJ, 2003, SYST BOT, V28, P567; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Drew BT, 2013, BOT J LINN SOC, V171, P171, DOI 10.1111/j.1095-8339.2012.01325.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dubey S, 2006, MOL PHYLOGENET EVOL, V38, P635, DOI 10.1016/j.ympev.2005.11.005; Eddie WMM, 2003, ANN MO BOT GARD, V90, P554, DOI 10.2307/3298542; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fedorov AA, 1957, FLORA URSS, P459; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Fenaroli F, 2013, PHYTOTAXA, V111, P27, DOI 10.11646/phytotaxa.111.1.2; Gaut BS, 1998, EVOL BIOL, V30, P93; GUSTAFSSON MHG, 1995, AM J BOT, V82, P250, DOI 10.2307/2445532; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Haberle RC, 2009, TAXON, V58, P715, DOI 10.1002/tax.583003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joly S, 2012, MOL ECOL RESOUR, V12, P179, DOI 10.1111/j.1755-0998.2011.03065.x; Knowles L.L., 2010, ESTIMATING SPECIES T; Kovanda M, 1977, FOLIA GEOBOT, V5, P23; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lammers TG, 2007, FAMILIES GENERA VASC, V8, P26, DOI DOI 10.1007/978-3-540-31051-8_5; Lancucka-srodoniowa, 1979, ACTA PALAEOBOT, V1, P3; LANCUCKA-SRODONIOWA M, 1977, Acta Palaeobotanica, V18, P37; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lu-Irving P, 2013, BOT J LINN SOC, V171, P103, DOI 10.1111/j.1095-8339.2012.01305.x; Lundberg J, 2003, INT J PLANT SCI, V164, P553, DOI 10.1086/374829; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mansion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050076; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nemcok M, 1998, TECTONOPHYSICS, V295, P307, DOI 10.1016/S0040-1951(98)00092-4; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Olesen JM, 2012, PERSPECT PLANT ECOL, V14, P169, DOI 10.1016/j.ppees.2012.01.003; OSZAST J, 1977, Acta Palaeobotanica, V18, P45; OSZCZYPKO N, 1972, Acta Palaeobotanica, V13, P137; Park JM, 2006, SYST BOT, V31, P862, DOI 10.1600/036364406779695924; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prebble JM, 2012, AUST SYST BOT, V25, P11, DOI 10.1071/SB11023; Prebble JM, 2011, MOL PHYLOGENET EVOL, V59, P636, DOI 10.1016/j.ympev.2011.03.013; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roquet C, 2008, SYST BOT, V33, P203, DOI 10.1600/036364408783887465; Roquet C, 2009, MOL PHYLOGENET EVOL, V52, P575, DOI 10.1016/j.ympev.2009.05.014; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Sang T, 2000, SYST BIOL, V49, P422, DOI 10.1080/10635159950127321; Schonswetter P, 2002, MOL ECOL, V11, P2637, DOI 10.1046/j.1365-294X.2002.01651.x; Small RL, 2000, MOL PHYLOGENET EVOL, V16, P73, DOI 10.1006/mpev.1999.0750; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steele PR, 2008, MOL PHYLOGENET EVOL, V48, P1013, DOI 10.1016/j.ympev.2008.05.017; Takhtajan A., 1987, SYSTEMA MAGNOLIOPHYT; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; Wendling BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023559; Yuan Y-W, 2010, MOL PHYLOGENETICS EV; YUAN YW, 2009, NEW PHYTOLOGIST	70	34	35	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94199	10.1371/journal.pone.0094199	http://dx.doi.org/10.1371/journal.pone.0094199			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718519	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000088
J	Double, MC; Andrews-Goff, V; Jenner, KCS; Jenner, MN; Laverick, SM; Branch, TA; Gales, NJ				Double, Michael C.; Andrews-Goff, Virginia; Jenner, K. Curt S.; Jenner, Micheline-Nicole; Laverick, Sarah M.; Branch, Trevor A.; Gales, Nicholas J.			Migratory Movements of Pygmy Blue Whales (Balaenoptera musculus brevicauda) between Australia and Indonesia as Revealed by Satellite Telemetry	PLOS ONE			English	Article							SOUTHERN-HEMISPHERE; NINGALOO REEF; WESTERN-AUSTRALIA; RHINCODON-TYPUS; SYMPATRIC AREA; CETACEANS; TRACKING; LINKS	In Australian waters during the austral summer, pygmy blue whales (Balaenoptera musculus brevicauda) occur predictably in two distinct feeding areas off western and southern Australia. As with other blue whale subspecies, outside the austral summer their distribution and movements are poorly understood. In order to describe the migratory movements of these whales, we present the satellite telemetry derived movements of eleven individuals tagged off western Australia over two years. Whales were tracked from between 8 and 308 days covering an average distance of 3,0096892 km (mean 6 se; range: 832 km-14,101 km) at a rate of 21.94 +/- 0.74 km per day (0.09 km-455.80 km/day). Whales were tagged during March and April and ultimately migrated northwards post tag deployment with the exception of a single animal which remained in the vicinity of the Perth Canyon/Naturaliste Plateau for its eight day tracking period. The tagged whales travelled relatively near to the Australian coastline (100.0 +/- 1.7 km) until reaching a prominent peninsula in the north-west of the state of Western Australia (North West Cape) after which they travelled offshore (238.0 +/- 13.9 km). Whales reached the northern terminus of their migration and potential breeding grounds in Indonesian waters by June. One satellite tag relayed intermittent information to describe aspects of the southern migration from Indonesia with the animal departing around September to arrive in the subtropical frontal zone, south of western Australia in December. Throughout their migratory range, these whales are exposed to impacts associated with industry, fishing and vessel traffic. These movements therefore provide a valuable tool to industry when assessing potential interactions with pygmy blue whales and should be considered by conservation managers and regulators when mitigating impacts of development. This is particularly relevant for this species as it continues to recover from past exploitation.	[Double, Michael C.; Andrews-Goff, Virginia; Laverick, Sarah M.; Gales, Nicholas J.] Australian Antarctic Div, Australian Marine Mammal Ctr, Kingston, Tas, Australia; [Jenner, K. Curt S.; Jenner, Micheline-Nicole] Ctr Whale Res Western Australia Inc, Fremantle, WA, Australia; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Australian Antarctic Division; University of Washington; University of Washington Seattle	Double, MC (corresponding author), Australian Antarctic Div, Australian Marine Mammal Ctr, Kingston, Tas, Australia.	Mike.Double@aad.gov.au		Andrews-Goff, Virginia/0000-0002-4609-7317	Western Australian Marine Science Institute (WAMSI); Woodside Energy Ltd.	Western Australian Marine Science Institute (WAMSI); Woodside Energy Ltd.	This project was partly funded by the Western Australian Marine Science Institute (WAMSI). WAMSI received financial support for this project from Woodside Energy Ltd. as the operator of the Browse LNG Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Attard CRM, 2012, MOL ECOL, V21, P5715, DOI 10.1111/mec.12025; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; Belkin I.M., 2007, ICES CM, V500, P21; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Branch TA, 2007, MAR MAMMAL SCI, V23, P803, DOI 10.1111/j.1748-7692.2007.00137.x; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2009, MAR MAMMAL SCI, V25, P833, DOI 10.1111/j.1748-7692.2009.00292.x; Breed GA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00021.1; Brown S. G., 1954, Discovery Reports, V26, P355; Bryant P.J., 1984, P375; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Cetacean Specialist Group, 1996, IUCN 2013 IUCN RED L; De Deckker P, 2012, NAT GEOSCI, V5, P266, DOI [10.1038/ngeo1431, 10.1038/NGEO1431]; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Freitas C, 2008, OECOLOGIA, V155, P193, DOI 10.1007/s00442-007-0894-9; Furnas M, 2007, CONT SHELF RES, V27, P958, DOI 10.1016/j.csr.2007.01.002; Gavrilov AN, 2013, J ACOUST SOC AM, V134, P2505, DOI 10.1121/1.4816576; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Geoscience Australia and BREE, 2012, AUSTR GAS RES ASS 20; Gill Peter C., 2002, Journal of Cetacean Research and Management, V4, P179; Gill PC, 2011, MAR ECOL PROG SER, V421, P243, DOI 10.3354/meps08914; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Heide-Jorgensen MP, 2001, MAR MAMMAL SCI, V17, P949, DOI 10.1111/j.1748-7692.2001.tb01309.x; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Ichihara T., 1966, WHALES DOLPHINS PORP, P79, DOI 10.1525/9780520321373-008; Jenner C, 2008, SCI COMM INT WHAL CO; Kato H, 2007, SCI COMM INT WHAL CO; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Mackintosh NA., 1966, WHALES DOLPHINS PORP, P125; McCauley R, 2004, W AUSTR EXERCISE ARE; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Morin PA, 2005, MOL ECOL, V14, P3275, DOI 10.1111/j.1365-294X.2005.02651.x; Morton AB, 2002, ICES J MAR SCI, V59, P71, DOI 10.1006/jmsc.2001.1136; R Core Team, 2012, R LANG ENV STAT COMP; Rennie S, 2009, J MARINE SYST, V77, P21, DOI 10.1016/j.jmarsys.2008.11.008; Rice D.W., 1998, MARINE MAMMALS WORLD, V4; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Salgado Kent CP, 2012, P AC 2012 NOV 21 23, P1; Samaran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071561; Samaran Flore, 2010, Endangered Species Research, V12, P157, DOI 10.3354/esr00302; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sleeman JC, 2007, MAR FRESHWATER RES, V58, P608, DOI 10.1071/MF06213; Stafford KM, 2011, MAR MAMMAL SCI, V27, P828, DOI 10.1111/j.1748-7692.2010.00437.x; Taylor JG, 1996, MAR FRESHWATER RES, V47, P637, DOI 10.1071/MF9960637; Tyack PL, 2008, J MAMMAL, V89, P549, DOI 10.1644/07-MAMM-S-307R.1; Tyack PL, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P142; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8	50	50	59	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93578	10.1371/journal.pone.0093578	http://dx.doi.org/10.1371/journal.pone.0093578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718589	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000035
J	Johnson, MA; Vidoni, S; Durigon, R; Pearce, SF; Rorbach, J; He, JY; Brea-Calvo, G; Minczuk, M; Reyes, A; Holt, IJ; Spinazzola, A				Johnson, Mark A.; Vidoni, Sara; Durigon, Romina; Pearce, Sarah F.; Rorbach, Joanna; He, Jiuya; Brea-Calvo, Gloria; Minczuk, Michal; Reyes, Aurelio; Holt, Ian J.; Spinazzola, Antonella			Amino Acid Starvation Has Opposite Effects on Mitochondrial and Cytosolic Protein Synthesis	PLOS ONE			English	Article							P70 S6 KINASE; LIFE-SPAN; CALORIE RESTRICTION; TRANSCRIPTION; BIOGENESIS; MTOR; RESPIRATION; DEGRADATION; CANCER; INTEGRATION	Amino acids are essential for cell growth and proliferation for they can serve as precursors of protein synthesis, be remodelled for nucleotide and fat biosynthesis, or be burnt as fuel. Mitochondria are energy producing organelles that additionally play a central role in amino acid homeostasis. One might expect mitochondrial metabolism to be geared towards the production and preservation of amino acids when cells are deprived of an exogenous supply. On the contrary, we find that human cells respond to amino acid starvation by upregulating the amino acid-consuming processes of respiration, protein synthesis, and amino acid catabolism in the mitochondria. The increased utilization of these nutrients in the organelle is not driven primarily by energy demand, as it occurs when glucose is plentiful. Instead it is proposed that the changes in the mitochondrial metabolism complement the repression of cytosolic protein synthesis to restrict cell growth and proliferation when amino acids are limiting. Therefore, stimulating mitochondrial function might offer a means of inhibiting nutrient-demanding anabolism that drives cellular proliferation.	[Johnson, Mark A.; Vidoni, Sara; Pearce, Sarah F.; Rorbach, Joanna; He, Jiuya; Brea-Calvo, Gloria; Minczuk, Michal; Reyes, Aurelio] Wellcome Trust Res Labs, Mitochondrial Biol Unit, MRC, Cambridge, England; [Durigon, Romina; Holt, Ian J.; Spinazzola, Antonella] Natl Inst Med Res, London NW7 1AA, England	Wellcome Trust Sanger Institute; MRC National Institute for Medical Research	Spinazzola, A (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	aspinaz@nimr.mrc.ac.uk	Pearce, Sarah/AAE-7196-2019; Brea-Calvo, Gloria/N-4728-2014; Spinazzola, Antonella/P-5298-2017; Spinazzola, Antonella/P-5791-2019; rorbach, Joanna/AAM-5683-2021; Minczuk, Michal/G-1638-2014	Brea-Calvo, Gloria/0000-0001-5536-6868; Spinazzola, Antonella/0000-0003-4242-8091; Spinazzola, Antonella/0000-0003-4242-8091; rorbach, Joanna/0000-0002-2891-2840; Minczuk, Michal/0000-0001-8242-1420; holt, ian/0000-0001-5468-0193	MRC [MC_U105697134];  [PIEF-GA-2009-255578]; Medical Research Council [MC_U105697135, MC_UP_1002/1, MC_U105697134, 1456890, 1365139, MC_U105663140, MC_PC_13029/1, MC_UP_1202/14] Funding Source: researchfish; MRC [MC_UP_1002/1, MC_UP_1202/14, MC_PC_13029/1, MC_U105697135, MC_U105663140] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the MRC: number MC_U105697134. In addition, AS awarded a Marie Curie fellowship, grant agreement PIEF-GA-2009-255578. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandhakavi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001598; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carter HN, 2012, AM J PHYSIOL-CELL PH, V303, pC540, DOI 10.1152/ajpcell.00156.2012; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hara-Kuge S, 2008, EXP CELL RES, V314, P3531, DOI 10.1016/j.yexcr.2008.09.015; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; WARBURG O, 1956, SCIENCE, V124, P269; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	35	35	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93597	10.1371/journal.pone.0093597	http://dx.doi.org/10.1371/journal.pone.0093597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718614	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000037
J	Jones, BA; Madden, GJ; Wengreen, HJ; Aguilar, SS; Desjardins, EA				Jones, Brooke A.; Madden, Gregory J.; Wengreen, Heidi J.; Aguilar, Sheryl S.; Desjardins, E. Anne			Gamification of Dietary Decision-Making in an Elementary-School Cafeteria	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; CHILDRENS FRUIT; PERCENTILE SCHEDULES; INTERVENTION; RISK	Despite the known health benefits of doing so, most US children do not consume enough fruits and vegetables (FV). School-based interventions can be effective in increasing FV consumption, but the most effective of these require that schools allocate their time, effort, and financial resources to implementing the program: expenditures that schools may be reluctant to provide in climates of academic accountability and economic austerity. The present demonstration project used a behaviorally based gamification approach to develop an intervention designed to increase FV consumption while minimizing material and labor costs to the school. During the intervention, the school (N = 180 students in grades K-8) played a cooperative game in which school-level goals were met by consuming higher-than-normal amounts of either fruit or vegetables (alternating-treatments experimental design). School-level consumption was quantified using a weight-based waste measure in the cafeteria. Over a period of 13 school days, fruit consumption increased by 66% and vegetable consumption by 44% above baseline levels. Use of an alternating-treatment time-series design with differential levels of FV consumption on days when fruit or vegetable was targeted for improvement supported the role of the intervention in these overall consumption increases. In post-intervention surveys, teachers rated the intervention as practical in the classroom and enjoyed by their students. Parent surveys revealed that children were more willing to try new FV at home and increased their consumption of FV following the intervention. These findings suggest that a behaviorally based gamification approach may prove practically useful in addressing concerns about poor dietary decision-making by children in schools.	[Jones, Brooke A.; Madden, Gregory J.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Wengreen, Heidi J.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA; [Aguilar, Sheryl S.] Utah State Univ, Ctr Human Nutr Studies, Logan, UT 84322 USA; [Desjardins, E. Anne] Bear River Charter Sch, Logan, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Jones, BA (corresponding author), Utah State Univ, Dept Psychol, Logan, UT 84322 USA.	jones.brookea@gmail.com	Madden, Gregory J/E-8524-2010; Lively, Curtis M/A-8057-2011; Clay, Keith/C-8730-2012	Madden, Gregory J/0000-0002-3663-1600; 	United States Department of Agriculture [ERS 59-5000-1-0033, ERS 59-5000-0-0065]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported by grants from the United States Department of Agriculture (ERS 59-5000-1-0033 & ERS 59-5000-0-0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2005, PUBLIC HEALTH NUTR, V8, P650, DOI 10.1079/PHN2004721; Athens ES, 2007, J APPL BEHAV ANAL, V40, P475, DOI 10.1901/jaba.2007.40-475; Bandura Albert, 1977, SOCIAL LEARNING THEO; Baranowski T, 2003, AM J PREV MED, V24, P52, DOI 10.1016/S0749-3797(02)00570-6; Barlow DH, 2009, SINGLE CASE EXPT DES, V3rd; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Borckardt J. J., 2013, METHODS PRINCIPLES, V1, P251, DOI DOI 10.1037/13937-011; Castronova E, 2001, EESIFO WORKING PAPER, V618; Crosbie J, 1994, ANAL CHANGE, P361; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; Echon RE, 2014, ADV IMAGE ANAL RES, P273; Epstein LH, 2001, OBES RES, V9, P171, DOI 10.1038/oby.2001.18; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Fisher WW, 2003, J APPL BEHAV ANAL, V36, P387, DOI 10.1901/jaba.2003.36-387; Foerster SB, 1998, FAM COMMUNITY HEALTH, V21, P46, DOI 10.1097/00003727-199804000-00007; GALBICKA G, 1994, J APPL BEHAV ANAL, V27, P739, DOI 10.1901/jaba.1994.27-739; Galbicka G, 1997, PHYSIOL BEHAV, V62, P1165, DOI 10.1016/S0031-9384(97)00350-8; Guenther PM, 2006, J AM DIET ASSOC, V106, P1371, DOI 10.1016/j.jada.2006.06.002; Hall SS, 2009, J APPL BEHAV ANAL, V42, P171, DOI 10.1901/jaba.2009.42-171; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hendy HM, 2005, APPETITE, V45, P250, DOI 10.1016/j.appet.2005.07.006; Hoffman JA, 2011, PREV MED, V52, P370, DOI 10.1016/j.ypmed.2011.02.013; Hoffman JA, 2010, J PEDIATR PSYCHOL, V35, P61, DOI 10.1093/jpepsy/jsp041; Horne PJ, 2009, EUR J CLIN NUTR, V63, P613, DOI 10.1038/ejcn.2008.34; Horne PJ, 2004, EUR J CLIN NUTR, V58, P1649, DOI 10.1038/sj.ejcn.1602024; Just D, 2013, PUBLIC HEALTH NUTR, V16, P2281, DOI 10.1017/S1368980013001468; KARAU SJ, 1995, CURR DIR PSYCHOL SCI, V4, P134, DOI 10.1111/1467-8721.ep10772570; Kazdin A.E., 2002, RES DESIGN CLIN PSYC, V3rd; Lamb RJ, 2004, DRUG ALCOHOL DEPEN, V76, P247, DOI 10.1016/j.drugalcdep.2004.05.008; Laraway S, 2003, J APPL BEHAV ANAL, V36, P407, DOI 10.1901/jaba.2003.36-407; Lowe CF, 2004, EUR J CLIN NUTR, V58, P510, DOI 10.1038/sj.ejcn.1601838; MACHADO A, 1989, J EXP ANAL BEHAV, V52, P155, DOI 10.1901/jeab.1989.52-155; Mangione-Smith R, 2002, HEALTH SERV RES, V37, P1603, DOI 10.1111/1475-6773.10482; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Miltenberger RG, 2013, APA HDB BEHAV ANAL, V1, P121; Newland MC, 2013, BEHAV BRAIN RES, V253, P196, DOI 10.1016/j.bbr.2013.05.038; Pink D.H., 2010, DRIVE SURPRISING TRU; Reeves B, 2009, TOTAL ENGAGEMENT USI; Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1-17, 10.1301/nr.2004.jan.1&ndash;17, 10.1111/j.1753-4887.2004.tb00001.x]; Skinner B.F., 2014, CONTINGENCIES REINFO; Striegel-Moore RH, 2006, PREV MED, V42, P223, DOI 10.1016/j.ypmed.2005.11.018; Wengreen HJ, 2013, J NUTR EDUC BEHAV, V45, P54, DOI 10.1016/j.jneb.2012.06.001	42	37	40	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93872	10.1371/journal.pone.0093872	http://dx.doi.org/10.1371/journal.pone.0093872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718587	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000054
J	Lee, DH; Cullum, JP; Anderson, JL; Daugherty, JL; Beckett, LM; Leskey, TC				Lee, Doo-Hyung; Cullum, John P.; Anderson, Jennifer L.; Daugherty, Jodi L.; Beckett, Lisa M.; Leskey, Tracy C.			Characterization of Overwintering Sites of the Invasive Brown Marmorated Stink Bug in Natural Landscapes Using Human Surveyors and Detector Canines	PLOS ONE			English	Article							HALYS HEMIPTERA-PENTATOMIDAE; HETEROPTERA; ABILITY; STAL; PEST	Halyomorpha halys is an invasive species from Asia causing major economic losses in agricultural production in the mid-Atlantic region of the United States. Unlike other crop pests, H. halys is also well-known for nuisance problems in urban, suburban, and rural areas, as massive numbers of adults often invade human-made structures to overwinter inside protected environments. Research efforts have focused on populations in human-made structures while overwintering ecology of H. halys in natural landscapes is virtually unknown. We explored forested landscapes in the mid-Atlantic region to locate and characterize natural overwintering structures used by H. halys. We also evaluated the use of detector canines to locate overwintering H. halys to enhance the accuracy and efficiency of surveys. From these studies, we indentified shared characteristics of overwintering sites used by H. halys in natural landscapes. Overwintering H. halys were recovered from dry crevices in dead, standing trees with thick bark, particularly oak (Quercus spp.)and locust (Robinia spp.); these characteristics were shared by 11.8% of all dead trees in surveyed landscapes. For trees with favorable characteristics, we sampled similar to 20% of the total above-ground tree area and recovered 5.9 adults per tree from the trees with H. halys present. Two detector canines were successfully trained to recognize and detect the odor of adult H. halys yielding >84% accuracy in laboratory and semi-field trials. Detector canines also found overwintering H. halys under field conditions. In particular, overwintering H. halys were recovered only from dead trees that yielded positive indications from the canines and shared key tree characteristics established by human surveyors. The identified characteristics of natural overwintering sites of H. halys will serve as baseline information to establish crop economic risk levels posed by overwintering populations, and accordingly develop sustainable management programs.	[Lee, Doo-Hyung; Leskey, Tracy C.] USDA ARS, Appalachian Fruit Res Stn, Kearneysville, WV 25430 USA; [Cullum, John P.] Virginia Tech, Dept Entomol, Winchester, VA USA; [Anderson, Jennifer L.; Daugherty, Jodi L.; Beckett, Lisa M.] Anim & Plant Hlth Inspect Serv, USDA, Natl Detector Dog Training Ctr, Newnan, GA USA	United States Department of Agriculture (USDA); Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA)	Lee, DH (corresponding author), Gachon Univ, Dept Life Sci, Songnam, Gyeonggi Do, South Korea.	dl343@cornell.edu			USDA-NIFA SCRI [2011-51181-30937]	USDA-NIFA SCRI	This work was supported in part by USDA-NIFA SCRI # 2011-51181-30937 award and a specific cooperative agreement with USDA-APHIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2009, MITTEILUNGEN THURING, V16, P10, DOI DOI 10.5281/ZENODO.45391; Brooks SE, 2003, J ECON ENTOMOL, V96, P1259, DOI 10.1603/0022-0493-96.4.1259; Brown Marmorated Stink Bug Working Group, 2012, BROWN MARM STINK BUG; Brown Marmorated Stink Bug Working Group, 2011, BROWN MARM STINK BUG; Callot Henry, 2013, Entomologiste (Paris), V69, P69; Coombs MT, 2000, ENVIRON ENTOMOL, V29, P1027, DOI 10.1603/0046-225X-29.5.1027; Fogain R., 2011, Journal of the Entomological Society of Ontario, V142, P45; Fujisawa T., 2001, JPN AGR TECHNOL, V45, P42; Hamilton George C., 2009, American Entomologist, V55, P19; Heckmann Ralf, 2012, Heteropteron, V36, P17; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Inkley DB, 2012, J ENTOMOL SCI, V47, P125; Johnson GR, 1977, TRACKING DOG THEORY; JONES WA, 1981, ENVIRON ENTOMOL, V10, P409, DOI 10.1093/ee/10.3.409; Kobayashi T., 1969, B TOHOKU NATL AGR EX, V37, P123; Leather S. R., 1993, ECOLOGY INSECT OVERW; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey Tracy C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/535062; Pfiester M, 2008, J ECON ENTOMOL, V101, P1389, DOI 10.1603/0022-0493(2008)101[1389:AOBBCT]2.0.CO;2; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Qin W., 1990, PLANT PROT, V16, P22; Toyama M, 2006, APPL ENTOMOL ZOOL, V41, P309, DOI 10.1303/aez.2006.309; Ueno W., 1978, N JPN PEST RES B, V29, P16; WALLNER WE, 1976, ENVIRON ENTOMOL, V5, P183, DOI 10.1093/ee/5.1.183; Wang Y., 1988, ACTA AGR BOR SIN, V3, P96; Watanabe Mamoru, 1994, Japanese Journal of Sanitary Zoology, V45, P25; WELCH JB, 1990, J ECON ENTOMOL, V83, P1932, DOI 10.1093/jee/83.5.1932; Wermelinger B, 2008, ENTOMOL GESELLSCHAFT, V81, P1, DOI DOI 10.5169/SEALS-402954; Zhang Cuituan, 1993, Forest Research, V6, P271	30	60	61	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e91575	10.1371/journal.pone.0091575	http://dx.doi.org/10.1371/journal.pone.0091575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717734	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000010
J	Loveday, M; Padayatchi, N; Wallengren, K; Roberts, J; Brust, JCM; Ngozo, J; Master, I; Voce, A				Loveday, Marian; Padayatchi, Nesri; Wallengren, Kristina; Roberts, Jacquelin; Brust, James C. M.; Ngozo, Jacqueline; Master, Iqbal; Voce, Anna			Association between Health Systems Performance and Treatment Outcomes in Patients Co-Infected with MDR-TB and HIV in KwaZulu-Natal, South Africa: Implications for TB Programmes	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; PRIMARY-CARE; IMPLEMENTATION; INTEGRATION; HIV/AIDS; INTERVENTIONS; OUTREACH; DEFAULT	Objective: To improve the treatment of MDR-TB and HIV co-infected patients, we investigated the relationship between health system performance and patient treatment outcomes at 4 decentralised MDR-TB sites. Methods: In this mixed methods case study which included prospective comparative data, we measured health system performance using a framework of domains comprising key health service components. Using Pearson Product Moment Correlation coefficients we quantified the direction and magnitude of the association between health system performance and MDR-TB treatment outcomes. Qualitative data from participant observation and interviews analysed using systematic text condensation (STC) complemented our quantitative findings. Findings: We found significant differences in treatment outcomes across the sites with successful outcomes varying from 72% at Site 1 to 52% at Site 4 (p<0.01). Health systems performance scores also varied considerably across the sites. Our findings suggest there is a correlation between treatment outcomes and overall health system performance which is significant (r = 0.99, p<0.01), with Site 1 having the highest number of successful treatment outcomes and the highest health system performance. Although the 'integration' domain, which measured integration of MDR-TB services into existing services appeared to have the strongest association with successful treatment outcomes (r = 0.99, p<0.01), qualitative data indicated that the 'context' domain influenced the other domains. Conclusion: We suggest that there is an association between treatment outcomes and health system performance. The chance of treatment success is greater if decentralised MDR-TB services are integrated into existing services. To optimise successful treatment outcomes, regular monitoring and support are needed at a district, facility and individual level to ensure the local context is supportive of new programmes and implementation is according to guidelines.	[Loveday, Marian] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Padayatchi, Nesri] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Wallengren, Kristina] TB & HIV Invest Network KwaZulu Natal THINK, Durban, South Africa; [Roberts, Jacquelin] Ctr Dis Control & Prevent, Atlanta, GA USA; [Brust, James C. M.] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Brust, James C. M.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ngozo, Jacqueline] KwaZulu Natal Dept Hlth, Pietermaritzburg, South Africa; [Master, Iqbal] KwaZulu Natal Dept Hlth, King Dinuzulu Hosp Complex, Durban, South Africa; [Voce, Anna] Univ KwaZulu Natal, Discipline Publ Hlth Med, Durban, South Africa	South African Medical Research Council; University of Kwazulu Natal; Centers for Disease Control & Prevention - USA; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Kwazulu Natal	Loveday, M (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa.	marian.loveday@mrc.ac.za	padayatchi, nesri/Q-2780-2019; Loveday, Marian/M-8016-2013	padayatchi, nesri/0000-0003-2543-9071; Loveday, Marian/0000-0001-9205-9314	Izumi Foundation; Medical Research Council of South Africa; Eli-Lilly Foundation; National Institute of Allergy and Infectious Diseases [K23AI083088]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI083088] Funding Source: NIH RePORTER	Izumi Foundation; Medical Research Council of South Africa(South African Medical Research Council); Eli-Lilly Foundation(Eli Lilly); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Izumi Foundation (http://izumi.org), the Medical Research Council of South Africa (www.mrc.ac.za), and the Eli-Lilly Foundation (www.lilly.com/about/lilly-foundation). James Brust is supported by the National Institute of Allergy and Infectious Diseases (K23AI083088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun RA, 2008, HLTH SYSTEMS COMMUNI; Atun R, 2012, HEALTH POLICY PLANN, V27, P4, DOI 10.1093/heapol/czs088; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Coker R, 2010, HEALTH POLICY PLANN, V25, pi21, DOI 10.1093/heapol/czq054; Edward A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001066; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Georgeu D, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-66; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Jain A, 2008, J BIOSCIENCES, V33, P605, DOI 10.1007/s12038-008-0078-8; Kawonga M, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-2; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Loveday M, 2012, INT J TUBERC LUNG D, V16, P209, DOI 10.5588/ijtld.11.0401; Loveday M, 2012, INT J TUBERC LUNG S1, V16, pS136; Loveday M, 2011, SAMJ S AFR MED J, V101, P887; Loveday M, 2011, TROP MED INT HEALTH, V16, P431, DOI 10.1111/j.1365-3156.2010.02721.x; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; May C, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-148; Mutale W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058650; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Pai M, 2012, INT J TUBERC LUNG D, V16, P1281, DOI 10.5588/ijtld.12.0391; Rao K, 2013, HLTH POLICY PLANNING, P1; Reynolds H, 2008, HLTH POLICY PLANNING, V23; Schneider H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S4; Scott V, 2010, S AFRICA HLTH RES PO, V8, P1; Tkatchenko-Schmidt E, 2008, HEALTH POLICY, V85, P162, DOI 10.1016/j.healthpol.2007.07.005; Tkatchenko-Schmidt E, 2010, HEALTH POLICY PLANN, V25, P283, DOI 10.1093/heapol/czq001; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; van Olmen J, 2012, HLTH CULTURE SOC, V2, DOI [10.5195/hcs.2012.5171, DOI 10.5195/HCS.2012.5171]; Van Rensburg D, 2006, ACTA ACAD S, V1, P44; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WHO, 2007, EV BUS STRENGTH HLTH; Willenbring ML, 2005, AIDS, V19, pS227, DOI 10.1097/01.aids.0000192094.84624.c2; Wong Carol A, 2007, J Nurs Manag, V15, P508, DOI 10.1111/j.1365-2834.2007.00723.x; World Health Organization, 2008, WHOHTMTB2008402; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; Zwarenstein M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2022	41	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94016	10.1371/journal.pone.0094016	http://dx.doi.org/10.1371/journal.pone.0094016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718306	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000065
J	Nokso-Koivisto, J; Chonmaitree, T; Jennings, K; Matalon, R; Block, S; Patel, JA				Nokso-Koivisto, Johanna; Chonmaitree, Tasnee; Jennings, Kristofer; Matalon, Reuben; Block, Stan; Patel, Janak A.			Polymorphisms of Immunity Genes and Susceptibility to Otitis Media in Children	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; RECEPTOR GENE; CYTOKINE; ASSOCIATION; RISK; SEVERITY; DISEASE; HERITABILITY; SYMPTOMS; INFANTS	Background: Acute otitis media (OM) is a common disease which often develops through complex interactions between the host, the pathogen and environmental factors. We studied single nucleotide polymorphisms (SNPs) of genes involved in innate and adaptive immunity, and other host and environmental factors for their role in OM. Methods: Using Sequenom Massarray platform, 21 SNPs were studied in 653 children from prospective (n = 202) and retrospective (n = 451) cohorts. Data were analyzed for the relationship between SNPs and upper respiratory infection (URI) frequency, risk of acute OM during URI episodes, and proneness to recurrent OM. Results: Increased risk for OM proneness was associated with CX3CR1 (Thr280Met) SNP and with a jointly interactive group of IL-10 (-1082) SNP, IL-1 beta (-511) wild type genotype and white race. Family history of OM proneness independently increased the risk for frequent URIs, OM occurrence during URI, and OM proneness. Additionally, IL-1 beta (-31) SNP was associated with increased risk for frequent URIs, but IL-10 (-592), IL-1 beta (-511), IL-5 (-746) and IL-8 (-251) SNPs were associated with decreased risk of URI. Conclusion: IL-1 beta (-31), CX3CR1 (Thr280Met), IL-10 (-1082) and IL-1 beta (-511) SNPs were associated with increased risk for frequent URIs or OM proneness.	[Nokso-Koivisto, Johanna; Chonmaitree, Tasnee; Matalon, Reuben; Patel, Janak A.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Jennings, Kristofer] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Block, Stan] Kentucky Pediat Res Inc, Bardstown, KY USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Patel, JA (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	jpatel@utmb.edu		Jennings, Kristofer/0000-0002-5442-9326	National Institute of Deafness and Other Communication Disorders [R01 DC005841]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000071]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005841] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Deafness and Other Communication Disorders [grant number R01 DC005841], and from the National Center for Advancing Translational Sciences [grant number UL1TR000071], National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper CM, 2009, EUR ARCH OTO-RHINO-L, V266, P199, DOI 10.1007/s00405-008-0729-2; Amanatidou V, 2006, PEDIATR INFECT DIS J, V25, P410, DOI 10.1097/01.inf.0000214998.16248.b7; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Chen Nijun, 2011, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V25, P197; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Hong SJ, 2005, J ALLERGY CLIN IMMUN, V115, P758, DOI 10.1016/j.jaci.2004.10.047; Hornsleth A, 2001, J CLIN VIROL, V21, P163, DOI 10.1016/S1386-6532(01)00159-7; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Lee YW, 2011, ANN OTO RHINOL LARYN, V120, P204, DOI 10.1177/000348941112000310; McCormick DP, 2011, INT J PEDIATR OTORHI, V75, P708, DOI 10.1016/j.ijporl.2011.02.021; Miyairi I, 2008, CLIN MICROBIOL REV, V21, P686, DOI 10.1128/CMR.00017-08; Nieters A, 2001, HUM GENET, V108, P241, DOI 10.1007/s004390100464; Patel JA, 2006, PEDIATRICS, V118, P2273, DOI 10.1542/peds.2006-0764; Patel JA, 2009, PEDIATR INFECT DIS J, V28, P1002, DOI 10.1097/INF.0b013e3181aa5b13; Revai K, 2009, CLIN INFECT DIS, V49, P257, DOI 10.1086/599833; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Rye MS, 2012, LARYNGOSCOPE, V122, P665, DOI 10.1002/lary.22506; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; Watanabe E, 2005, J TRAUMA, V59, P1181; Wiertsema SP, 2006, CLIN VACCINE IMMUNOL, V13, P892, DOI 10.1128/CVI.00100-06; Wiertsema SP, 2006, J ALLERGY CLIN IMMUN, V117, P1344, DOI 10.1016/j.jaci.2006.01.031	29	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93930	10.1371/journal.pone.0093930	http://dx.doi.org/10.1371/journal.pone.0093930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718616	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000058
J	Otto, CRV; Roloff, GJ; Thames, RE				Otto, Clint R. V.; Roloff, Gary J.; Thames, Rachael E.			Comparing Population Patterns to Processes: Abundance and Survival of a Forest Salamander following Habitat Degradation	PLOS ONE			English	Article							DETECTION PROBABILITY PARAMETERS; NORTHERN HARDWOOD FORESTS; PLETHODONTID SALAMANDERS; TERRESTRIAL SALAMANDERS; CLOSURE ASSUMPTION; MOLE SALAMANDERS; TIMBER HARVEST; LAND-USE; AMPHIBIANS; OCCUPANCY	Habitat degradation resulting from anthropogenic activities poses immediate and prolonged threats to biodiversity, particularly among declining amphibians. Many studies infer amphibian response to habitat degradation by correlating patterns in species occupancy or abundance with environmental effects, often without regard to the demographic processes underlying these patterns. We evaluated how retention of vertical green trees (CANOPY) and coarse woody debris (CWD) influenced terrestrial salamander abundance and apparent survival in recently clearcut forests. Estimated abundance of unmarked salamanders was positively related to CANOPY ((beta) over cap (Canopy) = 0.21 (0.02-1.19; 95% CI), but not CWD ((beta) over cap (CWD) = 0.11 (-0.13-0.35) within 3,600 m(2) sites, whereas estimated abundance of unmarked salamanders was not related to CANOPY ((beta) over cap (Canopy) = -0.01 (-0.21-0.18) or CWD ((beta) over cap (CWD) = -0.02 (-0.23-0.19) for 9 m(2) enclosures. In contrast, apparent survival of marked salamanders within our enclosures over 1 month was positively influenced by both CANOPY and CWD retention ((beta) over cap (Canopy) = 0.73 (0.27-1.19; 95% CI) and (beta) over cap (CWD) = 1.01 (0.53-1.50). Our results indicate that environmental correlates to abundance are scale dependent reflecting habitat selection processes and organism movements after a habitat disturbance event. Our study also provides a cautionary example of how scientific inference is conditional on the response variable(s), and scale(s) of measure chosen by the investigator, which can have important implications for species conservation and management. Our research highlights the need for joint evaluation of population state variables, such as abundance, and population-level process, such as survival, when assessing anthropogenic impacts on forest biodiversity.	[Otto, Clint R. V.; Roloff, Gary J.; Thames, Rachael E.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University	Otto, CRV (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA.	cotto@usgs.gov			MDNR-Wildlife Division; federal Pittman-Robertson Wildlife Restoration Act grant; United States Fish and Wildlife Service (Michigan's Statewide Wildlife Research and Restoration Program) [W-147-R]; Rocky Mountain Goat Foundation; Michigan Society of Herpetologists	MDNR-Wildlife Division; federal Pittman-Robertson Wildlife Restoration Act grant; United States Fish and Wildlife Service (Michigan's Statewide Wildlife Research and Restoration Program); Rocky Mountain Goat Foundation; Michigan Society of Herpetologists	Support for this project was provided by the MDNR-Wildlife Division with funds from the federal Pittman-Robertson Wildlife Restoration Act grant administered by the United States Fish and Wildlife Service (W-147-R: Michigan's Statewide Wildlife Research and Restoration Program), the Rocky Mountain Goat Foundation, and the Michigan Society of Herpetologists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SALAMANDERS US CANAD; Ash AN, 1997, CONSERV BIOL, V11, P983, DOI 10.1046/j.1523-1739.1997.96172.x; Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P1, DOI 10.2193/0022-541X(2004)068[0001:EDPPFP]2.0.CO;2; Bennett LT, 2004, J APPL ECOL, V41, P585, DOI 10.1111/j.0021-8901.2004.00924.x; Berg D.R., 1997, CREATING FORESTRY 21, P111; Bielecki J., 2006, STAND RETENTION GUID; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chazal AC, 1998, ECOL APPL, V8, P1133, DOI 10.1890/1051-0761(1998)008[1133:ROMSTC]2.0.CO;2; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Grant EHC, 2008, J WILDLIFE MANAGE, V72, P1247, DOI 10.2193/2007-183; HEATWOLE H, 1962, ECOLOGY, V43, P460, DOI 10.2307/1933374; Hocking DJ, 2013, BIOL CONSERV, V167, P194, DOI 10.1016/j.biocon.2013.08.006; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Homyack JA, 2009, BIOL CONSERV, V142, P110, DOI 10.1016/j.biocon.2008.10.003; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Knapp SM, 2003, CONSERV BIOL, V17, P752, DOI 10.1046/j.1523-1739.2003.02061.x; Kroll AJ, 2008, FOREST ECOL MANAG, V255, P3726, DOI 10.1016/j.foreco.2008.03.005; Kroll AJ, 2009, FOREST ECOL MANAG, V257, P1188, DOI 10.1016/j.foreco.2008.12.008; McDermott ME, 2009, BIOL CONSERV, V142, P212, DOI 10.1016/j.biocon.2008.10.016; McKenny HC, 2006, FOREST ECOL MANAG, V230, P186, DOI 10.1016/j.foreco.2006.04.034; Otto CRV, 2007, WETLANDS, V27, P261, DOI 10.1672/0277-5212(2007)27[261:IOWALC]2.0.CO;2; Otto CRV, 2013, ECOGRAPHY, V36, P1299, DOI 10.1111/j.1600-0587.2013.00137.x; Otto CRV, 2013, FOREST ECOL MANAG, V304, P275, DOI 10.1016/j.foreco.2013.04.023; Otto CRV, 2011, J HERPETOL, V45, P256, DOI 10.1670/10-039.1; Otto CRV, 2011, J WILDLIFE MANAGE, V75, P423, DOI 10.1002/jwmg.63; Patrick DA, 2006, FOREST ECOL MANAG, V234, P323, DOI 10.1016/j.foreco.2006.07.015; Peterman WE, 2011, FOREST ECOL MANAG, V262, P2344, DOI 10.1016/j.foreco.2011.08.030; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; Pollock K. H., 1982, J WILDLIFE MANAGE, V46, P757, DOI DOI 10.2307/3808568; Rittenhouse TAG, 2009, ECOLOGY, V90, P1620, DOI 10.1890/08-0326.1; Rittenhouse TAG, 2008, COPEIA, P807, DOI 10.1643/CH-07-176; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Rothermel BB, 2005, J HERPETOL, V39, P619, DOI 10.1670/251-04A.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Schmidt BR, 2005, CONSERV BIOL, V19, P1149, DOI 10.1111/j.1523-1739.2005.00164.x; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thompson ID, 2003, FOREST ECOL MANAG, V177, P441, DOI 10.1016/S0378-1127(02)00453-X; Todd BD, 2006, BIOL CONSERV, V133, P178, DOI 10.1016/j.biocon.2006.06.003; Van Horne P., 1983, J WILDLIFE MANAGE, V47, P893; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Welsh HH, 2008, BIOL CONSERV, V141, P1149, DOI 10.1016/j.biocon.2008.02.014; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	54	16	16	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93859	10.1371/journal.pone.0093859	http://dx.doi.org/10.1371/journal.pone.0093859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718498	gold, Green Published, Green Submitted			2022-12-27	WOS:000334339000051
J	Wilson, K; Lance, M; Jeffries, S; Acevedo-Gutierrez, A				Wilson, Kenady; Lance, Monique; Jeffries, Steven; Acevedo-Gutierrez, Alejandro			Fine-Scale Variability in Harbor Seal Foraging Behavior	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDSI; DIVING BEHAVIOR; PREY CONSUMPTION; ELEPHANT SEALS; CLASSIFICATION; SEX; MOVEMENT; PATTERNS; TACTICS; SYSTEM	Understanding the variability of foraging behavior within a population of predators is important for determining their role in the ecosystem and how they may respond to future ecosystem changes. However, such variability has seldom been studied in harbor seals on a fine spatial scale (<30 km). We used a combination of standard and Bayesian generalized linear mixed models to explore how environmental variables influenced the dive behavior of harbor seals. Time-depth recorders were deployed on harbor seals from two haul-out sites in the Salish Sea in 2007 (n = 18) and 2008 (n = 11). Three behavioral bout types were classified from six dive types within each bout; however, one of these bout types was related to haul-out activity and was excluded from analyses. Deep foraging bouts (Type I) were the predominant type used throughout the study; however, variation in the use of bout types was observed relative to haul-out site, season, sex, and light (day/night). The proportional use of Type I and Type II (shallow foraging/traveling) bouts differed dramatically between haul-out sites, seasons, sexes, and whether it was day or night; individual variability between seals also contributed to the observed differences. We hypothesize that this variation in dive behavior was related to habitat or prey specialization by seals from different haul-out sites, or individual variability between seals in the study area. The results highlight the potential influence of habitat and specialization on the foraging behavior of harbor seals, and may help explain the variability in diet that is observed between different haul-out site groups in this population.	[Wilson, Kenady; Acevedo-Gutierrez, Alejandro] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Lance, Monique; Jeffries, Steven] Washington Dept Fish & Wildlife, Wildlife Sci Program, Lakewood, WA USA	Western Washington University; Washington Department of Fish & Wildlife (WDFW)	Wilson, K (corresponding author), Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA.	kenady.wilson@duke.edu		Zucker-Scharff, Thomas/0000-0002-1790-7405; Acevedo-Gutierrez, Alejandro/0000-0002-9128-826X	National Science Foundation [0550443]; Western Washington University Department of Biology; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	National Science Foundation(National Science Foundation (NSF)); Western Washington University Department of Biology; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	This project was supported in part by Award #0550443 from the National Science Foundation (http://www.nsf.gov/) (A. A.) and by funds from the Western Washington University Department of Biology (http://www.biol.wwu.edu/biology/ (K. W.), the Office of Research for Sponsored Programs (http://www.wwu.edu/rsp/) (K. W.) and the Washington Department of Fish and Wildlife (http://wdfw.wa.gov) (S.J. and M. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Baechler J, 2002, CAN J ZOOL, V80, P1569, DOI 10.1139/Z02-150; Beck CA, 2003, J ANIM ECOL, V72, P979, DOI 10.1046/j.1365-2656.2003.00761.x; Bjorge A, 1995, DEV MAR BIO, V4, P211; Boness DJ, 2006, BEHAV ECOL SOCIOBIOL, V61, P119, DOI 10.1007/s00265-006-0242-9; BONESS DJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P95; Bowen WD, 1999, CAN J ZOOL, V77, P978, DOI 10.1139/cjz-77-6-978; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Bromaghin JF, 2013, FISH B-NOAA, V111, P13, DOI 10.7755/FB.111.1.2; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Clark J. S, 2007, MODELS ECOLOGICAL DA; Coltman DW, 1997, ANIM BEHAV, V54, P663, DOI 10.1006/anbe.1997.0470; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Gelman A., 2012, ARM DATA ANAL USING; Groot G, 1928, PACIFIC SALMON LIFE; Hardee S.E., 2008, THESIS W WASHINGTON; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; HARKONEN TJ, 1987, NETH J SEA RES, V21, P331, DOI 10.1016/0077-7579(87)90007-X; Hastings KK, 2004, CAN J ZOOL, V82, P1755, DOI 10.1139/Z04-145; Higgs MD, 2012, BIOMETRICS, V68, P965, DOI 10.1111/j.1541-0420.2011.01710.x; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries S. J., 2000, ATLAS SEAL SEA LION; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Johnson A, 2007, CAN J ZOOL, V85, P290, DOI 10.1139/Z06-213; Kuhn CE, 2006, J EXP BIOL, V209, P4524, DOI 10.1242/jeb.02530; Lance MM, 2012, MAR ECOL PROG SER, V464, P257, DOI 10.3354/meps09880; LEBOEUF BJ, 1992, CAN J ZOOL, V70, P786, DOI 10.1139/z92-111; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Lesage W, 2004, CAN J ZOOL, V82, P1070, DOI 10.1139/Z04-084; London JM, 2001, OBSERVATIONS HARBOR; Luxa K, 2013, AQUAT MAMM, V39, P10, DOI 10.1578/AM.39.1.2013.10; Macdonald D.W., 1978, P192; Middlemas SJ, 2006, P ROY SOC B-BIOL SCI, V273, P193, DOI 10.1098/rspb.2005.3215; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Olesiuk PF, 2010, DFO CAN SCI ADVIS SE, V2009; PAYNE PM, 1989, MAR MAMMAL SCI, V5, P173, DOI 10.1111/j.1748-7692.1989.tb00331.x; Peterson SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039046; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Schreer Jason F., 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P383, DOI 10.2307/1400572; Schreer JF, 1996, MAR MAMMAL SCI, V12, P227, DOI 10.1111/j.1748-7692.1996.tb00573.x; SCHREER JF, 1995, MAR MAMMAL SCI, V11, P85, DOI 10.1111/j.1748-7692.1995.tb00277.x; Schreer JF, 2001, ECOL MONOGR, V71, P137, DOI 10.1890/0012-9615(2001)071[0137:CDPOPA]2.0.CO;2; Scordino J., 2010, W COAST PINNIPED PRO; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Suryan RM, 1998, MAR MAMMAL SCI, V14, P361, DOI 10.1111/j.1748-7692.1998.tb00728.x; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; Thompson PM, 1998, CAN J ZOOL, V76, P1044, DOI 10.1139/cjz-76-6-1044; Thomson R, 1994, PHYS OCEANOGRAPHY ST; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; WILLIAMS TM, 1985, PHYSIOL ZOOL, V58, P576, DOI 10.1086/physzool.58.5.30158584	56	15	16	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92838	10.1371/journal.pone.0092838	http://dx.doi.org/10.1371/journal.pone.0092838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717815	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000022
J	Andersen, A; Jensen, KJ; Erikstrup, C; Ravn, H; Fisker, AB; Lisse, IM; Sartono, E; Aaby, P; Yazdanbakhsh, M; Benn, CS				Andersen, Andreas; Jensen, Kristoffer J.; Erikstrup, Christian; Ravn, Henrik; Fisker, Ane B.; Lisse, Ida M.; Sartono, Erliyani; Aaby, Peter; Yazdanbakhsh, Maria; Benn, Christine S.			Both Very Low- and Very High In Vitro Cytokine Responses Were Associated with Infant Death in Low-Birth-Weight Children from Guinea Bissau	PLOS ONE			English	Article							DIPHTHERIA-TETANUS-PERTUSSIS; VITAMIN-A SUPPLEMENTATION; CALMETTE-GUERIN VACCINATION; FEMALE-MALE MORTALITY; WHOLE-BLOOD CULTURE; RANDOMIZED-TRIAL; INTERFERON; MECHANISMS; EXPRESSION; CELLS	Background: The mechanisms behind heterologous immunity and non-specific effects of vaccines on mortality are not well understood. We examined associations between cytokine responses and subsequent mortality in low-birth-weight infants in Guinea-Bissau. Methods: A low-birth-weight trial randomized children to Bacille Calmette-Guerin (BCG) at birth or later according to local policy. Blood samples were obtained from a sub-group at age 6 weeks. Interleukin (IL)-5, IL-10, IL-13, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha were measured in whole-blood cell cultures stimulated with lipopolysaccharide (LPS), phytohaemagglutinin (PHA), or purified protein derivative (PPD). The outcome was mortality between bleeding and 1 year of age. Non-linear associations between cytokine responses and mortality were examined. Results: Cytokine measurements were available from 390 children. The mortality rate (MR) was high (6.8/100 person-years-observation (PYO)). Both low and high cytokine responses to LPS and PHA were associated with high mortality (MR up to 25/100 PYO in the lowest 10% and 9.2/100 PYO in the highest 10%). In BCG-vaccinated children, higher IFN-gamma responses to PPD were associated with better survival (MR ratio = 0.43 (0.24-0.77)). Conclusions: Data presented a rare opportunity to explore associations between cytokine responses and mortality. Both low and high cytokine responses were associated with high mortality; a balanced response to invading pathogens seems preferable.	[Andersen, Andreas; Jensen, Kristoffer J.; Ravn, Henrik; Fisker, Ane B.; Aaby, Peter; Benn, Christine S.] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen, Denmark; [Andersen, Andreas; Jensen, Kristoffer J.; Ravn, Henrik; Fisker, Ane B.; Aaby, Peter; Benn, Christine S.] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; [Lisse, Ida M.] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Benn, Christine S.] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, OPEN, Odense, Denmark	Statens Serum Institut; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Southern Denmark; Odense University Hospital	Andersen, A (corresponding author), Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen, Denmark.	a.andersen@bandim.org	Yazdanbakhsh, Maria/AAI-3996-2020; Fisker, Ane B/E-9283-2019	Yazdanbakhsh, Maria/0000-0002-7666-1441; Fisker, Ane B/0000-0002-8521-0992; Aaby, Peter/0000-0001-8331-1389; Erikstrup, Christian/0000-0001-6551-6647; Jensen, Kristoffer Jarlov/0000-0001-9687-5706	European Union [FP7-HEALTH-F3-2011-261375]; European Research Council [ERC-2009-StG-243149]; Danish Council for Independent Research [09-066317]; Danish National Research Foundation [DNRF108]; DANIDA; Novo Nordisk Foundation	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); DANIDA; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the European Union [FP7-HEALTH-F3-2011-261375]; the European Research Council [ERC-2009-StG-243149 to CSB]; a Female Research Leader Grant from the Danish Council for Independent Research [no. 09-066317 to CSB]; and the Danish National Research Foundation [DNRF108]. The Bandim Health Project was supported by DANIDA. PA holds a research professorship grant from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2004, INT J EPIDEMIOL, V33, P374, DOI 10.1093/ije/dyh005; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Baumgarten G, 2001, J INFECT DIS, V183, P1617, DOI 10.1086/320712; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; CHRISTOU NV, 1995, ANN SURG, V222, P534; Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005; Diness BR, 2007, AM J CLIN NUTR, V86, P1152, DOI 10.1093/ajcn/86.4.1152; ENK AH, 1995, J INVEST DERMATOL, V105, pS80, DOI 10.1111/1523-1747.ep12316112; Eriksson M, 2007, CLIN EXP IMMUNOL, V150, P469, DOI 10.1111/j.1365-2249.2007.03515.x; Jorgensen MJ, 2013, BRIT J NUTR, V109, P467, DOI 10.1017/S0007114512001304; Jorgensen MJ, 2012, BRIT J NUTR, V107, P615, DOI 10.1017/S0007114511003515; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; KOSTER FT, 1987, AM J CLIN NUTR, V46, P115, DOI 10.1093/ajcn/46.1.115; LICASTRO F, 1993, INT J BIOCHEM, V25, P845, DOI 10.1016/0020-711X(93)90239-B; Okoye IS, 2011, IMMUNOLOGY, V134, P368, DOI 10.1111/j.1365-2567.2011.03497.x; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Rose MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037851; Roth A, 2005, VACCINE, V23, P3991, DOI 10.1016/j.vaccine.2004.10.022; Roth A, 2006, EXPERT REV VACCINES, V5, P277, DOI 10.1586/14760584.5.2.277; Sartono E, 2010, PLOS ONE, V5; SAYERS NM, 1995, MED HYPOTHESES, V45, P369, DOI 10.1016/0306-9877(95)90096-9; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schwandt T, 2012, EMBO J, V31, P201, DOI 10.1038/emboj.2011.380; Vennemann MMT, 2012, INT J LEGAL MED, V126, P279, DOI 10.1007/s00414-011-0638-6; Waters KA, 2004, LANCET NEUROL, V3, P81, DOI 10.1016/S1474-4422(03)00657-4; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93562	10.1371/journal.pone.0093562	http://dx.doi.org/10.1371/journal.pone.0093562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714360	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900035
J	Silva, R; Santos, RHS; Tavares, WD; Leite, GLD; Wilcken, CF; Serrao, JE; Zanuncio, JC				Silva-Filho, Reinildes; Silva Santos, Ricardo Henrique; Tavares, Wagner de Souza; Leite, Germano Leao Demolin; Wilcken, Carlos Frederico; Serrao, Jose Eduardo; Zanuncio, Jose Cola			Rice-Straw Mulch Reduces the Green Peach Aphid, Myzus persicae (Hemiptera: Aphididae) Populations on Kale, Brassica oleracea var. acephala (Brassicaceae) Plants	PLOS ONE			English	Article							BEMISIA-ARGENTIFOLII HOMOPTERA; LOW-LATITUDE APHID; BREVICORYNE-BRASSICAE; GOSSYPII GLOVER; BIOLOGICAL-CONTROL; ALATE APHIDS; GROWTH; YIELD; SOIL; PARAMETERS	Organic mulches, like peel and rice-straw, besides other materials affect the UV and temperature, which cause a reduction in the aphid arrival. The aim was to evaluate the effect of covering the soil with straw on the populations of the green peach aphid, Myzus persicae on the kale, Brassica oleracea var. acephala plants. The first experiment evaluated the direct effect of the rice-straw mulch and the second its indirect effect on aphid immigration, testing the plant characteristics that could lead to the landing preference of this insect. The third experiment evaluated the direct effect of the mulch on the aphid population. In the second and third experiments, four plants, each in a 14 L polyethylene pot with holes at the bottom, were used in areas with and without soil mulching. These pots were changed between areas, after seven days, to evaluate the effects of this change on the arrival of the winged aphids to the plants. Each plant was covered with anti-aphid gauze and inoculated with one winged M. persicae. Winged and apterous adults of this insect were counted per plant after 15 days. The temperature increased in the mulched plots to a maximum of 21-36(circle)C and to 18-32(circle)C in the plots with or without soil covering, respectively. Plant growth reduced the numbers of the winged aphids landing before and after they were moved to the bare soil plots. The nutrient content was similar in plants in both the mulched and no mulched plots. The population growth of M. persicae was higher in the control than in the mulched plots. This was partially due to temperatures close to 30(circle)C in these plots and changes in the plant physiology. The soil mulching with rice-straw decreased the M. persicae landing, increased the plot temperatures and improved the vegetative growth of the kale plants.	[Silva-Filho, Reinildes; Zanuncio, Jose Cola] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil; [Silva Santos, Ricardo Henrique; Tavares, Wagner de Souza] Univ Fed Vicosa, Dept Fitotecnia, Vicosa, MG, Brazil; [Leite, Germano Leao Demolin] Univ Fed Minas Gerais, Inst Ciencias Agr, Montes Claros, Brazil; [Wilcken, Carlos Frederico] Univ Estadual Paulista, UNESP, Dept Protecao, Botucatu, SP, Brazil; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Federal de Vicosa	Zanuncio, JC (corresponding author), Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil.	zanuncio@ufv.br	Wilcken, Carlos F/D-1596-2012	Wilcken, Carlos F/0000-0001-9875-4158	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding was received from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalhaes CC, 2009, BIOSCI J, V25, P21; Ban D, 2009, J FOOD AGRIC ENVIRON, V7, P543; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Broad ST, 2008, ENTOMOL EXP APPL, V129, P166, DOI 10.1111/j.1570-7458.2008.00762.x; Castoldi R, 2009, HORTIC BRAS, V27, P438, DOI 10.1590/S0102-05362009000400007; Chakraborty D, 2010, AGR WATER MANAGE, V97, P738, DOI 10.1016/j.agwat.2010.01.006; Chen CY, 2013, B ENTOMOL RES, V103, P406, DOI 10.1017/S0007485312000867; Chiu MC, 2012, ENTOMOL EXP APPL, V142, P216, DOI 10.1111/j.1570-7458.2011.01213.x; Cividanes FJ, 2010, PESQUI AGROPECU BRAS, V45, P7, DOI 10.1590/S0100-204X2010000100002; COSTELLO MJ, 1995, ENTOMOL EXP APPL, V75, P109, DOI 10.1007/BF02382169; Culjak TG, 2008, CEREAL RES COMMUN, V36, P27; da Costa JG, 2011, EUPHYTICA, V177, P299, DOI 10.1007/s10681-010-0250-8; Davis JA, 2006, ENVIRON ENTOMOL, V35, P1461, DOI 10.1603/0046-225X(2006)35[1461:EOHAFT]2.0.CO;2; Neto SED, 2009, CIENC RURAL, V39, P1362, DOI 10.1590/S0103-84782009005000071; Doring TF, 2004, ENTOMOL EXP APPL, V113, P53, DOI 10.1111/j.0013-8703.2004.00208.x; Durak R, 2013, CENT EUR J BIOL, V8, P570, DOI 10.2478/s11535-013-0161-x; Fernandez-Grandon GM, 2013, B ENTOMOL RES, V103, P466, DOI 10.1017/S0007485313000126; de Munoz FGG, 2007, ARCH INSECT BIOCHEM, V65, P20, DOI 10.1002/arch.20174; Gencsoylu I, 2004, J AGRON CROP SCI, V190, P381, DOI 10.1111/j.1439-037X.2004.00104.x; Gill HK, 2012, INT J PEST MANAGE, V58, P33, DOI 10.1080/09670874.2011.641606; Gill HK, 2011, FLA ENTOMOL, V94, P226, DOI 10.1653/024.094.0215; Gill HK, 2010, FLA ENTOMOL, V93, P183, DOI 10.1653/024.093.0206; Greer L, 2003, HORTTECHNOLOGY, V13, P276, DOI 10.21273/HORTTECH.13.2.0276; Hansen LM, 2012, ACTA AGR SCAND B-S P, V62, P132, DOI 10.1080/09064710.2011.583936; Haque I, 2006, BIOPHYS CHEM, V119, P224, DOI 10.1016/j.bpc.2005.09.016; Hayes RC, 2009, CROP PASTURE SCI, V60, P1184, DOI 10.1071/CP09095; Heimbach U., 2002, Gesunde Pflanzen, V54, P119, DOI 10.1046/j.1439-0345.2002.02021.x; Homma SK, 2012, SOIL TILL RES, V120, P147, DOI 10.1016/j.still.2012.01.001; Hu ZQ, 2013, ARCH BIOL SCI, V65, P247, DOI 10.2298/ABS1301247H; Ibarra L, 2001, SCI HORTIC-AMSTERDAM, V87, P139, DOI 10.1016/S0304-4238(00)00172-2; Kamara AY, 2000, J AGRON CROP SCI, V184, P73, DOI 10.1046/j.1439-037x.2000.00359.x; Karamanos AJ, 2004, J AGRON CROP SCI, V190, P262, DOI 10.1111/j.1439-037X.2004.00101.x; Kasirajan S, 2012, AGRON SUSTAIN DEV, V32, P501, DOI 10.1007/s13593-011-0068-3; Laakso K, 2000, PLANT CELL ENVIRON, V23, P461, DOI 10.1046/j.1365-3040.2000.00566.x; Latham LJ, 2001, AUST J AGR RES, V52, P683, DOI 10.1071/AR00144; Legarrea S, 2012, HORTIC SCI, V39, P74, DOI 10.17221/79/2011-HORTSCI; Leite GLD, 1999, ENTOMOL EXP APPL, V91, P267, DOI 10.1023/A:1003557718110; Magar SJ, 2008, INDIAN J AGR SCI, V78, P726; Mirmohammadi S, 2009, ANN ENTOMOL SOC AM, V102, P450, DOI 10.1603/008.102.0314; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Nyoike TW, 2010, INT J PEST MANAGE, V56, P31, DOI 10.1080/09670870902991815; Olinik JR, 2011, HORTIC BRAS, V29, P130, DOI 10.1590/S0102-05362011000100023; Palumbo JC, 2000, J ECON ENTOMOL, V93, P1688, DOI 10.1603/0022-0493-93.6.1688; Parajulee MN, 2007, ENVIRON ENTOMOL, V36, P666, DOI 10.1603/0046-225X(2007)36[666:IOCTOL]2.0.CO;2; Prasifka JR, 2006, ENVIRON ENTOMOL, V35, P1423, DOI 10.1603/0046-225X(2006)35[1423:EOLMOP]2.0.CO;2; Pullaro TC, 2006, AGR ECOSYST ENVIRON, V115, P97, DOI 10.1016/j.agee.2005.12.021; Rajabaskar D, 2013, ENTOMOL EXP APPL, V148, P172, DOI 10.1111/eea.12087; Ranger CM, 2009, ENVIRON ENTOMOL, V38, P129, DOI 10.1603/022.038.0116; Reddy N, 2006, J AGR FOOD CHEM, V54, P8077, DOI 10.1021/jf0617723; Reitz SR, 2003, J ECON ENTOMOL, V96, P1201, DOI 10.1603/0022-0493-96.4.1201; SAEG, 2007, SAEG SIST AN EST VER; Saeidi F, 2012, ENVIRON ENTOMOL, V41, P1638, DOI 10.1603/EN12127; Sarangi SK, 2010, INDIAN J AGR SCI, V80, P603; Satar S, 2008, J PLANT DIS PROTECT, V115, P69, DOI 10.1007/BF03356241; Saucke H, 2004, ANN APPL BIOL, V144, P347, DOI 10.1111/j.1744-7348.2004.tb00350.x; Schmidt NP, 2007, ENVIRON ENTOMOL, V36, P416, DOI 10.1603/0046-225X(2007)36[416:ALMABC]2.0.CO;2; Silva EE, 2011, HORTIC BRAS, V29, P57, DOI [10.1590/S0102-05362011000100010, 10.1590/S0102-05362011000100022]; Simmons AM, 2010, CROP PROT, V29, P898, DOI 10.1016/j.cropro.2010.04.003; Slosser JE, 1998, SOUTHWEST ENTOMOL, V23, P31; Summers CG, 2004, ENVIRON ENTOMOL, V33, P1447, DOI 10.1603/0046-225X-33.5.1447; Summers CG, 2002, CROP PROT, V21, P921, DOI 10.1016/S0261-2194(02)00067-4; Trdan S, 2008, INT J PEST MANAGE, V54, P309, DOI 10.1080/09670870802220596; van Toor RF, 2009, CROP PROT, V28, P599, DOI 10.1016/j.cropro.2009.03.019; Zamani AA, 2006, J APPL ENTOMOL, V130, P453, DOI 10.1111/j.1439-0418.2006.01088.x; Zanic K, 2013, SPAN J AGRIC RES, V11, P1120, DOI 10.5424/sjar/2013114-4349; Zanic K, 2009, J FOOD AGRIC ENVIRON, V7, P496; Znidarcic D., 2008, Acta Agriculturae Slovenica, V91, P361, DOI 10.2478/v10014-008-0016-3	67	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94174	10.1371/journal.pone.0094174	http://dx.doi.org/10.1371/journal.pone.0094174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714367	gold, Green Submitted, Green Published			2022-12-27	WOS:000334160900096
J	Wagner, JM; Pajerowski, JD; Daniels, CL; McHugh, PM; Flynn, JA; Balliet, JW; Casimiro, DR; Subramanian, S				Wagner, James M.; Pajerowski, J. David; Daniels, Christopher L.; McHugh, Patrick M.; Flynn, Jessica A.; Balliet, John W.; Casimiro, Danilo R.; Subramanian, Shyamsundar			Enhanced Production of Chikungunya Virus-Like Particles Using a High-pH Adapted Spodoptera frugiperda Insect Cell Line	PLOS ONE			English	Article							SITE-DIRECTED MUTATIONS; E2 GLYCOPROTEINS; IN-VIVO; VACCINE; BACULOVIRUS; PALMITOYLATION; CHOLESTEROL; GENERATION; GROWTH; ENTRY	Chikungunya virus-like particles (VLPs) have potential to be used as a prophylactic vaccine based on testing in multiple animal models and are currently being evaluated for human use in a Phase I clinical trial. The current method for producing these enveloped alphavirus VLPs by transient gene expression in mammalian cells presents challenges for scalable and robust industrial manufacturing, so the insect cell baculovirus expression vector system was evaluated as an alternative expression technology. Subsequent to recombinant baculovirus infection of Sf21 cells in standard culture media (pH 6.2-6.4), properly processed Chikungunya structural proteins were detected and assembled capsids were observed. However, an increase in culture pH to 6.6-6.8 was necessary to produce detectable concentrations of assembled VLPs. Since this elevated production pH exceeds the optimum for growth medium stability and Sf21 culture, medium modifications were made and a novel insect cell variant (SfBasic) was derived by exposure of Sf21 to elevated culture pH for a prolonged period of time. The high-pH adapted SfBasic insect cell line described herein is capable of maintaining normal cell growth into the typical mammalian cell culture pH range of 7.0-7.2 and produces 11-fold higher Chikungunya VLP yields relative to the parental Sf21 cell line. After scale-up into stirred tank bioreactors, SfBasic derived VLPs were chromatographically purified and shown to be similar in size and structure to a VLP standard derived from transient gene expression in HEK293 cells. Total serum anti-Chikungunya IgG and neutralizing titers from guinea pigs vaccinated with SfBasic derived VLPs or HEK293 derived VLPs were not significantly different with respect to production method, suggesting that this adapted insect cell line and production process could be useful for manufacturing Chikungunya VLPs for use as a vaccine. The adaptation of Sf21 to produce high levels of recombinant protein and VLPs in an elevated pH range may also have applications for other pH-sensitive protein or VLP targets.	[Wagner, James M.; Pajerowski, J. David; Daniels, Christopher L.; McHugh, Patrick M.; Flynn, Jessica A.; Balliet, John W.; Casimiro, Danilo R.; Subramanian, Shyamsundar] Merck & Co Inc, Merck Res Labs, Vaccine Res & Dev, West Point, PA 19486 USA		Subramanian, S (corresponding author), Merck & Co Inc, Merck Res Labs, Vaccine Res & Dev, West Point, PA 19486 USA.	shyamsundar.subramanian@merck.com			Merck Co, Inc.	Merck Co, Inc.(Merck & Company)	All funding for this work was provided by Merck & Co, Inc. The funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2012, J VIROL, V86, P8879, DOI 10.1128/JVI.00370-12; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; [Anonymous], 2011, GUIDE CARE USE LAB A, Veighth, DOI DOI 10.17226/12910; Armitage P., 2002, STAT METHODS MED RES; Blanchard P, 2003, VACCINE, V21, P4565, DOI 10.1016/S0264-410X(03)00503-6; Caglioti C, 2013, NEW MICROBIOL, V36, P211; Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169; Cox MMJ, 2012, VACCINE, V30, P1759, DOI 10.1016/j.vaccine.2012.01.016; Dogan Ayse Dudu Altintas, 2013, Ugeskr Laeger, V175, P1716; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Fernandes F, 2013, EXPERT REV VACCINES, V12, P225, DOI [10.1586/erv.12.153, 10.1586/ERV.12.153]; FUNKE C, 1995, VIROLOGY, V208, P289, DOI 10.1006/viro.1995.1151; Garcia-Arriaza J, 2014, J VIROL; Gerbal Muriel, 2000, In Vitro Cellular and Developmental Biology Animal, V36, P117, DOI 10.1290/1071-2690(2000)036<0117:AOAICL>2.3.CO;2; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Grubbs F. E., 1974, PROCEDURES DETECTING; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; HARRAP KA, 1977, VIROLOGY, V79, P14, DOI 10.1016/0042-6822(77)90330-0; HENSLER W, 1994, ANN NY ACAD SCI, V745, P149; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Kahrstrom CT, 2014, NAT REV MICROBIOL, V12, P151; Kruse Jr P. F., 1973, TISSUE CULTURE METHO; Kurstak E, 1980, INVERTEBRATE SYSTEMS; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050; LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4; LICARI PJ, 1993, BIOTECHNOL PROGR, V9, P146, DOI 10.1021/bp00020a005; Lipin DI, 2008, ARCH VIROL, V153, P2027, DOI 10.1007/s00705-008-0220-9; Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; Lu YPE, 2001, J VIROL, V75, P8329, DOI 10.1128/JVI.75.17.8329-8339.2001; MAIORELLA B, 1988, BIO-TECHNOL, V6, P1406, DOI 10.1038/nbt1288-1406; MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57; MEDINA M, 1995, CYTOTECHNOLOGY, V17, P21, DOI 10.1007/BF00749217; Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124; Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353; Metz SW, 2013, VACCINE; Moormann RJM, 2000, VET MICROBIOL, V73, P209, DOI 10.1016/S0378-1135(00)00146-2; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Olsen CH, 2003, INFECT IMMUN, V71, P6689, DOI 10.1128/IAI.71.12.6689-6692.2003; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; PASUMARTHY MK, 1994, BIOTECHNOL PROGR, V10, P314, DOI 10.1021/bp00027a012; ROSS R. W., 1956, JOUR HYG, V54, P177; Ryan C, 1998, VIROLOGY, V249, P62, DOI 10.1006/viro.1998.9281; SCHARER CG, 1993, ARCH VIROL, V132, P237, DOI 10.1007/BF01309536; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; SUMMERS MD, 1976, J VIROL, V17, P962, DOI 10.1128/JVI.17.3.962-972.1976; Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Valley-Omar Z, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-462; Van Aarle P., 2003, VVolume 114, P193; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108; Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]; Wu Yan-lei, 2011, Virologica Sinica, V26, P198, DOI 10.1007/s12250-011-3177-x; Youil R, 2003, HUM GENE THER, V14, P1017, DOI 10.1089/104303403766682278; Zhang SXX, 2003, J VIROL, V77, P6265, DOI 10.1128/JVI.77.11.6265-6273.2003; ZHIRNOV OP, 1986, VOP VIRUSOL+, P723	65	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94401	10.1371/journal.pone.0094401	http://dx.doi.org/10.1371/journal.pone.0094401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713807	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900128
J	Nudds, RL				Nudds, Robert L.			Reassessment of the Wing Feathers of Archaeoptery lithographica Suggests No Robust Evidence for the Presence of Elongated Dorsal Wing Coverts	PLOS ONE			English	Article							EVOLUTION; FLIGHT; BIRDS; CONFUCIUSORNIS; SPECIMEN; RACHISES; THEROPOD; ORIGINS	Recently it was proposed that the primary feathers of Archaeopteryx lithographica (HMN1880) were overlaid by long covert feathers, and that a multilayered feathered wing was a feature of early fossils with feathered forelimbs. The proposed long covert feathers of Archaeopteryx were previously interpreted as dorsally displaced remiges or a second set of impressions made by the wing. The following study shows that the qualitative arguments forwarded in support of the elongated covert hypothesis are neither robust nor supported quantitatively. The idea that the extant bird wing with its single layer of overlapping primaries evolved from an earlier multilayered heavily coveted feathered forelimb as seen in Anchiornis huxleyi is reasonable. At this juncture, however, it is premature to conclude unequivocally that the wing of Archaeopteryx consisted of primary feathers overlaid with elongated coverts.	Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Nudds, RL (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	robert.nudds@manchester.ac.uk						Bock W.J., 1986, Memoirs of the California Academy of Sciences, P57; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; de Beer G., 1954, CRAFTSMANS HDB; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; Garner JP, 1999, P ROY SOC B-BIOL SCI, V266, P1259, DOI 10.1098/rspb.1999.0772; HEILMANN G, 1926, ORIGIN BIRDS; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hummel D., 1980, Acta Congressus Internationalis Ornithologici, V1, P391; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Mayr G, 2005, SCIENCE, V310, P1483, DOI 10.1126/science.1120331; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; Nudds RL, 2010, SCIENCE, V330, DOI 10.1126/science.1193474; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Ostrom J.H., 1986, Memoirs of the California Academy of Sciences, P73; Paul GS, 2010, SCIENCE, V330, DOI 10.1126/science.1192963; Rietschel S., 1985, P251; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Spedding GR, 1992, MECH ANIMAL LOCOMOTI; TUCKER VA, 1993, J EXP BIOL, V180, P285; VAZQUEZ RJ, 1992, J MORPHOL, V211, P259, DOI 10.1002/jmor.1052110303; Videler John J., 2000, Archaeopteryx, V18, P27; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Zheng Xiaoting, 2010, Science (Washington D C), V330	25	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93963	10.1371/journal.pone.0093963	http://dx.doi.org/10.1371/journal.pone.0093963			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710561	gold, Green Published, Green Submitted			2022-12-27	WOS:000334159800078
J	Beltrame, V; Ortolan, P; Coran, A; Zanato, R; Gazzola, M; Frigo, A; Bello, L; Pegoraro, E; Stramare, R				Beltrame, Valeria; Ortolan, Paolo; Coran, Alessandro; Zanato, Riccardo; Gazzola, Matteo; Frigo, Annachiara; Bello, Luca; Pegoraro, Elena; Stramare, Roberto			Muscle MR Imaging in Tubular Aggregate Myopathy	PLOS ONE			English	Article							DOMINANTLY INHERITED MYOPATHY; SKELETAL-MUSCLE	Purpose: To evaluate with Magnetic Resonance (MR) the degree of fatty replacement and edematous involvement in skeletal muscles in patients with Tubular Aggregate Myopathy (TAM). To asses the inter-observer agreement in evaluating muscle involvement and the symmetry index of fatty replacement. Materials and Methods: 13 patients were evaluated by MR to ascertain the degree of fatty replacement (T1W sequences) according to Mercuri's scale, and edema score (STIR sequences) according to extent and site. Results: Fatty replacement mainly affects the posterior superficial compartment of the leg; the anterior compartment is generally spared. Edema was generally poor and almost only in the superficial compartment of the leg. The inter-observer agreement is very good with a Krippendorff's coefficient >0.9. Data show a total symmetry in the muscular replacement (McNemar-Bowker test with p = 1). Conclusions: MR reveals characteristic muscular involvement, and is a reproducible technique for evaluation of TAM. There may also be a characteristic involvement of the long and short heads of the biceps femoris. It is useful for aimed biopsies, diagnostic hypotheses and evaluation of disease progression.	[Beltrame, Valeria; Ortolan, Paolo; Coran, Alessandro; Zanato, Riccardo; Gazzola, Matteo; Stramare, Roberto] Univ Padua, Sect Radiol, Dept Med, Padua, Italy; [Frigo, Annachiara] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy	University of Padua; University of Padua; University of Padua	Stramare, R (corresponding author), Univ Padua, Sect Radiol, Dept Med, Padua, Italy.	roberto.stramare@unipd.it	Stramare, Roberto/ABH-6752-2020	Stramare, Roberto/0000-0002-1818-2290; Bello, Luca/0000-0002-3075-6525; Coran, Alessandro/0000-0002-1037-0393				Akima H, 2012, NEUROMUSCULAR DISORD, V22, P16, DOI 10.1016/j.nmd.2011.06.750; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; CASTILLO J, 1993, EUR J RADIOL, V17, P141, DOI 10.1016/0720-048X(93)90091-Z; CHUI LA, 1975, NEUROLOGY, V25, P405, DOI 10.1212/WNL.25.5.405; Cupler EJ, 1998, NEUROMUSCULAR DISORD, V8, P321, DOI 10.1016/S0960-8966(98)00026-1; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ENGEL AG, 1966, MAYO CLIN PROC, V41, P797; ENGEL WK, 1970, J ULTRA MOL STRUCT R, V31, P507, DOI 10.1016/S0022-5320(70)90166-8; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Martin JJ, 1997, NEUROMUSCULAR DISORD, V7, P512, DOI 10.1016/S0960-8966(97)00119-3; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Messineo D, 1998, MAGN RESON IMAGING, V16, P731, DOI 10.1016/S0730-725X(98)00080-0; Morgan-Hughes JA, 1998, CURR OPIN NEUROL, V11, P439, DOI 10.1097/00019052-199810000-00005; Muller HD, 2001, ACTA NEUROPATHOL, V102, P27; SALVIATI G, 1985, MUSCLE NERVE, V8, P299, DOI 10.1002/mus.880080406; SCHEDEL H, 1992, EUR J RADIOL, V15, P230, DOI 10.1016/0720-048X(92)90113-N; SCHREIBER A, 1987, PEDIATR RADIOL, V17, P495, DOI 10.1007/BF02388288; Stramare R, 2010, RADIOL MED, V115, P585, DOI 10.1007/s11547-010-0531-2; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2	20	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94427	10.1371/journal.pone.0094427	http://dx.doi.org/10.1371/journal.pone.0094427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722334	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100070
J	Creswell, J; Sahu, S; Blok, L; Bakker, MI; Stevens, R; Ditiu, L				Creswell, Jacob; Sahu, Suvanand; Blok, Lucie; Bakker, Mirjam I.; Stevens, Robert; Ditiu, Lucica			A Multi-Site Evaluation of Innovative Approaches to Increase Tuberculosis Case Notification: Summary Results	PLOS ONE			English	Article							SOUTHERN ETHIOPIA; TREATMENT SUCCESS; STRATEGIES; COMMUNITIES; PREVALENCE; DIAGNOSIS; DISEASE	Background: Globally, TB notifications have stagnated since 2007, and sputum smear positive notifications have been declining despite policies to improve case detection. We evaluate results of 28 interventions focused on improving TB case detection. Methods: We measured additional sputum smear positive cases treated, defined as the intervention area's increase in case notification during the project compared to the previous year. Projects were encouraged to select control areas and collect historical notification data. We used time series negative binomial regression for over-dispersed cross-sectional data accounting for fixed and random effects to test the individual projects' effects on TB notification while controlling for trend and control populations. Results: Twenty-eight projects, 19 with control populations, completed at least four quarters of case finding activities, covering a population of 89.2 million. Among all projects sputum smear positive (SS+) TB notifications increased 24.9% and annualized notification rates increased from 69.1 to 86.2/100,000 (p = 0.0209) during interventions. Among the 19 projects with control populations, SS+ TB case notifications increased 36.9% increase while in the control populations a 3.6% decrease was observed. Fourteen (74%) of the 19 projects' SS+ TB notification rates in intervention areas increased from the baseline to intervention period when controlling for historical trends and notifications in control areas. Conclusions: Interventions were associated with large increases in TB notifications across many settings, using an array of interventions. Many people with TB are not reached using current approaches. Different methods and interventions tailored to local realities are urgently needed.	[Creswell, Jacob; Sahu, Suvanand; Ditiu, Lucica] Stop TB Partnership, Geneva, Switzerland; [Blok, Lucie] Royal Trop Inst KIT, Amsterdam, Netherlands; [Bakker, Mirjam I.] Royal Trop Inst KIT Biomed Res, Amsterdam, Netherlands; [Stevens, Robert] HLSP, London, England		Creswell, J (corresponding author), Stop TB Partnership, Geneva, Switzerland.	creswellj@who.int		Creswell, Jacob/0000-0002-4885-940X	Department of Foreign Affairs, Trade and Development of Canada	Department of Foreign Affairs, Trade and Development of Canada	TB REACH is supported by the Department of Foreign Affairs, Trade and Development of Canada. www.international.gc.ca/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077517; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; El-Sony AI, 2003, INT J TUBERC LUNG D, V7, P445; Global Fund, 2011, GLOB FUND INF NOT MO; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hinderaker SG, 2011, INT J TUBERC LUNG D, V15, P71; Horie T, 2007, INT J TUBERC LUNG D, V11, P562; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Lonnroth K, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P219; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Miller AC, 2010, INT J TUBERC LUNG D, V14, P720; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Saly Saint, 2006, Kekkaku, V81, P467; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Shah SA, 2013, INT J TUBERC LUNG D, V17, P1569, DOI 10.5588/ijtld.13.0169; Shargie EB, 2006, B WORLD HEALTH ORGAN, V84, P112, DOI 10.2471/BLT.05.024489; Stop TB Partnership, TB REACH; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CARE I; UNAIDS, 2007, PRACTICAL GUIDELINE; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Veron LJ, 2004, INT J TUBERC LUNG D, V8, P139; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, INT POL COLL TB HIV; WHO, 2009, GLOB TUB CONTR 2009; WHO, 2013, WHOHTMTB201304; World Health Organization, 2011, WHOHTMTB20118; Yanjindulam P, 2012, INT J TUBERC LUNG D, V16, P327, DOI 10.5588/ijtld.11.0251; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	36	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94465	10.1371/journal.pone.0094465	http://dx.doi.org/10.1371/journal.pone.0094465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722399	gold, Green Submitted, Green Published			2022-12-27	WOS:000336909100073
J	Gfeller, D; Ernst, A; Jarvik, N; Sidhu, SS; Bader, GD				Gfeller, David; Ernst, Andreas; Jarvik, Nick; Sidhu, Sachdev S.; Bader, Gary D.			Prediction and Experimental Characterization of nsSNPs Altering Human PDZ-Binding Motifs	PLOS ONE			English	Article							PROTEIN INTERACTIONS; HUMAN GENOME; DATABASE; POLYMORPHISMS; SPECIFICITY; MUTATION; CONTEXT; SERVER; ELM	Single nucleotide polymorphisms (SNPs) are a major contributor to genetic and phenotypic variation within populations. Non-synonymous SNPs (nsSNPs) modify the sequence of proteins and can affect their folding or binding properties. Experimental analysis of all nsSNPs is currently unfeasible and therefore computational predictions of the molecular effect of nsSNPs are helpful to guide experimental investigations. While some nsSNPs can be accurately characterized, for instance if they fall into strongly conserved or well annotated regions, the molecular consequences of many others are more challenging to predict. In particular, nsSNPs affecting less structured, and often less conserved regions, are difficult to characterize. Binding sites that mediate protein-protein or other protein interactions are an important class of functional sites on proteins and can be used to help interpret nsSNPs. Binding sites targeted by the PDZ modular peptide recognition domain have recently been characterized. Here we use this data to show that it is possible to computationally identify nsSNPs in PDZ binding motifs that modify or prevent binding to the proteins containing the motifs. We confirm these predictions by experimentally validating a selected subset with ELISA. Our work also highlights the importance of better characterizing linear motifs in proteins as many of these can be affected by genetic variations.	[Gfeller, David; Ernst, Andreas; Jarvik, Nick; Sidhu, Sachdev S.; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Gfeller, David] Swiss Inst Bioinformat, Lausanne, Switzerland; [Sidhu, Sachdev S.; Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; Swiss Institute of Bioinformatics; University of Toronto; University of Toronto	Bader, GD (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.	gary.bader@utoronto.ca	Bader, Gary/C-1176-2009; Gfeller, David/A-6493-2019; gfeller, david/D-3395-2009	Bader, Gary/0000-0003-0185-8861; Gfeller, David/0000-0002-3952-0930; gfeller, david/0000-0002-3952-0930	Canadian Institutes of Health Research [MOP-84324]; EMBO [EMBO-ALTF 241-2010]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant MOP-84324. David Gfeller acknowledges the financial support of EMBO (http://www.embo.org/) grant EMBO-ALTF 241-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Gfeller D, 2012, FEBS LETT, V586, P2764, DOI 10.1016/j.febslet.2012.03.054; Gfeller D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.18; Gonzalez-Perez A, 2013, NAT METHODS, V10, P723, DOI 10.1038/nmeth.2562; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Jordan DM, 2010, CURR OPIN STRUC BIOL, V20, P342, DOI 10.1016/j.sbi.2010.03.006; Kalay E, 2005, J MOL MED, V83, P1025, DOI 10.1007/s00109-005-0719-4; Kono H, 2008, NUCLEIC ACIDS RES, V36, pD409, DOI 10.1093/nar/gkm801; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; Luck K, 2011, BIOINFORMATICS, V27, P899, DOI 10.1093/bioinformatics/btr060; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Muller D, 2003, AM J HUM GENET, V73, P1293, DOI 10.1086/380418; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Reumers J, 2005, NUCLEIC ACIDS RES, V33, pD527; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Van Roey K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003345; Warnock DG, 1998, KIDNEY INT, V53, P18, DOI 10.1046/j.1523-1755.1998.00728.x; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Xin XF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.9; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94507	10.1371/journal.pone.0094507	http://dx.doi.org/10.1371/journal.pone.0094507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722214	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100086
J	Scheffler, K; Murrell, B; Pond, SLK				Scheffler, Konrad; Murrell, Ben; Pond, Sergei L. Kosakovsky			On the Validity of Evolutionary Models with Site-Specific Parameters	PLOS ONE			English	Article							AMINO-ACID SITES; SELECTION	Evolutionary models that make use of site-specific parameters have recently been criticized on the grounds that parameter estimates obtained under such models can be unreliable and lack theoretical guarantees of convergence. We present a simulation study providing empirical evidence that a simple version of the models in question does exhibit sensible convergence behavior and that additional taxa, despite not being independent of each other, lead to improved parameter estimates. Although it would be desirable to have theoretical guarantees of this, we argue that such guarantees would not be sufficient to justify the use of these models in practice. Instead, we emphasize the importance of taking the variance of parameter estimates into account rather than blindly trusting point estimates - this is standardly done by using the models to construct statistical hypothesis tests, which are then validated empirically via simulation studies.	[Scheffler, Konrad; Murrell, Ben; Pond, Sergei L. Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Scheffler, Konrad] Univ Stellenbosch, Dept Math Sci, ZA-7600 Stellenbosch, South Africa	University of California System; University of California San Diego; Stellenbosch University	Scheffler, K (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	kscheffler@ucsd.edu	Pond, Sergei LK/G-9830-2012; Murrell, Ben/AAM-1188-2021	Pond, Sergei LK/0000-0003-4817-4029; Murrell, Ben/0000-0002-0393-4445; Scheffler, Konrad/0000-0002-6041-8367	National Institutes of Health [AI47745, AI57167, AI74621, AI036214, DA034978, MH083552, MH101012, GM093939]; UC Laboratory Fees Research Program [12-LR-236617]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047745, P30AI036214, R56AI047745, R21AI047745, R01AI057167, P01AI074621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083552, R01MH101012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Laboratory Fees Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institutes of Health grants AI47745, AI57167, AI74621, AI036214, DA034978, MH083552, MH101012, and GM093939, and the UC Laboratory Fees Research Program grant 12-LR-236617. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Felsenstein J., 2004, INFERRING PHYLOGENIE; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Murrell B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002507; Neyman J, 1948, ECONOMETRICA, V16, P1, DOI 10.2307/1914288; Nielsen R, 1998, GENETICS, V148, P929; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rodrigue N, 2013, GENETICS, V193, P557, DOI 10.1534/genetics.112.145722; Steel M, 2011, SYST BIOL, V60, P96, DOI 10.1093/sysbio/syq069; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhai WW, 2012, MOL BIOL EVOL, V29, P2889, DOI 10.1093/molbev/mss104	17	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94534	10.1371/journal.pone.0094534	http://dx.doi.org/10.1371/journal.pone.0094534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722425	Green Published, gold			2022-12-27	WOS:000336909100093
J	Schurch, NJ; Cole, C; Sherstnev, A; Song, J; Duc, C; Storey, KG; McLean, WHI; Brown, SJ; Simpson, GG; Barton, GJ				Schurch, Nicholas J.; Cole, Christian; Sherstnev, Alexander; Song, Junfang; Duc, Celine; Storey, Kate G.; McLean, W. H. Irwin; Brown, Sara J.; Simpson, Gordon G.; Barton, Geoffrey J.			Improved Annotation of 3 ' Untranslated Regions and Complex Loci by Combination of Strand-Specific Direct RNA Sequencing, RNA-Seq and ESTs	PLOS ONE			English	Article							GENE ANNOTATION; GENOME; POLYADENYLATION; ZEBRAFISH; REANNOTATION; TRANSCRIPTS; EXPRESSION; RECEPTORS; ULTRAFAST; PROTEINS	The reference annotations made for a genome sequence provide the framework for all subsequent analyses of the genome. Correct and complete annotation in addition to the underlying genomic sequence is particularly important when interpreting the results of RNA-seq experiments where short sequence reads are mapped against the genome and assigned to genes according to the annotation. Inconsistencies in annotations between the reference and the experimental system can lead to incorrect interpretation of the effect on RNA expression of an experimental treatment or mutation in the system under study. Until recently, the genome-wide annotation of 39 untranslated regions received less attention than coding regions and the delineation of intron/exon boundaries. In this paper, data produced for samples in Human, Chicken and A. thaliana by the novel single-molecule, strand-specific, Direct RNA Sequencing technology from Helicos Biosciences which locates 3' polyadenylation sites to within +/- 2 nt, were combined with archival EST and RNA-Seq data. Nine examples are illustrated where this combination of data allowed: (1) gene and 3' UTR re-annotation (including extension of one 3' UTR by 5.9 kb); (2) disentangling of gene expression in complex regions; (3) clearer interpretation of small RNA expression and (4) identification of novel genes. While the specific examples displayed here may become obsolete as genome sequences and their annotations are refined, the principles laid out in this paper will be of general use both to those annotating genomes and those seeking to interpret existing publically available annotations in the context of their own experimental data.	[Schurch, Nicholas J.; Cole, Christian; Sherstnev, Alexander; Barton, Geoffrey J.] Univ Dundee, Div Computat Biol, Dundee, Scotland; [Song, Junfang; Storey, Kate G.] Univ Dundee, Div Cell & Dev Biol, Dundee, Scotland; [McLean, W. H. Irwin; Brown, Sara J.] Univ Dundee, Ctr Dermatol & Genet Med, Dundee, Scotland; [Duc, Celine; Simpson, Gordon G.] Univ Dundee, Div Plant Sci, Dundee, Scotland; [Schurch, Nicholas J.; Cole, Christian; Barton, Geoffrey J.] Univ Dundee, Div Biol Chem & Drug Discovery, Dundee, Scotland; [Schurch, Nicholas J.; Cole, Christian; Barton, Geoffrey J.] Univ Dundee, Ctr Gene Regulat & Express, Dundee, Scotland; [Simpson, Gordon G.] James Hutton Inst, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee; James Hutton Institute	Barton, GJ (corresponding author), Univ Dundee, Div Computat Biol, Dundee, Scotland.	g.j.barton@dundee.ac.uk	Brown, Sara J/AAF-7095-2019; Schurch, Nicholas/I-4339-2019; Barton, Geoffrey/N-1037-2019; Barton, Geoffrey J/C-6267-2011; duc, celine/F-1372-2015	Brown, Sara J/0000-0002-3232-5251; Schurch, Nicholas/0000-0001-9068-9654; Barton, Geoffrey/0000-0002-9014-5355; Simpson, Gordon/0000-0001-6744-5889; Cole, Christian/0000-0002-2560-2484; Storey, Kate/0000-0003-3506-1287; duc, celine/0000-0001-7426-4541	MRC [G1100552]; Wellcome Trust [086398/Z/08/Z, 92530/Z/10/Z, 100476/Z/12/Z, 097945/Z/11/Z]; National Childrena(sic)(TM)s Research Centre Dublin; BBSRC [BB/H002286/1]; Scottish Government; Biotechnology and Biological Sciences Research Council [BB/H002286/1, BB/J00247X/1] Funding Source: researchfish; Medical Research Council [G1100552] Funding Source: researchfish; BBSRC [BB/J00247X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Childrena(sic)(TM)s Research Centre Dublin; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Kate G. Storey and Junfang Song are supported by MRC (www.mrc.ac.uk) grant (G1100552). Sara J. Brown is supported by a Wellcome Trust (www.wellcome.ac.uk) Intermediate Clinical Fellowship (086398/Z/08/Z) and funding from the National Childrena(sic)(TM) s Research Centre Dublin (http://www.nationalchildrensresearchcentre.ie/). The authors are grateful to the Tayside Tissue Bank (tissuebank.dundee.ac.uk) for help in obtaining the human skin sample. CA (c) line Duc and Gordon G. Simpson are supported by the BBSRC (www.bbsrc.ac.uk) (BB/H002286/1) and Scottish Government. Christian Cole is supported by Wellcome Trust (www.wellcome.ac.uk) Grant (92530/Z/10/Z). Geoff Barton acknowledges support from Wellcome Trust (www.wellcome.ac.uk) Strategic Grants (100476/Z/12/Z) and (097945/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TS, 2012, DEV NEUROBIOL, V72, P415, DOI 10.1002/dneu.20888; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins JE, 2012, GENOME RES, V22, P2067, DOI 10.1101/gr.137901.112; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Graber JH, 2013, GENOME RES; Haas BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-7; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kurihara Y, 2012, G3-GENES GENOM GENET, V2, P487, DOI 10.1534/g3.111.001362; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Luo CW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-552; Moqtaderi Z, 2013, P NATL ACAD SCI USA, V110, P11073, DOI 10.1073/pnas.1309384110; Ozsolak F, 2011, WIRES RNA, V2, P565, DOI 10.1002/wrna.84; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Pelissier T, 2011, RNA, V17, P1502, DOI 10.1261/rna.2680711; Reese MG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s1; Reid AI, 2002, INT J DEV BIOL, V46, P209; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sherstnev A, 2012, NAT STRUCT MOL BIOL, V19, P845, DOI 10.1038/nsmb.2345; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	47	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94270	10.1371/journal.pone.0094270	http://dx.doi.org/10.1371/journal.pone.0094270			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722185	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100047
J	Chaillon, A; Samleerat, T; Zoveda, F; Ballesteros, S; Moreau, A; Ngo-Giang-Huong, N; Jourdain, G; Gianella, S; Lallemant, M; Depaulis, F; Barin, F				Chaillon, Antoine; Samleerat, Tanawan; Zoveda, Faustine; Ballesteros, Sebastien; Moreau, Alain; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Gianella, Sara; Lallemant, Marc; Depaulis, Frantz; Barin, Francis			Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; PHYLOGENETIC ANALYSIS; IN-UTERO; VERTICAL TRANSMISSION; SEXUAL TRANSMISSION; HIV-1 TRANSMISSION; GENETIC DIVERSITY; DNA-SEQUENCES; VARIANTS; HISTORY	Background: Mother-to-child transmission (MTCT) is responsible for most pediatric HIV-1 infections worldwide. It can occur during pregnancy, labor, or breastfeeding. Numerous studies have used coalescent and molecular clock methods to understand the epidemic history of HIV-1, but the timing of vertical transmission has not been studied using these methods. Taking advantage of the constant accumulation of HIV genetic variation over time and using longitudinally sampled viral sequences, we used a coalescent approach to investigate the timing of MTCT. Materials and Methods: Six-hundred and twenty-two clonal env sequences from the RNA and DNA viral population were longitudinally sampled from nine HIV-1 infected mother-and-child pairs [range: 277-1034 days]. For each transmission pair, timing of MTCT was determined using a coalescent-based model within a Bayesian statistical framework. Results were compared with available estimates of MTCT timing obtained with the classic biomedical approach based on serial HIV DNA detection by PCR assays. Results: Four children were infected during pregnancy, whereas the remaining five children were infected at time of delivery. For eight out of nine pairs, results were consistent with the transmission periods assessed by standard PCR-based assay. The discordance in the remaining case was likely confused by co-infection, with simultaneous introduction of multiple maternal viral variants at the time of delivery. Conclusions: The study provided the opportunity to validate the Bayesian coalescent approach that determines the timing of MTCT of HIV-1. It illustrates the power of population genetics approaches to reliably estimate the timing of transmission events and deepens our knowledge about the dynamics of viral evolution in HIV-infected children, accounting for the complexity of multiple transmission events.	[Chaillon, Antoine; Samleerat, Tanawan; Moreau, Alain; Barin, Francis] Univ Tours, INSERM, U966, Tours, France; [Chaillon, Antoine; Samleerat, Tanawan; Moreau, Alain; Barin, Francis] Univ Tours, Virol Lab, CHU Bretonneau, Tours, France; [Chaillon, Antoine; Gianella, Sara] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Samleerat, Tanawan] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Zoveda, Faustine; Ballesteros, Sebastien; Depaulis, Frantz] Ecole Normale Super, CNRS, Unite Mixte Rech 7625, Lab Ecol & Evolut, Paris, France; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] Inst Rech Dev, Chiang Mai, Thailand; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universite de Tours; University of California System; University of California San Diego; Chiang Mai University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Harvard University; Harvard T.H. Chan School of Public Health	Chaillon, A (corresponding author), Univ Tours, INSERM, U966, Tours, France.	achaillon@ucsd.edu	Jourdain, Gonzague/F-9117-2017; Chaillon, Antoine/GNH-6121-2022; chaillon, antoine/GNH-1623-2022; Ngo-Giang-Huong, Nicole/G-2860-2017	Jourdain, Gonzague/0000-0002-3365-7020; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; Gianella, Sara/0000-0002-9927-0849; Depaulis, Frantz/0000-0001-5761-2751	Agence Nationale de Recherches sur le Sida et les Hepatites (ANRS, Paris, France); Institut de Recherche pour le Developpement (IRD, Paris, France); National Institutes of Health [5 R01 HD 33326]; Agence Nationale de Recherche (ANR biodiversite); French Ministry of Foreign Affairs; Thai Ministry of Higher Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033326] Funding Source: NIH RePORTER	Agence Nationale de Recherches sur le Sida et les Hepatites (ANRS, Paris, France)(French National Research Agency (ANR)); Institut de Recherche pour le Developpement (IRD, Paris, France); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherche (ANR biodiversite)(French National Research Agency (ANR)); French Ministry of Foreign Affairs; Thai Ministry of Higher Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from the Agence Nationale de Recherches sur le Sida et les Hepatites (ANRS, Paris, France), the Institut de Recherche pour le Developpement (IRD, Paris, France), the National Institutes of Health (5 R01 HD 33326), and the Agence Nationale de Recherche (ANR biodiversite). T Samleerat was supported by a doctoral fellowship from the French Ministry of Foreign Affairs and the Thai Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD N, 1995, J VIROL, V69, P1001, DOI 10.1128/JVI.69.2.1001-1012.1995; Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; BRIANT L, 1995, J VIROL, V69, P3778, DOI 10.1128/JVI.69.6.3778-3788.1995; BROSSARD Y, 1995, AIDS, V9, P359, DOI 10.1097/00002030-199509040-00007; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dickover RE, 2001, J VIROL, V75, P2194, DOI 10.1128/JVI.75.5.2194-2203.2001; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eckert K A, 1991, PCR Methods Appl, V1, P17; Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28; English S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-54; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; HOLMES EC, 1995, PHILOS T R SOC B, V349, P33, DOI 10.1098/rstb.1995.0088; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kaye M, 2009, AIDS RES HUM RETROV, V25, P741, DOI 10.1089/aid.2008.0306; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kishko M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-67; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kwiek JJ, 2008, AIDS, V22, P863, DOI 10.1097/QAD.0b013e3282f51ea0; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Lemey P, 2006, AIDS REV, V8, P125; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Pasquier C, 1998, J VIROL, V72, P8493, DOI 10.1128/JVI.72.11.8493-8501.1998; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poon AFY, 2011, AIDS, V25, P2019, DOI 10.1097/QAD.0b013e32834b643c; Prendergast A, 2007, LANCET, V370, P68, DOI 10.1016/S0140-6736(07)61051-4; Pybus OG, 2000, GENETICS, V155, P1429; Rachinger A, 2011, AIDS, V25, P1035, DOI 10.1097/QAD.0b013e3283467020; Rachinger A, 2010, CLIN INFECT DIS, V50, P1309, DOI 10.1086/651687; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Renjifo B, 2003, VIROLOGY, V307, P278, DOI 10.1016/S0042-6822(02)00066-1; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251; SCARLATTI G, 1993, ANN NY ACAD SCI, V693, P277, DOI 10.1111/j.1749-6632.1993.tb26282.x; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Zhang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009294; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	62	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e90421	10.1371/journal.pone.0090421	http://dx.doi.org/10.1371/journal.pone.0090421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717647	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000008
J	Cheung, TT; Poon, RTP; Chok, KSH; Chan, ACY; Tsang, SHY; Dai, WC; Yau, TCC; Chan, SC; Fan, ST; Lo, CM				Cheung, Tan To; Poon, Ronnie T. P.; Chok, Kenneth S. H.; Chan, Albert C. Y.; Tsang, Simon H. Y.; Dai, Wing Chiu; Yau, Thomas C. C.; Chan, See Ching; Fan, Sheung Tat; Lo, Chung Mau			Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era	PLOS ONE			English	Article							FOCUSED ULTRASOUND ABLATION; SINGLE-CENTER-EXPERIENCE; LIVER-TRANSPLANTATION; SURVIVAL ANALYSIS; CIRRHOSIS; EMBOLIZATION; CHEMOEMBOLIZATION; HEPATECTOMY; TOLERANCE; SELECTION	Background and aim: Spontaneous rupture of hepatocellular carcinoma (HCC) carries a high mortality. The use of radiofrequency ablation (RFA) in recent years has enriched the armamentarium for hemostasis of spontaneously ruptured HCCs but its results have not been documented. This study investigated the prognosis and outcome of spontaneous rupture of HCC as well as the results of using RFA for hemostasis. Patients and method: From January 1991 to December 2010, 5283 patients were diagnosed with HCC at our hospital, and 189 of them had spontaneous rupture of HCCs. They were grouped under two periods: period 1, 1991-2000, n = 70; period 2, 2001-2010, n = 119. RFA was available in period 2 only. Results: Hepatitis B virus infection was predominant in both periods. Surgical hemostasis was mainly achieved by hepatic artery ligation in period 1 and by RFA in period 2. The 30-day hospital mortality after surgical treatment was 55.6% (n = 18) in period 1 and 19.2% (n = 26) in period 2 (p = 0.012). Multivariate analysis identified 4 independent factors for better overall survival, namely, hemostasis by transarterial chemoembolization (hazard ratio 0.516, 95% confidence interval 0.354-0.751), hemostasis by RFA (hazard ratio 0.431, 95% confidence interval 0.236-0.790), having surgery as a subsequent treatment (hazard ratio 0.305, 95% confidence interval 0.186-0.498), and a serum total bilirubin level < 19 umol/L (hazard ratio 1.596, 95% confidence interval 1.137-2.241). Conclusion: The use of RFA for hemostasis during laparotomy greatly reduced the hospital mortality rate when compared with conventional hepatic artery ligation.	[Cheung, Tan To; Poon, Ronnie T. P.; Chok, Kenneth S. H.; Chan, Albert C. Y.; Tsang, Simon H. Y.; Dai, Wing Chiu; Yau, Thomas C. C.; Chan, See Ching; Fan, Sheung Tat; Lo, Chung Mau] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheung, TT (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	tantocheung@hotmail.com	Chok, Kenneth Siu Ho/C-9606-2012; Chan, Albert/AAC-1642-2022; Yau, Thomas Chung Cheung/B-3429-2011	Chok, Kenneth Siu Ho/0000-0001-7921-3807; Chan, Albert/0000-0002-1383-2952; Yau, Thomas Chung Cheung/0000-0002-7114-0305				Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Buczkowski AK, 2006, J GASTROINTEST SURG, V10, P379, DOI 10.1016/j.gassur.2005.10.012; CHEARANAI O, 1983, CANCER, V51, P1532, DOI 10.1002/1097-0142(19830415)51:8<1532::AID-CNCR2820510829>3.0.CO;2-3; CHERQUI D, 1993, BRIT J SURG, V80, P747, DOI 10.1002/bjs.1800800631; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Cheung TT, 2013, HPB, V15, P567, DOI 10.1111/hpb.12025; Cheung TT, 2013, ANN SURG, V257, P506, DOI 10.1097/SLA.0b013e31827b947a; Cheung TT, 2013, J NUCL MED, V54, P192, DOI 10.2967/jnumed.112.107516; Cheung TT, 2012, WORLD J SURG, V36, P2420, DOI 10.1007/s00268-012-1660-7; Cheung TT, 2011, LIVER TRANSPLANT, V17, P1218, DOI 10.1002/lt.22362; Cheung TT, 2009, J HEPATO-BILIARY-PAN, V16, P655, DOI 10.1007/s00534-009-0103-9; Chiappa Antonio, 2008, Surg Technol Int, V17, P33; Chun YH, 2011, EUR J CANCER, V47, P2568, DOI 10.1016/j.ejca.2011.07.002; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Fan S T, 1999, Swiss Surg, V5, P107, DOI 10.1024/1023-9332.5.3.107; Fan ST, 1998, HEPATO-GASTROENTEROL, V45, P1288; HERMANN RE, 1973, SURGERY, V74, P715; Kan RWM, 2012, ANZ J SURG, V82, P505, DOI 10.1111/j.1445-2197.2012.06121.x; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Kim JY, 2012, EUR J GASTROEN HEPAT, V24, P640, DOI 10.1097/MEG.0b013e3283524d32; LAI ECS, 1989, ANN SURG, V210, P24, DOI 10.1097/00000658-198907000-00004; Liu CL, 2001, J CLIN ONCOL, V19, P3725, DOI 10.1200/JCO.2001.19.17.3725; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Mazzaferro V, 2004, ANN SURG, V240, P900, DOI 10.1097/01.sla.0000143301.56154.95; Ng KKC, 2003, HEPATO-GASTROENTEROL, V50, P1641; ONG GB, 1972, BMJ-BRIT MED J, V4, P146, DOI 10.1136/bmj.4.5833.146; ONG GB, 1965, BRIT J SURG, V52, P123, DOI 10.1002/bjs.1800520210; Poon RTP, 2004, ANN SURG ONCOL, V11, P281, DOI 10.1245/ASO.2004.08.018; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; SATO Y, 1985, GASTROENTEROLOGY, V89, P157, DOI 10.1016/0016-5085(85)90756-5; Silva MA, 2004, SEMIN HEMATOL, V41, P132, DOI 10.1053/j.seminhematol.2003.11.022; Toshikuni N, 2011, HEPATO-GASTROENTEROL, V58, P565; Yau T, 2009, CANCER-AM CANCER SOC, V115, P428, DOI 10.1002/cncr.24029; Yau T, 2008, CANCER, V113, P2742, DOI 10.1002/cncr.23878; Yau T, 2009, CANCER-AM CANCER SOC, V115, P5507, DOI 10.1002/cncr.24636	35	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94453	10.1371/journal.pone.0094453	http://dx.doi.org/10.1371/journal.pone.0094453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718254	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000122
J	Fratz, EJ; Hunter, GA; Ferreira, GC				Fratz, Erica J.; Hunter, Gregory A.; Ferreira, Gloria C.			Expression of Murine 5-Aminolevulinate Synthase Variants Causes Protoporphyrin IX Accumulation and Light-Induced Mammalian Cell Death	PLOS ONE			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; PHOTODYNAMIC THERAPY; INTRAMITOCHONDRIAL LOCALIZATION; HEME-BIOSYNTHESIS; ACTIVE-SITE; BINDING; ACID; PRECURSOR; COFACTOR; SUBUNIT	5-Aminolevulinate synthase (ALAS; EC 2.3.1.37) catalyzes the first committed step of heme biosynthesis in animals. The erythroid-specific ALAS isozyme (ALAS2) is negatively regulated by heme at the level of mitochondrial import and, in its mature form, certain mutations of the murine ALAS2 active site loop result in increased production of protoporphyrin IX (PPIX), the precursor for heme. Importantly, generation of PPIX is a crucial component in the widely used photodynamic therapies (PDT) of cancer and other dysplasias. ALAS2 variants that cause high levels of PPIX accumulation provide a new means of targeted, and potentially enhanced, photosensitization. In order to assess the prospective utility of ALAS2 variants in PPIX production for PDT, K562 human erythroleukemia cells and HeLa human cervical carcinoma cells were transfected with expression plasmids for ALAS2 variants with greater enzymatic activity than the wild-type enzyme. The levels of accumulated PPIX in ALAS2-expressing cells were analyzed using flow cytometry with fluorescence detection. Further, cells expressing ALAS2 variants were subjected to white light treatments (21-22 kLux) for 10 minutes after which cell viability was determined. Transfection of HeLa cells with expression plasmids for murine ALAS2 variants, specifically for those with mutated mitochondrial presequences and a mutation in the active site loop, caused significant cellular accumulation of PPIX, particularly in the membrane. Light treatments revealed that ALAS2 expression results in an increase in cell death in comparison to aminolevulinic acid (ALA) treatment producing a similar amount of PPIX. The delivery of stable and highly active ALAS2 variants has the potential to expand and improve upon current PDT regimes.	[Fratz, Erica J.; Hunter, Gregory A.; Ferreira, Gloria C.] Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Ferreira, GC (corresponding author), Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217; Fratz-Berilla, Erica J./0000-0002-9259-0540	American Heart Association, Greater Southeast Affiliate [10GRNT4300073]; National Institutes of Health [GM080270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	American Heart Association, Greater Southeast Affiliate(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Heart Association, Greater Southeast Affiliate (#10GRNT4300073); National Institutes of Health (#GM080270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES IZ, 1981, J BIOL CHEM, V256, P9329; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Issa MCA, 2010, AN BRAS DERMATOL, V85, P501, DOI 10.1590/S0365-05962010000400011; ANDERSSON LC, 1979, INT J CANCER, V24, P514, DOI 10.1002/ijc.2910240422; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Babilas P, 2006, EUR J DERMATOL, V16, P340; Bishop DF, 2012, J BIOL CHEM, V287, P28943, DOI 10.1074/jbc.M111.306423; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Buzzeo R, 2005, CLIN CANCER RES, V11, P6057, DOI 10.1158/1078-0432.CCR-04-2685; CANTI G, 1994, ANTI-CANCER DRUG, V5, P443, DOI 10.1097/00001813-199408000-00009; Cheung MC, 2005, ONCOLOGIST, V10, P412, DOI 10.1634/theoncologist.10-6-412; COX TC, 1990, AM J HUM GENET, V46, P107; Dailey TA, 2005, BIOCHEM J, V386, P381, DOI 10.1042/BJ20040570; Darlenski R, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061208; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Felitsyn N, 2008, J NEUROCHEM, V106, P2068, DOI 10.1111/j.1471-4159.2008.05552.x; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Gagnebin J, 1999, GENE THER, V6, P1742, DOI 10.1038/sj.gt.3300992; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; Gonzalez-Dominguez M, 2001, YEAST, V18, P41, DOI 10.1002/1097-0061(200101)18:1<41::AID-YEA654>3.0.CO;2-E; Goodfellow BJ, 2001, FEBS LETT, V505, P325, DOI 10.1016/S0014-5793(01)02818-6; Hoffbrand AV, 1997, J INTERN MED, V242, P37, DOI 10.1111/joim.1997.242.s740.37; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P12526, DOI 10.1021/bi995076q; Hunter GA, 2005, ARCH BIOCHEM BIOPHYS, V437, P128, DOI 10.1016/j.abb.2005.03.007; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Ji ZY, 2006, J PHOTOCH PHOTOBIO B, V84, P213, DOI 10.1016/j.jphotobiol.2006.03.006; Jordan PM, 1990, BIOSYNTHESIS HEME CH, P55; Juknat AA, 2003, J PINEAL RES, V35, P1, DOI 10.1034/j.1600-079X.2003.00030.x; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Korbelik M, 2010, METHODS MOL BIOL, V635, P147, DOI 10.1007/978-1-60761-697-9_11; Krammer B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI 10.1039/b712847a; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; Lendrihas T, 2010, J BIOL CHEM, V285, P3351, DOI 10.1074/jbc.M109.066548; Lendrihas T, 2009, PROTEIN SCI, V18, P1847, DOI 10.1002/pro.195; MANFREDI JJ, 1982, J CELL BIOL, V94, P688, DOI 10.1083/jcb.94.3.688; MCKAY R, 1969, BIOCHEM J, V114, P455, DOI 10.1042/bj1140455; MOLEBAJER J, 1983, J CELL BIOL, V96, P527, DOI 10.1083/jcb.96.2.527; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nikcevic G, 2003, CELL BIOL INT, V27, P735, DOI 10.1016/S1065-6995(03)00143-4; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ramalingam SS, 2009, ONCOLOGIST, V14, P412, DOI 10.1634/theoncologist.2008-0190; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Roberts DJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004450.pub2; RYAN WL, 1966, NATURE, V212, P292, DOI 10.1038/212292a0; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; SRIVASTAVA G, 1983, BIOCHEM BIOPH RES CO, V110, P23, DOI 10.1016/0006-291X(83)91254-8; SUTHERLAND GR, 1988, AM J HUM GENET, V43, P331; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, PROTEIN SCI, V7, P1208, DOI 10.1002/pro.5560070516; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; VOLLAND C, 1988, J BIOL CHEM, V263, P8294; Warren CB, 2009, J AM ACAD DERMATOL, V61, P1033, DOI 10.1016/j.jaad.2009.03.048; WATANABE N, 1983, BIOCHEM BIOPH RES CO, V113, P377, DOI 10.1016/0006-291X(83)91737-0; Weiss TS, 2003, J HEPATOL, V38, P476, DOI 10.1016/S0168-8278(02)00454-3; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; YAMAUCHI K, 1980, J BIOL CHEM, V255, P1746; Yanamandra N, 2011, J PHARMACOL EXP THER, V337, P636, DOI 10.1124/jpet.110.172809; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; ZUYDERHOUDT FM, 1969, BIOCHIM BIOPHYS ACTA, V178, P408, DOI 10.1016/0005-2744(69)90414-8	74	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93078	10.1371/journal.pone.0093078	http://dx.doi.org/10.1371/journal.pone.0093078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718052	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000025
J	Xu, YP; Deng, Y; Ji, ZH; Liu, HB; Liu, YY; Peng, H; Wu, J; Fan, JP				Xu, Yaping; Deng, Yue; Ji, Zhenhua; Liu, Haibin; Liu, Yueyang; Peng, Hu; Wu, Jian; Fan, Jingping			Identification of Thyroid Carcinoma Related Genes with mRMR and Shortest Path Approaches	PLOS ONE			English	Article							BCL2 PROMOTER POLYMORPHISM; BREAST-CANCER; AA GENOTYPE; EXPRESSION; PROTEIN; GROWTH; -938C-GREATER-THAN-A; ASSOCIATION; MARKER; WOMEN	Thyroid cancer is a malignant neoplasm originated from thyroid cells. It can be classified into papillary carcinomas (PTCs) and anaplastic carcinomas (ATCs). Although ATCs are in an very aggressive status and cause more death than PTCs, their difference is poorly understood at molecular level. In this study, we focus on the transcriptome difference among PTCs, ATCs and normal tissue from a published dataset including 45 normal tissues, 49 PTCs and 11 ATCs, by applying a machine learning method, maximum relevance minimum redundancy, and identified 9 genes (BCL2, MRPS31, ID4, RASAL2, DLG2, MY01B, ZBTB5, PRKCQ and PPP6C) and 1 miscRNA (miscellaneous RNA, LOC646736) as important candidates involved in the progression of thyroid cancer. We further identified the protein-protein interaction (PPI) sub network from the shortest paths among the 9 genes in a PPI network constructed based on STRING database. Our results may provide insights to the molecular mechanism of the progression of thyroid cancer.	[Xu, Yaping; Deng, Yue; Ji, Zhenhua; Liu, Haibin; Liu, Yueyang; Peng, Hu; Wu, Jian; Fan, Jingping] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Naval Medical University	Wu, J (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.	jianwu2008@126.com; fanjingp@163.com			Foundation for Military Medicine, China [BWS11C035]	Foundation for Military Medicine, China	This work was funded by Foundation for Military Medicine, China (BWS11C035). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO;2-L; Aksoy M, 2005, ACTA CHIR BELG, V105, P644, DOI 10.1080/00015458.2005.11679794; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bachmann HS, 2007, CLIN CANCER RES, V13, P5790, DOI 10.1158/1078-0432.CCR-06-2673; Bachmann HS, 2011, INT J CANCER, V129, P2390, DOI 10.1002/ijc.25904; Chen GG, 2008, CURR CANCER DRUG TAR, V8, P367, DOI 10.2174/156800908785133150; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Copland JA, 2006, ONCOGENE, V25, P2304, DOI 10.1038/sj.onc.1209267; Cronin SJF, 2007, IMMUNOL REV, V220, P151, DOI 10.1111/j.1600-065X.2007.00570.x; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Deleu S, 2002, EXP CELL RES, V279, P62, DOI 10.1006/excr.2002.5589; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eberhardt NL, 2010, MOL CELL ENDOCRINOL, V321, P50, DOI 10.1016/j.mce.2009.10.013; Eun YG, 2011, CLIN EXP OTORHINOLAR, V4, P149, DOI 10.3342/ceo.2011.4.3.149; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Fujimoto J, 1998, STEROIDS, V63, P146, DOI 10.1016/S0039-128X(97)00157-8; Hebrant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037807; Heubner M, 2009, INT J BIOL MARKER, V24, P223, DOI 10.1177/172460080902400402; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kebebew E, 2004, J CLIN ENDOCR METAB, V89, P6105, DOI 10.1210/jc.2004-1234; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Leeman-Neill RJ, 2013, CANCER-AM CANCER SOC, V119, P1792, DOI 10.1002/cncr.27893; LEHRER SP, 1993, BREAST CANCER RES TR, V26, P175, DOI 10.1007/BF00689690; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Maha R, 2009, J RECEPT SIG TRANSD, V29, P113, DOI 10.1080/10799890902845682; Massart F, 2001, FERTIL STERIL, V75, P567, DOI 10.1016/S0015-0282(00)01760-X; McIver Bryan, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P221, DOI 10.2174/1568008043339802; Montero-Conde C, 2008, ONCOGENE, V27, P1554, DOI 10.1038/sj.onc.1210792; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rigolet M, 1998, DNA Res, V5, P309, DOI 10.1093/dnares/5.5.309; Rossi D, 2008, BLOOD, V111, P466, DOI 10.1182/blood-2007-08-106823; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Smallridge RC, 2009, ENDOCR-RELAT CANCER, V16, P17, DOI 10.1677/ERC-08-0154; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973	38	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94022	10.1371/journal.pone.0094022	http://dx.doi.org/10.1371/journal.pone.0094022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718460	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000068
J	Chen, WL; Chen, YM; Chu, HS; Lin, CT; Chow, LP; Chen, CT; Hu, FR				Chen, Wei-Li; Chen, Yan-Ming; Chu, Hsiao-Sang; Lin, Chung-Tien; Chow, Lu-Ping; Chen, Chih-Ta; Hu, Fung-Rong			Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL MATURATION; SUBCONJUNCTIVAL BEVACIZUMAB; ANTI-VEGF; OCULAR NEOVASCULARIZATION; MACULAR DEGENERATION; TYROSINE KINASE; PDGF-B; ANGIOGENESIS; INJECTION	Purpose: To evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bevacizumab on the inhibition of corneal neovascularization (NV). Methods: Corneal NV was induced by closed eye contact lens wear followed by a silk suture tarsorrhaphy in rabbits. Weekly subconjunctival injections of bevacizumab (5.0 mg) for 1 month were started immediately (early treatment group) or 1 month after induction of corneal NV with continuous induction (late treatment group). The severity of corneal NV was evaluated. Immunostaining was used to evaluate the intracorneal diffusion of bevacizumab, and the existence of pericytes and smooth muscle cells around the NV. The expression of AM-3K, an anti-macrophage antibody, vascular endothelial growth factor (VEGF) with its receptors (VEGFR1 and VEGFR2), and vascular endothelial apoptosis were also evaluated. Western blot analysis was performed to quantify the expression level of VEGF, VEGFR1 and VEGFR2 on corneal epithelium and stroma in different groups. Results: Early treatment with bevacizumab inhibited corneal NV more significantly than late treatment. Intracorneal diffusion of bevacizumab was not different among different groups. Immunostaining showed pericytes and smooth muscle cells around newly formed vessels as early as 2 weeks after induction. Immunostaining and Western blot analysis showed that VEGF, VEGFR1, and VEGFR2 on corneal stroma increased significantly in no treatment groups and late treatment groups, but not in early treatment group. Bevacizumab significantly inhibited macrophage infiltration in the early but not late treatment group. Sporadic vascular endothelial apoptosis was found at 4 weeks in the late but not early treatment group. Conclusions: Early but not late injection of bevacizumab inhibited corneal NV. Late injection of bevacizumab did not alter macrophage infiltration, and can't inhibit the expression of VEGF, VEGFR1, and VEGFR2 on corneal vessels. The inhibition of corneal NV in early treatment group does not occur via vascular endothelial apoptosis.	[Chen, Wei-Li; Chen, Yan-Ming; Chu, Hsiao-Sang; Hu, Fung-Rong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Wei-Li; Hu, Fung-Rong] Natl Taiwan Univ Hosp, Ctr Corneal Tissue Engn & Stem Cell Biol, Taipei, Taiwan; [Chen, Yan-Ming] I Shou Univ, E Da Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lin, Chung-Tien] Natl Taiwan Univ Hosp, Coll Bioresource & Agr, Dept Vet Med, Taipei, Taiwan; [Chow, Lu-Ping; Chen, Chih-Ta] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Hu, FR (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	fungronghu@ntu.edu.tw		HU, FUNG-RONG/0000-0002-2102-5317; Chen, Yan-Ming/0000-0003-4602-3243; CHOW, LU-PING/0000-0002-4420-211X; CHEN, WEI-LI/0000-0002-1538-2414	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital, Taipei, Taiwan [NTUH 97-S831, NTUH 98A103, NTUH-100S-1633]; National Science Council [NSC 97-2314-B-002-085-MY3]; Executive Yuan, Taiwan; E-Da Hospital/I-Shou University, Kaohsiung, Taiwan [EDAHP101004]	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); Executive Yuan, Taiwan; E-Da Hospital/I-Shou University, Kaohsiung, Taiwan	Supported, in part, by the National Taiwan University Hospital Plan Asia One and the Department of Medical Research at the NTUH, the Research Grant NTUH 97-S831, NTUH 98A103, NTUH-100S-1633, National Taiwan University Hospital, Taipei, Taiwan and Grant NSC 97-2314-B-002-085-MY3 from the National Science Council, the Executive Yuan, Taiwan, and EDAHP101004, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; ASHTON N, 1966, BRIT J OPHTHALMOL, V50, P119, DOI 10.1136/bjo.50.3.119; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Bachmann B, 2010, OPHTHALMOLOGY, V117, P1300, DOI 10.1016/j.ophtha.2010.01.039; Bahar I, 2008, CURR EYE RES, V33, P23, DOI 10.1080/02713680701799101; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; Benelli U, 1997, INVEST OPHTH VIS SCI, V38, P274; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Chen WL, 2009, CORNEA, V28, pS26, DOI 10.1097/ICO.0b013e3181ae8ff4; Chen WL, 2009, INVEST OPHTH VIS SCI, V50, P1659, DOI 10.1167/iovs.08-1997; Chu HS, 2011, CORNEA, V30, P60, DOI 10.1097/ICO.0b013e3181e458c5; COGAN DG, 1962, INVEST OPHTH VISUAL, V1, P253; Cursiefen C, 2005, AM J PATHOL, V166, P1367, DOI 10.1016/S0002-9440(10)62355-3; Cursiefen C, 2004, INVEST OPHTH VIS SCI, V45, P2666, DOI 10.1167/iovs.03-1380; Cursiefen C, 2003, BRIT J OPHTHALMOL, V87, P101, DOI 10.1136/bjo.87.1.101; Cursiefen C, 1998, CORNEA, V17, P611, DOI 10.1097/00003226-199811000-00008; DANA MR, 1995, CORNEA, V14, P604; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Dastjerdi MH, 2010, INVEST OPHTH VIS SCI, V51, P2411, DOI 10.1167/iovs.09-3745; Dell S, 2006, INVEST OPHTH VIS SCI, V47, P1928, DOI 10.1167/iovs.05-1071; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Dhar K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-209; Dineen SP, 2008, CANCER RES, V68, P4340, DOI 10.1158/0008-5472.CAN-07-6705; Fujita N, 2010, INVEST OPHTH VIS SCI, V51, P790, DOI 10.1167/iovs.09-3420; Fujita S, 2007, INVEST OPHTH VIS SCI, V48, P3051, DOI 10.1167/iovs.06-1083; Gee MS, 2003, AM J PATHOL, V162, P183, DOI 10.1016/S0002-9440(10)63809-6; Goede V, 1998, LAB INVEST, V78, P1385; Hosseini H, 2007, CLIN EXP OPHTHALMOL, V35, P745, DOI 10.1111/j.1442-9071.2007.01572.x; Hurmeric V, 2008, CORNEA, V27, P357, DOI 10.1097/ICO.0b013e318160d019; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Kim Sang Woo, 2008, Ophthalmology, V115, pe33, DOI 10.1016/j.ophtha.2008.02.013; Kim TI, 2008, CORNEA, V27, P349, DOI 10.1097/ICO.0b013e31815cf67d; Kohno RI, 2010, AM J OPHTHALMOL, V150, P223, DOI 10.1016/j.ajo.2010.03.016; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Kubota T, 2010, RETINA-J RET VIT DIS, V30, P468, DOI 10.1097/IAE.0b013e3181bd2d7b; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Li ZR, 2012, CORNEA, V31, P1028, DOI 10.1097/ICO.0b013e31823f8b40; Lin CT, 2010, INVEST OPHTH VIS SCI, V51, P6277, DOI 10.1167/iovs.09-4571; Manzano RPA, 2007, BRIT J OPHTHALMOL, V91, P804, DOI 10.1136/bjo.2006.107912; Mastyugin V, 2001, CURR EYE RES, V23, P1, DOI 10.1076/ceyr.23.1.1.5422; MCCRACKEN JS, 1979, LAB INVEST, V41, P519; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Michels S, 2005, OPHTHALMOLOGY, V112, P1035, DOI 10.1016/j.ophtha.2005.02.007; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; MOORE JW, 1985, AM J PATHOL, V120, P87; Moreno SF, 2008, BRIT J OPHTHALMOL, V92, P866; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nguyen QD, 2005, BRIT J OPHTHALMOL, V89, P1368, DOI 10.1136/bjo.2005.066431; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Nisancioglu MH, 2010, CANCER RES, V70, P5109, DOI 10.1158/0008-5472.CAN-09-4245; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Papathanassiou M, 2008, AM J OPHTHALMOL, V145, P424, DOI 10.1016/j.ajo.2007.11.003; Perez-Santonja JJ, 2010, AM J OPHTHALMOL, V150, P519, DOI 10.1016/j.ajo.2010.04.024; Philipp W, 2000, INVEST OPHTH VIS SCI, V41, P2514; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Safvati A, 2009, CURR EYE RES, V34, P501, DOI 10.1080/02713680902919557; Salnikov AV, 2006, INT J CANCER, V119, P2795, DOI 10.1002/ijc.22217; SCHLINGEMANN RO, 1990, AM J PATHOL, V136, P1393; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Yu LL, 2008, INVEST OPHTH VIS SCI, V49, P522, DOI 10.1167/iovs.07-1175; Zakaria N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036451; Zeng L, 1996, J PATHOL, V178, P207; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	77	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94205	10.1371/journal.pone.0094205	http://dx.doi.org/10.1371/journal.pone.0094205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714670	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900105
J	Rothwell, JA; Fillatre, Y; Martin, JF; Lyan, B; Pujos-Guillot, E; Fezeu, L; Hercberg, S; Comte, B; Galan, P; Touvier, M; Manach, C				Rothwell, Joseph A.; Fillatre, Yoann; Martin, Jean-Francois; Lyan, Bernard; Pujos-Guillot, Estelle; Fezeu, Leopold; Hercberg, Serge; Comte, Blandine; Galan, Pilar; Touvier, Mathilde; Manach, Claudine			New Biomarkers of Coffee Consumption Identified by the Non-Targeted Metabolomic Profiling of Cohort Study Subjects	PLOS ONE			English	Article							MASS-SPECTROMETRY; CARDIOVASCULAR-DISEASE; CAFFEINE; RISK; DISCOVERY; HEALTH; METAANALYSIS; FLAVONOIDS; CAFESTOL; KAHWEOL	Coffee contains various bioactives implicated with human health and disease risk. To accurately assess the effects of overall consumption upon health and disease, individual intake must be measured in large epidemiological studies. Metabolomics has emerged as a powerful approach to discover biomarkers of intake for a large range of foods. Here we report the profiling of the urinary metabolome of cohort study subjects to search for new biomarkers of coffee intake. Using repeated 24-hour dietary records and a food frequency questionnaire, 20 high coffee consumers (183-540 mL/d) and 19 low consumers were selected from the French SU.VI.MAX2 cohort. Morning spot urine samples from each subject were profiled by high-resolution mass spectrometry. Partial least-square discriminant analysis of multidimensional liquid chromatography-mass spectrometry data clearly distinguished high consumers from low via 132 significant (p-value<0.05) discriminating features. Ion clusters whose intensities were most elevated in the high consumers were annotated using online and in-house databases and their identities checked using commercial standards and MS-MS fragmentation. The best discriminants, and thus potential markers of coffee consumption, were the glucuronide of the diterpenoid atractyligenin, the diketopiperazine cyclo(isoleucyl-prolyl), and the alkaloid trigonelline. Some caffeine metabolites, such as 1-methylxanthine, were also among the discriminants, however caffeine may be consumed from other sources and its metabolism is subject to inter-individual variation. Receiver operating characteristics curve analysis showed that the biomarkers identified could be used effectively in combination for increased sensitivity and specificity. Once validated in other cohorts or intervention studies, these specific single or combined biomarkers will become a valuable alternative to assessment of coffee intake by dietary survey and finally lead to a better understanding of the health implications of coffee consumption.	[Rothwell, Joseph A.; Fillatre, Yoann; Martin, Jean-Francois; Lyan, Bernard; Pujos-Guillot, Estelle; Comte, Blandine; Manach, Claudine] INRA, CRNH Auvergne, Human Nutr Unit, UMR 1019, Clermont Ferrand, France; [Rothwell, Joseph A.; Fillatre, Yoann; Comte, Blandine; Manach, Claudine] Clermont Univ, Human Nutr Unit, Clermont Ferrand, France; [Martin, Jean-Francois; Lyan, Bernard; Pujos-Guillot, Estelle] INRA, Clermont Ferrand, France; [Fezeu, Leopold; Hercberg, Serge; Galan, Pilar; Touvier, Mathilde] Univ Paris 07, Univ Paris 05,CNAM, Epidemiol & Biostat Res Ctr,INSERM U1153,INRA U11, Nutrit Epidemiol Res Team,Univ Paris 13,Sorbonne, Bobigny, France	INRAE; INRAE; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Manach, C (corresponding author), INRA, CRNH Auvergne, Human Nutr Unit, UMR 1019, Clermont Ferrand, France.	claudine.manach@clermont.inra.fr	Rothwell, Joseph/AAN-1413-2021; Fezeu, Leopold/F-2804-2017; Touvier, Mathilde/E-8817-2017; Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Pilar, Galan/F-2908-2017	Rothwell, Joseph/0000-0002-6927-3360; Fezeu, Leopold/0000-0002-7589-3179; Touvier, Mathilde/0000-0002-8322-8857; Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Pilar, Galan/0000-0003-1706-3107; Comte, Blandine/0000-0002-4662-6581; Manach, Claudine/0000-0003-1094-3363; PUJOS-GUILLOT, Estelle/0000-0002-4693-5712; Fillatre, Yoann/0000-0002-2801-0337	French National Agency for Research [PhenoMeNEp-ANR-ALIA2010-007]; FEDER-Region Auvergne	French National Agency for Research(French National Research Agency (ANR)); FEDER-Region Auvergne	This work was supported by the French National Agency for Research (http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/): project PhenoMeNEp-ANR-ALIA2010-007, Phenotyping using Metabolomics for Nutritional Epidemiology. YF was supported by a FEDER-Region Auvergne postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Habori M, 1998, PHYTOTHER RES, V12, P233, DOI 10.1002/(SICI)1099-1573(199806)12:4&lt;233::AID-PTR294&gt;3.0.CO;2-V; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933; Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a; Briancon S, 2011, INT J EPIDEMIOL, V40, P1605, DOI 10.1093/ije/dyr161; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04; Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A; De Roos B, 1998, J INTERN MED, V244, P451, DOI 10.1111/j.1365-2796.1998.00386.x; de Zwart FJ, 2003, FOOD CHEM, V83, P197, DOI 10.1016/S0308-8146(03)00063-3; Garrett R, 2013, LWT-FOOD SCI TECHNOL, V50, P496, DOI 10.1016/j.lwt.2012.08.016; Ginz M, 2000, J AGR FOOD CHEM, V48, P3528, DOI 10.1021/jf991256v; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; Ito H, 2005, BRIT J NUTR, V94, P500, DOI 10.1079/BJN20051522; Jenab M, 2009, HUM GENET, V125, P507, DOI 10.1007/s00439-009-0662-5; Kesse-Guyot E, 2011, ANN NUTR METAB, V57, P153, DOI 10.1159/000321680; Kuhnle GGC, 2012, J SCI FOOD AGR, V92, P1145, DOI 10.1002/jsfa.5631; Lang R, 2011, MOL NUTR FOOD RES, V55, P1613, DOI 10.1002/mnfr.201000656; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Liu JX, 2013, MAYO CLIN PROC, V88, P1493, DOI 10.1016/j.mayocp.2013.10.003; Llorach R, 2009, J PROTEOME RES, V8, P5060, DOI 10.1021/pr900470a; MENNEN LI, 2006, BRIT J NUTR, V96, P191, DOI DOI 10.1079/BJN20061808; Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196; Nagy K, 2011, J CHROMATOGR A, V1218, P491, DOI 10.1016/j.chroma.2010.11.076; Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d; Obatomi DK, 1998, FOOD CHEM TOXICOL, V36, P335, DOI 10.1016/S0278-6915(98)00002-7; OBERMANN H, 1976, CHEM BER-RECL, V109, P3450, DOI 10.1002/cber.19761091024; Perez-Jimenez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096; Pujos-Guillot E, 2013, J PROTEOME RES, V12, P1645, DOI 10.1021/pr300997c; Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Silva JA, 2012, FOOD ANAL METHOD, V5, P1404, DOI 10.1007/s12161-012-9387-5; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1; Zamora-Ros R, 2013, BRIT J NUTR, V109, P1498, DOI 10.1017/S0007114512003273; Zhang R, 2012, CENT EUR J MED, V7, P310, DOI 10.2478/s11536-011-0154-6	42	82	83	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93474	10.1371/journal.pone.0093474	http://dx.doi.org/10.1371/journal.pone.0093474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713823	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900028
J	Zhou, T; Wang, T; Garcia, JGN				Zhou, Tong; Wang, Ting; Garcia, Joe G. N.			Genes Influenced by the Non-Muscle Isoform of Myosin Light Chain Kinase Impact Human Cancer Prognosis	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXPRESSION; MIGRATION; SURVIVAL; CLASSIFICATION; MDA-MB-231; GENECARDS; INVASION	The multifunctional non-muscle isoform of myosin light chain kinase (nmMLCK) is critical to the rapid dynamic coordination of the cytoskeleton involved in cancer cell proliferation and migration. We identified 45 nmMLCK-influenced genes by bioinformatic filtering of genome-wide expression in wild type and nmMLCK knockout (KO) mice exposed to preclinical models of murine acute inflammatory lung injury, pathologies that are well established to include nmMLCK as an essential participant. To determine whether these nmMLCK-influenced genes were relevant to human cancers, the 45 mouse genes were matched to 38 distinct human orthologs (M38 signature) (GeneCards definition) and underwent Kaplan-Meier survival analysis in training and validation cohorts. These studies revealed that in training cohorts, the M38 signature successfully identified cancer patients with poor overall survival in breast cancer (P<0.001), colon cancer (P<0.001), glioma (P<0.001), and lung cancer (P<0.001). In validation cohorts, the M38 signature demonstrated significantly reduced overall survival for high-score patients of breast cancer (P = 0.002), colon cancer (P = 0.035), glioma (P = 0.023), and lung cancer (P = 0.023). The association between M38 risk score and overall survival was confirmed by univariate Cox proportional hazard analysis of overall survival in the both training and validation cohorts. This study, providing a novel prognostic cancer gene signature derived from a murine model of nmMLCK-associated lung inflammation, strongly supports nmMLCK-involved pathways in tumor growth and progression in human cancers and nmMLCK as an attractive candidate molecular target in both inflammatory and neoplastic processes.	[Garcia, Joe G. N.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; Univ Arizona, Dept Med, Tucson, AZ USA	University of Arizona; University of Arizona	Garcia, JGN (corresponding author), Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA.	skipgarcia@email.arizona.edu			National Institutes of Health [HL91899, HL58064]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants HL91899 and HL58064 (JGNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Cui WJ, 2010, ACTA PHARMACOL SIN, V31, P725, DOI 10.1038/aps.2010.56; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DRISKA SP, 1981, AM J PHYSIOL, V240, pC222, DOI 10.1152/ajpcell.1981.240.5.C222; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Harrison SMW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-501; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Nutt CL, 2003, CANCER RES, V63, P1602; Parmigiani G, 2002, J ROY STAT SOC B, V64, P717, DOI 10.1111/1467-9868.00358; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pitroda SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046104; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; R Development Core Team, 2005, R LANG ENV STAT COMP; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Siegler J, 2011, AM J RESP CRIT CARE, V183, pA5084; Spans L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090002; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang B, 2013, BIOMED PHARMACOTHER, V67, P357, DOI 10.1016/j.biopha.2013.03.016; Wang T, 2014, AM J RESP C IN PRESS; Zhou XL, 2008, CANCER LETT, V270, P312, DOI 10.1016/j.canlet.2008.05.028	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94325	10.1371/journal.pone.0094325	http://dx.doi.org/10.1371/journal.pone.0094325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714365	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900116
J	El Khoury, M; Braga, J; Dumoncel, J; Nancy, J; Esclassan, R; Vaysse, F				El Khoury, Marwan; Braga, Jose; Dumoncel, Jean; Nancy, Javotte; Esclassan, Remi; Vaysse, Frederic			The Human Semicircular Canals Orientation Is More Similar to the Bonobos than to the Chimpanzees	PLOS ONE			English	Article							AFRICAN PLIOPLEISTOCENE HOMINIDS; GEOMETRIC MORPHOMETRIC-ANALYSIS; BONY LABYRINTH; SEXUAL-DIMORPHISM; FLUCTUATING ASYMMETRY; COMPUTED-TOMOGRAPHY; DIVERGENCE TIMES; WILD CHIMPANZEES; PAN-TROGLODYTES; HUMAN-EVOLUTION	For some traits, the human genome is more closely related to either the bonobo or the chimpanzee genome than they are to each other. Therefore, it becomes crucial to understand whether and how morphostructural differences between humans, chimpanzees and bonobos reflect the well known phylogeny. Here we comparatively investigated intra and extra labyrinthine semicircular canals orientation using 260 computed tomography scans of extant humans ( Homo sapiens), bonobos (Pan paniscus) and chimpanzees (Pan troglodytes). Humans and bonobos proved more similarities between themselves than with chimpanzees. This finding did not fit with the well established chimpanzee - bonobo monophyly. One hypothesis was convergent evolution in which bonobos and humans produce independently similar phenotypes possibly in response to similar selective pressures that may be associated with postural adaptations. Another possibility was convergence following a ``random walk'' (Brownian motion) evolutionary model. A more parsimonious explanation was that the bonobo-human labyrinthine shared morphology more closely retained the ancestral condition with chimpanzees being subsequently derived. Finally, these results might be a consequence of genetic diversity and incomplete lineage sorting. The remarkable symmetry of the Semicircular Canals was the second major finding of this article with possible applications in taphonomy. It has the potential to investigate altered fossils, inferring the probability of post-mortem deformation which can lead to difficulties in understanding taxonomic variation, phylogenetic relationships, and functional morphology.	[El Khoury, Marwan; Braga, Jose; Dumoncel, Jean; Esclassan, Remi; Vaysse, Frederic] Univ Toulouse, Mol Anthropol & Image Synth Lab, CNRS, Toulouse, France; [Nancy, Javotte] Univ Bordeaux, Fac Dent, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; UDICE-French Research Universities; Universite de Bordeaux	Vaysse, F (corresponding author), Univ Toulouse, Mol Anthropol & Image Synth Lab, CNRS, Toulouse, France.	frederic.vaysse@univ-toulouse.fr	esclassan, remi/ACX-5520-2022; Braga, Jose/A-4025-2010; Esclassan, Remi/K-5651-2019	Braga, Jose/0000-0002-8483-076X; Esclassan, Remi/0000-0002-6605-9967; Dumoncel, Jean/0000-0003-0789-7458	University of Toulouse; Molecular Anthropology and Image Synthesis laboratory	University of Toulouse; Molecular Anthropology and Image Synthesis laboratory	The research was funded by the University of Toulouse (http://www.univ-tlse3.fr/) and the Molecular Anthropology and Image Synthesis laboratory (http://www.anthropobiologie.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2012, AURIS NASUS LARYNX, V39, P451, DOI 10.1016/j.anl.2011.07.020; Arcadi AC, 2011, BEHAVIOUR, V148, P1419, DOI 10.1163/156853911X616062; Bradshaw AP, 2010, JARO-J ASSOC RES OTO, V11, P145, DOI 10.1007/s10162-009-0195-6; BRAGA J, 1995, CR ACAD SCI II, V320, P1025; Braga J, 1997, J HUM EVOL, V33, P423, DOI 10.1006/jhev.1997.0135; Braga J, 1998, AM J PHYS ANTHROPOL, V105, P121, DOI 10.1002/(SICI)1096-8644(199802)105:2<121::AID-AJPA2>3.0.CO;2-Y; Braga J, 2013, J HUM EVOL, V65, P447, DOI 10.1016/j.jhevol.2013.07.013; Brunet M, 2002, NATURE, V418, P801, DOI 10.1038/nature01005; COUSIN RP, 1981, B MEM SOC ANTHRO PAR, V8, P189, DOI 10.3406/bmsap.1981.3818; Crespi BJ, 1997, HEREDITY, V79, P624, DOI 10.1038/hdy.1997.208; D'Aout K, 2004, J ANAT, V204, P353, DOI 10.1111/j.0021-8782.2004.00292.x; DARDENNE J, 1970, THESIS U LILLE; DEBLOCK R, 1973, THESIS U LILLE; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; Durrleman S, 2012, J HUM EVOL, V62, P74, DOI 10.1016/j.jhevol.2011.10.004; Enard W, 2004, ANNU REV GENOM HUM G, V5, P351, DOI 10.1146/annurev.genom.5.061903.180040; Fenart R, 1973, Arch Anat Pathol (Paris), V21, P341; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Gomez-Robles A, 2013, P NATL ACAD SCI USA, V110, P18196, DOI 10.1073/pnas.1302653110; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gunz P, 2012, J ANAT, V220, P529, DOI 10.1111/j.1469-7580.2012.01493.x; Hobolth A, 2011, GENOME RES, V21, P349, DOI 10.1101/gr.114751.110; Hunt G, 2007, P NATL ACAD SCI USA, V104, P18404, DOI 10.1073/pnas.0704088104; Jensen-Seaman MI, 2001, J HERED, V92, P475, DOI 10.1093/jhered/92.6.475; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kinzey W.G., 1984, P65; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lebrun R, 2010, J ANAT, V216, P368, DOI 10.1111/j.1469-7580.2009.01177.x; Lee JY, 2013, ANAT REC, V296, P834, DOI 10.1002/ar.22664; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Marcus S, 2013, INT J PEDIATR OTORHI, V77, P1118, DOI 10.1016/j.ijporl.2013.04.013; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Osipov B, 2013, AM J PHYS ANTHROPOL, V151, P290, DOI 10.1002/ajpa.22279; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pontzer H, 2014, J HUM EVOL, V66, P64, DOI 10.1016/j.jhevol.2013.10.002; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Richard C, 2010, AURIS NASUS LARYNX, V37, P155, DOI 10.1016/j.anl.2009.04.014; Robinson C, 2012, J HUM EVOL, V63, P191, DOI 10.1016/j.jhevol.2012.05.003; SATO H, 1991, ACTA OTO-LARYNGOL, V111, P1037, DOI 10.3109/00016489109138447; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; SHEA BT, 1989, YEARB PHYS ANTHROPOL, V32, P69; SHEA BT, 1993, SCIENCE, V259, P293, DOI 10.1126/science.259.5093.293-a; Shipman P., 1981, LIFE HIST FOSSIL INT; Silcox MT, 2009, J HUM EVOL, V56, P315, DOI 10.1016/j.jhevol.2008.10.007; Skinner MM, 2009, AM J PHYS ANTHROPOL, V140, P234, DOI 10.1002/ajpa.21057; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; SPOOR F, 1995, J ANAT, V186, P271; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; SPOOR F, 1993, MONOGRAPH UTRECHT U; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Stone AC, 2010, PHILOS T R SOC B, V365, P3277, DOI 10.1098/rstb.2010.0096; Suwa G, 2009, SCIENCE, V326, P1, DOI DOI 10.1126/SCIENCE.1175825; UCHIDA A, 1996, PEABODY MUS B, V4; Videan EN, 2001, AM J PRIMATOL, V54, P233, DOI 10.1002/ajp.1033; Walker A, 2008, EVOL ANTHROPOL, V17, P135, DOI 10.1002/evan.20165; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709	64	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93824	10.1371/journal.pone.0093824	http://dx.doi.org/10.1371/journal.pone.0093824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710502	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800055
J	Sandkuijl, D; Kontenis, L; Coelho, NM; McCulloch, C; Barzda, V				Sandkuijl, Daaf; Kontenis, Lukas; Coelho, Nuno M.; McCulloch, Christopher; Barzda, Virginijus			Interferometric Backward Third Harmonic Generation Microscopy for Axial Imaging with Accuracy Beyond the Diffraction Limit	PLOS ONE			English	Article							TISSUES	A new nonlinear microscopy technique based on interference of backward- reflected third harmonic generation (I-THG) from multiple interfaces is presented. The technique is used to measure height variations or changes of a layer thickness with an accuracy of up to 5 nm. Height variations of a patterned glass surface and thickness variations of fibroblasts are visualized with the interferometric epi-THG microscope with an accuracy at least two orders of magnitude better than diffraction limit. The microscopy technique can be broadly applied for measuring distance variations between membranes or multilayer structures inside biological tissue and for surface height variation imaging.	[Sandkuijl, Daaf; Kontenis, Lukas; Barzda, Virginijus] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Sandkuijl, Daaf; Kontenis, Lukas; Barzda, Virginijus] Univ Toronto, Inst Opt Sci, Toronto, ON, Canada; [Sandkuijl, Daaf; Kontenis, Lukas; Barzda, Virginijus] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; [Coelho, Nuno M.; McCulloch, Christopher] Univ Toronto, Matrix Dynam Grp, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Mississauga; University of Toronto	Barzda, V (corresponding author), Univ Toronto, Dept Phys, Toronto, ON, Canada.	virgis.barzda@utoronto.ca	Coelho, Nuno/GZM-0851-2022	Coelho, Nuno/0000-0001-7128-1362	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge funding from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) and the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Barzda V, 2005, OPT EXPRESS, V13, P8263, DOI 10.1364/OPEX.13.008263; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Huland DM, 2013, BIOMED OPT EXPRESS, V4, P652, DOI 10.1364/BOE.4.000652; Konig K, 1997, OPT LETT, V22, P135, DOI 10.1364/OL.22.000135; Malacara D., 2007, OPTICAL SHOP TESTING; Mir M., 2012, PROGR OPTICS; Potma EO, 2003, J RAMAN SPECTROSC, V34, P642, DOI 10.1002/jrs.1045; Sandkuijl D, 2013, J OPT SOC AM B, V30, P382, DOI 10.1364/JOSAB.30.000382; Sandkuijl D, 2010, BIOMED OPT EXPRESS, V1, P895, DOI 10.1364/BOE.1.000895; Squier JA, 1998, OPT EXPRESS, V3, P315, DOI 10.1364/OE.3.000315; Tuer AE, 2011, J PHYS CHEM B, V115, P12759, DOI 10.1021/jp206308k	14	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94458	10.1371/journal.pone.0094458	http://dx.doi.org/10.1371/journal.pone.0094458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710103	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800148
J	Takasuka, TE; Acheson, JF; Bianchetti, CM; Prom, BM; Bergeman, LF; Book, AJ; Currie, CR; Fox, BG				Takasuka, Taichi E.; Acheson, Justin F.; Bianchetti, Christopher M.; Prom, Ben M.; Bergeman, Lai F.; Book, Adam J.; Currie, Cameron R.; Fox, Brian G.			Biochemical Properties and Atomic Resolution Structure of a Proteolytically Processed beta-Mannanase from Cellulolytic Streptomyces sp SirexAA- E	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; XYLANASE XYS1; HALSTEDII JM8; CELL-WALL; X-RAY; GENE; PURIFICATION; ENZYME; EXPRESSION; RETICULI	beta-mannanase SACTE_2347 from cellulolytic Streptomyces sp. SirexAA-E is abundantly secreted into the culture medium during growth on cellulosic materials. The enzyme is composed of domains from the glycoside hydrolase family 5 (GH5), fibronectin type-III (Fn3), and carbohydrate binding module family 2 (CBM2). After secretion, the enzyme is proteolyzed into three different, catalytically active variants with masses of 53, 42 and 34 kDa corresponding to the intact protein, loss of the CBM2 domain, or loss of both the Fn3 and CBM2 domains. The three variants had identical N-termini starting with Ala51, and the positions of specific proteolytic reactions in the linker sequences separating the three domains were identified. To conduct biochemical and structural characterizations, the natural proteolytic variants were reproduced by cloning and heterologously expressed in Escherichia coli. Each SACTE_2347 variant hydrolyzed only beta-1,4 mannosidic linkages, and also reacted with pure mannans containing partial galactosyl-and/ or glucosyl substitutions. Examination of the X-ray crystal structure of the GH5 domain of SACTE_2347 suggests that two loops adjacent to the active site channel, which have differences in position and length relative to other closely related mannanases, play a role in producing the observed substrate selectivity.	[Takasuka, Taichi E.; Bianchetti, Christopher M.; Prom, Ben M.; Bergeman, Lai F.; Book, Adam J.; Currie, Cameron R.; Fox, Brian G.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Takasuka, Taichi E.; Acheson, Justin F.; Bianchetti, Christopher M.; Bergeman, Lai F.; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Book, Adam J.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fox, BG (corresponding author), Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Acheson, Justin/0000-0001-5051-9984	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE))	This work was funded by the Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). The use of Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. W-31-109-ENG-38. The use of Life Science Collaborative Access Team at the Advanced Photon Source was supported by the College of Agricultural and Life Sciences, Department of Biochemistry, and Graduate School of the University of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adham SAI, 2001, ARCH MICROBIOL, V177, P91, DOI 10.1007/s00203-001-0365-3; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P1490, DOI 10.1107/S0907444904014313; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; ARCAND N, 1993, BIOCHEM J, V290, P857, DOI 10.1042/bj2900857; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Bianchetti CM, 2013, J BIOL CHEM, V288, P18574, DOI 10.1074/jbc.M113.475848; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel Paul G., 2009, V498, P55, DOI 10.1007/978-1-59745-196-3_4; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Ishimizu T, 2004, J BIOL CHEM, V279, P38555, DOI 10.1074/jbc.M406886200; Kumagai Y, 2012, BIOCHIMIE, V94, P2783, DOI 10.1016/j.biochi.2012.09.012; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Malek MA, 1995, MICROBIOS, V83, P229; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MOORMANN M, 1993, APPL ENVIRON MICROB, V59, P1573, DOI 10.1128/AEM.59.5.1573-1578.1993; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petkowicz CLD, 2001, CARBOHYD POLYM, V44, P107, DOI 10.1016/S0144-8617(00)00212-5; RuizArribas A, 1997, APPL ENVIRON MICROB, V63, P2983, DOI 10.1128/AEM.63.8.2983-2988.1997; RUIZARRIBAS A, 1995, APPL ENVIRON MICROB, V61, P2414, DOI 10.1128/AEM.61.6.2414-2419.1995; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; SCHLOCHTERMEIER A, 1992, MOL MICROBIOL, V6, P3611, DOI 10.1111/j.1365-2958.1992.tb01797.x; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Takasuka TE, 2014, METHODS MOL BIOL, V1118, P71, DOI 10.1007/978-1-62703-782-2_5; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; TAMARU Y, 1995, APPL ENVIRON MICROB, V61, P4454, DOI 10.1128/AEM.61.12.4454-4458.1995; Teleman A, 2003, CARBOHYD RES, V338, P525, DOI 10.1016/S0008-6215(02)00491-3; Tobimatsu Y, 2012, CHEMSUSCHEM, V5, P676, DOI 10.1002/cssc.201100573; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; WANG QP, 1993, J BIOL CHEM, V268, P14096; White A, 1996, NAT STRUCT BIOL, V3, P149, DOI 10.1038/nsb0296-149; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	49	15	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94166	10.1371/journal.pone.0094166	http://dx.doi.org/10.1371/journal.pone.0094166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710170	Green Published, Green Submitted, gold			2022-12-27	WOS:000334159800110
J	Borg, MK; Ivarsen, P; Brondum, E; Povlsen, JV; Aalkjaer, C				Borg, Morten K.; Ivarsen, Per; Brondum, Emil; Povlsen, Johan V.; Aalkjaer, Christian			Hemodynamics and Function of Resistance Arteries in Healthy Persons and End Stage Renal Disease Patients	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ENDOTHELIAL DYSFUNCTION; ESRD; VASODILATION; INFLAMMATION; VENTILATION; BIOMARKERS; STIFFNESS; MORTALITY; UREMIA	Introduction: Cardiovascular disease is the leading cause of death in patients with end stage renal disease (ESRD). The vasodilator mechanisms in small resistance arteries are in earlier studies shown to be reduced in patients with end stage renal disease. We studied whether endothelium dependent vasodilatation were diminished in ESRD patients and the interaction between the macro- and microcirculation. Methods: Eleven patients with ESRD had prior to renal transplant or insertion of peritoneal dialysis catheter measured pulse wave velocity. During surgery, a subcutaneous fat biopsy was extracted. Resistance arteries were then dissected and mounted on a wire myograph for measurements of dilator response to increasing concentrations of acetylcholine after preconstriction with noradrenaline. Twelve healthy kidney donors served as controls. Results: Systolic blood pressure was elevated in patients compared to the healthy controls; no difference in the concentration of asymmetric dimethyl arginine was seen. No significant difference in the endothelium dependent vasodilatation between patients and controls was found. Correlation of small artery properties showed an inverse relationship between diastolic blood pressure and nitric oxide dependent vasodilatation in controls. Pulse pressure was positively correlated to the total endothelial vasodilatation in patients. A negative association between S-phosphate and endothelial derived hyperpolarisation-like vasodilatation was seen in resistance arteries from controls. Conclusion: This study finds similar vasodilator properties in kidney patients and controls. However, correlations of pulse pressure and diastolic blood pressure with resistance artery function indicate compensating measures in the microcirculation during end stage renal disease.	[Borg, Morten K.; Brondum, Emil; Aalkjaer, Christian] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Ivarsen, Per; Povlsen, Johan V.] Aarhus Univ Hosp, Dept Renal Med, DK-8000 Aarhus, Denmark; [Ivarsen, Per; Povlsen, Johan V.] Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Aalkjaer, C (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	ca@fi.au.dk		Ivarsen, Per/0000-0001-9626-6070; Borg, Morten/0000-0002-6204-2623; Aalkjaer, Christian/0000-0003-2618-4015	P Carl Petersen Foundation; Danish Kidney Association	P Carl Petersen Foundation; Danish Kidney Association	The study was funded by the P Carl Petersen Foundation and the Danish Kidney Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALKJAER C, 1986, CLIN SCI, V71, P657, DOI 10.1042/cs0710657; [Anonymous], 2013, NEPHROL DIAL TRAN S1, V28, pi1; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; CLEMENSEN P, 1994, J APPL PHYSIOL, V76, P2832, DOI 10.1152/jappl.1994.76.6.2832; Damgaard M, 2005, CLIN PHYSIOL FUNCT I, V25, P142, DOI 10.1111/j.1475-097X.2005.00602.x; Foley RN, 1998, J NEPHROL, V11, P239; FRIEDMAN M, 1984, J APPL PHYSIOL, V56, P364, DOI 10.1152/jappl.1984.56.2.364; HALPERN W, 1977, J PHYSIOL-LONDON, V265, pP21; Isakova T, 2009, KIDNEY INT, V76, P705, DOI 10.1038/ki.2009.246; London GM, 2004, KIDNEY INT, V65, P700, DOI 10.1111/j.1523-1755.2004.00434.x; Luksha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036056; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Mallamaci F, 2005, KIDNEY INT, V67, P2330, DOI 10.1111/j.1523-1755.2005.00338.x; Morris STW, 2001, KIDNEY INT, V60, P1077, DOI 10.1046/j.1523-1755.2001.0600031077.x; Olsen MH, 2001, AM J HYPERTENS, V14, P861, DOI 10.1016/S0895-7061(01)02148-3; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Passauer J, 2005, J AM SOC NEPHROL, V16, P959, DOI 10.1681/ASN.2004070582; PETRINI MF, 1978, J APPL PHYSIOL, V44, P795, DOI 10.1152/jappl.1978.44.5.795; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/Y2012-073, 10.1139/y2012-073]; Tripepi G, 2011, CLIN J AM SOC NEPHRO, V6, P1714, DOI 10.2215/CJN.11291210; Verbeke FH, 2011, CLIN J AM SOC NEPHRO, V6, P2009, DOI 10.2215/CJN.01260211; Yilmaz MI, 2013, AM J NEPHROL, V37, P126, DOI 10.1159/000346711	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94638	10.1371/journal.pone.0094638	http://dx.doi.org/10.1371/journal.pone.0094638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722412	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100111
J	Cocuzza, CE; Piazza, F; Musumeci, R; Oggioni, D; Andreoni, S; Gardinetti, M; Fusco, L; Frigo, M; Banfi, P; Rottoli, MR; Confalonieri, P; Rezzonico, M; Ferro, MT; Cavaletti, G				Cocuzza, Clementina E.; Piazza, Fabrizio; Musumeci, Rosario; Oggioni, Davide; Andreoni, Simona; Gardinetti, Margherita; Fusco, Letizia; Frigo, Maura; Banfi, Paola; Rottoli, Maria R.; Confalonieri, Paolo; Rezzonico, Monica; Ferro, Maria T.; Cavaletti, Guido		EBV-MS Italian Study Grp	Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							NUCLEIC-ACID EXTRACTION; BRAIN; INFECTION; PCR; MS; ASSOCIATION; ACTIVATION; SYSTEM; EBV	The presence of Epstein-Barr Virus (EBV) DNA in cerebrospinal fluid (CSF) and peripheral blood (PB) samples collected from 55 patients with clinical and radiologically-active relapsing-remitting MS (RRMS) and 51 subjects with other neurological diseases was determined using standardized commercially available kits for viral nucleic acid extraction and quantitative EBV DNA detection. Both cell-free and cell-associated CSF and PB fractions were analyzed, to distinguish latent from lytic EBV infection. EBV DNA was detected in 5.5% and 18.2% of cell-free and cell-associated CSF fractions of patients with RRMS as compared to 7.8% and 7.8% of controls; plasma and peripheral blood mononuclear cells (PBMC) positivity rates were 7.3% and 47.3% versus 5.8% and 31.4%, respectively. No significant difference in median EBV viral loads of positive samples was found between RRMS and control patients in all tested samples. Absence of statistically significant differences in EBV positivity rates between RRMS and control patients, despite the use of highly sensitive standardized methods, points to the lack of association between EBV and MS disease activity.	[Cocuzza, Clementina E.; Piazza, Fabrizio; Musumeci, Rosario; Oggioni, Davide; Andreoni, Simona; Gardinetti, Margherita; Fusco, Letizia; Cavaletti, Guido] Univ Milano Bicocca, Dipartimento Chirurg & Med Traslaz, Monza, Italy; [Frigo, Maura] AOS Gerardo, Clin Neurol, Monza, Italy; [Banfi, Paola] Osped Circolo & Fdn Macchi, Dipartimento Neurol, Varese, Italy; [Rottoli, Maria R.] AO Osped Papa Giovanni XXIII, Ctr Sclerosi Multipla, Bergamo, Italy; [Confalonieri, Paolo] Fdn Ist Neurol Carlo Besta, Ctr Sclerosi Multipla, UO Neurol 4, Milan, Italy; [Rezzonico, Monica] AO St Anna, Dipartimento Neurol, Como, Italy; [Ferro, Maria T.] AO Osped Maggiore, Dipartimento Neurol, Ctr Sclerosi Multipla, Crema, Italy	University of Milano-Bicocca; Ospedale Circolo & Fondazione Macchi; ASST Papa Giovanni XXIII; IRCCS Istituto Neurologico Besta; Ospedale Sant'Anna di Como	Musumeci, R (corresponding author), Univ Milano Bicocca, Dipartimento Chirurg & Med Traslaz, Monza, Italy.		Cocuzza, Clementina Elvezia/AAE-2064-2019; Piazza, Fabrizio/L-2094-2016; Antozzi, Carlo/AAB-8787-2019; Musumeci, Rosario/B-8306-2008; Cavaletti, Guido/AAA-7063-2022; Confalonieri, Paolo/AAS-8513-2021; Andreetta, Francesca/J-9957-2018	Cocuzza, Clementina Elvezia/0000-0001-6166-1134; Piazza, Fabrizio/0000-0002-3385-3224; Antozzi, Carlo/0000-0001-9270-5224; Musumeci, Rosario/0000-0003-0143-3601; Cavaletti, Guido/0000-0003-4128-2406; Confalonieri, Paolo/0000-0001-8030-5725; Andreetta, Francesca/0000-0001-8239-8830	Univesrioty of Milano Bicocca	Univesrioty of Milano Bicocca	The study has been supported by Institutional research funds of the Univesrioty of Milano Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle SW, 2002, J CLIN VIROL, V25, pS79, DOI 10.1016/S1386-6532(02)00037-9; Alvarez R, 2000, Enferm Infecc Microbiol Clin, V18, P223; Alvarez-Lafuente R, 2008, MULT SCLER J, V14, P595, DOI 10.1177/1352458507086425; Alvarez-Lafuente R, 2006, BRAIN PATHOL, V16, P20, DOI 10.1111/j.1750-3639.2006.tb00558.x; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Broccolo F, 2008, J VIROL METHODS, V148, P48, DOI 10.1016/j.jviromet.2007.10.003; Denne C, 2007, EUR J PAEDIATR NEURO, V11, P29, DOI 10.1016/j.ejpn.2006.10.003; Dundas N, 2008, J MOL DIAGN, V10, P311, DOI 10.2353/jmoldx.2008.070149; Francesca P, 2009, DIAGN MICR INFEC DIS, V64, P158, DOI 10.1016/j.diagmicrobio.2009.02.013; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Germi R, 2012, J CLIN MICROBIOL, V50, P1384, DOI 10.1128/JCM.05593-11; Jaquiery E, 2010, EUR J IMMUNOL, V40, P878, DOI 10.1002/eji.200939761; Kim S, 2009, J VIROL METHODS, V162, P208, DOI 10.1016/j.jviromet.2009.08.007; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Lindsey JW, 2009, MULT SCLER J, V15, P153, DOI 10.1177/1352458508097920; Loens K, 2007, J CLIN MICROBIOL, V45, P421, DOI 10.1128/JCM.00894-06; Lucas RM, 2011, J NEUROL NEUROSUR PS, V82, P1142, DOI 10.1136/jnnp-2011-300174; Lucas RM, 2011, NEUROLOGY, V77, P371, DOI 10.1212/WNL.0b013e318227062a; Lunemann JD, 2009, TRENDS IMMUNOL, V30, P243, DOI 10.1016/j.it.2009.03.007; Lunemann JD, 2007, J VIROL, V78, P11; Mancuso R, 2010, J MED VIROL, V82, P1051, DOI 10.1002/jmv.21764; Owens GP, 2012, MULT SCLER J, V18, P1204, DOI 10.1177/1352458512448109; Peferoen LAN, 2010, BRAIN, V133, DOI 10.1093/brain/awp296; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Salvetti M, 2009, CURR OPIN NEUROL, V22, P201, DOI 10.1097/WCO.0b013e32832b4c8d; Santiago O, 2010, EUR J CLIN MICROBIOL, V29, P857, DOI 10.1007/s10096-010-0940-0; Sargsyan SA, 2010, NEUROLOGY, V74, P1127, DOI 10.1212/WNL.0b013e3181d865a1; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; Sotelo J, 2007, J NEUROL, V254, P493, DOI 10.1007/s00415-006-0402-x; Tzartos JS, 2012, NEUROLOGY, V78, P15, DOI 10.1212/WNL.0b013e31823ed057; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; Yang GY, 2011, J VIROL METHODS, V171, P195, DOI 10.1016/j.jviromet.2010.10.024	33	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94497	10.1371/journal.pone.0094497	http://dx.doi.org/10.1371/journal.pone.0094497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722060	Green Published, gold, Green Submitted			2022-12-27	WOS:000336909100084
J	Ye, J; Zhu, R; He, XS; Feng, YY; Yang, LL; Zhu, XY; Deng, QF; Wu, TC; Zhang, XM				Ye, Jian; Zhu, Rui; He, Xiaosheng; Feng, Yingying; Yang, Liangle; Zhu, Xiaoyan; Deng, Qifei; Wu, Tangchun; Zhang, Xiaomin			Association of Plasma IL-6 and Hsp70 with HRV at Different Levels of PAHs Metabolites	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; POLYCYCLIC AROMATIC-HYDROCARBONS; INFLAMMATORY MARKERS; AIR-POLLUTION; CARDIOVASCULAR-DISEASES; SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; HEAT-SHOCK-PROTEIN-70; EXPOSURE; ATHEROSCLEROSIS	Background: Exposure to polycyclic aromatic hydrocarbons (PAHs) is associated with reduced heart rate variability (HRV), a strong predictor of cardiovascular diseases, but the mechanism is not well understood. Objectives: We hypothesized that PAHs might induce systemic inflammation and stress response, contributing to altered cardiac autonomic function. Methods: HRV indices were measured using a 3-channel digital Holter monitor in 800 coke oven workers. Plasma levels of interleukin-6 (IL-6) and heat shock protein 70 (Hsp70) were determined using ELISA. Twelve urinary PAHs metabolites (OH-PAHs) were measured by gas chromatography-mass spectrometry. Results: We found that significant dose-dependent relationships between four urinary OH-PAHs and IL-6 (all P-trend<0.05); and an increase in quartiles of IL-6 was significantly associated with a decrease in total power (TP) and low frequency (LF) (P-trend = 0.014 and 0.006, respectively). In particular, elevated IL-6 was associated in a dose-dependent manner with decreased TP and LF in the high-PAHs metabolites groups (all P-trend<0.05), but not in the low-PAHs metabolites groups. No significant association between Hsp70 and HRV in total population was found after multivariate adjustment. However, increased Hsp70 was significantly associated with elevated standard deviation of NN intervals (SDNN), TP and LF in the low-PAHs metabolites groups (all P-trend<0.05). We also observed that both IL-6 and Hsp70 significantly interacted with multiple PAHs metabolites in relation to HRV. Conclusions: In coke oven workers, increased IL-6 was associated with a dose-response decreased HRV in the high-PAHs metabolites groups, whereas increase of Hsp70 can result in significant dose-related increase in HRV in the low-PAHs metabolites groups.	[Ye, Jian; He, Xiaosheng; Feng, Yingying; Yang, Liangle; Zhu, Xiaoyan; Deng, Qifei; Wu, Tangchun; Zhang, Xiaomin] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Ye, Jian; He, Xiaosheng; Feng, Yingying; Yang, Liangle; Zhu, Xiaoyan; Deng, Qifei; Wu, Tangchun; Zhang, Xiaomin] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Zhu, Rui] Huazhong Univ Sci & Technol, Dept Tradit Chinese Med, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, XM (corresponding author), Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China.	mingxz117@hust.edu.cn	Zhang, Xiaomin/F-3206-2018; Zhang, Xiaomin/GVT-8927-2022		Program for New Century Excellent Talents in University [NCET-10-0420]; National Natural Science Foundation of China [NNSFC 30972453, 81373093]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the funds from Program for New Century Excellent Talents in University (NCET-10-0420) and the National Natural Science Foundation of China (NNSFC 30972453 and 81373093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bielecka-Dabrowa A, 2009, EXPERT OPIN THER TAR, V13, P307, DOI [10.1517/14728220902725149 , 10.1517/14728220902725149]; Burstyn I, 2005, EPIDEMIOLOGY, V16, P744, DOI 10.1097/01.ede.0000181310.65043.2f; Chuang HC, 2012, TOXICOL LETT, V214, P131, DOI 10.1016/j.toxlet.2012.08.012; Clark JD, 2012, ENVIRON RES, V117, P132, DOI 10.1016/j.envres.2012.04.012; Delfino RJ, 2010, ENVIRON HEALTH PERSP, V118, P756, DOI 10.1289/ehp.0901407; Dulin E, 2010, CELL STRESS CHAPERON, V15, P929, DOI 10.1007/s12192-010-0201-2; Dybdahl B, 2005, HEART, V91, P299, DOI 10.1136/hrt.2003.028092; Everett CJ, 2010, ENVIRON RES, V110, P79, DOI 10.1016/j.envres.2009.09.010; Gidron Y, 2007, ATHEROSCLEROSIS, V195, pE1, DOI 10.1016/j.atherosclerosis.2006.10.009; Giffard RG, 2008, ANESTHESIOLOGY, V109, P339, DOI 10.1097/ALN.0b013e31817f4ce0; Gonzalez-Clemente JM, 2007, EUR J ENDOCRINOL, V157, P31, DOI 10.1530/EJE-07-0090; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Huang WL, 2006, TOXICOL LETT, V163, P10, DOI 10.1016/j.toxlet.2005.08.003; International Programme on Chemical Safety (IPCS), 1998, ENV HLTH CRIT; Lampert R, 2008, AM HEART J, V156, DOI 10.1016/j.ahj.2008.07.009; Lee MS, 2011, OCCUP ENVIRON MED, V68, P474, DOI 10.1136/oem.2010.055681; Li XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044562; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2010, J EXPO SCI ENV EPID, V20, P526, DOI 10.1038/jes.2009.41; Luttmann-Gibson H, 2010, OCCUP ENVIRON MED, V67, P625, DOI 10.1136/oem.2009.050625; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Pockley AG, 2009, CELL STRESS CHAPERON, V14, P545, DOI 10.1007/s12192-009-0113-1; Pockley AG, 2003, HYPERTENSION, V42, P235, DOI 10.1161/01.HYP.0000086522.13672.23; Rich DQ, 2012, ENVIRON HEALTH PERSP, V120, P1162, DOI 10.1289/ehp.1104262; Riojas-Rodriguez H, 2011, ENVIRON HEALTH PERSP, V119, P1301, DOI 10.1289/ehp.1002927; Satoh M, 2006, EUR J HEART FAIL, V8, P810, DOI 10.1016/j.ejheart.2006.03.004; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Tateishi Y, 2007, SHOCK, V28, P549, DOI 10.1097/shk.0b013e3180638d1; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; von Kanel R, 2008, BRAIN BEHAV IMMUN, V22, P461, DOI 10.1016/j.bbi.2007.09.009; von Kanel R, 2011, CLIN RES CARDIOL, V100, P241, DOI 10.1007/s00392-010-0236-5; Weichenthal S, 2011, ENVIRON HEALTH PERSP, V119, P1373, DOI 10.1289/ehp.1003321; Wu SW, 2010, ENVIRON HEALTH PERSP, V118, P87, DOI 10.1289/ehp.0900818; Xu XH, 2010, SCI TOTAL ENVIRON, V408, P4943, DOI 10.1016/j.scitotenv.2010.07.034; Yang XB, 2007, ENVIRON HEALTH PERSP, V115, P1573, DOI 10.1289/ehp.10104; Zanobetti A, 2010, ENVIRON HEALTH PERSP, V118, P324, DOI 10.1289/ehp.0901003; Zhang XM, 2010, CELL STRESS CHAPERON, V15, P675, DOI 10.1007/s12192-010-0180-3; Zhu JH, 2003, ARTERIOSCL THROM VAS, V23, P1055, DOI 10.1161/01.ATV.0000074899.60898.FD	39	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e92964	10.1371/journal.pone.0092964	http://dx.doi.org/10.1371/journal.pone.0092964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722336	Green Submitted, Green Published, gold			2022-12-27	WOS:000336909100012
J	Bao, H; Kommadath, A; Plastow, GS; Tuggle, CK; Guan, LL; Stothard, P				Bao, Hua; Kommadath, Arun; Plastow, Graham S.; Tuggle, Christopher K.; Guan, Le Luo; Stothard, Paul			MicroRNA Buffering and Altered Variance of Gene Expression in Response to Salmonella Infection	PLOS ONE			English	Article							RNA-BINDING PROTEINS; SINGLE-CELL; NETWORK; TARGET; STOCHASTICITY; CANALIZATION; ROBUSTNESS; IMPACT	One potential role of miRNAs is to buffer variation in gene expression, although conflicting results have been reported. To investigate the buffering role of miRNAs in response to Salmonella infection in pigs, we sequenced miRNA and mRNA in whole blood from 15 pig samples before and after Salmonella challenge. By analyzing inter-individual variation in gene expression patterns, we found that for moderately and lowly expressed genes, putative miRNA targets showed significantly lower expression variance compared with non-miRNA-targets. Expression variance between highly expressed miRNA targets and non-miRNA-targets was not significantly different. Further, miRNA targets demonstrated significantly reduced variance after challenge whereas non-miRNA-targets did not. RNA binding proteins (RBPs) are significantly enriched among the miRNA targets with dramatically reduced variance of expression after Salmonella challenge. Moreover, we found evidence that targets of young (less-conserved) miRNAs showed lower expression variance compared with targets of old (evolutionarily conserved) miRNAs. These findings point to the importance of a buffering effect of miRNAs for relatively lowly expressed genes, and suggest that the reduced expression variation of RBPs may play an important role in response to Salmonella infection.	[Bao, Hua; Kommadath, Arun; Plastow, Graham S.; Guan, Le Luo; Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Tuggle, Christopher K.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Alberta; Iowa State University	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca; stothard@ualberta.ca	Kommadath, Arun/I-4644-2019	Kommadath, Arun/0000-0003-3587-6670; Plastow, Graham/0000-0002-3774-3110	Applied Livestock Genomics Program [ALGP13]; Genome Alberta; Alberta Livestock and Meat Agency	Applied Livestock Genomics Program; Genome Alberta; Alberta Livestock and Meat Agency	This work is supported by the Applied Livestock Genomics Program (ALGP13) funded by Genome Alberta and Alberta Livestock and Meat Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-609; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Enright AJ, 2004, GENOME BIOL, V5; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Komurov K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-154; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li L, 2012, J INSECT PHYSIOL, V58, P1438, DOI 10.1016/j.jinsphys.2012.08.008; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mittal N, 2011, J MOL BIOL, V409, P466, DOI 10.1016/j.jmb.2011.03.064; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pelaez N, 2012, CURR TOP DEV BIOL, V99, P237, DOI 10.1016/B978-0-12-387038-4.00009-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; Woloshen V, 2011, J PATHOG, V2011, DOI 10.4061/2011/278697; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wu K., 2007, GLOBIN REDUCTION PRO; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S14; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127	43	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94352	10.1371/journal.pone.0094352	http://dx.doi.org/10.1371/journal.pone.0094352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718561	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000108
J	Costa, SCP; Lesser, CF				Costa, Sonia C. P.; Lesser, Cammie F.			A Multifunctional Region of the Shigella Type 3 Effector IpgB1 Is Important for Secretion from Bacteria and Membrane Targeting in Eukaryotic Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; VIRULENCE FACTORS; PSEUDOMONAS-EXOS; PROTEIN; INVASION; SYSTEM; MOTIF; IDENTIFICATION; LOCALIZATION; EXPRESSION	Type 3 secretion systems are complex nanomachines used by many Gram-negative bacteria to deliver tens of proteins (effectors) directly into host cells. Once delivered into host cells, effectors often target to specific cellular loci where they usurp host cell processes to their advantage. Here, using the yeast model system, we identify the membrane localization domain (MLD) of IpgB1, a stretch of 20 amino acids enriched for hydrophobic residues essential for the targeting of this effector to the plasma membrane. Embedded within these residues are ten that define the IpgB1 chaperone-binding domain for Spa15. As observed with dedicated class IA chaperones that mask hydrophobic MLDs, Spa15, a class IB chaperone, promotes IpgB1 stability by binding this hydrophobic region. However, despite being stable, an IpgB1 allele that lacks the MLD is not recognized as a secreted substrate. Similarly, deletion of the chaperone binding domains of IpgB1 and three additional Spa15-dependent effectors result in alleles that are no longer recognized as secreted substrates despite the presence of intact N-terminal secretion signal sequences. This is in contrast with MLD-containing effectors that bind class IA dedicated chaperones, as deletion of the MLD of these effectors alleviates the chaperone requirement for secretion. These observations indicate that at least for substrates of class IB chaperones, the chaperone-effector complex plays a major role in defining type 3 secreted proteins and highlight how a single region of an effector can play important roles both within prokaryotic and eukaryotic cells.	[Lesser, Cammie F.] Massachusetts Gen Hosp, Div Infect Dis, Dept Med Microbiol & Immunol, Cambridge, MA USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Lesser, CF (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Dept Med Microbiol & Immunol, Cambridge, MA USA.	clesser@mgh.harvard.edu			National Institutes of Health [R01 AI064285, R21 AI096134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064285, R21AI096134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was conducted through support from the National Institutes of Health (R01 AI064285 and R21 AI096134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Geissler B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00075; Hachani A, 2008, MICROBES INFECT, V10, P260, DOI 10.1016/j.micinf.2007.11.011; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Isaksson EL, 2009, INFECT IMMUN, V77, P4740, DOI 10.1128/IAI.00333-09; Klink BU, 2010, J BIOL CHEM, V285, P17197, DOI 10.1074/jbc.M110.107953; Knodler LA, 2011, CELL MICROBIOL, V13, P1497, DOI 10.1111/j.1462-5822.2011.01635.x; Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Ogawa M, 2003, MOL MICROBIOL, V48, P913, DOI 10.1046/j.1365-2958.2003.03489.x; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Rodgers L, 2010, J BACTERIOL, V12; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Valdivia R, 2004, EUKARYOT CELL, V3; Zhang Y, 2005, INFECT IMMUN, V73, P7938, DOI 10.1128/IAI.73.12.7938-7945.2005; Zhang Y, 2007, J BIOL CHEM, V282, P13022, DOI 10.1074/jbc.M606305200	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93461	10.1371/journal.pone.0093461	http://dx.doi.org/10.1371/journal.pone.0093461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718571	Green Published, Green Submitted, gold			2022-12-27	WOS:000334339000034
J	Ding, WX; Zhang, XF; Huang, HP; Ding, N; Zhang, SJ; Hutchinson, SZ; Zhang, XL				Ding, Wenxiao; Zhang, Xiaofeng; Huang, Hanpeng; Ding, Ning; Zhang, Shijiang; Hutchinson, Sean Z.; Zhang, Xilong			Adiponectin Protects Rat Myocardium against Chronic Intermittent Hypoxia-Induced Injury via Inhibition of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; LEFT-VENTRICULAR DYSFUNCTION; ISCHEMIA-REPERFUSION INJURY; ADIPOSE-SPECIFIC PROTEIN; DILATED CARDIOMYOPATHY; PRESSURE-OVERLOAD; INDUCED APOPTOSIS; CYTOCHROME-C; CELL-DEATH; HYPOADIPONECTINEMIA	Obstructive sleep apnea syndrome (OSAS) is associated with many cardiovascular disorders such as heart failure, hypertension, atherosclerosis, and arrhythmia and so on. Of the many associated factors, chronic intermittent hypoxia (CIH) in particular is the primary player in OSAS. To assess the effects of CIH on cardiac function secondary to OSAS, we established a model to study the effects of CIH on Wistar rats. Specifically, we examined the possible underlying cellular mechanisms of hypoxic tissue damage and the possible protective role of adiponectin against hypoxic insults. In the first treatment group, rats were exposed to CIH conditions (nadir O2, 5-6%) for 8 hours/day, for 5 weeks. Subsequent CIH-induced cardiac dysfunction was measured by echocardiograph. Compared with the normal control (NC) group, rats in the CIH-exposed group experienced elevated levels of left ventricular end-systolic dimension and left ventricular end-systolic volume and depressed levels of left ventricular ejection fraction and left ventricular fractional shortening (p<0.05). However, when adiponectin (Ad) was added in CIH + Ad group, we saw a rescue in the elevations of the aforementioned left ventricular function (p < 0.05). To assess critical cardiac injury, we detected myocardial apoptosis by Terminal deoxynucleotidyl transfer-mediated dUTP nick end-labeling (TUNEL) analysis. It was showed that the apoptosis percentage in CIH group (2.948%) was significantly higher than that in NC group (0.4167%) and CIH + Ad group (1.219%) (p<0.05). Protein expressions of cleaved caspase-3, cleaved caspase-9, and cleaved-caspase-12 validated our TUNEL results (p<0.05). Mechanistically, our results demonstrated that the proteins expressed with endoplasmic reticulum stress and the expression of reactive oxygen species (ROS) were significantly elevated under CIH conditions, whereas Ad supplementation partially decreased them. Overall, our results suggested that Ad augmentation could improve CIH-induced left ventricular dysfunction and associated myocardial apoptosis by inhibition of ROS-dependent ER stress.	[Ding, Wenxiao; Zhang, Xiaofeng; Huang, Hanpeng; Ding, Ning; Zhang, Xilong] Nanjing Med Univ, Affiliated Hosp 1, Dept Respirol, Nanjing, Jiangsu, Peoples R China; [Zhang, Shijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Hutchinson, Sean Z.] Morsani Coll Med, Tampa, FL USA	Nanjing Medical University	Zhang, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Respirol, Nanjing, Jiangsu, Peoples R China.	zhangxilong1952@163.com			National Natural Science Foundation of China [81370184, 81270312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81370184 and 81270312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVERSA P, 1993, CARDIOVASC RES, V27, P145, DOI 10.1093/cvr/27.2.145; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BELTRAMI CA, 1995, J MOL CELL CARDIOL, V27, P291, DOI 10.1016/S0022-2828(08)80028-4; Bian YF, 2011, J INVEST MED, V59, P921, DOI 10.2310/JIM.0b013e318216ad04; Bitter T, 2012, Herzschrittmacherther Elektrophysiol, V23, P22, DOI 10.1007/s00399-011-0164-8; Brisco Meredith A, 2010, Curr Heart Fail Rep, V7, P175, DOI 10.1007/s11897-010-0033-5; Chen L, 2005, AM J RESP CRIT CARE, V172, P915, DOI 10.1164/rccm.200504-560OC; Chen L, 2008, J APPL PHYSIOL, V104, P218, DOI 10.1152/japplphysiol.00301.2007; Chen L, 2010, J APPL PHYSIOL, V109, P1675, DOI 10.1152/japplphysiol.01372.2009; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Duda MK, 2007, CARDIOVASC RES, V76, P303, DOI 10.1016/j.cardiores.2007.07.002; Eymin B, 1997, CANCER RES, V57, P686; Frantz S, 2003, J MOL CELL CARDIOL, V35, P685, DOI 10.1016/S0022-2828(03)00113-5; Friedman AD, 1996, CANCER RES, V56, P3250; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hashimoto N, 2006, METABOLISM, V55, P1653, DOI 10.1016/j.metabol.2006.08.005; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang HP, 2012, SLEEP BREATH, V16, P505, DOI 10.1007/s11325-011-0532-y; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Kim SM, 2012, J CARDIOL, V60, P475, DOI 10.1016/j.jjcc.2012.07.007; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lam JCM, 2008, SLEEP, V31, P1721, DOI 10.1093/sleep/31.12.1721; Liu ZW, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-158; Lu DY, 2013, J BIOL CHEM, V288, P8491, DOI 10.1074/jbc.M112.442061; Lui MMS, 2012, J THORAC DIS, V4, P164, DOI 10.3978/j.issn.2072-1439.2012.01.06; Magalang UJ, 2006, ANTIOXID REDOX SIGN, V8, P2179, DOI 10.1089/ars.2006.8.2179; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Mocanu MM, 2000, BRIT J PHARMACOL, V130, P197, DOI 10.1038/sj.bjp.0703336; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Pedrosa RP, 2011, ARQ BRAS CARDIOL, V97, pE40; Peralta C, 2011, CURR MED CHEM, V18, P2016, DOI 10.2174/092986711795590039; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sawada T, 2010, J MOL CELL CARDIOL, V48, P1280, DOI 10.1016/j.yjmcc.2010.02.004; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Shim CY, 2010, YONSEI MED J, V51, P375, DOI 10.3349/ymj.2010.51.3.375; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Skurk C, 2008, EUR HEART J, V29, P1168, DOI 10.1093/eurheartj/ehn136; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Zhang XF, 2013, CHINESE MED J-PEKING, V126, P3270, DOI 10.3760/cma.j.issn.0366-6999.20131660; Zhang XL, 2004, CHINESE MED J-PEKING, V117, P1603	64	63	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94545	10.1371/journal.pone.0094545	http://dx.doi.org/10.1371/journal.pone.0094545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718591	Green Published, gold, Green Submitted			2022-12-27	WOS:000334339000131
J	Guo, WS; Yang, GW; Wu, W; He, L; Sun, MY				Guo, Wensheng; Yang, Guowu; Wu, Wei; He, Lei; Sun, Mingyu			A Parallel Attractor Finding Algorithm Based on Boolean Satisfiability for Genetic Regulatory Networks	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; SIMULATION; MODEL; PREDICTS	In biological systems, the dynamic analysis method has gained increasing attention in the past decade. The Boolean network is the most common model of a genetic regulatory network. The interactions of activation and inhibition in the genetic regulatory network are modeled as a set of functions of the Boolean network, while the state transitions in the Boolean network reflect the dynamic property of a genetic regulatory network. A difficult problem for state transition analysis is the finding of attractors. In this paper, we modeled the genetic regulatory network as a Boolean network and proposed a solving algorithm to tackle the attractor finding problem. In the proposed algorithm, we partitioned the Boolean network into several blocks consisting of the strongly connected components according to their gradients, and defined the connection between blocks as decision node. Based on the solutions calculated on the decision nodes and using a satisfiability solving algorithm, we identified the attractors in the state transition graph of each block. The proposed algorithm is benchmarked on a variety of genetic regulatory networks. Compared with existing algorithms, it achieved similar performance on small test cases, and outperformed it on larger and more complex ones, which happens to be the trend of the modern genetic regulatory network. Furthermore, while the existing satisfiability-based algorithms cannot be parallelized due to their inherent algorithm design, the proposed algorithm exhibits a good scalability on parallel computing architectures.	[Guo, Wensheng; Yang, Guowu] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China; [Guo, Wensheng; Wu, Wei; He, Lei] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Sun, Mingyu] Shanghai Univ Tradit Chinese Med, ShuGuang Hosp, Inst Liver Dis, Shanghai, Peoples R China; [Sun, Mingyu] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of Electronic Science & Technology of China; University of California System; University of California Los Angeles; Shanghai University of Traditional Chinese Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Guo, WS (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.	wensh7608@gmail.com; mysun248@hotmail.com			National Natural Science Foundation of China [81273729, 61272175]; National Basic Research 973 Program of China [2010CB328004]; Major Project of Shanghai Municipal ST Commission [11DZ1971702]; Wang Bao-En Hepatic Fibrosis Research fund [20100048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research 973 Program of China(National Basic Research Program of China); Major Project of Shanghai Municipal ST Commission; Wang Bao-En Hepatic Fibrosis Research fund	This work was partially supported by the National Natural Science Foundation of China (No. 81273729, 61272175), the National Basic Research 973 Program of China (No. 2010CB328004), the Major Project of Shanghai Municipal S&T Commission (No. 11DZ1971702), and Wang Bao-En Hepatic Fibrosis Research fund (20100048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2012, IEEE ACM T COMPUT BI, V9, P1410, DOI 10.1109/TCBB.2012.87; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; BRYANT RE, 1986, IEEE T COMPUT, V35, P677, DOI 10.1109/TC.1986.1676819; Chaos A, 2006, J PLANT GROWTH REGUL, V25, P278, DOI 10.1007/s00344-006-0068-8; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Cheng DH, 2011, COMMUN CONTROL ENG, P1, DOI 10.1007/978-0-85729-097-7; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Christoph Mussel MH, 2013, BOOLNET; Clarke E, 2001, FORM METHOD SYST DES, V19, P7, DOI 10.1023/A:1011276507260; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Dubrova E, 2005, IEEE IC CAD, P479, DOI 10.1109/ICCAD.2005.1560115; Dubrova E, 2011, IEEE ACM T COMPUT BI, V8, P1393, DOI 10.1109/TCBB.2010.20; Een N, 2004, LECT NOTES COMPUT SC, V2919, P502, DOI 10.1007/978-3-540-24605-3_37; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Filippone M, 2008, PATTERN RECOGN, V41, P176, DOI 10.1016/j.patcog.2007.05.018; Gabow HN, 2000, INFORM PROCESS LETT, V74, P107, DOI 10.1016/S0020-0190(00)00051-X; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; Johnson D. B., 1975, SIAM Journal on Computing, V4, P77, DOI 10.1137/0204007; Karl S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-306; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Krumsiek J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-233; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Mateti P., 1976, SIAM Journal on Computing, V5, P90, DOI 10.1137/0205007; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Zhao QC, 2005, IEEE T NEURAL NETWOR, V16, P1715, DOI 10.1109/TNN.2005.857944; Zhao Y, 2013, IEEE T AUTOMAT CONTR, V58, P1976, DOI 10.1109/TAC.2013.2251819; Zheng DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060593	34	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94258	10.1371/journal.pone.0094258	http://dx.doi.org/10.1371/journal.pone.0094258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718686	Green Submitted, gold, Green Published			2022-12-27	WOS:000334339000098
J	Yoon, JH; Won, JU; Ahn, YS; Roh, J				Yoon, Jin-Ha; Won, Jong-Uk; Ahn, Yeon-Soon; Roh, Jaehoon			Poor Lung Function Has Inverse Relationship with Microalbuminuria, an Early Surrogate Marker of Kidney Damage and Atherosclerosis: The 5(th) Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC INFLAMMATION; RISK-FACTOR; PREVALENCE; MORTALITY; COPD; MANIFESTATIONS; ASSOCIATION	Background: Despite epidemiological evidences of relationship between poor lung function and atherosclerosis, the relationship between poor lung function and microalbuminuria (MAU), an early surrogate marker of both kidney damage and atherosclerosis, is not well understood. Hence, we plan to investigate the relationship between poor lung function and MAU using multivariate models to adjust for other atherogenic risk factors. Methods: We used data from the 5(th) Korean National Health and Nutrition Examination Survey. Poor lung function is determined by spirometric measurement, primarily through estimation of the forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1). Declines in the percent predicted FVC (> 80%) and in the FEV1/ FVC ratio (> 0.7) are defined as restrictive and obstructive patterns, respectively. Urine albumin to urine creatinine levels ratio (UACR) were measured in spot urine samples. MAU was defined as UACR > 30 mg/g. Results: Inverse relationship was observed between lung function and UACR. In an age-adjusted regression model, the regression coefficient (B) of 10% lower FVC was 11.09 in men (P = 0.002), which remained significant after adjustment for SBP, FBG, triglyceride level, BMI, smoking history, and heavy alcohol consumption (B = 7.52, P = 0.043). When the restrictive pattern was compared to the normal pattern, the odds ratios (OR) (95% confidence interval, 95% CI) for MAU were 1.90 (1.32-2.72) in men, after adjustment for age, hypertension, diabetes mellitus, triglyceride level, obesity, smoking history, physical activity, and heavy alcohol consumption. Conclusions: Our study, the first investigation in Asia, demonstrated that the restrictive pattern is related to MAU in men. Furthermore, there was linear relationship between lower FVC and UACR. Thus, our current study suggests that poor lung function, particularly the restrictive pattern, is related to kidney damage as well as atherosclerosis.	[Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea; [Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Grad Sch Publ Hlth, Seoul, South Korea; [Ahn, Yeon-Soon] Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Dongguk University; NHIS Ilsan Hospital	Roh, J (corresponding author), Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea.	jhroh@yuhs.ac		Yoon, Jin-Ha/0000-0003-4198-2955; Won, Jong-Uk/0000-0002-9200-3297				Akpinar EE, 2012, TUBERK TORAK, V60, P230, DOI 10.5578/tt.4018; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Cerasola G, 2010, J HYPERTENS, V28, P2357, DOI 10.1097/HJH.0b013e32833ec377; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Curkendall SM, 2006, EUR J EPIDEMIOL, V21, P803, DOI 10.1007/s10654-006-9066-1; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Ferretti A, 2001, CHEST, V119, P1401, DOI 10.1378/chest.119.5.1401; Fimognari FL, 2010, CURR VASC PHARMACOL, V8, P573; Garg JP, 2002, VASC MED, V7, P35, DOI 10.1191/1358863x02vm412ra; Gruffydd-Jones K, 2011, PRIM CARE RESP J, V20, P199, DOI 10.4104/pcrj.2011.00011; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; JENSEN JS, 1995, CLIN SCI, V88, P629, DOI 10.1042/cs0880629; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076244; Lu Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-53; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Mannino DM, 2005, INT J TUBERC LUNG D, V9, P613; Mercken EM, 2005, AM J RESP CRIT CARE, V172, P994, DOI 10.1164/rccm.200411-1580OC; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Shibata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083725; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; van Gestel YRBM, 2010, RESP MED, V104, P712, DOI 10.1016/j.rmed.2009.10.027; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273; Yoo KH, 2011, RESPIROLOGY, V16, P659, DOI 10.1111/j.1440-1843.2011.01951.x; Yoon Jin-Ha, 2012, Toxicology and Environmental Health Sciences, V4, P139, DOI 10.1007/s13530-012-0128-3; Zhang YH, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/819584	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94125	10.1371/journal.pone.0094125	http://dx.doi.org/10.1371/journal.pone.0094125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718679	gold, Green Submitted, Green Published			2022-12-27	WOS:000334339000078
J	Cai, LY; He, HS; Wu, ZW; Lewis, BL; Liang, Y				Cai, Longyan; He, Hong S.; Wu, Zhiwei; Lewis, Benard L.; Liang, Yu			Development of Standard Fuel Models in Boreal Forests of Northeast China through Calibration and Validation	PLOS ONE			English	Article							GREAT XINGAN MOUNTAINS; MAPPING WILDLAND FUELS; FIRE SPREAD; SENSITIVITY-ANALYSIS; MEASUREMENT UNCERTAINTY; LANDSCAPE; BEHAVIOR; CLASSIFICATION; ACCUMULATION; PREDICTION	Understanding the fire prediction capabilities of fuel models is vital to forest fire management. Various fuel models have been developed in the Great Xing'an Mountains in Northeast China. However, the performances of these fuel models have not been tested for historical occurrences of wildfires. Consequently, the applicability of these models requires further investigation. Thus, this paper aims to develop standard fuel models. Seven vegetation types were combined into three fuel models according to potential fire behaviors which were clustered using Euclidean distance algorithms. Fuel model parameter sensitivity was analyzed by the Morris screening method. Results showed that the fuel model parameters 1-hour time-lag loading, dead heat content, live heat content, 1-hour time-lag SAV(Surface Area-to-Volume), live shrub SAV, and fuel bed depth have high sensitivity. Two main sensitive fuel parameters: 1-hour time-lag loading and fuel bed depth, were determined as adjustment parameters because of their high spatio-temporal variability. The FARSITE model was then used to test the fire prediction capabilities of the combined fuel models (uncalibrated fuel models). FARSITE was shown to yield an unrealistic prediction of the historical fire. However, the calibrated fuel models significantly improved the capabilities of the fuel models to predict the actual fire with an accuracy of 89%. Validation results also showed that the model can estimate the actual fires with an accuracy exceeding 56% by using the calibrated fuel models. Therefore, these fuel models can be efficiently used to calculate fire behaviors, which can be helpful in forest fire management.	[Cai, Longyan; He, Hong S.; Wu, Zhiwei; Liang, Yu] Univ Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [He, Hong S.; Lewis, Benard L.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Wu, ZW (corresponding author), Univ Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	sanbei82@163.com	Yu, Liang/AFO-1361-2022; Wu, Zhiwei/AHC-9115-2022	He, Hong S./0000-0002-3983-2512	National Natural Science Foundation of China [41071120, 31200362]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by The National Natural Science Foundation of China (Grant Nos. 41071120 and 31200362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini F.A, 1979, ESTIMATING WINDSPEED; ALBINI FA, 1986, COMBUST SCI TECHNOL, V48, P65, DOI 10.1080/00102208608923884; Anderson H. E., 1982, BARK BEETLES FUELS F, P143; Anderson HE, 1983, PREDICTING WIND DRIV; ANDREWS P.L, 2003, BEHAVEPLUS FIRE MODE; Andrews P.L., 1986, GEN TECHNICAL REPORT, P1; Arca B, 2005, VALIDATION FARSITE M; Arca B, 2007, INT J WILDLAND FIRE, V16, P563, DOI 10.1071/WF06070; Arroyo LA, 2008, FOREST ECOL MANAG, V256, P1239, DOI 10.1016/j.foreco.2008.06.048; BAKER WL, 1989, CAN J FOREST RES, V19, P700, DOI 10.1139/x89-109; Barton HA, 2007, TOXICOL SCI, V99, P395, DOI 10.1093/toxsci/kfm100; Burgan R, 1984, BEHAVE FIRE BEHAV PR; Burgan RE, 1987, CONCEPTS INTERPRETED; Carlson JD, 2003, INT J REMOTE SENS, V24, P1601, DOI 10.1080/01431160210144651; Chang Y, 2008, FOREST ECOL MANAG, V254, P445, DOI 10.1016/j.foreco.2007.04.050; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Chen Hong-wei, 2008, Shengtaixue Zazhi, V27, P50; Clark JS, 1988, EFFECT CLIMATE CHANG; de Zorzi P, 2002, ACCREDIT QUAL ASSUR, V7, P182, DOI 10.1007/s00769-002-0447-1; DODGE M, 1972, SCIENCE, V177, P139, DOI 10.1126/science.177.4044.139; Du JH, 2004, STUDY BASAL INFORM D; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fernandes PAM, 2001, FOREST ECOL MANAG, V144, P67, DOI 10.1016/S0378-1127(00)00363-7; Finney M.A., 1998, FARSITE FIRE AREA SI; Finney MA, 2003, INT J WILDLAND FIRE, V12, P167, DOI 10.1071/WF03010; Finney MA, 2009, FARSITE FIRE AREA SI; Finney MA, 1997, USE FARSITE SIMULATI, P17; Francos A, 2003, RELIAB ENG SYST SAFE, V79, P205, DOI 10.1016/S0951-8320(02)00231-4; Fujioka FM, 2002, INT J WILDLAND FIRE, V11, P193, DOI 10.1071/WF02004; Hu HaiQing, 2005, Scientia Silvae Sinicae, V41, P96; [胡天宇 Hu Tianyu], 2012, [生态学报, Acta Ecologica Sinica], V32, P6984; Iliopoulos N, 2013, ADV METEOROLOGY CLIM, P131; Keane RE, 2001, INT J WILDLAND FIRE, V10, P301, DOI 10.1071/WF01028; Lenhart T, 2002, PHYS CHEM EARTH, V27, P645, DOI 10.1016/S1474-7065(02)00049-9; [李月辉 LI YueHui], 2006, [生态学报, Acta Ecologica Sinica], V26, P3347; Liu Z, 2012, GLOBAL CHANGE BIOL; McCaw WL, 2002, FOREST ECOL MANAG, V158, P263, DOI 10.1016/S0378-1127(00)00719-2; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Palmer MD, 2011, INT J CLIMATOL, V31, P980, DOI 10.1002/joc.2224; Parsons RA, 2011, ECOL MODEL, V222, P679, DOI 10.1016/j.ecolmodel.2010.10.023; Phillips SD, 1998, PRECIS ENG, V22, P87, DOI 10.1016/S0141-6359(98)00006-3; Pierce KB, 2009, CAN J FOREST RES, V39, P1901, DOI 10.1139/X09-102; Pinel F, 2012, LECT NOTES COMPUT SC, V7053, P204, DOI 10.1007/978-3-642-25261-7_16; Ramsey MH, 1997, SCI TOTAL ENVIRON, V198, P243, DOI 10.1016/S0048-9697(97)05456-9; Reich RM, 2004, INT J WILDLAND FIRE, V13, P119, DOI 10.1071/WF02049; REVELLE W, 1979, MULTIVAR BEHAV RES, V14, P57, DOI 10.1207/s15327906mbr1401_4; Riccardi CL, 2007, CAN J FOREST RES, V37, P2394, DOI 10.1139/X07-143; Rothermel R., 1972, MATH MODEL PREDICTIN; Ryu SR, 2007, LANDSCAPE URBAN PLAN, V83, P275, DOI 10.1016/j.landurbplan.2007.05.002; SAINTARNAUD S, 2003, CURRENT SOCIOLOGY, V0051; Salis M, 2008, SENSITIVITY FIRE BEH; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Schladow SG, 1997, ECOL MODEL, V96, P111, DOI 10.1016/S0304-3800(96)00063-4; Scott JH, 2005, BARK BEETLES FUELS F, P66; Shan Y L, 2003, STUDY FOREST FUEL DA; Sparks JC, 2002, RESTOR ECOL, V10, P714, DOI 10.1046/j.1526-100X.2002.01052.x; Stephens SL, 1998, FOREST ECOL MANAG, V105, P21, DOI 10.1016/S0378-1127(97)00293-4; Stratton R.D, 2006, GUIDANCE SPATIAL WIL; Stratton RD, 2004, J FOREST, V102, P32; Van Wagtendonk JW., 1996, SIERRA NEVADA ECOSYS, VII, P1155; Wang XG, 2007, LANDSCAPE URBAN PLAN, V79, P84, DOI 10.1016/j.landurbplan.2006.03.010; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wu ZW, 2011, ENVIRON MANAGE, V48, P1148, DOI 10.1007/s00267-011-9707-3; Wu ZW, 2013, ENVIRON MANAGE, V52, P821, DOI 10.1007/s00267-013-0128-3; Wu ZW, 2013, SCI TOTAL ENVIRON, V454, P30, DOI 10.1016/j.scitotenv.2013.02.058; Xu H., 1997, ACTA ECOL SIN, V17, P337; Zhou Y., 1991, VEGETATION GREAT XIN	67	9	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94043	10.1371/journal.pone.0094043	http://dx.doi.org/10.1371/journal.pone.0094043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714164	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900073
J	Lu, X; Yang, HB; Shu, XM; Chen, F; Zhang, YL; Zhang, SG; Peng, QL; Tian, XL; Wang, GC				Lu, Xin; Yang, Hanbo; Shu, Xiaoming; Chen, Fang; Zhang, Yinli; Zhang, Sigong; Peng, Qinglin; Tian, Xiaolan; Wang, Guochun			Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyostis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CANCER-ASSOCIATED MYOSITIS; ANTI-P155 AUTOANTIBODY; INFLAMMATORY MYOPATHY; RETROSPECTIVE COHORT; KOREAN PATIENTS; RISK; ASSOCIATIONS; VASCULITIS; FIBROSIS; DISEASE	Objective: To define potential factors that could predict concomitant neoplastic diseases in patients diagnosed with PM/DM, which could inform screening decisions. Methods: Two researchers independently reviewed articles from Pubmed (MEDLINE), EMBASE, Cochrane Plus Library and ISI Web of Knowledge with no restrictions on study design or language. Given that some of the studies combined PM and DM patients as research subjects while others included only DM patients, data were subjected to meta-analyses for all combined PM/DM studies and studies that included only DM patients to obtain informative results. Results: For PM/DM patients, the following factors are all associated with an increased risk of malignancy: older age, age greater than 45, male sex, dysphagia, cutaneous necrosis, cutaneous vasculitis, rapid onset of myostis (<4 weeks), elevated CK, higher ESR, higher CRP levels. Several factors were associated with lower-than-average risk, including the presence of ILD, arthritis/arthralgia, Raynaud's syndrome, or anti-Jo-1 antibody. For DM patients, results indicated an increased risk of malignancy with older age, male sex, the presence of cutaneous necrosis, elevated ESR (>35 mm/hr), higher CRP levels, or anti-p155 antibody. In addition, the presence of anti-ENA antibodies seem to be related to reduced risk of malignancy. Conclusion: Awareness and implementation of early-stage cancer screening in PM/DM patients who have these identified factors - such as being older than 45, male sex, cutaneous necrosis, cutaneous vasculitis - are of crucial importance from public health and clinical perspectives and provide insight into the etiopathogenesis of CAM.	[Lu, Xin; Yang, Hanbo; Shu, Xiaoming; Chen, Fang; Zhang, Yinli; Zhang, Sigong; Peng, Qinglin; Tian, Xiaolan; Wang, Guochun] China Japan Friendship Hosp, Beijing, Peoples R China	China-Japan Friendship Hospital	Wang, GC (corresponding author), China Japan Friendship Hosp, Beijing, Peoples R China.	guochunwang@hotmail.com	Ming, Shu Xiao/AAF-3356-2019		Beijing Science and Technology Committee [Z111107058811084]	Beijing Science and Technology Committee	This work was supported by a Beijing Science and Technology Committee grant (No: Z111107058811084) (http://www.bjkw.gov.cn/n8785584/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2013, RHEUMATOLOGY; Aggarwal R, 2011, RHEUM DIS CLIN N AM, V37, P607, DOI 10.1016/j.rdc.2011.09.007; AIRIO A, 1995, J RHEUMATOL, V22, P1300; Amerio P, 2002, EUR J DERMATOL, V12, P165; Amoura Z, 2005, CANCER EPIDEM BIOMAR, V14, P1279, DOI 10.1158/1055-9965.EPI-04-0624; Andras C, 2008, J RHEUMATOL, V35, P438; Antiochos BB, 2009, J RHEUMATOL, V36, P2704, DOI 10.3899/jrheum.090549; Anzures-Cabrera J, 2011, STAT MED, V30, P2967, DOI 10.1002/sim.4298; Azuma K, 2011, MOD RHEUMATOL, V21, P178, DOI 10.1007/s10165-010-0362-y; Buchbinder R, 2001, ANN INTERN MED, V134, P1087, DOI 10.7326/0003-4819-134-12-200106190-00008; Buchbinder Rachelle, 2002, Curr Rheumatol Rep, V4, P415, DOI 10.1007/s11926-002-0087-9; de Souza FHC, 2012, REV BRAS REUMATOL, V52, P717, DOI 10.1590/S0482-50042012000500006; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; Ceribelli A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3822; Chen YJ, 2001, BRIT J DERMATOL, V144, P825, DOI 10.1046/j.1365-2133.2001.04140.x; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Chinoy H, 2007, ANN RHEUM DIS, V66, P1345, DOI 10.1136/ard.2006.068502; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUNCAN AG, 1991, ACTA DERM-VENEREOL, V71, P312; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fain O, 2007, ARTHRIT RHEUM-ARTHR, V57, P1473, DOI 10.1002/art.23085; Fardet L, 2009, ARCH DERMATOL, V145, P889, DOI 10.1001/archdermatol.2009.152; Fardet L, 2009, MEDICINE, V88, P91, DOI 10.1097/MD.0b013e31819da352; FELDMAN D, 1983, J RHEUMATOL, V10, P85; Fiorentino D, 2012, ARTHRITIS RHEUM-US, V64, P346, DOI 10.1002/art.33402; FRAIRE AE, 1973, CANCER-AM CANCER SOC, V31, P1078, DOI 10.1002/1097-0142(197305)31:5<1078::AID-CNCR2820310507>3.0.CO;2-1; Fujikawa K, 2009, SCAND J RHEUMATOL, V38, P263, DOI 10.1080/03009740802687455; Gunawardena H, 2008, RHEUMATOLOGY, V47, P324, DOI 10.1093/rheumatology/kem359; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6; HOGUE CJR, 1983, AM J EPIDEMIOL, V118, P396, DOI 10.1093/oxfordjournals.aje.a113646; Hosono Y, 2012, ARTHRITIS RHEUMATI S; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5, DOI 10.1164/ajrccm.161.1.9906062; Hunger RE, 2001, DERMATOLOGY, V202, P123, DOI 10.1159/000051611; Ikeda N, 2011, J DERMATOL, V38, P973, DOI 10.1111/j.1346-8138.2011.01262.x; Kaji K, 2007, RHEUMATOLOGY, V46, P25, DOI 10.1093/rheumatology/kel161; Kang EH, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-223; Kannan MA, 2013, NEUROL INDIA, V61, P152, DOI 10.4103/0028-3886.111121; KAWAI T, 1987, ACTA PATHOL JAPON, V37, P11; Labrador-Horrillo M, 2012, ANN RHEUM DIS, V71, P993, DOI 10.1136/annrheumdis-2011-200871; Lee SW, 2006, YONSEI MED J, V47, P519, DOI 10.3349/ymj.2006.47.4.519; Liu WC, 2010, ANN ACAD MED SINGAP, V39, P843; Marie I, 2012, AUTOIMMUN REV, V11, P739, DOI 10.1016/j.autrev.2012.01.006; Morris P, 2010, J PEDIAT HEMATOL ONC, V32, P189, DOI 10.1097/MPH.0b013e3181bf29a2; Ponyi A, 2005, ANN NY ACAD SCI, V1051, P64, DOI 10.1196/annals.1361.047; Prohic A, 2009, J EUR ACAD DERMATOL, V23, P591, DOI 10.1111/j.1468-3083.2008.02971.x; Rider LG, 2013, MEDICINE, V92, P223, DOI 10.1097/MD.0b013e31829d08f9; ROSE C, 1994, REV MED INTERNE, V15, P19, DOI 10.1016/S0248-8663(05)82125-3; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Selva-O'Callaghan A, 2002, ARTHRITIS RHEUM, V46, P2547, DOI 10.1002/art.10435; So MW, 2011, J RHEUMATOL, V38, P2432, DOI 10.3899/jrheum.110320; Sparsa A, 2002, ARCH DERMATOL, V138, P885, DOI 10.1001/archderm.138.7.885; Stockton D, 2001, BRIT J CANCER, V85, P41, DOI 10.1054/bjoc.2001.1699; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Targoff IN, 2006, ARTHRITIS RHEUM, V54, P3682, DOI 10.1002/art.22164; Trallero-Araguas E, 2012, ARTHRITIS RHEUM-US, V64, P523, DOI 10.1002/art.33379; Trallero-Araguas E, 2010, MEDICINE, V89, P47, DOI 10.1097/MD.0b013e3181ca14ff; Uchino M, 2013, CLIN NEUROL NEUROSUR, V115, P603, DOI 10.1016/j.clineuro.2012.07.019; Volkert J, 2013, AGEING RES REV, V12, P339, DOI 10.1016/j.arr.2012.09.004; Wakata N, 2002, INT J DERMATOL, V41, P729, DOI 10.1046/j.1365-4362.2002.01648.x; Witchalls J, 2012, BRIT J SPORT MED, V46, P515, DOI 10.1136/bjsports-2011-090137; Zampieri S, 2010, AUTOIMMUN REV, V9, P449, DOI 10.1016/j.autrev.2009.12.005	63	77	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94128	10.1371/journal.pone.0094128	http://dx.doi.org/10.1371/journal.pone.0094128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713868	gold, Green Published, Green Submitted			2022-12-27	WOS:000334160900089
J	Moore, D; Paquette, C; Shropshire, JD; Seier, E; Joplin, KH				Moore, Darrell; Paquette, Caleb; Shropshire, J. Dylan; Seier, Edith; Joplin, Karl H.			Extensive Reorganization of Behavior Accompanies Ontogeny of Aggression in Male Flesh Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FEEDING TERRITORIALITY; GENE-EXPRESSION; COSTS; SEX; AGE; EXPERIENCE; BENEFITS; INSECTS	Aggression, costly in both time and energy, is often expressed by male animals in defense of valuable resources such as food or potential mates. Here we present a new insect model system for the study of aggression, the male flesh fly Sarcophaga crassipalpis, and ask whether there is an ontogeny of aggression that coincides with reproductive maturity. After establishing that reproductive maturity occurs by day 3 of age (post-eclosion), we examined the behavior of socially isolated males from different age cohorts (days 1, 2, 3, 4, and 6) upon introduction, in a test arena, with another male of the same age. The results show a pronounced development of aggression with age. The change from relative indifference to heightened aggression involves a profound increase in the frequency of high-intensity aggressive behaviors between days 1 and 3. Also noteworthy is an abrupt increase in the number of statistically significant transitions involving these full-contact agonistic behaviors on day 2. This elevated activity is trimmed back somewhat by day 3 and appears to maintain a stable plateau thereafter. No convincing evidence was found for escalation of aggression nor the establishment of a dominance relationship over the duration of the encounters. Despite the fact that aggressive interactions are brief, lasting only a few seconds, a major reorganization in the relative proportions of four major non-aggressive behaviors (accounting for at least 96% of the total observation time for each age cohort) accompanies the switch from low to high aggression. A series of control experiments, with single flies in the test arenas, indicates that these changes occur in the absence of the performance of aggressive behaviors. This parallel ontogeny of aggressive and non-aggressive behaviors has implications for understanding how the entire behavioral repertoire may be organized and reorganized to accommodate the needs of the organism.	[Moore, Darrell; Paquette, Caleb; Shropshire, J. Dylan; Joplin, Karl H.] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA; [Seier, Edith] E Tennessee State Univ, Dept Math & Stat, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University	Moore, D (corresponding author), E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	moored@etsu.edu		Shropshire, Dylan/0000-0003-4221-2178; Seier, Edith/0000-0002-8519-9869	United States Department of Agriculture [2006-35302-7278]; Howard Hughes Medical Institute [52005872]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank the United States Department of Agriculture (2006-35302-7278) and the Howard Hughes Medical Institute (52005872) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier A, 2002, J EXP BIOL, V205, P1233; Bishop YM., 2007, DISCRETE MULTIVARIAT; Boroczky K, 2013, P NATL ACAD SCI USA, V110, P3615, DOI 10.1073/pnas.1212466110; Briffa M, 2008, P R SOC B, V275, P1305, DOI 10.1098/rspb.2008.0025; Brown J. L., 1964, Wilson Bulletin, V76, P160; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Carney GE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-288; CARPENTER FL, 1983, P NATL ACAD SCI-BIOL, V80, P7259, DOI 10.1073/pnas.80.23.7259; Castro N, 2006, AGGRESSIVE BEHAV, V32, P474, DOI 10.1002/ab.20147; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; DEJONG P, 1984, BIOMETRICS, V40, P101, DOI 10.2307/2530748; DELAMOTTE I, 1983, NATURWISSENSCHAFTEN, V70, P451, DOI 10.1007/BF01079611; Dierick HA, 2007, NAT PROTOC, V2, P2712, DOI 10.1038/nprot.2007.404; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Edwards DH, 1997, CURR OPIN NEUROBIOL, V7, P812, DOI 10.1016/S0959-4388(97)80140-7; Egge AR, 2011, BEHAV ECOL SOCIOBIOL, V65, P369, DOI 10.1007/s00265-010-1054-5; Ellis LL, 2011, GENETICS, V187, P157, DOI 10.1534/genetics.110.122754; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Gilbert C, 2007, J INSECT BEHAV, V20, P427, DOI 10.1007/s10905-007-9088-x; GILL FB, 1975, ECOLOGY, V56, P333, DOI 10.2307/1934964; HART DD, 1987, AM ZOOL, V27, P371; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; HOFFMANN AA, 1990, ANIM BEHAV, V40, P526, DOI 10.1016/S0003-3472(05)80533-0; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; Holdsworth AR, 2000, AM MIDL NAT, V143, P201, DOI 10.1674/0003-0031(2000)143[0201:MGAABT]2.0.CO;2; Issa FA, 2006, CURR BIOL, V16, P2217, DOI 10.1016/j.cub.2006.08.065; IVES AR, 1991, ECOL MONOGR, V61, P75, DOI 10.2307/1943000; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; JACOBS ME, 1978, BEHAV GENET, V8, P487, DOI 10.1007/BF01067478; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; Kain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2908; Kemp DJ, 2004, P ROY SOC B-BIOL SCI, V271, P1707, DOI 10.1098/rspb.2004.2775; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Lorenz K., 1966, AGGRESSION; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; Nichols JG, 2012, NEURON BRAIN; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Panhuis TM, 1999, BEHAV ECOL SOCIOBIOL, V46, P221, DOI 10.1007/s002650050613; Paquette C, 2008, PHYSIOL ENTOMOL, V33, P382, DOI 10.1111/j.1365-3032.2008.00646.x; PERES CA, 1989, BEHAV ECOL SOCIOBIOL, V25, P227, DOI 10.1007/BF00302922; PHILLIS RW, 1993, GENETICS, V133, P581; Ruedi EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006150; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; WHITHAM TG, 1986, ECOLOGY, V67, P139, DOI 10.2307/1938512; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zwarts L, 2011, P NATL ACAD SCI USA, V108, P17070, DOI 10.1073/pnas.1113877108	51	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93196	10.1371/journal.pone.0093196	http://dx.doi.org/10.1371/journal.pone.0093196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714439	Green Submitted, Green Published, gold			2022-12-27	WOS:000334160900017
J	Bell, MP; Renner, DN; Johnson, AJ; Pavelko, KD				Bell, Michael P.; Renner, Danielle N.; Johnson, Aaron J.; Pavelko, Kevin D.			An Elite Controller of Picornavirus Infection Targets an Epitope That Is Resistant to Immune Escape	PLOS ONE			English	Article							MURINE ENCEPHALOMYELITIS VIRUS; T-CELL RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; THEILERS VIRUS; DEMYELINATING DISEASE; PERSISTENT INFECTION; VIRAL PERSISTENCE; DANIELS STRAIN; DA STRAIN; IMMUNODOMINANCE	The emergence of novel viral pathogens can lead to devastating consequences in the infected population. However, on occasion, rare hyper-responsive elite controllers are able to mount a protective primary response to infection and clear the new pathogen. Factors distinguishing elite controllers from other members of the population are not completely understood. We have been using Theiler's murine encephalomyelitis as a model of primary infection in mice and clearance of the virus is limited to one MHC genotype capable of generating a protective response to a single viral peptide VP2(121-130). The genetics of host susceptibility to TMEV, a natural mouse pathogen, has been studied extensively and non-protective CD8 responses to other peptides have been documented, however, little is known why the protective response to infection focuses on the VP2(121- 130) peptide. To study this question, we have generated TMEV mutants that encode for mutations within the VP2(121- 130) peptide. We find that very few of mutants are able to assemble and infect in vitro. These mutations are not related to virus RNA structure since non-coding mutations do not interfere with assembly. In the rare event when functional VP2(121- 130) mutant viruses did emerge, they were attenuated to some level or retained the ability to develop an immune response to the wild-type VP2(121- 130) sequence, demonstrating that the virus is incapable of escaping the protective response. These findings advance our understanding of how characteristics of the host immune response and an infectious agent can interact to lead to the appearance of rare super controllers in a population. Furthermore, the immutable nature of the viral antigen highlights the importance of choosing appropriate vaccine antigens and has implications for the development of agents that are able to generate protective CD8 T-cell responses.	[Bell, Michael P.; Johnson, Aaron J.; Pavelko, Kevin D.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Johnson, Aaron J.] Mayo Clin, Mayo Grad Sch, Dept Neurol, Rochester, MN USA; [Renner, Danielle N.] Mayo Clin, Neurobiol Dis Program, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Pavelko, KD (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	pavelko.kevin@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315	National Institutes of Health [5R01CA104996-09]; NATIONAL CANCER INSTITUTE [R01CA104996, P50CA108961, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (5R01CA104996-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; AZOULAY A, 1994, J VIROL, V68, P4049, DOI 10.1128/JVI.68.6.4049-4052.1994; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Borson ND, 1997, J VIROL, V71, P5244, DOI 10.1128/JVI.71.7.5244-5250.1997; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Deb C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012478; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; Farrington LA, 2013, J IMMUNOL, V190, P3410, DOI 10.4049/jimmunol.1203151; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; GRANT RA, 1992, P NATL ACAD SCI USA, V89, P2061, DOI 10.1073/pnas.89.6.2061; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Jnaoui K, 1998, VIROLOGY, V244, P397, DOI 10.1006/viro.1998.9134; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Lewis MJ, 2012, J VIROL, V86, P7459, DOI 10.1128/JVI.06724-11; Liang Z, 2008, J VIROL, V82, P11545, DOI 10.1128/JVI.01160-08; Lienert K, 1996, IMMUNOL CELL BIOL, V74, P349, DOI 10.1038/icb.1996.62; Lin XQ, 1998, J VIROL, V72, P1262, DOI 10.1128/JVI.72.2.1262-1269.1998; Lipton HL, 2008, REV MED VIROL, V18, P347, DOI 10.1002/rmv.585; Lobert PE, 1999, P NATL ACAD SCI USA, V96, P11560, DOI 10.1073/pnas.96.20.11560; Lyman MA, 2002, J VIROL, V76, P3125, DOI 10.1128/JVI.76.7.3125-3134.2002; McCright IJ, 2002, J NEUROVIROL, V8, P100, DOI 10.1080/13550280290049561; Mendez-Fernandez YV, 2003, EUR J IMMUNOL, V33, P2501, DOI 10.1002/eji.200324007; Myoung J, 2007, VIROLOGY, V360, P159, DOI 10.1016/j.virol.2006.09.045; NICHOLSON SM, 1994, J NEUROIMMUNOL, V52, P19, DOI 10.1016/0165-5728(94)90157-0; Nikolich-Zugich J, 2004, MICROBES INFECT, V6, P501, DOI 10.1016/j.micinf.2004.01.006; Njenga MK, 1996, J VIROL, V70, P1729, DOI 10.1128/JVI.70.3.1729-1737.1996; Obar JJ, 2006, J VIROL, V80, P8303, DOI 10.1128/JVI.00237-06; Pavelko KD, 2003, J NEUROSCI, V23, P481, DOI 10.1523/JNEUROSCI.23-02-00481.2003; Pavelko KD, 2000, MOL CELL NEUROSCI, V15, P495, DOI 10.1006/mcne.2000.0843; Pavelko KD, 2007, BRAIN PATHOL, V17, P184, DOI 10.1111/j.1750-3639.2007.00062.x; Pavelko KD, 2013, MOL THER, V21, P1087, DOI 10.1038/mt.2013.52; Pavelko KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002541; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; PRITCHARD AE, 1992, VIROLOGY, V191, P469, DOI 10.1016/0042-6822(92)90212-8; RODRIGUEZ M, 1983, LAB INVEST, V49, P672; RODRIGUEZ M, 1986, J EXP MED, V163, P620, DOI 10.1084/jem.163.3.620; RODRIGUEZ M, 1985, J IMMUNOL, V135, P2145; ROOS RP, 1989, J VIROL, V63, P5492, DOI 10.1128/JVI.63.12.5492-5496.1989; Ruhl M, 2012, J VIROL, V86, P991, DOI 10.1128/JVI.05603-11; Sato S, 1996, VIROLOGY, V226, P327, DOI 10.1006/viro.1996.0660; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith CL, 2005, J IMMUNOL, V175, P8431, DOI 10.4049/jimmunol.175.12.8431; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; ZURBRIGGEN A, 1989, J EXP MED, V170, P2037, DOI 10.1084/jem.170.6.2037	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94332	10.1371/journal.pone.0094332	http://dx.doi.org/10.1371/journal.pone.0094332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710606	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800138
J	Liu, YQ; Chew, MH; Goh, XW; Tan, SY; Loi, CTT; Tan, YM; Law, HY; Koh, PK; Tang, CL				Liu, Yanqun; Chew, Min Hoe; Goh, Xue Wei; Tan, Soo Yong; Loi, Carol Tien Tau; Tan, Yuen Ming; Law, Hai Yang; Koh, Poh Koon; Tang, Choong Leong			Systematic Study on Genetic and Epimutational Profile of a Cohort of Amsterdam Criteria-Defined Lynch Syndrome in Singapore	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MUTATION DETECTION RATE; GENOMIC REARRANGEMENTS; PROMOTER METHYLATION; MSH2; MLH1; HNPCC; FAMILIES; PREDISPOSITION; GUIDELINES	Background: Germline defects of mismatch repair (MMR) genes underlie Lynch Syndrome (LS). We aimed to gain comprehensive genetic and epigenetic profiles of LS families in Singapore, which will facilitate efficient molecular diagnosis of LS in Singapore and the region. Methods: Fifty nine unrelated families were studied. Mutations in exons, splice-site junctions and promoters of five MMR genes were scanned by high resolution melting assay followed by DNA sequencing, large fragment deletions/duplications and promoter methylation in MLH1, MSH2, MSH6 and PMS2 were evaluated by multiplex ligation-dependent probe amplification. Tumor microsatellite instability (MSI) was assessed with five mononucleotide markers and immunohistochemical staining (IHC) was also performed. Results: Pathogenic defects, all confined to MLH1 and MSH2, were identified in 17 out of 59 (28.8%) families. The mutational spectrum was highly heterogeneous and 28 novel variants were identified. One recurrent mutation in MLH1 (c.793C>T) was also observed. 92.9% sensitivity for indication of germline mutations conferred by IHC surpassed 64.3% sensitivity by MSI. Furthermore, 15.6% patients with MSS tumors harbored pathogenic mutations. Conclusions: Among major ethnic groups in Singapore, all pathogenic germline defects were confined to MLH1 and MSH2. Caution should be applied when the Amsterdam criteria and consensus microsatellite marker panel recommended in the revised Bethesda guidelines are applied to the local context. We recommend a screening strategy for the local LS by starting with tumor IHC and the hotspot mutation testing at MLH1 c.793C>T followed by comprehensive mutation scanning in MLH1 and MSH2 prior to proceeding to other MMR genes.	[Liu, Yanqun; Chew, Min Hoe; Goh, Xue Wei; Loi, Carol Tien Tau; Koh, Poh Koon; Tang, Choong Leong] Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore; [Tan, Soo Yong] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Tan, Yuen Ming; Law, Hai Yang] KK Womens & Childrens Hosp, Dept Paediat Med, Singapore, Singapore	Singapore General Hospital; Singapore General Hospital; KK Women's & Children's Hospital	Liu, YQ (corresponding author), Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore.	liu.yan.qun@sgh.com.sg		Tan, Soo-Yong/0000-0002-6348-2823	Biomedical Research Council, Singapore [08/1/27/19/572]	Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR))	The present study was financially supported by a grant from Biomedical Research Council, Singapore (No. 08/1/27/19/572, website www.a-star.edu.sg/bmrc). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; Baudhuin LM, 2005, GASTROENTEROLOGY, V129, P846, DOI 10.1053/j.gastro.2005.06.026; Bonis Peter A, 2007, Evid Rep Technol Assess (Full Rep), P1; Chan TL, 2004, AM J HUM GENET, V74, P1035, DOI 10.1086/383591; Chew MH, 2008, ANZ J SURG, V78, P556, DOI 10.1111/j.1445-2197.2008.04570.x; Di Fiore F, 2004, J MED GENET, V41, P18, DOI 10.1136/jmg.2003.012062; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Domingo E, 2004, J MED GENET, V41, P664, DOI 10.1136/jmg.2004.020651; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evans DG, 2007, SEMIN ONCOL, V34, P411, DOI 10.1053/j.seminoncol.2007.07.001; Evans GD, 2006, J CLIN ONCOL, V24, P1960, DOI 10.1200/JCO.2005.05.3207; Funkhouser WK, 2012, J MOL DIAGN, V14, P91, DOI 10.1016/j.jmoldx.2011.11.001; Jensen LH, 2008, COLORECTAL DIS, V10, P490, DOI 10.1111/j.1463-1318.2007.01378.x; Joensuu EI, 2008, CANCER RES, V68, P4597, DOI 10.1158/0008-5472.CAN-07-6645; Lee SC, 2005, CLIN GENET, V68, P137, DOI 10.1111/j.1399-0004.2005.00469.x; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Liu YQ, 2008, CANCER BIOMARK, V4, P111, DOI 10.3233/CBM-2008-4207; Nakagawa H, 2009, ONCOL REP, V21, P1577, DOI 10.3892/or_00000390; Nakahara M, 1997, CANCER EPIDEM BIOMAR, V6, P1057; Park JG, 2002, INT J COLORECTAL DIS, V17, P109, DOI 10.1007/s003840100348; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Plaschke J, 2003, J MED GENET, V40, P597, DOI 10.1136/jmg.40.8.597; Rumilla K, 2011, J MOL DIAGN, V13, P93, DOI 10.1016/j.jmoldx.2010.11.011; Shia J, 2008, J MOL DIAGN, V10, P293, DOI 10.2353/jmoldx.2008.080031; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tang R, 2009, CLIN GENET, V75, P334, DOI 10.1111/j.1399-0004.2009.01162.x; Thodi G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-544; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Wang XL, 2006, WORLD J GASTROENTERO, V12, P4074, DOI 10.3748/wjg.v12.i25.4074; Wei WQ, 2010, J BIOINFORM COMPUT B, V8, P111, DOI 10.1142/S0219720010005154; Xicola R.M., 2009, COLORECTAL CANC EARL, P149	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94170	10.1371/journal.pone.0094170	http://dx.doi.org/10.1371/journal.pone.0094170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710284	Green Published, gold, Green Submitted			2022-12-27	WOS:000334159800111
J	Garcia-Sherman, MC; Lysak, N; Filonenko, A; Richards, H; Sobonya, RE; Klotz, SA; Lipke, PN				Garcia-Sherman, Melissa C.; Lysak, Nataliya; Filonenko, Alexandra; Richards, Hazel; Sobonya, Richard E.; Klotz, Stephen A.; Lipke, Peter N.			Peptide Detection of Fungal Functional Amyloids in Infected Tissue	PLOS ONE			English	Article							CANDIDA-ALBICANS ADHESIN; ALS PROTEIN FAMILY; INVASIVE CANDIDIASIS; MICROBIAL AMYLOIDS; FORMING SEQUENCES; BIOFILM FORMATION; GENE-EXPRESSION; HOST; NANODOMAINS; DIVERSITY	Many fungal cell adhesion proteins form functional amyloid patches on the surface of adhering cells. The Candida albicans Agglutinin-like sequence (Als) adhesins are exemplars for this phenomenon, and have amyloid forming sequences that are conserved between family members. The Als5p amyloid sequence mediates amyloid fibril formation and is critical for cell adhesion and biofilm formation, and is also present in the related adhesins Als1p and Als3p. We have developed a fluorescent peptide probe containing the conserved Als amyloid-forming sequence. This peptide bound specifically to yeast expressing Als5p, but not to cells lacking the adhesin. The probe bound to both yeast and hyphal forms of C. albicans. Delta als1/Delta als3 single and double deletion strains exhibited reduced fluorescence, indicating that probe binding required expression of these proteins. Additionally, the Als peptide specifically stained fungal cells in abscesses in autopsy sections. Counterstaining with calcofluor white showed colocalization with the amyloid peptide. In addition, fungi in autopsy sections derived from the gastrointestinal tract showed colocalization of the amyloid-specific dye thioflavin T and the fluorescent peptide. Collectively, our data demonstrate that we can exploit amyloid sequence specificity for detection of functional amyloids in situ.	[Garcia-Sherman, Melissa C.; Lysak, Nataliya; Filonenko, Alexandra; Richards, Hazel; Lipke, Peter N.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Sobonya, Richard E.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Klotz, Stephen A.] Univ Arizona, Div Infect Dis, Tucson, AZ USA	City University of New York (CUNY) System; Brooklyn College (CUNY); University of Arizona; University of Arizona	Garcia-Sherman, MC (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	mgarcia@brooklyn.cuny.edu	Fowler, James H/C-2750-2008; Moro, Esteban/AAB-1159-2019; Lipke, Peter N./AAW-4914-2020; Garcia-Herranz, Manuel/ABB-2617-2021; Garcia-Herranz, Manuel/L-3213-2013	Fowler, James H/0000-0001-7795-1638; Moro, Esteban/0000-0003-2894-1024; Lipke, Peter N./0000-0003-1733-0690; Garcia-Sherman, Melissa/0000-0003-1409-4397; Garcia-Herranz, Manuel/0000-0002-4252-4975	National Institutes of Health [R01 GM098616, SC1 GM083756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM098616 and SC1 GM083756 to PNL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035305; Alsteens D, 2012, ACS NANO, V6, P7703, DOI 10.1021/nn3025699; Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Aoki W, 2012, FEMS IMMUNOL MED MIC, V65, P121, DOI 10.1111/j.1574-695X.2012.00941.x; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bois M, 2013, EUKARYOT CELL, V12, P703, DOI 10.1128/EC.00020-13; Chauhan Neeraj, 2009, V499, P197, DOI 10.1007/978-1-60327-151-6_18; Cheng G, 2005, INFECT IMMUN, V73, P1656, DOI 10.1128/IAI.73.3.1656-1663.2005; Dong JH, 2010, NEUROPHARMACOLOGY, V59, P268, DOI 10.1016/j.neuropharm.2010.04.007; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frank AT, 2010, EUKARYOT CELL, V9, P405, DOI 10.1128/EC.00235-09; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Ganguly S, 2011, CURR OPIN MICROBIOL, V14, P380, DOI 10.1016/j.mib.2011.06.001; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; GAUTAM H, 2010, J INT ASS PHYS AIDS, P38112; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Gilchrist KB, 2012, J INFECT DIS, V206, P1473, DOI 10.1093/infdis/jis464; Green CB, 2006, MED MYCOL, V44, P103, DOI 10.1080/13693780500086527; Harriott MM, 2010, ANTIMICROB AGENTS CH, V54, P3746, DOI 10.1128/AAC.00573-10; Hoyer LL, 2001, YEAST, V18, P49, DOI 10.1002/1097-0061(200101)18:1&lt;49::AID-YEA646&gt;3.0.CO;2-M; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Morris KL, 2013, BIOCHEM J, V450, P275, DOI 10.1042/BJ20121773; Murciano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033362; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Pepys MB, 2012, J INFECT DIS, V206, P1339, DOI 10.1093/infdis/jis521; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606; Salgado PS, 2011, P NATL ACAD SCI USA, V108, P15775, DOI 10.1073/pnas.1103496108; Schwartz K, 2013, CURR OPIN MICROBIOL, V16, P93, DOI 10.1016/j.mib.2012.12.001; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Silverman RJ, 2010, INFECT IMMUN, V78, P4644, DOI 10.1128/IAI.00685-10; SOLL DR, 1991, J CLIN MICROBIOL, V29, P1702, DOI 10.1128/JCM.29.8.1702-1710.1991; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Tokuraku K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008492; TUKEL C, 2009, CELL HOST, P38112; Zhao X, 2007, MED MYCOL, V45, P429, DOI 10.1080/13693780701377162	51	58	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86067	10.1371/journal.pone.0086067	http://dx.doi.org/10.1371/journal.pone.0086067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24718030	Green Published, gold			2022-12-27	WOS:000330244500173
J	Jia, H; Pustovyy, OM; Waggoner, P; Beyers, RJ; Schumacher, J; Wildey, C; Barrett, J; Morrison, E; Salibi, N; Denney, TS; Vodyanoy, VJ; Deshpande, G				Jia, Hao; Pustovyy, Oleg M.; Waggoner, Paul; Beyers, Ronald J.; Schumacher, John; Wildey, Chester; Barrett, Jay; Morrison, Edward; Salibi, Nouha; Denney, Thomas S.; Vodyanoy, Vitaly J.; Deshpande, Gopikrishna			Functional MRI of the Olfactory System in Conscious Dogs	PLOS ONE			English	Article							ADENYLATE-CYCLASE ACTIVITY; HUMAN BRAIN; SIGNAL CHANGES; FMRI; ACTIVATION; RESPONSES; CORTEX; BULB; RAT; STIMULATION	We depend upon the olfactory abilities of dogs for critical tasks such as detecting bombs, landmines, other hazardous chemicals and illicit substances. Hence, a mechanistic understanding of the olfactory system in dogs is of great scientific interest. Previous studies explored this aspect at the cellular and behavior levels; however, the cognitive-level neural substrates linking them have never been explored. This is critical given the fact that behavior is driven by filtered sensory representations in higher order cognitive areas rather than the raw odor maps of the olfactory bulb. Since sedated dogs cannot sniff, we investigated this using functional magnetic resonance imaging of conscious dogs. We addressed the technical challenges of head motion using a two pronged strategy of behavioral training to keep dogs' head as still as possible and a single camera optical head motion tracking system to account for residual jerky movements. We built a custom computer-controlled odorant delivery system which was synchronized with image acquisition, allowing the investigation of brain regions activated by odors. The olfactory bulb and piriform lobes were commonly activated in both awake and anesthetized dogs, while the frontal cortex was activated mainly in conscious dogs. Comparison of responses to low and high odor intensity showed differences in either the strength or spatial extent of activation in the olfactory bulb, piriform lobes, cerebellum, and frontal cortex. Our results demonstrate the viability of the proposed method for functional imaging of the olfactory system in conscious dogs. This could potentially open up a new field of research in detector dog technology.	[Jia, Hao; Beyers, Ronald J.; Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, MRI Res Ctr, Auburn, AL 36849 USA; [Pustovyy, Oleg M.; Morrison, Edward; Vodyanoy, Vitaly J.] Auburn Univ, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Waggoner, Paul] Auburn Univ, Canine Detect Res Inst, Auburn, AL 36849 USA; [Schumacher, John] Auburn Univ, Dept Clin Sci, Auburn, AL 36849 USA; [Wildey, Chester] MRRA Inc, Euless, TX USA; [Barrett, Jay] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA; [Salibi, Nouha] Siemens Healthcare, MR R&D, Malvern, PA USA; [Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Siemens AG; Auburn University System; Auburn University	Deshpande, G (corresponding author), Auburn Univ, Dept Elect & Comp Engn, MRI Res Ctr, Auburn, AL 36849 USA.	gopi@auburn.edu	; Wang, Nian/HDM-2087-2022	Deshpande, Gopikrishna/0000-0001-7471-5357; Denney, Thomas/0000-0002-6695-4777; Wang, Nian/0000-0001-7743-0728	Auburn University Intramural Level-3 from the Office of the Vice President for Research, Auburn University; Defense Advanced Research Projects Agency [W911QX-13-C-0123]	Auburn University Intramural Level-3 from the Office of the Vice President for Research, Auburn University; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors acknowledge financial support for this work from Auburn University Intramural Level-3 research grant from the Office of the Vice President for Research, Auburn University. This work was also supported by The Defense Advanced Research Projects Agency (government contract/grant number W911QX-13-C-0123). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the Defense Advanced Research Projects Agency, Department of Defense or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bear MF, 2007, NEUROSCIENCE EXPLORI, P265; Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Boyett-Anderson JM, 2003, NEUROIMAGE, V20, P257, DOI 10.1016/S1053-8119(03)00288-X; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; BUTTS K, 1994, MAGNET RESON MED, V31, P67, DOI 10.1002/mrm.1910310111; Datta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052140; De Groof G, 2013, BEHAV BRAIN RES, V239, P43, DOI 10.1016/j.bbr.2012.10.044; DOTY RL, 1990, BRAIN RES, V527, P130, DOI 10.1016/0006-8993(90)91070-W; Ferris CF, 2011, REV NEUROSCIENCE, V22, P665, DOI 10.1515/RNS.2011.050; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frederick BR, 1962, J COMP PHYSIOL PSYCH, V55, P773; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Harel D, 2003, COMPUT BIOL CHEM, V27, P121, DOI 10.1016/S1476-9271(02)00092-0; Hirai T, 1996, NEUROPATH APPL NEURO, V22, P531, DOI 10.1111/j.1365-2990.1996.tb01132.x; Howell TJ, 2012, BEHAV PROCESS, V89, P8, DOI 10.1016/j.beproc.2011.09.009; Jensen P, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P1, DOI 10.1079/9781845931872.0000; Kandel, 2000, PRICIPLES NEURAL SCI; Kondoh T, 2005, CHEM SENSES, V30, pI172, DOI 10.1093/chemse/bjh169; KRESTEL D, 1984, NEUROSCI BIOBEHAV R, V8, P169, DOI 10.1016/0149-7634(84)90037-X; Kruse A, 2007, DEFENSE SCI RES TECH; Kujala MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061818; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; LOWE G, 1988, CHEM SENSES, V13, P710; Lowen SB, 2006, BEHAV RES METHODS, V38, P307, DOI 10.3758/BF03192782; MacFarlane DL, 2010, IEEE ENG MED BIO, P5673, DOI 10.1109/IEMBS.2010.5627894; Martin C, 2007, NEUROIMAGE, V36, P1288, DOI 10.1016/j.neuroimage.2007.04.029; Mori K, 2005, CHEM SENSES, V30, pI103, DOI 10.1093/chemse/bjh135; NADI NS, 1980, J NEUROCHEM, V34, P138, DOI 10.1111/j.1471-4159.1980.tb04632.x; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Orban GA, 2001, CURR OPIN NEUROL, V14, P47, DOI 10.1097/00019052-200102000-00008; OTTOSON D, 1955, Acta Physiol Scand Suppl, V35, P1; Oxley JC, 2009, ASPECTS OF EXPLOSIVES DETECTION, P27, DOI 10.1016/B978-0-12-374533-0.00003-9; PATHIRANA S, 1992, J AM CHEM SOC, V114, P1404, DOI 10.1021/ja00030a041; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Popp R, 2004, ACTA NEUROBIOL EXP, V64, P171; PRICE S, 1978, CHEM SENS FLAV, V3, P51, DOI 10.1093/chemse/3.1.51; Qin L, 2009, MAGN RESON MED, V62, P924, DOI 10.1002/mrm.22076; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ross H. E., 1996, EH WEBER TACTILE SEN, V2; Savic I, 2005, CHEM SENSES, V30, pI222, DOI 10.1093/chemse/bjh194; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Slotnick B, 2005, OLFACTOMETRY MICE; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sommer JU, 2012, J NEUROSCI METH, V209, P189, DOI 10.1016/j.jneumeth.2012.05.026; Studzinski CM, 2005, PROG NEURO-PSYCHOPH, V29, P489, DOI 10.1016/j.pnpbp.2004.12.014; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Tornqvist H, 2013, ANIM COGN, V16, P973, DOI 10.1007/s10071-013-0630-2; Tremblay M, 2005, MAGN RESON MED, V53, P141, DOI 10.1002/mrm.20319; Viswaprakash N, 2009, CHEM SENSES, V34, P547, DOI 10.1093/chemse/bjp031; Vodyanoy V, 2005, US Patent, Patent No. [6,979,298, 69792982712]; Walker DB, 2006, APPL ANIM BEHAV SCI, V97, P241, DOI 10.1016/j.applanim.2005.07.009; Wildey C, 2011, APPL OPTICS, V50, P2088, DOI 10.1364/AO.50.002088; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Williams M, 1998, P SOC PHOTO-OPT INS, V3575, P291, DOI 10.1117/12.334998; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zobel S, 2010, J NEUROL, V257, P2037, DOI 10.1007/s00415-010-5656-7	70	182	187	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86362	10.1371/journal.pone.0086362	http://dx.doi.org/10.1371/journal.pone.0086362			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24710347	gold, Green Published			2022-12-27	WOS:000330288000090
J	Chretien, JP; George, D; Shaman, J; Chitale, RA; McKenzie, FE				Chretien, Jean-Paul; George, Dylan; Shaman, Jeffrey; Chitale, Rohit A.; McKenzie, F. Ellis			Influenza Forecasting in Human Populations: A Scoping Review	PLOS ONE			English	Review							TIME-SERIES MODEL; INFECTIOUS-DISEASE; PREDICTION; EPIDEMICS; STRATEGIES; OUTBREAKS; ILLNESS; SPREAD	Forecasts of influenza activity in human populations could help guide key preparedness tasks. We conducted a scoping review to characterize these methodological approaches and identify research gaps. Adapting the PRISMA methodology for systematic reviews, we searched PubMed, CINAHL, Project Euclid, and Cochrane Database of Systematic Reviews for publications in English since January 1, 2000 using the terms '' influenza AND (forecast* OR predict*)'', excluding studies that did not validate forecasts against independent data or incorporate influenza-related surveillance data from the season or pandemic for which the forecasts were applied. We included 35 publications describing population-based (N = 27), medical facility-based (N = 4), and regional or global pandemic spread (N = 4) forecasts. They included areas of North America (N = 15), Europe (N = 14), and/or Asia-Pacific region (N = 4), or had global scope (N = 3). Forecasting models were statistical (N = 18) or epidemiological (N = 17). Five studies used data assimilation methods to update forecasts with new surveillance data. Models used virological (N = 14), syndromic (N = 13), meteorological (N = 6), internet search query (N = 4), and/or other surveillance data as inputs. Forecasting outcomes and validation metrics varied widely. Two studies compared distinct modeling approaches using common data, 2 assessed model calibration, and 1 systematically incorporated expert input. Of the 17 studies using epidemiological models, 8 included sensitivity analysis. This review suggests need for use of good practices in influenza forecasting (e. g., sensitivity analysis); direct comparisons of diverse approaches; assessment of model calibration; integration of subjective expert input; operational research in pilot, real-world applications; and improved mutual understanding among modelers and public health officials.	[Chretien, Jean-Paul; Chitale, Rohit A.] Armed Forces Hlth Surveillance Ctr, Div Integrated Biosurveillance, Silver Spring, MD USA; [George, Dylan] Dept Hlth & Human Serv, Biomed Adv Res & Dev Author, Div Analyt Decis Support, Washington, DC USA; [Shaman, Jeffrey] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA; [McKenzie, F. Ellis] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Chretien, JP (corresponding author), Armed Forces Hlth Surveillance Ctr, Div Integrated Biosurveillance, Silver Spring, MD USA.	jean.chretien.mil@mail.mil		Chretien, Jean-Paul/0000-0001-8143-6823	US NIH [GM100467]; NIH Models of Infectious Disease Agent Study program [1U54GM088558]; NIEHS Center [ES009089]; RAPIDD program of the Science and Technology Directorate, US Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558, R01GM100467] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Models of Infectious Disease Agent Study program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); RAPIDD program of the Science and Technology Directorate, US Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for JS was provided by US NIH grant GM100467 and the NIH Models of Infectious Disease Agent Study program through cooperative agreement 1U54GM088558, as well as NIEHS Center grant ES009089 and the RAPIDD program of the Science and Technology Directorate, US Department of Homeland Security, and Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2011, EPIDEMIOL INFECT, V139, P68, DOI 10.1017/S0950268810001317; Andersson E, 2008, SCAND J PUBLIC HEALT, V36, P475, DOI 10.1177/1403494808089566; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Benth JS, 2008, EPIDEMIOL INFECT, V136, P1658, DOI 10.1017/S0950268808000307; Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108; *CDCP, PRED INFL SEAS CHALL; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Dorjee S, 2013, ZOONOSES PUBLIC HLTH, V60, P383, DOI 10.1111/zph.12010; Dugas AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056176; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Held L, 2012, BIOMETRICAL J, V54, P824, DOI 10.1002/bimj.201200037; Hosseini P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012763; Hwang GM, 2012, TRAVEL MED INFECT DI, V10, P32, DOI 10.1016/j.tmaid.2011.12.003; Hyder A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065459; Jiang X, 2009, J BIOMED INFORM, V42, P90, DOI 10.1016/j.jbi.2008.05.013; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; MCLEANSLOUGHTER J, 2013, MON WEATHER REV, V141, P2107, DOI DOI 10.1175/MWR-D-12-00002.1; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mooney J D, 2002, Euro Surveill, V7, P184; Morina D, 2011, STAT MED, V30, P3125, DOI 10.1002/sim.4336; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nsoesie Elaine, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.bb1e879a23137022ea79a8c508b030bc; Nsoesie Elaine O, 2011, Stat Commun Infect Dis, V3; Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226; Nsoesie EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067164; Nsoesie EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045414; Ohkusa Y, 2011, J INFECT CHEMOTHER, V17, P468, DOI 10.1007/s10156-010-0200-3; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Palmer TN, 2004, B AM METEOROL SOC, V85, P853, DOI 10.1175/BAMS-85-6-853; Paul M, 2011, STAT MED, V30, P1118, DOI 10.1002/sim.4177; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Prieto DM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-251; Rhodes CJ, 2009, J THEOR BIOL, V258, P591, DOI 10.1016/j.jtbi.2009.02.017; Roberts MG, 2013, J MATH BIOL, V66, P1463, DOI 10.1007/s00285-012-0540-y; Saramaki J, 2005, J THEOR BIOL, V234, P413, DOI 10.1016/j.jtbi.2004.12.003; Sebastiani P, 2006, STAT MED, V25, P1803, DOI 10.1002/sim.2566; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Siegrist David, 2004, MMWR Suppl, V53, P152; Socan M, 2012, CENT EUR J PUBL HEAL, V20, P156, DOI 10.21101/cejph.a3735; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Spaeder MC, 2012, EPIDEMIOL INFECT, V140, P798, DOI 10.1017/S0950268811001749; Spaeder MC, 2011, MED DECIS MAKING, V31, P494, DOI 10.1177/0272989X10388042; Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; *WHO, INFL FACT SHEET; *WHO, INFL VIR INF HUM; WOOLHOUSE M, 2011, GUIDE GOOD PRACTICE	51	134	134	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94130	10.1371/journal.pone.0094130	http://dx.doi.org/10.1371/journal.pone.0094130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	25642378	Green Published, Green Submitted, gold			2022-12-27	WOS:000334160900090
J	Lin, YF; Nagasawa, H; Little, JB; Kato, TA; Shih, HY; Xie, XJ; Wilson, PF; Brogan, JR; Kurimasa, A; Chen, DJ; Bedford, JS; Chen, BPC				Lin, Yu-Fen; Nagasawa, Hatsumi; Little, John B.; Kato, Takamitsu A.; Shih, Hung-Ying; Xie, Xian-Jin; Wilson, Paul F., Jr.; Brogan, John R.; Kurimasa, Akihiro; Chen, David J.; Bedford, Joel S.; Chen, Benjamin P. C.			Differential Radiosensitivity Phenotypes of DNA-PKcs Mutations Affecting NHEJ and HRR Systems following Irradiation with Gamma-Rays or Very Low Fluences of Alpha Particles	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SISTER-CHROMATID EXCHANGES; RADIATION-SENSITIVE MUTANT; POTENTIALLY LETHAL DAMAGE; CELL-CYCLE PROGRESSION; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; CHROMOSOME-ABERRATIONS; CATALYTIC SUBUNIT	We have examined cell-cycle dependence of chromosomal aberration induction and cell killing after high or low dose-rate gamma irradiation in cells bearing DNA-PKcs mutations in the S2056 cluster, the T2609 cluster, or the kinase domain. We also compared sister chromatid exchanges (SCE) production by very low fluences of alpha-particles in DNA-PKcs mutant cells, and in homologous recombination repair (HRR) mutant cells including Rad51C, Rad51D, and Fancg/xrcc9. Generally, chromosomal aberrations and cell killing by gamma-rays were similarly affected by mutations in DNA-PKcs, and these mutant cells were more sensitive in G(1) than in S/G(2) phase. In G(1)-irradiated DNA-PKcs mutant cells, both chromosome- and chromatid-type breaks and exchanges were in excess than wild-type cells. For cells irradiated in late S/G(2) phase, mutant cells showed very high yields of chromatid breaks compared to wild-type cells. Few exchanges were seen in DNA-PKcs-null, Ku80-null, or DNA-PKcs kinase dead mutants, but exchanges in excess were detected in the S2506 or T2609 cluster mutants. SCE induction by very low doses of alpha-particles is resulted from bystander effects in cells not traversed by alpha-particles. SCE seen in wild-type cells was completely abolished in Rad51C- or Rad51D-deficient cells, but near normal in Fancg/xrcc9 cells. In marked contrast, very high levels of SCEs were observed in DNA-PKcs-null, DNA-PKcs kinase-dead and Ku80-null mutants. SCE induction was also abolished in T2609 cluster mutant cells, but was only slightly reduced in the S2056 cluster mutant cells. Since both non-homologous end-joining (NHEJ) and HRR systems utilize initial DNA lesions as a substrate, these results suggest the possibility of a competitive interference phenomenon operating between NHEJ and at least the Rad51C/D components of HRR; the level of interaction between damaged DNA and a particular DNA-PK component may determine the level of interaction of such DNA with a relevant HRR component.	[Lin, Yu-Fen; Shih, Hung-Ying; Chen, David J.; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Nagasawa, Hatsumi; Kato, Takamitsu A.; Brogan, John R.; Bedford, Joel S.] Colorado State Univ, Dept & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Little, John B.] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Boston, MA USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wilson, Paul F., Jr.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA; [Kurimasa, Akihiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Tottori 680, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Colorado State University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Brookhaven National Laboratory	Chen, BPC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	benjamin.chen@utsouthwestern.edu	Kato, Takamitsu A/D-7969-2015; Lin, Yu-Fen/A-2570-2016	Kato, Takamitsu/0000-0002-6263-600X	National Cancer Institute/National Institutes of Health [CA166677]; U.S. Department of Energy Low Dose Radiation Research Program [DE-FG02-07ER64350, DE-FG02-05ER64089]; Cancer Prevention Research Institute of Texas [RP110465-P1]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA166677] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy Low Dose Radiation Research Program(United States Department of Energy (DOE)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA166677 from the National Cancer Institute/National Institutes of Health, DE-FG02-07ER64350 and DE-FG02-05ER64089 from the U.S. Department of Energy Low Dose Radiation Research Program, and RP110465-P1 from the Cancer Prevention Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLETT CF, 1980, CANCER RES, V40, P926; Bedford JS, 2002, RADIAT RES, V158, P251, DOI 10.1667/0033-7587(2002)158[0251:HACHIR]2.0.CO;2; BEDFORD JS, 1978, RADIAT RES, V76, P573, DOI 10.2307/3574806; CARRANO AV, 1973, MUTAT RES, V17, P341, DOI 10.1016/0027-5107(73)90006-7; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; CORNFORTH MN, 1987, RADIAT RES, V111, P385, DOI 10.2307/3576926; COX R, 1978, ARCH DIS CHILD, V53, P386, DOI 10.1136/adc.53.5.386; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; DEWEY WC, 1971, P NATL ACAD SCI USA, V68, P667, DOI 10.1073/pnas.68.3.667; DEWEY WC, 1962, RADIAT RES, V16, P503, DOI 10.2307/3571085; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; DRITSCHILO A, 1984, RADIAT RES, V100, P387, DOI 10.2307/3576359; FORNACE AJ, 1980, MUTAT RES, V70, P323, DOI 10.1016/0027-5107(80)90022-6; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; Hashimoto M, 2001, J BIOL CHEM, V276, P12827, DOI 10.1074/jbc.M010906200; HIGURASHI M, 1973, CANCER-AM CANCER SOC, V32, P380, DOI 10.1002/1097-0142(197308)32:2<380::AID-CNCR2820320214>3.0.CO;2-2; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Hsu FM, 2012, TRANSL CANCER RES, V1, P22, DOI 10.3978/j.issn.2218-676X.2012.04.01; HSU TC, 1958, J NATL CANCER I, V21, P437; ILIAKIS GE, 1991, INT J RADIAT BIOL, V59, P321, DOI 10.1080/09553009114550311; JEGGO PA, 1982, BIOCHIMIE, V64, P713, DOI 10.1016/S0300-9084(82)80116-8; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leenhouts HP, 1978, ADV RADIAT BIOL, P55; Lin JYD, 1997, RADIAT RES, V147, P166, DOI 10.2307/3579417; LITTLE JB, 1985, RADIAT RES, V101, P81, DOI 10.2307/3576305; METTING NF, 1995, HEALTH PHYS, V68, P710, DOI 10.1097/00004032-199505000-00012; NAGASAWA H, 1985, MUTAT RES, V148, P71, DOI 10.1016/0027-5107(85)90209-X; Nagasawa H, 2005, RADIAT RES, V164, P141, DOI 10.1667/RR3420; NAGASAWA H, 1981, RADIAT RES, V87, P538, DOI 10.2307/3575519; NAGASAWA H, 1989, RADIAT RES, V118, P559, DOI 10.2307/3577413; NAGASAWA H, 1983, MUTAT RES, V107, P315, DOI 10.1016/0027-5107(83)90173-2; NAGASAWA H, 1994, INT J RADIAT BIOL, V66, P373, DOI 10.1080/09553009414551311; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAGASAWA H, 1992, RADIAT RES, V132, P375, DOI 10.2307/3578247; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Nagasawa H, 2008, DNA REPAIR, V7, P515, DOI 10.1016/j.dnarep.2007.11.014; Nagasawa H, 2011, RADIAT RES, V175, P83, DOI 10.1667/RR2092.1; Nagasawa H, 2010, MUTAT RES-GEN TOX EN, V701, P12, DOI 10.1016/j.mrgentox.2010.03.003; NATARAJAN AT, 1979, HUM GENET, V52, P127; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PARSHAD R, 1983, P NATL ACAD SCI-BIOL, V80, P5612, DOI 10.1073/pnas.80.18.5612; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Perryman LE, 2004, VET PATHOL, V41, P95, DOI 10.1354/vp.41-2-95; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Revell SH., 1983, RAD INDUCED CHROMOSO, P215; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Scott D, 1993, ATAXIA TELANGIECTASI, P101; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; STACKHOUSE MA, 1993, RADIAT RES, V136, P241, DOI 10.2307/3578617; STACKHOUSE MA, 1994, INT J RADIAT BIOL, V65, P571, DOI 10.1080/09553009414550661; STACKHOUSE MA, 1993, RADIAT RES, V136, P250, DOI 10.2307/3578618; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; TAYLOR AMR, 1976, NATURE, V260, P441, DOI 10.1038/260441a0; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; THOMPSON LH, 1980, MUTAT RES, V74, P21, DOI 10.1016/0165-1161(80)90188-0; TOBEY RA, 1971, CANCER RES, V31, P46; Wang XS, 2008, CANCER RES, V68, P971, DOI 10.1158/0008-5472.CAN-07-6272; WEICHSELBAUM RR, 1978, NATURE, V271, P261, DOI 10.1038/271261a0; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; ZDZIENICKA MZ, 1987, MUTAT RES, V178, P235, DOI 10.1016/0027-5107(87)90274-0; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	74	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93579	10.1371/journal.pone.0093579	http://dx.doi.org/10.1371/journal.pone.0093579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714417	Green Published, gold, Green Submitted			2022-12-27	WOS:000334160900037
J	Garcia-Herranz, M; Moro, E; Cebrian, M; Christakis, NA; Fowler, JH				Garcia-Herranz, Manuel; Moro, Esteban; Cebrian, Manuel; Christakis, Nicholas A.; Fowler, James H.			Using Friends as Sensors to Detect Global-Scale Contagious Outbreaks	PLOS ONE			English	Article								Recent research has focused on the monitoring of global-scale online data for improved detection of epidemics, mood patterns, movements in the stock market political revolutions, box-office revenues, consumer behaviour and many other important phenomena. However, privacy considerations and the sheer scale of data available online are quickly making global monitoring infeasible, and existing methods do not take full advantage of local network structure to identify key nodes for monitoring. Here, we develop a model of the contagious spread of information in a global-scale, publicly-articulated social network and show that a simple method can yield not just early detection, but advance warning of contagious outbreaks. In this method, we randomly choose a small fraction of nodes in the network and then we randomly choose a friend of each node to include in a group for local monitoring. Using six months of data from most of the full Twittersphere, we show that this friend group is more central in the network and it helps us to detect viral outbreaks of the use of novel hashtags about 7 days earlier than we could with an equal-sized randomly chosen group. Moreover, the method actually works better than expected due to network structure alone because highly central actors are both more active and exhibit increased diversity in the information they transmit to others. These results suggest that local monitoring is not just more efficient, but also more effective, and it may be applied to monitor contagious processes in global-scale networks.	[Garcia-Herranz, Manuel] Univ Autonoma Madrid, Escuela Politecn Super, Dept Comp Sci, Madrid, Spain; [Moro, Esteban] Univ Carlos III Madrid, Dept Math, Leganes, Spain; [Moro, Esteban] Univ Carlos III Madrid, GISC, Leganes, Spain; [Moro, Esteban] Univ Autonoma Madrid, Inst Ingn Conocimiento, Madrid, Spain; [Cebrian, Manuel] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Cebrian, Manuel] MIT, Media Lab, Cambridge, MA 02139 USA; [Cebrian, Manuel] Natl Informat & Commun Technol Australia, Melbourne, Vic, Australia; [Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Christakis, Nicholas A.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Fowler, James H.] Univ Calif San Diego, Sch Med, Div Med Genet, San Diego, CA 92103 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Autonomous University of Madrid; Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; Autonomous University of Madrid; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Yale University; Yale University; Yale University; University of California System; University of California San Diego; University of California System; University of California San Diego	Garcia-Herranz, M (corresponding author), Univ Autonoma Madrid, Escuela Politecn Super, Dept Comp Sci, Madrid, Spain.	manuel.garciaherranz@uam.es	Fowler, James H/C-2750-2008; Moro, Esteban/AAB-1159-2019; Lipke, Peter N./AAW-4914-2020; Garcia-Herranz, Manuel/ABB-2617-2021; Garcia-Herranz, Manuel/L-3213-2013	Fowler, James H/0000-0001-7795-1638; Moro, Esteban/0000-0003-2894-1024; Lipke, Peter N./0000-0003-1733-0690; Garcia-Sherman, Melissa/0000-0003-1409-4397; Garcia-Herranz, Manuel/0000-0002-4252-4975	National Institute for General Medical Sciences [P-41 GM103504-03]; Pioneer Portfolio of the Robert Wood Johnson Foundation; NICTA; Australian Government; Army Research Office [W911NF-11-1-0363]; Ministerio de Educacion y Ciencia (Spain) [FIS2006-01485, FIS2010-22047-C05-04]; Spanish Government [TIN2010-17344]; R&D program of the Community of Madrid [S2009/TIC-1650]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pioneer Portfolio of the Robert Wood Johnson Foundation; NICTA(NICTA); Australian Government(Australian GovernmentCGIAR); Army Research Office; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Spanish Government(Spanish GovernmentEuropean Commission); R&D program of the Community of Madrid; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute for General Medical Sciences (P-41 GM103504-03) (JHF) and a grant from the Pioneer Portfolio of the Robert Wood Johnson Foundation (NAC and JHF). MC acknowledges support from NICTA and the Australian Government, as represented by the Department of Broadband, Communications and the Digital Economy and the Australian Research Council through the ICT Centre of Excellence program; the DARPA/Lockheed Martin Guard Dog Program; and the Army Research Office under Grant W911NF-11-1-0363. EM acknowledges funding from Ministerio de Educacion y Ciencia (Spain) through projects i-Math, FIS2006-01485 (MOSAICO), and FIS2010-22047-C05-04. MGH acknowledges support from the Spanish Government (TIN2010-17344) and the R&D program of the Community of Madrid (S2009/TIC-1650). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrekar H., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P702, DOI 10.1109/INFCOMW.2011.5928903; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Backstrom L., 2007, P 16 INT C WORLD WID, P181, DOI DOI 10.1145/1242572.1242598; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Borgs Christian, 2012, WINE, P406, DOI DOI 10.1007/978-3-642-35311-6; Boyd D., 2011, DECADE INTERNET TIME; Brautbar Michael, 2010, INNOVATIONS THEORETI, P188; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Dodds PS, 2010, J HAPPINESS STUD, V11, P441, DOI 10.1007/s10902-009-9150-9; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Gross R., 2005, P WPES 2005, P71, DOI DOI 10.1145/1102199.1102214; Huang J., 2010, P 21 ACM C HYP HYP, P173, DOI [10.1145/1810617.1810647, DOI 10.1145/1810617.1810647]; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Lotan G., 2011, INT J COMMUNICATION, V5, P31; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Romero D. M., 2011, P 20 INT C WORLD WID, P695, DOI [10.1145/1963405.1963503, DOI 10.1145/1963405.1963503]; Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Shih HP, 2004, INFORM MANAGE-AMSTER, V41, P351, DOI 10.1016/S0378-7206(03)00079-X; Yang J., 2011, P 4 ACM INT C WEB SE, P177	31	58	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92413	10.1371/journal.pone.0092413	http://dx.doi.org/10.1371/journal.pone.0092413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718030	Green Submitted, Green Published, gold			2022-12-27	WOS:000334339000015
J	Chen, ZF; Zhang, HM; Wang, H; Matsumura, K; Wong, YH; Ravasi, T; Qian, PY				Chen, Zhang-Fan; Zhang, Huoming; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Ravasi, Timothy; Qian, Pei-Yuan			Quantitative Proteomics Study of Larval Settlement in the Barnacle Balanus amphitrite	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; STATISTICAL-MODEL; ARGININE KINASE; GENE-EXPRESSION; CYPRIS LARVAE; CYCLIC-AMP; METAMORPHOSIS; PROTEIN; MUSCLE; INVOLVEMENT	Barnacles are major sessile components of the intertidal areas worldwide, and also one of the most dominant fouling organisms in fouling communities. Larval settlement has a crucial ecological effect not only on the distribution of the barnacle population but also intertidal community structures. However, the molecular mechanisms involved in the transition process from the larval to the juvenile stage remain largely unclear. In this study, we carried out comparative proteomic profiles of stage II nauplii, stage VI nauplii, cyprids, and juveniles of the barnacle Balanus amphitrite using labelfree quantitative proteomics, followed by the measurement of the gene expression levels of candidate proteins. More than 700 proteins were identified at each stage; 80 were significantly up-regulated in cyprids and 95 in juveniles vs other stages. Specifically, proteins involved in energy and metabolism, the nervous system and signal transduction were significantly up-regulated in cyprids, whereas proteins involved in cytoskeletal remodeling, transcription and translation, cell proliferation and differentiation, and biomineralization were up-regulated in juveniles, consistent with changes associated with larval metamorphosis and tissue remodeling in juveniles. These findings provided molecular evidence for the morphological, physiological and biological changes that occur during the transition process from the larval to the juvenile stages in B. amphitrite.	[Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China; [Zhang, Huoming] King Abdullah Univ Sci & Technol, Biosci Core Lab, Thuwal, Saudi Arabia; [Ravasi, Timothy] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal, Saudi Arabia	Hong Kong University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Ravasi, Timothy/B-8777-2008	Zhang, Huoming/0000-0001-5416-0358; Qian, Pei-Yuan/0000-0003-4074-9078; Ravasi, Timothy/0000-0002-9950-465X	Research Grants Council of the Hong Kong Special Administrative Region [GRF662413, AoE/P-04/04-II]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (GRF662413 and AoE/P-04/04-II) and an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016) to P.-Y. Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil AC, 2010, J EXP MAR BIOL ECOL, V392, P89, DOI 10.1016/j.jembe.2010.04.012; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; BAXTER GT, 1992, BIOL BULL, V183, P147, DOI 10.2307/1542416; Berg J.M., 2002, BIOCHEMISTRY-US, V5th ed.; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2001, J EXP ZOOL, V289, P374, DOI 10.1002/jez.1019; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Chamberlin ME, 1997, J EXP BIOL, V200, P2789; Chandramouli KH, 2013, J PROTEOME RES, V12, P1344, DOI 10.1021/pr3010088; Chandramouli KH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-51; Chen WT, 2008, DEV NEUROBIOL, V68, P1029, DOI 10.1002/dneu.20644; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; CHOU TC, 1952, J BIOL CHEM, V196, P89; Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276; CLARE AS, 1995, J EXP BIOL, V198, P655; COSTLOW JOHN D., 1959, PHYSIOL ZOOL, V32, P177; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faimali M, 2003, BIOFOULING, V19, P213, DOI 10.1080/0892701021000044228; Footitt S, 2007, J EXP BOT, V58, P2959, DOI 10.1093/jxb/erm146; Gallus L, 2010, BIOFOULING, V26, P155, DOI 10.1080/08927010903391193; GIRAUD MM, 1981, COMP BIOCHEM PHYS A, V69, P381, DOI 10.1016/0300-9629(81)92993-5; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; Gunter HM, 2007, DEV GENES EVOL, V217, P603, DOI 10.1007/s00427-007-0171-2; Han Z, 2013, J PROTEOME RES, V12, P2090, DOI 10.1021/pr301083e; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; He LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064130; Heikkila JJ, 1997, CELL MOL LIFE SCI, V53, P114, DOI 10.1007/PL00000573; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kaneko Y, 2006, ZOOL SCI, V23, P533, DOI 10.2108/zsj.23.533; Katti C, 2010, J EXP BIOL, V213, P2589, DOI 10.1242/jeb.043869; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knight J, 2000, J MAR BIOL ASSOC UK, V80, P113; KOULISH S, 1973, J MORPHOL, V140, P1, DOI 10.1002/jmor.1051400102; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Lagersson NC, 2002, J MAR BIOL ASSOC UK, V82, P573, DOI 10.1017/S0025315402005891; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Levine MZ, 2001, J NEUROBIOL, V49, P277, DOI 10.1002/neu.10010; Li HL, 2010, J EXP MAR BIOL ECOL, V389, P45, DOI 10.1016/j.jembe.2010.03.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; LUCAS MI, 1979, MAR BIOL, V55, P221, DOI 10.1007/BF00396822; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; Maruzzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037408; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Meng W, 2008, ANAL CHEM, V80, P9797, DOI 10.1021/ac801344z; Miller M.A., 2010, P GAT COMP ENV WORKS; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; Pechenik JA, 2007, BIOL BULL-US, V213, P160, DOI 10.2307/25066632; Qian PY, 1999, HYDROBIOLOGIA, V402, P239, DOI 10.1023/A:1003704928668; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHLAEPFER DD, 1990, J CELL BIOL, V111, P229, DOI 10.1083/jcb.111.1.229; SCHNEIDER A, 1989, INSECT BIOCHEM, V19, P471, DOI 10.1016/0020-1790(89)90029-2; Shimizu K, 1996, J EXP ZOOL, V276, P87, DOI 10.1002/(SICI)1097-010X(19961001)276:2<87::AID-JEZ1>3.0.CO;2-9; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang H, 2013, RES VET SCI, V95, P1125, DOI 10.1016/j.rvsc.2013.07.022; WOOLLACOTT RM, 1971, J MORPHOL, V134, P351, DOI 10.1002/jmor.1051340307; WROBLEWSKA B, 1993, J NEUROCHEM, V61, P943, DOI 10.1111/j.1471-4159.1993.tb03606.x; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yamamoto H, 1996, J EXP ZOOL, V275, P339, DOI 10.1002/(SICI)1097-010X(19960801)275:5<339::AID-JEZ2>3.0.CO;2-Q; Yamamoto H, 1997, ZOOL SCI, V14, P887, DOI 10.2108/zsj.14.887; Zhang HM, 2007, PROTEOMICS, V7, P1654, DOI 10.1002/pmic.200600579; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v; Zhang HM, 2010, PROTEOMICS, V10, P2780, DOI 10.1002/pmic.201000066; Zhang YF, 2012, ACS CHEM BIOL, V7, P1049, DOI 10.1021/cb200545s; Zhang YF, 2011, BIOFOULING, V27, P467, DOI 10.1080/08927014.2011.583985; Zhang Y, 2010, J PROTEOME RES, V9, P4851, DOI 10.1021/pr100645z; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x	83	55	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88744	10.1371/journal.pone.0088744	http://dx.doi.org/10.1371/journal.pone.0088744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24714416	gold, Green Published, Green Submitted			2022-12-27	WOS:000331266000059
J	Jiang, YH; Liu, HT; Kuo, HC				Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng			Decrease of Urinary Nerve Growth Factor but Not Brain-Derived Neurotrophic Factor in Patients with Interstitial Cystitis/Bladder Pain Syndrome Treated with Hyaluronic Acid	PLOS ONE			English	Article							DYSFUNCTION; THERAPY	Aims: To investigate urinary nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in interstitial cystitis/bladder pain syndrome (IC/BPS) patients after hyaluronic acid (HA) therapy. Methods: Thirty-three patients with IC/BPS were prospectively studied; a group of 45 age-matched healthy subjects served as controls. All IC/BPS patients received nine intravesical HA instillations during the 6-month treatment regimen. Urine samples were collected for measuring urinary NGF and BDNF levels at baseline and 2 weeks after the last HA treatment. The clinical parameters including visual analog scale (VAS) of pain, daily frequency nocturia episodes, functional bladder capacity (FBC) and global response assessment (GRA) were recorded. Urinary NGF and BDNF levels were compared between IC/BPS patients and controls at baseline and after HA treatment. Results: Urinary NGF, NGF/Cr, BDNF, and BDNF/Cr levels were significantly higher in IC/BPS patients compared to controls. Both NGF and NGF/Cr levels significantly decreased after HA treatment. Urinary NGF and NGF/Cr levels significantly decreased in the responders with a VAS pain reduction by 2 (both p < 0.05) and the GRA improved by 2 (both p < 0.05), but not in non-responders. Urinary BDNF and BDNF/Cr did not decrease in responders or non-responders after HA therapy. Conclusions: Urinary NGF, but not BDNF, levels decreased significantly after HA therapy; both of these factors remained higher than in controls even after HA treatment. HA had a beneficial effect on IC/BPS, but it was limited. The reduction of urinary NGF levels was significant in responders, with a reduction of pain and improved GRA.	[Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw		Chen, Peisong/0000-0003-0640-3663; Liao, Chun-Hou/0000-0002-7340-110X				Antunes-Lopes T, 2013, J UROLOGY, V189, P359, DOI 10.1016/j.juro.2012.08.187; Chung SD, 2012, PAIN PHYSICIAN, V15, P197; Daha LK, 2005, EUR UROL, V47, P393, DOI 10.1016/j.eururo.2004.10.022; Daha LK, 2008, SCAND J UROL NEPHROL, V42, P369, DOI 10.1080/00365590701871518; Engelhardt PF, 2011, INT UROGYNECOL J, V22, P401, DOI 10.1007/s00192-010-1294-y; Frias B, 2011, CURR NEUROPHARMACOL, V9, P553, DOI 10.2174/157015911798376253; Ho DR, 2011, INT J UROL, V18, P525, DOI 10.1111/j.1442-2042.2011.02779.x; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Hurst RE, 1996, UROLOGY, V48, P817, DOI 10.1016/S0090-4295(96)00322-6; HURST RE, 1987, J UROLOGY, V138, P433, DOI 10.1016/S0022-5347(17)43180-6; Iavazzo C, 2007, EUR UROL, V51, P1534, DOI 10.1016/j.eururo.2007.03.020; Kallestrup EB, 2005, SCAND J UROL NEPHROL, V39, P143, DOI 10.1080/00365590410015876-1; Kuo HannChorng, 2012, Clinical Investigation, V2, P1085; Lai MC, 2013, INT J UROL, V20, P203, DOI 10.1111/j.1442-2042.2012.03135.x; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044687; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Lokeshwar VB, 2006, J UROLOGY, V176, P1001, DOI 10.1016/j.juro.2006.04.012; Morales A, 1996, J UROLOGY, V156, P45, DOI 10.1016/S0022-5347(01)65933-0; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Nickel JC, 2004, MED CLIN N AM, V88, P467, DOI 10.1016/S0025-7125(03)00151-2; Ochodnicky P, 2012, NAT REV UROL, V9, P628, DOI 10.1038/nrurol.2012.178; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; PARSONS CL, 1991, J UROLOGY, V145, P732, DOI 10.1016/S0022-5347(17)38437-9; Pezet S, 2002, BRAIN RES REV, V40, P240, DOI 10.1016/S0165-0173(02)00206-0; Pinto R, 2010, NEUROSCIENCE, V166, P907, DOI 10.1016/j.neuroscience.2010.01.015; Pinto R, 2010, EUR UROL, V58, P360, DOI 10.1016/j.eururo.2010.02.031; Porru D, 1997, UROL INT, V59, P26, DOI 10.1159/000283012; Riedl CR, 2008, INT UROGYNECOL J, V19, P717, DOI 10.1007/s00192-007-0515-5; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254	33	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91609	10.1371/journal.pone.0091609	http://dx.doi.org/10.1371/journal.pone.0091609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614892	Green Submitted, Green Published, gold			2022-12-27	WOS:000332839300143
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300008
